data_2klt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2klt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.911 0 N-CA-C 110.973 -0.851 . . . . 74.420000000000002 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.27 114.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.18 -0.674 . . . . 75.439999999999998 109.18 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.19 136.58 52.8 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.084 0.24 . . . . 73.319999999999993 110.445 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.1 t -148.64 160.23 43.34 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.993 -0.373 . . . . 74.129999999999995 109.993 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.71 158.57 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 122.164 0.186 . . . . 72.349999999999994 110.583 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 45.6 mt-10 -58.48 -49.97 75.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.179 0.514 . . . . 75.200000000000003 110.716 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . 0.544 ' OE2' ' HD2' ' A' ' 510' ' ' PRO . 7.7 tp10 -141.96 137.76 16.3 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.523 -2.029 . . . . 64.329999999999998 105.523 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 41.4 Cg_endo -70.79 -10.65 28.17 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.491 2.127 . . . . 72.0 114.656 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 642' ' ' GLU . 72.7 t -140.73 126.93 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 122.028 -0.42 . . . . 74.329999999999998 110.161 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 643' ' ' VAL . 14.0 t -133.96 130.57 37.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.484 0.659 . . . . 62.329999999999998 109.615 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -110.07 121.61 45.67 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.646 -0.501 . . . . 72.540000000000006 109.646 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.81 160.91 36.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.128 -0.487 . . . . 72.400000000000006 111.709 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.454 ' O ' HG21 ' A' ' 518' ' ' ILE . 20.2 m -71.88 156.47 39.24 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 74.099999999999994 110.832 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -30.73 58.3 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.811 -1.181 . . . . 73.319999999999993 107.811 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.1 p -90.83 16.71 8.83 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.435 -1.257 . . . . 75.329999999999998 111.777 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.454 HG21 ' O ' ' A' ' 515' ' ' SER . 7.5 tt -78.73 -30.09 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 120.281 -0.568 . . . . 75.140000000000001 110.607 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.39 -68.09 3.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.108 -1.044 . . . . 73.120000000000005 112.444 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.2 mm -130.79 132.12 64.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.638 -1.245 . . . . 74.200000000000003 107.638 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -107.15 154.51 21.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.167 -1.049 . . . . 74.420000000000002 108.167 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.55 124.25 40.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.923 0.392 . . . . 71.030000000000001 111.595 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 8.6 p -124.86 133.15 70.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.019 -0.734 . . . . 72.099999999999994 109.019 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 98.7 mttt -93.27 138.68 31.42 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.407 -0.59 . . . . 75.400000000000006 109.407 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 85.3 t -96.03 121.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.926 -1.509 . . . . 75.019999999999996 106.926 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.16 155.59 16.99 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.235 -0.893 . . . . 73.349999999999994 110.314 -174.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.437 ' N ' ' HD3' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -124.86 104.61 8.7 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.327 -0.99 . . . . 74.019999999999996 108.327 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.8 m -64.93 -56.11 15.23 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.28 -0.873 . . . . 73.540000000000006 111.153 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.6 p -73.79 -48.21 33.23 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.593 0.711 . . . . 73.239999999999995 110.005 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.41 -159.91 26.8 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 111.171 -0.771 . . . . 71.519999999999996 111.171 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 565' ' ' ASP . . . -148.51 144.95 27.68 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.999 -1.482 . . . . 54.530000000000001 106.999 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -161.12 77.61 0.57 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.759 -0.83 . . . . 75.439999999999998 108.759 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 157.87 -127.67 1.95 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.018 -1.087 . . . . 75.120000000000005 111.311 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -137.22 102.57 4.86 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.395 -1.706 . . . . 65.200000000000003 106.395 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 120.0 62.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.335 0.588 . . . . 72.140000000000001 110.347 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.88 115.88 34.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 N-CA-C 108.457 -0.942 . . . . 63.420000000000002 108.457 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.77 101.51 51.46 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.607 -0.724 . . . . 63.5 109.835 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 2.7 Cg_endo -76.66 155.79 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.088 1.858 . . . . 65.450000000000003 112.275 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -142.15 160.66 39.79 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.435 -0.95 . . . . 74.530000000000001 108.435 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -151.43 136.43 17.37 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.875 0.369 . . . . 74.049999999999997 110.977 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.3 p -85.0 126.89 33.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.853 -0.612 . . . . 64.430000000000007 111.271 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.65 121.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.267 -1.012 . . . . 74.319999999999993 108.267 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -79.16 104.88 10.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.843 -0.799 . . . . 73.439999999999998 108.843 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -86.24 -94.3 0.84 Allowed Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.386 -1.086 . . . . 63.210000000000001 110.386 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.8 p -102.8 -12.27 17.72 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.172 0.511 . . . . 72.109999999999999 110.538 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.43 152.89 21.24 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.391 -0.966 . . . . 65.549999999999997 108.391 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -107.61 131.4 54.41 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.157 -0.617 . . . . 74.219999999999999 109.856 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.19 -154.76 20.35 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.271 -1.132 . . . . 50.340000000000003 110.271 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.92 79.81 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.513 -0.851 . . . . 72.099999999999994 112.094 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 576' ' ' PHE . . . 92.29 11.38 59.82 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.779 -0.724 . . . . 74.230000000000004 113.104 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -76.25 -77.95 0.13 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 117.45 0.625 . . . . 75.319999999999993 110.802 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -93.84 -42.72 8.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.882 -1.155 . . . . 52.32 107.882 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -135.36 163.05 30.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 108.966 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.435 ' HB2' ' CE1' ' A' ' 576' ' ' PHE . 28.2 tt0 -97.62 116.62 30.19 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.294 -1.743 . . . . 74.439999999999998 106.294 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.17 142.15 54.38 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.364 -0.606 . . . . 74.420000000000002 109.364 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -140.12 132.44 28.33 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.684 0.755 . . . . 74.540000000000006 110.229 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.4 p -140.65 122.14 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.714 -1.217 . . . . 54.340000000000003 107.714 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.68 -176.97 36.13 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 109.743 -1.343 . . . . 74.340000000000003 109.743 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 0.3 OUTLIER -126.31 128.68 47.5 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.628 0.728 . . . . 70.329999999999998 111.961 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 79.7 mt -89.53 144.34 26.11 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.094 -1.412 . . . . 74.219999999999999 110.061 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -105.59 101.87 11.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.395 0.617 . . . . 73.420000000000002 111.506 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 42.7 m-85 -100.21 100.41 11.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.791 -0.818 . . . . 70.219999999999999 108.791 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.402 ' H ' HD11 ' A' ' 567' ' ' ILE . 81.4 mt-30 -83.1 -77.9 0.23 Allowed 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.792 -0.763 . . . . 73.340000000000003 110.239 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -105.43 159.25 16.07 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.843 -0.617 . . . . 74.150000000000006 109.369 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 531' ' ' ALA . 13.2 t70 -57.99 -23.21 53.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.415 1.086 . . . . 73.129999999999995 111.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.08 -43.49 78.08 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.724 1.209 . . . . 73.340000000000003 112.0 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.402 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -96.39 158.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.255 0.55 . . . . 73.019999999999996 110.705 -173.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.68 154.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.879 -1.156 . . . . 75.150000000000006 107.879 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.5 mmpt? -115.49 154.71 28.83 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.861 0.362 . . . . 71.329999999999998 111.167 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 53.0 mt -128.54 136.62 59.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.581 -1.191 . . . . 71.209999999999994 109.529 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.513 ' HB ' HG12 ' A' ' 523' ' ' VAL . 56.3 mt -97.78 125.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.563 -1.643 . . . . 74.030000000000001 106.563 174.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 21.7 p -110.41 112.38 24.27 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.672 -0.862 . . . . 73.430000000000007 108.672 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.439 HD11 HD22 ' A' ' 589' ' ' LEU . 42.5 mt -108.27 134.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.819 -0.808 . . . . 73.519999999999996 108.819 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.18 117.13 22.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 109.566 -0.531 . . . . 71.420000000000002 109.566 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.42 123.69 57.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.59 -2.004 . . . . 73.349999999999994 105.59 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . 0.456 ' CE1' ' HA2' ' A' ' 550' ' ' GLY . 90.4 m-85 . . . . . 0 C--N 1.298 -1.646 0 C-N-CA 120.55 -0.46 . . . . 73.400000000000006 111.297 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.433 -1.299 0 CA-C-O 122.47 1.129 . . . . 72.120000000000005 113.352 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.7 m -143.65 153.09 42.14 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.368 -1.345 . . . . 62.43 107.368 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -133.49 153.11 51.9 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.406 -0.961 . . . . 75.319999999999993 108.406 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.8 m -111.25 154.51 24.35 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.687 -0.857 . . . . 71.439999999999998 108.687 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.439 HD22 HD11 ' A' ' 573' ' ' ILE . 39.7 tp -129.07 130.46 46.56 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.068 -1.456 . . . . 73.349999999999994 107.068 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.43 158.7 38.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 123.218 0.324 . . . . 74.340000000000003 110.313 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.05 145.52 26.45 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.128 -0.942 . . . . 74.150000000000006 108.49 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -101.59 165.99 10.94 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.324 -0.621 . . . . 74.219999999999999 109.324 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.32 114.55 7.4 Favored Pre-proline 0 C--O 1.245 0.851 0 O-C-N 124.233 0.958 . . . . 75.109999999999999 111.303 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.62 150.56 27.92 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.132 2.554 . . . . 74.439999999999998 111.443 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.93 140.27 51.15 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.415 -0.178 . . . . 64.010000000000005 111.471 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -103.03 118.05 35.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.675 -0.491 . . . . 74.129999999999995 109.675 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--N 1.294 -1.846 0 C-N-CA 123.407 0.683 . . . . 75.340000000000003 110.432 -179.133 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 N--CA 1.434 -1.238 0 N-CA-C 109.698 -0.482 . . . . 73.409999999999997 109.698 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.48 177.98 4.71 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.229 -1.026 . . . . 74.219999999999999 108.229 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.5 170.65 42.11 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.46 -0.656 . . . . 73.299999999999997 111.46 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -49.75 -61.61 2.03 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.249 1.02 . . . . 74.420000000000002 112.043 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -129.33 102.17 6.31 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.787 -1.56 . . . . 74.340000000000003 106.787 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 3.6 t -129.51 111.85 13.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 122.337 1.065 . . . . 64.420000000000002 110.865 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 37.0 ttmt -147.19 151.74 37.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.876 -1.898 . . . . 75.140000000000001 105.876 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 51.8 tp -123.38 103.45 8.5 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.977 -0.749 . . . . 73.549999999999997 108.977 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.493 ' HB2' HG21 ' A' ' 511' ' ' VAL . 44.2 mt-10 -87.45 106.53 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.551 -0.907 . . . . 73.430000000000007 108.551 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 512' ' ' THR . 32.0 t -96.9 121.69 47.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 114.91 -1.041 . . . . 72.099999999999994 108.197 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 27.9 mt -115.55 133.49 61.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.108 -0.951 . . . . 73.310000000000002 110.896 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.249 0 C-N-CA 125.062 1.345 . . . . 71.140000000000001 108.402 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.829 0 N-CA-C 112.067 -0.413 . . . . 54.299999999999997 112.067 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 67.3 mt -127.02 116.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.805 -1.183 . . . . 75.209999999999994 107.805 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -108.16 137.66 45.76 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.618 0.574 . . . . 75.219999999999999 111.67 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.2 t -148.91 157.37 43.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.83 -0.623 . . . . 64.420000000000002 109.371 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.46 ' CE2' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.37 155.68 36.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.086 -0.339 . . . . 75.239999999999995 110.086 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -59.39 -48.18 82.63 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 123.615 0.572 . . . . 73.530000000000001 110.47 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.42 151.09 77.31 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.42 -0.956 . . . . 55.530000000000001 108.42 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 2.4 Cg_endo -78.35 -20.63 10.96 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.631 1.554 . . . . 62.140000000000001 110.496 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 65.8 t -139.98 127.3 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.711 -0.848 . . . . 74.430000000000007 108.711 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -129.42 133.57 47.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.269 -0.641 . . . . 72.140000000000001 109.269 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -107.09 121.41 44.43 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.642 -0.873 . . . . 73.439999999999998 108.642 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.54 148.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.406 0.622 . . . . 72.140000000000001 111.022 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 50.7 m -65.12 141.27 58.76 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.542 -1.208 . . . . 75.219999999999999 110.262 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.55 -24.26 62.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 109.832 177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.39 17.99 17.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.066 -0.515 . . . . 74.140000000000001 110.828 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.1 -23.27 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.247 0.546 . . . . 73.430000000000007 111.036 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.43 -73.32 2.24 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.448 -0.882 . . . . 72.549999999999997 110.935 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.72 126.79 69.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.899 -1.148 . . . . 74.430000000000007 107.899 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.404 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.5 ppp? -98.15 148.7 23.3 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.865 -1.161 . . . . 73.420000000000002 107.865 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.3 119.16 28.5 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.414 0.446 . . . . 71.239999999999995 111.692 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.43 126.72 68.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.107 -0.701 . . . . 74.409999999999997 109.107 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -91.96 147.75 22.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.026 -0.534 . . . . 74.200000000000003 110.699 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.07 116.15 38.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.293 -1.373 . . . . 74.239999999999995 107.293 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.9 155.99 18.77 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.408 -0.814 . . . . 63.009999999999998 110.428 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.88 104.63 12.13 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 107.787 -1.19 . . . . 74.299999999999997 107.787 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.1 m -65.24 -61.22 2.25 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.421 -0.354 . . . . 72.129999999999995 110.709 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.2 t -74.57 -49.17 22.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.224 0.535 . . . . 65.140000000000001 109.851 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 151.78 -159.73 28.44 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.381 -1.488 . . . . 71.310000000000002 109.381 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -161.95 139.47 8.65 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.028 -0.73 . . . . 74.299999999999997 109.028 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -156.67 133.81 10.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 106.432 -1.692 . . . . 73.230000000000004 106.432 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.409 ' N ' ' HD3' ' A' ' 532' ' ' ARG . . . 108.63 -133.4 11.64 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.335 -0.936 . . . . 61.439999999999998 111.748 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -137.58 108.42 6.67 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.993 -1.114 . . . . 74.510000000000005 107.993 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.49 124.73 70.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.672 0.749 . . . . 74.239999999999995 111.199 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 559' ' ' GLU . 31.9 mm -93.7 116.45 34.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.043 -0.98 . . . . 74.439999999999998 108.687 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.4 t -108.81 99.24 33.49 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.912 -1.144 . . . . 75.109999999999999 107.912 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.1 159.98 23.66 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.682 1.588 . . . . 75.5 111.514 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -144.82 161.05 40.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.035 -1.098 . . . . 72.409999999999997 108.035 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -152.37 134.83 15.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.009 0.433 . . . . 75.150000000000006 111.006 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.9 138.59 34.99 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.089 -0.96 . . . . 74.430000000000007 112.006 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.2 mm -115.52 126.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.582 -1.636 . . . . 63.130000000000003 106.582 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.91 166.72 22.95 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.901 0.382 . . . . 64.109999999999999 110.792 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -162.87 -111.43 0.26 Allowed Glycine 0 CA--C 1.495 -1.215 0 N-CA-C 110.474 -1.05 . . . . 72.040000000000006 110.474 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -31.04 58.75 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.469 -1.308 . . . . 70.019999999999996 107.469 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.56 143.4 26.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.932 -1.485 . . . . 62.119999999999997 107.146 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.48 ' HD2' ' OD1' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -109.42 153.35 24.13 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 113.531 0.937 . . . . 75.310000000000002 113.531 -171.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 43.11 -119.58 2.36 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 126.771 2.129 . . . . 73.510000000000005 118.372 168.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -164.89 96.35 0.13 Allowed Glycine 0 N--CA 1.412 -2.902 0 N-CA-C 108.649 -1.78 . . . . 71.430000000000007 108.649 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 123.01 -19.5 7.77 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 109.595 -1.402 . . . . 74.109999999999999 109.595 -175.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -76.97 -73.05 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.981 -0.609 . . . . 64.209999999999994 110.101 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 547' ' ' ARG . 5.7 m-20 -103.22 -44.17 5.26 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 122.136 0.969 . . . . 72.400000000000006 108.988 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -133.79 155.61 49.49 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 107.277 -1.379 . . . . 75.230000000000004 107.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.482 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 3.8 tm-20 -89.01 129.77 35.6 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.529 -1.285 . . . . 74.239999999999995 107.529 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.55 103.1 3.43 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.451 0.644 . . . . 72.040000000000006 111.199 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.6 t -108.43 113.7 26.95 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.384 -0.969 . . . . 74.049999999999997 108.384 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -143.41 100.6 3.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.503 -0.771 . . . . 74.420000000000002 109.231 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.81 -163.56 10.76 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.622 -0.799 . . . . 64.519999999999996 112.228 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.425 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.6 mt-10 -116.83 117.9 31.0 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.422 0.689 . . . . 64.030000000000001 110.582 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.4 mt -89.31 139.5 30.43 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.047 -0.723 . . . . 72.329999999999998 109.047 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.88 105.07 14.71 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.67 -0.812 . . . . 71.329999999999998 111.417 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 31.5 m-85 -96.21 143.79 26.99 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.397 -1.334 . . . . 64.510000000000005 107.397 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.429 ' H ' HD13 ' A' ' 567' ' ' ILE . 79.4 mt-30 -116.29 -86.94 0.61 Allowed 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.245 -1.02 . . . . 74.200000000000003 108.245 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.97 168.53 9.0 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.527 -0.869 . . . . 70.209999999999994 109.043 173.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -59.28 -11.05 3.51 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.244 1.418 . . . . 75.310000000000002 113.575 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.468 ' HG3' HG21 ' A' ' 567' ' ' ILE . 16.1 pt-20 -69.77 -17.88 63.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.729 0.412 . . . . 72.439999999999998 111.973 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 566' ' ' GLU . 41.0 pt -116.13 163.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 C-N-CA 120.319 -0.552 . . . . 73.140000000000001 111.464 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.3 146.45 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 108.181 -1.044 . . . . 71.549999999999997 108.181 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 70.9 mmtt -109.83 145.05 37.4 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.591 -0.522 . . . . 74.439999999999998 109.591 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.92 133.6 63.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.368 -1.287 . . . . 74.010000000000005 108.287 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 55.5 mt -93.15 113.08 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 106.932 -1.507 . . . . 72.129999999999995 106.932 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -102.48 112.31 24.99 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.106 -0.952 . . . . 65.140000000000001 109.55 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 521' ' ' MET . 48.6 mt -107.65 129.43 61.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.983 -1.117 . . . . 74.519999999999996 107.983 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.482 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 63.8 mtt85 -78.25 114.62 17.31 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.504 -0.924 . . . . 74.519999999999996 108.504 176.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.4 mm -101.0 126.67 54.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.603 -0.888 . . . . 64.430000000000007 108.603 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 50.8 m-85 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 121.039 0.447 . . . . 65.239999999999995 110.912 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.435 -1.205 0 CA-C-O 120.647 0.26 . . . . 74.329999999999998 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 6.7 m -130.57 152.44 49.95 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.743 -0.383 . . . . 55.350000000000001 110.558 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.8 p90 -138.95 175.59 9.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.381 -1.34 . . . . 72.530000000000001 107.381 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 14.7 m -125.59 158.88 33.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.632 -0.827 . . . . 71.450000000000003 110.577 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 59.2 tp -136.61 132.92 35.72 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 106.551 -1.648 . . . . 72.200000000000003 106.551 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.58 155.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 120.96 -0.296 . . . . 75.219999999999999 110.363 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 85.7 mt -92.1 142.53 27.41 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.317 -0.994 . . . . 73.439999999999998 108.317 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -93.87 175.57 6.67 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.463 -0.79 . . . . 73.340000000000003 109.404 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -66.58 113.9 14.98 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 123.734 0.646 . . . . 72.510000000000005 109.364 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.57 143.85 34.9 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.754 1.636 . . . . 72.209999999999994 111.264 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.05 140.46 51.9 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.375 -0.829 . . . . 63.509999999999998 110.472 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -102.06 124.22 47.29 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.084 -1.45 . . . . 74.150000000000006 107.084 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--N 1.295 -1.781 0 CA-C-O 121.764 0.793 . . . . 75.319999999999993 108.932 -179.691 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.048 0 CA-C-O 121.19 0.519 . . . . 74.340000000000003 111.358 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.74 176.39 6.37 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.469 -0.937 . . . . 74.310000000000002 108.469 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.06 -128.55 0.21 Allowed Glycine 0 C--N 1.309 -0.929 0 CA-C-O 121.968 0.76 . . . . 62.549999999999997 113.102 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.33 -84.17 0.05 OUTLIER 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.834 -0.683 . . . . 65.420000000000002 109.241 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -141.75 94.93 2.74 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 105.085 -2.191 . . . . 74.209999999999994 105.085 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.3 t -100.65 118.34 36.59 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-O 122.401 1.096 . . . . 75.019999999999996 110.954 -172.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 3.7 ttmp? -145.05 143.64 30.56 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.848 -1.908 . . . . 75.450000000000003 105.848 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 28.4 tp -119.59 105.68 11.44 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 108.232 -1.025 . . . . 74.140000000000001 108.232 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.79 121.76 32.93 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.985 -1.117 . . . . 75.25 107.985 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.69 120.27 59.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.978 -1.01 . . . . 75.019999999999996 109.308 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.21 121.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 CA-C-N 114.696 -1.138 . . . . 65.340000000000003 108.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.29 -2.019 0 CA-C-N 115.334 -0.848 . . . . 75.439999999999998 110.184 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.684 0 N-CA-C 110.278 -1.129 . . . . 54.329999999999998 110.278 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 68.6 mt -127.54 118.94 50.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.92 -1.511 . . . . 74.319999999999993 106.92 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.33 133.07 51.6 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.221 0.452 . . . . 74.310000000000002 112.221 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -148.11 153.97 39.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.688 -0.856 . . . . 70.120000000000005 108.688 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.444 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 68.1 m-85 -74.28 156.3 37.32 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.806 -0.442 . . . . 72.049999999999997 109.806 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.58 -49.11 79.03 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.235 0.54 . . . . 74.340000000000003 110.381 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.77 153.7 81.16 Favored Pre-proline 0 N--CA 1.432 -1.35 0 N-CA-C 107.721 -1.215 . . . . 73.25 107.721 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 83.3 Cg_endo -86.24 -11.32 6.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.024 1.816 . . . . 62.0 113.3 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 70.4 t -143.81 135.34 22.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.281 -0.637 . . . . 75.409999999999997 109.281 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.96 133.97 42.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.712 -0.477 . . . . 75.230000000000004 109.712 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -106.18 110.86 23.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.622 -1.251 . . . . 65.310000000000002 107.622 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.85 155.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 110.757 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.464 ' O ' HG21 ' A' ' 518' ' ' ILE . 2.6 t -77.13 147.03 36.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.668 -1.975 . . . . 73.140000000000001 105.668 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -77.58 -16.94 58.31 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.068 -1.053 . . . . 74.430000000000007 110.813 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.7 m -91.31 13.19 18.01 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.202 -0.454 . . . . 73.019999999999996 111.427 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 515' ' ' SER . 8.1 tt -74.06 -25.67 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.033 0.444 . . . . 72.25 111.736 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.37 -68.96 2.61 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.982 -1.104 . . . . 65.030000000000001 112.2 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.97 132.31 61.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.299999999999997 108.286 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 19.0 ptm -108.42 143.02 37.93 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.011 -0.737 . . . . 74.519999999999996 109.011 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -99.25 124.21 44.15 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 123.55 0.531 . . . . 73.510000000000005 110.524 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.0 t -115.55 120.23 64.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.461 -1.311 . . . . 74.219999999999999 107.461 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -106.29 123.68 48.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.297 -0.961 . . . . 75.310000000000002 110.275 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 78.5 t -88.59 110.99 21.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.168 -0.924 . . . . 73.430000000000007 108.833 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.79 122.61 30.11 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.443 -0.798 . . . . 74.209999999999994 110.592 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -87.13 101.3 13.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.908 -1.145 . . . . 71.5 107.908 171.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.9 t -67.19 -47.53 70.66 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 75.209999999999994 112.401 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.1 t -74.58 -24.06 58.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.271 0.558 . . . . 63.329999999999998 109.924 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 115.09 -158.69 14.18 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 110.378 -1.089 . . . . 65.420000000000002 110.378 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.87 136.41 17.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.26 -1.385 . . . . 64.340000000000003 107.26 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -135.27 87.1 2.3 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.716 -0.394 . . . . 74.450000000000003 109.967 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 98.63 -178.98 31.54 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.81 -1.316 . . . . 72.230000000000004 109.81 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.518 HD22 ' HG3' ' A' ' 561' ' ' GLU . 4.6 t-20 -74.5 111.54 9.78 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.457 -0.897 . . . . 74.120000000000005 111.201 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.89 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.872 -1.158 . . . . 53.049999999999997 107.872 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.3 mm -99.47 122.65 51.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.553 -0.906 . . . . 75.120000000000005 108.553 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 28.4 t -112.78 105.59 55.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 123.555 0.535 . . . . 63.549999999999997 109.754 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.44 150.55 28.48 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.917 1.745 . . . . 74.310000000000002 111.514 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -142.02 168.29 20.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.989 -1.115 . . . . 70.409999999999997 107.989 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 589' ' ' LEU . 55.0 pttt -161.23 145.14 13.15 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.123 0.487 . . . . 73.430000000000007 111.07 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.5 p -83.6 133.46 34.84 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.994 -1.003 . . . . 72.400000000000006 110.454 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 42.4 mm -104.2 112.41 37.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.062 -1.459 . . . . 64.439999999999998 107.062 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.89 152.16 41.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.656 0.598 . . . . 70.319999999999993 110.064 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -145.51 -116.97 1.06 Allowed Glycine 0 C--N 1.293 -1.837 0 N-CA-C 108.801 -1.72 . . . . 52.32 108.801 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 24.9 p -75.35 -27.71 59.29 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.21 -1.033 . . . . 74.409999999999997 108.21 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.38 127.98 34.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.604 -1.258 . . . . 72.040000000000006 107.604 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.494 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 3.2 tmt_? -104.26 139.67 38.94 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.578 -1.267 . . . . 72.510000000000005 107.578 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . 0.467 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -86.94 -156.33 29.08 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.889 -0.672 . . . . 74.540000000000006 112.806 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.81 1.86 59.81 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.798 -0.239 . . . . 74.120000000000005 113.532 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 117.22 0.64 18.91 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.173 -1.013 . . . . 55.420000000000002 113.08 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 12.8 tp10 -69.77 -76.46 0.1 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 117.393 0.597 . . . . 74.239999999999995 109.793 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.18 -35.42 9.65 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.77 -1.196 . . . . 74.129999999999995 107.77 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -144.17 166.63 24.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.869 -1.16 . . . . 73.329999999999998 107.869 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.44 144.2 26.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.467 -1.679 . . . . 74.420000000000002 106.467 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.91 122.08 28.24 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.264 -0.643 . . . . 74.219999999999999 109.264 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -129.5 124.05 32.99 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.989 0.9 . . . . 75.540000000000006 112.653 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 9.4 p -131.39 129.26 41.1 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.031 -1.841 . . . . 74.5 106.031 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -160.35 171.76 36.63 Favored Glycine 0 CA--C 1.48 -2.128 0 C-N-CA 118.997 -1.573 . . . . 65.200000000000003 112.474 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 7.7 mp0 -107.67 115.61 30.46 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.537 -0.912 . . . . 75.040000000000006 108.537 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.117 -0.327 . . . . 71.109999999999999 110.117 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.518 ' HG3' HD22 ' A' ' 534' ' ' ASN . 40.4 tt0 -106.5 101.97 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.172 0.51 . . . . 74.109999999999999 111.771 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -97.37 156.47 16.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.097 -0.705 . . . . 75.530000000000001 109.097 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -136.79 -81.13 0.38 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.816 1.293 . . . . 74.010000000000005 109.21 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -104.19 159.05 16.02 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 115.38 -0.827 . . . . 71.519999999999996 109.594 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -60.65 -16.37 38.18 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 125.151 1.381 . . . . 72.239999999999995 114.017 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -80.75 -16.34 54.12 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.687 -0.805 . . . . 73.420000000000002 112.237 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 37.1 pt -99.58 158.98 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.215 -0.994 . . . . 73.430000000000007 110.307 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.57 143.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.267 -1.382 . . . . 75.540000000000006 107.267 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.1 mmpt? -101.69 147.27 26.65 Favored 'General case' 0 CA--C 1.468 -2.186 0 C-N-CA 120.108 -0.637 . . . . 73.239999999999995 110.636 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 22.2 mt -125.28 128.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 CA-C-N 114.578 -1.192 . . . . 72.340000000000003 108.771 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 52.9 mt -90.46 134.05 30.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.803 -1.554 . . . . 74.510000000000005 106.803 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 18.3 p -116.18 111.93 20.93 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.714 -0.847 . . . . 71.230000000000004 108.714 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.39 128.41 60.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.833 -0.803 . . . . 73.540000000000006 108.833 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.62 111.93 11.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 124.115 0.884 . . . . 74.430000000000007 109.378 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -106.9 131.39 56.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.238 -1.393 . . . . 73.019999999999996 107.238 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . 0.48 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 51.5 m-85 . . . . . 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 74.409999999999997 108.316 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.419 -2.023 0 CA-C-O 121.022 0.439 . . . . 74.25 111.103 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 45.7 p -137.34 146.66 44.84 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.716 -0.846 . . . . 71.140000000000001 108.716 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -133.17 173.75 11.11 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.23 -1.026 . . . . 73.010000000000005 108.23 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 10.9 m -124.84 156.07 38.42 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.538 -0.912 . . . . 73.109999999999999 108.538 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 540' ' ' LYS . 63.6 tp -128.3 129.1 45.8 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 106.548 -1.649 . . . . 74.299999999999997 106.548 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 31.7 m -127.74 159.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 123.215 0.322 . . . . 73.340000000000003 110.14 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.444 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 93.0 mt -102.33 154.97 18.55 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.533 -0.914 . . . . 72.450000000000003 108.533 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.6 171.4 7.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.641 -0.874 . . . . 73.299999999999997 108.641 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.3 120.88 59.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 O-C-N 123.674 0.609 . . . . 74.340000000000003 110.656 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.58 156.23 44.94 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.367 2.045 . . . . 73.450000000000003 111.932 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -121.25 144.9 48.36 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.572 -0.74 . . . . 74.450000000000003 109.455 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -104.59 121.33 43.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.674 -0.861 . . . . 72.140000000000001 108.674 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . 0.405 HD11 HG12 ' A' ' 536' ' ' ILE . 2.2 mp . . . . . 0 C--N 1.301 -1.54 0 CA-C-O 122.663 1.22 . . . . 74.219999999999999 111.089 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 27.3 pt . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.338 0.589 . . . . 74.340000000000003 111.175 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.85 172.7 8.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.537 -1.282 . . . . 71.340000000000003 107.537 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.44 -172.86 38.62 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 120.358 -0.925 . . . . 64.219999999999999 111.249 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . 0.451 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 43.3 tt0 -54.9 -62.36 1.71 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.162 0.585 . . . . 74.530000000000001 110.465 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . 0.451 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 37.1 m80 -135.14 106.11 6.62 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.972 -0.751 . . . . 74.219999999999999 108.972 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 9.0 t -119.41 108.81 15.01 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 122.18 0.99 . . . . 64.129999999999995 110.387 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 40.9 ttmt -147.91 142.33 26.37 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.686 -1.227 . . . . 73.209999999999994 107.686 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 62.1 tp -119.34 110.51 17.05 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.695 -0.854 . . . . 64.409999999999997 108.695 174.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.98 117.55 28.87 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.445 -0.946 . . . . 70.420000000000002 108.445 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.58 124.74 60.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 114.713 -1.131 . . . . 70.200000000000003 109.542 -175.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.38 123.48 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.598 0 N-CA-C 107.942 -1.133 . . . . 75.129999999999995 107.942 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 115.682 -0.69 . . . . 74.129999999999995 111.153 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.42 -2.391 0 N-CA-C 109.951 -1.26 . . . . 61.210000000000001 109.951 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 83.6 mt -127.15 114.88 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.586 -1.265 . . . . 74.129999999999995 107.586 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -103.77 134.65 46.72 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 74.409999999999997 111.873 -175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.1 t -148.13 163.34 37.25 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.934 -0.575 . . . . 75.140000000000001 109.654 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.9 162.37 20.53 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-O 120.958 0.409 . . . . 63.219999999999999 110.678 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.0 -55.77 19.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.106 -0.952 . . . . 73.140000000000001 109.167 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.33 159.36 57.66 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.515 -0.766 . . . . 73.129999999999995 108.976 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.06 -18.16 6.4 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.221 1.281 . . . . 74.209999999999994 111.224 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 79.4 t -142.0 130.38 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.247 0.619 . . . . 75.129999999999995 109.364 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.62 140.96 47.42 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.63 -0.878 . . . . 72.310000000000002 108.63 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -119.49 117.21 27.82 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.776 -0.824 . . . . 73.239999999999995 108.776 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.1 m -106.35 162.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.248 0.546 . . . . 75.340000000000003 112.472 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 16.3 m -74.38 138.22 43.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.9 -1.045 . . . . 73.510000000000005 110.052 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -58.71 -33.93 70.75 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.404 0.682 . . . . 72.430000000000007 110.916 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.5 m -110.22 25.42 11.8 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.594 0.59 . . . . 72.040000000000006 112.594 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.6 tt -71.27 -33.2 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.361 0.601 . . . . 74.140000000000001 112.276 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 574' ' ' ARG . . . 89.85 -75.16 1.81 Allowed Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.215 -0.993 . . . . 75.239999999999995 110.845 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.7 mm -120.25 123.27 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.918 -0.401 . . . . 73.109999999999999 109.918 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.479 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 21.5 ptm -94.03 130.05 40.3 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.437 -0.949 . . . . 74.409999999999997 108.437 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -106.56 113.45 26.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.577 0.751 . . . . 70.140000000000001 111.339 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 57.5 t -119.76 131.06 73.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.599 -0.519 . . . . 65.329999999999998 109.599 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -92.76 133.71 35.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.062 0.458 . . . . 74.439999999999998 110.366 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 97.6 t -90.3 114.02 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.952 -1.499 . . . . 74.219999999999999 106.952 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.41 151.01 24.32 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.131 -0.94 . . . . 72.409999999999997 109.584 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 530' ' ' GLY . 0.0 OUTLIER -122.46 104.4 9.36 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.167 -1.049 . . . . 75.129999999999995 108.167 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.8 m -63.82 -63.34 1.19 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.99 -1.004 . . . . 71.420000000000002 111.861 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 10.8 p -74.13 -33.68 63.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.641 0.734 . . . . 70.140000000000001 110.725 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . 0.54 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 140.36 -148.6 20.22 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 109.567 -1.413 . . . . 74.120000000000005 109.567 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -162.96 144.01 9.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 74.140000000000001 106.687 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -149.04 131.21 15.45 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.429 0.529 . . . . 73.129999999999995 112.429 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 99.06 -126.38 8.89 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 115.219 -0.901 . . . . 73.219999999999999 111.359 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.02 109.53 7.42 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.321 -1.363 . . . . 73.319999999999993 107.321 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.09 122.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 121.146 0.498 . . . . 73.299999999999997 110.715 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.77 117.77 32.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.127 -1.434 . . . . 75.329999999999998 107.127 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.2 t -108.18 101.1 40.23 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.151 -1.055 . . . . 74.530000000000001 108.151 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.23 139.26 6.98 Favored 'Trans proline' 0 N--CA 1.425 -2.558 0 C-N-CA 121.63 1.553 . . . . 71.510000000000005 111.983 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.508 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.4 p90 -119.6 159.49 24.28 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.963 -1.495 . . . . 75.150000000000006 106.963 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . 0.463 ' HA ' ' SG ' ' A' ' 557' ' ' CYS . 62.3 pttt -146.33 140.66 26.58 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.004 -0.678 . . . . 74.150000000000006 110.963 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.1 p -85.94 132.77 34.01 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.64 -1.164 . . . . 64.5 110.593 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 39.3 mm -109.59 116.74 52.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.875 -1.157 . . . . 72.010000000000005 107.875 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -67.87 167.76 12.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.398 0.618 . . . . 71.299999999999997 111.047 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . 0.457 ' C ' ' HG1' ' A' ' 545' ' ' THR . . . 156.99 116.44 0.51 Allowed Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 107.733 -2.147 . . . . 75.540000000000006 107.733 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' THR . . . . . 0.457 ' HG1' ' C ' ' A' ' 544' ' ' GLY 0.295 7.9 p 66.85 -44.43 0.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.124 1.77 . . . . 70.310000000000002 112.437 -172.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.01 19.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.962 -1.496 . . . . 73.549999999999997 106.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.491 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 3.4 mpt_? -111.27 152.53 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.283 0.563 . . . . 73.340000000000003 110.511 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.77 170.47 32.17 Favored Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.323 -1.111 . . . . 62.310000000000002 110.323 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 106.77 23.84 6.95 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.267 -1.133 . . . . 72.430000000000007 110.267 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 63.61 36.36 93.24 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.96 -0.856 . . . . 62.200000000000003 110.96 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.02 -76.36 0.47 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.145 0.578 . . . . 75.030000000000001 111.506 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.61 -40.39 15.2 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.615 -1.254 . . . . 64.450000000000003 107.615 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.26 160.67 39.46 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.001 -1.454 . . . . 75.230000000000004 107.469 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.8 OUTLIER -88.71 104.94 17.35 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.084 -1.45 . . . . 75.109999999999999 107.084 177.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.19 98.91 0.84 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.149 . . . . 72.349999999999994 109.039 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.54 138.69 54.31 Favored 'General case' 0 N--CA 1.398 -3.033 0 CA-C-N 114.472 -1.24 . . . . 72.319999999999993 107.993 -171.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 540' ' ' LYS . 56.1 m -149.17 125.0 10.54 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.437 -0.209 . . . . 74.239999999999995 110.437 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 121.3 -133.21 9.45 Favored Glycine 0 C--O 1.211 -1.308 0 N-CA-C 111.222 -0.751 . . . . 75.230000000000004 111.222 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 60.44 -10.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 118.277 2.695 . . . . 75.409999999999997 118.277 171.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 569' ' ' LYS . 39.8 mt -99.41 135.22 41.14 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.523 -1.361 . . . . 73.329999999999998 112.93 -175.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.402 ' HG2' ' NE2' ' A' ' 563' ' ' GLN . 41.6 tt0 -137.12 115.66 11.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.071 -1.085 . . . . 75.209999999999994 108.071 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.99 145.87 29.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.388 -0.967 . . . . 64.120000000000005 108.388 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.439 ' H ' HD11 ' A' ' 567' ' ' ILE . 2.0 mp0 -103.63 -94.55 0.32 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.73 -1.581 . . . . 74.150000000000006 106.73 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -105.22 176.09 5.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.866 -0.606 . . . . 74.349999999999994 111.875 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.09 -25.53 22.33 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.636 1.574 . . . . 73.420000000000002 112.436 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.08 -20.56 54.53 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.001 0.92 . . . . 74.219999999999999 113.153 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.439 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.8 pt -119.64 157.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 119.497 -0.881 . . . . 73.209999999999994 110.617 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.93 148.4 32.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 106.707 -1.59 . . . . 75.409999999999997 106.707 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.501 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.6 mmpt? -113.02 164.56 13.31 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.519 -0.472 . . . . 72.25 112.027 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.11 134.41 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.173 -0.921 . . . . 70.540000000000006 110.426 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.508 HG23 ' CZ ' ' A' ' 539' ' ' TYR . 70.2 mt -90.67 125.64 43.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.531 -1.285 . . . . 73.150000000000006 107.531 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -111.86 112.65 24.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.511 0.672 . . . . 62.130000000000003 110.588 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.479 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 62.2 mt -118.83 130.06 74.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.635 -0.876 . . . . 74.299999999999997 108.635 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.529 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 84.0 mtp180 -83.69 132.82 34.84 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.726 0.641 . . . . 73.129999999999995 110.142 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.73 130.18 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.922 -1.14 . . . . 74.109999999999999 107.922 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 . . . . . 0 C--N 1.315 -0.903 0 N-CA-C 112.466 0.543 . . . . 74.510000000000005 112.466 -175.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 75.0 m . . . . . 0 N--CA 1.418 -2.07 0 N-CA-C 112.002 0.371 . . . . 75.430000000000007 112.002 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 61.1 p -130.65 120.76 24.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.751 -0.659 . . . . 61.539999999999999 109.797 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -108.13 168.86 8.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.62 -1.252 . . . . 74.310000000000002 107.62 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 3.6 m -121.28 162.89 19.47 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.243 -0.983 . . . . 52.229999999999997 109.887 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 540' ' ' LYS . 65.9 tp -136.54 125.94 25.02 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.808 -1.553 . . . . 74.430000000000007 106.808 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.52 159.62 30.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.786 -0.45 . . . . 63.240000000000002 109.786 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.61 135.46 43.09 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.265 -1.013 . . . . 74.329999999999998 108.265 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.97 171.63 8.15 Favored 'General case' 0 C--N 1.271 -2.822 0 CA-C-N 115.69 -0.686 . . . . 72.310000000000002 109.476 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.43 121.2 46.29 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 113.49 0.922 . . . . 75.400000000000006 113.49 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -77.06 144.51 23.84 Favored 'Trans proline' 0 N--CA 1.415 -3.094 0 C-N-CA 121.428 1.419 . . . . 73.25 111.191 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . 0.528 ' HB3' ' HZ1' ' A' ' 595' ' ' LYS . 0.1 OUTLIER -118.72 132.37 56.15 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.114 -0.948 . . . . 74.319999999999993 110.062 -176.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -98.27 119.69 37.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.63 -0.714 . . . . 74.409999999999997 109.262 -175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--N 1.294 -1.809 0 N-CA-C 106.997 -1.482 . . . . 75.310000000000002 106.997 176.552 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 109.482 -0.562 . . . . 74.230000000000004 109.482 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -94.19 171.25 8.95 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.163 -0.68 . . . . 74.409999999999997 109.163 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -74.34 179.02 43.61 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.029 -0.605 . . . . 74.549999999999997 111.803 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . 0.415 ' HG2' ' ND1' ' A' ' 638' ' ' HIS . 34.1 tt0 -46.97 -68.79 0.16 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.399 . . . . 71.099999999999994 111.238 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . 0.415 ' ND1' ' HG2' ' A' ' 637' ' ' GLU . 39.7 m80 -134.31 94.04 3.16 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.461 -0.94 . . . . 74.299999999999997 108.461 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 10.2 t -113.18 108.41 17.24 Favored 'General case' 0 N--CA 1.408 -2.567 0 C-N-CA 119.496 -0.882 . . . . 74.230000000000004 109.725 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -147.96 135.96 21.15 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.869 -1.53 . . . . 74.430000000000007 106.869 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.1 tp -113.44 116.27 29.35 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 108.58 -0.896 . . . . 75.329999999999998 108.58 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.84 126.55 39.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.248 -1.019 . . . . 75.200000000000003 108.248 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.55 122.76 67.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.786 -0.643 . . . . 64.040000000000006 109.471 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.95 130.14 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 115.483 -0.78 . . . . 73.450000000000003 109.42 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.094 0 CA-C-O 121.313 0.578 . . . . 65.349999999999994 111.794 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -1.054 0 N-CA-C 112.16 -0.376 . . . . 61.140000000000001 112.16 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 86.5 mt -92.95 114.83 30.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 123.68 0.792 . . . . 71.340000000000003 108.912 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.63 144.76 41.58 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.102 -0.333 . . . . 73.349999999999994 110.102 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -149.78 159.45 44.34 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 116.435 -0.348 . . . . 63.520000000000003 110.238 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.553 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 85.8 m-85 -73.01 154.19 40.6 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 109.796 -0.446 . . . . 73.400000000000006 109.796 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.01 -57.24 12.94 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 124.06 0.85 . . . . 73.219999999999999 109.733 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -120.11 163.29 29.02 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.058 -0.974 . . . . 75.219999999999999 109.596 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -22.84 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 110.83 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 642' ' ' GLU . 76.2 t -142.1 134.15 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.149 -1.056 . . . . 71.340000000000003 108.149 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.5 t -134.14 126.58 30.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.121 0.486 . . . . 63.329999999999998 109.922 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -98.65 120.69 39.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.466 -1.309 . . . . 75.019999999999996 107.466 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.01 154.44 18.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 116.201 -0.454 . . . . 53.32 109.963 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.464 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 45.8 m -60.0 154.27 19.43 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 124.246 0.966 . . . . 72.319999999999993 111.424 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.98 -33.3 57.62 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.942 -1.133 . . . . 74.329999999999998 107.942 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.6 m -98.89 28.82 4.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.16 -0.927 . . . . 73.420000000000002 110.232 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -76.94 -34.85 22.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 112.983 0.734 . . . . 74.150000000000006 112.983 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.32 -70.93 3.06 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.204 -0.998 . . . . 55.43 111.867 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.3 mm -130.96 131.57 64.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.776 -0.824 . . . . 75.040000000000006 108.776 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.415 ' SD ' HD11 ' A' ' 573' ' ' ILE . 16.9 ptm -106.29 127.28 53.13 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.601 -0.727 . . . . 75.040000000000006 109.152 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -88.81 114.46 25.45 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.262 0.351 . . . . 75.019999999999996 110.842 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 40.1 t -108.03 114.51 46.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.29 -0.633 . . . . 75.329999999999998 109.29 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -89.13 130.58 35.54 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.528 -0.545 . . . . 73.530000000000001 109.528 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.8 110.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.004 -1.48 . . . . 74.329999999999998 107.004 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.3 151.91 23.2 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.069 -0.969 . . . . 65.109999999999999 109.897 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -115.66 107.93 15.74 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.588 -0.893 . . . . 73.010000000000005 108.588 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.6 m -65.28 -58.68 5.32 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.395 -0.82 . . . . 72.299999999999997 109.967 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.4 p -74.59 -51.25 15.07 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.665 -0.698 . . . . 71.219999999999999 111.068 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.44 -166.31 26.87 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.347 -1.101 . . . . 71.439999999999998 110.347 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -146.77 134.44 21.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -153.32 99.4 2.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.423 -0.584 . . . . 70.150000000000006 109.423 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 127.01 -125.46 5.34 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 110.422 -1.071 . . . . 63.5 110.422 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -138.01 109.32 6.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.592 -0.521 . . . . 73.340000000000003 109.592 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 34.5 t -124.86 128.65 73.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.745 -0.835 . . . . 72.519999999999996 108.745 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.527 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.0 mm -105.34 126.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.379 -0.601 . . . . 75.209999999999994 109.379 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.42 109.76 60.11 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.791 -0.641 . . . . 71.25 109.956 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.48 146.03 13.51 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.883 1.722 . . . . 74.209999999999994 111.428 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -137.05 157.46 46.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.363 -0.977 . . . . 73.299999999999997 108.363 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -149.9 139.86 21.94 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.099 0.476 . . . . 72.239999999999995 111.235 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -84.65 124.77 31.84 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.197 -0.91 . . . . 62.420000000000002 111.977 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.6 mm -97.29 115.84 38.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.993 -1.484 . . . . 70.129999999999995 106.993 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.34 163.17 25.09 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.836 -0.431 . . . . 74.519999999999996 109.836 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -156.4 -116.67 0.53 Allowed Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 109.426 -1.47 . . . . 71.140000000000001 109.426 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.6 m -70.26 -27.06 64.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.239 -1.023 . . . . 74.239999999999995 108.239 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.18 131.42 38.26 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.782 -1.099 . . . . 74.299999999999997 108.292 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 132.84 43.49 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.424 -1.695 . . . . 75.420000000000002 106.424 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.0 29.1 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.849 -0.691 . . . . 75.200000000000003 111.995 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.28 63.51 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 114.518 0.567 . . . . 70.540000000000006 114.518 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.48 9.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 119.558 -1.306 . . . . 53.030000000000001 113.691 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.86 -79.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.357 0.578 . . . . 74.25 112.357 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.05 -41.49 12.29 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.048 -1.093 . . . . 70.340000000000003 108.048 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -143.17 163.76 32.01 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.508 -1.224 . . . . 74.349999999999994 107.962 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.581 ' HG3' ' NH2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -90.5 146.08 24.4 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.399 -1.334 . . . . 63.0 107.399 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.83 122.19 29.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.885 -0.413 . . . . 74.25 109.885 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -128.35 105.18 8.16 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.819 0.818 . . . . 74.019999999999996 109.73 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.55 131.58 51.53 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.227 -1.768 . . . . 72.310000000000002 106.227 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.26 -167.28 34.21 Favored Glycine 0 N--CA 1.432 -1.599 0 C-N-CA 119.169 -1.491 . . . . 64.319999999999993 113.249 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.507 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.3 mt-10 -113.83 122.72 47.9 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.811 0.844 . . . . 75.400000000000006 110.774 -176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.63 140.79 29.38 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.88 -0.785 . . . . 75.340000000000003 108.88 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.25 113.35 26.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.49 -0.323 . . . . 72.140000000000001 110.719 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 54.5 m-85 -115.88 115.83 26.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.202 -0.453 . . . . 75.349999999999994 110.061 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -90.08 -84.57 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.141 0.972 . . . . 73.120000000000005 110.507 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.4 HD21 ' HG2' ' A' ' 566' ' ' GLU . 8.8 t30 -105.11 157.8 17.01 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.31 -1.314 . . . . 64.340000000000003 111.216 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.84 -26.3 58.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.543 2.053 . . . . 73.310000000000002 116.543 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.4 ' HG2' HD21 ' A' ' 564' ' ' ASN . 7.9 pt-20 -80.25 7.24 9.85 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.034 1.124 . . . . 73.049999999999997 114.034 -174.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 35.6 pt -119.36 161.93 18.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.396 -0.594 . . . . 64.409999999999997 109.396 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.92 154.57 34.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.128 -1.064 . . . . 71.420000000000002 108.128 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -113.97 147.09 39.18 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.988 0.423 . . . . 72.219999999999999 111.204 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -125.26 130.92 72.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.501 -1.227 . . . . 75.150000000000006 109.279 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 40.5 mt -91.99 126.39 44.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.477 -1.675 . . . . 75.519999999999996 106.477 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.1 p -108.52 112.25 24.53 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.461 -0.57 . . . . 63.439999999999998 109.461 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.42 HD12 HD21 ' A' ' 589' ' ' LEU . 52.2 mt -105.19 123.93 59.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 109.02 -0.733 . . . . 73.140000000000001 109.02 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.581 ' NH2' ' HG3' ' A' ' 554' ' ' GLU . 74.6 mtm180 -80.68 108.77 14.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 123.821 0.701 . . . . 74.129999999999995 111.201 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.1 mm -95.26 135.54 29.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.058 -1.83 . . . . 73.510000000000005 106.058 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 . . . . . 0 C--N 1.295 -1.787 0 C-N-CA 120.131 -0.627 . . . . 72.200000000000003 110.437 -178.046 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 121.129 0.49 . . . . 72.340000000000003 110.944 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 28.4 p -123.78 155.62 37.6 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 119.861 -0.735 . . . . 75.219999999999999 111.998 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -139.12 -177.98 5.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.772 -1.195 . . . . 73.129999999999995 107.772 173.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 26.3 m -135.06 156.58 48.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.653 -0.655 . . . . 72.049999999999997 109.946 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.42 HD21 HD12 ' A' ' 573' ' ' ILE . 42.8 tp -130.83 130.8 44.08 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.06 -1.459 . . . . 51.149999999999999 107.06 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.02 151.48 33.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 120.964 -0.294 . . . . 74.340000000000003 110.903 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.553 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 96.3 mt -95.57 140.01 31.01 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.26 -1.015 . . . . 73.439999999999998 108.26 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -100.41 159.42 15.16 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.357 -0.838 . . . . 62.43 109.05 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 120.84 19.22 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 124.122 0.888 . . . . 74.439999999999998 110.461 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.63 148.13 41.49 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.521 2.814 . . . . 74.340000000000003 112.643 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . 0.527 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 18.2 ptpt -102.42 133.29 47.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.867 -1.16 . . . . 74.140000000000001 107.867 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -105.36 117.6 34.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.28 -0.637 . . . . 72.409999999999997 109.28 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.424 -1.737 0 N-CA-C 107.677 -1.231 . . . . 74.239999999999995 107.677 178.197 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . 0.407 ' HB ' ' H ' ' A' ' 635' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.017 0 CA-C-O 121.012 0.434 . . . . 74.099999999999994 111.143 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.407 ' H ' ' HB ' ' A' ' 634' ' ' ILE . 26.9 mt -109.63 -158.32 0.64 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.272 -0.877 . . . . 75.450000000000003 109.616 -173.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.36 -164.4 13.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.14 -0.552 . . . . 70.209999999999994 112.465 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -59.75 -73.36 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.489 0.716 . . . . 72.409999999999997 109.568 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -131.24 127.35 37.66 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 106.559 -1.645 . . . . 74.530000000000001 106.559 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 2.6 t -137.94 109.13 6.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 123.139 1.447 . . . . 72.209999999999994 110.664 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -147.18 140.38 25.3 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.564 -1.653 . . . . 75.530000000000001 106.575 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.83 106.92 13.99 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.605 -0.887 . . . . 74.439999999999998 108.605 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.436 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.0 mt-10 -86.4 124.46 32.77 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.92 -1.141 . . . . 74.530000000000001 107.92 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.27 123.73 69.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.737 -0.665 . . . . 74.540000000000006 109.653 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.11 122.9 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 108.474 -0.936 . . . . 72.430000000000007 108.474 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 CA-C-O 121.245 0.545 . . . . 74.409999999999997 111.651 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.429 -1.805 0 N-CA-C 111.304 -0.718 . . . . 63.340000000000003 111.304 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 62.5 mt -113.84 114.56 47.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 107.274 -1.38 . . . . 75.540000000000006 107.274 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.06 137.94 47.12 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.236 0.335 . . . . 74.239999999999995 111.056 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.5 t -148.91 165.9 30.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.955 -0.387 . . . . 65.409999999999997 109.955 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 75.6 m-85 -79.16 157.76 27.84 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.339 0.656 . . . . 72.439999999999998 110.337 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.13 -50.58 71.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.72 0.772 . . . . 64.299999999999997 109.534 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.81 151.32 72.19 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 114.891 -1.049 . . . . 75.219999999999999 108.56 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.94 -22.37 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.115 1.877 . . . . 71.150000000000006 112.559 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.81 131.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.962 -0.385 . . . . 74.209999999999994 109.962 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.8 t -133.68 141.03 47.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.088 0.471 . . . . 75.430000000000007 109.84 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -112.99 119.74 38.96 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.346 -0.983 . . . . 64.25 108.346 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.67 155.52 19.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.365 0.603 . . . . 72.129999999999995 111.032 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 518' ' ' ILE . 68.7 m -83.1 157.2 22.92 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.513 -0.767 . . . . 73.140000000000001 110.305 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.729 0.776 . . . . 73.129999999999995 111.366 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.5 p -89.84 24.42 2.39 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.213 -0.903 . . . . 75.299999999999997 112.156 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 515' ' ' SER . 5.8 tt -86.46 -25.49 6.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.297 0.57 . . . . 65.239999999999995 110.512 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.25 -71.82 2.86 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.614 -0.803 . . . . 74.319999999999993 111.961 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.2 mm -131.2 138.33 53.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.239 -1.763 . . . . 73.409999999999997 106.239 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.406 ' HE2' ' CG2' ' A' ' 523' ' ' VAL . 5.4 ppp? -112.21 147.85 35.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.176 -0.676 . . . . 72.109999999999999 109.176 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -113.03 130.37 56.17 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.832 0.707 . . . . 65.200000000000003 111.201 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 39.5 t -125.11 124.21 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 107.973 -1.121 . . . . 72.329999999999998 107.973 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.406 ' HG2' HG12 ' A' ' 570' ' ' ILE . 59.6 mttm -91.05 131.19 36.79 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.994 -1.082 . . . . 75.439999999999998 109.383 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 89.3 t -91.34 109.67 21.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 106.948 -1.501 . . . . 64.409999999999997 106.948 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.1 mt -87.12 143.29 27.37 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.742 -1.117 . . . . 75.120000000000005 110.167 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.88 113.54 26.54 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.972 -1.013 . . . . 62.119999999999997 108.672 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 41.0 p -66.54 -63.64 1.03 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.023 -0.671 . . . . 73.430000000000007 111.592 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 51.0 m -74.46 -52.55 11.68 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.041 0.448 . . . . 63.240000000000002 111.513 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . 0.557 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 160.21 -143.85 9.45 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.607 -0.806 . . . . 62.100000000000001 111.735 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.64 161.18 18.12 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 106.248 -1.76 . . . . 75.400000000000006 106.248 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -157.19 126.52 6.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.463 0.574 . . . . 74.109999999999999 110.527 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.34 -118.7 5.61 Favored Glycine 0 CA--C 1.494 -1.28 0 C-N-CA 120.723 -0.751 . . . . 52.340000000000003 111.857 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -138.51 111.99 8.16 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.284 -1.006 . . . . 74.129999999999995 108.284 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.6 t -122.34 130.26 74.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.877 -0.515 . . . . 73.519999999999996 110.686 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.37 118.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.497 -0.927 . . . . 74.230000000000004 108.497 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.1 106.63 58.84 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.888 -0.782 . . . . 72.109999999999999 108.888 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -83.98 159.61 13.71 Favored 'Trans proline' 0 N--CA 1.42 -2.798 0 C-N-CA 121.838 1.692 . . . . 71.310000000000002 111.027 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.36 163.34 39.15 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.915 -1.883 . . . . 72.420000000000002 105.915 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -150.81 129.07 11.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.248 -0.581 . . . . 70.329999999999998 110.863 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.3 p -78.01 117.38 19.28 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 115.464 -0.789 . . . . 75.430000000000007 110.293 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.5 mm -88.4 120.45 37.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.216 -1.402 . . . . 74.129999999999995 107.216 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.56 113.63 13.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.684 -0.487 . . . . 74.120000000000005 109.684 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -94.18 -108.69 2.07 Favored Glycine 0 CA--C 1.496 -1.128 0 N-CA-C 110.423 -1.071 . . . . 34.32 110.423 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 42.4 p -86.26 -24.22 26.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.591 -0.892 . . . . 74.120000000000005 108.591 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.09 145.41 25.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.22 -0.9 . . . . 74.400000000000006 109.363 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 36.6 mmm-85 -95.02 138.24 33.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.747 0.784 . . . . 71.099999999999994 112.685 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -110.58 129.48 9.32 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 114.182 -1.372 . . . . 74.230000000000004 110.978 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 141.49 -17.82 2.65 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.581 -1.008 . . . . 62.43 110.581 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 155.51 -16.64 0.49 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.858 -1.163 . . . . 73.530000000000001 113.445 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.67 -81.79 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.459 0.63 . . . . 64.030000000000001 111.462 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -86.37 -53.7 4.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.981 0.896 . . . . 74.310000000000002 108.617 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -131.2 160.84 33.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.273 -0.876 . . . . 73.299999999999997 110.445 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.449 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 27.2 tt0 -96.26 119.06 34.06 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.788 -1.93 . . . . 74.120000000000005 105.788 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.79 143.4 54.63 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.31 0.576 . . . . 74.450000000000003 111.501 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 4.9 t -140.72 136.53 32.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.833 -0.621 . . . . 74.010000000000005 110.076 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.1 p -143.46 110.41 5.64 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.23 0.538 . . . . 64.140000000000001 112.2 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 79.22 105.78 0.23 Allowed Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.535 -0.757 . . . . 74.510000000000005 113.122 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.42 14.54 0.31 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.65 -0.87 . . . . 71.310000000000002 108.65 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 569' ' ' LYS . 46.2 mt -117.45 135.89 53.58 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.289 -0.882 . . . . 75.340000000000003 112.198 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -134.91 109.69 8.65 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.588 -1.264 . . . . 74.319999999999993 107.588 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 48.8 m-85 -102.37 115.28 30.25 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.822 -0.807 . . . . 63.439999999999998 108.822 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.438 ' H ' HD11 ' A' ' 567' ' ' ILE . 44.6 mt-30 -90.15 -79.64 0.34 Allowed 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.798 -0.637 . . . . 74.120000000000005 109.898 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -104.33 167.1 9.96 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.005 -0.739 . . . . 74.030000000000001 109.005 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -69.34 -20.13 63.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.479 0.712 . . . . 62.439999999999998 112.33 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.2 -10.26 59.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.143 1.164 . . . . 72.219999999999999 114.143 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.438 HD11 ' H ' ' A' ' 563' ' ' GLN . 40.0 pt -113.44 166.46 7.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.223 -0.591 . . . . 64.540000000000006 110.892 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.86 148.23 29.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.863 -1.532 . . . . 73.340000000000003 106.863 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 20.8 mttm -116.48 155.67 28.19 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 112.876 0.695 . . . . 73.010000000000005 112.876 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 32.7 mt -122.0 133.08 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.915 -1.039 . . . . 72.120000000000005 110.594 -174.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 47.8 mt -90.99 129.21 42.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.947 -1.501 . . . . 73.219999999999999 106.947 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -115.1 112.66 22.92 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.449 -0.574 . . . . 73.299999999999997 109.449 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.401 HD12 HD23 ' A' ' 589' ' ' LEU . 62.1 mt -108.36 130.7 60.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.82 -0.807 . . . . 73.200000000000003 108.82 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.449 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 70.7 ttt180 -76.9 112.58 13.66 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.484 -0.561 . . . . 73.510000000000005 109.484 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.16 119.16 47.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.344 -2.095 . . . . 70.109999999999999 105.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 C--N 1.301 -1.507 0 CA-C-O 121.645 0.736 . . . . 74.549999999999997 112.524 -175.066 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 63.4 m . . . . . 0 N--CA 1.427 -1.62 0 CA-C-O 121.0 0.428 . . . . 74.409999999999997 110.518 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.6 p -147.42 151.61 36.75 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.714 -0.847 . . . . 62.039999999999999 108.714 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -149.97 176.69 10.55 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.852 -1.166 . . . . 75.030000000000001 107.852 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 20.0 m -129.85 163.96 25.17 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.972 -0.691 . . . . 74.120000000000005 109.853 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.401 HD23 HD12 ' A' ' 573' ' ' ILE . 41.9 tp -139.67 127.36 21.83 Favored 'General case' 0 C--N 1.263 -3.165 0 N-CA-C 106.729 -1.582 . . . . 75.430000000000007 106.729 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.52 151.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.546 -0.539 . . . . 70.409999999999997 109.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.578 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 85.0 mt -92.1 139.42 30.65 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.901 -1.148 . . . . 74.430000000000007 107.901 175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.42 167.55 10.56 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 115.476 -0.784 . . . . 73.439999999999998 108.979 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.24 115.19 9.18 Favored Pre-proline 0 N--CA 1.446 -0.637 0 O-C-N 124.598 1.186 . . . . 73.510000000000005 109.333 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.42 142.7 23.98 Favored 'Trans proline' 0 N--CA 1.428 -2.346 0 C-N-CA 121.703 1.602 . . . . 72.109999999999999 111.412 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -110.3 132.34 54.26 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.957 -0.565 . . . . 65.299999999999997 110.421 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -85.02 118.81 24.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.451 -1.314 . . . . 73.219999999999999 107.451 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 N--CA 1.411 -2.391 0 N-CA-C 106.0 -1.852 . . . . 65.120000000000005 106.0 176.907 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 121.842 0.829 . . . . 74.510000000000005 111.53 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -99.0 178.87 4.8 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.388 -1.338 . . . . 73.430000000000007 107.388 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.89 -154.79 7.15 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 119.917 -1.135 . . . . 71.209999999999994 113.0 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.53 -68.07 0.36 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 124.388 1.075 . . . . 75.209999999999994 110.269 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -138.44 119.36 14.3 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.641 -1.985 . . . . 74.010000000000005 105.641 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 4.8 t -134.69 110.24 9.13 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-O 122.361 1.077 . . . . 72.310000000000002 110.839 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -147.89 137.85 22.69 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.177 -1.416 . . . . 74.519999999999996 107.177 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 111.82 22.65 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.177 -1.416 . . . . 73.319999999999993 107.177 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.37 122.26 37.9 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.963 -0.754 . . . . 74.230000000000004 108.963 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.93 125.41 68.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.252 -0.885 . . . . 75.340000000000003 109.139 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.84 139.19 44.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.568 -1.271 . . . . 74.329999999999998 107.568 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.308 -1.22 0 N-CA-C 109.435 -0.579 . . . . 74.040000000000006 109.435 -175.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.682 0 N-CA-C 111.076 -0.81 . . . . 71.120000000000005 111.076 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.95 114.8 36.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.38 -1.711 . . . . 75.409999999999997 106.38 172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.62 132.8 53.88 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.669 0.606 . . . . 62.420000000000002 109.975 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -148.39 152.39 36.93 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 120.766 0.317 . . . . 71.439999999999998 110.496 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.555 ' CG ' ' HB2' ' A' ' 641' ' ' LEU . 69.2 m-85 -71.4 148.17 47.2 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.282 0.633 . . . . 74.040000000000006 111.395 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.85 -55.85 20.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.62 0.575 . . . . 74.409999999999997 110.655 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . 0.57 ' O ' HD21 ' A' ' 641' ' ' LEU . 39.2 mt-10 -126.96 158.36 68.95 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 107.542 -1.281 . . . . 64.040000000000006 107.542 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.29 -23.98 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.684 1.589 . . . . 74.540000000000006 112.226 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 78.0 t -138.0 138.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.017 -0.364 . . . . 62.039999999999999 110.017 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.2 t -131.33 128.06 38.92 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 74.019999999999996 109.347 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.41 110.73 22.76 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.157 -1.423 . . . . 75.140000000000001 107.157 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.39 159.34 14.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.744 -0.382 . . . . 75.230000000000004 110.148 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 46.2 m -84.27 173.52 10.92 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.478 -0.783 . . . . 73.109999999999999 110.792 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.89 -34.16 18.27 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.738 -0.838 . . . . 73.329999999999998 108.738 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 49.4 m -92.19 17.25 9.87 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.958 -1.019 . . . . 72.140000000000001 111.874 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.16 -29.52 17.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.271 0.558 . . . . 73.530000000000001 110.372 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.19 -70.15 3.24 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.858 -0.687 . . . . 40.340000000000003 112.27 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.9 mm -129.06 124.01 59.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.345 -0.983 . . . . 75.109999999999999 108.345 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.41 ' SD ' HD11 ' A' ' 573' ' ' ILE . 5.5 ppp? -95.85 149.86 21.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.878 -1.156 . . . . 73.530000000000001 107.878 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -129.18 112.95 14.47 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.606 0.595 . . . . 72.319999999999993 112.606 -173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 68.8 t -121.3 128.58 75.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.482 -0.781 . . . . 74.530000000000001 109.535 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.08 149.59 21.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.242 0.544 . . . . 74.049999999999997 109.793 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.29 107.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.621 -1.622 . . . . 74.349999999999994 106.621 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 81.8 mt -76.16 137.15 39.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.339 -0.846 . . . . 73.109999999999999 109.877 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.51 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 40.9 mtp180 -104.61 102.18 11.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.335 -1.357 . . . . 73.340000000000003 107.335 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.2 m -68.05 -62.45 1.4 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.565 1.32 . . . . 72.209999999999994 114.565 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 33.4 t -73.13 -50.83 20.54 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.596 0.591 . . . . 75.030000000000001 112.596 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 156.89 -160.44 30.35 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 111.146 -0.782 . . . . 72.219999999999999 111.146 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.38 165.88 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.522 0.729 . . . . 75.349999999999994 109.662 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -176.09 105.02 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.244 1.018 . . . . 75.25 108.52 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 121.35 -126.25 6.47 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 110.719 -0.952 . . . . 62.310000000000002 110.719 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -136.47 127.78 28.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.239 -1.023 . . . . 71.439999999999998 108.239 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.05 130.29 68.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.134 -0.691 . . . . 74.310000000000002 109.134 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 51.5 mm -100.88 122.47 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.284 -1.006 . . . . 73.109999999999999 108.284 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 43.4 t -116.76 102.33 53.18 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.499 -0.926 . . . . 75.239999999999995 108.499 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.51 135.28 13.04 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.801 1.667 . . . . 73.310000000000002 112.742 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -119.51 168.1 11.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.181 -1.044 . . . . 75.519999999999996 108.181 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -158.43 135.6 9.97 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.822 0.344 . . . . 74.420000000000002 111.154 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 17.8 p -80.41 121.0 25.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.348 -0.842 . . . . 71.010000000000005 110.441 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 29.9 mm -96.11 121.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.47 -1.307 . . . . 72.400000000000006 107.47 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.48 125.23 28.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.691 -0.485 . . . . 74.420000000000002 109.691 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -103.21 -109.02 3.32 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.724 -1.75 . . . . 72.439999999999998 108.724 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 585' ' ' CYS . 8.7 p -89.23 -5.85 57.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.198 0.999 . . . . 72.030000000000001 109.579 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.81 140.49 38.02 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.805 -1.089 . . . . 73.129999999999995 108.427 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.87 147.61 28.53 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.089 0.471 . . . . 72.319999999999993 111.511 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.2 -147.54 9.34 Favored Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 115.189 -0.914 . . . . 75.129999999999995 111.113 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.15 28.47 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 121.679 -0.296 . . . . 54.329999999999998 113.07 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.44 -3.84 34.86 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 111.493 -0.643 . . . . 74.099999999999994 111.493 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.76 -79.95 0.03 OUTLIER 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.001 0.429 . . . . 73.430000000000007 111.543 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -87.2 -46.16 9.99 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.718 -1.216 . . . . 74.409999999999997 107.718 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -139.5 165.87 26.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.574 -1.194 . . . . 72.109999999999999 109.732 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.96 116.4 28.88 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.303 -2.11 . . . . 72.010000000000005 105.303 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.72 132.18 35.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.5 0.667 . . . . 73.150000000000006 111.554 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.0 t -128.19 148.39 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.494 -0.775 . . . . 74.209999999999994 109.795 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 15.0 p -148.99 140.11 23.05 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.866 0.365 . . . . 61.310000000000002 111.4 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 80.12 -125.2 6.81 Favored Glycine 0 C--O 1.212 -1.263 0 CA-C-N 115.684 -0.689 . . . . 70.450000000000003 111.576 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 58.73 -6.09 0.05 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.072 2.99 . . . . 74.510000000000005 119.072 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 537' ' ' VAL . 62.2 mt -95.27 133.58 39.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 120.049 1.295 . . . . 74.310000000000002 112.29 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -134.23 108.91 8.52 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.603 -1.18 . . . . 75.540000000000006 107.939 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.51 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 73.8 m-85 -103.53 129.02 50.65 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.207 -0.451 . . . . 75.310000000000002 110.592 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.4 ' HB2' HD13 ' A' ' 567' ' ' ILE . 1.6 mp0 -96.16 -107.03 0.15 Allowed 'General case' 0 C--O 1.246 0.912 0 C-N-CA 118.631 -1.227 . . . . 74.349999999999994 111.306 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.4 155.79 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.715 -0.476 . . . . 73.109999999999999 109.715 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.89 -25.97 67.1 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 114.52 1.304 . . . . 74.230000000000004 114.52 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.52 -15.59 60.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.118 0.784 . . . . 62.119999999999997 113.118 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 563' ' ' GLN . 34.2 pt -103.32 157.09 5.14 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 C-N-CA 119.694 -0.802 . . . . 74.040000000000006 110.174 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.58 156.99 29.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.574 -0.528 . . . . 64.299999999999997 109.574 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 6.8 mmpt? -110.29 163.82 13.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 110.026 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 570' ' ' ILE . 62.9 mt -128.42 134.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.773 -1.103 . . . . 74.340000000000003 108.681 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 58.8 mt -90.14 118.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 106.619 -1.622 . . . . 65.340000000000003 106.619 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 12.8 p -110.47 111.74 23.2 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.622 -0.717 . . . . 54.439999999999998 110.008 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.41 HD11 ' SD ' ' A' ' 521' ' ' MET . 69.5 mt -110.85 132.55 59.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.665 -0.698 . . . . 72.319999999999993 109.564 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -76.99 111.82 12.96 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 123.807 0.692 . . . . 75.420000000000002 110.203 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.29 121.94 55.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.401 -1.703 . . . . 75.519999999999996 106.401 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 . . . . . 0 C--N 1.293 -1.86 0 C-N-CA 120.441 -0.504 . . . . 75.400000000000006 109.921 -178.283 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . 0.435 ' HA ' ' OG1' ' A' ' 545' ' ' THR . 21.4 p . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 121.498 0.666 . . . . 74.040000000000006 110.174 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 44.9 m -144.08 164.36 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.522 -0.547 . . . . 72.420000000000002 109.522 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.1 p90 -142.6 -178.94 6.02 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.78 -0.452 . . . . 74.400000000000006 109.78 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 70.9 m -131.09 167.52 18.96 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.238 0.542 . . . . 62.439999999999998 111.024 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 63.9 tp -136.47 124.51 22.9 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.152 -1.796 . . . . 73.420000000000002 106.152 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.73 159.0 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.489 -0.56 . . . . 71.329999999999998 109.489 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.508 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 74.6 mt -104.58 144.09 32.16 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.235 -1.024 . . . . 75.239999999999995 108.235 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.01 170.95 7.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.173 -0.677 . . . . 74.519999999999996 109.173 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.17 109.92 2.28 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 123.92 0.763 . . . . 72.319999999999993 112.749 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.65 158.52 39.59 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.122 2.548 . . . . 74.25 112.384 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -123.3 140.71 52.74 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 74.519999999999996 110.294 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -103.14 124.54 48.76 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.136 -1.061 . . . . 73.319999999999993 108.136 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 107.184 -1.413 . . . . 73.439999999999998 107.184 176.17 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 38.3 pt . . . . . 0 N--CA 1.426 -1.674 0 CA-C-O 121.432 0.634 . . . . 74.329999999999998 110.951 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.5 176.15 5.25 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.068 -1.456 . . . . 74.129999999999995 107.068 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.22 153.37 52.71 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.231 -1.947 . . . . 53.43 108.231 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . 0.453 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 41.5 tt0 -41.1 -61.22 1.04 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.157 1.383 . . . . 73.099999999999994 112.737 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . 0.453 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 46.8 m80 -126.22 92.99 3.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.876 -0.787 . . . . 70.409999999999997 108.876 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.8 t -116.09 110.8 19.37 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.556 1.169 . . . . 74.439999999999998 108.954 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -146.29 116.7 7.49 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.211 -1.774 . . . . 75.519999999999996 106.211 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 509' ' ' GLU . 1.6 tm? -106.76 108.62 20.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.059 -1.089 . . . . 73.430000000000007 108.059 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -88.44 131.77 34.74 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.134 -0.939 . . . . 72.409999999999997 109.425 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.49 118.62 59.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.905 -0.776 . . . . 74.540000000000006 108.905 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.34 130.08 64.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.565 -1.198 . . . . 75.340000000000003 109.285 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.814 0 CA-C-O 122.254 1.026 . . . . 71.030000000000001 112.101 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.592 0 N-CA-C 110.663 -0.975 . . . . 74.150000000000006 110.663 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -127.08 114.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.11 134.55 48.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.824 0.702 . . . . 74.530000000000001 109.928 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -147.99 156.73 42.99 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.321 -0.622 . . . . 74.219999999999999 109.321 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 74.4 m-85 -73.39 153.18 40.55 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.22 -0.289 . . . . 75.340000000000003 110.22 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.3 -51.86 67.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.978 0.799 . . . . 73.310000000000002 110.536 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -135.66 155.66 78.05 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 114.606 -1.179 . . . . 63.32 108.278 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.59 -25.74 2.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.934 1.756 . . . . 74.349999999999994 113.006 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 642' ' ' GLU . 89.3 t -142.02 132.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.127 -0.694 . . . . 72.540000000000006 109.127 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.3 t -133.94 138.26 45.38 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.079 0.466 . . . . 63.240000000000002 109.943 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -102.73 112.92 25.92 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.774 -1.195 . . . . 75.540000000000006 107.774 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.5 m -108.5 145.19 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.313 -0.555 . . . . 73.329999999999998 110.254 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.507 ' O ' HG21 ' A' ' 518' ' ' ILE . 70.8 m -70.81 137.91 49.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.131 -0.941 . . . . 70.230000000000004 111.38 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -31.3 61.65 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.752 1.019 . . . . 75.329999999999998 113.752 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 7.4 p -106.84 25.35 11.39 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.844 0.354 . . . . 63.240000000000002 111.884 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.507 HG21 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -76.13 -31.02 20.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.511 0.672 . . . . 72.519999999999996 110.228 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 87.12 -70.35 2.89 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.623 -0.798 . . . . 74.230000000000004 111.795 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.75 133.36 68.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.975 -1.121 . . . . 72.319999999999993 107.975 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 572' ' ' THR . 19.6 ptm -107.62 136.4 47.44 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.146 -0.687 . . . . 73.150000000000006 109.146 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -103.14 124.6 48.89 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.397 0.679 . . . . 74.420000000000002 110.0 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.5 t -121.24 123.71 70.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.423 -0.954 . . . . 74.230000000000004 108.423 175.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.77 127.4 35.6 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.684 -0.406 . . . . 73.200000000000003 110.01 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.68 107.93 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.529 -1.656 . . . . 75.409999999999997 106.529 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.8 mt -87.16 153.04 21.82 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.02 -0.991 . . . . 74.120000000000005 110.191 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -121.64 104.83 9.9 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.874 -0.603 . . . . 74.219999999999999 110.062 -178.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.5 m -63.59 -60.78 2.89 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 72.319999999999993 110.133 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -73.04 -43.8 61.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.157 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.02 -152.35 23.13 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 110.209 -1.156 . . . . 70.549999999999997 110.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -157.75 146.69 19.53 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.194 -1.78 . . . . 74.310000000000002 106.194 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.452 ' NH2' ' HA2' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -160.9 114.55 2.04 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.152 -1.425 . . . . 74.510000000000005 107.152 -178.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.452 ' HA2' ' NH2' ' A' ' 532' ' ' ARG . . . 119.25 -131.45 9.05 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 111.229 -0.748 . . . . 63.0 111.229 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -136.89 103.81 5.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.282 -2.118 . . . . 75.209999999999994 105.282 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 41.2 t -120.14 125.04 73.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 C-N-CA 119.644 -0.822 . . . . 65.409999999999997 111.086 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.73 122.64 42.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 74.329999999999998 107.938 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.12 103.13 54.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 109.006 -0.738 . . . . 73.519999999999996 109.006 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.12 133.27 9.82 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.819 1.68 . . . . 63.219999999999999 112.63 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -119.82 161.75 20.27 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.375 -1.343 . . . . 74.519999999999996 107.375 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -155.42 139.66 16.61 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.957 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.0 p -84.47 130.78 34.73 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.285 -0.871 . . . . 50.310000000000002 110.894 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 43.7 mm -99.09 114.01 35.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.542 -1.281 . . . . 75.329999999999998 107.542 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.01 161.97 27.92 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.989 -0.55 . . . . 75.140000000000001 111.002 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 144.53 117.27 1.14 Allowed Glycine 0 C--O 1.201 -1.939 0 N-CA-C 108.376 -1.889 . . . . 73.329999999999998 108.376 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 47.3 p 75.87 5.53 3.86 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 127.484 2.314 . . . . 62.520000000000003 110.395 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -169.21 140.1 2.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.706 -1.134 . . . . 72.319999999999993 108.249 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -102.47 138.08 39.86 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 123.501 0.501 . . . . 75.129999999999995 109.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -105.44 131.75 10.79 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 116.003 -0.544 . . . . 73.329999999999998 112.823 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 160.38 -49.53 0.38 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.818 -1.713 . . . . 73.209999999999994 108.818 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 179.65 -9.01 0.02 OUTLIER Glycine 0 C--N 1.294 -1.789 0 CA-C-N 113.933 -1.134 . . . . 72.420000000000002 111.286 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -65.16 -61.63 2.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.875 1.27 . . . . 75.230000000000004 111.686 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -122.88 -41.13 2.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.784 0.802 . . . . 72.239999999999995 109.122 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -136.37 160.29 39.18 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.931 -1.507 . . . . 74.120000000000005 106.931 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.539 ' OE2' ' HD2' ' A' ' 574' ' ' ARG . 22.1 tt0 -89.01 141.45 28.47 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.857 -0.794 . . . . 74.239999999999995 108.857 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.89 106.72 15.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.453 -0.944 . . . . 75.200000000000003 108.453 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -117.38 131.54 56.75 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.1 -1.074 . . . . 64.099999999999994 108.1 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.5 131.59 15.36 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 112.275 0.472 . . . . 73.430000000000007 112.275 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 85.21 -139.26 17.38 Favored Glycine 0 C--O 1.189 -2.708 0 N-CA-C 111.794 -0.522 . . . . 64.129999999999995 111.794 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 71.2 -8.0 1.07 Allowed 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.698 1.74 . . . . 64.349999999999994 115.698 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 569' ' ' LYS . 41.0 mt -93.4 131.28 38.73 Favored 'General case' 0 CA--C 1.5 -0.97 0 O-C-N 120.647 -1.283 . . . . 72.439999999999998 112.327 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -129.77 118.73 22.28 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.104 -0.953 . . . . 75.400000000000006 109.454 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 37.5 m-85 -104.54 155.31 18.93 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.555 -0.906 . . . . 74.409999999999997 108.555 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -120.66 -88.22 0.63 Allowed 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.721 -1.215 . . . . 74.040000000000006 107.721 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -104.45 165.48 11.03 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.197 -1.038 . . . . 71.430000000000007 108.197 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 4.4 p30 -63.21 -11.87 24.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.789 1.033 . . . . 73.439999999999998 113.789 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.8 -18.75 63.49 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.945 0.498 . . . . 74.140000000000001 111.794 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.8 pt -114.12 164.29 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 120.865 0.364 . . . . 74.400000000000006 110.625 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.56 158.37 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.08 -1.452 . . . . 75.439999999999998 107.08 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.454 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -121.69 149.19 43.58 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 120.965 0.412 . . . . 73.140000000000001 110.435 173.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.56 134.27 64.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.914 -1.039 . . . . 73.540000000000006 109.964 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 50.4 mt -90.91 126.73 43.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 106.552 -1.647 . . . . 74.310000000000002 106.552 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 521' ' ' MET . 15.5 p -117.28 112.5 20.85 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.836 -0.802 . . . . 73.129999999999995 108.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.416 HD13 HD23 ' A' ' 589' ' ' LEU . 50.4 mt -109.84 131.77 59.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.175 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.539 ' HD2' ' OE2' ' A' ' 554' ' ' GLU . 61.6 mtt180 -78.47 112.04 15.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 123.964 0.79 . . . . 74.430000000000007 111.397 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.5 125.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 106.356 -1.72 . . . . 70.420000000000002 106.356 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . 0.433 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 78.3 m-85 . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 113.129 0.788 . . . . 75.349999999999994 113.129 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . 0.419 ' O ' HD11 ' A' ' 645' ' ' ILE . 6.4 p . . . . . 0 N--CA 1.422 -1.853 0 CA-C-O 120.393 0.139 . . . . 73.099999999999994 110.638 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.4 p -134.54 168.18 19.43 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.41 -0.218 . . . . 62.219999999999999 110.41 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' A' ' 645' ' ' ILE . 54.8 p90 -163.86 162.33 23.57 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.982 -1.858 . . . . 75.420000000000002 105.982 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 11.0 t -113.41 171.96 7.25 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 118.802 -1.159 . . . . 62.439999999999998 108.815 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.416 HD23 HD13 ' A' ' 573' ' ' ILE . 61.0 tp -145.09 126.84 15.28 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.585 -1.635 . . . . 74.299999999999997 106.585 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 120.668 0.27 . . . . 73.230000000000004 110.383 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 56.5 mt -99.79 141.0 33.18 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.212 -1.033 . . . . 72.219999999999999 108.212 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.76 167.07 10.02 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.077 -1.083 . . . . 75.400000000000006 108.077 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.63 116.17 21.68 Favored Pre-proline 0 C--O 1.247 0.946 0 N-CA-C 112.606 0.595 . . . . 75.219999999999999 112.606 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.15 144.82 47.7 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.0 2.467 . . . . 75.230000000000004 111.527 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 130.71 55.95 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.643 -0.708 . . . . 73.239999999999995 110.788 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -84.79 116.05 23.05 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.33 -1.359 . . . . 74.230000000000004 107.33 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 38.7 mm . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 108.389 -0.967 . . . . 62.25 108.389 179.861 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 31.3 pt . . . . . 0 N--CA 1.433 -1.303 0 CA-C-O 121.581 0.705 . . . . 74.519999999999996 111.444 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.07 179.64 5.14 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.033 -1.099 . . . . 63.32 108.033 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -68.7 167.77 44.42 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.899 -0.88 . . . . 74.519999999999996 110.899 175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -48.78 -43.7 38.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.594 1.158 . . . . 74.25 110.782 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.17 123.53 9.63 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.036 -1.438 . . . . 75.329999999999998 107.3 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.2 t -148.97 112.89 5.14 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.812 0.815 . . . . 74.239999999999995 110.209 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -147.42 130.39 16.27 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.888 -1.051 . . . . 74.140000000000001 108.618 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 68.5 tp -108.23 118.86 37.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.917 -0.771 . . . . 75.140000000000001 108.917 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.419 ' HB2' HG23 ' A' ' 511' ' ' VAL . 39.7 mt-10 -103.05 122.87 45.53 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.983 -1.117 . . . . 72.120000000000005 107.983 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.0 t -109.88 128.8 65.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.788 -0.819 . . . . 71.239999999999995 108.788 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.03 133.29 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.605 0 N-CA-C 107.269 -1.382 . . . . 74.450000000000003 107.269 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . 0.419 HD11 ' O ' ' A' ' 585' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.414 -2.245 0 CA-C-N 115.977 -0.556 . . . . 73.420000000000002 109.516 -174.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.656 0 N-CA-C 112.831 -0.108 . . . . 75.430000000000007 112.831 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.401 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.1 mt -93.19 121.61 44.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 110.414 -0.217 . . . . 75.129999999999995 110.414 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 91.2 m-85 -109.0 138.5 45.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.769 -0.826 . . . . 72.530000000000001 108.769 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -149.34 158.68 44.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.683 -0.488 . . . . 73.109999999999999 109.683 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.669 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.6 m-85 -74.51 156.79 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.607 0.242 . . . . 75.439999999999998 110.362 174.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.47 -53.03 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.169 0.918 . . . . 72.430000000000007 110.675 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -121.47 157.53 56.12 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.259 -0.882 . . . . 74.420000000000002 108.82 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -84.0 -30.26 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.521 1.481 . . . . 75.140000000000001 110.527 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 642' ' ' GLU . 70.6 t -137.64 129.89 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.0 t -133.89 131.89 39.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.045 -0.724 . . . . 74.239999999999995 109.045 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -96.17 138.01 34.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.384 -1.339 . . . . 75.510000000000005 107.384 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.87 145.49 32.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 120.853 0.359 . . . . 63.520000000000003 110.266 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 518' ' ' ILE . 69.5 m -75.3 156.27 35.77 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.208 -0.906 . . . . 73.030000000000001 111.749 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -68.17 -46.17 71.44 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.934 -1.03 . . . . 74.109999999999999 111.046 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 11.2 t -95.17 36.04 1.25 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.771 0.796 . . . . 75.420000000000002 110.173 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 515' ' ' SER . 8.6 tt -89.91 -31.66 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 121.722 -0.612 . . . . 75.200000000000003 110.514 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.16 -72.85 2.74 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.818 -0.706 . . . . 74.120000000000005 111.463 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.65 123.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.515 -0.55 . . . . 72.400000000000006 109.515 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.418 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 22.1 ptm -91.36 138.6 31.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.111 -1.07 . . . . 73.209999999999994 108.111 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.74 108.87 20.57 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 123.442 0.464 . . . . 64.200000000000003 111.076 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 40.1 t -105.24 117.63 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.312 -0.625 . . . . 62.409999999999997 109.312 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -96.45 132.39 42.05 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.217 0.532 . . . . 74.420000000000002 110.093 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.8 t -90.96 112.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.463 -1.31 . . . . 74.430000000000007 107.463 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.422 ' HA ' HH21 ' A' ' 527' ' ' ARG . 59.3 mt -82.36 141.99 32.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.292 -0.867 . . . . 72.120000000000005 110.191 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -106.56 102.12 11.53 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.997 -1.483 . . . . 75.239999999999995 106.997 178.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.7 m -67.73 -63.75 1.0 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.802 -0.635 . . . . 73.540000000000006 110.701 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 10.3 t -75.63 -31.77 59.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 75.310000000000002 110.283 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 131.67 -159.14 23.11 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.919 -0.872 . . . . 72.010000000000005 110.919 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.545 ' N ' ' HB3' ' A' ' 565' ' ' ASP . . . -168.73 142.09 2.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.637 -1.616 . . . . 70.349999999999994 106.637 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -146.06 129.4 16.78 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.128 -0.693 . . . . 74.129999999999995 109.128 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 100.72 -122.85 7.74 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 121.386 -0.435 . . . . 55.340000000000003 112.758 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.62 102.77 5.02 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.749 -1.945 . . . . 74.310000000000002 105.749 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.62 129.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.234 0.54 . . . . 73.299999999999997 110.552 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.517 ' CG2' ' HB2' ' A' ' 559' ' ' GLU . 50.9 mm -98.29 127.62 50.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.536 -0.757 . . . . 75.310000000000002 109.147 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -112.61 104.58 55.99 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.45 0.7 . . . . 74.420000000000002 109.892 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.35 141.27 28.49 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.741 2.294 . . . . 63.229999999999997 113.262 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.53 163.91 30.02 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.375 -0.972 . . . . 72.519999999999996 108.375 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -161.69 137.82 7.98 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 123.192 0.308 . . . . 75.439999999999998 110.655 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.5 p -84.26 126.29 33.03 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.381 0.61 . . . . 71.109999999999999 110.992 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.4 117.77 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.299 -1.741 . . . . 74.230000000000004 106.299 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.86 146.38 49.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 123.355 0.409 . . . . 72.510000000000005 110.125 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.36 -108.13 0.74 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 109.16 -1.576 . . . . 75.230000000000004 109.16 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -72.08 -43.36 64.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.301 -1.74 . . . . 73.5 106.301 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 587' ' ' PHE . . . -73.16 133.88 44.23 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 113.815 -1.539 . . . . 74.349999999999994 108.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 37.2 ttt180 -111.27 143.24 42.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.551 0.945 . . . . 71.430000000000007 113.551 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 48.66 -149.75 3.94 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 125.952 1.739 . . . . 74.120000000000005 117.444 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -128.11 80.72 0.36 Allowed Glycine 0 N--CA 1.405 -3.431 0 N-CA-C 109.232 -1.547 . . . . 71.219999999999999 109.232 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 146.14 -21.14 1.75 Allowed Glycine 0 C--N 1.292 -1.892 0 C-N-CA 121.054 -0.593 . . . . 74.439999999999998 111.991 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 10.3 mm-40 -77.84 -67.57 0.71 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.315 0.578 . . . . 75.420000000000002 109.908 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -108.28 -43.37 4.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.772 0.796 . . . . 52.450000000000003 109.763 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -136.79 170.73 15.6 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.276 -1.379 . . . . 75.030000000000001 107.276 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.448 ' HG3' ' HE ' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -99.67 128.94 45.76 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.362 -1.718 . . . . 75.109999999999999 106.362 176.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.6 111.37 1.8 Allowed 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 123.802 0.841 . . . . 75.430000000000007 110.815 -173.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 104.7 14.48 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-O 122.075 0.941 . . . . 71.530000000000001 110.946 -174.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.5 p -139.48 129.6 25.17 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.862 -1.063 . . . . 72.040000000000006 108.562 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.24 -168.38 41.12 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.264 -1.134 . . . . 74.120000000000005 110.264 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.517 ' HB2' ' CG2' ' A' ' 536' ' ' ILE . 9.8 pt-20 -131.3 129.26 41.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.306 0.574 . . . . 72.430000000000007 110.904 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.435 HD22 ' CG ' ' A' ' 569' ' ' LYS . 85.5 mt -90.37 143.91 26.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.994 -1.003 . . . . 71.549999999999997 111.436 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.89 117.16 34.41 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.128 -0.629 . . . . 75.430000000000007 110.439 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -111.29 157.72 19.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.625 -1.25 . . . . 74.439999999999998 107.625 172.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -121.08 -87.8 0.63 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.901 -1.148 . . . . 71.420000000000002 107.901 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -104.47 162.43 13.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.826 -1.175 . . . . 74.230000000000004 107.826 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.545 ' HB3' ' N ' ' A' ' 531' ' ' ALA . 4.2 p30 -64.06 -15.41 59.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 113.718 1.007 . . . . 73.209999999999994 113.718 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.32 -19.42 63.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.736 0.303 . . . . 73.430000000000007 111.726 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 40.3 pt -107.18 163.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.82 154.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 108.153 -1.054 . . . . 63.310000000000002 108.153 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.435 ' CG ' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -119.19 162.53 18.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 104.884 -2.265 . . . . 73.109999999999999 104.884 175.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 76.6 mt -131.6 137.64 54.76 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.535 0 N-CA-C 107.954 -1.128 . . . . 74.219999999999999 107.954 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.448 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 48.7 mt -93.27 122.07 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.125 -1.805 . . . . 72.219999999999999 106.125 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 44.5 p -105.56 112.71 25.9 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.789 -0.448 . . . . 71.420000000000002 109.789 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.418 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 59.7 mt -110.85 122.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.563 -0.532 . . . . 73.299999999999997 109.563 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.448 ' HE ' ' HG3' ' A' ' 554' ' ' GLU . 23.3 mtm-85 -72.89 115.89 12.73 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.868 0.73 . . . . 73.140000000000001 110.774 174.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.0 mm -96.06 127.88 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.25 -0.886 . . . . 73.349999999999994 109.077 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 108.797 -0.816 . . . . 73.420000000000002 108.797 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.429 -1.506 0 CA-C-O 120.879 0.371 . . . . 55.32 111.242 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 12.9 m -119.95 130.94 55.02 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.852 -0.425 . . . . 74.540000000000006 109.852 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 52.1 p90 -129.57 -179.45 5.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.375 -1.342 . . . . 75.319999999999993 107.375 171.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 8.6 t -131.72 168.16 18.24 Favored 'General case' 0 N--CA 1.409 -2.507 0 C-N-CA 119.07 -1.052 . . . . 73.299999999999997 109.926 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 573' ' ' ILE . 51.5 tp -140.57 123.25 16.23 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 105.688 -1.967 . . . . 65.340000000000003 105.688 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.46 157.06 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 116.423 -0.353 . . . . 75.099999999999994 110.185 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.669 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 64.9 mt -107.79 151.66 25.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.211 -1.033 . . . . 73.230000000000004 108.211 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -115.17 178.06 4.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.206 0.316 . . . . 72.430000000000007 110.237 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -59.34 119.17 36.88 Favored Pre-proline 0 C--O 1.245 0.856 0 O-C-N 124.161 0.913 . . . . 73.230000000000004 111.7 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.42 ' HD3' HD23 ' A' ' 635' ' ' LEU . 55.6 Cg_endo -71.11 157.41 57.68 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 122.883 2.388 . . . . 75.010000000000005 112.032 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -124.42 138.1 54.39 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.385 -0.825 . . . . 71.400000000000006 110.328 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -95.32 123.38 38.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.536 -1.283 . . . . 73.109999999999999 107.536 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 44.2 mm . . . . . 0 C--N 1.292 -1.906 0 N-CA-C 108.202 -1.036 . . . . 74.230000000000004 108.202 179.306 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 50.9 pt . . . . . 0 N--CA 1.415 -2.2 0 N-CA-C 107.361 -1.348 . . . . 74.230000000000004 107.361 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 505' ' ' PHE . 2.2 pt? -87.41 -170.18 2.92 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 115.584 -0.734 . . . . 73.349999999999994 111.618 -171.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -61.85 144.36 48.95 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.632 -0.987 . . . . 72.140000000000001 110.632 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.08 -51.88 67.52 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.168 0.508 . . . . 75.239999999999995 110.127 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -123.25 104.35 9.09 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.368 0.604 . . . . 75.120000000000005 109.835 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.0 t -133.22 116.53 16.32 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.627 -0.879 . . . . 71.25 108.627 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -145.39 142.0 28.95 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.453 -0.943 . . . . 75.409999999999997 108.453 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.8 tp -121.84 110.45 15.9 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.932 -0.766 . . . . 64.530000000000001 108.932 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.494 ' HB2' HG23 ' A' ' 511' ' ' VAL . 40.5 mt-10 -88.28 112.42 22.79 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.043 -1.095 . . . . 75.209999999999994 108.043 174.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.41 120.67 51.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.976 -1.011 . . . . 75.140000000000001 108.838 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 23.5 mt -119.06 114.45 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-N 114.878 -1.055 . . . . 75.129999999999995 111.159 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . 0.432 ' H ' HD13 ' A' ' 645' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 N-CA-C 107.423 -1.325 . . . . 71.519999999999996 107.423 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.375 0 N-CA-C 112.906 -0.078 . . . . 64.439999999999998 112.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.1 mt -127.15 114.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.126 -2.176 . . . . 73.239999999999995 105.126 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.54 ' CE1' ' HD2' ' A' ' 527' ' ' ARG . 97.6 m-85 -113.84 128.94 56.61 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.91 -0.316 . . . . 75.340000000000003 110.309 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.44 148.97 30.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.969 -0.56 . . . . 73.25 110.11 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -67.31 154.08 42.15 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 110.323 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.16 -55.4 35.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.096 -0.705 . . . . 74.439999999999998 109.096 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -127.48 157.38 73.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.914 -1.039 . . . . 72.319999999999993 108.899 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -88.99 -13.76 2.99 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.403 2.069 . . . . 72.230000000000004 113.002 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 642' ' ' GLU . 91.4 t -143.45 133.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.66 -0.496 . . . . 73.030000000000001 109.66 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.3 t -134.51 133.23 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.64 -0.504 . . . . 74.510000000000005 109.64 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -108.85 112.1 24.16 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.301 -1.0 . . . . 64.129999999999995 108.301 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.1 m -121.26 162.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.146 0.498 . . . . 74.519999999999996 110.919 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 518' ' ' ILE . 37.0 m -77.19 149.63 35.53 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.198 -0.455 . . . . 63.520000000000003 112.009 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.03 -27.58 69.21 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.332 0.587 . . . . 64.209999999999994 110.228 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.3 m -110.59 28.63 8.49 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.762 -0.654 . . . . 73.120000000000005 111.143 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.44 HG21 ' O ' ' A' ' 515' ' ' SER . 10.0 tt -76.89 -28.33 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.101 0.477 . . . . 73.409999999999997 111.417 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.43 -77.8 0.84 Allowed Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.081 -0.808 . . . . 75.409999999999997 111.081 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.2 mm -130.14 146.22 34.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.691 -1.226 . . . . 64.510000000000005 107.691 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.0 ppp? -119.6 153.64 35.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.968 -1.493 . . . . 75.120000000000005 106.968 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -128.13 126.57 41.36 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.068 0.23 . . . . 74.230000000000004 111.153 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.37 131.35 54.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.223 -0.658 . . . . 64.010000000000005 109.223 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -90.76 151.07 21.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.142 0.496 . . . . 72.510000000000005 110.171 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.0 t -103.95 113.45 40.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 105.964 -1.865 . . . . 74.519999999999996 105.964 172.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.09 134.84 34.46 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.118 -0.492 . . . . 74.319999999999993 110.189 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 73.3 ttt180 -106.87 102.61 11.96 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.988 -1.115 . . . . 73.400000000000006 107.988 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.0 m -65.82 -47.7 74.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.588 -1.187 . . . . 72.430000000000007 113.901 -171.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.6 p -69.01 -51.35 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.357 0.873 . . . . 62.140000000000001 113.357 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 155.48 172.83 23.48 Favored Glycine 0 CA--C 1.48 -2.156 0 N-CA-C 108.644 -1.782 . . . . 70.209999999999994 108.644 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 527' ' ' ARG . . . -150.03 121.56 7.98 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 117.658 0.729 . . . . 73.209999999999994 112.552 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.499 ' HD3' ' C ' ' A' ' 532' ' ' ARG . 0.8 OUTLIER -156.71 110.82 2.72 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.633 -0.877 . . . . 74.109999999999999 108.633 171.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 149.19 -142.82 10.18 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 109.614 -1.394 . . . . 75.040000000000006 109.614 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -137.43 112.76 9.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.319 -1.363 . . . . 72.340000000000003 107.319 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.95 132.15 65.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 120.676 -0.41 . . . . 73.099999999999994 111.415 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.64 116.82 47.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.716 -0.674 . . . . 73.519999999999996 109.291 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.44 111.1 65.13 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.816 -0.809 . . . . 75.230000000000004 108.816 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -84.6 149.02 11.32 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.945 1.764 . . . . 74.439999999999998 111.082 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -138.21 159.24 42.56 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.159 -1.052 . . . . 75.400000000000006 108.159 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 589' ' ' LEU . 57.2 pttt -151.59 137.5 18.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.452 . . . . 74.400000000000006 110.021 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -84.2 143.12 29.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.881 -0.6 . . . . 71.010000000000005 111.124 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 48.5 mm -102.37 115.72 44.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.336 -1.728 . . . . 74.319999999999993 106.336 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -73.55 109.88 7.41 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.627 0.58 . . . . 74.129999999999995 111.513 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -135.34 126.17 3.91 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.363 -1.095 . . . . 55.539999999999999 110.363 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.3 m 69.06 -49.34 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.268 2.227 . . . . 73.310000000000002 112.459 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -90.16 150.14 22.14 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.431 -0.952 . . . . 63.409999999999997 108.431 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 40.9 ttp180 -93.14 135.49 34.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.956 0.408 . . . . 71.400000000000006 110.597 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.56 -161.15 35.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.542 -0.754 . . . . 62.409999999999997 111.355 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 85.97 18.56 59.34 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.043 -1.223 . . . . 74.450000000000003 110.043 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.76 27.79 60.22 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.029 -0.829 . . . . 72.239999999999995 111.029 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 10.1 tp10 -87.67 -87.26 0.15 Allowed 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 122.849 0.459 . . . . 63.439999999999998 110.611 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.03 -30.34 17.81 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.065 0.936 . . . . 72.540000000000006 109.208 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.92 148.74 40.9 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 106.704 -1.591 . . . . 71.319999999999993 106.704 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 0.6 OUTLIER -86.28 105.83 16.92 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 105.988 -1.856 . . . . 73.329999999999998 105.988 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.94 91.14 1.18 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.763 1.268 . . . . 74.219999999999999 109.718 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.9 t -83.33 132.77 34.99 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 113.334 -1.757 . . . . 74.450000000000003 112.252 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.0 p -139.46 119.8 13.85 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.447 -2.057 . . . . 74.430000000000007 105.447 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.89 -179.75 27.8 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 119.473 -1.346 . . . . 72.030000000000001 113.048 -173.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -105.17 111.45 24.2 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 123.977 0.911 . . . . 74.030000000000001 108.703 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.99 126.86 43.6 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.57 -0.852 . . . . 72.439999999999998 109.42 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.93 98.58 8.4 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 121.468 0.651 . . . . 72.0 111.72 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 53.1 m-85 -94.37 101.78 13.73 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.591 -0.892 . . . . 73.519999999999996 108.591 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.438 ' H ' HD13 ' A' ' 567' ' ' ILE . 75.4 mt-30 -86.55 -79.59 0.26 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.73 -0.668 . . . . 64.129999999999995 109.735 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -104.63 163.48 12.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.719 -0.673 . . . . 73.430000000000007 109.701 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.37 -21.24 66.66 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.658 1.183 . . . . 74.299999999999997 112.269 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.69 -16.65 63.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.864 0.69 . . . . 73.239999999999995 112.864 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.438 HD13 ' H ' ' A' ' 563' ' ' GLN . 38.7 pt -112.63 160.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.539 -0.464 . . . . 73.019999999999996 110.767 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.47 144.9 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.315 -1.365 . . . . 72.25 107.315 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 73.0 mmtt -102.51 149.82 24.01 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.045 0.45 . . . . 75.200000000000003 110.756 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 66.2 mt -123.01 128.62 75.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.421 -1.263 . . . . 74.319999999999993 108.807 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 62.5 mt -90.76 121.72 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 107.529 -1.286 . . . . 72.5 107.529 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 521' ' ' MET . 40.1 p -110.23 113.28 25.83 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.801 -0.636 . . . . 74.239999999999995 109.411 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.411 HD11 ' SD ' ' A' ' 521' ' ' MET . 61.0 mt -103.97 122.5 56.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.061 -1.089 . . . . 73.400000000000006 108.061 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 80.3 mtt85 -75.76 115.92 15.94 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.868 0.73 . . . . 73.310000000000002 109.522 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.05 139.56 19.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.212 -1.403 . . . . 73.019999999999996 107.212 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 C--N 1.297 -1.711 0 CA-C-O 121.194 0.521 . . . . 74.540000000000006 110.166 -178.216 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . 0.406 ' HB2' HG12 ' A' ' 645' ' ' ILE . 59.2 m . . . . . 0 N--CA 1.425 -1.678 0 N-CA-C 108.973 -0.751 . . . . 65.420000000000002 108.973 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 27.4 p -139.43 113.53 8.81 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.492 0.663 . . . . 71.25 111.229 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.3 p90 -109.81 -178.43 3.53 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.169 -1.049 . . . . 75.209999999999994 108.169 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 19.7 m -135.01 167.52 20.79 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.989 -0.684 . . . . 61.219999999999999 110.447 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 540' ' ' LYS . 51.7 tp -137.97 132.49 32.4 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.55 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.663 -0.495 . . . . 74.329999999999998 109.663 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.39 145.31 29.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.7 -0.682 . . . . 75.25 109.304 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.71 174.19 6.07 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.679 -0.86 . . . . 74.439999999999998 108.679 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -66.03 116.8 36.3 Favored Pre-proline 0 C--O 1.246 0.888 0 CA-C-O 121.106 0.479 . . . . 73.329999999999998 111.766 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.28 147.56 53.52 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.422 2.081 . . . . 71.129999999999995 111.573 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -113.12 140.27 48.03 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 109.402 -0.592 . . . . 75.200000000000003 109.402 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -92.42 127.57 37.96 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.148 -1.797 . . . . 75.430000000000007 106.148 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 34.6 mm . . . . . 0 C--N 1.287 -2.149 0 N-CA-C 108.692 -0.855 . . . . 75.150000000000006 108.692 -178.811 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.015 0 CA-C-O 121.014 0.435 . . . . 64.040000000000006 111.001 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.27 -174.38 4.15 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.903 -0.777 . . . . 73.030000000000001 108.903 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -81.69 -152.8 10.09 Favored Glycine 0 C--N 1.306 -1.106 0 C-N-CA 120.452 -0.88 . . . . 71.420000000000002 112.272 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -64.85 -42.0 95.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.85 0.833 . . . . 74.409999999999997 109.232 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -167.41 145.34 4.7 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 125.583 1.553 . . . . 73.400000000000006 107.068 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.1 t -153.29 116.53 4.61 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.824 0.821 . . . . 72.209999999999994 110.446 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -146.19 142.93 28.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.714 -1.217 . . . . 73.310000000000002 107.714 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 45.5 tp -121.97 113.01 18.99 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.743 -0.836 . . . . 74.319999999999993 108.743 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.1 mt-10 -92.35 122.86 35.22 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.816 -1.179 . . . . 73.010000000000005 107.816 176.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.12 117.53 55.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 109.243 -0.651 . . . . 72.530000000000001 109.243 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.04 123.42 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.717 0 N-CA-C 108.059 -1.089 . . . . 73.519999999999996 108.059 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . 0.406 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 121.501 0.667 . . . . 64.430000000000007 110.399 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.341 0 N-CA-C 111.128 -0.789 . . . . 71.310000000000002 111.128 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -79.27 112.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.28 -1.378 . . . . 75.239999999999995 107.28 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 94.9 m-85 -96.3 134.94 38.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.394 0.434 . . . . 74.510000000000005 110.385 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.4 t -149.2 158.24 44.02 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 124.06 0.85 . . . . 71.409999999999997 108.948 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.502 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 64.4 m-85 -79.85 169.39 17.98 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.374 -0.602 . . . . 74.530000000000001 109.374 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.69 -41.71 59.74 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.43 0.633 . . . . 73.530000000000001 109.643 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.67 161.52 61.33 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.286 -0.87 . . . . 73.140000000000001 108.934 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.03 -12.18 7.2 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.926 1.751 . . . . 75.140000000000001 112.079 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.435 HG23 ' HB2' ' A' ' 642' ' ' GLU . 72.3 t -142.43 138.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.033 -0.729 . . . . 72.099999999999994 109.033 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.2 t -133.7 136.56 44.76 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.121 -0.696 . . . . 74.439999999999998 109.121 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -107.33 114.45 28.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.058 -0.519 . . . . 70.310000000000002 110.193 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 27.5 m -129.16 166.0 27.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.051 -0.522 . . . . 72.209999999999994 109.872 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.3 t -85.99 162.76 18.35 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.933 0.397 . . . . 72.420000000000002 110.4 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -80.95 -19.87 43.25 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.955 -1.498 . . . . 74.310000000000002 106.955 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.1 m -107.14 25.83 10.9 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.03 -0.986 . . . . 62.310000000000002 111.296 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 515' ' ' SER . 7.7 tt -87.18 -21.38 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 121.433 0.635 . . . . 74.329999999999998 111.419 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.93 -74.58 1.85 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.491 -0.862 . . . . 74.109999999999999 112.221 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.0 mm -134.97 147.12 29.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.647 -1.612 . . . . 74.430000000000007 106.647 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.429 ' HE3' ' CG2' ' A' ' 523' ' ' VAL . 5.2 ppp? -123.29 145.47 48.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.678 -1.23 . . . . 71.329999999999998 107.678 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -111.97 129.01 56.33 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 123.57 0.544 . . . . 71.140000000000001 111.631 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.429 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 45.4 t -122.07 103.95 14.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.415 -0.357 . . . . 71.400000000000006 110.227 174.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.477 ' HB3' HG12 ' A' ' 570' ' ' ILE . 17.9 ptpt -86.69 129.0 35.04 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.613 -0.884 . . . . 72.430000000000007 108.613 172.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.04 133.54 30.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.623 -0.51 . . . . 71.400000000000006 109.623 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 74.6 mt -96.89 149.23 22.11 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.946 -0.57 . . . . 72.239999999999995 110.574 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 504' ' ' ILE 0.285 0.0 OUTLIER -130.69 109.21 10.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.655 0.741 . . . . 72.510000000000005 111.397 171.918 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 14.3 m -65.04 -44.9 87.58 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.35 -1.296 . . . . 75.209999999999994 113.277 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 p -72.96 -39.73 65.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.016 0.436 . . . . 62.5 112.153 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.78 -167.0 26.83 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.685 -1.366 . . . . 73.299999999999997 109.685 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.421 ' HB3' ' HG3' ' A' ' 527' ' ' ARG . . . -162.63 116.31 1.72 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.441 -0.577 . . . . 65.439999999999998 109.441 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -154.95 106.8 2.68 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.634 -1.247 . . . . 75.450000000000003 107.634 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 146.25 -140.5 8.86 Favored Glycine 0 C--N 1.298 -1.538 0 N-CA-C 110.753 -0.939 . . . . 74.409999999999997 110.753 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -136.91 101.03 4.46 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.359 -1.719 . . . . 74.219999999999999 106.359 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.48 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.254 0.55 . . . . 74.329999999999998 110.355 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.0 123.77 55.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.886 -0.783 . . . . 75.400000000000006 108.886 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.43 108.83 60.16 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.715 -0.846 . . . . 72.310000000000002 108.715 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -78.16 146.61 22.77 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 73.420000000000002 111.789 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.56 162.4 35.45 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.565 -1.272 . . . . 72.099999999999994 107.565 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -162.1 145.91 12.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.228 0.537 . . . . 74.450000000000003 111.845 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.6 p -85.82 133.84 33.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.936 -1.029 . . . . 63.219999999999999 111.078 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.55 114.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.988 -1.486 . . . . 75.299999999999997 106.988 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.44 126.5 32.81 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.804 -0.443 . . . . 71.209999999999994 109.804 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -128.68 -94.58 0.79 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.658 -0.782 . . . . 65.409999999999997 111.661 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 18.4 p -92.12 17.61 9.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.379 1.085 . . . . 64.430000000000007 110.554 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -146.92 134.7 21.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.888 -1.523 . . . . 40.340000000000003 106.888 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.52 132.83 46.94 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 109.081 -0.711 . . . . 65.420000000000002 109.081 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -97.69 138.41 13.87 Favored Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 115.836 -0.62 . . . . 72.239999999999995 111.97 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 129.25 11.07 2.87 Favored Glycine 0 C--N 1.294 -1.752 0 C-N-CA 120.894 -0.669 . . . . 60.32 111.93 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . 0.441 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 133.49 -17.42 4.48 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.517 -1.325 . . . . 61.119999999999997 113.671 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.86 -79.48 0.12 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.111 -0.636 . . . . 63.149999999999999 111.407 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.06 -42.75 9.78 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.974 -1.121 . . . . 71.129999999999995 107.974 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -144.53 174.07 11.26 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.149 -0.932 . . . . 72.450000000000003 109.119 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -103.42 120.56 41.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.231 -2.137 . . . . 64.120000000000005 105.231 177.533 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.63 139.22 45.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.55 -0.46 . . . . 74.109999999999999 110.353 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -138.54 128.67 25.59 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.813 0.816 . . . . 72.420000000000002 111.33 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.3 p -145.35 133.37 21.41 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.485 -1.302 . . . . 72.420000000000002 107.485 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.25 -165.19 31.59 Favored Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.016 -1.564 . . . . 54.310000000000002 112.718 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -109.85 116.06 30.97 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.436 0.694 . . . . 74.340000000000003 111.13 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.47 138.08 32.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.546 -0.909 . . . . 74.310000000000002 108.546 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -104.8 102.93 12.47 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.626 0.727 . . . . 74.140000000000001 111.976 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.4 m-85 -101.49 99.98 10.37 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.231 -1.025 . . . . 74.549999999999997 108.231 174.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.24 -82.59 0.13 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.933 -0.707 . . . . 61.539999999999999 110.813 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -104.83 177.16 4.93 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.765 0.793 . . . . 55.109999999999999 112.127 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.433 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 23.9 t70 -75.33 -16.21 60.43 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.728 -1.123 . . . . 72.109999999999999 112.049 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.38 -19.62 63.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.082 0.771 . . . . 70.239999999999995 113.082 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 45.0 pt -113.14 168.93 5.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.715 -1.217 . . . . 73.450000000000003 107.715 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.32 143.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.444 -0.947 . . . . 72.400000000000006 108.444 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 71.4 mmtt -98.89 142.53 30.29 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-O 121.253 0.549 . . . . 74.219999999999999 110.73 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 524' ' ' LYS . 14.7 mt -129.25 130.41 67.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.222 -1.354 . . . . 75.5 109.729 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 44.9 mt -90.23 126.7 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.155 -1.424 . . . . 73.329999999999998 107.155 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 20.9 p -112.71 113.5 25.65 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.287 -0.634 . . . . 73.430000000000007 109.287 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.413 HD12 ' SD ' ' A' ' 521' ' ' MET . 71.6 mt -104.1 126.06 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 N-CA-C 108.728 -0.841 . . . . 65.420000000000002 108.728 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.407 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.5 OUTLIER -79.27 108.2 12.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.554 -1.276 . . . . 73.099999999999994 107.554 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.78 127.99 46.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.061 -1.829 . . . . 75.519999999999996 106.061 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . 0.441 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 96.3 m-85 . . . . . 0 C--N 1.286 -2.162 0 C-N-CA 119.766 -0.774 . . . . 74.430000000000007 110.731 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.428 -1.555 0 CA-C-O 121.171 0.51 . . . . 75.120000000000005 109.709 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.2 m -147.05 138.28 23.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.454 -0.573 . . . . 74.430000000000007 109.454 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -137.13 163.63 30.37 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.312 -0.995 . . . . 75.209999999999994 108.312 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.6 m -112.94 161.37 17.08 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 119.842 -0.743 . . . . 72.319999999999993 109.828 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 70.0 tp -132.71 126.32 32.26 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.458 -1.682 . . . . 71.140000000000001 106.458 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.22 158.14 28.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 120.861 0.362 . . . . 75.230000000000004 110.739 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.502 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 80.0 mt -106.41 148.04 28.59 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.914 -1.143 . . . . 75.219999999999999 107.914 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.08 177.31 4.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.772 -0.455 . . . . 72.409999999999997 109.772 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.23 122.49 73.21 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 113.077 0.769 . . . . 75.340000000000003 113.077 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.469 ' HD3' HD21 ' A' ' 635' ' ' LEU . 75.2 Cg_endo -75.17 145.85 31.36 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.888 2.392 . . . . 71.209999999999994 111.868 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -116.53 140.62 49.17 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 115.704 -0.68 . . . . 71.549999999999997 109.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -104.98 124.21 49.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.252 -1.018 . . . . 74.340000000000003 108.252 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.291 -1.968 0 N-CA-C 107.604 -1.258 . . . . 75.120000000000005 107.604 177.568 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.953 -0.388 . . . . 71.239999999999995 109.953 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.469 HD21 ' HD3' ' A' ' 594' ' ' PRO . 2.5 pt? -112.0 -163.13 0.83 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.62 -1.252 . . . . 75.140000000000001 107.62 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.33 143.48 47.26 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.646 -1.382 . . . . 74.239999999999995 109.646 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.92 -39.49 72.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.722 -0.391 . . . . 75.200000000000003 111.558 -173.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -124.55 107.79 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.347 -0.541 . . . . 64.530000000000001 110.497 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 115.42 5.18 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.742 0.782 . . . . 75.019999999999996 109.397 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -147.9 127.9 13.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.664 -0.865 . . . . 74.409999999999997 108.664 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.93 112.34 25.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.645 -0.502 . . . . 73.420000000000002 109.645 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 511' ' ' VAL . 45.0 mt-10 -89.76 113.45 24.98 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.605 0.717 . . . . 63.399999999999999 109.438 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 36.7 t -100.43 115.53 41.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.387 -1.279 . . . . 75.140000000000001 108.439 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 21.2 mt -112.32 126.78 69.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 CA-C-N 114.823 -1.081 . . . . 61.439999999999998 109.169 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 514' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.221 0 CA-C-N 115.818 -0.628 . . . . 73.120000000000005 112.582 -176.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.83 0 N-CA-C 109.18 -1.568 . . . . 60.229999999999997 109.18 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.488 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.2 mt -127.97 124.26 62.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.609 -0.515 . . . . 74.540000000000006 109.609 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.51 137.3 43.57 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.669 0.606 . . . . 73.150000000000006 110.601 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -149.18 156.28 41.93 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.248 -0.278 . . . . 74.230000000000004 110.248 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.477 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 61.4 m-85 -77.2 168.76 19.52 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.213 -1.032 . . . . 71.040000000000006 108.213 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.49 -46.94 36.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.662 0.744 . . . . 73.230000000000004 109.005 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -122.91 164.6 26.14 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 114.838 -1.074 . . . . 75.209999999999994 109.847 -174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -90.47 -19.53 1.09 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.613 2.209 . . . . 73.420000000000002 112.011 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.2 132.75 38.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.363 -0.977 . . . . 73.040000000000006 108.363 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' THR . . . . . 0.447 HG23 HD23 ' A' ' 641' ' ' LEU . 10.0 t -131.22 127.31 37.62 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.995 -0.743 . . . . 63.119999999999997 108.995 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -99.88 125.11 45.8 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.492 -0.929 . . . . 75.349999999999994 108.492 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.8 m -134.59 162.31 39.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.408 0.623 . . . . 65.25 109.713 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 518' ' ' ILE . 39.3 m -80.9 157.34 25.65 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.71 -0.677 . . . . 72.230000000000004 110.284 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -77.62 -23.66 49.74 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.556 -1.276 . . . . 63.420000000000002 107.556 172.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.0 p -95.73 18.95 12.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.035 -1.439 . . . . 75.310000000000002 111.45 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 515' ' ' SER . 9.0 tt -81.77 -31.73 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.941 -0.704 . . . . 75.109999999999999 111.274 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.09 -75.27 1.59 Allowed Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.413 -0.898 . . . . 72.530000000000001 111.139 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 44.2 mm -126.65 125.67 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.377 -0.972 . . . . 71.519999999999996 108.377 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -97.36 147.22 24.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.357 -0.979 . . . . 73.430000000000007 108.357 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -118.15 115.49 24.91 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.282 0.633 . . . . 72.150000000000006 112.238 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 36.8 t -109.92 124.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.56 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.33 127.99 41.83 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.795 -0.817 . . . . 72.0 108.795 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.56 118.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 75.019999999999996 109.032 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.7 mt -93.46 148.34 22.16 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.312 -0.858 . . . . 74.219999999999999 109.514 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 102.92 12.28 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.029 -2.582 . . . . 74.319999999999993 104.029 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 10.4 t -66.86 -46.64 74.4 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.844 -0.742 . . . . 71.109999999999999 110.583 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' SER . . . . . 0.488 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 30.1 t -74.4 -45.28 47.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.2 0.524 . . . . 74.430000000000007 110.095 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.57 -168.83 23.72 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 109.802 -1.319 . . . . 63.32 109.802 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -156.08 137.68 14.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.652 -0.87 . . . . 41.340000000000003 108.652 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -155.81 103.85 2.28 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.952 . . . . 71.25 108.431 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 137.76 -131.08 5.32 Favored Glycine 0 C--N 1.308 -0.991 0 N-CA-C 110.826 -0.909 . . . . 73.409999999999997 110.826 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -136.98 102.5 4.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.337 -1.357 . . . . 54.140000000000001 107.337 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 26.5 t -121.56 122.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.885 -0.726 . . . . 72.030000000000001 111.421 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.7 mm -88.17 120.98 37.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.483 -1.302 . . . . 75.150000000000006 107.483 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.4 t -110.42 104.77 56.42 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.062 -0.718 . . . . 64.319999999999993 109.062 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 592' ' ' GLU . 14.8 Cg_endo -85.16 163.28 11.47 Favored 'Trans proline' 0 N--CA 1.419 -2.89 0 C-N-CA 121.475 1.45 . . . . 74.420000000000002 111.375 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.427 ' CZ ' HG21 ' A' ' 571' ' ' ILE . 23.6 p90 -149.91 164.29 35.81 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.046 -1.835 . . . . 73.340000000000003 106.046 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.15 133.01 16.03 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.22 -0.592 . . . . 74.430000000000007 111.089 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 555' ' ' ASP . 17.7 p -82.35 121.15 26.33 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.843 -1.071 . . . . 71.329999999999998 109.719 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.72 116.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.289 -1.374 . . . . 73.319999999999993 107.289 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -72.47 110.05 6.59 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.704 0.628 . . . . 61.439999999999998 110.129 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -98.54 -107.68 2.71 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.809 -0.917 . . . . 63.43 110.809 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.1 p -85.04 -20.59 30.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.571 0.701 . . . . 73.319999999999993 109.901 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.26 134.3 35.6 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.893 -1.151 . . . . 72.230000000000004 107.893 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -92.26 138.42 31.54 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 120.832 0.349 . . . . 73.200000000000003 111.7 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.1 -158.58 20.51 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 111.147 -0.781 . . . . 61.310000000000002 111.147 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.91 17.14 79.29 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.198 -0.761 . . . . 75.519999999999996 111.198 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.16 32.76 60.01 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 111.372 -0.691 . . . . 62.299999999999997 111.372 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.28 -71.23 0.64 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.804 -0.813 . . . . 74.230000000000004 108.804 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.53 -31.01 13.53 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.556 -1.275 . . . . 73.099999999999994 107.556 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.97 150.08 33.35 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 115.276 -0.875 . . . . 74.420000000000002 109.045 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -87.14 105.63 17.32 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 105.929 -1.878 . . . . 74.519999999999996 105.929 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . 0.426 ' HB2' ' OG1' ' A' ' 541' ' ' THR . 7.5 p-10 -76.65 135.29 39.13 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.84 0.828 . . . . 72.200000000000003 111.321 -173.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 3.2 t -133.53 148.98 51.69 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.026 -0.988 . . . . 72.409999999999997 110.548 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.9 p -148.33 111.29 4.84 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.136 0.574 . . . . 74.129999999999995 110.925 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 101.51 -164.02 17.76 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.95 -0.643 . . . . 64.310000000000002 112.28 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 84.51 10.51 0.38 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.513 1.525 . . . . 73.030000000000001 114.024 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 569' ' ' LYS . 32.0 mt -106.4 133.43 51.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 118.977 -1.089 . . . . 71.129999999999995 111.061 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -132.1 114.97 15.17 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.919 -0.771 . . . . 72.310000000000002 108.919 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.3 m-85 -111.09 105.94 14.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.321 -0.992 . . . . 72.340000000000003 108.321 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.432 ' H ' HD12 ' A' ' 567' ' ' ILE . 49.2 mt-30 -83.89 -69.15 0.66 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.322 -0.992 . . . . 71.310000000000002 108.322 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -105.2 160.93 14.7 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.4 -0.818 . . . . 75.530000000000001 109.228 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.38 -22.63 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.077 0.465 . . . . 73.109999999999999 111.959 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.86 -6.94 9.36 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.987 1.106 . . . . 73.340000000000003 113.987 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -115.21 162.61 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.896 -0.779 . . . . 73.340000000000003 108.896 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.7 p -131.18 150.71 34.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.688 -1.227 . . . . 72.25 107.688 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -120.61 155.94 32.7 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.905 -0.405 . . . . 75.129999999999995 109.905 174.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.9 mt -125.34 135.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 124.275 0.984 . . . . 74.430000000000007 109.641 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.3 mt -92.32 120.92 42.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.491 -1.67 . . . . 74.420000000000002 106.491 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 31.2 p -110.52 112.79 24.94 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.615 0.572 . . . . 73.239999999999995 109.718 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 70.4 mt -112.48 128.43 69.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.897 -0.779 . . . . 73.219999999999999 108.897 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -85.07 126.94 34.0 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.588 0.555 . . . . 72.209999999999994 109.526 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.2 142.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.039 -1.097 . . . . 70.129999999999995 108.039 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 . . . . . 0 C--N 1.306 -1.297 0 CA-C-O 121.196 0.522 . . . . 75.109999999999999 109.787 -179.121 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.429 -1.52 0 N-CA-C 109.617 -0.512 . . . . 62.43 109.617 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 35.2 p -138.34 153.58 48.97 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.289 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.92 161.34 37.82 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.661 -1.237 . . . . 74.340000000000003 107.661 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.0 m -110.81 158.6 18.5 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 119.541 -0.863 . . . . 65.319999999999993 109.511 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 47.0 tp -134.78 121.69 21.07 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.798 -1.186 . . . . 73.450000000000003 107.798 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.73 155.87 26.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 109.584 -0.524 . . . . 71.239999999999995 109.584 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.477 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 82.9 mt -90.96 146.63 23.72 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.137 -1.06 . . . . 71.430000000000007 108.137 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 538' ' ' PRO . 4.7 tp10 -107.12 175.86 5.36 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.78 -1.563 . . . . 75.329999999999998 106.78 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 0.0 OUTLIER -60.82 115.36 13.53 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 113.824 1.046 . . . . 64.219999999999999 113.824 -177.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.41 ' HB2' ' CG1' ' A' ' 535' ' ' VAL . 42.4 Cg_endo -73.82 141.03 29.82 Favored 'Trans proline' 0 N--CA 1.418 -2.949 0 C-N-CA 121.648 1.566 . . . . 72.109999999999999 110.623 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 129.49 56.39 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.857 -0.611 . . . . 75.219999999999999 110.702 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -92.37 117.36 29.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 71.099999999999994 108.18 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--N 1.281 -2.392 0 N-CA-C 106.949 -1.5 . . . . 71.140000000000001 106.949 177.587 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 33.8 pt . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 121.207 0.527 . . . . 63.049999999999997 111.125 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -101.15 175.13 5.7 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.093 -1.077 . . . . 73.219999999999999 108.093 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.45 179.44 29.43 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 121.009 -0.615 . . . . 75.219999999999999 112.478 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.5 -60.91 2.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.74 -0.837 . . . . 73.0 108.74 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -136.46 114.71 11.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.895 -1.52 . . . . 74.129999999999995 106.895 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.7 t -134.19 109.25 8.76 Favored 'General case' 0 N--CA 1.41 -2.433 0 C-N-CA 119.178 -1.009 . . . . 72.329999999999998 109.979 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -149.35 137.63 20.74 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.45 -1.25 . . . . 75.019999999999996 108.13 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . 0.447 HD23 HG23 ' A' ' 512' ' ' THR . 9.3 mt -104.07 116.65 32.61 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.384 -0.599 . . . . 70.319999999999993 109.384 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.29 113.74 26.08 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.441 -1.689 . . . . 72.310000000000002 106.441 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.4 117.82 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 114.435 -1.257 . . . . 71.5 109.143 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -105.01 127.99 59.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.926 -1.033 . . . . 73.439999999999998 108.406 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 121.61 0.719 . . . . 75.409999999999997 110.323 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.21 0 CA-C-O 120.568 -0.018 . . . . 74.230000000000004 113.12 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.11 114.1 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 105.367 -2.086 . . . . 71.230000000000004 105.367 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.549 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 85.8 m-85 -100.83 138.28 38.08 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 123.571 0.544 . . . . 74.420000000000002 111.103 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 3.8 t -148.27 152.85 37.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.967 -0.56 . . . . 64.25 110.385 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.441 ' CE2' ' HG ' ' A' ' 591' ' ' LEU . 82.3 m-85 -71.68 158.95 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.798 -0.816 . . . . 73.319999999999993 108.798 171.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.0 -47.54 84.32 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.769 0.668 . . . . 75.430000000000007 110.638 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.5 153.9 79.4 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 107.913 -1.143 . . . . 61.399999999999999 107.913 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.39 -18.76 8.19 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.06 1.84 . . . . 73.349999999999994 112.747 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 642' ' ' GLU . 68.7 t -138.82 136.45 43.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.183 -1.043 . . . . 74.319999999999993 108.183 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.1 t -133.51 128.97 36.47 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.42 0.629 . . . . 71.129999999999995 109.607 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -97.96 117.43 32.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.985 -0.746 . . . . 74.010000000000005 108.985 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.54 174.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 121.421 0.629 . . . . 74.329999999999998 109.777 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.446 ' O ' HG21 ' A' ' 518' ' ' ILE . 5.2 m -98.63 150.99 21.18 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.615 -0.72 . . . . 74.319999999999993 110.052 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -66.78 -27.87 67.93 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.383 -0.969 . . . . 73.439999999999998 108.383 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.1 m -103.04 20.82 16.87 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 114.568 -1.196 . . . . 74.140000000000001 111.801 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 515' ' ' SER . 10.6 tt -78.31 -28.09 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 121.446 -0.784 . . . . 74.049999999999997 112.678 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.41 -75.04 1.9 Allowed Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.332 -0.937 . . . . 74.120000000000005 111.483 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.8 mm -133.61 144.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 107.672 -1.233 . . . . 61.32 107.672 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.401 ' SD ' HD12 ' A' ' 573' ' ' ILE . 18.4 ptm -117.96 128.5 54.86 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.254 -0.647 . . . . 74.040000000000006 109.254 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -100.38 120.31 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.838 0.711 . . . . 73.200000000000003 110.512 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 131.74 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.306 -0.627 . . . . 74.219999999999999 109.306 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.62 149.97 20.87 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.817 0.818 . . . . 74.120000000000005 111.938 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.52 113.06 42.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 106.984 -1.487 . . . . 73.239999999999995 106.984 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.5 mt -90.17 160.31 16.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.295 -0.866 . . . . 72.430000000000007 110.147 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 104.3 9.14 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.224 -1.028 . . . . 74.299999999999997 108.224 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.5 m -65.85 -52.67 48.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.669 0.747 . . . . 75.200000000000003 109.776 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 30.6 t -73.52 -52.25 14.2 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.932 . . . . 71.230000000000004 111.26 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.77 -156.78 26.8 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 109.681 -1.368 . . . . 72.430000000000007 109.681 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.1 137.07 3.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.957 -0.756 . . . . 75.340000000000003 108.957 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -148.66 148.45 30.09 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 123.427 0.691 . . . . 75.420000000000002 109.186 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 85.7 -124.47 6.85 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.84 -0.695 . . . . 73.099999999999994 111.865 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -137.38 104.36 5.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.927 -0.768 . . . . 74.310000000000002 108.927 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.54 125.81 74.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.521 0.677 . . . . 72.420000000000002 110.856 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 30.7 mm -96.51 119.54 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.69 -0.687 . . . . 74.030000000000001 109.262 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 50.1 t -106.89 103.11 45.99 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.249 -1.019 . . . . 54.210000000000001 108.249 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.71 147.37 27.72 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.798 1.666 . . . . 73.239999999999995 111.743 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.405 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 52.0 p90 -138.17 158.22 44.74 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.021 -1.103 . . . . 74.439999999999998 108.021 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -154.34 135.5 13.96 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.111 0.482 . . . . 72.209999999999994 110.818 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.54 131.24 36.72 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.976 -1.011 . . . . 71.25 110.481 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 46.3 mm -100.44 120.31 49.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.61 104.81 5.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.682 -0.69 . . . . 74.340000000000003 109.32 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -88.72 -122.1 1.94 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.528 -1.029 . . . . 72.439999999999998 110.528 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -6.61 58.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.923 0.868 . . . . 73.019999999999996 108.926 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.75 27.8 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.567 -1.197 . . . . 65.109999999999999 108.794 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.418 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 38.9 mmt180 -79.47 147.85 32.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.628 -1.249 . . . . 74.219999999999999 107.628 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -109.54 148.49 17.17 Favored Glycine 0 C--N 1.263 -3.498 0 CA-C-N 115.267 -0.879 . . . . 65.319999999999993 114.085 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 88.59 48.02 4.09 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.542 -0.837 . . . . 51.310000000000002 113.657 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.86 43.85 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.706 -1.235 . . . . 73.530000000000001 113.996 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 37.8 mm-40 -96.29 -84.39 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.631 0.715 . . . . 71.129999999999995 110.342 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.6 -44.37 21.15 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.772 -1.566 . . . . 73.010000000000005 106.772 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -136.39 157.58 46.45 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.421 -1.263 . . . . 71.549999999999997 108.83 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -92.24 142.05 27.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.079 -1.822 . . . . 61.5 106.079 175.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.86 100.78 11.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 75.25 110.713 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -111.29 104.47 12.95 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-O 122.582 1.182 . . . . 75.340000000000003 109.129 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.7 p -126.72 140.02 52.71 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.959 -1.497 . . . . 54.109999999999999 106.959 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 177.51 -151.32 10.8 Favored Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.487 -1.816 . . . . 73.519999999999996 113.261 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.18 125.94 41.97 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.222 1.009 . . . . 55.439999999999998 112.033 -171.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.405 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 86.1 mt -100.92 135.54 42.21 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.63 -0.878 . . . . 73.099999999999994 108.63 173.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.84 109.36 21.06 Favored 'General case' 0 C--N 1.276 -2.603 0 CA-C-O 121.185 0.517 . . . . 74.019999999999996 111.011 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 51.3 m-85 -105.27 101.79 11.31 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.172 -1.047 . . . . 74.450000000000003 108.172 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -80.2 -79.18 0.15 Allowed 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.649 -0.82 . . . . 73.120000000000005 110.754 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -104.8 158.14 16.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.649 -0.82 . . . . 73.329999999999998 108.953 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.13 -11.55 9.27 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.897 1.279 . . . . 74.439999999999998 113.269 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.92 -11.03 54.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.648 0.779 . . . . 64.129999999999995 111.966 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 35.3 pt -119.07 158.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.48 0.657 . . . . 75.109999999999999 110.674 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.77 143.38 41.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.087 -1.82 . . . . 64.409999999999997 106.087 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 27.1 mttm -111.14 155.99 22.05 Favored 'General case' 0 CA--C 1.469 -2.156 0 C-N-CA 119.393 -0.923 . . . . 75.219999999999999 112.973 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 72.3 mt -124.45 136.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.245 -1.343 . . . . 73.25 109.773 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 59.1 mt -98.06 129.03 48.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.816 -1.55 . . . . 74.209999999999994 106.816 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.9 p -118.28 112.56 20.24 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.295 0.569 . . . . 71.219999999999999 110.777 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.435 HD13 HD22 ' A' ' 589' ' ' LEU . 49.4 mt -106.4 135.47 44.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.812 -0.631 . . . . 75.25 109.969 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 70.9 mtt180 -80.06 112.01 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.198 -0.667 . . . . 73.209999999999994 109.198 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.83 131.09 49.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.337 -0.847 . . . . 71.299999999999997 108.735 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 N--CA 1.422 -1.831 0 N-CA-C 109.57 -0.53 . . . . 73.329999999999998 109.57 -178.68 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 112.57 0.581 . . . . 74.400000000000006 112.57 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 44.8 p -142.82 147.74 35.94 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.261 0.553 . . . . 74.239999999999995 111.81 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -136.86 -179.88 5.97 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.028 -1.471 . . . . 73.200000000000003 107.028 173.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 22.0 m -130.85 168.43 17.28 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.342 -0.943 . . . . 75.030000000000001 110.631 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.435 HD22 HD13 ' A' ' 573' ' ' ILE . 46.6 tp -142.12 132.72 25.38 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.977 -1.49 . . . . 73.519999999999996 106.977 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.75 159.27 41.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 120.54 0.21 . . . . 62.100000000000001 110.608 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.441 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 65.5 mt -101.65 147.65 26.18 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 106.17 -1.789 . . . . 73.319999999999993 106.17 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.33 177.62 4.8 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.225 -0.657 . . . . 73.120000000000005 109.225 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -61.49 118.49 37.83 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 123.411 0.445 . . . . 74.150000000000006 109.819 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.437 ' HD3' HD21 ' A' ' 635' ' ' LEU . 66.1 Cg_endo -71.99 156.57 56.0 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.451 2.101 . . . . 74.230000000000004 111.333 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -129.55 124.13 33.11 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.044 -0.526 . . . . 75.319999999999993 110.824 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -90.0 120.87 31.57 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.32 -1.363 . . . . 74.340000000000003 107.32 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--N 1.293 -1.864 0 N-CA-C 107.763 -1.199 . . . . 74.340000000000003 107.763 177.066 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 109.255 -0.646 . . . . 75.540000000000006 109.255 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.549 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 1.9 pt? -133.55 179.02 6.48 Favored 'General case' 0 C--N 1.268 -2.966 0 C-N-CA 120.141 -0.624 . . . . 74.239999999999995 109.415 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.94 142.13 42.85 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.846 -1.302 . . . . 73.209999999999994 109.846 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -48.5 -51.05 29.15 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.141 0.977 . . . . 74.140000000000001 111.401 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -126.63 89.77 3.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.112 -0.699 . . . . 70.420000000000002 109.112 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 639' ' ' THR . . . . . 0.4 ' CG2' HD13 ' A' ' 635' ' ' LEU . 15.4 t -119.34 111.02 17.65 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.482 1.135 . . . . 75.120000000000005 109.477 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -145.06 147.44 32.58 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.81 -1.552 . . . . 75.099999999999994 106.81 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 33.6 tp -117.21 107.02 13.94 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.125 -1.065 . . . . 74.420000000000002 108.125 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.432 ' HB2' HG21 ' A' ' 511' ' ' VAL . 35.9 mt-10 -86.99 111.28 20.7 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.308 -0.997 . . . . 71.019999999999996 108.308 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.8 118.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.614 -1.176 . . . . 62.420000000000002 109.284 -174.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 17.3 mt -117.74 119.34 61.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.852 . . . . 72.209999999999994 110.166 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 109.221 -0.659 . . . . 74.319999999999993 109.221 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.06 0 N-CA-C 108.532 -1.827 . . . . 75.239999999999995 108.532 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 57.1 mt -98.75 115.19 38.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.485 -0.561 . . . . 74.450000000000003 109.485 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.44 ' CE1' ' HG3' ' A' ' 527' ' ' ARG . 86.8 m-85 -103.24 139.86 38.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.034 -0.53 . . . . 74.329999999999998 111.456 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.11 154.09 39.72 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.677 -0.49 . . . . 73.25 109.677 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.647 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 58.1 m-85 -75.67 160.36 30.15 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.681 -0.489 . . . . 74.439999999999998 109.681 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.61 -49.48 75.05 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.523 0.514 . . . . 73.109999999999999 110.197 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.87 166.44 27.43 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 116.286 -0.415 . . . . 73.530000000000001 111.168 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 4.7 Cg_exo -83.67 -30.9 0.67 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.501 2.134 . . . . 75.019999999999996 111.729 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 70.3 t -143.35 130.66 18.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.3 t -134.13 131.13 38.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.794 -0.817 . . . . 75.219999999999999 108.794 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -106.36 112.43 25.44 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.133 -0.692 . . . . 74.150000000000006 109.133 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 30.6 m -112.87 157.87 13.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.988 0.899 . . . . 74.219999999999999 111.523 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 68.0 m -81.79 174.02 11.72 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.5 -1.227 . . . . 73.349999999999994 110.498 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.03 -30.86 17.47 Favored 'General case' 0 CA--C 1.509 -0.596 0 O-C-N 121.741 -0.6 . . . . 71.439999999999998 110.031 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.4 m -80.23 5.89 13.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.474 -0.784 . . . . 73.340000000000003 110.798 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 4.9 tt -75.69 -28.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.159 0.505 . . . . 74.340000000000003 110.137 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 82.94 -71.61 2.98 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.785 -0.722 . . . . 55.210000000000001 113.199 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 44.6 mm -132.04 126.28 56.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.622 -0.881 . . . . 72.519999999999996 108.622 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.414 ' SD ' HD13 ' A' ' 573' ' ' ILE . 5.2 ppp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.178 -0.675 . . . . 74.049999999999997 109.178 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.61 131.69 56.86 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.27 0.628 . . . . 72.239999999999995 111.384 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 38.6 t -127.5 115.25 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 109.199 -0.667 . . . . 75.219999999999999 109.199 171.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -90.19 127.35 36.1 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.229 -0.588 . . . . 73.25 110.115 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.37 114.58 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.608 -0.886 . . . . 74.319999999999993 108.608 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 51.7 mt -93.14 143.89 25.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.051 -0.977 . . . . 75.120000000000005 110.53 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.44 ' HG3' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -105.54 104.77 14.56 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.394 -1.706 . . . . 75.019999999999996 106.394 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.8 t -66.91 -48.17 69.5 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.943 -0.703 . . . . 72.430000000000007 111.443 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.4 p -74.34 -52.44 12.2 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.495 0.664 . . . . 55.310000000000002 111.479 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 147.96 -170.15 28.64 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 109.53 -1.428 . . . . 72.010000000000005 109.53 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.19 129.24 2.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.61 -0.885 . . . . 64.109999999999999 108.61 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -153.21 81.68 1.19 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.162 0.506 . . . . 74.219999999999999 109.986 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 167.77 -129.43 1.9 Allowed Glycine 0 C--N 1.303 -1.297 0 N-CA-C 109.505 -1.438 . . . . 71.439999999999998 109.505 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -137.32 112.54 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.288 -1.375 . . . . 72.439999999999998 107.288 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.61 130.42 74.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 120.926 0.393 . . . . 71.140000000000001 110.724 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 39.2 mm -100.09 113.5 35.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.633 -0.877 . . . . 74.319999999999993 108.633 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.03 102.77 44.78 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.494 -0.928 . . . . 74.519999999999996 108.494 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -80.63 161.56 21.87 Favored 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 121.719 1.612 . . . . 73.109999999999999 110.949 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -151.12 163.61 38.42 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.676 -0.861 . . . . 71.219999999999999 108.676 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . 0.417 ' HE2' ' OE2' ' A' ' 592' ' ' GLU . 61.8 pttt -148.99 137.92 21.36 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 112.679 0.622 . . . . 72.140000000000001 112.679 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 22.0 p -87.2 117.55 26.03 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 109.944 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 35.9 mm -92.18 124.54 44.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.248 -1.019 . . . . 75.430000000000007 108.248 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.41 119.33 18.46 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.325 -0.62 . . . . 73.230000000000004 109.325 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -97.96 -107.67 2.63 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.742 -1.343 . . . . 74.129999999999995 109.742 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -86.98 -25.9 24.07 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.643 0.735 . . . . 73.510000000000005 109.035 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.02 149.45 30.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.009 -0.996 . . . . 71.219999999999999 109.034 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -104.55 146.27 29.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.481 0.657 . . . . 75.5 110.833 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.55 -155.43 30.66 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 114.357 -1.292 . . . . 65.129999999999995 112.354 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.19 6.36 53.03 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 114.128 0.411 . . . . 75.409999999999997 114.128 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.78 -0.72 34.06 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.164 -1.017 . . . . 73.25 113.249 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -69.62 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.078 0.439 . . . . 65.140000000000001 110.846 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -99.76 -35.78 9.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.349 -0.611 . . . . 64.329999999999998 109.349 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.56 165.11 30.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.742 -0.663 . . . . 74.219999999999999 109.453 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.558 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.9 tm-20 -100.81 122.99 44.35 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.023 -1.473 . . . . 75.109999999999999 107.023 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.09 136.18 57.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 123.162 0.585 . . . . 73.439999999999998 111.4 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.3 t -140.56 105.78 5.03 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.043 0.925 . . . . 74.219999999999999 109.437 174.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 46.9 m -129.57 94.89 3.86 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 106.734 -1.58 . . . . 70.5 106.734 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -136.24 -156.93 7.63 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.378 -0.828 . . . . 44.240000000000002 111.449 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.46 138.98 47.8 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.224 0.535 . . . . 75.310000000000002 110.963 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 73.1 mt -105.5 141.26 37.3 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.201 -0.909 . . . . 71.219999999999999 108.775 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.565 ' HG2' ' NE2' ' A' ' 563' ' ' GLN . 32.9 tt0 -112.92 105.51 13.6 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.409 0.623 . . . . 74.310000000000002 110.398 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 55.3 m-85 -98.15 133.34 42.72 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.574 -0.739 . . . . 75.150000000000006 109.057 177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.565 ' NE2' ' HG2' ' A' ' 561' ' ' GLU . 2.1 mp0 -98.2 -85.38 0.37 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.33 1.062 . . . . 73.0 108.224 174.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 566' ' ' GLU . 0.3 OUTLIER -105.46 161.82 14.0 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.26 -1.336 . . . . 63.439999999999998 110.597 175.04 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.73 -13.35 31.66 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.708 1.203 . . . . 71.030000000000001 113.162 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.46 ' HB3' ' ND2' ' A' ' 564' ' ' ASN . 32.4 tt0 -56.34 -37.05 69.48 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.021 0.929 . . . . 74.450000000000003 111.277 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.21 162.4 6.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.289 -0.869 . . . . 72.120000000000005 109.665 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.426 HG22 ' NH1' ' A' ' 527' ' ' ARG . 14.8 p -131.1 160.1 42.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.386 -1.339 . . . . 74.209999999999994 107.386 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -117.49 150.96 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.547 0.213 . . . . 74.230000000000004 110.499 176.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 65.8 mt -125.25 131.71 72.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 124.366 1.041 . . . . 75.040000000000006 108.922 -177.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.0 mt -90.6 120.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.242 -1.392 . . . . 73.040000000000006 107.242 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -105.24 112.75 25.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.606 0.566 . . . . 74.319999999999993 109.725 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.469 HD11 HD21 ' A' ' 589' ' ' LEU . 51.1 mt -107.3 132.19 55.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.831 -1.174 . . . . 73.109999999999999 107.831 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -81.34 116.05 21.0 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.086 -0.646 . . . . 74.129999999999995 109.939 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.57 124.37 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.201 -1.037 . . . . 74.510000000000005 108.201 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 58.3 m-85 . . . . . 0 C--N 1.295 -1.785 0 N-CA-C 109.755 -0.461 . . . . 73.530000000000001 109.755 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . 0.41 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.2 m . . . . . 0 N--CA 1.42 -1.928 0 CA-C-O 121.401 0.62 . . . . 72.329999999999998 110.9 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 10.5 m -140.08 142.25 36.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.979 -0.749 . . . . 61.100000000000001 108.979 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 50.0 p90 -141.17 165.5 27.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.211 -1.403 . . . . 74.319999999999993 107.211 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 12.1 m -116.64 164.48 14.54 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.614 -0.835 . . . . 75.310000000000002 109.847 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.469 HD21 HD11 ' A' ' 573' ' ' ILE . 49.3 tp -135.56 130.71 34.96 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.073 -1.454 . . . . 74.420000000000002 107.073 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.4 156.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.787 -0.449 . . . . 74.140000000000001 109.787 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.647 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 70.9 mt -97.05 139.16 33.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.595 -0.891 . . . . 73.340000000000003 108.595 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . 0.417 ' OE2' ' HE2' ' A' ' 540' ' ' LYS . 30.6 mm-40 -94.1 167.26 11.69 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.432 -0.951 . . . . 65.109999999999999 108.432 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.27 116.25 16.82 Favored Pre-proline 0 C--N 1.317 -0.831 0 O-C-N 123.916 0.76 . . . . 63.210000000000001 110.281 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.66 145.32 20.39 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 C-N-CA 122.407 2.071 . . . . 75.230000000000004 110.859 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -118.72 143.92 46.57 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.666 -0.494 . . . . 71.349999999999994 109.666 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -104.07 123.09 46.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.617 -0.883 . . . . 73.319999999999993 108.617 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.294 -1.823 0 N-CA-C 106.637 -1.616 . . . . 73.340000000000003 106.637 177.149 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 34.5 pt . . . . . 0 N--CA 1.441 -0.92 0 CA-C-O 121.088 0.47 . . . . 71.299999999999997 110.334 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.29 167.99 10.07 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.848 -0.797 . . . . 75.519999999999996 108.848 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.77 -178.2 21.11 Favored Glycine 0 C--O 1.249 1.06 0 O-C-N 123.465 0.478 . . . . 74.450000000000003 112.585 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -46.98 -61.96 1.63 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.04 0.936 . . . . 74.540000000000006 110.408 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -141.11 104.82 4.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.063 -1.458 . . . . 75.030000000000001 107.063 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.5 t -121.05 109.07 14.6 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 118.659 -1.217 . . . . 73.400000000000006 110.438 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.814 -1.18 . . . . 73.329999999999998 107.814 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 510' ' ' PRO . 62.4 tp -119.79 113.48 20.67 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 123.443 0.464 . . . . 73.25 111.074 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.22 128.65 34.7 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 74.239999999999995 108.07 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.65 111.89 38.09 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 107.234 -1.395 . . . . 73.310000000000002 107.234 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.82 134.44 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 CA-C-N 114.711 -1.132 . . . . 74.239999999999995 108.251 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 514' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.175 0 N-CA-C 109.484 -0.561 . . . . 75.019999999999996 109.484 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.519 0 N-CA-C 111.47 -0.652 . . . . 73.030000000000001 111.47 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 635' ' ' LEU . 55.8 mt -86.39 114.33 25.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 110.129 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -112.49 146.11 39.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.48 -0.933 . . . . 72.120000000000005 108.48 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.8 t -148.26 163.54 36.71 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.639 0.587 . . . . 73.120000000000005 109.775 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.647 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 69.2 m-85 -83.96 153.89 23.65 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 123.232 0.613 . . . . 75.219999999999999 110.396 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 49.3 mt-10 -60.35 -41.83 94.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.989 0.423 . . . . 73.319999999999993 110.457 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.2 mt-10 -132.65 151.91 78.98 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.494 -0.928 . . . . 72.109999999999999 108.494 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.53 -20.94 1.96 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.125 1.883 . . . . 75.439999999999998 111.137 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 52.8 t -146.05 125.67 5.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 124.945 1.298 . . . . 72.430000000000007 107.534 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -133.65 141.03 47.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.33 0.586 . . . . 75.219999999999999 110.064 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -107.93 127.36 53.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.641 -0.708 . . . . 74.049999999999997 109.198 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.8 m -126.08 158.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.06 0.457 . . . . 71.540000000000006 110.92 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.0 m -73.43 157.76 36.25 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.599 -0.728 . . . . 75.430000000000007 109.702 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -29.17 39.84 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.465 0.65 . . . . 71.409999999999997 109.991 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -97.81 18.7 15.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.48 -0.782 . . . . 54.299999999999997 111.086 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.78 -29.85 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 75.299999999999997 111.617 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.15 -72.49 2.83 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.621 -0.799 . . . . 75.25 111.886 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.0 mm -127.42 123.54 61.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.999 -0.741 . . . . 73.230000000000004 108.999 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.444 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.8 ptm -101.18 131.35 47.2 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.627 -0.879 . . . . 65.120000000000005 108.627 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.58 118.46 33.13 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 123.714 0.634 . . . . 75.299999999999997 110.848 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.61 114.64 45.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.384 -1.339 . . . . 75.310000000000002 107.384 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 29.0 mtmm -94.06 133.56 37.4 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 119.912 -0.715 . . . . 73.030000000000001 110.486 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.53 109.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.995 -1.113 . . . . 72.129999999999995 107.995 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.7 mt -89.09 122.51 32.48 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.256 -0.884 . . . . 70.540000000000006 110.037 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 103.2 15.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 118.673 -1.211 . . . . 74.219999999999999 108.3 174.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.0 p -67.77 -54.32 20.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.513 -0.767 . . . . 73.209999999999994 111.1 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' SER . . . . . 0.416 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 23.1 t -72.94 -50.41 23.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.071 -0.968 . . . . 74.530000000000001 110.211 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . 0.445 ' HA2' ' OD1' ' A' ' 565' ' ' ASP . . . 149.61 -179.91 25.99 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.776 -1.202 . . . . 75.239999999999995 112.458 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.61 27.98 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 107.086 -1.45 . . . . 73.209999999999994 107.086 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -149.32 127.75 12.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.562 -0.455 . . . . 74.540000000000006 110.164 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.89 -115.64 4.71 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.886 -0.886 . . . . 64.230000000000004 110.886 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -138.1 109.98 7.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.714 -1.217 . . . . 73.150000000000006 107.714 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.09 123.5 66.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.131 0.491 . . . . 73.340000000000003 109.896 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 48.6 mm -96.17 120.59 45.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.245 -0.65 . . . . 71.409999999999997 109.245 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.79 104.36 51.08 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 72.319999999999993 107.993 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.01 143.29 17.9 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.948 1.765 . . . . 70.209999999999994 111.309 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -130.43 163.74 26.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.333 -0.988 . . . . 74.439999999999998 108.333 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -159.29 132.81 7.24 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.276 0.36 . . . . 72.209999999999994 110.847 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 20.7 p -79.75 136.12 36.68 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.884 -0.598 . . . . 71.319999999999993 110.368 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.55 117.29 46.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.444 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 40.4 mt-10 -74.88 104.62 5.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.586 -0.524 . . . . 72.049999999999997 109.586 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.63 -102.57 1.21 Allowed Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.838 -1.305 . . . . 72.200000000000003 109.838 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 13.2 t -100.83 4.82 43.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.271 0.558 . . . . 71.120000000000005 110.067 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -105.35 149.45 26.06 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.344 -1.354 . . . . 74.400000000000006 107.344 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.444 ' HD2' ' OE1' ' A' ' 543' ' ' GLU . 29.7 tpt180 -107.12 134.07 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.808 0.337 . . . . 71.230000000000004 110.977 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.01 -151.76 9.5 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.741 -0.663 . . . . 74.239999999999995 111.626 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 75.17 -33.76 1.09 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 122.461 -0.434 . . . . 73.310000000000002 114.066 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 144.35 5.76 0.58 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.091 -0.576 . . . . 62.130000000000003 112.55 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -75.13 -79.17 0.1 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.868 0.365 . . . . 73.420000000000002 111.88 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -89.78 -41.19 12.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.829 -1.174 . . . . 75.109999999999999 107.829 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -149.33 169.48 20.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.452 -1.249 . . . . 74.150000000000006 108.717 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.06 119.03 37.13 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.803 -2.295 . . . . 70.319999999999993 104.803 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.39 105.28 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.967 0.889 . . . . 71.219999999999999 110.555 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.9 t -101.91 127.15 48.88 Favored 'General case' 0 N--CA 1.412 -2.354 0 CA-C-N 115.1 -0.955 . . . . 73.420000000000002 111.155 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -140.55 97.82 3.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.607 -1.179 . . . . 74.209999999999994 108.353 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -132.34 179.31 17.33 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 115.485 -0.78 . . . . 62.100000000000001 111.737 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.3 mt-10 -111.07 114.84 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.224 -0.658 . . . . 74.329999999999998 109.224 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.06 138.19 31.63 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 110.117 -0.327 . . . . 75.310000000000002 110.117 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -105.98 106.28 16.71 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.459 0.647 . . . . 63.25 111.485 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 36.6 m-85 -96.43 147.6 23.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.036 -1.468 . . . . 74.140000000000001 107.036 172.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -124.96 -79.06 0.61 Allowed 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 108.862 -0.792 . . . . 73.510000000000005 108.862 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' A' ' 566' ' ' GLU . 24.5 t-20 -104.03 156.04 18.18 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.149 -0.686 . . . . 64.200000000000003 109.149 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . 0.445 ' OD1' ' HA2' ' A' ' 530' ' ' GLY . 12.0 t70 -56.1 -25.9 47.52 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.162 1.385 . . . . 64.319999999999993 113.193 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.402 ' HG2' ' OD1' ' A' ' 564' ' ' ASN . 11.3 pt-20 -68.47 -18.52 64.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.139 0.792 . . . . 74.109999999999999 113.139 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.2 pt -106.37 167.5 3.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 119.843 -0.743 . . . . 73.319999999999993 110.935 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.99 159.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.818 -1.179 . . . . 75.230000000000004 107.818 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 122.208 -0.307 . . . . 71.439999999999998 110.26 175.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.422 HG12 ' HG2' ' A' ' 524' ' ' LYS . 18.7 mt -122.2 134.89 64.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 123.825 0.703 . . . . 73.25 110.259 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 55.2 mt -91.26 122.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.368 -1.345 . . . . 75.5 107.368 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 9.4 p -106.7 112.86 26.03 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 123.866 0.729 . . . . 74.019999999999996 109.269 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.445 HD11 HD22 ' A' ' 589' ' ' LEU . 38.2 mt -110.76 125.63 68.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.232 -0.655 . . . . 74.450000000000003 109.232 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -79.59 110.59 15.07 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.136 0.898 . . . . 75.329999999999998 109.765 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.4 135.05 36.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.917 -1.512 . . . . 74.030000000000001 106.917 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 109.818 -0.438 . . . . 74.319999999999993 109.818 -178.097 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.409 -2.502 0 CA-C-O 122.093 0.949 . . . . 63.420000000000002 113.181 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 34.7 p -143.32 154.75 44.09 Favored 'General case' 0 N--CA 1.405 -2.704 0 CA-C-N 114.633 -1.167 . . . . 65.400000000000006 108.967 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -138.53 161.61 36.62 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 74.129999999999995 106.844 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.1 t -113.73 175.69 5.35 Favored 'General case' 0 C--N 1.27 -2.887 0 C-N-CA 119.147 -1.021 . . . . 72.040000000000006 109.108 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.445 HD22 HD11 ' A' ' 573' ' ' ILE . 33.5 tp -149.9 126.69 11.06 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.016 -1.475 . . . . 75.420000000000002 107.016 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.13 157.34 31.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.716 -0.476 . . . . 71.219999999999999 109.716 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.647 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 40.2 mt -101.79 142.97 32.29 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.337 -1.727 . . . . 74.120000000000005 106.337 174.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.86 173.59 6.79 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.869 -0.789 . . . . 71.299999999999997 108.869 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.67 115.46 18.75 Favored Pre-proline 0 C--N 1.316 -0.88 0 O-C-N 123.733 0.646 . . . . 72.319999999999993 110.739 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.38 153.96 75.81 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.761 2.307 . . . . 74.129999999999995 113.399 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -119.62 134.91 55.03 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.783 -1.099 . . . . 73.030000000000001 109.64 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -99.34 125.07 44.93 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.098 -0.705 . . . . 74.099999999999994 109.098 -175.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 C--N 1.29 -1.986 0 N-CA-C 105.225 -2.139 . . . . 71.310000000000002 105.225 172.672 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . 0.274 2.6 pp . . . . . 0 N--CA 1.415 -2.216 0 CA-C-O 122.222 1.011 . . . . 74.409999999999997 112.006 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 504' ' ' ILE . 2.2 pt? -76.35 -165.22 0.47 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.255 -2.248 . . . . 73.329999999999998 111.873 -174.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.23 136.25 37.21 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 109.46 -1.456 . . . . 73.310000000000002 109.46 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.56 -42.32 70.85 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.469 0.708 . . . . 74.340000000000003 111.848 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -131.37 84.86 2.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 110.864 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.9 t -119.71 114.71 22.59 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 107.872 -1.158 . . . . 61.229999999999997 107.872 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -147.59 140.24 24.73 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.777 -0.823 . . . . 70.530000000000001 108.777 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 509' ' ' GLU . 60.0 tp -117.59 123.14 45.48 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 123.347 0.404 . . . . 72.239999999999995 109.913 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.78 124.94 43.98 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.941 -1.503 . . . . 74.230000000000004 106.941 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.22 120.22 60.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.464 -0.939 . . . . 73.540000000000006 108.464 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.87 124.18 63.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-N 115.618 -0.719 . . . . 63.210000000000001 109.262 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.31 -1.148 0 CA-C-O 122.213 1.006 . . . . 74.219999999999999 111.125 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.393 0 N-CA-C 114.638 0.615 . . . . 65.5 114.638 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 57.1 mt -128.28 113.94 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 104.72 -2.326 . . . . 72.239999999999995 104.72 167.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.528 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 76.1 m-85 -107.49 132.35 53.32 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.645 -0.502 . . . . 75.540000000000006 109.645 -176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 8.8 t -148.03 152.76 37.96 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.534 0.521 . . . . 54.119999999999997 110.036 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.496 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 90.1 m-85 -74.43 154.5 38.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.909 -0.404 . . . . 74.450000000000003 109.909 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -52.78 -49.92 64.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.819 0.848 . . . . 72.439999999999998 111.147 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -135.32 161.53 62.76 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 107.753 -1.203 . . . . 64.219999999999999 107.753 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 68.4 Cg_endo -82.4 -17.61 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 121.673 1.582 . . . . 64.519999999999996 112.029 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.426 HG23 ' HB2' ' A' ' 642' ' ' GLU . 77.9 t -143.07 127.11 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 123.306 0.642 . . . . 75.049999999999997 109.966 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 643' ' ' VAL . 12.0 t -135.11 141.5 46.03 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.474 -0.935 . . . . 73.430000000000007 108.474 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -111.14 142.45 43.31 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.301 -1.74 . . . . 74.049999999999997 106.301 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.19 154.81 29.02 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 CA-C-O 121.327 0.584 . . . . 75.230000000000004 111.462 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 518' ' ' ILE . 20.5 m -73.92 137.46 43.65 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.891 -1.049 . . . . 73.030000000000001 109.482 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.58 1.58 13.99 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.799 0.809 . . . . 74.140000000000001 112.886 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.5 p -125.53 18.75 8.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.32 -0.855 . . . . 75.530000000000001 110.902 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 515' ' ' SER . 8.2 tt -80.76 -23.76 11.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-O 121.376 0.608 . . . . 72.409999999999997 110.479 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.51 -76.26 2.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.721 -0.951 . . . . 72.230000000000004 110.721 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 47.9 mm -125.41 128.58 72.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.724 -0.843 . . . . 72.030000000000001 108.724 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.471 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.3 ptm -98.48 141.61 31.12 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.673 -0.492 . . . . 75.230000000000004 109.673 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -102.39 128.81 48.83 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 123.792 0.682 . . . . 74.430000000000007 109.917 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 44.0 t -124.92 124.53 67.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.459 -0.941 . . . . 72.150000000000006 108.459 174.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -93.87 132.34 38.4 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.006 -0.678 . . . . 75.450000000000003 110.768 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 84.3 t -95.98 111.76 26.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.581 -1.637 . . . . 72.219999999999999 106.581 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.43 143.42 26.62 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.547 -0.751 . . . . 72.239999999999995 110.39 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.0 104.65 14.14 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.844 -0.617 . . . . 75.310000000000002 111.767 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 504' ' ' ILE . 22.9 m -64.78 -61.64 2.06 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.953 -0.567 . . . . 73.430000000000007 112.086 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.1 p -73.76 -52.54 12.84 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.107 0.41 . . . . 74.230000000000004 112.107 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 158.02 -145.77 12.31 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.943 -0.863 . . . . 72.409999999999997 110.943 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -178.66 130.8 0.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.211 1.404 . . . . 73.209999999999994 107.467 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -150.59 91.44 1.74 Allowed 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.537 -0.865 . . . . 75.109999999999999 111.879 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 145.51 -116.97 0.95 Allowed Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 110.183 -1.167 . . . . 75.450000000000003 110.183 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.82 104.49 5.3 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.137 -1.06 . . . . 71.420000000000002 108.137 172.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 595' ' ' LYS . 39.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.331 -0.548 . . . . 71.340000000000003 111.381 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.6 mm -98.99 115.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.423 -0.808 . . . . 73.120000000000005 109.139 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.78 100.24 30.15 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 108.523 -0.917 . . . . 75.150000000000006 108.523 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.65 146.54 27.09 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 121.924 1.75 . . . . 74.519999999999996 111.186 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.457 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 25.1 p90 -136.68 157.33 47.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.239 -0.652 . . . . 70.239999999999995 109.239 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -147.6 135.04 20.76 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.835 0.35 . . . . 75.310000000000002 111.019 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.4 p -82.72 123.03 28.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.777 -0.647 . . . . 74.140000000000001 111.184 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 41.0 mm -92.16 118.22 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.959 -1.126 . . . . 75.319999999999993 107.959 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.69 143.99 34.09 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.266 -0.642 . . . . 75.310000000000002 109.266 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.72 -110.18 0.83 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 109.076 -1.609 . . . . 62.409999999999997 109.076 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 16.6 p -78.64 -25.21 44.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.586 -0.894 . . . . 74.549999999999997 108.586 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -90.2 131.9 35.78 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.43 -1.322 . . . . 73.340000000000003 107.43 172.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 43.1 ttp180 -104.72 140.96 37.3 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.121 -0.696 . . . . 74.219999999999999 109.121 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.75 -157.4 31.59 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 121.166 -0.54 . . . . 72.340000000000003 112.639 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.09 19.94 74.35 Favored Glycine 0 C--N 1.31 -0.871 0 C-N-CA 121.619 -0.324 . . . . 64.109999999999999 112.932 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.03 19.21 40.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.33 -0.938 . . . . 60.43 112.646 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 11.0 tp10 -86.0 -79.51 0.25 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 110.0 -0.37 . . . . 75.319999999999993 110.0 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -94.9 -30.29 14.24 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.701 -1.222 . . . . 64.430000000000007 107.701 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.32 155.79 43.41 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.396 -1.274 . . . . 72.329999999999998 107.952 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -88.46 139.98 29.93 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 105.412 -2.07 . . . . 75.209999999999994 105.412 177.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.33 121.72 24.13 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.167 -0.308 . . . . 64.430000000000007 110.167 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -127.33 104.43 7.93 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 122.474 1.131 . . . . 72.349999999999994 110.46 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -125.96 102.27 7.18 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.725 -1.954 . . . . 63.350000000000001 105.725 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -133.36 -174.75 13.67 Favored Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.39 -0.91 . . . . 63.009999999999998 112.248 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.11 122.46 40.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.313 0.577 . . . . 73.409999999999997 110.669 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 83.8 mt -96.58 136.92 36.42 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.882 -0.414 . . . . 71.310000000000002 109.882 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.01 102.53 11.25 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.709 0.766 . . . . 63.539999999999999 111.392 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 60.0 m-85 -99.58 96.8 7.89 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 106.971 -1.492 . . . . 74.099999999999994 106.971 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -75.18 -67.11 0.68 Allowed 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.233 -0.987 . . . . 75.120000000000005 109.829 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -105.94 161.65 14.27 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.222 -0.658 . . . . 65.310000000000002 109.222 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.55 -11.82 60.45 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.208 1.003 . . . . 73.129999999999995 113.527 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -68.09 -7.99 34.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.61 0.967 . . . . 53.130000000000003 113.61 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 45.1 pt -122.32 168.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 O-C-N 121.952 -0.467 . . . . 72.329999999999998 110.837 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.7 p -131.79 140.73 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.839 -1.541 . . . . 72.040000000000006 106.839 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 69.5 mmtt -104.45 145.95 29.55 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.438 -0.505 . . . . 75.430000000000007 111.25 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 69.3 mt -117.45 135.07 59.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.474 -1.239 . . . . 73.349999999999994 110.498 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 64.5 mt -93.55 127.89 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.835 -1.172 . . . . 73.219999999999999 107.835 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 25.7 p -106.59 112.18 25.06 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.374 0.607 . . . . 74.420000000000002 110.139 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.471 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 30.9 mt -112.64 130.04 67.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.74 -1.207 . . . . 73.430000000000007 107.74 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 11.5 ttm180 -85.86 122.92 30.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 44.7 mm -102.33 136.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.724 -0.671 . . . . 65.439999999999998 109.394 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . 0.442 ' CZ ' ' HD2' ' A' ' 574' ' ' ARG . 92.7 m-85 . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 108.682 -0.858 . . . . 74.140000000000001 108.682 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.418 -2.032 0 CA-C-O 121.054 0.454 . . . . 73.519999999999996 111.118 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 23.9 m -144.99 153.71 41.78 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.037 -0.727 . . . . 73.219999999999999 109.037 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.2 p90 -138.6 -176.87 4.62 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.79 -0.448 . . . . 75.209999999999994 109.79 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 35.8 m -132.6 162.83 30.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.589 -0.522 . . . . 73.109999999999999 109.589 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 31.2 tp -139.38 134.83 32.98 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.562 -1.273 . . . . 74.420000000000002 107.562 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.85 157.34 43.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 123.18 0.3 . . . . 74.010000000000005 110.696 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.496 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 48.9 mt -101.8 139.79 36.97 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.027 -1.471 . . . . 74.329999999999998 107.027 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -96.36 178.43 5.37 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 123.332 0.395 . . . . 74.420000000000002 110.125 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.52 121.39 78.81 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 109.676 -0.49 . . . . 74.450000000000003 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.48 164.44 35.6 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.408 2.072 . . . . 70.519999999999996 113.734 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 75.5 mmtt -116.93 140.98 48.82 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 114.847 -1.07 . . . . 75.329999999999998 109.06 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -113.84 109.34 18.37 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 107.227 -1.397 . . . . 75.510000000000005 107.227 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--N 1.281 -2.385 0 N-CA-C 107.599 -1.26 . . . . 65.109999999999999 107.599 179.15 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.662 0.268 . . . . 74.430000000000007 110.292 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.528 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 2.1 pt? -139.53 -168.27 2.44 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.882 -0.784 . . . . 74.430000000000007 108.882 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -66.75 159.62 48.59 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.582 -0.818 . . . . 62.509999999999998 112.612 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.61 -64.71 0.74 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.981 1.313 . . . . 73.200000000000003 110.135 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -130.93 104.33 7.07 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.925 -1.139 . . . . 74.450000000000003 107.925 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.6 t -129.45 114.0 15.6 Favored 'General case' 0 N--CA 1.404 -2.735 0 CA-C-O 122.547 1.165 . . . . 71.439999999999998 110.326 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.8 ttmt -144.09 148.95 35.83 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 106.586 -1.635 . . . . 73.219999999999999 106.586 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 56.4 tp -126.76 109.99 12.63 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.478 -0.934 . . . . 72.150000000000006 108.478 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.426 ' HB2' HG23 ' A' ' 511' ' ' VAL . 40.9 mt-10 -87.0 126.42 34.73 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 107.421 -1.325 . . . . 73.140000000000001 107.421 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 512' ' ' THR . 43.9 t -113.62 122.41 67.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 109.048 -0.723 . . . . 73.230000000000004 109.048 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.62 135.55 50.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.79 -1.096 . . . . 73.230000000000004 110.014 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.155 0 C-N-CA 123.096 0.558 . . . . 75.019999999999996 110.142 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.588 0 N-CA-C 110.185 -1.166 . . . . 74.340000000000003 110.185 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 68.3 mt -96.89 114.88 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.306 -0.627 . . . . 74.230000000000004 109.306 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -101.24 132.26 46.83 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.017 -0.735 . . . . 75.120000000000005 109.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.1 t -146.38 153.81 40.92 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 120.795 0.331 . . . . 64.299999999999997 110.436 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.541 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.15 153.73 38.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.649 -0.5 . . . . 71.329999999999998 109.649 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 41.7 mt-10 -56.19 -56.19 23.98 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.941 0.775 . . . . 72.430000000000007 110.397 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -122.35 160.84 46.29 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.721 -1.127 . . . . 75.439999999999998 109.136 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -86.73 -20.74 2.39 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.032 1.821 . . . . 73.420000000000002 112.071 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 75.6 t -144.22 135.61 21.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 71.230000000000004 108.891 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.0 t -133.21 123.96 26.54 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.449 0.643 . . . . 72.319999999999993 110.07 177.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -98.98 115.96 30.12 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.964 -1.124 . . . . 75.209999999999994 107.964 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.14 169.15 17.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 123.492 0.495 . . . . 75.25 110.422 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 44.6 t -78.3 155.95 29.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.98 -0.554 . . . . 73.230000000000004 111.069 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.14 -20.96 54.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.486 -0.931 . . . . 71.510000000000005 108.486 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 32.75 5.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.66 -0.7 . . . . 74.430000000000007 110.728 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 6.5 tt -82.83 -23.2 8.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 72.120000000000005 109.657 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.76 -74.76 2.03 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.33 -0.708 . . . . 73.519999999999996 111.33 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.7 mm -130.28 128.17 63.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.449 -1.315 . . . . 74.319999999999993 107.449 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -99.61 157.04 16.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.296 -0.631 . . . . 74.430000000000007 109.296 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.06 131.59 56.9 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.572 0.545 . . . . 74.310000000000002 111.919 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 41.4 t -126.26 116.33 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 109.603 -0.517 . . . . 61.039999999999999 109.603 173.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 97.5 mttt -92.34 124.87 36.72 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.975 -0.69 . . . . 75.329999999999998 110.027 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.88 112.73 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.479 -1.304 . . . . 75.409999999999997 107.479 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 40.3 mt -96.07 152.76 18.24 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.129 -0.941 . . . . 74.420000000000002 110.406 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 1.8 mpp_? -106.65 114.83 29.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.043 -0.725 . . . . 73.450000000000003 109.043 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.3 m -65.36 -50.87 63.95 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.82 0.819 . . . . 74.239999999999995 109.998 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.0 p -73.75 -52.25 13.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.19 -0.914 . . . . 73.219999999999999 112.248 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 138.9 -155.95 24.05 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 108.423 -1.871 . . . . 55.130000000000003 108.423 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -169.47 149.13 3.92 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 117.339 0.569 . . . . 73.129999999999995 109.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -156.57 102.11 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.573 -2.01 . . . . 73.340000000000003 105.573 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 124.66 -173.04 16.99 Favored Glycine 0 C--N 1.295 -1.738 0 N-CA-C 110.046 -1.222 . . . . 72.430000000000007 110.046 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.434 HD22 ' HG3' ' A' ' 561' ' ' GLU . 3.5 t-20 -99.21 118.98 37.11 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 108.968 -0.753 . . . . 72.030000000000001 108.968 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 14.1 t -120.69 121.31 65.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 109.171 -0.677 . . . . 75.099999999999994 109.171 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.467 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.9 mm -94.39 117.03 37.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.79 -0.818 . . . . 73.310000000000002 108.79 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.7 106.73 56.7 Favored Pre-proline 0 C--N 1.301 -1.516 0 CA-C-N 115.446 -0.797 . . . . 74.319999999999993 110.673 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 5.0 Cg_exo -76.88 150.87 30.75 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.129 1.886 . . . . 65.140000000000001 111.7 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -141.72 161.48 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.84 -1.17 . . . . 73.5 107.84 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . 0.437 ' HE2' HD11 ' A' ' 542' ' ' ILE . 24.0 pttm -152.49 137.06 16.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.056 0.455 . . . . 64.400000000000006 111.638 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.8 p -83.51 134.39 34.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.575 -0.739 . . . . 75.409999999999997 110.224 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 48.1 mm -103.55 126.38 58.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.357 -0.979 . . . . 73.049999999999997 108.357 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -78.95 112.31 16.01 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.113 -1.069 . . . . 72.420000000000002 108.113 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -101.36 -106.17 2.9 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.771 -1.332 . . . . 72.25 109.771 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 23.9 p -89.5 -11.37 43.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.438 0.637 . . . . 71.540000000000006 109.827 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -100.65 141.36 33.63 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.06 -1.089 . . . . 73.230000000000004 108.06 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -100.05 133.68 44.07 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.861 0.363 . . . . 64.409999999999997 110.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.72 -159.97 35.43 Favored Glycine 0 N--CA 1.431 -1.66 0 C-N-CA 120.777 -0.725 . . . . 60.409999999999997 111.355 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.0 37.39 64.32 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.025 -0.607 . . . . 41.420000000000002 112.187 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.69 5.13 86.89 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.361 -0.447 . . . . 54.539999999999999 113.529 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -81.89 -82.21 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.849 0.325 . . . . 75.219999999999999 111.771 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -46.76 7.63 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.712 -1.218 . . . . 71.140000000000001 107.712 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -131.89 160.63 35.15 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.36 -1.291 . . . . 65.420000000000002 107.575 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.0 OUTLIER -91.98 131.97 36.88 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.861 -1.533 . . . . 53.43 106.861 175.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.21 125.5 29.93 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.947 -0.569 . . . . 63.539999999999999 109.732 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.8 t -133.99 121.99 22.41 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 122.026 0.917 . . . . 64.340000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.7 p -133.55 129.53 37.19 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.825 -1.546 . . . . 71.5 106.825 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -172.63 -177.39 41.98 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.029 -1.081 . . . . 73.519999999999996 111.036 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.1 mt-10 -113.24 129.51 56.5 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.362 0.601 . . . . 75.519999999999996 111.945 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.7 mt -89.24 140.11 29.81 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.649 -1.16 . . . . 72.519999999999996 109.699 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.434 ' HG3' HD22 ' A' ' 534' ' ' ASN . 37.6 tt0 -99.83 101.78 13.02 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.944 -0.571 . . . . 61.229999999999997 109.931 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 43.0 m-85 -96.17 149.71 21.33 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.624 0.725 . . . . 73.329999999999998 110.439 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -127.41 -140.54 0.26 Allowed 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.128 -1.804 . . . . 74.200000000000003 106.128 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -62.21 157.72 18.71 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 122.958 0.503 . . . . 61.340000000000003 110.088 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.55 -21.11 9.28 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.598 1.159 . . . . 72.209999999999994 113.74 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.417 ' HG3' HG22 ' A' ' 567' ' ' ILE . 13.1 pt-20 -59.27 -30.96 68.67 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.678 0.791 . . . . 73.430000000000007 112.781 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.417 HG22 ' HG3' ' A' ' 566' ' ' GLU . 34.7 pt -101.08 168.93 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.643 0.259 . . . . 74.409999999999997 110.955 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.34 152.38 15.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.88 -1.526 . . . . 72.099999999999994 106.88 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.506 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.1 mmpt? -112.8 157.44 21.35 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 120.783 -0.367 . . . . 73.140000000000001 110.8 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -127.32 129.41 70.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.231 -0.895 . . . . 70.409999999999997 109.822 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.9 mt -90.63 122.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.61 -1.626 . . . . 75.140000000000001 106.61 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.0 p -106.86 122.01 45.55 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.239 -0.652 . . . . 71.510000000000005 109.239 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 61.6 mt -118.31 128.44 75.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.472 -0.566 . . . . 74.140000000000001 109.472 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.423 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.4 mtt180 -74.31 119.48 18.58 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.944 0.778 . . . . 72.420000000000002 110.1 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.6 mm -107.25 135.75 44.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.719 -0.845 . . . . 74.040000000000006 108.719 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 C--N 1.305 -1.365 0 N-CA-C 107.776 -1.194 . . . . 74.549999999999997 107.776 -178.625 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 645' ' ' ILE . 60.0 m . . . . . 0 N--CA 1.436 -1.128 0 CA-C-O 121.63 0.729 . . . . 73.299999999999997 112.031 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 m -146.77 128.04 14.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.91 -0.774 . . . . 75.340000000000003 108.91 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.2 p90 -131.22 165.76 22.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.714 -0.847 . . . . 64.530000000000001 108.714 174.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 5.0 m -119.7 162.52 18.88 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.523 -0.871 . . . . 70.409999999999997 110.221 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 47.0 tp -135.69 130.06 33.68 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.276 -1.379 . . . . 75.219999999999999 107.276 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.83 160.14 42.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 123.603 0.564 . . . . 74.329999999999998 109.674 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.541 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 44.9 mt -106.26 144.4 33.0 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.976 0.798 . . . . 73.400000000000006 109.004 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.77 178.3 5.35 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.178 -1.045 . . . . 73.310000000000002 108.178 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.29 117.36 23.51 Favored Pre-proline 0 C--O 1.247 0.954 0 O-C-N 123.642 0.589 . . . . 62.43 109.759 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.46 147.78 25.76 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.409 2.072 . . . . 73.200000000000003 111.375 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . 0.467 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 8.7 ptpp? -113.63 123.59 50.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.133 -0.485 . . . . 75.299999999999997 110.055 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -98.23 110.58 23.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.014 -0.539 . . . . 75.420000000000002 110.256 -173.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--N 1.288 -2.078 0 N-CA-C 106.693 -1.595 . . . . 73.329999999999998 106.693 175.803 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 31.2 pt . . . . . 0 N--CA 1.444 -0.754 0 CA-C-O 121.459 0.647 . . . . 75.319999999999993 110.973 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.61 170.31 8.41 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 75.420000000000002 107.364 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.82 154.59 50.92 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.388 -1.885 . . . . 73.349999999999994 108.388 172.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -39.86 -64.06 0.53 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.1 0.96 . . . . 65.430000000000007 112.641 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -130.07 83.43 2.13 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.827 -1.175 . . . . 73.510000000000005 107.827 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.2 t -100.67 110.88 23.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.241 1.019 . . . . 64.200000000000003 110.64 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -146.72 134.86 21.61 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.411 -1.329 . . . . 72.519999999999996 107.411 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 65.0 tp -113.2 112.91 24.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.312 -0.625 . . . . 73.450000000000003 109.312 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -90.47 117.03 28.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.63 116.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 N-CA-C 107.66 -1.237 . . . . 62.549999999999997 107.66 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 16.0 mt -115.47 128.22 72.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.547 0 CA-C-N 114.787 -1.097 . . . . 75.109999999999999 109.901 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.116 0 CA-C-N 114.474 -1.239 . . . . 75.219999999999999 108.308 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 C--O 1.204 -1.732 0 N-CA-C 114.134 0.413 . . . . 72.0 114.134 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 91.9 mt -71.78 114.22 9.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 116.876 0.338 . . . . 73.109999999999999 110.984 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -100.5 132.73 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.882 -0.784 . . . . 74.409999999999997 108.882 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -148.23 157.59 43.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.841 -0.537 . . . . 74.319999999999993 110.641 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.565 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 91.9 m-85 -71.56 155.57 40.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.258 . . . . 75.040000000000006 110.319 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.91 -56.28 22.58 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.914 0.759 . . . . 73.030000000000001 109.623 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.6 mt-10 -134.09 159.51 72.08 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 107.952 -1.129 . . . . 74.409999999999997 107.952 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 62.8 Cg_endo -79.04 -21.49 9.35 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 121.93 1.753 . . . . 74.349999999999994 113.808 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.4 t -138.59 133.34 42.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.702 -0.481 . . . . 73.129999999999995 109.702 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.6 139.11 46.34 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.206 0.527 . . . . 73.439999999999998 109.705 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -109.39 132.84 53.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.989 -1.485 . . . . 71.420000000000002 106.989 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.87 163.72 26.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 C-N-CA 120.621 -0.432 . . . . 71.510000000000005 110.449 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 27.2 m -82.44 163.68 21.47 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.569 -0.741 . . . . 71.150000000000006 109.574 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -81.05 -34.72 32.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.729 -1.212 . . . . 61.409999999999997 107.729 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.4 m -96.34 27.54 3.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.144 -0.934 . . . . 75.209999999999994 111.022 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 7.4 tt -79.8 -25.08 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.409 0.623 . . . . 75.150000000000006 110.601 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 86.45 -75.71 2.21 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.926 -0.654 . . . . 73.120000000000005 111.668 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 48.4 mm -130.51 137.56 55.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.458 -1.682 . . . . 74.549999999999997 106.458 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.1 ppp? -110.09 147.98 32.6 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.403 -0.962 . . . . 74.219999999999999 108.403 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -110.97 134.38 52.63 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.596 0.56 . . . . 74.219999999999999 110.825 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 46.1 t -121.19 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.68 -0.859 . . . . 74.099999999999994 108.68 171.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -85.52 120.79 27.37 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.572 -0.851 . . . . 75.400000000000006 110.058 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.25 101.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.987 -1.486 . . . . 71.319999999999993 106.987 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.1 mt -84.32 163.4 19.62 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 114.183 -1.371 . . . . 74.010000000000005 111.006 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.6 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 74.6 mtt180 -118.12 109.08 15.98 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.865 -1.062 . . . . 70.230000000000004 110.446 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 22.7 m -66.27 -62.93 1.21 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.269 -0.423 . . . . 71.340000000000003 110.416 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.9 p -75.31 -36.44 61.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.663 0.744 . . . . 72.239999999999995 112.009 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 124.55 -128.78 6.87 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.211 -1.155 . . . . 65.040000000000006 110.211 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . 177.16 168.69 0.58 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.052 1.341 . . . . 73.049999999999997 107.437 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.522 ' HD2' ' OD1' ' A' ' 564' ' ' ASN . 9.9 tpt180 -163.41 81.17 0.46 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.524 -1.287 . . . . 74.25 107.524 172.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 135.34 171.3 12.37 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 110.075 -1.21 . . . . 70.010000000000005 110.075 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -86.84 128.72 35.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.17 0.509 . . . . 71.150000000000006 110.843 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.8 t -136.07 134.32 50.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 70.120000000000005 109.474 -177.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.412 HG12 HD12 ' A' ' 597' ' ' ILE . 44.7 mm -93.75 122.04 44.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.795 -0.817 . . . . 73.420000000000002 108.795 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.65 102.07 54.41 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 123.471 0.482 . . . . 74.209999999999994 110.438 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 6.1 Cg_exo -76.49 148.73 30.02 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 121.932 1.754 . . . . 74.420000000000002 111.127 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -138.05 166.68 23.49 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.972 -1.122 . . . . 74.019999999999996 107.972 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -157.45 134.83 10.44 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.03 0.443 . . . . 75.239999999999995 111.254 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.6 p -80.44 126.61 31.41 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.678 -0.692 . . . . 74.209999999999994 110.156 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.2 mm -95.16 116.45 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.101 -1.444 . . . . 73.329999999999998 107.101 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.73 111.66 18.19 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.41 0.444 . . . . 74.109999999999999 110.672 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.64 -110.93 3.31 Favored Glycine 0 C--N 1.31 -0.894 0 N-CA-C 110.159 -1.176 . . . . 71.120000000000005 110.159 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 6.5 m -70.06 -35.48 74.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.684 -1.228 . . . . 65.439999999999998 107.684 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.92 132.69 35.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.325 -1.307 . . . . 72.209999999999994 108.439 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -114.6 157.11 23.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.587 0.708 . . . . 75.109999999999999 111.412 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -88.17 -154.0 27.0 Favored Glycine 0 N--CA 1.427 -1.948 0 CA-C-N 114.829 -1.078 . . . . 73.150000000000006 111.972 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.43 8.84 47.59 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.964 -0.16 . . . . 61.520000000000003 112.99 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.65 24.22 26.35 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 121.152 -0.547 . . . . 71.420000000000002 111.982 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.57 -69.59 0.61 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.478 -0.934 . . . . 61.229999999999997 108.478 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.92 -40.13 6.34 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.398 -1.334 . . . . 73.129999999999995 107.398 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -143.12 172.59 12.52 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-N 114.943 -1.026 . . . . 64.430000000000007 109.761 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 576' ' ' PHE . 1.7 tm-20 -98.04 114.26 26.36 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 75.439999999999998 105.241 175.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.78 136.81 37.47 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.647 0.737 . . . . 75.150000000000006 111.466 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -130.27 125.74 35.56 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 122.145 0.974 . . . . 75.129999999999995 111.734 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 38.6 t -132.43 127.13 34.68 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 105.861 -1.903 . . . . 71.319999999999993 105.861 172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.68 -174.61 37.5 Favored Glycine 0 C--N 1.269 -3.161 0 N-CA-C 109.649 -1.38 . . . . 72.540000000000006 109.649 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 8.6 pt-20 -121.01 127.98 52.26 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.364 0.602 . . . . 71.319999999999993 111.424 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.13 136.22 33.07 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.226 -0.897 . . . . 73.030000000000001 108.817 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.17 98.84 9.2 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 121.496 0.665 . . . . 74.549999999999997 109.606 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.6 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 36.2 m-85 -92.61 124.24 36.48 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.823 -0.626 . . . . 72.540000000000006 110.516 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.549 ' H ' HD11 ' A' ' 567' ' ' ILE . 27.8 mm-40 -83.63 -146.98 0.09 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.057 -1.831 . . . . 71.349999999999994 106.057 172.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.522 ' OD1' ' HD2' ' A' ' 532' ' ' ARG . 61.2 t30 -63.47 170.49 3.09 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.15 0.58 . . . . 62.399999999999999 110.429 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.81 -11.58 8.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.618 1.167 . . . . 61.210000000000001 113.864 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.07 -21.79 66.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.656 0.782 . . . . 74.129999999999995 112.839 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.549 HD11 ' H ' ' A' ' 563' ' ' GLN . 23.7 pt -114.18 168.9 5.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 O-C-N 121.793 -0.567 . . . . 74.230000000000004 111.265 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.17 147.42 25.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.442 -1.318 . . . . 74.140000000000001 107.442 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 68.4 mmtt -111.34 148.5 32.85 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.088 0.471 . . . . 71.150000000000006 111.224 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.1 mt -120.38 132.53 69.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.834 -1.075 . . . . 74.430000000000007 110.328 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.2 mt -91.91 126.46 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.7 -1.593 . . . . 73.329999999999998 106.7 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 572' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 521' ' ' MET . 16.2 p -113.94 112.78 23.87 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.052 0.453 . . . . 72.120000000000005 109.966 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.41 HD11 ' SD ' ' A' ' 521' ' ' MET . 70.1 mt -105.0 130.62 55.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.617 -0.512 . . . . 75.040000000000006 109.617 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.53 114.95 17.9 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.131 0.491 . . . . 74.5 110.309 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.9 mm -103.22 137.49 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 106.166 -1.79 . . . . 75.099999999999994 106.166 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 554' ' ' GLU . 47.6 m-85 . . . . . 0 C--N 1.298 -1.655 0 C-N-CA 119.89 -0.724 . . . . 73.510000000000005 111.739 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 120.553 0.215 . . . . 63.140000000000001 111.278 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 63.9 p -117.69 149.03 41.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.911 -0.493 . . . . 72.540000000000006 110.875 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.6 p90 -137.15 174.84 10.18 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.324 -0.991 . . . . 74.219999999999999 108.324 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 13.0 m -124.85 167.03 15.2 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 120.256 -0.577 . . . . 74.310000000000002 109.616 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 39.3 tp -141.45 130.87 23.75 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.083 -1.451 . . . . 75.310000000000002 107.083 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.72 157.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 123.343 0.402 . . . . 71.219999999999999 110.041 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.565 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 75.2 mt -96.76 142.78 28.37 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.096 -1.446 . . . . 75.450000000000003 107.096 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -104.43 172.24 6.9 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 123.441 0.463 . . . . 73.230000000000004 110.033 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -52.64 112.2 3.24 Favored Pre-proline 0 C--N 1.316 -0.876 0 O-C-N 124.957 1.411 . . . . 75.019999999999996 110.987 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -76.04 153.8 37.21 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 C-N-CA 121.705 1.603 . . . . 73.129999999999995 111.504 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -124.09 132.14 53.63 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.378 -0.601 . . . . 75.519999999999996 109.378 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -93.77 140.82 29.21 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.491 -0.559 . . . . 74.340000000000003 109.491 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . 0.412 HD12 HG12 ' A' ' 536' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.423 -1.795 0 CA-C-O 122.752 1.263 . . . . 75.040000000000006 110.458 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 122.233 1.016 . . . . 75.200000000000003 113.22 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.83 -175.2 2.73 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.893 -1.503 . . . . 70.219999999999999 108.006 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.7 143.71 47.2 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 108.012 -2.035 . . . . 61.32 108.012 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . 0.451 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 32.7 tt0 -52.55 -42.44 64.42 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.04 0.536 . . . . 73.239999999999995 111.869 -174.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . 0.451 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 52.3 m80 -128.24 101.02 6.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.028 -1.101 . . . . 75.109999999999999 108.028 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 5.0 t -136.0 110.55 8.58 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-O 122.383 1.087 . . . . 74.129999999999995 111.041 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 35.9 ttmt -146.49 150.82 36.33 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.6 -1.63 . . . . 74.049999999999997 106.6 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 509' ' ' GLU . 61.5 tp -127.54 112.76 15.29 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.2 -0.667 . . . . 62.109999999999999 109.2 174.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 511' ' ' VAL . 43.5 mt-10 -89.62 125.35 35.2 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.658 -0.867 . . . . 64.040000000000006 108.658 175.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.36 119.45 59.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.427 -0.953 . . . . 74.5 108.427 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.26 125.0 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 115.576 -0.738 . . . . 75.409999999999997 110.207 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.187 0 CA-C-O 121.718 0.77 . . . . 73.219999999999999 110.991 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.963 0 N-CA-C 111.303 -0.719 . . . . 72.349999999999994 111.303 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 84.6 mt -127.25 114.73 37.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.013 -1.477 . . . . 73.519999999999996 107.013 176.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -103.48 136.98 42.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.793 0.33 . . . . 75.019999999999996 110.809 -176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.2 t -148.02 160.79 42.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.49 -0.929 . . . . 74.019999999999996 108.49 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -79.9 156.09 27.45 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.668 -0.493 . . . . 74.420000000000002 109.668 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.03 -51.1 68.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.894 0.746 . . . . 75.040000000000006 110.07 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -131.85 157.17 78.93 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.16 -0.927 . . . . 74.299999999999997 109.132 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.52 -21.71 7.22 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.261 1.974 . . . . 75.099999999999994 112.501 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 642' ' ' GLU . 73.7 t -143.13 133.93 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.372 0.669 . . . . 75.400000000000006 109.275 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -133.59 138.37 45.96 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 109.313 -0.625 . . . . 74.439999999999998 109.313 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -109.52 110.93 22.17 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.857 -1.164 . . . . 74.329999999999998 107.857 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.33 158.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 116.191 -0.459 . . . . 62.420000000000002 110.439 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.553 ' O ' HG21 ' A' ' 518' ' ' ILE . 22.1 m -78.07 137.35 38.19 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.569 -0.741 . . . . 74.349999999999994 109.232 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -65.43 -24.77 67.28 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 123.664 0.786 . . . . 75.439999999999998 110.733 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.4 p -100.45 11.11 40.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.781 -0.645 . . . . 72.549999999999997 112.286 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 515' ' ' SER . 11.1 tt -71.32 -37.69 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 120.295 -0.562 . . . . 75.150000000000006 112.129 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.21 -73.22 1.51 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.239 -0.982 . . . . 71.519999999999996 111.389 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.28 125.21 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.442 -1.318 . . . . 74.540000000000006 107.442 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.97 143.31 31.28 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.229 -0.656 . . . . 73.439999999999998 109.229 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -110.19 124.63 51.92 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.836 0.71 . . . . 72.549999999999997 110.848 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.86 131.34 66.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 110.373 -0.232 . . . . 74.450000000000003 110.373 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.29 136.65 32.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.479 0.487 . . . . 73.439999999999998 110.184 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 96.3 t -95.48 118.14 41.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 105.872 -1.899 . . . . 74.409999999999997 105.872 171.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.6 mt -95.87 135.73 37.23 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 116.099 -0.501 . . . . 75.209999999999994 110.774 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 104.12 15.94 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.441 -0.8 . . . . 74.200000000000003 110.391 174.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.0 m -61.0 -62.45 1.85 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.404 1.081 . . . . 65.439999999999998 111.923 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.5 p -73.3 -31.62 64.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.851 0.834 . . . . 74.299999999999997 109.766 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.62 -155.51 22.28 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 109.814 -1.314 . . . . 64.329999999999998 109.814 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.63 155.06 38.63 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.732 -1.951 . . . . 73.120000000000005 105.732 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -157.86 126.73 5.68 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.859 -0.793 . . . . 74.349999999999994 108.859 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.86 -125.42 8.24 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 111.171 -0.771 . . . . 73.219999999999999 111.171 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -136.42 102.33 4.92 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 106.311 -1.737 . . . . 72.349999999999994 106.311 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 37.9 t -113.88 120.4 63.6 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.569 0 C-N-CA 119.236 -0.986 . . . . 72.040000000000006 110.79 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.3 mm -92.11 116.4 33.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 114.803 -1.09 . . . . 72.129999999999995 108.628 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.73 100.6 43.27 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.102 -0.954 . . . . 74.129999999999995 109.248 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 2.0 Cg_endo -77.1 153.54 32.21 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.861 1.707 . . . . 73.439999999999998 112.497 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -139.65 159.23 42.64 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.7 -0.852 . . . . 70.310000000000002 108.7 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . 0.515 ' O ' HD12 ' A' ' 589' ' ' LEU . 60.5 pttt -152.13 145.97 25.13 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.022 0.439 . . . . 74.420000000000002 111.017 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -88.09 127.37 35.41 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.286 -0.87 . . . . 74.430000000000007 111.911 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 42.4 mm -100.69 116.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.678 -1.23 . . . . 73.519999999999996 107.678 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 547' ' ' ARG . 39.7 mt-10 -77.66 116.19 18.01 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.601 -0.272 . . . . 74.420000000000002 110.491 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.19 -115.95 4.06 Favored Glycine 0 C--N 1.306 -1.134 0 N-CA-C 109.028 -1.629 . . . . 73.030000000000001 109.028 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.2 p -75.59 -23.98 56.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.738 0.78 . . . . 75.150000000000006 109.387 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.63 129.27 34.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.523 -1.217 . . . . 73.319999999999993 108.602 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 543' ' ' GLU . 7.4 tpm_? -95.4 140.72 29.87 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 109.202 -0.666 . . . . 73.450000000000003 109.202 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.15 -160.73 33.16 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.935 -0.866 . . . . 74.319999999999993 110.935 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 79.0 16.72 78.42 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.767 -0.73 . . . . 70.349999999999994 111.636 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 80.29 31.69 37.23 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 111.644 -0.582 . . . . 74.209999999999994 111.644 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -94.25 -71.09 0.68 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 122.447 -0.443 . . . . 74.409999999999997 110.543 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -29.82 12.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.685 1.231 . . . . 74.129999999999995 107.757 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -143.98 157.69 44.18 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.117 -1.438 . . . . 74.219999999999999 107.117 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.511 ' CD ' ' HD2' ' A' ' 574' ' ' ARG . 6.8 tt0 -96.03 135.98 37.08 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 106.861 -1.533 . . . . 73.409999999999997 106.861 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -74.64 120.4 20.14 Favored 'General case' 0 CA--C 1.472 -2.031 0 C-N-CA 120.643 -0.423 . . . . 60.240000000000002 110.745 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.476 ' CG2' HG12 ' A' ' 573' ' ' ILE . 10.1 t -124.58 120.12 31.02 Favored 'General case' 0 N--CA 1.392 -3.325 0 N-CA-C 105.44 -2.059 . . . . 72.400000000000006 105.44 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.5 p -137.14 139.4 41.15 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.412 -1.699 . . . . 65.310000000000002 106.412 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 538' ' ' PRO . . . -175.88 -166.59 33.56 Favored Glycine 0 N--CA 1.397 -3.952 0 C-N-CA 117.951 -2.071 . . . . 73.120000000000005 112.828 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.58 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.7 mt-10 -123.46 114.09 19.64 Favored 'General case' 0 N--CA 1.403 -2.777 0 C-N-CA 124.364 1.066 . . . . 75.430000000000007 108.969 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.33 142.62 27.59 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.57 -0.741 . . . . 74.25 109.207 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -103.56 117.25 33.99 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.8 m-85 -115.94 100.17 7.79 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.281 -1.007 . . . . 72.549999999999997 108.281 173.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.514 ' H ' HD12 ' A' ' 567' ' ' ILE . 77.0 mt-30 -77.35 -87.7 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.948 -0.569 . . . . 75.230000000000004 110.502 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -105.27 164.88 11.51 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 109.881 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -56.9 -11.38 1.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.991 1.478 . . . . 74.530000000000001 114.991 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -79.73 -14.34 58.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.089 0.774 . . . . 75.209999999999994 113.089 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.514 HD12 ' H ' ' A' ' 563' ' ' GLN . 28.3 pt -114.82 169.31 5.86 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.115 0.483 . . . . 74.420000000000002 112.244 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.17 160.17 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.42 -0.956 . . . . 73.25 108.42 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -124.02 154.9 39.2 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 111.925 0.343 . . . . 72.530000000000001 111.925 177.405 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 73.5 mt -125.33 130.65 72.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.011 -0.995 . . . . 74.239999999999995 110.108 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.9 129.08 42.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 107.312 -1.366 . . . . 75.420000000000002 107.312 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 7.7 p -115.91 112.84 22.49 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 123.858 0.724 . . . . 71.439999999999998 110.132 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.476 HG12 ' CG2' ' A' ' 556' ' ' THR . 48.9 mt -116.03 130.96 69.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 121.021 -0.271 . . . . 72.120000000000005 110.711 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.511 ' HD2' ' CD ' ' A' ' 554' ' ' GLU . 92.2 mtt180 -71.19 116.75 11.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.559 0.537 . . . . 74.349999999999994 109.977 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 38.0 mm -101.47 135.95 35.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.752 -1.113 . . . . 75.349999999999994 109.744 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 105.313 -2.106 . . . . 75.209999999999994 105.313 178.378 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 121.443 0.64 . . . . 71.219999999999999 110.29 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 80.4 p -134.95 150.73 50.43 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 121.433 0.635 . . . . 74.5 111.179 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.38 156.87 46.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.013 -1.477 . . . . 72.439999999999998 107.013 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 9.4 m -112.19 153.22 27.38 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.669 -0.813 . . . . 61.229999999999997 109.024 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 540' ' ' LYS . 43.1 tp -124.96 131.51 53.41 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.806 -1.553 . . . . 70.450000000000003 106.806 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.05 159.32 43.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 110.071 -0.344 . . . . 72.400000000000006 110.071 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.16 145.75 27.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.705 0.628 . . . . 75.430000000000007 109.685 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . 0.417 ' O ' HD12 ' A' ' 635' ' ' LEU . 6.6 mm-40 -96.69 163.02 13.19 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.177 -1.045 . . . . 62.020000000000003 108.177 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.0 122.53 72.8 Favored Pre-proline 0 C--N 1.311 -1.096 0 O-C-N 123.678 0.611 . . . . 71.420000000000002 110.383 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.2 151.17 23.24 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 122.841 2.361 . . . . 74.310000000000002 113.31 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -122.11 128.7 51.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.772 -1.104 . . . . 73.310000000000002 110.38 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -84.16 116.81 23.1 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.265 -1.383 . . . . 74.5 107.265 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 C--N 1.28 -2.421 0 N-CA-C 108.354 -0.98 . . . . 73.200000000000003 108.354 -179.221 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.429 -1.503 0 CA-C-O 121.626 0.727 . . . . 71.040000000000006 110.069 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 592' ' ' GLU . 22.6 mt -97.59 170.82 8.76 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.196 -1.039 . . . . 71.200000000000003 108.196 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.57 151.08 49.11 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.121 -2.392 . . . . 52.240000000000002 107.121 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.51 -42.06 66.95 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.235 0.517 . . . . 72.340000000000003 111.28 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -124.34 101.0 6.95 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.508 0.67 . . . . 73.140000000000001 110.733 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 7.5 t -136.02 109.78 8.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 122.243 1.02 . . . . 74.409999999999997 109.411 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -146.77 148.87 32.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.828 -1.175 . . . . 73.349999999999994 107.828 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 56.5 tp -129.6 112.98 14.25 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.425 -0.583 . . . . 63.119999999999997 109.425 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . 0.404 ' HB2' HG21 ' A' ' 511' ' ' VAL . 46.8 mt-10 -89.24 127.98 35.8 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.636 -0.875 . . . . 72.030000000000001 108.636 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.61 120.68 62.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.31 -0.996 . . . . 73.329999999999998 108.31 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.87 134.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.435 -0.802 . . . . 73.409999999999997 110.829 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 C-N-CA 124.821 1.248 . . . . 71.510000000000005 109.551 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.42 -2.394 0 N-CA-C 111.548 -0.621 . . . . 75.209999999999994 111.548 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.48 121.32 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.785 -1.561 . . . . 74.019999999999996 106.785 172.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 56.4 m-85 -110.84 134.46 52.51 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.511 0.507 . . . . 73.230000000000004 110.078 -175.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 6.3 t -148.25 152.79 37.77 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 110.386 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.2 m-85 -74.26 159.74 32.06 Favored 'General case' 0 C--O 1.262 1.718 0 N-CA-C 108.862 -0.792 . . . . 75.109999999999999 108.862 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.35 -51.87 57.54 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.789 0.681 . . . . 71.200000000000003 109.613 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.49 161.54 54.22 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.146 -0.934 . . . . 73.310000000000002 109.088 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.2 Cg_endo -84.73 -20.8 3.59 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.613 1.542 . . . . 74.450000000000003 112.425 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 77.7 t -141.53 134.96 30.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.654 -0.499 . . . . 74.329999999999998 109.654 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -133.9 138.23 45.43 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.571 -0.529 . . . . 73.310000000000002 109.571 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -111.06 119.28 38.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 74.239999999999995 107.875 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.93 170.79 16.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.894 0.378 . . . . 70.310000000000002 110.381 -178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.2 t -88.88 158.97 17.91 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.6 0.714 . . . . 63.130000000000003 111.248 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -8.25 59.54 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.122 -0.945 . . . . 72.129999999999995 110.195 172.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 71.2 m -113.8 19.18 16.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.941 -0.572 . . . . 73.230000000000004 111.248 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 7.2 tt -82.22 -26.23 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.15 -0.62 . . . . 72.439999999999998 111.189 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.85 -74.24 2.52 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.588 -0.815 . . . . 64.120000000000005 111.588 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 573' ' ' ILE . 46.1 mm -129.92 131.17 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.503 -0.925 . . . . 72.120000000000005 108.503 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 17.9 ptm -107.15 145.75 32.15 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.97 -0.752 . . . . 63.109999999999999 108.97 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -106.36 129.31 54.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 123.374 0.421 . . . . 75.230000000000004 110.631 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.8 t -115.52 121.19 66.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.81 -0.811 . . . . 73.5 108.81 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -95.59 130.0 42.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.236 0.541 . . . . 75.329999999999998 110.594 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.43 115.17 35.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.152 -1.055 . . . . 75.25 108.152 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.4 mt -88.08 149.67 23.82 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.661 -0.7 . . . . 75.209999999999994 109.583 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.92 103.78 11.27 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.266 -1.013 . . . . 74.409999999999997 108.266 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.1 p -67.23 -58.11 5.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.519 0.676 . . . . 62.140000000000001 110.939 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 24.3 t -73.97 -23.76 59.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.324 -0.853 . . . . 74.140000000000001 110.157 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . 0.501 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 108.88 -149.18 16.99 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 110.229 -1.149 . . . . 63.119999999999997 110.229 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -160.16 135.79 8.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.185 -1.413 . . . . 75.030000000000001 107.185 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -136.35 121.47 18.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.261 -0.644 . . . . 75.140000000000001 109.261 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.44 -121.99 7.29 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.798 -0.715 . . . . 73.040000000000006 113.038 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -137.75 104.89 5.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.028 -1.101 . . . . 72.329999999999998 108.028 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.88 126.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.619 0.723 . . . . 54.43 110.634 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 559' ' ' GLU . 29.8 mm -95.78 118.01 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.349 -0.842 . . . . 70.510000000000005 109.468 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.65 103.72 50.23 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 115.295 -0.866 . . . . 75.049999999999997 108.792 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 1.0 OUTLIER -78.16 156.67 29.92 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 121.424 1.416 . . . . 65.340000000000003 111.082 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -143.01 161.0 39.28 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.384 -1.339 . . . . 73.319999999999993 107.384 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -156.17 135.07 11.89 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.951 0.405 . . . . 74.530000000000001 111.14 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.6 p -82.92 122.96 28.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.661 -0.699 . . . . 75.319999999999993 110.378 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 37.0 mm -92.71 125.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.764 -1.199 . . . . 75.120000000000005 107.764 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.58 113.11 13.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.922 0.392 . . . . 73.140000000000001 111.242 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -92.4 -103.47 1.49 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.433 -1.067 . . . . 65.099999999999994 110.433 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -94.1 -18.01 22.23 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 109.69 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.01 149.1 24.21 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.392 -0.822 . . . . 75.530000000000001 108.924 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -101.84 134.83 44.4 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.11 0.481 . . . . 74.340000000000003 112.055 -176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.96 -179.75 47.26 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.476 -0.783 . . . . 53.149999999999999 111.367 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.87 57.62 Favored Glycine 0 C--N 1.306 -1.125 0 N-CA-C 110.594 -1.002 . . . . 60.409999999999997 110.594 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.33 19.95 50.65 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 111.491 -0.644 . . . . 71.439999999999998 111.491 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -80.08 -80.1 0.14 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.795 0.331 . . . . 75.450000000000003 110.361 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.79 -32.18 16.21 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.825 -0.805 . . . . 72.120000000000005 108.825 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -143.94 152.8 41.57 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.02 -1.104 . . . . 75.439999999999998 108.02 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 23.3 tt0 -87.89 105.08 17.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.681 -2.34 . . . . 75.109999999999999 104.681 176.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.32 144.96 56.78 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.024 0.828 . . . . 65.439999999999998 109.725 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -140.06 114.06 8.93 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-O 122.046 0.927 . . . . 72.129999999999995 110.885 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.2 p -125.15 118.54 26.31 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.212 -1.358 . . . . 73.129999999999995 107.373 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.17 15.54 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 110.668 -0.973 . . . . 75.510000000000005 110.668 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 8.0 pt-20 -132.84 139.18 47.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.334 0.588 . . . . 70.439999999999998 111.866 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.97 144.71 33.2 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.48 -1.236 . . . . 74.109999999999999 108.692 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -109.73 104.21 13.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.208 0.528 . . . . 74.540000000000006 111.052 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.7 m-85 -98.71 120.0 38.41 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.27 -1.011 . . . . 64.420000000000002 108.27 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.442 ' H ' HD13 ' A' ' 567' ' ' ILE . 49.6 mt-30 -98.21 -80.18 0.46 Allowed 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.734 -0.839 . . . . 73.340000000000003 108.734 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -105.33 155.17 19.35 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.966 -0.561 . . . . 74.200000000000003 110.131 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -46.51 -29.16 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.171 1.788 . . . . 72.430000000000007 114.213 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.62 -14.14 56.64 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.95 1.093 . . . . 64.140000000000001 113.95 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 563' ' ' GLN . 37.2 pt -112.76 156.46 13.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 119.706 -0.798 . . . . 74.439999999999998 110.283 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.65 144.32 37.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.692 -0.855 . . . . 72.439999999999998 108.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.549 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.4 mmpt? -111.36 149.57 30.97 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 120.404 -0.519 . . . . 73.129999999999995 109.662 176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 570' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 73.3 mt -126.05 131.45 71.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.481 -1.236 . . . . 75.549999999999997 110.595 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 41.6 mt -92.87 123.75 45.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.321 -1.362 . . . . 75.340000000000003 107.321 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 19.5 p -108.29 114.27 28.0 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 123.466 0.479 . . . . 73.25 109.814 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 36.6 mt -110.01 135.03 50.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.554 -0.535 . . . . 74.549999999999997 109.554 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 574' ' ' ARG . . . . . 0.516 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 71.3 ttt180 -92.21 123.82 35.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.263 -0.643 . . . . 74.340000000000003 109.263 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.2 134.22 46.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.313 -0.625 . . . . 74.310000000000002 109.313 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 109.251 -0.648 . . . . 74.010000000000005 109.251 179.487 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.424 -1.759 0 N-CA-C 109.166 -0.679 . . . . 71.230000000000004 109.166 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 15.0 m -138.26 148.55 44.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.23 -0.656 . . . . 73.400000000000006 109.23 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.1 166.25 25.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.855 -1.165 . . . . 72.140000000000001 107.855 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 26.5 m -116.29 166.86 11.56 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 119.935 -0.706 . . . . 64.430000000000007 109.686 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 573' ' ' ILE . 31.8 tp -139.58 127.8 22.57 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 107.591 -1.263 . . . . 74.5 107.591 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.36 157.31 36.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.614 -0.513 . . . . 75.329999999999998 109.614 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 45.2 mt -95.34 147.23 23.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.114 -1.81 . . . . 63.130000000000003 106.114 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 593' ' ' GLU . 6.8 tp10 -98.43 177.67 5.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.857 -1.535 . . . . 74.409999999999997 106.857 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 37.6 mt-10 -75.16 119.78 78.54 Favored Pre-proline 0 C--N 1.288 -2.105 0 CA-C-N 116.341 -0.39 . . . . 73.5 110.638 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.41 146.14 44.22 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.351 2.701 . . . . 74.200000000000003 113.703 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -110.31 149.28 30.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.442 -0.947 . . . . 74.319999999999993 108.442 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -107.14 127.88 53.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.673 -1.232 . . . . 75.400000000000006 107.673 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.3 -1.578 0 CA-C-O 122.229 1.014 . . . . 71.450000000000003 108.717 178.523 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 19.9 pt . . . . . 0 N--CA 1.424 -1.728 0 CA-C-O 120.792 0.329 . . . . 73.310000000000002 110.326 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 635' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 505' ' ' PHE . 1.9 pt? -134.56 -171.87 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.321 -0.622 . . . . 72.109999999999999 109.321 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -63.66 156.52 43.0 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 121.026 -0.607 . . . . 51.049999999999997 111.822 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.39 -57.2 13.97 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.29 1.036 . . . . 74.299999999999997 110.025 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.4 98.8 4.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.733 -0.84 . . . . 74.019999999999996 108.733 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.6 t -130.94 110.45 11.27 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-O 122.625 1.202 . . . . 75.540000000000006 110.465 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 640' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 39.5 ttpt -147.61 141.06 25.37 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.924 -1.51 . . . . 73.230000000000004 106.924 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 63.2 tp -117.18 110.0 17.6 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.878 -0.786 . . . . 75.150000000000006 108.878 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.36 123.9 32.81 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.648 -0.871 . . . . 75.109999999999999 108.648 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.4 121.37 61.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.148 -0.933 . . . . 75.200000000000003 109.373 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.61 128.43 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.191 -0.913 . . . . 71.209999999999994 109.534 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.462 0 CA-C-N 115.25 -0.886 . . . . 75.239999999999995 110.066 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.4 ' HB2' ' CH2' ' A' ' 596' ' ' TRP . 61.5 m80 . . . . . 0 C--O 1.242 0.696 0 N-CA-C 107.298 -1.371 . . . . 72.430000000000007 107.298 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -83.12 87.85 6.9 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.457 -0.572 . . . . 73.299999999999997 109.457 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -83.39 133.95 12.36 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.973 -0.851 . . . . 74.420000000000002 110.973 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.27 114.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.18 -0.674 . . . . 75.439999999999998 109.18 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.19 136.58 52.8 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.084 0.24 . . . . 73.319999999999993 110.445 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.1 t -148.64 160.23 43.34 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.993 -0.373 . . . . 74.129999999999995 109.993 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.71 158.57 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 122.164 0.186 . . . . 72.349999999999994 110.583 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 45.6 mt-10 -58.48 -49.97 75.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.179 0.514 . . . . 75.200000000000003 110.716 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . 0.544 ' OE2' ' HD2' ' A' ' 510' ' ' PRO . 7.7 tp10 -141.96 137.76 16.3 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.523 -2.029 . . . . 64.329999999999998 105.523 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 41.4 Cg_endo -70.79 -10.65 28.17 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.491 2.127 . . . . 72.0 114.656 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 642' ' ' GLU . 72.7 t -140.73 126.93 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 122.028 -0.42 . . . . 74.329999999999998 110.161 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 643' ' ' VAL . 14.0 t -133.96 130.57 37.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.484 0.659 . . . . 62.329999999999998 109.615 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -110.07 121.61 45.67 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.646 -0.501 . . . . 72.540000000000006 109.646 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.81 160.91 36.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.128 -0.487 . . . . 72.400000000000006 111.709 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.454 ' O ' HG21 ' A' ' 518' ' ' ILE . 20.2 m -71.88 156.47 39.24 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 74.099999999999994 110.832 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -30.73 58.3 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.811 -1.181 . . . . 73.319999999999993 107.811 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.1 p -90.83 16.71 8.83 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.435 -1.257 . . . . 75.329999999999998 111.777 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.454 HG21 ' O ' ' A' ' 515' ' ' SER . 7.5 tt -78.73 -30.09 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 120.281 -0.568 . . . . 75.140000000000001 110.607 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.39 -68.09 3.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.108 -1.044 . . . . 73.120000000000005 112.444 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.2 mm -130.79 132.12 64.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.638 -1.245 . . . . 74.200000000000003 107.638 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -107.15 154.51 21.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.167 -1.049 . . . . 74.420000000000002 108.167 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.55 124.25 40.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.923 0.392 . . . . 71.030000000000001 111.595 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 8.6 p -124.86 133.15 70.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.019 -0.734 . . . . 72.099999999999994 109.019 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 98.7 mttt -93.27 138.68 31.42 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.407 -0.59 . . . . 75.400000000000006 109.407 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 85.3 t -96.03 121.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.926 -1.509 . . . . 75.019999999999996 106.926 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.16 155.59 16.99 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.235 -0.893 . . . . 73.349999999999994 110.314 -174.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -124.86 104.61 8.7 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.327 -0.99 . . . . 74.019999999999996 108.327 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.8 m -64.93 -56.11 15.23 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.28 -0.873 . . . . 73.540000000000006 111.153 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.6 p -73.79 -48.21 33.23 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.593 0.711 . . . . 73.239999999999995 110.005 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.41 -159.91 26.8 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 111.171 -0.771 . . . . 71.519999999999996 111.171 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 565' ' ' ASP . . . -148.51 144.95 27.68 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.999 -1.482 . . . . 54.530000000000001 106.999 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -161.12 77.61 0.57 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.759 -0.83 . . . . 75.439999999999998 108.759 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.523 ' HA2' ' C ' ' A' ' 600' ' ' GLY . . . 157.87 -127.67 1.95 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.018 -1.087 . . . . 75.120000000000005 111.311 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -137.22 102.57 4.86 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.395 -1.706 . . . . 65.200000000000003 106.395 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 120.0 62.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.335 0.588 . . . . 72.140000000000001 110.347 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.88 115.88 34.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 N-CA-C 108.457 -0.942 . . . . 63.420000000000002 108.457 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.77 101.51 51.46 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.607 -0.724 . . . . 63.5 109.835 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 2.7 Cg_endo -76.66 155.79 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.088 1.858 . . . . 65.450000000000003 112.275 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -142.15 160.66 39.79 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.435 -0.95 . . . . 74.530000000000001 108.435 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -151.43 136.43 17.37 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.875 0.369 . . . . 74.049999999999997 110.977 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.3 p -85.0 126.89 33.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.853 -0.612 . . . . 64.430000000000007 111.271 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.65 121.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.267 -1.012 . . . . 74.319999999999993 108.267 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -79.16 104.88 10.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.843 -0.799 . . . . 73.439999999999998 108.843 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -86.24 -94.3 0.84 Allowed Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.386 -1.086 . . . . 63.210000000000001 110.386 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.8 p -102.8 -12.27 17.72 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.172 0.511 . . . . 72.109999999999999 110.538 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.43 152.89 21.24 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.391 -0.966 . . . . 65.549999999999997 108.391 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -107.61 131.4 54.41 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.157 -0.617 . . . . 74.219999999999999 109.856 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.19 -154.76 20.35 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.271 -1.132 . . . . 50.340000000000003 110.271 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.92 79.81 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.513 -0.851 . . . . 72.099999999999994 112.094 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . 0.456 ' HA2' ' CE1' ' A' ' 576' ' ' PHE . . . 92.29 11.38 59.82 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.779 -0.724 . . . . 74.230000000000004 113.104 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -76.25 -77.95 0.13 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 117.45 0.625 . . . . 75.319999999999993 110.802 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -93.84 -42.72 8.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.882 -1.155 . . . . 52.32 107.882 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -135.36 163.05 30.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 108.966 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.435 ' HB2' ' CE1' ' A' ' 576' ' ' PHE . 28.2 tt0 -97.62 116.62 30.19 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.294 -1.743 . . . . 74.439999999999998 106.294 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.17 142.15 54.38 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.364 -0.606 . . . . 74.420000000000002 109.364 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -140.12 132.44 28.33 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.684 0.755 . . . . 74.540000000000006 110.229 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.4 p -140.65 122.14 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.714 -1.217 . . . . 54.340000000000003 107.714 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.68 -176.97 36.13 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 109.743 -1.343 . . . . 74.340000000000003 109.743 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 0.3 OUTLIER -126.31 128.68 47.5 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.628 0.728 . . . . 70.329999999999998 111.961 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 79.7 mt -89.53 144.34 26.11 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.094 -1.412 . . . . 74.219999999999999 110.061 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -105.59 101.87 11.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.395 0.617 . . . . 73.420000000000002 111.506 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 42.7 m-85 -100.21 100.41 11.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.791 -0.818 . . . . 70.219999999999999 108.791 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.402 ' H ' HD11 ' A' ' 567' ' ' ILE . 81.4 mt-30 -83.1 -77.9 0.23 Allowed 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.792 -0.763 . . . . 73.340000000000003 110.239 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -105.43 159.25 16.07 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.843 -0.617 . . . . 74.150000000000006 109.369 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 531' ' ' ALA . 13.2 t70 -57.99 -23.21 53.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.415 1.086 . . . . 73.129999999999995 111.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.08 -43.49 78.08 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.724 1.209 . . . . 73.340000000000003 112.0 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.402 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -96.39 158.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.255 0.55 . . . . 73.019999999999996 110.705 -173.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.68 154.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.879 -1.156 . . . . 75.150000000000006 107.879 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.5 mmpt? -115.49 154.71 28.83 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.861 0.362 . . . . 71.329999999999998 111.167 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 53.0 mt -128.54 136.62 59.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.581 -1.191 . . . . 71.209999999999994 109.529 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.513 ' HB ' HG12 ' A' ' 523' ' ' VAL . 56.3 mt -97.78 125.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.563 -1.643 . . . . 74.030000000000001 106.563 174.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 21.7 p -110.41 112.38 24.27 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.672 -0.862 . . . . 73.430000000000007 108.672 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.439 HD11 HD22 ' A' ' 589' ' ' LEU . 42.5 mt -108.27 134.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.819 -0.808 . . . . 73.519999999999996 108.819 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.18 117.13 22.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 109.566 -0.531 . . . . 71.420000000000002 109.566 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.42 123.69 57.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.59 -2.004 . . . . 73.349999999999994 105.59 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . 0.456 ' CE1' ' HA2' ' A' ' 550' ' ' GLY . 90.4 m-85 -85.67 147.24 26.46 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.55 -0.46 . . . . 73.400000000000006 111.297 -175.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.05 75.77 2.92 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.617 -1.253 . . . . 64.329999999999998 107.617 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.11 115.16 29.7 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.38 -1.282 . . . . 73.239999999999995 109.243 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -112.57 78.93 1.17 Allowed 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 105.527 -2.027 . . . . 74.430000000000007 105.527 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -91.88 -94.44 0.14 Allowed 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.244 -1.344 . . . . 74.409999999999997 110.079 -174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -155.0 153.52 31.13 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 105.032 -2.21 . . . . 74.5 105.032 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.13 120.58 11.75 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.907 0.706 . . . . 73.409999999999997 112.907 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 646' ' ' GLU . 35.3 mtmm -129.35 176.15 8.18 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.946 -1.501 . . . . 75.109999999999999 106.946 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -108.77 42.41 1.41 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.567 -1.642 . . . . 70.049999999999997 106.567 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 16.2 p -67.77 120.51 14.23 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.075 -1.421 . . . . 72.120000000000005 113.352 -172.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.7 m -143.65 153.09 42.14 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.368 -1.345 . . . . 62.43 107.368 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -133.49 153.11 51.9 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.406 -0.961 . . . . 75.319999999999993 108.406 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.8 m -111.25 154.51 24.35 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.687 -0.857 . . . . 71.439999999999998 108.687 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.439 HD22 HD11 ' A' ' 573' ' ' ILE . 39.7 tp -129.07 130.46 46.56 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.068 -1.456 . . . . 73.349999999999994 107.068 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.43 158.7 38.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 123.218 0.324 . . . . 74.340000000000003 110.313 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.05 145.52 26.45 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.128 -0.942 . . . . 74.150000000000006 108.49 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -101.59 165.99 10.94 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.324 -0.621 . . . . 74.219999999999999 109.324 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.32 114.55 7.4 Favored Pre-proline 0 C--O 1.245 0.851 0 O-C-N 124.233 0.958 . . . . 75.109999999999999 111.303 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.405 ' O ' ' HG2' ' A' ' 633' ' ' PRO . 88.6 Cg_endo -77.62 150.56 27.92 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.132 2.554 . . . . 74.439999999999998 111.443 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.93 140.27 51.15 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.415 -0.178 . . . . 64.010000000000005 111.471 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . 0.4 ' CH2' ' HB2' ' A' ' 501' ' ' HIS . 1.0 OUTLIER -103.03 118.05 35.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.675 -0.491 . . . . 74.129999999999995 109.675 -176.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.01 150.08 4.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 123.407 0.683 . . . . 75.340000000000003 110.432 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -65.83 -179.98 0.78 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.51 1.524 . . . . 74.140000000000001 112.412 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 67.15 -21.08 0.11 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.54 1.681 . . . . 74.540000000000006 115.54 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . 0.523 ' C ' ' HA2' ' A' ' 533' ' ' GLY . . . -87.59 -6.75 76.61 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.066 -1.064 . . . . 73.439999999999998 112.62 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 88.3 mtp -100.76 -167.92 1.5 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.517 -0.92 . . . . 73.150000000000006 108.517 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -143.93 131.83 21.53 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.633 -0.506 . . . . 74.430000000000007 109.633 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 89.13 -79.27 1.61 Allowed Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 111.648 -0.581 . . . . 71.25 111.648 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -94.62 128.98 9.71 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.713 -0.955 . . . . 73.430000000000007 110.713 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -128.28 134.39 48.93 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.618 -0.882 . . . . 73.120000000000005 108.618 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 68.2 m -86.63 102.96 14.66 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 108.813 -0.81 . . . . 73.120000000000005 108.813 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 40.1 mm -86.88 91.44 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 107.54 -1.282 . . . . 75.239999999999995 107.54 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 7.1 m -70.71 89.6 0.74 Allowed 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 114.976 -1.011 . . . . 74.010000000000005 109.594 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.97 -13.16 12.54 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.414 -0.812 . . . . 61.149999999999999 110.393 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -102.03 99.77 9.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.544 -0.909 . . . . 74.230000000000004 108.544 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -145.93 148.66 33.03 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.374 -1.713 . . . . 74.109999999999999 106.374 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 619' ' ' SER . 16.5 t70 -119.23 131.11 55.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.322 -0.621 . . . . 72.310000000000002 109.322 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.81 -21.52 56.55 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 125.152 1.381 . . . . 73.310000000000002 112.727 -174.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -67.96 -49.44 61.68 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 119.345 -0.36 . . . . 74.409999999999997 111.261 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -175.68 -56.71 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 114.762 1.393 . . . . 72.319999999999993 114.762 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -86.77 171.47 7.05 Favored 'Trans proline' 0 C--N 1.363 1.304 0 N-CA-C 115.953 1.482 . . . . 73.209999999999994 115.953 -169.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.49 -51.92 5.29 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 105.809 -1.923 . . . . 73.310000000000002 105.809 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 26.5 m -82.54 93.79 7.36 Favored 'General case' 0 N--CA 1.404 -2.728 0 CA-C-N 113.791 -1.55 . . . . 73.019999999999996 107.921 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 612' ' ' ASP . 10.5 p -90.48 22.43 3.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 123.67 0.788 . . . . 63.409999999999997 111.304 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 -158.56 0.67 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.71 -1.219 . . . . 74.400000000000006 107.71 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -84.55 -157.05 0.26 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.293 -1.002 . . . . 61.509999999999998 108.293 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.7 71.39 10.4 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.369 -0.832 . . . . 72.329999999999998 113.085 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -82.55 63.25 6.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.605 -0.725 . . . . 73.519999999999996 110.132 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 56.63 35.06 25.53 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.593 -0.73 . . . . 74.230000000000004 110.734 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -57.16 -34.97 68.98 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.0 -1.0 . . . . 74.109999999999999 112.379 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 630' ' ' MET . 20.4 ttp180 -67.16 -38.65 85.82 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 120.578 -0.449 . . . . 75.409999999999997 110.363 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 65.8 mt -70.06 -37.03 71.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.258 -0.645 . . . . 70.109999999999999 109.258 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.57 96.49 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.536 -0.756 . . . . 51.439999999999998 109.499 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -70.18 -25.9 63.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.566 0.58 . . . . 74.439999999999998 112.566 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.495 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 71.4 mtm -76.23 -8.32 56.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.355 0.598 . . . . 75.140000000000001 110.275 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -103.51 14.63 54.01 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.524 -1.03 . . . . 75.099999999999994 110.524 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -107.95 156.47 38.15 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.349 -0.982 . . . . 74.510000000000005 108.349 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' A' ' 594' ' ' PRO . 37.4 Cg_endo -66.89 143.58 67.15 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.047 1.831 . . . . 75.230000000000004 110.689 175.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 26.4 pt -133.24 -176.98 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 C-N-CA 123.086 0.554 . . . . 73.409999999999997 109.698 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.48 177.98 4.71 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.229 -1.026 . . . . 74.219999999999999 108.229 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.5 170.65 42.11 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.46 -0.656 . . . . 73.299999999999997 111.46 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -49.75 -61.61 2.03 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.249 1.02 . . . . 74.420000000000002 112.043 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -129.33 102.17 6.31 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.787 -1.56 . . . . 74.340000000000003 106.787 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 3.6 t -129.51 111.85 13.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 122.337 1.065 . . . . 64.420000000000002 110.865 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 37.0 ttmt -147.19 151.74 37.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.876 -1.898 . . . . 75.140000000000001 105.876 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 51.8 tp -123.38 103.45 8.5 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.977 -0.749 . . . . 73.549999999999997 108.977 175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.493 ' HB2' HG21 ' A' ' 511' ' ' VAL . 44.2 mt-10 -87.45 106.53 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.551 -0.907 . . . . 73.430000000000007 108.551 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 512' ' ' THR . 32.0 t -96.9 121.69 47.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 114.91 -1.041 . . . . 72.099999999999994 108.197 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 27.9 mt -115.55 133.49 61.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.108 -0.951 . . . . 73.310000000000002 110.896 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 646' ' ' GLU . 0.1 OUTLIER -142.58 163.23 18.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 125.062 1.345 . . . . 71.140000000000001 108.402 -176.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 583' ' ' LYS . 8.1 tp10 144.74 164.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 127.486 2.314 . . . . 73.049999999999997 106.967 169.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.07 123.67 18.75 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.452 -0.573 . . . . 75.319999999999993 109.452 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 50.0 m 67.96 86.36 0.13 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.412 1.085 . . . . 71.530000000000001 113.563 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -111.23 168.5 9.46 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.22 -1.77 . . . . 73.200000000000003 106.22 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -106.48 128.38 54.04 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.132 -0.627 . . . . 71.230000000000004 110.412 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -92.24 107.22 19.05 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.655 -0.702 . . . . 75.140000000000001 109.368 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 652' ' ' LYS . 0.0 OUTLIER -90.26 166.71 13.18 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.22 -1.03 . . . . 72.140000000000001 108.22 177.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 37.0 p -70.36 88.12 0.64 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.182 0.515 . . . . 74.129999999999995 111.653 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 18.2 m -84.85 99.51 10.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.22 -1.03 . . . . 75.219999999999999 108.22 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 45.5 t -133.19 151.86 34.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.16 -0.473 . . . . 73.400000000000006 109.784 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 109.428 -0.582 . . . . 74.340000000000003 109.428 174.416 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 27.2 p80 . . . . . 0 C--O 1.243 0.737 0 CA-C-O 121.577 0.703 . . . . 74.209999999999994 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -140.6 -178.3 5.45 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.095 -0.957 . . . . 70.430000000000007 108.838 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -67.74 137.55 32.43 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.797 -0.716 . . . . 54.299999999999997 112.067 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 67.3 mt -127.02 116.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.805 -1.183 . . . . 75.209999999999994 107.805 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -108.16 137.66 45.76 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.618 0.574 . . . . 75.219999999999999 111.67 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.2 t -148.91 157.37 43.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.83 -0.623 . . . . 64.420000000000002 109.371 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.46 ' CE2' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.37 155.68 36.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.086 -0.339 . . . . 75.239999999999995 110.086 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -59.39 -48.18 82.63 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 123.615 0.572 . . . . 73.530000000000001 110.47 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.42 151.09 77.31 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.42 -0.956 . . . . 55.530000000000001 108.42 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 2.4 Cg_endo -78.35 -20.63 10.96 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.631 1.554 . . . . 62.140000000000001 110.496 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 65.8 t -139.98 127.3 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.711 -0.848 . . . . 74.430000000000007 108.711 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -129.42 133.57 47.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.269 -0.641 . . . . 72.140000000000001 109.269 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -107.09 121.41 44.43 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.642 -0.873 . . . . 73.439999999999998 108.642 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.54 148.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.406 0.622 . . . . 72.140000000000001 111.022 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.515 ' HB3' ' OE1' ' A' ' 647' ' ' GLU . 50.7 m -65.12 141.27 58.76 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.542 -1.208 . . . . 75.219999999999999 110.262 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 647' ' ' GLU . 12.2 pt-20 -70.55 -24.26 62.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 109.832 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.39 17.99 17.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.066 -0.515 . . . . 74.140000000000001 110.828 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.1 -23.27 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.247 0.546 . . . . 73.430000000000007 111.036 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.43 -73.32 2.24 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.448 -0.882 . . . . 72.549999999999997 110.935 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.72 126.79 69.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.899 -1.148 . . . . 74.430000000000007 107.899 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.404 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.5 ppp? -98.15 148.7 23.3 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.865 -1.161 . . . . 73.420000000000002 107.865 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.3 119.16 28.5 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.414 0.446 . . . . 71.239999999999995 111.692 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.43 126.72 68.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.107 -0.701 . . . . 74.409999999999997 109.107 173.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -91.96 147.75 22.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.026 -0.534 . . . . 74.200000000000003 110.699 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.07 116.15 38.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.293 -1.373 . . . . 74.239999999999995 107.293 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.9 155.99 18.77 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.408 -0.814 . . . . 63.009999999999998 110.428 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.88 104.63 12.13 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 107.787 -1.19 . . . . 74.299999999999997 107.787 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.1 m -65.24 -61.22 2.25 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.421 -0.354 . . . . 72.129999999999995 110.709 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.2 t -74.57 -49.17 22.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.224 0.535 . . . . 65.140000000000001 109.851 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 151.78 -159.73 28.44 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.381 -1.488 . . . . 71.310000000000002 109.381 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -161.95 139.47 8.65 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.028 -0.73 . . . . 74.299999999999997 109.028 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -156.67 133.81 10.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 106.432 -1.692 . . . . 73.230000000000004 106.432 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.409 ' N ' ' HD3' ' A' ' 532' ' ' ARG . . . 108.63 -133.4 11.64 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.335 -0.936 . . . . 61.439999999999998 111.748 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -137.58 108.42 6.67 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.993 -1.114 . . . . 74.510000000000005 107.993 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.49 124.73 70.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.672 0.749 . . . . 74.239999999999995 111.199 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 559' ' ' GLU . 31.9 mm -93.7 116.45 34.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.043 -0.98 . . . . 74.439999999999998 108.687 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.4 t -108.81 99.24 33.49 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.912 -1.144 . . . . 75.109999999999999 107.912 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.1 159.98 23.66 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.682 1.588 . . . . 75.5 111.514 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -144.82 161.05 40.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.035 -1.098 . . . . 72.409999999999997 108.035 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -152.37 134.83 15.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.009 0.433 . . . . 75.150000000000006 111.006 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.9 138.59 34.99 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.089 -0.96 . . . . 74.430000000000007 112.006 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.2 mm -115.52 126.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.582 -1.636 . . . . 63.130000000000003 106.582 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.91 166.72 22.95 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.901 0.382 . . . . 64.109999999999999 110.792 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -162.87 -111.43 0.26 Allowed Glycine 0 CA--C 1.495 -1.215 0 N-CA-C 110.474 -1.05 . . . . 72.040000000000006 110.474 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -31.04 58.75 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.469 -1.308 . . . . 70.019999999999996 107.469 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.56 143.4 26.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.932 -1.485 . . . . 62.119999999999997 107.146 177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.48 ' HD2' ' OD1' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -109.42 153.35 24.13 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 113.531 0.937 . . . . 75.310000000000002 113.531 -171.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 43.11 -119.58 2.36 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 126.771 2.129 . . . . 73.510000000000005 118.372 168.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -164.89 96.35 0.13 Allowed Glycine 0 N--CA 1.412 -2.902 0 N-CA-C 108.649 -1.78 . . . . 71.430000000000007 108.649 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 123.01 -19.5 7.77 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 109.595 -1.402 . . . . 74.109999999999999 109.595 -175.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -76.97 -73.05 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.981 -0.609 . . . . 64.209999999999994 110.101 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 547' ' ' ARG . 5.7 m-20 -103.22 -44.17 5.26 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 122.136 0.969 . . . . 72.400000000000006 108.988 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -133.79 155.61 49.49 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 107.277 -1.379 . . . . 75.230000000000004 107.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.482 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 3.8 tm-20 -89.01 129.77 35.6 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.529 -1.285 . . . . 74.239999999999995 107.529 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.55 103.1 3.43 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.451 0.644 . . . . 72.040000000000006 111.199 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.6 t -108.43 113.7 26.95 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.384 -0.969 . . . . 74.049999999999997 108.384 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -143.41 100.6 3.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.503 -0.771 . . . . 74.420000000000002 109.231 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.81 -163.56 10.76 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.622 -0.799 . . . . 64.519999999999996 112.228 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.425 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.6 mt-10 -116.83 117.9 31.0 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.422 0.689 . . . . 64.030000000000001 110.582 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.4 mt -89.31 139.5 30.43 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.047 -0.723 . . . . 72.329999999999998 109.047 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.88 105.07 14.71 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.67 -0.812 . . . . 71.329999999999998 111.417 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 31.5 m-85 -96.21 143.79 26.99 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.397 -1.334 . . . . 64.510000000000005 107.397 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.429 ' H ' HD13 ' A' ' 567' ' ' ILE . 79.4 mt-30 -116.29 -86.94 0.61 Allowed 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.245 -1.02 . . . . 74.200000000000003 108.245 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.97 168.53 9.0 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.527 -0.869 . . . . 70.209999999999994 109.043 173.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -59.28 -11.05 3.51 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.244 1.418 . . . . 75.310000000000002 113.575 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.468 ' HG3' HG21 ' A' ' 567' ' ' ILE . 16.1 pt-20 -69.77 -17.88 63.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.729 0.412 . . . . 72.439999999999998 111.973 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 566' ' ' GLU . 41.0 pt -116.13 163.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 C-N-CA 120.319 -0.552 . . . . 73.140000000000001 111.464 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.3 146.45 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 108.181 -1.044 . . . . 71.549999999999997 108.181 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 70.9 mmtt -109.83 145.05 37.4 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.591 -0.522 . . . . 74.439999999999998 109.591 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 63.1 mt -116.92 133.6 63.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.368 -1.287 . . . . 74.010000000000005 108.287 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 55.5 mt -93.15 113.08 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 106.932 -1.507 . . . . 72.129999999999995 106.932 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -102.48 112.31 24.99 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.106 -0.952 . . . . 65.140000000000001 109.55 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 521' ' ' MET . 48.6 mt -107.65 129.43 61.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.983 -1.117 . . . . 74.519999999999996 107.983 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.482 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 63.8 mtt85 -78.25 114.62 17.31 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.504 -0.924 . . . . 74.519999999999996 108.504 176.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.4 mm -101.0 126.67 54.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.603 -0.888 . . . . 64.430000000000007 108.603 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 50.8 m-85 -107.45 112.13 24.76 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.039 0.447 . . . . 65.239999999999995 110.912 -177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.44 150.36 48.21 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.165 0.986 . . . . 64.120000000000005 111.402 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -138.73 -46.66 0.49 Allowed 'General case' 0 C--O 1.246 0.898 0 CA-C-N 116.035 -0.529 . . . . 75.530000000000001 111.354 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -119.15 -177.41 3.34 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 120.96 0.409 . . . . 71.329999999999998 111.167 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -78.49 -36.65 44.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.536 -1.653 . . . . 75.25 106.536 174.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -145.32 98.36 3.14 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.791 -1.095 . . . . 74.040000000000006 108.587 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.44 ' OE1' ' HA ' ' A' ' 582' ' ' GLU . 3.1 mm-40 -63.9 157.14 25.57 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 119.228 -0.989 . . . . 72.439999999999998 111.672 171.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 583' ' ' LYS . 5.9 mptt -88.31 69.03 9.06 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.058 0.392 . . . . 73.530000000000001 112.058 -168.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 51.98 31.58 8.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.162 0.985 . . . . 75.549999999999997 112.594 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 2.2 p -63.12 128.49 36.08 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 120.647 0.26 . . . . 74.329999999999998 110.711 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 6.7 m -130.57 152.44 49.95 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.743 -0.383 . . . . 55.350000000000001 110.558 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.8 p90 -138.95 175.59 9.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.381 -1.34 . . . . 72.530000000000001 107.381 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 14.7 m -125.59 158.88 33.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.632 -0.827 . . . . 71.450000000000003 110.577 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 59.2 tp -136.61 132.92 35.72 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 106.551 -1.648 . . . . 72.200000000000003 106.551 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.58 155.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 120.96 -0.296 . . . . 75.219999999999999 110.363 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 85.7 mt -92.1 142.53 27.41 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.317 -0.994 . . . . 73.439999999999998 108.317 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -93.87 175.57 6.67 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.463 -0.79 . . . . 73.340000000000003 109.404 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -66.58 113.9 14.98 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 123.734 0.646 . . . . 72.510000000000005 109.364 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.57 143.85 34.9 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.754 1.636 . . . . 72.209999999999994 111.264 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.05 140.46 51.9 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.375 -0.829 . . . . 63.509999999999998 110.472 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -102.06 124.22 47.29 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.084 -1.45 . . . . 74.150000000000006 107.084 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.56 98.48 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.764 0.793 . . . . 75.319999999999993 108.932 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -58.88 126.41 27.57 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.695 -1.593 . . . . 74.25 111.748 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -74.32 114.24 12.46 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.121 -1.066 . . . . 75.329999999999998 108.121 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 97.58 81.8 1.61 Allowed Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 108.884 -1.686 . . . . 64.319999999999993 108.884 -173.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 21.5 ptp -96.02 162.37 13.58 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.541 -0.54 . . . . 71.310000000000002 109.541 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -115.93 112.38 21.79 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.805 0.812 . . . . 73.450000000000003 112.3 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -150.56 -46.77 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 109.675 -1.37 . . . . 72.409999999999997 109.675 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -85.68 56.96 4.89 Favored Glycine 0 CA--C 1.506 -0.507 0 N-CA-C 110.532 -1.027 . . . . 54.219999999999999 110.532 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -95.27 156.91 16.12 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.759 -0.83 . . . . 75.519999999999996 108.759 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 4.9 m -68.21 105.25 2.04 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.06 0.544 . . . . 75.239999999999995 111.16 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 37.2 mm -120.05 88.08 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.032 -1.099 . . . . 75.319999999999993 108.032 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 21.1 m -132.28 -54.17 0.97 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.655 -0.498 . . . . 73.510000000000005 109.655 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -89.97 -19.21 24.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.68 -0.859 . . . . 74.409999999999997 108.68 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -79.62 137.52 37.13 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.326 -1.307 . . . . 75.219999999999999 108.089 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -104.69 -15.67 15.19 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.013 0.435 . . . . 74.329999999999998 110.511 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -111.03 127.05 55.41 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.512 -0.313 . . . . 72.349999999999994 110.291 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -68.78 146.15 53.16 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 120.878 0.37 . . . . 74.0 110.463 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.19 83.79 6.94 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.301 1.048 . . . . 65.120000000000005 110.787 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . 0.544 ' OE1' ' HD2' ' A' ' 616' ' ' PRO . 6.5 tp-100 -137.14 127.55 15.97 Favored Pre-proline 0 C--N 1.285 -2.22 0 N-CA-C 104.76 -2.311 . . . . 75.049999999999997 104.76 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.544 ' HD2' ' OE1' ' A' ' 615' ' ' GLN . 27.7 Cg_exo -56.96 136.96 79.75 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 C-N-CA 122.031 1.821 . . . . 75.109999999999999 110.401 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.1 104.23 10.52 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 108.656 -0.868 . . . . 75.030000000000001 108.656 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 6.5 p -82.94 -7.14 59.69 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.962 0.887 . . . . 75.439999999999998 110.065 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 10.0 p -70.58 -17.08 62.91 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.403 -1.271 . . . . 61.329999999999998 108.164 172.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -134.57 -150.93 0.41 Allowed 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 126.467 1.907 . . . . 74.019999999999996 106.212 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -125.84 179.51 5.16 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 104.653 -2.351 . . . . 61.399999999999999 104.653 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.88 105.24 17.27 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.061 -2.2 . . . . 74.340000000000003 105.061 164.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -51.02 155.62 1.2 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.562 -0.744 . . . . 75.230000000000004 112.042 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 64.22 34.17 11.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.13 0.967 . . . . 70.530000000000001 108.489 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 0.2 OUTLIER -55.72 -27.34 49.92 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 113.852 -1.522 . . . . 72.120000000000005 112.956 -175.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.576 ' O ' ' HG3' ' A' ' 630' ' ' MET . 95.2 mtt180 -58.76 -46.0 88.46 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.139 0.495 . . . . 72.040000000000006 110.452 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.06 -35.79 65.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.041 -0.981 . . . . 73.129999999999995 109.624 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.67 78.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.927 -0.578 . . . . 74.310000000000002 110.261 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 35.6 mt-10 -79.47 -15.72 57.3 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.08 -0.509 . . . . 73.120000000000005 111.207 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.576 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 64.6 mtt -76.63 -10.27 59.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.895 -1.15 . . . . 75.219999999999999 107.895 173.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -105.84 21.44 34.11 Favored Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.551 -1.419 . . . . 63.219999999999999 109.551 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -129.3 156.65 78.07 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 107.512 -1.292 . . . . 75.340000000000003 107.512 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -71.24 156.11 59.7 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 N-CA-C 107.707 -1.69 . . . . 71.239999999999995 107.707 168.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER -131.45 -177.95 2.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 CA-C-O 121.19 0.519 . . . . 74.340000000000003 111.358 -175.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.74 176.39 6.37 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.469 -0.937 . . . . 74.310000000000002 108.469 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.06 -128.55 0.21 Allowed Glycine 0 C--N 1.309 -0.929 0 CA-C-O 121.968 0.76 . . . . 62.549999999999997 113.102 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.33 -84.17 0.05 OUTLIER 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.834 -0.683 . . . . 65.420000000000002 109.241 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -141.75 94.93 2.74 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 105.085 -2.191 . . . . 74.209999999999994 105.085 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.3 t -100.65 118.34 36.59 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-O 122.401 1.096 . . . . 75.019999999999996 110.954 -172.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 3.7 ttmp? -145.05 143.64 30.56 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.848 -1.908 . . . . 75.450000000000003 105.848 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 28.4 tp -119.59 105.68 11.44 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 108.232 -1.025 . . . . 74.140000000000001 108.232 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.79 121.76 32.93 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.985 -1.117 . . . . 75.25 107.985 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.69 120.27 59.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.978 -1.01 . . . . 75.019999999999996 109.308 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.21 121.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 CA-C-N 114.696 -1.138 . . . . 65.340000000000003 108.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.71 117.73 53.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.334 -0.848 . . . . 75.439999999999998 110.184 -178.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -165.88 136.5 3.6 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.406 -1.702 . . . . 74.409999999999997 106.406 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.515 ' OE1' ' HB3' ' A' ' 515' ' ' SER . 10.4 tp10 -78.87 82.33 5.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.31 -1.356 . . . . 75.010000000000005 110.25 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 17.1 t -88.25 88.94 7.8 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.472 -1.677 . . . . 74.230000000000004 106.472 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -130.41 145.09 51.76 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.738 0.78 . . . . 75.340000000000003 111.821 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.54 147.8 12.35 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 101.141 -3.651 . . . . 73.310000000000002 101.141 169.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -78.33 -23.41 47.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.057 -0.719 . . . . 71.519999999999996 109.057 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? 57.29 26.22 12.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.388 1.475 . . . . 74.099999999999994 113.679 174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 27.5 t -98.62 83.76 3.04 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 108.695 -0.854 . . . . 62.43 108.695 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 56.7 m -126.83 118.76 25.27 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.314 -0.857 . . . . 73.409999999999997 109.429 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 8.6 p -115.23 117.89 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 108.373 -0.973 . . . . 73.239999999999995 108.373 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.679 -0.86 . . . . 54.539999999999999 108.679 -178.108 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' A' ' 632' ' ' ARG . 53.2 t60 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.702 -0.851 . . . . 71.329999999999998 108.702 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . 71.72 -51.22 0.69 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.874 1.67 . . . . 44.310000000000002 111.617 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -124.17 125.27 5.75 Favored Glycine 0 N--CA 1.416 -2.684 0 N-CA-C 110.278 -1.129 . . . . 54.329999999999998 110.278 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 68.6 mt -127.54 118.94 50.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.92 -1.511 . . . . 74.319999999999993 106.92 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.33 133.07 51.6 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.221 0.452 . . . . 74.310000000000002 112.221 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -148.11 153.97 39.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.688 -0.856 . . . . 70.120000000000005 108.688 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.444 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 68.1 m-85 -74.28 156.3 37.32 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.806 -0.442 . . . . 72.049999999999997 109.806 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.58 -49.11 79.03 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.235 0.54 . . . . 74.340000000000003 110.381 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.77 153.7 81.16 Favored Pre-proline 0 N--CA 1.432 -1.35 0 N-CA-C 107.721 -1.215 . . . . 73.25 107.721 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 83.3 Cg_endo -86.24 -11.32 6.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.024 1.816 . . . . 62.0 113.3 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 70.4 t -143.81 135.34 22.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.281 -0.637 . . . . 75.409999999999997 109.281 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.96 133.97 42.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.712 -0.477 . . . . 75.230000000000004 109.712 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -106.18 110.86 23.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.622 -1.251 . . . . 65.310000000000002 107.622 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.85 155.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 110.757 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.464 ' O ' HG21 ' A' ' 518' ' ' ILE . 2.6 t -77.13 147.03 36.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.668 -1.975 . . . . 73.140000000000001 105.668 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -77.58 -16.94 58.31 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.068 -1.053 . . . . 74.430000000000007 110.813 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.7 m -91.31 13.19 18.01 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.202 -0.454 . . . . 73.019999999999996 111.427 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 515' ' ' SER . 8.1 tt -74.06 -25.67 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.033 0.444 . . . . 72.25 111.736 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.37 -68.96 2.61 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.982 -1.104 . . . . 65.030000000000001 112.2 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.5 mm -131.97 132.31 61.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.299999999999997 108.286 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 19.0 ptm -108.42 143.02 37.93 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.011 -0.737 . . . . 74.519999999999996 109.011 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -99.25 124.21 44.15 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 123.55 0.531 . . . . 73.510000000000005 110.524 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.0 t -115.55 120.23 64.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.461 -1.311 . . . . 74.219999999999999 107.461 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -106.29 123.68 48.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.297 -0.961 . . . . 75.310000000000002 110.275 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 78.5 t -88.59 110.99 21.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.168 -0.924 . . . . 73.430000000000007 108.833 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.79 122.61 30.11 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.443 -0.798 . . . . 74.209999999999994 110.592 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -87.13 101.3 13.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.908 -1.145 . . . . 71.5 107.908 171.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.9 t -67.19 -47.53 70.66 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 75.209999999999994 112.401 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.1 t -74.58 -24.06 58.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.271 0.558 . . . . 63.329999999999998 109.924 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 115.09 -158.69 14.18 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 110.378 -1.089 . . . . 65.420000000000002 110.378 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.87 136.41 17.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.26 -1.385 . . . . 64.340000000000003 107.26 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -135.27 87.1 2.3 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.716 -0.394 . . . . 74.450000000000003 109.967 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 98.63 -178.98 31.54 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.81 -1.316 . . . . 72.230000000000004 109.81 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.518 HD22 ' HG3' ' A' ' 561' ' ' GLU . 4.6 t-20 -74.5 111.54 9.78 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.457 -0.897 . . . . 74.120000000000005 111.201 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.89 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.872 -1.158 . . . . 53.049999999999997 107.872 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.438 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.3 mm -99.47 122.65 51.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.553 -0.906 . . . . 75.120000000000005 108.553 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 28.4 t -112.78 105.59 55.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 123.555 0.535 . . . . 63.549999999999997 109.754 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.44 150.55 28.48 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.917 1.745 . . . . 74.310000000000002 111.514 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -142.02 168.29 20.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.989 -1.115 . . . . 70.409999999999997 107.989 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 589' ' ' LEU . 55.0 pttt -161.23 145.14 13.15 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.123 0.487 . . . . 73.430000000000007 111.07 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.5 p -83.6 133.46 34.84 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.994 -1.003 . . . . 72.400000000000006 110.454 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 42.4 mm -104.2 112.41 37.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.062 -1.459 . . . . 64.439999999999998 107.062 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.89 152.16 41.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.656 0.598 . . . . 70.319999999999993 110.064 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -145.51 -116.97 1.06 Allowed Glycine 0 C--N 1.293 -1.837 0 N-CA-C 108.801 -1.72 . . . . 52.32 108.801 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 24.9 p -75.35 -27.71 59.29 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.21 -1.033 . . . . 74.409999999999997 108.21 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.38 127.98 34.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.604 -1.258 . . . . 72.040000000000006 107.604 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.494 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 3.2 tmt_? -104.26 139.67 38.94 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.578 -1.267 . . . . 72.510000000000005 107.578 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . 0.467 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -86.94 -156.33 29.08 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.889 -0.672 . . . . 74.540000000000006 112.806 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.81 1.86 59.81 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.798 -0.239 . . . . 74.120000000000005 113.532 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 117.22 0.64 18.91 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.173 -1.013 . . . . 55.420000000000002 113.08 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 12.8 tp10 -69.77 -76.46 0.1 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 117.393 0.597 . . . . 74.239999999999995 109.793 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.466 ' OD1' ' HD3' ' A' ' 578' ' ' ARG . 12.8 m-20 -100.18 -35.42 9.65 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.77 -1.196 . . . . 74.129999999999995 107.77 174.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -144.17 166.63 24.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.869 -1.16 . . . . 73.329999999999998 107.869 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.44 144.2 26.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.467 -1.679 . . . . 74.420000000000002 106.467 176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.91 122.08 28.24 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.264 -0.643 . . . . 74.219999999999999 109.264 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -129.5 124.05 32.99 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.989 0.9 . . . . 75.540000000000006 112.653 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 9.4 p -131.39 129.26 41.1 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.031 -1.841 . . . . 74.5 106.031 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -160.35 171.76 36.63 Favored Glycine 0 CA--C 1.48 -2.128 0 C-N-CA 118.997 -1.573 . . . . 65.200000000000003 112.474 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.438 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 7.7 mp0 -107.67 115.61 30.46 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.537 -0.912 . . . . 75.040000000000006 108.537 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.117 -0.327 . . . . 71.109999999999999 110.117 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.518 ' HG3' HD22 ' A' ' 534' ' ' ASN . 40.4 tt0 -106.5 101.97 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.172 0.51 . . . . 74.109999999999999 111.771 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -97.37 156.47 16.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.097 -0.705 . . . . 75.530000000000001 109.097 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -136.79 -81.13 0.38 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.816 1.293 . . . . 74.010000000000005 109.21 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -104.19 159.05 16.02 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 115.38 -0.827 . . . . 71.519999999999996 109.594 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -60.65 -16.37 38.18 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 125.151 1.381 . . . . 72.239999999999995 114.017 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -80.75 -16.34 54.12 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.687 -0.805 . . . . 73.420000000000002 112.237 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 37.1 pt -99.58 158.98 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.215 -0.994 . . . . 73.430000000000007 110.307 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.57 143.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.267 -1.382 . . . . 75.540000000000006 107.267 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.1 mmpt? -101.69 147.27 26.65 Favored 'General case' 0 CA--C 1.468 -2.186 0 C-N-CA 120.108 -0.637 . . . . 73.239999999999995 110.636 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 22.2 mt -125.28 128.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 CA-C-N 114.578 -1.192 . . . . 72.340000000000003 108.771 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 52.9 mt -90.46 134.05 30.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.803 -1.554 . . . . 74.510000000000005 106.803 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 18.3 p -116.18 111.93 20.93 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.714 -0.847 . . . . 71.230000000000004 108.714 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.39 128.41 60.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.833 -0.803 . . . . 73.540000000000006 108.833 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.62 111.93 11.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 124.115 0.884 . . . . 74.430000000000007 109.378 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -106.9 131.39 56.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.238 -1.393 . . . . 73.019999999999996 107.238 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . 0.48 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 51.5 m-85 -119.31 143.79 47.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 74.409999999999997 108.316 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -80.81 127.25 32.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.292 -1.373 . . . . 74.329999999999998 107.292 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.466 ' HD3' ' OD1' ' A' ' 552' ' ' ASP . 56.7 ttt-85 -121.13 138.53 54.15 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.697 -0.683 . . . . 75.049999999999997 112.039 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -73.39 108.03 6.03 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.839 -1.073 . . . . 74.230000000000004 110.776 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 582' ' ' GLU . 38.3 tt0 -167.52 141.63 3.63 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.272 -1.381 . . . . 65.420000000000002 107.272 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -87.21 -22.24 25.37 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.543 -0.863 . . . . 75.230000000000004 111.378 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 580' ' ' GLU . 33.9 mt-10 -76.03 -71.42 0.38 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.124 -0.489 . . . . 73.040000000000006 110.656 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 585' ' ' CYS . 25.2 mmmt 64.51 36.84 8.42 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 124.186 0.994 . . . . 72.5 113.58 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.33 31.96 0.87 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.923 -1.14 . . . . 65.120000000000005 107.923 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . 0.442 ' H ' ' C ' ' A' ' 583' ' ' LYS . 57.7 m -80.16 115.94 19.99 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.729 -1.578 . . . . 74.25 111.103 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 45.7 p -137.34 146.66 44.84 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.716 -0.846 . . . . 71.140000000000001 108.716 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -133.17 173.75 11.11 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.23 -1.026 . . . . 73.010000000000005 108.23 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 10.9 m -124.84 156.07 38.42 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.538 -0.912 . . . . 73.109999999999999 108.538 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 540' ' ' LYS . 63.6 tp -128.3 129.1 45.8 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 106.548 -1.649 . . . . 74.299999999999997 106.548 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 31.7 m -127.74 159.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 123.215 0.322 . . . . 73.340000000000003 110.14 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.444 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 93.0 mt -102.33 154.97 18.55 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.533 -0.914 . . . . 72.450000000000003 108.533 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.6 171.4 7.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.641 -0.874 . . . . 73.299999999999997 108.641 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.3 120.88 59.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 O-C-N 123.674 0.609 . . . . 74.340000000000003 110.656 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.522 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 52.2 Cg_endo -74.58 156.23 44.94 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.367 2.045 . . . . 73.450000000000003 111.932 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -121.25 144.9 48.36 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.572 -0.74 . . . . 74.450000000000003 109.455 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -104.59 121.33 43.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.674 -0.861 . . . . 72.140000000000001 108.674 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . 0.405 HD11 HG12 ' A' ' 536' ' ' ILE . 2.2 mp -106.27 91.1 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 122.663 1.22 . . . . 74.219999999999999 111.089 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -116.49 164.84 13.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.427 -1.715 . . . . 71.409999999999997 107.38 172.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -72.67 114.29 10.65 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.499 -0.926 . . . . 72.340000000000003 108.499 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 119.26 -11.77 11.43 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.74 -0.944 . . . . 74.420000000000002 110.74 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 92.3 mmm -80.18 122.15 26.47 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 108.464 -0.939 . . . . 72.230000000000004 108.464 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -107.59 110.06 21.86 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.536 0.684 . . . . 74.340000000000003 111.202 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 166.19 39.37 0.02 OUTLIER Glycine 0 C--N 1.298 -1.548 0 N-CA-C 110.223 -1.151 . . . . 71.129999999999995 110.223 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -126.06 63.29 0.59 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 111.33 -0.708 . . . . 52.210000000000001 111.33 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -122.67 25.67 8.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.43 -1.322 . . . . 74.430000000000007 107.43 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 67.2 m -74.1 129.57 38.09 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.501 -1.227 . . . . 72.150000000000006 108.483 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 51.2 mm -82.06 99.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 N-CA-C 108.708 -0.849 . . . . 75.150000000000006 108.708 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 7.5 t -94.66 -14.15 25.16 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.584 -0.735 . . . . 74.409999999999997 110.552 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.57 -26.34 66.24 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.686 0.755 . . . . 72.099999999999994 110.294 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -120.44 150.44 40.8 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 106.197 -1.779 . . . . 75.120000000000005 106.197 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -88.05 132.2 34.37 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.498 0.666 . . . . 75.439999999999998 111.271 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -135.95 134.23 38.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.408 -1.701 . . . . 63.350000000000001 106.408 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.91 -67.71 0.65 Allowed 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 120.494 -0.482 . . . . 74.409999999999997 110.506 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -160.67 103.93 1.37 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.379 -0.971 . . . . 72.439999999999998 108.379 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -142.79 116.64 6.3 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 116.5 -0.318 . . . . 71.230000000000004 110.469 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.79 150.48 39.3 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.217 1.944 . . . . 73.140000000000001 110.567 173.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.55 161.25 14.27 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.499 -0.773 . . . . 72.019999999999996 111.018 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 18.0 m -57.79 120.41 8.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.113 0.965 . . . . 74.450000000000003 108.864 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 20.2 m -119.71 167.61 11.88 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.317 -0.402 . . . . 64.120000000000005 110.886 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -105.86 163.28 12.86 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.323 -1.362 . . . . 73.430000000000007 107.323 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -92.18 85.41 5.45 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.616 -0.433 . . . . 74.219999999999999 110.162 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.71 177.02 6.14 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.195 -1.002 . . . . 74.430000000000007 109.553 173.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.43 160.69 14.17 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 122.319 -0.238 . . . . 74.540000000000006 111.057 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 62.03 24.75 14.77 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.193 0.933 . . . . 54.329999999999998 111.934 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.582 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 35.9 mtp-105 -61.83 -47.85 83.21 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.018 -0.364 . . . . 71.340000000000003 110.018 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 630' ' ' MET . 54.5 ttp180 -75.53 -34.79 60.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.917 -1.038 . . . . 73.150000000000006 110.14 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 98.6 mt -65.86 -35.76 75.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.775 -0.648 . . . . 74.239999999999995 110.509 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.55 73.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.111 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 42.7 mt-10 -73.57 -23.24 59.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.856 -0.611 . . . . 70.099999999999994 110.39 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.407 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 60.0 mtt -75.93 -28.06 57.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.547 -0.751 . . . . 71.25 109.037 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -92.03 42.31 2.76 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.043 -0.823 . . . . 60.119999999999997 111.043 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.523 ' NH1' ' HG2' ' A' ' 629' ' ' GLU . 96.6 mtt180 -135.16 163.28 52.17 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 105.646 -1.983 . . . . 74.340000000000003 105.646 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.522 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 45.1 Cg_exo -62.68 151.37 84.06 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 108.087 -1.543 . . . . 75.120000000000005 108.087 171.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 27.3 pt -130.73 -179.4 3.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-O 121.338 0.589 . . . . 74.340000000000003 111.175 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.85 172.7 8.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.537 -1.282 . . . . 71.340000000000003 107.537 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.44 -172.86 38.62 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 120.358 -0.925 . . . . 64.219999999999999 111.249 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . 0.451 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 43.3 tt0 -54.9 -62.36 1.71 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.162 0.585 . . . . 74.530000000000001 110.465 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . 0.451 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 37.1 m80 -135.14 106.11 6.62 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.972 -0.751 . . . . 74.219999999999999 108.972 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 9.0 t -119.41 108.81 15.01 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 122.18 0.99 . . . . 64.129999999999995 110.387 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 40.9 ttmt -147.91 142.33 26.37 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.686 -1.227 . . . . 73.209999999999994 107.686 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 62.1 tp -119.34 110.51 17.05 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.695 -0.854 . . . . 64.409999999999997 108.695 174.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.98 117.55 28.87 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.445 -0.946 . . . . 70.420000000000002 108.445 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.58 124.74 60.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 114.713 -1.131 . . . . 70.200000000000003 109.542 -175.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.38 123.48 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.598 0 N-CA-C 107.942 -1.133 . . . . 75.129999999999995 107.942 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.85 110.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.682 -0.69 . . . . 74.129999999999995 111.153 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -149.54 154.13 38.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.922 -1.51 . . . . 75.420000000000002 106.922 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -73.06 89.48 1.46 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.787 0.803 . . . . 73.540000000000006 110.211 170.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 17.6 t -161.12 -177.37 6.03 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 105.847 -1.908 . . . . 62.32 105.847 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -145.17 169.29 18.47 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.398 -1.334 . . . . 73.439999999999998 107.398 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.59 125.18 46.13 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.704 -1.961 . . . . 70.049999999999997 105.704 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -74.19 109.96 8.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.12 -1.067 . . . . 74.430000000000007 108.12 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -118.83 168.54 10.67 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.208 -0.906 . . . . 73.400000000000006 111.441 -172.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 8.5 t -108.4 134.52 51.08 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.113 -1.81 . . . . 73.209999999999994 106.113 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 19.6 m -63.6 109.52 1.7 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.057 0.456 . . . . 64.409999999999997 110.753 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.42 170.55 19.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.959 -0.564 . . . . 73.209999999999994 109.667 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--N 1.309 -1.185 0 N-CA-C 109.686 -0.487 . . . . 70.219999999999999 109.686 -179.118 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.7 p80 . . . . . 0 CA--C 1.511 -0.527 0 CA-C-O 121.768 0.794 . . . . 73.239999999999995 109.674 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -67.33 -16.0 64.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.349 -1.296 . . . . 70.450000000000003 110.166 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . -133.81 119.72 2.35 Favored Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 109.951 -1.26 . . . . 61.210000000000001 109.951 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 83.6 mt -127.15 114.88 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.586 -1.265 . . . . 74.129999999999995 107.586 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -103.77 134.65 46.72 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 74.409999999999997 111.873 -175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.1 t -148.13 163.34 37.25 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.934 -0.575 . . . . 75.140000000000001 109.654 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.9 162.37 20.53 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-O 120.958 0.409 . . . . 63.219999999999999 110.678 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.0 -55.77 19.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.106 -0.952 . . . . 73.140000000000001 109.167 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.33 159.36 57.66 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.515 -0.766 . . . . 73.129999999999995 108.976 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.06 -18.16 6.4 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.221 1.281 . . . . 74.209999999999994 111.224 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 79.4 t -142.0 130.38 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.247 0.619 . . . . 75.129999999999995 109.364 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.62 140.96 47.42 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.63 -0.878 . . . . 72.310000000000002 108.63 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -119.49 117.21 27.82 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.776 -0.824 . . . . 73.239999999999995 108.776 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.1 m -106.35 162.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.248 0.546 . . . . 75.340000000000003 112.472 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 16.3 m -74.38 138.22 43.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.9 -1.045 . . . . 73.510000000000005 110.052 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -58.71 -33.93 70.75 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.404 0.682 . . . . 72.430000000000007 110.916 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.5 m -110.22 25.42 11.8 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.594 0.59 . . . . 72.040000000000006 112.594 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.6 tt -71.27 -33.2 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.361 0.601 . . . . 74.140000000000001 112.276 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 574' ' ' ARG . . . 89.85 -75.16 1.81 Allowed Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.215 -0.993 . . . . 75.239999999999995 110.845 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.7 mm -120.25 123.27 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.918 -0.401 . . . . 73.109999999999999 109.918 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.479 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 21.5 ptm -94.03 130.05 40.3 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.437 -0.949 . . . . 74.409999999999997 108.437 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -106.56 113.45 26.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.577 0.751 . . . . 70.140000000000001 111.339 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 57.5 t -119.76 131.06 73.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.599 -0.519 . . . . 65.329999999999998 109.599 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -92.76 133.71 35.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.062 0.458 . . . . 74.439999999999998 110.366 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 97.6 t -90.3 114.02 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.952 -1.499 . . . . 74.219999999999999 106.952 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.41 151.01 24.32 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.131 -0.94 . . . . 72.409999999999997 109.584 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 530' ' ' GLY . 0.0 OUTLIER -122.46 104.4 9.36 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.167 -1.049 . . . . 75.129999999999995 108.167 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.8 m -63.82 -63.34 1.19 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.99 -1.004 . . . . 71.420000000000002 111.861 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 10.8 p -74.13 -33.68 63.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.641 0.734 . . . . 70.140000000000001 110.725 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . 0.54 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 140.36 -148.6 20.22 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 109.567 -1.413 . . . . 74.120000000000005 109.567 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -162.96 144.01 9.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 74.140000000000001 106.687 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -149.04 131.21 15.45 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.429 0.529 . . . . 73.129999999999995 112.429 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 99.06 -126.38 8.89 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 115.219 -0.901 . . . . 73.219999999999999 111.359 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.02 109.53 7.42 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.321 -1.363 . . . . 73.319999999999993 107.321 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.09 122.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 121.146 0.498 . . . . 73.299999999999997 110.715 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.77 117.77 32.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.127 -1.434 . . . . 75.329999999999998 107.127 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.2 t -108.18 101.1 40.23 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.151 -1.055 . . . . 74.530000000000001 108.151 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.23 139.26 6.98 Favored 'Trans proline' 0 N--CA 1.425 -2.558 0 C-N-CA 121.63 1.553 . . . . 71.510000000000005 111.983 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.508 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.4 p90 -119.6 159.49 24.28 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.963 -1.495 . . . . 75.150000000000006 106.963 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . 0.463 ' HA ' ' SG ' ' A' ' 557' ' ' CYS . 62.3 pttt -146.33 140.66 26.58 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.004 -0.678 . . . . 74.150000000000006 110.963 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.1 p -85.94 132.77 34.01 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.64 -1.164 . . . . 64.5 110.593 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 39.3 mm -109.59 116.74 52.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.875 -1.157 . . . . 72.010000000000005 107.875 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -67.87 167.76 12.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.398 0.618 . . . . 71.299999999999997 111.047 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.457 ' C ' ' HG1' ' A' ' 545' ' ' THR . . . 156.99 116.44 0.51 Allowed Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 107.733 -2.147 . . . . 75.540000000000006 107.733 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' THR . . . . . 0.457 ' HG1' ' C ' ' A' ' 544' ' ' GLY 0.295 7.9 p 66.85 -44.43 0.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.124 1.77 . . . . 70.310000000000002 112.437 -172.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.01 19.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.962 -1.496 . . . . 73.549999999999997 106.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.491 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 3.4 mpt_? -111.27 152.53 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.283 0.563 . . . . 73.340000000000003 110.511 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.77 170.47 32.17 Favored Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.323 -1.111 . . . . 62.310000000000002 110.323 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 106.77 23.84 6.95 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.267 -1.133 . . . . 72.430000000000007 110.267 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 63.61 36.36 93.24 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.96 -0.856 . . . . 62.200000000000003 110.96 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.436 ' HB3' ' OH ' ' A' ' 581' ' ' TYR . 6.1 mm-40 -93.02 -76.36 0.47 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.145 0.578 . . . . 75.030000000000001 111.506 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.61 -40.39 15.2 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.615 -1.254 . . . . 64.450000000000003 107.615 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.26 160.67 39.46 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.001 -1.454 . . . . 75.230000000000004 107.469 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.8 OUTLIER -88.71 104.94 17.35 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.084 -1.45 . . . . 75.109999999999999 107.084 177.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.19 98.91 0.84 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.149 . . . . 72.349999999999994 109.039 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.54 138.69 54.31 Favored 'General case' 0 N--CA 1.398 -3.033 0 CA-C-N 114.472 -1.24 . . . . 72.319999999999993 107.993 -171.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 540' ' ' LYS . 56.1 m -149.17 125.0 10.54 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.437 -0.209 . . . . 74.239999999999995 110.437 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 121.3 -133.21 9.45 Favored Glycine 0 C--O 1.211 -1.308 0 N-CA-C 111.222 -0.751 . . . . 75.230000000000004 111.222 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 60.44 -10.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 118.277 2.695 . . . . 75.409999999999997 118.277 171.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 569' ' ' LYS . 39.8 mt -99.41 135.22 41.14 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.523 -1.361 . . . . 73.329999999999998 112.93 -175.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.402 ' HG2' ' NE2' ' A' ' 563' ' ' GLN . 41.6 tt0 -137.12 115.66 11.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.071 -1.085 . . . . 75.209999999999994 108.071 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.99 145.87 29.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.388 -0.967 . . . . 64.120000000000005 108.388 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.439 ' H ' HD11 ' A' ' 567' ' ' ILE . 2.0 mp0 -103.63 -94.55 0.32 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.73 -1.581 . . . . 74.150000000000006 106.73 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -105.22 176.09 5.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.866 -0.606 . . . . 74.349999999999994 111.875 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.09 -25.53 22.33 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.636 1.574 . . . . 73.420000000000002 112.436 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.08 -20.56 54.53 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.001 0.92 . . . . 74.219999999999999 113.153 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.439 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.8 pt -119.64 157.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 119.497 -0.881 . . . . 73.209999999999994 110.617 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.93 148.4 32.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 106.707 -1.59 . . . . 75.409999999999997 106.707 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.501 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.6 mmpt? -113.02 164.56 13.31 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.519 -0.472 . . . . 72.25 112.027 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.11 134.41 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.173 -0.921 . . . . 70.540000000000006 110.426 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.508 HG23 ' CZ ' ' A' ' 539' ' ' TYR . 70.2 mt -90.67 125.64 43.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.531 -1.285 . . . . 73.150000000000006 107.531 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -111.86 112.65 24.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.511 0.672 . . . . 62.130000000000003 110.588 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.479 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 62.2 mt -118.83 130.06 74.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.635 -0.876 . . . . 74.299999999999997 108.635 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.529 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 84.0 mtp180 -83.69 132.82 34.84 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.726 0.641 . . . . 73.129999999999995 110.142 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.73 130.18 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.922 -1.14 . . . . 74.109999999999999 107.922 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -116.09 115.01 25.31 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.466 0.543 . . . . 74.510000000000005 112.466 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -117.67 123.61 46.53 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.11 -0.7 . . . . 71.519999999999996 109.11 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -128.31 -72.85 0.6 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.823 -0.806 . . . . 75.530000000000001 108.823 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -102.98 -165.69 1.2 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.28 -1.007 . . . . 74.510000000000005 108.28 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.17 -68.05 0.36 Allowed 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.649 -1.241 . . . . 74.409999999999997 107.649 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.436 ' OH ' ' HB3' ' A' ' 551' ' ' GLU . 17.4 t80 61.43 17.68 8.63 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 113.957 1.095 . . . . 75.209999999999994 113.957 166.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.9 81.04 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.789 0.663 . . . . 74.519999999999996 112.789 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -98.09 85.57 3.51 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.863 0.84 . . . . 75.329999999999998 109.313 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -156.28 27.31 0.35 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 104.224 -2.51 . . . . 75.450000000000003 104.224 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 75.0 m -102.93 141.52 35.58 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 112.956 -1.929 . . . . 75.430000000000007 112.002 -170.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 61.1 p -130.65 120.76 24.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.751 -0.659 . . . . 61.539999999999999 109.797 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -108.13 168.86 8.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.62 -1.252 . . . . 74.310000000000002 107.62 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 3.6 m -121.28 162.89 19.47 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.243 -0.983 . . . . 52.229999999999997 109.887 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 540' ' ' LYS . 65.9 tp -136.54 125.94 25.02 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.808 -1.553 . . . . 74.430000000000007 106.808 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.52 159.62 30.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.786 -0.45 . . . . 63.240000000000002 109.786 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.61 135.46 43.09 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.265 -1.013 . . . . 74.329999999999998 108.265 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.97 171.63 8.15 Favored 'General case' 0 C--N 1.271 -2.822 0 CA-C-N 115.69 -0.686 . . . . 72.310000000000002 109.476 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.43 121.2 46.29 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 113.49 0.922 . . . . 75.400000000000006 113.49 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.471 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 28.7 Cg_endo -77.06 144.51 23.84 Favored 'Trans proline' 0 N--CA 1.415 -3.094 0 C-N-CA 121.428 1.419 . . . . 73.25 111.191 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.528 ' HB3' ' HZ1' ' A' ' 595' ' ' LYS . 0.1 OUTLIER -118.72 132.37 56.15 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.114 -0.948 . . . . 74.319999999999993 110.062 -176.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -98.27 119.69 37.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.63 -0.714 . . . . 74.409999999999997 109.262 -175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.15 92.07 3.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.997 -1.482 . . . . 75.310000000000002 106.997 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -124.18 154.75 39.62 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.878 -1.056 . . . . 72.430000000000007 109.842 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -74.32 117.46 16.16 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.514 -0.55 . . . . 75.219999999999999 109.514 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 147.59 -41.46 0.93 Allowed Glycine 0 C--N 1.307 -1.066 0 N-CA-C 109.905 -1.278 . . . . 64.120000000000005 109.905 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 24.4 ttt -82.89 65.63 8.11 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.553 0.692 . . . . 73.420000000000002 109.497 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -165.46 -57.88 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.267 -0.879 . . . . 64.340000000000003 109.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 80.52 -66.12 3.75 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.526 -0.629 . . . . 70.439999999999998 111.526 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.41 31.57 0.02 OUTLIER Glycine 0 C--N 1.296 -1.64 0 N-CA-C 109.036 -1.625 . . . . 74.239999999999995 109.036 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -164.84 -175.5 3.8 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.497 -1.297 . . . . 75.439999999999998 107.497 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 50.9 m -98.46 122.9 42.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.936 -0.764 . . . . 74.019999999999996 108.936 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.42 103.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 108.26 -1.015 . . . . 74.010000000000005 108.26 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 19.1 m -92.55 -10.29 38.17 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.853 0.835 . . . . 73.430000000000007 108.901 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.85 81.83 3.43 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.01 0.909 . . . . 65.109999999999999 109.662 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -145.97 131.08 18.35 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 113.999 -1.455 . . . . 74.349999999999994 107.762 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 613' ' ' ASP . 27.6 t80 -69.16 138.75 54.41 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.41 -1.33 . . . . 75.409999999999997 107.41 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -60.77 -37.18 81.0 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 120.662 -0.415 . . . . 75.099999999999994 111.137 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . 0.495 ' HB2' ' CE2' ' A' ' 611' ' ' TYR . 23.2 m-20 -81.57 145.0 30.87 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.844 -0.799 . . . . 60.43 108.844 174.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -55.68 -45.08 77.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 123.598 0.561 . . . . 72.209999999999994 111.958 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -153.42 162.63 26.07 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 104.754 -2.313 . . . . 73.310000000000002 104.754 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.36 132.92 23.32 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.009 1.139 . . . . 65.409999999999997 109.583 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.11 -53.89 3.13 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.492 -0.929 . . . . 75.140000000000001 108.492 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 2.9 m -102.35 92.06 4.54 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.73 -1.211 . . . . 74.239999999999995 107.73 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 47.4 m -86.6 130.99 34.28 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.963 0.411 . . . . 72.310000000000002 111.296 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -114.08 -27.67 7.6 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.951 -0.759 . . . . 75.319999999999993 108.951 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -94.95 150.84 19.73 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.193 -1.04 . . . . 75.349999999999994 108.193 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.88 131.88 41.06 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.768 -0.827 . . . . 72.150000000000006 108.768 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -126.02 154.19 43.31 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.207 -0.597 . . . . 70.319999999999993 110.443 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.36 19.16 18.53 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 124.142 0.977 . . . . 72.109999999999999 109.032 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -52.41 -37.05 55.66 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 114.229 -1.35 . . . . 61.240000000000002 112.317 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.629 ' O ' ' HG3' ' A' ' 630' ' ' MET . 40.2 mmt180 -57.22 -42.04 80.61 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 122.231 0.212 . . . . 75.519999999999996 111.142 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.466 ' HA ' ' SD ' ' A' ' 630' ' ' MET . 64.9 mt -68.65 -33.17 58.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.241 0.543 . . . . 74.310000000000002 109.836 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -72.59 -37.53 68.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.819 -0.628 . . . . 74.099999999999994 109.526 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.09 -23.29 62.09 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 115.982 -0.553 . . . . 74.219999999999999 111.02 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.629 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 64.5 mtt -64.76 -8.85 16.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.216 0.606 . . . . 75.439999999999998 111.849 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -101.95 -4.75 51.14 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 121.014 -0.612 . . . . 70.109999999999999 112.132 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -122.16 165.42 20.79 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 108.964 -0.754 . . . . 72.439999999999998 108.964 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 19.3 Cg_endo -61.55 137.08 67.05 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.777 1.651 . . . . 74.040000000000006 109.797 170.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER -136.2 -177.38 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 109.482 -0.562 . . . . 74.230000000000004 109.482 -178.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -94.19 171.25 8.95 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.163 -0.68 . . . . 74.409999999999997 109.163 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -74.34 179.02 43.61 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.029 -0.605 . . . . 74.549999999999997 111.803 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . 0.415 ' HG2' ' ND1' ' A' ' 638' ' ' HIS . 34.1 tt0 -46.97 -68.79 0.16 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.399 . . . . 71.099999999999994 111.238 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . 0.415 ' ND1' ' HG2' ' A' ' 637' ' ' GLU . 39.7 m80 -134.31 94.04 3.16 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.461 -0.94 . . . . 74.299999999999997 108.461 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 10.2 t -113.18 108.41 17.24 Favored 'General case' 0 N--CA 1.408 -2.567 0 C-N-CA 119.496 -0.882 . . . . 74.230000000000004 109.725 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -147.96 135.96 21.15 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.869 -1.53 . . . . 74.430000000000007 106.869 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.1 tp -113.44 116.27 29.35 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 108.58 -0.896 . . . . 75.329999999999998 108.58 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.84 126.55 39.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.248 -1.019 . . . . 75.200000000000003 108.248 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.55 122.76 67.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.786 -0.643 . . . . 64.040000000000006 109.471 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.95 130.14 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 115.483 -0.78 . . . . 73.450000000000003 109.42 -177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.17 99.67 7.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.313 0.578 . . . . 65.349999999999994 111.794 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -173.84 168.27 4.3 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.63 -1.619 . . . . 71.420000000000002 106.63 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.21 -35.92 19.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.469 0.544 . . . . 75.450000000000003 112.469 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 15.6 m -94.29 87.61 5.28 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.468 0.652 . . . . 73.25 112.521 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -99.98 122.67 43.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.057 -1.46 . . . . 74.439999999999998 107.057 173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -101.2 100.65 11.22 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 120.339 -0.544 . . . . 74.239999999999995 110.912 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -83.22 78.84 9.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.266 -1.383 . . . . 74.299999999999997 107.266 175.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.13 112.27 1.64 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.601 -1.636 . . . . 74.239999999999995 109.703 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 38.6 m -111.71 114.12 26.93 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.052 -0.976 . . . . 70.549999999999997 110.69 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 12.4 t -151.94 176.23 11.68 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.283 -1.747 . . . . 71.430000000000007 106.283 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 57.7 t -102.96 94.32 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 117.981 0.355 . . . . 74.409999999999997 110.054 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.485 1.283 0 C-N-CA 123.844 0.858 . . . . 74.420000000000002 112.915 176.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 48.4 t60 . . . . . 0 C--O 1.238 0.475 0 CA-C-O 120.969 0.414 . . . . 73.310000000000002 110.116 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -145.96 163.54 34.87 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.572 -1.64 . . . . 73.040000000000006 106.572 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -90.24 104.29 3.12 Favored Glycine 0 C--O 1.215 -1.054 0 C-N-CA 120.772 -0.728 . . . . 61.140000000000001 112.16 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 86.5 mt -92.95 114.83 30.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 123.68 0.792 . . . . 71.340000000000003 108.912 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.63 144.76 41.58 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.102 -0.333 . . . . 73.349999999999994 110.102 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -149.78 159.45 44.34 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 116.435 -0.348 . . . . 63.520000000000003 110.238 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.553 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 85.8 m-85 -73.01 154.19 40.6 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 109.796 -0.446 . . . . 73.400000000000006 109.796 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.01 -57.24 12.94 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 124.06 0.85 . . . . 73.219999999999999 109.733 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -120.11 163.29 29.02 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.058 -0.974 . . . . 75.219999999999999 109.596 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -22.84 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 110.83 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 642' ' ' GLU . 76.2 t -142.1 134.15 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.149 -1.056 . . . . 71.340000000000003 108.149 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.5 t -134.14 126.58 30.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.121 0.486 . . . . 63.329999999999998 109.922 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -98.65 120.69 39.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.466 -1.309 . . . . 75.019999999999996 107.466 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.01 154.44 18.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 116.201 -0.454 . . . . 53.32 109.963 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.464 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 45.8 m -60.0 154.27 19.43 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 124.246 0.966 . . . . 72.319999999999993 111.424 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.98 -33.3 57.62 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.942 -1.133 . . . . 74.329999999999998 107.942 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.6 m -98.89 28.82 4.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.16 -0.927 . . . . 73.420000000000002 110.232 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -76.94 -34.85 22.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 112.983 0.734 . . . . 74.150000000000006 112.983 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.32 -70.93 3.06 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.204 -0.998 . . . . 55.43 111.867 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.3 mm -130.96 131.57 64.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.776 -0.824 . . . . 75.040000000000006 108.776 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.415 ' SD ' HD11 ' A' ' 573' ' ' ILE . 16.9 ptm -106.29 127.28 53.13 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.601 -0.727 . . . . 75.040000000000006 109.152 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -88.81 114.46 25.45 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.262 0.351 . . . . 75.019999999999996 110.842 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 40.1 t -108.03 114.51 46.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.29 -0.633 . . . . 75.329999999999998 109.29 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -89.13 130.58 35.54 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.528 -0.545 . . . . 73.530000000000001 109.528 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.8 110.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.004 -1.48 . . . . 74.329999999999998 107.004 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.3 151.91 23.2 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.069 -0.969 . . . . 65.109999999999999 109.897 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.436 ' HD3' ' H ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -115.66 107.93 15.74 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.588 -0.893 . . . . 73.010000000000005 108.588 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.6 m -65.28 -58.68 5.32 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.395 -0.82 . . . . 72.299999999999997 109.967 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.4 p -74.59 -51.25 15.07 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.665 -0.698 . . . . 71.219999999999999 111.068 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.44 -166.31 26.87 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.347 -1.101 . . . . 71.439999999999998 110.347 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -146.77 134.44 21.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -153.32 99.4 2.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.423 -0.584 . . . . 70.150000000000006 109.423 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 127.01 -125.46 5.34 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 110.422 -1.071 . . . . 63.5 110.422 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -138.01 109.32 6.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.592 -0.521 . . . . 73.340000000000003 109.592 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 34.5 t -124.86 128.65 73.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.745 -0.835 . . . . 72.519999999999996 108.745 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.527 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.0 mm -105.34 126.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.379 -0.601 . . . . 75.209999999999994 109.379 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.42 109.76 60.11 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.791 -0.641 . . . . 71.25 109.956 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.48 146.03 13.51 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.883 1.722 . . . . 74.209999999999994 111.428 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -137.05 157.46 46.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.363 -0.977 . . . . 73.299999999999997 108.363 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -149.9 139.86 21.94 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.099 0.476 . . . . 72.239999999999995 111.235 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -84.65 124.77 31.84 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.197 -0.91 . . . . 62.420000000000002 111.977 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.6 mm -97.29 115.84 38.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.993 -1.484 . . . . 70.129999999999995 106.993 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.34 163.17 25.09 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.836 -0.431 . . . . 74.519999999999996 109.836 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -156.4 -116.67 0.53 Allowed Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 109.426 -1.47 . . . . 71.140000000000001 109.426 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.6 m -70.26 -27.06 64.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.239 -1.023 . . . . 74.239999999999995 108.239 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.18 131.42 38.26 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.782 -1.099 . . . . 74.299999999999997 108.292 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 132.84 43.49 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.424 -1.695 . . . . 75.420000000000002 106.424 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.0 29.1 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.849 -0.691 . . . . 75.200000000000003 111.995 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.28 63.51 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 114.518 0.567 . . . . 70.540000000000006 114.518 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.48 9.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 119.558 -1.306 . . . . 53.030000000000001 113.691 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.86 -79.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.357 0.578 . . . . 74.25 112.357 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.05 -41.49 12.29 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.048 -1.093 . . . . 70.340000000000003 108.048 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -143.17 163.76 32.01 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.508 -1.224 . . . . 74.349999999999994 107.962 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.581 ' HG3' ' NH2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -90.5 146.08 24.4 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.399 -1.334 . . . . 63.0 107.399 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.83 122.19 29.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.885 -0.413 . . . . 74.25 109.885 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -128.35 105.18 8.16 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.819 0.818 . . . . 74.019999999999996 109.73 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.55 131.58 51.53 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.227 -1.768 . . . . 72.310000000000002 106.227 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.26 -167.28 34.21 Favored Glycine 0 N--CA 1.432 -1.599 0 C-N-CA 119.169 -1.491 . . . . 64.319999999999993 113.249 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.507 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.3 mt-10 -113.83 122.72 47.9 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.811 0.844 . . . . 75.400000000000006 110.774 -176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.63 140.79 29.38 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.88 -0.785 . . . . 75.340000000000003 108.88 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.25 113.35 26.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.49 -0.323 . . . . 72.140000000000001 110.719 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 54.5 m-85 -115.88 115.83 26.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.202 -0.453 . . . . 75.349999999999994 110.061 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -90.08 -84.57 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.141 0.972 . . . . 73.120000000000005 110.507 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.4 HD21 ' HG2' ' A' ' 566' ' ' GLU . 8.8 t30 -105.11 157.8 17.01 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.31 -1.314 . . . . 64.340000000000003 111.216 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.84 -26.3 58.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.543 2.053 . . . . 73.310000000000002 116.543 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.4 ' HG2' HD21 ' A' ' 564' ' ' ASN . 7.9 pt-20 -80.25 7.24 9.85 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.034 1.124 . . . . 73.049999999999997 114.034 -174.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 35.6 pt -119.36 161.93 18.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.396 -0.594 . . . . 64.409999999999997 109.396 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.92 154.57 34.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.128 -1.064 . . . . 71.420000000000002 108.128 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -113.97 147.09 39.18 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.988 0.423 . . . . 72.219999999999999 111.204 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -125.26 130.92 72.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.501 -1.227 . . . . 75.150000000000006 109.279 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 40.5 mt -91.99 126.39 44.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.477 -1.675 . . . . 75.519999999999996 106.477 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.1 p -108.52 112.25 24.53 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.461 -0.57 . . . . 63.439999999999998 109.461 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.42 HD12 HD21 ' A' ' 589' ' ' LEU . 52.2 mt -105.19 123.93 59.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 109.02 -0.733 . . . . 73.140000000000001 109.02 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.581 ' NH2' ' HG3' ' A' ' 554' ' ' GLU . 74.6 mtm180 -80.68 108.77 14.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 123.821 0.701 . . . . 74.129999999999995 111.201 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.1 mm -95.26 135.54 29.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.058 -1.83 . . . . 73.510000000000005 106.058 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -112.19 161.97 15.97 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.131 -0.627 . . . . 72.200000000000003 110.437 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 580' ' ' GLU . 8.2 p-10 -141.86 88.89 2.15 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.666 1.222 . . . . 72.030000000000001 109.117 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 578' ' ' ARG . 3.0 mmp_? -118.61 -50.49 2.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.473 -1.24 . . . . 75.5 108.734 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -111.8 -25.98 9.19 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.281 -0.872 . . . . 74.209999999999994 109.972 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.496 ' HB3' ' CD ' ' A' ' 583' ' ' LYS . 1.5 pm0 -77.85 97.74 5.36 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.195 1.183 . . . . 63.340000000000003 114.195 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -136.56 7.38 3.04 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.878 -1.51 . . . . 75.400000000000006 108.058 172.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -144.39 15.8 1.66 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.565 -1.198 . . . . 72.450000000000003 110.332 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.496 ' CD ' ' HB3' ' A' ' 580' ' ' GLU . 89.5 mttt -92.76 167.75 11.66 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 118.992 -1.083 . . . . 75.349999999999994 113.769 -173.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -150.05 21.66 0.87 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.584 -1.189 . . . . 74.230000000000004 108.227 174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 10.0 p -61.22 140.69 57.89 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.757 -1.111 . . . . 72.340000000000003 110.944 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 28.4 p -123.78 155.62 37.6 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 119.861 -0.735 . . . . 75.219999999999999 111.998 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -139.12 -177.98 5.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.772 -1.195 . . . . 73.129999999999995 107.772 173.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 26.3 m -135.06 156.58 48.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.653 -0.655 . . . . 72.049999999999997 109.946 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.42 HD21 HD12 ' A' ' 573' ' ' ILE . 42.8 tp -130.83 130.8 44.08 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.06 -1.459 . . . . 51.149999999999999 107.06 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.02 151.48 33.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 120.964 -0.294 . . . . 74.340000000000003 110.903 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.553 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 96.3 mt -95.57 140.01 31.01 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.26 -1.015 . . . . 73.439999999999998 108.26 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -100.41 159.42 15.16 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.357 -0.838 . . . . 62.43 109.05 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 120.84 19.22 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 124.122 0.888 . . . . 74.439999999999998 110.461 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.63 148.13 41.49 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.521 2.814 . . . . 74.340000000000003 112.643 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.527 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 18.2 ptpt -102.42 133.29 47.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.867 -1.16 . . . . 74.140000000000001 107.867 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -105.36 117.6 34.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.28 -0.637 . . . . 72.409999999999997 109.28 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.28 96.82 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 107.677 -1.231 . . . . 74.239999999999995 107.677 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -129.26 84.72 2.25 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.943 -1.026 . . . . 75.530000000000001 110.423 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -121.97 -43.01 2.36 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.779 -1.193 . . . . 75.540000000000006 107.779 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 108.54 133.64 6.99 Favored Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 107.357 -2.297 . . . . 70.430000000000007 107.357 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 52.0 ttp -73.81 101.56 3.77 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 117.947 0.874 . . . . 75.349999999999994 110.013 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -85.57 173.1 10.42 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.104 -0.953 . . . . 71.349999999999994 110.663 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -76.41 64.15 2.9 Favored Glycine 0 C--O 1.237 0.291 0 CA-C-N 116.437 -0.347 . . . . 61.219999999999999 113.767 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 179.84 167.11 36.5 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 110.032 -1.227 . . . . 63.329999999999998 110.032 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -97.31 -40.25 8.83 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.29 -1.004 . . . . 72.450000000000003 108.29 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 12.7 m -117.25 107.27 14.22 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 106.989 -1.486 . . . . 62.340000000000003 106.989 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 43.5 mm -87.79 -30.69 5.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.858 -0.423 . . . . 73.230000000000004 109.858 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 608' ' ' THR . 33.6 m 63.18 34.81 13.19 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.748 1.261 . . . . 54.109999999999999 109.645 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -89.71 -25.25 21.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 121.541 -0.724 . . . . 71.129999999999995 110.42 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -100.32 124.93 46.41 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 108.666 -0.864 . . . . 72.120000000000005 108.666 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -95.18 -33.68 12.53 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.469 -0.787 . . . . 74.450000000000003 111.378 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -131.52 158.16 41.64 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.046 0.387 . . . . 74.150000000000006 112.046 -169.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -78.51 139.19 38.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.739 -0.664 . . . . 71.239999999999995 110.665 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 614' ' ' LYS . 10.9 mmpt? -86.72 92.84 9.08 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.092 0.472 . . . . 75.140000000000001 109.839 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -83.2 130.57 56.41 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 108.67 -0.863 . . . . 73.120000000000005 108.67 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.54 148.4 87.5 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 121.923 1.749 . . . . 74.030000000000001 110.986 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 30.9 mt -103.63 137.76 41.23 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.547 -1.206 . . . . 75.019999999999996 110.812 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 20.8 p -90.95 17.21 8.16 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.237 1.018 . . . . 62.350000000000001 109.635 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.0 m -75.75 105.49 6.82 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 114.25 -1.341 . . . . 65.200000000000003 108.89 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -92.83 116.26 28.87 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.454 -0.898 . . . . 74.099999999999994 109.193 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.3 156.42 35.61 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.778 -0.823 . . . . 75.120000000000005 108.778 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -80.27 61.26 4.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.467 1.127 . . . . 74.409999999999997 111.059 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -153.03 169.0 23.99 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 126.721 2.008 . . . . 65.219999999999999 106.031 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -62.33 146.18 51.82 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 123.438 0.461 . . . . 74.230000000000004 110.577 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -58.88 -39.93 82.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.082 -0.508 . . . . 73.319999999999993 111.272 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 630' ' ' MET . 61.7 ttt180 -67.53 -39.32 85.04 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-N 116.124 -0.489 . . . . 74.420000000000002 110.953 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 630' ' ' MET . 84.2 mt -72.08 -33.66 47.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.381 0.61 . . . . 64.299999999999997 110.389 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -70.16 -51.34 32.05 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.458 -0.497 . . . . 74.310000000000002 110.326 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 632' ' ' ARG . 38.8 mt-10 -82.8 -2.25 53.99 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 113.668 0.988 . . . . 72.519999999999996 113.668 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 626' ' ' ARG . 17.2 ptm -62.11 -15.98 49.26 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.834 -0.541 . . . . 72.230000000000004 110.594 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -85.97 -3.93 84.98 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.579 -0.737 . . . . 52.310000000000002 112.585 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 629' ' ' GLU . 11.8 ptm180 -116.28 159.32 40.24 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 106.599 -1.63 . . . . 64.239999999999995 106.599 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.31 126.78 16.91 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.477 1.451 . . . . 72.420000000000002 110.521 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . 0.407 ' HB ' ' H ' ' A' ' 635' ' ' LEU . 0.2 OUTLIER -133.21 -177.72 2.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.012 0.434 . . . . 74.099999999999994 111.143 -178.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.407 ' H ' ' HB ' ' A' ' 634' ' ' ILE . 26.9 mt -109.63 -158.32 0.64 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.272 -0.877 . . . . 75.450000000000003 109.616 -173.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.36 -164.4 13.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.14 -0.552 . . . . 70.209999999999994 112.465 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -59.75 -73.36 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.489 0.716 . . . . 72.409999999999997 109.568 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -131.24 127.35 37.66 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 106.559 -1.645 . . . . 74.530000000000001 106.559 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 2.6 t -137.94 109.13 6.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 123.139 1.447 . . . . 72.209999999999994 110.664 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -147.18 140.38 25.3 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.564 -1.653 . . . . 75.530000000000001 106.575 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.83 106.92 13.99 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.605 -0.887 . . . . 74.439999999999998 108.605 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.436 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.0 mt-10 -86.4 124.46 32.77 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.92 -1.141 . . . . 74.530000000000001 107.92 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.27 123.73 69.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.737 -0.665 . . . . 74.540000000000006 109.653 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.11 122.9 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 108.474 -0.936 . . . . 72.430000000000007 108.474 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.4 106.65 20.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.245 0.545 . . . . 74.409999999999997 111.651 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -152.67 139.92 19.43 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.544 -1.65 . . . . 73.010000000000005 106.544 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -82.35 65.57 7.54 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.95 0.881 . . . . 72.329999999999998 109.409 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 48.9 m -160.07 94.0 1.09 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.838 -1.073 . . . . 42.049999999999997 109.551 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -91.09 157.63 17.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.165 -1.05 . . . . 74.109999999999999 108.165 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -94.25 129.06 41.04 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.815 -0.754 . . . . 70.340000000000003 111.51 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -137.9 80.51 1.81 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.334 -1.728 . . . . 73.329999999999998 106.334 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 652' ' ' LYS . 1.3 tpmt? -92.79 -38.34 11.83 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.49 -1.232 . . . . 75.430000000000007 109.93 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 19.8 m -123.32 140.61 52.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.124 0.488 . . . . 72.099999999999994 111.121 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 24.2 m -101.4 129.12 47.36 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.534 -1.284 . . . . 75.340000000000003 107.534 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.4 133.66 29.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.745 -0.465 . . . . 74.420000000000002 109.745 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 109.445 -0.576 . . . . 74.329999999999998 109.445 178.805 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 121.183 0.516 . . . . 74.409999999999997 110.619 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -75.53 102.97 5.45 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.51 -0.768 . . . . 61.32 110.776 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . -79.23 95.3 1.41 Allowed Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 115.329 -0.851 . . . . 63.340000000000003 111.304 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 62.5 mt -113.84 114.56 47.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 107.274 -1.38 . . . . 75.540000000000006 107.274 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.06 137.94 47.12 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.236 0.335 . . . . 74.239999999999995 111.056 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.5 t -148.91 165.9 30.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.955 -0.387 . . . . 65.409999999999997 109.955 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.578 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 75.6 m-85 -79.16 157.76 27.84 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.339 0.656 . . . . 72.439999999999998 110.337 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.13 -50.58 71.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.72 0.772 . . . . 64.299999999999997 109.534 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.81 151.32 72.19 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 114.891 -1.049 . . . . 75.219999999999999 108.56 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.94 -22.37 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.115 1.877 . . . . 71.150000000000006 112.559 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.81 131.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.962 -0.385 . . . . 74.209999999999994 109.962 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.8 t -133.68 141.03 47.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.088 0.471 . . . . 75.430000000000007 109.84 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . 0.454 ' CD2' ' HA ' ' A' ' 648' ' ' SER . 77.0 m80 -112.99 119.74 38.96 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.346 -0.983 . . . . 64.25 108.346 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.67 155.52 19.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.365 0.603 . . . . 72.129999999999995 111.032 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 518' ' ' ILE . 68.7 m -83.1 157.2 22.92 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.513 -0.767 . . . . 73.140000000000001 110.305 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.729 0.776 . . . . 73.129999999999995 111.366 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.5 p -89.84 24.42 2.39 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.213 -0.903 . . . . 75.299999999999997 112.156 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 515' ' ' SER . 5.8 tt -86.46 -25.49 6.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.297 0.57 . . . . 65.239999999999995 110.512 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.25 -71.82 2.86 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.614 -0.803 . . . . 74.319999999999993 111.961 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.2 mm -131.2 138.33 53.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.239 -1.763 . . . . 73.409999999999997 106.239 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.406 ' HE2' ' CG2' ' A' ' 523' ' ' VAL . 5.4 ppp? -112.21 147.85 35.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.176 -0.676 . . . . 72.109999999999999 109.176 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -113.03 130.37 56.17 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.832 0.707 . . . . 65.200000000000003 111.201 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 39.5 t -125.11 124.21 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 107.973 -1.121 . . . . 72.329999999999998 107.973 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.406 ' HG2' HG12 ' A' ' 570' ' ' ILE . 59.6 mttm -91.05 131.19 36.79 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.994 -1.082 . . . . 75.439999999999998 109.383 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 89.3 t -91.34 109.67 21.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 106.948 -1.501 . . . . 64.409999999999997 106.948 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.1 mt -87.12 143.29 27.37 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.742 -1.117 . . . . 75.120000000000005 110.167 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.88 113.54 26.54 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.972 -1.013 . . . . 62.119999999999997 108.672 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 41.0 p -66.54 -63.64 1.03 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.023 -0.671 . . . . 73.430000000000007 111.592 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 51.0 m -74.46 -52.55 11.68 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.041 0.448 . . . . 63.240000000000002 111.513 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . 0.557 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 160.21 -143.85 9.45 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.607 -0.806 . . . . 62.100000000000001 111.735 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.64 161.18 18.12 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 106.248 -1.76 . . . . 75.400000000000006 106.248 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -157.19 126.52 6.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.463 0.574 . . . . 74.109999999999999 110.527 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.34 -118.7 5.61 Favored Glycine 0 CA--C 1.494 -1.28 0 C-N-CA 120.723 -0.751 . . . . 52.340000000000003 111.857 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -138.51 111.99 8.16 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.284 -1.006 . . . . 74.129999999999995 108.284 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.6 t -122.34 130.26 74.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.877 -0.515 . . . . 73.519999999999996 110.686 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.37 118.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.497 -0.927 . . . . 74.230000000000004 108.497 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.1 106.63 58.84 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.888 -0.782 . . . . 72.109999999999999 108.888 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -83.98 159.61 13.71 Favored 'Trans proline' 0 N--CA 1.42 -2.798 0 C-N-CA 121.838 1.692 . . . . 71.310000000000002 111.027 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.36 163.34 39.15 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.915 -1.883 . . . . 72.420000000000002 105.915 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -150.81 129.07 11.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.248 -0.581 . . . . 70.329999999999998 110.863 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.3 p -78.01 117.38 19.28 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 115.464 -0.789 . . . . 75.430000000000007 110.293 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.5 mm -88.4 120.45 37.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.216 -1.402 . . . . 74.129999999999995 107.216 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.56 113.63 13.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.684 -0.487 . . . . 74.120000000000005 109.684 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -94.18 -108.69 2.07 Favored Glycine 0 CA--C 1.496 -1.128 0 N-CA-C 110.423 -1.071 . . . . 34.32 110.423 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 42.4 p -86.26 -24.22 26.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.591 -0.892 . . . . 74.120000000000005 108.591 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.09 145.41 25.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.22 -0.9 . . . . 74.400000000000006 109.363 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 36.6 mmm-85 -95.02 138.24 33.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.747 0.784 . . . . 71.099999999999994 112.685 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -110.58 129.48 9.32 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 114.182 -1.372 . . . . 74.230000000000004 110.978 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 141.49 -17.82 2.65 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.581 -1.008 . . . . 62.43 110.581 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 155.51 -16.64 0.49 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.858 -1.163 . . . . 73.530000000000001 113.445 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -69.67 -81.79 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.459 0.63 . . . . 64.030000000000001 111.462 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -86.37 -53.7 4.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.981 0.896 . . . . 74.310000000000002 108.617 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -131.2 160.84 33.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.273 -0.876 . . . . 73.299999999999997 110.445 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.449 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 27.2 tt0 -96.26 119.06 34.06 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.788 -1.93 . . . . 74.120000000000005 105.788 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.79 143.4 54.63 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.31 0.576 . . . . 74.450000000000003 111.501 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 4.9 t -140.72 136.53 32.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.833 -0.621 . . . . 74.010000000000005 110.076 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.1 p -143.46 110.41 5.64 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.23 0.538 . . . . 64.140000000000001 112.2 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 79.22 105.78 0.23 Allowed Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.535 -0.757 . . . . 74.510000000000005 113.122 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.42 14.54 0.31 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.65 -0.87 . . . . 71.310000000000002 108.65 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 569' ' ' LYS . 46.2 mt -117.45 135.89 53.58 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.289 -0.882 . . . . 75.340000000000003 112.198 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -134.91 109.69 8.65 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.588 -1.264 . . . . 74.319999999999993 107.588 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 48.8 m-85 -102.37 115.28 30.25 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.822 -0.807 . . . . 63.439999999999998 108.822 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.438 ' H ' HD11 ' A' ' 567' ' ' ILE . 44.6 mt-30 -90.15 -79.64 0.34 Allowed 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.798 -0.637 . . . . 74.120000000000005 109.898 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -104.33 167.1 9.96 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.005 -0.739 . . . . 74.030000000000001 109.005 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -69.34 -20.13 63.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.479 0.712 . . . . 62.439999999999998 112.33 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.2 -10.26 59.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.143 1.164 . . . . 72.219999999999999 114.143 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.438 HD11 ' H ' ' A' ' 563' ' ' GLN . 40.0 pt -113.44 166.46 7.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.223 -0.591 . . . . 64.540000000000006 110.892 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.86 148.23 29.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.863 -1.532 . . . . 73.340000000000003 106.863 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 20.8 mttm -116.48 155.67 28.19 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 112.876 0.695 . . . . 73.010000000000005 112.876 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 32.7 mt -122.0 133.08 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.915 -1.039 . . . . 72.120000000000005 110.594 -174.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 47.8 mt -90.99 129.21 42.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.947 -1.501 . . . . 73.219999999999999 106.947 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -115.1 112.66 22.92 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.449 -0.574 . . . . 73.299999999999997 109.449 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.401 HD12 HD23 ' A' ' 589' ' ' LEU . 62.1 mt -108.36 130.7 60.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.82 -0.807 . . . . 73.200000000000003 108.82 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.449 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 70.7 ttt180 -76.9 112.58 13.66 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.484 -0.561 . . . . 73.510000000000005 109.484 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.16 119.16 47.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.344 -2.095 . . . . 70.109999999999999 105.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -73.06 100.14 2.94 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.645 0.736 . . . . 74.549999999999997 112.524 -175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.91 -19.16 61.32 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.737 -1.12 . . . . 75.319999999999993 110.795 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 578' ' ' ARG . 71.7 ttt180 -92.9 31.86 1.35 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 122.495 1.141 . . . . 64.530000000000001 108.35 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -147.77 155.98 42.26 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 106.985 -1.487 . . . . 74.230000000000004 106.985 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -161.55 124.74 3.15 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.421 -0.585 . . . . 75.120000000000005 109.421 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.46 158.69 22.17 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.708 -0.849 . . . . 74.129999999999995 108.708 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.08 31.18 5.72 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.581 1.181 . . . . 63.530000000000001 109.317 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -118.16 154.75 31.64 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 106.779 -1.563 . . . . 75.040000000000006 106.779 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.22 85.34 3.04 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.515 1.15 . . . . 74.409999999999997 109.902 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 63.4 m -72.17 124.26 24.64 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.103 -1.408 . . . . 74.409999999999997 110.518 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.6 p -147.42 151.61 36.75 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.714 -0.847 . . . . 62.039999999999999 108.714 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -149.97 176.69 10.55 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.852 -1.166 . . . . 75.030000000000001 107.852 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 20.0 m -129.85 163.96 25.17 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.972 -0.691 . . . . 74.120000000000005 109.853 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.401 HD23 HD12 ' A' ' 573' ' ' ILE . 41.9 tp -139.67 127.36 21.83 Favored 'General case' 0 C--N 1.263 -3.165 0 N-CA-C 106.729 -1.582 . . . . 75.430000000000007 106.729 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.52 151.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.546 -0.539 . . . . 70.409999999999997 109.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.578 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 85.0 mt -92.1 139.42 30.65 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.901 -1.148 . . . . 74.430000000000007 107.901 175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.42 167.55 10.56 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 115.476 -0.784 . . . . 73.439999999999998 108.979 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.24 115.19 9.18 Favored Pre-proline 0 N--CA 1.446 -0.637 0 O-C-N 124.598 1.186 . . . . 73.510000000000005 109.333 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.42 142.7 23.98 Favored 'Trans proline' 0 N--CA 1.428 -2.346 0 C-N-CA 121.703 1.602 . . . . 72.109999999999999 111.412 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -110.3 132.34 54.26 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.957 -0.565 . . . . 65.299999999999997 110.421 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -85.02 118.81 24.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.451 -1.314 . . . . 73.219999999999999 107.451 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 43.1 mm -86.92 88.4 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 N-CA-C 106.0 -1.852 . . . . 65.120000000000005 106.0 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . 0.45 ' HA ' ' HE ' ' A' ' 598' ' ' ARG . 3.9 tpm_? -110.53 106.96 16.43 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.288 -1.375 . . . . 64.5 107.288 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -83.16 119.06 24.06 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.849 -0.797 . . . . 74.0 108.849 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 127.48 -14.85 6.43 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 120.832 -0.699 . . . . 61.219999999999999 111.898 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -83.83 -25.54 30.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.637 0.732 . . . . 64.430000000000007 109.969 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -85.57 84.23 7.67 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.57 -1.27 . . . . 75.409999999999997 107.57 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -159.84 -78.72 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 119.596 -1.288 . . . . 64.109999999999999 112.662 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -84.4 35.59 2.99 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 121.262 -0.494 . . . . 71.0 113.137 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -131.88 164.13 26.77 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.596 -1.261 . . . . 72.140000000000001 107.596 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 28.3 m -81.18 99.69 8.69 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.638 0.732 . . . . 75.510000000000005 109.325 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 42.3 mm -94.29 101.85 12.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 107.677 -1.231 . . . . 73.219999999999999 107.677 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 9.8 t -80.38 -21.39 42.38 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.919 -0.582 . . . . 71.219999999999999 110.251 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 71.18 -50.17 0.68 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.949 1.7 . . . . 73.140000000000001 112.823 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -74.91 154.58 38.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.049 -0.723 . . . . 62.240000000000002 109.049 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -82.29 71.45 9.35 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.538 0.685 . . . . 73.310000000000002 111.651 -173.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -107.95 2.33 23.22 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.424 -1.324 . . . . 64.019999999999996 107.424 171.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.8 149.35 24.91 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.618 -1.628 . . . . 65.129999999999995 107.856 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -75.91 -46.41 30.17 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.229 -0.656 . . . . 72.109999999999999 109.229 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 616' ' ' PRO . 35.1 tt0 -174.36 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 125.266 1.426 . . . . 71.049999999999997 108.118 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 615' ' ' GLN . 16.5 Cg_exo -71.89 156.06 57.01 Favored 'Trans proline' 0 C--N 1.374 1.894 0 N-CA-C 107.024 -1.952 . . . . 73.310000000000002 107.024 165.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.97 -37.56 69.88 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.599 0.714 . . . . 73.540000000000006 110.106 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 10.6 p -94.3 126.39 39.52 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.364 -0.834 . . . . 75.329999999999998 111.35 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 46.4 m -74.42 -33.66 63.04 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.821 -0.807 . . . . 64.150000000000006 108.821 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -79.21 99.76 7.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.054 -1.462 . . . . 74.140000000000001 107.054 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.0 106.62 17.23 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.751 0.786 . . . . 73.030000000000001 111.765 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.36 -26.17 17.38 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.505 -0.77 . . . . 74.010000000000005 110.775 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -79.69 116.06 19.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.822 -1.547 . . . . 74.219999999999999 106.822 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -55.41 142.26 33.25 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 123.528 0.518 . . . . 71.349999999999994 110.75 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 629' ' ' GLU . 32.7 ttt180 -51.86 -45.82 64.22 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 112.902 0.704 . . . . 74.299999999999997 112.902 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' A' ' 630' ' ' MET . 51.1 ttp180 -61.55 -36.04 79.46 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.35 0.595 . . . . 75.040000000000006 110.771 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 71.2 mt -72.89 -41.79 60.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.075 -0.713 . . . . 74.329999999999998 109.075 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.43 94.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.913 -0.585 . . . . 71.239999999999995 110.308 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 625' ' ' ARG . 51.1 mt-10 -72.1 -19.28 61.83 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 116.291 -0.413 . . . . 75.329999999999998 111.361 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.524 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 73.4 mtm -82.57 -8.08 59.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.607 0.718 . . . . 74.340000000000003 109.645 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -108.6 24.74 21.39 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.415 -0.812 . . . . 72.439999999999998 111.652 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 8.2 ptp180 -142.38 170.85 8.09 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 106.378 -1.712 . . . . 74.420000000000002 106.378 177.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -79.74 143.57 16.77 Favored 'Trans proline' 0 N--CA 1.441 -1.574 0 N-CA-C 107.922 -1.607 . . . . 74.129999999999995 107.922 171.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.06 177.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-O 121.842 0.829 . . . . 74.510000000000005 111.53 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -99.0 178.87 4.8 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.388 -1.338 . . . . 73.430000000000007 107.388 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.89 -154.79 7.15 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 119.917 -1.135 . . . . 71.209999999999994 113.0 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.53 -68.07 0.36 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 124.388 1.075 . . . . 75.209999999999994 110.269 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -138.44 119.36 14.3 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.641 -1.985 . . . . 74.010000000000005 105.641 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 4.8 t -134.69 110.24 9.13 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-O 122.361 1.077 . . . . 72.310000000000002 110.839 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -147.89 137.85 22.69 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.177 -1.416 . . . . 74.519999999999996 107.177 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 111.82 22.65 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.177 -1.416 . . . . 73.319999999999993 107.177 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.37 122.26 37.9 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.963 -0.754 . . . . 74.230000000000004 108.963 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.93 125.41 68.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.252 -0.885 . . . . 75.340000000000003 109.139 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.84 139.19 44.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.568 -1.271 . . . . 74.329999999999998 107.568 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.3 136.75 42.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 109.435 -0.579 . . . . 74.040000000000006 109.435 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 71.53 -54.57 0.67 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.772 1.629 . . . . 62.520000000000003 111.598 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.5 151.88 45.34 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 123.854 0.862 . . . . 75.400000000000006 109.655 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' SER . . . . . 0.454 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 29.1 t -146.33 105.02 3.84 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 108.527 -0.916 . . . . 64.329999999999998 108.527 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -127.78 120.08 27.11 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.173 0.511 . . . . 73.530000000000001 110.273 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -142.56 130.41 21.68 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.771 -0.826 . . . . 73.340000000000003 108.771 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.62 58.32 1.76 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 104.403 -2.443 . . . . 72.209999999999994 104.403 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -35.67 113.02 0.19 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 128.185 2.594 . . . . 74.430000000000007 115.969 -170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 54.2 m 53.76 33.85 17.76 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 114.718 1.377 . . . . 74.230000000000004 114.718 170.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 98.1 m -64.29 -42.66 96.28 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.018 -1.475 . . . . 71.310000000000002 107.018 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.44 109.88 29.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 105.53 -2.026 . . . . 74.030000000000001 105.53 169.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--N 1.3 -1.551 0 CA-C-N 116.385 -0.37 . . . . 73.239999999999995 110.496 -175.391 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.53 ' N ' HH22 ' A' ' 598' ' ' ARG . 53.6 m-70 . . . . . 0 CA--C 1.504 -0.821 0 N-CA-C 109.395 -0.594 . . . . 74.25 109.395 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -122.2 146.32 47.37 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.04 -1.096 . . . . 71.049999999999997 108.04 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -114.83 126.79 7.39 Favored Glycine 0 N--CA 1.416 -2.682 0 C-N-CA 119.948 -1.12 . . . . 71.120000000000005 111.076 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.95 114.8 36.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.38 -1.711 . . . . 75.409999999999997 106.38 172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.62 132.8 53.88 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.669 0.606 . . . . 62.420000000000002 109.975 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -148.39 152.39 36.93 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 120.766 0.317 . . . . 71.439999999999998 110.496 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.555 ' CG ' ' HB2' ' A' ' 641' ' ' LEU . 69.2 m-85 -71.4 148.17 47.2 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.282 0.633 . . . . 74.040000000000006 111.395 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.85 -55.85 20.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.62 0.575 . . . . 74.409999999999997 110.655 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . 0.57 ' O ' HD21 ' A' ' 641' ' ' LEU . 39.2 mt-10 -126.96 158.36 68.95 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 107.542 -1.281 . . . . 64.040000000000006 107.542 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.29 -23.98 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.684 1.589 . . . . 74.540000000000006 112.226 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 78.0 t -138.0 138.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.017 -0.364 . . . . 62.039999999999999 110.017 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.2 t -131.33 128.06 38.92 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 74.019999999999996 109.347 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.41 110.73 22.76 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.157 -1.423 . . . . 75.140000000000001 107.157 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.39 159.34 14.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.744 -0.382 . . . . 75.230000000000004 110.148 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 646' ' ' GLU . 46.2 m -84.27 173.52 10.92 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.478 -0.783 . . . . 73.109999999999999 110.792 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.459 ' HB2' ' H ' ' A' ' 578' ' ' ARG . 0.3 OUTLIER -87.89 -34.16 18.27 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.738 -0.838 . . . . 73.329999999999998 108.738 179.172 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 49.4 m -92.19 17.25 9.87 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.958 -1.019 . . . . 72.140000000000001 111.874 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.16 -29.52 17.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.271 0.558 . . . . 73.530000000000001 110.372 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.19 -70.15 3.24 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.858 -0.687 . . . . 40.340000000000003 112.27 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.9 mm -129.06 124.01 59.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.345 -0.983 . . . . 75.109999999999999 108.345 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.41 ' SD ' HD11 ' A' ' 573' ' ' ILE . 5.5 ppp? -95.85 149.86 21.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.878 -1.156 . . . . 73.530000000000001 107.878 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -129.18 112.95 14.47 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.606 0.595 . . . . 72.319999999999993 112.606 -173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 68.8 t -121.3 128.58 75.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.482 -0.781 . . . . 74.530000000000001 109.535 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.08 149.59 21.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.242 0.544 . . . . 74.049999999999997 109.793 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.29 107.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.621 -1.622 . . . . 74.349999999999994 106.621 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 81.8 mt -76.16 137.15 39.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.339 -0.846 . . . . 73.109999999999999 109.877 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.51 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 40.9 mtp180 -104.61 102.18 11.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.335 -1.357 . . . . 73.340000000000003 107.335 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.2 m -68.05 -62.45 1.4 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.565 1.32 . . . . 72.209999999999994 114.565 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 33.4 t -73.13 -50.83 20.54 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.596 0.591 . . . . 75.030000000000001 112.596 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 156.89 -160.44 30.35 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 111.146 -0.782 . . . . 72.219999999999999 111.146 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.38 165.88 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.522 0.729 . . . . 75.349999999999994 109.662 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -176.09 105.02 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.244 1.018 . . . . 75.25 108.52 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 121.35 -126.25 6.47 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 110.719 -0.952 . . . . 62.310000000000002 110.719 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -136.47 127.78 28.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.239 -1.023 . . . . 71.439999999999998 108.239 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.05 130.29 68.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.134 -0.691 . . . . 74.310000000000002 109.134 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 51.5 mm -100.88 122.47 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.284 -1.006 . . . . 73.109999999999999 108.284 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 43.4 t -116.76 102.33 53.18 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.499 -0.926 . . . . 75.239999999999995 108.499 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.51 135.28 13.04 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.801 1.667 . . . . 73.310000000000002 112.742 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -119.51 168.1 11.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.181 -1.044 . . . . 75.519999999999996 108.181 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -158.43 135.6 9.97 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.822 0.344 . . . . 74.420000000000002 111.154 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 17.8 p -80.41 121.0 25.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.348 -0.842 . . . . 71.010000000000005 110.441 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 29.9 mm -96.11 121.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.47 -1.307 . . . . 72.400000000000006 107.47 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.48 125.23 28.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.691 -0.485 . . . . 74.420000000000002 109.691 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -103.21 -109.02 3.32 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.724 -1.75 . . . . 72.439999999999998 108.724 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 585' ' ' CYS . 8.7 p -89.23 -5.85 57.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.198 0.999 . . . . 72.030000000000001 109.579 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.81 140.49 38.02 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.805 -1.089 . . . . 73.129999999999995 108.427 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.87 147.61 28.53 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.089 0.471 . . . . 72.319999999999993 111.511 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.2 -147.54 9.34 Favored Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 115.189 -0.914 . . . . 75.129999999999995 111.113 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.15 28.47 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 121.679 -0.296 . . . . 54.329999999999998 113.07 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.44 -3.84 34.86 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 111.493 -0.643 . . . . 74.099999999999994 111.493 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.76 -79.95 0.03 OUTLIER 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.001 0.429 . . . . 73.430000000000007 111.543 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -87.2 -46.16 9.99 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.718 -1.216 . . . . 74.409999999999997 107.718 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -139.5 165.87 26.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.574 -1.194 . . . . 72.109999999999999 109.732 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.96 116.4 28.88 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.303 -2.11 . . . . 72.010000000000005 105.303 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.72 132.18 35.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.5 0.667 . . . . 73.150000000000006 111.554 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.0 t -128.19 148.39 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.494 -0.775 . . . . 74.209999999999994 109.795 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 15.0 p -148.99 140.11 23.05 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.866 0.365 . . . . 61.310000000000002 111.4 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 80.12 -125.2 6.81 Favored Glycine 0 C--O 1.212 -1.263 0 CA-C-N 115.684 -0.689 . . . . 70.450000000000003 111.576 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 58.73 -6.09 0.05 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.072 2.99 . . . . 74.510000000000005 119.072 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 537' ' ' VAL . 62.2 mt -95.27 133.58 39.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 120.049 1.295 . . . . 74.310000000000002 112.29 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -134.23 108.91 8.52 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.603 -1.18 . . . . 75.540000000000006 107.939 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.51 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 73.8 m-85 -103.53 129.02 50.65 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.207 -0.451 . . . . 75.310000000000002 110.592 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.4 ' HB2' HD13 ' A' ' 567' ' ' ILE . 1.6 mp0 -96.16 -107.03 0.15 Allowed 'General case' 0 C--O 1.246 0.912 0 C-N-CA 118.631 -1.227 . . . . 74.349999999999994 111.306 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.4 155.79 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.715 -0.476 . . . . 73.109999999999999 109.715 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.89 -25.97 67.1 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 114.52 1.304 . . . . 74.230000000000004 114.52 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.52 -15.59 60.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.118 0.784 . . . . 62.119999999999997 113.118 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 563' ' ' GLN . 34.2 pt -103.32 157.09 5.14 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 C-N-CA 119.694 -0.802 . . . . 74.040000000000006 110.174 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.58 156.99 29.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.574 -0.528 . . . . 64.299999999999997 109.574 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 6.8 mmpt? -110.29 163.82 13.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 110.026 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 570' ' ' ILE . 62.9 mt -128.42 134.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.773 -1.103 . . . . 74.340000000000003 108.681 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 58.8 mt -90.14 118.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 106.619 -1.622 . . . . 65.340000000000003 106.619 176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 12.8 p -110.47 111.74 23.2 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.622 -0.717 . . . . 54.439999999999998 110.008 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.41 HD11 ' SD ' ' A' ' 521' ' ' MET . 69.5 mt -110.85 132.55 59.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.665 -0.698 . . . . 72.319999999999993 109.564 -177.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -76.99 111.82 12.96 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 123.807 0.692 . . . . 75.420000000000002 110.203 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.29 121.94 55.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.401 -1.703 . . . . 75.519999999999996 106.401 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -94.42 158.5 15.53 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.441 -0.504 . . . . 75.400000000000006 109.921 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.06 93.49 0.44 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.712 0.767 . . . . 71.409999999999997 110.191 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.459 ' H ' ' HB2' ' A' ' 516' ' ' GLU . 1.3 tpm_? -66.48 106.33 1.73 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.377 -1.283 . . . . 75.530000000000001 109.928 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -81.68 -22.94 37.16 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.788 -0.642 . . . . 72.310000000000002 111.1 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.2 126.27 35.76 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.111 -0.95 . . . . 74.150000000000006 109.996 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -121.98 24.55 9.53 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.249 -0.649 . . . . 74.150000000000006 109.249 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -39.4 -62.87 0.62 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.279 1.832 . . . . 75.129999999999995 111.163 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.34 175.94 10.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.826 -1.546 . . . . 74.530000000000001 106.826 177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.63 103.19 4.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.211 0.529 . . . . 73.219999999999999 111.654 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . 0.435 ' HA ' ' OG1' ' A' ' 545' ' ' THR . 21.4 p -97.48 126.86 43.0 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.498 0.666 . . . . 74.040000000000006 110.174 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 44.9 m -144.08 164.36 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.522 -0.547 . . . . 72.420000000000002 109.522 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.1 p90 -142.6 -178.94 6.02 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.78 -0.452 . . . . 74.400000000000006 109.78 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 70.9 m -131.09 167.52 18.96 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.238 0.542 . . . . 62.439999999999998 111.024 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 63.9 tp -136.47 124.51 22.9 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.152 -1.796 . . . . 73.420000000000002 106.152 176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.73 159.0 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.489 -0.56 . . . . 71.329999999999998 109.489 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.508 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 74.6 mt -104.58 144.09 32.16 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.235 -1.024 . . . . 75.239999999999995 108.235 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.01 170.95 7.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.173 -0.677 . . . . 74.519999999999996 109.173 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.17 109.92 2.28 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 123.92 0.763 . . . . 72.319999999999993 112.749 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.65 158.52 39.59 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.122 2.548 . . . . 74.25 112.384 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -123.3 140.71 52.74 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 74.519999999999996 110.294 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -103.14 124.54 48.76 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.136 -1.061 . . . . 73.319999999999993 108.136 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.32 89.58 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.184 -1.413 . . . . 73.439999999999998 107.184 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . 0.53 HH22 ' N ' ' A' ' 501' ' ' HIS . 14.1 ttm180 -108.05 -29.34 9.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.402 -1.332 . . . . 74.019999999999996 107.402 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -135.93 155.43 50.3 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.704 -1.135 . . . . 74.519999999999996 108.745 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -156.41 41.06 0.57 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 110.365 -1.094 . . . . 74.120000000000005 110.365 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' MET . . . . . 0.558 ' SD ' ' HG2' ' A' ' 602' ' ' LYS . 0.0 OUTLIER -78.96 -56.51 4.33 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 106.932 -1.507 . . . . 72.129999999999995 106.932 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.558 ' HG2' ' SD ' ' A' ' 601' ' ' MET . 21.6 pttp -171.89 136.71 0.92 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.705 1.602 . . . . 75.140000000000001 108.111 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -72.76 -39.28 55.72 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.309 -0.472 . . . . 45.299999999999997 113.138 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.27 -142.4 7.43 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.043 -1.075 . . . . 71.340000000000003 111.936 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -151.16 132.58 14.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 123.023 0.529 . . . . 73.530000000000001 109.598 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 85.3 m -149.35 98.12 2.75 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.622 -1.251 . . . . 71.409999999999997 107.622 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.47 125.54 40.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.611 -0.885 . . . . 74.140000000000001 108.611 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 47.2 m -75.88 84.63 2.82 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 122.074 0.94 . . . . 74.25 110.416 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.79 -20.37 20.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.612 -1.176 . . . . 63.43 108.732 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.74 81.29 8.94 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 122.669 1.223 . . . . 75.319999999999993 108.429 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -95.52 -5.34 43.01 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.635 -2.075 . . . . 75.299999999999997 109.376 -174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -110.16 159.08 17.67 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.913 -1.143 . . . . 73.530000000000001 107.913 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 35.5 t70 59.35 83.77 0.12 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.223 1.009 . . . . 71.329999999999998 111.22 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.427 ' HZ1' ' HB2' ' A' ' 614' ' ' LYS . 0.1 OUTLIER -117.36 95.01 4.78 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.493 -0.776 . . . . 71.099999999999994 109.735 -177.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -170.55 -55.77 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.15 0 O-C-N 123.606 0.566 . . . . 74.340000000000003 110.801 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.94 -165.98 0.3 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-N 120.082 1.065 . . . . 74.140000000000001 109.692 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.96 138.07 36.6 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.346 -0.983 . . . . 74.209999999999994 108.346 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 2.3 p -58.28 108.98 0.68 Allowed 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 123.648 0.593 . . . . 72.219999999999999 110.056 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 22.1 m -83.71 -5.08 59.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.436 -0.802 . . . . 71.420000000000002 112.881 -172.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -88.59 106.86 18.59 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 119.994 -0.682 . . . . 74.239999999999995 109.616 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.15 104.65 7.2 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.315 0.579 . . . . 75.400000000000006 110.198 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.27 -16.27 57.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.59 0.709 . . . . 70.310000000000002 110.713 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.76 129.02 49.27 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.452 -1.314 . . . . 61.119999999999997 107.452 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -76.16 94.05 3.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.589 -0.523 . . . . 73.510000000000005 109.589 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -67.29 -39.97 86.05 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.819 -0.628 . . . . 74.340000000000003 110.999 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 630' ' ' MET . 46.9 ttt180 -61.07 -45.63 93.97 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.768 0.318 . . . . 73.310000000000002 110.431 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 70.1 mt -65.91 -37.25 79.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.345 -0.389 . . . . 71.040000000000006 110.406 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.02 -43.21 99.34 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.963 -0.384 . . . . 60.240000000000002 109.963 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.01 -14.59 60.63 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 112.344 0.498 . . . . 64.530000000000001 112.344 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.407 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 75.3 mtm -84.52 -5.21 59.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.535 0.683 . . . . 71.209999999999994 110.101 172.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -96.05 5.16 65.8 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.328 -1.109 . . . . 72.230000000000004 110.328 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -85.1 162.53 48.96 Favored Pre-proline 0 C--N 1.307 -1.24 0 C-N-CA 124.344 1.058 . . . . 75.099999999999994 109.142 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.7 146.39 95.2 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 N-CA-C 107.262 -1.861 . . . . 71.25 107.262 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 38.3 pt -129.76 -177.38 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-O 121.432 0.634 . . . . 74.329999999999998 110.951 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.5 176.15 5.25 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.068 -1.456 . . . . 74.129999999999995 107.068 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.22 153.37 52.71 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.231 -1.947 . . . . 53.43 108.231 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . 0.453 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 41.5 tt0 -41.1 -61.22 1.04 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.157 1.383 . . . . 73.099999999999994 112.737 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . 0.453 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 46.8 m80 -126.22 92.99 3.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.876 -0.787 . . . . 70.409999999999997 108.876 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.8 t -116.09 110.8 19.37 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.556 1.169 . . . . 74.439999999999998 108.954 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -146.29 116.7 7.49 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.211 -1.774 . . . . 75.519999999999996 106.211 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 509' ' ' GLU . 1.6 tm? -106.76 108.62 20.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.059 -1.089 . . . . 73.430000000000007 108.059 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -88.44 131.77 34.74 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.134 -0.939 . . . . 72.409999999999997 109.425 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.49 118.62 59.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.905 -0.776 . . . . 74.540000000000006 108.905 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.34 130.08 64.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.565 -1.198 . . . . 75.340000000000003 109.285 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.95 108.75 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 CA-C-O 122.254 1.026 . . . . 71.030000000000001 112.101 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 515' ' ' SER . 73.6 mm-40 -145.96 -154.3 0.53 Allowed 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 102.596 -3.112 . . . . 55.350000000000001 102.596 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -105.08 125.26 50.78 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.44 -1.689 . . . . 74.239999999999995 106.44 166.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 13.5 t -72.1 110.62 6.7 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 106.952 -1.499 . . . . 54.140000000000001 106.952 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -75.11 149.63 39.03 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.933 -0.576 . . . . 64.420000000000002 111.201 -176.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -165.81 90.36 0.45 Allowed 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 105.599 -2.0 . . . . 72.0 105.599 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -79.74 -34.45 39.94 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 108.042 -1.096 . . . . 74.430000000000007 108.042 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -132.57 142.5 49.19 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.257 -1.386 . . . . 71.329999999999998 107.257 171.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 22.6 m -76.27 85.87 3.07 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.786 0.803 . . . . 74.450000000000003 108.914 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 9.8 t -121.1 9.06 10.43 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.958 -1.019 . . . . 75.209999999999994 109.151 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 8.1 p -117.58 143.27 28.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.86 -1.163 . . . . 74.329999999999998 107.86 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.305 -1.343 0 N-CA-C 110.192 -0.299 . . . . 64.140000000000001 110.192 -179.326 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 . . . . . 0 C--O 1.24 0.584 0 N-CA-C 109.529 -0.545 . . . . 74.239999999999995 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -121.54 90.45 3.32 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.404 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -70.51 147.96 44.61 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.663 -0.975 . . . . 74.150000000000006 110.663 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -127.08 114.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.11 134.55 48.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.824 0.702 . . . . 74.530000000000001 109.928 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -147.99 156.73 42.99 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.321 -0.622 . . . . 74.219999999999999 109.321 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 74.4 m-85 -73.39 153.18 40.55 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.22 -0.289 . . . . 75.340000000000003 110.22 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.3 -51.86 67.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.978 0.799 . . . . 73.310000000000002 110.536 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -135.66 155.66 78.05 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 114.606 -1.179 . . . . 63.32 108.278 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.59 -25.74 2.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.934 1.756 . . . . 74.349999999999994 113.006 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 642' ' ' GLU . 89.3 t -142.02 132.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.127 -0.694 . . . . 72.540000000000006 109.127 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.3 t -133.94 138.26 45.38 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.079 0.466 . . . . 63.240000000000002 109.943 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -102.73 112.92 25.92 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.774 -1.195 . . . . 75.540000000000006 107.774 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.5 m -108.5 145.19 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.313 -0.555 . . . . 73.329999999999998 110.254 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.507 ' O ' HG21 ' A' ' 518' ' ' ILE . 70.8 m -70.81 137.91 49.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.131 -0.941 . . . . 70.230000000000004 111.38 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -31.3 61.65 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.752 1.019 . . . . 75.329999999999998 113.752 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 7.4 p -106.84 25.35 11.39 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.844 0.354 . . . . 63.240000000000002 111.884 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.507 HG21 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -76.13 -31.02 20.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.511 0.672 . . . . 72.519999999999996 110.228 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 87.12 -70.35 2.89 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.623 -0.798 . . . . 74.230000000000004 111.795 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.75 133.36 68.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.975 -1.121 . . . . 72.319999999999993 107.975 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 572' ' ' THR . 19.6 ptm -107.62 136.4 47.44 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.146 -0.687 . . . . 73.150000000000006 109.146 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -103.14 124.6 48.89 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.397 0.679 . . . . 74.420000000000002 110.0 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.5 t -121.24 123.71 70.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.423 -0.954 . . . . 74.230000000000004 108.423 175.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.77 127.4 35.6 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.684 -0.406 . . . . 73.200000000000003 110.01 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.68 107.93 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.529 -1.656 . . . . 75.409999999999997 106.529 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.8 mt -87.16 153.04 21.82 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.02 -0.991 . . . . 74.120000000000005 110.191 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -121.64 104.83 9.9 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.874 -0.603 . . . . 74.219999999999999 110.062 -178.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.5 m -63.59 -60.78 2.89 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 72.319999999999993 110.133 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -73.04 -43.8 61.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.157 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.02 -152.35 23.13 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 110.209 -1.156 . . . . 70.549999999999997 110.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -157.75 146.69 19.53 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.194 -1.78 . . . . 74.310000000000002 106.194 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.452 ' NH2' ' HA2' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -160.9 114.55 2.04 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.152 -1.425 . . . . 74.510000000000005 107.152 -178.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.452 ' HA2' ' NH2' ' A' ' 532' ' ' ARG . . . 119.25 -131.45 9.05 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 111.229 -0.748 . . . . 63.0 111.229 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -136.89 103.81 5.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.282 -2.118 . . . . 75.209999999999994 105.282 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 41.2 t -120.14 125.04 73.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 C-N-CA 119.644 -0.822 . . . . 65.409999999999997 111.086 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.73 122.64 42.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 74.329999999999998 107.938 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.12 103.13 54.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 109.006 -0.738 . . . . 73.519999999999996 109.006 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.12 133.27 9.82 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.819 1.68 . . . . 63.219999999999999 112.63 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -119.82 161.75 20.27 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.375 -1.343 . . . . 74.519999999999996 107.375 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -155.42 139.66 16.61 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.957 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.0 p -84.47 130.78 34.73 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.285 -0.871 . . . . 50.310000000000002 110.894 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 43.7 mm -99.09 114.01 35.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.542 -1.281 . . . . 75.329999999999998 107.542 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.01 161.97 27.92 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.989 -0.55 . . . . 75.140000000000001 111.002 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 144.53 117.27 1.14 Allowed Glycine 0 C--O 1.201 -1.939 0 N-CA-C 108.376 -1.889 . . . . 73.329999999999998 108.376 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 47.3 p 75.87 5.53 3.86 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 127.484 2.314 . . . . 62.520000000000003 110.395 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -169.21 140.1 2.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.706 -1.134 . . . . 72.319999999999993 108.249 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -102.47 138.08 39.86 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 123.501 0.501 . . . . 75.129999999999995 109.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -105.44 131.75 10.79 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 116.003 -0.544 . . . . 73.329999999999998 112.823 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 160.38 -49.53 0.38 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.818 -1.713 . . . . 73.209999999999994 108.818 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 179.65 -9.01 0.02 OUTLIER Glycine 0 C--N 1.294 -1.789 0 CA-C-N 113.933 -1.134 . . . . 72.420000000000002 111.286 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -65.16 -61.63 2.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.875 1.27 . . . . 75.230000000000004 111.686 -177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -122.88 -41.13 2.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.784 0.802 . . . . 72.239999999999995 109.122 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -136.37 160.29 39.18 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.931 -1.507 . . . . 74.120000000000005 106.931 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.539 ' OE2' ' HD2' ' A' ' 574' ' ' ARG . 22.1 tt0 -89.01 141.45 28.47 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.857 -0.794 . . . . 74.239999999999995 108.857 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.89 106.72 15.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.453 -0.944 . . . . 75.200000000000003 108.453 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -117.38 131.54 56.75 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.1 -1.074 . . . . 64.099999999999994 108.1 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.5 131.59 15.36 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 112.275 0.472 . . . . 73.430000000000007 112.275 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 85.21 -139.26 17.38 Favored Glycine 0 C--O 1.189 -2.708 0 N-CA-C 111.794 -0.522 . . . . 64.129999999999995 111.794 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 71.2 -8.0 1.07 Allowed 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.698 1.74 . . . . 64.349999999999994 115.698 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 569' ' ' LYS . 41.0 mt -93.4 131.28 38.73 Favored 'General case' 0 CA--C 1.5 -0.97 0 O-C-N 120.647 -1.283 . . . . 72.439999999999998 112.327 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -129.77 118.73 22.28 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.104 -0.953 . . . . 75.400000000000006 109.454 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 37.5 m-85 -104.54 155.31 18.93 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.555 -0.906 . . . . 74.409999999999997 108.555 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -120.66 -88.22 0.63 Allowed 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.721 -1.215 . . . . 74.040000000000006 107.721 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -104.45 165.48 11.03 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.197 -1.038 . . . . 71.430000000000007 108.197 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 4.4 p30 -63.21 -11.87 24.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.789 1.033 . . . . 73.439999999999998 113.789 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -69.8 -18.75 63.49 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.945 0.498 . . . . 74.140000000000001 111.794 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.8 pt -114.12 164.29 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 120.865 0.364 . . . . 74.400000000000006 110.625 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.56 158.37 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.08 -1.452 . . . . 75.439999999999998 107.08 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.454 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -121.69 149.19 43.58 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 120.965 0.412 . . . . 73.140000000000001 110.435 173.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.56 134.27 64.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.914 -1.039 . . . . 73.540000000000006 109.964 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 50.4 mt -90.91 126.73 43.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 106.552 -1.647 . . . . 74.310000000000002 106.552 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 521' ' ' MET . 15.5 p -117.28 112.5 20.85 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.836 -0.802 . . . . 73.129999999999995 108.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.416 HD13 HD23 ' A' ' 589' ' ' LEU . 50.4 mt -109.84 131.77 59.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.175 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.539 ' HD2' ' OE2' ' A' ' 554' ' ' GLU . 61.6 mtt180 -78.47 112.04 15.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 123.964 0.79 . . . . 74.430000000000007 111.397 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.5 125.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 106.356 -1.72 . . . . 70.420000000000002 106.356 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . 0.433 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 78.3 m-85 -105.63 113.64 27.32 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.129 0.788 . . . . 75.349999999999994 113.129 -174.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -79.49 121.72 25.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.36 -1.718 . . . . 72.109999999999999 106.36 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.583 ' HD2' ' O ' ' A' ' 578' ' ' ARG . 1.8 tmm_? -121.22 6.01 10.24 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.586 -0.894 . . . . 73.129999999999995 108.586 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 81.51 90.03 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 125.874 1.67 . . . . 71.109999999999999 111.563 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -140.43 164.05 31.18 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 113.806 -1.543 . . . . 73.329999999999998 110.138 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.36 -48.72 3.07 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.292 -0.413 . . . . 74.510000000000005 110.436 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -124.26 89.83 3.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.199 0.523 . . . . 71.340000000000003 112.097 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -138.12 83.36 1.97 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.135 -0.939 . . . . 74.25 110.404 173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.37 90.6 6.7 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 106.052 -1.833 . . . . 74.209999999999994 106.052 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . 0.419 ' O ' HD11 ' A' ' 645' ' ' ILE . 6.4 p -108.66 142.74 38.7 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.986 -1.006 . . . . 73.099999999999994 110.638 -175.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.4 p -134.54 168.18 19.43 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.41 -0.218 . . . . 62.219999999999999 110.41 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.4 ' CE1' HD12 ' A' ' 645' ' ' ILE . 54.8 p90 -163.86 162.33 23.57 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.982 -1.858 . . . . 75.420000000000002 105.982 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 11.0 t -113.41 171.96 7.25 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 118.802 -1.159 . . . . 62.439999999999998 108.815 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.416 HD23 HD13 ' A' ' 573' ' ' ILE . 61.0 tp -145.09 126.84 15.28 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.585 -1.635 . . . . 74.299999999999997 106.585 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 120.668 0.27 . . . . 73.230000000000004 110.383 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 56.5 mt -99.79 141.0 33.18 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.212 -1.033 . . . . 72.219999999999999 108.212 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.76 167.07 10.02 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.077 -1.083 . . . . 75.400000000000006 108.077 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.63 116.17 21.68 Favored Pre-proline 0 C--O 1.247 0.946 0 N-CA-C 112.606 0.595 . . . . 75.219999999999999 112.606 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.15 144.82 47.7 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.0 2.467 . . . . 75.230000000000004 111.527 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.68 130.71 55.95 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.643 -0.708 . . . . 73.239999999999995 110.788 -178.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -84.79 116.05 23.05 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.33 -1.359 . . . . 74.230000000000004 107.33 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.34 89.62 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 108.389 -0.967 . . . . 62.25 108.389 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -96.14 127.87 42.53 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.703 -1.135 . . . . 75.310000000000002 107.963 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -103.11 141.04 36.51 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.785 0.326 . . . . 72.040000000000006 110.394 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 150.82 176.03 23.34 Favored Glycine 0 C--N 1.303 -1.292 0 N-CA-C 110.289 -1.124 . . . . 64.219999999999999 110.289 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -115.55 111.24 20.41 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.844 -1.539 . . . . 75.209999999999994 106.844 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -78.53 -24.01 45.93 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 114.216 1.191 . . . . 73.329999999999998 114.216 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 80.59 -56.33 4.72 Favored Glycine 0 C--N 1.312 -0.76 0 C-N-CA 121.188 -0.529 . . . . 75.140000000000001 112.621 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -91.62 31.34 5.88 Favored Glycine 0 N--CA 1.44 -1.088 0 O-C-N 122.656 -0.32 . . . . 51.299999999999997 112.757 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -84.99 88.06 7.42 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.976 0.893 . . . . 73.120000000000005 109.782 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 14.9 m -85.91 122.3 29.77 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.841 -0.618 . . . . 64.430000000000007 109.404 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 49.1 mm -82.58 119.44 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 107.138 -1.43 . . . . 75.099999999999994 107.138 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 30.6 m -71.6 89.58 0.99 Allowed 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.698 0.761 . . . . 64.409999999999997 111.484 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -88.71 -12.66 41.67 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.19 -0.914 . . . . 73.439999999999998 108.772 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.99 150.72 47.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.405 -1.702 . . . . 74.409999999999997 106.405 171.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -80.16 103.35 9.97 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.73 -0.788 . . . . 72.510000000000005 108.986 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -102.4 -177.62 3.45 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.51 -0.768 . . . . 73.140000000000001 109.226 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.62 165.94 18.58 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.681 -0.489 . . . . 73.400000000000006 109.681 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.483 ' HZ2' ' HB3' ' A' ' 614' ' ' LYS . 8.8 mtpm? -73.86 -28.04 61.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.759 -0.46 . . . . 71.230000000000004 109.759 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 69.8 96.4 0.05 OUTLIER Pre-proline 0 C--O 1.24 0.574 0 C-N-CA 125.195 1.398 . . . . 75.510000000000005 111.343 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.49 154.53 73.28 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.663 2.242 . . . . 62.0 112.195 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.85 -23.93 38.76 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.641 0.734 . . . . 72.439999999999998 109.273 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 6.1 p -77.11 -64.13 1.2 Allowed 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.938 -1.028 . . . . 71.120000000000005 111.191 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 42.4 m -130.89 132.59 45.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 120.682 0.277 . . . . 73.200000000000003 111.213 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -134.13 145.76 49.6 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.511 -0.922 . . . . 74.430000000000007 108.511 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -83.88 -33.95 24.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.537 0.684 . . . . 75.099999999999994 109.826 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -97.97 89.46 4.57 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.643 -0.708 . . . . 74.099999999999994 110.769 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.53 78.06 1.1 Allowed 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 122.646 1.212 . . . . 75.409999999999997 108.427 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.72 153.8 23.97 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.395 -1.275 . . . . 72.150000000000006 109.91 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 1.8 mpp_? -60.13 -38.63 83.64 Favored 'General case' 0 C--O 1.209 -1.042 0 O-C-N 123.598 0.561 . . . . 65.239999999999995 110.468 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.539 ' O ' ' HG3' ' A' ' 630' ' ' MET . 50.5 ttt180 -60.94 -42.63 98.55 Favored 'General case' 0 C--O 1.213 -0.868 0 C-N-CA 120.796 -0.362 . . . . 74.030000000000001 110.818 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.53 -41.01 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.662 -0.495 . . . . 72.209999999999994 109.662 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.02 78.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.787 -0.642 . . . . 72.140000000000001 110.312 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 48.6 mt-10 -76.99 -25.4 52.69 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.121 -0.491 . . . . 75.540000000000006 111.684 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 67.0 mtt -68.46 -56.6 7.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.061 -1.089 . . . . 73.239999999999995 108.061 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -98.22 45.89 1.62 Allowed Glycine 0 N--CA 1.418 -2.512 0 CA-C-N 114.685 -1.143 . . . . 71.340000000000003 114.147 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.447 ' N ' ' HD2' ' A' ' 633' ' ' PRO 0.591 0.1 OUTLIER -91.52 -27.74 0.3 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 116.704 2.113 . . . . 74.310000000000002 116.704 170.598 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 632' ' ' ARG . 18.1 Cg_endo -65.73 109.67 1.5 Allowed 'Trans proline' 0 C--N 1.376 1.978 0 N-CA-C 106.922 -1.992 . . . . 75.420000000000002 106.922 163.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 31.3 pt -132.89 -176.71 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.581 0.705 . . . . 74.519999999999996 111.444 -171.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.07 179.64 5.14 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.033 -1.099 . . . . 63.32 108.033 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -68.7 167.77 44.42 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.899 -0.88 . . . . 74.519999999999996 110.899 175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -48.78 -43.7 38.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.594 1.158 . . . . 74.25 110.782 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.17 123.53 9.63 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.036 -1.438 . . . . 75.329999999999998 107.3 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.2 t -148.97 112.89 5.14 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.812 0.815 . . . . 74.239999999999995 110.209 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -147.42 130.39 16.27 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.888 -1.051 . . . . 74.140000000000001 108.618 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 68.5 tp -108.23 118.86 37.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.917 -0.771 . . . . 75.140000000000001 108.917 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.419 ' HB2' HG23 ' A' ' 511' ' ' VAL . 39.7 mt-10 -103.05 122.87 45.53 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.983 -1.117 . . . . 72.120000000000005 107.983 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.0 t -109.88 128.8 65.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.788 -0.819 . . . . 71.239999999999995 108.788 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.03 133.29 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.605 0 N-CA-C 107.269 -1.382 . . . . 74.450000000000003 107.269 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . 0.419 HD11 ' O ' ' A' ' 585' ' ' CYS . 1.0 OUTLIER -115.16 130.82 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 CA-C-N 115.977 -0.556 . . . . 73.420000000000002 109.516 -174.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . 0.467 ' HB3' ' OG ' ' A' ' 648' ' ' SER . 2.9 tm-20 -174.33 -177.37 1.24 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 103.195 -2.891 . . . . 73.549999999999997 103.195 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -86.23 27.1 0.95 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 120.861 1.664 . . . . 72.209999999999994 109.656 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 646' ' ' GLU . 13.0 m -45.11 113.48 0.58 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 126.35 1.86 . . . . 73.519999999999996 112.843 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -92.01 120.85 33.03 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 105.889 -1.893 . . . . 73.129999999999995 105.889 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -103.38 111.29 23.65 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.595 0.712 . . . . 74.129999999999995 112.6 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -82.85 -10.65 58.74 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.868 -1.06 . . . . 75.219999999999999 108.432 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -67.61 103.69 1.43 Allowed 'General case' 0 C--O 1.245 0.864 0 CA-C-N 115.078 -0.965 . . . . 72.439999999999998 108.629 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 15.3 m -148.11 79.24 1.46 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 121.352 0.596 . . . . 75.340000000000003 112.048 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 62.5 m -151.35 99.75 2.67 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.791 -1.189 . . . . 72.200000000000003 107.791 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 18.9 m 52.5 24.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 125.687 1.595 . . . . 73.209999999999994 112.05 -174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 . . . . . 0 C--O 1.253 1.246 0 CA-C-N 115.154 -0.93 . . . . 72.299999999999997 109.883 -179.003 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 C--O 1.245 0.856 0 CA-C-O 121.857 0.836 . . . . 75.150000000000006 110.199 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -98.94 -33.17 10.95 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.145 -0.934 . . . . 70.150000000000006 110.781 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 174.92 97.24 0.11 Allowed Glycine 0 C--O 1.222 -0.656 0 C-N-CA 120.729 -0.748 . . . . 75.430000000000007 112.831 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.401 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.1 mt -93.19 121.61 44.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 110.414 -0.217 . . . . 75.129999999999995 110.414 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 91.2 m-85 -109.0 138.5 45.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.769 -0.826 . . . . 72.530000000000001 108.769 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -149.34 158.68 44.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.683 -0.488 . . . . 73.109999999999999 109.683 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.669 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.6 m-85 -74.51 156.79 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.607 0.242 . . . . 75.439999999999998 110.362 174.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.47 -53.03 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.169 0.918 . . . . 72.430000000000007 110.675 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -121.47 157.53 56.12 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.259 -0.882 . . . . 74.420000000000002 108.82 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -84.0 -30.26 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.521 1.481 . . . . 75.140000000000001 110.527 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 642' ' ' GLU . 70.6 t -137.64 129.89 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.0 t -133.89 131.89 39.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.045 -0.724 . . . . 74.239999999999995 109.045 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -96.17 138.01 34.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.384 -1.339 . . . . 75.510000000000005 107.384 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.87 145.49 32.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 120.853 0.359 . . . . 63.520000000000003 110.266 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 518' ' ' ILE . 69.5 m -75.3 156.27 35.77 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.208 -0.906 . . . . 73.030000000000001 111.749 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -68.17 -46.17 71.44 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.934 -1.03 . . . . 74.109999999999999 111.046 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 11.2 t -95.17 36.04 1.25 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.771 0.796 . . . . 75.420000000000002 110.173 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 515' ' ' SER . 8.6 tt -89.91 -31.66 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 121.722 -0.612 . . . . 75.200000000000003 110.514 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.16 -72.85 2.74 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.818 -0.706 . . . . 74.120000000000005 111.463 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.65 123.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.515 -0.55 . . . . 72.400000000000006 109.515 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.418 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 22.1 ptm -91.36 138.6 31.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.111 -1.07 . . . . 73.209999999999994 108.111 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.74 108.87 20.57 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 123.442 0.464 . . . . 64.200000000000003 111.076 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 40.1 t -105.24 117.63 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.312 -0.625 . . . . 62.409999999999997 109.312 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -96.45 132.39 42.05 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.217 0.532 . . . . 74.420000000000002 110.093 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.8 t -90.96 112.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.463 -1.31 . . . . 74.430000000000007 107.463 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.422 ' HA ' HH21 ' A' ' 527' ' ' ARG . 59.3 mt -82.36 141.99 32.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.292 -0.867 . . . . 72.120000000000005 110.191 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -106.56 102.12 11.53 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.997 -1.483 . . . . 75.239999999999995 106.997 178.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.7 m -67.73 -63.75 1.0 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.802 -0.635 . . . . 73.540000000000006 110.701 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' SER . . . . . 0.401 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 10.3 t -75.63 -31.77 59.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 75.310000000000002 110.283 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 131.67 -159.14 23.11 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.919 -0.872 . . . . 72.010000000000005 110.919 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.545 ' N ' ' HB3' ' A' ' 565' ' ' ASP . . . -168.73 142.09 2.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.637 -1.616 . . . . 70.349999999999994 106.637 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -146.06 129.4 16.78 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.128 -0.693 . . . . 74.129999999999995 109.128 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 100.72 -122.85 7.74 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 121.386 -0.435 . . . . 55.340000000000003 112.758 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.62 102.77 5.02 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.749 -1.945 . . . . 74.310000000000002 105.749 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.62 129.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.234 0.54 . . . . 73.299999999999997 110.552 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.517 ' CG2' ' HB2' ' A' ' 559' ' ' GLU . 50.9 mm -98.29 127.62 50.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.536 -0.757 . . . . 75.310000000000002 109.147 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -112.61 104.58 55.99 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.45 0.7 . . . . 74.420000000000002 109.892 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.35 141.27 28.49 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.741 2.294 . . . . 63.229999999999997 113.262 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.53 163.91 30.02 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.375 -0.972 . . . . 72.519999999999996 108.375 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -161.69 137.82 7.98 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 123.192 0.308 . . . . 75.439999999999998 110.655 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.5 p -84.26 126.29 33.03 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.381 0.61 . . . . 71.109999999999999 110.992 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.4 117.77 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.299 -1.741 . . . . 74.230000000000004 106.299 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.86 146.38 49.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 123.355 0.409 . . . . 72.510000000000005 110.125 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.36 -108.13 0.74 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 109.16 -1.576 . . . . 75.230000000000004 109.16 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -72.08 -43.36 64.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.301 -1.74 . . . . 73.5 106.301 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 587' ' ' PHE . . . -73.16 133.88 44.23 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 113.815 -1.539 . . . . 74.349999999999994 108.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 37.2 ttt180 -111.27 143.24 42.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.551 0.945 . . . . 71.430000000000007 113.551 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 48.66 -149.75 3.94 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 125.952 1.739 . . . . 74.120000000000005 117.444 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -128.11 80.72 0.36 Allowed Glycine 0 N--CA 1.405 -3.431 0 N-CA-C 109.232 -1.547 . . . . 71.219999999999999 109.232 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 146.14 -21.14 1.75 Allowed Glycine 0 C--N 1.292 -1.892 0 C-N-CA 121.054 -0.593 . . . . 74.439999999999998 111.991 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 10.3 mm-40 -77.84 -67.57 0.71 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.315 0.578 . . . . 75.420000000000002 109.908 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -108.28 -43.37 4.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.772 0.796 . . . . 52.450000000000003 109.763 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -136.79 170.73 15.6 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.276 -1.379 . . . . 75.030000000000001 107.276 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.448 ' HG3' ' HE ' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -99.67 128.94 45.76 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.362 -1.718 . . . . 75.109999999999999 106.362 176.302 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.6 111.37 1.8 Allowed 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 123.802 0.841 . . . . 75.430000000000007 110.815 -173.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 104.7 14.48 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-O 122.075 0.941 . . . . 71.530000000000001 110.946 -174.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.5 p -139.48 129.6 25.17 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.862 -1.063 . . . . 72.040000000000006 108.562 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.24 -168.38 41.12 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.264 -1.134 . . . . 74.120000000000005 110.264 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.517 ' HB2' ' CG2' ' A' ' 536' ' ' ILE . 9.8 pt-20 -131.3 129.26 41.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.306 0.574 . . . . 72.430000000000007 110.904 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.435 HD22 ' CG ' ' A' ' 569' ' ' LYS . 85.5 mt -90.37 143.91 26.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.994 -1.003 . . . . 71.549999999999997 111.436 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.89 117.16 34.41 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.128 -0.629 . . . . 75.430000000000007 110.439 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -111.29 157.72 19.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.625 -1.25 . . . . 74.439999999999998 107.625 172.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -121.08 -87.8 0.63 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.901 -1.148 . . . . 71.420000000000002 107.901 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -104.47 162.43 13.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.826 -1.175 . . . . 74.230000000000004 107.826 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.545 ' HB3' ' N ' ' A' ' 531' ' ' ALA . 4.2 p30 -64.06 -15.41 59.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 113.718 1.007 . . . . 73.209999999999994 113.718 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.32 -19.42 63.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.736 0.303 . . . . 73.430000000000007 111.726 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 40.3 pt -107.18 163.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.82 154.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 108.153 -1.054 . . . . 63.310000000000002 108.153 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.435 ' CG ' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -119.19 162.53 18.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 104.884 -2.265 . . . . 73.109999999999999 104.884 175.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 76.6 mt -131.6 137.64 54.76 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.535 0 N-CA-C 107.954 -1.128 . . . . 74.219999999999999 107.954 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.448 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 48.7 mt -93.27 122.07 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.125 -1.805 . . . . 72.219999999999999 106.125 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 44.5 p -105.56 112.71 25.9 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.789 -0.448 . . . . 71.420000000000002 109.789 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.418 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 59.7 mt -110.85 122.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.563 -0.532 . . . . 73.299999999999997 109.563 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.448 ' HE ' ' HG3' ' A' ' 554' ' ' GLU . 23.3 mtm-85 -72.89 115.89 12.73 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.868 0.73 . . . . 73.140000000000001 110.774 174.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.0 mm -96.06 127.88 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.25 -0.886 . . . . 73.349999999999994 109.077 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -105.61 109.78 21.86 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.797 -0.816 . . . . 73.420000000000002 108.797 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.95 157.39 29.74 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.097 -0.956 . . . . 71.109999999999999 113.24 -171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -131.31 175.47 9.1 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.618 -1.623 . . . . 71.549999999999997 106.618 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -99.64 -13.24 19.45 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.468 -0.493 . . . . 72.200000000000003 111.796 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -95.49 113.47 25.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 112.242 0.46 . . . . 74.340000000000003 112.242 -173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -77.86 -8.24 57.79 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.07 -0.514 . . . . 74.129999999999995 111.854 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -66.17 -19.97 66.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.435 -0.348 . . . . 64.519999999999996 110.998 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -91.44 107.59 19.31 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.937 -0.394 . . . . 74.299999999999997 109.937 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.08 111.78 22.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.994 -1.113 . . . . 75.319999999999993 107.994 172.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 84.0 m -110.73 132.54 54.11 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.885 -0.726 . . . . 55.32 111.242 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 12.9 m -119.95 130.94 55.02 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.852 -0.425 . . . . 74.540000000000006 109.852 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.409 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 52.1 p90 -129.57 -179.45 5.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.375 -1.342 . . . . 75.319999999999993 107.375 171.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 8.6 t -131.72 168.16 18.24 Favored 'General case' 0 N--CA 1.409 -2.507 0 C-N-CA 119.07 -1.052 . . . . 73.299999999999997 109.926 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 573' ' ' ILE . 51.5 tp -140.57 123.25 16.23 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 105.688 -1.967 . . . . 65.340000000000003 105.688 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.46 157.06 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 116.423 -0.353 . . . . 75.099999999999994 110.185 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.669 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 64.9 mt -107.79 151.66 25.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.211 -1.033 . . . . 73.230000000000004 108.211 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -115.17 178.06 4.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.206 0.316 . . . . 72.430000000000007 110.237 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -59.34 119.17 36.88 Favored Pre-proline 0 C--O 1.245 0.856 0 O-C-N 124.161 0.913 . . . . 73.230000000000004 111.7 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.518 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 55.6 Cg_endo -71.11 157.41 57.68 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 122.883 2.388 . . . . 75.010000000000005 112.032 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -124.42 138.1 54.39 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.385 -0.825 . . . . 71.400000000000006 110.328 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -95.32 123.38 38.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.536 -1.283 . . . . 73.109999999999999 107.536 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.45 97.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.202 -1.036 . . . . 74.230000000000004 108.202 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -152.82 142.4 21.82 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 109.248 -0.649 . . . . 72.349999999999994 109.248 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 63.3 ttt-85 -143.64 139.79 29.78 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.291 -1.744 . . . . 73.430000000000007 106.291 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -132.01 -175.79 14.14 Favored Glycine 0 C--N 1.284 -2.339 0 N-CA-C 109.693 -1.363 . . . . 54.32 109.693 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 28.1 ttt -75.31 102.87 5.23 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.007 -1.479 . . . . 74.25 107.007 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -81.21 105.44 12.41 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.394 -0.821 . . . . 72.409999999999997 111.263 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 82.48 -134.36 12.89 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.282 -0.727 . . . . 65.150000000000006 111.282 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -151.69 -151.56 5.65 Favored Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 111.201 -0.76 . . . . 71.450000000000003 111.201 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 57.0 65.83 1.3 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.573 1.149 . . . . 75.109999999999999 111.222 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' THR . . . . . 0.457 ' O ' HD11 ' A' ' 607' ' ' ILE . 59.5 m -137.65 86.2 2.17 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.407 0.622 . . . . 75.420000000000002 110.939 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . 0.457 HD11 ' O ' ' A' ' 606' ' ' THR . 20.3 mm -130.76 96.85 2.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.789 -1.559 . . . . 73.519999999999996 106.789 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 26.6 m 75.46 -21.86 0.29 Allowed 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.367 0.877 . . . . 74.129999999999995 113.367 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.42 -39.93 92.58 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.238 0.615 . . . . 71.420000000000002 110.456 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -83.07 92.97 7.5 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-O 122.385 1.088 . . . . 71.299999999999997 109.579 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -87.9 -30.89 19.78 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 112.945 -1.934 . . . . 72.040000000000006 107.674 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.17 109.01 11.1 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.735 -1.58 . . . . 75.239999999999995 106.735 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -96.91 -39.65 9.29 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 114.709 1.374 . . . . 72.109999999999999 114.709 -168.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -76.62 86.82 3.29 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.617 0.969 . . . . 62.200000000000003 113.617 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -163.76 150.78 10.37 Favored Pre-proline 0 C--N 1.314 -0.964 0 C-N-CA 125.153 1.381 . . . . 71.420000000000002 108.912 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.9 144.56 98.83 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 121.942 1.761 . . . . 72.450000000000003 107.699 167.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.0 97.11 0.47 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.218 0.821 . . . . 74.25 113.218 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 4.9 p -95.14 138.71 32.49 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.28 -0.873 . . . . 73.030000000000001 109.051 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 40.0 m 70.01 11.53 7.68 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.569 1.148 . . . . 71.230000000000004 111.179 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -147.02 78.16 1.48 Allowed 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.628 -1.249 . . . . 74.239999999999995 107.628 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.26 124.79 41.17 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.968 -1.014 . . . . 73.200000000000003 108.779 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 624' ' ' GLU . 0.0 OUTLIER -126.18 -171.68 2.44 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.587 -0.733 . . . . 62.009999999999998 110.007 -172.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.46 -25.88 59.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.234 0.54 . . . . 74.340000000000003 111.516 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 622' ' ' GLU . 4.1 mp0 -67.34 -12.66 60.73 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.814 -0.63 . . . . 74.129999999999995 111.659 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -38.7 91.99 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 108.007 -1.108 . . . . 73.400000000000006 108.007 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 630' ' ' MET . 38.8 ttp180 -67.04 -37.64 84.46 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.868 -1.06 . . . . 73.530000000000001 109.513 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.05 -35.69 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.182 0.515 . . . . 74.519999999999996 110.221 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -66.19 -29.27 69.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.219 0.533 . . . . 72.439999999999998 110.332 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -81.89 -25.72 34.75 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.748 -0.66 . . . . 75.409999999999997 110.699 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 66.6 mtt -66.97 -35.25 79.55 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.594 -0.891 . . . . 74.239999999999995 108.594 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -81.73 44.44 3.11 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.798 -1.092 . . . . 73.409999999999997 112.306 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -124.2 140.88 35.88 Favored Pre-proline 0 C--N 1.292 -1.92 0 N-CA-C 106.246 -1.761 . . . . 74.349999999999994 106.246 175.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 11.9 Cg_exo -72.41 150.77 52.75 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.981 1.787 . . . . 75.439999999999998 111.454 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 50.9 pt -126.44 145.81 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 N-CA-C 107.361 -1.348 . . . . 74.230000000000004 107.361 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 505' ' ' PHE . 2.2 pt? -87.41 -170.18 2.92 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 115.584 -0.734 . . . . 73.349999999999994 111.618 -171.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -61.85 144.36 48.95 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.632 -0.987 . . . . 72.140000000000001 110.632 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.08 -51.88 67.52 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.168 0.508 . . . . 75.239999999999995 110.127 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -123.25 104.35 9.09 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.368 0.604 . . . . 75.120000000000005 109.835 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.0 t -133.22 116.53 16.32 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.627 -0.879 . . . . 71.25 108.627 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -145.39 142.0 28.95 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.453 -0.943 . . . . 75.409999999999997 108.453 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.8 tp -121.84 110.45 15.9 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.932 -0.766 . . . . 64.530000000000001 108.932 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.494 ' HB2' HG23 ' A' ' 511' ' ' VAL . 40.5 mt-10 -88.28 112.42 22.79 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.043 -1.095 . . . . 75.209999999999994 108.043 174.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.41 120.67 51.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.976 -1.011 . . . . 75.140000000000001 108.838 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 23.5 mt -119.06 114.45 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-N 114.878 -1.055 . . . . 75.129999999999995 111.159 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . 0.432 ' H ' HD13 ' A' ' 645' ' ' ILE . 0.0 OUTLIER -89.31 108.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.423 -1.325 . . . . 71.519999999999996 107.423 175.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.79 153.28 28.07 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.489 -1.232 . . . . 73.430000000000007 108.073 -172.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -80.79 79.09 7.5 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 104.884 -2.265 . . . . 70.030000000000001 104.884 168.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.5 t -92.05 121.18 33.37 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 114.993 -1.003 . . . . 72.230000000000004 109.542 -170.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -110.22 121.1 44.48 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 120.45 -0.5 . . . . 63.539999999999999 110.169 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -147.39 120.76 9.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.116 -1.438 . . . . 75.409999999999997 107.116 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -95.91 102.02 13.76 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 108.958 -0.756 . . . . 75.349999999999994 108.958 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -93.85 123.16 37.02 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 119.971 -0.692 . . . . 74.030000000000001 110.01 175.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 25.9 t -98.06 135.58 39.54 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.39 -0.823 . . . . 62.32 110.071 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 38.3 m -114.89 112.9 23.45 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.947 -1.131 . . . . 74.439999999999998 107.947 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 27.3 t -78.99 132.51 32.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.47 -0.567 . . . . 74.439999999999998 109.47 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 C--N 1.302 -1.464 0 CA-C-N 115.837 -0.619 . . . . 64.420000000000002 109.855 -178.141 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 122.168 0.985 . . . . 62.219999999999999 109.068 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -83.88 -60.39 2.12 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.032 -0.985 . . . . 75.329999999999998 110.376 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -177.89 124.49 0.94 Allowed Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.323 -0.941 . . . . 64.439999999999998 112.906 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.1 mt -127.15 114.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.126 -2.176 . . . . 73.239999999999995 105.126 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.54 ' CE1' ' HD2' ' A' ' 527' ' ' ARG . 97.6 m-85 -113.84 128.94 56.61 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.91 -0.316 . . . . 75.340000000000003 110.309 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.44 148.97 30.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.969 -0.56 . . . . 73.25 110.11 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -67.31 154.08 42.15 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 110.323 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.16 -55.4 35.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.096 -0.705 . . . . 74.439999999999998 109.096 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -127.48 157.38 73.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.914 -1.039 . . . . 72.319999999999993 108.899 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -88.99 -13.76 2.99 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.403 2.069 . . . . 72.230000000000004 113.002 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 642' ' ' GLU . 91.4 t -143.45 133.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.66 -0.496 . . . . 73.030000000000001 109.66 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.3 t -134.51 133.23 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.64 -0.504 . . . . 74.510000000000005 109.64 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -108.85 112.1 24.16 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.301 -1.0 . . . . 64.129999999999995 108.301 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.1 m -121.26 162.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.146 0.498 . . . . 74.519999999999996 110.919 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 518' ' ' ILE . 37.0 m -77.19 149.63 35.53 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.198 -0.455 . . . . 63.520000000000003 112.009 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.03 -27.58 69.21 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.332 0.587 . . . . 64.209999999999994 110.228 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.3 m -110.59 28.63 8.49 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.762 -0.654 . . . . 73.120000000000005 111.143 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.44 HG21 ' O ' ' A' ' 515' ' ' SER . 10.0 tt -76.89 -28.33 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.101 0.477 . . . . 73.409999999999997 111.417 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.43 -77.8 0.84 Allowed Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.081 -0.808 . . . . 75.409999999999997 111.081 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.2 mm -130.14 146.22 34.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.691 -1.226 . . . . 64.510000000000005 107.691 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.0 ppp? -119.6 153.64 35.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.968 -1.493 . . . . 75.120000000000005 106.968 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -128.13 126.57 41.36 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.068 0.23 . . . . 74.230000000000004 111.153 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.37 131.35 54.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.223 -0.658 . . . . 64.010000000000005 109.223 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -90.76 151.07 21.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.142 0.496 . . . . 72.510000000000005 110.171 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.0 t -103.95 113.45 40.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 105.964 -1.865 . . . . 74.519999999999996 105.964 172.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.09 134.84 34.46 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.118 -0.492 . . . . 74.319999999999993 110.189 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 73.3 ttt180 -106.87 102.61 11.96 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.988 -1.115 . . . . 73.400000000000006 107.988 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.0 m -65.82 -47.7 74.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.588 -1.187 . . . . 72.430000000000007 113.901 -171.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.6 p -69.01 -51.35 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.357 0.873 . . . . 62.140000000000001 113.357 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 155.48 172.83 23.48 Favored Glycine 0 CA--C 1.48 -2.156 0 N-CA-C 108.644 -1.782 . . . . 70.209999999999994 108.644 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 527' ' ' ARG . . . -150.03 121.56 7.98 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 117.658 0.729 . . . . 73.209999999999994 112.552 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.499 ' HD3' ' C ' ' A' ' 532' ' ' ARG . 0.8 OUTLIER -156.71 110.82 2.72 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.633 -0.877 . . . . 74.109999999999999 108.633 171.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 149.19 -142.82 10.18 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 109.614 -1.394 . . . . 75.040000000000006 109.614 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -137.43 112.76 9.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.319 -1.363 . . . . 72.340000000000003 107.319 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.95 132.15 65.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 120.676 -0.41 . . . . 73.099999999999994 111.415 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.64 116.82 47.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.716 -0.674 . . . . 73.519999999999996 109.291 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.44 111.1 65.13 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.816 -0.809 . . . . 75.230000000000004 108.816 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -84.6 149.02 11.32 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.945 1.764 . . . . 74.439999999999998 111.082 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -138.21 159.24 42.56 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.159 -1.052 . . . . 75.400000000000006 108.159 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 589' ' ' LEU . 57.2 pttt -151.59 137.5 18.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.452 . . . . 74.400000000000006 110.021 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -84.2 143.12 29.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.881 -0.6 . . . . 71.010000000000005 111.124 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 48.5 mm -102.37 115.72 44.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.336 -1.728 . . . . 74.319999999999993 106.336 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -73.55 109.88 7.41 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.627 0.58 . . . . 74.129999999999995 111.513 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -135.34 126.17 3.91 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.363 -1.095 . . . . 55.539999999999999 110.363 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.3 m 69.06 -49.34 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.268 2.227 . . . . 73.310000000000002 112.459 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -90.16 150.14 22.14 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.431 -0.952 . . . . 63.409999999999997 108.431 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 40.9 ttp180 -93.14 135.49 34.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.956 0.408 . . . . 71.400000000000006 110.597 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.56 -161.15 35.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.542 -0.754 . . . . 62.409999999999997 111.355 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 85.97 18.56 59.34 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.043 -1.223 . . . . 74.450000000000003 110.043 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.76 27.79 60.22 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.029 -0.829 . . . . 72.239999999999995 111.029 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 10.1 tp10 -87.67 -87.26 0.15 Allowed 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 122.849 0.459 . . . . 63.439999999999998 110.611 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 578' ' ' ARG . 32.8 t70 -90.03 -30.34 17.81 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.065 0.936 . . . . 72.540000000000006 109.208 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.92 148.74 40.9 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 106.704 -1.591 . . . . 71.319999999999993 106.704 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.436 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 0.6 OUTLIER -86.28 105.83 16.92 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 105.988 -1.856 . . . . 73.329999999999998 105.988 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.94 91.14 1.18 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.763 1.268 . . . . 74.219999999999999 109.718 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.9 t -83.33 132.77 34.99 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 113.334 -1.757 . . . . 74.450000000000003 112.252 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.0 p -139.46 119.8 13.85 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.447 -2.057 . . . . 74.430000000000007 105.447 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.89 -179.75 27.8 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 119.473 -1.346 . . . . 72.030000000000001 113.048 -173.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -105.17 111.45 24.2 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 123.977 0.911 . . . . 74.030000000000001 108.703 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.99 126.86 43.6 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.57 -0.852 . . . . 72.439999999999998 109.42 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.93 98.58 8.4 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 121.468 0.651 . . . . 72.0 111.72 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 53.1 m-85 -94.37 101.78 13.73 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.591 -0.892 . . . . 73.519999999999996 108.591 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.438 ' H ' HD13 ' A' ' 567' ' ' ILE . 75.4 mt-30 -86.55 -79.59 0.26 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.73 -0.668 . . . . 64.129999999999995 109.735 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -104.63 163.48 12.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.719 -0.673 . . . . 73.430000000000007 109.701 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.37 -21.24 66.66 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.658 1.183 . . . . 74.299999999999997 112.269 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.69 -16.65 63.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.864 0.69 . . . . 73.239999999999995 112.864 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.438 HD13 ' H ' ' A' ' 563' ' ' GLN . 38.7 pt -112.63 160.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.539 -0.464 . . . . 73.019999999999996 110.767 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.47 144.9 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.315 -1.365 . . . . 72.25 107.315 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 73.0 mmtt -102.51 149.82 24.01 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.045 0.45 . . . . 75.200000000000003 110.756 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 66.2 mt -123.01 128.62 75.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.421 -1.263 . . . . 74.319999999999993 108.807 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 62.5 mt -90.76 121.72 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 107.529 -1.286 . . . . 72.5 107.529 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 521' ' ' MET . 40.1 p -110.23 113.28 25.83 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.801 -0.636 . . . . 74.239999999999995 109.411 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.411 HD11 ' SD ' ' A' ' 521' ' ' MET . 61.0 mt -103.97 122.5 56.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.061 -1.089 . . . . 73.400000000000006 108.061 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 80.3 mtt85 -75.76 115.92 15.94 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.868 0.73 . . . . 73.310000000000002 109.522 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.05 139.56 19.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.212 -1.403 . . . . 73.019999999999996 107.212 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -128.1 163.04 25.49 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.194 0.521 . . . . 74.540000000000006 110.166 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.3 87.34 3.61 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.781 -1.562 . . . . 72.510000000000005 106.781 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 552' ' ' ASP . 38.3 mmt180 -132.93 -27.7 1.63 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.427 1.64 . . . . 75.540000000000006 115.427 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.451 ' HG3' ' SG ' ' A' ' 585' ' ' CYS . 64.5 mm-40 -67.55 101.64 1.03 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.952 0.882 . . . . 75.540000000000006 110.82 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -78.49 -47.78 16.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.353 -1.748 . . . . 73.219999999999999 111.951 -170.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -98.56 -21.05 16.7 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.295 -0.562 . . . . 73.409999999999997 111.917 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -75.26 149.73 38.76 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.69 0.281 . . . . 73.519999999999996 110.709 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -92.21 -49.46 6.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.849 -0.614 . . . . 74.25 109.976 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.65 137.7 38.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.562 -0.745 . . . . 73.230000000000004 109.285 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . 0.451 ' SG ' ' HG3' ' A' ' 579' ' ' GLU . 59.2 m -122.85 140.35 53.04 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.973 -0.751 . . . . 65.420000000000002 108.973 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 27.4 p -139.43 113.53 8.81 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.492 0.663 . . . . 71.25 111.229 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.3 p90 -109.81 -178.43 3.53 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.169 -1.049 . . . . 75.209999999999994 108.169 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 19.7 m -135.01 167.52 20.79 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.989 -0.684 . . . . 61.219999999999999 110.447 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 540' ' ' LYS . 51.7 tp -137.97 132.49 32.4 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.55 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.663 -0.495 . . . . 74.329999999999998 109.663 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.39 145.31 29.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.7 -0.682 . . . . 75.25 109.304 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.71 174.19 6.07 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.679 -0.86 . . . . 74.439999999999998 108.679 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -66.03 116.8 36.3 Favored Pre-proline 0 C--O 1.246 0.888 0 CA-C-O 121.106 0.479 . . . . 73.329999999999998 111.766 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 44.4 Cg_endo -71.28 147.56 53.52 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.422 2.081 . . . . 71.129999999999995 111.573 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -113.12 140.27 48.03 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 109.402 -0.592 . . . . 75.200000000000003 109.402 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -92.42 127.57 37.96 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.148 -1.797 . . . . 75.430000000000007 106.148 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 34.6 mm -83.3 109.98 17.66 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 108.692 -0.855 . . . . 75.150000000000006 108.692 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 600' ' ' GLY . 16.2 mmm180 -72.33 99.3 2.39 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 114.39 -1.277 . . . . 74.409999999999997 111.457 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -69.49 -38.46 77.65 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.539 -1.652 . . . . 73.319999999999993 106.539 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 598' ' ' ARG . . . -84.35 111.94 3.54 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 106.576 -2.61 . . . . 71.409999999999997 106.576 169.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 57.6 ttp -66.19 99.46 0.53 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.243 0.831 . . . . 74.409999999999997 113.243 -171.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -164.56 101.95 0.82 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.869 -1.9 . . . . 73.319999999999993 105.869 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -76.56 170.19 54.95 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.962 -0.563 . . . . 75.420000000000002 112.974 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -95.39 119.97 6.36 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 108.809 -1.716 . . . . 42.530000000000001 108.809 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -74.43 91.78 2.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.043 -0.725 . . . . 73.340000000000003 109.043 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 21.2 m -129.68 134.18 47.51 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 106.367 -1.716 . . . . 74.329999999999998 106.367 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.84 85.15 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.684 0.754 . . . . 74.420000000000002 110.452 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 14.0 t -125.16 7.87 7.9 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.673 1.225 . . . . 75.109999999999999 108.05 174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -79.43 -24.85 42.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.629 -1.619 . . . . 75.239999999999995 106.629 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -137.3 140.77 41.76 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 101.775 -3.417 . . . . 74.349999999999994 101.775 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -81.55 99.15 8.66 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.305 -1.358 . . . . 72.409999999999997 112.49 -173.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.75 125.97 35.86 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 104.199 -2.519 . . . . 75.209999999999994 104.199 170.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.17 143.91 55.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.998 -0.681 . . . . 74.219999999999999 110.289 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -53.25 -37.08 61.77 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.807 0.669 . . . . 73.430000000000007 112.807 -174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -107.66 145.04 30.5 Favored Pre-proline 0 C--N 1.316 -0.863 0 C-N-CA 120.0 -0.68 . . . . 72.530000000000001 110.28 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.04 169.21 18.02 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.113 1.875 . . . . 72.200000000000003 110.774 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.55 -26.73 24.36 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.597 0.713 . . . . 75.430000000000007 109.528 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.68 169.01 14.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.992 -1.004 . . . . 74.140000000000001 110.242 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 17.7 m -85.42 26.67 0.89 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.187 0.518 . . . . 71.409999999999997 112.085 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -103.36 81.27 1.91 Allowed 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.64 -0.663 . . . . 74.439999999999998 110.295 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -102.67 108.0 19.1 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.465 -1.309 . . . . 71.230000000000004 107.465 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.33 127.0 29.95 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.994 1.109 . . . . 73.129999999999995 113.994 -170.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.71 -31.2 59.57 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.693 -1.139 . . . . 73.420000000000002 108.034 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.4 -26.7 68.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.426 -1.261 . . . . 65.510000000000005 110.279 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.521 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 2.2 mmm180 -60.71 -43.56 97.66 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 115.879 -0.6 . . . . 71.400000000000006 110.175 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 630' ' ' MET . 29.7 tpt180 -73.19 -35.88 66.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.625 -0.43 . . . . 74.120000000000005 110.198 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 630' ' ' MET . 90.3 mt -63.4 -37.59 79.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.927 -0.397 . . . . 71.239999999999995 109.927 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.63 81.8 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.138 -0.483 . . . . 73.349999999999994 109.976 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 44.1 mt-10 -67.78 -19.22 65.07 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.171 -0.468 . . . . 65.120000000000005 111.345 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 67.9 mtt -68.27 -16.26 63.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.344 0.592 . . . . 75.129999999999995 110.248 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -107.69 23.12 26.88 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.035 -1.226 . . . . 75.049999999999997 110.035 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -133.65 163.67 49.49 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 106.975 -1.491 . . . . 71.310000000000002 106.975 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 64.5 Cg_endo -86.81 126.19 2.47 Favored 'Trans proline' 0 N--CA 1.435 -1.921 0 C-N-CA 120.816 1.011 . . . . 73.409999999999997 110.51 174.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.52 -177.41 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.014 0.435 . . . . 64.040000000000006 111.001 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.27 -174.38 4.15 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.903 -0.777 . . . . 73.030000000000001 108.903 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -81.69 -152.8 10.09 Favored Glycine 0 C--N 1.306 -1.106 0 C-N-CA 120.452 -0.88 . . . . 71.420000000000002 112.272 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -64.85 -42.0 95.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.85 0.833 . . . . 74.409999999999997 109.232 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -167.41 145.34 4.7 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 125.583 1.553 . . . . 73.400000000000006 107.068 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.1 t -153.29 116.53 4.61 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.824 0.821 . . . . 72.209999999999994 110.446 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -146.19 142.93 28.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.714 -1.217 . . . . 73.310000000000002 107.714 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 45.5 tp -121.97 113.01 18.99 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.743 -0.836 . . . . 74.319999999999993 108.743 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.1 mt-10 -92.35 122.86 35.22 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.816 -1.179 . . . . 73.010000000000005 107.816 176.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.12 117.53 55.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 109.243 -0.651 . . . . 72.530000000000001 109.243 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.04 123.42 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.717 0 N-CA-C 108.059 -1.089 . . . . 73.519999999999996 108.059 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . 0.406 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.1 OUTLIER -106.23 115.43 47.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.501 0.667 . . . . 64.430000000000007 110.399 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -161.06 -75.43 0.06 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.499 -1.297 . . . . 75.230000000000004 107.499 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -153.18 161.75 42.08 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.178 -2.156 . . . . 73.209999999999994 105.178 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 50.1 m -78.51 79.4 4.94 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.195 0.998 . . . . 75.040000000000006 110.451 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.55 128.8 39.85 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.386 -2.079 . . . . 74.140000000000001 105.386 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -100.89 104.91 16.13 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 118.354 -1.339 . . . . 73.150000000000006 110.077 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -136.73 124.8 22.91 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.657 -1.156 . . . . 75.310000000000002 108.777 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -106.19 143.24 34.6 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.48 -0.933 . . . . 72.519999999999996 108.48 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 14.2 m -89.61 103.46 16.1 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.595 -1.261 . . . . 72.430000000000007 107.595 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 35.3 m -144.02 106.16 4.37 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.082 -1.081 . . . . 74.519999999999996 108.082 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.14 131.86 70.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.996 -0.547 . . . . 74.530000000000001 110.317 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 C--N 1.299 -1.608 0 CA-C-N 115.605 -0.725 . . . . 64.040000000000006 110.202 178.1 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.4 p80 . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.254 0.549 . . . . 75.430000000000007 109.866 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -111.66 150.83 29.58 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.554 -0.748 . . . . 51.43 110.084 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -90.4 123.53 7.08 Favored Glycine 0 N--CA 1.421 -2.341 0 N-CA-C 111.128 -0.789 . . . . 71.310000000000002 111.128 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -79.27 112.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.28 -1.378 . . . . 75.239999999999995 107.28 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 94.9 m-85 -96.3 134.94 38.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.394 0.434 . . . . 74.510000000000005 110.385 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.4 t -149.2 158.24 44.02 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 124.06 0.85 . . . . 71.409999999999997 108.948 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.502 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 64.4 m-85 -79.85 169.39 17.98 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.374 -0.602 . . . . 74.530000000000001 109.374 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.69 -41.71 59.74 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.43 0.633 . . . . 73.530000000000001 109.643 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.67 161.52 61.33 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.286 -0.87 . . . . 73.140000000000001 108.934 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.03 -12.18 7.2 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.926 1.751 . . . . 75.140000000000001 112.079 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.435 HG23 ' HB2' ' A' ' 642' ' ' GLU . 72.3 t -142.43 138.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.033 -0.729 . . . . 72.099999999999994 109.033 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.2 t -133.7 136.56 44.76 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.121 -0.696 . . . . 74.439999999999998 109.121 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -107.33 114.45 28.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.058 -0.519 . . . . 70.310000000000002 110.193 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 27.5 m -129.16 166.0 27.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.051 -0.522 . . . . 72.209999999999994 109.872 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.458 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.3 t -85.99 162.76 18.35 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.933 0.397 . . . . 72.420000000000002 110.4 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -80.95 -19.87 43.25 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.955 -1.498 . . . . 74.310000000000002 106.955 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.1 m -107.14 25.83 10.9 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.03 -0.986 . . . . 62.310000000000002 111.296 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 515' ' ' SER . 7.7 tt -87.18 -21.38 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 121.433 0.635 . . . . 74.329999999999998 111.419 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.93 -74.58 1.85 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.491 -0.862 . . . . 74.109999999999999 112.221 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.0 mm -134.97 147.12 29.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.647 -1.612 . . . . 74.430000000000007 106.647 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.429 ' HE3' ' CG2' ' A' ' 523' ' ' VAL . 5.2 ppp? -123.29 145.47 48.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.678 -1.23 . . . . 71.329999999999998 107.678 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -111.97 129.01 56.33 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 123.57 0.544 . . . . 71.140000000000001 111.631 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.429 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 45.4 t -122.07 103.95 14.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.415 -0.357 . . . . 71.400000000000006 110.227 174.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.477 ' HB3' HG12 ' A' ' 570' ' ' ILE . 17.9 ptpt -86.69 129.0 35.04 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.613 -0.884 . . . . 72.430000000000007 108.613 172.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.04 133.54 30.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.623 -0.51 . . . . 71.400000000000006 109.623 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 74.6 mt -96.89 149.23 22.11 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.946 -0.57 . . . . 72.239999999999995 110.574 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 504' ' ' ILE 0.285 0.0 OUTLIER -130.69 109.21 10.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.655 0.741 . . . . 72.510000000000005 111.397 171.918 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 14.3 m -65.04 -44.9 87.58 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.35 -1.296 . . . . 75.209999999999994 113.277 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 p -72.96 -39.73 65.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.016 0.436 . . . . 62.5 112.153 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.78 -167.0 26.83 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.685 -1.366 . . . . 73.299999999999997 109.685 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.421 ' HB3' ' HG3' ' A' ' 527' ' ' ARG . . . -162.63 116.31 1.72 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.441 -0.577 . . . . 65.439999999999998 109.441 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -154.95 106.8 2.68 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.634 -1.247 . . . . 75.450000000000003 107.634 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 146.25 -140.5 8.86 Favored Glycine 0 C--N 1.298 -1.538 0 N-CA-C 110.753 -0.939 . . . . 74.409999999999997 110.753 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -136.91 101.03 4.46 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.359 -1.719 . . . . 74.219999999999999 106.359 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.48 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.254 0.55 . . . . 74.329999999999998 110.355 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.0 123.77 55.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.886 -0.783 . . . . 75.400000000000006 108.886 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.43 108.83 60.16 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.715 -0.846 . . . . 72.310000000000002 108.715 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -78.16 146.61 22.77 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 73.420000000000002 111.789 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.56 162.4 35.45 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.565 -1.272 . . . . 72.099999999999994 107.565 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -162.1 145.91 12.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.228 0.537 . . . . 74.450000000000003 111.845 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.6 p -85.82 133.84 33.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.936 -1.029 . . . . 63.219999999999999 111.078 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 43.9 mm -100.55 114.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.988 -1.486 . . . . 75.299999999999997 106.988 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.44 126.5 32.81 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.804 -0.443 . . . . 71.209999999999994 109.804 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -128.68 -94.58 0.79 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.658 -0.782 . . . . 65.409999999999997 111.661 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 18.4 p -92.12 17.61 9.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.379 1.085 . . . . 64.430000000000007 110.554 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -146.92 134.7 21.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.888 -1.523 . . . . 40.340000000000003 106.888 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.52 132.83 46.94 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 109.081 -0.711 . . . . 65.420000000000002 109.081 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -97.69 138.41 13.87 Favored Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 115.836 -0.62 . . . . 72.239999999999995 111.97 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 129.25 11.07 2.87 Favored Glycine 0 C--N 1.294 -1.752 0 C-N-CA 120.894 -0.669 . . . . 60.32 111.93 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . 0.441 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 133.49 -17.42 4.48 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.517 -1.325 . . . . 61.119999999999997 113.671 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.86 -79.48 0.12 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.111 -0.636 . . . . 63.149999999999999 111.407 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.06 -42.75 9.78 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.974 -1.121 . . . . 71.129999999999995 107.974 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -144.53 174.07 11.26 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.149 -0.932 . . . . 72.450000000000003 109.119 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -103.42 120.56 41.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.231 -2.137 . . . . 64.120000000000005 105.231 177.533 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.63 139.22 45.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.55 -0.46 . . . . 74.109999999999999 110.353 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -138.54 128.67 25.59 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.813 0.816 . . . . 72.420000000000002 111.33 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.3 p -145.35 133.37 21.41 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.485 -1.302 . . . . 72.420000000000002 107.485 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.25 -165.19 31.59 Favored Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.016 -1.564 . . . . 54.310000000000002 112.718 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -109.85 116.06 30.97 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.436 0.694 . . . . 74.340000000000003 111.13 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.47 138.08 32.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.546 -0.909 . . . . 74.310000000000002 108.546 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -104.8 102.93 12.47 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.626 0.727 . . . . 74.140000000000001 111.976 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.655 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.4 m-85 -101.49 99.98 10.37 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.231 -1.025 . . . . 74.549999999999997 108.231 174.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.24 -82.59 0.13 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.933 -0.707 . . . . 61.539999999999999 110.813 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -104.83 177.16 4.93 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.765 0.793 . . . . 55.109999999999999 112.127 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.433 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 23.9 t70 -75.33 -16.21 60.43 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.728 -1.123 . . . . 72.109999999999999 112.049 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.38 -19.62 63.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.082 0.771 . . . . 70.239999999999995 113.082 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 45.0 pt -113.14 168.93 5.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.715 -1.217 . . . . 73.450000000000003 107.715 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.32 143.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.444 -0.947 . . . . 72.400000000000006 108.444 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.655 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 71.4 mmtt -98.89 142.53 30.29 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-O 121.253 0.549 . . . . 74.219999999999999 110.73 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 524' ' ' LYS . 14.7 mt -129.25 130.41 67.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.222 -1.354 . . . . 75.5 109.729 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 44.9 mt -90.23 126.7 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.155 -1.424 . . . . 73.329999999999998 107.155 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 20.9 p -112.71 113.5 25.65 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.287 -0.634 . . . . 73.430000000000007 109.287 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.413 HD12 ' SD ' ' A' ' 521' ' ' MET . 71.6 mt -104.1 126.06 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 N-CA-C 108.728 -0.841 . . . . 65.420000000000002 108.728 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.407 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.5 OUTLIER -79.27 108.2 12.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.554 -1.276 . . . . 73.099999999999994 107.554 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.78 127.99 46.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.061 -1.829 . . . . 75.519999999999996 106.061 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . 0.441 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 96.3 m-85 -95.03 141.54 28.56 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.766 -0.774 . . . . 74.430000000000007 110.731 -177.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.74 90.09 2.31 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 106.749 -1.575 . . . . 75.239999999999995 106.749 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.449 ' HG3' ' OE1' ' A' ' 579' ' ' GLU . 5.0 tpm_? -114.49 -64.43 1.32 Allowed 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.791 -1.095 . . . . 72.349999999999994 109.826 -175.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.47 ' OE2' ' HG3' ' A' ' 583' ' ' LYS . 6.5 mm-40 -101.41 163.18 12.4 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.487 -0.779 . . . . 73.109999999999999 109.31 -176.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.27 6.99 0.09 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 123.981 0.801 . . . . 74.5 111.533 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -126.87 82.82 2.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 111.953 0.353 . . . . 73.340000000000003 111.953 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 42.55 56.44 3.81 Favored 'General case' 0 C--O 1.247 0.972 0 O-C-N 124.762 1.289 . . . . 73.150000000000006 112.266 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.571 ' HD2' ' SG ' ' A' ' 585' ' ' CYS . 4.7 tmtp? -104.82 129.07 53.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.422 -1.325 . . . . 75.209999999999994 107.422 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -79.95 79.03 6.53 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.048 0.451 . . . . 73.209999999999994 110.907 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . 0.571 ' SG ' ' HD2' ' A' ' 583' ' ' LYS . 75.2 m -107.52 115.3 29.91 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.937 -0.574 . . . . 75.120000000000005 109.709 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.2 m -147.05 138.28 23.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.454 -0.573 . . . . 74.430000000000007 109.454 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -137.13 163.63 30.37 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.312 -0.995 . . . . 75.209999999999994 108.312 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.6 m -112.94 161.37 17.08 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 119.842 -0.743 . . . . 72.319999999999993 109.828 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 70.0 tp -132.71 126.32 32.26 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.458 -1.682 . . . . 71.140000000000001 106.458 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.22 158.14 28.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 120.861 0.362 . . . . 75.230000000000004 110.739 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.502 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 80.0 mt -106.41 148.04 28.59 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.914 -1.143 . . . . 75.219999999999999 107.914 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.08 177.31 4.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.772 -0.455 . . . . 72.409999999999997 109.772 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.23 122.49 73.21 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 113.077 0.769 . . . . 75.340000000000003 113.077 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.469 ' HD3' HD21 ' A' ' 635' ' ' LEU . 75.2 Cg_endo -75.17 145.85 31.36 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.888 2.392 . . . . 71.209999999999994 111.868 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -116.53 140.62 49.17 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 115.704 -0.68 . . . . 71.549999999999997 109.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -104.98 124.21 49.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.252 -1.018 . . . . 74.340000000000003 108.252 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.2 mp -88.39 103.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.604 -1.258 . . . . 75.120000000000005 107.604 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -68.64 -45.6 71.41 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.912 -1.04 . . . . 72.219999999999999 109.674 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 600' ' ' GLY . 33.3 ttp-105 -177.52 -176.84 0.64 Allowed 'General case' 0 C--O 1.249 1.03 0 N-CA-C 104.116 -2.55 . . . . 75.049999999999997 104.116 -175.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 599' ' ' ARG . . . -68.03 98.51 0.5 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 105.964 -2.855 . . . . 54.119999999999997 105.964 166.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 12.8 tpt -79.79 88.33 5.23 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.05 1.13 . . . . 62.43 114.05 -165.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -101.5 95.74 6.67 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.074 -1.824 . . . . 74.409999999999997 106.074 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 151.15 32.71 0.04 OUTLIER Glycine 0 C--N 1.296 -1.65 0 N-CA-C 110.595 -1.002 . . . . 75.040000000000006 110.595 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -152.92 49.26 0.52 Allowed Glycine 0 CA--C 1.483 -1.945 0 N-CA-C 105.96 -2.856 . . . . 72.430000000000007 105.96 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -59.82 103.71 0.23 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.168 -1.516 . . . . 74.120000000000005 112.82 -170.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 11.2 m -137.23 91.3 2.6 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 105.923 -1.88 . . . . 74.319999999999993 105.923 175.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.55 134.25 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.879 -0.785 . . . . 73.409999999999997 108.879 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 34.3 m 64.1 67.2 0.61 Allowed 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 122.339 1.066 . . . . 75.510000000000005 109.121 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.25 -23.93 19.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.11 -0.95 . . . . 75.030000000000001 111.418 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.68 81.2 5.85 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.893 -1.151 . . . . 71.400000000000006 107.893 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -146.35 107.17 4.12 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 113.912 -1.494 . . . . 65.319999999999993 107.736 -174.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.32 -18.96 43.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.456 -0.793 . . . . 74.540000000000006 111.506 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.76 95.14 3.96 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 107.831 -1.174 . . . . 74.450000000000003 107.831 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -62.3 139.86 58.51 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.69 0.757 . . . . 71.530000000000001 112.355 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -90.58 161.58 36.16 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 114.47 -1.241 . . . . 73.519999999999996 108.973 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.64 137.74 65.72 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.711 1.607 . . . . 74.209999999999994 108.503 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.72 105.16 11.74 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.926 -0.398 . . . . 74.120000000000005 109.926 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 39.0 p -67.23 125.08 24.93 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.173 -0.677 . . . . 70.420000000000002 109.173 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.3 m -77.38 -2.95 37.71 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.923 0.392 . . . . 61.140000000000001 111.946 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 161.14 39.8 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.225 -1.398 . . . . 74.450000000000003 107.225 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 70.87 7.19 6.13 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.755 1.222 . . . . 73.450000000000003 113.291 175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.61 145.89 43.07 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.864 -1.161 . . . . 73.319999999999993 107.864 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -86.25 136.34 33.21 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 106.64 -1.615 . . . . 73.140000000000001 106.64 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -57.46 115.65 2.87 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 122.065 0.936 . . . . 72.450000000000003 112.466 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 10.1 ttm180 -62.91 -35.13 79.04 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.513 -1.676 . . . . 75.219999999999999 111.057 -173.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -62.4 -39.38 93.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.086 0.469 . . . . 74.540000000000006 110.224 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.75 -38.16 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.58 -0.526 . . . . 63.310000000000002 109.58 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.558 ' O ' ' HG2' ' A' ' 632' ' ' ARG . . . -59.84 -41.38 91.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.872 -0.604 . . . . 72.200000000000003 110.461 177.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 44.1 mt-10 -67.49 -37.08 82.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.945 -0.571 . . . . 73.230000000000004 110.768 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 75.4 mtm -66.77 -31.73 72.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.652 0.263 . . . . 72.239999999999995 111.404 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -80.72 -8.61 87.31 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.952 -0.642 . . . . 43.310000000000002 112.703 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 628' ' ' ALA . 39.2 mmt180 -77.19 145.77 73.61 Favored Pre-proline 0 C--N 1.32 -0.704 0 O-C-N 122.617 -0.343 . . . . 74.140000000000001 111.105 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.94 141.28 36.52 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.29 1.993 . . . . 71.239999999999995 110.047 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 36.0 pt -128.01 162.71 33.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.953 -0.388 . . . . 71.239999999999995 109.953 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.469 HD21 ' HD3' ' A' ' 594' ' ' PRO . 2.5 pt? -112.0 -163.13 0.83 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.62 -1.252 . . . . 75.140000000000001 107.62 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.33 143.48 47.26 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.646 -1.382 . . . . 74.239999999999995 109.646 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.92 -39.49 72.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.722 -0.391 . . . . 75.200000000000003 111.558 -173.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -124.55 107.79 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.347 -0.541 . . . . 64.530000000000001 110.497 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 115.42 5.18 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.742 0.782 . . . . 75.019999999999996 109.397 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -147.9 127.9 13.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.664 -0.865 . . . . 74.409999999999997 108.664 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.93 112.34 25.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.645 -0.502 . . . . 73.420000000000002 109.645 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 511' ' ' VAL . 45.0 mt-10 -89.76 113.45 24.98 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.605 0.717 . . . . 63.399999999999999 109.438 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 36.7 t -100.43 115.53 41.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.387 -1.279 . . . . 75.140000000000001 108.439 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 21.2 mt -112.32 126.78 69.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 CA-C-N 114.823 -1.081 . . . . 61.439999999999998 109.169 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 514' ' ' VAL . 0.0 OUTLIER -106.85 112.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.818 -0.628 . . . . 73.120000000000005 112.582 -176.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -176.13 146.89 0.7 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.519 -2.03 . . . . 75.530000000000001 105.519 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -67.04 118.5 10.58 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 119.153 0.888 . . . . 73.219999999999999 111.818 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 9.1 m -86.93 91.05 8.55 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-N 114.723 -1.126 . . . . 65.219999999999999 111.032 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -106.79 -24.66 12.01 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.908 0.861 . . . . 64.310000000000002 109.15 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -84.3 175.36 9.45 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.87 -1.53 . . . . 75.319999999999993 106.87 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 653' ' ' SER . 64.3 t80 -115.92 89.75 3.18 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.596 -0.842 . . . . 74.129999999999995 111.209 -176.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -87.44 83.56 7.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.292 0.568 . . . . 74.420000000000002 109.764 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' SER . . . . . 0.432 ' HB2' ' CE2' ' A' ' 651' ' ' PHE . 50.8 m -154.59 166.12 34.34 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.42 -1.326 . . . . 64.5 107.42 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.0 m -72.31 124.78 25.8 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.737 -0.468 . . . . 74.310000000000002 109.737 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 10.1 p -130.51 147.74 33.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.49 -0.93 . . . . 74.510000000000005 108.49 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 110.116 -0.327 . . . . 65.200000000000003 110.116 -178.438 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 CA--C 1.522 -0.122 0 N-CA-C 108.93 -0.767 . . . . 74.200000000000003 108.93 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -107.24 115.19 29.73 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.208 -1.034 . . . . 73.209999999999994 108.208 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 98.66 88.24 1.93 Allowed Glycine 0 C--N 1.307 -1.053 0 N-CA-C 109.18 -1.568 . . . . 60.229999999999997 109.18 -174.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.488 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.2 mt -127.97 124.26 62.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.609 -0.515 . . . . 74.540000000000006 109.609 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.51 137.3 43.57 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.669 0.606 . . . . 73.150000000000006 110.601 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -149.18 156.28 41.93 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.248 -0.278 . . . . 74.230000000000004 110.248 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.477 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 61.4 m-85 -77.2 168.76 19.52 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.213 -1.032 . . . . 71.040000000000006 108.213 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.49 -46.94 36.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.662 0.744 . . . . 73.230000000000004 109.005 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -122.91 164.6 26.14 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 114.838 -1.074 . . . . 75.209999999999994 109.847 -174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -90.47 -19.53 1.09 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.613 2.209 . . . . 73.420000000000002 112.011 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.2 132.75 38.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.363 -0.977 . . . . 73.040000000000006 108.363 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' THR . . . . . 0.447 HG23 HD23 ' A' ' 641' ' ' LEU . 10.0 t -131.22 127.31 37.62 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.995 -0.743 . . . . 63.119999999999997 108.995 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -99.88 125.11 45.8 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.492 -0.929 . . . . 75.349999999999994 108.492 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.8 m -134.59 162.31 39.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.408 0.623 . . . . 65.25 109.713 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 518' ' ' ILE . 39.3 m -80.9 157.34 25.65 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.71 -0.677 . . . . 72.230000000000004 110.284 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -77.62 -23.66 49.74 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.556 -1.276 . . . . 63.420000000000002 107.556 172.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.0 p -95.73 18.95 12.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.035 -1.439 . . . . 75.310000000000002 111.45 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 515' ' ' SER . 9.0 tt -81.77 -31.73 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.941 -0.704 . . . . 75.109999999999999 111.274 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.09 -75.27 1.59 Allowed Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.413 -0.898 . . . . 72.530000000000001 111.139 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 44.2 mm -126.65 125.67 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.377 -0.972 . . . . 71.519999999999996 108.377 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -97.36 147.22 24.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.357 -0.979 . . . . 73.430000000000007 108.357 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -118.15 115.49 24.91 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.282 0.633 . . . . 72.150000000000006 112.238 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 36.8 t -109.92 124.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.182 -0.463 . . . . 74.420000000000002 110.56 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.33 127.99 41.83 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.795 -0.817 . . . . 72.0 108.795 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.56 118.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 75.019999999999996 109.032 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.7 mt -93.46 148.34 22.16 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.312 -0.858 . . . . 74.219999999999999 109.514 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 102.92 12.28 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.029 -2.582 . . . . 74.319999999999993 104.029 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 10.4 t -66.86 -46.64 74.4 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.844 -0.742 . . . . 71.109999999999999 110.583 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' SER . . . . . 0.488 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 30.1 t -74.4 -45.28 47.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.2 0.524 . . . . 74.430000000000007 110.095 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.57 -168.83 23.72 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 109.802 -1.319 . . . . 63.32 109.802 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -156.08 137.68 14.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.652 -0.87 . . . . 41.340000000000003 108.652 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -155.81 103.85 2.28 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.952 . . . . 71.25 108.431 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 137.76 -131.08 5.32 Favored Glycine 0 C--N 1.308 -0.991 0 N-CA-C 110.826 -0.909 . . . . 73.409999999999997 110.826 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -136.98 102.5 4.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.337 -1.357 . . . . 54.140000000000001 107.337 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 26.5 t -121.56 122.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.885 -0.726 . . . . 72.030000000000001 111.421 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.7 mm -88.17 120.98 37.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.483 -1.302 . . . . 75.150000000000006 107.483 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.4 t -110.42 104.77 56.42 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.062 -0.718 . . . . 64.319999999999993 109.062 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 592' ' ' GLU . 14.8 Cg_endo -85.16 163.28 11.47 Favored 'Trans proline' 0 N--CA 1.419 -2.89 0 C-N-CA 121.475 1.45 . . . . 74.420000000000002 111.375 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.427 ' CZ ' HG21 ' A' ' 571' ' ' ILE . 23.6 p90 -149.91 164.29 35.81 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.046 -1.835 . . . . 73.340000000000003 106.046 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.15 133.01 16.03 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.22 -0.592 . . . . 74.430000000000007 111.089 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 555' ' ' ASP . 17.7 p -82.35 121.15 26.33 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.843 -1.071 . . . . 71.329999999999998 109.719 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.72 116.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.289 -1.374 . . . . 73.319999999999993 107.289 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -72.47 110.05 6.59 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.704 0.628 . . . . 61.439999999999998 110.129 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -98.54 -107.68 2.71 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.809 -0.917 . . . . 63.43 110.809 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.1 p -85.04 -20.59 30.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.571 0.701 . . . . 73.319999999999993 109.901 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.26 134.3 35.6 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.893 -1.151 . . . . 72.230000000000004 107.893 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -92.26 138.42 31.54 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 120.832 0.349 . . . . 73.200000000000003 111.7 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.1 -158.58 20.51 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 111.147 -0.781 . . . . 61.310000000000002 111.147 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.91 17.14 79.29 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.198 -0.761 . . . . 75.519999999999996 111.198 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.16 32.76 60.01 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 111.372 -0.691 . . . . 62.299999999999997 111.372 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.28 -71.23 0.64 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.804 -0.813 . . . . 74.230000000000004 108.804 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.53 -31.01 13.53 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.556 -1.275 . . . . 73.099999999999994 107.556 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.97 150.08 33.35 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 115.276 -0.875 . . . . 74.420000000000002 109.045 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -87.14 105.63 17.32 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 105.929 -1.878 . . . . 74.519999999999996 105.929 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . 0.426 ' HB2' ' OG1' ' A' ' 541' ' ' THR . 7.5 p-10 -76.65 135.29 39.13 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.84 0.828 . . . . 72.200000000000003 111.321 -173.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 3.2 t -133.53 148.98 51.69 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.026 -0.988 . . . . 72.409999999999997 110.548 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.9 p -148.33 111.29 4.84 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.136 0.574 . . . . 74.129999999999995 110.925 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 101.51 -164.02 17.76 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.95 -0.643 . . . . 64.310000000000002 112.28 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 84.51 10.51 0.38 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.513 1.525 . . . . 73.030000000000001 114.024 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 569' ' ' LYS . 32.0 mt -106.4 133.43 51.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 118.977 -1.089 . . . . 71.129999999999995 111.061 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -132.1 114.97 15.17 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.919 -0.771 . . . . 72.310000000000002 108.919 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.3 m-85 -111.09 105.94 14.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.321 -0.992 . . . . 72.340000000000003 108.321 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.432 ' H ' HD12 ' A' ' 567' ' ' ILE . 49.2 mt-30 -83.89 -69.15 0.66 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.322 -0.992 . . . . 71.310000000000002 108.322 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -105.2 160.93 14.7 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.4 -0.818 . . . . 75.530000000000001 109.228 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.38 -22.63 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.077 0.465 . . . . 73.109999999999999 111.959 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.86 -6.94 9.36 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.987 1.106 . . . . 73.340000000000003 113.987 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -115.21 162.61 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.896 -0.779 . . . . 73.340000000000003 108.896 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.7 p -131.18 150.71 34.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.688 -1.227 . . . . 72.25 107.688 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -120.61 155.94 32.7 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.905 -0.405 . . . . 75.129999999999995 109.905 174.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.9 mt -125.34 135.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 124.275 0.984 . . . . 74.430000000000007 109.641 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.3 mt -92.32 120.92 42.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.491 -1.67 . . . . 74.420000000000002 106.491 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 31.2 p -110.52 112.79 24.94 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.615 0.572 . . . . 73.239999999999995 109.718 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 70.4 mt -112.48 128.43 69.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.897 -0.779 . . . . 73.219999999999999 108.897 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -85.07 126.94 34.0 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.588 0.555 . . . . 72.209999999999994 109.526 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.2 142.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.039 -1.097 . . . . 70.129999999999995 108.039 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.14 113.51 19.07 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.196 0.522 . . . . 75.109999999999999 109.787 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -84.29 2.81 38.41 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.779 -0.823 . . . . 75.540000000000006 108.779 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.437 ' HG3' ' HG2' ' A' ' 579' ' ' GLU . 33.8 ptt180 -58.78 -38.36 78.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.643 -0.708 . . . . 73.230000000000004 111.427 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.437 ' HG2' ' HG3' ' A' ' 578' ' ' ARG . 26.2 mm-40 -95.9 -8.6 33.53 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 112.994 0.739 . . . . 61.240000000000002 112.994 -174.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -132.59 149.72 52.27 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 118.437 -1.305 . . . . 74.040000000000006 111.967 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -103.69 -58.71 1.83 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.56 -0.745 . . . . 73.219999999999999 109.079 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -163.28 133.6 4.46 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.366 -0.975 . . . . 73.109999999999999 108.366 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -176.7 156.34 1.42 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.297 -2.112 . . . . 72.230000000000004 105.297 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -82.4 76.46 9.27 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.475 -0.89 . . . . 72.319999999999993 109.518 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 70.2 m -92.82 122.65 35.42 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.527 -0.761 . . . . 62.43 109.617 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 35.2 p -138.34 153.58 48.97 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.289 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.92 161.34 37.82 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.661 -1.237 . . . . 74.340000000000003 107.661 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.0 m -110.81 158.6 18.5 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 119.541 -0.863 . . . . 65.319999999999993 109.511 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 47.0 tp -134.78 121.69 21.07 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.798 -1.186 . . . . 73.450000000000003 107.798 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.73 155.87 26.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 109.584 -0.524 . . . . 71.239999999999995 109.584 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.477 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 82.9 mt -90.96 146.63 23.72 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.137 -1.06 . . . . 71.430000000000007 108.137 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . 0.516 ' HB3' ' HG2' ' A' ' 538' ' ' PRO . 4.7 tp10 -107.12 175.86 5.36 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.78 -1.563 . . . . 75.329999999999998 106.78 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 0.0 OUTLIER -60.82 115.36 13.53 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 113.824 1.046 . . . . 64.219999999999999 113.824 -177.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 42.4 Cg_endo -73.82 141.03 29.82 Favored 'Trans proline' 0 N--CA 1.418 -2.949 0 C-N-CA 121.648 1.566 . . . . 72.109999999999999 110.623 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 129.49 56.39 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.857 -0.611 . . . . 75.219999999999999 110.702 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . 0.486 ' CG ' ' HB3' ' A' ' 599' ' ' ARG . 4.2 t90 -92.37 117.36 29.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 71.099999999999994 108.18 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . 0.414 HG22 ' HG3' ' A' ' 598' ' ' ARG . 2.5 mp -93.84 133.37 35.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 106.949 -1.5 . . . . 71.140000000000001 106.949 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . 0.414 ' HG3' HG22 ' A' ' 597' ' ' ILE . 88.5 mtt180 70.65 55.18 0.27 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.516 -0.92 . . . . 73.049999999999997 108.516 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . 0.486 ' HB3' ' CG ' ' A' ' 596' ' ' TRP . 5.3 ppt_? -103.24 26.51 8.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.867 0.841 . . . . 74.400000000000006 111.651 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 161.76 -38.64 0.39 Allowed Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.598 -1.401 . . . . 73.120000000000005 109.598 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 47.2 ttm -152.9 147.93 26.56 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.463 -0.94 . . . . 63.219999999999999 108.463 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -77.26 100.24 5.78 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.004 -2.221 . . . . 74.540000000000006 105.004 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 140.25 -138.15 8.86 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 108.844 -1.702 . . . . 51.140000000000001 108.844 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 85.85 53.73 2.95 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 108.621 -1.792 . . . . 72.510000000000005 108.621 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -64.06 107.77 1.35 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.41 -0.895 . . . . 74.420000000000002 110.164 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 15.4 m -76.59 135.54 39.21 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.572 -1.194 . . . . 75.540000000000006 108.263 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 33.0 mm -61.25 116.74 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 108.796 -0.816 . . . . 72.120000000000005 108.796 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 38.8 m 69.53 82.36 0.16 Allowed 'General case' 0 N--CA 1.422 -1.872 0 O-C-N 124.273 0.983 . . . . 62.140000000000001 111.863 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 614' ' ' LYS . 8.3 tp10 -118.97 -6.12 10.52 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.189 -1.412 . . . . 74.109999999999999 107.189 172.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -122.52 138.34 54.59 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 103.25 -2.87 . . . . 74.200000000000003 103.25 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 72.5 t80 62.99 27.48 15.93 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 123.552 1.644 . . . . 73.209999999999994 107.555 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . 0.523 ' OD1' ' HG2' ' A' ' 614' ' ' LYS . 16.1 t70 -88.93 146.75 24.72 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 112.913 -1.949 . . . . 74.219999999999999 111.192 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -143.99 39.51 1.35 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.684 -0.858 . . . . 64.530000000000001 108.684 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.523 ' HG2' ' OD1' ' A' ' 612' ' ' ASP . 21.9 pttm -81.59 68.79 8.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 123.294 1.521 . . . . 73.310000000000002 110.502 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . 0.466 ' HB3' ' HD3' ' A' ' 616' ' ' PRO . 35.9 tt0 -77.0 -49.73 2.4 Favored Pre-proline 0 N--CA 1.419 -2.013 0 CA-C-N 112.883 -1.962 . . . . 73.409999999999997 110.501 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 615' ' ' GLN . 1.1 Cg_endo -85.6 135.72 5.14 Favored 'Trans proline' 0 N--CA 1.42 -2.845 0 CA-C-N 120.255 1.127 . . . . 74.140000000000001 110.191 174.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . 0.457 ' O ' ' HG2' ' A' ' 626' ' ' ARG . 2.0 mm? -89.24 -20.12 24.54 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.998 -1.482 . . . . 75.040000000000006 106.998 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 19.1 m -90.84 78.33 6.1 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 107.038 -1.468 . . . . 70.400000000000006 107.038 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 14.8 m -60.61 133.1 55.77 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.899 -1.046 . . . . 71.200000000000003 109.024 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -72.19 -23.05 61.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.037 0.446 . . . . 75.200000000000003 109.844 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.36 145.55 28.98 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.427 -1.694 . . . . 73.019999999999996 106.427 171.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.98 89.11 2.39 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.343 1.068 . . . . 62.240000000000002 109.226 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -111.64 127.53 55.78 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.868 -1.514 . . . . 74.109999999999999 109.118 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -9.49 52.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.658 0.783 . . . . 74.519999999999996 112.995 -175.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -51.77 -40.27 60.04 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 123.489 0.493 . . . . 73.030000000000001 110.017 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.652 ' O ' ' HG3' ' A' ' 630' ' ' MET . 73.9 mtm180 -56.24 -51.68 67.23 Favored 'General case' 0 C--O 1.198 -1.641 0 CA-C-N 115.111 -0.949 . . . . 75.420000000000002 110.671 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.24 -32.39 57.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.237 0.541 . . . . 72.230000000000004 110.816 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.18 62.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.097 -0.502 . . . . 53.240000000000002 109.668 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -77.14 -8.38 57.41 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.771 0.656 . . . . 73.239999999999995 112.771 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.652 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 64.4 mtt -71.73 -27.69 63.16 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.234 -0.654 . . . . 73.349999999999994 109.234 170.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -117.7 73.9 0.29 Allowed Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.338 -0.846 . . . . 74.120000000000005 111.165 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.525 ' HG3' ' O ' ' A' ' 633' ' ' PRO . 11.2 ptm180 -148.72 -175.39 0.47 Allowed Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 105.045 -2.206 . . . . 73.540000000000006 105.045 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.525 ' O ' ' HG3' ' A' ' 632' ' ' ARG . 50.3 Cg_exo -59.67 126.49 20.71 Favored 'Trans proline' 0 C--N 1.358 1.031 0 N-CA-C 107.164 -1.899 . . . . 75.420000000000002 107.164 167.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 33.8 pt -127.88 -177.37 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-O 121.207 0.527 . . . . 63.049999999999997 111.125 -172.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -101.15 175.13 5.7 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.093 -1.077 . . . . 73.219999999999999 108.093 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.45 179.44 29.43 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 121.009 -0.615 . . . . 75.219999999999999 112.478 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.5 -60.91 2.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.74 -0.837 . . . . 73.0 108.74 178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -136.46 114.71 11.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.895 -1.52 . . . . 74.129999999999995 106.895 175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.7 t -134.19 109.25 8.76 Favored 'General case' 0 N--CA 1.41 -2.433 0 C-N-CA 119.178 -1.009 . . . . 72.329999999999998 109.979 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -149.35 137.63 20.74 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.45 -1.25 . . . . 75.019999999999996 108.13 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . 0.447 HD23 HG23 ' A' ' 512' ' ' THR . 9.3 mt -104.07 116.65 32.61 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.384 -0.599 . . . . 70.319999999999993 109.384 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.29 113.74 26.08 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.441 -1.689 . . . . 72.310000000000002 106.441 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.4 117.82 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 114.435 -1.257 . . . . 71.5 109.143 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -105.01 127.99 59.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.926 -1.033 . . . . 73.439999999999998 108.406 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.96 90.04 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.61 0.719 . . . . 75.409999999999997 110.323 177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 647' ' ' GLU . 6.7 tp10 -171.81 95.27 0.16 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.525 -1.216 . . . . 63.420000000000002 110.085 -176.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 646' ' ' GLU . 5.3 tp10 171.04 94.71 0.0 OUTLIER 'General case' 0 C--O 1.242 0.705 0 O-C-N 124.141 0.901 . . . . 74.319999999999993 111.441 174.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 49.5 m -92.97 108.82 20.3 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.691 -1.596 . . . . 73.209999999999994 106.691 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -143.08 169.46 17.55 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.626 -0.509 . . . . 75.239999999999995 109.626 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -127.94 120.67 28.13 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-O 121.716 0.769 . . . . 64.439999999999998 109.786 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -118.14 115.33 24.59 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 105.99 -1.856 . . . . 75.230000000000004 105.99 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 652' ' ' LYS . 0.0 OUTLIER -82.41 86.45 6.73 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.63 0.728 . . . . 71.400000000000006 110.26 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 5.1 p -70.28 128.39 36.07 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.966 -1.015 . . . . 74.150000000000006 109.324 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 88.4 m -68.34 110.1 3.94 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.612 -0.722 . . . . 75.239999999999995 111.078 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.54 163.33 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.133 -0.94 . . . . 75.329999999999998 108.647 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 C--N 1.301 -1.54 0 N-CA-C 109.127 -0.694 . . . . 50.140000000000001 109.127 178.414 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.446 ' CD2' ' HE ' ' A' ' 532' ' ' ARG . 15.9 p-80 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 120.808 0.337 . . . . 72.0 110.299 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.32 76.82 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.121 -0.945 . . . . 74.219999999999999 110.428 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 105.88 115.88 4.11 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.328 -0.939 . . . . 74.230000000000004 113.12 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.11 114.1 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 105.367 -2.086 . . . . 71.230000000000004 105.367 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.549 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 85.8 m-85 -100.83 138.28 38.08 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 123.571 0.544 . . . . 74.420000000000002 111.103 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 3.8 t -148.27 152.85 37.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.967 -0.56 . . . . 64.25 110.385 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.441 ' CE2' ' HG ' ' A' ' 591' ' ' LEU . 82.3 m-85 -71.68 158.95 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.798 -0.816 . . . . 73.319999999999993 108.798 171.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.0 -47.54 84.32 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.769 0.668 . . . . 75.430000000000007 110.638 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.5 153.9 79.4 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 107.913 -1.143 . . . . 61.399999999999999 107.913 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.39 -18.76 8.19 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.06 1.84 . . . . 73.349999999999994 112.747 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 642' ' ' GLU . 68.7 t -138.82 136.45 43.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.183 -1.043 . . . . 74.319999999999993 108.183 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.1 t -133.51 128.97 36.47 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.42 0.629 . . . . 71.129999999999995 109.607 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -97.96 117.43 32.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.985 -0.746 . . . . 74.010000000000005 108.985 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.54 174.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 121.421 0.629 . . . . 74.329999999999998 109.777 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.446 ' O ' HG21 ' A' ' 518' ' ' ILE . 5.2 m -98.63 150.99 21.18 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.615 -0.72 . . . . 74.319999999999993 110.052 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -66.78 -27.87 67.93 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.383 -0.969 . . . . 73.439999999999998 108.383 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.1 m -103.04 20.82 16.87 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 114.568 -1.196 . . . . 74.140000000000001 111.801 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.446 HG21 ' O ' ' A' ' 515' ' ' SER . 10.6 tt -78.31 -28.09 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 121.446 -0.784 . . . . 74.049999999999997 112.678 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.41 -75.04 1.9 Allowed Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.332 -0.937 . . . . 74.120000000000005 111.483 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.8 mm -133.61 144.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 107.672 -1.233 . . . . 61.32 107.672 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.401 ' SD ' HD12 ' A' ' 573' ' ' ILE . 18.4 ptm -117.96 128.5 54.86 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.254 -0.647 . . . . 74.040000000000006 109.254 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -100.38 120.31 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.838 0.711 . . . . 73.200000000000003 110.512 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 59.1 t -126.55 131.74 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.306 -0.627 . . . . 74.219999999999999 109.306 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -95.62 149.97 20.87 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.817 0.818 . . . . 74.120000000000005 111.938 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.52 113.06 42.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 106.984 -1.487 . . . . 73.239999999999995 106.984 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.5 mt -90.17 160.31 16.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.295 -0.866 . . . . 72.430000000000007 110.147 -174.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 104.3 9.14 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.224 -1.028 . . . . 74.299999999999997 108.224 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.5 m -65.85 -52.67 48.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.669 0.747 . . . . 75.200000000000003 109.776 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 30.6 t -73.52 -52.25 14.2 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.932 . . . . 71.230000000000004 111.26 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.77 -156.78 26.8 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 109.681 -1.368 . . . . 72.430000000000007 109.681 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.1 137.07 3.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.957 -0.756 . . . . 75.340000000000003 108.957 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.446 ' HE ' ' CD2' ' A' ' 501' ' ' HIS . 28.2 mtm180 -148.66 148.45 30.09 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 123.427 0.691 . . . . 75.420000000000002 109.186 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 85.7 -124.47 6.85 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.84 -0.695 . . . . 73.099999999999994 111.865 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -137.38 104.36 5.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.927 -0.768 . . . . 74.310000000000002 108.927 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.54 125.81 74.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.521 0.677 . . . . 72.420000000000002 110.856 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 30.7 mm -96.51 119.54 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.69 -0.687 . . . . 74.030000000000001 109.262 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 50.1 t -106.89 103.11 45.99 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.249 -1.019 . . . . 54.210000000000001 108.249 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.71 147.37 27.72 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.798 1.666 . . . . 73.239999999999995 111.743 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.405 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 52.0 p90 -138.17 158.22 44.74 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.021 -1.103 . . . . 74.439999999999998 108.021 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -154.34 135.5 13.96 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.111 0.482 . . . . 72.209999999999994 110.818 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.54 131.24 36.72 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.976 -1.011 . . . . 71.25 110.481 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 46.3 mm -100.44 120.31 49.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.61 104.81 5.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.682 -0.69 . . . . 74.340000000000003 109.32 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -88.72 -122.1 1.94 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.528 -1.029 . . . . 72.439999999999998 110.528 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -6.61 58.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.923 0.868 . . . . 73.019999999999996 108.926 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.75 27.8 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.567 -1.197 . . . . 65.109999999999999 108.794 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.418 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 38.9 mmt180 -79.47 147.85 32.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.628 -1.249 . . . . 74.219999999999999 107.628 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -109.54 148.49 17.17 Favored Glycine 0 C--N 1.263 -3.498 0 CA-C-N 115.267 -0.879 . . . . 65.319999999999993 114.085 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 88.59 48.02 4.09 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.542 -0.837 . . . . 51.310000000000002 113.657 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.86 43.85 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.706 -1.235 . . . . 73.530000000000001 113.996 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 37.8 mm-40 -96.29 -84.39 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.631 0.715 . . . . 71.129999999999995 110.342 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.6 -44.37 21.15 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.772 -1.566 . . . . 73.010000000000005 106.772 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -136.39 157.58 46.45 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.421 -1.263 . . . . 71.549999999999997 108.83 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -92.24 142.05 27.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.079 -1.822 . . . . 61.5 106.079 175.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.86 100.78 11.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 75.25 110.713 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -111.29 104.47 12.95 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-O 122.582 1.182 . . . . 75.340000000000003 109.129 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.7 p -126.72 140.02 52.71 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.959 -1.497 . . . . 54.109999999999999 106.959 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 177.51 -151.32 10.8 Favored Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.487 -1.816 . . . . 73.519999999999996 113.261 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.18 125.94 41.97 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.222 1.009 . . . . 55.439999999999998 112.033 -171.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.405 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 86.1 mt -100.92 135.54 42.21 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.63 -0.878 . . . . 73.099999999999994 108.63 173.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.84 109.36 21.06 Favored 'General case' 0 C--N 1.276 -2.603 0 CA-C-O 121.185 0.517 . . . . 74.019999999999996 111.011 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 51.3 m-85 -105.27 101.79 11.31 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.172 -1.047 . . . . 74.450000000000003 108.172 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -80.2 -79.18 0.15 Allowed 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.649 -0.82 . . . . 73.120000000000005 110.754 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -104.8 158.14 16.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.649 -0.82 . . . . 73.329999999999998 108.953 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.13 -11.55 9.27 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.897 1.279 . . . . 74.439999999999998 113.269 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.92 -11.03 54.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.648 0.779 . . . . 64.129999999999995 111.966 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 35.3 pt -119.07 158.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.48 0.657 . . . . 75.109999999999999 110.674 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.77 143.38 41.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.087 -1.82 . . . . 64.409999999999997 106.087 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 27.1 mttm -111.14 155.99 22.05 Favored 'General case' 0 CA--C 1.469 -2.156 0 C-N-CA 119.393 -0.923 . . . . 75.219999999999999 112.973 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 72.3 mt -124.45 136.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.245 -1.343 . . . . 73.25 109.773 -175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 59.1 mt -98.06 129.03 48.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.816 -1.55 . . . . 74.209999999999994 106.816 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.9 p -118.28 112.56 20.24 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.295 0.569 . . . . 71.219999999999999 110.777 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.435 HD13 HD22 ' A' ' 589' ' ' LEU . 49.4 mt -106.4 135.47 44.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.812 -0.631 . . . . 75.25 109.969 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 70.9 mtt180 -80.06 112.01 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.198 -0.667 . . . . 73.209999999999994 109.198 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.83 131.09 49.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.337 -0.847 . . . . 71.299999999999997 108.735 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -113.85 154.8 26.84 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.57 -0.53 . . . . 73.329999999999998 109.57 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.94 13.96 17.08 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.818 -0.628 . . . . 65.219999999999999 110.889 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -98.99 99.84 10.93 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.714 -0.675 . . . . 74.409999999999997 110.81 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -110.86 146.68 36.05 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.994 -1.484 . . . . 72.430000000000007 106.994 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -73.18 -38.41 66.16 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.162 1.171 . . . . 74.439999999999998 114.162 -168.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.22 -96.91 0.46 Allowed 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.584 -0.846 . . . . 74.519999999999996 110.643 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -164.91 81.65 0.37 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.655 -1.609 . . . . 72.420000000000002 106.655 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -132.85 148.93 52.3 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.573 -1.194 . . . . 75.25 108.893 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.57 75.72 8.51 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.039 -1.837 . . . . 74.430000000000007 106.039 167.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 9.1 t -62.91 141.4 58.71 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 111.829 -2.441 . . . . 74.400000000000006 112.57 -168.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 44.8 p -142.82 147.74 35.94 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.261 0.553 . . . . 74.239999999999995 111.81 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -136.86 -179.88 5.97 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.028 -1.471 . . . . 73.200000000000003 107.028 173.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 22.0 m -130.85 168.43 17.28 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.342 -0.943 . . . . 75.030000000000001 110.631 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.435 HD22 HD13 ' A' ' 573' ' ' ILE . 46.6 tp -142.12 132.72 25.38 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.977 -1.49 . . . . 73.519999999999996 106.977 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.75 159.27 41.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 120.54 0.21 . . . . 62.100000000000001 110.608 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.441 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 65.5 mt -101.65 147.65 26.18 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 106.17 -1.789 . . . . 73.319999999999993 106.17 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.33 177.62 4.8 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.225 -0.657 . . . . 73.120000000000005 109.225 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -61.49 118.49 37.83 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 123.411 0.445 . . . . 74.150000000000006 109.819 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.437 ' HD3' HD21 ' A' ' 635' ' ' LEU . 66.1 Cg_endo -71.99 156.57 56.0 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.451 2.101 . . . . 74.230000000000004 111.333 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -129.55 124.13 33.11 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.044 -0.526 . . . . 75.319999999999993 110.824 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . 0.455 ' HB2' ' HG3' ' A' ' 633' ' ' PRO . 3.1 t90 -90.0 120.87 31.57 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.32 -1.363 . . . . 74.340000000000003 107.32 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.19 94.93 3.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 107.763 -1.199 . . . . 74.340000000000003 107.763 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -88.33 113.37 23.87 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.748 -1.115 . . . . 75.030000000000001 110.271 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -79.35 -25.02 42.34 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.832 -1.173 . . . . 74.319999999999993 107.832 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -138.24 124.25 2.88 Favored Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 108.65 -1.78 . . . . 74.340000000000003 108.65 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -154.05 179.36 9.0 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 117.108 0.454 . . . . 74.340000000000003 110.922 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -64.18 123.6 19.5 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 123.892 0.745 . . . . 74.109999999999999 110.426 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -135.47 146.62 18.63 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.193 -1.163 . . . . 74.340000000000003 110.193 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 87.55 36.25 8.81 Favored Glycine 0 C--N 1.302 -1.345 0 N-CA-C 111.233 -0.747 . . . . 75.329999999999998 111.233 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -134.14 141.81 47.24 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.16 -0.681 . . . . 74.129999999999995 109.16 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 8.4 m -78.59 100.12 6.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.879 -1.156 . . . . 72.409999999999997 107.879 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 37.9 mm -83.1 -41.13 16.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.032 -0.729 . . . . 72.200000000000003 109.032 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 52.7 m -113.64 97.62 6.54 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 109.477 -0.564 . . . . 73.040000000000006 109.477 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -9.69 45.15 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.852 -0.613 . . . . 73.329999999999998 111.321 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -63.16 135.44 57.15 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 116.183 -0.462 . . . . 71.209999999999994 109.856 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -79.65 -36.6 37.53 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 123.226 0.61 . . . . 71.239999999999995 112.32 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 16.0 t70 56.34 86.12 0.07 Allowed 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.236 0.96 . . . . 72.010000000000005 110.018 -176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -138.28 -48.95 0.54 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.426 -0.807 . . . . 75.540000000000006 110.818 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 615' ' ' GLN . 0.0 OUTLIER -80.99 44.13 0.74 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 124.325 1.05 . . . . 73.420000000000002 110.138 -176.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 614' ' ' LYS . 2.0 mp0 72.51 167.67 0.12 Allowed Pre-proline 0 C--O 1.243 0.724 0 C-N-CA 124.245 1.018 . . . . 73.239999999999995 109.053 -171.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.47 132.32 51.46 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 121.386 1.391 . . . . 72.420000000000002 110.928 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -83.56 118.55 23.88 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.086 -0.961 . . . . 74.209999999999994 111.337 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 72.0 m -60.58 103.65 0.27 Allowed 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.733 -1.21 . . . . 70.140000000000001 107.733 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 15.3 m -85.56 88.37 7.51 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-O 121.746 0.784 . . . . 73.120000000000005 111.524 -171.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -92.97 75.11 4.78 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 122.658 1.218 . . . . 74.319999999999993 109.942 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -153.09 98.64 2.31 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.67 -1.604 . . . . 75.439999999999998 108.309 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.82 -21.42 18.12 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.429 -0.35 . . . . 75.310000000000002 111.156 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -73.91 -54.81 7.12 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.477 -0.329 . . . . 72.540000000000006 111.697 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -63.25 -33.72 76.12 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 119.723 -0.791 . . . . 72.439999999999998 110.645 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 71.7 ttt180 -59.06 -49.55 77.47 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 123.842 0.714 . . . . 74.409999999999997 110.249 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.521 ' O ' ' HG3' ' A' ' 630' ' ' MET . 0.3 OUTLIER -57.17 -43.84 82.97 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.278 0.361 . . . . 70.109999999999999 110.694 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.3 -44.44 91.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.446 -0.343 . . . . 74.239999999999995 110.76 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -62.41 -35.85 80.51 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.356 0.598 . . . . 63.299999999999997 110.572 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 71.8 mt-10 -73.2 -22.99 60.34 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 115.948 -0.569 . . . . 73.239999999999995 110.898 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.521 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 76.3 mtm -79.76 0.12 32.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.326 0.584 . . . . 75.319999999999993 111.146 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.21 15.91 32.78 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.001 -0.84 . . . . 63.020000000000003 111.001 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -146.58 167.66 13.33 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 106.488 -1.671 . . . . 73.329999999999998 106.488 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.455 ' HG3' ' HB2' ' A' ' 596' ' ' TRP . 61.5 Cg_endo -70.82 135.34 27.7 Favored 'Trans proline' 0 C--O 1.262 1.678 0 C-N-CA 121.194 1.263 . . . . 65.299999999999997 110.295 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.1 -176.6 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 115.431 -0.804 . . . . 75.540000000000006 109.255 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.549 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 1.9 pt? -133.55 179.02 6.48 Favored 'General case' 0 C--N 1.268 -2.966 0 C-N-CA 120.141 -0.624 . . . . 74.239999999999995 109.415 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.94 142.13 42.85 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.846 -1.302 . . . . 73.209999999999994 109.846 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -48.5 -51.05 29.15 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.141 0.977 . . . . 74.140000000000001 111.401 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -126.63 89.77 3.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.112 -0.699 . . . . 70.420000000000002 109.112 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' THR . . . . . 0.4 ' CG2' HD13 ' A' ' 635' ' ' LEU . 15.4 t -119.34 111.02 17.65 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.482 1.135 . . . . 75.120000000000005 109.477 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -145.06 147.44 32.58 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.81 -1.552 . . . . 75.099999999999994 106.81 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 33.6 tp -117.21 107.02 13.94 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.125 -1.065 . . . . 74.420000000000002 108.125 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.432 ' HB2' HG21 ' A' ' 511' ' ' VAL . 35.9 mt-10 -86.99 111.28 20.7 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.308 -0.997 . . . . 71.019999999999996 108.308 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.8 118.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.614 -1.176 . . . . 62.420000000000002 109.284 -174.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 17.3 mt -117.74 119.34 61.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.852 . . . . 72.209999999999994 110.166 -176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.4 110.45 24.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 109.221 -0.659 . . . . 74.319999999999993 109.221 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -132.22 95.23 3.61 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.642 -0.708 . . . . 74.129999999999995 110.759 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 55.55 -163.53 0.14 Allowed 'General case' 0 C--O 1.253 1.238 0 C-N-CA 124.807 1.243 . . . . 72.310000000000002 112.721 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 24.7 m -90.85 98.05 11.54 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.82 -0.807 . . . . 74.439999999999998 108.82 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.429 ' HB3' ' HG ' ' A' ' 515' ' ' SER . 31.4 t80 -96.71 127.91 43.15 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.34 -0.985 . . . . 71.519999999999996 108.34 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -103.68 152.43 21.81 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 120.538 -0.465 . . . . 73.400000000000006 111.06 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 47.6 t80 66.49 88.21 0.11 Allowed 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.935 1.294 . . . . 75.129999999999995 112.979 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 91.12 2.92 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.237 -0.892 . . . . 74.140000000000001 108.753 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 32.6 t -73.03 129.57 38.38 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.638 -1.164 . . . . 54.43 110.977 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.3 m -96.67 114.35 25.99 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.689 -1.597 . . . . 74.209999999999994 106.689 176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 33.3 m -101.61 145.87 10.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.895 0.379 . . . . 72.420000000000002 110.57 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 109.714 -0.476 . . . . 74.140000000000001 109.714 178.655 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 . . . . . 0 CA--C 1.512 -0.512 0 CA-C-O 121.216 0.531 . . . . 71.209999999999994 110.004 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -64.09 -64.67 0.83 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.173 -0.921 . . . . 63.25 109.929 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -125.2 102.5 0.68 Allowed Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 108.532 -1.827 . . . . 75.239999999999995 108.532 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 57.1 mt -98.75 115.19 38.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.485 -0.561 . . . . 74.450000000000003 109.485 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.44 ' CE1' ' HG3' ' A' ' 527' ' ' ARG . 86.8 m-85 -103.24 139.86 38.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.034 -0.53 . . . . 74.329999999999998 111.456 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.11 154.09 39.72 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.677 -0.49 . . . . 73.25 109.677 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.647 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 58.1 m-85 -75.67 160.36 30.15 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.681 -0.489 . . . . 74.439999999999998 109.681 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.61 -49.48 75.05 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.523 0.514 . . . . 73.109999999999999 110.197 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.87 166.44 27.43 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 116.286 -0.415 . . . . 73.530000000000001 111.168 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 4.7 Cg_exo -83.67 -30.9 0.67 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.501 2.134 . . . . 75.019999999999996 111.729 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 70.3 t -143.35 130.66 18.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.3 t -134.13 131.13 38.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.794 -0.817 . . . . 75.219999999999999 108.794 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -106.36 112.43 25.44 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.133 -0.692 . . . . 74.150000000000006 109.133 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 30.6 m -112.87 157.87 13.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.988 0.899 . . . . 74.219999999999999 111.523 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 68.0 m -81.79 174.02 11.72 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.5 -1.227 . . . . 73.349999999999994 110.498 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.03 -30.86 17.47 Favored 'General case' 0 CA--C 1.509 -0.596 0 O-C-N 121.741 -0.6 . . . . 71.439999999999998 110.031 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.4 m -80.23 5.89 13.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.474 -0.784 . . . . 73.340000000000003 110.798 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 4.9 tt -75.69 -28.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.159 0.505 . . . . 74.340000000000003 110.137 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 82.94 -71.61 2.98 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.785 -0.722 . . . . 55.210000000000001 113.199 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 44.6 mm -132.04 126.28 56.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.622 -0.881 . . . . 72.519999999999996 108.622 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.414 ' SD ' HD13 ' A' ' 573' ' ' ILE . 5.2 ppp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.178 -0.675 . . . . 74.049999999999997 109.178 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.61 131.69 56.86 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.27 0.628 . . . . 72.239999999999995 111.384 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 38.6 t -127.5 115.25 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 109.199 -0.667 . . . . 75.219999999999999 109.199 171.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -90.19 127.35 36.1 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.229 -0.588 . . . . 73.25 110.115 174.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.37 114.58 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.608 -0.886 . . . . 74.319999999999993 108.608 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 51.7 mt -93.14 143.89 25.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.051 -0.977 . . . . 75.120000000000005 110.53 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.44 ' HG3' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -105.54 104.77 14.56 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.394 -1.706 . . . . 75.019999999999996 106.394 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.8 t -66.91 -48.17 69.5 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.943 -0.703 . . . . 72.430000000000007 111.443 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.4 p -74.34 -52.44 12.2 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.495 0.664 . . . . 55.310000000000002 111.479 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 147.96 -170.15 28.64 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 109.53 -1.428 . . . . 72.010000000000005 109.53 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.19 129.24 2.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.61 -0.885 . . . . 64.109999999999999 108.61 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -153.21 81.68 1.19 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.162 0.506 . . . . 74.219999999999999 109.986 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 167.77 -129.43 1.9 Allowed Glycine 0 C--N 1.303 -1.297 0 N-CA-C 109.505 -1.438 . . . . 71.439999999999998 109.505 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -137.32 112.54 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.288 -1.375 . . . . 72.439999999999998 107.288 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.61 130.42 74.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 120.926 0.393 . . . . 71.140000000000001 110.724 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 39.2 mm -100.09 113.5 35.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.633 -0.877 . . . . 74.319999999999993 108.633 177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.03 102.77 44.78 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.494 -0.928 . . . . 74.519999999999996 108.494 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -80.63 161.56 21.87 Favored 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 121.719 1.612 . . . . 73.109999999999999 110.949 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -151.12 163.61 38.42 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.676 -0.861 . . . . 71.219999999999999 108.676 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . 0.417 ' HE2' ' OE2' ' A' ' 592' ' ' GLU . 61.8 pttt -148.99 137.92 21.36 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 112.679 0.622 . . . . 72.140000000000001 112.679 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 22.0 p -87.2 117.55 26.03 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 109.944 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 35.9 mm -92.18 124.54 44.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.248 -1.019 . . . . 75.430000000000007 108.248 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.41 119.33 18.46 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.325 -0.62 . . . . 73.230000000000004 109.325 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -97.96 -107.67 2.63 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.742 -1.343 . . . . 74.129999999999995 109.742 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -86.98 -25.9 24.07 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.643 0.735 . . . . 73.510000000000005 109.035 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.02 149.45 30.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.009 -0.996 . . . . 71.219999999999999 109.034 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -104.55 146.27 29.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.481 0.657 . . . . 75.5 110.833 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.55 -155.43 30.66 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 114.357 -1.292 . . . . 65.129999999999995 112.354 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.19 6.36 53.03 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 114.128 0.411 . . . . 75.409999999999997 114.128 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.78 -0.72 34.06 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.164 -1.017 . . . . 73.25 113.249 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -69.62 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.078 0.439 . . . . 65.140000000000001 110.846 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -99.76 -35.78 9.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.349 -0.611 . . . . 64.329999999999998 109.349 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.56 165.11 30.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.742 -0.663 . . . . 74.219999999999999 109.453 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.558 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.9 tm-20 -100.81 122.99 44.35 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.023 -1.473 . . . . 75.109999999999999 107.023 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.09 136.18 57.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 123.162 0.585 . . . . 73.439999999999998 111.4 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.3 t -140.56 105.78 5.03 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.043 0.925 . . . . 74.219999999999999 109.437 174.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 46.9 m -129.57 94.89 3.86 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 106.734 -1.58 . . . . 70.5 106.734 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -136.24 -156.93 7.63 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.378 -0.828 . . . . 44.240000000000002 111.449 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.46 138.98 47.8 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.224 0.535 . . . . 75.310000000000002 110.963 -177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 73.1 mt -105.5 141.26 37.3 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.201 -0.909 . . . . 71.219999999999999 108.775 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.565 ' HG2' ' NE2' ' A' ' 563' ' ' GLN . 32.9 tt0 -112.92 105.51 13.6 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.409 0.623 . . . . 74.310000000000002 110.398 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 55.3 m-85 -98.15 133.34 42.72 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.574 -0.739 . . . . 75.150000000000006 109.057 177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.565 ' NE2' ' HG2' ' A' ' 561' ' ' GLU . 2.1 mp0 -98.2 -85.38 0.37 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.33 1.062 . . . . 73.0 108.224 174.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 566' ' ' GLU . 0.3 OUTLIER -105.46 161.82 14.0 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.26 -1.336 . . . . 63.439999999999998 110.597 175.04 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.73 -13.35 31.66 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.708 1.203 . . . . 71.030000000000001 113.162 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.46 ' HB3' ' ND2' ' A' ' 564' ' ' ASN . 32.4 tt0 -56.34 -37.05 69.48 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.021 0.929 . . . . 74.450000000000003 111.277 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.21 162.4 6.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.289 -0.869 . . . . 72.120000000000005 109.665 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.426 HG22 ' NH1' ' A' ' 527' ' ' ARG . 14.8 p -131.1 160.1 42.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.386 -1.339 . . . . 74.209999999999994 107.386 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -117.49 150.96 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.547 0.213 . . . . 74.230000000000004 110.499 176.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 65.8 mt -125.25 131.71 72.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 124.366 1.041 . . . . 75.040000000000006 108.922 -177.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.436 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.0 mt -90.6 120.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.242 -1.392 . . . . 73.040000000000006 107.242 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -105.24 112.75 25.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.606 0.566 . . . . 74.319999999999993 109.725 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.469 HD11 HD21 ' A' ' 589' ' ' LEU . 51.1 mt -107.3 132.19 55.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.831 -1.174 . . . . 73.109999999999999 107.831 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -81.34 116.05 21.0 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.086 -0.646 . . . . 74.129999999999995 109.939 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.57 124.37 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.201 -1.037 . . . . 74.510000000000005 108.201 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 58.3 m-85 -108.47 154.88 21.27 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.755 -0.461 . . . . 73.530000000000001 109.755 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.14 136.1 35.2 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 104.147 -2.538 . . . . 75.209999999999994 104.147 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.46 ' HD3' ' N ' ' A' ' 578' ' ' ARG . 0.0 OUTLIER -112.35 -97.19 0.43 Allowed 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 113.631 0.975 . . . . 73.230000000000004 113.631 -170.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -120.93 121.35 37.87 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 107.094 -1.447 . . . . 74.109999999999999 107.094 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -56.71 130.71 46.63 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 123.996 0.81 . . . . 74.120000000000005 109.848 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 65.14 81.61 0.2 Allowed 'General case' 0 C--O 1.244 0.801 0 CA-C-O 122.473 1.13 . . . . 74.540000000000006 108.44 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -95.29 161.71 13.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 113.544 -1.662 . . . . 73.230000000000004 112.924 -167.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -58.65 -62.42 1.87 Allowed 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 125.45 1.5 . . . . 73.109999999999999 112.544 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 155.9 92.02 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 102.948 -2.982 . . . . 72.420000000000002 102.948 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . 0.41 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.2 m -91.53 115.87 28.4 Favored 'General case' 0 C--N 1.279 -2.491 0 C-N-CA 119.78 -0.768 . . . . 72.329999999999998 110.9 -172.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 10.5 m -140.08 142.25 36.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.979 -0.749 . . . . 61.100000000000001 108.979 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 50.0 p90 -141.17 165.5 27.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.211 -1.403 . . . . 74.319999999999993 107.211 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 12.1 m -116.64 164.48 14.54 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.614 -0.835 . . . . 75.310000000000002 109.847 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.469 HD21 HD11 ' A' ' 573' ' ' ILE . 49.3 tp -135.56 130.71 34.96 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.073 -1.454 . . . . 74.420000000000002 107.073 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.4 156.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.787 -0.449 . . . . 74.140000000000001 109.787 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.647 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 70.9 mt -97.05 139.16 33.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.595 -0.891 . . . . 73.340000000000003 108.595 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . 0.417 ' OE2' ' HE2' ' A' ' 540' ' ' LYS . 30.6 mm-40 -94.1 167.26 11.69 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.432 -0.951 . . . . 65.109999999999999 108.432 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.27 116.25 16.82 Favored Pre-proline 0 C--N 1.317 -0.831 0 O-C-N 123.916 0.76 . . . . 63.210000000000001 110.281 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.66 145.32 20.39 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 C-N-CA 122.407 2.071 . . . . 75.230000000000004 110.859 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -118.72 143.92 46.57 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.666 -0.494 . . . . 71.349999999999994 109.666 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . 0.451 ' HB2' ' HD3' ' A' ' 633' ' ' PRO . 1.9 t90 -104.07 123.09 46.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.617 -0.883 . . . . 73.319999999999993 108.617 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.86 89.17 2.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 106.637 -1.616 . . . . 73.340000000000003 106.637 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -99.05 103.76 15.72 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 113.638 -1.619 . . . . 75.239999999999995 108.738 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -92.7 -75.05 0.5 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.852 -1.067 . . . . 73.340000000000003 109.298 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 62.74 -120.07 20.03 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 111.423 -0.671 . . . . 72.209999999999994 111.423 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 55.4 ttp -105.64 -7.15 18.68 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.615 -0.513 . . . . 61.219999999999999 109.615 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -86.68 121.73 29.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.472 0.653 . . . . 73.519999999999996 112.501 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -126.22 -118.24 2.21 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 107.795 -2.122 . . . . 63.350000000000001 107.795 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 55.62 59.15 11.02 Favored Glycine 0 CA--C 1.504 -0.617 0 O-C-N 124.12 0.541 . . . . 64.420000000000002 112.426 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -79.46 81.67 5.69 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.713 0.768 . . . . 75.239999999999995 111.458 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 15.1 m -99.77 96.78 7.83 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 106.111 -1.811 . . . . 74.450000000000003 106.111 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 31.8 mm -83.32 70.08 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 122.754 1.264 . . . . 62.439999999999998 109.268 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 27.7 m -129.68 -6.71 4.6 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 113.786 -1.552 . . . . 71.209999999999994 108.582 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -31.54 51.77 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.901 -1.045 . . . . 64.040000000000006 108.4 174.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.6 117.61 20.69 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 105.477 -2.046 . . . . 73.230000000000004 105.477 171.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -60.21 128.19 35.53 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.956 0.902 . . . . 72.430000000000007 113.194 -176.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.23 -36.62 13.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.59 -0.732 . . . . 65.200000000000003 109.422 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.16 -28.17 38.86 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.373 -0.603 . . . . 72.319999999999993 109.373 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 59.64 22.46 11.19 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.089 1.144 . . . . 73.329999999999998 114.089 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -122.27 82.58 45.57 Favored Pre-proline 0 N--CA 1.432 -1.33 0 CA-C-O 121.574 0.702 . . . . 73.430000000000007 109.738 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.76 150.52 68.3 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.689 2.259 . . . . 74.120000000000005 112.638 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.83 -177.58 3.26 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.599 -1.63 . . . . 72.010000000000005 106.599 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 1.2 p -68.75 92.37 0.48 Allowed 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.783 0.802 . . . . 73.409999999999997 109.335 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 50.4 m -155.08 166.17 34.42 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.669 -1.151 . . . . 74.530000000000001 108.111 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . 0.505 ' HB2' ' HZ2' ' A' ' 620' ' ' LYS . 5.0 ttmp? -101.19 137.56 39.37 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.489 -0.93 . . . . 73.219999999999999 108.489 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.62 103.7 10.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.692 0.758 . . . . 74.239999999999995 110.677 176.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -84.96 76.92 10.21 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.965 0.888 . . . . 71.239999999999995 109.036 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 625' ' ' ARG . 13.5 pt-20 -88.43 143.26 27.1 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.048 -1.433 . . . . 71.540000000000006 108.386 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.17 -8.64 58.5 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 116.248 -0.433 . . . . 75.439999999999998 110.255 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.4 ' HB3' ' OE1' ' A' ' 623' ' ' GLU . 1.2 tmm_? -61.03 -36.85 80.64 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.731 -0.668 . . . . 72.329999999999998 110.071 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.611 ' O ' ' HG3' ' A' ' 630' ' ' MET . 31.0 mmt180 -67.03 -36.76 82.81 Favored 'General case' 0 C--O 1.208 -1.102 0 N-CA-C 109.354 -0.61 . . . . 75.150000000000006 109.354 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.468 ' HA ' ' SD ' ' A' ' 630' ' ' MET . 67.4 mt -67.61 -38.29 80.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.664 -0.698 . . . . 73.530000000000001 109.128 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -62.44 -32.58 73.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.408 -0.815 . . . . 74.109999999999999 109.768 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.09 -14.71 53.16 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 112.309 0.485 . . . . 73.420000000000002 112.309 177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.611 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 65.6 mtt -73.11 -25.88 61.02 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.554 -0.906 . . . . 74.140000000000001 108.554 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -135.21 70.96 0.5 Allowed Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 110.082 -1.207 . . . . 62.109999999999999 110.082 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.72 149.31 52.86 Favored Pre-proline 0 N--CA 1.431 -1.414 0 CA-C-O 120.454 0.169 . . . . 73.019999999999996 111.23 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 596' ' ' TRP . 33.7 Cg_endo -70.64 145.34 51.77 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.344 2.029 . . . . 72.010000000000005 109.616 176.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 34.5 pt -134.18 -177.82 2.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.088 0.47 . . . . 71.299999999999997 110.334 -174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.29 167.99 10.07 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.848 -0.797 . . . . 75.519999999999996 108.848 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.77 -178.2 21.11 Favored Glycine 0 C--O 1.249 1.06 0 O-C-N 123.465 0.478 . . . . 74.450000000000003 112.585 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -46.98 -61.96 1.63 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.04 0.936 . . . . 74.540000000000006 110.408 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -141.11 104.82 4.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.063 -1.458 . . . . 75.030000000000001 107.063 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.5 t -121.05 109.07 14.6 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 118.659 -1.217 . . . . 73.400000000000006 110.438 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.814 -1.18 . . . . 73.329999999999998 107.814 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 510' ' ' PRO . 62.4 tp -119.79 113.48 20.67 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 123.443 0.464 . . . . 73.25 111.074 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.22 128.65 34.7 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 74.239999999999995 108.07 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.65 111.89 38.09 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 107.234 -1.395 . . . . 73.310000000000002 107.234 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . 0.441 HG22 ' HG3' ' A' ' 646' ' ' GLU . 4.7 mp -105.82 134.44 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 CA-C-N 114.711 -1.132 . . . . 74.239999999999995 108.251 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 514' ' ' VAL . 0.0 OUTLIER -116.91 114.78 46.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 109.484 -0.561 . . . . 75.019999999999996 109.484 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . 0.441 ' HG3' HG22 ' A' ' 644' ' ' ILE . 44.0 mt-10 -135.22 123.95 23.8 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.818 -0.628 . . . . 74.239999999999995 110.787 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.98 157.12 23.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 105.862 -1.903 . . . . 73.219999999999999 105.862 167.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 46.5 m 70.12 28.64 3.98 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.049 -1.093 . . . . 72.510000000000005 108.049 -170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -145.36 139.17 26.8 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.47 -1.241 . . . . 71.420000000000002 107.746 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . 0.436 ' OE2' HG23 ' A' ' 654' ' ' THR . 5.7 mm-40 -110.86 126.28 54.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.185 0.809 . . . . 74.310000000000002 113.185 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -81.68 -45.17 16.11 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.23 -1.396 . . . . 72.510000000000005 107.23 174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -139.67 112.17 7.78 Favored 'General case' 0 N--CA 1.399 -2.987 0 N-CA-C 106.356 -1.72 . . . . 75.310000000000002 106.356 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 33.8 m -52.0 115.32 1.64 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.877 1.066 . . . . 74.129999999999995 113.877 -175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.436 HG23 ' OE2' ' A' ' 650' ' ' GLU . 8.8 t -82.79 -18.64 39.88 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.745 -0.835 . . . . 73.140000000000001 108.745 171.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 64.5 t -120.97 98.75 6.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.194 -1.41 . . . . 75.349999999999994 107.194 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 C--N 1.3 -1.564 0 CA-C-N 116.013 -0.539 . . . . 73.120000000000005 110.761 -177.084 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 C--O 1.24 0.571 0 N-CA-C 110.78 -0.081 . . . . 73.150000000000006 110.78 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . 73.86 -48.31 0.66 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.092 1.757 . . . . 73.150000000000006 112.936 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -148.68 87.4 0.15 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.47 -0.652 . . . . 73.030000000000001 111.47 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 635' ' ' LEU . 55.8 mt -86.39 114.33 25.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 110.129 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -112.49 146.11 39.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.48 -0.933 . . . . 72.120000000000005 108.48 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.8 t -148.26 163.54 36.71 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.639 0.587 . . . . 73.120000000000005 109.775 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.647 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 69.2 m-85 -83.96 153.89 23.65 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 123.232 0.613 . . . . 75.219999999999999 110.396 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 49.3 mt-10 -60.35 -41.83 94.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.989 0.423 . . . . 73.319999999999993 110.457 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . 0.448 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.2 mt-10 -132.65 151.91 78.98 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.494 -0.928 . . . . 72.109999999999999 108.494 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.53 -20.94 1.96 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.125 1.883 . . . . 75.439999999999998 111.137 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 52.8 t -146.05 125.67 5.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 124.945 1.298 . . . . 72.430000000000007 107.534 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -133.65 141.03 47.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.33 0.586 . . . . 75.219999999999999 110.064 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -107.93 127.36 53.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.641 -0.708 . . . . 74.049999999999997 109.198 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.8 m -126.08 158.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.06 0.457 . . . . 71.540000000000006 110.92 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.0 m -73.43 157.76 36.25 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.599 -0.728 . . . . 75.430000000000007 109.702 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -29.17 39.84 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.465 0.65 . . . . 71.409999999999997 109.991 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -97.81 18.7 15.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.48 -0.782 . . . . 54.299999999999997 111.086 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.78 -29.85 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 75.299999999999997 111.617 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.15 -72.49 2.83 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.621 -0.799 . . . . 75.25 111.886 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.0 mm -127.42 123.54 61.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.999 -0.741 . . . . 73.230000000000004 108.999 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.444 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.8 ptm -101.18 131.35 47.2 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.627 -0.879 . . . . 65.120000000000005 108.627 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.58 118.46 33.13 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 123.714 0.634 . . . . 75.299999999999997 110.848 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.61 114.64 45.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.384 -1.339 . . . . 75.310000000000002 107.384 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 29.0 mtmm -94.06 133.56 37.4 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 119.912 -0.715 . . . . 73.030000000000001 110.486 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.53 109.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.995 -1.113 . . . . 72.129999999999995 107.995 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.7 mt -89.09 122.51 32.48 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.256 -0.884 . . . . 70.540000000000006 110.037 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 103.2 15.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 118.673 -1.211 . . . . 74.219999999999999 108.3 174.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.0 p -67.77 -54.32 20.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.513 -0.767 . . . . 73.209999999999994 111.1 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' SER . . . . . 0.416 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 23.1 t -72.94 -50.41 23.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.071 -0.968 . . . . 74.530000000000001 110.211 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . 0.445 ' HA2' ' OD1' ' A' ' 565' ' ' ASP . . . 149.61 -179.91 25.99 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.776 -1.202 . . . . 75.239999999999995 112.458 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.61 27.98 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 107.086 -1.45 . . . . 73.209999999999994 107.086 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -149.32 127.75 12.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.562 -0.455 . . . . 74.540000000000006 110.164 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.89 -115.64 4.71 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.886 -0.886 . . . . 64.230000000000004 110.886 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -138.1 109.98 7.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.714 -1.217 . . . . 73.150000000000006 107.714 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.09 123.5 66.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.131 0.491 . . . . 73.340000000000003 109.896 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 48.6 mm -96.17 120.59 45.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.245 -0.65 . . . . 71.409999999999997 109.245 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.79 104.36 51.08 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 72.319999999999993 107.993 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.01 143.29 17.9 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.948 1.765 . . . . 70.209999999999994 111.309 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -130.43 163.74 26.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.333 -0.988 . . . . 74.439999999999998 108.333 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -159.29 132.81 7.24 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.276 0.36 . . . . 72.209999999999994 110.847 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 20.7 p -79.75 136.12 36.68 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.884 -0.598 . . . . 71.319999999999993 110.368 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.55 117.29 46.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.444 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 40.4 mt-10 -74.88 104.62 5.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.586 -0.524 . . . . 72.049999999999997 109.586 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.63 -102.57 1.21 Allowed Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.838 -1.305 . . . . 72.200000000000003 109.838 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 13.2 t -100.83 4.82 43.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.271 0.558 . . . . 71.120000000000005 110.067 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -105.35 149.45 26.06 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.344 -1.354 . . . . 74.400000000000006 107.344 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.444 ' HD2' ' OE1' ' A' ' 543' ' ' GLU . 29.7 tpt180 -107.12 134.07 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.808 0.337 . . . . 71.230000000000004 110.977 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.01 -151.76 9.5 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.741 -0.663 . . . . 74.239999999999995 111.626 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 75.17 -33.76 1.09 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 122.461 -0.434 . . . . 73.310000000000002 114.066 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 144.35 5.76 0.58 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.091 -0.576 . . . . 62.130000000000003 112.55 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.479 ' HB3' ' NH1' ' A' ' 578' ' ' ARG . 56.0 mm-40 -75.13 -79.17 0.1 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.868 0.365 . . . . 73.420000000000002 111.88 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -89.78 -41.19 12.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.829 -1.174 . . . . 75.109999999999999 107.829 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -149.33 169.48 20.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.452 -1.249 . . . . 74.150000000000006 108.717 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.06 119.03 37.13 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.803 -2.295 . . . . 70.319999999999993 104.803 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.39 105.28 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.967 0.889 . . . . 71.219999999999999 110.555 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.9 t -101.91 127.15 48.88 Favored 'General case' 0 N--CA 1.412 -2.354 0 CA-C-N 115.1 -0.955 . . . . 73.420000000000002 111.155 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -140.55 97.82 3.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.607 -1.179 . . . . 74.209999999999994 108.353 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -132.34 179.31 17.33 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 115.485 -0.78 . . . . 62.100000000000001 111.737 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.3 mt-10 -111.07 114.84 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.224 -0.658 . . . . 74.329999999999998 109.224 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.06 138.19 31.63 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 110.117 -0.327 . . . . 75.310000000000002 110.117 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -105.98 106.28 16.71 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.459 0.647 . . . . 63.25 111.485 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 36.6 m-85 -96.43 147.6 23.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.036 -1.468 . . . . 74.140000000000001 107.036 172.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -124.96 -79.06 0.61 Allowed 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 108.862 -0.792 . . . . 73.510000000000005 108.862 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' A' ' 566' ' ' GLU . 24.5 t-20 -104.03 156.04 18.18 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.149 -0.686 . . . . 64.200000000000003 109.149 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . 0.445 ' OD1' ' HA2' ' A' ' 530' ' ' GLY . 12.0 t70 -56.1 -25.9 47.52 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.162 1.385 . . . . 64.319999999999993 113.193 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.402 ' HG2' ' OD1' ' A' ' 564' ' ' ASN . 11.3 pt-20 -68.47 -18.52 64.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.139 0.792 . . . . 74.109999999999999 113.139 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.2 pt -106.37 167.5 3.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 119.843 -0.743 . . . . 73.319999999999993 110.935 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.99 159.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.818 -1.179 . . . . 75.230000000000004 107.818 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 122.208 -0.307 . . . . 71.439999999999998 110.26 175.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.422 HG12 ' HG2' ' A' ' 524' ' ' LYS . 18.7 mt -122.2 134.89 64.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 123.825 0.703 . . . . 73.25 110.259 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 55.2 mt -91.26 122.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.368 -1.345 . . . . 75.5 107.368 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 9.4 p -106.7 112.86 26.03 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 123.866 0.729 . . . . 74.019999999999996 109.269 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.445 HD11 HD22 ' A' ' 589' ' ' LEU . 38.2 mt -110.76 125.63 68.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.232 -0.655 . . . . 74.450000000000003 109.232 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -79.59 110.59 15.07 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.136 0.898 . . . . 75.329999999999998 109.765 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.4 135.05 36.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.917 -1.512 . . . . 74.030000000000001 106.917 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -116.53 131.46 56.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.818 -0.438 . . . . 74.319999999999993 109.818 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -85.86 86.53 7.36 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 122.836 1.303 . . . . 74.310000000000002 111.271 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.479 ' NH1' ' HB3' ' A' ' 551' ' ' GLU . 28.5 ttp180 -101.05 155.24 18.1 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.883 -1.525 . . . . 75.120000000000005 106.883 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -80.05 157.17 26.81 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.087 -1.079 . . . . 70.319999999999993 108.087 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -148.26 168.63 22.02 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 120.375 -0.53 . . . . 74.510000000000005 110.451 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -125.12 101.32 6.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.625 -0.261 . . . . 72.439999999999998 111.471 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 65.19 17.14 10.91 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.83 1.789 . . . . 62.299999999999997 115.83 170.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.8 110.56 19.24 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.4 -0.812 . . . . 65.430000000000007 111.647 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.46 87.17 3.81 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.709 -1.96 . . . . 72.5 105.709 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.99 138.78 39.01 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.501 -1.227 . . . . 63.420000000000002 113.181 -172.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 34.7 p -143.32 154.75 44.09 Favored 'General case' 0 N--CA 1.405 -2.704 0 CA-C-N 114.633 -1.167 . . . . 65.400000000000006 108.967 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -138.53 161.61 36.62 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 74.129999999999995 106.844 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.1 t -113.73 175.69 5.35 Favored 'General case' 0 C--N 1.27 -2.887 0 C-N-CA 119.147 -1.021 . . . . 72.040000000000006 109.108 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.445 HD22 HD11 ' A' ' 573' ' ' ILE . 33.5 tp -149.9 126.69 11.06 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.016 -1.475 . . . . 75.420000000000002 107.016 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.13 157.34 31.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.716 -0.476 . . . . 71.219999999999999 109.716 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.647 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 40.2 mt -101.79 142.97 32.29 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.337 -1.727 . . . . 74.120000000000005 106.337 174.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.86 173.59 6.79 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.869 -0.789 . . . . 71.299999999999997 108.869 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.67 115.46 18.75 Favored Pre-proline 0 C--N 1.316 -0.88 0 O-C-N 123.733 0.646 . . . . 72.319999999999993 110.739 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.535 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 32.6 Cg_endo -65.38 153.96 75.81 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.761 2.307 . . . . 74.129999999999995 113.399 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -119.62 134.91 55.03 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.783 -1.099 . . . . 73.030000000000001 109.64 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -99.34 125.07 44.93 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.098 -0.705 . . . . 74.099999999999994 109.098 -175.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.09 89.87 2.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 105.225 -2.139 . . . . 71.310000000000002 105.225 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -86.97 -13.2 45.27 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.195 -1.366 . . . . 74.409999999999997 110.077 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -89.37 120.61 30.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.674 -0.862 . . . . 75.129999999999995 108.674 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -70.73 -46.88 43.7 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.649 -0.58 . . . . 74.310000000000002 111.649 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 23.0 ptp -101.25 163.64 12.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.26 -0.644 . . . . 75.120000000000005 109.26 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -140.61 100.94 3.98 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.847 -0.797 . . . . 74.510000000000005 108.847 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -147.02 60.39 0.47 Allowed Glycine 0 C--N 1.286 -2.245 0 N-CA-C 108.558 -1.817 . . . . 73.109999999999999 108.558 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -122.65 -120.31 2.61 Favored Glycine 0 N--CA 1.421 -2.311 0 CA-C-N 114.839 -0.68 . . . . 71.349999999999994 111.97 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -122.8 14.72 10.07 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.848 0.684 . . . . 75.510000000000005 112.848 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 18.9 m -137.9 124.87 21.33 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.811 -0.755 . . . . 74.519999999999996 110.879 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 44.9 mm -85.05 147.56 5.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.435 -1.321 . . . . 75.340000000000003 107.435 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 31.7 m -56.11 -28.03 56.22 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.837 0.855 . . . . 64.030000000000001 113.26 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . 0.25 0.2 OUTLIER -86.48 -7.31 58.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.521 -0.872 . . . . 73.430000000000007 113.324 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.23 178.94 7.69 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.171 -0.678 . . . . 73.329999999999998 109.171 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -55.56 108.54 0.44 Allowed 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 122.205 1.002 . . . . 74.25 112.346 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.43 -54.07 4.25 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.708 -1.133 . . . . 72.340000000000003 108.839 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -126.66 106.47 9.42 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.121 -0.945 . . . . 75.099999999999994 110.816 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.505 ' HZ3' ' HB3' ' A' ' 614' ' ' LYS . 9.1 mtpm? -91.27 96.3 10.48 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.54 -0.464 . . . . 75.420000000000002 110.066 177.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -68.2 127.37 93.28 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.272 -0.64 . . . . 75.109999999999999 109.272 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -91.39 -179.38 1.37 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.136 1.89 . . . . 73.019999999999996 111.808 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.26 -40.06 10.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.708 -1.219 . . . . 74.239999999999995 107.708 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 19.2 m -125.15 122.87 38.35 Favored 'General case' 0 N--CA 1.406 -2.646 0 CA-C-N 114.92 -1.036 . . . . 73.310000000000002 109.434 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 18.6 t -82.37 -15.68 51.87 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.474 -0.936 . . . . 62.409999999999997 108.474 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . 0.5 ' HB3' ' HZ2' ' A' ' 620' ' ' LYS . 3.8 mmmp? -69.82 79.61 0.45 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.848 0.832 . . . . 72.299999999999997 110.192 174.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 625' ' ' ARG . 37.3 tt0 -127.6 70.91 1.33 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.194 -1.41 . . . . 53.409999999999997 107.194 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 59.56 22.09 10.69 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.218 -1.356 . . . . 74.519999999999996 111.055 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 626' ' ' ARG . 0.7 OUTLIER 58.33 11.92 1.79 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.22 1.408 . . . . 71.120000000000005 113.61 -174.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -74.31 -30.22 61.96 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.559 -0.904 . . . . 72.299999999999997 108.559 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' A' ' 621' ' ' GLU . 0.0 OUTLIER -71.55 -30.3 65.73 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.083 -1.08 . . . . 75.140000000000001 108.083 176.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 623' ' ' GLU . 65.7 ttt180 -65.43 -38.91 91.28 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 109.033 -0.729 . . . . 75.120000000000005 109.033 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 73.8 mt -68.36 -35.78 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.071 0.463 . . . . 75.430000000000007 109.771 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.3 96.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.472 -0.331 . . . . 73.430000000000007 110.391 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -74.91 -19.52 60.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.016 0.436 . . . . 72.129999999999995 111.91 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 46.7 ttm -75.5 -28.23 59.09 Favored 'General case' 0 N--CA 1.406 -2.633 0 C-N-CA 123.907 0.883 . . . . 73.329999999999998 108.694 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -82.63 -0.93 90.42 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.22 -0.9 . . . . 74.349999999999994 111.088 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -96.05 140.04 22.08 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.833 -1.543 . . . . 74.329999999999998 106.833 174.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.535 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 36.8 Cg_endo -68.62 138.05 40.62 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 N-CA-C 106.691 -2.08 . . . . 64.099999999999994 106.691 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . 0.274 2.6 pp -124.89 144.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 C-N-CA 117.314 -1.755 . . . . 74.409999999999997 112.006 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 504' ' ' ILE . 2.2 pt? -76.35 -165.22 0.47 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.255 -2.248 . . . . 73.329999999999998 111.873 -174.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.23 136.25 37.21 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 109.46 -1.456 . . . . 73.310000000000002 109.46 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.56 -42.32 70.85 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.469 0.708 . . . . 74.340000000000003 111.848 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -131.37 84.86 2.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 110.864 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.9 t -119.71 114.71 22.59 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 107.872 -1.158 . . . . 61.229999999999997 107.872 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -147.59 140.24 24.73 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.777 -0.823 . . . . 70.530000000000001 108.777 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 509' ' ' GLU . 60.0 tp -117.59 123.14 45.48 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 123.347 0.404 . . . . 72.239999999999995 109.913 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.78 124.94 43.98 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.941 -1.503 . . . . 74.230000000000004 106.941 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.22 120.22 60.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.464 -0.939 . . . . 73.540000000000006 108.464 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.87 124.18 63.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-N 115.618 -0.719 . . . . 63.210000000000001 109.262 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.51 92.16 2.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 122.213 1.006 . . . . 74.219999999999999 111.125 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -163.11 159.67 23.39 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.279 -2.119 . . . . 75.340000000000003 105.279 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -73.84 97.43 2.76 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.358 -0.608 . . . . 75.040000000000006 109.358 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 19.4 t -88.47 98.81 11.84 Favored 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 105.611 -1.996 . . . . 74.409999999999997 105.611 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -108.59 153.43 23.39 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.131 -0.94 . . . . 75.120000000000005 110.547 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -106.48 116.71 32.4 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.96 -1.867 . . . . 75.340000000000003 105.96 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -75.73 -24.4 56.13 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.027 -0.669 . . . . 74.120000000000005 109.27 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 134.38 46.16 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.126 0.488 . . . . 73.239999999999995 110.517 176.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 23.1 t -81.99 113.33 19.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.749 -1.204 . . . . 62.210000000000001 107.749 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 16.3 m -82.45 131.13 35.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.897 -0.779 . . . . 74.140000000000001 108.897 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 28.8 t -80.48 84.28 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 122.186 0.993 . . . . 74.439999999999998 109.162 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 C--N 1.289 -2.032 0 CA-C-N 113.985 -1.461 . . . . 74.510000000000005 109.269 -179.1 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 . . . . . 0 C--O 1.234 0.283 0 CA-C-O 120.832 0.349 . . . . 71.230000000000004 110.648 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -89.6 -26.07 20.99 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.489 -0.93 . . . . 54.119999999999997 108.489 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.0 144.41 8.57 Favored Glycine 0 N--CA 1.42 -2.393 0 CA-C-N 114.445 -1.252 . . . . 65.5 114.638 174.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 57.1 mt -128.28 113.94 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 104.72 -2.326 . . . . 72.239999999999995 104.72 167.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.528 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 76.1 m-85 -107.49 132.35 53.32 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.645 -0.502 . . . . 75.540000000000006 109.645 -176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 8.8 t -148.03 152.76 37.96 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.534 0.521 . . . . 54.119999999999997 110.036 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.496 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 90.1 m-85 -74.43 154.5 38.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.909 -0.404 . . . . 74.450000000000003 109.909 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -52.78 -49.92 64.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.819 0.848 . . . . 72.439999999999998 111.147 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -135.32 161.53 62.76 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 107.753 -1.203 . . . . 64.219999999999999 107.753 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 68.4 Cg_endo -82.4 -17.61 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 121.673 1.582 . . . . 64.519999999999996 112.029 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.426 HG23 ' HB2' ' A' ' 642' ' ' GLU . 77.9 t -143.07 127.11 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 123.306 0.642 . . . . 75.049999999999997 109.966 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 643' ' ' VAL . 12.0 t -135.11 141.5 46.03 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.474 -0.935 . . . . 73.430000000000007 108.474 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 648' ' ' SER . 14.2 p-80 -111.14 142.45 43.31 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.301 -1.74 . . . . 74.049999999999997 106.301 172.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.19 154.81 29.02 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 CA-C-O 121.327 0.584 . . . . 75.230000000000004 111.462 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 518' ' ' ILE . 20.5 m -73.92 137.46 43.65 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.891 -1.049 . . . . 73.030000000000001 109.482 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.58 1.58 13.99 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.799 0.809 . . . . 74.140000000000001 112.886 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.5 p -125.53 18.75 8.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.32 -0.855 . . . . 75.530000000000001 110.902 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 515' ' ' SER . 8.2 tt -80.76 -23.76 11.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-O 121.376 0.608 . . . . 72.409999999999997 110.479 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.51 -76.26 2.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.721 -0.951 . . . . 72.230000000000004 110.721 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 47.9 mm -125.41 128.58 72.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.724 -0.843 . . . . 72.030000000000001 108.724 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.471 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.3 ptm -98.48 141.61 31.12 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.673 -0.492 . . . . 75.230000000000004 109.673 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -102.39 128.81 48.83 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 123.792 0.682 . . . . 74.430000000000007 109.917 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 44.0 t -124.92 124.53 67.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.459 -0.941 . . . . 72.150000000000006 108.459 174.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -93.87 132.34 38.4 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.006 -0.678 . . . . 75.450000000000003 110.768 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 84.3 t -95.98 111.76 26.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.581 -1.637 . . . . 72.219999999999999 106.581 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.43 143.42 26.62 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.547 -0.751 . . . . 72.239999999999995 110.39 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.0 104.65 14.14 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.844 -0.617 . . . . 75.310000000000002 111.767 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 504' ' ' ILE . 22.9 m -64.78 -61.64 2.06 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.953 -0.567 . . . . 73.430000000000007 112.086 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.1 p -73.76 -52.54 12.84 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.107 0.41 . . . . 74.230000000000004 112.107 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 158.02 -145.77 12.31 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.943 -0.863 . . . . 72.409999999999997 110.943 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -178.66 130.8 0.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.211 1.404 . . . . 73.209999999999994 107.467 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -150.59 91.44 1.74 Allowed 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.537 -0.865 . . . . 75.109999999999999 111.879 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 145.51 -116.97 0.95 Allowed Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 110.183 -1.167 . . . . 75.450000000000003 110.183 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.82 104.49 5.3 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.137 -1.06 . . . . 71.420000000000002 108.137 172.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 595' ' ' LYS . 39.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.331 -0.548 . . . . 71.340000000000003 111.381 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.6 mm -98.99 115.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.423 -0.808 . . . . 73.120000000000005 109.139 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.78 100.24 30.15 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 108.523 -0.917 . . . . 75.150000000000006 108.523 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.65 146.54 27.09 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 121.924 1.75 . . . . 74.519999999999996 111.186 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.457 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 25.1 p90 -136.68 157.33 47.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.239 -0.652 . . . . 70.239999999999995 109.239 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -147.6 135.04 20.76 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.835 0.35 . . . . 75.310000000000002 111.019 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.4 p -82.72 123.03 28.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.777 -0.647 . . . . 74.140000000000001 111.184 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 41.0 mm -92.16 118.22 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.959 -1.126 . . . . 75.319999999999993 107.959 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.69 143.99 34.09 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.266 -0.642 . . . . 75.310000000000002 109.266 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.72 -110.18 0.83 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 109.076 -1.609 . . . . 62.409999999999997 109.076 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 16.6 p -78.64 -25.21 44.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.586 -0.894 . . . . 74.549999999999997 108.586 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -90.2 131.9 35.78 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.43 -1.322 . . . . 73.340000000000003 107.43 172.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 43.1 ttp180 -104.72 140.96 37.3 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.121 -0.696 . . . . 74.219999999999999 109.121 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.75 -157.4 31.59 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 121.166 -0.54 . . . . 72.340000000000003 112.639 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.09 19.94 74.35 Favored Glycine 0 C--N 1.31 -0.871 0 C-N-CA 121.619 -0.324 . . . . 64.109999999999999 112.932 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.03 19.21 40.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.33 -0.938 . . . . 60.43 112.646 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 11.0 tp10 -86.0 -79.51 0.25 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 110.0 -0.37 . . . . 75.319999999999993 110.0 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.493 ' OD1' ' HD2' ' A' ' 578' ' ' ARG . 14.1 m-20 -94.9 -30.29 14.24 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.701 -1.222 . . . . 64.430000000000007 107.701 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.32 155.79 43.41 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.396 -1.274 . . . . 72.329999999999998 107.952 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -88.46 139.98 29.93 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 105.412 -2.07 . . . . 75.209999999999994 105.412 177.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -77.33 121.72 24.13 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.167 -0.308 . . . . 64.430000000000007 110.167 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -127.33 104.43 7.93 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 122.474 1.131 . . . . 72.349999999999994 110.46 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -125.96 102.27 7.18 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.725 -1.954 . . . . 63.350000000000001 105.725 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -133.36 -174.75 13.67 Favored Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.39 -0.91 . . . . 63.009999999999998 112.248 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.11 122.46 40.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.313 0.577 . . . . 73.409999999999997 110.669 -177.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 83.8 mt -96.58 136.92 36.42 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.882 -0.414 . . . . 71.310000000000002 109.882 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.01 102.53 11.25 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.709 0.766 . . . . 63.539999999999999 111.392 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 60.0 m-85 -99.58 96.8 7.89 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 106.971 -1.492 . . . . 74.099999999999994 106.971 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -75.18 -67.11 0.68 Allowed 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.233 -0.987 . . . . 75.120000000000005 109.829 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -105.94 161.65 14.27 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.222 -0.658 . . . . 65.310000000000002 109.222 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.55 -11.82 60.45 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.208 1.003 . . . . 73.129999999999995 113.527 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -68.09 -7.99 34.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.61 0.967 . . . . 53.130000000000003 113.61 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 45.1 pt -122.32 168.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 O-C-N 121.952 -0.467 . . . . 72.329999999999998 110.837 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.7 p -131.79 140.73 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.839 -1.541 . . . . 72.040000000000006 106.839 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 69.5 mmtt -104.45 145.95 29.55 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.438 -0.505 . . . . 75.430000000000007 111.25 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 69.3 mt -117.45 135.07 59.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.474 -1.239 . . . . 73.349999999999994 110.498 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 64.5 mt -93.55 127.89 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.835 -1.172 . . . . 73.219999999999999 107.835 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 25.7 p -106.59 112.18 25.06 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.374 0.607 . . . . 74.420000000000002 110.139 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.471 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 30.9 mt -112.64 130.04 67.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.74 -1.207 . . . . 73.430000000000007 107.74 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 11.5 ttm180 -85.86 122.92 30.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 44.7 mm -102.33 136.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.724 -0.671 . . . . 65.439999999999998 109.394 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . 0.442 ' CZ ' ' HD2' ' A' ' 574' ' ' ARG . 92.7 m-85 -112.11 162.11 15.77 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.682 -0.858 . . . . 74.140000000000001 108.682 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.44 156.49 18.17 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.787 -0.449 . . . . 74.010000000000005 109.787 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.493 ' HD2' ' OD1' ' A' ' 552' ' ' ASP . 4.3 tpm_? -130.51 173.66 10.65 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.231 -0.655 . . . . 71.310000000000002 109.231 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.443 ' N ' ' HG3' ' A' ' 578' ' ' ARG . 64.5 mm-40 -68.47 126.1 28.57 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.547 -1.279 . . . . 75.409999999999997 107.547 173.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.56 -25.37 64.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.421 0.629 . . . . 73.129999999999995 109.653 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -108.53 81.37 1.46 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.159 0.98 . . . . 73.25 108.562 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -162.7 -163.15 0.85 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.526 -1.67 . . . . 64.430000000000007 106.936 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -98.98 117.52 33.67 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.839 -1.171 . . . . 72.030000000000001 107.839 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -52.01 122.63 8.76 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 123.959 0.787 . . . . 73.519999999999996 110.779 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 4.5 p -91.14 140.82 29.45 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 115.38 -0.827 . . . . 73.519999999999996 111.118 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 23.9 m -144.99 153.71 41.78 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.037 -0.727 . . . . 73.219999999999999 109.037 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.2 p90 -138.6 -176.87 4.62 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.79 -0.448 . . . . 75.209999999999994 109.79 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 35.8 m -132.6 162.83 30.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.589 -0.522 . . . . 73.109999999999999 109.589 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 31.2 tp -139.38 134.83 32.98 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.562 -1.273 . . . . 74.420000000000002 107.562 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.85 157.34 43.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 123.18 0.3 . . . . 74.010000000000005 110.696 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.496 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 48.9 mt -101.8 139.79 36.97 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.027 -1.471 . . . . 74.329999999999998 107.027 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -96.36 178.43 5.37 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 123.332 0.395 . . . . 74.420000000000002 110.125 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.52 121.39 78.81 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 109.676 -0.49 . . . . 74.450000000000003 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.48 164.44 35.6 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.408 2.072 . . . . 70.519999999999996 113.734 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 75.5 mmtt -116.93 140.98 48.82 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 114.847 -1.07 . . . . 75.329999999999998 109.06 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . 0.404 ' N ' ' HG3' ' A' ' 633' ' ' PRO . 3.9 t90 -113.84 109.34 18.37 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 107.227 -1.397 . . . . 75.510000000000005 107.227 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.9 mp -95.74 90.18 2.47 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 107.599 -1.26 . . . . 65.109999999999999 107.599 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.0 98.18 9.25 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.141 -1.059 . . . . 71.409999999999997 108.141 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -98.68 125.13 43.88 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.681 -0.69 . . . . 74.340000000000003 109.812 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -173.65 163.25 34.41 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 107.789 -2.124 . . . . 32.240000000000002 107.789 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 14.6 tpt -83.04 -33.18 26.53 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 117.694 0.747 . . . . 75.450000000000003 110.253 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -98.54 83.32 2.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.232 -0.655 . . . . 75.420000000000002 109.232 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -117.57 -18.58 5.24 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.28 -0.962 . . . . 74.439999999999998 112.209 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 66.94 32.7 81.71 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.428 -1.069 . . . . 72.099999999999994 110.428 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -64.43 103.34 0.64 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.111 0.481 . . . . 72.510000000000005 110.008 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 7.1 m -127.04 81.11 2.0 Allowed 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 121.854 0.835 . . . . 74.200000000000003 108.871 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 26.5 mm -81.46 75.81 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.267 -0.879 . . . . 72.230000000000004 109.31 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 30.0 m -130.88 -25.29 2.31 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.086 -1.415 . . . . 73.209999999999994 107.998 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -62.43 -46.71 87.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.909 -1.515 . . . . 75.209999999999994 106.909 173.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.22 124.1 39.08 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 105.23 -2.137 . . . . 73.540000000000006 105.23 173.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -148.53 150.98 34.32 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 105.384 -2.08 . . . . 74.409999999999997 105.384 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . 0.268 17.2 m-20 -79.25 72.85 5.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 122.396 1.093 . . . . 55.149999999999999 113.135 -176.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 34.5 t70 165.32 72.79 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 129.583 3.153 . . . . 73.150000000000006 104.578 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 616' ' ' PRO . 12.9 tppt? -152.16 95.25 2.04 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.715 -1.13 . . . . 75.120000000000005 109.411 -175.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -81.83 -49.01 0.94 Allowed Pre-proline 0 C--N 1.293 -1.878 0 CA-C-N 116.032 -0.531 . . . . 71.400000000000006 110.948 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.41 ' O ' ' HG3' ' A' ' 614' ' ' LYS . 38.3 Cg_endo -67.65 177.33 4.17 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 120.884 1.056 . . . . 71.219999999999999 109.461 170.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . 0.408 ' H ' HD21 ' A' ' 617' ' ' LEU . 2.4 mm? -65.84 -60.99 2.32 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.703 -0.481 . . . . 63.25 109.703 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 4.8 m -142.16 158.68 43.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 105.606 -1.998 . . . . 74.040000000000006 105.606 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 41.4 m -88.19 71.2 9.24 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.664 0.745 . . . . 63.130000000000003 110.049 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -144.37 164.17 31.61 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 105.177 -2.157 . . . . 75.140000000000001 105.177 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -83.21 151.04 25.84 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.414 -0.514 . . . . 54.409999999999997 109.998 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 68.91 24.3 6.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.516 1.126 . . . . 72.140000000000001 113.006 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -76.18 101.67 5.47 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.647 0.737 . . . . 75.409999999999997 110.606 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.437 ' OE1' ' HD3' ' A' ' 625' ' ' ARG . 0.3 OUTLIER -112.18 142.79 44.21 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.853 -1.536 . . . . 75.129999999999995 106.853 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 0.1 OUTLIER -63.3 -30.32 71.48 Favored 'General case' 0 C--O 1.206 -1.234 0 C-N-CA 120.256 -0.577 . . . . 74.400000000000006 111.108 -177.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 53.9 ttp85 -63.03 -33.4 75.34 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.286 0.565 . . . . 74.409999999999997 110.901 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.496 ' O ' ' HG2' ' A' ' 630' ' ' MET . 63.9 mt -80.41 -33.8 14.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.457 -0.571 . . . . 71.219999999999999 109.457 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.67 88.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.076 -0.713 . . . . 73.239999999999995 109.076 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 48.6 mt-10 -71.42 -30.76 66.44 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.494 -0.775 . . . . 73.0 111.392 176.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' A' ' 627' ' ' ILE . 7.8 ptp -74.86 -7.36 53.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.213 -0.595 . . . . 74.040000000000006 110.06 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -107.38 22.67 28.45 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.571 -0.612 . . . . 63.219999999999999 111.571 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 14.4 ptp180 -145.37 168.82 11.01 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.72 -1.215 . . . . 72.109999999999999 107.72 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' A' ' 632' ' ' ARG . 56.3 Cg_endo -67.7 142.84 59.64 Favored 'Trans proline' 0 C--O 1.255 1.354 0 C-N-CA 121.858 1.705 . . . . 74.400000000000006 109.674 172.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 28.7 pt -134.56 -177.89 2.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 116.387 -0.37 . . . . 74.430000000000007 110.292 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.528 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 2.1 pt? -139.53 -168.27 2.44 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.882 -0.784 . . . . 74.430000000000007 108.882 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -66.75 159.62 48.59 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.582 -0.818 . . . . 62.509999999999998 112.612 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.61 -64.71 0.74 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.981 1.313 . . . . 73.200000000000003 110.135 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -130.93 104.33 7.07 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.925 -1.139 . . . . 74.450000000000003 107.925 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.6 t -129.45 114.0 15.6 Favored 'General case' 0 N--CA 1.404 -2.735 0 CA-C-O 122.547 1.165 . . . . 71.439999999999998 110.326 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.8 ttmt -144.09 148.95 35.83 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 106.586 -1.635 . . . . 73.219999999999999 106.586 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 56.4 tp -126.76 109.99 12.63 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.478 -0.934 . . . . 72.150000000000006 108.478 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.426 ' HB2' HG23 ' A' ' 511' ' ' VAL . 40.9 mt-10 -87.0 126.42 34.73 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 107.421 -1.325 . . . . 73.140000000000001 107.421 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 512' ' ' THR . 43.9 t -113.62 122.41 67.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 109.048 -0.723 . . . . 73.230000000000004 109.048 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.62 135.55 50.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.79 -1.096 . . . . 73.230000000000004 110.014 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . 0.407 ' C ' ' H ' ' A' ' 647' ' ' GLU . 0.0 OUTLIER -126.75 148.08 31.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 123.096 0.558 . . . . 75.019999999999996 110.142 178.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 73.53 -28.86 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.982 1.313 . . . . 71.030000000000001 111.87 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 645' ' ' ILE . 0.5 OUTLIER -93.7 96.56 9.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.05 -1.833 . . . . 71.319999999999993 106.05 175.558 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' SER . . . . . 0.406 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 29.6 t -98.7 133.35 43.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.785 -0.45 . . . . 75.409999999999997 109.785 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -131.68 178.14 6.98 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.603 -0.888 . . . . 75.549999999999997 108.603 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.55 112.9 18.34 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.207 -0.597 . . . . 74.140000000000001 109.838 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -71.18 113.36 8.14 Favored 'General case' 0 N--CA 1.401 -2.89 0 N-CA-C 108.874 -0.787 . . . . 71.519999999999996 108.874 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -23.82 55.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.517 1.302 . . . . 74.549999999999997 114.517 -171.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 19.4 m 60.75 20.37 10.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.491 0.717 . . . . 63.450000000000003 111.547 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.4 m -135.65 121.53 19.86 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.772 -0.649 . . . . 73.120000000000005 109.838 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 29.8 m -98.46 147.83 6.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.982 -0.748 . . . . 74.439999999999998 108.982 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 116.584 -0.28 . . . . 72.150000000000006 111.201 -176.298 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.157 0.503 . . . . 74.310000000000002 111.711 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -76.41 -54.43 6.75 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.903 -0.777 . . . . 65.230000000000004 108.903 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -142.94 91.43 0.17 Allowed Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 110.185 -1.166 . . . . 74.340000000000003 110.185 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 68.3 mt -96.89 114.88 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.306 -0.627 . . . . 74.230000000000004 109.306 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -101.24 132.26 46.83 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.017 -0.735 . . . . 75.120000000000005 109.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.1 t -146.38 153.81 40.92 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 120.795 0.331 . . . . 64.299999999999997 110.436 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.541 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.15 153.73 38.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.649 -0.5 . . . . 71.329999999999998 109.649 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 41.7 mt-10 -56.19 -56.19 23.98 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.941 0.775 . . . . 72.430000000000007 110.397 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -122.35 160.84 46.29 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.721 -1.127 . . . . 75.439999999999998 109.136 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -86.73 -20.74 2.39 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.032 1.821 . . . . 73.420000000000002 112.071 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 75.6 t -144.22 135.61 21.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 71.230000000000004 108.891 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.0 t -133.21 123.96 26.54 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.449 0.643 . . . . 72.319999999999993 110.07 177.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -98.98 115.96 30.12 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.964 -1.124 . . . . 75.209999999999994 107.964 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.14 169.15 17.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 123.492 0.495 . . . . 75.25 110.422 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 44.6 t -78.3 155.95 29.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.98 -0.554 . . . . 73.230000000000004 111.069 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.14 -20.96 54.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.486 -0.931 . . . . 71.510000000000005 108.486 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 32.75 5.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.66 -0.7 . . . . 74.430000000000007 110.728 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 6.5 tt -82.83 -23.2 8.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 72.120000000000005 109.657 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.76 -74.76 2.03 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.33 -0.708 . . . . 73.519999999999996 111.33 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.7 mm -130.28 128.17 63.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.449 -1.315 . . . . 74.319999999999993 107.449 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -99.61 157.04 16.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.296 -0.631 . . . . 74.430000000000007 109.296 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.06 131.59 56.9 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.572 0.545 . . . . 74.310000000000002 111.919 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 41.4 t -126.26 116.33 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 109.603 -0.517 . . . . 61.039999999999999 109.603 173.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 97.5 mttt -92.34 124.87 36.72 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.975 -0.69 . . . . 75.329999999999998 110.027 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.88 112.73 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.479 -1.304 . . . . 75.409999999999997 107.479 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 40.3 mt -96.07 152.76 18.24 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.129 -0.941 . . . . 74.420000000000002 110.406 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 1.8 mpp_? -106.65 114.83 29.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.043 -0.725 . . . . 73.450000000000003 109.043 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.3 m -65.36 -50.87 63.95 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.82 0.819 . . . . 74.239999999999995 109.998 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.0 p -73.75 -52.25 13.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.19 -0.914 . . . . 73.219999999999999 112.248 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 138.9 -155.95 24.05 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 108.423 -1.871 . . . . 55.130000000000003 108.423 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -169.47 149.13 3.92 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 117.339 0.569 . . . . 73.129999999999995 109.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -156.57 102.11 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.573 -2.01 . . . . 73.340000000000003 105.573 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 124.66 -173.04 16.99 Favored Glycine 0 C--N 1.295 -1.738 0 N-CA-C 110.046 -1.222 . . . . 72.430000000000007 110.046 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.434 HD22 ' HG3' ' A' ' 561' ' ' GLU . 3.5 t-20 -99.21 118.98 37.11 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 108.968 -0.753 . . . . 72.030000000000001 108.968 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 14.1 t -120.69 121.31 65.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 109.171 -0.677 . . . . 75.099999999999994 109.171 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.467 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.9 mm -94.39 117.03 37.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.79 -0.818 . . . . 73.310000000000002 108.79 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.7 106.73 56.7 Favored Pre-proline 0 C--N 1.301 -1.516 0 CA-C-N 115.446 -0.797 . . . . 74.319999999999993 110.673 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 5.0 Cg_exo -76.88 150.87 30.75 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.129 1.886 . . . . 65.140000000000001 111.7 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -141.72 161.48 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.84 -1.17 . . . . 73.5 107.84 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . 0.437 ' HE2' HD11 ' A' ' 542' ' ' ILE . 24.0 pttm -152.49 137.06 16.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.056 0.455 . . . . 64.400000000000006 111.638 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.8 p -83.51 134.39 34.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.575 -0.739 . . . . 75.409999999999997 110.224 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 48.1 mm -103.55 126.38 58.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.357 -0.979 . . . . 73.049999999999997 108.357 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -78.95 112.31 16.01 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.113 -1.069 . . . . 72.420000000000002 108.113 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -101.36 -106.17 2.9 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.771 -1.332 . . . . 72.25 109.771 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 23.9 p -89.5 -11.37 43.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.438 0.637 . . . . 71.540000000000006 109.827 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -100.65 141.36 33.63 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.06 -1.089 . . . . 73.230000000000004 108.06 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -100.05 133.68 44.07 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.861 0.363 . . . . 64.409999999999997 110.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.72 -159.97 35.43 Favored Glycine 0 N--CA 1.431 -1.66 0 C-N-CA 120.777 -0.725 . . . . 60.409999999999997 111.355 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.0 37.39 64.32 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.025 -0.607 . . . . 41.420000000000002 112.187 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.69 5.13 86.89 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.361 -0.447 . . . . 54.539999999999999 113.529 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -81.89 -82.21 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.849 0.325 . . . . 75.219999999999999 111.771 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -46.76 7.63 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.712 -1.218 . . . . 71.140000000000001 107.712 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -131.89 160.63 35.15 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.36 -1.291 . . . . 65.420000000000002 107.575 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.0 OUTLIER -91.98 131.97 36.88 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.861 -1.533 . . . . 53.43 106.861 175.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.21 125.5 29.93 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.947 -0.569 . . . . 63.539999999999999 109.732 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.8 t -133.99 121.99 22.41 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 122.026 0.917 . . . . 64.340000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.7 p -133.55 129.53 37.19 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.825 -1.546 . . . . 71.5 106.825 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -172.63 -177.39 41.98 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.029 -1.081 . . . . 73.519999999999996 111.036 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.1 mt-10 -113.24 129.51 56.5 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.362 0.601 . . . . 75.519999999999996 111.945 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.7 mt -89.24 140.11 29.81 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.649 -1.16 . . . . 72.519999999999996 109.699 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.434 ' HG3' HD22 ' A' ' 534' ' ' ASN . 37.6 tt0 -99.83 101.78 13.02 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.944 -0.571 . . . . 61.229999999999997 109.931 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 43.0 m-85 -96.17 149.71 21.33 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.624 0.725 . . . . 73.329999999999998 110.439 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -127.41 -140.54 0.26 Allowed 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.128 -1.804 . . . . 74.200000000000003 106.128 177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -62.21 157.72 18.71 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 122.958 0.503 . . . . 61.340000000000003 110.088 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.55 -21.11 9.28 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.598 1.159 . . . . 72.209999999999994 113.74 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.417 ' HG3' HG22 ' A' ' 567' ' ' ILE . 13.1 pt-20 -59.27 -30.96 68.67 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.678 0.791 . . . . 73.430000000000007 112.781 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.417 HG22 ' HG3' ' A' ' 566' ' ' GLU . 34.7 pt -101.08 168.93 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.643 0.259 . . . . 74.409999999999997 110.955 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.34 152.38 15.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.88 -1.526 . . . . 72.099999999999994 106.88 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.506 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.1 mmpt? -112.8 157.44 21.35 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 120.783 -0.367 . . . . 73.140000000000001 110.8 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -127.32 129.41 70.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.231 -0.895 . . . . 70.409999999999997 109.822 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.9 mt -90.63 122.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.61 -1.626 . . . . 75.140000000000001 106.61 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.0 p -106.86 122.01 45.55 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.239 -0.652 . . . . 71.510000000000005 109.239 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 61.6 mt -118.31 128.44 75.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.472 -0.566 . . . . 74.140000000000001 109.472 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.423 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.4 mtt180 -74.31 119.48 18.58 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.944 0.778 . . . . 72.420000000000002 110.1 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.6 mm -107.25 135.75 44.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.719 -0.845 . . . . 74.040000000000006 108.719 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -123.33 164.48 18.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.776 -1.194 . . . . 74.549999999999997 107.776 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.81 143.72 20.27 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 123.017 0.198 . . . . 71.120000000000005 111.406 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 578' ' ' ARG . 0.0 OUTLIER -40.34 113.3 0.35 Allowed 'General case' 0 CA--C 1.564 1.502 0 O-C-N 125.128 1.518 . . . . 73.510000000000005 113.34 -174.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -102.84 141.7 35.2 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 120.82 -1.175 . . . . 65.140000000000001 110.265 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 68.81 97.07 0.06 Allowed 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 124.77 1.228 . . . . 74.049999999999997 111.573 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -77.04 167.54 21.62 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.269 -0.878 . . . . 74.549999999999997 108.633 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 72.53 12.18 5.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.665 0.786 . . . . 54.219999999999999 110.238 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -139.14 154.59 48.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.99 -1.485 . . . . 72.420000000000002 106.99 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.51 129.55 52.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.994 -1.113 . . . . 71.25 107.994 172.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 645' ' ' ILE . 60.0 m -73.95 115.45 13.42 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.63 0.729 . . . . 73.299999999999997 112.031 -174.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 m -146.77 128.04 14.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.91 -0.774 . . . . 75.340000000000003 108.91 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.2 p90 -131.22 165.76 22.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.714 -0.847 . . . . 64.530000000000001 108.714 174.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 5.0 m -119.7 162.52 18.88 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.523 -0.871 . . . . 70.409999999999997 110.221 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 47.0 tp -135.69 130.06 33.68 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.276 -1.379 . . . . 75.219999999999999 107.276 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.83 160.14 42.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 123.603 0.564 . . . . 74.329999999999998 109.674 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.541 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 44.9 mt -106.26 144.4 33.0 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.976 0.798 . . . . 73.400000000000006 109.004 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.77 178.3 5.35 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.178 -1.045 . . . . 73.310000000000002 108.178 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.29 117.36 23.51 Favored Pre-proline 0 C--O 1.247 0.954 0 O-C-N 123.642 0.589 . . . . 62.43 109.759 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.428 ' HG2' ' HB2' ' A' ' 633' ' ' PRO . 56.4 Cg_endo -77.46 147.78 25.76 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.409 2.072 . . . . 73.200000000000003 111.375 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.467 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 8.7 ptpp? -113.63 123.59 50.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.133 -0.485 . . . . 75.299999999999997 110.055 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -98.23 110.58 23.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.014 -0.539 . . . . 75.420000000000002 110.256 -173.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.74 89.4 2.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 106.693 -1.595 . . . . 73.329999999999998 106.693 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . 0.544 ' O ' ' HA3' ' A' ' 603' ' ' GLY . 15.0 ptm180 -103.43 91.76 4.19 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.886 -1.052 . . . . 75.219999999999999 109.027 177.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -41.78 111.38 0.23 Allowed 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.88 1.672 . . . . 73.409999999999997 112.421 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -171.25 -164.67 27.33 Favored Glycine 0 N--CA 1.418 -2.515 0 N-CA-C 110.342 -1.103 . . . . 73.409999999999997 110.342 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 52.6 tpp -72.94 -43.17 62.64 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.271 0.557 . . . . 61.229999999999997 109.615 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -90.15 -26.46 20.16 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.048 -0.524 . . . . 75.140000000000001 110.345 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 598' ' ' ARG . . . -89.29 68.17 2.75 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 111.395 -0.682 . . . . 72.010000000000005 111.395 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -135.46 61.86 0.62 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.02 -1.232 . . . . 72.5 110.02 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -147.19 146.33 29.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.656 -0.498 . . . . 73.400000000000006 109.656 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 85.1 m -146.66 109.94 4.77 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.632 -1.247 . . . . 73.120000000000005 107.632 173.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 47.6 mm -96.12 123.56 48.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.758 -0.83 . . . . 72.209999999999994 108.758 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 11.4 m -115.14 18.04 16.43 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 123.061 1.41 . . . . 74.450000000000003 107.498 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -125.76 83.54 2.18 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-N 114.089 -1.414 . . . . 75.140000000000001 110.809 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -80.58 104.28 11.0 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 105.113 -2.181 . . . . 75.340000000000003 105.113 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -71.49 -26.8 62.84 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.668 -1.151 . . . . 75.510000000000005 113.983 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -144.45 103.02 3.91 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.179 0.514 . . . . 72.329999999999998 110.075 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -91.08 69.73 6.24 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.832 -1.173 . . . . 74.209999999999994 107.832 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 616' ' ' PRO . 30.9 mmmt -140.75 22.46 2.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.418 -0.355 . . . . 63.119999999999997 111.295 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.28 117.04 68.03 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 120.632 -0.427 . . . . 75.319999999999993 111.782 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 614' ' ' LYS . 93.9 Cg_endo -93.23 171.0 2.12 Favored 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.328 2.019 . . . . 70.109999999999999 110.397 174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.27 77.64 1.98 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.271 1.034 . . . . 72.319999999999993 109.765 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 16.8 p -126.55 137.13 53.31 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.649 -1.614 . . . . 71.120000000000005 108.401 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.4 m -133.23 114.07 13.39 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.034 0.445 . . . . 75.450000000000003 110.029 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -137.75 64.87 1.5 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.388 -1.338 . . . . 74.510000000000005 107.388 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -122.23 164.73 17.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.373 -1.285 . . . . 74.299999999999997 109.688 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . 0.407 ' OE1' ' HG2' ' A' ' 624' ' ' GLU . 0.9 OUTLIER -78.67 145.44 34.58 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.617 -2.364 . . . . 72.129999999999995 104.617 174.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.72 -16.36 64.18 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 115.149 1.537 . . . . 73.329999999999998 115.149 -171.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.407 ' HG2' ' OE1' ' A' ' 622' ' ' GLU . 10.2 pt-20 -65.7 -26.8 67.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 119.018 -1.073 . . . . 74.230000000000004 110.789 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -67.08 -39.55 86.8 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.961 -0.755 . . . . 63.140000000000001 108.961 173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.29 -33.91 76.28 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.06 -0.973 . . . . 74.299999999999997 110.781 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 94.6 mt -58.47 -40.96 80.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 CA-C-O 120.866 0.365 . . . . 74.319999999999993 110.373 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 632' ' ' ARG . . . -67.55 -41.99 83.38 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.654 -0.703 . . . . 74.329999999999998 109.574 177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -63.22 -29.34 70.7 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.698 -0.683 . . . . 74.530000000000001 111.599 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 71.0 mtm -66.67 -9.66 38.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.228 0.537 . . . . 64.530000000000001 112.397 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -112.31 12.72 26.06 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.246 -1.142 . . . . 73.319999999999993 110.246 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 628' ' ' ALA . 28.3 mmm180 -119.82 162.24 34.03 Favored Pre-proline 0 C--N 1.313 -1.013 0 C-N-CA 122.932 0.493 . . . . 74.409999999999997 109.996 -177.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.428 ' HB2' ' HG2' ' A' ' 594' ' ' PRO . 49.5 Cg_endo -70.81 120.61 7.2 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.25 1.967 . . . . 74.420000000000002 108.977 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 31.2 pt -138.87 -178.61 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.459 0.647 . . . . 75.319999999999993 110.973 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.61 170.31 8.41 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 75.420000000000002 107.364 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.82 154.59 50.92 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.388 -1.885 . . . . 73.349999999999994 108.388 172.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -39.86 -64.06 0.53 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.1 0.96 . . . . 65.430000000000007 112.641 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -130.07 83.43 2.13 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.827 -1.175 . . . . 73.510000000000005 107.827 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.2 t -100.67 110.88 23.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.241 1.019 . . . . 64.200000000000003 110.64 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -146.72 134.86 21.61 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.411 -1.329 . . . . 72.519999999999996 107.411 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 65.0 tp -113.2 112.91 24.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.312 -0.625 . . . . 73.450000000000003 109.312 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -90.47 117.03 28.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.63 116.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 N-CA-C 107.66 -1.237 . . . . 62.549999999999997 107.66 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 16.0 mt -115.47 128.22 72.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.547 0 CA-C-N 114.787 -1.097 . . . . 75.109999999999999 109.901 -176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER -119.34 125.37 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 114.474 -1.239 . . . . 75.219999999999999 108.308 179.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -131.46 140.32 49.56 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.403 -0.591 . . . . 75.329999999999998 109.403 -175.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -84.36 129.43 34.87 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 105.476 -2.046 . . . . 74.109999999999999 105.476 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 70.6 m 68.57 32.51 4.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.924 0.869 . . . . 75.439999999999998 109.457 -174.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -56.05 165.68 0.93 Allowed 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.957 1.303 . . . . 75.430000000000007 112.508 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.72 111.18 19.43 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.26 -1.755 . . . . 73.430000000000007 106.26 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -116.98 132.11 56.79 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.431 -1.322 . . . . 75.319999999999993 107.431 -177.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.2 -35.65 61.49 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.322 0.86 . . . . 71.049999999999997 113.322 -174.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 54.2 m 52.56 30.94 9.2 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.768 0.827 . . . . 75.239999999999995 112.034 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.2 m -87.6 110.68 20.55 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.719 -0.673 . . . . 43.32 110.025 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.38 -21.6 6.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.578 0.704 . . . . 73.219999999999999 110.102 -176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.3 -1.555 0 CA-C-N 115.254 -0.884 . . . . 71.540000000000006 110.742 -179.19 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.793 0.806 . . . . 72.140000000000001 110.12 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -72.93 110.39 7.2 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.826 -1.079 . . . . 52.240000000000002 111.562 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . 63.82 58.83 9.76 Favored Glycine 0 C--O 1.204 -1.732 0 CA-C-N 114.872 -1.058 . . . . 72.0 114.134 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 91.9 mt -71.78 114.22 9.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 116.876 0.338 . . . . 73.109999999999999 110.984 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -100.5 132.73 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.882 -0.784 . . . . 74.409999999999997 108.882 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -148.23 157.59 43.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.841 -0.537 . . . . 74.319999999999993 110.641 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.565 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 91.9 m-85 -71.56 155.57 40.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.258 . . . . 75.040000000000006 110.319 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.91 -56.28 22.58 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.914 0.759 . . . . 73.030000000000001 109.623 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.6 mt-10 -134.09 159.51 72.08 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 107.952 -1.129 . . . . 74.409999999999997 107.952 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 62.8 Cg_endo -79.04 -21.49 9.35 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 121.93 1.753 . . . . 74.349999999999994 113.808 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.4 t -138.59 133.34 42.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.702 -0.481 . . . . 73.129999999999995 109.702 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.6 139.11 46.34 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.206 0.527 . . . . 73.439999999999998 109.705 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -109.39 132.84 53.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.989 -1.485 . . . . 71.420000000000002 106.989 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.87 163.72 26.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 C-N-CA 120.621 -0.432 . . . . 71.510000000000005 110.449 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.408 ' HB3' ' OE2' ' A' ' 647' ' ' GLU . 27.2 m -82.44 163.68 21.47 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.569 -0.741 . . . . 71.150000000000006 109.574 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.428 ' HG2' ' HA ' ' A' ' 577' ' ' ASP . 19.5 tt0 -81.05 -34.72 32.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.729 -1.212 . . . . 61.409999999999997 107.729 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.444 ' HA ' ' HB3' ' A' ' 577' ' ' ASP . 17.4 m -96.34 27.54 3.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.144 -0.934 . . . . 75.209999999999994 111.022 -176.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 7.4 tt -79.8 -25.08 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.409 0.623 . . . . 75.150000000000006 110.601 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 86.45 -75.71 2.21 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.926 -0.654 . . . . 73.120000000000005 111.668 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 48.4 mm -130.51 137.56 55.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.458 -1.682 . . . . 74.549999999999997 106.458 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.1 ppp? -110.09 147.98 32.6 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.403 -0.962 . . . . 74.219999999999999 108.403 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -110.97 134.38 52.63 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.596 0.56 . . . . 74.219999999999999 110.825 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 46.1 t -121.19 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.68 -0.859 . . . . 74.099999999999994 108.68 171.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -85.52 120.79 27.37 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.572 -0.851 . . . . 75.400000000000006 110.058 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.25 101.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.987 -1.486 . . . . 71.319999999999993 106.987 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.1 mt -84.32 163.4 19.62 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 114.183 -1.371 . . . . 74.010000000000005 111.006 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.6 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 74.6 mtt180 -118.12 109.08 15.98 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.865 -1.062 . . . . 70.230000000000004 110.446 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 22.7 m -66.27 -62.93 1.21 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.269 -0.423 . . . . 71.340000000000003 110.416 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.9 p -75.31 -36.44 61.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.663 0.744 . . . . 72.239999999999995 112.009 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . 0.426 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 124.55 -128.78 6.87 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.211 -1.155 . . . . 65.040000000000006 110.211 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . 177.16 168.69 0.58 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.052 1.341 . . . . 73.049999999999997 107.437 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.522 ' HD2' ' OD1' ' A' ' 564' ' ' ASN . 9.9 tpt180 -163.41 81.17 0.46 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.524 -1.287 . . . . 74.25 107.524 172.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 135.34 171.3 12.37 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 110.075 -1.21 . . . . 70.010000000000005 110.075 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -86.84 128.72 35.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.17 0.509 . . . . 71.150000000000006 110.843 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.8 t -136.07 134.32 50.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 70.120000000000005 109.474 -177.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.412 HG12 HD12 ' A' ' 597' ' ' ILE . 44.7 mm -93.75 122.04 44.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.795 -0.817 . . . . 73.420000000000002 108.795 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.65 102.07 54.41 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 123.471 0.482 . . . . 74.209999999999994 110.438 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 6.1 Cg_exo -76.49 148.73 30.02 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 121.932 1.754 . . . . 74.420000000000002 111.127 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -138.05 166.68 23.49 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.972 -1.122 . . . . 74.019999999999996 107.972 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -157.45 134.83 10.44 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.03 0.443 . . . . 75.239999999999995 111.254 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.6 p -80.44 126.61 31.41 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.678 -0.692 . . . . 74.209999999999994 110.156 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.2 mm -95.16 116.45 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.101 -1.444 . . . . 73.329999999999998 107.101 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.73 111.66 18.19 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.41 0.444 . . . . 74.109999999999999 110.672 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.64 -110.93 3.31 Favored Glycine 0 C--N 1.31 -0.894 0 N-CA-C 110.159 -1.176 . . . . 71.120000000000005 110.159 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 6.5 m -70.06 -35.48 74.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.684 -1.228 . . . . 65.439999999999998 107.684 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.92 132.69 35.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.325 -1.307 . . . . 72.209999999999994 108.439 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -114.6 157.11 23.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.587 0.708 . . . . 75.109999999999999 111.412 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -88.17 -154.0 27.0 Favored Glycine 0 N--CA 1.427 -1.948 0 CA-C-N 114.829 -1.078 . . . . 73.150000000000006 111.972 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.43 8.84 47.59 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.964 -0.16 . . . . 61.520000000000003 112.99 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.65 24.22 26.35 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 121.152 -0.547 . . . . 71.420000000000002 111.982 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.57 -69.59 0.61 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.478 -0.934 . . . . 61.229999999999997 108.478 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.92 -40.13 6.34 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.398 -1.334 . . . . 73.129999999999995 107.398 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -143.12 172.59 12.52 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-N 114.943 -1.026 . . . . 64.430000000000007 109.761 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 576' ' ' PHE . 1.7 tm-20 -98.04 114.26 26.36 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 75.439999999999998 105.241 175.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.78 136.81 37.47 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.647 0.737 . . . . 75.150000000000006 111.466 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -130.27 125.74 35.56 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 122.145 0.974 . . . . 75.129999999999995 111.734 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 38.6 t -132.43 127.13 34.68 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 105.861 -1.903 . . . . 71.319999999999993 105.861 172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.68 -174.61 37.5 Favored Glycine 0 C--N 1.269 -3.161 0 N-CA-C 109.649 -1.38 . . . . 72.540000000000006 109.649 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 8.6 pt-20 -121.01 127.98 52.26 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.364 0.602 . . . . 71.319999999999993 111.424 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.13 136.22 33.07 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.226 -0.897 . . . . 73.030000000000001 108.817 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.17 98.84 9.2 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 121.496 0.665 . . . . 74.549999999999997 109.606 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.6 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 36.2 m-85 -92.61 124.24 36.48 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.823 -0.626 . . . . 72.540000000000006 110.516 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.549 ' H ' HD11 ' A' ' 567' ' ' ILE . 27.8 mm-40 -83.63 -146.98 0.09 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.057 -1.831 . . . . 71.349999999999994 106.057 172.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.522 ' OD1' ' HD2' ' A' ' 532' ' ' ARG . 61.2 t30 -63.47 170.49 3.09 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.15 0.58 . . . . 62.399999999999999 110.429 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.81 -11.58 8.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.618 1.167 . . . . 61.210000000000001 113.864 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.07 -21.79 66.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.656 0.782 . . . . 74.129999999999995 112.839 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.549 HD11 ' H ' ' A' ' 563' ' ' GLN . 23.7 pt -114.18 168.9 5.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 O-C-N 121.793 -0.567 . . . . 74.230000000000004 111.265 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.17 147.42 25.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.442 -1.318 . . . . 74.140000000000001 107.442 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 68.4 mmtt -111.34 148.5 32.85 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.088 0.471 . . . . 71.150000000000006 111.224 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.1 mt -120.38 132.53 69.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.834 -1.075 . . . . 74.430000000000007 110.328 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.2 mt -91.91 126.46 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.7 -1.593 . . . . 73.329999999999998 106.7 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 572' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 521' ' ' MET . 16.2 p -113.94 112.78 23.87 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.052 0.453 . . . . 72.120000000000005 109.966 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.41 HD11 ' SD ' ' A' ' 521' ' ' MET . 70.1 mt -105.0 130.62 55.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.617 -0.512 . . . . 75.040000000000006 109.617 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.53 114.95 17.9 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.131 0.491 . . . . 74.5 110.309 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.9 mm -103.22 137.49 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 106.166 -1.79 . . . . 75.099999999999994 106.166 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 554' ' ' GLU . 47.6 m-85 -105.72 122.9 47.02 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.89 -0.724 . . . . 73.510000000000005 111.739 -176.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 578' ' ' ARG . 4.0 p-10 -88.64 160.55 17.33 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 115.333 -0.849 . . . . 71.299999999999997 108.831 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 577' ' ' ASP . 17.7 ptp180 61.05 12.76 4.17 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.129 1.772 . . . . 74.340000000000003 111.144 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 581' ' ' TYR . 21.2 tp10 -95.86 43.17 1.08 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 105.884 -1.895 . . . . 62.450000000000003 105.884 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -76.35 30.99 0.12 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.632 -1.622 . . . . 73.319999999999993 112.62 -172.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 579' ' ' GLU . 92.8 m-85 -83.01 -18.94 38.03 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.851 -1.166 . . . . 74.239999999999995 107.851 176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -104.68 -163.07 0.93 Allowed 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.308 -1.315 . . . . 72.319999999999993 110.397 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.478 ' HD3' ' N ' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -138.07 -152.91 0.45 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 110.241 -0.281 . . . . 74.120000000000005 110.241 -170.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -74.77 101.71 4.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.919 -1.141 . . . . 63.43 107.919 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 63.3 m -120.87 140.98 51.02 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.191 -0.459 . . . . 63.140000000000001 111.278 -173.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 63.9 p -117.69 149.03 41.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.911 -0.493 . . . . 72.540000000000006 110.875 175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.6 p90 -137.15 174.84 10.18 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.324 -0.991 . . . . 74.219999999999999 108.324 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 13.0 m -124.85 167.03 15.2 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 120.256 -0.577 . . . . 74.310000000000002 109.616 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 39.3 tp -141.45 130.87 23.75 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.083 -1.451 . . . . 75.310000000000002 107.083 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.72 157.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 123.343 0.402 . . . . 71.219999999999999 110.041 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.565 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 75.2 mt -96.76 142.78 28.37 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.096 -1.446 . . . . 75.450000000000003 107.096 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -104.43 172.24 6.9 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 123.441 0.463 . . . . 73.230000000000004 110.033 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -52.64 112.2 3.24 Favored Pre-proline 0 C--N 1.316 -0.876 0 O-C-N 124.957 1.411 . . . . 75.019999999999996 110.987 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' A' ' 632' ' ' ARG . 33.1 Cg_endo -76.04 153.8 37.21 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 C-N-CA 121.705 1.603 . . . . 73.129999999999995 111.504 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -124.09 132.14 53.63 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.378 -0.601 . . . . 75.519999999999996 109.378 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -93.77 140.82 29.21 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.491 -0.559 . . . . 74.340000000000003 109.491 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . 0.412 HD12 HG12 ' A' ' 536' ' ' ILE . 1.8 mp -83.42 89.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 122.752 1.263 . . . . 75.040000000000006 110.458 178.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -128.15 85.52 2.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 105.888 -1.893 . . . . 74.310000000000002 105.888 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -70.91 155.95 40.18 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.26 -1.337 . . . . 72.030000000000001 113.553 -172.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 176.69 -154.73 16.99 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 107.418 -2.273 . . . . 71.129999999999995 107.418 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.23 122.15 33.61 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.894 -1.521 . . . . 73.310000000000002 106.894 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -149.9 127.38 11.52 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.159 -0.682 . . . . 64.040000000000006 109.159 -173.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 131.12 -119.86 2.77 Favored Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 119.907 -1.139 . . . . 74.239999999999995 112.804 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 95.89 -142.73 16.27 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 108.993 -1.643 . . . . 72.319999999999993 108.993 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -111.12 87.65 2.59 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.344 1.069 . . . . 74.099999999999994 110.61 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 40.1 m -152.24 144.07 23.66 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 104.891 -2.262 . . . . 74.25 104.891 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 49.0 mm -81.04 -70.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.734 -0.387 . . . . 71.340000000000003 110.454 -175.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 31.5 m 68.6 -44.16 0.51 Allowed 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 124.543 1.137 . . . . 70.140000000000001 112.131 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.5 59.15 4.49 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.899 1.28 . . . . 72.230000000000004 110.838 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -93.95 142.98 26.76 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.332 -0.849 . . . . 73.25 109.703 176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -80.64 85.15 6.07 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.368 -1.345 . . . . 73.329999999999998 107.368 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -111.32 -58.23 2.14 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.003 -1.48 . . . . 62.530000000000001 107.003 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 69.37 -62.78 0.4 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 114.749 1.389 . . . . 73.040000000000006 114.749 170.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 614' ' ' LYS . 1.8 tpmt? -88.17 88.81 7.75 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.821 0.82 . . . . 75.310000000000002 109.613 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -105.29 170.02 6.42 Favored Pre-proline 0 C--N 1.28 -2.448 0 CA-C-N 114.726 -1.124 . . . . 75.25 108.565 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.46 140.09 93.24 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.745 1.63 . . . . 74.140000000000001 109.406 172.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -86.23 -94.32 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 112.42 0.526 . . . . 74.349999999999994 112.42 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 21.6 m -83.0 -36.85 24.7 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 116.318 -0.401 . . . . 63.350000000000001 110.111 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 31.9 t -77.93 97.41 5.3 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.524 0.678 . . . . 71.109999999999999 109.903 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . 0.451 ' HE2' ' OE1' ' A' ' 629' ' ' GLU . 65.5 mttp -113.66 176.14 5.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.541 -0.754 . . . . 75.340000000000003 109.562 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -109.88 177.46 4.71 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.147 -0.479 . . . . 70.329999999999998 110.205 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -74.5 93.09 2.42 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.868 -0.79 . . . . 73.5 108.868 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -140.94 151.26 44.06 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.656 -0.702 . . . . 74.450000000000003 109.872 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.96 -26.01 64.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.405 -0.361 . . . . 61.43 111.639 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 32.3 ttp180 -59.61 -35.67 74.8 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 110.297 -0.26 . . . . 75.319999999999993 110.297 -178.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -63.37 -31.46 72.62 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-O 121.265 0.555 . . . . 74.549999999999997 110.51 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 64.9 mt -70.7 -31.95 47.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.544 0.687 . . . . 72.439999999999998 109.208 177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -72.68 -38.36 67.6 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.996 -0.547 . . . . 72.430000000000007 109.852 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.451 ' OE1' ' HE2' ' A' ' 620' ' ' LYS . 36.4 mt-10 -69.67 -28.12 65.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.574 0.702 . . . . 73.109999999999999 110.038 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 49.0 ttm -72.42 -18.46 61.71 Favored 'General case' 0 N--CA 1.404 -2.743 0 C-N-CA 125.004 1.322 . . . . 70.040000000000006 109.929 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -98.92 17.78 57.74 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.588 -0.605 . . . . 73.030000000000001 111.588 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 594' ' ' PRO . 14.0 mmt85 -97.01 154.27 38.25 Favored Pre-proline 0 C--N 1.301 -1.527 0 C-N-CA 122.703 0.401 . . . . 65.129999999999995 110.025 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -67.51 154.39 73.79 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 106.546 -2.136 . . . . 73.030000000000001 106.546 165.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.79 176.87 7.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 C-N-CA 118.541 -1.264 . . . . 75.200000000000003 113.22 -176.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.83 -175.2 2.73 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.893 -1.503 . . . . 70.219999999999999 108.006 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.7 143.71 47.2 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 108.012 -2.035 . . . . 61.32 108.012 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . 0.451 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 32.7 tt0 -52.55 -42.44 64.42 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.04 0.536 . . . . 73.239999999999995 111.869 -174.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . 0.451 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 52.3 m80 -128.24 101.02 6.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.028 -1.101 . . . . 75.109999999999999 108.028 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 5.0 t -136.0 110.55 8.58 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-O 122.383 1.087 . . . . 74.129999999999995 111.041 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 35.9 ttmt -146.49 150.82 36.33 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.6 -1.63 . . . . 74.049999999999997 106.6 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 509' ' ' GLU . 61.5 tp -127.54 112.76 15.29 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.2 -0.667 . . . . 62.109999999999999 109.2 174.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 511' ' ' VAL . 43.5 mt-10 -89.62 125.35 35.2 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.658 -0.867 . . . . 64.040000000000006 108.658 175.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.36 119.45 59.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.427 -0.953 . . . . 74.5 108.427 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.26 125.0 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 115.576 -0.738 . . . . 75.409999999999997 110.207 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.31 96.01 4.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 121.718 0.77 . . . . 73.219999999999999 110.991 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.06 117.07 15.3 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.542 -1.208 . . . . 72.299999999999997 109.704 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 515' ' ' SER . 7.3 tp10 -123.29 18.89 9.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.925 1.345 . . . . 74.030000000000001 108.207 -177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.4 p -83.52 20.44 1.38 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 125.815 1.646 . . . . 73.219999999999999 113.099 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -158.8 172.72 17.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.015 -0.735 . . . . 74.120000000000005 109.015 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.97 131.65 51.0 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 123.73 0.643 . . . . 74.340000000000003 109.278 175.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -140.3 139.98 35.59 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.584 -1.265 . . . . 75.430000000000007 107.584 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -84.37 108.43 17.2 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.175 -0.676 . . . . 75.150000000000006 109.175 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 33.2 m -78.33 94.84 4.91 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.405 0.621 . . . . 72.129999999999995 109.702 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.1 m -126.64 115.36 19.35 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.496 -0.774 . . . . 71.340000000000003 109.01 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 10.1 p -86.79 130.85 36.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.059 -0.719 . . . . 73.319999999999993 109.059 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.256 1.397 0 CA-C-N 116.384 -0.371 . . . . 72.230000000000004 110.576 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 121.211 0.529 . . . . 74.409999999999997 110.199 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -137.39 104.97 5.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.894 -0.594 . . . . 74.450000000000003 109.957 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -78.33 149.64 34.14 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 115.496 -0.775 . . . . 72.349999999999994 111.303 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 84.6 mt -127.25 114.73 37.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.013 -1.477 . . . . 73.519999999999996 107.013 176.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -103.48 136.98 42.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.793 0.33 . . . . 75.019999999999996 110.809 -176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.2 t -148.02 160.79 42.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.49 -0.929 . . . . 74.019999999999996 108.49 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -79.9 156.09 27.45 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.668 -0.493 . . . . 74.420000000000002 109.668 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.03 -51.1 68.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.894 0.746 . . . . 75.040000000000006 110.07 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -131.85 157.17 78.93 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.16 -0.927 . . . . 74.299999999999997 109.132 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.52 -21.71 7.22 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.261 1.974 . . . . 75.099999999999994 112.501 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 642' ' ' GLU . 73.7 t -143.13 133.93 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.372 0.669 . . . . 75.400000000000006 109.275 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -133.59 138.37 45.96 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 109.313 -0.625 . . . . 74.439999999999998 109.313 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -109.52 110.93 22.17 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.857 -1.164 . . . . 74.329999999999998 107.857 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.33 158.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 116.191 -0.459 . . . . 62.420000000000002 110.439 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.553 ' O ' HG21 ' A' ' 518' ' ' ILE . 22.1 m -78.07 137.35 38.19 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.569 -0.741 . . . . 74.349999999999994 109.232 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 646' ' ' GLU . 2.9 mp0 -65.43 -24.77 67.28 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 123.664 0.786 . . . . 75.439999999999998 110.733 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.4 p -100.45 11.11 40.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.781 -0.645 . . . . 72.549999999999997 112.286 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 515' ' ' SER . 11.1 tt -71.32 -37.69 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 120.295 -0.562 . . . . 75.150000000000006 112.129 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.21 -73.22 1.51 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.239 -0.982 . . . . 71.519999999999996 111.389 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.28 125.21 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.442 -1.318 . . . . 74.540000000000006 107.442 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -100.97 143.31 31.28 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.229 -0.656 . . . . 73.439999999999998 109.229 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -110.19 124.63 51.92 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.836 0.71 . . . . 72.549999999999997 110.848 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.86 131.34 66.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 110.373 -0.232 . . . . 74.450000000000003 110.373 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.29 136.65 32.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.479 0.487 . . . . 73.439999999999998 110.184 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 96.3 t -95.48 118.14 41.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 105.872 -1.899 . . . . 74.409999999999997 105.872 171.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.6 mt -95.87 135.73 37.23 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 116.099 -0.501 . . . . 75.209999999999994 110.774 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 104.12 15.94 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.441 -0.8 . . . . 74.200000000000003 110.391 174.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.0 m -61.0 -62.45 1.85 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.404 1.081 . . . . 65.439999999999998 111.923 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.5 p -73.3 -31.62 64.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.851 0.834 . . . . 74.299999999999997 109.766 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.62 -155.51 22.28 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 109.814 -1.314 . . . . 64.329999999999998 109.814 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.63 155.06 38.63 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.732 -1.951 . . . . 73.120000000000005 105.732 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -157.86 126.73 5.68 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.859 -0.793 . . . . 74.349999999999994 108.859 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.86 -125.42 8.24 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 111.171 -0.771 . . . . 73.219999999999999 111.171 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -136.42 102.33 4.92 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 106.311 -1.737 . . . . 72.349999999999994 106.311 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 37.9 t -113.88 120.4 63.6 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.569 0 C-N-CA 119.236 -0.986 . . . . 72.040000000000006 110.79 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.3 mm -92.11 116.4 33.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 114.803 -1.09 . . . . 72.129999999999995 108.628 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.73 100.6 43.27 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.102 -0.954 . . . . 74.129999999999995 109.248 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 2.0 Cg_endo -77.1 153.54 32.21 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.861 1.707 . . . . 73.439999999999998 112.497 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -139.65 159.23 42.64 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.7 -0.852 . . . . 70.310000000000002 108.7 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . 0.515 ' O ' HD12 ' A' ' 589' ' ' LEU . 60.5 pttt -152.13 145.97 25.13 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.022 0.439 . . . . 74.420000000000002 111.017 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -88.09 127.37 35.41 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.286 -0.87 . . . . 74.430000000000007 111.911 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 42.4 mm -100.69 116.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.678 -1.23 . . . . 73.519999999999996 107.678 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 547' ' ' ARG . 39.7 mt-10 -77.66 116.19 18.01 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.601 -0.272 . . . . 74.420000000000002 110.491 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.19 -115.95 4.06 Favored Glycine 0 C--N 1.306 -1.134 0 N-CA-C 109.028 -1.629 . . . . 73.030000000000001 109.028 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.2 p -75.59 -23.98 56.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.738 0.78 . . . . 75.150000000000006 109.387 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.63 129.27 34.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.523 -1.217 . . . . 73.319999999999993 108.602 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 543' ' ' GLU . 7.4 tpm_? -95.4 140.72 29.87 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 109.202 -0.666 . . . . 73.450000000000003 109.202 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.15 -160.73 33.16 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.935 -0.866 . . . . 74.319999999999993 110.935 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 79.0 16.72 78.42 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.767 -0.73 . . . . 70.349999999999994 111.636 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 652' ' ' LYS . . . 80.29 31.69 37.23 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 111.644 -0.582 . . . . 74.209999999999994 111.644 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -94.25 -71.09 0.68 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 122.447 -0.443 . . . . 74.409999999999997 110.543 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -29.82 12.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.685 1.231 . . . . 74.129999999999995 107.757 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -143.98 157.69 44.18 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.117 -1.438 . . . . 74.219999999999999 107.117 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.511 ' CD ' ' HD2' ' A' ' 574' ' ' ARG . 6.8 tt0 -96.03 135.98 37.08 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 106.861 -1.533 . . . . 73.409999999999997 106.861 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -74.64 120.4 20.14 Favored 'General case' 0 CA--C 1.472 -2.031 0 C-N-CA 120.643 -0.423 . . . . 60.240000000000002 110.745 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.476 ' CG2' HG12 ' A' ' 573' ' ' ILE . 10.1 t -124.58 120.12 31.02 Favored 'General case' 0 N--CA 1.392 -3.325 0 N-CA-C 105.44 -2.059 . . . . 72.400000000000006 105.44 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.5 p -137.14 139.4 41.15 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.412 -1.699 . . . . 65.310000000000002 106.412 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 538' ' ' PRO . . . -175.88 -166.59 33.56 Favored Glycine 0 N--CA 1.397 -3.952 0 C-N-CA 117.951 -2.071 . . . . 73.120000000000005 112.828 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.58 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.7 mt-10 -123.46 114.09 19.64 Favored 'General case' 0 N--CA 1.403 -2.777 0 C-N-CA 124.364 1.066 . . . . 75.430000000000007 108.969 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.33 142.62 27.59 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.57 -0.741 . . . . 74.25 109.207 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -103.56 117.25 33.99 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.8 m-85 -115.94 100.17 7.79 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.281 -1.007 . . . . 72.549999999999997 108.281 173.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.514 ' H ' HD12 ' A' ' 567' ' ' ILE . 77.0 mt-30 -77.35 -87.7 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.948 -0.569 . . . . 75.230000000000004 110.502 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -105.27 164.88 11.51 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 109.881 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -56.9 -11.38 1.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.991 1.478 . . . . 74.530000000000001 114.991 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -79.73 -14.34 58.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.089 0.774 . . . . 75.209999999999994 113.089 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.514 HD12 ' H ' ' A' ' 563' ' ' GLN . 28.3 pt -114.82 169.31 5.86 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.115 0.483 . . . . 74.420000000000002 112.244 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.17 160.17 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.42 -0.956 . . . . 73.25 108.42 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -124.02 154.9 39.2 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 111.925 0.343 . . . . 72.530000000000001 111.925 177.405 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 73.5 mt -125.33 130.65 72.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.011 -0.995 . . . . 74.239999999999995 110.108 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 62.1 mt -90.9 129.08 42.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 107.312 -1.366 . . . . 75.420000000000002 107.312 176.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 7.7 p -115.91 112.84 22.49 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 123.858 0.724 . . . . 71.439999999999998 110.132 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.476 HG12 ' CG2' ' A' ' 556' ' ' THR . 48.9 mt -116.03 130.96 69.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 121.021 -0.271 . . . . 72.120000000000005 110.711 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.511 ' HD2' ' CD ' ' A' ' 554' ' ' GLU . 92.2 mtt180 -71.19 116.75 11.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.559 0.537 . . . . 74.349999999999994 109.977 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 38.0 mm -101.47 135.95 35.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.752 -1.113 . . . . 75.349999999999994 109.744 -178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -139.17 164.05 30.81 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.313 -2.106 . . . . 75.209999999999994 105.313 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . 0.482 ' H ' ' HB3' ' A' ' 650' ' ' GLU . 2.2 p-10 -115.93 109.24 17.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.258 -2.127 . . . . 74.319999999999993 105.258 165.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 579' ' ' GLU . 9.6 tpt180 -58.64 -79.06 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.964 1.098 . . . . 75.319999999999993 113.964 -174.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 578' ' ' ARG . 43.2 tt0 169.6 106.26 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.374 -1.343 . . . . 72.420000000000002 107.374 -169.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -145.9 170.37 16.72 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 121.566 0.698 . . . . 65.019999999999996 112.782 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -145.93 122.49 11.09 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.634 -1.621 . . . . 73.040000000000006 107.442 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 59.1 82.18 0.15 Allowed 'General case' 0 C--O 1.249 1.031 0 C-N-CA 125.35 1.46 . . . . 72.219999999999999 113.304 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? 163.01 169.86 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.006 1.722 . . . . 74.450000000000003 109.248 173.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -113.88 116.24 28.98 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.58 -2.008 . . . . 74.239999999999995 105.58 173.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 5.1 p -77.41 124.7 28.23 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.988 -0.685 . . . . 71.219999999999999 110.29 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 80.4 p -134.95 150.73 50.43 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 121.433 0.635 . . . . 74.5 111.179 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.38 156.87 46.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.013 -1.477 . . . . 72.439999999999998 107.013 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 9.4 m -112.19 153.22 27.38 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.669 -0.813 . . . . 61.229999999999997 109.024 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 540' ' ' LYS . 43.1 tp -124.96 131.51 53.41 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.806 -1.553 . . . . 70.450000000000003 106.806 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.05 159.32 43.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 110.071 -0.344 . . . . 72.400000000000006 110.071 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.16 145.75 27.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.705 0.628 . . . . 75.430000000000007 109.685 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . 0.417 ' O ' HD12 ' A' ' 635' ' ' LEU . 6.6 mm-40 -96.69 163.02 13.19 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.177 -1.045 . . . . 62.020000000000003 108.177 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.0 122.53 72.8 Favored Pre-proline 0 C--N 1.311 -1.096 0 O-C-N 123.678 0.611 . . . . 71.420000000000002 110.383 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.55 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 59.7 Cg_endo -79.2 151.17 23.24 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 122.841 2.361 . . . . 74.310000000000002 113.31 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -122.11 128.7 51.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.772 -1.104 . . . . 73.310000000000002 110.38 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -84.16 116.81 23.1 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.265 -1.383 . . . . 74.5 107.265 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 45.4 mm -89.31 128.95 41.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.354 -0.98 . . . . 73.200000000000003 108.354 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -73.68 155.54 38.88 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.081 -0.711 . . . . 74.040000000000006 109.081 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 69.74 -73.46 0.09 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.843 1.257 . . . . 73.129999999999995 111.452 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 150.37 161.62 10.04 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 120.551 -0.833 . . . . 54.520000000000003 112.386 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 92.7 mmm -140.89 -174.01 3.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.695 -1.224 . . . . 73.319999999999993 107.695 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -155.94 -68.98 0.11 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.908 -1.515 . . . . 74.549999999999997 106.908 170.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 75.5 -59.97 2.86 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 116.06 -0.518 . . . . 54.43 113.889 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 108.66 -58.87 0.38 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 108.676 -1.77 . . . . 62.420000000000002 108.676 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -135.07 -171.78 2.89 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.413 -1.328 . . . . 75.400000000000006 107.413 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 37.3 m -81.39 125.09 29.97 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.666 -0.243 . . . . 72.400000000000006 110.35 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 43.8 mm -96.95 91.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 105.034 -2.21 . . . . 75.439999999999998 105.034 173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 12.2 t -94.09 81.97 4.14 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 122.469 1.128 . . . . 74.120000000000005 112.632 -172.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.59 -28.92 14.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.809 -1.923 . . . . 74.409999999999997 105.809 170.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -92.66 121.43 34.06 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.78 -1.933 . . . . 63.439999999999998 105.78 170.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -105.28 -24.34 12.72 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.359 0.6 . . . . 72.430000000000007 110.709 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -139.86 -145.1 0.18 Allowed 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.592 -2.003 . . . . 63.229999999999997 105.592 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 50.27 42.77 26.11 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 122.601 1.191 . . . . 73.010000000000005 111.893 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -56.64 -74.86 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.976 -1.92 . . . . 74.230000000000004 113.525 -172.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . 0.488 ' HB2' ' HD3' ' A' ' 616' ' ' PRO . 75.9 mt-30 -111.49 -61.95 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 113.083 0.771 . . . . 73.450000000000003 113.083 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 615' ' ' GLN . 1.6 Cg_endo -82.1 148.21 15.03 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.273 1.315 . . . . 74.219999999999999 111.321 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 41.2 mt -120.65 -42.26 2.54 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.297 -1.319 . . . . 72.430000000000007 110.884 -169.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 19.0 p -103.79 -179.4 3.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.809 -0.811 . . . . 74.010000000000005 108.809 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 50.4 m -79.7 114.4 18.6 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.886 0.374 . . . . 73.140000000000001 110.01 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -93.89 131.74 39.01 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.299 -0.41 . . . . 75.439999999999998 110.218 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.12 154.03 7.19 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 124.071 0.948 . . . . 72.450000000000003 110.193 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.69 44.0 30.3 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.972 0.795 . . . . 74.310000000000002 112.397 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.81 166.9 13.11 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.217 -0.593 . . . . 72.099999999999994 110.436 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 8.54 14.27 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.356 -0.979 . . . . 73.010000000000005 108.356 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -54.23 -39.18 66.52 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 114.38 -1.282 . . . . 74.140000000000001 112.718 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 630' ' ' MET . 21.8 tpt180 -58.59 -31.22 67.84 Favored 'General case' 0 C--O 1.211 -0.973 0 C-N-CA 122.617 0.367 . . . . 74.409999999999997 111.844 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.85 -29.08 28.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.367 0.603 . . . . 74.129999999999995 110.284 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -83.85 -40.33 18.79 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.918 0.866 . . . . 73.430000000000007 109.005 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -74.67 -6.22 47.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.196 -0.911 . . . . 72.430000000000007 111.516 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.409 ' HB3' ' O ' ' A' ' 626' ' ' ARG . 9.3 ptm -76.65 -13.42 60.06 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.036 -1.098 . . . . 75.030000000000001 108.036 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -90.64 0.88 77.84 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.28 -0.873 . . . . 75.310000000000002 111.829 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -76.0 167.1 39.76 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 109.753 -0.462 . . . . 71.409999999999997 109.753 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.55 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 34.5 Cg_exo -67.39 121.94 9.11 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 N-CA-C 107.762 -1.669 . . . . 72.049999999999997 107.762 164.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . 0.575 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER -131.56 -175.98 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-O 121.626 0.727 . . . . 71.040000000000006 110.069 -175.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 592' ' ' GLU . 22.6 mt -97.59 170.82 8.76 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.196 -1.039 . . . . 71.200000000000003 108.196 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.57 151.08 49.11 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.121 -2.392 . . . . 52.240000000000002 107.121 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.51 -42.06 66.95 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.235 0.517 . . . . 72.340000000000003 111.28 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -124.34 101.0 6.95 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.508 0.67 . . . . 73.140000000000001 110.733 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 7.5 t -136.02 109.78 8.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 122.243 1.02 . . . . 74.409999999999997 109.411 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -146.77 148.87 32.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.828 -1.175 . . . . 73.349999999999994 107.828 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 56.5 tp -129.6 112.98 14.25 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.425 -0.583 . . . . 63.119999999999997 109.425 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . 0.404 ' HB2' HG21 ' A' ' 511' ' ' VAL . 46.8 mt-10 -89.24 127.98 35.8 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.636 -0.875 . . . . 72.030000000000001 108.636 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.61 120.68 62.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.31 -0.996 . . . . 73.329999999999998 108.31 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.87 134.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.435 -0.802 . . . . 73.409999999999997 110.829 -176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.51 164.06 31.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 124.821 1.248 . . . . 71.510000000000005 109.551 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 516' ' ' GLU . 45.0 mt-10 -133.42 178.93 6.54 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.899 0.38 . . . . 75.319999999999993 110.716 -174.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -72.96 122.06 21.09 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 123.969 0.908 . . . . 72.510000000000005 110.626 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 57.9 m -133.66 -91.33 0.36 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 114.718 1.377 . . . . 51.109999999999999 114.718 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -156.81 -11.35 0.09 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 112.891 0.7 . . . . 63.439999999999998 112.891 -170.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . 0.482 ' HB3' ' H ' ' A' ' 577' ' ' ASP . 8.7 tp10 -64.16 137.84 58.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.3 1.048 . . . . 73.400000000000006 113.29 -168.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -128.58 116.16 19.2 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 105.98 -1.859 . . . . 75.239999999999995 105.98 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 550' ' ' GLY . 5.9 tmmm? -65.19 121.12 14.03 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.456 -0.942 . . . . 75.019999999999996 108.456 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 19.3 m -73.85 87.97 1.79 Allowed 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.354 -0.839 . . . . 75.129999999999995 109.989 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 16.3 m -62.33 115.4 4.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.539 -1.21 . . . . 74.120000000000005 110.264 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.83 145.44 12.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 109.2 -0.667 . . . . 74.129999999999995 109.2 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--N 1.301 -1.522 0 CA-C-N 116.165 -0.471 . . . . 71.409999999999997 110.704 -176.081 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 121.124 0.487 . . . . 72.120000000000005 110.309 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -156.23 -64.97 0.11 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.654 -1.61 . . . . 74.450000000000003 106.654 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . 151.35 128.66 1.49 Allowed Glycine 0 N--CA 1.42 -2.394 0 CA-C-N 114.883 -1.053 . . . . 75.209999999999994 111.548 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.48 121.32 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.785 -1.561 . . . . 74.019999999999996 106.785 172.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 56.4 m-85 -110.84 134.46 52.51 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.511 0.507 . . . . 73.230000000000004 110.078 -175.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 6.3 t -148.25 152.79 37.77 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 110.386 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.2 m-85 -74.26 159.74 32.06 Favored 'General case' 0 C--O 1.262 1.718 0 N-CA-C 108.862 -0.792 . . . . 75.109999999999999 108.862 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.35 -51.87 57.54 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.789 0.681 . . . . 71.200000000000003 109.613 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.49 161.54 54.22 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.146 -0.934 . . . . 73.310000000000002 109.088 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.2 Cg_endo -84.73 -20.8 3.59 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.613 1.542 . . . . 74.450000000000003 112.425 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 77.7 t -141.53 134.96 30.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.654 -0.499 . . . . 74.329999999999998 109.654 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -133.9 138.23 45.43 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.571 -0.529 . . . . 73.310000000000002 109.571 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -111.06 119.28 38.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 74.239999999999995 107.875 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.93 170.79 16.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.894 0.378 . . . . 70.310000000000002 110.381 -178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.2 t -88.88 158.97 17.91 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.6 0.714 . . . . 63.130000000000003 111.248 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -8.25 59.54 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.122 -0.945 . . . . 72.129999999999995 110.195 172.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 71.2 m -113.8 19.18 16.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.941 -0.572 . . . . 73.230000000000004 111.248 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 7.2 tt -82.22 -26.23 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.15 -0.62 . . . . 72.439999999999998 111.189 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.85 -74.24 2.52 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.588 -0.815 . . . . 64.120000000000005 111.588 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 573' ' ' ILE . 46.1 mm -129.92 131.17 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.503 -0.925 . . . . 72.120000000000005 108.503 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 17.9 ptm -107.15 145.75 32.15 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.97 -0.752 . . . . 63.109999999999999 108.97 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -106.36 129.31 54.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 123.374 0.421 . . . . 75.230000000000004 110.631 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.8 t -115.52 121.19 66.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.81 -0.811 . . . . 73.5 108.81 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -95.59 130.0 42.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.236 0.541 . . . . 75.329999999999998 110.594 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.43 115.17 35.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.152 -1.055 . . . . 75.25 108.152 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.4 mt -88.08 149.67 23.82 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.661 -0.7 . . . . 75.209999999999994 109.583 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.92 103.78 11.27 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.266 -1.013 . . . . 74.409999999999997 108.266 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.1 p -67.23 -58.11 5.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.519 0.676 . . . . 62.140000000000001 110.939 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 24.3 t -73.97 -23.76 59.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.324 -0.853 . . . . 74.140000000000001 110.157 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . 0.501 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 108.88 -149.18 16.99 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 110.229 -1.149 . . . . 63.119999999999997 110.229 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -160.16 135.79 8.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.185 -1.413 . . . . 75.030000000000001 107.185 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -136.35 121.47 18.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.261 -0.644 . . . . 75.140000000000001 109.261 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.44 -121.99 7.29 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.798 -0.715 . . . . 73.040000000000006 113.038 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -137.75 104.89 5.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.028 -1.101 . . . . 72.329999999999998 108.028 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.88 126.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.619 0.723 . . . . 54.43 110.634 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' A' ' 559' ' ' GLU . 29.8 mm -95.78 118.01 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.349 -0.842 . . . . 70.510000000000005 109.468 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.65 103.72 50.23 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 115.295 -0.866 . . . . 75.049999999999997 108.792 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 1.0 OUTLIER -78.16 156.67 29.92 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 121.424 1.416 . . . . 65.340000000000003 111.082 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -143.01 161.0 39.28 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.384 -1.339 . . . . 73.319999999999993 107.384 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -156.17 135.07 11.89 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.951 0.405 . . . . 74.530000000000001 111.14 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.6 p -82.92 122.96 28.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.661 -0.699 . . . . 75.319999999999993 110.378 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 37.0 mm -92.71 125.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.764 -1.199 . . . . 75.120000000000005 107.764 -176.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.58 113.11 13.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.922 0.392 . . . . 73.140000000000001 111.242 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -92.4 -103.47 1.49 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.433 -1.067 . . . . 65.099999999999994 110.433 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -94.1 -18.01 22.23 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 109.69 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.01 149.1 24.21 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.392 -0.822 . . . . 75.530000000000001 108.924 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -101.84 134.83 44.4 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.11 0.481 . . . . 74.340000000000003 112.055 -176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.96 -179.75 47.26 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.476 -0.783 . . . . 53.149999999999999 111.367 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.87 57.62 Favored Glycine 0 C--N 1.306 -1.125 0 N-CA-C 110.594 -1.002 . . . . 60.409999999999997 110.594 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.33 19.95 50.65 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 111.491 -0.644 . . . . 71.439999999999998 111.491 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -80.08 -80.1 0.14 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.795 0.331 . . . . 75.450000000000003 110.361 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.79 -32.18 16.21 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.825 -0.805 . . . . 72.120000000000005 108.825 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -143.94 152.8 41.57 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.02 -1.104 . . . . 75.439999999999998 108.02 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 23.3 tt0 -87.89 105.08 17.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.681 -2.34 . . . . 75.109999999999999 104.681 176.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.32 144.96 56.78 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.024 0.828 . . . . 65.439999999999998 109.725 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -140.06 114.06 8.93 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-O 122.046 0.927 . . . . 72.129999999999995 110.885 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.2 p -125.15 118.54 26.31 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.212 -1.358 . . . . 73.129999999999995 107.373 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.17 15.54 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 110.668 -0.973 . . . . 75.510000000000005 110.668 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 8.0 pt-20 -132.84 139.18 47.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.334 0.588 . . . . 70.439999999999998 111.866 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.97 144.71 33.2 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.48 -1.236 . . . . 74.109999999999999 108.692 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -109.73 104.21 13.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.208 0.528 . . . . 74.540000000000006 111.052 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.7 m-85 -98.71 120.0 38.41 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.27 -1.011 . . . . 64.420000000000002 108.27 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.442 ' H ' HD13 ' A' ' 567' ' ' ILE . 49.6 mt-30 -98.21 -80.18 0.46 Allowed 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.734 -0.839 . . . . 73.340000000000003 108.734 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -105.33 155.17 19.35 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.966 -0.561 . . . . 74.200000000000003 110.131 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -46.51 -29.16 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.171 1.788 . . . . 72.430000000000007 114.213 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -64.62 -14.14 56.64 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.95 1.093 . . . . 64.140000000000001 113.95 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 563' ' ' GLN . 37.2 pt -112.76 156.46 13.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 119.706 -0.798 . . . . 74.439999999999998 110.283 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.65 144.32 37.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.692 -0.855 . . . . 72.439999999999998 108.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.549 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.4 mmpt? -111.36 149.57 30.97 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 120.404 -0.519 . . . . 73.129999999999995 109.662 176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 570' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 73.3 mt -126.05 131.45 71.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.481 -1.236 . . . . 75.549999999999997 110.595 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 41.6 mt -92.87 123.75 45.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.321 -1.362 . . . . 75.340000000000003 107.321 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 19.5 p -108.29 114.27 28.0 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 123.466 0.479 . . . . 73.25 109.814 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 520' ' ' ILE . 36.6 mt -110.01 135.03 50.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.554 -0.535 . . . . 74.549999999999997 109.554 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' ARG . . . . . 0.516 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 71.3 ttt180 -92.21 123.82 35.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.263 -0.643 . . . . 74.340000000000003 109.263 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.2 134.22 46.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.313 -0.625 . . . . 74.310000000000002 109.313 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -114.22 162.6 16.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.251 -0.648 . . . . 74.010000000000005 109.251 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -104.33 112.0 24.86 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.025 -0.534 . . . . 73.030000000000001 111.124 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -142.63 -43.75 0.31 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.027 -0.533 . . . . 74.109999999999999 110.619 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -81.11 145.04 31.27 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.408 -0.589 . . . . 75.150000000000006 109.408 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -90.16 177.56 6.4 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.286 -0.635 . . . . 72.340000000000003 109.286 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -57.85 -20.39 36.0 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.328 1.051 . . . . 73.0 110.417 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.67 -45.02 77.82 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.504 1.922 . . . . 71.120000000000005 112.714 -173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -125.79 137.38 53.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.177 -0.675 . . . . 74.409999999999997 109.177 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -78.85 96.67 5.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.864 0.84 . . . . 74.25 111.109 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 3.5 p -74.06 115.89 14.05 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.455 -0.793 . . . . 71.230000000000004 109.166 174.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 15.0 m -138.26 148.55 44.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.23 -0.656 . . . . 73.400000000000006 109.23 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.1 166.25 25.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.855 -1.165 . . . . 72.140000000000001 107.855 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 26.5 m -116.29 166.86 11.56 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 119.935 -0.706 . . . . 64.430000000000007 109.686 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 573' ' ' ILE . 31.8 tp -139.58 127.8 22.57 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 107.591 -1.263 . . . . 74.5 107.591 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.36 157.31 36.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.614 -0.513 . . . . 75.329999999999998 109.614 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 45.2 mt -95.34 147.23 23.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.114 -1.81 . . . . 63.130000000000003 106.114 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 593' ' ' GLU . 6.8 tp10 -98.43 177.67 5.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.857 -1.535 . . . . 74.409999999999997 106.857 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 37.6 mt-10 -75.16 119.78 78.54 Favored Pre-proline 0 C--N 1.288 -2.105 0 CA-C-N 116.341 -0.39 . . . . 73.5 110.638 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -72.41 146.14 44.22 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.351 2.701 . . . . 74.200000000000003 113.703 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -110.31 149.28 30.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.442 -0.947 . . . . 74.319999999999993 108.442 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -107.14 127.88 53.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.673 -1.232 . . . . 75.400000000000006 107.673 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.39 90.12 2.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.229 1.014 . . . . 71.450000000000003 108.717 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -74.62 108.57 7.46 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 113.343 -1.753 . . . . 74.530000000000001 107.706 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -78.26 79.07 4.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.06 0.933 . . . . 74.519999999999996 109.962 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -179.96 34.63 0.07 OUTLIER Glycine 0 C--N 1.286 -2.234 0 N-CA-C 106.752 -2.539 . . . . 73.219999999999999 106.752 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 27.3 ttt -172.07 89.53 0.1 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.731 1.612 . . . . 74.409999999999997 106.909 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 602' ' ' LYS . 0.4 OUTLIER -74.04 131.87 41.79 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.872 -0.604 . . . . 73.510000000000005 112.367 -177.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 86.99 -107.29 3.23 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.771 -0.728 . . . . 72.25 111.45 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 86.84 22.17 47.22 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.196 -1.162 . . . . 73.129999999999995 110.196 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 31.3 t80 62.22 82.17 0.18 Allowed 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.223 1.409 . . . . 61.329999999999998 109.804 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 48.2 m -79.4 123.61 27.67 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.905 -1.043 . . . . 73.450000000000003 110.921 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 47.6 mm -89.12 -29.34 5.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.514 -0.766 . . . . 72.200000000000003 110.014 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 11.9 m -70.73 80.91 0.61 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 115.547 1.684 . . . . 75.519999999999996 115.547 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.61 6.58 2.28 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 123.599 1.666 . . . . 73.230000000000004 107.026 165.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -157.36 142.05 16.66 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 100.878 -3.749 . . . . 74.420000000000002 100.878 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -91.7 -76.84 0.44 Allowed 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 118.775 0.716 . . . . 71.219999999999999 111.396 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' ASP . . . . . 0.446 ' OD2' ' HA ' ' A' ' 616' ' ' PRO . 6.7 t70 -159.1 -164.3 1.38 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.79 -1.189 . . . . 72.409999999999997 107.79 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . 0.453 ' OD1' ' HG2' ' A' ' 614' ' ' LYS . 13.0 t70 -133.24 -49.04 0.85 Allowed 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.316 -1.364 . . . . 64.530000000000001 107.316 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' LYS . . . . . 0.511 ' HG3' ' OE1' ' A' ' 615' ' ' GLN . 14.9 pttm 167.12 -23.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.394 2.677 . . . . 71.299999999999997 107.561 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' GLN . . . . . 0.511 ' OE1' ' HG3' ' A' ' 614' ' ' LYS . 26.1 mp0 -126.52 135.96 27.99 Favored Pre-proline 0 C--O 1.246 0.907 0 N-CA-C 106.011 -1.848 . . . . 71.439999999999998 106.011 169.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.446 ' HA ' ' OD2' ' A' ' 612' ' ' ASP . 35.9 Cg_exo -57.16 150.0 60.01 Favored 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 123.177 2.585 . . . . 71.129999999999995 114.638 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -101.47 8.13 42.19 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.551 -0.749 . . . . 71.200000000000003 110.097 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 17.3 p -81.13 -63.68 1.35 Allowed 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.493 -0.776 . . . . 75.219999999999999 109.804 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 30.7 m 54.52 34.62 21.53 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.995 0.918 . . . . 74.040000000000006 110.028 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -96.0 107.6 19.9 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.354 -0.839 . . . . 74.019999999999996 112.634 -172.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -89.39 86.45 6.8 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.921 -1.14 . . . . 64.439999999999998 107.921 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -86.78 149.22 25.01 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.193 -1.367 . . . . 73.340000000000003 109.428 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.54 135.07 50.99 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.075 -0.511 . . . . 74.519999999999996 111.555 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 64.35 25.83 13.5 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.009 1.324 . . . . 71.209999999999994 112.658 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . 0.64 ' O ' ' HG2' ' A' ' 629' ' ' GLU . 2.0 mmt180 -60.41 -40.8 92.29 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 114.552 1.316 . . . . 64.140000000000001 114.552 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.604 ' O ' ' HG3' ' A' ' 630' ' ' MET . 14.4 mmm180 -63.99 -46.13 85.93 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 118.62 0.645 . . . . 74.010000000000005 109.397 -178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' ILE . . . . . 0.437 ' HA ' ' SD ' ' A' ' 630' ' ' MET . 79.4 mt -64.91 -36.53 77.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.057 -0.974 . . . . 65.450000000000003 109.631 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 632' ' ' ARG . . . -57.07 -52.12 66.56 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.692 -0.686 . . . . 74.049999999999997 109.953 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' GLU . . . . . 0.64 ' HG2' ' O ' ' A' ' 625' ' ' ARG . 31.5 mm-40 -61.51 -30.51 70.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.51 -0.768 . . . . 74.409999999999997 111.893 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' MET . . . . . 0.604 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 60.8 mtt -63.1 -26.27 68.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.389 -0.823 . . . . 74.209999999999994 110.872 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.43 27.94 11.66 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.491 -0.644 . . . . 51.240000000000002 111.491 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 628' ' ' ALA . 85.8 mtt180 -116.76 163.62 21.82 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.681 -0.488 . . . . 71.239999999999995 109.681 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -63.85 150.4 88.49 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.675 1.583 . . . . 73.109999999999999 109.833 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 19.9 pt -126.85 -177.25 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.966 -0.561 . . . . 73.310000000000002 110.326 -173.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 505' ' ' PHE . 1.9 pt? -134.56 -171.87 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.321 -0.622 . . . . 72.109999999999999 109.321 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -63.66 156.52 43.0 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 121.026 -0.607 . . . . 51.049999999999997 111.822 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.39 -57.2 13.97 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.29 1.036 . . . . 74.299999999999997 110.025 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.4 98.8 4.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.733 -0.84 . . . . 74.019999999999996 108.733 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.6 t -130.94 110.45 11.27 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-O 122.625 1.202 . . . . 75.540000000000006 110.465 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 39.5 ttpt -147.61 141.06 25.37 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.924 -1.51 . . . . 73.230000000000004 106.924 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 63.2 tp -117.18 110.0 17.6 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.878 -0.786 . . . . 75.150000000000006 108.878 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.36 123.9 32.81 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.648 -0.871 . . . . 75.109999999999999 108.648 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.4 121.37 61.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.148 -0.933 . . . . 75.200000000000003 109.373 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.61 128.43 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.191 -0.913 . . . . 71.209999999999994 109.534 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.83 127.27 75.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.25 -0.886 . . . . 75.239999999999995 110.066 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.18 156.66 45.9 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.281 -1.378 . . . . 71.409999999999997 107.281 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -55.96 111.36 0.92 Allowed 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 124.116 0.885 . . . . 73.430000000000007 110.616 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 15.2 m -105.71 96.22 6.34 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 109.457 -0.571 . . . . 73.519999999999996 109.457 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -76.95 -37.92 54.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.196 -1.409 . . . . 74.349999999999994 107.196 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -88.63 84.07 6.74 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 106.945 -1.502 . . . . 74.329999999999998 106.945 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -81.43 120.46 25.01 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 107.468 -1.308 . . . . 73.409999999999997 107.468 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -78.68 142.23 37.31 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.877 -0.601 . . . . 71.040000000000006 112.446 -170.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 12.9 m -85.72 107.51 17.62 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.596 -0.729 . . . . 72.150000000000006 109.607 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 15.1 t -86.97 -21.59 26.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.514 0.673 . . . . 74.430000000000007 110.13 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 47.6 t -91.5 93.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.381 -0.97 . . . . 75.019999999999996 108.381 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 C--N 1.308 -1.209 0 N-CA-C 109.717 -0.475 . . . . 74.230000000000004 109.717 -179.527 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.911 0 N-CA-C 110.973 -0.851 . . . . 74.420000000000002 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.27 114.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.18 -0.674 . . . . 71.040000000000006 109.18 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.19 136.58 52.8 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.084 0.24 . . . . 73.319999999999993 110.445 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.1 t -148.64 160.23 43.34 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.993 -0.373 . . . . 74.129999999999995 109.993 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.71 158.57 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 122.164 0.186 . . . . 72.349999999999994 110.583 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 45.6 mt-10 -58.48 -49.97 75.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.179 0.514 . . . . 75.200000000000003 110.716 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 509' ' ' GLU . . . . . 0.56 ' OE2' ' HD2' ' A' ' 510' ' ' PRO . 7.7 tp10 -141.96 137.76 16.3 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.523 -2.029 . . . . 64.329999999999998 105.523 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.56 ' HD2' ' OE2' ' A' ' 509' ' ' GLU . 41.4 Cg_endo -70.79 -10.65 28.17 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.491 2.127 . . . . 72.0 114.656 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 642' ' ' GLU . 72.7 t -140.73 126.93 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 122.028 -0.42 . . . . 72.400000000000006 110.161 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.96 130.57 37.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.484 0.659 . . . . 33.439999999999998 109.615 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -110.07 121.61 45.67 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.646 -0.501 . . . . 72.540000000000006 109.646 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.81 160.91 36.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.128 -0.487 . . . . 63.439999999999998 111.709 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 518' ' ' ILE . 20.2 m -71.88 156.47 39.24 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 73.400000000000006 110.832 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -30.73 58.3 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.811 -1.181 . . . . 60.509999999999998 107.811 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.1 p -90.83 16.71 8.83 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.435 -1.257 . . . . 74.349999999999994 111.777 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 515' ' ' SER . 7.5 tt -78.73 -30.09 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 120.281 -0.568 . . . . 72.230000000000004 110.607 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.39 -68.09 3.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.108 -1.044 . . . . 73.120000000000005 112.444 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.2 mm -130.79 132.12 64.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.638 -1.245 . . . . 74.200000000000003 107.638 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -107.15 154.51 21.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.167 -1.049 . . . . 73.340000000000003 108.167 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.55 124.25 40.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.923 0.392 . . . . 71.030000000000001 111.595 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.637 HG12 ' HB ' ' A' ' 571' ' ' ILE . 8.6 p -124.86 133.15 70.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.019 -0.734 . . . . 72.099999999999994 109.019 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 98.7 mttt -93.27 138.68 31.42 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.407 -0.59 . . . . 75.400000000000006 109.407 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 85.3 t -96.03 121.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.926 -1.509 . . . . 71.329999999999998 106.926 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.16 155.59 16.99 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.235 -0.893 . . . . 73.349999999999994 110.314 -174.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -124.86 104.61 8.7 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.327 -0.99 . . . . 65.140000000000001 108.327 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.8 m -64.93 -56.11 15.23 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.28 -0.873 . . . . 73.540000000000006 111.153 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.6 p -73.79 -48.21 33.23 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.593 0.711 . . . . 61.310000000000002 110.005 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.41 -159.91 26.8 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 111.171 -0.771 . . . . 71.519999999999996 111.171 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.485 ' H ' ' HB2' ' A' ' 565' ' ' ASP . . . -148.51 144.95 27.68 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.999 -1.482 . . . . 54.530000000000001 106.999 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -161.12 77.61 0.57 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.759 -0.83 . . . . 75.439999999999998 108.759 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.446 ' HA3' ' HE1' ' A' ' 596' ' ' TRP . . . 157.87 -127.67 1.95 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.018 -1.087 . . . . 24.41 111.311 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -137.22 102.57 4.86 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.395 -1.706 . . . . 65.200000000000003 106.395 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 120.0 62.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.335 0.588 . . . . 61.149999999999999 110.347 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.88 115.88 34.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 N-CA-C 108.457 -0.942 . . . . 63.329999999999998 108.457 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.77 101.51 51.46 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.607 -0.724 . . . . 63.5 109.835 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 2.7 Cg_endo -76.66 155.79 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.088 1.858 . . . . 60.109999999999999 112.275 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -142.15 160.66 39.79 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.435 -0.95 . . . . 74.530000000000001 108.435 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -151.43 136.43 17.37 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.875 0.369 . . . . 71.019999999999996 110.977 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.3 p -85.0 126.89 33.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.853 -0.612 . . . . 63.009999999999998 111.271 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.65 121.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.267 -1.012 . . . . 72.219999999999999 108.267 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -79.16 104.88 10.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.843 -0.799 . . . . 73.439999999999998 108.843 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -86.24 -94.3 0.84 Allowed Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.386 -1.086 . . . . 63.210000000000001 110.386 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.8 p -102.8 -12.27 17.72 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.172 0.511 . . . . 72.109999999999999 110.538 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.43 152.89 21.24 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.391 -0.966 . . . . 65.549999999999997 108.391 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -107.61 131.4 54.41 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.157 -0.617 . . . . 74.219999999999999 109.856 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.19 -154.76 20.35 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.271 -1.132 . . . . 45.130000000000003 110.271 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.92 79.81 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.513 -0.851 . . . . 65.219999999999999 112.094 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' A' ' 576' ' ' PHE . . . 92.29 11.38 59.82 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.779 -0.724 . . . . 74.230000000000004 113.104 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -76.25 -77.95 0.13 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 117.45 0.625 . . . . 70.329999999999998 110.802 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -93.84 -42.72 8.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.882 -1.155 . . . . 42.200000000000003 107.882 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -135.36 163.05 30.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 108.966 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 576' ' ' PHE . 28.2 tt0 -97.62 116.62 30.19 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.294 -1.743 . . . . 72.420000000000002 106.294 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.17 142.15 54.38 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.364 -0.606 . . . . 74.420000000000002 109.364 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -140.12 132.44 28.33 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.684 0.755 . . . . 64.510000000000005 110.229 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.4 p -140.65 122.14 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.714 -1.217 . . . . 40.210000000000001 107.714 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.68 -176.97 36.13 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 109.743 -1.343 . . . . 74.340000000000003 109.743 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 0.3 OUTLIER -126.31 128.68 47.5 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.628 0.728 . . . . 64.329999999999998 111.961 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 79.7 mt -89.53 144.34 26.11 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.094 -1.412 . . . . 72.120000000000005 110.061 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -105.59 101.87 11.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.395 0.617 . . . . 73.409999999999997 111.506 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 42.7 m-85 -100.21 100.41 11.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.791 -0.818 . . . . 70.219999999999999 108.791 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.473 ' H ' HD11 ' A' ' 567' ' ' ILE . 81.4 mt-30 -83.1 -77.9 0.23 Allowed 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.792 -0.763 . . . . 73.340000000000003 110.239 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -105.43 159.25 16.07 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.843 -0.617 . . . . 62.140000000000001 109.369 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.485 ' HB2' ' H ' ' A' ' 531' ' ' ALA . 13.2 t70 -57.99 -23.21 53.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.415 1.086 . . . . 71.439999999999998 111.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.08 -43.49 78.08 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.724 1.209 . . . . 73.340000000000003 112.0 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.473 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -96.39 158.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.255 0.55 . . . . 73.019999999999996 110.705 -173.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.68 154.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.879 -1.156 . . . . 74.5 107.879 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.59 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.5 mmpt? -115.49 154.71 28.83 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.861 0.362 . . . . 65.25 111.167 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 53.0 mt -128.54 136.62 59.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.581 -1.191 . . . . 71.209999999999994 109.529 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.637 ' HB ' HG12 ' A' ' 523' ' ' VAL . 56.3 mt -97.78 125.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.563 -1.643 . . . . 74.030000000000001 106.563 174.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 21.7 p -110.41 112.38 24.27 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.672 -0.862 . . . . 73.430000000000007 108.672 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.618 HD11 HD22 ' A' ' 589' ' ' LEU . 42.5 mt -108.27 134.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.819 -0.808 . . . . 52.43 108.819 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.415 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.0 OUTLIER -82.18 117.13 22.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 109.566 -0.531 . . . . 71.420000000000002 109.566 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.42 123.69 57.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.59 -2.004 . . . . 73.200000000000003 105.59 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 550' ' ' GLY . 90.4 m-85 . . . . . 0 C--N 1.298 -1.646 0 C-N-CA 120.55 -0.46 . . . . 73.400000000000006 111.297 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.433 -1.299 0 CA-C-O 122.47 1.129 . . . . 72.120000000000005 113.352 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.7 m -143.65 153.09 42.14 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.368 -1.345 . . . . 62.43 107.368 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -133.49 153.11 51.9 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.406 -0.961 . . . . 75.319999999999993 108.406 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.8 m -111.25 154.51 24.35 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.687 -0.857 . . . . 71.439999999999998 108.687 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.618 HD22 HD11 ' A' ' 573' ' ' ILE . 39.7 tp -129.07 130.46 46.56 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.068 -1.456 . . . . 73.349999999999994 107.068 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.43 158.7 38.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 123.218 0.324 . . . . 71.200000000000003 110.313 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.05 145.52 26.45 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.128 -0.942 . . . . 74.150000000000006 108.49 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 592' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 538' ' ' PRO . 17.6 mm-40 -101.59 165.99 10.94 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.324 -0.621 . . . . 71.530000000000001 109.324 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.32 114.55 7.4 Favored Pre-proline 0 C--O 1.245 0.851 0 O-C-N 124.233 0.958 . . . . 75.109999999999999 111.303 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.62 150.56 27.92 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.132 2.554 . . . . 72.420000000000002 111.443 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.93 140.27 51.15 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.415 -0.178 . . . . 51.219999999999999 111.471 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 596' ' ' TRP . . . . . 0.446 ' HE1' ' HA3' ' A' ' 533' ' ' GLY . 1.0 OUTLIER -103.03 118.05 35.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.675 -0.491 . . . . 74.129999999999995 109.675 -176.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--N 1.294 -1.846 0 C-N-CA 123.407 0.683 . . . . 72.530000000000001 110.432 -179.133 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 N--CA 1.434 -1.238 0 N-CA-C 109.698 -0.482 . . . . 64.209999999999994 109.698 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.48 177.98 4.71 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.229 -1.026 . . . . 74.219999999999999 108.229 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.5 170.65 42.11 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.46 -0.656 . . . . 73.299999999999997 111.46 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -49.75 -61.61 2.03 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.249 1.02 . . . . 72.409999999999997 112.043 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -129.33 102.17 6.31 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.787 -1.56 . . . . 74.030000000000001 106.787 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 3.6 t -129.51 111.85 13.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 122.337 1.065 . . . . 64.420000000000002 110.865 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 640' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 37.0 ttmt -147.19 151.74 37.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.876 -1.898 . . . . 74.109999999999999 105.876 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 523' ' ' VAL . 51.8 tp -123.38 103.45 8.5 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.977 -0.749 . . . . 73.549999999999997 108.977 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 511' ' ' VAL . 44.2 mt-10 -87.45 106.53 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.551 -0.907 . . . . 73.430000000000007 108.551 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 32.0 t -96.9 121.69 47.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 114.91 -1.041 . . . . 62.539999999999999 108.197 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 27.9 mt -115.55 133.49 61.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.108 -0.951 . . . . 72.409999999999997 110.896 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.249 0 C-N-CA 125.062 1.345 . . . . 71.140000000000001 108.402 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.829 0 N-CA-C 112.067 -0.413 . . . . 52.219999999999999 112.067 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 67.3 mt -127.02 116.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.805 -1.183 . . . . 75.209999999999994 107.805 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -108.16 137.66 45.76 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.618 0.574 . . . . 75.219999999999999 111.67 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.2 t -148.91 157.37 43.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.83 -0.623 . . . . 64.030000000000001 109.371 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.37 155.68 36.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.086 -0.339 . . . . 74.099999999999994 110.086 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -59.39 -48.18 82.63 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 123.615 0.572 . . . . 73.530000000000001 110.47 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.42 151.09 77.31 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.42 -0.956 . . . . 55.530000000000001 108.42 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 2.4 Cg_endo -78.35 -20.63 10.96 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.631 1.554 . . . . 41.32 110.496 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 642' ' ' GLU . 65.8 t -139.98 127.3 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.711 -0.848 . . . . 52.109999999999999 108.711 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -129.42 133.57 47.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.269 -0.641 . . . . 50.539999999999999 109.269 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -107.09 121.41 44.43 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.642 -0.873 . . . . 73.439999999999998 108.642 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.54 148.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.406 0.622 . . . . 72.140000000000001 111.022 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 50.7 m -65.12 141.27 58.76 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.542 -1.208 . . . . 70.200000000000003 110.262 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.55 -24.26 62.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 109.832 177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.39 17.99 17.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.066 -0.515 . . . . 45.109999999999999 110.828 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.1 -23.27 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.247 0.546 . . . . 73.430000000000007 111.036 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.43 -73.32 2.24 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.448 -0.882 . . . . 71.439999999999998 110.935 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.72 126.79 69.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.899 -1.148 . . . . 52.420000000000002 107.899 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.404 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.5 ppp? -98.15 148.7 23.3 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.865 -1.161 . . . . 73.420000000000002 107.865 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.3 119.16 28.5 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.414 0.446 . . . . 71.239999999999995 111.692 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.46 HG21 HD21 ' A' ' 641' ' ' LEU . 52.5 t -127.43 126.72 68.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.107 -0.701 . . . . 74.409999999999997 109.107 173.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.462 ' HG2' HG12 ' A' ' 570' ' ' ILE . 62.6 mttp -91.96 147.75 22.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.026 -0.534 . . . . 64.310000000000002 110.699 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.07 116.15 38.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.293 -1.373 . . . . 74.239999999999995 107.293 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.9 155.99 18.77 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.408 -0.814 . . . . 42.43 110.428 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.88 104.63 12.13 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 107.787 -1.19 . . . . 74.299999999999997 107.787 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.1 m -65.24 -61.22 2.25 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.421 -0.354 . . . . 63.43 110.709 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.2 t -74.57 -49.17 22.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.224 0.535 . . . . 65.140000000000001 109.851 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 151.78 -159.73 28.44 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.381 -1.488 . . . . 50.530000000000001 109.381 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -161.95 139.47 8.65 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.028 -0.73 . . . . 74.299999999999997 109.028 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -156.67 133.81 10.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 106.432 -1.692 . . . . 65.099999999999994 106.432 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 532' ' ' ARG . . . 108.63 -133.4 11.64 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.335 -0.936 . . . . 60.43 111.748 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -137.58 108.42 6.67 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.993 -1.114 . . . . 72.209999999999994 107.993 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.49 124.73 70.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.672 0.749 . . . . 74.239999999999995 111.199 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 559' ' ' GLU . 31.9 mm -93.7 116.45 34.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.043 -0.98 . . . . 71.230000000000004 108.687 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.4 t -108.81 99.24 33.49 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.912 -1.144 . . . . 71.319999999999993 107.912 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.1 159.98 23.66 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.682 1.588 . . . . 75.5 111.514 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -144.82 161.05 40.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.035 -1.098 . . . . 72.409999999999997 108.035 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -152.37 134.83 15.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.009 0.433 . . . . 75.150000000000006 111.006 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' THR . . . . . 0.411 HG23 HD13 ' A' ' 589' ' ' LEU . 0.7 OUTLIER -81.9 138.59 34.99 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.089 -0.96 . . . . 74.430000000000007 112.006 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.2 mm -115.52 126.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.582 -1.636 . . . . 62.020000000000003 106.582 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.91 166.72 22.95 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.901 0.382 . . . . 41.109999999999999 110.792 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -162.87 -111.43 0.26 Allowed Glycine 0 CA--C 1.495 -1.215 0 N-CA-C 110.474 -1.05 . . . . 72.040000000000006 110.474 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -31.04 58.75 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.469 -1.308 . . . . 64.239999999999995 107.469 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 552' ' ' ASP . . . -88.56 143.4 26.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.932 -1.485 . . . . 45.229999999999997 107.146 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -109.42 153.35 24.13 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 113.531 0.937 . . . . 75.310000000000002 113.531 -171.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 43.11 -119.58 2.36 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 126.771 2.129 . . . . 73.510000000000005 118.372 168.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -164.89 96.35 0.13 Allowed Glycine 0 N--CA 1.412 -2.902 0 N-CA-C 108.649 -1.78 . . . . 64.340000000000003 108.649 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 123.01 -19.5 7.77 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 109.595 -1.402 . . . . 74.109999999999999 109.595 -175.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 6.2 mp0 -76.97 -73.05 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.981 -0.609 . . . . 52.229999999999997 110.101 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 547' ' ' ARG . 5.7 m-20 -103.22 -44.17 5.26 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 122.136 0.969 . . . . 72.400000000000006 108.988 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -133.79 155.61 49.49 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 107.277 -1.379 . . . . 75.230000000000004 107.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.498 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 3.8 tm-20 -89.01 129.77 35.6 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.529 -1.285 . . . . 74.239999999999995 107.529 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.55 103.1 3.43 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.451 0.644 . . . . 72.040000000000006 111.199 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.6 t -108.43 113.7 26.95 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.384 -0.969 . . . . 70.409999999999997 108.384 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -143.41 100.6 3.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.503 -0.771 . . . . 73.310000000000002 109.231 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.81 -163.56 10.76 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.622 -0.799 . . . . 54.530000000000001 112.228 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.518 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.6 mt-10 -116.83 117.9 31.0 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.422 0.689 . . . . 64.030000000000001 110.582 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.4 mt -89.31 139.5 30.43 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.047 -0.723 . . . . 70.439999999999998 109.047 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.88 105.07 14.71 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.67 -0.812 . . . . 71.329999999999998 111.417 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 31.5 m-85 -96.21 143.79 26.99 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.397 -1.334 . . . . 53.109999999999999 107.397 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.458 ' H ' HD11 ' A' ' 567' ' ' ILE . 79.4 mt-30 -116.29 -86.94 0.61 Allowed 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.245 -1.02 . . . . 65.150000000000006 108.245 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.97 168.53 9.0 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.527 -0.869 . . . . 64.519999999999996 109.043 173.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -59.28 -11.05 3.51 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.244 1.418 . . . . 64.420000000000002 113.575 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.589 ' HG3' HG23 ' A' ' 567' ' ' ILE . 16.1 pt-20 -69.77 -17.88 63.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.729 0.412 . . . . 72.200000000000003 111.973 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.589 HG23 ' HG3' ' A' ' 566' ' ' GLU . 41.0 pt -116.13 163.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 C-N-CA 120.319 -0.552 . . . . 73.140000000000001 111.464 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.3 146.45 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 108.181 -1.044 . . . . 65.319999999999993 108.181 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 70.9 mmtt -109.83 145.05 37.4 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.591 -0.522 . . . . 73.129999999999995 109.591 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 524' ' ' LYS . 63.1 mt -116.92 133.6 63.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.368 -1.287 . . . . 52.0 108.287 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.436 HD13 HD21 ' A' ' 589' ' ' LEU . 55.5 mt -93.15 113.08 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 106.932 -1.507 . . . . 61.219999999999999 106.932 174.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -102.48 112.31 24.99 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.106 -0.952 . . . . 65.140000000000001 109.55 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 521' ' ' MET . 48.6 mt -107.65 129.43 61.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.983 -1.117 . . . . 74.140000000000001 107.983 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.498 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 63.8 mtt85 -78.25 114.62 17.31 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.504 -0.924 . . . . 64.400000000000006 108.504 176.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.4 mm -101.0 126.67 54.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.603 -0.888 . . . . 64.430000000000007 108.603 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 50.8 m-85 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 121.039 0.447 . . . . 65.239999999999995 110.912 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 645' ' ' ILE . 2.2 p . . . . . 0 N--CA 1.435 -1.205 0 CA-C-O 120.647 0.26 . . . . 70.109999999999999 110.711 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 6.7 m -130.57 152.44 49.95 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.743 -0.383 . . . . 55.350000000000001 110.558 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.8 p90 -138.95 175.59 9.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.381 -1.34 . . . . 62.310000000000002 107.381 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 14.7 m -125.59 158.88 33.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.632 -0.827 . . . . 71.450000000000003 110.577 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.436 HD21 HD13 ' A' ' 571' ' ' ILE . 59.2 tp -136.61 132.92 35.72 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 106.551 -1.648 . . . . 72.200000000000003 106.551 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.58 155.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 120.96 -0.296 . . . . 75.219999999999999 110.363 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.469 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 85.7 mt -92.1 142.53 27.41 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.317 -0.994 . . . . 63.240000000000002 108.317 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -93.87 175.57 6.67 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.463 -0.79 . . . . 73.340000000000003 109.404 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -66.58 113.9 14.98 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 123.734 0.646 . . . . 55.210000000000001 109.364 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.57 143.85 34.9 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.754 1.636 . . . . 72.209999999999994 111.264 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.05 140.46 51.9 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.375 -0.829 . . . . 44.130000000000003 110.472 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -102.06 124.22 47.29 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.084 -1.45 . . . . 74.150000000000006 107.084 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--N 1.295 -1.781 0 CA-C-O 121.764 0.793 . . . . 71.299999999999997 108.932 -179.691 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 634' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.048 0 CA-C-O 121.19 0.519 . . . . 63.310000000000002 111.358 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.74 176.39 6.37 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.469 -0.937 . . . . 63.509999999999998 108.469 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.06 -128.55 0.21 Allowed Glycine 0 C--N 1.309 -0.929 0 CA-C-O 121.968 0.76 . . . . 52.130000000000003 113.102 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.33 -84.17 0.05 OUTLIER 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.834 -0.683 . . . . 64.519999999999996 109.241 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -141.75 94.93 2.74 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 105.085 -2.191 . . . . 74.209999999999994 105.085 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 639' ' ' THR . . . . . 0.41 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 13.3 t -100.65 118.34 36.59 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-O 122.401 1.096 . . . . 54.399999999999999 110.954 -172.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 640' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 3.7 ttmp? -145.05 143.64 30.56 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.848 -1.908 . . . . 75.030000000000001 105.848 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.46 HD21 HG21 ' A' ' 523' ' ' VAL . 28.4 tp -119.59 105.68 11.44 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 108.232 -1.025 . . . . 72.310000000000002 108.232 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.405 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.7 mt-10 -90.79 121.76 32.93 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.985 -1.117 . . . . 65.140000000000001 107.985 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.69 120.27 59.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.978 -1.01 . . . . 75.019999999999996 109.308 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.21 121.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 CA-C-N 114.696 -1.138 . . . . 65.340000000000003 108.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.446 HG12 ' SG ' ' A' ' 585' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.29 -2.019 0 CA-C-N 115.334 -0.848 . . . . 75.439999999999998 110.184 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.684 0 N-CA-C 110.278 -1.129 . . . . 54.329999999999998 110.278 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 68.6 mt -127.54 118.94 50.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.92 -1.511 . . . . 71.519999999999996 106.92 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.33 133.07 51.6 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.221 0.452 . . . . 74.310000000000002 112.221 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -148.11 153.97 39.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.688 -0.856 . . . . 70.120000000000005 108.688 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 68.1 m-85 -74.28 156.3 37.32 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.806 -0.442 . . . . 71.340000000000003 109.806 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.58 -49.11 79.03 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.235 0.54 . . . . 74.340000000000003 110.381 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.77 153.7 81.16 Favored Pre-proline 0 N--CA 1.432 -1.35 0 N-CA-C 107.721 -1.215 . . . . 63.109999999999999 107.721 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 83.3 Cg_endo -86.24 -11.32 6.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.024 1.816 . . . . 62.0 113.3 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 70.4 t -143.81 135.34 22.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.281 -0.637 . . . . 64.219999999999999 109.281 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.96 133.97 42.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.712 -0.477 . . . . 73.209999999999994 109.712 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -106.18 110.86 23.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.622 -1.251 . . . . 65.310000000000002 107.622 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.85 155.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 110.757 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.451 ' O ' HG22 ' A' ' 518' ' ' ILE . 2.6 t -77.13 147.03 36.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.668 -1.975 . . . . 71.420000000000002 105.668 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -77.58 -16.94 58.31 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.068 -1.053 . . . . 63.009999999999998 110.813 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.7 m -91.31 13.19 18.01 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.202 -0.454 . . . . 72.030000000000001 111.427 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 515' ' ' SER . 8.1 tt -74.06 -25.67 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.033 0.444 . . . . 72.25 111.736 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.37 -68.96 2.61 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.982 -1.104 . . . . 65.030000000000001 112.2 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 574' ' ' ARG . 41.5 mm -131.97 132.31 61.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.299999999999997 108.286 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 19.0 ptm -108.42 143.02 37.93 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.011 -0.737 . . . . 53.340000000000003 109.011 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -99.25 124.21 44.15 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 123.55 0.531 . . . . 70.310000000000002 110.524 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.0 t -115.55 120.23 64.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.461 -1.311 . . . . 73.040000000000006 107.461 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -106.29 123.68 48.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.297 -0.961 . . . . 75.310000000000002 110.275 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 78.5 t -88.59 110.99 21.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.168 -0.924 . . . . 73.430000000000007 108.833 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.79 122.61 30.11 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.443 -0.798 . . . . 63.509999999999998 110.592 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -87.13 101.3 13.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.908 -1.145 . . . . 71.5 107.908 171.164 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.9 t -67.19 -47.53 70.66 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 75.209999999999994 112.401 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.1 t -74.58 -24.06 58.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.271 0.558 . . . . 63.329999999999998 109.924 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 115.09 -158.69 14.18 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 110.378 -1.089 . . . . 33.32 110.378 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.87 136.41 17.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.26 -1.385 . . . . 64.340000000000003 107.26 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -135.27 87.1 2.3 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.716 -0.394 . . . . 74.109999999999999 109.967 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 98.63 -178.98 31.54 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.81 -1.316 . . . . 72.230000000000004 109.81 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.5 111.54 9.78 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.457 -0.897 . . . . 74.120000000000005 111.201 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.89 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.872 -1.158 . . . . 45.149999999999999 107.872 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.496 HG12 HD13 ' A' ' 597' ' ' ILE . 46.3 mm -99.47 122.65 51.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.553 -0.906 . . . . 70.019999999999996 108.553 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 28.4 t -112.78 105.59 55.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 123.555 0.535 . . . . 52.310000000000002 109.754 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.44 150.55 28.48 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.917 1.745 . . . . 74.310000000000002 111.514 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -142.02 168.29 20.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.989 -1.115 . . . . 70.409999999999997 107.989 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 589' ' ' LEU . 55.0 pttt -161.23 145.14 13.15 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.123 0.487 . . . . 72.450000000000003 111.07 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.5 p -83.6 133.46 34.84 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.994 -1.003 . . . . 72.239999999999995 110.454 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.4 mm -104.2 112.41 37.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.062 -1.459 . . . . 52.32 107.062 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.89 152.16 41.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.656 0.598 . . . . 70.319999999999993 110.064 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -145.51 -116.97 1.06 Allowed Glycine 0 C--N 1.293 -1.837 0 N-CA-C 108.801 -1.72 . . . . 42.420000000000002 108.801 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 24.9 p -75.35 -27.71 59.29 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.21 -1.033 . . . . 64.120000000000005 108.21 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.38 127.98 34.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.604 -1.258 . . . . 62.350000000000001 107.604 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 3.2 tmt_? -104.26 139.67 38.94 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.578 -1.267 . . . . 63.130000000000003 107.578 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 548' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -86.94 -156.33 29.08 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.889 -0.672 . . . . 74.540000000000006 112.806 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.81 1.86 59.81 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.798 -0.239 . . . . 72.299999999999997 113.532 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 117.22 0.64 18.91 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.173 -1.013 . . . . 55.420000000000002 113.08 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 12.8 tp10 -69.77 -76.46 0.1 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 117.393 0.597 . . . . 74.239999999999995 109.793 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.18 -35.42 9.65 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.77 -1.196 . . . . 74.129999999999995 107.77 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -144.17 166.63 24.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.869 -1.16 . . . . 73.329999999999998 107.869 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.1 OUTLIER -95.44 144.2 26.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.467 -1.679 . . . . 65.510000000000005 106.467 176.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.91 122.08 28.24 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.264 -0.643 . . . . 74.219999999999999 109.264 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -129.5 124.05 32.99 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.989 0.9 . . . . 74.200000000000003 112.653 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 9.4 p -131.39 129.26 41.1 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.031 -1.841 . . . . 74.5 106.031 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -160.35 171.76 36.63 Favored Glycine 0 CA--C 1.48 -2.128 0 C-N-CA 118.997 -1.573 . . . . 41.109999999999999 112.474 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 7.7 mp0 -107.67 115.61 30.46 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.537 -0.912 . . . . 75.040000000000006 108.537 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.117 -0.327 . . . . 52.240000000000002 110.117 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -106.5 101.97 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.172 0.51 . . . . 73.109999999999999 111.771 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -97.37 156.47 16.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.097 -0.705 . . . . 75.439999999999998 109.097 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.433 ' H ' HD11 ' A' ' 567' ' ' ILE . 70.1 mm-40 -136.79 -81.13 0.38 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.816 1.293 . . . . 74.010000000000005 109.21 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 567' ' ' ILE . 4.3 t-20 -104.19 159.05 16.02 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 115.38 -0.827 . . . . 61.340000000000003 109.594 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -60.65 -16.37 38.18 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 125.151 1.381 . . . . 72.239999999999995 114.017 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -80.75 -16.34 54.12 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.687 -0.805 . . . . 72.299999999999997 112.237 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 563' ' ' GLN . 37.1 pt -99.58 158.98 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.215 -0.994 . . . . 73.310000000000002 110.307 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.57 143.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.267 -1.382 . . . . 55.229999999999997 107.267 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.1 mmpt? -101.69 147.27 26.65 Favored 'General case' 0 CA--C 1.468 -2.186 0 C-N-CA 120.108 -0.637 . . . . 72.349999999999994 110.636 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 22.2 mt -125.28 128.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 CA-C-N 114.578 -1.192 . . . . 63.530000000000001 108.771 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 52.9 mt -90.46 134.05 30.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.803 -1.554 . . . . 74.510000000000005 106.803 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 18.3 p -116.18 111.93 20.93 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.714 -0.847 . . . . 71.230000000000004 108.714 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.445 HD11 HD22 ' A' ' 589' ' ' LEU . 50.0 mt -106.39 128.41 60.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.833 -0.803 . . . . 53.210000000000001 108.833 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.7 mtt180 -75.62 111.93 11.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 124.115 0.884 . . . . 74.430000000000007 109.378 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -106.9 131.39 56.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.238 -1.393 . . . . 71.530000000000001 107.238 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 51.5 m-85 . . . . . 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 73.129999999999995 108.316 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.419 -2.023 0 CA-C-O 121.022 0.439 . . . . 73.519999999999996 111.103 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 45.7 p -137.34 146.66 44.84 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.716 -0.846 . . . . 62.439999999999998 108.716 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -133.17 173.75 11.11 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.23 -1.026 . . . . 73.010000000000005 108.23 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 10.9 m -124.84 156.07 38.42 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.538 -0.912 . . . . 35.130000000000003 108.538 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 540' ' ' LYS . 63.6 tp -128.3 129.1 45.8 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 106.548 -1.649 . . . . 65.310000000000002 106.548 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 31.7 m -127.74 159.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 123.215 0.322 . . . . 73.120000000000005 110.14 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.439 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 93.0 mt -102.33 154.97 18.55 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.533 -0.914 . . . . 72.450000000000003 108.533 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.6 171.4 7.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.641 -0.874 . . . . 73.299999999999997 108.641 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.3 120.88 59.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 O-C-N 123.674 0.609 . . . . 74.340000000000003 110.656 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.58 156.23 44.94 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.367 2.045 . . . . 70.400000000000006 111.932 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -121.25 144.9 48.36 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.572 -0.74 . . . . 54.240000000000002 109.455 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -104.59 121.33 43.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.674 -0.861 . . . . 64.230000000000004 108.674 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 597' ' ' ILE . . . . . 0.496 HD13 HG12 ' A' ' 536' ' ' ILE . 2.2 mp . . . . . 0 C--N 1.301 -1.54 0 CA-C-O 122.663 1.22 . . . . 64.230000000000004 111.089 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 634' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 27.3 pt . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.338 0.589 . . . . 71.310000000000002 111.175 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.85 172.7 8.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.537 -1.282 . . . . 64.319999999999993 107.537 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.44 -172.86 38.62 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 120.358 -0.925 . . . . 63.140000000000001 111.249 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 637' ' ' GLU . . . . . 0.459 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 43.3 tt0 -54.9 -62.36 1.71 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.162 0.585 . . . . 74.530000000000001 110.465 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 638' ' ' HIS . . . . . 0.459 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 37.1 m80 -135.14 106.11 6.62 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.972 -0.751 . . . . 74.219999999999999 108.972 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 9.0 t -119.41 108.81 15.01 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 122.18 0.99 . . . . 53.32 110.387 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 640' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 40.9 ttmt -147.91 142.33 26.37 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.686 -1.227 . . . . 71.400000000000006 107.686 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.424 HD22 HG13 ' A' ' 523' ' ' VAL . 62.1 tp -119.34 110.51 17.05 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.695 -0.854 . . . . 64.409999999999997 108.695 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.98 117.55 28.87 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.445 -0.946 . . . . 70.420000000000002 108.445 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.58 124.74 60.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 114.713 -1.131 . . . . 51.439999999999998 109.542 -175.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.38 123.48 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.598 0 N-CA-C 107.942 -1.133 . . . . 75.129999999999995 107.942 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 115.682 -0.69 . . . . 64.25 111.153 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.42 -2.391 0 N-CA-C 109.951 -1.26 . . . . 54.329999999999998 109.951 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 83.6 mt -127.15 114.88 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.586 -1.265 . . . . 45.509999999999998 107.586 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -103.77 134.65 46.72 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 70.010000000000005 111.873 -175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.1 t -148.13 163.34 37.25 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.934 -0.575 . . . . 75.140000000000001 109.654 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.9 162.37 20.53 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-O 120.958 0.409 . . . . 63.219999999999999 110.678 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.0 -55.77 19.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.106 -0.952 . . . . 73.140000000000001 109.167 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.33 159.36 57.66 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.515 -0.766 . . . . 73.129999999999995 108.976 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.06 -18.16 6.4 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.221 1.281 . . . . 53.240000000000002 111.224 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 642' ' ' GLU . 79.4 t -142.0 130.38 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.247 0.619 . . . . 61.009999999999998 109.364 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.62 140.96 47.42 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.63 -0.878 . . . . 61.240000000000002 108.63 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -119.49 117.21 27.82 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.776 -0.824 . . . . 73.239999999999995 108.776 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.1 m -106.35 162.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.248 0.546 . . . . 61.219999999999999 112.472 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 16.3 m -74.38 138.22 43.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.9 -1.045 . . . . 73.510000000000005 110.052 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -58.71 -33.93 70.75 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.404 0.682 . . . . 72.430000000000007 110.916 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.5 m -110.22 25.42 11.8 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.594 0.59 . . . . 54.420000000000002 112.594 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.6 tt -71.27 -33.2 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.361 0.601 . . . . 64.209999999999994 112.276 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 574' ' ' ARG . . . 89.85 -75.16 1.81 Allowed Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.215 -0.993 . . . . 62.210000000000001 110.845 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.7 mm -120.25 123.27 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.918 -0.401 . . . . 72.510000000000005 109.918 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.495 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 21.5 ptm -94.03 130.05 40.3 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.437 -0.949 . . . . 73.310000000000002 108.437 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -106.56 113.45 26.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.577 0.751 . . . . 70.140000000000001 111.339 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 57.5 t -119.76 131.06 73.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.599 -0.519 . . . . 53.0 109.599 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -92.76 133.71 35.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.062 0.458 . . . . 74.299999999999997 110.366 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 97.6 t -90.3 114.02 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.952 -1.499 . . . . 65.299999999999997 106.952 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.41 151.01 24.32 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.131 -0.94 . . . . 52.539999999999999 109.584 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 530' ' ' GLY . 0.0 OUTLIER -122.46 104.4 9.36 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.167 -1.049 . . . . 75.129999999999995 108.167 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.8 m -63.82 -63.34 1.19 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.99 -1.004 . . . . 71.420000000000002 111.861 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 10.8 p -74.13 -33.68 63.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.641 0.734 . . . . 54.420000000000002 110.725 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' GLY . . . . . 0.559 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 140.36 -148.6 20.22 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 109.567 -1.413 . . . . 63.450000000000003 109.567 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -162.96 144.01 9.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 54.140000000000001 106.687 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -149.04 131.21 15.45 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.429 0.529 . . . . 73.129999999999995 112.429 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 99.06 -126.38 8.89 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 115.219 -0.901 . . . . 72.450000000000003 111.359 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.02 109.53 7.42 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.321 -1.363 . . . . 73.319999999999993 107.321 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.09 122.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 121.146 0.498 . . . . 71.310000000000002 110.715 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.77 117.77 32.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.127 -1.434 . . . . 63.109999999999999 107.127 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.2 t -108.18 101.1 40.23 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.151 -1.055 . . . . 74.519999999999996 108.151 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.23 139.26 6.98 Favored 'Trans proline' 0 N--CA 1.425 -2.558 0 C-N-CA 121.63 1.553 . . . . 71.400000000000006 111.983 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.509 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.4 p90 -119.6 159.49 24.28 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.963 -1.495 . . . . 75.150000000000006 106.963 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.495 ' HA ' ' SG ' ' A' ' 557' ' ' CYS . 62.3 pttt -146.33 140.66 26.58 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.004 -0.678 . . . . 74.150000000000006 110.963 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.1 p -85.94 132.77 34.01 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.64 -1.164 . . . . 63.030000000000001 110.593 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 39.3 mm -109.59 116.74 52.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.875 -1.157 . . . . 72.010000000000005 107.875 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -67.87 167.76 12.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.398 0.618 . . . . 71.299999999999997 111.047 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 156.99 116.44 0.51 Allowed Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 107.733 -2.147 . . . . 75.540000000000006 107.733 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.407 ' HB ' ' SG ' ' A' ' 585' ' ' CYS 0.295 7.9 p 66.85 -44.43 0.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.124 1.77 . . . . 43.219999999999999 112.437 -172.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.01 19.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.962 -1.496 . . . . 72.439999999999998 106.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.498 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 3.4 mpt_? -111.27 152.53 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.283 0.563 . . . . 71.129999999999995 110.511 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.77 170.47 32.17 Favored Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.323 -1.111 . . . . 62.310000000000002 110.323 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 106.77 23.84 6.95 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.267 -1.133 . . . . 72.430000000000007 110.267 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 63.61 36.36 93.24 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.96 -0.856 . . . . 62.200000000000003 110.96 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.02 -76.36 0.47 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.145 0.578 . . . . 63.240000000000002 111.506 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.61 -40.39 15.2 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.615 -1.254 . . . . 62.43 107.615 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.26 160.67 39.46 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.001 -1.454 . . . . 75.230000000000004 107.469 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.8 OUTLIER -88.71 104.94 17.35 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.084 -1.45 . . . . 75.109999999999999 107.084 177.281 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.19 98.91 0.84 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.149 . . . . 72.349999999999994 109.039 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.54 138.69 54.31 Favored 'General case' 0 N--CA 1.398 -3.033 0 CA-C-N 114.472 -1.24 . . . . 71.310000000000002 107.993 -171.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 557' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 540' ' ' LYS . 56.1 m -149.17 125.0 10.54 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.437 -0.209 . . . . 74.239999999999995 110.437 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 121.3 -133.21 9.45 Favored Glycine 0 C--O 1.211 -1.308 0 N-CA-C 111.222 -0.751 . . . . 75.230000000000004 111.222 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 60.44 -10.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 118.277 2.695 . . . . 74.230000000000004 118.277 171.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 569' ' ' LYS . 39.8 mt -99.41 135.22 41.14 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.523 -1.361 . . . . 70.219999999999999 112.93 -175.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.12 115.66 11.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.071 -1.085 . . . . 75.209999999999994 108.071 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.99 145.87 29.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.388 -0.967 . . . . 63.049999999999997 108.388 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.477 ' H ' HD11 ' A' ' 567' ' ' ILE . 1.9 mp0 -103.63 -94.55 0.32 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.73 -1.581 . . . . 74.150000000000006 106.73 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -105.22 176.09 5.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.866 -0.606 . . . . 74.349999999999994 111.875 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.09 -25.53 22.33 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.636 1.574 . . . . 73.420000000000002 112.436 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.08 -20.56 54.53 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.001 0.92 . . . . 74.219999999999999 113.153 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.477 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.8 pt -119.64 157.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 119.497 -0.881 . . . . 63.450000000000003 110.617 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.93 148.4 32.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 106.707 -1.59 . . . . 70.439999999999998 106.707 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.6 mmpt? -113.02 164.56 13.31 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.519 -0.472 . . . . 52.439999999999998 112.027 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.11 134.41 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.173 -0.921 . . . . 64.400000000000006 110.426 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.509 HG23 ' CZ ' ' A' ' 539' ' ' TYR . 70.2 mt -90.67 125.64 43.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.531 -1.285 . . . . 71.430000000000007 107.531 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -111.86 112.65 24.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.511 0.672 . . . . 60.509999999999998 110.588 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.495 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 62.2 mt -118.83 130.06 74.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.635 -0.876 . . . . 74.299999999999997 108.635 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 84.0 mtp180 -83.69 132.82 34.84 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.726 0.641 . . . . 73.129999999999995 110.142 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.73 130.18 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.922 -1.14 . . . . 74.109999999999999 107.922 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 . . . . . 0 C--N 1.315 -0.903 0 N-CA-C 112.466 0.543 . . . . 72.340000000000003 112.466 -175.553 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 545' ' ' THR . 75.0 m . . . . . 0 N--CA 1.418 -2.07 0 N-CA-C 112.002 0.371 . . . . 75.430000000000007 112.002 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 644' ' ' ILE . 61.1 p -130.65 120.76 24.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.751 -0.659 . . . . 61.539999999999999 109.797 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -108.13 168.86 8.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.62 -1.252 . . . . 74.310000000000002 107.62 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 3.6 m -121.28 162.89 19.47 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.243 -0.983 . . . . 51.43 109.887 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.495 HD21 HD13 ' A' ' 571' ' ' ILE . 65.9 tp -136.54 125.94 25.02 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.808 -1.553 . . . . 52.140000000000001 106.808 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 590' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' A' ' 640' ' ' LYS . 26.8 m -124.52 159.62 30.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.786 -0.45 . . . . 63.240000000000002 109.786 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.61 135.46 43.09 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.265 -1.013 . . . . 53.009999999999998 108.265 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.97 171.63 8.15 Favored 'General case' 0 C--N 1.271 -2.822 0 CA-C-N 115.69 -0.686 . . . . 71.340000000000003 109.476 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.43 121.2 46.29 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 113.49 0.922 . . . . 75.400000000000006 113.49 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -77.06 144.51 23.84 Favored 'Trans proline' 0 N--CA 1.415 -3.094 0 C-N-CA 121.428 1.419 . . . . 73.25 111.191 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 595' ' ' LYS . . . . . 0.41 ' HB3' ' NZ ' ' A' ' 595' ' ' LYS . 0.1 OUTLIER -118.72 132.37 56.15 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.114 -0.948 . . . . 73.329999999999998 110.062 -176.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -98.27 119.69 37.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.63 -0.714 . . . . 73.109999999999999 109.262 -175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--N 1.294 -1.809 0 N-CA-C 106.997 -1.482 . . . . 54.350000000000001 106.997 176.552 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 634' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -94.19 171.25 8.95 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.163 -0.68 . . . . 73.5 109.163 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -74.34 179.02 43.61 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.029 -0.605 . . . . 70.439999999999998 111.803 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 637' ' ' GLU . . . . . 0.417 ' HG2' ' ND1' ' A' ' 638' ' ' HIS . 34.1 tt0 -46.97 -68.79 0.16 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.399 . . . . 71.030000000000001 111.238 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 638' ' ' HIS . . . . . 0.417 ' ND1' ' HG2' ' A' ' 637' ' ' GLU . 39.7 m80 -134.31 94.04 3.16 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.461 -0.94 . . . . 74.299999999999997 108.461 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 10.2 t -113.18 108.41 17.24 Favored 'General case' 0 N--CA 1.408 -2.567 0 C-N-CA 119.496 -0.882 . . . . 32.32 109.725 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 640' ' ' LYS . . . . . 0.404 ' HG3' HG12 ' A' ' 590' ' ' VAL . 39.7 ttpt -147.96 135.96 21.15 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.869 -1.53 . . . . 61.520000000000003 106.869 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.1 tp -113.44 116.27 29.35 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 108.58 -0.896 . . . . 75.329999999999998 108.58 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 511' ' ' VAL . 39.7 mt-10 -93.84 126.55 39.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.248 -1.019 . . . . 75.200000000000003 108.248 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.55 122.76 67.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.786 -0.643 . . . . 60.299999999999997 109.471 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 644' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 586' ' ' SER . 3.9 mp -108.95 130.14 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 115.483 -0.78 . . . . 73.450000000000003 109.42 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.094 0 CA-C-O 121.313 0.578 . . . . 65.349999999999994 111.794 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -1.054 0 N-CA-C 112.16 -0.376 . . . . 61.140000000000001 112.16 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 86.5 mt -92.95 114.83 30.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 123.68 0.792 . . . . 55.25 108.912 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.63 144.76 41.58 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.102 -0.333 . . . . 73.349999999999994 110.102 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -149.78 159.45 44.34 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 116.435 -0.348 . . . . 63.149999999999999 110.238 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 85.8 m-85 -73.01 154.19 40.6 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 109.796 -0.446 . . . . 70.329999999999998 109.796 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.01 -57.24 12.94 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 124.06 0.85 . . . . 73.219999999999999 109.733 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -120.11 163.29 29.02 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.058 -0.974 . . . . 34.109999999999999 109.596 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -22.84 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 110.83 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 642' ' ' GLU . 76.2 t -142.1 134.15 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.149 -1.056 . . . . 71.340000000000003 108.149 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.5 t -134.14 126.58 30.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.121 0.486 . . . . 63.329999999999998 109.922 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -98.65 120.69 39.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.466 -1.309 . . . . 75.019999999999996 107.466 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.01 154.44 18.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 116.201 -0.454 . . . . 44.109999999999999 109.963 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.488 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 45.8 m -60.0 154.27 19.43 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 124.246 0.966 . . . . 65.109999999999999 111.424 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.98 -33.3 57.62 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.942 -1.133 . . . . 63.409999999999997 107.942 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.6 m -98.89 28.82 4.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.16 -0.927 . . . . 73.420000000000002 110.232 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -76.94 -34.85 22.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 112.983 0.734 . . . . 74.150000000000006 112.983 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.32 -70.93 3.06 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.204 -0.998 . . . . 55.43 111.867 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.3 mm -130.96 131.57 64.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.776 -0.824 . . . . 74.109999999999999 108.776 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 16.9 ptm -106.29 127.28 53.13 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.601 -0.727 . . . . 71.239999999999995 109.152 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -88.81 114.46 25.45 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.262 0.351 . . . . 71.349999999999994 110.842 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 40.1 t -108.03 114.51 46.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.29 -0.633 . . . . 74.150000000000006 109.29 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -89.13 130.58 35.54 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.528 -0.545 . . . . 73.439999999999998 109.528 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.8 110.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.004 -1.48 . . . . 74.329999999999998 107.004 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.3 151.91 23.2 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.069 -0.969 . . . . 65.0 109.897 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.543 ' HD3' ' H ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -115.66 107.93 15.74 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.588 -0.893 . . . . 54.520000000000003 108.588 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.6 m -65.28 -58.68 5.32 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.395 -0.82 . . . . 54.420000000000002 109.967 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.4 p -74.59 -51.25 15.07 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.665 -0.698 . . . . 71.219999999999999 111.068 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.44 -166.31 26.87 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.347 -1.101 . . . . 71.439999999999998 110.347 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -146.77 134.44 21.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -153.32 99.4 2.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.423 -0.584 . . . . 63.43 109.423 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 127.01 -125.46 5.34 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 110.422 -1.071 . . . . 63.5 110.422 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -138.01 109.32 6.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.592 -0.521 . . . . 73.340000000000003 109.592 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 34.5 t -124.86 128.65 73.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.745 -0.835 . . . . 64.239999999999995 108.745 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.538 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.0 mm -105.34 126.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.379 -0.601 . . . . 74.099999999999994 109.379 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.42 109.76 60.11 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.791 -0.641 . . . . 45.450000000000003 109.956 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.48 146.03 13.51 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.883 1.722 . . . . 74.209999999999994 111.428 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -137.05 157.46 46.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.363 -0.977 . . . . 71.049999999999997 108.363 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -149.9 139.86 21.94 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.099 0.476 . . . . 72.030000000000001 111.235 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -84.65 124.77 31.84 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.197 -0.91 . . . . 50.450000000000003 111.977 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.6 mm -97.29 115.84 38.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.993 -1.484 . . . . 70.129999999999995 106.993 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.34 163.17 25.09 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.836 -0.431 . . . . 41.520000000000003 109.836 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -156.4 -116.67 0.53 Allowed Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 109.426 -1.47 . . . . 71.140000000000001 109.426 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.6 m -70.26 -27.06 64.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.239 -1.023 . . . . 74.239999999999995 108.239 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.18 131.42 38.26 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.782 -1.099 . . . . 64.219999999999999 108.292 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 132.84 43.49 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.424 -1.695 . . . . 74.310000000000002 106.424 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.0 29.1 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.849 -0.691 . . . . 52.399999999999999 111.995 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.28 63.51 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 114.518 0.567 . . . . 70.540000000000006 114.518 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.48 9.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 119.558 -1.306 . . . . 53.030000000000001 113.691 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.86 -79.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.357 0.578 . . . . 62.399999999999999 112.357 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.05 -41.49 12.29 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.048 -1.093 . . . . 54.240000000000002 108.048 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -143.17 163.76 32.01 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.508 -1.224 . . . . 74.349999999999994 107.962 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.587 ' HG3' ' NH2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -90.5 146.08 24.4 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.399 -1.334 . . . . 63.0 107.399 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.83 122.19 29.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.885 -0.413 . . . . 65.219999999999999 109.885 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -128.35 105.18 8.16 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.819 0.818 . . . . 74.019999999999996 109.73 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.55 131.58 51.53 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.227 -1.768 . . . . 44.310000000000002 106.227 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.26 -167.28 34.21 Favored Glycine 0 N--CA 1.432 -1.599 0 C-N-CA 119.169 -1.491 . . . . 64.319999999999993 113.249 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.3 mt-10 -113.83 122.72 47.9 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.811 0.844 . . . . 74.319999999999993 110.774 -176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.63 140.79 29.38 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.88 -0.785 . . . . 51.409999999999997 108.88 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.25 113.35 26.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.49 -0.323 . . . . 72.140000000000001 110.719 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 54.5 m-85 -115.88 115.83 26.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 110.061 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.454 ' H ' HD11 ' A' ' 567' ' ' ILE . 24.9 mp0 -90.08 -84.57 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.141 0.972 . . . . 72.409999999999997 110.507 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.4 ' O ' HG12 ' A' ' 567' ' ' ILE . 28.5 t-20 -105.11 157.8 17.01 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.31 -1.314 . . . . 64.340000000000003 111.216 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.84 -26.3 58.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.543 2.053 . . . . 64.219999999999999 116.543 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.25 7.24 9.85 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.034 1.124 . . . . 73.049999999999997 114.034 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.454 HD11 ' H ' ' A' ' 563' ' ' GLN . 35.6 pt -119.36 161.93 18.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.396 -0.594 . . . . 62.229999999999997 109.396 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.92 154.57 34.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.128 -1.064 . . . . 71.420000000000002 108.128 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -113.97 147.09 39.18 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.988 0.423 . . . . 72.219999999999999 111.204 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -125.26 130.92 72.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.501 -1.227 . . . . 65.129999999999995 109.279 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 40.5 mt -91.99 126.39 44.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.477 -1.675 . . . . 70.150000000000006 106.477 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.1 p -108.52 112.25 24.53 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.461 -0.57 . . . . 63.439999999999998 109.461 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.52 HD11 HD22 ' A' ' 589' ' ' LEU . 52.2 mt -105.19 123.93 59.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 109.02 -0.733 . . . . 73.140000000000001 109.02 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.587 ' NH2' ' HG3' ' A' ' 554' ' ' GLU . 74.6 mtm180 -80.68 108.77 14.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 123.821 0.701 . . . . 73.099999999999994 111.201 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.1 mm -95.26 135.54 29.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.058 -1.83 . . . . 73.510000000000005 106.058 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 . . . . . 0 C--N 1.295 -1.787 0 C-N-CA 120.131 -0.627 . . . . 72.200000000000003 110.437 -178.046 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 121.129 0.49 . . . . 72.340000000000003 110.944 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 28.4 p -123.78 155.62 37.6 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 119.861 -0.735 . . . . 62.539999999999999 111.998 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -139.12 -177.98 5.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.772 -1.195 . . . . 73.129999999999995 107.772 173.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 588' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 26.3 m -135.06 156.58 48.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.653 -0.655 . . . . 72.049999999999997 109.946 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 573' ' ' ILE . 42.8 tp -130.83 130.8 44.08 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.06 -1.459 . . . . 51.149999999999999 107.06 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.02 151.48 33.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 120.964 -0.294 . . . . 74.010000000000005 110.903 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 96.3 mt -95.57 140.01 31.01 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.26 -1.015 . . . . 61.450000000000003 108.26 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -100.41 159.42 15.16 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.357 -0.838 . . . . 62.43 109.05 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 120.84 19.22 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 124.122 0.888 . . . . 74.439999999999998 110.461 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.63 148.13 41.49 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.521 2.814 . . . . 74.340000000000003 112.643 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 595' ' ' LYS . . . . . 0.538 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 18.2 ptpt -102.42 133.29 47.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.867 -1.16 . . . . 74.140000000000001 107.867 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -105.36 117.6 34.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.28 -0.637 . . . . 72.230000000000004 109.28 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 597' ' ' ILE . . . . . 0.435 HD13 HG12 ' A' ' 536' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.424 -1.737 0 N-CA-C 107.677 -1.231 . . . . 74.239999999999995 107.677 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.017 0 CA-C-O 121.012 0.434 . . . . 74.099999999999994 111.143 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 26.9 mt -109.63 -158.32 0.64 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.272 -0.877 . . . . 64.439999999999998 109.616 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.36 -164.4 13.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.14 -0.552 . . . . 62.130000000000003 112.465 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -59.75 -73.36 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.489 0.716 . . . . 71.329999999999998 109.568 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -131.24 127.35 37.66 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 106.559 -1.645 . . . . 72.140000000000001 106.559 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 2.6 t -137.94 109.13 6.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 123.139 1.447 . . . . 63.530000000000001 110.664 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -147.18 140.38 25.3 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.564 -1.653 . . . . 71.409999999999997 106.575 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.83 106.92 13.99 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.605 -0.887 . . . . 74.439999999999998 108.605 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.475 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.0 mt-10 -86.4 124.46 32.77 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.92 -1.141 . . . . 44.399999999999999 107.92 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.27 123.73 69.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.737 -0.665 . . . . 74.540000000000006 109.653 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.11 122.9 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 108.474 -0.936 . . . . 72.430000000000007 108.474 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 CA-C-O 121.245 0.545 . . . . 71.230000000000004 111.651 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.429 -1.805 0 N-CA-C 111.304 -0.718 . . . . 32.32 111.304 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 62.5 mt -113.84 114.56 47.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 107.274 -1.38 . . . . 75.219999999999999 107.274 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.06 137.94 47.12 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.236 0.335 . . . . 74.239999999999995 111.056 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.5 t -148.91 165.9 30.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.955 -0.387 . . . . 52.149999999999999 109.955 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.577 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 75.6 m-85 -79.16 157.76 27.84 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.339 0.656 . . . . 72.439999999999998 110.337 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.13 -50.58 71.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.72 0.772 . . . . 63.43 109.534 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.81 151.32 72.19 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 114.891 -1.049 . . . . 75.219999999999999 108.56 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.94 -22.37 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.115 1.877 . . . . 60.200000000000003 112.559 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.81 131.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.962 -0.385 . . . . 74.209999999999994 109.962 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.8 t -133.68 141.03 47.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.088 0.471 . . . . 63.520000000000003 109.84 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -112.99 119.74 38.96 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.346 -0.983 . . . . 43.420000000000002 108.346 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.67 155.52 19.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.365 0.603 . . . . 72.129999999999995 111.032 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 518' ' ' ILE . 68.7 m -83.1 157.2 22.92 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.513 -0.767 . . . . 73.140000000000001 110.305 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.729 0.776 . . . . 73.129999999999995 111.366 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.5 p -89.84 24.42 2.39 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.213 -0.903 . . . . 71.420000000000002 112.156 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 515' ' ' SER . 5.8 tt -86.46 -25.49 6.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.297 0.57 . . . . 65.239999999999995 110.512 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.25 -71.82 2.86 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.614 -0.803 . . . . 31.309999999999999 111.961 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.2 mm -131.2 138.33 53.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.239 -1.763 . . . . 60.020000000000003 106.239 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.406 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.4 ppp? -112.21 147.85 35.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.176 -0.676 . . . . 70.430000000000007 109.176 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -113.03 130.37 56.17 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.832 0.707 . . . . 64.129999999999995 111.201 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 39.5 t -125.11 124.21 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 107.973 -1.121 . . . . 55.43 107.973 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 570' ' ' ILE . 59.6 mttm -91.05 131.19 36.79 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.994 -1.082 . . . . 61.439999999999998 109.383 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 89.3 t -91.34 109.67 21.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 106.948 -1.501 . . . . 64.25 106.948 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.1 mt -87.12 143.29 27.37 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.742 -1.117 . . . . 74.209999999999994 110.167 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.88 113.54 26.54 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.972 -1.013 . . . . 62.119999999999997 108.672 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 41.0 p -66.54 -63.64 1.03 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.023 -0.671 . . . . 73.430000000000007 111.592 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 51.0 m -74.46 -52.55 11.68 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.041 0.448 . . . . 43.130000000000003 111.513 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' GLY . . . . . 0.565 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 160.21 -143.85 9.45 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.607 -0.806 . . . . 52.43 111.735 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.64 161.18 18.12 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 106.248 -1.76 . . . . 72.219999999999999 106.248 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -157.19 126.52 6.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.463 0.574 . . . . 62.100000000000001 110.527 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.34 -118.7 5.61 Favored Glycine 0 CA--C 1.494 -1.28 0 C-N-CA 120.723 -0.751 . . . . 43.219999999999999 111.857 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -138.51 111.99 8.16 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.284 -1.006 . . . . 73.329999999999998 108.284 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.6 t -122.34 130.26 74.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.877 -0.515 . . . . 73.519999999999996 110.686 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.37 118.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.497 -0.927 . . . . 74.230000000000004 108.497 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.1 106.63 58.84 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.888 -0.782 . . . . 71.239999999999995 108.888 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -83.98 159.61 13.71 Favored 'Trans proline' 0 N--CA 1.42 -2.798 0 C-N-CA 121.838 1.692 . . . . 62.399999999999999 111.027 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.36 163.34 39.15 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.915 -1.883 . . . . 72.420000000000002 105.915 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -150.81 129.07 11.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.248 -0.581 . . . . 62.43 110.863 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.3 p -78.01 117.38 19.28 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 115.464 -0.789 . . . . 74.230000000000004 110.293 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.5 mm -88.4 120.45 37.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.216 -1.402 . . . . 72.329999999999998 107.216 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.56 113.63 13.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.684 -0.487 . . . . 74.120000000000005 109.684 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -94.18 -108.69 2.07 Favored Glycine 0 CA--C 1.496 -1.128 0 N-CA-C 110.423 -1.071 . . . . 34.32 110.423 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 42.4 p -86.26 -24.22 26.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.591 -0.892 . . . . 74.109999999999999 108.591 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 585' ' ' CYS . . . -88.09 145.41 25.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.22 -0.9 . . . . 74.400000000000006 109.363 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 36.6 mmm-85 -95.02 138.24 33.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.747 0.784 . . . . 64.310000000000002 112.685 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -110.58 129.48 9.32 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 114.182 -1.372 . . . . 74.230000000000004 110.978 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 141.49 -17.82 2.65 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.581 -1.008 . . . . 62.43 110.581 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 155.51 -16.64 0.49 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.858 -1.163 . . . . 73.530000000000001 113.445 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 2.2 mp0 -69.67 -81.79 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.459 0.63 . . . . 64.030000000000001 111.462 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -86.37 -53.7 4.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.981 0.896 . . . . 73.349999999999994 108.617 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -131.2 160.84 33.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.273 -0.876 . . . . 60.5 110.445 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.534 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 27.2 tt0 -96.26 119.06 34.06 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.788 -1.93 . . . . 74.120000000000005 105.788 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.79 143.4 54.63 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.31 0.576 . . . . 74.450000000000003 111.501 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 4.9 t -140.72 136.53 32.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.833 -0.621 . . . . 71.540000000000006 110.076 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.1 p -143.46 110.41 5.64 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.23 0.538 . . . . 64.140000000000001 112.2 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 79.22 105.78 0.23 Allowed Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.535 -0.757 . . . . 74.510000000000005 113.122 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.42 14.54 0.31 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.65 -0.87 . . . . 70.019999999999996 108.65 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 569' ' ' LYS . 46.2 mt -117.45 135.89 53.58 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.289 -0.882 . . . . 71.030000000000001 112.198 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.452 ' H ' ' HD2' ' A' ' 569' ' ' LYS . 36.0 tt0 -134.91 109.69 8.65 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.588 -1.264 . . . . 74.319999999999993 107.588 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 48.8 m-85 -102.37 115.28 30.25 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.822 -0.807 . . . . 63.439999999999998 108.822 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.481 ' H ' HD11 ' A' ' 567' ' ' ILE . 44.6 mt-30 -90.15 -79.64 0.34 Allowed 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.798 -0.637 . . . . 74.040000000000006 109.898 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -104.33 167.1 9.96 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.005 -0.739 . . . . 63.299999999999997 109.005 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -69.34 -20.13 63.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.479 0.712 . . . . 62.439999999999998 112.33 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.2 -10.26 59.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.143 1.164 . . . . 72.219999999999999 114.143 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.481 HD11 ' H ' ' A' ' 563' ' ' GLN . 40.0 pt -113.44 166.46 7.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.223 -0.591 . . . . 64.540000000000006 110.892 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.86 148.23 29.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.863 -1.532 . . . . 71.129999999999995 106.863 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.463 ' HB3' HD22 ' A' ' 560' ' ' LEU . 20.8 mttm -116.48 155.67 28.19 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 112.876 0.695 . . . . 63.520000000000003 112.876 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 32.7 mt -122.0 133.08 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.915 -1.039 . . . . 55.32 110.594 -174.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.462 HD13 HD21 ' A' ' 589' ' ' LEU . 47.8 mt -90.99 129.21 42.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.947 -1.501 . . . . 73.219999999999999 106.947 174.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -115.1 112.66 22.92 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.449 -0.574 . . . . 73.299999999999997 109.449 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 589' ' ' LEU . 62.1 mt -108.36 130.7 60.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.82 -0.807 . . . . 73.200000000000003 108.82 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.534 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 70.7 ttt180 -76.9 112.58 13.66 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.484 -0.561 . . . . 73.510000000000005 109.484 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.16 119.16 47.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.344 -2.095 . . . . 62.329999999999998 105.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 C--N 1.301 -1.507 0 CA-C-O 121.645 0.736 . . . . 74.140000000000001 112.524 -175.066 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 63.4 m . . . . . 0 N--CA 1.427 -1.62 0 CA-C-O 121.0 0.428 . . . . 72.340000000000003 110.518 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.6 p -147.42 151.61 36.75 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.714 -0.847 . . . . 62.039999999999999 108.714 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -149.97 176.69 10.55 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.852 -1.166 . . . . 71.109999999999999 107.852 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 20.0 m -129.85 163.96 25.17 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.972 -0.691 . . . . 74.120000000000005 109.853 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.462 HD21 HD13 ' A' ' 571' ' ' ILE . 41.9 tp -139.67 127.36 21.83 Favored 'General case' 0 C--N 1.263 -3.165 0 N-CA-C 106.729 -1.582 . . . . 74.140000000000001 106.729 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.52 151.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.546 -0.539 . . . . 70.409999999999997 109.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 85.0 mt -92.1 139.42 30.65 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.901 -1.148 . . . . 53.25 107.901 175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.42 167.55 10.56 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 115.476 -0.784 . . . . 73.439999999999998 108.979 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.24 115.19 9.18 Favored Pre-proline 0 N--CA 1.446 -0.637 0 O-C-N 124.598 1.186 . . . . 71.150000000000006 109.333 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.42 142.7 23.98 Favored 'Trans proline' 0 N--CA 1.428 -2.346 0 C-N-CA 121.703 1.602 . . . . 72.109999999999999 111.412 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -110.3 132.34 54.26 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.957 -0.565 . . . . 63.240000000000002 110.421 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -85.02 118.81 24.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.451 -1.314 . . . . 73.219999999999999 107.451 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 N--CA 1.411 -2.391 0 N-CA-C 106.0 -1.852 . . . . 65.120000000000005 106.0 176.907 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 121.842 0.829 . . . . 74.510000000000005 111.53 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -99.0 178.87 4.8 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.388 -1.338 . . . . 72.109999999999999 107.388 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.89 -154.79 7.15 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 119.917 -1.135 . . . . 65.420000000000002 113.0 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.53 -68.07 0.36 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 124.388 1.075 . . . . 75.209999999999994 110.269 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -138.44 119.36 14.3 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.641 -1.985 . . . . 50.229999999999997 105.641 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 639' ' ' THR . . . . . 0.402 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 4.8 t -134.69 110.24 9.13 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-O 122.361 1.077 . . . . 72.310000000000002 110.839 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -147.89 137.85 22.69 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.177 -1.416 . . . . 74.519999999999996 107.177 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 111.82 22.65 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.177 -1.416 . . . . 70.040000000000006 107.177 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.37 122.26 37.9 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.963 -0.754 . . . . 74.230000000000004 108.963 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.93 125.41 68.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.252 -0.885 . . . . 75.340000000000003 109.139 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.84 139.19 44.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.568 -1.271 . . . . 74.219999999999999 107.568 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.308 -1.22 0 N-CA-C 109.435 -0.579 . . . . 74.040000000000006 109.435 -175.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.682 0 N-CA-C 111.076 -0.81 . . . . 71.120000000000005 111.076 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.95 114.8 36.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.38 -1.711 . . . . 51.030000000000001 106.38 172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.62 132.8 53.88 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.669 0.606 . . . . 62.420000000000002 109.975 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -148.39 152.39 36.93 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 120.766 0.317 . . . . 71.439999999999998 110.496 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.566 ' CG ' ' HB2' ' A' ' 641' ' ' LEU . 69.2 m-85 -71.4 148.17 47.2 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.282 0.633 . . . . 73.109999999999999 111.395 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.85 -55.85 20.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.62 0.575 . . . . 74.409999999999997 110.655 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' GLU . . . . . 0.576 ' O ' HD23 ' A' ' 641' ' ' LEU . 39.2 mt-10 -126.96 158.36 68.95 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 107.542 -1.281 . . . . 64.040000000000006 107.542 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.29 -23.98 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.684 1.589 . . . . 73.430000000000007 112.226 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 644' ' ' ILE . 78.0 t -138.0 138.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.017 -0.364 . . . . 62.039999999999999 110.017 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.2 t -131.33 128.06 38.92 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 74.019999999999996 109.347 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.41 110.73 22.76 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.157 -1.423 . . . . 71.019999999999996 107.157 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.39 159.34 14.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.744 -0.382 . . . . 75.230000000000004 110.148 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 46.2 m -84.27 173.52 10.92 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.478 -0.783 . . . . 62.119999999999997 110.792 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.89 -34.16 18.27 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.738 -0.838 . . . . 64.109999999999999 108.738 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 49.4 m -92.19 17.25 9.87 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.958 -1.019 . . . . 71.409999999999997 111.874 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.16 -29.52 17.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.271 0.558 . . . . 71.299999999999997 110.372 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.19 -70.15 3.24 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.858 -0.687 . . . . 31.34 112.27 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.9 mm -129.06 124.01 59.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.345 -0.983 . . . . 64.450000000000003 108.345 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -95.85 149.86 21.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.878 -1.156 . . . . 73.530000000000001 107.878 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -129.18 112.95 14.47 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.606 0.595 . . . . 72.319999999999993 112.606 -173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 68.8 t -121.3 128.58 75.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.482 -0.781 . . . . 74.319999999999993 109.535 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.08 149.59 21.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.242 0.544 . . . . 64.310000000000002 109.793 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.29 107.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.621 -1.622 . . . . 50.140000000000001 106.621 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 81.8 mt -76.16 137.15 39.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.339 -0.846 . . . . 72.030000000000001 109.877 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.523 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 40.9 mtp180 -104.61 102.18 11.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.335 -1.357 . . . . 73.340000000000003 107.335 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.2 m -68.05 -62.45 1.4 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.565 1.32 . . . . 72.040000000000006 114.565 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 33.4 t -73.13 -50.83 20.54 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.596 0.591 . . . . 70.230000000000004 112.596 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 156.89 -160.44 30.35 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 111.146 -0.782 . . . . 72.219999999999999 111.146 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.38 165.88 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.522 0.729 . . . . 71.019999999999996 109.662 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -176.09 105.02 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.244 1.018 . . . . 74.120000000000005 108.52 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 121.35 -126.25 6.47 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 110.719 -0.952 . . . . 53.350000000000001 110.719 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -136.47 127.78 28.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.239 -1.023 . . . . 71.439999999999998 108.239 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.05 130.29 68.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.134 -0.691 . . . . 74.310000000000002 109.134 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 51.5 mm -100.88 122.47 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.284 -1.006 . . . . 72.209999999999994 108.284 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 43.4 t -116.76 102.33 53.18 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.499 -0.926 . . . . 71.450000000000003 108.499 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.51 135.28 13.04 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.801 1.667 . . . . 70.319999999999993 112.742 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -119.51 168.1 11.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.181 -1.044 . . . . 75.519999999999996 108.181 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -158.43 135.6 9.97 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.822 0.344 . . . . 55.119999999999997 111.154 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 17.8 p -80.41 121.0 25.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.348 -0.842 . . . . 54.329999999999998 110.441 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 29.9 mm -96.11 121.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.47 -1.307 . . . . 71.219999999999999 107.47 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.48 125.23 28.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.691 -0.485 . . . . 74.420000000000002 109.691 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -103.21 -109.02 3.32 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.724 -1.75 . . . . 43.039999999999999 108.724 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 585' ' ' CYS . 8.7 p -89.23 -5.85 57.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.198 0.999 . . . . 72.030000000000001 109.579 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.81 140.49 38.02 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.805 -1.089 . . . . 73.129999999999995 108.427 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.87 147.61 28.53 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.089 0.471 . . . . 64.109999999999999 111.511 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.2 -147.54 9.34 Favored Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 115.189 -0.914 . . . . 72.109999999999999 111.113 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.15 28.47 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 121.679 -0.296 . . . . 54.329999999999998 113.07 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.44 -3.84 34.86 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 111.493 -0.643 . . . . 34.409999999999997 111.493 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.76 -79.95 0.03 OUTLIER 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.001 0.429 . . . . 72.409999999999997 111.543 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -87.2 -46.16 9.99 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.718 -1.216 . . . . 34.0 107.718 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -139.5 165.87 26.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.574 -1.194 . . . . 64.549999999999997 109.732 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 574' ' ' ARG . 1.0 OUTLIER -95.96 116.4 28.88 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.303 -2.11 . . . . 72.010000000000005 105.303 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.72 132.18 35.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.5 0.667 . . . . 73.150000000000006 111.554 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.0 t -128.19 148.39 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.494 -0.775 . . . . 74.209999999999994 109.795 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 15.0 p -148.99 140.11 23.05 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.866 0.365 . . . . 53.299999999999997 111.4 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 80.12 -125.2 6.81 Favored Glycine 0 C--O 1.212 -1.263 0 CA-C-N 115.684 -0.689 . . . . 70.450000000000003 111.576 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 58.73 -6.09 0.05 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.072 2.99 . . . . 74.510000000000005 119.072 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 537' ' ' VAL . 62.2 mt -95.27 133.58 39.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 120.049 1.295 . . . . 74.310000000000002 112.29 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -134.23 108.91 8.52 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.603 -1.18 . . . . 75.540000000000006 107.939 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.523 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 73.8 m-85 -103.53 129.02 50.65 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.207 -0.451 . . . . 63.450000000000003 110.592 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.483 ' HB2' HD11 ' A' ' 567' ' ' ILE . 1.6 mp0 -96.16 -107.03 0.15 Allowed 'General case' 0 C--O 1.246 0.912 0 C-N-CA 118.631 -1.227 . . . . 74.349999999999994 111.306 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.4 155.79 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.715 -0.476 . . . . 64.549999999999997 109.715 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.89 -25.97 67.1 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 114.52 1.304 . . . . 74.230000000000004 114.52 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.52 -15.59 60.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.118 0.784 . . . . 61.530000000000001 113.118 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 563' ' ' GLN . 34.2 pt -103.32 157.09 5.14 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 C-N-CA 119.694 -0.802 . . . . 74.040000000000006 110.174 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.58 156.99 29.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.574 -0.528 . . . . 63.149999999999999 109.574 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.8 mmpt? -110.29 163.82 13.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 110.026 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 62.9 mt -128.42 134.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.773 -1.103 . . . . 71.409999999999997 108.681 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.488 HD13 HD21 ' A' ' 589' ' ' LEU . 58.8 mt -90.14 118.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 106.619 -1.622 . . . . 65.340000000000003 106.619 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 12.8 p -110.47 111.74 23.2 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.622 -0.717 . . . . 54.439999999999998 110.008 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.85 132.55 59.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.665 -0.698 . . . . 63.43 109.564 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 554' ' ' GLU . 79.5 mtt180 -76.99 111.82 12.96 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 123.807 0.692 . . . . 55.049999999999997 110.203 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.29 121.94 55.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.401 -1.703 . . . . 75.519999999999996 106.401 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 74.3 m-85 . . . . . 0 C--N 1.293 -1.86 0 C-N-CA 120.441 -0.504 . . . . 75.400000000000006 109.921 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.435 ' HA ' ' OG1' ' A' ' 545' ' ' THR . 21.4 p . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 121.498 0.666 . . . . 74.040000000000006 110.174 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 44.9 m -144.08 164.36 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.522 -0.547 . . . . 72.420000000000002 109.522 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.1 p90 -142.6 -178.94 6.02 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.78 -0.452 . . . . 72.25 109.78 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 70.9 m -131.09 167.52 18.96 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.238 0.542 . . . . 62.439999999999998 111.024 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.488 HD21 HD13 ' A' ' 571' ' ' ILE . 63.9 tp -136.47 124.51 22.9 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.152 -1.796 . . . . 73.420000000000002 106.152 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.73 159.0 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.489 -0.56 . . . . 71.329999999999998 109.489 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.505 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 74.6 mt -104.58 144.09 32.16 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.235 -1.024 . . . . 61.299999999999997 108.235 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.01 170.95 7.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.173 -0.677 . . . . 74.519999999999996 109.173 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -59.17 109.92 2.28 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 123.92 0.763 . . . . 72.319999999999993 112.749 -175.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.65 158.52 39.59 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.122 2.548 . . . . 61.149999999999999 112.384 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -123.3 140.71 52.74 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 72.030000000000001 110.294 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -103.14 124.54 48.76 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.136 -1.061 . . . . 72.209999999999994 108.136 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 107.184 -1.413 . . . . 73.439999999999998 107.184 176.17 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 38.3 pt . . . . . 0 N--CA 1.426 -1.674 0 CA-C-O 121.432 0.634 . . . . 62.100000000000001 110.951 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.5 176.15 5.25 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.068 -1.456 . . . . 71.439999999999998 107.068 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.22 153.37 52.71 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.231 -1.947 . . . . 44.340000000000003 108.231 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 637' ' ' GLU . . . . . 0.462 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 41.5 tt0 -41.1 -61.22 1.04 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.157 1.383 . . . . 73.099999999999994 112.737 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 638' ' ' HIS . . . . . 0.462 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 46.8 m80 -126.22 92.99 3.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.876 -0.787 . . . . 70.409999999999997 108.876 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.8 t -116.09 110.8 19.37 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.556 1.169 . . . . 74.439999999999998 108.954 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -146.29 116.7 7.49 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.211 -1.774 . . . . 71.329999999999998 106.211 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 509' ' ' GLU . 1.6 tm? -106.76 108.62 20.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.059 -1.089 . . . . 73.209999999999994 108.059 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -88.44 131.77 34.74 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.134 -0.939 . . . . 72.409999999999997 109.425 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.49 118.62 59.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.905 -0.776 . . . . 74.540000000000006 108.905 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 644' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 511' ' ' VAL . 3.7 mp -110.34 130.08 64.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.565 -1.198 . . . . 72.019999999999996 109.285 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.814 0 CA-C-O 122.254 1.026 . . . . 64.400000000000006 112.101 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.592 0 N-CA-C 110.663 -0.975 . . . . 52.340000000000003 110.663 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -127.08 114.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.11 134.55 48.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.824 0.702 . . . . 74.530000000000001 109.928 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -147.99 156.73 42.99 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.321 -0.622 . . . . 61.100000000000001 109.321 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 74.4 m-85 -73.39 153.18 40.55 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.22 -0.289 . . . . 70.25 110.22 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.3 -51.86 67.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.978 0.799 . . . . 73.310000000000002 110.536 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -135.66 155.66 78.05 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 114.606 -1.179 . . . . 63.32 108.278 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.59 -25.74 2.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.934 1.756 . . . . 74.349999999999994 113.006 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 642' ' ' GLU . 89.3 t -142.02 132.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.127 -0.694 . . . . 72.030000000000001 109.127 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.3 t -133.94 138.26 45.38 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.079 0.466 . . . . 44.340000000000003 109.943 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.73 112.92 25.92 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.774 -1.195 . . . . 75.540000000000006 107.774 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.5 m -108.5 145.19 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.313 -0.555 . . . . 71.010000000000005 110.254 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 518' ' ' ILE . 70.8 m -70.81 137.91 49.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.131 -0.941 . . . . 64.129999999999995 111.38 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -31.3 61.65 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.752 1.019 . . . . 75.329999999999998 113.752 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 7.4 p -106.84 25.35 11.39 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.844 0.354 . . . . 54.119999999999997 111.884 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -76.13 -31.02 20.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.511 0.672 . . . . 72.519999999999996 110.228 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 87.12 -70.35 2.89 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.623 -0.798 . . . . 71.329999999999998 111.795 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.75 133.36 68.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.975 -1.121 . . . . 72.319999999999993 107.975 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 572' ' ' THR . 19.6 ptm -107.62 136.4 47.44 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.146 -0.687 . . . . 53.130000000000003 109.146 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -103.14 124.6 48.89 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.397 0.679 . . . . 74.420000000000002 110.0 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.5 t -121.24 123.71 70.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.423 -0.954 . . . . 74.230000000000004 108.423 175.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.77 127.4 35.6 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.684 -0.406 . . . . 73.200000000000003 110.01 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.68 107.93 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.529 -1.656 . . . . 71.109999999999999 106.529 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.8 mt -87.16 153.04 21.82 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.02 -0.991 . . . . 63.109999999999999 110.191 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -121.64 104.83 9.9 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.874 -0.603 . . . . 74.219999999999999 110.062 -178.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.5 m -63.59 -60.78 2.89 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 72.319999999999993 110.133 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -73.04 -43.8 61.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.157 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.02 -152.35 23.13 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 110.209 -1.156 . . . . 70.549999999999997 110.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.532 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -157.75 146.69 19.53 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.194 -1.78 . . . . 74.310000000000002 106.194 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.462 ' NH2' ' HA2' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -160.9 114.55 2.04 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.152 -1.425 . . . . 72.230000000000004 107.152 -178.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.462 ' HA2' ' NH2' ' A' ' 532' ' ' ARG . . . 119.25 -131.45 9.05 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 111.229 -0.748 . . . . 63.0 111.229 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.428 HD21 ' HB ' ' A' ' 597' ' ' ILE . 42.6 t30 -136.89 103.81 5.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.282 -2.118 . . . . 75.209999999999994 105.282 174.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 41.2 t -120.14 125.04 73.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 C-N-CA 119.644 -0.822 . . . . 61.140000000000001 111.086 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.73 122.64 42.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 72.349999999999994 107.938 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.12 103.13 54.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 109.006 -0.738 . . . . 45.100000000000001 109.006 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.414 ' HA ' ' HA2' ' A' ' 558' ' ' GLY . 0.9 OUTLIER -80.12 133.27 9.82 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.819 1.68 . . . . 62.43 112.63 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -119.82 161.75 20.27 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.375 -1.343 . . . . 71.209999999999994 107.375 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -155.42 139.66 16.61 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.957 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.0 p -84.47 130.78 34.73 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.285 -0.871 . . . . 44.409999999999997 110.894 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 588' ' ' SER . 43.7 mm -99.09 114.01 35.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.542 -1.281 . . . . 75.329999999999998 107.542 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.01 161.97 27.92 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.989 -0.55 . . . . 75.140000000000001 111.002 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 144.53 117.27 1.14 Allowed Glycine 0 C--O 1.201 -1.939 0 N-CA-C 108.376 -1.889 . . . . 72.340000000000003 108.376 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 47.3 p 75.87 5.53 3.86 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 127.484 2.314 . . . . 61.420000000000002 110.395 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -169.21 140.1 2.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.706 -1.134 . . . . 65.129999999999995 108.249 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -102.47 138.08 39.86 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 123.501 0.501 . . . . 73.010000000000005 109.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -105.44 131.75 10.79 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 116.003 -0.544 . . . . 73.329999999999998 112.823 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 160.38 -49.53 0.38 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.818 -1.713 . . . . 51.240000000000002 108.818 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 179.65 -9.01 0.02 OUTLIER Glycine 0 C--N 1.294 -1.789 0 CA-C-N 113.933 -1.134 . . . . 72.420000000000002 111.286 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.426 ' H ' ' H ' ' A' ' 550' ' ' GLY . 20.5 mp0 -65.16 -61.63 2.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.875 1.27 . . . . 73.430000000000007 111.686 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -122.88 -41.13 2.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.784 0.802 . . . . 72.239999999999995 109.122 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -136.37 160.29 39.18 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.931 -1.507 . . . . 74.120000000000005 106.931 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 22.1 tt0 -89.01 141.45 28.47 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.857 -0.794 . . . . 43.399999999999999 108.857 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.89 106.72 15.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.453 -0.944 . . . . 75.200000000000003 108.453 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -117.38 131.54 56.75 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.1 -1.074 . . . . 64.099999999999994 108.1 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.5 131.59 15.36 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 112.275 0.472 . . . . 62.140000000000001 112.275 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 538' ' ' PRO . . . 85.21 -139.26 17.38 Favored Glycine 0 C--O 1.189 -2.708 0 N-CA-C 111.794 -0.522 . . . . 63.509999999999998 111.794 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 71.2 -8.0 1.07 Allowed 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.698 1.74 . . . . 64.349999999999994 115.698 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 569' ' ' LYS . 41.0 mt -93.4 131.28 38.73 Favored 'General case' 0 CA--C 1.5 -0.97 0 O-C-N 120.647 -1.283 . . . . 72.439999999999998 112.327 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -129.77 118.73 22.28 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.104 -0.953 . . . . 75.400000000000006 109.454 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 37.5 m-85 -104.54 155.31 18.93 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.555 -0.906 . . . . 65.299999999999997 108.555 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.434 ' H ' HD11 ' A' ' 567' ' ' ILE . 72.1 mm-40 -120.66 -88.22 0.63 Allowed 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.721 -1.215 . . . . 73.310000000000002 107.721 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -104.45 165.48 11.03 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.197 -1.038 . . . . 71.430000000000007 108.197 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.532 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 4.4 p30 -63.21 -11.87 24.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.789 1.033 . . . . 63.119999999999997 113.789 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.456 ' HG3' HG23 ' A' ' 567' ' ' ILE . 11.3 pt-20 -69.8 -18.75 63.49 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.945 0.498 . . . . 74.140000000000001 111.794 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.456 HG23 ' HG3' ' A' ' 566' ' ' GLU . 38.8 pt -114.12 164.29 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 120.865 0.364 . . . . 73.319999999999993 110.625 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.56 158.37 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.08 -1.452 . . . . 75.439999999999998 107.08 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.507 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -121.69 149.19 43.58 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 120.965 0.412 . . . . 73.140000000000001 110.435 173.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.56 134.27 64.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.914 -1.039 . . . . 64.310000000000002 109.964 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 50.4 mt -90.91 126.73 43.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 106.552 -1.647 . . . . 74.310000000000002 106.552 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 572' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 521' ' ' MET . 15.5 p -117.28 112.5 20.85 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.836 -0.802 . . . . 73.129999999999995 108.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.484 HD11 HD22 ' A' ' 589' ' ' LEU . 50.4 mt -109.84 131.77 59.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.175 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 61.6 mtt180 -78.47 112.04 15.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 123.964 0.79 . . . . 74.230000000000004 111.397 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.5 125.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 106.356 -1.72 . . . . 64.140000000000001 106.356 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.44 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 78.3 m-85 . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 113.129 0.788 . . . . 75.349999999999994 113.129 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.402 ' O ' HD12 ' A' ' 645' ' ' ILE . 6.4 p . . . . . 0 N--CA 1.422 -1.853 0 CA-C-O 120.393 0.139 . . . . 73.099999999999994 110.638 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.4 p -134.54 168.18 19.43 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.41 -0.218 . . . . 62.219999999999999 110.41 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.411 ' CE1' HD11 ' A' ' 645' ' ' ILE . 54.8 p90 -163.86 162.33 23.57 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.982 -1.858 . . . . 75.420000000000002 105.982 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 542' ' ' ILE . 11.0 t -113.41 171.96 7.25 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 118.802 -1.159 . . . . 62.439999999999998 108.815 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 573' ' ' ILE . 61.0 tp -145.09 126.84 15.28 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.585 -1.635 . . . . 61.420000000000002 106.585 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 120.668 0.27 . . . . 73.230000000000004 110.383 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 56.5 mt -99.79 141.0 33.18 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.212 -1.033 . . . . 72.219999999999999 108.212 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.76 167.07 10.02 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.077 -1.083 . . . . 75.400000000000006 108.077 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.63 116.17 21.68 Favored Pre-proline 0 C--O 1.247 0.946 0 N-CA-C 112.606 0.595 . . . . 75.219999999999999 112.606 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.401 ' HB2' ' CG1' ' A' ' 535' ' ' VAL . 65.7 Cg_endo -71.15 144.82 47.7 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.0 2.467 . . . . 71.329999999999998 111.527 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 595' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 595' ' ' LYS . 0.0 OUTLIER -112.68 130.71 55.95 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.643 -0.708 . . . . 73.239999999999995 110.788 -178.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -84.79 116.05 23.05 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.33 -1.359 . . . . 74.230000000000004 107.33 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 597' ' ' ILE . . . . . 0.428 ' HB ' HD21 ' A' ' 534' ' ' ASN . 38.7 mm . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 108.389 -0.967 . . . . 62.25 108.389 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 634' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 31.3 pt . . . . . 0 N--CA 1.433 -1.303 0 CA-C-O 121.581 0.705 . . . . 74.019999999999996 111.444 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.07 179.64 5.14 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.033 -1.099 . . . . 53.32 108.033 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -68.7 167.77 44.42 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.899 -0.88 . . . . 74.519999999999996 110.899 175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -48.78 -43.7 38.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.594 1.158 . . . . 74.25 110.782 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.17 123.53 9.63 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.036 -1.438 . . . . 75.329999999999998 107.3 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 639' ' ' THR . . . . . 0.426 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 11.2 t -148.97 112.89 5.14 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.812 0.815 . . . . 71.040000000000006 110.209 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -147.42 130.39 16.27 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.888 -1.051 . . . . 74.109999999999999 108.618 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 68.5 tp -108.23 118.86 37.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.917 -0.771 . . . . 75.140000000000001 108.917 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 511' ' ' VAL . 39.7 mt-10 -103.05 122.87 45.53 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.983 -1.117 . . . . 72.120000000000005 107.983 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.0 t -109.88 128.8 65.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.788 -0.819 . . . . 71.239999999999995 108.788 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.03 133.29 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.605 0 N-CA-C 107.269 -1.382 . . . . 74.329999999999998 107.269 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.411 HD11 ' CE1' ' A' ' 587' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.414 -2.245 0 CA-C-N 115.977 -0.556 . . . . 72.530000000000001 109.516 -174.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.656 0 N-CA-C 112.831 -0.108 . . . . 75.430000000000007 112.831 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.47 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.1 mt -93.19 121.61 44.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 110.414 -0.217 . . . . 73.129999999999995 110.414 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 91.2 m-85 -109.0 138.5 45.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.769 -0.826 . . . . 72.530000000000001 108.769 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -149.34 158.68 44.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.683 -0.488 . . . . 64.329999999999998 109.683 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.669 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.6 m-85 -74.51 156.79 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.607 0.242 . . . . 75.439999999999998 110.362 174.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.47 -53.03 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.169 0.918 . . . . 41.439999999999998 110.675 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -121.47 157.53 56.12 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.259 -0.882 . . . . 64.019999999999996 108.82 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -84.0 -30.26 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.521 1.481 . . . . 75.140000000000001 110.527 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 642' ' ' GLU . 70.6 t -137.64 129.89 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.0 t -133.89 131.89 39.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.045 -0.724 . . . . 74.239999999999995 109.045 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -96.17 138.01 34.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.384 -1.339 . . . . 70.319999999999993 107.384 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.87 145.49 32.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 120.853 0.359 . . . . 55.350000000000001 110.266 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 69.5 m -75.3 156.27 35.77 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.208 -0.906 . . . . 73.030000000000001 111.749 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -68.17 -46.17 71.44 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.934 -1.03 . . . . 74.109999999999999 111.046 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 11.2 t -95.17 36.04 1.25 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.771 0.796 . . . . 75.420000000000002 110.173 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.91 -31.66 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 121.722 -0.612 . . . . 73.109999999999999 110.514 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.16 -72.85 2.74 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.818 -0.706 . . . . 61.399999999999999 111.463 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.65 123.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.515 -0.55 . . . . 65.409999999999997 109.515 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.43 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 22.1 ptm -91.36 138.6 31.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.111 -1.07 . . . . 72.430000000000007 108.111 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.74 108.87 20.57 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 123.442 0.464 . . . . 53.240000000000002 111.076 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 40.1 t -105.24 117.63 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.312 -0.625 . . . . 54.229999999999997 109.312 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -96.45 132.39 42.05 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.217 0.532 . . . . 65.230000000000004 110.093 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.8 t -90.96 112.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.463 -1.31 . . . . 72.439999999999998 107.463 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.462 ' HA ' HH21 ' A' ' 527' ' ' ARG . 59.3 mt -82.36 141.99 32.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.292 -0.867 . . . . 54.310000000000002 110.191 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.462 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -106.56 102.12 11.53 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.997 -1.483 . . . . 75.239999999999995 106.997 178.064 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.7 m -67.73 -63.75 1.0 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.802 -0.635 . . . . 73.540000000000006 110.701 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 10.3 t -75.63 -31.77 59.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 75.310000000000002 110.283 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 131.67 -159.14 23.11 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.919 -0.872 . . . . 42.049999999999997 110.919 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.549 ' N ' ' HB3' ' A' ' 565' ' ' ASP . . . -168.73 142.09 2.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.637 -1.616 . . . . 63.109999999999999 106.637 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -146.06 129.4 16.78 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.128 -0.693 . . . . 71.120000000000005 109.128 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 100.72 -122.85 7.74 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 121.386 -0.435 . . . . 55.340000000000003 112.758 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -136.62 102.77 5.02 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.749 -1.945 . . . . 74.310000000000002 105.749 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.62 129.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.234 0.54 . . . . 73.299999999999997 110.552 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 559' ' ' GLU . 50.9 mm -98.29 127.62 50.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.536 -0.757 . . . . 74.439999999999998 109.147 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -112.61 104.58 55.99 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.45 0.7 . . . . 70.310000000000002 109.892 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.35 141.27 28.49 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.741 2.294 . . . . 63.229999999999997 113.262 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.53 163.91 30.02 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.375 -0.972 . . . . 72.519999999999996 108.375 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -161.69 137.82 7.98 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 123.192 0.308 . . . . 75.439999999999998 110.655 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.5 p -84.26 126.29 33.03 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.381 0.61 . . . . 31.199999999999999 110.992 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.4 117.77 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.299 -1.741 . . . . 45.130000000000003 106.299 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.86 146.38 49.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 123.355 0.409 . . . . 72.510000000000005 110.125 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.36 -108.13 0.74 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 109.16 -1.576 . . . . 75.230000000000004 109.16 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -72.08 -43.36 64.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.301 -1.74 . . . . 71.310000000000002 106.301 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -73.16 133.88 44.23 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 113.815 -1.539 . . . . 53.32 108.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 37.2 ttt180 -111.27 143.24 42.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.551 0.945 . . . . 71.430000000000007 113.551 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 48.66 -149.75 3.94 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 125.952 1.739 . . . . 74.120000000000005 117.444 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -128.11 80.72 0.36 Allowed Glycine 0 N--CA 1.405 -3.431 0 N-CA-C 109.232 -1.547 . . . . 53.43 109.232 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 146.14 -21.14 1.75 Allowed Glycine 0 C--N 1.292 -1.892 0 C-N-CA 121.054 -0.593 . . . . 74.439999999999998 111.991 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 10.3 mm-40 -77.84 -67.57 0.71 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.315 0.578 . . . . 65.540000000000006 109.908 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -108.28 -43.37 4.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.772 0.796 . . . . 52.450000000000003 109.763 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -136.79 170.73 15.6 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.276 -1.379 . . . . 64.299999999999997 107.276 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.492 ' HG3' ' HE ' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -99.67 128.94 45.76 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.362 -1.718 . . . . 73.230000000000004 106.362 176.302 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.6 111.37 1.8 Allowed 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 123.802 0.841 . . . . 75.430000000000007 110.815 -173.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 104.7 14.48 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-O 122.075 0.941 . . . . 71.530000000000001 110.946 -174.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.5 p -139.48 129.6 25.17 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.862 -1.063 . . . . 72.040000000000006 108.562 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.24 -168.38 41.12 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.264 -1.134 . . . . 74.120000000000005 110.264 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.522 ' HB2' ' CG2' ' A' ' 536' ' ' ILE . 9.8 pt-20 -131.3 129.26 41.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.306 0.574 . . . . 72.430000000000007 110.904 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.441 HD22 ' CG ' ' A' ' 569' ' ' LYS . 85.5 mt -90.37 143.91 26.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.994 -1.003 . . . . 53.329999999999998 111.436 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.89 117.16 34.41 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.128 -0.629 . . . . 72.040000000000006 110.439 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -111.29 157.72 19.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.625 -1.25 . . . . 52.130000000000003 107.625 172.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -121.08 -87.8 0.63 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.901 -1.148 . . . . 71.420000000000002 107.901 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -104.47 162.43 13.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.826 -1.175 . . . . 74.230000000000004 107.826 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.549 ' HB3' ' N ' ' A' ' 531' ' ' ALA . 4.2 p30 -64.06 -15.41 59.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 113.718 1.007 . . . . 53.32 113.718 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.32 -19.42 63.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.736 0.303 . . . . 72.209999999999994 111.726 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 40.3 pt -107.18 163.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.82 154.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 108.153 -1.054 . . . . 62.109999999999999 108.153 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.441 ' CG ' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -119.19 162.53 18.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 104.884 -2.265 . . . . 72.519999999999996 104.884 175.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 76.6 mt -131.6 137.64 54.76 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.535 0 N-CA-C 107.954 -1.128 . . . . 71.230000000000004 107.954 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 48.7 mt -93.27 122.07 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.125 -1.805 . . . . 72.219999999999999 106.125 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 44.5 p -105.56 112.71 25.9 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.789 -0.448 . . . . 62.43 109.789 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.459 HD11 HD22 ' A' ' 589' ' ' LEU . 59.7 mt -110.85 122.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.563 -0.532 . . . . 72.140000000000001 109.563 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.492 ' HE ' ' HG3' ' A' ' 554' ' ' GLU . 23.3 mtm-85 -72.89 115.89 12.73 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.868 0.73 . . . . 73.140000000000001 110.774 174.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.0 mm -96.06 127.88 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.25 -0.886 . . . . 63.100000000000001 109.077 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 108.797 -0.816 . . . . 73.420000000000002 108.797 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.49 ' HB2' HG12 ' A' ' 645' ' ' ILE . 84.0 m . . . . . 0 N--CA 1.429 -1.506 0 CA-C-O 120.879 0.371 . . . . 55.32 111.242 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 12.9 m -119.95 130.94 55.02 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.852 -0.425 . . . . 74.540000000000006 109.852 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 52.1 p90 -129.57 -179.45 5.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.375 -1.342 . . . . 75.129999999999995 107.375 171.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 8.6 t -131.72 168.16 18.24 Favored 'General case' 0 N--CA 1.409 -2.507 0 C-N-CA 119.07 -1.052 . . . . 73.299999999999997 109.926 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 573' ' ' ILE . 51.5 tp -140.57 123.25 16.23 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 105.688 -1.967 . . . . 51.439999999999998 105.688 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.46 157.06 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 116.423 -0.353 . . . . 75.099999999999994 110.185 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.669 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 64.9 mt -107.79 151.66 25.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.211 -1.033 . . . . 60.25 108.211 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -115.17 178.06 4.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.206 0.316 . . . . 72.430000000000007 110.237 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -59.34 119.17 36.88 Favored Pre-proline 0 C--O 1.245 0.856 0 O-C-N 124.161 0.913 . . . . 65.439999999999998 111.7 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.488 ' HD3' HD22 ' A' ' 635' ' ' LEU . 55.6 Cg_endo -71.11 157.41 57.68 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 122.883 2.388 . . . . 74.340000000000003 112.032 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -124.42 138.1 54.39 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.385 -0.825 . . . . 71.400000000000006 110.328 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -95.32 123.38 38.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.536 -1.283 . . . . 73.109999999999999 107.536 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 44.2 mm . . . . . 0 C--N 1.292 -1.906 0 N-CA-C 108.202 -1.036 . . . . 74.209999999999994 108.202 179.306 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 50.9 pt . . . . . 0 N--CA 1.415 -2.2 0 N-CA-C 107.361 -1.348 . . . . 74.230000000000004 107.361 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 635' ' ' LEU . 2.2 pt? -87.41 -170.18 2.92 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 115.584 -0.734 . . . . 73.349999999999994 111.618 -171.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -61.85 144.36 48.95 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.632 -0.987 . . . . 34.030000000000001 110.632 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.08 -51.88 67.52 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.168 0.508 . . . . 75.239999999999995 110.127 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -123.25 104.35 9.09 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.368 0.604 . . . . 75.120000000000005 109.835 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.0 t -133.22 116.53 16.32 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.627 -0.879 . . . . 71.25 108.627 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -145.39 142.0 28.95 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.453 -0.943 . . . . 73.439999999999998 108.453 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.8 tp -121.84 110.45 15.9 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.932 -0.766 . . . . 64.530000000000001 108.932 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.562 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.5 mt-10 -88.28 112.42 22.79 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.043 -1.095 . . . . 75.209999999999994 108.043 174.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.41 120.67 51.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.976 -1.011 . . . . 75.140000000000001 108.838 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 23.5 mt -119.06 114.45 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-N 114.878 -1.055 . . . . 75.129999999999995 111.159 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.523 ' H ' HD13 ' A' ' 645' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 N-CA-C 107.423 -1.325 . . . . 71.519999999999996 107.423 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.375 0 N-CA-C 112.906 -0.078 . . . . 43.240000000000002 112.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.1 mt -127.15 114.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.126 -2.176 . . . . 73.239999999999995 105.126 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.533 ' CE1' ' HD2' ' A' ' 527' ' ' ARG . 97.6 m-85 -113.84 128.94 56.61 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.91 -0.316 . . . . 74.510000000000005 110.309 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.44 148.97 30.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.969 -0.56 . . . . 64.049999999999997 110.11 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -67.31 154.08 42.15 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 110.323 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.16 -55.4 35.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.096 -0.705 . . . . 74.439999999999998 109.096 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -127.48 157.38 73.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.914 -1.039 . . . . 72.319999999999993 108.899 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -88.99 -13.76 2.99 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.403 2.069 . . . . 72.230000000000004 113.002 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 642' ' ' GLU . 91.4 t -143.45 133.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.66 -0.496 . . . . 40.200000000000003 109.66 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.3 t -134.51 133.23 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.64 -0.504 . . . . 64.319999999999993 109.64 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -108.85 112.1 24.16 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.301 -1.0 . . . . 64.129999999999995 108.301 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 645' ' ' ILE . 24.1 m -121.26 162.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.146 0.498 . . . . 54.310000000000002 110.919 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 518' ' ' ILE . 37.0 m -77.19 149.63 35.53 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.198 -0.455 . . . . 63.520000000000003 112.009 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.03 -27.58 69.21 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.332 0.587 . . . . 64.129999999999995 110.228 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.3 m -110.59 28.63 8.49 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.762 -0.654 . . . . 73.120000000000005 111.143 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 515' ' ' SER . 10.0 tt -76.89 -28.33 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.101 0.477 . . . . 63.350000000000001 111.417 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.43 -77.8 0.84 Allowed Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.081 -0.808 . . . . 75.409999999999997 111.081 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.2 mm -130.14 146.22 34.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.691 -1.226 . . . . 54.009999999999998 107.691 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.0 ppp? -119.6 153.64 35.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.968 -1.493 . . . . 73.140000000000001 106.968 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -128.13 126.57 41.36 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.068 0.23 . . . . 74.230000000000004 111.153 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.468 HG21 HD21 ' A' ' 641' ' ' LEU . 55.5 t -134.37 131.35 54.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.223 -0.658 . . . . 64.010000000000005 109.223 174.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.42 ' HG2' HG12 ' A' ' 570' ' ' ILE . 55.2 mttp -90.76 151.07 21.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.142 0.496 . . . . 62.539999999999999 110.171 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.0 t -103.95 113.45 40.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 105.964 -1.865 . . . . 64.400000000000006 105.964 172.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.09 134.84 34.46 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.118 -0.492 . . . . 64.439999999999998 110.189 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.685 ' HD3' ' HB2' ' A' ' 531' ' ' ALA . 73.3 ttt180 -106.87 102.61 11.96 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.988 -1.115 . . . . 71.010000000000005 107.988 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.0 m -65.82 -47.7 74.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.588 -1.187 . . . . 71.349999999999994 113.901 -171.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.6 p -69.01 -51.35 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.357 0.873 . . . . 62.119999999999997 113.357 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 155.48 172.83 23.48 Favored Glycine 0 CA--C 1.48 -2.156 0 N-CA-C 108.644 -1.782 . . . . 43.340000000000003 108.644 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.685 ' HB2' ' HD3' ' A' ' 527' ' ' ARG . . . -150.03 121.56 7.98 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 117.658 0.729 . . . . 65.400000000000006 112.552 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.501 ' HD3' ' C ' ' A' ' 532' ' ' ARG . 0.8 OUTLIER -156.71 110.82 2.72 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.633 -0.877 . . . . 74.109999999999999 108.633 171.183 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 149.19 -142.82 10.18 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 109.614 -1.394 . . . . 75.040000000000006 109.614 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -137.43 112.76 9.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.319 -1.363 . . . . 62.200000000000003 107.319 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.95 132.15 65.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 120.676 -0.41 . . . . 61.5 111.415 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.64 116.82 47.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.716 -0.674 . . . . 72.450000000000003 109.291 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.44 111.1 65.13 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.816 -0.809 . . . . 75.230000000000004 108.816 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 594' ' ' PRO . 10.2 Cg_endo -84.6 149.02 11.32 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.945 1.764 . . . . 71.310000000000002 111.082 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -138.21 159.24 42.56 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.159 -1.052 . . . . 75.400000000000006 108.159 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 589' ' ' LEU . 57.2 pttt -151.59 137.5 18.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.452 . . . . 74.400000000000006 110.021 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -84.2 143.12 29.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.881 -0.6 . . . . 70.450000000000003 111.124 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 48.5 mm -102.37 115.72 44.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.336 -1.728 . . . . 74.319999999999993 106.336 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -73.55 109.88 7.41 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.627 0.58 . . . . 74.129999999999995 111.513 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -135.34 126.17 3.91 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.363 -1.095 . . . . 55.539999999999999 110.363 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.3 m 69.06 -49.34 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.268 2.227 . . . . 73.010000000000005 112.459 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -90.16 150.14 22.14 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.431 -0.952 . . . . 63.409999999999997 108.431 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 40.9 ttp180 -93.14 135.49 34.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.956 0.408 . . . . 71.120000000000005 110.597 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.56 -161.15 35.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.542 -0.754 . . . . 62.409999999999997 111.355 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 85.97 18.56 59.34 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.043 -1.223 . . . . 74.450000000000003 110.043 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.76 27.79 60.22 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.029 -0.829 . . . . 72.239999999999995 111.029 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 10.1 tp10 -87.67 -87.26 0.15 Allowed 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 122.849 0.459 . . . . 61.210000000000001 110.611 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.03 -30.34 17.81 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.065 0.936 . . . . 72.540000000000006 109.208 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.92 148.74 40.9 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 106.704 -1.591 . . . . 71.319999999999993 106.704 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.455 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 0.6 OUTLIER -86.28 105.83 16.92 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 105.988 -1.856 . . . . 71.5 105.988 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.94 91.14 1.18 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.763 1.268 . . . . 74.219999999999999 109.718 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.9 t -83.33 132.77 34.99 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 113.334 -1.757 . . . . 74.450000000000003 112.252 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.0 p -139.46 119.8 13.85 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.447 -2.057 . . . . 74.430000000000007 105.447 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.89 -179.75 27.8 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 119.473 -1.346 . . . . 72.030000000000001 113.048 -173.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -105.17 111.45 24.2 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 123.977 0.911 . . . . 65.439999999999998 108.703 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.99 126.86 43.6 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.57 -0.852 . . . . 71.400000000000006 109.42 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.93 98.58 8.4 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 121.468 0.651 . . . . 72.0 111.72 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 53.1 m-85 -94.37 101.78 13.73 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.591 -0.892 . . . . 73.519999999999996 108.591 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.518 ' H ' HD11 ' A' ' 567' ' ' ILE . 75.4 mt-30 -86.55 -79.59 0.26 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.73 -0.668 . . . . 51.420000000000002 109.735 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -104.63 163.48 12.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.719 -0.673 . . . . 53.130000000000003 109.701 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 531' ' ' ALA . 17.9 t70 -65.37 -21.24 66.66 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.658 1.183 . . . . 74.299999999999997 112.269 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.69 -16.65 63.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.864 0.69 . . . . 73.239999999999995 112.864 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.518 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.7 pt -112.63 160.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.539 -0.464 . . . . 72.120000000000005 110.767 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.47 144.9 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.315 -1.365 . . . . 62.439999999999998 107.315 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 73.0 mmtt -102.51 149.82 24.01 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.045 0.45 . . . . 75.200000000000003 110.756 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.42 HG12 ' HG2' ' A' ' 524' ' ' LYS . 66.2 mt -123.01 128.62 75.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.421 -1.263 . . . . 63.219999999999999 108.807 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.433 HD13 HD21 ' A' ' 589' ' ' LEU . 62.5 mt -90.76 121.72 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 107.529 -1.286 . . . . 72.5 107.529 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 572' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 521' ' ' MET . 40.1 p -110.23 113.28 25.83 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.801 -0.636 . . . . 52.119999999999997 109.411 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 589' ' ' LEU . 61.0 mt -103.97 122.5 56.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.061 -1.089 . . . . 71.299999999999997 108.061 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.455 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 80.3 mtt85 -75.76 115.92 15.94 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.868 0.73 . . . . 61.25 109.522 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.05 139.56 19.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.212 -1.403 . . . . 73.019999999999996 107.212 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 C--N 1.297 -1.711 0 CA-C-O 121.194 0.521 . . . . 74.540000000000006 110.166 -178.216 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.469 ' HB2' HG12 ' A' ' 645' ' ' ILE . 59.2 m . . . . . 0 N--CA 1.425 -1.678 0 N-CA-C 108.973 -0.751 . . . . 65.420000000000002 108.973 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 27.4 p -139.43 113.53 8.81 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.492 0.663 . . . . 71.25 111.229 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.3 p90 -109.81 -178.43 3.53 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.169 -1.049 . . . . 70.150000000000006 108.169 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 19.7 m -135.01 167.52 20.79 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.989 -0.684 . . . . 61.219999999999999 110.447 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 573' ' ' ILE . 51.7 tp -137.97 132.49 32.4 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.55 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.663 -0.495 . . . . 71.219999999999999 109.663 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.39 145.31 29.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.7 -0.682 . . . . 73.299999999999997 109.304 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.71 174.19 6.07 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.679 -0.86 . . . . 61.32 108.679 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -66.03 116.8 36.3 Favored Pre-proline 0 C--O 1.246 0.888 0 CA-C-O 121.106 0.479 . . . . 44.43 111.766 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 538' ' ' PRO . 44.4 Cg_endo -71.28 147.56 53.52 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.422 2.081 . . . . 71.129999999999995 111.573 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -113.12 140.27 48.03 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 109.402 -0.592 . . . . 64.239999999999995 109.402 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -92.42 127.57 37.96 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.148 -1.797 . . . . 75.430000000000007 106.148 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 34.6 mm . . . . . 0 C--N 1.287 -2.149 0 N-CA-C 108.692 -0.855 . . . . 75.150000000000006 108.692 -178.811 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.015 0 CA-C-O 121.014 0.435 . . . . 63.210000000000001 111.001 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.27 -174.38 4.15 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.903 -0.777 . . . . 73.030000000000001 108.903 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -81.69 -152.8 10.09 Favored Glycine 0 C--N 1.306 -1.106 0 C-N-CA 120.452 -0.88 . . . . 71.420000000000002 112.272 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -64.85 -42.0 95.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.85 0.833 . . . . 74.409999999999997 109.232 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -167.41 145.34 4.7 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 125.583 1.553 . . . . 73.040000000000006 107.068 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.1 t -153.29 116.53 4.61 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.824 0.821 . . . . 63.420000000000002 110.446 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -146.19 142.93 28.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.714 -1.217 . . . . 73.310000000000002 107.714 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 523' ' ' VAL . 45.5 tp -121.97 113.01 18.99 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.743 -0.836 . . . . 74.319999999999993 108.743 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.433 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.1 mt-10 -92.35 122.86 35.22 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.816 -1.179 . . . . 73.010000000000005 107.816 176.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.12 117.53 55.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 109.243 -0.651 . . . . 63.439999999999998 109.243 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.04 123.42 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.717 0 N-CA-C 108.059 -1.089 . . . . 73.519999999999996 108.059 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 121.501 0.667 . . . . 63.119999999999997 110.399 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.341 0 N-CA-C 111.128 -0.789 . . . . 53.039999999999999 111.128 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -79.27 112.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.28 -1.378 . . . . 71.439999999999998 107.28 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 94.9 m-85 -96.3 134.94 38.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.394 0.434 . . . . 71.540000000000006 110.385 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.4 t -149.2 158.24 44.02 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 124.06 0.85 . . . . 61.130000000000003 108.948 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.5 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 64.4 m-85 -79.85 169.39 17.98 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.374 -0.602 . . . . 71.129999999999995 109.374 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 526' ' ' LEU . 48.1 mt-10 -74.69 -41.71 59.74 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.43 0.633 . . . . 73.530000000000001 109.643 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.67 161.52 61.33 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.286 -0.87 . . . . 73.140000000000001 108.934 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.03 -12.18 7.2 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.926 1.751 . . . . 75.140000000000001 112.079 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 642' ' ' GLU . 72.3 t -142.43 138.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.033 -0.729 . . . . 52.520000000000003 109.033 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.2 t -133.7 136.56 44.76 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.121 -0.696 . . . . 74.439999999999998 109.121 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -107.33 114.45 28.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.058 -0.519 . . . . 62.43 110.193 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 27.5 m -129.16 166.0 27.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.051 -0.522 . . . . 72.209999999999994 109.872 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.3 t -85.99 162.76 18.35 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.933 0.397 . . . . 71.140000000000001 110.4 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -80.95 -19.87 43.25 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.955 -1.498 . . . . 74.310000000000002 106.955 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.1 m -107.14 25.83 10.9 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.03 -0.986 . . . . 43.520000000000003 111.296 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 515' ' ' SER . 7.7 tt -87.18 -21.38 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 121.433 0.635 . . . . 73.019999999999996 111.419 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.93 -74.58 1.85 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.491 -0.862 . . . . 74.109999999999999 112.221 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.0 mm -134.97 147.12 29.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.647 -1.612 . . . . 74.140000000000001 106.647 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.2 ppp? -123.29 145.47 48.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.678 -1.23 . . . . 71.329999999999998 107.678 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -111.97 129.01 56.33 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 123.57 0.544 . . . . 62.310000000000002 111.631 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.4 t -122.07 103.95 14.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.415 -0.357 . . . . 55.409999999999997 110.227 174.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.513 ' HB3' HG12 ' A' ' 570' ' ' ILE . 17.9 ptpt -86.69 129.0 35.04 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.613 -0.884 . . . . 71.219999999999999 108.613 172.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.04 133.54 30.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.623 -0.51 . . . . 71.400000000000006 109.623 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 74.6 mt -96.89 149.23 22.11 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.946 -0.57 . . . . 63.43 110.574 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 504' ' ' ILE 0.285 0.0 OUTLIER -130.69 109.21 10.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.655 0.741 . . . . 72.510000000000005 111.397 171.918 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 14.3 m -65.04 -44.9 87.58 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.35 -1.296 . . . . 75.209999999999994 113.277 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 p -72.96 -39.73 65.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.016 0.436 . . . . 51.350000000000001 112.153 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.78 -167.0 26.83 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.685 -1.366 . . . . 73.299999999999997 109.685 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 527' ' ' ARG . . . -162.63 116.31 1.72 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.441 -0.577 . . . . 55.539999999999999 109.441 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -154.95 106.8 2.68 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.634 -1.247 . . . . 61.229999999999997 107.634 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 146.25 -140.5 8.86 Favored Glycine 0 C--N 1.298 -1.538 0 N-CA-C 110.753 -0.939 . . . . 74.409999999999997 110.753 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -136.91 101.03 4.46 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.359 -1.719 . . . . 65.400000000000006 106.359 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.48 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.254 0.55 . . . . 73.430000000000007 110.355 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 559' ' ' GLU . 45.0 mm -102.0 123.77 55.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.886 -0.783 . . . . 64.129999999999995 108.886 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.43 108.83 60.16 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.715 -0.846 . . . . 72.310000000000002 108.715 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -78.16 146.61 22.77 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 73.420000000000002 111.789 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.56 162.4 35.45 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.565 -1.272 . . . . 54.130000000000003 107.565 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -162.1 145.91 12.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.228 0.537 . . . . 74.450000000000003 111.845 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.6 p -85.82 133.84 33.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.936 -1.029 . . . . 63.219999999999999 111.078 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 43.9 mm -100.55 114.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.988 -1.486 . . . . 72.099999999999994 106.988 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.44 126.5 32.81 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.804 -0.443 . . . . 64.319999999999993 109.804 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -128.68 -94.58 0.79 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.658 -0.782 . . . . 64.010000000000005 111.661 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 18.4 p -92.12 17.61 9.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.379 1.085 . . . . 64.430000000000007 110.554 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -146.92 134.7 21.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.888 -1.523 . . . . 24.030000000000001 106.888 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.52 132.83 46.94 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 109.081 -0.711 . . . . 65.420000000000002 109.081 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -97.69 138.41 13.87 Favored Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 115.836 -0.62 . . . . 72.239999999999995 111.97 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 129.25 11.07 2.87 Favored Glycine 0 C--N 1.294 -1.752 0 C-N-CA 120.894 -0.669 . . . . 54.140000000000001 111.93 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 133.49 -17.42 4.48 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.517 -1.325 . . . . 61.119999999999997 113.671 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.86 -79.48 0.12 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.111 -0.636 . . . . 62.32 111.407 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.06 -42.75 9.78 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.974 -1.121 . . . . 71.129999999999995 107.974 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -144.53 174.07 11.26 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.149 -0.932 . . . . 70.040000000000006 109.119 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -103.42 120.56 41.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.231 -2.137 . . . . 64.120000000000005 105.231 177.533 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.63 139.22 45.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.55 -0.46 . . . . 74.109999999999999 110.353 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -138.54 128.67 25.59 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.813 0.816 . . . . 50.409999999999997 111.33 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.3 p -145.35 133.37 21.41 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.485 -1.302 . . . . 53.210000000000001 107.485 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.25 -165.19 31.59 Favored Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.016 -1.564 . . . . 54.310000000000002 112.718 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.401 ' HB3' HG23 ' A' ' 536' ' ' ILE . 49.8 mt-10 -109.85 116.06 30.97 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.436 0.694 . . . . 61.5 111.13 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.47 138.08 32.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.546 -0.909 . . . . 73.349999999999994 108.546 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -104.8 102.93 12.47 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.626 0.727 . . . . 74.140000000000001 111.976 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.4 m-85 -101.49 99.98 10.37 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.231 -1.025 . . . . 70.450000000000003 108.231 174.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.24 -82.59 0.13 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.933 -0.707 . . . . 61.539999999999999 110.813 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -104.83 177.16 4.93 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.765 0.793 . . . . 54.539999999999999 112.127 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.457 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 23.9 t70 -75.33 -16.21 60.43 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.728 -1.123 . . . . 72.109999999999999 112.049 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.38 -19.62 63.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.082 0.771 . . . . 70.239999999999995 113.082 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 45.0 pt -113.14 168.93 5.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.715 -1.217 . . . . 73.450000000000003 107.715 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.32 143.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.444 -0.947 . . . . 63.340000000000003 108.444 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 71.4 mmtt -98.89 142.53 30.29 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-O 121.253 0.549 . . . . 74.200000000000003 110.73 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 524' ' ' LYS . 14.7 mt -129.25 130.41 67.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.222 -1.354 . . . . 65.329999999999998 109.729 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 44.9 mt -90.23 126.7 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.155 -1.424 . . . . 61.539999999999999 107.155 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 20.9 p -112.71 113.5 25.65 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.287 -0.634 . . . . 55.200000000000003 109.287 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.43 HD11 HD22 ' A' ' 589' ' ' LEU . 71.6 mt -104.1 126.06 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 N-CA-C 108.728 -0.841 . . . . 63.420000000000002 108.728 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.5 OUTLIER -79.27 108.2 12.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.554 -1.276 . . . . 71.430000000000007 107.554 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.78 127.99 46.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.061 -1.829 . . . . 74.109999999999999 106.061 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 96.3 m-85 . . . . . 0 C--N 1.286 -2.162 0 C-N-CA 119.766 -0.774 . . . . 74.430000000000007 110.731 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.475 ' HB2' HG12 ' A' ' 645' ' ' ILE . 75.2 m . . . . . 0 N--CA 1.428 -1.555 0 CA-C-O 121.171 0.51 . . . . 72.109999999999999 109.709 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.2 m -147.05 138.28 23.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.454 -0.573 . . . . 54.43 109.454 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.1 p90 -137.13 163.63 30.37 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.312 -0.995 . . . . 75.209999999999994 108.312 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.6 m -112.94 161.37 17.08 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 119.842 -0.743 . . . . 72.319999999999993 109.828 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 573' ' ' ILE . 70.0 tp -132.71 126.32 32.26 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.458 -1.682 . . . . 71.140000000000001 106.458 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.22 158.14 28.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 120.861 0.362 . . . . 75.230000000000004 110.739 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.5 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 80.0 mt -106.41 148.04 28.59 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.914 -1.143 . . . . 65.109999999999999 107.914 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.08 177.31 4.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.772 -0.455 . . . . 52.140000000000001 109.772 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.23 122.49 73.21 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 113.077 0.769 . . . . 74.239999999999995 113.077 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.566 ' HD3' HD22 ' A' ' 635' ' ' LEU . 75.2 Cg_endo -75.17 145.85 31.36 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.888 2.392 . . . . 71.209999999999994 111.868 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -116.53 140.62 49.17 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 115.704 -0.68 . . . . 71.549999999999997 109.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -104.98 124.21 49.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.252 -1.018 . . . . 74.340000000000003 108.252 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.291 -1.968 0 N-CA-C 107.604 -1.258 . . . . 64.209999999999994 107.604 177.568 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.953 -0.388 . . . . 71.109999999999999 109.953 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.566 HD22 ' HD3' ' A' ' 594' ' ' PRO . 2.5 pt? -112.0 -163.13 0.83 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.62 -1.252 . . . . 75.140000000000001 107.62 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.33 143.48 47.26 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.646 -1.382 . . . . 74.239999999999995 109.646 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.92 -39.49 72.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.722 -0.391 . . . . 75.200000000000003 111.558 -173.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -124.55 107.79 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.347 -0.541 . . . . 64.530000000000001 110.497 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 115.42 5.18 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.742 0.782 . . . . 74.439999999999998 109.397 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -147.9 127.9 13.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.664 -0.865 . . . . 74.329999999999998 108.664 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.93 112.34 25.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.645 -0.502 . . . . 64.230000000000004 109.645 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.463 ' HB2' HG22 ' A' ' 511' ' ' VAL . 45.0 mt-10 -89.76 113.45 24.98 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.605 0.717 . . . . 63.399999999999999 109.438 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 36.7 t -100.43 115.53 41.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.387 -1.279 . . . . 64.230000000000004 108.439 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 21.2 mt -112.32 126.78 69.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 CA-C-N 114.823 -1.081 . . . . 54.43 109.169 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 514' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.221 0 CA-C-N 115.818 -0.628 . . . . 73.120000000000005 112.582 -176.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.658 ' N ' ' HG ' ' A' ' 529' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.83 0 N-CA-C 109.18 -1.568 . . . . 60.229999999999997 109.18 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.586 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.2 mt -127.97 124.26 62.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.609 -0.515 . . . . 74.230000000000004 109.609 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.51 137.3 43.57 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.669 0.606 . . . . 71.019999999999996 110.601 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -149.18 156.28 41.93 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.248 -0.278 . . . . 72.25 110.248 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.47 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 61.4 m-85 -77.2 168.76 19.52 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.213 -1.032 . . . . 71.040000000000006 108.213 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.49 -46.94 36.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.662 0.744 . . . . 73.230000000000004 109.005 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -122.91 164.6 26.14 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 114.838 -1.074 . . . . 73.129999999999995 109.847 -174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -90.47 -19.53 1.09 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.613 2.209 . . . . 70.150000000000006 112.011 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.2 132.75 38.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.363 -0.977 . . . . 71.329999999999998 108.363 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' THR . . . . . 0.452 HG22 HD22 ' A' ' 641' ' ' LEU . 10.0 t -131.22 127.31 37.62 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.995 -0.743 . . . . 63.119999999999997 108.995 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -99.88 125.11 45.8 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.492 -0.929 . . . . 75.239999999999995 108.492 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 645' ' ' ILE . 19.8 m -134.59 162.31 39.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.408 0.623 . . . . 64.230000000000004 109.713 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.407 ' O ' HG22 ' A' ' 518' ' ' ILE . 39.3 m -80.9 157.34 25.65 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.71 -0.677 . . . . 64.049999999999997 110.284 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 516' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -77.62 -23.66 49.74 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.556 -1.276 . . . . 55.25 107.556 172.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.0 p -95.73 18.95 12.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.035 -1.439 . . . . 70.409999999999997 111.45 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 515' ' ' SER . 9.0 tt -81.77 -31.73 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.941 -0.704 . . . . 72.25 111.274 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.09 -75.27 1.59 Allowed Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.413 -0.898 . . . . 72.530000000000001 111.139 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 574' ' ' ARG . 44.2 mm -126.65 125.67 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.377 -0.972 . . . . 62.219999999999999 108.377 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -97.36 147.22 24.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.357 -0.979 . . . . 64.430000000000007 108.357 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -118.15 115.49 24.91 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.282 0.633 . . . . 60.030000000000001 112.238 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 36.8 t -109.92 124.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.182 -0.463 . . . . 63.020000000000003 110.56 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.33 127.99 41.83 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.795 -0.817 . . . . 72.0 108.795 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.56 118.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 75.019999999999996 109.032 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.7 mt -93.46 148.34 22.16 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.312 -0.858 . . . . 74.219999999999999 109.514 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 102.92 12.28 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.029 -2.582 . . . . 74.319999999999993 104.029 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 10.4 t -66.86 -46.64 74.4 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.844 -0.742 . . . . 71.109999999999999 110.583 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' SER . . . . . 0.658 ' HG ' ' N ' ' A' ' 503' ' ' GLY . 30.1 t -74.4 -45.28 47.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.2 0.524 . . . . 71.0 110.095 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.57 -168.83 23.72 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 109.802 -1.319 . . . . 63.32 109.802 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -156.08 137.68 14.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.652 -0.87 . . . . 31.120000000000001 108.652 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -155.81 103.85 2.28 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.952 . . . . 63.43 108.431 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 137.76 -131.08 5.32 Favored Glycine 0 C--N 1.308 -0.991 0 N-CA-C 110.826 -0.909 . . . . 73.409999999999997 110.826 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -136.98 102.5 4.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.337 -1.357 . . . . 54.140000000000001 107.337 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 26.5 t -121.56 122.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.885 -0.726 . . . . 72.030000000000001 111.421 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.429 HG12 HD13 ' A' ' 597' ' ' ILE . 38.7 mm -88.17 120.98 37.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.483 -1.302 . . . . 70.420000000000002 107.483 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.4 t -110.42 104.77 56.42 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.062 -0.718 . . . . 64.319999999999993 109.062 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.497 ' HG2' ' HB3' ' A' ' 592' ' ' GLU . 14.8 Cg_endo -85.16 163.28 11.47 Favored 'Trans proline' 0 N--CA 1.419 -2.89 0 C-N-CA 121.475 1.45 . . . . 74.420000000000002 111.375 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.436 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.6 p90 -149.91 164.29 35.81 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.046 -1.835 . . . . 73.340000000000003 106.046 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.15 133.01 16.03 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.22 -0.592 . . . . 74.430000000000007 111.089 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 555' ' ' ASP . 17.7 p -82.35 121.15 26.33 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.843 -1.071 . . . . 71.329999999999998 109.719 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.72 116.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.289 -1.374 . . . . 71.329999999999998 107.289 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -72.47 110.05 6.59 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.704 0.628 . . . . 61.439999999999998 110.129 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -98.54 -107.68 2.71 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.809 -0.917 . . . . 43.049999999999997 110.809 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.1 p -85.04 -20.59 30.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.571 0.701 . . . . 73.319999999999993 109.901 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.26 134.3 35.6 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.893 -1.151 . . . . 72.219999999999999 107.893 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -92.26 138.42 31.54 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 120.832 0.349 . . . . 73.200000000000003 111.7 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.1 -158.58 20.51 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 111.147 -0.781 . . . . 61.310000000000002 111.147 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.91 17.14 79.29 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.198 -0.761 . . . . 75.519999999999996 111.198 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.16 32.76 60.01 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 111.372 -0.691 . . . . 60.210000000000001 111.372 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.28 -71.23 0.64 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.804 -0.813 . . . . 74.230000000000004 108.804 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.53 -31.01 13.53 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.556 -1.275 . . . . 73.099999999999994 107.556 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.97 150.08 33.35 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 115.276 -0.875 . . . . 72.299999999999997 109.045 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.4 tm-20 -87.14 105.63 17.32 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 105.929 -1.878 . . . . 74.329999999999998 105.929 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.447 ' HB2' ' OG1' ' A' ' 541' ' ' THR . 7.5 p-10 -76.65 135.29 39.13 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.84 0.828 . . . . 70.230000000000004 111.321 -173.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 3.2 t -133.53 148.98 51.69 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.026 -0.988 . . . . 71.209999999999994 110.548 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.9 p -148.33 111.29 4.84 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.136 0.574 . . . . 74.129999999999995 110.925 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 101.51 -164.02 17.76 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.95 -0.643 . . . . 64.310000000000002 112.28 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 84.51 10.51 0.38 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.513 1.525 . . . . 73.030000000000001 114.024 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 569' ' ' LYS . 32.0 mt -106.4 133.43 51.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 118.977 -1.089 . . . . 71.129999999999995 111.061 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -132.1 114.97 15.17 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.919 -0.771 . . . . 72.310000000000002 108.919 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.3 m-85 -111.09 105.94 14.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.321 -0.992 . . . . 72.340000000000003 108.321 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.432 ' H ' HD11 ' A' ' 567' ' ' ILE . 49.2 mt-30 -83.89 -69.15 0.66 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.322 -0.992 . . . . 64.0 108.322 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -105.2 160.93 14.7 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.4 -0.818 . . . . 75.530000000000001 109.228 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.38 -22.63 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.077 0.465 . . . . 70.239999999999995 111.959 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.86 -6.94 9.36 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.987 1.106 . . . . 73.340000000000003 113.987 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.432 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -115.21 162.61 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.896 -0.779 . . . . 73.340000000000003 108.896 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.7 p -131.18 150.71 34.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.688 -1.227 . . . . 65.150000000000006 107.688 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -120.61 155.94 32.7 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.905 -0.405 . . . . 75.129999999999995 109.905 174.402 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.9 mt -125.34 135.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 124.275 0.984 . . . . 74.25 109.641 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.3 mt -92.32 120.92 42.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.491 -1.67 . . . . 74.420000000000002 106.491 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 31.2 p -110.52 112.79 24.94 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.615 0.572 . . . . 73.239999999999995 109.718 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 589' ' ' LEU . 70.4 mt -112.48 128.43 69.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.897 -0.779 . . . . 65.140000000000001 108.897 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.422 ' HA ' HD13 ' A' ' 520' ' ' ILE . 35.3 ttm180 -85.07 126.94 34.0 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.588 0.555 . . . . 72.209999999999994 109.526 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.2 142.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.039 -1.097 . . . . 53.32 108.039 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 76.3 m-85 . . . . . 0 C--N 1.306 -1.297 0 CA-C-O 121.196 0.522 . . . . 71.040000000000006 109.787 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.429 -1.52 0 N-CA-C 109.617 -0.512 . . . . 53.420000000000002 109.617 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 35.2 p -138.34 153.58 48.97 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.289 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.92 161.34 37.82 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.661 -1.237 . . . . 70.409999999999997 107.661 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.0 m -110.81 158.6 18.5 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 119.541 -0.863 . . . . 65.319999999999993 109.511 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 573' ' ' ILE . 47.0 tp -134.78 121.69 21.07 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.798 -1.186 . . . . 73.450000000000003 107.798 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.73 155.87 26.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 109.584 -0.524 . . . . 71.239999999999995 109.584 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.47 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 82.9 mt -90.96 146.63 23.72 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.137 -1.06 . . . . 71.430000000000007 108.137 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 592' ' ' GLU . . . . . 0.497 ' HB3' ' HG2' ' A' ' 538' ' ' PRO . 4.7 tp10 -107.12 175.86 5.36 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.78 -1.563 . . . . 71.140000000000001 106.78 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 0.0 OUTLIER -60.82 115.36 13.53 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 113.824 1.046 . . . . 61.240000000000002 113.824 -177.416 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.424 ' HB2' ' CG1' ' A' ' 535' ' ' VAL . 42.4 Cg_endo -73.82 141.03 29.82 Favored 'Trans proline' 0 N--CA 1.418 -2.949 0 C-N-CA 121.648 1.566 . . . . 72.109999999999999 110.623 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 129.49 56.39 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.857 -0.611 . . . . 74.319999999999993 110.702 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -92.37 117.36 29.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 64.200000000000003 108.18 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 597' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 536' ' ' ILE . 2.5 mp . . . . . 0 C--N 1.281 -2.392 0 N-CA-C 106.949 -1.5 . . . . 62.240000000000002 106.949 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 634' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 33.8 pt . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 121.207 0.527 . . . . 63.049999999999997 111.125 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -101.15 175.13 5.7 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.093 -1.077 . . . . 73.049999999999997 108.093 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.45 179.44 29.43 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 121.009 -0.615 . . . . 65.349999999999994 112.478 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 637' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 638' ' ' HIS . 12.3 tp10 -52.5 -60.91 2.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.74 -0.837 . . . . 73.0 108.74 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 638' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 637' ' ' GLU . 37.2 m80 -136.46 114.71 11.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.895 -1.52 . . . . 65.109999999999999 106.895 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.7 t -134.19 109.25 8.76 Favored 'General case' 0 N--CA 1.41 -2.433 0 C-N-CA 119.178 -1.009 . . . . 64.310000000000002 109.979 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -149.35 137.63 20.74 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.45 -1.25 . . . . 74.120000000000005 108.13 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 512' ' ' THR . 9.3 mt -104.07 116.65 32.61 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.384 -0.599 . . . . 43.020000000000003 109.384 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.29 113.74 26.08 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.441 -1.689 . . . . 72.310000000000002 106.441 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.4 117.82 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 114.435 -1.257 . . . . 71.5 109.143 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -105.01 127.99 59.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.926 -1.033 . . . . 73.439999999999998 108.406 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.405 HG22 HG23 ' A' ' 514' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.323 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.434 ' N ' ' HG ' ' A' ' 529' ' ' SER . . . . . . . . 0 N--CA 1.423 -2.21 0 CA-C-O 120.568 -0.018 . . . . 73.140000000000001 113.12 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.11 114.1 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 105.367 -2.086 . . . . 51.25 105.367 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.634 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 85.8 m-85 -100.83 138.28 38.08 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 123.571 0.544 . . . . 74.420000000000002 111.103 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 3.8 t -148.27 152.85 37.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.967 -0.56 . . . . 61.219999999999999 110.385 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.488 ' HD2' ' HG1' ' A' ' 639' ' ' THR . 82.3 m-85 -71.68 158.95 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.798 -0.816 . . . . 73.319999999999993 108.798 171.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.0 -47.54 84.32 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.769 0.668 . . . . 75.430000000000007 110.638 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.5 153.9 79.4 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 107.913 -1.143 . . . . 61.399999999999999 107.913 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.3 Cg_endo -81.39 -18.76 8.19 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.06 1.84 . . . . 73.140000000000001 112.747 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' A' ' 642' ' ' GLU . 68.7 t -138.82 136.45 43.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.183 -1.043 . . . . 72.299999999999997 108.183 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.1 t -133.51 128.97 36.47 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.42 0.629 . . . . 43.520000000000003 109.607 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -97.96 117.43 32.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.985 -0.746 . . . . 62.43 108.985 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.54 174.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 121.421 0.629 . . . . 64.120000000000005 109.777 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 518' ' ' ILE . 5.2 m -98.63 150.99 21.18 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.615 -0.72 . . . . 74.319999999999993 110.052 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -66.78 -27.87 67.93 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.383 -0.969 . . . . 73.439999999999998 108.383 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.1 m -103.04 20.82 16.87 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 114.568 -1.196 . . . . 64.219999999999999 111.801 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 515' ' ' SER . 10.6 tt -78.31 -28.09 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 121.446 -0.784 . . . . 55.039999999999999 112.678 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.41 -75.04 1.9 Allowed Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.332 -0.937 . . . . 72.400000000000006 111.483 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 574' ' ' ARG . 45.8 mm -133.61 144.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 107.672 -1.233 . . . . 61.32 107.672 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 18.4 ptm -117.96 128.5 54.86 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.254 -0.647 . . . . 74.040000000000006 109.254 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -100.38 120.31 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.838 0.711 . . . . 71.519999999999996 110.512 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 641' ' ' LEU . 59.1 t -126.55 131.74 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.306 -0.627 . . . . 74.219999999999999 109.306 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 570' ' ' ILE . 61.9 mttp -95.62 149.97 20.87 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.817 0.818 . . . . 74.120000000000005 111.938 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.52 113.06 42.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 106.984 -1.487 . . . . 73.239999999999995 106.984 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 79.5 mt -90.17 160.31 16.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.295 -0.866 . . . . 72.430000000000007 110.147 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 104.3 9.14 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.224 -1.028 . . . . 72.109999999999999 108.224 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.5 m -65.85 -52.67 48.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.669 0.747 . . . . 75.200000000000003 109.776 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 529' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 503' ' ' GLY . 30.6 t -73.52 -52.25 14.2 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.932 . . . . 62.140000000000001 111.26 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.77 -156.78 26.8 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 109.681 -1.368 . . . . 64.209999999999994 109.681 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.1 137.07 3.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.957 -0.756 . . . . 75.340000000000003 108.957 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -148.66 148.45 30.09 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 123.427 0.691 . . . . 74.0 109.186 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 85.7 -124.47 6.85 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.84 -0.695 . . . . 73.099999999999994 111.865 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -137.38 104.36 5.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.927 -0.768 . . . . 74.310000000000002 108.927 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.54 125.81 74.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.521 0.677 . . . . 60.009999999999998 110.856 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 559' ' ' GLU . 30.7 mm -96.51 119.54 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.69 -0.687 . . . . 62.119999999999997 109.262 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 50.1 t -106.89 103.11 45.99 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.249 -1.019 . . . . 53.109999999999999 108.249 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.71 147.37 27.72 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.798 1.666 . . . . 71.040000000000006 111.743 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.413 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 52.0 p90 -138.17 158.22 44.74 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.021 -1.103 . . . . 73.019999999999996 108.021 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -154.34 135.5 13.96 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.111 0.482 . . . . 54.119999999999997 110.818 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.54 131.24 36.72 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.976 -1.011 . . . . 64.239999999999995 110.481 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 46.3 mm -100.44 120.31 49.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.695 -0.854 . . . . 71.420000000000002 108.695 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.61 104.81 5.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.682 -0.69 . . . . 74.340000000000003 109.32 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -88.72 -122.1 1.94 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.528 -1.029 . . . . 72.439999999999998 110.528 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -6.61 58.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.923 0.868 . . . . 71.530000000000001 108.926 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.75 27.8 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.567 -1.197 . . . . 63.219999999999999 108.794 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.507 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 38.9 mmt180 -79.47 147.85 32.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.628 -1.249 . . . . 74.219999999999999 107.628 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -109.54 148.49 17.17 Favored Glycine 0 C--N 1.263 -3.498 0 CA-C-N 115.267 -0.879 . . . . 65.030000000000001 114.085 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 88.59 48.02 4.09 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.542 -0.837 . . . . 51.310000000000002 113.657 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.86 43.85 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.706 -1.235 . . . . 73.530000000000001 113.996 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 37.8 mm-40 -96.29 -84.39 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.631 0.715 . . . . 62.509999999999998 110.342 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.6 -44.37 21.15 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.772 -1.566 . . . . 73.010000000000005 106.772 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -136.39 157.58 46.45 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.421 -1.263 . . . . 71.549999999999997 108.83 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -92.24 142.05 27.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.079 -1.822 . . . . 54.420000000000002 106.079 175.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.86 100.78 11.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 72.140000000000001 110.713 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -111.29 104.47 12.95 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-O 122.582 1.182 . . . . 75.340000000000003 109.129 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.7 p -126.72 140.02 52.71 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.959 -1.497 . . . . 54.109999999999999 106.959 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 177.51 -151.32 10.8 Favored Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.487 -1.816 . . . . 42.329999999999998 113.261 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.1 OUTLIER -127.18 125.94 41.97 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.222 1.009 . . . . 55.439999999999998 112.033 -171.602 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.413 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 86.1 mt -100.92 135.54 42.21 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.63 -0.878 . . . . 64.219999999999999 108.63 173.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.84 109.36 21.06 Favored 'General case' 0 C--N 1.276 -2.603 0 CA-C-O 121.185 0.517 . . . . 74.019999999999996 111.011 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 51.3 m-85 -105.27 101.79 11.31 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.172 -1.047 . . . . 74.450000000000003 108.172 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -80.2 -79.18 0.15 Allowed 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.649 -0.82 . . . . 64.030000000000001 110.754 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 567' ' ' ILE . 59.4 t30 -104.8 158.14 16.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.649 -0.82 . . . . 73.329999999999998 108.953 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.13 -11.55 9.27 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.897 1.279 . . . . 74.439999999999998 113.269 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.463 ' HG3' HG23 ' A' ' 567' ' ' ILE . 12.7 pt-20 -66.92 -11.03 54.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.648 0.779 . . . . 64.129999999999995 111.966 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.463 HG23 ' HG3' ' A' ' 566' ' ' GLU . 35.3 pt -119.07 158.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.48 0.657 . . . . 74.319999999999993 110.674 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.77 143.38 41.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.087 -1.82 . . . . 64.409999999999997 106.087 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 27.1 mttm -111.14 155.99 22.05 Favored 'General case' 0 CA--C 1.469 -2.156 0 C-N-CA 119.393 -0.923 . . . . 75.219999999999999 112.973 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 524' ' ' LYS . 72.3 mt -124.45 136.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.245 -1.343 . . . . 73.25 109.773 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 59.1 mt -98.06 129.03 48.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.816 -1.55 . . . . 64.439999999999998 106.816 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.9 p -118.28 112.56 20.24 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.295 0.569 . . . . 54.229999999999997 110.777 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 589' ' ' LEU . 49.4 mt -106.4 135.47 44.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.812 -0.631 . . . . 64.340000000000003 109.969 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 70.9 mtt180 -80.06 112.01 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.198 -0.667 . . . . 73.209999999999994 109.198 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.83 131.09 49.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.337 -0.847 . . . . 51.25 108.735 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 N--CA 1.422 -1.831 0 N-CA-C 109.57 -0.53 . . . . 73.329999999999998 109.57 -178.68 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 112.57 0.581 . . . . 71.530000000000001 112.57 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.422 ' HB3' HG12 ' A' ' 644' ' ' ILE . 44.8 p -142.82 147.74 35.94 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.261 0.553 . . . . 73.120000000000005 111.81 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -136.86 -179.88 5.97 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.028 -1.471 . . . . 73.140000000000001 107.028 173.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 588' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 22.0 m -130.85 168.43 17.28 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.342 -0.943 . . . . 75.030000000000001 110.631 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 573' ' ' ILE . 46.6 tp -142.12 132.72 25.38 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.977 -1.49 . . . . 72.519999999999996 106.977 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.75 159.27 41.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 120.54 0.21 . . . . 61.399999999999999 110.608 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 65.5 mt -101.65 147.65 26.18 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 106.17 -1.789 . . . . 33.420000000000002 106.17 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.33 177.62 4.8 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.225 -0.657 . . . . 73.120000000000005 109.225 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -61.49 118.49 37.83 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 123.411 0.445 . . . . 74.150000000000006 109.819 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.575 ' HD3' HD22 ' A' ' 635' ' ' LEU . 66.1 Cg_endo -71.99 156.57 56.0 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.451 2.101 . . . . 73.409999999999997 111.333 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -129.55 124.13 33.11 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.044 -0.526 . . . . 62.149999999999999 110.824 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -90.0 120.87 31.57 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.32 -1.363 . . . . 74.340000000000003 107.32 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--N 1.293 -1.864 0 N-CA-C 107.763 -1.199 . . . . 74.340000000000003 107.763 177.066 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 109.255 -0.646 . . . . 64.409999999999997 109.255 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.634 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 1.9 pt? -133.55 179.02 6.48 Favored 'General case' 0 C--N 1.268 -2.966 0 C-N-CA 120.141 -0.624 . . . . 55.100000000000001 109.415 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.94 142.13 42.85 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.846 -1.302 . . . . 72.420000000000002 109.846 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -48.5 -51.05 29.15 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.141 0.977 . . . . 71.040000000000006 111.401 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -126.63 89.77 3.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.112 -0.699 . . . . 61.200000000000003 109.112 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 639' ' ' THR . . . . . 0.488 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 15.4 t -119.34 111.02 17.65 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.482 1.135 . . . . 75.120000000000005 109.477 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 640' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.9 ttmt -145.06 147.44 32.58 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.81 -1.552 . . . . 64.099999999999994 106.81 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 523' ' ' VAL . 33.6 tp -117.21 107.02 13.94 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.125 -1.065 . . . . 73.519999999999996 108.125 176.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.469 ' HB2' HG22 ' A' ' 511' ' ' VAL . 35.9 mt-10 -86.99 111.28 20.7 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.308 -0.997 . . . . 61.140000000000001 108.308 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.8 118.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.614 -1.176 . . . . 62.420000000000002 109.284 -174.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 644' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 586' ' ' SER . 17.3 mt -117.74 119.34 61.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.852 . . . . 44.240000000000002 110.166 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 109.221 -0.659 . . . . 74.319999999999993 109.221 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.06 0 N-CA-C 108.532 -1.827 . . . . 75.239999999999995 108.532 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 57.1 mt -98.75 115.19 38.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.485 -0.561 . . . . 74.450000000000003 109.485 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.458 ' CE1' ' HG3' ' A' ' 527' ' ' ARG . 86.8 m-85 -103.24 139.86 38.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.034 -0.53 . . . . 73.310000000000002 111.456 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.11 154.09 39.72 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.677 -0.49 . . . . 73.25 109.677 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.648 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 58.1 m-85 -75.67 160.36 30.15 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.681 -0.489 . . . . 73.239999999999995 109.681 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.61 -49.48 75.05 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.523 0.514 . . . . 73.109999999999999 110.197 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.87 166.44 27.43 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 116.286 -0.415 . . . . 63.43 111.168 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 4.7 Cg_exo -83.67 -30.9 0.67 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.501 2.134 . . . . 75.019999999999996 111.729 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 642' ' ' GLU . 70.3 t -143.35 130.66 18.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -175.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.3 t -134.13 131.13 38.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.794 -0.817 . . . . 53.219999999999999 108.794 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -106.36 112.43 25.44 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.133 -0.692 . . . . 74.150000000000006 109.133 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 30.6 m -112.87 157.87 13.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.988 0.899 . . . . 73.099999999999994 111.523 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 68.0 m -81.79 174.02 11.72 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.5 -1.227 . . . . 70.109999999999999 110.498 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.03 -30.86 17.47 Favored 'General case' 0 CA--C 1.509 -0.596 0 O-C-N 121.741 -0.6 . . . . 71.439999999999998 110.031 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.4 m -80.23 5.89 13.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.474 -0.784 . . . . 73.340000000000003 110.798 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 4.9 tt -75.69 -28.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.159 0.505 . . . . 74.340000000000003 110.137 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 82.94 -71.61 2.98 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.785 -0.722 . . . . 55.210000000000001 113.199 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 44.6 mm -132.04 126.28 56.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.622 -0.881 . . . . 72.519999999999996 108.622 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.417 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.2 ppp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.178 -0.675 . . . . 71.430000000000007 109.178 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.61 131.69 56.86 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.27 0.628 . . . . 61.32 111.384 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 38.6 t -127.5 115.25 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 109.199 -0.667 . . . . 75.219999999999999 109.199 171.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.4 ' HG2' HG12 ' A' ' 570' ' ' ILE . 98.5 mttt -90.19 127.35 36.1 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.229 -0.588 . . . . 63.240000000000002 110.115 174.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.37 114.58 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.608 -0.886 . . . . 70.329999999999998 108.608 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 51.7 mt -93.14 143.89 25.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.051 -0.977 . . . . 75.120000000000005 110.53 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.458 ' HG3' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -105.54 104.77 14.56 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.394 -1.706 . . . . 73.310000000000002 106.394 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.8 t -66.91 -48.17 69.5 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.943 -0.703 . . . . 64.150000000000006 111.443 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.4 p -74.34 -52.44 12.2 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.495 0.664 . . . . 55.310000000000002 111.479 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 147.96 -170.15 28.64 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 109.53 -1.428 . . . . 72.010000000000005 109.53 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.19 129.24 2.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.61 -0.885 . . . . 52.109999999999999 108.61 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -153.21 81.68 1.19 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.162 0.506 . . . . 64.540000000000006 109.986 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 167.77 -129.43 1.9 Allowed Glycine 0 C--N 1.303 -1.297 0 N-CA-C 109.505 -1.438 . . . . 71.439999999999998 109.505 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -137.32 112.54 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.288 -1.375 . . . . 63.039999999999999 107.288 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.61 130.42 74.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 120.926 0.393 . . . . 71.140000000000001 110.724 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 559' ' ' GLU . 39.2 mm -100.09 113.5 35.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.633 -0.877 . . . . 73.129999999999995 108.633 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.03 102.77 44.78 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.494 -0.928 . . . . 74.519999999999996 108.494 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 4.3 Cg_endo -80.63 161.56 21.87 Favored 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 121.719 1.612 . . . . 65.409999999999997 110.949 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -151.12 163.61 38.42 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.676 -0.861 . . . . 71.219999999999999 108.676 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.425 ' HE2' ' OE2' ' A' ' 592' ' ' GLU . 61.8 pttt -148.99 137.92 21.36 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 112.679 0.622 . . . . 64.239999999999995 112.679 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 22.0 p -87.2 117.55 26.03 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 109.944 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 35.9 mm -92.18 124.54 44.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.248 -1.019 . . . . 71.310000000000002 108.248 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.41 119.33 18.46 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.325 -0.62 . . . . 73.230000000000004 109.325 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -97.96 -107.67 2.63 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.742 -1.343 . . . . 73.530000000000001 109.742 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -86.98 -25.9 24.07 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.643 0.735 . . . . 73.510000000000005 109.035 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.02 149.45 30.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.009 -0.996 . . . . 63.539999999999999 109.034 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -104.55 146.27 29.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.481 0.657 . . . . 75.319999999999993 110.833 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.55 -155.43 30.66 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 114.357 -1.292 . . . . 65.129999999999995 112.354 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.19 6.36 53.03 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 114.128 0.411 . . . . 74.0 114.128 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.78 -0.72 34.06 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.164 -1.017 . . . . 73.25 113.249 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -69.62 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.078 0.439 . . . . 64.530000000000001 110.846 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -99.76 -35.78 9.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.349 -0.611 . . . . 64.329999999999998 109.349 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.56 165.11 30.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.742 -0.663 . . . . 71.109999999999999 109.453 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.9 tm-20 -100.81 122.99 44.35 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.023 -1.473 . . . . 75.109999999999999 107.023 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.09 136.18 57.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 123.162 0.585 . . . . 73.439999999999998 111.4 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.41 ' CG2' HG12 ' A' ' 573' ' ' ILE . 9.3 t -140.56 105.78 5.03 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.043 0.925 . . . . 74.219999999999999 109.437 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 46.9 m -129.57 94.89 3.86 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 106.734 -1.58 . . . . 60.020000000000003 106.734 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -136.24 -156.93 7.63 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.378 -0.828 . . . . 44.240000000000002 111.449 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.1 OUTLIER -132.46 138.98 47.8 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.224 0.535 . . . . 52.240000000000002 110.963 -177.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 73.1 mt -105.5 141.26 37.3 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.201 -0.909 . . . . 61.530000000000001 108.775 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.417 ' HG2' ' OE1' ' A' ' 563' ' ' GLN . 32.9 tt0 -112.92 105.51 13.6 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.409 0.623 . . . . 74.310000000000002 110.398 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 55.3 m-85 -98.15 133.34 42.72 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.574 -0.739 . . . . 74.099999999999994 109.057 177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.417 ' OE1' ' HG2' ' A' ' 561' ' ' GLU . 2.4 mp0 -98.2 -85.38 0.37 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.33 1.062 . . . . 73.0 108.224 174.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -105.46 161.82 14.0 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.26 -1.336 . . . . 63.439999999999998 110.597 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.73 -13.35 31.66 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.708 1.203 . . . . 55.229999999999997 113.162 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.34 -37.05 69.48 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.021 0.929 . . . . 52.350000000000001 111.277 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.21 162.4 6.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.289 -0.869 . . . . 72.109999999999999 109.665 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.441 HG23 ' NH1' ' A' ' 527' ' ' ARG . 14.8 p -131.1 160.1 42.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.386 -1.339 . . . . 61.43 107.386 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.526 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -117.49 150.96 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.547 0.213 . . . . 74.030000000000001 110.499 176.048 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 65.8 mt -125.25 131.71 72.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 124.366 1.041 . . . . 72.310000000000002 108.922 -177.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.0 mt -90.6 120.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.242 -1.392 . . . . 73.040000000000006 107.242 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -105.24 112.75 25.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.606 0.566 . . . . 74.319999999999993 109.725 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.505 HD11 HD22 ' A' ' 589' ' ' LEU . 51.1 mt -107.3 132.19 55.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.831 -1.174 . . . . 73.109999999999999 107.831 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -81.34 116.05 21.0 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.086 -0.646 . . . . 61.210000000000001 109.939 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.57 124.37 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.201 -1.037 . . . . 74.510000000000005 108.201 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 58.3 m-85 . . . . . 0 C--N 1.295 -1.785 0 N-CA-C 109.755 -0.461 . . . . 73.530000000000001 109.755 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.53 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.2 m . . . . . 0 N--CA 1.42 -1.928 0 CA-C-O 121.401 0.62 . . . . 63.43 110.9 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 10.5 m -140.08 142.25 36.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.979 -0.749 . . . . 61.100000000000001 108.979 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 50.0 p90 -141.17 165.5 27.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.211 -1.403 . . . . 72.030000000000001 107.211 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 12.1 m -116.64 164.48 14.54 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.614 -0.835 . . . . 75.310000000000002 109.847 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 573' ' ' ILE . 49.3 tp -135.56 130.71 34.96 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.073 -1.454 . . . . 64.450000000000003 107.073 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.4 156.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.787 -0.449 . . . . 61.149999999999999 109.787 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.648 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 70.9 mt -97.05 139.16 33.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.595 -0.891 . . . . 71.400000000000006 108.595 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 592' ' ' GLU . . . . . 0.425 ' OE2' ' HE2' ' A' ' 540' ' ' LYS . 30.6 mm-40 -94.1 167.26 11.69 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.432 -0.951 . . . . 65.109999999999999 108.432 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.27 116.25 16.82 Favored Pre-proline 0 C--N 1.317 -0.831 0 O-C-N 123.916 0.76 . . . . 60.329999999999998 110.281 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.66 145.32 20.39 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 C-N-CA 122.407 2.071 . . . . 61.119999999999997 110.859 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -118.72 143.92 46.57 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.666 -0.494 . . . . 62.200000000000003 109.666 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -104.07 123.09 46.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.617 -0.883 . . . . 64.25 108.617 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.294 -1.823 0 N-CA-C 106.637 -1.616 . . . . 73.340000000000003 106.637 177.149 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 34.5 pt . . . . . 0 N--CA 1.441 -0.92 0 CA-C-O 121.088 0.47 . . . . 54.149999999999999 110.334 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.29 167.99 10.07 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.848 -0.797 . . . . 75.519999999999996 108.848 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.77 -178.2 21.11 Favored Glycine 0 C--O 1.249 1.06 0 O-C-N 123.465 0.478 . . . . 74.450000000000003 112.585 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -46.98 -61.96 1.63 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.04 0.936 . . . . 74.540000000000006 110.408 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -141.11 104.82 4.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.063 -1.458 . . . . 75.030000000000001 107.063 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.5 t -121.05 109.07 14.6 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 118.659 -1.217 . . . . 73.400000000000006 110.438 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.814 -1.18 . . . . 73.329999999999998 107.814 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 510' ' ' PRO . 62.4 tp -119.79 113.48 20.67 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 123.443 0.464 . . . . 61.439999999999998 111.074 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.415 ' HB2' HG22 ' A' ' 511' ' ' VAL . 2.1 mp0 -84.22 128.65 34.7 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 74.239999999999995 108.07 170.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.65 111.89 38.09 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 107.234 -1.395 . . . . 73.209999999999994 107.234 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.82 134.44 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 CA-C-N 114.711 -1.132 . . . . 73.030000000000001 108.251 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.53 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.175 0 N-CA-C 109.484 -0.561 . . . . 75.019999999999996 109.484 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.519 0 N-CA-C 111.47 -0.652 . . . . 73.030000000000001 111.47 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 635' ' ' LEU . 55.8 mt -86.39 114.33 25.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.858 0.361 . . . . 73.209999999999994 110.129 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -112.49 146.11 39.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.48 -0.933 . . . . 65.109999999999999 108.48 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.8 t -148.26 163.54 36.71 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.639 0.587 . . . . 73.120000000000005 109.775 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.65 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 69.2 m-85 -83.96 153.89 23.65 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 123.232 0.613 . . . . 75.219999999999999 110.396 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 49.3 mt-10 -60.35 -41.83 94.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.989 0.423 . . . . 73.319999999999993 110.457 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.2 mt-10 -132.65 151.91 78.98 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.494 -0.928 . . . . 72.109999999999999 108.494 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.407 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 69.9 Cg_endo -87.53 -20.94 1.96 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.125 1.883 . . . . 75.439999999999998 111.137 174.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 52.8 t -146.05 125.67 5.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 124.945 1.298 . . . . 70.319999999999993 107.534 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -133.65 141.03 47.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.33 0.586 . . . . 75.219999999999999 110.064 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -107.93 127.36 53.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.641 -0.708 . . . . 72.239999999999995 109.198 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.8 m -126.08 158.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.06 0.457 . . . . 71.540000000000006 110.92 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.0 m -73.43 157.76 36.25 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.599 -0.728 . . . . 74.409999999999997 109.702 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -29.17 39.84 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.465 0.65 . . . . 71.409999999999997 109.991 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -97.81 18.7 15.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.48 -0.782 . . . . 54.299999999999997 111.086 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.78 -29.85 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 75.299999999999997 111.617 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.15 -72.49 2.83 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.621 -0.799 . . . . 75.25 111.886 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.0 mm -127.42 123.54 61.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.999 -0.741 . . . . 73.230000000000004 108.999 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.457 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.8 ptm -101.18 131.35 47.2 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.627 -0.879 . . . . 65.109999999999999 108.627 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.58 118.46 33.13 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 123.714 0.634 . . . . 72.400000000000006 110.848 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.61 114.64 45.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.384 -1.339 . . . . 75.209999999999994 107.384 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 570' ' ' ILE . 29.0 mtmm -94.06 133.56 37.4 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 119.912 -0.715 . . . . 65.219999999999999 110.486 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.53 109.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.995 -1.113 . . . . 71.200000000000003 107.995 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.7 mt -89.09 122.51 32.48 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.256 -0.884 . . . . 70.150000000000006 110.037 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.465 ' H ' ' NE ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -89.16 103.2 15.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 118.673 -1.211 . . . . 73.319999999999993 108.3 174.04 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.0 p -67.77 -54.32 20.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.513 -0.767 . . . . 73.109999999999999 111.1 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' SER . . . . . 0.515 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 23.1 t -72.94 -50.41 23.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.071 -0.968 . . . . 74.530000000000001 110.211 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 530' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' A' ' 565' ' ' ASP . . . 149.61 -179.91 25.99 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.776 -1.202 . . . . 75.239999999999995 112.458 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.61 27.98 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 107.086 -1.45 . . . . 73.209999999999994 107.086 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -149.32 127.75 12.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.562 -0.455 . . . . 74.540000000000006 110.164 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.89 -115.64 4.71 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.886 -0.886 . . . . 24.25 110.886 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -138.1 109.98 7.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.714 -1.217 . . . . 73.150000000000006 107.714 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.09 123.5 66.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.131 0.491 . . . . 64.140000000000001 109.896 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 48.6 mm -96.17 120.59 45.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.245 -0.65 . . . . 71.409999999999997 109.245 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.79 104.36 51.08 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 52.140000000000001 107.993 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.01 143.29 17.9 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.948 1.765 . . . . 70.109999999999999 111.309 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -130.43 163.74 26.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.333 -0.988 . . . . 72.519999999999996 108.333 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -159.29 132.81 7.24 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.276 0.36 . . . . 44.329999999999998 110.847 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 20.7 p -79.75 136.12 36.68 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.884 -0.598 . . . . 63.43 110.368 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.55 117.29 46.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.449 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 40.4 mt-10 -74.88 104.62 5.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.586 -0.524 . . . . 72.049999999999997 109.586 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.63 -102.57 1.21 Allowed Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.838 -1.305 . . . . 72.200000000000003 109.838 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 585' ' ' CYS . 13.2 t -100.83 4.82 43.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.271 0.558 . . . . 71.120000000000005 110.067 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -105.35 149.45 26.06 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.344 -1.354 . . . . 74.400000000000006 107.344 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.449 ' HD2' ' OE1' ' A' ' 543' ' ' GLU . 29.7 tpt180 -107.12 134.07 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.808 0.337 . . . . 64.129999999999995 110.977 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.01 -151.76 9.5 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.741 -0.663 . . . . 64.140000000000001 111.626 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 75.17 -33.76 1.09 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 122.461 -0.434 . . . . 70.230000000000004 114.066 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 144.35 5.76 0.58 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.091 -0.576 . . . . 62.130000000000003 112.55 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -75.13 -79.17 0.1 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.868 0.365 . . . . 73.420000000000002 111.88 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -89.78 -41.19 12.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.829 -1.174 . . . . 75.109999999999999 107.829 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -149.33 169.48 20.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.452 -1.249 . . . . 74.150000000000006 108.717 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.06 119.03 37.13 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.803 -2.295 . . . . 70.319999999999993 104.803 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.39 105.28 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.967 0.889 . . . . 70.040000000000006 110.555 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.9 t -101.91 127.15 48.88 Favored 'General case' 0 N--CA 1.412 -2.354 0 CA-C-N 115.1 -0.955 . . . . 64.400000000000006 111.155 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -140.55 97.82 3.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.607 -1.179 . . . . 73.109999999999999 108.353 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -132.34 179.31 17.33 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 115.485 -0.78 . . . . 61.350000000000001 111.737 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.44 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.3 mt-10 -111.07 114.84 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.224 -0.658 . . . . 64.409999999999997 109.224 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.06 138.19 31.63 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 110.117 -0.327 . . . . 75.310000000000002 110.117 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -105.98 106.28 16.71 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.459 0.647 . . . . 61.32 111.485 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 36.6 m-85 -96.43 147.6 23.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.036 -1.468 . . . . 74.140000000000001 107.036 172.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -124.96 -79.06 0.61 Allowed 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 108.862 -0.792 . . . . 73.510000000000005 108.862 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.03 156.04 18.18 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.149 -0.686 . . . . 64.200000000000003 109.149 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.459 ' OD1' ' HA2' ' A' ' 530' ' ' GLY . 12.0 t70 -56.1 -25.9 47.52 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.162 1.385 . . . . 50.219999999999999 113.193 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.47 -18.52 64.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.139 0.792 . . . . 74.109999999999999 113.139 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.2 pt -106.37 167.5 3.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 119.843 -0.743 . . . . 73.319999999999993 110.935 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.99 159.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.818 -1.179 . . . . 75.230000000000004 107.818 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.495 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 122.208 -0.307 . . . . 71.439999999999998 110.26 175.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 524' ' ' LYS . 18.7 mt -122.2 134.89 64.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 123.825 0.703 . . . . 62.030000000000001 110.259 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 55.2 mt -91.26 122.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.368 -1.345 . . . . 73.340000000000003 107.368 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 9.4 p -106.7 112.86 26.03 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 123.866 0.729 . . . . 72.200000000000003 109.269 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.555 HD11 HD22 ' A' ' 589' ' ' LEU . 38.2 mt -110.76 125.63 68.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.232 -0.655 . . . . 74.450000000000003 109.232 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -79.59 110.59 15.07 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.136 0.898 . . . . 73.099999999999994 109.765 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.4 135.05 36.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.917 -1.512 . . . . 64.319999999999993 106.917 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 109.818 -0.438 . . . . 74.319999999999993 109.818 -178.097 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.534 ' HA ' HG23 ' A' ' 545' ' ' THR . 5.5 p . . . . . 0 N--CA 1.409 -2.502 0 CA-C-O 122.093 0.949 . . . . 33.299999999999997 113.181 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 34.7 p -143.32 154.75 44.09 Favored 'General case' 0 N--CA 1.405 -2.704 0 CA-C-N 114.633 -1.167 . . . . 65.400000000000006 108.967 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -138.53 161.61 36.62 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 61.130000000000003 106.844 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.1 t -113.73 175.69 5.35 Favored 'General case' 0 C--N 1.27 -2.887 0 C-N-CA 119.147 -1.021 . . . . 72.040000000000006 109.108 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 573' ' ' ILE . 33.5 tp -149.9 126.69 11.06 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.016 -1.475 . . . . 71.25 107.016 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.13 157.34 31.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.716 -0.476 . . . . 65.310000000000002 109.716 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.65 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 40.2 mt -101.79 142.97 32.29 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.337 -1.727 . . . . 70.209999999999994 106.337 174.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.86 173.59 6.79 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.869 -0.789 . . . . 71.299999999999997 108.869 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.67 115.46 18.75 Favored Pre-proline 0 C--N 1.316 -0.88 0 O-C-N 123.733 0.646 . . . . 72.319999999999993 110.739 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.411 ' HD3' HD22 ' A' ' 635' ' ' LEU . 32.6 Cg_endo -65.38 153.96 75.81 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.761 2.307 . . . . 64.310000000000002 113.399 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -119.62 134.91 55.03 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.783 -1.099 . . . . 71.230000000000004 109.64 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -99.34 125.07 44.93 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.098 -0.705 . . . . 74.099999999999994 109.098 -175.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 597' ' ' ILE . . . . . 0.437 HD13 HG12 ' A' ' 536' ' ' ILE . 2.7 mp . . . . . 0 C--N 1.29 -1.986 0 N-CA-C 105.225 -2.139 . . . . 55.25 105.225 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . 0.274 2.6 pp . . . . . 0 N--CA 1.415 -2.216 0 CA-C-O 122.222 1.011 . . . . 74.409999999999997 112.006 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 635' ' ' LEU . 2.2 pt? -76.35 -165.22 0.47 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.255 -2.248 . . . . 72.140000000000001 111.873 -174.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.23 136.25 37.21 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 109.46 -1.456 . . . . 73.310000000000002 109.46 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.56 -42.32 70.85 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.469 0.708 . . . . 74.340000000000003 111.848 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -131.37 84.86 2.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 110.864 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.9 t -119.71 114.71 22.59 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 107.872 -1.158 . . . . 61.229999999999997 107.872 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -147.59 140.24 24.73 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.777 -0.823 . . . . 52.539999999999999 108.777 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 509' ' ' GLU . 60.0 tp -117.59 123.14 45.48 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 123.347 0.404 . . . . 71.209999999999994 109.913 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.78 124.94 43.98 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.941 -1.503 . . . . 74.230000000000004 106.941 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.22 120.22 60.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.464 -0.939 . . . . 73.540000000000006 108.464 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.87 124.18 63.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-N 115.618 -0.719 . . . . 60.420000000000002 109.262 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.31 -1.148 0 CA-C-O 122.213 1.006 . . . . 73.030000000000001 111.125 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.393 0 N-CA-C 114.638 0.615 . . . . 65.5 114.638 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 57.1 mt -128.28 113.94 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 104.72 -2.326 . . . . 72.239999999999995 104.72 167.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.601 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 76.1 m-85 -107.49 132.35 53.32 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.645 -0.502 . . . . 75.329999999999998 109.645 -176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 8.8 t -148.03 152.76 37.96 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.534 0.521 . . . . 54.119999999999997 110.036 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.496 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 90.1 m-85 -74.43 154.5 38.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.909 -0.404 . . . . 74.450000000000003 109.909 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -52.78 -49.92 64.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.819 0.848 . . . . 42.329999999999998 111.147 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -135.32 161.53 62.76 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 107.753 -1.203 . . . . 62.450000000000003 107.753 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 68.4 Cg_endo -82.4 -17.61 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 121.673 1.582 . . . . 64.519999999999996 112.029 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 642' ' ' GLU . 77.9 t -143.07 127.11 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 123.306 0.642 . . . . 72.5 109.966 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 512' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 643' ' ' VAL . 12.0 t -135.11 141.5 46.03 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.474 -0.935 . . . . 73.430000000000007 108.474 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -111.14 142.45 43.31 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.301 -1.74 . . . . 74.049999999999997 106.301 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.19 154.81 29.02 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 CA-C-O 121.327 0.584 . . . . 75.230000000000004 111.462 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 20.5 m -73.92 137.46 43.65 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.891 -1.049 . . . . 73.030000000000001 109.482 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 516' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -75.58 1.58 13.99 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.799 0.809 . . . . 73.25 112.886 -178.603 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.5 p -125.53 18.75 8.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.32 -0.855 . . . . 74.430000000000007 110.902 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 8.2 tt -80.76 -23.76 11.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-O 121.376 0.608 . . . . 55.350000000000001 110.479 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.51 -76.26 2.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.721 -0.951 . . . . 72.209999999999994 110.721 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 574' ' ' ARG . 47.9 mm -125.41 128.58 72.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.724 -0.843 . . . . 63.25 108.724 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.488 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.3 ptm -98.48 141.61 31.12 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.673 -0.492 . . . . 71.230000000000004 109.673 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -102.39 128.81 48.83 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 123.792 0.682 . . . . 61.310000000000002 109.917 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 44.0 t -124.92 124.53 67.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.459 -0.941 . . . . 62.43 108.459 174.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -93.87 132.34 38.4 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.006 -0.678 . . . . 70.230000000000004 110.768 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 84.3 t -95.98 111.76 26.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.581 -1.637 . . . . 72.219999999999999 106.581 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.43 143.42 26.62 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.547 -0.751 . . . . 72.239999999999995 110.39 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.0 104.65 14.14 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.844 -0.617 . . . . 75.310000000000002 111.767 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 504' ' ' ILE . 22.9 m -64.78 -61.64 2.06 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.953 -0.567 . . . . 61.5 112.086 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.1 p -73.76 -52.54 12.84 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.107 0.41 . . . . 74.230000000000004 112.107 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 158.02 -145.77 12.31 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.943 -0.863 . . . . 70.099999999999994 110.943 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -178.66 130.8 0.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.211 1.404 . . . . 62.229999999999997 107.467 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -150.59 91.44 1.74 Allowed 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.537 -0.865 . . . . 75.109999999999999 111.879 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 145.51 -116.97 0.95 Allowed Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 110.183 -1.167 . . . . 75.450000000000003 110.183 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.82 104.49 5.3 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.137 -1.06 . . . . 71.420000000000002 108.137 172.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 595' ' ' LYS . 39.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.331 -0.548 . . . . 61.439999999999998 111.381 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 559' ' ' GLU . 42.6 mm -98.99 115.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.423 -0.808 . . . . 73.120000000000005 109.139 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.78 100.24 30.15 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 108.523 -0.917 . . . . 71.430000000000007 108.523 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 536' ' ' ILE . 3.4 Cg_exo -76.65 146.54 27.09 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 121.924 1.75 . . . . 74.519999999999996 111.186 176.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 25.1 p90 -136.68 157.33 47.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.239 -0.652 . . . . 70.239999999999995 109.239 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -147.6 135.04 20.76 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.835 0.35 . . . . 65.109999999999999 111.019 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.4 p -82.72 123.03 28.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.777 -0.647 . . . . 74.140000000000001 111.184 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 41.0 mm -92.16 118.22 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.959 -1.126 . . . . 71.109999999999999 107.959 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.69 143.99 34.09 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.266 -0.642 . . . . 75.310000000000002 109.266 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.72 -110.18 0.83 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 109.076 -1.609 . . . . 62.020000000000003 109.076 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 16.6 p -78.64 -25.21 44.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.586 -0.894 . . . . 74.549999999999997 108.586 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -90.2 131.9 35.78 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.43 -1.322 . . . . 73.340000000000003 107.43 172.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 43.1 ttp180 -104.72 140.96 37.3 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.121 -0.696 . . . . 74.219999999999999 109.121 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.75 -157.4 31.59 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 121.166 -0.54 . . . . 72.340000000000003 112.639 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 549' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 69.09 19.94 74.35 Favored Glycine 0 C--N 1.31 -0.871 0 C-N-CA 121.619 -0.324 . . . . 41.229999999999997 112.932 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.03 19.21 40.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.33 -0.938 . . . . 60.43 112.646 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 11.0 tp10 -86.0 -79.51 0.25 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 110.0 -0.37 . . . . 75.319999999999993 110.0 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -94.9 -30.29 14.24 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.701 -1.222 . . . . 63.450000000000003 107.701 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.32 155.79 43.41 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.396 -1.274 . . . . 72.329999999999998 107.952 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -88.46 139.98 29.93 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 105.412 -2.07 . . . . 75.209999999999994 105.412 177.277 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 15.9 t70 -77.33 121.72 24.13 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.167 -0.308 . . . . 64.409999999999997 110.167 -171.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -127.33 104.43 7.93 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 122.474 1.131 . . . . 61.119999999999997 110.46 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -125.96 102.27 7.18 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.725 -1.954 . . . . 60.310000000000002 105.725 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -133.36 -174.75 13.67 Favored Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.39 -0.91 . . . . 54.130000000000003 112.248 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.0 OUTLIER -121.11 122.46 40.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.313 0.577 . . . . 73.409999999999997 110.669 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 569' ' ' LYS . 83.8 mt -96.58 136.92 36.42 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.882 -0.414 . . . . 71.310000000000002 109.882 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.01 102.53 11.25 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.709 0.766 . . . . 63.539999999999999 111.392 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 60.0 m-85 -99.58 96.8 7.89 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 106.971 -1.492 . . . . 74.099999999999994 106.971 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -75.18 -67.11 0.68 Allowed 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.233 -0.987 . . . . 70.439999999999998 109.829 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -105.94 161.65 14.27 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.222 -0.658 . . . . 65.310000000000002 109.222 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.55 -11.82 60.45 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.208 1.003 . . . . 72.430000000000007 113.527 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.456 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.6 pt-20 -68.09 -7.99 34.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.61 0.967 . . . . 50.350000000000001 113.61 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.456 HG23 ' HG3' ' A' ' 566' ' ' GLU . 45.1 pt -122.32 168.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 O-C-N 121.952 -0.467 . . . . 45.450000000000003 110.837 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.7 p -131.79 140.73 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.839 -1.541 . . . . 63.310000000000002 106.839 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 69.5 mmtt -104.45 145.95 29.55 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.438 -0.505 . . . . 74.239999999999995 111.25 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 69.3 mt -117.45 135.07 59.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.474 -1.239 . . . . 73.349999999999994 110.498 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 64.5 mt -93.55 127.89 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.835 -1.172 . . . . 64.219999999999999 107.835 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 25.7 p -106.59 112.18 25.06 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.374 0.607 . . . . 74.150000000000006 110.139 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.488 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 30.9 mt -112.64 130.04 67.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.74 -1.207 . . . . 62.530000000000001 107.74 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 11.5 ttm180 -85.86 122.92 30.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 0.407 HG23 HG21 ' A' ' 645' ' ' ILE . 44.7 mm -102.33 136.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.724 -0.671 . . . . 65.439999999999998 109.394 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.475 ' CZ ' ' HD2' ' A' ' 574' ' ' ARG . 92.7 m-85 . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 108.682 -0.858 . . . . 72.010000000000005 108.682 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.418 -2.032 0 CA-C-O 121.054 0.454 . . . . 73.519999999999996 111.118 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 23.9 m -144.99 153.71 41.78 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.037 -0.727 . . . . 65.010000000000005 109.037 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.2 p90 -138.6 -176.87 4.62 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.79 -0.448 . . . . 75.140000000000001 109.79 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 35.8 m -132.6 162.83 30.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.589 -0.522 . . . . 32.119999999999997 109.589 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 571' ' ' ILE . 31.2 tp -139.38 134.83 32.98 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.562 -1.273 . . . . 65.439999999999998 107.562 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.85 157.34 43.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 123.18 0.3 . . . . 63.130000000000003 110.696 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.496 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 48.9 mt -101.8 139.79 36.97 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.027 -1.471 . . . . 74.329999999999998 107.027 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -96.36 178.43 5.37 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 123.332 0.395 . . . . 74.420000000000002 110.125 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.52 121.39 78.81 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 109.676 -0.49 . . . . 74.450000000000003 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.505 ' HD3' HD22 ' A' ' 635' ' ' LEU . 59.1 Cg_endo -72.48 164.44 35.6 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.408 2.072 . . . . 70.519999999999996 113.734 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 75.5 mmtt -116.93 140.98 48.82 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 114.847 -1.07 . . . . 75.329999999999998 109.06 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -113.84 109.34 18.37 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 107.227 -1.397 . . . . 75.510000000000005 107.227 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--N 1.281 -2.385 0 N-CA-C 107.599 -1.26 . . . . 53.539999999999999 107.599 179.15 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.662 0.268 . . . . 74.430000000000007 110.292 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.601 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 2.1 pt? -139.53 -168.27 2.44 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.882 -0.784 . . . . 74.430000000000007 108.882 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -66.75 159.62 48.59 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.582 -0.818 . . . . 24.239999999999998 112.612 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.61 -64.71 0.74 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.981 1.313 . . . . 55.240000000000002 110.135 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -130.93 104.33 7.07 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.925 -1.139 . . . . 74.450000000000003 107.925 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 639' ' ' THR . . . . . 0.419 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 14.6 t -129.45 114.0 15.6 Favored 'General case' 0 N--CA 1.404 -2.735 0 CA-C-O 122.547 1.165 . . . . 71.439999999999998 110.326 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 640' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.8 ttmt -144.09 148.95 35.83 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 106.586 -1.635 . . . . 73.219999999999999 106.586 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 56.4 tp -126.76 109.99 12.63 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.478 -0.934 . . . . 71.530000000000001 108.478 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.445 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.9 mt-10 -87.0 126.42 34.73 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 107.421 -1.325 . . . . 73.140000000000001 107.421 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 643' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 512' ' ' THR . 43.9 t -113.62 122.41 67.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 109.048 -0.723 . . . . 64.409999999999997 109.048 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.62 135.55 50.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.79 -1.096 . . . . 73.230000000000004 110.014 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.407 HG21 HG23 ' A' ' 575' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.155 0 C-N-CA 123.096 0.558 . . . . 74.150000000000006 110.142 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.588 0 N-CA-C 110.185 -1.166 . . . . 60.43 110.185 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 68.3 mt -96.89 114.88 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.306 -0.627 . . . . 73.219999999999999 109.306 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -101.24 132.26 46.83 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.017 -0.735 . . . . 75.120000000000005 109.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.1 t -146.38 153.81 40.92 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 120.795 0.331 . . . . 64.299999999999997 110.436 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.54 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.15 153.73 38.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.649 -0.5 . . . . 71.329999999999998 109.649 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 41.7 mt-10 -56.19 -56.19 23.98 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.941 0.775 . . . . 72.430000000000007 110.397 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -122.35 160.84 46.29 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.721 -1.127 . . . . 75.439999999999998 109.136 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -86.73 -20.74 2.39 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.032 1.821 . . . . 73.420000000000002 112.071 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.437 HG13 HD12 ' A' ' 644' ' ' ILE . 75.6 t -144.22 135.61 21.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 71.230000000000004 108.891 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.0 t -133.21 123.96 26.54 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.449 0.643 . . . . 72.319999999999993 110.07 177.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -98.98 115.96 30.12 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.964 -1.124 . . . . 75.209999999999994 107.964 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.14 169.15 17.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 123.492 0.495 . . . . 62.450000000000003 110.422 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 44.6 t -78.3 155.95 29.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.98 -0.554 . . . . 64.129999999999995 111.069 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.14 -20.96 54.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.486 -0.931 . . . . 71.510000000000005 108.486 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 32.75 5.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.66 -0.7 . . . . 74.430000000000007 110.728 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 6.5 tt -82.83 -23.2 8.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 62.0 109.657 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.76 -74.76 2.03 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.33 -0.708 . . . . 73.519999999999996 111.33 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.7 mm -130.28 128.17 63.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.449 -1.315 . . . . 70.239999999999995 107.449 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -99.61 157.04 16.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.296 -0.631 . . . . 74.150000000000006 109.296 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.06 131.59 56.9 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.572 0.545 . . . . 74.310000000000002 111.919 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 41.4 t -126.26 116.33 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 109.603 -0.517 . . . . 44.219999999999999 109.603 173.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 97.5 mttt -92.34 124.87 36.72 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.975 -0.69 . . . . 70.420000000000002 110.027 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.88 112.73 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.479 -1.304 . . . . 75.409999999999997 107.479 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 40.3 mt -96.07 152.76 18.24 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.129 -0.941 . . . . 74.420000000000002 110.406 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 1.8 mpp_? -106.65 114.83 29.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.043 -0.725 . . . . 53.119999999999997 109.043 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.3 m -65.36 -50.87 63.95 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.82 0.819 . . . . 72.329999999999998 109.998 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.0 p -73.75 -52.25 13.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.19 -0.914 . . . . 73.219999999999999 112.248 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 138.9 -155.95 24.05 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 108.423 -1.871 . . . . 44.329999999999998 108.423 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -169.47 149.13 3.92 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 117.339 0.569 . . . . 73.129999999999995 109.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -156.57 102.11 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.573 -2.01 . . . . 65.219999999999999 105.573 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 124.66 -173.04 16.99 Favored Glycine 0 C--N 1.295 -1.738 0 N-CA-C 110.046 -1.222 . . . . 72.430000000000007 110.046 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -99.21 118.98 37.11 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 108.968 -0.753 . . . . 65.140000000000001 108.968 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 14.1 t -120.69 121.31 65.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 109.171 -0.677 . . . . 60.229999999999997 109.171 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.477 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.9 mm -94.39 117.03 37.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.79 -0.818 . . . . 52.229999999999997 108.79 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.7 106.73 56.7 Favored Pre-proline 0 C--N 1.301 -1.516 0 CA-C-N 115.446 -0.797 . . . . 74.319999999999993 110.673 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 5.0 Cg_exo -76.88 150.87 30.75 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.129 1.886 . . . . 65.140000000000001 111.7 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -141.72 161.48 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.84 -1.17 . . . . 73.5 107.84 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.584 ' HE2' HD11 ' A' ' 542' ' ' ILE . 24.0 pttm -152.49 137.06 16.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.056 0.455 . . . . 63.030000000000001 111.638 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.8 p -83.51 134.39 34.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.575 -0.739 . . . . 65.200000000000003 110.224 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.584 HD11 ' HE2' ' A' ' 540' ' ' LYS . 48.1 mm -103.55 126.38 58.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.357 -0.979 . . . . 61.32 108.357 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -78.95 112.31 16.01 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.113 -1.069 . . . . 72.319999999999993 108.113 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -101.36 -106.17 2.9 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.771 -1.332 . . . . 72.25 109.771 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 23.9 p -89.5 -11.37 43.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.438 0.637 . . . . 71.540000000000006 109.827 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -100.65 141.36 33.63 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.06 -1.089 . . . . 73.230000000000004 108.06 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -100.05 133.68 44.07 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.861 0.363 . . . . 64.409999999999997 110.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.72 -159.97 35.43 Favored Glycine 0 N--CA 1.431 -1.66 0 C-N-CA 120.777 -0.725 . . . . 60.409999999999997 111.355 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.0 37.39 64.32 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.025 -0.607 . . . . 41.25 112.187 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.69 5.13 86.89 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.361 -0.447 . . . . 53.240000000000002 113.529 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -81.89 -82.21 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.849 0.325 . . . . 75.219999999999999 111.771 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -46.76 7.63 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.712 -1.218 . . . . 65.040000000000006 107.712 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -131.89 160.63 35.15 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.36 -1.291 . . . . 64.129999999999995 107.575 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.0 OUTLIER -91.98 131.97 36.88 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.861 -1.533 . . . . 51.039999999999999 106.861 175.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.21 125.5 29.93 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.947 -0.569 . . . . 63.539999999999999 109.732 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.8 t -133.99 121.99 22.41 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 122.026 0.917 . . . . 43.020000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.7 p -133.55 129.53 37.19 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.825 -1.546 . . . . 71.019999999999996 106.825 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -172.63 -177.39 41.98 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.029 -1.081 . . . . 73.519999999999996 111.036 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.462 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.1 mt-10 -113.24 129.51 56.5 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.362 0.601 . . . . 70.319999999999993 111.945 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.7 mt -89.24 140.11 29.81 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.649 -1.16 . . . . 62.240000000000002 109.699 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -99.83 101.78 13.02 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.944 -0.571 . . . . 61.229999999999997 109.931 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 43.0 m-85 -96.17 149.71 21.33 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.624 0.725 . . . . 73.329999999999998 110.439 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.411 ' H ' HD11 ' A' ' 567' ' ' ILE . 79.7 mm-40 -127.41 -140.54 0.26 Allowed 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.128 -1.804 . . . . 74.200000000000003 106.128 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -62.21 157.72 18.71 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 122.958 0.503 . . . . 61.340000000000003 110.088 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.422 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 33.6 t70 -54.55 -21.11 9.28 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.598 1.159 . . . . 72.209999999999994 113.74 -175.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.533 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.1 pt-20 -59.27 -30.96 68.67 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.678 0.791 . . . . 71.040000000000006 112.781 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.533 HG23 ' HG3' ' A' ' 566' ' ' GLU . 34.7 pt -101.08 168.93 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.643 0.259 . . . . 74.409999999999997 110.955 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.34 152.38 15.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.88 -1.526 . . . . 72.099999999999994 106.88 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.1 mmpt? -112.8 157.44 21.35 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 120.783 -0.367 . . . . 52.210000000000001 110.8 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -127.32 129.41 70.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.231 -0.895 . . . . 70.409999999999997 109.822 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.9 mt -90.63 122.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.61 -1.626 . . . . 75.140000000000001 106.61 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.0 p -106.86 122.01 45.55 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.239 -0.652 . . . . 63.149999999999999 109.239 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.419 HD11 HD22 ' A' ' 589' ' ' LEU . 61.6 mt -118.31 128.44 75.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.472 -0.566 . . . . 43.130000000000003 109.472 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.4 mtt180 -74.31 119.48 18.58 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.944 0.778 . . . . 70.019999999999996 110.1 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.6 mm -107.25 135.75 44.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.719 -0.845 . . . . 74.040000000000006 108.719 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 C--N 1.305 -1.365 0 N-CA-C 107.776 -1.194 . . . . 71.0 107.776 -178.625 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.517 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.0 m . . . . . 0 N--CA 1.436 -1.128 0 CA-C-O 121.63 0.729 . . . . 73.299999999999997 112.031 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 m -146.77 128.04 14.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.91 -0.774 . . . . 75.340000000000003 108.91 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.2 p90 -131.22 165.76 22.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.714 -0.847 . . . . 55.530000000000001 108.714 174.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 5.0 m -119.7 162.52 18.88 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.523 -0.871 . . . . 70.409999999999997 110.221 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 573' ' ' ILE . 47.0 tp -135.69 130.06 33.68 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.276 -1.379 . . . . 64.239999999999995 107.276 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.83 160.14 42.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 123.603 0.564 . . . . 74.329999999999998 109.674 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.54 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 44.9 mt -106.26 144.4 33.0 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.976 0.798 . . . . 70.230000000000004 109.004 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.77 178.3 5.35 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.178 -1.045 . . . . 73.310000000000002 108.178 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.29 117.36 23.51 Favored Pre-proline 0 C--O 1.247 0.954 0 O-C-N 123.642 0.589 . . . . 62.43 109.759 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.426 ' HD3' HD21 ' A' ' 635' ' ' LEU . 56.4 Cg_endo -77.46 147.78 25.76 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.409 2.072 . . . . 73.200000000000003 111.375 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 595' ' ' LYS . . . . . 0.477 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 8.7 ptpp? -113.63 123.59 50.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.133 -0.485 . . . . 75.299999999999997 110.055 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -98.23 110.58 23.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.014 -0.539 . . . . 75.420000000000002 110.256 -173.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--N 1.288 -2.078 0 N-CA-C 106.693 -1.595 . . . . 70.340000000000003 106.693 175.803 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 31.2 pt . . . . . 0 N--CA 1.444 -0.754 0 CA-C-O 121.459 0.647 . . . . 75.319999999999993 110.973 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.426 HD21 ' HD3' ' A' ' 594' ' ' PRO . 2.2 mm? -114.61 170.31 8.41 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 64.219999999999999 107.364 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.82 154.59 50.92 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.388 -1.885 . . . . 72.049999999999997 108.388 172.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -39.86 -64.06 0.53 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.1 0.96 . . . . 63.240000000000002 112.641 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -130.07 83.43 2.13 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.827 -1.175 . . . . 71.239999999999995 107.827 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.2 t -100.67 110.88 23.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.241 1.019 . . . . 64.200000000000003 110.64 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -146.72 134.86 21.61 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.411 -1.329 . . . . 72.5 107.411 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 65.0 tp -113.2 112.91 24.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.312 -0.625 . . . . 70.540000000000006 109.312 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.41 ' HB2' HG22 ' A' ' 511' ' ' VAL . 48.7 mt-10 -90.47 117.03 28.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 176.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.63 116.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 N-CA-C 107.66 -1.237 . . . . 54.310000000000002 107.66 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 644' ' ' ILE . . . . . 0.437 HD12 HG13 ' A' ' 511' ' ' VAL . 16.0 mt -115.47 128.22 72.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.547 0 CA-C-N 114.787 -1.097 . . . . 75.109999999999999 109.901 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.116 0 CA-C-N 114.474 -1.239 . . . . 71.030000000000001 108.308 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 C--O 1.204 -1.732 0 N-CA-C 114.134 0.413 . . . . 72.0 114.134 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 91.9 mt -71.78 114.22 9.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 116.876 0.338 . . . . 73.109999999999999 110.984 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.424 ' HE1' ' HE ' ' A' ' 527' ' ' ARG . 38.2 m-85 -100.5 132.73 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.882 -0.784 . . . . 74.049999999999997 108.882 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -148.23 157.59 43.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.841 -0.537 . . . . 74.319999999999993 110.641 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.572 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 91.9 m-85 -71.56 155.57 40.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.258 . . . . 63.420000000000002 110.319 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.91 -56.28 22.58 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.914 0.759 . . . . 73.030000000000001 109.623 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 509' ' ' GLU . . . . . 0.416 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.6 mt-10 -134.09 159.51 72.08 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 107.952 -1.129 . . . . 71.420000000000002 107.952 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 62.8 Cg_endo -79.04 -21.49 9.35 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 121.93 1.753 . . . . 65.519999999999996 113.808 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.4 t -138.59 133.34 42.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.702 -0.481 . . . . 60.43 109.702 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.6 139.11 46.34 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.206 0.527 . . . . 55.100000000000001 109.705 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -109.39 132.84 53.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.989 -1.485 . . . . 61.509999999999998 106.989 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.87 163.72 26.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 C-N-CA 120.621 -0.432 . . . . 71.510000000000005 110.449 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 27.2 m -82.44 163.68 21.47 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.569 -0.741 . . . . 71.150000000000006 109.574 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -81.05 -34.72 32.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.729 -1.212 . . . . 61.119999999999997 107.729 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.4 m -96.34 27.54 3.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.144 -0.934 . . . . 75.209999999999994 111.022 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 7.4 tt -79.8 -25.08 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.409 0.623 . . . . 74.439999999999998 110.601 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 86.45 -75.71 2.21 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.926 -0.654 . . . . 73.120000000000005 111.668 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 48.4 mm -130.51 137.56 55.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.458 -1.682 . . . . 44.409999999999997 106.458 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.1 ppp? -110.09 147.98 32.6 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.403 -0.962 . . . . 74.219999999999999 108.403 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -110.97 134.38 52.63 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.596 0.56 . . . . 74.219999999999999 110.825 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 46.1 t -121.19 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.68 -0.859 . . . . 74.099999999999994 108.68 171.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -85.52 120.79 27.37 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.572 -0.851 . . . . 74.420000000000002 110.058 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.25 101.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.987 -1.486 . . . . 71.209999999999994 106.987 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.1 mt -84.32 163.4 19.62 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 114.183 -1.371 . . . . 74.010000000000005 111.006 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.608 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 74.6 mtt180 -118.12 109.08 15.98 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.865 -1.062 . . . . 64.430000000000007 110.446 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 22.7 m -66.27 -62.93 1.21 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.269 -0.423 . . . . 65.049999999999997 110.416 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.9 p -75.31 -36.44 61.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.663 0.744 . . . . 72.239999999999995 112.009 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 124.55 -128.78 6.87 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.211 -1.155 . . . . 65.040000000000006 110.211 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . 177.16 168.69 0.58 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.052 1.341 . . . . 63.409999999999997 107.437 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.529 ' HD2' ' OD1' ' A' ' 564' ' ' ASN . 9.9 tpt180 -163.41 81.17 0.46 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.524 -1.287 . . . . 74.25 107.524 172.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 135.34 171.3 12.37 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 110.075 -1.21 . . . . 70.010000000000005 110.075 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -86.84 128.72 35.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.17 0.509 . . . . 71.150000000000006 110.843 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.8 t -136.07 134.32 50.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 70.120000000000005 109.474 -177.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.545 HG12 HD11 ' A' ' 597' ' ' ILE . 44.7 mm -93.75 122.04 44.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.795 -0.817 . . . . 73.420000000000002 108.795 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.65 102.07 54.41 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 123.471 0.482 . . . . 73.420000000000002 110.438 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 6.1 Cg_exo -76.49 148.73 30.02 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 121.932 1.754 . . . . 74.299999999999997 111.127 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -138.05 166.68 23.49 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.972 -1.122 . . . . 74.019999999999996 107.972 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 589' ' ' LEU . 54.3 pttt -157.45 134.83 10.44 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.03 0.443 . . . . 71.299999999999997 111.254 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.6 p -80.44 126.61 31.41 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.678 -0.692 . . . . 74.209999999999994 110.156 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 42.2 mm -95.16 116.45 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.101 -1.444 . . . . 62.109999999999999 107.101 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.73 111.66 18.19 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.41 0.444 . . . . 74.109999999999999 110.672 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.64 -110.93 3.31 Favored Glycine 0 C--N 1.31 -0.894 0 N-CA-C 110.159 -1.176 . . . . 64.040000000000006 110.159 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 586' ' ' SER . 6.5 m -70.06 -35.48 74.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.684 -1.228 . . . . 61.210000000000001 107.684 175.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.92 132.69 35.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.325 -1.307 . . . . 53.32 108.439 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -114.6 157.11 23.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.587 0.708 . . . . 75.109999999999999 111.412 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -88.17 -154.0 27.0 Favored Glycine 0 N--CA 1.427 -1.948 0 CA-C-N 114.829 -1.078 . . . . 73.150000000000006 111.972 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.43 8.84 47.59 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.964 -0.16 . . . . 51.130000000000003 112.99 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.65 24.22 26.35 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 121.152 -0.547 . . . . 71.420000000000002 111.982 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.57 -69.59 0.61 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.478 -0.934 . . . . 60.229999999999997 108.478 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.92 -40.13 6.34 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.398 -1.334 . . . . 73.129999999999995 107.398 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -143.12 172.59 12.52 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-N 114.943 -1.026 . . . . 64.430000000000007 109.761 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 574' ' ' ARG . 1.7 tm-20 -98.04 114.26 26.36 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 75.439999999999998 105.241 175.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.78 136.81 37.47 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.647 0.737 . . . . 75.150000000000006 111.466 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -130.27 125.74 35.56 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 122.145 0.974 . . . . 60.43 111.734 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 38.6 t -132.43 127.13 34.68 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 105.861 -1.903 . . . . 52.009999999999998 105.861 172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.68 -174.61 37.5 Favored Glycine 0 C--N 1.269 -3.161 0 N-CA-C 109.649 -1.38 . . . . 44.399999999999999 109.649 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 8.6 pt-20 -121.01 127.98 52.26 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.364 0.602 . . . . 71.319999999999993 111.424 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.13 136.22 33.07 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.226 -0.897 . . . . 73.030000000000001 108.817 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.17 98.84 9.2 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 121.496 0.665 . . . . 74.549999999999997 109.606 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.608 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 36.2 m-85 -92.61 124.24 36.48 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.823 -0.626 . . . . 71.349999999999994 110.516 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.646 ' H ' HD11 ' A' ' 567' ' ' ILE . 12.9 mm100 -83.63 -146.98 0.09 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.057 -1.831 . . . . 71.349999999999994 106.057 172.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.529 ' OD1' ' HD2' ' A' ' 532' ' ' ARG . 61.2 t30 -63.47 170.49 3.09 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.15 0.58 . . . . 62.399999999999999 110.429 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.81 -11.58 8.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.618 1.167 . . . . 61.009999999999998 113.864 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.07 -21.79 66.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.656 0.782 . . . . 74.129999999999995 112.839 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.646 HD11 ' H ' ' A' ' 563' ' ' GLN . 23.7 pt -114.18 168.9 5.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 O-C-N 121.793 -0.567 . . . . 72.109999999999999 111.265 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.17 147.42 25.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.442 -1.318 . . . . 63.420000000000002 107.442 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 68.4 mmtt -111.34 148.5 32.85 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.088 0.471 . . . . 62.0 111.224 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.1 mt -120.38 132.53 69.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.834 -1.075 . . . . 74.109999999999999 110.328 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.2 mt -91.91 126.46 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.7 -1.593 . . . . 73.329999999999998 106.7 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 572' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 521' ' ' MET . 16.2 p -113.94 112.78 23.87 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.052 0.453 . . . . 63.310000000000002 109.966 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 589' ' ' LEU . 70.1 mt -105.0 130.62 55.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.617 -0.512 . . . . 71.439999999999998 109.617 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' A' ' 554' ' ' GLU . 99.3 mtt180 -78.53 114.95 17.9 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.131 0.491 . . . . 71.239999999999995 110.309 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.9 mm -103.22 137.49 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 106.166 -1.79 . . . . 55.140000000000001 106.166 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 554' ' ' GLU . 47.6 m-85 . . . . . 0 C--N 1.298 -1.655 0 C-N-CA 119.89 -0.724 . . . . 72.329999999999998 111.739 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 120.553 0.215 . . . . 62.439999999999998 111.278 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.405 ' H ' ' HB ' ' A' ' 545' ' ' THR . 63.9 p -117.69 149.03 41.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.911 -0.493 . . . . 72.540000000000006 110.875 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.6 p90 -137.15 174.84 10.18 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.324 -0.991 . . . . 74.219999999999999 108.324 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 588' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 13.0 m -124.85 167.03 15.2 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 120.256 -0.577 . . . . 74.239999999999995 109.616 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 573' ' ' ILE . 39.3 tp -141.45 130.87 23.75 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.083 -1.451 . . . . 70.040000000000006 107.083 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.72 157.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 123.343 0.402 . . . . 65.5 110.041 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 75.2 mt -96.76 142.78 28.37 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.096 -1.446 . . . . 75.450000000000003 107.096 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 592' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 538' ' ' PRO . 10.9 mm-40 -104.43 172.24 6.9 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 123.441 0.463 . . . . 73.230000000000004 110.033 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -52.64 112.2 3.24 Favored Pre-proline 0 C--N 1.316 -0.876 0 O-C-N 124.957 1.411 . . . . 75.019999999999996 110.987 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -76.04 153.8 37.21 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 C-N-CA 121.705 1.603 . . . . 73.129999999999995 111.504 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -124.09 132.14 53.63 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.378 -0.601 . . . . 75.519999999999996 109.378 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -93.77 140.82 29.21 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.491 -0.559 . . . . 74.340000000000003 109.491 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 597' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 536' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.423 -1.795 0 CA-C-O 122.752 1.263 . . . . 60.43 110.458 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 122.233 1.016 . . . . 64.230000000000004 113.22 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.83 -175.2 2.73 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.893 -1.503 . . . . 65.340000000000003 108.006 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.7 143.71 47.2 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 108.012 -2.035 . . . . 61.32 108.012 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -52.55 -42.44 64.42 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.04 0.536 . . . . 71.040000000000006 111.869 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -128.24 101.02 6.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.028 -1.101 . . . . 64.340000000000003 108.028 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 5.0 t -136.0 110.55 8.58 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-O 122.383 1.087 . . . . 63.43 111.041 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 640' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 35.9 ttmt -146.49 150.82 36.33 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.6 -1.63 . . . . 64.329999999999998 106.6 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 509' ' ' GLU . 61.5 tp -127.54 112.76 15.29 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.2 -0.667 . . . . 62.109999999999999 109.2 174.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.429 ' HB2' HG22 ' A' ' 511' ' ' VAL . 43.5 mt-10 -89.62 125.35 35.2 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.658 -0.867 . . . . 64.040000000000006 108.658 175.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.36 119.45 59.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.427 -0.953 . . . . 71.430000000000007 108.427 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.26 125.0 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 115.576 -0.738 . . . . 71.140000000000001 110.207 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.187 0 CA-C-O 121.718 0.77 . . . . 73.219999999999999 110.991 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.963 0 N-CA-C 111.303 -0.719 . . . . 72.349999999999994 111.303 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 84.6 mt -127.25 114.73 37.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.013 -1.477 . . . . 73.519999999999996 107.013 176.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.419 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 37.4 m-85 -103.48 136.98 42.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.793 0.33 . . . . 73.219999999999999 110.809 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.2 t -148.02 160.79 42.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.49 -0.929 . . . . 44.020000000000003 108.49 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -79.9 156.09 27.45 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.668 -0.493 . . . . 74.420000000000002 109.668 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.03 -51.1 68.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.894 0.746 . . . . 71.129999999999995 110.07 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -131.85 157.17 78.93 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.16 -0.927 . . . . 74.299999999999997 109.132 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.52 -21.71 7.22 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.261 1.974 . . . . 74.340000000000003 112.501 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.7 t -143.13 133.93 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.372 0.669 . . . . 70.109999999999999 109.275 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -133.59 138.37 45.96 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 109.313 -0.625 . . . . 72.129999999999995 109.313 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -109.52 110.93 22.17 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.857 -1.164 . . . . 74.329999999999998 107.857 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.33 158.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 116.191 -0.459 . . . . 62.420000000000002 110.439 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 518' ' ' ILE . 22.1 m -78.07 137.35 38.19 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.569 -0.741 . . . . 74.349999999999994 109.232 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -65.43 -24.77 67.28 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 123.664 0.786 . . . . 74.200000000000003 110.733 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.4 p -100.45 11.11 40.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.781 -0.645 . . . . 63.32 112.286 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 515' ' ' SER . 11.1 tt -71.32 -37.69 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 120.295 -0.562 . . . . 53.409999999999997 112.129 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.21 -73.22 1.51 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.239 -0.982 . . . . 21.120000000000001 111.389 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.28 125.21 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.442 -1.318 . . . . 74.540000000000006 107.442 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.2 ppp? -100.97 143.31 31.28 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.229 -0.656 . . . . 73.439999999999998 109.229 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -110.19 124.63 51.92 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.836 0.71 . . . . 72.549999999999997 110.848 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 641' ' ' LEU . 41.6 t -129.86 131.34 66.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 110.373 -0.232 . . . . 74.450000000000003 110.373 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.29 136.65 32.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.479 0.487 . . . . 73.439999999999998 110.184 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 96.3 t -95.48 118.14 41.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 105.872 -1.899 . . . . 74.409999999999997 105.872 171.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.6 mt -95.87 135.73 37.23 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 116.099 -0.501 . . . . 75.209999999999994 110.774 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 104.12 15.94 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.441 -0.8 . . . . 74.200000000000003 110.391 174.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.0 m -61.0 -62.45 1.85 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.404 1.081 . . . . 63.210000000000001 111.923 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.5 p -73.3 -31.62 64.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.851 0.834 . . . . 73.319999999999993 109.766 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.62 -155.51 22.28 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 109.814 -1.314 . . . . 64.329999999999998 109.814 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -150.63 155.06 38.63 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.732 -1.951 . . . . 42.509999999999998 105.732 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -157.86 126.73 5.68 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.859 -0.793 . . . . 74.310000000000002 108.859 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.86 -125.42 8.24 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 111.171 -0.771 . . . . 73.219999999999999 111.171 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -136.42 102.33 4.92 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 106.311 -1.737 . . . . 72.349999999999994 106.311 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 37.9 t -113.88 120.4 63.6 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.569 0 C-N-CA 119.236 -0.986 . . . . 72.040000000000006 110.79 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.3 mm -92.11 116.4 33.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 114.803 -1.09 . . . . 72.129999999999995 108.628 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.73 100.6 43.27 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.102 -0.954 . . . . 74.129999999999995 109.248 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 558' ' ' GLY . 2.0 Cg_endo -77.1 153.54 32.21 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.861 1.707 . . . . 61.399999999999999 112.497 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -139.65 159.23 42.64 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.7 -0.852 . . . . 62.109999999999999 108.7 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.517 ' O ' HD12 ' A' ' 589' ' ' LEU . 60.5 pttt -152.13 145.97 25.13 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.022 0.439 . . . . 74.420000000000002 111.017 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -88.09 127.37 35.41 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.286 -0.87 . . . . 73.150000000000006 111.911 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 42.4 mm -100.69 116.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.678 -1.23 . . . . 70.319999999999993 107.678 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.473 ' CD ' HH21 ' A' ' 547' ' ' ARG . 39.7 mt-10 -77.66 116.19 18.01 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.601 -0.272 . . . . 74.420000000000002 110.491 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.19 -115.95 4.06 Favored Glycine 0 C--N 1.306 -1.134 0 N-CA-C 109.028 -1.629 . . . . 73.030000000000001 109.028 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.2 p -75.59 -23.98 56.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.738 0.78 . . . . 72.450000000000003 109.387 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.63 129.27 34.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.523 -1.217 . . . . 73.319999999999993 108.602 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.473 HH21 ' CD ' ' A' ' 543' ' ' GLU . 7.4 tpm_? -95.4 140.72 29.87 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 109.202 -0.666 . . . . 73.400000000000006 109.202 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.15 -160.73 33.16 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.935 -0.866 . . . . 74.239999999999995 110.935 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 79.0 16.72 78.42 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.767 -0.73 . . . . 70.349999999999994 111.636 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 80.29 31.69 37.23 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 111.644 -0.582 . . . . 70.049999999999997 111.644 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -94.25 -71.09 0.68 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 122.447 -0.443 . . . . 74.409999999999997 110.543 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -29.82 12.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.685 1.231 . . . . 74.129999999999995 107.757 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -143.98 157.69 44.18 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.117 -1.438 . . . . 74.219999999999999 107.117 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.525 ' CD ' ' HD2' ' A' ' 574' ' ' ARG . 6.8 tt0 -96.03 135.98 37.08 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 106.861 -1.533 . . . . 73.409999999999997 106.861 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -74.64 120.4 20.14 Favored 'General case' 0 CA--C 1.472 -2.031 0 C-N-CA 120.643 -0.423 . . . . 52.210000000000001 110.745 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.493 ' CG2' HG12 ' A' ' 573' ' ' ILE . 10.1 t -124.58 120.12 31.02 Favored 'General case' 0 N--CA 1.392 -3.325 0 N-CA-C 105.44 -2.059 . . . . 72.400000000000006 105.44 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.5 p -137.14 139.4 41.15 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.412 -1.699 . . . . 63.229999999999997 106.412 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 558' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 538' ' ' PRO . . . -175.88 -166.59 33.56 Favored Glycine 0 N--CA 1.397 -3.952 0 C-N-CA 117.951 -2.071 . . . . 71.239999999999995 112.828 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.7 mt-10 -123.46 114.09 19.64 Favored 'General case' 0 N--CA 1.403 -2.777 0 C-N-CA 124.364 1.066 . . . . 70.430000000000007 108.969 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.33 142.62 27.59 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.57 -0.741 . . . . 74.25 109.207 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -103.56 117.25 33.99 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.8 m-85 -115.94 100.17 7.79 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.281 -1.007 . . . . 72.549999999999997 108.281 173.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.661 ' H ' HD11 ' A' ' 567' ' ' ILE . 77.0 mt-30 -77.35 -87.7 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.948 -0.569 . . . . 75.230000000000004 110.502 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -105.27 164.88 11.51 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 109.881 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 565' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 3.7 p30 -56.9 -11.38 1.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.991 1.478 . . . . 74.530000000000001 114.991 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 566' ' ' GLU . 10.2 pt-20 -79.73 -14.34 58.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.089 0.774 . . . . 71.340000000000003 113.089 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.661 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.3 pt -114.82 169.31 5.86 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.115 0.483 . . . . 72.099999999999994 112.244 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.17 160.17 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.42 -0.956 . . . . 63.439999999999998 108.42 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -124.02 154.9 39.2 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 111.925 0.343 . . . . 71.140000000000001 111.925 177.405 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 73.5 mt -125.33 130.65 72.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.011 -0.995 . . . . 73.030000000000001 110.108 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 589' ' ' LEU . 62.1 mt -90.9 129.08 42.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 107.312 -1.366 . . . . 61.219999999999999 107.312 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 7.7 p -115.91 112.84 22.49 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 123.858 0.724 . . . . 71.439999999999998 110.132 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.493 HG12 ' CG2' ' A' ' 556' ' ' THR . 48.9 mt -116.03 130.96 69.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 121.021 -0.271 . . . . 71.209999999999994 110.711 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.525 ' HD2' ' CD ' ' A' ' 554' ' ' GLU . 92.2 mtt180 -71.19 116.75 11.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.559 0.537 . . . . 74.349999999999994 109.977 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 645' ' ' ILE . 38.0 mm -101.47 135.95 35.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.752 -1.113 . . . . 75.349999999999994 109.744 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 105.313 -2.106 . . . . 74.049999999999997 105.313 178.378 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' ' 645' ' ' ILE . 5.1 p . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 121.443 0.64 . . . . 41.240000000000002 110.29 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 80.4 p -134.95 150.73 50.43 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 121.433 0.635 . . . . 52.210000000000001 111.179 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.38 156.87 46.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.013 -1.477 . . . . 61.43 107.013 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 9.4 m -112.19 153.22 27.38 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.669 -0.813 . . . . 54.340000000000003 109.024 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 540' ' ' LYS . 43.1 tp -124.96 131.51 53.41 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.806 -1.553 . . . . 53.109999999999999 106.806 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.05 159.32 43.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 110.071 -0.344 . . . . 72.400000000000006 110.071 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.16 145.75 27.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.705 0.628 . . . . 75.409999999999997 109.685 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 592' ' ' GLU . . . . . 0.417 ' O ' HD11 ' A' ' 635' ' ' LEU . 6.6 mm-40 -96.69 163.02 13.19 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.177 -1.045 . . . . 62.020000000000003 108.177 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.0 122.53 72.8 Favored Pre-proline 0 C--N 1.311 -1.096 0 O-C-N 123.678 0.611 . . . . 71.420000000000002 110.383 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.453 ' HD3' ' HG ' ' A' ' 635' ' ' LEU . 59.7 Cg_endo -79.2 151.17 23.24 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 122.841 2.361 . . . . 74.310000000000002 113.31 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -122.11 128.7 51.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.772 -1.104 . . . . 72.430000000000007 110.38 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -84.16 116.81 23.1 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.265 -1.383 . . . . 74.5 107.265 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 C--N 1.28 -2.421 0 N-CA-C 108.354 -0.98 . . . . 44.119999999999997 108.354 -179.221 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 634' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.429 -1.503 0 CA-C-O 121.626 0.727 . . . . 71.010000000000005 110.069 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.453 ' HG ' ' HD3' ' A' ' 594' ' ' PRO . 22.6 mt -97.59 170.82 8.76 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.196 -1.039 . . . . 64.129999999999995 108.196 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.57 151.08 49.11 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.121 -2.392 . . . . 52.240000000000002 107.121 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.51 -42.06 66.95 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.235 0.517 . . . . 72.340000000000003 111.28 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -124.34 101.0 6.95 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.508 0.67 . . . . 73.140000000000001 110.733 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 7.5 t -136.02 109.78 8.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 122.243 1.02 . . . . 74.049999999999997 109.411 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -146.77 148.87 32.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.828 -1.175 . . . . 72.519999999999996 107.828 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 641' ' ' LEU . . . . . 0.415 HD22 HG11 ' A' ' 523' ' ' VAL . 56.5 tp -129.6 112.98 14.25 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.425 -0.583 . . . . 50.450000000000003 109.425 175.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 642' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 511' ' ' VAL . 46.8 mt-10 -89.24 127.98 35.8 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.636 -0.875 . . . . 72.030000000000001 108.636 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.61 120.68 62.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.31 -0.996 . . . . 71.209999999999994 108.31 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 644' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 644' ' ' ILE . 3.6 mp -110.87 134.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.435 -0.802 . . . . 63.520000000000003 110.829 -176.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.439 HG21 HG23 ' A' ' 575' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 C-N-CA 124.821 1.248 . . . . 63.350000000000001 109.551 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.42 -2.394 0 N-CA-C 111.548 -0.621 . . . . 75.209999999999994 111.548 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.48 121.32 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.785 -1.561 . . . . 72.140000000000001 106.785 172.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 56.4 m-85 -110.84 134.46 52.51 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.511 0.507 . . . . 73.230000000000004 110.078 -175.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 6.3 t -148.25 152.79 37.77 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 110.386 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' PHE . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.2 m-85 -74.26 159.74 32.06 Favored 'General case' 0 C--O 1.262 1.718 0 N-CA-C 108.862 -0.792 . . . . 75.109999999999999 108.862 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.35 -51.87 57.54 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.789 0.681 . . . . 63.399999999999999 109.613 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.49 161.54 54.22 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.146 -0.934 . . . . 73.310000000000002 109.088 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.2 Cg_endo -84.73 -20.8 3.59 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.613 1.542 . . . . 34.43 112.425 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 77.7 t -141.53 134.96 30.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.654 -0.499 . . . . 74.329999999999998 109.654 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -133.9 138.23 45.43 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.571 -0.529 . . . . 73.310000000000002 109.571 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -111.06 119.28 38.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 74.239999999999995 107.875 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.93 170.79 16.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.894 0.378 . . . . 70.310000000000002 110.381 -178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.2 t -88.88 158.97 17.91 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.6 0.714 . . . . 34.119999999999997 111.248 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -8.25 59.54 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.122 -0.945 . . . . 63.039999999999999 110.195 172.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 71.2 m -113.8 19.18 16.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.941 -0.572 . . . . 61.210000000000001 111.248 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 7.2 tt -82.22 -26.23 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.15 -0.62 . . . . 45.119999999999997 111.189 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.85 -74.24 2.52 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.588 -0.815 . . . . 64.120000000000005 111.588 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 574' ' ' ARG . 46.1 mm -129.92 131.17 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.503 -0.925 . . . . 63.109999999999999 108.503 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 17.9 ptm -107.15 145.75 32.15 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.97 -0.752 . . . . 63.109999999999999 108.97 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -106.36 129.31 54.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 123.374 0.421 . . . . 54.399999999999999 110.631 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.8 t -115.52 121.19 66.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.81 -0.811 . . . . 73.239999999999995 108.81 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -95.59 130.0 42.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.236 0.541 . . . . 61.329999999999998 110.594 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.43 115.17 35.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.152 -1.055 . . . . 74.409999999999997 108.152 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.422 ' HA ' HH21 ' A' ' 527' ' ' ARG . 79.4 mt -88.08 149.67 23.82 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.661 -0.7 . . . . 73.099999999999994 109.583 -176.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -114.92 103.78 11.27 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.266 -1.013 . . . . 74.409999999999997 108.266 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.1 p -67.23 -58.11 5.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.519 0.676 . . . . 62.140000000000001 110.939 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 24.3 t -73.97 -23.76 59.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.324 -0.853 . . . . 74.140000000000001 110.157 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' GLY . . . . . 0.516 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 108.88 -149.18 16.99 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 110.229 -1.149 . . . . 44.229999999999997 110.229 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -160.16 135.79 8.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.185 -1.413 . . . . 75.030000000000001 107.185 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -136.35 121.47 18.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.261 -0.644 . . . . 73.400000000000006 109.261 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.44 -121.99 7.29 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.798 -0.715 . . . . 43.340000000000003 113.038 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -137.75 104.89 5.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.028 -1.101 . . . . 65.120000000000005 108.028 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.88 126.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.619 0.723 . . . . 54.210000000000001 110.634 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 559' ' ' GLU . 29.8 mm -95.78 118.01 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.349 -0.842 . . . . 70.510000000000005 109.468 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.65 103.72 50.23 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 115.295 -0.866 . . . . 71.420000000000002 108.792 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 1.0 OUTLIER -78.16 156.67 29.92 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 121.424 1.416 . . . . 65.340000000000003 111.082 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -143.01 161.0 39.28 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.384 -1.339 . . . . 73.319999999999993 107.384 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -156.17 135.07 11.89 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.951 0.405 . . . . 74.530000000000001 111.14 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.6 p -82.92 122.96 28.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.661 -0.699 . . . . 71.519999999999996 110.378 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 37.0 mm -92.71 125.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.764 -1.199 . . . . 75.120000000000005 107.764 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.58 113.11 13.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.922 0.392 . . . . 73.140000000000001 111.242 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -92.4 -103.47 1.49 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.433 -1.067 . . . . 41.43 110.433 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -94.1 -18.01 22.23 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 109.69 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.01 149.1 24.21 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.392 -0.822 . . . . 75.530000000000001 108.924 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 45.0 ttt180 -101.84 134.83 44.4 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.11 0.481 . . . . 71.219999999999999 112.055 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.96 -179.75 47.26 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.476 -0.783 . . . . 41.229999999999997 111.367 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.87 57.62 Favored Glycine 0 C--N 1.306 -1.125 0 N-CA-C 110.594 -1.002 . . . . 54.530000000000001 110.594 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.33 19.95 50.65 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 111.491 -0.644 . . . . 71.140000000000001 111.491 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 15.7 mm-40 -80.08 -80.1 0.14 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.361 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.79 -32.18 16.21 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.825 -0.805 . . . . 72.120000000000005 108.825 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -143.94 152.8 41.57 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.02 -1.104 . . . . 75.439999999999998 108.02 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.584 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 23.3 tt0 -87.89 105.08 17.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.681 -2.34 . . . . 75.109999999999999 104.681 176.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.32 144.96 56.78 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.024 0.828 . . . . 62.240000000000002 109.725 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -140.06 114.06 8.93 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-O 122.046 0.927 . . . . 72.129999999999995 110.885 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.2 p -125.15 118.54 26.31 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.212 -1.358 . . . . 52.409999999999997 107.373 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.17 15.54 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 110.668 -0.973 . . . . 75.510000000000005 110.668 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.502 ' HB2' HG23 ' A' ' 536' ' ' ILE . 8.0 pt-20 -132.84 139.18 47.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.334 0.588 . . . . 70.439999999999998 111.866 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.97 144.71 33.2 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.48 -1.236 . . . . 64.540000000000006 108.692 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -109.73 104.21 13.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.208 0.528 . . . . 74.540000000000006 111.052 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.7 m-85 -98.71 120.0 38.41 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.27 -1.011 . . . . 53.210000000000001 108.27 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.491 ' H ' HD11 ' A' ' 567' ' ' ILE . 49.6 mt-30 -98.21 -80.18 0.46 Allowed 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.734 -0.839 . . . . 63.100000000000001 108.734 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -105.33 155.17 19.35 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.966 -0.561 . . . . 63.210000000000001 110.131 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -46.51 -29.16 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.171 1.788 . . . . 72.430000000000007 114.213 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.475 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.8 pt-20 -64.62 -14.14 56.64 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.95 1.093 . . . . 61.329999999999998 113.95 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.491 HD11 ' H ' ' A' ' 563' ' ' GLN . 37.2 pt -112.76 156.46 13.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 119.706 -0.798 . . . . 74.439999999999998 110.283 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.65 144.32 37.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.692 -0.855 . . . . 72.439999999999998 108.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.655 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.4 mmpt? -111.36 149.57 30.97 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 120.404 -0.519 . . . . 73.129999999999995 109.662 176.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 570' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 73.3 mt -126.05 131.45 71.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.481 -1.236 . . . . 75.549999999999997 110.595 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 41.6 mt -92.87 123.75 45.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.321 -1.362 . . . . 75.340000000000003 107.321 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 19.5 p -108.29 114.27 28.0 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 123.466 0.479 . . . . 72.420000000000002 109.814 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 589' ' ' LEU . 36.6 mt -110.01 135.03 50.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.554 -0.535 . . . . 62.409999999999997 109.554 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 574' ' ' ARG . . . . . 0.584 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 71.3 ttt180 -92.21 123.82 35.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.263 -0.643 . . . . 74.340000000000003 109.263 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.2 134.22 46.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.313 -0.625 . . . . 74.310000000000002 109.313 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 576' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 83.1 m-85 . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 109.251 -0.648 . . . . 65.219999999999999 109.251 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 585' ' ' CYS . . . . . 0.424 ' SG ' HG12 ' A' ' 645' ' ' ILE . 3.5 p . . . . . 0 N--CA 1.424 -1.759 0 N-CA-C 109.166 -0.679 . . . . 71.230000000000004 109.166 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 15.0 m -138.26 148.55 44.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.23 -0.656 . . . . 73.400000000000006 109.23 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.1 166.25 25.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.855 -1.165 . . . . 71.540000000000006 107.855 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 588' ' ' SER . . . . . 0.412 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 26.5 m -116.29 166.86 11.56 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 119.935 -0.706 . . . . 64.430000000000007 109.686 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 573' ' ' ILE . 31.8 tp -139.58 127.8 22.57 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 107.591 -1.263 . . . . 64.299999999999997 107.591 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.36 157.31 36.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.614 -0.513 . . . . 75.329999999999998 109.614 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 591' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 45.2 mt -95.34 147.23 23.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.114 -1.81 . . . . 55.509999999999998 106.114 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 592' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 593' ' ' GLU . 6.8 tp10 -98.43 177.67 5.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.857 -1.535 . . . . 71.310000000000002 106.857 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 37.6 mt-10 -75.16 119.78 78.54 Favored Pre-proline 0 C--N 1.288 -2.105 0 CA-C-N 116.341 -0.39 . . . . 72.219999999999999 110.638 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.454 ' HD3' HD22 ' A' ' 635' ' ' LEU . 77.3 Cg_endo -72.41 146.14 44.22 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.351 2.701 . . . . 74.200000000000003 113.703 -174.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -110.31 149.28 30.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.442 -0.947 . . . . 74.319999999999993 108.442 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -107.14 127.88 53.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.673 -1.232 . . . . 75.400000000000006 107.673 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 597' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 597' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.3 -1.578 0 CA-C-O 122.229 1.014 . . . . 71.450000000000003 108.717 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 19.9 pt . . . . . 0 N--CA 1.424 -1.728 0 CA-C-O 120.792 0.329 . . . . 63.130000000000003 110.326 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 635' ' ' LEU . . . . . 0.454 HD22 ' HD3' ' A' ' 594' ' ' PRO . 1.9 pt? -134.56 -171.87 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.321 -0.622 . . . . 64.129999999999995 109.321 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -63.66 156.52 43.0 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 121.026 -0.607 . . . . 51.049999999999997 111.822 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.39 -57.2 13.97 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.29 1.036 . . . . 74.200000000000003 110.025 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -131.4 98.8 4.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.733 -0.84 . . . . 71.310000000000002 108.733 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.6 t -130.94 110.45 11.27 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-O 122.625 1.202 . . . . 75.540000000000006 110.465 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 640' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 39.5 ttpt -147.61 141.06 25.37 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.924 -1.51 . . . . 72.140000000000001 106.924 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 63.2 tp -117.18 110.0 17.6 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.878 -0.786 . . . . 74.329999999999998 108.878 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.36 123.9 32.81 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.648 -0.871 . . . . 74.129999999999995 108.648 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.4 121.37 61.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.148 -0.933 . . . . 71.5 109.373 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.61 128.43 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.191 -0.913 . . . . 62.229999999999997 109.534 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.424 HG12 ' SG ' ' A' ' 585' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.462 0 CA-C-N 115.25 -0.886 . . . . 75.239999999999995 110.066 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.5 m80 . . . . . 0 C--O 1.242 0.696 0 N-CA-C 107.298 -1.371 . . . . 72.430000000000007 107.298 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -83.12 87.85 6.9 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.457 -0.572 . . . . 50.229999999999997 109.457 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -83.39 133.95 12.36 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.973 -0.851 . . . . 74.420000000000002 110.973 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.27 114.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.18 -0.674 . . . . 71.040000000000006 109.18 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.19 136.58 52.8 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.084 0.24 . . . . 73.319999999999993 110.445 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.1 t -148.64 160.23 43.34 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.993 -0.373 . . . . 74.129999999999995 109.993 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.71 158.57 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 122.164 0.186 . . . . 72.349999999999994 110.583 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 45.6 mt-10 -58.48 -49.97 75.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.179 0.514 . . . . 75.200000000000003 110.716 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLU . . . . . 0.56 ' OE2' ' HD2' ' A' ' 510' ' ' PRO . 7.7 tp10 -141.96 137.76 16.3 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.523 -2.029 . . . . 64.329999999999998 105.523 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.56 ' HD2' ' OE2' ' A' ' 509' ' ' GLU . 41.4 Cg_endo -70.79 -10.65 28.17 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.491 2.127 . . . . 72.0 114.656 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 642' ' ' GLU . 72.7 t -140.73 126.93 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 122.028 -0.42 . . . . 72.400000000000006 110.161 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.96 130.57 37.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.484 0.659 . . . . 33.439999999999998 109.615 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -110.07 121.61 45.67 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.646 -0.501 . . . . 72.540000000000006 109.646 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.81 160.91 36.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.128 -0.487 . . . . 63.439999999999998 111.709 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 518' ' ' ILE . 20.2 m -71.88 156.47 39.24 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 73.400000000000006 110.832 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -30.73 58.3 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.811 -1.181 . . . . 60.509999999999998 107.811 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.1 p -90.83 16.71 8.83 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.435 -1.257 . . . . 74.349999999999994 111.777 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 515' ' ' SER . 7.5 tt -78.73 -30.09 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 120.281 -0.568 . . . . 72.230000000000004 110.607 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.39 -68.09 3.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.108 -1.044 . . . . 73.120000000000005 112.444 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.2 mm -130.79 132.12 64.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.638 -1.245 . . . . 74.200000000000003 107.638 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -107.15 154.51 21.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.167 -1.049 . . . . 73.340000000000003 108.167 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.55 124.25 40.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.923 0.392 . . . . 71.030000000000001 111.595 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.637 HG12 ' HB ' ' A' ' 571' ' ' ILE . 8.6 p -124.86 133.15 70.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.019 -0.734 . . . . 72.099999999999994 109.019 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 98.7 mttt -93.27 138.68 31.42 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.407 -0.59 . . . . 75.400000000000006 109.407 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 85.3 t -96.03 121.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.926 -1.509 . . . . 71.329999999999998 106.926 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.16 155.59 16.99 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.235 -0.893 . . . . 73.349999999999994 110.314 -174.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -124.86 104.61 8.7 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.327 -0.99 . . . . 65.140000000000001 108.327 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.8 m -64.93 -56.11 15.23 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.28 -0.873 . . . . 73.540000000000006 111.153 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.6 p -73.79 -48.21 33.23 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.593 0.711 . . . . 61.310000000000002 110.005 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.41 -159.91 26.8 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 111.171 -0.771 . . . . 71.519999999999996 111.171 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.485 ' H ' ' HB2' ' A' ' 565' ' ' ASP . . . -148.51 144.95 27.68 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.999 -1.482 . . . . 54.530000000000001 106.999 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -161.12 77.61 0.57 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.759 -0.83 . . . . 75.439999999999998 108.759 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.535 ' HA2' ' C ' ' A' ' 600' ' ' GLY . . . 157.87 -127.67 1.95 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.018 -1.087 . . . . 24.41 111.311 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -137.22 102.57 4.86 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.395 -1.706 . . . . 65.200000000000003 106.395 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 120.0 62.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.335 0.588 . . . . 61.149999999999999 110.347 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.88 115.88 34.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 N-CA-C 108.457 -0.942 . . . . 63.329999999999998 108.457 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.77 101.51 51.46 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.607 -0.724 . . . . 63.5 109.835 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 2.7 Cg_endo -76.66 155.79 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.088 1.858 . . . . 60.109999999999999 112.275 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -142.15 160.66 39.79 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.435 -0.95 . . . . 74.530000000000001 108.435 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -151.43 136.43 17.37 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.875 0.369 . . . . 71.019999999999996 110.977 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.3 p -85.0 126.89 33.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.853 -0.612 . . . . 63.009999999999998 111.271 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.65 121.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.267 -1.012 . . . . 72.219999999999999 108.267 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -79.16 104.88 10.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.843 -0.799 . . . . 73.439999999999998 108.843 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -86.24 -94.3 0.84 Allowed Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.386 -1.086 . . . . 63.210000000000001 110.386 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.8 p -102.8 -12.27 17.72 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.172 0.511 . . . . 72.109999999999999 110.538 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.43 152.89 21.24 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.391 -0.966 . . . . 65.549999999999997 108.391 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -107.61 131.4 54.41 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.157 -0.617 . . . . 74.219999999999999 109.856 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.19 -154.76 20.35 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.271 -1.132 . . . . 45.130000000000003 110.271 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.92 79.81 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.513 -0.851 . . . . 65.219999999999999 112.094 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' A' ' 576' ' ' PHE . . . 92.29 11.38 59.82 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.779 -0.724 . . . . 74.230000000000004 113.104 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -76.25 -77.95 0.13 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 117.45 0.625 . . . . 70.329999999999998 110.802 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -93.84 -42.72 8.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.882 -1.155 . . . . 42.200000000000003 107.882 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -135.36 163.05 30.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 108.966 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 576' ' ' PHE . 28.2 tt0 -97.62 116.62 30.19 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.294 -1.743 . . . . 72.420000000000002 106.294 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.17 142.15 54.38 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.364 -0.606 . . . . 74.420000000000002 109.364 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -140.12 132.44 28.33 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.684 0.755 . . . . 64.510000000000005 110.229 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.4 p -140.65 122.14 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.714 -1.217 . . . . 40.210000000000001 107.714 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.68 -176.97 36.13 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 109.743 -1.343 . . . . 74.340000000000003 109.743 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 0.3 OUTLIER -126.31 128.68 47.5 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.628 0.728 . . . . 64.329999999999998 111.961 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 79.7 mt -89.53 144.34 26.11 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.094 -1.412 . . . . 72.120000000000005 110.061 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -105.59 101.87 11.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.395 0.617 . . . . 73.409999999999997 111.506 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 42.7 m-85 -100.21 100.41 11.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.791 -0.818 . . . . 70.219999999999999 108.791 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.473 ' H ' HD11 ' A' ' 567' ' ' ILE . 81.4 mt-30 -83.1 -77.9 0.23 Allowed 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.792 -0.763 . . . . 73.340000000000003 110.239 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -105.43 159.25 16.07 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.843 -0.617 . . . . 62.140000000000001 109.369 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.485 ' HB2' ' H ' ' A' ' 531' ' ' ALA . 13.2 t70 -57.99 -23.21 53.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.415 1.086 . . . . 71.439999999999998 111.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.08 -43.49 78.08 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.724 1.209 . . . . 73.340000000000003 112.0 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.473 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -96.39 158.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.255 0.55 . . . . 73.019999999999996 110.705 -173.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.68 154.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.879 -1.156 . . . . 74.5 107.879 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.59 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.5 mmpt? -115.49 154.71 28.83 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.861 0.362 . . . . 65.25 111.167 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 53.0 mt -128.54 136.62 59.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.581 -1.191 . . . . 71.209999999999994 109.529 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.637 ' HB ' HG12 ' A' ' 523' ' ' VAL . 56.3 mt -97.78 125.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.563 -1.643 . . . . 74.030000000000001 106.563 174.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 21.7 p -110.41 112.38 24.27 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.672 -0.862 . . . . 73.430000000000007 108.672 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.618 HD11 HD22 ' A' ' 589' ' ' LEU . 42.5 mt -108.27 134.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.819 -0.808 . . . . 52.43 108.819 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.415 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.0 OUTLIER -82.18 117.13 22.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 109.566 -0.531 . . . . 71.420000000000002 109.566 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.42 123.69 57.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.59 -2.004 . . . . 73.200000000000003 105.59 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 550' ' ' GLY . 90.4 m-85 -85.67 147.24 26.46 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.55 -0.46 . . . . 73.400000000000006 111.297 -175.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.05 75.77 2.92 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.617 -1.253 . . . . 64.329999999999998 107.617 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.11 115.16 29.7 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.38 -1.282 . . . . 73.239999999999995 109.243 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -112.57 78.93 1.17 Allowed 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 105.527 -2.027 . . . . 74.25 105.527 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -91.88 -94.44 0.14 Allowed 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.244 -1.344 . . . . 72.230000000000004 110.079 -174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -155.0 153.52 31.13 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 105.032 -2.21 . . . . 71.150000000000006 105.032 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.13 120.58 11.75 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.907 0.706 . . . . 73.409999999999997 112.907 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 646' ' ' GLU . 35.3 mtmm -129.35 176.15 8.18 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.946 -1.501 . . . . 74.420000000000002 106.946 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -108.77 42.41 1.41 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.567 -1.642 . . . . 70.049999999999997 106.567 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 583' ' ' LYS . 16.2 p -67.77 120.51 14.23 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.075 -1.421 . . . . 72.120000000000005 113.352 -172.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.7 m -143.65 153.09 42.14 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.368 -1.345 . . . . 62.43 107.368 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -133.49 153.11 51.9 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.406 -0.961 . . . . 75.319999999999993 108.406 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.8 m -111.25 154.51 24.35 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.687 -0.857 . . . . 71.439999999999998 108.687 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.618 HD22 HD11 ' A' ' 573' ' ' ILE . 39.7 tp -129.07 130.46 46.56 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.068 -1.456 . . . . 73.349999999999994 107.068 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.43 158.7 38.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 123.218 0.324 . . . . 71.200000000000003 110.313 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.05 145.52 26.45 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.128 -0.942 . . . . 74.150000000000006 108.49 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 592' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 538' ' ' PRO . 17.6 mm-40 -101.59 165.99 10.94 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.324 -0.621 . . . . 71.530000000000001 109.324 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.32 114.55 7.4 Favored Pre-proline 0 C--O 1.245 0.851 0 O-C-N 124.233 0.958 . . . . 75.109999999999999 111.303 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 633' ' ' PRO . 88.6 Cg_endo -77.62 150.56 27.92 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.132 2.554 . . . . 72.420000000000002 111.443 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.93 140.27 51.15 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.415 -0.178 . . . . 51.219999999999999 111.471 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 596' ' ' TRP . . . . . 0.446 ' HE1' ' HA3' ' A' ' 533' ' ' GLY . 1.0 OUTLIER -103.03 118.05 35.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.675 -0.491 . . . . 74.129999999999995 109.675 -176.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.01 150.08 4.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 123.407 0.683 . . . . 72.530000000000001 110.432 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -65.83 -179.98 0.78 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.51 1.524 . . . . 74.140000000000001 112.412 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 67.15 -21.08 0.11 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.54 1.681 . . . . 74.540000000000006 115.54 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' GLY . . . . . 0.535 ' C ' ' HA2' ' A' ' 533' ' ' GLY . . . -87.59 -6.75 76.61 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.066 -1.064 . . . . 73.439999999999998 112.62 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 88.3 mtp -100.76 -167.92 1.5 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.517 -0.92 . . . . 54.109999999999999 108.517 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -143.93 131.83 21.53 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.633 -0.506 . . . . 74.230000000000004 109.633 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 89.13 -79.27 1.61 Allowed Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 111.648 -0.581 . . . . 71.25 111.648 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -94.62 128.98 9.71 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.713 -0.955 . . . . 73.430000000000007 110.713 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -128.28 134.39 48.93 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.618 -0.882 . . . . 73.120000000000005 108.618 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 68.2 m -86.63 102.96 14.66 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 108.813 -0.81 . . . . 72.099999999999994 108.813 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 40.1 mm -86.88 91.44 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 107.54 -1.282 . . . . 75.239999999999995 107.54 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 7.1 m -70.71 89.6 0.74 Allowed 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 114.976 -1.011 . . . . 74.010000000000005 109.594 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.97 -13.16 12.54 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.414 -0.812 . . . . 51.539999999999999 110.393 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -102.03 99.77 9.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.544 -0.909 . . . . 74.230000000000004 108.544 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -145.93 148.66 33.03 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.374 -1.713 . . . . 74.109999999999999 106.374 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' ' 619' ' ' SER . 16.5 t70 -119.23 131.11 55.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.322 -0.621 . . . . 51.210000000000001 109.322 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.81 -21.52 56.55 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 125.152 1.381 . . . . 73.310000000000002 112.727 -174.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -67.96 -49.44 61.68 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 119.345 -0.36 . . . . 61.439999999999998 111.261 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -175.68 -56.71 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 114.762 1.393 . . . . 71.040000000000006 114.762 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -86.77 171.47 7.05 Favored 'Trans proline' 0 C--N 1.363 1.304 0 N-CA-C 115.953 1.482 . . . . 35.340000000000003 115.953 -169.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.49 -51.92 5.29 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 105.809 -1.923 . . . . 73.310000000000002 105.809 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 26.5 m -82.54 93.79 7.36 Favored 'General case' 0 N--CA 1.404 -2.728 0 CA-C-N 113.791 -1.55 . . . . 73.019999999999996 107.921 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.601 ' HB3' ' HB2' ' A' ' 612' ' ' ASP . 10.5 p -90.48 22.43 3.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 123.67 0.788 . . . . 63.409999999999997 111.304 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 -158.56 0.67 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.71 -1.219 . . . . 74.400000000000006 107.71 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -84.55 -157.05 0.26 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.293 -1.002 . . . . 54.409999999999997 108.293 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.7 71.39 10.4 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.369 -0.832 . . . . 63.130000000000003 113.085 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -82.55 63.25 6.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.605 -0.725 . . . . 73.519999999999996 110.132 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 56.63 35.06 25.53 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.593 -0.73 . . . . 74.230000000000004 110.734 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -57.16 -34.97 68.98 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.0 -1.0 . . . . 72.219999999999999 112.379 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 630' ' ' MET . 20.4 ttp180 -67.16 -38.65 85.82 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 120.578 -0.449 . . . . 64.519999999999996 110.363 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 65.8 mt -70.06 -37.03 71.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.258 -0.645 . . . . 61.43 109.258 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.57 96.49 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.536 -0.756 . . . . 41.299999999999997 109.499 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 632' ' ' ARG . 48.8 mt-10 -70.18 -25.9 63.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.566 0.58 . . . . 74.439999999999998 112.566 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 71.4 mtm -76.23 -8.32 56.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.355 0.598 . . . . 75.140000000000001 110.275 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -103.51 14.63 54.01 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.524 -1.03 . . . . 70.329999999999998 110.524 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 629' ' ' GLU . 83.3 mtp180 -107.95 156.47 38.15 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.349 -0.982 . . . . 72.400000000000006 108.349 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 594' ' ' PRO . 37.4 Cg_endo -66.89 143.58 67.15 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.047 1.831 . . . . 75.230000000000004 110.689 175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 26.4 pt -133.24 -176.98 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 C-N-CA 123.086 0.554 . . . . 64.209999999999994 109.698 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.48 177.98 4.71 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.229 -1.026 . . . . 74.219999999999999 108.229 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.5 170.65 42.11 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.46 -0.656 . . . . 73.299999999999997 111.46 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -49.75 -61.61 2.03 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.249 1.02 . . . . 72.409999999999997 112.043 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -129.33 102.17 6.31 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.787 -1.56 . . . . 74.030000000000001 106.787 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 3.6 t -129.51 111.85 13.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 122.337 1.065 . . . . 64.420000000000002 110.865 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 37.0 ttmt -147.19 151.74 37.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.876 -1.898 . . . . 74.109999999999999 105.876 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 523' ' ' VAL . 51.8 tp -123.38 103.45 8.5 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.977 -0.749 . . . . 73.549999999999997 108.977 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 511' ' ' VAL . 44.2 mt-10 -87.45 106.53 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.551 -0.907 . . . . 73.430000000000007 108.551 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 32.0 t -96.9 121.69 47.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 114.91 -1.041 . . . . 62.539999999999999 108.197 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 27.9 mt -115.55 133.49 61.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.108 -0.951 . . . . 72.409999999999997 110.896 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 646' ' ' GLU . 0.1 OUTLIER -142.58 163.23 18.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 125.062 1.345 . . . . 71.140000000000001 108.402 -176.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 646' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 583' ' ' LYS . 8.1 tp10 144.74 164.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 127.486 2.314 . . . . 73.049999999999997 106.967 169.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.07 123.67 18.75 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.452 -0.573 . . . . 75.319999999999993 109.452 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 50.0 m 67.96 86.36 0.13 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.412 1.085 . . . . 71.530000000000001 113.563 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -111.23 168.5 9.46 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.22 -1.77 . . . . 63.049999999999997 106.22 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -106.48 128.38 54.04 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.132 -0.627 . . . . 71.230000000000004 110.412 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -92.24 107.22 19.05 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.655 -0.702 . . . . 75.140000000000001 109.368 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 166.71 13.18 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.22 -1.03 . . . . 72.140000000000001 108.22 177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 37.0 p -70.36 88.12 0.64 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.182 0.515 . . . . 74.129999999999995 111.653 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 18.2 m -84.85 99.51 10.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.22 -1.03 . . . . 75.219999999999999 108.22 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 45.5 t -133.19 151.86 34.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 109.784 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 109.428 -0.582 . . . . 63.020000000000003 109.428 174.416 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 C--O 1.243 0.737 0 CA-C-O 121.577 0.703 . . . . 74.209999999999994 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -140.6 -178.3 5.45 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.095 -0.957 . . . . 70.430000000000007 108.838 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -67.74 137.55 32.43 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.797 -0.716 . . . . 52.219999999999999 112.067 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 67.3 mt -127.02 116.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.805 -1.183 . . . . 75.209999999999994 107.805 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -108.16 137.66 45.76 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.618 0.574 . . . . 75.219999999999999 111.67 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.2 t -148.91 157.37 43.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.83 -0.623 . . . . 64.030000000000001 109.371 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.37 155.68 36.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.086 -0.339 . . . . 74.099999999999994 110.086 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -59.39 -48.18 82.63 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 123.615 0.572 . . . . 73.530000000000001 110.47 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.42 151.09 77.31 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.42 -0.956 . . . . 55.530000000000001 108.42 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 2.4 Cg_endo -78.35 -20.63 10.96 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.631 1.554 . . . . 41.32 110.496 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 642' ' ' GLU . 65.8 t -139.98 127.3 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.711 -0.848 . . . . 52.109999999999999 108.711 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -129.42 133.57 47.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.269 -0.641 . . . . 50.539999999999999 109.269 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -107.09 121.41 44.43 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.642 -0.873 . . . . 73.439999999999998 108.642 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.54 148.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.406 0.622 . . . . 72.140000000000001 111.022 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.52 ' HB3' ' OE1' ' A' ' 647' ' ' GLU . 50.7 m -65.12 141.27 58.76 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.542 -1.208 . . . . 70.200000000000003 110.262 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 647' ' ' GLU . 12.2 pt-20 -70.55 -24.26 62.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 109.832 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.39 17.99 17.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.066 -0.515 . . . . 45.109999999999999 110.828 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.1 -23.27 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.247 0.546 . . . . 73.430000000000007 111.036 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.43 -73.32 2.24 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.448 -0.882 . . . . 71.439999999999998 110.935 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.72 126.79 69.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.899 -1.148 . . . . 52.420000000000002 107.899 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.404 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.5 ppp? -98.15 148.7 23.3 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.865 -1.161 . . . . 73.420000000000002 107.865 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.3 119.16 28.5 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.414 0.446 . . . . 71.239999999999995 111.692 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.46 HG21 HD21 ' A' ' 641' ' ' LEU . 52.5 t -127.43 126.72 68.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.107 -0.701 . . . . 74.409999999999997 109.107 173.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.462 ' HG2' HG12 ' A' ' 570' ' ' ILE . 62.6 mttp -91.96 147.75 22.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.026 -0.534 . . . . 64.310000000000002 110.699 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.07 116.15 38.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.293 -1.373 . . . . 74.239999999999995 107.293 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.9 155.99 18.77 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.408 -0.814 . . . . 42.43 110.428 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.88 104.63 12.13 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 107.787 -1.19 . . . . 74.299999999999997 107.787 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.1 m -65.24 -61.22 2.25 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.421 -0.354 . . . . 63.43 110.709 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.2 t -74.57 -49.17 22.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.224 0.535 . . . . 65.140000000000001 109.851 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 151.78 -159.73 28.44 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.381 -1.488 . . . . 50.530000000000001 109.381 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -161.95 139.47 8.65 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.028 -0.73 . . . . 74.299999999999997 109.028 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -156.67 133.81 10.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 106.432 -1.692 . . . . 65.099999999999994 106.432 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 532' ' ' ARG . . . 108.63 -133.4 11.64 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.335 -0.936 . . . . 60.43 111.748 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -137.58 108.42 6.67 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.993 -1.114 . . . . 72.209999999999994 107.993 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.49 124.73 70.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.672 0.749 . . . . 74.239999999999995 111.199 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 559' ' ' GLU . 31.9 mm -93.7 116.45 34.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.043 -0.98 . . . . 71.230000000000004 108.687 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.4 t -108.81 99.24 33.49 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.912 -1.144 . . . . 71.319999999999993 107.912 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.1 159.98 23.66 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.682 1.588 . . . . 75.5 111.514 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -144.82 161.05 40.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.035 -1.098 . . . . 72.409999999999997 108.035 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -152.37 134.83 15.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.009 0.433 . . . . 75.150000000000006 111.006 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' THR . . . . . 0.411 HG23 HD13 ' A' ' 589' ' ' LEU . 0.7 OUTLIER -81.9 138.59 34.99 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.089 -0.96 . . . . 74.430000000000007 112.006 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.2 mm -115.52 126.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.582 -1.636 . . . . 62.020000000000003 106.582 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.91 166.72 22.95 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.901 0.382 . . . . 41.109999999999999 110.792 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -162.87 -111.43 0.26 Allowed Glycine 0 CA--C 1.495 -1.215 0 N-CA-C 110.474 -1.05 . . . . 72.040000000000006 110.474 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -31.04 58.75 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.469 -1.308 . . . . 64.239999999999995 107.469 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 552' ' ' ASP . . . -88.56 143.4 26.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.932 -1.485 . . . . 45.229999999999997 107.146 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -109.42 153.35 24.13 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 113.531 0.937 . . . . 75.310000000000002 113.531 -171.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 43.11 -119.58 2.36 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 126.771 2.129 . . . . 73.510000000000005 118.372 168.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -164.89 96.35 0.13 Allowed Glycine 0 N--CA 1.412 -2.902 0 N-CA-C 108.649 -1.78 . . . . 64.340000000000003 108.649 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 123.01 -19.5 7.77 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 109.595 -1.402 . . . . 74.109999999999999 109.595 -175.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 6.2 mp0 -76.97 -73.05 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.981 -0.609 . . . . 52.229999999999997 110.101 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 547' ' ' ARG . 5.7 m-20 -103.22 -44.17 5.26 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 122.136 0.969 . . . . 72.400000000000006 108.988 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -133.79 155.61 49.49 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 107.277 -1.379 . . . . 75.230000000000004 107.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.498 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 3.8 tm-20 -89.01 129.77 35.6 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.529 -1.285 . . . . 74.239999999999995 107.529 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.55 103.1 3.43 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.451 0.644 . . . . 72.040000000000006 111.199 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.6 t -108.43 113.7 26.95 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.384 -0.969 . . . . 70.409999999999997 108.384 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -143.41 100.6 3.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.503 -0.771 . . . . 73.310000000000002 109.231 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.81 -163.56 10.76 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.622 -0.799 . . . . 54.530000000000001 112.228 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.518 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.6 mt-10 -116.83 117.9 31.0 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.422 0.689 . . . . 64.030000000000001 110.582 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.4 mt -89.31 139.5 30.43 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.047 -0.723 . . . . 70.439999999999998 109.047 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.88 105.07 14.71 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.67 -0.812 . . . . 71.329999999999998 111.417 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 31.5 m-85 -96.21 143.79 26.99 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.397 -1.334 . . . . 53.109999999999999 107.397 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.458 ' H ' HD11 ' A' ' 567' ' ' ILE . 79.4 mt-30 -116.29 -86.94 0.61 Allowed 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.245 -1.02 . . . . 65.150000000000006 108.245 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.97 168.53 9.0 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.527 -0.869 . . . . 64.519999999999996 109.043 173.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -59.28 -11.05 3.51 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.244 1.418 . . . . 64.420000000000002 113.575 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.589 ' HG3' HG23 ' A' ' 567' ' ' ILE . 16.1 pt-20 -69.77 -17.88 63.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.729 0.412 . . . . 72.200000000000003 111.973 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.589 HG23 ' HG3' ' A' ' 566' ' ' GLU . 41.0 pt -116.13 163.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 C-N-CA 120.319 -0.552 . . . . 73.140000000000001 111.464 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.3 146.45 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 108.181 -1.044 . . . . 65.319999999999993 108.181 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 70.9 mmtt -109.83 145.05 37.4 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.591 -0.522 . . . . 73.129999999999995 109.591 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 524' ' ' LYS . 63.1 mt -116.92 133.6 63.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.368 -1.287 . . . . 52.0 108.287 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.436 HD13 HD21 ' A' ' 589' ' ' LEU . 55.5 mt -93.15 113.08 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 106.932 -1.507 . . . . 61.219999999999999 106.932 174.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -102.48 112.31 24.99 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.106 -0.952 . . . . 65.140000000000001 109.55 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 521' ' ' MET . 48.6 mt -107.65 129.43 61.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.983 -1.117 . . . . 74.140000000000001 107.983 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.498 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 63.8 mtt85 -78.25 114.62 17.31 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.504 -0.924 . . . . 64.400000000000006 108.504 176.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.4 mm -101.0 126.67 54.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.603 -0.888 . . . . 64.430000000000007 108.603 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 50.8 m-85 -107.45 112.13 24.76 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.039 0.447 . . . . 65.239999999999995 110.912 -177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.44 150.36 48.21 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.165 0.986 . . . . 64.120000000000005 111.402 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -138.73 -46.66 0.49 Allowed 'General case' 0 C--O 1.246 0.898 0 CA-C-N 116.035 -0.529 . . . . 75.530000000000001 111.354 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -119.15 -177.41 3.34 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 120.96 0.409 . . . . 71.329999999999998 111.167 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -78.49 -36.65 44.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.536 -1.653 . . . . 75.25 106.536 174.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -145.32 98.36 3.14 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.791 -1.095 . . . . 63.420000000000002 108.587 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.5 ' OE1' ' HA ' ' A' ' 582' ' ' GLU . 3.1 mm-40 -63.9 157.14 25.57 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 119.228 -0.989 . . . . 71.109999999999999 111.672 171.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' A' ' 583' ' ' LYS . 5.9 mptt -88.31 69.03 9.06 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.058 0.392 . . . . 73.530000000000001 112.058 -168.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 51.98 31.58 8.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.162 0.985 . . . . 74.530000000000001 112.594 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 645' ' ' ILE . 2.2 p -63.12 128.49 36.08 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 120.647 0.26 . . . . 70.109999999999999 110.711 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 6.7 m -130.57 152.44 49.95 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.743 -0.383 . . . . 55.350000000000001 110.558 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.8 p90 -138.95 175.59 9.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.381 -1.34 . . . . 62.310000000000002 107.381 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 14.7 m -125.59 158.88 33.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.632 -0.827 . . . . 71.450000000000003 110.577 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.436 HD21 HD13 ' A' ' 571' ' ' ILE . 59.2 tp -136.61 132.92 35.72 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 106.551 -1.648 . . . . 72.200000000000003 106.551 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.58 155.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 120.96 -0.296 . . . . 75.219999999999999 110.363 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.469 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 85.7 mt -92.1 142.53 27.41 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.317 -0.994 . . . . 63.240000000000002 108.317 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -93.87 175.57 6.67 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.463 -0.79 . . . . 73.340000000000003 109.404 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -66.58 113.9 14.98 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 123.734 0.646 . . . . 55.210000000000001 109.364 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.4 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 49.4 Cg_endo -73.57 143.85 34.9 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.754 1.636 . . . . 72.209999999999994 111.264 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.05 140.46 51.9 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.375 -0.829 . . . . 44.130000000000003 110.472 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 596' ' ' TRP . . . . . 0.424 ' HB2' ' HD3' ' A' ' 633' ' ' PRO . 3.7 t90 -102.06 124.22 47.29 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.084 -1.45 . . . . 74.150000000000006 107.084 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.56 98.48 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.764 0.793 . . . . 71.299999999999997 108.932 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -58.88 126.41 27.57 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.695 -1.593 . . . . 63.310000000000002 111.748 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -74.32 114.24 12.46 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.121 -1.066 . . . . 71.040000000000006 108.121 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 97.58 81.8 1.61 Allowed Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 108.884 -1.686 . . . . 54.009999999999998 108.884 -173.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 21.5 ptp -96.02 162.37 13.58 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.541 -0.54 . . . . 71.310000000000002 109.541 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -115.93 112.38 21.79 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.805 0.812 . . . . 73.450000000000003 112.3 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -150.56 -46.77 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 109.675 -1.37 . . . . 70.230000000000004 109.675 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -85.68 56.96 4.89 Favored Glycine 0 CA--C 1.506 -0.507 0 N-CA-C 110.532 -1.027 . . . . 54.219999999999999 110.532 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -95.27 156.91 16.12 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.759 -0.83 . . . . 75.519999999999996 108.759 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 4.9 m -68.21 105.25 2.04 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.06 0.544 . . . . 60.149999999999999 111.16 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 37.2 mm -120.05 88.08 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.032 -1.099 . . . . 75.319999999999993 108.032 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 21.1 m -132.28 -54.17 0.97 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.655 -0.498 . . . . 62.32 109.655 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -89.97 -19.21 24.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.68 -0.859 . . . . 64.409999999999997 108.68 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -79.62 137.52 37.13 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.326 -1.307 . . . . 75.219999999999999 108.089 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -104.69 -15.67 15.19 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.013 0.435 . . . . 74.329999999999998 110.511 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -111.03 127.05 55.41 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.512 -0.313 . . . . 63.439999999999998 110.291 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -68.78 146.15 53.16 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 120.878 0.37 . . . . 74.0 110.463 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.19 83.79 6.94 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.301 1.048 . . . . 65.120000000000005 110.787 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 615' ' ' GLN . . . . . 0.557 ' OE1' ' HD2' ' A' ' 616' ' ' PRO . 6.5 tp-100 -137.14 127.55 15.97 Favored Pre-proline 0 C--N 1.285 -2.22 0 N-CA-C 104.76 -2.311 . . . . 71.510000000000005 104.76 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.557 ' HD2' ' OE1' ' A' ' 615' ' ' GLN . 27.7 Cg_exo -56.96 136.96 79.75 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 C-N-CA 122.031 1.821 . . . . 75.109999999999999 110.401 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.1 104.23 10.52 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 108.656 -0.868 . . . . 75.030000000000001 108.656 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 6.5 p -82.94 -7.14 59.69 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.962 0.887 . . . . 75.439999999999998 110.065 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 10.0 p -70.58 -17.08 62.91 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.403 -1.271 . . . . 52.439999999999998 108.164 172.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -134.57 -150.93 0.41 Allowed 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 126.467 1.907 . . . . 74.019999999999996 106.212 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -125.84 179.51 5.16 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 104.653 -2.351 . . . . 61.350000000000001 104.653 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.88 105.24 17.27 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.061 -2.2 . . . . 62.299999999999997 105.061 164.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -51.02 155.62 1.2 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.562 -0.744 . . . . 75.230000000000004 112.042 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 64.22 34.17 11.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.13 0.967 . . . . 70.530000000000001 108.489 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 0.2 OUTLIER -55.72 -27.34 49.92 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 113.852 -1.522 . . . . 70.329999999999998 112.956 -175.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.581 ' O ' ' HG3' ' A' ' 630' ' ' MET . 95.2 mtt180 -58.76 -46.0 88.46 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.139 0.495 . . . . 65.140000000000001 110.452 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.06 -35.79 65.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.041 -0.981 . . . . 55.100000000000001 109.624 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.67 78.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.927 -0.578 . . . . 74.310000000000002 110.261 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 35.6 mt-10 -79.47 -15.72 57.3 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.08 -0.509 . . . . 73.120000000000005 111.207 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 64.6 mtt -76.63 -10.27 59.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.895 -1.15 . . . . 64.019999999999996 107.895 173.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -105.84 21.44 34.11 Favored Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.551 -1.419 . . . . 42.340000000000003 109.551 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -129.3 156.65 78.07 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 107.512 -1.292 . . . . 61.439999999999998 107.512 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 596' ' ' TRP . 23.7 Cg_exo -71.24 156.11 59.7 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 N-CA-C 107.707 -1.69 . . . . 64.239999999999995 107.707 168.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 634' ' ' ILE . 0.2 OUTLIER -131.45 -177.95 2.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 CA-C-O 121.19 0.519 . . . . 63.310000000000002 111.358 -175.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.74 176.39 6.37 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.469 -0.937 . . . . 63.509999999999998 108.469 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.06 -128.55 0.21 Allowed Glycine 0 C--N 1.309 -0.929 0 CA-C-O 121.968 0.76 . . . . 52.130000000000003 113.102 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.33 -84.17 0.05 OUTLIER 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.834 -0.683 . . . . 64.519999999999996 109.241 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -141.75 94.93 2.74 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 105.085 -2.191 . . . . 74.209999999999994 105.085 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 639' ' ' THR . . . . . 0.41 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 13.3 t -100.65 118.34 36.59 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-O 122.401 1.096 . . . . 54.399999999999999 110.954 -172.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 640' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 3.7 ttmp? -145.05 143.64 30.56 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.848 -1.908 . . . . 75.030000000000001 105.848 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.46 HD21 HG21 ' A' ' 523' ' ' VAL . 28.4 tp -119.59 105.68 11.44 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 108.232 -1.025 . . . . 72.310000000000002 108.232 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.405 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.7 mt-10 -90.79 121.76 32.93 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.985 -1.117 . . . . 65.140000000000001 107.985 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.69 120.27 59.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.978 -1.01 . . . . 75.019999999999996 109.308 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.21 121.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 CA-C-N 114.696 -1.138 . . . . 65.340000000000003 108.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.446 HG12 ' SG ' ' A' ' 585' ' ' CYS . 0.1 OUTLIER -106.71 117.73 53.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.334 -0.848 . . . . 75.439999999999998 110.184 -178.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -165.88 136.5 3.6 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.406 -1.702 . . . . 74.409999999999997 106.406 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 516' ' ' GLU . 10.4 tp10 -78.87 82.33 5.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.31 -1.356 . . . . 75.010000000000005 110.25 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 17.1 t -88.25 88.94 7.8 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.472 -1.677 . . . . 74.230000000000004 106.472 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -130.41 145.09 51.76 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.738 0.78 . . . . 64.430000000000007 111.821 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.54 147.8 12.35 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 101.141 -3.651 . . . . 64.010000000000005 101.141 169.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -78.33 -23.41 47.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.057 -0.719 . . . . 42.219999999999999 109.057 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? 57.29 26.22 12.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.388 1.475 . . . . 62.240000000000002 113.679 174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 27.5 t -98.62 83.76 3.04 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 108.695 -0.854 . . . . 62.43 108.695 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 56.7 m -126.83 118.76 25.27 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.314 -0.857 . . . . 73.409999999999997 109.429 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 8.6 p -115.23 117.89 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 108.373 -0.973 . . . . 65.409999999999997 108.373 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.679 -0.86 . . . . 43.25 108.679 -178.108 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.45 ' HB3' ' O ' ' A' ' 632' ' ' ARG . 53.2 t60 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.702 -0.851 . . . . 71.329999999999998 108.702 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . 71.72 -51.22 0.69 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.874 1.67 . . . . 25.149999999999999 111.617 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -124.17 125.27 5.75 Favored Glycine 0 N--CA 1.416 -2.684 0 N-CA-C 110.278 -1.129 . . . . 54.329999999999998 110.278 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 68.6 mt -127.54 118.94 50.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.92 -1.511 . . . . 71.519999999999996 106.92 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.33 133.07 51.6 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.221 0.452 . . . . 74.310000000000002 112.221 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -148.11 153.97 39.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.688 -0.856 . . . . 70.120000000000005 108.688 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 68.1 m-85 -74.28 156.3 37.32 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.806 -0.442 . . . . 71.340000000000003 109.806 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.58 -49.11 79.03 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.235 0.54 . . . . 74.340000000000003 110.381 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.77 153.7 81.16 Favored Pre-proline 0 N--CA 1.432 -1.35 0 N-CA-C 107.721 -1.215 . . . . 63.109999999999999 107.721 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 83.3 Cg_endo -86.24 -11.32 6.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.024 1.816 . . . . 62.0 113.3 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 70.4 t -143.81 135.34 22.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.281 -0.637 . . . . 64.219999999999999 109.281 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.96 133.97 42.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.712 -0.477 . . . . 73.209999999999994 109.712 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -106.18 110.86 23.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.622 -1.251 . . . . 65.310000000000002 107.622 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.85 155.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 110.757 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.451 ' O ' HG22 ' A' ' 518' ' ' ILE . 2.6 t -77.13 147.03 36.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.668 -1.975 . . . . 71.420000000000002 105.668 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -77.58 -16.94 58.31 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.068 -1.053 . . . . 63.009999999999998 110.813 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.7 m -91.31 13.19 18.01 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.202 -0.454 . . . . 72.030000000000001 111.427 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 515' ' ' SER . 8.1 tt -74.06 -25.67 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.033 0.444 . . . . 72.25 111.736 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.37 -68.96 2.61 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.982 -1.104 . . . . 65.030000000000001 112.2 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 574' ' ' ARG . 41.5 mm -131.97 132.31 61.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.299999999999997 108.286 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 19.0 ptm -108.42 143.02 37.93 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.011 -0.737 . . . . 53.340000000000003 109.011 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -99.25 124.21 44.15 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 123.55 0.531 . . . . 70.310000000000002 110.524 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.0 t -115.55 120.23 64.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.461 -1.311 . . . . 73.040000000000006 107.461 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -106.29 123.68 48.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.297 -0.961 . . . . 75.310000000000002 110.275 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 78.5 t -88.59 110.99 21.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.168 -0.924 . . . . 73.430000000000007 108.833 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.79 122.61 30.11 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.443 -0.798 . . . . 63.509999999999998 110.592 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -87.13 101.3 13.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.908 -1.145 . . . . 71.5 107.908 171.164 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.9 t -67.19 -47.53 70.66 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 75.209999999999994 112.401 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.1 t -74.58 -24.06 58.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.271 0.558 . . . . 63.329999999999998 109.924 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 115.09 -158.69 14.18 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 110.378 -1.089 . . . . 33.32 110.378 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.87 136.41 17.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.26 -1.385 . . . . 64.340000000000003 107.26 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -135.27 87.1 2.3 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.716 -0.394 . . . . 74.109999999999999 109.967 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 98.63 -178.98 31.54 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.81 -1.316 . . . . 72.230000000000004 109.81 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.5 111.54 9.78 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.457 -0.897 . . . . 74.120000000000005 111.201 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.89 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.872 -1.158 . . . . 45.149999999999999 107.872 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.496 HG12 HD13 ' A' ' 597' ' ' ILE . 46.3 mm -99.47 122.65 51.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.553 -0.906 . . . . 70.019999999999996 108.553 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 28.4 t -112.78 105.59 55.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 123.555 0.535 . . . . 52.310000000000002 109.754 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.44 150.55 28.48 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.917 1.745 . . . . 74.310000000000002 111.514 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -142.02 168.29 20.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.989 -1.115 . . . . 70.409999999999997 107.989 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 589' ' ' LEU . 55.0 pttt -161.23 145.14 13.15 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.123 0.487 . . . . 72.450000000000003 111.07 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.5 p -83.6 133.46 34.84 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.994 -1.003 . . . . 72.239999999999995 110.454 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.4 mm -104.2 112.41 37.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.062 -1.459 . . . . 52.32 107.062 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.89 152.16 41.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.656 0.598 . . . . 70.319999999999993 110.064 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -145.51 -116.97 1.06 Allowed Glycine 0 C--N 1.293 -1.837 0 N-CA-C 108.801 -1.72 . . . . 42.420000000000002 108.801 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 24.9 p -75.35 -27.71 59.29 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.21 -1.033 . . . . 64.120000000000005 108.21 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.38 127.98 34.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.604 -1.258 . . . . 62.350000000000001 107.604 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 3.2 tmt_? -104.26 139.67 38.94 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.578 -1.267 . . . . 63.130000000000003 107.578 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 548' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -86.94 -156.33 29.08 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.889 -0.672 . . . . 74.540000000000006 112.806 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.81 1.86 59.81 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.798 -0.239 . . . . 72.299999999999997 113.532 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 117.22 0.64 18.91 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.173 -1.013 . . . . 55.420000000000002 113.08 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 12.8 tp10 -69.77 -76.46 0.1 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 117.393 0.597 . . . . 74.239999999999995 109.793 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.479 ' OD1' ' HD3' ' A' ' 578' ' ' ARG . 12.8 m-20 -100.18 -35.42 9.65 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.77 -1.196 . . . . 74.129999999999995 107.77 174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -144.17 166.63 24.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.869 -1.16 . . . . 73.329999999999998 107.869 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.1 OUTLIER -95.44 144.2 26.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.467 -1.679 . . . . 65.510000000000005 106.467 176.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.91 122.08 28.24 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.264 -0.643 . . . . 74.219999999999999 109.264 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -129.5 124.05 32.99 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.989 0.9 . . . . 74.200000000000003 112.653 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 9.4 p -131.39 129.26 41.1 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.031 -1.841 . . . . 74.5 106.031 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -160.35 171.76 36.63 Favored Glycine 0 CA--C 1.48 -2.128 0 C-N-CA 118.997 -1.573 . . . . 41.109999999999999 112.474 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 7.7 mp0 -107.67 115.61 30.46 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.537 -0.912 . . . . 75.040000000000006 108.537 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.117 -0.327 . . . . 52.240000000000002 110.117 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -106.5 101.97 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.172 0.51 . . . . 73.109999999999999 111.771 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -97.37 156.47 16.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.097 -0.705 . . . . 75.439999999999998 109.097 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.433 ' H ' HD11 ' A' ' 567' ' ' ILE . 70.1 mm-40 -136.79 -81.13 0.38 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.816 1.293 . . . . 74.010000000000005 109.21 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 567' ' ' ILE . 4.3 t-20 -104.19 159.05 16.02 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 115.38 -0.827 . . . . 61.340000000000003 109.594 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -60.65 -16.37 38.18 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 125.151 1.381 . . . . 72.239999999999995 114.017 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -80.75 -16.34 54.12 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.687 -0.805 . . . . 72.299999999999997 112.237 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 563' ' ' GLN . 37.1 pt -99.58 158.98 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.215 -0.994 . . . . 73.310000000000002 110.307 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.57 143.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.267 -1.382 . . . . 55.229999999999997 107.267 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.1 mmpt? -101.69 147.27 26.65 Favored 'General case' 0 CA--C 1.468 -2.186 0 C-N-CA 120.108 -0.637 . . . . 72.349999999999994 110.636 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 22.2 mt -125.28 128.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 CA-C-N 114.578 -1.192 . . . . 63.530000000000001 108.771 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 52.9 mt -90.46 134.05 30.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.803 -1.554 . . . . 74.510000000000005 106.803 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 18.3 p -116.18 111.93 20.93 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.714 -0.847 . . . . 71.230000000000004 108.714 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.445 HD11 HD22 ' A' ' 589' ' ' LEU . 50.0 mt -106.39 128.41 60.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.833 -0.803 . . . . 53.210000000000001 108.833 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.7 mtt180 -75.62 111.93 11.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 124.115 0.884 . . . . 74.430000000000007 109.378 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -106.9 131.39 56.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.238 -1.393 . . . . 71.530000000000001 107.238 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 51.5 m-85 -119.31 143.79 47.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 73.129999999999995 108.316 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -80.81 127.25 32.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.292 -1.373 . . . . 72.230000000000004 107.292 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.479 ' HD3' ' OD1' ' A' ' 552' ' ' ASP . 56.7 ttt-85 -121.13 138.53 54.15 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.697 -0.683 . . . . 74.049999999999997 112.039 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -73.39 108.03 6.03 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.839 -1.073 . . . . 71.140000000000001 110.776 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.471 ' HG2' ' H ' ' A' ' 582' ' ' GLU . 38.3 tt0 -167.52 141.63 3.63 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.272 -1.381 . . . . 63.210000000000001 107.272 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -87.21 -22.24 25.37 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.543 -0.863 . . . . 75.230000000000004 111.378 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 580' ' ' GLU . 33.9 mt-10 -76.03 -71.42 0.38 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.124 -0.489 . . . . 73.040000000000006 110.656 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 585' ' ' CYS . 25.2 mmmt 64.51 36.84 8.42 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 124.186 0.994 . . . . 72.439999999999998 113.58 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.33 31.96 0.87 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.923 -1.14 . . . . 64.239999999999995 107.923 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.412 ' H ' ' C ' ' A' ' 583' ' ' LYS . 57.7 m -80.16 115.94 19.99 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.729 -1.578 . . . . 73.519999999999996 111.103 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 45.7 p -137.34 146.66 44.84 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.716 -0.846 . . . . 62.439999999999998 108.716 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -133.17 173.75 11.11 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.23 -1.026 . . . . 73.010000000000005 108.23 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 10.9 m -124.84 156.07 38.42 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.538 -0.912 . . . . 35.130000000000003 108.538 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 540' ' ' LYS . 63.6 tp -128.3 129.1 45.8 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 106.548 -1.649 . . . . 65.310000000000002 106.548 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 31.7 m -127.74 159.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 123.215 0.322 . . . . 73.120000000000005 110.14 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.439 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 93.0 mt -102.33 154.97 18.55 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.533 -0.914 . . . . 72.450000000000003 108.533 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.6 171.4 7.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.641 -0.874 . . . . 73.299999999999997 108.641 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.3 120.88 59.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 O-C-N 123.674 0.609 . . . . 74.340000000000003 110.656 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 52.2 Cg_endo -74.58 156.23 44.94 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.367 2.045 . . . . 70.400000000000006 111.932 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -121.25 144.9 48.36 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.572 -0.74 . . . . 54.240000000000002 109.455 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -104.59 121.33 43.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.674 -0.861 . . . . 64.230000000000004 108.674 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 597' ' ' ILE . . . . . 0.496 HD13 HG12 ' A' ' 536' ' ' ILE . 2.2 mp -106.27 91.1 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 122.663 1.22 . . . . 64.230000000000004 111.089 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -116.49 164.84 13.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.427 -1.715 . . . . 63.32 107.38 172.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -72.67 114.29 10.65 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.499 -0.926 . . . . 72.230000000000004 108.499 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 119.26 -11.77 11.43 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.74 -0.944 . . . . 73.209999999999994 110.74 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 92.3 mmm -80.18 122.15 26.47 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 108.464 -0.939 . . . . 72.109999999999999 108.464 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -107.59 110.06 21.86 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.536 0.684 . . . . 65.319999999999993 111.202 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 166.19 39.37 0.02 OUTLIER Glycine 0 C--N 1.298 -1.548 0 N-CA-C 110.223 -1.151 . . . . 64.219999999999999 110.223 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -126.06 63.29 0.59 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 111.33 -0.708 . . . . 52.210000000000001 111.33 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -122.67 25.67 8.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.43 -1.322 . . . . 70.010000000000005 107.43 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 67.2 m -74.1 129.57 38.09 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.501 -1.227 . . . . 72.150000000000006 108.483 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 51.2 mm -82.06 99.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 N-CA-C 108.708 -0.849 . . . . 54.130000000000003 108.708 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 7.5 t -94.66 -14.15 25.16 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.584 -0.735 . . . . 65.109999999999999 110.552 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.57 -26.34 66.24 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.686 0.755 . . . . 72.099999999999994 110.294 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -120.44 150.44 40.8 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 106.197 -1.779 . . . . 75.120000000000005 106.197 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -88.05 132.2 34.37 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.498 0.666 . . . . 75.439999999999998 111.271 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -135.95 134.23 38.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.408 -1.701 . . . . 63.350000000000001 106.408 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.91 -67.71 0.65 Allowed 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 120.494 -0.482 . . . . 74.409999999999997 110.506 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -160.67 103.93 1.37 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.379 -0.971 . . . . 72.439999999999998 108.379 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -142.79 116.64 6.3 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 116.5 -0.318 . . . . 53.030000000000001 110.469 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.79 150.48 39.3 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.217 1.944 . . . . 52.439999999999998 110.567 173.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.55 161.25 14.27 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.499 -0.773 . . . . 65.450000000000003 111.018 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 18.0 m -57.79 120.41 8.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.113 0.965 . . . . 74.450000000000003 108.864 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 20.2 m -119.71 167.61 11.88 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.317 -0.402 . . . . 64.120000000000005 110.886 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -105.86 163.28 12.86 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.323 -1.362 . . . . 72.340000000000003 107.323 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -92.18 85.41 5.45 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.616 -0.433 . . . . 74.219999999999999 110.162 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.71 177.02 6.14 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.195 -1.002 . . . . 74.430000000000007 109.553 173.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.43 160.69 14.17 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 122.319 -0.238 . . . . 60.530000000000001 111.057 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 62.03 24.75 14.77 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.193 0.933 . . . . 54.100000000000001 111.934 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.593 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 35.9 mtp-105 -61.83 -47.85 83.21 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.018 -0.364 . . . . 64.409999999999997 110.018 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 630' ' ' MET . 54.5 ttp180 -75.53 -34.79 60.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.917 -1.038 . . . . 73.150000000000006 110.14 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 98.6 mt -65.86 -35.76 75.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.775 -0.648 . . . . 74.239999999999995 110.509 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.55 73.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.111 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 42.7 mt-10 -73.57 -23.24 59.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.856 -0.611 . . . . 62.030000000000001 110.39 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 60.0 mtt -75.93 -28.06 57.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.547 -0.751 . . . . 62.350000000000001 109.037 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -92.03 42.31 2.76 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.043 -0.823 . . . . 60.119999999999997 111.043 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.523 ' NH1' ' HG2' ' A' ' 629' ' ' GLU . 96.6 mtt180 -135.16 163.28 52.17 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 105.646 -1.983 . . . . 63.329999999999998 105.646 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.53 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 45.1 Cg_exo -62.68 151.37 84.06 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 108.087 -1.543 . . . . 75.120000000000005 108.087 171.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 27.3 pt -130.73 -179.4 3.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-O 121.338 0.589 . . . . 71.310000000000002 111.175 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.85 172.7 8.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.537 -1.282 . . . . 64.319999999999993 107.537 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.44 -172.86 38.62 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 120.358 -0.925 . . . . 63.140000000000001 111.249 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 637' ' ' GLU . . . . . 0.459 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 43.3 tt0 -54.9 -62.36 1.71 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.162 0.585 . . . . 74.530000000000001 110.465 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 638' ' ' HIS . . . . . 0.459 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 37.1 m80 -135.14 106.11 6.62 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.972 -0.751 . . . . 74.219999999999999 108.972 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 9.0 t -119.41 108.81 15.01 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 122.18 0.99 . . . . 53.32 110.387 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 640' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 40.9 ttmt -147.91 142.33 26.37 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.686 -1.227 . . . . 71.400000000000006 107.686 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.424 HD22 HG13 ' A' ' 523' ' ' VAL . 62.1 tp -119.34 110.51 17.05 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.695 -0.854 . . . . 64.409999999999997 108.695 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.98 117.55 28.87 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.445 -0.946 . . . . 70.420000000000002 108.445 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.58 124.74 60.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 114.713 -1.131 . . . . 51.439999999999998 109.542 -175.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.38 123.48 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.598 0 N-CA-C 107.942 -1.133 . . . . 75.129999999999995 107.942 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.85 110.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.682 -0.69 . . . . 64.25 111.153 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 646' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 515' ' ' SER . 32.9 tt0 -149.54 154.13 38.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.922 -1.51 . . . . 73.239999999999995 106.922 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -73.06 89.48 1.46 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.787 0.803 . . . . 61.140000000000001 110.211 170.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 17.6 t -161.12 -177.37 6.03 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 105.847 -1.908 . . . . 62.32 105.847 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -145.17 169.29 18.47 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.398 -1.334 . . . . 73.439999999999998 107.398 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.59 125.18 46.13 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.704 -1.961 . . . . 65.230000000000004 105.704 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -74.19 109.96 8.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.12 -1.067 . . . . 73.109999999999999 108.12 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -118.83 168.54 10.67 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.208 -0.906 . . . . 73.400000000000006 111.441 -172.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 8.5 t -108.4 134.52 51.08 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.113 -1.81 . . . . 52.329999999999998 106.113 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 19.6 m -63.6 109.52 1.7 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.057 0.456 . . . . 63.109999999999999 110.753 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.42 170.55 19.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.959 -0.564 . . . . 65.409999999999997 109.667 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--N 1.309 -1.185 0 N-CA-C 109.686 -0.487 . . . . 70.219999999999999 109.686 -179.118 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.7 p80 . . . . . 0 CA--C 1.511 -0.527 0 CA-C-O 121.768 0.794 . . . . 71.439999999999998 109.674 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -67.33 -16.0 64.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.349 -1.296 . . . . 61.350000000000001 110.166 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . -133.81 119.72 2.35 Favored Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 109.951 -1.26 . . . . 54.329999999999998 109.951 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 83.6 mt -127.15 114.88 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.586 -1.265 . . . . 45.509999999999998 107.586 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -103.77 134.65 46.72 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 70.010000000000005 111.873 -175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.1 t -148.13 163.34 37.25 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.934 -0.575 . . . . 75.140000000000001 109.654 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.9 162.37 20.53 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-O 120.958 0.409 . . . . 63.219999999999999 110.678 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.0 -55.77 19.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.106 -0.952 . . . . 73.140000000000001 109.167 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.33 159.36 57.66 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.515 -0.766 . . . . 73.129999999999995 108.976 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.06 -18.16 6.4 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.221 1.281 . . . . 53.240000000000002 111.224 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 642' ' ' GLU . 79.4 t -142.0 130.38 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.247 0.619 . . . . 61.009999999999998 109.364 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.62 140.96 47.42 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.63 -0.878 . . . . 61.240000000000002 108.63 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -119.49 117.21 27.82 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.776 -0.824 . . . . 73.239999999999995 108.776 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.1 m -106.35 162.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.248 0.546 . . . . 61.219999999999999 112.472 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 16.3 m -74.38 138.22 43.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.9 -1.045 . . . . 73.510000000000005 110.052 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -58.71 -33.93 70.75 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.404 0.682 . . . . 72.430000000000007 110.916 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.5 m -110.22 25.42 11.8 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.594 0.59 . . . . 54.420000000000002 112.594 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.6 tt -71.27 -33.2 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.361 0.601 . . . . 64.209999999999994 112.276 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 574' ' ' ARG . . . 89.85 -75.16 1.81 Allowed Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.215 -0.993 . . . . 62.210000000000001 110.845 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.7 mm -120.25 123.27 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.918 -0.401 . . . . 72.510000000000005 109.918 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.495 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 21.5 ptm -94.03 130.05 40.3 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.437 -0.949 . . . . 73.310000000000002 108.437 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -106.56 113.45 26.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.577 0.751 . . . . 70.140000000000001 111.339 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 57.5 t -119.76 131.06 73.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.599 -0.519 . . . . 53.0 109.599 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -92.76 133.71 35.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.062 0.458 . . . . 74.299999999999997 110.366 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 97.6 t -90.3 114.02 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.952 -1.499 . . . . 65.299999999999997 106.952 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.41 151.01 24.32 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.131 -0.94 . . . . 52.539999999999999 109.584 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 530' ' ' GLY . 0.0 OUTLIER -122.46 104.4 9.36 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.167 -1.049 . . . . 75.129999999999995 108.167 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.8 m -63.82 -63.34 1.19 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.99 -1.004 . . . . 71.420000000000002 111.861 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 10.8 p -74.13 -33.68 63.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.641 0.734 . . . . 54.420000000000002 110.725 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' GLY . . . . . 0.559 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 140.36 -148.6 20.22 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 109.567 -1.413 . . . . 63.450000000000003 109.567 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -162.96 144.01 9.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 54.140000000000001 106.687 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -149.04 131.21 15.45 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.429 0.529 . . . . 73.129999999999995 112.429 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 99.06 -126.38 8.89 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 115.219 -0.901 . . . . 72.450000000000003 111.359 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.02 109.53 7.42 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.321 -1.363 . . . . 73.319999999999993 107.321 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.09 122.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 121.146 0.498 . . . . 71.310000000000002 110.715 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.77 117.77 32.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.127 -1.434 . . . . 63.109999999999999 107.127 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.2 t -108.18 101.1 40.23 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.151 -1.055 . . . . 74.519999999999996 108.151 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.23 139.26 6.98 Favored 'Trans proline' 0 N--CA 1.425 -2.558 0 C-N-CA 121.63 1.553 . . . . 71.400000000000006 111.983 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.509 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.4 p90 -119.6 159.49 24.28 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.963 -1.495 . . . . 75.150000000000006 106.963 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.495 ' HA ' ' SG ' ' A' ' 557' ' ' CYS . 62.3 pttt -146.33 140.66 26.58 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.004 -0.678 . . . . 74.150000000000006 110.963 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.1 p -85.94 132.77 34.01 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.64 -1.164 . . . . 63.030000000000001 110.593 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 39.3 mm -109.59 116.74 52.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.875 -1.157 . . . . 72.010000000000005 107.875 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -67.87 167.76 12.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.398 0.618 . . . . 71.299999999999997 111.047 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 156.99 116.44 0.51 Allowed Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 107.733 -2.147 . . . . 75.540000000000006 107.733 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.407 ' HB ' ' SG ' ' A' ' 585' ' ' CYS 0.295 7.9 p 66.85 -44.43 0.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.124 1.77 . . . . 43.219999999999999 112.437 -172.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.01 19.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.962 -1.496 . . . . 72.439999999999998 106.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.498 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 3.4 mpt_? -111.27 152.53 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.283 0.563 . . . . 71.129999999999995 110.511 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.77 170.47 32.17 Favored Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.323 -1.111 . . . . 62.310000000000002 110.323 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 106.77 23.84 6.95 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.267 -1.133 . . . . 72.430000000000007 110.267 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 63.61 36.36 93.24 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.96 -0.856 . . . . 62.200000000000003 110.96 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.448 ' HB3' ' OH ' ' A' ' 581' ' ' TYR . 6.1 mm-40 -93.02 -76.36 0.47 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.145 0.578 . . . . 63.240000000000002 111.506 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.61 -40.39 15.2 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.615 -1.254 . . . . 62.43 107.615 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.26 160.67 39.46 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.001 -1.454 . . . . 75.230000000000004 107.469 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.8 OUTLIER -88.71 104.94 17.35 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.084 -1.45 . . . . 75.109999999999999 107.084 177.281 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.19 98.91 0.84 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.149 . . . . 72.349999999999994 109.039 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.54 138.69 54.31 Favored 'General case' 0 N--CA 1.398 -3.033 0 CA-C-N 114.472 -1.24 . . . . 71.310000000000002 107.993 -171.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 557' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 540' ' ' LYS . 56.1 m -149.17 125.0 10.54 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.437 -0.209 . . . . 74.239999999999995 110.437 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 121.3 -133.21 9.45 Favored Glycine 0 C--O 1.211 -1.308 0 N-CA-C 111.222 -0.751 . . . . 75.230000000000004 111.222 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 60.44 -10.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 118.277 2.695 . . . . 74.230000000000004 118.277 171.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 569' ' ' LYS . 39.8 mt -99.41 135.22 41.14 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.523 -1.361 . . . . 70.219999999999999 112.93 -175.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.12 115.66 11.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.071 -1.085 . . . . 75.209999999999994 108.071 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.99 145.87 29.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.388 -0.967 . . . . 63.049999999999997 108.388 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.477 ' H ' HD11 ' A' ' 567' ' ' ILE . 1.9 mp0 -103.63 -94.55 0.32 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.73 -1.581 . . . . 74.150000000000006 106.73 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -105.22 176.09 5.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.866 -0.606 . . . . 74.349999999999994 111.875 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.09 -25.53 22.33 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.636 1.574 . . . . 73.420000000000002 112.436 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.08 -20.56 54.53 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.001 0.92 . . . . 74.219999999999999 113.153 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.477 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.8 pt -119.64 157.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 119.497 -0.881 . . . . 63.450000000000003 110.617 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.93 148.4 32.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 106.707 -1.59 . . . . 70.439999999999998 106.707 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.6 mmpt? -113.02 164.56 13.31 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.519 -0.472 . . . . 52.439999999999998 112.027 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.11 134.41 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.173 -0.921 . . . . 64.400000000000006 110.426 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.509 HG23 ' CZ ' ' A' ' 539' ' ' TYR . 70.2 mt -90.67 125.64 43.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.531 -1.285 . . . . 71.430000000000007 107.531 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -111.86 112.65 24.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.511 0.672 . . . . 60.509999999999998 110.588 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.495 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 62.2 mt -118.83 130.06 74.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.635 -0.876 . . . . 74.299999999999997 108.635 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 84.0 mtp180 -83.69 132.82 34.84 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.726 0.641 . . . . 73.129999999999995 110.142 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.73 130.18 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.922 -1.14 . . . . 74.109999999999999 107.922 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -116.09 115.01 25.31 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.466 0.543 . . . . 72.340000000000003 112.466 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -117.67 123.61 46.53 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.11 -0.7 . . . . 71.519999999999996 109.11 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -128.31 -72.85 0.6 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.823 -0.806 . . . . 75.530000000000001 108.823 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -102.98 -165.69 1.2 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.28 -1.007 . . . . 62.329999999999998 108.28 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.17 -68.05 0.36 Allowed 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.649 -1.241 . . . . 74.409999999999997 107.649 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.448 ' OH ' ' HB3' ' A' ' 551' ' ' GLU . 17.4 t80 61.43 17.68 8.63 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 113.957 1.095 . . . . 75.209999999999994 113.957 166.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.9 81.04 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.789 0.663 . . . . 60.310000000000002 112.789 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -98.09 85.57 3.51 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.863 0.84 . . . . 71.319999999999993 109.313 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -156.28 27.31 0.35 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 104.224 -2.51 . . . . 73.25 104.224 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 545' ' ' THR . 75.0 m -102.93 141.52 35.58 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 112.956 -1.929 . . . . 75.430000000000007 112.002 -170.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 644' ' ' ILE . 61.1 p -130.65 120.76 24.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.751 -0.659 . . . . 61.539999999999999 109.797 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -108.13 168.86 8.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.62 -1.252 . . . . 74.310000000000002 107.62 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 3.6 m -121.28 162.89 19.47 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.243 -0.983 . . . . 51.43 109.887 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.495 HD21 HD13 ' A' ' 571' ' ' ILE . 65.9 tp -136.54 125.94 25.02 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.808 -1.553 . . . . 52.140000000000001 106.808 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 590' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' A' ' 640' ' ' LYS . 26.8 m -124.52 159.62 30.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.786 -0.45 . . . . 63.240000000000002 109.786 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.61 135.46 43.09 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.265 -1.013 . . . . 53.009999999999998 108.265 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.97 171.63 8.15 Favored 'General case' 0 C--N 1.271 -2.822 0 CA-C-N 115.69 -0.686 . . . . 71.340000000000003 109.476 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.43 121.2 46.29 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 113.49 0.922 . . . . 75.400000000000006 113.49 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.476 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 28.7 Cg_endo -77.06 144.51 23.84 Favored 'Trans proline' 0 N--CA 1.415 -3.094 0 C-N-CA 121.428 1.419 . . . . 73.25 111.191 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.41 ' HB3' ' NZ ' ' A' ' 595' ' ' LYS . 0.1 OUTLIER -118.72 132.37 56.15 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.114 -0.948 . . . . 73.329999999999998 110.062 -176.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -98.27 119.69 37.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.63 -0.714 . . . . 73.109999999999999 109.262 -175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.15 92.07 3.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.997 -1.482 . . . . 54.350000000000001 106.997 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -124.18 154.75 39.62 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.878 -1.056 . . . . 71.019999999999996 109.842 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -74.32 117.46 16.16 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.514 -0.55 . . . . 62.039999999999999 109.514 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 147.59 -41.46 0.93 Allowed Glycine 0 C--N 1.307 -1.066 0 N-CA-C 109.905 -1.278 . . . . 64.120000000000005 109.905 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 24.4 ttt -82.89 65.63 8.11 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.553 0.692 . . . . 73.420000000000002 109.497 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -165.46 -57.88 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.267 -0.879 . . . . 63.299999999999997 109.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 80.52 -66.12 3.75 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.526 -0.629 . . . . 43.009999999999998 111.526 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.41 31.57 0.02 OUTLIER Glycine 0 C--N 1.296 -1.64 0 N-CA-C 109.036 -1.625 . . . . 74.239999999999995 109.036 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -164.84 -175.5 3.8 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.497 -1.297 . . . . 65.200000000000003 107.497 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 50.9 m -98.46 122.9 42.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.936 -0.764 . . . . 70.5 108.936 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.42 103.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 108.26 -1.015 . . . . 73.409999999999997 108.26 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 19.1 m -92.55 -10.29 38.17 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.853 0.835 . . . . 72.120000000000005 108.901 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.85 81.83 3.43 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.01 0.909 . . . . 64.430000000000007 109.662 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -145.97 131.08 18.35 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 113.999 -1.455 . . . . 74.349999999999994 107.762 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 611' ' ' TYR . . . . . 0.506 ' CE2' ' HB2' ' A' ' 613' ' ' ASP . 27.6 t80 -69.16 138.75 54.41 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.41 -1.33 . . . . 75.319999999999993 107.41 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -60.77 -37.18 81.0 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 120.662 -0.415 . . . . 75.099999999999994 111.137 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 613' ' ' ASP . . . . . 0.506 ' HB2' ' CE2' ' A' ' 611' ' ' TYR . 23.2 m-20 -81.57 145.0 30.87 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.844 -0.799 . . . . 60.43 108.844 174.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -55.68 -45.08 77.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 123.598 0.561 . . . . 72.120000000000005 111.958 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -153.42 162.63 26.07 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 104.754 -2.313 . . . . 73.310000000000002 104.754 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.36 132.92 23.32 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.009 1.139 . . . . 61.149999999999999 109.583 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.11 -53.89 3.13 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.492 -0.929 . . . . 51.420000000000002 108.492 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 2.9 m -102.35 92.06 4.54 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.73 -1.211 . . . . 74.239999999999995 107.73 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 47.4 m -86.6 130.99 34.28 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.963 0.411 . . . . 72.140000000000001 111.296 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -114.08 -27.67 7.6 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.951 -0.759 . . . . 75.319999999999993 108.951 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -94.95 150.84 19.73 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.193 -1.04 . . . . 72.239999999999995 108.193 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.88 131.88 41.06 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.768 -0.827 . . . . 72.150000000000006 108.768 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -126.02 154.19 43.31 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.207 -0.597 . . . . 65.400000000000006 110.443 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 624' ' ' GLU . 0.1 OUTLIER -111.36 19.16 18.53 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 124.142 0.977 . . . . 72.109999999999999 109.032 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -52.41 -37.05 55.66 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 114.229 -1.35 . . . . 54.109999999999999 112.317 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.628 ' O ' ' HG3' ' A' ' 630' ' ' MET . 40.2 mmt180 -57.22 -42.04 80.61 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 122.231 0.212 . . . . 75.519999999999996 111.142 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.477 ' HA ' ' SD ' ' A' ' 630' ' ' MET . 64.9 mt -68.65 -33.17 58.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.241 0.543 . . . . 74.310000000000002 109.836 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -72.59 -37.53 68.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.819 -0.628 . . . . 74.099999999999994 109.526 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 632' ' ' ARG . 45.2 mt-10 -71.09 -23.29 62.09 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 115.982 -0.553 . . . . 44.240000000000002 111.02 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 64.5 mtt -64.76 -8.85 16.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.216 0.606 . . . . 75.439999999999998 111.849 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -101.95 -4.75 51.14 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 121.014 -0.612 . . . . 70.109999999999999 112.132 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 29.5 ptt180 -122.16 165.42 20.79 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 108.964 -0.754 . . . . 55.130000000000003 108.964 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 19.3 Cg_endo -61.55 137.08 67.05 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.777 1.651 . . . . 72.329999999999998 109.797 170.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER -136.2 -177.38 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 -178.231 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -94.19 171.25 8.95 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.163 -0.68 . . . . 73.5 109.163 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -74.34 179.02 43.61 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.029 -0.605 . . . . 70.439999999999998 111.803 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 637' ' ' GLU . . . . . 0.417 ' HG2' ' ND1' ' A' ' 638' ' ' HIS . 34.1 tt0 -46.97 -68.79 0.16 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.399 . . . . 71.030000000000001 111.238 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 638' ' ' HIS . . . . . 0.417 ' ND1' ' HG2' ' A' ' 637' ' ' GLU . 39.7 m80 -134.31 94.04 3.16 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.461 -0.94 . . . . 74.299999999999997 108.461 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 10.2 t -113.18 108.41 17.24 Favored 'General case' 0 N--CA 1.408 -2.567 0 C-N-CA 119.496 -0.882 . . . . 32.32 109.725 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' LYS . . . . . 0.404 ' HG3' HG12 ' A' ' 590' ' ' VAL . 39.7 ttpt -147.96 135.96 21.15 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.869 -1.53 . . . . 61.520000000000003 106.869 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.1 tp -113.44 116.27 29.35 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 108.58 -0.896 . . . . 75.329999999999998 108.58 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 511' ' ' VAL . 39.7 mt-10 -93.84 126.55 39.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.248 -1.019 . . . . 75.200000000000003 108.248 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.55 122.76 67.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.786 -0.643 . . . . 60.299999999999997 109.471 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 586' ' ' SER . 3.9 mp -108.95 130.14 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 115.483 -0.78 . . . . 73.450000000000003 109.42 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.17 99.67 7.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.313 0.578 . . . . 65.349999999999994 111.794 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -173.84 168.27 4.3 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.63 -1.619 . . . . 71.420000000000002 106.63 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.21 -35.92 19.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.469 0.544 . . . . 71.010000000000005 112.469 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 15.6 m -94.29 87.61 5.28 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.468 0.652 . . . . 73.25 112.521 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -99.98 122.67 43.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.057 -1.46 . . . . 74.439999999999998 107.057 173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -101.2 100.65 11.22 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 120.339 -0.544 . . . . 52.340000000000003 110.912 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -83.22 78.84 9.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.266 -1.383 . . . . 73.329999999999998 107.266 175.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.13 112.27 1.64 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.601 -1.636 . . . . 72.510000000000005 109.703 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 38.6 m -111.71 114.12 26.93 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.052 -0.976 . . . . 70.549999999999997 110.69 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 12.4 t -151.94 176.23 11.68 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.283 -1.747 . . . . 62.509999999999998 106.283 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 57.7 t -102.96 94.32 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 117.981 0.355 . . . . 74.409999999999997 110.054 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.485 1.283 0 C-N-CA 123.844 0.858 . . . . 74.010000000000005 112.915 176.941 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 48.4 t60 . . . . . 0 C--O 1.238 0.475 0 CA-C-O 120.969 0.414 . . . . 62.439999999999998 110.116 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -145.96 163.54 34.87 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.572 -1.64 . . . . 73.040000000000006 106.572 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -90.24 104.29 3.12 Favored Glycine 0 C--O 1.215 -1.054 0 C-N-CA 120.772 -0.728 . . . . 61.140000000000001 112.16 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 86.5 mt -92.95 114.83 30.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 123.68 0.792 . . . . 55.25 108.912 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.63 144.76 41.58 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.102 -0.333 . . . . 73.349999999999994 110.102 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -149.78 159.45 44.34 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 116.435 -0.348 . . . . 63.149999999999999 110.238 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 85.8 m-85 -73.01 154.19 40.6 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 109.796 -0.446 . . . . 70.329999999999998 109.796 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.01 -57.24 12.94 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 124.06 0.85 . . . . 73.219999999999999 109.733 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -120.11 163.29 29.02 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.058 -0.974 . . . . 34.109999999999999 109.596 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -22.84 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 110.83 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 642' ' ' GLU . 76.2 t -142.1 134.15 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.149 -1.056 . . . . 71.340000000000003 108.149 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.5 t -134.14 126.58 30.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.121 0.486 . . . . 63.329999999999998 109.922 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 649' ' ' TYR . 6.8 p-80 -98.65 120.69 39.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.466 -1.309 . . . . 75.019999999999996 107.466 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.01 154.44 18.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 116.201 -0.454 . . . . 44.109999999999999 109.963 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.488 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 45.8 m -60.0 154.27 19.43 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 124.246 0.966 . . . . 65.109999999999999 111.424 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.98 -33.3 57.62 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.942 -1.133 . . . . 63.409999999999997 107.942 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.6 m -98.89 28.82 4.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.16 -0.927 . . . . 73.420000000000002 110.232 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -76.94 -34.85 22.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 112.983 0.734 . . . . 74.150000000000006 112.983 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.32 -70.93 3.06 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.204 -0.998 . . . . 55.43 111.867 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.3 mm -130.96 131.57 64.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.776 -0.824 . . . . 74.109999999999999 108.776 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 16.9 ptm -106.29 127.28 53.13 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.601 -0.727 . . . . 71.239999999999995 109.152 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -88.81 114.46 25.45 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.262 0.351 . . . . 71.349999999999994 110.842 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 40.1 t -108.03 114.51 46.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.29 -0.633 . . . . 74.150000000000006 109.29 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -89.13 130.58 35.54 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.528 -0.545 . . . . 73.439999999999998 109.528 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.8 110.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.004 -1.48 . . . . 74.329999999999998 107.004 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.3 151.91 23.2 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.069 -0.969 . . . . 65.0 109.897 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.543 ' HD3' ' H ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -115.66 107.93 15.74 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.588 -0.893 . . . . 54.520000000000003 108.588 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.6 m -65.28 -58.68 5.32 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.395 -0.82 . . . . 54.420000000000002 109.967 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.4 p -74.59 -51.25 15.07 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.665 -0.698 . . . . 71.219999999999999 111.068 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.44 -166.31 26.87 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.347 -1.101 . . . . 71.439999999999998 110.347 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -146.77 134.44 21.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -153.32 99.4 2.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.423 -0.584 . . . . 63.43 109.423 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 127.01 -125.46 5.34 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 110.422 -1.071 . . . . 63.5 110.422 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -138.01 109.32 6.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.592 -0.521 . . . . 73.340000000000003 109.592 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 34.5 t -124.86 128.65 73.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.745 -0.835 . . . . 64.239999999999995 108.745 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.538 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.0 mm -105.34 126.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.379 -0.601 . . . . 74.099999999999994 109.379 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.42 109.76 60.11 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.791 -0.641 . . . . 45.450000000000003 109.956 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.48 146.03 13.51 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.883 1.722 . . . . 74.209999999999994 111.428 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -137.05 157.46 46.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.363 -0.977 . . . . 71.049999999999997 108.363 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -149.9 139.86 21.94 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.099 0.476 . . . . 72.030000000000001 111.235 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -84.65 124.77 31.84 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.197 -0.91 . . . . 50.450000000000003 111.977 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.6 mm -97.29 115.84 38.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.993 -1.484 . . . . 70.129999999999995 106.993 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.34 163.17 25.09 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.836 -0.431 . . . . 41.520000000000003 109.836 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -156.4 -116.67 0.53 Allowed Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 109.426 -1.47 . . . . 71.140000000000001 109.426 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.6 m -70.26 -27.06 64.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.239 -1.023 . . . . 74.239999999999995 108.239 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.18 131.42 38.26 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.782 -1.099 . . . . 64.219999999999999 108.292 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 132.84 43.49 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.424 -1.695 . . . . 74.310000000000002 106.424 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.0 29.1 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.849 -0.691 . . . . 52.399999999999999 111.995 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.28 63.51 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 114.518 0.567 . . . . 70.540000000000006 114.518 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.48 9.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 119.558 -1.306 . . . . 53.030000000000001 113.691 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.86 -79.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.357 0.578 . . . . 62.399999999999999 112.357 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.05 -41.49 12.29 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.048 -1.093 . . . . 54.240000000000002 108.048 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -143.17 163.76 32.01 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.508 -1.224 . . . . 74.349999999999994 107.962 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.587 ' HG3' ' NH2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -90.5 146.08 24.4 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.399 -1.334 . . . . 63.0 107.399 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.83 122.19 29.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.885 -0.413 . . . . 65.219999999999999 109.885 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -128.35 105.18 8.16 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.819 0.818 . . . . 74.019999999999996 109.73 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.55 131.58 51.53 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.227 -1.768 . . . . 44.310000000000002 106.227 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.26 -167.28 34.21 Favored Glycine 0 N--CA 1.432 -1.599 0 C-N-CA 119.169 -1.491 . . . . 64.319999999999993 113.249 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.3 mt-10 -113.83 122.72 47.9 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.811 0.844 . . . . 74.319999999999993 110.774 -176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.63 140.79 29.38 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.88 -0.785 . . . . 51.409999999999997 108.88 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.25 113.35 26.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.49 -0.323 . . . . 72.140000000000001 110.719 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 54.5 m-85 -115.88 115.83 26.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 110.061 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.454 ' H ' HD11 ' A' ' 567' ' ' ILE . 24.9 mp0 -90.08 -84.57 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.141 0.972 . . . . 72.409999999999997 110.507 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.4 ' O ' HG12 ' A' ' 567' ' ' ILE . 28.5 t-20 -105.11 157.8 17.01 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.31 -1.314 . . . . 64.340000000000003 111.216 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.84 -26.3 58.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.543 2.053 . . . . 64.219999999999999 116.543 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.25 7.24 9.85 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.034 1.124 . . . . 73.049999999999997 114.034 -174.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.454 HD11 ' H ' ' A' ' 563' ' ' GLN . 35.6 pt -119.36 161.93 18.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.396 -0.594 . . . . 62.229999999999997 109.396 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.92 154.57 34.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.128 -1.064 . . . . 71.420000000000002 108.128 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -113.97 147.09 39.18 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.988 0.423 . . . . 72.219999999999999 111.204 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -125.26 130.92 72.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.501 -1.227 . . . . 65.129999999999995 109.279 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 40.5 mt -91.99 126.39 44.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.477 -1.675 . . . . 70.150000000000006 106.477 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.1 p -108.52 112.25 24.53 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.461 -0.57 . . . . 63.439999999999998 109.461 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.52 HD11 HD22 ' A' ' 589' ' ' LEU . 52.2 mt -105.19 123.93 59.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 109.02 -0.733 . . . . 73.140000000000001 109.02 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.587 ' NH2' ' HG3' ' A' ' 554' ' ' GLU . 74.6 mtm180 -80.68 108.77 14.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 123.821 0.701 . . . . 73.099999999999994 111.201 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.1 mm -95.26 135.54 29.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.058 -1.83 . . . . 73.510000000000005 106.058 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -112.19 161.97 15.97 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.131 -0.627 . . . . 72.200000000000003 110.437 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 577' ' ' ASP . . . . . 0.459 ' HA ' ' HG2' ' A' ' 580' ' ' GLU . 8.2 p-10 -141.86 88.89 2.15 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.666 1.222 . . . . 72.030000000000001 109.117 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.448 ' HA ' ' NE ' ' A' ' 578' ' ' ARG . 3.0 mmp_? -118.61 -50.49 2.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.473 -1.24 . . . . 65.299999999999997 108.734 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -111.8 -25.98 9.19 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.281 -0.872 . . . . 71.219999999999999 109.972 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.604 ' HB3' ' HD2' ' A' ' 583' ' ' LYS . 1.5 pm0 -77.85 97.74 5.36 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.195 1.183 . . . . 63.340000000000003 114.195 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -136.56 7.38 3.04 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.878 -1.51 . . . . 70.5 108.058 172.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -144.39 15.8 1.66 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.565 -1.198 . . . . 72.450000000000003 110.332 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.604 ' HD2' ' HB3' ' A' ' 580' ' ' GLU . 89.5 mttt -92.76 167.75 11.66 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 118.992 -1.083 . . . . 75.349999999999994 113.769 -173.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -150.05 21.66 0.87 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.584 -1.189 . . . . 65.219999999999999 108.227 174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 10.0 p -61.22 140.69 57.89 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.757 -1.111 . . . . 72.340000000000003 110.944 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 28.4 p -123.78 155.62 37.6 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 119.861 -0.735 . . . . 62.539999999999999 111.998 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -139.12 -177.98 5.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.772 -1.195 . . . . 73.129999999999995 107.772 173.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 588' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 26.3 m -135.06 156.58 48.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.653 -0.655 . . . . 72.049999999999997 109.946 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 573' ' ' ILE . 42.8 tp -130.83 130.8 44.08 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.06 -1.459 . . . . 51.149999999999999 107.06 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.02 151.48 33.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 120.964 -0.294 . . . . 74.010000000000005 110.903 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 96.3 mt -95.57 140.01 31.01 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.26 -1.015 . . . . 61.450000000000003 108.26 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -100.41 159.42 15.16 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.357 -0.838 . . . . 62.43 109.05 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 120.84 19.22 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 124.122 0.888 . . . . 74.439999999999998 110.461 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.63 148.13 41.49 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.521 2.814 . . . . 74.340000000000003 112.643 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.538 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 18.2 ptpt -102.42 133.29 47.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.867 -1.16 . . . . 74.140000000000001 107.867 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -105.36 117.6 34.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.28 -0.637 . . . . 72.230000000000004 109.28 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 597' ' ' ILE . . . . . 0.435 HD13 HG12 ' A' ' 536' ' ' ILE . 2.3 mp -93.28 96.82 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 107.677 -1.231 . . . . 74.239999999999995 107.677 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -129.26 84.72 2.25 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.943 -1.026 . . . . 75.209999999999994 110.423 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -121.97 -43.01 2.36 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.779 -1.193 . . . . 75.540000000000006 107.779 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 108.54 133.64 6.99 Favored Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 107.357 -2.297 . . . . 34.439999999999998 107.357 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 52.0 ttp -73.81 101.56 3.77 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 117.947 0.874 . . . . 73.420000000000002 110.013 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -85.57 173.1 10.42 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.104 -0.953 . . . . 70.25 110.663 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -76.41 64.15 2.9 Favored Glycine 0 C--O 1.237 0.291 0 CA-C-N 116.437 -0.347 . . . . 45.109999999999999 113.767 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 179.84 167.11 36.5 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 110.032 -1.227 . . . . 63.329999999999998 110.032 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -97.31 -40.25 8.83 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.29 -1.004 . . . . 64.209999999999994 108.29 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 12.7 m -117.25 107.27 14.22 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 106.989 -1.486 . . . . 62.340000000000003 106.989 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 43.5 mm -87.79 -30.69 5.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.858 -0.423 . . . . 73.230000000000004 109.858 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 608' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 608' ' ' THR . 33.6 m 63.18 34.81 13.19 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.748 1.261 . . . . 53.509999999999998 109.645 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -89.71 -25.25 21.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 121.541 -0.724 . . . . 71.129999999999995 110.42 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -100.32 124.93 46.41 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 108.666 -0.864 . . . . 72.120000000000005 108.666 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -95.18 -33.68 12.53 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.469 -0.787 . . . . 74.450000000000003 111.378 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -131.52 158.16 41.64 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.046 0.387 . . . . 74.150000000000006 112.046 -169.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -78.51 139.19 38.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.739 -0.664 . . . . 64.519999999999996 110.665 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 614' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 614' ' ' LYS . 10.9 mmpt? -86.72 92.84 9.08 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.092 0.472 . . . . 75.140000000000001 109.839 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -83.2 130.57 56.41 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 108.67 -0.863 . . . . 63.039999999999999 108.67 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.54 148.4 87.5 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 121.923 1.749 . . . . 74.030000000000001 110.986 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 30.9 mt -103.63 137.76 41.23 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.547 -1.206 . . . . 52.450000000000003 110.812 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 20.8 p -90.95 17.21 8.16 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.237 1.018 . . . . 62.350000000000001 109.635 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.0 m -75.75 105.49 6.82 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 114.25 -1.341 . . . . 54.100000000000001 108.89 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -92.83 116.26 28.87 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.454 -0.898 . . . . 74.099999999999994 109.193 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.3 156.42 35.61 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.778 -0.823 . . . . 75.120000000000005 108.778 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -80.27 61.26 4.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.467 1.127 . . . . 61.43 111.059 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -153.03 169.0 23.99 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 126.721 2.008 . . . . 63.310000000000002 106.031 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -62.33 146.18 51.82 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 123.438 0.461 . . . . 74.230000000000004 110.577 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -58.88 -39.93 82.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.082 -0.508 . . . . 64.200000000000003 111.272 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 630' ' ' MET . 61.7 ttt180 -67.53 -39.32 85.04 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-N 116.124 -0.489 . . . . 64.319999999999993 110.953 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 630' ' ' MET . 84.2 mt -72.08 -33.66 47.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.381 0.61 . . . . 64.299999999999997 110.389 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -70.16 -51.34 32.05 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.458 -0.497 . . . . 61.200000000000003 110.326 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 632' ' ' ARG . 38.8 mt-10 -82.8 -2.25 53.99 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 113.668 0.988 . . . . 72.519999999999996 113.668 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.474 ' HB3' ' O ' ' A' ' 626' ' ' ARG . 17.2 ptm -62.11 -15.98 49.26 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.834 -0.541 . . . . 71.510000000000005 110.594 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -85.97 -3.93 84.98 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.579 -0.737 . . . . 52.310000000000002 112.585 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 629' ' ' GLU . 11.8 ptm180 -116.28 159.32 40.24 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 106.599 -1.63 . . . . 62.520000000000003 106.599 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.31 126.78 16.91 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.477 1.451 . . . . 72.420000000000002 110.521 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.21 -177.72 2.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.012 0.434 . . . . 74.099999999999994 111.143 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 26.9 mt -109.63 -158.32 0.64 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.272 -0.877 . . . . 64.439999999999998 109.616 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.36 -164.4 13.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.14 -0.552 . . . . 62.130000000000003 112.465 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -59.75 -73.36 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.489 0.716 . . . . 71.329999999999998 109.568 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -131.24 127.35 37.66 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 106.559 -1.645 . . . . 72.140000000000001 106.559 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 2.6 t -137.94 109.13 6.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 123.139 1.447 . . . . 63.530000000000001 110.664 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -147.18 140.38 25.3 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.564 -1.653 . . . . 71.409999999999997 106.575 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.83 106.92 13.99 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.605 -0.887 . . . . 74.439999999999998 108.605 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.475 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.0 mt-10 -86.4 124.46 32.77 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.92 -1.141 . . . . 44.399999999999999 107.92 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.27 123.73 69.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.737 -0.665 . . . . 74.540000000000006 109.653 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.11 122.9 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 108.474 -0.936 . . . . 72.430000000000007 108.474 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.4 106.65 20.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.245 0.545 . . . . 71.230000000000004 111.651 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -152.67 139.92 19.43 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.544 -1.65 . . . . 65.219999999999999 106.544 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -82.35 65.57 7.54 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.95 0.881 . . . . 72.329999999999998 109.409 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 48.9 m -160.07 94.0 1.09 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.838 -1.073 . . . . 41.219999999999999 109.551 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.403 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 14.7 p90 -91.09 157.63 17.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.165 -1.05 . . . . 74.109999999999999 108.165 174.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -94.25 129.06 41.04 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.815 -0.754 . . . . 70.340000000000003 111.51 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -137.9 80.51 1.81 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.334 -1.728 . . . . 73.329999999999998 106.334 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 652' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 652' ' ' LYS . 1.3 tpmt? -92.79 -38.34 11.83 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.49 -1.232 . . . . 73.109999999999999 109.93 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 19.8 m -123.32 140.61 52.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.124 0.488 . . . . 51.350000000000001 111.121 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 24.2 m -101.4 129.12 47.36 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.534 -1.284 . . . . 74.430000000000007 107.534 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.4 133.66 29.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.745 -0.465 . . . . 72.099999999999994 109.745 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 109.445 -0.576 . . . . 64.310000000000002 109.445 178.805 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 121.183 0.516 . . . . 74.409999999999997 110.619 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -75.53 102.97 5.45 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.51 -0.768 . . . . 61.32 110.776 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . -79.23 95.3 1.41 Allowed Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 115.329 -0.851 . . . . 32.32 111.304 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 62.5 mt -113.84 114.56 47.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 107.274 -1.38 . . . . 75.219999999999999 107.274 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.06 137.94 47.12 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.236 0.335 . . . . 74.239999999999995 111.056 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.5 t -148.91 165.9 30.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.955 -0.387 . . . . 52.149999999999999 109.955 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.577 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 75.6 m-85 -79.16 157.76 27.84 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.339 0.656 . . . . 72.439999999999998 110.337 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.13 -50.58 71.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.72 0.772 . . . . 63.43 109.534 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.81 151.32 72.19 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 114.891 -1.049 . . . . 75.219999999999999 108.56 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.94 -22.37 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.115 1.877 . . . . 60.200000000000003 112.559 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.81 131.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.962 -0.385 . . . . 74.209999999999994 109.962 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.8 t -133.68 141.03 47.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.088 0.471 . . . . 63.520000000000003 109.84 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.45 ' CD2' ' HA ' ' A' ' 648' ' ' SER . 77.0 m80 -112.99 119.74 38.96 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.346 -0.983 . . . . 43.420000000000002 108.346 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.67 155.52 19.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.365 0.603 . . . . 72.129999999999995 111.032 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 518' ' ' ILE . 68.7 m -83.1 157.2 22.92 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.513 -0.767 . . . . 73.140000000000001 110.305 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.729 0.776 . . . . 73.129999999999995 111.366 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.5 p -89.84 24.42 2.39 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.213 -0.903 . . . . 71.420000000000002 112.156 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 515' ' ' SER . 5.8 tt -86.46 -25.49 6.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.297 0.57 . . . . 65.239999999999995 110.512 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.25 -71.82 2.86 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.614 -0.803 . . . . 31.309999999999999 111.961 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.2 mm -131.2 138.33 53.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.239 -1.763 . . . . 60.020000000000003 106.239 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.406 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.4 ppp? -112.21 147.85 35.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.176 -0.676 . . . . 70.430000000000007 109.176 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -113.03 130.37 56.17 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.832 0.707 . . . . 64.129999999999995 111.201 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 39.5 t -125.11 124.21 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 107.973 -1.121 . . . . 55.43 107.973 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 570' ' ' ILE . 59.6 mttm -91.05 131.19 36.79 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.994 -1.082 . . . . 61.439999999999998 109.383 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 89.3 t -91.34 109.67 21.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 106.948 -1.501 . . . . 64.25 106.948 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.1 mt -87.12 143.29 27.37 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.742 -1.117 . . . . 74.209999999999994 110.167 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.88 113.54 26.54 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.972 -1.013 . . . . 62.119999999999997 108.672 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 41.0 p -66.54 -63.64 1.03 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.023 -0.671 . . . . 73.430000000000007 111.592 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 51.0 m -74.46 -52.55 11.68 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.041 0.448 . . . . 43.130000000000003 111.513 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' GLY . . . . . 0.565 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 160.21 -143.85 9.45 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.607 -0.806 . . . . 52.43 111.735 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.64 161.18 18.12 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 106.248 -1.76 . . . . 72.219999999999999 106.248 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -157.19 126.52 6.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.463 0.574 . . . . 62.100000000000001 110.527 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.34 -118.7 5.61 Favored Glycine 0 CA--C 1.494 -1.28 0 C-N-CA 120.723 -0.751 . . . . 43.219999999999999 111.857 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -138.51 111.99 8.16 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.284 -1.006 . . . . 73.329999999999998 108.284 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.6 t -122.34 130.26 74.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.877 -0.515 . . . . 73.519999999999996 110.686 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.37 118.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.497 -0.927 . . . . 74.230000000000004 108.497 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.1 106.63 58.84 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.888 -0.782 . . . . 71.239999999999995 108.888 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -83.98 159.61 13.71 Favored 'Trans proline' 0 N--CA 1.42 -2.798 0 C-N-CA 121.838 1.692 . . . . 62.399999999999999 111.027 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.36 163.34 39.15 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.915 -1.883 . . . . 72.420000000000002 105.915 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -150.81 129.07 11.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.248 -0.581 . . . . 62.43 110.863 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.3 p -78.01 117.38 19.28 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 115.464 -0.789 . . . . 74.230000000000004 110.293 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.5 mm -88.4 120.45 37.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.216 -1.402 . . . . 72.329999999999998 107.216 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.56 113.63 13.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.684 -0.487 . . . . 74.120000000000005 109.684 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -94.18 -108.69 2.07 Favored Glycine 0 CA--C 1.496 -1.128 0 N-CA-C 110.423 -1.071 . . . . 34.32 110.423 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 42.4 p -86.26 -24.22 26.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.591 -0.892 . . . . 74.109999999999999 108.591 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 585' ' ' CYS . . . -88.09 145.41 25.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.22 -0.9 . . . . 74.400000000000006 109.363 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 36.6 mmm-85 -95.02 138.24 33.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.747 0.784 . . . . 64.310000000000002 112.685 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -110.58 129.48 9.32 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 114.182 -1.372 . . . . 74.230000000000004 110.978 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 141.49 -17.82 2.65 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.581 -1.008 . . . . 62.43 110.581 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 155.51 -16.64 0.49 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.858 -1.163 . . . . 73.530000000000001 113.445 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 2.2 mp0 -69.67 -81.79 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.459 0.63 . . . . 64.030000000000001 111.462 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -86.37 -53.7 4.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.981 0.896 . . . . 73.349999999999994 108.617 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -131.2 160.84 33.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.273 -0.876 . . . . 60.5 110.445 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.534 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 27.2 tt0 -96.26 119.06 34.06 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.788 -1.93 . . . . 74.120000000000005 105.788 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.79 143.4 54.63 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.31 0.576 . . . . 74.450000000000003 111.501 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 4.9 t -140.72 136.53 32.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.833 -0.621 . . . . 71.540000000000006 110.076 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.1 p -143.46 110.41 5.64 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.23 0.538 . . . . 64.140000000000001 112.2 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 79.22 105.78 0.23 Allowed Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.535 -0.757 . . . . 74.510000000000005 113.122 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.42 14.54 0.31 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.65 -0.87 . . . . 70.019999999999996 108.65 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 569' ' ' LYS . 46.2 mt -117.45 135.89 53.58 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.289 -0.882 . . . . 71.030000000000001 112.198 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.452 ' H ' ' HD2' ' A' ' 569' ' ' LYS . 36.0 tt0 -134.91 109.69 8.65 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.588 -1.264 . . . . 74.319999999999993 107.588 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 48.8 m-85 -102.37 115.28 30.25 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.822 -0.807 . . . . 63.439999999999998 108.822 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.481 ' H ' HD11 ' A' ' 567' ' ' ILE . 44.6 mt-30 -90.15 -79.64 0.34 Allowed 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.798 -0.637 . . . . 74.040000000000006 109.898 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -104.33 167.1 9.96 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.005 -0.739 . . . . 63.299999999999997 109.005 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -69.34 -20.13 63.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.479 0.712 . . . . 62.439999999999998 112.33 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.2 -10.26 59.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.143 1.164 . . . . 72.219999999999999 114.143 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.481 HD11 ' H ' ' A' ' 563' ' ' GLN . 40.0 pt -113.44 166.46 7.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.223 -0.591 . . . . 64.540000000000006 110.892 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.86 148.23 29.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.863 -1.532 . . . . 71.129999999999995 106.863 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.463 ' HB3' HD22 ' A' ' 560' ' ' LEU . 20.8 mttm -116.48 155.67 28.19 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 112.876 0.695 . . . . 63.520000000000003 112.876 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 32.7 mt -122.0 133.08 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.915 -1.039 . . . . 55.32 110.594 -174.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.462 HD13 HD21 ' A' ' 589' ' ' LEU . 47.8 mt -90.99 129.21 42.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.947 -1.501 . . . . 73.219999999999999 106.947 174.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -115.1 112.66 22.92 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.449 -0.574 . . . . 73.299999999999997 109.449 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 589' ' ' LEU . 62.1 mt -108.36 130.7 60.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.82 -0.807 . . . . 73.200000000000003 108.82 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.534 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 70.7 ttt180 -76.9 112.58 13.66 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.484 -0.561 . . . . 73.510000000000005 109.484 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.16 119.16 47.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.344 -2.095 . . . . 62.329999999999998 105.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -73.06 100.14 2.94 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.645 0.736 . . . . 74.140000000000001 112.524 -175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.91 -19.16 61.32 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.737 -1.12 . . . . 72.420000000000002 110.795 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 578' ' ' ARG . 71.7 ttt180 -92.9 31.86 1.35 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 122.495 1.141 . . . . 64.530000000000001 108.35 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -147.77 155.98 42.26 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 106.985 -1.487 . . . . 74.230000000000004 106.985 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -161.55 124.74 3.15 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.421 -0.585 . . . . 75.120000000000005 109.421 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.46 158.69 22.17 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.708 -0.849 . . . . 74.129999999999995 108.708 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.08 31.18 5.72 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.581 1.181 . . . . 63.530000000000001 109.317 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -118.16 154.75 31.64 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 106.779 -1.563 . . . . 75.040000000000006 106.779 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.22 85.34 3.04 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.515 1.15 . . . . 74.409999999999997 109.902 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 63.4 m -72.17 124.26 24.64 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.103 -1.408 . . . . 72.340000000000003 110.518 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.6 p -147.42 151.61 36.75 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.714 -0.847 . . . . 62.039999999999999 108.714 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -149.97 176.69 10.55 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.852 -1.166 . . . . 71.109999999999999 107.852 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 20.0 m -129.85 163.96 25.17 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.972 -0.691 . . . . 74.120000000000005 109.853 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.462 HD21 HD13 ' A' ' 571' ' ' ILE . 41.9 tp -139.67 127.36 21.83 Favored 'General case' 0 C--N 1.263 -3.165 0 N-CA-C 106.729 -1.582 . . . . 74.140000000000001 106.729 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.52 151.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.546 -0.539 . . . . 70.409999999999997 109.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 85.0 mt -92.1 139.42 30.65 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.901 -1.148 . . . . 53.25 107.901 175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.42 167.55 10.56 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 115.476 -0.784 . . . . 73.439999999999998 108.979 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.24 115.19 9.18 Favored Pre-proline 0 N--CA 1.446 -0.637 0 O-C-N 124.598 1.186 . . . . 71.150000000000006 109.333 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.42 142.7 23.98 Favored 'Trans proline' 0 N--CA 1.428 -2.346 0 C-N-CA 121.703 1.602 . . . . 72.109999999999999 111.412 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -110.3 132.34 54.26 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.957 -0.565 . . . . 63.240000000000002 110.421 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -85.02 118.81 24.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.451 -1.314 . . . . 73.219999999999999 107.451 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 43.1 mm -86.92 88.4 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 N-CA-C 106.0 -1.852 . . . . 65.120000000000005 106.0 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 598' ' ' ARG . . . . . 0.513 ' HA ' ' HE ' ' A' ' 598' ' ' ARG . 3.9 tpm_? -110.53 106.96 16.43 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.288 -1.375 . . . . 64.5 107.288 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -83.16 119.06 24.06 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.849 -0.797 . . . . 74.0 108.849 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 127.48 -14.85 6.43 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 120.832 -0.699 . . . . 61.219999999999999 111.898 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -83.83 -25.54 30.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.637 0.732 . . . . 51.539999999999999 109.969 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -85.57 84.23 7.67 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.57 -1.27 . . . . 72.329999999999998 107.57 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -159.84 -78.72 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 119.596 -1.288 . . . . 41.329999999999998 112.662 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -84.4 35.59 2.99 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 121.262 -0.494 . . . . 71.0 113.137 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -131.88 164.13 26.77 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.596 -1.261 . . . . 70.450000000000003 107.596 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 28.3 m -81.18 99.69 8.69 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.638 0.732 . . . . 75.510000000000005 109.325 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 42.3 mm -94.29 101.85 12.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 107.677 -1.231 . . . . 73.200000000000003 107.677 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 9.8 t -80.38 -21.39 42.38 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.919 -0.582 . . . . 65.239999999999995 110.251 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 71.18 -50.17 0.68 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.949 1.7 . . . . 52.240000000000002 112.823 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -74.91 154.58 38.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.049 -0.723 . . . . 62.219999999999999 109.049 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -82.29 71.45 9.35 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.538 0.685 . . . . 73.25 111.651 -173.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -107.95 2.33 23.22 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.424 -1.324 . . . . 64.019999999999996 107.424 171.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.8 149.35 24.91 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.618 -1.628 . . . . 64.299999999999997 107.856 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -75.91 -46.41 30.17 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.229 -0.656 . . . . 65.209999999999994 109.229 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 615' ' ' GLN . . . . . 0.561 ' HB3' ' HD3' ' A' ' 616' ' ' PRO . 35.1 tt0 -174.36 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 125.266 1.426 . . . . 70.319999999999993 108.118 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 615' ' ' GLN . 16.5 Cg_exo -71.89 156.06 57.01 Favored 'Trans proline' 0 C--N 1.374 1.894 0 N-CA-C 107.024 -1.952 . . . . 73.310000000000002 107.024 165.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.97 -37.56 69.88 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.599 0.714 . . . . 52.439999999999998 110.106 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 10.6 p -94.3 126.39 39.52 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.364 -0.834 . . . . 75.329999999999998 111.35 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 46.4 m -74.42 -33.66 63.04 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.821 -0.807 . . . . 64.150000000000006 108.821 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -79.21 99.76 7.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.054 -1.462 . . . . 74.140000000000001 107.054 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.0 106.62 17.23 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.751 0.786 . . . . 73.030000000000001 111.765 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.36 -26.17 17.38 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.505 -0.77 . . . . 54.020000000000003 110.775 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -79.69 116.06 19.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.822 -1.547 . . . . 74.219999999999999 106.822 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -55.41 142.26 33.25 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 123.528 0.518 . . . . 71.230000000000004 110.75 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.457 ' HE ' ' CD ' ' A' ' 629' ' ' GLU . 32.7 ttt180 -51.86 -45.82 64.22 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 112.902 0.704 . . . . 74.299999999999997 112.902 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.526 ' O ' ' HG3' ' A' ' 630' ' ' MET . 51.1 ttp180 -61.55 -36.04 79.46 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.35 0.595 . . . . 75.040000000000006 110.771 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 71.2 mt -72.89 -41.79 60.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.075 -0.713 . . . . 74.329999999999998 109.075 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.43 94.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.913 -0.585 . . . . 34.119999999999997 110.308 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.457 ' CD ' ' HE ' ' A' ' 625' ' ' ARG . 51.1 mt-10 -72.1 -19.28 61.83 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 116.291 -0.413 . . . . 60.25 111.361 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 73.4 mtm -82.57 -8.08 59.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.607 0.718 . . . . 62.310000000000002 109.645 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -108.6 24.74 21.39 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.415 -0.812 . . . . 55.5 111.652 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 8.2 ptp180 -142.38 170.85 8.09 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 106.378 -1.712 . . . . 74.420000000000002 106.378 177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -79.74 143.57 16.77 Favored 'Trans proline' 0 N--CA 1.441 -1.574 0 N-CA-C 107.922 -1.607 . . . . 63.439999999999998 107.922 171.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.407 ' H ' HD13 ' A' ' 634' ' ' ILE . 0.2 OUTLIER -136.06 177.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-O 121.842 0.829 . . . . 74.510000000000005 111.53 -174.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -99.0 178.87 4.8 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.388 -1.338 . . . . 72.109999999999999 107.388 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.89 -154.79 7.15 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 119.917 -1.135 . . . . 65.420000000000002 113.0 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.53 -68.07 0.36 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 124.388 1.075 . . . . 75.209999999999994 110.269 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -138.44 119.36 14.3 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.641 -1.985 . . . . 50.229999999999997 105.641 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' THR . . . . . 0.402 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 4.8 t -134.69 110.24 9.13 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-O 122.361 1.077 . . . . 72.310000000000002 110.839 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -147.89 137.85 22.69 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.177 -1.416 . . . . 74.519999999999996 107.177 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 111.82 22.65 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.177 -1.416 . . . . 70.040000000000006 107.177 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.37 122.26 37.9 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.963 -0.754 . . . . 74.230000000000004 108.963 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.93 125.41 68.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.252 -0.885 . . . . 75.340000000000003 109.139 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 644' ' ' ILE . . . . . 0.407 ' HB ' ' CD2' ' A' ' 513' ' ' HIS . 4.4 mp -116.84 139.19 44.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.568 -1.271 . . . . 74.219999999999999 107.568 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.3 136.75 42.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 109.435 -0.579 . . . . 74.040000000000006 109.435 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 71.53 -54.57 0.67 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.772 1.629 . . . . 62.520000000000003 111.598 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.5 151.88 45.34 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 123.854 0.862 . . . . 75.400000000000006 109.655 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 648' ' ' SER . . . . . 0.45 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 29.1 t -146.33 105.02 3.84 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 108.527 -0.916 . . . . 64.329999999999998 108.527 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -127.78 120.08 27.11 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.173 0.511 . . . . 64.409999999999997 110.273 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -142.56 130.41 21.68 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.771 -0.826 . . . . 71.239999999999995 108.771 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.62 58.32 1.76 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 104.403 -2.443 . . . . 60.340000000000003 104.403 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -35.67 113.02 0.19 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 128.185 2.594 . . . . 74.430000000000007 115.969 -170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 54.2 m 53.76 33.85 17.76 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 114.718 1.377 . . . . 71.040000000000006 114.718 170.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 98.1 m -64.29 -42.66 96.28 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.018 -1.475 . . . . 51.130000000000003 107.018 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.44 109.88 29.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 105.53 -2.026 . . . . 74.030000000000001 105.53 169.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--N 1.3 -1.551 0 CA-C-N 116.385 -0.37 . . . . 63.530000000000001 110.496 -175.391 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.544 ' N ' HH22 ' A' ' 598' ' ' ARG . 53.6 m-70 . . . . . 0 CA--C 1.504 -0.821 0 N-CA-C 109.395 -0.594 . . . . 71.530000000000001 109.395 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -122.2 146.32 47.37 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.04 -1.096 . . . . 71.049999999999997 108.04 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -114.83 126.79 7.39 Favored Glycine 0 N--CA 1.416 -2.682 0 C-N-CA 119.948 -1.12 . . . . 71.120000000000005 111.076 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.95 114.8 36.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.38 -1.711 . . . . 51.030000000000001 106.38 172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.62 132.8 53.88 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.669 0.606 . . . . 62.420000000000002 109.975 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -148.39 152.39 36.93 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 120.766 0.317 . . . . 71.439999999999998 110.496 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.566 ' CG ' ' HB2' ' A' ' 641' ' ' LEU . 69.2 m-85 -71.4 148.17 47.2 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.282 0.633 . . . . 73.109999999999999 111.395 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.85 -55.85 20.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.62 0.575 . . . . 74.409999999999997 110.655 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLU . . . . . 0.576 ' O ' HD23 ' A' ' 641' ' ' LEU . 39.2 mt-10 -126.96 158.36 68.95 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 107.542 -1.281 . . . . 64.040000000000006 107.542 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.29 -23.98 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.684 1.589 . . . . 73.430000000000007 112.226 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 644' ' ' ILE . 78.0 t -138.0 138.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.017 -0.364 . . . . 62.039999999999999 110.017 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.2 t -131.33 128.06 38.92 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 74.019999999999996 109.347 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.41 110.73 22.76 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.157 -1.423 . . . . 71.019999999999996 107.157 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.39 159.34 14.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.744 -0.382 . . . . 75.230000000000004 110.148 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 646' ' ' GLU . 46.2 m -84.27 173.52 10.92 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.478 -0.783 . . . . 62.119999999999997 110.792 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.537 ' HB2' ' H ' ' A' ' 578' ' ' ARG . 0.3 OUTLIER -87.89 -34.16 18.27 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.738 -0.838 . . . . 64.109999999999999 108.738 179.172 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 49.4 m -92.19 17.25 9.87 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.958 -1.019 . . . . 71.409999999999997 111.874 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.16 -29.52 17.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.271 0.558 . . . . 71.299999999999997 110.372 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.19 -70.15 3.24 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.858 -0.687 . . . . 31.34 112.27 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.9 mm -129.06 124.01 59.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.345 -0.983 . . . . 64.450000000000003 108.345 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -95.85 149.86 21.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.878 -1.156 . . . . 73.530000000000001 107.878 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -129.18 112.95 14.47 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.606 0.595 . . . . 72.319999999999993 112.606 -173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 68.8 t -121.3 128.58 75.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.482 -0.781 . . . . 74.319999999999993 109.535 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.08 149.59 21.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.242 0.544 . . . . 64.310000000000002 109.793 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.29 107.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.621 -1.622 . . . . 50.140000000000001 106.621 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 81.8 mt -76.16 137.15 39.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.339 -0.846 . . . . 72.030000000000001 109.877 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.523 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 40.9 mtp180 -104.61 102.18 11.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.335 -1.357 . . . . 73.340000000000003 107.335 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.2 m -68.05 -62.45 1.4 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.565 1.32 . . . . 72.040000000000006 114.565 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 33.4 t -73.13 -50.83 20.54 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.596 0.591 . . . . 70.230000000000004 112.596 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 156.89 -160.44 30.35 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 111.146 -0.782 . . . . 72.219999999999999 111.146 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.38 165.88 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.522 0.729 . . . . 71.019999999999996 109.662 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -176.09 105.02 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.244 1.018 . . . . 74.120000000000005 108.52 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 121.35 -126.25 6.47 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 110.719 -0.952 . . . . 53.350000000000001 110.719 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -136.47 127.78 28.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.239 -1.023 . . . . 71.439999999999998 108.239 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.05 130.29 68.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.134 -0.691 . . . . 74.310000000000002 109.134 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 51.5 mm -100.88 122.47 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.284 -1.006 . . . . 72.209999999999994 108.284 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 43.4 t -116.76 102.33 53.18 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.499 -0.926 . . . . 71.450000000000003 108.499 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.51 135.28 13.04 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.801 1.667 . . . . 70.319999999999993 112.742 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -119.51 168.1 11.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.181 -1.044 . . . . 75.519999999999996 108.181 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -158.43 135.6 9.97 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.822 0.344 . . . . 55.119999999999997 111.154 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 17.8 p -80.41 121.0 25.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.348 -0.842 . . . . 54.329999999999998 110.441 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 29.9 mm -96.11 121.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.47 -1.307 . . . . 71.219999999999999 107.47 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.48 125.23 28.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.691 -0.485 . . . . 74.420000000000002 109.691 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -103.21 -109.02 3.32 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.724 -1.75 . . . . 43.039999999999999 108.724 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 585' ' ' CYS . 8.7 p -89.23 -5.85 57.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.198 0.999 . . . . 72.030000000000001 109.579 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.81 140.49 38.02 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.805 -1.089 . . . . 73.129999999999995 108.427 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.87 147.61 28.53 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.089 0.471 . . . . 64.109999999999999 111.511 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.2 -147.54 9.34 Favored Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 115.189 -0.914 . . . . 72.109999999999999 111.113 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.15 28.47 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 121.679 -0.296 . . . . 54.329999999999998 113.07 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.44 -3.84 34.86 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 111.493 -0.643 . . . . 34.409999999999997 111.493 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.76 -79.95 0.03 OUTLIER 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.001 0.429 . . . . 72.409999999999997 111.543 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -87.2 -46.16 9.99 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.718 -1.216 . . . . 34.0 107.718 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -139.5 165.87 26.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.574 -1.194 . . . . 64.549999999999997 109.732 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 574' ' ' ARG . 1.0 OUTLIER -95.96 116.4 28.88 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.303 -2.11 . . . . 72.010000000000005 105.303 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.72 132.18 35.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.5 0.667 . . . . 73.150000000000006 111.554 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.0 t -128.19 148.39 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.494 -0.775 . . . . 74.209999999999994 109.795 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 15.0 p -148.99 140.11 23.05 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.866 0.365 . . . . 53.299999999999997 111.4 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 80.12 -125.2 6.81 Favored Glycine 0 C--O 1.212 -1.263 0 CA-C-N 115.684 -0.689 . . . . 70.450000000000003 111.576 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 58.73 -6.09 0.05 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.072 2.99 . . . . 74.510000000000005 119.072 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 537' ' ' VAL . 62.2 mt -95.27 133.58 39.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 120.049 1.295 . . . . 74.310000000000002 112.29 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -134.23 108.91 8.52 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.603 -1.18 . . . . 75.540000000000006 107.939 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.523 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 73.8 m-85 -103.53 129.02 50.65 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.207 -0.451 . . . . 63.450000000000003 110.592 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.483 ' HB2' HD11 ' A' ' 567' ' ' ILE . 1.6 mp0 -96.16 -107.03 0.15 Allowed 'General case' 0 C--O 1.246 0.912 0 C-N-CA 118.631 -1.227 . . . . 74.349999999999994 111.306 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.4 155.79 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.715 -0.476 . . . . 64.549999999999997 109.715 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.89 -25.97 67.1 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 114.52 1.304 . . . . 74.230000000000004 114.52 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.52 -15.59 60.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.118 0.784 . . . . 61.530000000000001 113.118 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 563' ' ' GLN . 34.2 pt -103.32 157.09 5.14 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 C-N-CA 119.694 -0.802 . . . . 74.040000000000006 110.174 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.58 156.99 29.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.574 -0.528 . . . . 63.149999999999999 109.574 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.8 mmpt? -110.29 163.82 13.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 110.026 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 62.9 mt -128.42 134.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.773 -1.103 . . . . 71.409999999999997 108.681 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.488 HD13 HD21 ' A' ' 589' ' ' LEU . 58.8 mt -90.14 118.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 106.619 -1.622 . . . . 65.340000000000003 106.619 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 12.8 p -110.47 111.74 23.2 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.622 -0.717 . . . . 54.439999999999998 110.008 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.85 132.55 59.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.665 -0.698 . . . . 63.43 109.564 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 554' ' ' GLU . 79.5 mtt180 -76.99 111.82 12.96 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 123.807 0.692 . . . . 55.049999999999997 110.203 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.29 121.94 55.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.401 -1.703 . . . . 75.519999999999996 106.401 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 74.3 m-85 -94.42 158.5 15.53 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.441 -0.504 . . . . 75.400000000000006 109.921 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.06 93.49 0.44 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.712 0.767 . . . . 71.409999999999997 110.191 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.537 ' H ' ' HB2' ' A' ' 516' ' ' GLU . 1.3 tpm_? -66.48 106.33 1.73 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.377 -1.283 . . . . 62.520000000000003 109.928 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -81.68 -22.94 37.16 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.788 -0.642 . . . . 72.310000000000002 111.1 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.2 126.27 35.76 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.111 -0.95 . . . . 73.450000000000003 109.996 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -121.98 24.55 9.53 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.249 -0.649 . . . . 74.150000000000006 109.249 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -39.4 -62.87 0.62 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.279 1.832 . . . . 74.200000000000003 111.163 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.452 ' HA ' ' HE3' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -148.34 175.94 10.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.826 -1.546 . . . . 74.530000000000001 106.826 177.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.63 103.19 4.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.211 0.529 . . . . 73.219999999999999 111.654 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.435 ' HA ' ' OG1' ' A' ' 545' ' ' THR . 21.4 p -97.48 126.86 43.0 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.498 0.666 . . . . 74.040000000000006 110.174 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 44.9 m -144.08 164.36 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.522 -0.547 . . . . 72.420000000000002 109.522 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.1 p90 -142.6 -178.94 6.02 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.78 -0.452 . . . . 72.25 109.78 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 70.9 m -131.09 167.52 18.96 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.238 0.542 . . . . 62.439999999999998 111.024 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.488 HD21 HD13 ' A' ' 571' ' ' ILE . 63.9 tp -136.47 124.51 22.9 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.152 -1.796 . . . . 73.420000000000002 106.152 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.73 159.0 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.489 -0.56 . . . . 71.329999999999998 109.489 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.505 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 74.6 mt -104.58 144.09 32.16 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.235 -1.024 . . . . 61.299999999999997 108.235 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.01 170.95 7.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.173 -0.677 . . . . 74.519999999999996 109.173 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -59.17 109.92 2.28 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 123.92 0.763 . . . . 72.319999999999993 112.749 -175.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.65 158.52 39.59 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.122 2.548 . . . . 61.149999999999999 112.384 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -123.3 140.71 52.74 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 72.030000000000001 110.294 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -103.14 124.54 48.76 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.136 -1.061 . . . . 72.209999999999994 108.136 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.32 89.58 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.184 -1.413 . . . . 73.439999999999998 107.184 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 598' ' ' ARG . . . . . 0.544 HH22 ' N ' ' A' ' 501' ' ' HIS . 14.1 ttm180 -108.05 -29.34 9.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.402 -1.332 . . . . 72.319999999999993 107.402 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -135.93 155.43 50.3 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.704 -1.135 . . . . 74.519999999999996 108.745 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -156.41 41.06 0.57 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 110.365 -1.094 . . . . 71.120000000000005 110.365 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 601' ' ' MET . . . . . 0.553 ' SD ' ' HG2' ' A' ' 602' ' ' LYS . 0.0 OUTLIER -78.96 -56.51 4.33 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 106.932 -1.507 . . . . 71.409999999999997 106.932 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.553 ' HG2' ' SD ' ' A' ' 601' ' ' MET . 21.6 pttp -171.89 136.71 0.92 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.705 1.602 . . . . 55.450000000000003 108.111 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -72.76 -39.28 55.72 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.309 -0.472 . . . . 45.299999999999997 113.138 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.27 -142.4 7.43 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.043 -1.075 . . . . 71.340000000000003 111.936 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -151.16 132.58 14.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 123.023 0.529 . . . . 73.530000000000001 109.598 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 85.3 m -149.35 98.12 2.75 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.622 -1.251 . . . . 71.409999999999997 107.622 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.47 125.54 40.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.611 -0.885 . . . . 74.140000000000001 108.611 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 47.2 m -75.88 84.63 2.82 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 122.074 0.94 . . . . 72.129999999999995 110.416 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.79 -20.37 20.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.612 -1.176 . . . . 60.520000000000003 108.732 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.74 81.29 8.94 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 122.669 1.223 . . . . 75.319999999999993 108.429 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 611' ' ' TYR . . . . . 0.403 ' O ' ' HD2' ' A' ' 614' ' ' LYS . 62.9 t80 -95.52 -5.34 43.01 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.635 -2.075 . . . . 75.299999999999997 109.376 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -110.16 159.08 17.67 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.913 -1.143 . . . . 73.530000000000001 107.913 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 35.5 t70 59.35 83.77 0.12 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.223 1.009 . . . . 71.329999999999998 111.22 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 614' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 614' ' ' LYS . 0.1 OUTLIER -117.36 95.01 4.78 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.493 -0.776 . . . . 63.119999999999997 109.735 -177.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 615' ' ' GLN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 616' ' ' PRO . 34.9 tt0 -170.55 -55.77 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.15 0 O-C-N 123.606 0.566 . . . . 74.340000000000003 110.801 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 615' ' ' GLN . 97.0 Cg_endo -85.94 -165.98 0.3 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-N 120.082 1.065 . . . . 50.340000000000003 109.692 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.96 138.07 36.6 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.346 -0.983 . . . . 60.420000000000002 108.346 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 2.3 p -58.28 108.98 0.68 Allowed 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 123.648 0.593 . . . . 62.109999999999999 110.056 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 22.1 m -83.71 -5.08 59.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.436 -0.802 . . . . 71.420000000000002 112.881 -172.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -88.59 106.86 18.59 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 119.994 -0.682 . . . . 73.219999999999999 109.616 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.15 104.65 7.2 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.315 0.579 . . . . 74.140000000000001 110.198 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.27 -16.27 57.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.59 0.709 . . . . 64.030000000000001 110.713 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.76 129.02 49.27 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.452 -1.314 . . . . 61.119999999999997 107.452 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -76.16 94.05 3.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.589 -0.523 . . . . 64.409999999999997 109.589 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -67.29 -39.97 86.05 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.819 -0.628 . . . . 65.150000000000006 110.999 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 630' ' ' MET . 46.9 ttt180 -61.07 -45.63 93.97 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.768 0.318 . . . . 73.310000000000002 110.431 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 70.1 mt -65.91 -37.25 79.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.345 -0.389 . . . . 61.409999999999997 110.406 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.02 -43.21 99.34 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.963 -0.384 . . . . 60.240000000000002 109.963 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.01 -14.59 60.63 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 112.344 0.498 . . . . 64.530000000000001 112.344 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 75.3 mtm -84.52 -5.21 59.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.535 0.683 . . . . 62.130000000000003 110.101 172.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -96.05 5.16 65.8 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.328 -1.109 . . . . 61.140000000000001 110.328 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -85.1 162.53 48.96 Favored Pre-proline 0 C--N 1.307 -1.24 0 C-N-CA 124.344 1.058 . . . . 65.230000000000004 109.142 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.7 146.39 95.2 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 N-CA-C 107.262 -1.861 . . . . 71.25 107.262 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 38.3 pt -129.76 -177.38 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-O 121.432 0.634 . . . . 62.100000000000001 110.951 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.5 176.15 5.25 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.068 -1.456 . . . . 71.439999999999998 107.068 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.22 153.37 52.71 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.231 -1.947 . . . . 44.340000000000003 108.231 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 637' ' ' GLU . . . . . 0.462 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 41.5 tt0 -41.1 -61.22 1.04 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.157 1.383 . . . . 73.099999999999994 112.737 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 638' ' ' HIS . . . . . 0.462 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 46.8 m80 -126.22 92.99 3.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.876 -0.787 . . . . 70.409999999999997 108.876 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.8 t -116.09 110.8 19.37 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.556 1.169 . . . . 74.439999999999998 108.954 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -146.29 116.7 7.49 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.211 -1.774 . . . . 71.329999999999998 106.211 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 509' ' ' GLU . 1.6 tm? -106.76 108.62 20.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.059 -1.089 . . . . 73.209999999999994 108.059 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -88.44 131.77 34.74 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.134 -0.939 . . . . 72.409999999999997 109.425 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.49 118.62 59.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.905 -0.776 . . . . 74.540000000000006 108.905 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 511' ' ' VAL . 3.7 mp -110.34 130.08 64.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.565 -1.198 . . . . 72.019999999999996 109.285 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.95 108.75 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 CA-C-O 122.254 1.026 . . . . 64.400000000000006 112.101 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 646' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 515' ' ' SER . 73.6 mm-40 -145.96 -154.3 0.53 Allowed 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 102.596 -3.112 . . . . 44.350000000000001 102.596 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -105.08 125.26 50.78 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.44 -1.689 . . . . 72.219999999999999 106.44 166.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 13.5 t -72.1 110.62 6.7 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 106.952 -1.499 . . . . 54.140000000000001 106.952 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -75.11 149.63 39.03 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.933 -0.576 . . . . 64.420000000000002 111.201 -176.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -165.81 90.36 0.45 Allowed 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 105.599 -2.0 . . . . 72.0 105.599 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -79.74 -34.45 39.94 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 108.042 -1.096 . . . . 73.329999999999998 108.042 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -132.57 142.5 49.19 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.257 -1.386 . . . . 71.329999999999998 107.257 171.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 22.6 m -76.27 85.87 3.07 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.786 0.803 . . . . 74.450000000000003 108.914 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 9.8 t -121.1 9.06 10.43 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.958 -1.019 . . . . 75.209999999999994 109.151 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 8.1 p -117.58 143.27 28.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.86 -1.163 . . . . 63.030000000000001 107.86 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.305 -1.343 0 N-CA-C 110.192 -0.299 . . . . 61.530000000000001 110.192 -179.326 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 . . . . . 0 C--O 1.24 0.584 0 N-CA-C 109.529 -0.545 . . . . 74.239999999999995 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -121.54 90.45 3.32 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.404 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -70.51 147.96 44.61 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.663 -0.975 . . . . 52.340000000000003 110.663 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -127.08 114.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.11 134.55 48.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.824 0.702 . . . . 74.530000000000001 109.928 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -147.99 156.73 42.99 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.321 -0.622 . . . . 61.100000000000001 109.321 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 74.4 m-85 -73.39 153.18 40.55 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.22 -0.289 . . . . 70.25 110.22 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.3 -51.86 67.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.978 0.799 . . . . 73.310000000000002 110.536 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -135.66 155.66 78.05 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 114.606 -1.179 . . . . 63.32 108.278 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.59 -25.74 2.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.934 1.756 . . . . 74.349999999999994 113.006 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 642' ' ' GLU . 89.3 t -142.02 132.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.127 -0.694 . . . . 72.030000000000001 109.127 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.3 t -133.94 138.26 45.38 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.079 0.466 . . . . 44.340000000000003 109.943 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -102.73 112.92 25.92 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.774 -1.195 . . . . 75.540000000000006 107.774 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.5 m -108.5 145.19 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.313 -0.555 . . . . 71.010000000000005 110.254 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 518' ' ' ILE . 70.8 m -70.81 137.91 49.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.131 -0.941 . . . . 64.129999999999995 111.38 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -31.3 61.65 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.752 1.019 . . . . 75.329999999999998 113.752 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 7.4 p -106.84 25.35 11.39 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.844 0.354 . . . . 54.119999999999997 111.884 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -76.13 -31.02 20.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.511 0.672 . . . . 72.519999999999996 110.228 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 87.12 -70.35 2.89 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.623 -0.798 . . . . 71.329999999999998 111.795 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.75 133.36 68.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.975 -1.121 . . . . 72.319999999999993 107.975 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 572' ' ' THR . 19.6 ptm -107.62 136.4 47.44 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.146 -0.687 . . . . 53.130000000000003 109.146 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -103.14 124.6 48.89 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.397 0.679 . . . . 74.420000000000002 110.0 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.5 t -121.24 123.71 70.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.423 -0.954 . . . . 74.230000000000004 108.423 175.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.77 127.4 35.6 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.684 -0.406 . . . . 73.200000000000003 110.01 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.68 107.93 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.529 -1.656 . . . . 71.109999999999999 106.529 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.8 mt -87.16 153.04 21.82 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.02 -0.991 . . . . 63.109999999999999 110.191 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -121.64 104.83 9.9 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.874 -0.603 . . . . 74.219999999999999 110.062 -178.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.5 m -63.59 -60.78 2.89 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 72.319999999999993 110.133 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -73.04 -43.8 61.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.157 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.02 -152.35 23.13 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 110.209 -1.156 . . . . 70.549999999999997 110.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.532 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -157.75 146.69 19.53 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.194 -1.78 . . . . 74.310000000000002 106.194 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.462 ' NH2' ' HA2' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -160.9 114.55 2.04 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.152 -1.425 . . . . 72.230000000000004 107.152 -178.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.462 ' HA2' ' NH2' ' A' ' 532' ' ' ARG . . . 119.25 -131.45 9.05 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 111.229 -0.748 . . . . 63.0 111.229 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.428 HD21 ' HB ' ' A' ' 597' ' ' ILE . 42.6 t30 -136.89 103.81 5.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.282 -2.118 . . . . 75.209999999999994 105.282 174.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 41.2 t -120.14 125.04 73.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 C-N-CA 119.644 -0.822 . . . . 61.140000000000001 111.086 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.73 122.64 42.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 72.349999999999994 107.938 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.12 103.13 54.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 109.006 -0.738 . . . . 45.100000000000001 109.006 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.414 ' HA ' ' HA2' ' A' ' 558' ' ' GLY . 0.9 OUTLIER -80.12 133.27 9.82 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.819 1.68 . . . . 62.43 112.63 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -119.82 161.75 20.27 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.375 -1.343 . . . . 71.209999999999994 107.375 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -155.42 139.66 16.61 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.957 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.0 p -84.47 130.78 34.73 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.285 -0.871 . . . . 44.409999999999997 110.894 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 588' ' ' SER . 43.7 mm -99.09 114.01 35.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.542 -1.281 . . . . 75.329999999999998 107.542 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.01 161.97 27.92 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.989 -0.55 . . . . 75.140000000000001 111.002 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 144.53 117.27 1.14 Allowed Glycine 0 C--O 1.201 -1.939 0 N-CA-C 108.376 -1.889 . . . . 72.340000000000003 108.376 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 47.3 p 75.87 5.53 3.86 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 127.484 2.314 . . . . 61.420000000000002 110.395 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -169.21 140.1 2.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.706 -1.134 . . . . 65.129999999999995 108.249 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -102.47 138.08 39.86 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 123.501 0.501 . . . . 73.010000000000005 109.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -105.44 131.75 10.79 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 116.003 -0.544 . . . . 73.329999999999998 112.823 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 160.38 -49.53 0.38 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.818 -1.713 . . . . 51.240000000000002 108.818 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 179.65 -9.01 0.02 OUTLIER Glycine 0 C--N 1.294 -1.789 0 CA-C-N 113.933 -1.134 . . . . 72.420000000000002 111.286 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.426 ' H ' ' H ' ' A' ' 550' ' ' GLY . 20.5 mp0 -65.16 -61.63 2.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.875 1.27 . . . . 73.430000000000007 111.686 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -122.88 -41.13 2.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.784 0.802 . . . . 72.239999999999995 109.122 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -136.37 160.29 39.18 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.931 -1.507 . . . . 74.120000000000005 106.931 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 22.1 tt0 -89.01 141.45 28.47 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.857 -0.794 . . . . 43.399999999999999 108.857 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.89 106.72 15.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.453 -0.944 . . . . 75.200000000000003 108.453 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -117.38 131.54 56.75 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.1 -1.074 . . . . 64.099999999999994 108.1 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.5 131.59 15.36 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 112.275 0.472 . . . . 62.140000000000001 112.275 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 538' ' ' PRO . . . 85.21 -139.26 17.38 Favored Glycine 0 C--O 1.189 -2.708 0 N-CA-C 111.794 -0.522 . . . . 63.509999999999998 111.794 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 71.2 -8.0 1.07 Allowed 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.698 1.74 . . . . 64.349999999999994 115.698 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 569' ' ' LYS . 41.0 mt -93.4 131.28 38.73 Favored 'General case' 0 CA--C 1.5 -0.97 0 O-C-N 120.647 -1.283 . . . . 72.439999999999998 112.327 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -129.77 118.73 22.28 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.104 -0.953 . . . . 75.400000000000006 109.454 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 37.5 m-85 -104.54 155.31 18.93 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.555 -0.906 . . . . 65.299999999999997 108.555 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.434 ' H ' HD11 ' A' ' 567' ' ' ILE . 72.1 mm-40 -120.66 -88.22 0.63 Allowed 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.721 -1.215 . . . . 73.310000000000002 107.721 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -104.45 165.48 11.03 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.197 -1.038 . . . . 71.430000000000007 108.197 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.532 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 4.4 p30 -63.21 -11.87 24.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.789 1.033 . . . . 63.119999999999997 113.789 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.456 ' HG3' HG23 ' A' ' 567' ' ' ILE . 11.3 pt-20 -69.8 -18.75 63.49 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.945 0.498 . . . . 74.140000000000001 111.794 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.456 HG23 ' HG3' ' A' ' 566' ' ' GLU . 38.8 pt -114.12 164.29 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 120.865 0.364 . . . . 73.319999999999993 110.625 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.56 158.37 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.08 -1.452 . . . . 75.439999999999998 107.08 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.507 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -121.69 149.19 43.58 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 120.965 0.412 . . . . 73.140000000000001 110.435 173.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.56 134.27 64.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.914 -1.039 . . . . 64.310000000000002 109.964 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 50.4 mt -90.91 126.73 43.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 106.552 -1.647 . . . . 74.310000000000002 106.552 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 572' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 521' ' ' MET . 15.5 p -117.28 112.5 20.85 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.836 -0.802 . . . . 73.129999999999995 108.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.484 HD11 HD22 ' A' ' 589' ' ' LEU . 50.4 mt -109.84 131.77 59.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.175 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 61.6 mtt180 -78.47 112.04 15.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 123.964 0.79 . . . . 74.230000000000004 111.397 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.5 125.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 106.356 -1.72 . . . . 64.140000000000001 106.356 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.44 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 78.3 m-85 -105.63 113.64 27.32 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.129 0.788 . . . . 75.349999999999994 113.129 -174.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -79.49 121.72 25.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.36 -1.718 . . . . 72.109999999999999 106.36 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 578' ' ' ARG . 1.8 tmm_? -121.22 6.01 10.24 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.586 -0.894 . . . . 72.450000000000003 108.586 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 81.51 90.03 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 125.874 1.67 . . . . 63.5 111.563 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -140.43 164.05 31.18 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 113.806 -1.543 . . . . 73.329999999999998 110.138 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.36 -48.72 3.07 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.292 -0.413 . . . . 74.510000000000005 110.436 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -124.26 89.83 3.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.199 0.523 . . . . 71.340000000000003 112.097 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -138.12 83.36 1.97 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.135 -0.939 . . . . 65.200000000000003 110.404 173.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.37 90.6 6.7 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 106.052 -1.833 . . . . 74.209999999999994 106.052 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.402 ' O ' HD12 ' A' ' 645' ' ' ILE . 6.4 p -108.66 142.74 38.7 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.986 -1.006 . . . . 73.099999999999994 110.638 -175.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.4 p -134.54 168.18 19.43 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.41 -0.218 . . . . 62.219999999999999 110.41 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.411 ' CE1' HD11 ' A' ' 645' ' ' ILE . 54.8 p90 -163.86 162.33 23.57 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.982 -1.858 . . . . 75.420000000000002 105.982 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 542' ' ' ILE . 11.0 t -113.41 171.96 7.25 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 118.802 -1.159 . . . . 62.439999999999998 108.815 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 573' ' ' ILE . 61.0 tp -145.09 126.84 15.28 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.585 -1.635 . . . . 61.420000000000002 106.585 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 120.668 0.27 . . . . 73.230000000000004 110.383 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 56.5 mt -99.79 141.0 33.18 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.212 -1.033 . . . . 72.219999999999999 108.212 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.76 167.07 10.02 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.077 -1.083 . . . . 75.400000000000006 108.077 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.63 116.17 21.68 Favored Pre-proline 0 C--O 1.247 0.946 0 N-CA-C 112.606 0.595 . . . . 75.219999999999999 112.606 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.401 ' HB2' ' CG1' ' A' ' 535' ' ' VAL . 65.7 Cg_endo -71.15 144.82 47.7 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.0 2.467 . . . . 71.329999999999998 111.527 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 595' ' ' LYS . 0.0 OUTLIER -112.68 130.71 55.95 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.643 -0.708 . . . . 73.239999999999995 110.788 -178.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -84.79 116.05 23.05 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.33 -1.359 . . . . 74.230000000000004 107.33 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 597' ' ' ILE . . . . . 0.428 ' HB ' HD21 ' A' ' 534' ' ' ASN . 38.7 mm -81.34 89.62 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 108.389 -0.967 . . . . 62.25 108.389 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -96.14 127.87 42.53 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.703 -1.135 . . . . 73.010000000000005 107.963 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -103.11 141.04 36.51 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.785 0.326 . . . . 55.340000000000003 110.394 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 150.82 176.03 23.34 Favored Glycine 0 C--N 1.303 -1.292 0 N-CA-C 110.289 -1.124 . . . . 64.219999999999999 110.289 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -115.55 111.24 20.41 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.844 -1.539 . . . . 53.240000000000002 106.844 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -78.53 -24.01 45.93 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 114.216 1.191 . . . . 73.329999999999998 114.216 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 80.59 -56.33 4.72 Favored Glycine 0 C--N 1.312 -0.76 0 C-N-CA 121.188 -0.529 . . . . 23.219999999999999 112.621 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -91.62 31.34 5.88 Favored Glycine 0 N--CA 1.44 -1.088 0 O-C-N 122.656 -0.32 . . . . 51.299999999999997 112.757 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -84.99 88.06 7.42 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.976 0.893 . . . . 73.120000000000005 109.782 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 14.9 m -85.91 122.3 29.77 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.841 -0.618 . . . . 64.099999999999994 109.404 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 49.1 mm -82.58 119.44 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 107.138 -1.43 . . . . 71.120000000000005 107.138 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 30.6 m -71.6 89.58 0.99 Allowed 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.698 0.761 . . . . 64.129999999999995 111.484 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -88.71 -12.66 41.67 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.19 -0.914 . . . . 73.299999999999997 108.772 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.99 150.72 47.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.405 -1.702 . . . . 74.409999999999997 106.405 171.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -80.16 103.35 9.97 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.73 -0.788 . . . . 72.510000000000005 108.986 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -102.4 -177.62 3.45 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.51 -0.768 . . . . 73.140000000000001 109.226 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.62 165.94 18.58 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.681 -0.489 . . . . 73.400000000000006 109.681 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -73.86 -28.04 61.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.759 -0.46 . . . . 62.119999999999997 109.759 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 69.8 96.4 0.05 OUTLIER Pre-proline 0 C--O 1.24 0.574 0 C-N-CA 125.195 1.398 . . . . 73.040000000000006 111.343 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.49 154.53 73.28 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.663 2.242 . . . . 62.0 112.195 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.85 -23.93 38.76 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.641 0.734 . . . . 65.019999999999996 109.273 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 6.1 p -77.11 -64.13 1.2 Allowed 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.938 -1.028 . . . . 64.420000000000002 111.191 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 42.4 m -130.89 132.59 45.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 120.682 0.277 . . . . 73.200000000000003 111.213 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -134.13 145.76 49.6 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.511 -0.922 . . . . 74.430000000000007 108.511 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -83.88 -33.95 24.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.537 0.684 . . . . 63.409999999999997 109.826 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -97.97 89.46 4.57 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.643 -0.708 . . . . 74.099999999999994 110.769 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.53 78.06 1.1 Allowed 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 122.646 1.212 . . . . 75.409999999999997 108.427 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.72 153.8 23.97 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.395 -1.275 . . . . 72.150000000000006 109.91 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 1.8 mpp_? -60.13 -38.63 83.64 Favored 'General case' 0 C--O 1.209 -1.042 0 O-C-N 123.598 0.561 . . . . 64.209999999999994 110.468 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 630' ' ' MET . 50.5 ttt180 -60.94 -42.63 98.55 Favored 'General case' 0 C--O 1.213 -0.868 0 C-N-CA 120.796 -0.362 . . . . 73.329999999999998 110.818 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.53 -41.01 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.662 -0.495 . . . . 72.209999999999994 109.662 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.02 78.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.787 -0.642 . . . . 55.329999999999998 110.312 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 48.6 mt-10 -76.99 -25.4 52.69 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.121 -0.491 . . . . 64.140000000000001 111.684 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 67.0 mtt -68.46 -56.6 7.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.061 -1.089 . . . . 54.009999999999998 108.061 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -98.22 45.89 1.62 Allowed Glycine 0 N--CA 1.418 -2.512 0 CA-C-N 114.685 -1.143 . . . . 71.140000000000001 114.147 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 633' ' ' PRO 0.591 0.1 OUTLIER -91.52 -27.74 0.3 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 116.704 2.113 . . . . 74.310000000000002 116.704 170.598 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 632' ' ' ARG . 18.1 Cg_endo -65.73 109.67 1.5 Allowed 'Trans proline' 0 C--N 1.376 1.978 0 N-CA-C 106.922 -1.992 . . . . 75.420000000000002 106.922 163.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 31.3 pt -132.89 -176.71 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.581 0.705 . . . . 74.019999999999996 111.444 -171.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.07 179.64 5.14 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.033 -1.099 . . . . 53.32 108.033 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -68.7 167.77 44.42 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.899 -0.88 . . . . 74.519999999999996 110.899 175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -48.78 -43.7 38.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.594 1.158 . . . . 74.25 110.782 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.17 123.53 9.63 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.036 -1.438 . . . . 75.329999999999998 107.3 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 639' ' ' THR . . . . . 0.426 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 11.2 t -148.97 112.89 5.14 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.812 0.815 . . . . 71.040000000000006 110.209 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -147.42 130.39 16.27 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.888 -1.051 . . . . 74.109999999999999 108.618 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 68.5 tp -108.23 118.86 37.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.917 -0.771 . . . . 75.140000000000001 108.917 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 511' ' ' VAL . 39.7 mt-10 -103.05 122.87 45.53 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.983 -1.117 . . . . 72.120000000000005 107.983 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.0 t -109.88 128.8 65.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.788 -0.819 . . . . 71.239999999999995 108.788 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.03 133.29 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.605 0 N-CA-C 107.269 -1.382 . . . . 74.329999999999998 107.269 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.411 HD11 ' CE1' ' A' ' 587' ' ' PHE . 1.0 OUTLIER -115.16 130.82 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 CA-C-N 115.977 -0.556 . . . . 72.530000000000001 109.516 -174.087 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 646' ' ' GLU . . . . . 0.477 ' HB3' ' OG ' ' A' ' 648' ' ' SER . 2.9 tm-20 -174.33 -177.37 1.24 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 103.195 -2.891 . . . . 65.109999999999999 103.195 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -86.23 27.1 0.95 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 120.861 1.664 . . . . 72.209999999999994 109.656 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 648' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 646' ' ' GLU . 13.0 m -45.11 113.48 0.58 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 126.35 1.86 . . . . 71.129999999999995 112.843 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -92.01 120.85 33.03 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 105.889 -1.893 . . . . 71.129999999999995 105.889 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -103.38 111.29 23.65 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.595 0.712 . . . . 74.129999999999995 112.6 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -82.85 -10.65 58.74 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.868 -1.06 . . . . 63.109999999999999 108.432 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -67.61 103.69 1.43 Allowed 'General case' 0 C--O 1.245 0.864 0 CA-C-N 115.078 -0.965 . . . . 71.109999999999999 108.629 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 15.3 m -148.11 79.24 1.46 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 121.352 0.596 . . . . 75.340000000000003 112.048 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 62.5 m -151.35 99.75 2.67 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.791 -1.189 . . . . 72.200000000000003 107.791 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 18.9 m 52.5 24.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 125.687 1.595 . . . . 72.340000000000003 112.05 -174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 . . . . . 0 C--O 1.253 1.246 0 CA-C-N 115.154 -0.93 . . . . 72.299999999999997 109.883 -179.003 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 C--O 1.245 0.856 0 CA-C-O 121.857 0.836 . . . . 75.150000000000006 110.199 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -98.94 -33.17 10.95 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.145 -0.934 . . . . 60.409999999999997 110.781 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 174.92 97.24 0.11 Allowed Glycine 0 C--O 1.222 -0.656 0 C-N-CA 120.729 -0.748 . . . . 75.430000000000007 112.831 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.47 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.1 mt -93.19 121.61 44.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 110.414 -0.217 . . . . 73.129999999999995 110.414 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 91.2 m-85 -109.0 138.5 45.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.769 -0.826 . . . . 72.530000000000001 108.769 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -149.34 158.68 44.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.683 -0.488 . . . . 64.329999999999998 109.683 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.669 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.6 m-85 -74.51 156.79 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.607 0.242 . . . . 75.439999999999998 110.362 174.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.47 -53.03 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.169 0.918 . . . . 41.439999999999998 110.675 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -121.47 157.53 56.12 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.259 -0.882 . . . . 64.019999999999996 108.82 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -84.0 -30.26 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.521 1.481 . . . . 75.140000000000001 110.527 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 642' ' ' GLU . 70.6 t -137.64 129.89 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.0 t -133.89 131.89 39.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.045 -0.724 . . . . 74.239999999999995 109.045 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -96.17 138.01 34.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.384 -1.339 . . . . 70.319999999999993 107.384 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.87 145.49 32.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 120.853 0.359 . . . . 55.350000000000001 110.266 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 69.5 m -75.3 156.27 35.77 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.208 -0.906 . . . . 73.030000000000001 111.749 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 577' ' ' ASP . 15.2 mm-40 -68.17 -46.17 71.44 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.934 -1.03 . . . . 74.109999999999999 111.046 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 11.2 t -95.17 36.04 1.25 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.771 0.796 . . . . 75.420000000000002 110.173 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.91 -31.66 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 121.722 -0.612 . . . . 73.109999999999999 110.514 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.16 -72.85 2.74 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.818 -0.706 . . . . 61.399999999999999 111.463 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.65 123.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.515 -0.55 . . . . 65.409999999999997 109.515 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.43 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 22.1 ptm -91.36 138.6 31.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.111 -1.07 . . . . 72.430000000000007 108.111 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.74 108.87 20.57 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 123.442 0.464 . . . . 53.240000000000002 111.076 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 40.1 t -105.24 117.63 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.312 -0.625 . . . . 54.229999999999997 109.312 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -96.45 132.39 42.05 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.217 0.532 . . . . 65.230000000000004 110.093 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.8 t -90.96 112.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.463 -1.31 . . . . 72.439999999999998 107.463 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.462 ' HA ' HH21 ' A' ' 527' ' ' ARG . 59.3 mt -82.36 141.99 32.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.292 -0.867 . . . . 54.310000000000002 110.191 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.462 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -106.56 102.12 11.53 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.997 -1.483 . . . . 75.239999999999995 106.997 178.064 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.7 m -67.73 -63.75 1.0 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.802 -0.635 . . . . 73.540000000000006 110.701 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 10.3 t -75.63 -31.77 59.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 75.310000000000002 110.283 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 131.67 -159.14 23.11 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.919 -0.872 . . . . 42.049999999999997 110.919 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.549 ' N ' ' HB3' ' A' ' 565' ' ' ASP . . . -168.73 142.09 2.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.637 -1.616 . . . . 63.109999999999999 106.637 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -146.06 129.4 16.78 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.128 -0.693 . . . . 71.120000000000005 109.128 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 100.72 -122.85 7.74 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 121.386 -0.435 . . . . 55.340000000000003 112.758 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -136.62 102.77 5.02 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.749 -1.945 . . . . 74.310000000000002 105.749 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.62 129.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.234 0.54 . . . . 73.299999999999997 110.552 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 559' ' ' GLU . 50.9 mm -98.29 127.62 50.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.536 -0.757 . . . . 74.439999999999998 109.147 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -112.61 104.58 55.99 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.45 0.7 . . . . 70.310000000000002 109.892 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.35 141.27 28.49 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.741 2.294 . . . . 63.229999999999997 113.262 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.53 163.91 30.02 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.375 -0.972 . . . . 72.519999999999996 108.375 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -161.69 137.82 7.98 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 123.192 0.308 . . . . 75.439999999999998 110.655 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.5 p -84.26 126.29 33.03 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.381 0.61 . . . . 31.199999999999999 110.992 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.4 117.77 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.299 -1.741 . . . . 45.130000000000003 106.299 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.86 146.38 49.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 123.355 0.409 . . . . 72.510000000000005 110.125 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.36 -108.13 0.74 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 109.16 -1.576 . . . . 75.230000000000004 109.16 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -72.08 -43.36 64.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.301 -1.74 . . . . 71.310000000000002 106.301 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -73.16 133.88 44.23 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 113.815 -1.539 . . . . 53.32 108.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 37.2 ttt180 -111.27 143.24 42.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.551 0.945 . . . . 71.430000000000007 113.551 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 48.66 -149.75 3.94 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 125.952 1.739 . . . . 74.120000000000005 117.444 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -128.11 80.72 0.36 Allowed Glycine 0 N--CA 1.405 -3.431 0 N-CA-C 109.232 -1.547 . . . . 53.43 109.232 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 146.14 -21.14 1.75 Allowed Glycine 0 C--N 1.292 -1.892 0 C-N-CA 121.054 -0.593 . . . . 74.439999999999998 111.991 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 10.3 mm-40 -77.84 -67.57 0.71 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.315 0.578 . . . . 65.540000000000006 109.908 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -108.28 -43.37 4.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.772 0.796 . . . . 52.450000000000003 109.763 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -136.79 170.73 15.6 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.276 -1.379 . . . . 64.299999999999997 107.276 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.492 ' HG3' ' HE ' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -99.67 128.94 45.76 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.362 -1.718 . . . . 73.230000000000004 106.362 176.302 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.6 111.37 1.8 Allowed 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 123.802 0.841 . . . . 75.430000000000007 110.815 -173.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 104.7 14.48 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-O 122.075 0.941 . . . . 71.530000000000001 110.946 -174.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.5 p -139.48 129.6 25.17 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.862 -1.063 . . . . 72.040000000000006 108.562 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.24 -168.38 41.12 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.264 -1.134 . . . . 74.120000000000005 110.264 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.522 ' HB2' ' CG2' ' A' ' 536' ' ' ILE . 9.8 pt-20 -131.3 129.26 41.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.306 0.574 . . . . 72.430000000000007 110.904 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.441 HD22 ' CG ' ' A' ' 569' ' ' LYS . 85.5 mt -90.37 143.91 26.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.994 -1.003 . . . . 53.329999999999998 111.436 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.89 117.16 34.41 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.128 -0.629 . . . . 72.040000000000006 110.439 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -111.29 157.72 19.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.625 -1.25 . . . . 52.130000000000003 107.625 172.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -121.08 -87.8 0.63 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.901 -1.148 . . . . 71.420000000000002 107.901 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -104.47 162.43 13.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.826 -1.175 . . . . 74.230000000000004 107.826 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.549 ' HB3' ' N ' ' A' ' 531' ' ' ALA . 4.2 p30 -64.06 -15.41 59.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 113.718 1.007 . . . . 53.32 113.718 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.32 -19.42 63.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.736 0.303 . . . . 72.209999999999994 111.726 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 40.3 pt -107.18 163.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.82 154.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 108.153 -1.054 . . . . 62.109999999999999 108.153 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.441 ' CG ' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -119.19 162.53 18.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 104.884 -2.265 . . . . 72.519999999999996 104.884 175.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 76.6 mt -131.6 137.64 54.76 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.535 0 N-CA-C 107.954 -1.128 . . . . 71.230000000000004 107.954 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 48.7 mt -93.27 122.07 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.125 -1.805 . . . . 72.219999999999999 106.125 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 44.5 p -105.56 112.71 25.9 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.789 -0.448 . . . . 62.43 109.789 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.459 HD11 HD22 ' A' ' 589' ' ' LEU . 59.7 mt -110.85 122.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.563 -0.532 . . . . 72.140000000000001 109.563 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.492 ' HE ' ' HG3' ' A' ' 554' ' ' GLU . 23.3 mtm-85 -72.89 115.89 12.73 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.868 0.73 . . . . 73.140000000000001 110.774 174.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.0 mm -96.06 127.88 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.25 -0.886 . . . . 63.100000000000001 109.077 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -105.61 109.78 21.86 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.797 -0.816 . . . . 73.420000000000002 108.797 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 577' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 516' ' ' GLU . 7.3 p-10 -77.95 157.39 29.74 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.097 -0.956 . . . . 64.219999999999999 113.24 -171.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -131.31 175.47 9.1 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.618 -1.623 . . . . 64.439999999999998 106.618 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -99.64 -13.24 19.45 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.468 -0.493 . . . . 72.200000000000003 111.796 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -95.49 113.47 25.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 112.242 0.46 . . . . 62.530000000000001 112.242 -173.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -77.86 -8.24 57.79 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.07 -0.514 . . . . 74.129999999999995 111.854 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.468 ' HG3' ' HD2' ' A' ' 583' ' ' LYS . 6.9 pt-20 -66.17 -19.97 66.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.435 -0.348 . . . . 64.519999999999996 110.998 173.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.468 ' HD2' ' HG3' ' A' ' 582' ' ' GLU . 14.1 mptt -91.44 107.59 19.31 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.937 -0.394 . . . . 60.310000000000002 109.937 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.08 111.78 22.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.994 -1.113 . . . . 73.420000000000002 107.994 172.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.49 ' HB2' HG12 ' A' ' 645' ' ' ILE . 84.0 m -110.73 132.54 54.11 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.885 -0.726 . . . . 55.32 111.242 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 12.9 m -119.95 130.94 55.02 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.852 -0.425 . . . . 74.540000000000006 109.852 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 52.1 p90 -129.57 -179.45 5.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.375 -1.342 . . . . 75.129999999999995 107.375 171.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 8.6 t -131.72 168.16 18.24 Favored 'General case' 0 N--CA 1.409 -2.507 0 C-N-CA 119.07 -1.052 . . . . 73.299999999999997 109.926 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 573' ' ' ILE . 51.5 tp -140.57 123.25 16.23 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 105.688 -1.967 . . . . 51.439999999999998 105.688 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.46 157.06 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 116.423 -0.353 . . . . 75.099999999999994 110.185 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.669 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 64.9 mt -107.79 151.66 25.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.211 -1.033 . . . . 60.25 108.211 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -115.17 178.06 4.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.206 0.316 . . . . 72.430000000000007 110.237 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -59.34 119.17 36.88 Favored Pre-proline 0 C--O 1.245 0.856 0 O-C-N 124.161 0.913 . . . . 65.439999999999998 111.7 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.523 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 55.6 Cg_endo -71.11 157.41 57.68 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 122.883 2.388 . . . . 74.340000000000003 112.032 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -124.42 138.1 54.39 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.385 -0.825 . . . . 71.400000000000006 110.328 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 596' ' ' TRP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 633' ' ' PRO . 3.5 t90 -95.32 123.38 38.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.536 -1.283 . . . . 73.109999999999999 107.536 -178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.45 97.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.202 -1.036 . . . . 74.209999999999994 108.202 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -152.82 142.4 21.82 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 109.248 -0.649 . . . . 65.340000000000003 109.248 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 63.3 ttt-85 -143.64 139.79 29.78 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.291 -1.744 . . . . 73.430000000000007 106.291 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -132.01 -175.79 14.14 Favored Glycine 0 C--N 1.284 -2.339 0 N-CA-C 109.693 -1.363 . . . . 33.130000000000003 109.693 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 28.1 ttt -75.31 102.87 5.23 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.007 -1.479 . . . . 74.25 107.007 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -81.21 105.44 12.41 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.394 -0.821 . . . . 62.109999999999999 111.263 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 82.48 -134.36 12.89 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.282 -0.727 . . . . 65.150000000000006 111.282 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -151.69 -151.56 5.65 Favored Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 111.201 -0.76 . . . . 41.310000000000002 111.201 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 57.0 65.83 1.3 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.573 1.149 . . . . 75.109999999999999 111.222 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 606' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 607' ' ' ILE . 59.5 m -137.65 86.2 2.17 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.407 0.622 . . . . 65.349999999999994 110.939 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 607' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 606' ' ' THR . 20.3 mm -130.76 96.85 2.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.789 -1.559 . . . . 72.519999999999996 106.789 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 26.6 m 75.46 -21.86 0.29 Allowed 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.367 0.877 . . . . 61.240000000000002 113.367 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.42 -39.93 92.58 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.238 0.615 . . . . 63.439999999999998 110.456 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -83.07 92.97 7.5 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-O 122.385 1.088 . . . . 71.030000000000001 109.579 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -87.9 -30.89 19.78 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 112.945 -1.934 . . . . 70.5 107.674 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.17 109.01 11.1 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.735 -1.58 . . . . 73.540000000000006 106.735 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -96.91 -39.65 9.29 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 114.709 1.374 . . . . 72.109999999999999 114.709 -168.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -76.62 86.82 3.29 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.617 0.969 . . . . 62.200000000000003 113.617 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -163.76 150.78 10.37 Favored Pre-proline 0 C--N 1.314 -0.964 0 C-N-CA 125.153 1.381 . . . . 71.420000000000002 108.912 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.9 144.56 98.83 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 121.942 1.761 . . . . 72.450000000000003 107.699 167.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.0 97.11 0.47 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.218 0.821 . . . . 71.109999999999999 113.218 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 4.9 p -95.14 138.71 32.49 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.28 -0.873 . . . . 73.030000000000001 109.051 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 40.0 m 70.01 11.53 7.68 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.569 1.148 . . . . 65.5 111.179 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -147.02 78.16 1.48 Allowed 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.628 -1.249 . . . . 74.239999999999995 107.628 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.26 124.79 41.17 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.968 -1.014 . . . . 73.200000000000003 108.779 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 622' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' A' ' 624' ' ' GLU . 0.0 OUTLIER -126.18 -171.68 2.44 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.587 -0.733 . . . . 62.009999999999998 110.007 -172.301 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.46 -25.88 59.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.234 0.54 . . . . 74.340000000000003 111.516 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.531 ' H ' ' HG2' ' A' ' 622' ' ' GLU . 4.1 mp0 -67.34 -12.66 60.73 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.814 -0.63 . . . . 74.129999999999995 111.659 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -38.7 91.99 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 108.007 -1.108 . . . . 73.400000000000006 108.007 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 630' ' ' MET . 38.8 ttp180 -67.04 -37.64 84.46 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.868 -1.06 . . . . 73.530000000000001 109.513 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.05 -35.69 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.182 0.515 . . . . 74.519999999999996 110.221 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -66.19 -29.27 69.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.219 0.533 . . . . 72.439999999999998 110.332 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -81.89 -25.72 34.75 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.748 -0.66 . . . . 75.409999999999997 110.699 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 66.6 mtt -66.97 -35.25 79.55 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.594 -0.891 . . . . 71.430000000000007 108.594 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -81.73 44.44 3.11 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.798 -1.092 . . . . 73.409999999999997 112.306 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 633' ' ' PRO . 98.2 mtt180 -124.2 140.88 35.88 Favored Pre-proline 0 C--N 1.292 -1.92 0 N-CA-C 106.246 -1.761 . . . . 64.400000000000006 106.246 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 11.9 Cg_exo -72.41 150.77 52.75 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.981 1.787 . . . . 75.439999999999998 111.454 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 50.9 pt -126.44 145.81 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 N-CA-C 107.361 -1.348 . . . . 74.230000000000004 107.361 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 635' ' ' LEU . 2.2 pt? -87.41 -170.18 2.92 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 115.584 -0.734 . . . . 73.349999999999994 111.618 -171.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -61.85 144.36 48.95 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.632 -0.987 . . . . 34.030000000000001 110.632 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.08 -51.88 67.52 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.168 0.508 . . . . 75.239999999999995 110.127 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -123.25 104.35 9.09 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.368 0.604 . . . . 75.120000000000005 109.835 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.0 t -133.22 116.53 16.32 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.627 -0.879 . . . . 71.25 108.627 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -145.39 142.0 28.95 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.453 -0.943 . . . . 73.439999999999998 108.453 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.8 tp -121.84 110.45 15.9 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.932 -0.766 . . . . 64.530000000000001 108.932 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.562 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.5 mt-10 -88.28 112.42 22.79 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.043 -1.095 . . . . 75.209999999999994 108.043 174.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.41 120.67 51.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.976 -1.011 . . . . 75.140000000000001 108.838 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 23.5 mt -119.06 114.45 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-N 114.878 -1.055 . . . . 75.129999999999995 111.159 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.523 ' H ' HD13 ' A' ' 645' ' ' ILE . 0.0 OUTLIER -89.31 108.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.423 -1.325 . . . . 71.519999999999996 107.423 175.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.79 153.28 28.07 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.489 -1.232 . . . . 73.430000000000007 108.073 -172.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -80.79 79.09 7.5 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 104.884 -2.265 . . . . 70.030000000000001 104.884 168.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.5 t -92.05 121.18 33.37 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 114.993 -1.003 . . . . 62.039999999999999 109.542 -170.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -110.22 121.1 44.48 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 120.45 -0.5 . . . . 63.539999999999999 110.169 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -147.39 120.76 9.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.116 -1.438 . . . . 74.310000000000002 107.116 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -95.91 102.02 13.76 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 108.958 -0.756 . . . . 75.349999999999994 108.958 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -93.85 123.16 37.02 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 119.971 -0.692 . . . . 74.030000000000001 110.01 175.341 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 25.9 t -98.06 135.58 39.54 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.39 -0.823 . . . . 62.32 110.071 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 38.3 m -114.89 112.9 23.45 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.947 -1.131 . . . . 73.200000000000003 107.947 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 27.3 t -78.99 132.51 32.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.47 -0.567 . . . . 72.129999999999995 109.47 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 C--N 1.302 -1.464 0 CA-C-N 115.837 -0.619 . . . . 55.329999999999998 109.855 -178.141 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 122.168 0.985 . . . . 62.219999999999999 109.068 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -83.88 -60.39 2.12 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.032 -0.985 . . . . 64.209999999999994 110.376 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -177.89 124.49 0.94 Allowed Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.323 -0.941 . . . . 43.240000000000002 112.906 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.1 mt -127.15 114.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.126 -2.176 . . . . 73.239999999999995 105.126 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.533 ' CE1' ' HD2' ' A' ' 527' ' ' ARG . 97.6 m-85 -113.84 128.94 56.61 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.91 -0.316 . . . . 74.510000000000005 110.309 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.44 148.97 30.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.969 -0.56 . . . . 64.049999999999997 110.11 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -67.31 154.08 42.15 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 110.323 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.16 -55.4 35.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.096 -0.705 . . . . 74.439999999999998 109.096 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -127.48 157.38 73.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.914 -1.039 . . . . 72.319999999999993 108.899 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -88.99 -13.76 2.99 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.403 2.069 . . . . 72.230000000000004 113.002 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 642' ' ' GLU . 91.4 t -143.45 133.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.66 -0.496 . . . . 40.200000000000003 109.66 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.3 t -134.51 133.23 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.64 -0.504 . . . . 64.319999999999993 109.64 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 649' ' ' TYR . 69.9 m80 -108.85 112.1 24.16 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.301 -1.0 . . . . 64.129999999999995 108.301 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 645' ' ' ILE . 24.1 m -121.26 162.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.146 0.498 . . . . 54.310000000000002 110.919 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 518' ' ' ILE . 37.0 m -77.19 149.63 35.53 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.198 -0.455 . . . . 63.520000000000003 112.009 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.03 -27.58 69.21 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.332 0.587 . . . . 64.129999999999995 110.228 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.3 m -110.59 28.63 8.49 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.762 -0.654 . . . . 73.120000000000005 111.143 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 515' ' ' SER . 10.0 tt -76.89 -28.33 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.101 0.477 . . . . 63.350000000000001 111.417 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.43 -77.8 0.84 Allowed Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.081 -0.808 . . . . 75.409999999999997 111.081 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.2 mm -130.14 146.22 34.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.691 -1.226 . . . . 54.009999999999998 107.691 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.0 ppp? -119.6 153.64 35.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.968 -1.493 . . . . 73.140000000000001 106.968 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -128.13 126.57 41.36 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.068 0.23 . . . . 74.230000000000004 111.153 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.468 HG21 HD21 ' A' ' 641' ' ' LEU . 55.5 t -134.37 131.35 54.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.223 -0.658 . . . . 64.010000000000005 109.223 174.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.42 ' HG2' HG12 ' A' ' 570' ' ' ILE . 55.2 mttp -90.76 151.07 21.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.142 0.496 . . . . 62.539999999999999 110.171 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.0 t -103.95 113.45 40.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 105.964 -1.865 . . . . 64.400000000000006 105.964 172.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.09 134.84 34.46 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.118 -0.492 . . . . 64.439999999999998 110.189 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.685 ' HD3' ' HB2' ' A' ' 531' ' ' ALA . 73.3 ttt180 -106.87 102.61 11.96 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.988 -1.115 . . . . 71.010000000000005 107.988 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.0 m -65.82 -47.7 74.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.588 -1.187 . . . . 71.349999999999994 113.901 -171.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.6 p -69.01 -51.35 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.357 0.873 . . . . 62.119999999999997 113.357 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 155.48 172.83 23.48 Favored Glycine 0 CA--C 1.48 -2.156 0 N-CA-C 108.644 -1.782 . . . . 43.340000000000003 108.644 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.685 ' HB2' ' HD3' ' A' ' 527' ' ' ARG . . . -150.03 121.56 7.98 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 117.658 0.729 . . . . 65.400000000000006 112.552 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.501 ' HD3' ' C ' ' A' ' 532' ' ' ARG . 0.8 OUTLIER -156.71 110.82 2.72 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.633 -0.877 . . . . 74.109999999999999 108.633 171.183 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 149.19 -142.82 10.18 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 109.614 -1.394 . . . . 75.040000000000006 109.614 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -137.43 112.76 9.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.319 -1.363 . . . . 62.200000000000003 107.319 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.95 132.15 65.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 120.676 -0.41 . . . . 61.5 111.415 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.64 116.82 47.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.716 -0.674 . . . . 72.450000000000003 109.291 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.44 111.1 65.13 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.816 -0.809 . . . . 75.230000000000004 108.816 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 594' ' ' PRO . 10.2 Cg_endo -84.6 149.02 11.32 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.945 1.764 . . . . 71.310000000000002 111.082 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -138.21 159.24 42.56 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.159 -1.052 . . . . 75.400000000000006 108.159 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 589' ' ' LEU . 57.2 pttt -151.59 137.5 18.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.452 . . . . 74.400000000000006 110.021 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -84.2 143.12 29.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.881 -0.6 . . . . 70.450000000000003 111.124 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 48.5 mm -102.37 115.72 44.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.336 -1.728 . . . . 74.319999999999993 106.336 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -73.55 109.88 7.41 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.627 0.58 . . . . 74.129999999999995 111.513 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -135.34 126.17 3.91 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.363 -1.095 . . . . 55.539999999999999 110.363 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.3 m 69.06 -49.34 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.268 2.227 . . . . 73.010000000000005 112.459 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -90.16 150.14 22.14 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.431 -0.952 . . . . 63.409999999999997 108.431 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 40.9 ttp180 -93.14 135.49 34.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.956 0.408 . . . . 71.120000000000005 110.597 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.56 -161.15 35.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.542 -0.754 . . . . 62.409999999999997 111.355 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 85.97 18.56 59.34 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.043 -1.223 . . . . 74.450000000000003 110.043 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.76 27.79 60.22 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.029 -0.829 . . . . 72.239999999999995 111.029 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 10.1 tp10 -87.67 -87.26 0.15 Allowed 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 122.849 0.459 . . . . 61.210000000000001 110.611 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 578' ' ' ARG . 32.8 t70 -90.03 -30.34 17.81 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.065 0.936 . . . . 72.540000000000006 109.208 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.92 148.74 40.9 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 106.704 -1.591 . . . . 71.319999999999993 106.704 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.455 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 0.6 OUTLIER -86.28 105.83 16.92 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 105.988 -1.856 . . . . 71.5 105.988 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.94 91.14 1.18 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.763 1.268 . . . . 74.219999999999999 109.718 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.9 t -83.33 132.77 34.99 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 113.334 -1.757 . . . . 74.450000000000003 112.252 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.0 p -139.46 119.8 13.85 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.447 -2.057 . . . . 74.430000000000007 105.447 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.89 -179.75 27.8 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 119.473 -1.346 . . . . 72.030000000000001 113.048 -173.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -105.17 111.45 24.2 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 123.977 0.911 . . . . 65.439999999999998 108.703 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.99 126.86 43.6 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.57 -0.852 . . . . 71.400000000000006 109.42 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.93 98.58 8.4 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 121.468 0.651 . . . . 72.0 111.72 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 53.1 m-85 -94.37 101.78 13.73 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.591 -0.892 . . . . 73.519999999999996 108.591 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.518 ' H ' HD11 ' A' ' 567' ' ' ILE . 75.4 mt-30 -86.55 -79.59 0.26 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.73 -0.668 . . . . 51.420000000000002 109.735 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -104.63 163.48 12.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.719 -0.673 . . . . 53.130000000000003 109.701 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 531' ' ' ALA . 17.9 t70 -65.37 -21.24 66.66 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.658 1.183 . . . . 74.299999999999997 112.269 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.69 -16.65 63.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.864 0.69 . . . . 73.239999999999995 112.864 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.518 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.7 pt -112.63 160.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.539 -0.464 . . . . 72.120000000000005 110.767 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.47 144.9 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.315 -1.365 . . . . 62.439999999999998 107.315 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 73.0 mmtt -102.51 149.82 24.01 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.045 0.45 . . . . 75.200000000000003 110.756 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.42 HG12 ' HG2' ' A' ' 524' ' ' LYS . 66.2 mt -123.01 128.62 75.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.421 -1.263 . . . . 63.219999999999999 108.807 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.433 HD13 HD21 ' A' ' 589' ' ' LEU . 62.5 mt -90.76 121.72 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 107.529 -1.286 . . . . 72.5 107.529 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 572' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 521' ' ' MET . 40.1 p -110.23 113.28 25.83 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.801 -0.636 . . . . 52.119999999999997 109.411 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 589' ' ' LEU . 61.0 mt -103.97 122.5 56.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.061 -1.089 . . . . 71.299999999999997 108.061 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.455 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 80.3 mtt85 -75.76 115.92 15.94 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.868 0.73 . . . . 61.25 109.522 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.05 139.56 19.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.212 -1.403 . . . . 73.019999999999996 107.212 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -128.1 163.04 25.49 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.194 0.521 . . . . 74.540000000000006 110.166 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.3 87.34 3.61 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.781 -1.562 . . . . 50.32 106.781 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 552' ' ' ASP . 38.3 mmt180 -132.93 -27.7 1.63 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.427 1.64 . . . . 73.340000000000003 115.427 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.463 ' HG3' ' SG ' ' A' ' 585' ' ' CYS . 64.5 mm-40 -67.55 101.64 1.03 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.952 0.882 . . . . 75.010000000000005 110.82 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -78.49 -47.78 16.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.353 -1.748 . . . . 73.219999999999999 111.951 -170.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -98.56 -21.05 16.7 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.295 -0.562 . . . . 62.439999999999998 111.917 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 579' ' ' GLU . 10.5 tp10 -75.26 149.73 38.76 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.69 0.281 . . . . 73.519999999999996 110.709 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -92.21 -49.46 6.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.849 -0.614 . . . . 54.539999999999999 109.976 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.65 137.7 38.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.562 -0.745 . . . . 73.230000000000004 109.285 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.469 ' HB2' HG12 ' A' ' 645' ' ' ILE . 59.2 m -122.85 140.35 53.04 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.973 -0.751 . . . . 65.420000000000002 108.973 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 27.4 p -139.43 113.53 8.81 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.492 0.663 . . . . 71.25 111.229 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.3 p90 -109.81 -178.43 3.53 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.169 -1.049 . . . . 70.150000000000006 108.169 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 19.7 m -135.01 167.52 20.79 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.989 -0.684 . . . . 61.219999999999999 110.447 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 573' ' ' ILE . 51.7 tp -137.97 132.49 32.4 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.55 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.663 -0.495 . . . . 71.219999999999999 109.663 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.39 145.31 29.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.7 -0.682 . . . . 73.299999999999997 109.304 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.71 174.19 6.07 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.679 -0.86 . . . . 61.32 108.679 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -66.03 116.8 36.3 Favored Pre-proline 0 C--O 1.246 0.888 0 CA-C-O 121.106 0.479 . . . . 44.43 111.766 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 538' ' ' PRO . 44.4 Cg_endo -71.28 147.56 53.52 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.422 2.081 . . . . 71.129999999999995 111.573 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -113.12 140.27 48.03 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 109.402 -0.592 . . . . 64.239999999999995 109.402 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -92.42 127.57 37.96 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.148 -1.797 . . . . 75.430000000000007 106.148 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 34.6 mm -83.3 109.98 17.66 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 108.692 -0.855 . . . . 75.150000000000006 108.692 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 598' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 600' ' ' GLY . 16.2 mmm180 -72.33 99.3 2.39 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 114.39 -1.277 . . . . 63.240000000000002 111.457 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -69.49 -38.46 77.65 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.539 -1.652 . . . . 73.319999999999993 106.539 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 600' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 598' ' ' ARG . . . -84.35 111.94 3.54 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 106.576 -2.61 . . . . 62.439999999999998 106.576 169.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 57.6 ttp -66.19 99.46 0.53 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.243 0.831 . . . . 54.539999999999999 113.243 -171.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -164.56 101.95 0.82 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.869 -1.9 . . . . 72.239999999999995 105.869 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -76.56 170.19 54.95 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.962 -0.563 . . . . 75.420000000000002 112.974 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -95.39 119.97 6.36 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 108.809 -1.716 . . . . 33.25 108.809 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -74.43 91.78 2.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.043 -0.725 . . . . 73.340000000000003 109.043 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 21.2 m -129.68 134.18 47.51 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 106.367 -1.716 . . . . 74.329999999999998 106.367 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.84 85.15 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.684 0.754 . . . . 71.329999999999998 110.452 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 14.0 t -125.16 7.87 7.9 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.673 1.225 . . . . 74.510000000000005 108.05 174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -79.43 -24.85 42.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.629 -1.619 . . . . 62.210000000000001 106.629 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -137.3 140.77 41.76 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 101.775 -3.417 . . . . 73.200000000000003 101.775 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -81.55 99.15 8.66 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.305 -1.358 . . . . 71.549999999999997 112.49 -173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.75 125.97 35.86 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 104.199 -2.519 . . . . 73.019999999999996 104.199 170.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.17 143.91 55.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.998 -0.681 . . . . 74.219999999999999 110.289 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -53.25 -37.08 61.77 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.807 0.669 . . . . 72.329999999999998 112.807 -174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -107.66 145.04 30.5 Favored Pre-proline 0 C--N 1.316 -0.863 0 C-N-CA 120.0 -0.68 . . . . 71.349999999999994 110.28 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.04 169.21 18.02 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.113 1.875 . . . . 72.200000000000003 110.774 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.55 -26.73 24.36 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.597 0.713 . . . . 71.319999999999993 109.528 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.68 169.01 14.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.992 -1.004 . . . . 54.530000000000001 110.242 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 17.7 m -85.42 26.67 0.89 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.187 0.518 . . . . 65.219999999999999 112.085 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -103.36 81.27 1.91 Allowed 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.64 -0.663 . . . . 74.439999999999998 110.295 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -102.67 108.0 19.1 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.465 -1.309 . . . . 71.230000000000004 107.465 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.33 127.0 29.95 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.994 1.109 . . . . 73.129999999999995 113.994 -170.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.71 -31.2 59.57 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.693 -1.139 . . . . 71.430000000000007 108.034 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.4 -26.7 68.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.426 -1.261 . . . . 65.510000000000005 110.279 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 2.2 mmm180 -60.71 -43.56 97.66 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 115.879 -0.6 . . . . 70.420000000000002 110.175 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' A' ' 630' ' ' MET . 29.7 tpt180 -73.19 -35.88 66.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.625 -0.43 . . . . 74.120000000000005 110.198 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 630' ' ' MET . 90.3 mt -63.4 -37.59 79.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.927 -0.397 . . . . 51.310000000000002 109.927 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.63 81.8 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.138 -0.483 . . . . 73.349999999999994 109.976 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 44.1 mt-10 -67.78 -19.22 65.07 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.171 -0.468 . . . . 65.120000000000005 111.345 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.524 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 67.9 mtt -68.27 -16.26 63.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.344 0.592 . . . . 75.129999999999995 110.248 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -107.69 23.12 26.88 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.035 -1.226 . . . . 75.049999999999997 110.035 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -133.65 163.67 49.49 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 106.975 -1.491 . . . . 63.43 106.975 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 64.5 Cg_endo -86.81 126.19 2.47 Favored 'Trans proline' 0 N--CA 1.435 -1.921 0 C-N-CA 120.816 1.011 . . . . 73.329999999999998 110.51 174.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.52 -177.41 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.014 0.435 . . . . 63.210000000000001 111.001 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.27 -174.38 4.15 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.903 -0.777 . . . . 73.030000000000001 108.903 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -81.69 -152.8 10.09 Favored Glycine 0 C--N 1.306 -1.106 0 C-N-CA 120.452 -0.88 . . . . 71.420000000000002 112.272 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -64.85 -42.0 95.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.85 0.833 . . . . 74.409999999999997 109.232 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -167.41 145.34 4.7 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 125.583 1.553 . . . . 73.040000000000006 107.068 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.1 t -153.29 116.53 4.61 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.824 0.821 . . . . 63.420000000000002 110.446 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -146.19 142.93 28.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.714 -1.217 . . . . 73.310000000000002 107.714 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 523' ' ' VAL . 45.5 tp -121.97 113.01 18.99 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.743 -0.836 . . . . 74.319999999999993 108.743 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.433 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.1 mt-10 -92.35 122.86 35.22 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.816 -1.179 . . . . 73.010000000000005 107.816 176.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.12 117.53 55.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 109.243 -0.651 . . . . 63.439999999999998 109.243 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.04 123.42 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.717 0 N-CA-C 108.059 -1.089 . . . . 73.519999999999996 108.059 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.1 OUTLIER -106.23 115.43 47.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.501 0.667 . . . . 63.119999999999997 110.399 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -161.06 -75.43 0.06 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.499 -1.297 . . . . 75.230000000000004 107.499 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -153.18 161.75 42.08 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.178 -2.156 . . . . 73.209999999999994 105.178 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 50.1 m -78.51 79.4 4.94 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.195 0.998 . . . . 74.040000000000006 110.451 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 513' ' ' HIS . 9.0 t80 -93.55 128.8 39.85 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.386 -2.079 . . . . 74.129999999999995 105.386 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -100.89 104.91 16.13 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 118.354 -1.339 . . . . 72.120000000000005 110.077 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -136.73 124.8 22.91 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.657 -1.156 . . . . 74.099999999999994 108.777 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -106.19 143.24 34.6 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.48 -0.933 . . . . 52.130000000000003 108.48 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 14.2 m -89.61 103.46 16.1 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.595 -1.261 . . . . 72.140000000000001 107.595 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 35.3 m -144.02 106.16 4.37 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.082 -1.081 . . . . 74.25 108.082 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.14 131.86 70.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.996 -0.547 . . . . 74.530000000000001 110.317 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 C--N 1.299 -1.608 0 CA-C-N 115.605 -0.725 . . . . 51.32 110.202 178.1 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.4 p80 . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.254 0.549 . . . . 64.25 109.866 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -111.66 150.83 29.58 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.554 -0.748 . . . . 34.539999999999999 110.084 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -90.4 123.53 7.08 Favored Glycine 0 N--CA 1.421 -2.341 0 N-CA-C 111.128 -0.789 . . . . 53.039999999999999 111.128 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -79.27 112.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.28 -1.378 . . . . 71.439999999999998 107.28 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 94.9 m-85 -96.3 134.94 38.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.394 0.434 . . . . 71.540000000000006 110.385 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.4 t -149.2 158.24 44.02 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 124.06 0.85 . . . . 61.130000000000003 108.948 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.5 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 64.4 m-85 -79.85 169.39 17.98 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.374 -0.602 . . . . 71.129999999999995 109.374 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 526' ' ' LEU . 48.1 mt-10 -74.69 -41.71 59.74 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.43 0.633 . . . . 73.530000000000001 109.643 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.67 161.52 61.33 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.286 -0.87 . . . . 73.140000000000001 108.934 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.03 -12.18 7.2 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.926 1.751 . . . . 75.140000000000001 112.079 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 642' ' ' GLU . 72.3 t -142.43 138.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.033 -0.729 . . . . 52.520000000000003 109.033 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.2 t -133.7 136.56 44.76 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.121 -0.696 . . . . 74.439999999999998 109.121 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -107.33 114.45 28.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.058 -0.519 . . . . 62.43 110.193 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 27.5 m -129.16 166.0 27.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.051 -0.522 . . . . 72.209999999999994 109.872 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.3 t -85.99 162.76 18.35 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.933 0.397 . . . . 71.140000000000001 110.4 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -80.95 -19.87 43.25 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.955 -1.498 . . . . 74.310000000000002 106.955 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.1 m -107.14 25.83 10.9 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.03 -0.986 . . . . 43.520000000000003 111.296 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 515' ' ' SER . 7.7 tt -87.18 -21.38 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 121.433 0.635 . . . . 73.019999999999996 111.419 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.93 -74.58 1.85 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.491 -0.862 . . . . 74.109999999999999 112.221 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.0 mm -134.97 147.12 29.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.647 -1.612 . . . . 74.140000000000001 106.647 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.2 ppp? -123.29 145.47 48.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.678 -1.23 . . . . 71.329999999999998 107.678 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -111.97 129.01 56.33 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 123.57 0.544 . . . . 62.310000000000002 111.631 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.4 t -122.07 103.95 14.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.415 -0.357 . . . . 55.409999999999997 110.227 174.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.513 ' HB3' HG12 ' A' ' 570' ' ' ILE . 17.9 ptpt -86.69 129.0 35.04 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.613 -0.884 . . . . 71.219999999999999 108.613 172.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.04 133.54 30.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.623 -0.51 . . . . 71.400000000000006 109.623 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 74.6 mt -96.89 149.23 22.11 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.946 -0.57 . . . . 63.43 110.574 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 504' ' ' ILE 0.285 0.0 OUTLIER -130.69 109.21 10.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.655 0.741 . . . . 72.510000000000005 111.397 171.918 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 14.3 m -65.04 -44.9 87.58 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.35 -1.296 . . . . 75.209999999999994 113.277 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 p -72.96 -39.73 65.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.016 0.436 . . . . 51.350000000000001 112.153 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.78 -167.0 26.83 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.685 -1.366 . . . . 73.299999999999997 109.685 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 527' ' ' ARG . . . -162.63 116.31 1.72 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.441 -0.577 . . . . 55.539999999999999 109.441 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -154.95 106.8 2.68 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.634 -1.247 . . . . 61.229999999999997 107.634 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 146.25 -140.5 8.86 Favored Glycine 0 C--N 1.298 -1.538 0 N-CA-C 110.753 -0.939 . . . . 74.409999999999997 110.753 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -136.91 101.03 4.46 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.359 -1.719 . . . . 65.400000000000006 106.359 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.48 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.254 0.55 . . . . 73.430000000000007 110.355 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 559' ' ' GLU . 45.0 mm -102.0 123.77 55.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.886 -0.783 . . . . 64.129999999999995 108.886 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.43 108.83 60.16 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.715 -0.846 . . . . 72.310000000000002 108.715 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -78.16 146.61 22.77 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 73.420000000000002 111.789 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.56 162.4 35.45 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.565 -1.272 . . . . 54.130000000000003 107.565 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -162.1 145.91 12.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.228 0.537 . . . . 74.450000000000003 111.845 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.6 p -85.82 133.84 33.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.936 -1.029 . . . . 63.219999999999999 111.078 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 43.9 mm -100.55 114.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.988 -1.486 . . . . 72.099999999999994 106.988 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.44 126.5 32.81 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.804 -0.443 . . . . 64.319999999999993 109.804 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -128.68 -94.58 0.79 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.658 -0.782 . . . . 64.010000000000005 111.661 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 18.4 p -92.12 17.61 9.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.379 1.085 . . . . 64.430000000000007 110.554 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -146.92 134.7 21.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.888 -1.523 . . . . 24.030000000000001 106.888 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.52 132.83 46.94 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 109.081 -0.711 . . . . 65.420000000000002 109.081 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -97.69 138.41 13.87 Favored Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 115.836 -0.62 . . . . 72.239999999999995 111.97 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 129.25 11.07 2.87 Favored Glycine 0 C--N 1.294 -1.752 0 C-N-CA 120.894 -0.669 . . . . 54.140000000000001 111.93 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 133.49 -17.42 4.48 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.517 -1.325 . . . . 61.119999999999997 113.671 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.86 -79.48 0.12 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.111 -0.636 . . . . 62.32 111.407 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.06 -42.75 9.78 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.974 -1.121 . . . . 71.129999999999995 107.974 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -144.53 174.07 11.26 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.149 -0.932 . . . . 70.040000000000006 109.119 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -103.42 120.56 41.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.231 -2.137 . . . . 64.120000000000005 105.231 177.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.63 139.22 45.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.55 -0.46 . . . . 74.109999999999999 110.353 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -138.54 128.67 25.59 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.813 0.816 . . . . 50.409999999999997 111.33 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.3 p -145.35 133.37 21.41 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.485 -1.302 . . . . 53.210000000000001 107.485 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.25 -165.19 31.59 Favored Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.016 -1.564 . . . . 54.310000000000002 112.718 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.401 ' HB3' HG23 ' A' ' 536' ' ' ILE . 49.8 mt-10 -109.85 116.06 30.97 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.436 0.694 . . . . 61.5 111.13 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.47 138.08 32.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.546 -0.909 . . . . 73.349999999999994 108.546 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -104.8 102.93 12.47 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.626 0.727 . . . . 74.140000000000001 111.976 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.4 m-85 -101.49 99.98 10.37 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.231 -1.025 . . . . 70.450000000000003 108.231 174.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.24 -82.59 0.13 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.933 -0.707 . . . . 61.539999999999999 110.813 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -104.83 177.16 4.93 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.765 0.793 . . . . 54.539999999999999 112.127 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.457 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 23.9 t70 -75.33 -16.21 60.43 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.728 -1.123 . . . . 72.109999999999999 112.049 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.38 -19.62 63.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.082 0.771 . . . . 70.239999999999995 113.082 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 45.0 pt -113.14 168.93 5.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.715 -1.217 . . . . 73.450000000000003 107.715 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.32 143.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.444 -0.947 . . . . 63.340000000000003 108.444 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 71.4 mmtt -98.89 142.53 30.29 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-O 121.253 0.549 . . . . 74.200000000000003 110.73 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 524' ' ' LYS . 14.7 mt -129.25 130.41 67.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.222 -1.354 . . . . 65.329999999999998 109.729 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 44.9 mt -90.23 126.7 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.155 -1.424 . . . . 61.539999999999999 107.155 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 20.9 p -112.71 113.5 25.65 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.287 -0.634 . . . . 55.200000000000003 109.287 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.43 HD11 HD22 ' A' ' 589' ' ' LEU . 71.6 mt -104.1 126.06 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 N-CA-C 108.728 -0.841 . . . . 63.420000000000002 108.728 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.5 OUTLIER -79.27 108.2 12.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.554 -1.276 . . . . 71.430000000000007 107.554 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.78 127.99 46.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.061 -1.829 . . . . 74.109999999999999 106.061 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 96.3 m-85 -95.03 141.54 28.56 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.766 -0.774 . . . . 74.430000000000007 110.731 -177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.74 90.09 2.31 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 106.749 -1.575 . . . . 75.239999999999995 106.749 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.458 ' HG3' ' OE1' ' A' ' 579' ' ' GLU . 5.0 tpm_? -114.49 -64.43 1.32 Allowed 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.791 -1.095 . . . . 70.310000000000002 109.826 -175.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.481 ' OE2' ' HG3' ' A' ' 583' ' ' LYS . 6.5 mm-40 -101.41 163.18 12.4 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.487 -0.779 . . . . 73.109999999999999 109.31 -176.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.27 6.99 0.09 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 123.981 0.801 . . . . 74.019999999999996 111.533 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -126.87 82.82 2.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 111.953 0.353 . . . . 73.340000000000003 111.953 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 42.55 56.44 3.81 Favored 'General case' 0 C--O 1.247 0.972 0 O-C-N 124.762 1.289 . . . . 73.150000000000006 112.266 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.58 ' HD2' ' SG ' ' A' ' 585' ' ' CYS . 4.7 tmtp? -104.82 129.07 53.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.422 -1.325 . . . . 65.109999999999999 107.422 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -79.95 79.03 6.53 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.048 0.451 . . . . 53.340000000000003 110.907 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 583' ' ' LYS . 75.2 m -107.52 115.3 29.91 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.937 -0.574 . . . . 72.109999999999999 109.709 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.2 m -147.05 138.28 23.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.454 -0.573 . . . . 54.43 109.454 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.1 p90 -137.13 163.63 30.37 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.312 -0.995 . . . . 75.209999999999994 108.312 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.6 m -112.94 161.37 17.08 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 119.842 -0.743 . . . . 72.319999999999993 109.828 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 573' ' ' ILE . 70.0 tp -132.71 126.32 32.26 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.458 -1.682 . . . . 71.140000000000001 106.458 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.22 158.14 28.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 120.861 0.362 . . . . 75.230000000000004 110.739 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.5 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 80.0 mt -106.41 148.04 28.59 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.914 -1.143 . . . . 65.109999999999999 107.914 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.08 177.31 4.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.772 -0.455 . . . . 52.140000000000001 109.772 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.23 122.49 73.21 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 113.077 0.769 . . . . 74.239999999999995 113.077 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.566 ' HD3' HD22 ' A' ' 635' ' ' LEU . 75.2 Cg_endo -75.17 145.85 31.36 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.888 2.392 . . . . 71.209999999999994 111.868 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -116.53 140.62 49.17 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 115.704 -0.68 . . . . 71.549999999999997 109.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -104.98 124.21 49.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.252 -1.018 . . . . 74.340000000000003 108.252 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.2 mp -88.39 103.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.604 -1.258 . . . . 64.209999999999994 107.604 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -68.64 -45.6 71.41 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.912 -1.04 . . . . 71.299999999999997 109.674 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 599' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 600' ' ' GLY . 33.3 ttp-105 -177.52 -176.84 0.64 Allowed 'General case' 0 C--O 1.249 1.03 0 N-CA-C 104.116 -2.55 . . . . 75.049999999999997 104.116 -175.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 600' ' ' GLY . . . . . 0.409 ' H ' ' HG2' ' A' ' 599' ' ' ARG . . . -68.03 98.51 0.5 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 105.964 -2.855 . . . . 54.119999999999997 105.964 166.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 12.8 tpt -79.79 88.33 5.23 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.05 1.13 . . . . 62.43 114.05 -165.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -101.5 95.74 6.67 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.074 -1.824 . . . . 74.409999999999997 106.074 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 151.15 32.71 0.04 OUTLIER Glycine 0 C--N 1.296 -1.65 0 N-CA-C 110.595 -1.002 . . . . 43.119999999999997 110.595 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -152.92 49.26 0.52 Allowed Glycine 0 CA--C 1.483 -1.945 0 N-CA-C 105.96 -2.856 . . . . 72.430000000000007 105.96 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -59.82 103.71 0.23 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.168 -1.516 . . . . 74.120000000000005 112.82 -170.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 11.2 m -137.23 91.3 2.6 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 105.923 -1.88 . . . . 74.319999999999993 105.923 175.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.55 134.25 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.879 -0.785 . . . . 73.409999999999997 108.879 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 34.3 m 64.1 67.2 0.61 Allowed 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 122.339 1.066 . . . . 74.439999999999998 109.121 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.25 -23.93 19.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.11 -0.95 . . . . 63.240000000000002 111.418 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.68 81.2 5.85 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.893 -1.151 . . . . 71.400000000000006 107.893 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -146.35 107.17 4.12 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 113.912 -1.494 . . . . 65.319999999999993 107.736 -174.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.32 -18.96 43.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.456 -0.793 . . . . 74.540000000000006 111.506 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.76 95.14 3.96 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 107.831 -1.174 . . . . 74.450000000000003 107.831 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -62.3 139.86 58.51 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.69 0.757 . . . . 71.530000000000001 112.355 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -90.58 161.58 36.16 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 114.47 -1.241 . . . . 73.519999999999996 108.973 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.64 137.74 65.72 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.711 1.607 . . . . 74.209999999999994 108.503 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.72 105.16 11.74 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.926 -0.398 . . . . 74.120000000000005 109.926 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 39.0 p -67.23 125.08 24.93 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.173 -0.677 . . . . 70.420000000000002 109.173 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.3 m -77.38 -2.95 37.71 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.923 0.392 . . . . 61.140000000000001 111.946 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 161.14 39.8 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.225 -1.398 . . . . 72.150000000000006 107.225 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 70.87 7.19 6.13 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.755 1.222 . . . . 73.450000000000003 113.291 175.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.61 145.89 43.07 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.864 -1.161 . . . . 73.319999999999993 107.864 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -86.25 136.34 33.21 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 106.64 -1.615 . . . . 63.140000000000001 106.64 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -57.46 115.65 2.87 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 122.065 0.936 . . . . 72.450000000000003 112.466 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.525 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 10.1 ttm180 -62.91 -35.13 79.04 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.513 -1.676 . . . . 62.32 111.057 -173.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 626' ' ' ARG . 2.5 tpm_? -62.4 -39.38 93.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.086 0.469 . . . . 74.540000000000006 110.224 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.75 -38.16 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.58 -0.526 . . . . 61.25 109.58 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.567 ' O ' ' HG2' ' A' ' 632' ' ' ARG . . . -59.84 -41.38 91.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.872 -0.604 . . . . 54.119999999999997 110.461 177.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 44.1 mt-10 -67.49 -37.08 82.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.945 -0.571 . . . . 73.230000000000004 110.768 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 75.4 mtm -66.77 -31.73 72.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.652 0.263 . . . . 64.5 111.404 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -80.72 -8.61 87.31 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.952 -0.642 . . . . 43.310000000000002 112.703 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 628' ' ' ALA . 39.2 mmt180 -77.19 145.77 73.61 Favored Pre-proline 0 C--N 1.32 -0.704 0 O-C-N 122.617 -0.343 . . . . 74.140000000000001 111.105 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 632' ' ' ARG . 7.8 Cg_exo -71.94 141.28 36.52 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.29 1.993 . . . . 71.239999999999995 110.047 174.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 36.0 pt -128.01 162.71 33.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.953 -0.388 . . . . 71.109999999999999 109.953 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.566 HD22 ' HD3' ' A' ' 594' ' ' PRO . 2.5 pt? -112.0 -163.13 0.83 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.62 -1.252 . . . . 75.140000000000001 107.62 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.33 143.48 47.26 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.646 -1.382 . . . . 74.239999999999995 109.646 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.92 -39.49 72.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.722 -0.391 . . . . 75.200000000000003 111.558 -173.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -124.55 107.79 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.347 -0.541 . . . . 64.530000000000001 110.497 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 115.42 5.18 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.742 0.782 . . . . 74.439999999999998 109.397 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -147.9 127.9 13.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.664 -0.865 . . . . 74.329999999999998 108.664 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.93 112.34 25.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.645 -0.502 . . . . 64.230000000000004 109.645 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.463 ' HB2' HG22 ' A' ' 511' ' ' VAL . 45.0 mt-10 -89.76 113.45 24.98 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.605 0.717 . . . . 63.399999999999999 109.438 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 36.7 t -100.43 115.53 41.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.387 -1.279 . . . . 64.230000000000004 108.439 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 21.2 mt -112.32 126.78 69.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 CA-C-N 114.823 -1.081 . . . . 54.43 109.169 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 514' ' ' VAL . 0.0 OUTLIER -106.85 112.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.818 -0.628 . . . . 73.120000000000005 112.582 -176.048 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -176.13 146.89 0.7 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.519 -2.03 . . . . 75.530000000000001 105.519 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -67.04 118.5 10.58 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 119.153 0.888 . . . . 73.219999999999999 111.818 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 9.1 m -86.93 91.05 8.55 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-N 114.723 -1.126 . . . . 65.219999999999999 111.032 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -106.79 -24.66 12.01 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.908 0.861 . . . . 63.039999999999999 109.15 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -84.3 175.36 9.45 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.87 -1.53 . . . . 75.319999999999993 106.87 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 651' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 653' ' ' SER . 64.3 t80 -115.92 89.75 3.18 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.596 -0.842 . . . . 74.129999999999995 111.209 -176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -87.44 83.56 7.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.292 0.568 . . . . 71.450000000000003 109.764 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 653' ' ' SER . . . . . 0.443 ' HB2' ' CE2' ' A' ' 651' ' ' PHE . 50.8 m -154.59 166.12 34.34 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.42 -1.326 . . . . 60.140000000000001 107.42 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.0 m -72.31 124.78 25.8 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.737 -0.468 . . . . 63.329999999999998 109.737 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 10.1 p -130.51 147.74 33.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.49 -0.93 . . . . 74.510000000000005 108.49 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 110.116 -0.327 . . . . 65.200000000000003 110.116 -178.438 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 CA--C 1.522 -0.122 0 N-CA-C 108.93 -0.767 . . . . 74.200000000000003 108.93 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -107.24 115.19 29.73 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.208 -1.034 . . . . 73.209999999999994 108.208 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 98.66 88.24 1.93 Allowed Glycine 0 C--N 1.307 -1.053 0 N-CA-C 109.18 -1.568 . . . . 60.229999999999997 109.18 -174.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.586 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.2 mt -127.97 124.26 62.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.609 -0.515 . . . . 74.230000000000004 109.609 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.51 137.3 43.57 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.669 0.606 . . . . 71.019999999999996 110.601 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -149.18 156.28 41.93 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.248 -0.278 . . . . 72.25 110.248 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.47 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 61.4 m-85 -77.2 168.76 19.52 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.213 -1.032 . . . . 71.040000000000006 108.213 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.49 -46.94 36.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.662 0.744 . . . . 73.230000000000004 109.005 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -122.91 164.6 26.14 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 114.838 -1.074 . . . . 73.129999999999995 109.847 -174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -90.47 -19.53 1.09 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.613 2.209 . . . . 70.150000000000006 112.011 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.2 132.75 38.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.363 -0.977 . . . . 71.329999999999998 108.363 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' THR . . . . . 0.452 HG22 HD22 ' A' ' 641' ' ' LEU . 10.0 t -131.22 127.31 37.62 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.995 -0.743 . . . . 63.119999999999997 108.995 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -99.88 125.11 45.8 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.492 -0.929 . . . . 75.239999999999995 108.492 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 645' ' ' ILE . 19.8 m -134.59 162.31 39.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.408 0.623 . . . . 64.230000000000004 109.713 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.407 ' O ' HG22 ' A' ' 518' ' ' ILE . 39.3 m -80.9 157.34 25.65 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.71 -0.677 . . . . 64.049999999999997 110.284 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -77.62 -23.66 49.74 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.556 -1.276 . . . . 55.25 107.556 172.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.0 p -95.73 18.95 12.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.035 -1.439 . . . . 70.409999999999997 111.45 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 515' ' ' SER . 9.0 tt -81.77 -31.73 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.941 -0.704 . . . . 72.25 111.274 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.09 -75.27 1.59 Allowed Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.413 -0.898 . . . . 72.530000000000001 111.139 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 574' ' ' ARG . 44.2 mm -126.65 125.67 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.377 -0.972 . . . . 62.219999999999999 108.377 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -97.36 147.22 24.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.357 -0.979 . . . . 64.430000000000007 108.357 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -118.15 115.49 24.91 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.282 0.633 . . . . 60.030000000000001 112.238 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 36.8 t -109.92 124.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.182 -0.463 . . . . 63.020000000000003 110.56 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.33 127.99 41.83 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.795 -0.817 . . . . 72.0 108.795 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.56 118.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 75.019999999999996 109.032 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.7 mt -93.46 148.34 22.16 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.312 -0.858 . . . . 74.219999999999999 109.514 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 102.92 12.28 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.029 -2.582 . . . . 74.319999999999993 104.029 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 10.4 t -66.86 -46.64 74.4 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.844 -0.742 . . . . 71.109999999999999 110.583 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' SER . . . . . 0.586 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 30.1 t -74.4 -45.28 47.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.2 0.524 . . . . 71.0 110.095 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.57 -168.83 23.72 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 109.802 -1.319 . . . . 63.32 109.802 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -156.08 137.68 14.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.652 -0.87 . . . . 31.120000000000001 108.652 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -155.81 103.85 2.28 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.952 . . . . 63.43 108.431 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 137.76 -131.08 5.32 Favored Glycine 0 C--N 1.308 -0.991 0 N-CA-C 110.826 -0.909 . . . . 73.409999999999997 110.826 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -136.98 102.5 4.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.337 -1.357 . . . . 54.140000000000001 107.337 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 26.5 t -121.56 122.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.885 -0.726 . . . . 72.030000000000001 111.421 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.429 HG12 HD13 ' A' ' 597' ' ' ILE . 38.7 mm -88.17 120.98 37.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.483 -1.302 . . . . 70.420000000000002 107.483 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.4 t -110.42 104.77 56.42 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.062 -0.718 . . . . 64.319999999999993 109.062 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.497 ' HG2' ' HB3' ' A' ' 592' ' ' GLU . 14.8 Cg_endo -85.16 163.28 11.47 Favored 'Trans proline' 0 N--CA 1.419 -2.89 0 C-N-CA 121.475 1.45 . . . . 74.420000000000002 111.375 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.436 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.6 p90 -149.91 164.29 35.81 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.046 -1.835 . . . . 73.340000000000003 106.046 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.15 133.01 16.03 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.22 -0.592 . . . . 74.430000000000007 111.089 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 555' ' ' ASP . 17.7 p -82.35 121.15 26.33 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.843 -1.071 . . . . 71.329999999999998 109.719 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.72 116.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.289 -1.374 . . . . 71.329999999999998 107.289 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -72.47 110.05 6.59 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.704 0.628 . . . . 61.439999999999998 110.129 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -98.54 -107.68 2.71 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.809 -0.917 . . . . 43.049999999999997 110.809 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.1 p -85.04 -20.59 30.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.571 0.701 . . . . 73.319999999999993 109.901 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.26 134.3 35.6 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.893 -1.151 . . . . 72.219999999999999 107.893 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -92.26 138.42 31.54 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 120.832 0.349 . . . . 73.200000000000003 111.7 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.1 -158.58 20.51 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 111.147 -0.781 . . . . 61.310000000000002 111.147 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.91 17.14 79.29 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.198 -0.761 . . . . 75.519999999999996 111.198 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.16 32.76 60.01 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 111.372 -0.691 . . . . 60.210000000000001 111.372 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.28 -71.23 0.64 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.804 -0.813 . . . . 74.230000000000004 108.804 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.53 -31.01 13.53 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.556 -1.275 . . . . 73.099999999999994 107.556 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.97 150.08 33.35 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 115.276 -0.875 . . . . 72.299999999999997 109.045 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.4 tm-20 -87.14 105.63 17.32 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 105.929 -1.878 . . . . 74.329999999999998 105.929 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.447 ' HB2' ' OG1' ' A' ' 541' ' ' THR . 7.5 p-10 -76.65 135.29 39.13 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.84 0.828 . . . . 70.230000000000004 111.321 -173.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 3.2 t -133.53 148.98 51.69 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.026 -0.988 . . . . 71.209999999999994 110.548 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.9 p -148.33 111.29 4.84 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.136 0.574 . . . . 74.129999999999995 110.925 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 101.51 -164.02 17.76 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.95 -0.643 . . . . 64.310000000000002 112.28 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 84.51 10.51 0.38 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.513 1.525 . . . . 73.030000000000001 114.024 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 569' ' ' LYS . 32.0 mt -106.4 133.43 51.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 118.977 -1.089 . . . . 71.129999999999995 111.061 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -132.1 114.97 15.17 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.919 -0.771 . . . . 72.310000000000002 108.919 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.3 m-85 -111.09 105.94 14.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.321 -0.992 . . . . 72.340000000000003 108.321 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.432 ' H ' HD11 ' A' ' 567' ' ' ILE . 49.2 mt-30 -83.89 -69.15 0.66 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.322 -0.992 . . . . 64.0 108.322 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -105.2 160.93 14.7 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.4 -0.818 . . . . 75.530000000000001 109.228 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.38 -22.63 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.077 0.465 . . . . 70.239999999999995 111.959 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.86 -6.94 9.36 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.987 1.106 . . . . 73.340000000000003 113.987 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.432 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -115.21 162.61 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.896 -0.779 . . . . 73.340000000000003 108.896 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.7 p -131.18 150.71 34.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.688 -1.227 . . . . 65.150000000000006 107.688 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -120.61 155.94 32.7 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.905 -0.405 . . . . 75.129999999999995 109.905 174.402 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.9 mt -125.34 135.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 124.275 0.984 . . . . 74.25 109.641 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.3 mt -92.32 120.92 42.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.491 -1.67 . . . . 74.420000000000002 106.491 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 31.2 p -110.52 112.79 24.94 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.615 0.572 . . . . 73.239999999999995 109.718 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 589' ' ' LEU . 70.4 mt -112.48 128.43 69.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.897 -0.779 . . . . 65.140000000000001 108.897 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.422 ' HA ' HD13 ' A' ' 520' ' ' ILE . 35.3 ttm180 -85.07 126.94 34.0 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.588 0.555 . . . . 72.209999999999994 109.526 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.2 142.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.039 -1.097 . . . . 53.32 108.039 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 76.3 m-85 -123.14 113.51 19.07 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.196 0.522 . . . . 71.040000000000006 109.787 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -84.29 2.81 38.41 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.779 -0.823 . . . . 73.409999999999997 108.779 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.516 ' HG3' ' HG2' ' A' ' 579' ' ' GLU . 33.8 ptt180 -58.78 -38.36 78.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.643 -0.708 . . . . 63.539999999999999 111.427 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 578' ' ' ARG . 26.2 mm-40 -95.9 -8.6 33.53 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 112.994 0.739 . . . . 60.229999999999997 112.994 -174.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -132.59 149.72 52.27 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 118.437 -1.305 . . . . 74.040000000000006 111.967 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -103.69 -58.71 1.83 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.56 -0.745 . . . . 73.219999999999999 109.079 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.406 ' HB2' ' OE1' ' A' ' 646' ' ' GLU . 1.6 pm0 -163.28 133.6 4.46 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.366 -0.975 . . . . 73.109999999999999 108.366 171.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -176.7 156.34 1.42 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.297 -2.112 . . . . 72.230000000000004 105.297 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -82.4 76.46 9.27 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.475 -0.89 . . . . 71.310000000000002 109.518 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 70.2 m -92.82 122.65 35.42 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.527 -0.761 . . . . 53.420000000000002 109.617 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 35.2 p -138.34 153.58 48.97 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.289 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.92 161.34 37.82 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.661 -1.237 . . . . 70.409999999999997 107.661 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.0 m -110.81 158.6 18.5 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 119.541 -0.863 . . . . 65.319999999999993 109.511 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 573' ' ' ILE . 47.0 tp -134.78 121.69 21.07 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.798 -1.186 . . . . 73.450000000000003 107.798 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.73 155.87 26.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 109.584 -0.524 . . . . 71.239999999999995 109.584 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.47 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 82.9 mt -90.96 146.63 23.72 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.137 -1.06 . . . . 71.430000000000007 108.137 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 592' ' ' GLU . . . . . 0.497 ' HB3' ' HG2' ' A' ' 538' ' ' PRO . 4.7 tp10 -107.12 175.86 5.36 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.78 -1.563 . . . . 71.140000000000001 106.78 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 0.0 OUTLIER -60.82 115.36 13.53 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 113.824 1.046 . . . . 61.240000000000002 113.824 -177.416 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 42.4 Cg_endo -73.82 141.03 29.82 Favored 'Trans proline' 0 N--CA 1.418 -2.949 0 C-N-CA 121.648 1.566 . . . . 72.109999999999999 110.623 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 129.49 56.39 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.857 -0.611 . . . . 74.319999999999993 110.702 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 596' ' ' TRP . . . . . 0.494 ' CG ' ' HB3' ' A' ' 599' ' ' ARG . 4.2 t90 -92.37 117.36 29.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 64.200000000000003 108.18 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 597' ' ' ILE . . . . . 0.531 HG22 ' HG3' ' A' ' 598' ' ' ARG . 2.5 mp -93.84 133.37 35.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 106.949 -1.5 . . . . 62.240000000000002 106.949 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 598' ' ' ARG . . . . . 0.531 ' HG3' HG22 ' A' ' 597' ' ' ILE . 88.5 mtt180 70.65 55.18 0.27 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.516 -0.92 . . . . 73.049999999999997 108.516 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 599' ' ' ARG . . . . . 0.494 ' HB3' ' CG ' ' A' ' 596' ' ' TRP . 5.3 ppt_? -103.24 26.51 8.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.867 0.841 . . . . 72.5 111.651 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 161.76 -38.64 0.39 Allowed Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.598 -1.401 . . . . 73.120000000000005 109.598 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 47.2 ttm -152.9 147.93 26.56 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.463 -0.94 . . . . 62.340000000000003 108.463 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -77.26 100.24 5.78 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.004 -2.221 . . . . 74.150000000000006 105.004 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 140.25 -138.15 8.86 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 108.844 -1.702 . . . . 51.140000000000001 108.844 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 85.85 53.73 2.95 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 108.621 -1.792 . . . . 72.510000000000005 108.621 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -64.06 107.77 1.35 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.41 -0.895 . . . . 74.420000000000002 110.164 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 15.4 m -76.59 135.54 39.21 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.572 -1.194 . . . . 73.420000000000002 108.263 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 33.0 mm -61.25 116.74 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 108.796 -0.816 . . . . 72.120000000000005 108.796 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 38.8 m 69.53 82.36 0.16 Allowed 'General case' 0 N--CA 1.422 -1.872 0 O-C-N 124.273 0.983 . . . . 61.030000000000001 111.863 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -118.97 -6.12 10.52 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.189 -1.412 . . . . 74.109999999999999 107.189 172.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -122.52 138.34 54.59 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 103.25 -2.87 . . . . 74.200000000000003 103.25 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 72.5 t80 62.99 27.48 15.93 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 123.552 1.644 . . . . 73.209999999999994 107.555 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 612' ' ' ASP . . . . . 0.517 ' OD1' ' HG2' ' A' ' 614' ' ' LYS . 16.1 t70 -88.93 146.75 24.72 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 112.913 -1.949 . . . . 74.219999999999999 111.192 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -143.99 39.51 1.35 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.684 -0.858 . . . . 64.530000000000001 108.684 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 614' ' ' LYS . . . . . 0.517 ' HG2' ' OD1' ' A' ' 612' ' ' ASP . 21.9 pttm -81.59 68.79 8.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 123.294 1.521 . . . . 73.129999999999995 110.502 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 615' ' ' GLN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 616' ' ' PRO . 35.9 tt0 -77.0 -49.73 2.4 Favored Pre-proline 0 N--CA 1.419 -2.013 0 CA-C-N 112.883 -1.962 . . . . 73.409999999999997 110.501 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 615' ' ' GLN . 1.1 Cg_endo -85.6 135.72 5.14 Favored 'Trans proline' 0 N--CA 1.42 -2.845 0 CA-C-N 120.255 1.127 . . . . 73.439999999999998 110.191 174.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 617' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 626' ' ' ARG . 2.0 mm? -89.24 -20.12 24.54 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.998 -1.482 . . . . 63.43 106.998 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 19.1 m -90.84 78.33 6.1 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 107.038 -1.468 . . . . 70.400000000000006 107.038 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 14.8 m -60.61 133.1 55.77 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.899 -1.046 . . . . 71.200000000000003 109.024 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -72.19 -23.05 61.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.037 0.446 . . . . 74.030000000000001 109.844 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.36 145.55 28.98 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.427 -1.694 . . . . 73.019999999999996 106.427 171.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.98 89.11 2.39 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.343 1.068 . . . . 62.240000000000002 109.226 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -111.64 127.53 55.78 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.868 -1.514 . . . . 74.109999999999999 109.118 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -9.49 52.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.658 0.783 . . . . 74.519999999999996 112.995 -175.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -51.77 -40.27 60.04 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 123.489 0.493 . . . . 63.299999999999997 110.017 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.655 ' O ' ' HG3' ' A' ' 630' ' ' MET . 73.9 mtm180 -56.24 -51.68 67.23 Favored 'General case' 0 C--O 1.198 -1.641 0 CA-C-N 115.111 -0.949 . . . . 64.0 110.671 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.24 -32.39 57.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.237 0.541 . . . . 64.340000000000003 110.816 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.18 62.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.097 -0.502 . . . . 44.409999999999997 109.668 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 632' ' ' ARG . 51.3 mt-10 -77.14 -8.38 57.41 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.771 0.656 . . . . 73.239999999999995 112.771 -178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.655 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 64.4 mtt -71.73 -27.69 63.16 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.234 -0.654 . . . . 73.349999999999994 109.234 170.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -117.7 73.9 0.29 Allowed Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.338 -0.846 . . . . 74.120000000000005 111.165 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 633' ' ' PRO . 11.2 ptm180 -148.72 -175.39 0.47 Allowed Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 105.045 -2.206 . . . . 73.219999999999999 105.045 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.537 ' O ' ' HG3' ' A' ' 632' ' ' ARG . 50.3 Cg_exo -59.67 126.49 20.71 Favored 'Trans proline' 0 C--N 1.358 1.031 0 N-CA-C 107.164 -1.899 . . . . 54.210000000000001 107.164 167.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 33.8 pt -127.88 -177.37 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-O 121.207 0.527 . . . . 63.049999999999997 111.125 -172.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -101.15 175.13 5.7 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.093 -1.077 . . . . 73.049999999999997 108.093 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.45 179.44 29.43 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 121.009 -0.615 . . . . 65.349999999999994 112.478 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 637' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 638' ' ' HIS . 12.3 tp10 -52.5 -60.91 2.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.74 -0.837 . . . . 73.0 108.74 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 638' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 637' ' ' GLU . 37.2 m80 -136.46 114.71 11.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.895 -1.52 . . . . 65.109999999999999 106.895 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.7 t -134.19 109.25 8.76 Favored 'General case' 0 N--CA 1.41 -2.433 0 C-N-CA 119.178 -1.009 . . . . 64.310000000000002 109.979 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -149.35 137.63 20.74 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.45 -1.25 . . . . 74.120000000000005 108.13 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 512' ' ' THR . 9.3 mt -104.07 116.65 32.61 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.384 -0.599 . . . . 43.020000000000003 109.384 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.29 113.74 26.08 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.441 -1.689 . . . . 72.310000000000002 106.441 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.4 117.82 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 114.435 -1.257 . . . . 71.5 109.143 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -105.01 127.99 59.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.926 -1.033 . . . . 73.439999999999998 108.406 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.405 HG22 HG23 ' A' ' 514' ' ' VAL . 0.0 OUTLIER -112.96 90.04 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.323 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 646' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 647' ' ' GLU . 6.7 tp10 -171.81 95.27 0.16 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.525 -1.216 . . . . 63.420000000000002 110.085 -176.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 646' ' ' GLU . 5.3 tp10 171.04 94.71 0.0 OUTLIER 'General case' 0 C--O 1.242 0.705 0 O-C-N 124.141 0.901 . . . . 74.319999999999993 111.441 174.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 49.5 m -92.97 108.82 20.3 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.691 -1.596 . . . . 73.109999999999999 106.691 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -143.08 169.46 17.55 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.626 -0.509 . . . . 71.319999999999993 109.626 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -127.94 120.67 28.13 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-O 121.716 0.769 . . . . 63.240000000000002 109.786 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -118.14 115.33 24.59 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 105.99 -1.856 . . . . 75.230000000000004 105.99 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 652' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 652' ' ' LYS . 0.0 OUTLIER -82.41 86.45 6.73 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.63 0.728 . . . . 71.400000000000006 110.26 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 5.1 p -70.28 128.39 36.07 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.966 -1.015 . . . . 62.219999999999999 109.324 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 88.4 m -68.34 110.1 3.94 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.612 -0.722 . . . . 75.019999999999996 111.078 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.54 163.33 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.133 -0.94 . . . . 75.329999999999998 108.647 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 C--N 1.301 -1.54 0 N-CA-C 109.127 -0.694 . . . . 50.140000000000001 109.127 178.414 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.468 ' CD2' ' HE ' ' A' ' 532' ' ' ARG . 15.9 p-80 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 120.808 0.337 . . . . 72.0 110.299 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.32 76.82 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.121 -0.945 . . . . 74.219999999999999 110.428 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 105.88 115.88 4.11 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.328 -0.939 . . . . 73.140000000000001 113.12 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.11 114.1 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 105.367 -2.086 . . . . 51.25 105.367 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.634 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 85.8 m-85 -100.83 138.28 38.08 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 123.571 0.544 . . . . 74.420000000000002 111.103 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 3.8 t -148.27 152.85 37.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.967 -0.56 . . . . 61.219999999999999 110.385 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.488 ' HD2' ' HG1' ' A' ' 639' ' ' THR . 82.3 m-85 -71.68 158.95 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.798 -0.816 . . . . 73.319999999999993 108.798 171.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.0 -47.54 84.32 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.769 0.668 . . . . 75.430000000000007 110.638 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.5 153.9 79.4 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 107.913 -1.143 . . . . 61.399999999999999 107.913 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.3 Cg_endo -81.39 -18.76 8.19 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.06 1.84 . . . . 73.140000000000001 112.747 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' A' ' 642' ' ' GLU . 68.7 t -138.82 136.45 43.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.183 -1.043 . . . . 72.299999999999997 108.183 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.1 t -133.51 128.97 36.47 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.42 0.629 . . . . 43.520000000000003 109.607 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -97.96 117.43 32.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.985 -0.746 . . . . 62.43 108.985 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.54 174.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 121.421 0.629 . . . . 64.120000000000005 109.777 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 518' ' ' ILE . 5.2 m -98.63 150.99 21.18 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.615 -0.72 . . . . 74.319999999999993 110.052 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -66.78 -27.87 67.93 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.383 -0.969 . . . . 73.439999999999998 108.383 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.1 m -103.04 20.82 16.87 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 114.568 -1.196 . . . . 64.219999999999999 111.801 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 515' ' ' SER . 10.6 tt -78.31 -28.09 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 121.446 -0.784 . . . . 55.039999999999999 112.678 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.41 -75.04 1.9 Allowed Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.332 -0.937 . . . . 72.400000000000006 111.483 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 574' ' ' ARG . 45.8 mm -133.61 144.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 107.672 -1.233 . . . . 61.32 107.672 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 18.4 ptm -117.96 128.5 54.86 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.254 -0.647 . . . . 74.040000000000006 109.254 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -100.38 120.31 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.838 0.711 . . . . 71.519999999999996 110.512 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 641' ' ' LEU . 59.1 t -126.55 131.74 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.306 -0.627 . . . . 74.219999999999999 109.306 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 570' ' ' ILE . 61.9 mttp -95.62 149.97 20.87 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.817 0.818 . . . . 74.120000000000005 111.938 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.52 113.06 42.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 106.984 -1.487 . . . . 73.239999999999995 106.984 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 79.5 mt -90.17 160.31 16.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.295 -0.866 . . . . 72.430000000000007 110.147 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 104.3 9.14 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.224 -1.028 . . . . 72.109999999999999 108.224 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.5 m -65.85 -52.67 48.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.669 0.747 . . . . 75.200000000000003 109.776 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 30.6 t -73.52 -52.25 14.2 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.932 . . . . 62.140000000000001 111.26 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.77 -156.78 26.8 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 109.681 -1.368 . . . . 64.209999999999994 109.681 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.1 137.07 3.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.957 -0.756 . . . . 75.340000000000003 108.957 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.468 ' HE ' ' CD2' ' A' ' 501' ' ' HIS . 28.2 mtm180 -148.66 148.45 30.09 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 123.427 0.691 . . . . 74.0 109.186 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 85.7 -124.47 6.85 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.84 -0.695 . . . . 73.099999999999994 111.865 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -137.38 104.36 5.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.927 -0.768 . . . . 74.310000000000002 108.927 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.54 125.81 74.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.521 0.677 . . . . 60.009999999999998 110.856 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 559' ' ' GLU . 30.7 mm -96.51 119.54 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.69 -0.687 . . . . 62.119999999999997 109.262 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 50.1 t -106.89 103.11 45.99 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.249 -1.019 . . . . 53.109999999999999 108.249 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.71 147.37 27.72 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.798 1.666 . . . . 71.040000000000006 111.743 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.413 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 52.0 p90 -138.17 158.22 44.74 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.021 -1.103 . . . . 73.019999999999996 108.021 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -154.34 135.5 13.96 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.111 0.482 . . . . 54.119999999999997 110.818 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.54 131.24 36.72 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.976 -1.011 . . . . 64.239999999999995 110.481 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 46.3 mm -100.44 120.31 49.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.695 -0.854 . . . . 71.420000000000002 108.695 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.61 104.81 5.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.682 -0.69 . . . . 74.340000000000003 109.32 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -88.72 -122.1 1.94 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.528 -1.029 . . . . 72.439999999999998 110.528 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -6.61 58.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.923 0.868 . . . . 71.530000000000001 108.926 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.75 27.8 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.567 -1.197 . . . . 63.219999999999999 108.794 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.507 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 38.9 mmt180 -79.47 147.85 32.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.628 -1.249 . . . . 74.219999999999999 107.628 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -109.54 148.49 17.17 Favored Glycine 0 C--N 1.263 -3.498 0 CA-C-N 115.267 -0.879 . . . . 65.030000000000001 114.085 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 88.59 48.02 4.09 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.542 -0.837 . . . . 51.310000000000002 113.657 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.86 43.85 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.706 -1.235 . . . . 73.530000000000001 113.996 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 37.8 mm-40 -96.29 -84.39 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.631 0.715 . . . . 62.509999999999998 110.342 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.6 -44.37 21.15 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.772 -1.566 . . . . 73.010000000000005 106.772 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -136.39 157.58 46.45 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.421 -1.263 . . . . 71.549999999999997 108.83 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -92.24 142.05 27.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.079 -1.822 . . . . 54.420000000000002 106.079 175.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.86 100.78 11.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 72.140000000000001 110.713 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -111.29 104.47 12.95 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-O 122.582 1.182 . . . . 75.340000000000003 109.129 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.7 p -126.72 140.02 52.71 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.959 -1.497 . . . . 54.109999999999999 106.959 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 177.51 -151.32 10.8 Favored Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.487 -1.816 . . . . 42.329999999999998 113.261 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.1 OUTLIER -127.18 125.94 41.97 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.222 1.009 . . . . 55.439999999999998 112.033 -171.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.413 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 86.1 mt -100.92 135.54 42.21 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.63 -0.878 . . . . 64.219999999999999 108.63 173.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.84 109.36 21.06 Favored 'General case' 0 C--N 1.276 -2.603 0 CA-C-O 121.185 0.517 . . . . 74.019999999999996 111.011 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 51.3 m-85 -105.27 101.79 11.31 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.172 -1.047 . . . . 74.450000000000003 108.172 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -80.2 -79.18 0.15 Allowed 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.649 -0.82 . . . . 64.030000000000001 110.754 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 567' ' ' ILE . 59.4 t30 -104.8 158.14 16.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.649 -0.82 . . . . 73.329999999999998 108.953 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.13 -11.55 9.27 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.897 1.279 . . . . 74.439999999999998 113.269 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.463 ' HG3' HG23 ' A' ' 567' ' ' ILE . 12.7 pt-20 -66.92 -11.03 54.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.648 0.779 . . . . 64.129999999999995 111.966 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.463 HG23 ' HG3' ' A' ' 566' ' ' GLU . 35.3 pt -119.07 158.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.48 0.657 . . . . 74.319999999999993 110.674 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.77 143.38 41.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.087 -1.82 . . . . 64.409999999999997 106.087 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 27.1 mttm -111.14 155.99 22.05 Favored 'General case' 0 CA--C 1.469 -2.156 0 C-N-CA 119.393 -0.923 . . . . 75.219999999999999 112.973 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 524' ' ' LYS . 72.3 mt -124.45 136.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.245 -1.343 . . . . 73.25 109.773 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 59.1 mt -98.06 129.03 48.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.816 -1.55 . . . . 64.439999999999998 106.816 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.9 p -118.28 112.56 20.24 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.295 0.569 . . . . 54.229999999999997 110.777 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 589' ' ' LEU . 49.4 mt -106.4 135.47 44.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.812 -0.631 . . . . 64.340000000000003 109.969 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 70.9 mtt180 -80.06 112.01 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.198 -0.667 . . . . 73.209999999999994 109.198 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.83 131.09 49.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.337 -0.847 . . . . 51.25 108.735 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -113.85 154.8 26.84 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.57 -0.53 . . . . 73.329999999999998 109.57 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.94 13.96 17.08 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.818 -0.628 . . . . 52.43 110.889 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -98.99 99.84 10.93 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.714 -0.675 . . . . 64.400000000000006 110.81 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -110.86 146.68 36.05 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.994 -1.484 . . . . 72.430000000000007 106.994 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -73.18 -38.41 66.16 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.162 1.171 . . . . 73.439999999999998 114.162 -168.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.22 -96.91 0.46 Allowed 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.584 -0.846 . . . . 71.519999999999996 110.643 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -164.91 81.65 0.37 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.655 -1.609 . . . . 70.219999999999999 106.655 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -132.85 148.93 52.3 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.573 -1.194 . . . . 60.32 108.893 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 584' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 584' ' ' GLU . 0.9 OUTLIER -81.57 75.72 8.51 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.039 -1.837 . . . . 74.430000000000007 106.039 167.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 9.1 t -62.91 141.4 58.71 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 111.829 -2.441 . . . . 71.530000000000001 112.57 -168.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.422 ' HB3' HG12 ' A' ' 644' ' ' ILE . 44.8 p -142.82 147.74 35.94 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.261 0.553 . . . . 73.120000000000005 111.81 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -136.86 -179.88 5.97 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.028 -1.471 . . . . 73.140000000000001 107.028 173.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 588' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 22.0 m -130.85 168.43 17.28 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.342 -0.943 . . . . 75.030000000000001 110.631 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 573' ' ' ILE . 46.6 tp -142.12 132.72 25.38 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.977 -1.49 . . . . 72.519999999999996 106.977 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.75 159.27 41.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 120.54 0.21 . . . . 61.399999999999999 110.608 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 65.5 mt -101.65 147.65 26.18 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 106.17 -1.789 . . . . 33.420000000000002 106.17 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.33 177.62 4.8 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.225 -0.657 . . . . 73.120000000000005 109.225 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -61.49 118.49 37.83 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 123.411 0.445 . . . . 74.150000000000006 109.819 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.575 ' HD3' HD22 ' A' ' 635' ' ' LEU . 66.1 Cg_endo -71.99 156.57 56.0 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.451 2.101 . . . . 73.409999999999997 111.333 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -129.55 124.13 33.11 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.044 -0.526 . . . . 62.149999999999999 110.824 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 596' ' ' TRP . . . . . 0.505 ' HB2' ' HG3' ' A' ' 633' ' ' PRO . 3.1 t90 -90.0 120.87 31.57 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.32 -1.363 . . . . 74.340000000000003 107.32 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.19 94.93 3.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 107.763 -1.199 . . . . 74.340000000000003 107.763 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -88.33 113.37 23.87 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.748 -1.115 . . . . 74.109999999999999 110.271 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -79.35 -25.02 42.34 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.832 -1.173 . . . . 71.140000000000001 107.832 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -138.24 124.25 2.88 Favored Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 108.65 -1.78 . . . . 74.340000000000003 108.65 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -154.05 179.36 9.0 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 117.108 0.454 . . . . 74.340000000000003 110.922 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -64.18 123.6 19.5 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 123.892 0.745 . . . . 63.439999999999998 110.426 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -135.47 146.62 18.63 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.193 -1.163 . . . . 54.119999999999997 110.193 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 87.55 36.25 8.81 Favored Glycine 0 C--N 1.302 -1.345 0 N-CA-C 111.233 -0.747 . . . . 53.32 111.233 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -134.14 141.81 47.24 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.16 -0.681 . . . . 74.129999999999995 109.16 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 8.4 m -78.59 100.12 6.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.879 -1.156 . . . . 72.409999999999997 107.879 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 37.9 mm -83.1 -41.13 16.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.032 -0.729 . . . . 63.119999999999997 109.032 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 52.7 m -113.64 97.62 6.54 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 109.477 -0.564 . . . . 62.439999999999998 109.477 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -9.69 45.15 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.852 -0.613 . . . . 73.329999999999998 111.321 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -63.16 135.44 57.15 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 116.183 -0.462 . . . . 71.209999999999994 109.856 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -79.65 -36.6 37.53 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 123.226 0.61 . . . . 71.010000000000005 112.32 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 16.0 t70 56.34 86.12 0.07 Allowed 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.236 0.96 . . . . 72.010000000000005 110.018 -176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -138.28 -48.95 0.54 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.426 -0.807 . . . . 61.539999999999999 110.818 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 614' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 615' ' ' GLN . 0.0 OUTLIER -80.99 44.13 0.74 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 124.325 1.05 . . . . 71.010000000000005 110.138 -176.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 615' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 614' ' ' LYS . 2.0 mp0 72.51 167.67 0.12 Allowed Pre-proline 0 C--O 1.243 0.724 0 C-N-CA 124.245 1.018 . . . . 71.400000000000006 109.053 -171.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.47 132.32 51.46 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 121.386 1.391 . . . . 72.420000000000002 110.928 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -83.56 118.55 23.88 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.086 -0.961 . . . . 74.209999999999994 111.337 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 72.0 m -60.58 103.65 0.27 Allowed 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.733 -1.21 . . . . 70.140000000000001 107.733 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 15.3 m -85.56 88.37 7.51 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-O 121.746 0.784 . . . . 63.409999999999997 111.524 -171.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -92.97 75.11 4.78 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 122.658 1.218 . . . . 74.319999999999993 109.942 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -153.09 98.64 2.31 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.67 -1.604 . . . . 74.510000000000005 108.309 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.82 -21.42 18.12 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.429 -0.35 . . . . 71.25 111.156 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -73.91 -54.81 7.12 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.477 -0.329 . . . . 72.540000000000006 111.697 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -63.25 -33.72 76.12 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 119.723 -0.791 . . . . 72.439999999999998 110.645 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 71.7 ttt180 -59.06 -49.55 77.47 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 123.842 0.714 . . . . 72.549999999999997 110.249 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.581 ' HA ' ' HE ' ' A' ' 626' ' ' ARG . 0.3 OUTLIER -57.17 -43.84 82.97 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.278 0.361 . . . . 65.120000000000005 110.694 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.3 -44.44 91.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.446 -0.343 . . . . 74.239999999999995 110.76 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -62.41 -35.85 80.51 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.356 0.598 . . . . 50.350000000000001 110.572 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 71.8 mt-10 -73.2 -22.99 60.34 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 115.948 -0.569 . . . . 62.200000000000003 110.898 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 76.3 mtm -79.76 0.12 32.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.326 0.584 . . . . 72.299999999999997 111.146 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.21 15.91 32.78 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.001 -0.84 . . . . 63.020000000000003 111.001 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -146.58 167.66 13.33 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 106.488 -1.671 . . . . 73.329999999999998 106.488 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.505 ' HG3' ' HB2' ' A' ' 596' ' ' TRP . 61.5 Cg_endo -70.82 135.34 27.7 Favored 'Trans proline' 0 C--O 1.262 1.678 0 C-N-CA 121.194 1.263 . . . . 65.010000000000005 110.295 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.411 HG21 ' HB3' ' A' ' 629' ' ' GLU . 0.2 OUTLIER -135.1 -176.6 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 115.431 -0.804 . . . . 64.409999999999997 109.255 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.634 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 1.9 pt? -133.55 179.02 6.48 Favored 'General case' 0 C--N 1.268 -2.966 0 C-N-CA 120.141 -0.624 . . . . 55.100000000000001 109.415 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.94 142.13 42.85 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.846 -1.302 . . . . 72.420000000000002 109.846 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -48.5 -51.05 29.15 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.141 0.977 . . . . 71.040000000000006 111.401 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -126.63 89.77 3.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.112 -0.699 . . . . 61.200000000000003 109.112 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 639' ' ' THR . . . . . 0.488 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 15.4 t -119.34 111.02 17.65 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.482 1.135 . . . . 75.120000000000005 109.477 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 640' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.9 ttmt -145.06 147.44 32.58 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.81 -1.552 . . . . 64.099999999999994 106.81 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 523' ' ' VAL . 33.6 tp -117.21 107.02 13.94 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.125 -1.065 . . . . 73.519999999999996 108.125 176.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.469 ' HB2' HG22 ' A' ' 511' ' ' VAL . 35.9 mt-10 -86.99 111.28 20.7 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.308 -0.997 . . . . 61.140000000000001 108.308 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.8 118.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.614 -1.176 . . . . 62.420000000000002 109.284 -174.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 644' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 586' ' ' SER . 17.3 mt -117.74 119.34 61.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.852 . . . . 44.240000000000002 110.166 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.4 110.45 24.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 109.221 -0.659 . . . . 74.319999999999993 109.221 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -132.22 95.23 3.61 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.642 -0.708 . . . . 65.329999999999998 110.759 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 55.55 -163.53 0.14 Allowed 'General case' 0 C--O 1.253 1.238 0 C-N-CA 124.807 1.243 . . . . 71.439999999999998 112.721 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 24.7 m -90.85 98.05 11.54 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.82 -0.807 . . . . 45.210000000000001 108.82 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -96.71 127.91 43.15 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.34 -0.985 . . . . 71.519999999999996 108.34 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -103.68 152.43 21.81 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 120.538 -0.465 . . . . 73.400000000000006 111.06 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 47.6 t80 66.49 88.21 0.11 Allowed 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.935 1.294 . . . . 71.209999999999994 112.979 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 91.12 2.92 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.237 -0.892 . . . . 72.230000000000004 108.753 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 32.6 t -73.03 129.57 38.38 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.638 -1.164 . . . . 53.310000000000002 110.977 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.3 m -96.67 114.35 25.99 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.689 -1.597 . . . . 53.299999999999997 106.689 176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 33.3 m -101.61 145.87 10.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.895 0.379 . . . . 72.400000000000006 110.57 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 109.714 -0.476 . . . . 52.350000000000001 109.714 178.655 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 . . . . . 0 CA--C 1.512 -0.512 0 CA-C-O 121.216 0.531 . . . . 71.209999999999994 110.004 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -64.09 -64.67 0.83 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.173 -0.921 . . . . 44.240000000000002 109.929 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -125.2 102.5 0.68 Allowed Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 108.532 -1.827 . . . . 75.239999999999995 108.532 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 57.1 mt -98.75 115.19 38.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.485 -0.561 . . . . 74.450000000000003 109.485 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.458 ' CE1' ' HG3' ' A' ' 527' ' ' ARG . 86.8 m-85 -103.24 139.86 38.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.034 -0.53 . . . . 73.310000000000002 111.456 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.11 154.09 39.72 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.677 -0.49 . . . . 73.25 109.677 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.648 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 58.1 m-85 -75.67 160.36 30.15 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.681 -0.489 . . . . 73.239999999999995 109.681 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.61 -49.48 75.05 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.523 0.514 . . . . 73.109999999999999 110.197 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.87 166.44 27.43 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 116.286 -0.415 . . . . 63.43 111.168 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 4.7 Cg_exo -83.67 -30.9 0.67 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.501 2.134 . . . . 75.019999999999996 111.729 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 642' ' ' GLU . 70.3 t -143.35 130.66 18.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -175.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.3 t -134.13 131.13 38.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.794 -0.817 . . . . 53.219999999999999 108.794 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -106.36 112.43 25.44 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.133 -0.692 . . . . 74.150000000000006 109.133 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 30.6 m -112.87 157.87 13.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.988 0.899 . . . . 73.099999999999994 111.523 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 68.0 m -81.79 174.02 11.72 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.5 -1.227 . . . . 70.109999999999999 110.498 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.03 -30.86 17.47 Favored 'General case' 0 CA--C 1.509 -0.596 0 O-C-N 121.741 -0.6 . . . . 71.439999999999998 110.031 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.4 m -80.23 5.89 13.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.474 -0.784 . . . . 73.340000000000003 110.798 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 4.9 tt -75.69 -28.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.159 0.505 . . . . 74.340000000000003 110.137 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 82.94 -71.61 2.98 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.785 -0.722 . . . . 55.210000000000001 113.199 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 44.6 mm -132.04 126.28 56.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.622 -0.881 . . . . 72.519999999999996 108.622 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.417 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.2 ppp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.178 -0.675 . . . . 71.430000000000007 109.178 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.61 131.69 56.86 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.27 0.628 . . . . 61.32 111.384 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 38.6 t -127.5 115.25 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 109.199 -0.667 . . . . 75.219999999999999 109.199 171.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.4 ' HG2' HG12 ' A' ' 570' ' ' ILE . 98.5 mttt -90.19 127.35 36.1 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.229 -0.588 . . . . 63.240000000000002 110.115 174.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.37 114.58 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.608 -0.886 . . . . 70.329999999999998 108.608 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 51.7 mt -93.14 143.89 25.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.051 -0.977 . . . . 75.120000000000005 110.53 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.458 ' HG3' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -105.54 104.77 14.56 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.394 -1.706 . . . . 73.310000000000002 106.394 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.8 t -66.91 -48.17 69.5 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.943 -0.703 . . . . 64.150000000000006 111.443 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.4 p -74.34 -52.44 12.2 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.495 0.664 . . . . 55.310000000000002 111.479 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 147.96 -170.15 28.64 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 109.53 -1.428 . . . . 72.010000000000005 109.53 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.19 129.24 2.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.61 -0.885 . . . . 52.109999999999999 108.61 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -153.21 81.68 1.19 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.162 0.506 . . . . 64.540000000000006 109.986 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 167.77 -129.43 1.9 Allowed Glycine 0 C--N 1.303 -1.297 0 N-CA-C 109.505 -1.438 . . . . 71.439999999999998 109.505 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -137.32 112.54 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.288 -1.375 . . . . 63.039999999999999 107.288 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.61 130.42 74.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 120.926 0.393 . . . . 71.140000000000001 110.724 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 559' ' ' GLU . 39.2 mm -100.09 113.5 35.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.633 -0.877 . . . . 73.129999999999995 108.633 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.03 102.77 44.78 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.494 -0.928 . . . . 74.519999999999996 108.494 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 4.3 Cg_endo -80.63 161.56 21.87 Favored 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 121.719 1.612 . . . . 65.409999999999997 110.949 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -151.12 163.61 38.42 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.676 -0.861 . . . . 71.219999999999999 108.676 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.425 ' HE2' ' OE2' ' A' ' 592' ' ' GLU . 61.8 pttt -148.99 137.92 21.36 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 112.679 0.622 . . . . 64.239999999999995 112.679 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 22.0 p -87.2 117.55 26.03 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 109.944 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 35.9 mm -92.18 124.54 44.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.248 -1.019 . . . . 71.310000000000002 108.248 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.41 119.33 18.46 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.325 -0.62 . . . . 73.230000000000004 109.325 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -97.96 -107.67 2.63 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.742 -1.343 . . . . 73.530000000000001 109.742 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -86.98 -25.9 24.07 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.643 0.735 . . . . 73.510000000000005 109.035 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.02 149.45 30.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.009 -0.996 . . . . 63.539999999999999 109.034 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -104.55 146.27 29.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.481 0.657 . . . . 75.319999999999993 110.833 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.55 -155.43 30.66 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 114.357 -1.292 . . . . 65.129999999999995 112.354 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.19 6.36 53.03 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 114.128 0.411 . . . . 74.0 114.128 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.78 -0.72 34.06 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.164 -1.017 . . . . 73.25 113.249 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -69.62 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.078 0.439 . . . . 64.530000000000001 110.846 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -99.76 -35.78 9.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.349 -0.611 . . . . 64.329999999999998 109.349 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.56 165.11 30.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.742 -0.663 . . . . 71.109999999999999 109.453 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.9 tm-20 -100.81 122.99 44.35 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.023 -1.473 . . . . 75.109999999999999 107.023 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.09 136.18 57.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 123.162 0.585 . . . . 73.439999999999998 111.4 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.41 ' CG2' HG12 ' A' ' 573' ' ' ILE . 9.3 t -140.56 105.78 5.03 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.043 0.925 . . . . 74.219999999999999 109.437 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 46.9 m -129.57 94.89 3.86 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 106.734 -1.58 . . . . 60.020000000000003 106.734 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -136.24 -156.93 7.63 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.378 -0.828 . . . . 44.240000000000002 111.449 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.1 OUTLIER -132.46 138.98 47.8 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.224 0.535 . . . . 52.240000000000002 110.963 -177.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 73.1 mt -105.5 141.26 37.3 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.201 -0.909 . . . . 61.530000000000001 108.775 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.417 ' HG2' ' OE1' ' A' ' 563' ' ' GLN . 32.9 tt0 -112.92 105.51 13.6 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.409 0.623 . . . . 74.310000000000002 110.398 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 55.3 m-85 -98.15 133.34 42.72 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.574 -0.739 . . . . 74.099999999999994 109.057 177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.417 ' OE1' ' HG2' ' A' ' 561' ' ' GLU . 2.4 mp0 -98.2 -85.38 0.37 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.33 1.062 . . . . 73.0 108.224 174.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -105.46 161.82 14.0 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.26 -1.336 . . . . 63.439999999999998 110.597 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.73 -13.35 31.66 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.708 1.203 . . . . 55.229999999999997 113.162 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -56.34 -37.05 69.48 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.021 0.929 . . . . 52.350000000000001 111.277 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.21 162.4 6.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.289 -0.869 . . . . 72.109999999999999 109.665 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.441 HG23 ' NH1' ' A' ' 527' ' ' ARG . 14.8 p -131.1 160.1 42.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.386 -1.339 . . . . 61.43 107.386 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.526 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -117.49 150.96 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.547 0.213 . . . . 74.030000000000001 110.499 176.048 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 65.8 mt -125.25 131.71 72.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 124.366 1.041 . . . . 72.310000000000002 108.922 -177.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.0 mt -90.6 120.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.242 -1.392 . . . . 73.040000000000006 107.242 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -105.24 112.75 25.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.606 0.566 . . . . 74.319999999999993 109.725 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.505 HD11 HD22 ' A' ' 589' ' ' LEU . 51.1 mt -107.3 132.19 55.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.831 -1.174 . . . . 73.109999999999999 107.831 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -81.34 116.05 21.0 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.086 -0.646 . . . . 61.210000000000001 109.939 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.57 124.37 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.201 -1.037 . . . . 74.510000000000005 108.201 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 58.3 m-85 -108.47 154.88 21.27 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.755 -0.461 . . . . 73.530000000000001 109.755 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.14 136.1 35.2 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 104.147 -2.538 . . . . 75.209999999999994 104.147 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.46 ' NH2' ' HB ' ' A' ' 645' ' ' ILE . 0.0 OUTLIER -112.35 -97.19 0.43 Allowed 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 113.631 0.975 . . . . 73.219999999999999 113.631 -170.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -120.93 121.35 37.87 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 107.094 -1.447 . . . . 73.450000000000003 107.094 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.407 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 44.6 tt0 -56.71 130.71 46.63 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 123.996 0.81 . . . . 74.120000000000005 109.848 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.407 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 49.5 m-85 65.14 81.61 0.2 Allowed 'General case' 0 C--O 1.244 0.801 0 CA-C-O 122.473 1.13 . . . . 73.400000000000006 108.44 -173.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -95.29 161.71 13.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 113.544 -1.662 . . . . 73.230000000000004 112.924 -167.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -58.65 -62.42 1.87 Allowed 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 125.45 1.5 . . . . 61.210000000000001 112.544 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 155.9 92.02 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 102.948 -2.982 . . . . 72.420000000000002 102.948 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.53 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.2 m -91.53 115.87 28.4 Favored 'General case' 0 C--N 1.279 -2.491 0 C-N-CA 119.78 -0.768 . . . . 63.43 110.9 -172.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 10.5 m -140.08 142.25 36.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.979 -0.749 . . . . 61.100000000000001 108.979 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 50.0 p90 -141.17 165.5 27.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.211 -1.403 . . . . 72.030000000000001 107.211 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 12.1 m -116.64 164.48 14.54 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.614 -0.835 . . . . 75.310000000000002 109.847 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 573' ' ' ILE . 49.3 tp -135.56 130.71 34.96 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.073 -1.454 . . . . 64.450000000000003 107.073 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.4 156.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.787 -0.449 . . . . 61.149999999999999 109.787 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.648 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 70.9 mt -97.05 139.16 33.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.595 -0.891 . . . . 71.400000000000006 108.595 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 592' ' ' GLU . . . . . 0.425 ' OE2' ' HE2' ' A' ' 540' ' ' LYS . 30.6 mm-40 -94.1 167.26 11.69 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.432 -0.951 . . . . 65.109999999999999 108.432 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.27 116.25 16.82 Favored Pre-proline 0 C--N 1.317 -0.831 0 O-C-N 123.916 0.76 . . . . 60.329999999999998 110.281 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.66 145.32 20.39 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 C-N-CA 122.407 2.071 . . . . 61.119999999999997 110.859 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -118.72 143.92 46.57 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.666 -0.494 . . . . 62.200000000000003 109.666 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 596' ' ' TRP . . . . . 0.516 ' HB2' ' HD3' ' A' ' 633' ' ' PRO . 1.9 t90 -104.07 123.09 46.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.617 -0.883 . . . . 64.25 108.617 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.86 89.17 2.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 106.637 -1.616 . . . . 73.340000000000003 106.637 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -99.05 103.76 15.72 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 113.638 -1.619 . . . . 75.239999999999995 108.738 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -92.7 -75.05 0.5 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.852 -1.067 . . . . 73.340000000000003 109.298 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 62.74 -120.07 20.03 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 111.423 -0.671 . . . . 64.150000000000006 111.423 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 55.4 ttp -105.64 -7.15 18.68 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.615 -0.513 . . . . 61.219999999999999 109.615 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -86.68 121.73 29.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.472 0.653 . . . . 70.209999999999994 112.501 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -126.22 -118.24 2.21 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 107.795 -2.122 . . . . 13.5 107.795 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 55.62 59.15 11.02 Favored Glycine 0 CA--C 1.504 -0.617 0 O-C-N 124.12 0.541 . . . . 64.420000000000002 112.426 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -79.46 81.67 5.69 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.713 0.768 . . . . 75.239999999999995 111.458 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 15.1 m -99.77 96.78 7.83 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 106.111 -1.811 . . . . 64.349999999999994 106.111 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 31.8 mm -83.32 70.08 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 122.754 1.264 . . . . 61.530000000000001 109.268 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 27.7 m -129.68 -6.71 4.6 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 113.786 -1.552 . . . . 61.520000000000003 108.582 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -31.54 51.77 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.901 -1.045 . . . . 61.25 108.4 174.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.6 117.61 20.69 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 105.477 -2.046 . . . . 73.230000000000004 105.477 171.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 611' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 614' ' ' LYS . 0.9 OUTLIER -60.21 128.19 35.53 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.956 0.902 . . . . 71.310000000000002 113.194 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.23 -36.62 13.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.59 -0.732 . . . . 65.200000000000003 109.422 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.16 -28.17 38.86 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.373 -0.603 . . . . 63.25 109.373 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 614' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 611' ' ' TYR . 66.1 mttm 59.64 22.46 11.19 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.089 1.144 . . . . 60.32 114.089 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -122.27 82.58 45.57 Favored Pre-proline 0 N--CA 1.432 -1.33 0 CA-C-O 121.574 0.702 . . . . 73.430000000000007 109.738 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.76 150.52 68.3 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.689 2.259 . . . . 74.120000000000005 112.638 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.83 -177.58 3.26 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.599 -1.63 . . . . 63.439999999999998 106.599 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 1.2 p -68.75 92.37 0.48 Allowed 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.783 0.802 . . . . 72.200000000000003 109.335 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 50.4 m -155.08 166.17 34.42 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.669 -1.151 . . . . 51.439999999999998 108.111 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -101.19 137.56 39.37 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.489 -0.93 . . . . 73.040000000000006 108.489 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.62 103.7 10.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.692 0.758 . . . . 74.239999999999995 110.677 176.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -84.96 76.92 10.21 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.965 0.888 . . . . 71.239999999999995 109.036 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 626' ' ' ARG . 13.5 pt-20 -88.43 143.26 27.1 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.048 -1.433 . . . . 62.229999999999997 108.386 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.17 -8.64 58.5 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 116.248 -0.433 . . . . 75.439999999999998 110.255 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.409 ' HB3' ' OE1' ' A' ' 623' ' ' GLU . 1.2 tmm_? -61.03 -36.85 80.64 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.731 -0.668 . . . . 72.329999999999998 110.071 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 630' ' ' MET . 31.0 mmt180 -67.03 -36.76 82.81 Favored 'General case' 0 C--O 1.208 -1.102 0 N-CA-C 109.354 -0.61 . . . . 71.129999999999995 109.354 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.481 ' HA ' ' SD ' ' A' ' 630' ' ' MET . 67.4 mt -67.61 -38.29 80.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.664 -0.698 . . . . 73.530000000000001 109.128 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -62.44 -32.58 73.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.408 -0.815 . . . . 54.43 109.768 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 632' ' ' ARG . 50.5 mt-10 -83.09 -14.71 53.16 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 112.309 0.485 . . . . 64.439999999999998 112.309 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 65.6 mtt -73.11 -25.88 61.02 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.554 -0.906 . . . . 74.140000000000001 108.554 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -135.21 70.96 0.5 Allowed Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 110.082 -1.207 . . . . 62.109999999999999 110.082 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 0.1 OUTLIER -121.72 149.31 52.86 Favored Pre-proline 0 N--CA 1.431 -1.414 0 CA-C-O 120.454 0.169 . . . . 70.239999999999995 111.23 -178.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 596' ' ' TRP . 33.7 Cg_endo -70.64 145.34 51.77 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.344 2.029 . . . . 65.540000000000006 109.616 176.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 34.5 pt -134.18 -177.82 2.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.088 0.47 . . . . 54.149999999999999 110.334 -174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.29 167.99 10.07 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.848 -0.797 . . . . 75.519999999999996 108.848 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.77 -178.2 21.11 Favored Glycine 0 C--O 1.249 1.06 0 O-C-N 123.465 0.478 . . . . 74.450000000000003 112.585 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -46.98 -61.96 1.63 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.04 0.936 . . . . 74.540000000000006 110.408 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -141.11 104.82 4.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.063 -1.458 . . . . 75.030000000000001 107.063 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.5 t -121.05 109.07 14.6 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 118.659 -1.217 . . . . 73.400000000000006 110.438 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.814 -1.18 . . . . 73.329999999999998 107.814 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 510' ' ' PRO . 62.4 tp -119.79 113.48 20.67 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 123.443 0.464 . . . . 61.439999999999998 111.074 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.415 ' HB2' HG22 ' A' ' 511' ' ' VAL . 2.1 mp0 -84.22 128.65 34.7 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 74.239999999999995 108.07 170.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.65 111.89 38.09 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 107.234 -1.395 . . . . 73.209999999999994 107.234 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' ILE . . . . . 0.51 HG22 ' HG3' ' A' ' 646' ' ' GLU . 4.7 mp -105.82 134.44 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 CA-C-N 114.711 -1.132 . . . . 73.030000000000001 108.251 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.53 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER -116.91 114.78 46.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 109.484 -0.561 . . . . 75.019999999999996 109.484 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 646' ' ' GLU . . . . . 0.51 ' HG3' HG22 ' A' ' 644' ' ' ILE . 44.0 mt-10 -135.22 123.95 23.8 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.818 -0.628 . . . . 72.019999999999996 110.787 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.98 157.12 23.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 105.862 -1.903 . . . . 73.209999999999994 105.862 167.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 46.5 m 70.12 28.64 3.98 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.049 -1.093 . . . . 71.319999999999993 108.049 -170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -145.36 139.17 26.8 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.47 -1.241 . . . . 63.100000000000001 107.746 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 650' ' ' GLU . . . . . 0.444 ' OE2' HG22 ' A' ' 654' ' ' THR . 5.7 mm-40 -110.86 126.28 54.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.185 0.809 . . . . 73.409999999999997 113.185 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -81.68 -45.17 16.11 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.23 -1.396 . . . . 72.510000000000005 107.23 174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -139.67 112.17 7.78 Favored 'General case' 0 N--CA 1.399 -2.987 0 N-CA-C 106.356 -1.72 . . . . 62.200000000000003 106.356 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 33.8 m -52.0 115.32 1.64 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.877 1.066 . . . . 74.129999999999995 113.877 -175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.444 HG22 ' OE2' ' A' ' 650' ' ' GLU . 8.8 t -82.79 -18.64 39.88 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.745 -0.835 . . . . 71.510000000000005 108.745 171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 64.5 t -120.97 98.75 6.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.194 -1.41 . . . . 71.340000000000003 107.194 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 C--N 1.3 -1.564 0 CA-C-N 116.013 -0.539 . . . . 61.219999999999999 110.761 -177.084 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 C--O 1.24 0.571 0 N-CA-C 110.78 -0.081 . . . . 73.150000000000006 110.78 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . 73.86 -48.31 0.66 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.092 1.757 . . . . 33.140000000000001 112.936 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -148.68 87.4 0.15 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.47 -0.652 . . . . 73.030000000000001 111.47 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 635' ' ' LEU . 55.8 mt -86.39 114.33 25.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.858 0.361 . . . . 73.209999999999994 110.129 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -112.49 146.11 39.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.48 -0.933 . . . . 65.109999999999999 108.48 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.8 t -148.26 163.54 36.71 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.639 0.587 . . . . 73.120000000000005 109.775 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.65 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 69.2 m-85 -83.96 153.89 23.65 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 123.232 0.613 . . . . 75.219999999999999 110.396 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 49.3 mt-10 -60.35 -41.83 94.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.989 0.423 . . . . 73.319999999999993 110.457 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.2 mt-10 -132.65 151.91 78.98 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.494 -0.928 . . . . 72.109999999999999 108.494 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.407 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 69.9 Cg_endo -87.53 -20.94 1.96 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.125 1.883 . . . . 75.439999999999998 111.137 174.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 52.8 t -146.05 125.67 5.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 124.945 1.298 . . . . 70.319999999999993 107.534 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -133.65 141.03 47.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.33 0.586 . . . . 75.219999999999999 110.064 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -107.93 127.36 53.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.641 -0.708 . . . . 72.239999999999995 109.198 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.8 m -126.08 158.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.06 0.457 . . . . 71.540000000000006 110.92 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.0 m -73.43 157.76 36.25 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.599 -0.728 . . . . 74.409999999999997 109.702 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -29.17 39.84 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.465 0.65 . . . . 71.409999999999997 109.991 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -97.81 18.7 15.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.48 -0.782 . . . . 54.299999999999997 111.086 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.78 -29.85 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 75.299999999999997 111.617 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.15 -72.49 2.83 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.621 -0.799 . . . . 75.25 111.886 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.0 mm -127.42 123.54 61.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.999 -0.741 . . . . 73.230000000000004 108.999 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.457 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.8 ptm -101.18 131.35 47.2 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.627 -0.879 . . . . 65.109999999999999 108.627 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.58 118.46 33.13 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 123.714 0.634 . . . . 72.400000000000006 110.848 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.61 114.64 45.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.384 -1.339 . . . . 75.209999999999994 107.384 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 570' ' ' ILE . 29.0 mtmm -94.06 133.56 37.4 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 119.912 -0.715 . . . . 65.219999999999999 110.486 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.53 109.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.995 -1.113 . . . . 71.200000000000003 107.995 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.7 mt -89.09 122.51 32.48 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.256 -0.884 . . . . 70.150000000000006 110.037 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.465 ' H ' ' NE ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -89.16 103.2 15.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 118.673 -1.211 . . . . 73.319999999999993 108.3 174.04 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.0 p -67.77 -54.32 20.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.513 -0.767 . . . . 73.109999999999999 111.1 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' SER . . . . . 0.515 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 23.1 t -72.94 -50.41 23.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.071 -0.968 . . . . 74.530000000000001 110.211 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 530' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' A' ' 565' ' ' ASP . . . 149.61 -179.91 25.99 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.776 -1.202 . . . . 75.239999999999995 112.458 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.61 27.98 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 107.086 -1.45 . . . . 73.209999999999994 107.086 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -149.32 127.75 12.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.562 -0.455 . . . . 74.540000000000006 110.164 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.89 -115.64 4.71 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.886 -0.886 . . . . 24.25 110.886 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -138.1 109.98 7.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.714 -1.217 . . . . 73.150000000000006 107.714 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.09 123.5 66.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.131 0.491 . . . . 64.140000000000001 109.896 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 48.6 mm -96.17 120.59 45.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.245 -0.65 . . . . 71.409999999999997 109.245 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.79 104.36 51.08 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 52.140000000000001 107.993 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.01 143.29 17.9 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.948 1.765 . . . . 70.109999999999999 111.309 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -130.43 163.74 26.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.333 -0.988 . . . . 72.519999999999996 108.333 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -159.29 132.81 7.24 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.276 0.36 . . . . 44.329999999999998 110.847 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 20.7 p -79.75 136.12 36.68 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.884 -0.598 . . . . 63.43 110.368 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.55 117.29 46.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.449 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 40.4 mt-10 -74.88 104.62 5.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.586 -0.524 . . . . 72.049999999999997 109.586 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.63 -102.57 1.21 Allowed Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.838 -1.305 . . . . 72.200000000000003 109.838 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 585' ' ' CYS . 13.2 t -100.83 4.82 43.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.271 0.558 . . . . 71.120000000000005 110.067 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -105.35 149.45 26.06 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.344 -1.354 . . . . 74.400000000000006 107.344 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.449 ' HD2' ' OE1' ' A' ' 543' ' ' GLU . 29.7 tpt180 -107.12 134.07 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.808 0.337 . . . . 64.129999999999995 110.977 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.01 -151.76 9.5 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.741 -0.663 . . . . 64.140000000000001 111.626 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 75.17 -33.76 1.09 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 122.461 -0.434 . . . . 70.230000000000004 114.066 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 144.35 5.76 0.58 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.091 -0.576 . . . . 62.130000000000003 112.55 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.487 ' HB3' ' NH1' ' A' ' 578' ' ' ARG . 56.0 mm-40 -75.13 -79.17 0.1 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.868 0.365 . . . . 73.420000000000002 111.88 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -89.78 -41.19 12.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.829 -1.174 . . . . 75.109999999999999 107.829 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -149.33 169.48 20.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.452 -1.249 . . . . 74.150000000000006 108.717 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.06 119.03 37.13 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.803 -2.295 . . . . 70.319999999999993 104.803 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.39 105.28 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.967 0.889 . . . . 70.040000000000006 110.555 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.9 t -101.91 127.15 48.88 Favored 'General case' 0 N--CA 1.412 -2.354 0 CA-C-N 115.1 -0.955 . . . . 64.400000000000006 111.155 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -140.55 97.82 3.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.607 -1.179 . . . . 73.109999999999999 108.353 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -132.34 179.31 17.33 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 115.485 -0.78 . . . . 61.350000000000001 111.737 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.44 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.3 mt-10 -111.07 114.84 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.224 -0.658 . . . . 64.409999999999997 109.224 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.06 138.19 31.63 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 110.117 -0.327 . . . . 75.310000000000002 110.117 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -105.98 106.28 16.71 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.459 0.647 . . . . 61.32 111.485 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 36.6 m-85 -96.43 147.6 23.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.036 -1.468 . . . . 74.140000000000001 107.036 172.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -124.96 -79.06 0.61 Allowed 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 108.862 -0.792 . . . . 73.510000000000005 108.862 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.03 156.04 18.18 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.149 -0.686 . . . . 64.200000000000003 109.149 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.459 ' OD1' ' HA2' ' A' ' 530' ' ' GLY . 12.0 t70 -56.1 -25.9 47.52 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.162 1.385 . . . . 50.219999999999999 113.193 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.47 -18.52 64.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.139 0.792 . . . . 74.109999999999999 113.139 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.2 pt -106.37 167.5 3.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 119.843 -0.743 . . . . 73.319999999999993 110.935 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.99 159.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.818 -1.179 . . . . 75.230000000000004 107.818 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.495 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 122.208 -0.307 . . . . 71.439999999999998 110.26 175.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 524' ' ' LYS . 18.7 mt -122.2 134.89 64.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 123.825 0.703 . . . . 62.030000000000001 110.259 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 55.2 mt -91.26 122.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.368 -1.345 . . . . 73.340000000000003 107.368 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 9.4 p -106.7 112.86 26.03 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 123.866 0.729 . . . . 72.200000000000003 109.269 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.555 HD11 HD22 ' A' ' 589' ' ' LEU . 38.2 mt -110.76 125.63 68.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.232 -0.655 . . . . 74.450000000000003 109.232 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -79.59 110.59 15.07 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.136 0.898 . . . . 73.099999999999994 109.765 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.4 135.05 36.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.917 -1.512 . . . . 64.319999999999993 106.917 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -116.53 131.46 56.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.818 -0.438 . . . . 74.319999999999993 109.818 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -85.86 86.53 7.36 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 122.836 1.303 . . . . 74.239999999999995 111.271 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.487 ' NH1' ' HB3' ' A' ' 551' ' ' GLU . 28.5 ttp180 -101.05 155.24 18.1 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.883 -1.525 . . . . 70.099999999999994 106.883 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -80.05 157.17 26.81 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.087 -1.079 . . . . 70.319999999999993 108.087 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.429 ' HB3' HH21 ' A' ' 578' ' ' ARG . 2.5 pp20? -148.26 168.63 22.02 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 120.375 -0.53 . . . . 72.420000000000002 110.451 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -125.12 101.32 6.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.625 -0.261 . . . . 72.439999999999998 111.471 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 65.19 17.14 10.91 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.83 1.789 . . . . 62.299999999999997 115.83 170.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.8 110.56 19.24 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.4 -0.812 . . . . 65.430000000000007 111.647 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.46 87.17 3.81 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.709 -1.96 . . . . 72.5 105.709 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.534 ' HA ' HG23 ' A' ' 545' ' ' THR . 5.5 p -77.99 138.78 39.01 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.501 -1.227 . . . . 33.299999999999997 113.181 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 34.7 p -143.32 154.75 44.09 Favored 'General case' 0 N--CA 1.405 -2.704 0 CA-C-N 114.633 -1.167 . . . . 65.400000000000006 108.967 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -138.53 161.61 36.62 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 61.130000000000003 106.844 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.1 t -113.73 175.69 5.35 Favored 'General case' 0 C--N 1.27 -2.887 0 C-N-CA 119.147 -1.021 . . . . 72.040000000000006 109.108 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 573' ' ' ILE . 33.5 tp -149.9 126.69 11.06 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.016 -1.475 . . . . 71.25 107.016 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.13 157.34 31.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.716 -0.476 . . . . 65.310000000000002 109.716 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.65 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 40.2 mt -101.79 142.97 32.29 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.337 -1.727 . . . . 70.209999999999994 106.337 174.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.86 173.59 6.79 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.869 -0.789 . . . . 71.299999999999997 108.869 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.67 115.46 18.75 Favored Pre-proline 0 C--N 1.316 -0.88 0 O-C-N 123.733 0.646 . . . . 72.319999999999993 110.739 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 32.6 Cg_endo -65.38 153.96 75.81 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.761 2.307 . . . . 64.310000000000002 113.399 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -119.62 134.91 55.03 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.783 -1.099 . . . . 71.230000000000004 109.64 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -99.34 125.07 44.93 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.098 -0.705 . . . . 74.099999999999994 109.098 -175.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 597' ' ' ILE . . . . . 0.437 HD13 HG12 ' A' ' 536' ' ' ILE . 2.7 mp -97.09 89.87 2.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 105.225 -2.139 . . . . 55.25 105.225 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -86.97 -13.2 45.27 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.195 -1.366 . . . . 74.409999999999997 110.077 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -89.37 120.61 30.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.674 -0.862 . . . . 75.129999999999995 108.674 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -70.73 -46.88 43.7 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.649 -0.58 . . . . 50.130000000000003 111.649 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 23.0 ptp -101.25 163.64 12.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.26 -0.644 . . . . 75.120000000000005 109.26 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -140.61 100.94 3.98 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.847 -0.797 . . . . 62.310000000000002 108.847 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -147.02 60.39 0.47 Allowed Glycine 0 C--N 1.286 -2.245 0 N-CA-C 108.558 -1.817 . . . . 73.109999999999999 108.558 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -122.65 -120.31 2.61 Favored Glycine 0 N--CA 1.421 -2.311 0 CA-C-N 114.839 -0.68 . . . . 71.349999999999994 111.97 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -122.8 14.72 10.07 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.848 0.684 . . . . 75.510000000000005 112.848 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 18.9 m -137.9 124.87 21.33 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.811 -0.755 . . . . 54.409999999999997 110.879 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 44.9 mm -85.05 147.56 5.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.435 -1.321 . . . . 75.340000000000003 107.435 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 31.7 m -56.11 -28.03 56.22 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.837 0.855 . . . . 63.32 113.26 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . 0.25 0.2 OUTLIER -86.48 -7.31 58.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.521 -0.872 . . . . 73.430000000000007 113.324 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.23 178.94 7.69 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.171 -0.678 . . . . 71.439999999999998 109.171 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -55.56 108.54 0.44 Allowed 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 122.205 1.002 . . . . 72.510000000000005 112.346 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.43 -54.07 4.25 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.708 -1.133 . . . . 72.340000000000003 108.839 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -126.66 106.47 9.42 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.121 -0.945 . . . . 75.099999999999994 110.816 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -91.27 96.3 10.48 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.54 -0.464 . . . . 65.430000000000007 110.066 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -68.2 127.37 93.28 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.272 -0.64 . . . . 74.120000000000005 109.272 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -91.39 -179.38 1.37 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.136 1.89 . . . . 71.340000000000003 111.808 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.26 -40.06 10.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.708 -1.219 . . . . 74.239999999999995 107.708 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 19.2 m -125.15 122.87 38.35 Favored 'General case' 0 N--CA 1.406 -2.646 0 CA-C-N 114.92 -1.036 . . . . 73.209999999999994 109.434 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 18.6 t -82.37 -15.68 51.87 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.474 -0.936 . . . . 54.509999999999998 108.474 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -69.82 79.61 0.45 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.848 0.832 . . . . 72.299999999999997 110.192 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 621' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 625' ' ' ARG . 37.3 tt0 -127.6 70.91 1.33 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.194 -1.41 . . . . 53.409999999999997 107.194 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 59.56 22.09 10.69 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.218 -1.356 . . . . 64.209999999999994 111.055 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 626' ' ' ARG . 0.7 OUTLIER 58.33 11.92 1.79 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.22 1.408 . . . . 71.120000000000005 113.61 -174.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -74.31 -30.22 61.96 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.559 -0.904 . . . . 72.299999999999997 108.559 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 621' ' ' GLU . 0.0 OUTLIER -71.55 -30.3 65.73 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.083 -1.08 . . . . 75.140000000000001 108.083 176.359 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 623' ' ' GLU . 65.7 ttt180 -65.43 -38.91 91.28 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 109.033 -0.729 . . . . 75.120000000000005 109.033 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 73.8 mt -68.36 -35.78 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.071 0.463 . . . . 71.319999999999993 109.771 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.3 96.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.472 -0.331 . . . . 61.009999999999998 110.391 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -74.91 -19.52 60.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.016 0.436 . . . . 72.129999999999995 111.91 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 46.7 ttm -75.5 -28.23 59.09 Favored 'General case' 0 N--CA 1.406 -2.633 0 C-N-CA 123.907 0.883 . . . . 71.519999999999996 108.694 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -82.63 -0.93 90.42 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.22 -0.9 . . . . 74.349999999999994 111.088 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -96.05 140.04 22.08 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.833 -1.543 . . . . 72.010000000000005 106.833 174.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.53 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 36.8 Cg_endo -68.62 138.05 40.62 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 N-CA-C 106.691 -2.08 . . . . 64.099999999999994 106.691 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . 0.274 2.6 pp -124.89 144.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 C-N-CA 117.314 -1.755 . . . . 74.409999999999997 112.006 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 635' ' ' LEU . 2.2 pt? -76.35 -165.22 0.47 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.255 -2.248 . . . . 72.140000000000001 111.873 -174.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.23 136.25 37.21 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 109.46 -1.456 . . . . 73.310000000000002 109.46 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.56 -42.32 70.85 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.469 0.708 . . . . 74.340000000000003 111.848 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -131.37 84.86 2.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 110.864 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.9 t -119.71 114.71 22.59 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 107.872 -1.158 . . . . 61.229999999999997 107.872 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -147.59 140.24 24.73 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.777 -0.823 . . . . 52.539999999999999 108.777 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 509' ' ' GLU . 60.0 tp -117.59 123.14 45.48 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 123.347 0.404 . . . . 71.209999999999994 109.913 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.78 124.94 43.98 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.941 -1.503 . . . . 74.230000000000004 106.941 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.22 120.22 60.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.464 -0.939 . . . . 73.540000000000006 108.464 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.87 124.18 63.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-N 115.618 -0.719 . . . . 60.420000000000002 109.262 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.51 92.16 2.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 122.213 1.006 . . . . 73.030000000000001 111.125 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -163.11 159.67 23.39 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.279 -2.119 . . . . 75.340000000000003 105.279 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -73.84 97.43 2.76 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.358 -0.608 . . . . 73.120000000000005 109.358 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 19.4 t -88.47 98.81 11.84 Favored 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 105.611 -1.996 . . . . 74.409999999999997 105.611 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -108.59 153.43 23.39 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.131 -0.94 . . . . 74.310000000000002 110.547 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -106.48 116.71 32.4 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.96 -1.867 . . . . 64.299999999999997 105.96 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -75.73 -24.4 56.13 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.027 -0.669 . . . . 74.120000000000005 109.27 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 134.38 46.16 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.126 0.488 . . . . 72.340000000000003 110.517 176.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 23.1 t -81.99 113.33 19.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.749 -1.204 . . . . 61.409999999999997 107.749 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 16.3 m -82.45 131.13 35.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.897 -0.779 . . . . 74.140000000000001 108.897 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 28.8 t -80.48 84.28 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 122.186 0.993 . . . . 65.120000000000005 109.162 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 C--N 1.289 -2.032 0 CA-C-N 113.985 -1.461 . . . . 73.109999999999999 109.269 -179.1 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 . . . . . 0 C--O 1.234 0.283 0 CA-C-O 120.832 0.349 . . . . 71.230000000000004 110.648 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -89.6 -26.07 20.99 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.489 -0.93 . . . . 54.119999999999997 108.489 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.0 144.41 8.57 Favored Glycine 0 N--CA 1.42 -2.393 0 CA-C-N 114.445 -1.252 . . . . 65.5 114.638 174.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 57.1 mt -128.28 113.94 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 104.72 -2.326 . . . . 72.239999999999995 104.72 167.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.601 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 76.1 m-85 -107.49 132.35 53.32 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.645 -0.502 . . . . 75.329999999999998 109.645 -176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 8.8 t -148.03 152.76 37.96 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.534 0.521 . . . . 54.119999999999997 110.036 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.496 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 90.1 m-85 -74.43 154.5 38.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.909 -0.404 . . . . 74.450000000000003 109.909 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -52.78 -49.92 64.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.819 0.848 . . . . 42.329999999999998 111.147 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -135.32 161.53 62.76 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 107.753 -1.203 . . . . 62.450000000000003 107.753 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 68.4 Cg_endo -82.4 -17.61 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 121.673 1.582 . . . . 64.519999999999996 112.029 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 642' ' ' GLU . 77.9 t -143.07 127.11 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 123.306 0.642 . . . . 72.5 109.966 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 512' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 643' ' ' VAL . 12.0 t -135.11 141.5 46.03 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.474 -0.935 . . . . 73.430000000000007 108.474 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 648' ' ' SER . 14.2 p-80 -111.14 142.45 43.31 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.301 -1.74 . . . . 74.049999999999997 106.301 172.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.19 154.81 29.02 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 CA-C-O 121.327 0.584 . . . . 75.230000000000004 111.462 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 20.5 m -73.92 137.46 43.65 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.891 -1.049 . . . . 73.030000000000001 109.482 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -75.58 1.58 13.99 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.799 0.809 . . . . 73.25 112.886 -178.603 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.5 p -125.53 18.75 8.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.32 -0.855 . . . . 74.430000000000007 110.902 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 8.2 tt -80.76 -23.76 11.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-O 121.376 0.608 . . . . 55.350000000000001 110.479 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.51 -76.26 2.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.721 -0.951 . . . . 72.209999999999994 110.721 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 574' ' ' ARG . 47.9 mm -125.41 128.58 72.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.724 -0.843 . . . . 63.25 108.724 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.488 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.3 ptm -98.48 141.61 31.12 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.673 -0.492 . . . . 71.230000000000004 109.673 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -102.39 128.81 48.83 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 123.792 0.682 . . . . 61.310000000000002 109.917 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 44.0 t -124.92 124.53 67.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.459 -0.941 . . . . 62.43 108.459 174.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -93.87 132.34 38.4 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.006 -0.678 . . . . 70.230000000000004 110.768 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 84.3 t -95.98 111.76 26.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.581 -1.637 . . . . 72.219999999999999 106.581 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.43 143.42 26.62 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.547 -0.751 . . . . 72.239999999999995 110.39 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.0 104.65 14.14 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.844 -0.617 . . . . 75.310000000000002 111.767 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 504' ' ' ILE . 22.9 m -64.78 -61.64 2.06 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.953 -0.567 . . . . 61.5 112.086 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.1 p -73.76 -52.54 12.84 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.107 0.41 . . . . 74.230000000000004 112.107 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 158.02 -145.77 12.31 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.943 -0.863 . . . . 70.099999999999994 110.943 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -178.66 130.8 0.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.211 1.404 . . . . 62.229999999999997 107.467 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -150.59 91.44 1.74 Allowed 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.537 -0.865 . . . . 75.109999999999999 111.879 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 145.51 -116.97 0.95 Allowed Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 110.183 -1.167 . . . . 75.450000000000003 110.183 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.82 104.49 5.3 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.137 -1.06 . . . . 71.420000000000002 108.137 172.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 595' ' ' LYS . 39.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.331 -0.548 . . . . 61.439999999999998 111.381 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 559' ' ' GLU . 42.6 mm -98.99 115.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.423 -0.808 . . . . 73.120000000000005 109.139 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.78 100.24 30.15 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 108.523 -0.917 . . . . 71.430000000000007 108.523 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 536' ' ' ILE . 3.4 Cg_exo -76.65 146.54 27.09 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 121.924 1.75 . . . . 74.519999999999996 111.186 176.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 25.1 p90 -136.68 157.33 47.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.239 -0.652 . . . . 70.239999999999995 109.239 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -147.6 135.04 20.76 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.835 0.35 . . . . 65.109999999999999 111.019 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.4 p -82.72 123.03 28.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.777 -0.647 . . . . 74.140000000000001 111.184 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 41.0 mm -92.16 118.22 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.959 -1.126 . . . . 71.109999999999999 107.959 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.69 143.99 34.09 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.266 -0.642 . . . . 75.310000000000002 109.266 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.72 -110.18 0.83 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 109.076 -1.609 . . . . 62.020000000000003 109.076 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 16.6 p -78.64 -25.21 44.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.586 -0.894 . . . . 74.549999999999997 108.586 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -90.2 131.9 35.78 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.43 -1.322 . . . . 73.340000000000003 107.43 172.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 43.1 ttp180 -104.72 140.96 37.3 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.121 -0.696 . . . . 74.219999999999999 109.121 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.75 -157.4 31.59 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 121.166 -0.54 . . . . 72.340000000000003 112.639 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 69.09 19.94 74.35 Favored Glycine 0 C--N 1.31 -0.871 0 C-N-CA 121.619 -0.324 . . . . 41.229999999999997 112.932 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.03 19.21 40.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.33 -0.938 . . . . 60.43 112.646 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 11.0 tp10 -86.0 -79.51 0.25 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 110.0 -0.37 . . . . 75.319999999999993 110.0 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 578' ' ' ARG . 14.1 m-20 -94.9 -30.29 14.24 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.701 -1.222 . . . . 63.450000000000003 107.701 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.32 155.79 43.41 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.396 -1.274 . . . . 72.329999999999998 107.952 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -88.46 139.98 29.93 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 105.412 -2.07 . . . . 75.209999999999994 105.412 177.277 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 15.9 t70 -77.33 121.72 24.13 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.167 -0.308 . . . . 64.409999999999997 110.167 -171.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -127.33 104.43 7.93 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 122.474 1.131 . . . . 61.119999999999997 110.46 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -125.96 102.27 7.18 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.725 -1.954 . . . . 60.310000000000002 105.725 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -133.36 -174.75 13.67 Favored Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.39 -0.91 . . . . 54.130000000000003 112.248 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.0 OUTLIER -121.11 122.46 40.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.313 0.577 . . . . 73.409999999999997 110.669 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 569' ' ' LYS . 83.8 mt -96.58 136.92 36.42 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.882 -0.414 . . . . 71.310000000000002 109.882 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.01 102.53 11.25 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.709 0.766 . . . . 63.539999999999999 111.392 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 60.0 m-85 -99.58 96.8 7.89 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 106.971 -1.492 . . . . 74.099999999999994 106.971 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -75.18 -67.11 0.68 Allowed 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.233 -0.987 . . . . 70.439999999999998 109.829 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -105.94 161.65 14.27 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.222 -0.658 . . . . 65.310000000000002 109.222 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.55 -11.82 60.45 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.208 1.003 . . . . 72.430000000000007 113.527 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.456 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.6 pt-20 -68.09 -7.99 34.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.61 0.967 . . . . 50.350000000000001 113.61 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.456 HG23 ' HG3' ' A' ' 566' ' ' GLU . 45.1 pt -122.32 168.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 O-C-N 121.952 -0.467 . . . . 45.450000000000003 110.837 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.7 p -131.79 140.73 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.839 -1.541 . . . . 63.310000000000002 106.839 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 69.5 mmtt -104.45 145.95 29.55 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.438 -0.505 . . . . 74.239999999999995 111.25 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 69.3 mt -117.45 135.07 59.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.474 -1.239 . . . . 73.349999999999994 110.498 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 64.5 mt -93.55 127.89 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.835 -1.172 . . . . 64.219999999999999 107.835 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 25.7 p -106.59 112.18 25.06 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.374 0.607 . . . . 74.150000000000006 110.139 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.488 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 30.9 mt -112.64 130.04 67.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.74 -1.207 . . . . 62.530000000000001 107.74 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 11.5 ttm180 -85.86 122.92 30.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 0.407 HG23 HG21 ' A' ' 645' ' ' ILE . 44.7 mm -102.33 136.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.724 -0.671 . . . . 65.439999999999998 109.394 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.475 ' CZ ' ' HD2' ' A' ' 574' ' ' ARG . 92.7 m-85 -112.11 162.11 15.77 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.682 -0.858 . . . . 72.010000000000005 108.682 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.44 156.49 18.17 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.787 -0.449 . . . . 74.010000000000005 109.787 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 552' ' ' ASP . 4.3 tpm_? -130.51 173.66 10.65 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.231 -0.655 . . . . 71.310000000000002 109.231 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 578' ' ' ARG . 64.5 mm-40 -68.47 126.1 28.57 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.547 -1.279 . . . . 73.219999999999999 107.547 173.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.56 -25.37 64.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.421 0.629 . . . . 73.129999999999995 109.653 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -108.53 81.37 1.46 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.159 0.98 . . . . 73.25 108.562 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -162.7 -163.15 0.85 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.526 -1.67 . . . . 64.409999999999997 106.936 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -98.98 117.52 33.67 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.839 -1.171 . . . . 72.030000000000001 107.839 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -52.01 122.63 8.76 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 123.959 0.787 . . . . 73.519999999999996 110.779 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 4.5 p -91.14 140.82 29.45 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 115.38 -0.827 . . . . 73.519999999999996 111.118 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 23.9 m -144.99 153.71 41.78 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.037 -0.727 . . . . 65.010000000000005 109.037 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.2 p90 -138.6 -176.87 4.62 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.79 -0.448 . . . . 75.140000000000001 109.79 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 35.8 m -132.6 162.83 30.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.589 -0.522 . . . . 32.119999999999997 109.589 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 571' ' ' ILE . 31.2 tp -139.38 134.83 32.98 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.562 -1.273 . . . . 65.439999999999998 107.562 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.85 157.34 43.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 123.18 0.3 . . . . 63.130000000000003 110.696 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.496 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 48.9 mt -101.8 139.79 36.97 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.027 -1.471 . . . . 74.329999999999998 107.027 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -96.36 178.43 5.37 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 123.332 0.395 . . . . 74.420000000000002 110.125 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.52 121.39 78.81 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 109.676 -0.49 . . . . 74.450000000000003 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.505 ' HD3' HD22 ' A' ' 635' ' ' LEU . 59.1 Cg_endo -72.48 164.44 35.6 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.408 2.072 . . . . 70.519999999999996 113.734 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 75.5 mmtt -116.93 140.98 48.82 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 114.847 -1.07 . . . . 75.329999999999998 109.06 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 596' ' ' TRP . . . . . 0.416 ' N ' ' HG3' ' A' ' 633' ' ' PRO . 3.9 t90 -113.84 109.34 18.37 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 107.227 -1.397 . . . . 75.510000000000005 107.227 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 597' ' ' ILE . . . . . 0.416 HG22 ' HG2' ' A' ' 599' ' ' ARG . 2.9 mp -95.74 90.18 2.47 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 107.599 -1.26 . . . . 53.539999999999999 107.599 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.0 98.18 9.25 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.141 -1.059 . . . . 71.409999999999997 108.141 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 599' ' ' ARG . . . . . 0.416 ' HG2' HG22 ' A' ' 597' ' ' ILE . 35.1 mmt180 -98.68 125.13 43.88 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.681 -0.69 . . . . 74.340000000000003 109.812 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -173.65 163.25 34.41 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 107.789 -2.124 . . . . 32.130000000000003 107.789 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 14.6 tpt -83.04 -33.18 26.53 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 117.694 0.747 . . . . 75.409999999999997 110.253 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -98.54 83.32 2.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.232 -0.655 . . . . 72.099999999999994 109.232 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -117.57 -18.58 5.24 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.28 -0.962 . . . . 54.299999999999997 112.209 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 66.94 32.7 81.71 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.428 -1.069 . . . . 52.299999999999997 110.428 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -64.43 103.34 0.64 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.111 0.481 . . . . 72.310000000000002 110.008 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 7.1 m -127.04 81.11 2.0 Allowed 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 121.854 0.835 . . . . 74.200000000000003 108.871 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 26.5 mm -81.46 75.81 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.267 -0.879 . . . . 63.329999999999998 109.31 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 30.0 m -130.88 -25.29 2.31 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.086 -1.415 . . . . 73.209999999999994 107.998 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -62.43 -46.71 87.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.909 -1.515 . . . . 75.209999999999994 106.909 173.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.22 124.1 39.08 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 105.23 -2.137 . . . . 73.140000000000001 105.23 173.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -148.53 150.98 34.32 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 105.384 -2.08 . . . . 74.409999999999997 105.384 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . 0.268 17.2 m-20 -79.25 72.85 5.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 122.396 1.093 . . . . 50.200000000000003 113.135 -176.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 34.5 t70 165.32 72.79 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 129.583 3.153 . . . . 73.150000000000006 104.578 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 614' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 616' ' ' PRO . 12.9 tppt? -152.16 95.25 2.04 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.715 -1.13 . . . . 75.120000000000005 109.411 -175.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -81.83 -49.01 0.94 Allowed Pre-proline 0 C--N 1.293 -1.878 0 CA-C-N 116.032 -0.531 . . . . 71.400000000000006 110.948 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 614' ' ' LYS . 38.3 Cg_endo -67.65 177.33 4.17 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 120.884 1.056 . . . . 71.219999999999999 109.461 170.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 617' ' ' LEU . . . . . 0.475 HD22 ' H ' ' A' ' 617' ' ' LEU . 2.4 mm? -65.84 -60.99 2.32 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.703 -0.481 . . . . 55.25 109.703 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 4.8 m -142.16 158.68 43.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 105.606 -1.998 . . . . 74.040000000000006 105.606 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 41.4 m -88.19 71.2 9.24 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.664 0.745 . . . . 63.130000000000003 110.049 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -144.37 164.17 31.61 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 105.177 -2.157 . . . . 72.510000000000005 105.177 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -83.21 151.04 25.84 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.414 -0.514 . . . . 54.409999999999997 109.998 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 68.91 24.3 6.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.516 1.126 . . . . 72.140000000000001 113.006 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -76.18 101.67 5.47 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.647 0.737 . . . . 73.230000000000004 110.606 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.446 ' OE1' ' HD3' ' A' ' 625' ' ' ARG . 0.3 OUTLIER -112.18 142.79 44.21 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.853 -1.536 . . . . 75.129999999999995 106.853 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 0.1 OUTLIER -63.3 -30.32 71.48 Favored 'General case' 0 C--O 1.206 -1.234 0 C-N-CA 120.256 -0.577 . . . . 74.019999999999996 111.108 -177.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 53.9 ttp85 -63.03 -33.4 75.34 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.286 0.565 . . . . 74.409999999999997 110.901 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.5 ' O ' ' HG2' ' A' ' 630' ' ' MET . 63.9 mt -80.41 -33.8 14.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.457 -0.571 . . . . 61.399999999999999 109.457 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.67 88.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.076 -0.713 . . . . 60.130000000000003 109.076 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 48.6 mt-10 -71.42 -30.76 66.44 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.494 -0.775 . . . . 73.0 111.392 176.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 627' ' ' ILE . 7.8 ptp -74.86 -7.36 53.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.213 -0.595 . . . . 74.040000000000006 110.06 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -107.38 22.67 28.45 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.571 -0.612 . . . . 54.149999999999999 111.571 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 14.4 ptp180 -145.37 168.82 11.01 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.72 -1.215 . . . . 72.109999999999999 107.72 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 632' ' ' ARG . 56.3 Cg_endo -67.7 142.84 59.64 Favored 'Trans proline' 0 C--O 1.255 1.354 0 C-N-CA 121.858 1.705 . . . . 71.209999999999994 109.674 172.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 28.7 pt -134.56 -177.89 2.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 116.387 -0.37 . . . . 74.430000000000007 110.292 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.601 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 2.1 pt? -139.53 -168.27 2.44 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.882 -0.784 . . . . 74.430000000000007 108.882 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -66.75 159.62 48.59 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.582 -0.818 . . . . 24.239999999999998 112.612 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.61 -64.71 0.74 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.981 1.313 . . . . 55.240000000000002 110.135 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -130.93 104.33 7.07 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.925 -1.139 . . . . 74.450000000000003 107.925 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 639' ' ' THR . . . . . 0.419 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 14.6 t -129.45 114.0 15.6 Favored 'General case' 0 N--CA 1.404 -2.735 0 CA-C-O 122.547 1.165 . . . . 71.439999999999998 110.326 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 640' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.8 ttmt -144.09 148.95 35.83 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 106.586 -1.635 . . . . 73.219999999999999 106.586 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 56.4 tp -126.76 109.99 12.63 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.478 -0.934 . . . . 71.530000000000001 108.478 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.445 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.9 mt-10 -87.0 126.42 34.73 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 107.421 -1.325 . . . . 73.140000000000001 107.421 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 512' ' ' THR . 43.9 t -113.62 122.41 67.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 109.048 -0.723 . . . . 64.409999999999997 109.048 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.62 135.55 50.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.79 -1.096 . . . . 73.230000000000004 110.014 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.407 HG21 HG23 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -126.75 148.08 31.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 123.096 0.558 . . . . 74.150000000000006 110.142 178.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 73.53 -28.86 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.982 1.313 . . . . 71.030000000000001 111.87 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.7 96.56 9.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.05 -1.833 . . . . 63.229999999999997 106.05 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 648' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 29.6 t -98.7 133.35 43.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.785 -0.45 . . . . 75.409999999999997 109.785 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -131.68 178.14 6.98 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.603 -0.888 . . . . 75.549999999999997 108.603 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.55 112.9 18.34 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.207 -0.597 . . . . 74.140000000000001 109.838 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -71.18 113.36 8.14 Favored 'General case' 0 N--CA 1.401 -2.89 0 N-CA-C 108.874 -0.787 . . . . 71.519999999999996 108.874 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -23.82 55.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.517 1.302 . . . . 73.030000000000001 114.517 -171.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 19.4 m 60.75 20.37 10.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.491 0.717 . . . . 63.450000000000003 111.547 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.4 m -135.65 121.53 19.86 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.772 -0.649 . . . . 50.509999999999998 109.838 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 29.8 m -98.46 147.83 6.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.982 -0.748 . . . . 72.319999999999993 108.982 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 116.584 -0.28 . . . . 72.150000000000006 111.201 -176.298 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.157 0.503 . . . . 74.310000000000002 111.711 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -76.41 -54.43 6.75 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.903 -0.777 . . . . 64.439999999999998 108.903 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -142.94 91.43 0.17 Allowed Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 110.185 -1.166 . . . . 60.43 110.185 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 68.3 mt -96.89 114.88 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.306 -0.627 . . . . 73.219999999999999 109.306 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -101.24 132.26 46.83 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.017 -0.735 . . . . 75.120000000000005 109.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.1 t -146.38 153.81 40.92 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 120.795 0.331 . . . . 64.299999999999997 110.436 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.54 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.15 153.73 38.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.649 -0.5 . . . . 71.329999999999998 109.649 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 41.7 mt-10 -56.19 -56.19 23.98 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.941 0.775 . . . . 72.430000000000007 110.397 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -122.35 160.84 46.29 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.721 -1.127 . . . . 75.439999999999998 109.136 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -86.73 -20.74 2.39 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.032 1.821 . . . . 73.420000000000002 112.071 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.437 HG13 HD12 ' A' ' 644' ' ' ILE . 75.6 t -144.22 135.61 21.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 71.230000000000004 108.891 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.0 t -133.21 123.96 26.54 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.449 0.643 . . . . 72.319999999999993 110.07 177.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -98.98 115.96 30.12 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.964 -1.124 . . . . 75.209999999999994 107.964 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.14 169.15 17.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 123.492 0.495 . . . . 62.450000000000003 110.422 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 44.6 t -78.3 155.95 29.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.98 -0.554 . . . . 64.129999999999995 111.069 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.14 -20.96 54.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.486 -0.931 . . . . 71.510000000000005 108.486 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 32.75 5.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.66 -0.7 . . . . 74.430000000000007 110.728 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 6.5 tt -82.83 -23.2 8.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 62.0 109.657 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.76 -74.76 2.03 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.33 -0.708 . . . . 73.519999999999996 111.33 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.7 mm -130.28 128.17 63.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.449 -1.315 . . . . 70.239999999999995 107.449 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -99.61 157.04 16.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.296 -0.631 . . . . 74.150000000000006 109.296 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.06 131.59 56.9 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.572 0.545 . . . . 74.310000000000002 111.919 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 41.4 t -126.26 116.33 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 109.603 -0.517 . . . . 44.219999999999999 109.603 173.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 97.5 mttt -92.34 124.87 36.72 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.975 -0.69 . . . . 70.420000000000002 110.027 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.88 112.73 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.479 -1.304 . . . . 75.409999999999997 107.479 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 40.3 mt -96.07 152.76 18.24 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.129 -0.941 . . . . 74.420000000000002 110.406 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 1.8 mpp_? -106.65 114.83 29.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.043 -0.725 . . . . 53.119999999999997 109.043 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.3 m -65.36 -50.87 63.95 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.82 0.819 . . . . 72.329999999999998 109.998 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.0 p -73.75 -52.25 13.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.19 -0.914 . . . . 73.219999999999999 112.248 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 138.9 -155.95 24.05 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 108.423 -1.871 . . . . 44.329999999999998 108.423 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -169.47 149.13 3.92 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 117.339 0.569 . . . . 73.129999999999995 109.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -156.57 102.11 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.573 -2.01 . . . . 65.219999999999999 105.573 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 124.66 -173.04 16.99 Favored Glycine 0 C--N 1.295 -1.738 0 N-CA-C 110.046 -1.222 . . . . 72.430000000000007 110.046 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -99.21 118.98 37.11 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 108.968 -0.753 . . . . 65.140000000000001 108.968 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 14.1 t -120.69 121.31 65.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 109.171 -0.677 . . . . 60.229999999999997 109.171 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.477 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.9 mm -94.39 117.03 37.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.79 -0.818 . . . . 52.229999999999997 108.79 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.7 106.73 56.7 Favored Pre-proline 0 C--N 1.301 -1.516 0 CA-C-N 115.446 -0.797 . . . . 74.319999999999993 110.673 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 5.0 Cg_exo -76.88 150.87 30.75 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.129 1.886 . . . . 65.140000000000001 111.7 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -141.72 161.48 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.84 -1.17 . . . . 73.5 107.84 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.584 ' HE2' HD11 ' A' ' 542' ' ' ILE . 24.0 pttm -152.49 137.06 16.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.056 0.455 . . . . 63.030000000000001 111.638 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.8 p -83.51 134.39 34.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.575 -0.739 . . . . 65.200000000000003 110.224 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.584 HD11 ' HE2' ' A' ' 540' ' ' LYS . 48.1 mm -103.55 126.38 58.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.357 -0.979 . . . . 61.32 108.357 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -78.95 112.31 16.01 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.113 -1.069 . . . . 72.319999999999993 108.113 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -101.36 -106.17 2.9 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.771 -1.332 . . . . 72.25 109.771 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 23.9 p -89.5 -11.37 43.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.438 0.637 . . . . 71.540000000000006 109.827 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -100.65 141.36 33.63 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.06 -1.089 . . . . 73.230000000000004 108.06 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -100.05 133.68 44.07 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.861 0.363 . . . . 64.409999999999997 110.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.72 -159.97 35.43 Favored Glycine 0 N--CA 1.431 -1.66 0 C-N-CA 120.777 -0.725 . . . . 60.409999999999997 111.355 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.0 37.39 64.32 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.025 -0.607 . . . . 41.25 112.187 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.69 5.13 86.89 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.361 -0.447 . . . . 53.240000000000002 113.529 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -81.89 -82.21 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.849 0.325 . . . . 75.219999999999999 111.771 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -46.76 7.63 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.712 -1.218 . . . . 65.040000000000006 107.712 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -131.89 160.63 35.15 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.36 -1.291 . . . . 64.129999999999995 107.575 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.0 OUTLIER -91.98 131.97 36.88 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.861 -1.533 . . . . 51.039999999999999 106.861 175.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.21 125.5 29.93 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.947 -0.569 . . . . 63.539999999999999 109.732 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.8 t -133.99 121.99 22.41 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 122.026 0.917 . . . . 43.020000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.7 p -133.55 129.53 37.19 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.825 -1.546 . . . . 71.019999999999996 106.825 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -172.63 -177.39 41.98 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.029 -1.081 . . . . 73.519999999999996 111.036 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.462 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.1 mt-10 -113.24 129.51 56.5 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.362 0.601 . . . . 70.319999999999993 111.945 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.7 mt -89.24 140.11 29.81 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.649 -1.16 . . . . 62.240000000000002 109.699 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -99.83 101.78 13.02 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.944 -0.571 . . . . 61.229999999999997 109.931 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 43.0 m-85 -96.17 149.71 21.33 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.624 0.725 . . . . 73.329999999999998 110.439 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.411 ' H ' HD11 ' A' ' 567' ' ' ILE . 79.7 mm-40 -127.41 -140.54 0.26 Allowed 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.128 -1.804 . . . . 74.200000000000003 106.128 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -62.21 157.72 18.71 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 122.958 0.503 . . . . 61.340000000000003 110.088 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.422 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 33.6 t70 -54.55 -21.11 9.28 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.598 1.159 . . . . 72.209999999999994 113.74 -175.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.533 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.1 pt-20 -59.27 -30.96 68.67 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.678 0.791 . . . . 71.040000000000006 112.781 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.533 HG23 ' HG3' ' A' ' 566' ' ' GLU . 34.7 pt -101.08 168.93 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.643 0.259 . . . . 74.409999999999997 110.955 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.34 152.38 15.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.88 -1.526 . . . . 72.099999999999994 106.88 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.1 mmpt? -112.8 157.44 21.35 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 120.783 -0.367 . . . . 52.210000000000001 110.8 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -127.32 129.41 70.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.231 -0.895 . . . . 70.409999999999997 109.822 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.9 mt -90.63 122.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.61 -1.626 . . . . 75.140000000000001 106.61 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.0 p -106.86 122.01 45.55 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.239 -0.652 . . . . 63.149999999999999 109.239 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.419 HD11 HD22 ' A' ' 589' ' ' LEU . 61.6 mt -118.31 128.44 75.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.472 -0.566 . . . . 43.130000000000003 109.472 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.4 mtt180 -74.31 119.48 18.58 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.944 0.778 . . . . 70.019999999999996 110.1 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.6 mm -107.25 135.75 44.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.719 -0.845 . . . . 74.040000000000006 108.719 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -123.33 164.48 18.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.776 -1.194 . . . . 71.0 107.776 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.81 143.72 20.27 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 123.017 0.198 . . . . 61.299999999999997 111.406 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 578' ' ' ARG . 0.0 OUTLIER -40.34 113.3 0.35 Allowed 'General case' 0 CA--C 1.564 1.502 0 O-C-N 125.128 1.518 . . . . 73.510000000000005 113.34 -174.306 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -102.84 141.7 35.2 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 120.82 -1.175 . . . . 65.140000000000001 110.265 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 68.81 97.07 0.06 Allowed 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 124.77 1.228 . . . . 62.409999999999997 111.573 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -77.04 167.54 21.62 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.269 -0.878 . . . . 64.510000000000005 108.633 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 72.53 12.18 5.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.665 0.786 . . . . 54.219999999999999 110.238 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -139.14 154.59 48.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.99 -1.485 . . . . 71.340000000000003 106.99 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.51 129.55 52.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.994 -1.113 . . . . 71.25 107.994 172.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.517 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.0 m -73.95 115.45 13.42 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.63 0.729 . . . . 73.299999999999997 112.031 -174.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 m -146.77 128.04 14.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.91 -0.774 . . . . 75.340000000000003 108.91 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.2 p90 -131.22 165.76 22.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.714 -0.847 . . . . 55.530000000000001 108.714 174.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 5.0 m -119.7 162.52 18.88 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.523 -0.871 . . . . 70.409999999999997 110.221 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 573' ' ' ILE . 47.0 tp -135.69 130.06 33.68 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.276 -1.379 . . . . 64.239999999999995 107.276 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.83 160.14 42.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 123.603 0.564 . . . . 74.329999999999998 109.674 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.54 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 44.9 mt -106.26 144.4 33.0 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.976 0.798 . . . . 70.230000000000004 109.004 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.77 178.3 5.35 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.178 -1.045 . . . . 73.310000000000002 108.178 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.29 117.36 23.51 Favored Pre-proline 0 C--O 1.247 0.954 0 O-C-N 123.642 0.589 . . . . 62.43 109.759 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.43 ' HG2' ' HB2' ' A' ' 633' ' ' PRO . 56.4 Cg_endo -77.46 147.78 25.76 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.409 2.072 . . . . 73.200000000000003 111.375 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.477 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 8.7 ptpp? -113.63 123.59 50.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.133 -0.485 . . . . 75.299999999999997 110.055 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 596' ' ' TRP . . . . . 0.405 ' HB2' ' HG3' ' A' ' 633' ' ' PRO . 2.9 t90 -98.23 110.58 23.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.014 -0.539 . . . . 75.420000000000002 110.256 -173.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.74 89.4 2.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 106.693 -1.595 . . . . 70.340000000000003 106.693 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 598' ' ' ARG . . . . . 0.548 ' O ' ' HA3' ' A' ' 603' ' ' GLY . 15.0 ptm180 -103.43 91.76 4.19 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.886 -1.052 . . . . 64.409999999999997 109.027 177.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -41.78 111.38 0.23 Allowed 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.88 1.672 . . . . 70.329999999999998 112.421 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -171.25 -164.67 27.33 Favored Glycine 0 N--CA 1.418 -2.515 0 N-CA-C 110.342 -1.103 . . . . 73.409999999999997 110.342 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 52.6 tpp -72.94 -43.17 62.64 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.271 0.557 . . . . 61.119999999999997 109.615 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -90.15 -26.46 20.16 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.048 -0.524 . . . . 73.140000000000001 110.345 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 603' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 598' ' ' ARG . . . -89.29 68.17 2.75 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 111.395 -0.682 . . . . 72.010000000000005 111.395 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -135.46 61.86 0.62 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.02 -1.232 . . . . 72.5 110.02 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -147.19 146.33 29.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.656 -0.498 . . . . 73.400000000000006 109.656 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 85.1 m -146.66 109.94 4.77 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.632 -1.247 . . . . 73.120000000000005 107.632 173.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 607' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 609' ' ' GLU . 47.6 mm -96.12 123.56 48.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.758 -0.83 . . . . 72.209999999999994 108.758 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 11.4 m -115.14 18.04 16.43 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 123.061 1.41 . . . . 74.450000000000003 107.498 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 609' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 607' ' ' ILE . 9.3 pt-20 -125.76 83.54 2.18 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-N 114.089 -1.414 . . . . 75.140000000000001 110.809 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -80.58 104.28 11.0 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 105.113 -2.181 . . . . 75.340000000000003 105.113 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -71.49 -26.8 62.84 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.668 -1.151 . . . . 73.299999999999997 113.983 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -144.45 103.02 3.91 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.179 0.514 . . . . 65.549999999999997 110.075 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -91.08 69.73 6.24 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.832 -1.173 . . . . 74.209999999999994 107.832 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 614' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 616' ' ' PRO . 30.9 mmmt -140.75 22.46 2.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.418 -0.355 . . . . 62.399999999999999 111.295 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.28 117.04 68.03 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 120.632 -0.427 . . . . 75.319999999999993 111.782 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 614' ' ' LYS . 93.9 Cg_endo -93.23 171.0 2.12 Favored 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.328 2.019 . . . . 54.340000000000003 110.397 174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 617' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' A' ' 639' ' ' THR . 2.7 mm? -100.27 77.64 1.98 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.271 1.034 . . . . 70.010000000000005 109.765 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 16.8 p -126.55 137.13 53.31 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.649 -1.614 . . . . 71.120000000000005 108.401 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.4 m -133.23 114.07 13.39 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.034 0.445 . . . . 75.450000000000003 110.029 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -137.75 64.87 1.5 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.388 -1.338 . . . . 60.020000000000003 107.388 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -122.23 164.73 17.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.373 -1.285 . . . . 70.540000000000006 109.688 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 622' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' A' ' 624' ' ' GLU . 0.9 OUTLIER -78.67 145.44 34.58 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.617 -2.364 . . . . 72.129999999999995 104.617 174.164 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.72 -16.36 64.18 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 115.149 1.537 . . . . 73.329999999999998 115.149 -171.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.409 ' HG2' ' OE1' ' A' ' 622' ' ' GLU . 10.2 pt-20 -65.7 -26.8 67.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 119.018 -1.073 . . . . 74.230000000000004 110.789 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -67.08 -39.55 86.8 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.961 -0.755 . . . . 63.140000000000001 108.961 173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.29 -33.91 76.28 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.06 -0.973 . . . . 74.299999999999997 110.781 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 94.6 mt -58.47 -40.96 80.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 CA-C-O 120.866 0.365 . . . . 44.420000000000002 110.373 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 632' ' ' ARG . . . -67.55 -41.99 83.38 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.654 -0.703 . . . . 35.210000000000001 109.574 177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.411 ' HB3' HG21 ' A' ' 634' ' ' ILE . 47.4 mt-10 -63.22 -29.34 70.7 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.698 -0.683 . . . . 74.530000000000001 111.599 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 71.0 mtm -66.67 -9.66 38.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.228 0.537 . . . . 64.530000000000001 112.397 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -112.31 12.72 26.06 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.246 -1.142 . . . . 72.530000000000001 110.246 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 628' ' ' ALA . 28.3 mmm180 -119.82 162.24 34.03 Favored Pre-proline 0 C--N 1.313 -1.013 0 C-N-CA 122.932 0.493 . . . . 73.409999999999997 109.996 -177.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.43 ' HB2' ' HG2' ' A' ' 594' ' ' PRO . 49.5 Cg_endo -70.81 120.61 7.2 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.25 1.967 . . . . 74.420000000000002 108.977 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.411 HG21 ' HB3' ' A' ' 629' ' ' GLU . 31.2 pt -138.87 -178.61 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.459 0.647 . . . . 75.319999999999993 110.973 -175.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.426 HD21 ' HD3' ' A' ' 594' ' ' PRO . 2.2 mm? -114.61 170.31 8.41 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 64.219999999999999 107.364 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.82 154.59 50.92 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.388 -1.885 . . . . 72.049999999999997 108.388 172.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -39.86 -64.06 0.53 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.1 0.96 . . . . 63.240000000000002 112.641 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -130.07 83.43 2.13 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.827 -1.175 . . . . 71.239999999999995 107.827 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 639' ' ' THR . . . . . 0.425 HG22 ' HG ' ' A' ' 617' ' ' LEU . 11.2 t -100.67 110.88 23.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.241 1.019 . . . . 64.200000000000003 110.64 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -146.72 134.86 21.61 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.411 -1.329 . . . . 72.5 107.411 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 65.0 tp -113.2 112.91 24.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.312 -0.625 . . . . 70.540000000000006 109.312 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.41 ' HB2' HG22 ' A' ' 511' ' ' VAL . 48.7 mt-10 -90.47 117.03 28.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 176.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.63 116.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 N-CA-C 107.66 -1.237 . . . . 54.310000000000002 107.66 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 644' ' ' ILE . . . . . 0.437 HD12 HG13 ' A' ' 511' ' ' VAL . 16.0 mt -115.47 128.22 72.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.547 0 CA-C-N 114.787 -1.097 . . . . 75.109999999999999 109.901 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER -119.34 125.37 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 114.474 -1.239 . . . . 71.030000000000001 108.308 179.108 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -131.46 140.32 49.56 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.403 -0.591 . . . . 75.329999999999998 109.403 -175.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -84.36 129.43 34.87 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 105.476 -2.046 . . . . 74.109999999999999 105.476 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 70.6 m 68.57 32.51 4.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.924 0.869 . . . . 53.25 109.457 -174.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -56.05 165.68 0.93 Allowed 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.957 1.303 . . . . 75.430000000000007 112.508 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.72 111.18 19.43 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.26 -1.755 . . . . 72.420000000000002 106.26 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -116.98 132.11 56.79 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.431 -1.322 . . . . 64.040000000000006 107.431 -177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.2 -35.65 61.49 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.322 0.86 . . . . 61.420000000000002 113.322 -174.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 54.2 m 52.56 30.94 9.2 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.768 0.827 . . . . 62.140000000000001 112.034 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.2 m -87.6 110.68 20.55 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.719 -0.673 . . . . 35.350000000000001 110.025 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.38 -21.6 6.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.578 0.704 . . . . 73.219999999999999 110.102 -176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.3 -1.555 0 CA-C-N 115.254 -0.884 . . . . 71.540000000000006 110.742 -179.19 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.793 0.806 . . . . 72.140000000000001 110.12 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -72.93 110.39 7.2 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.826 -1.079 . . . . 44.119999999999997 111.562 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . 63.82 58.83 9.76 Favored Glycine 0 C--O 1.204 -1.732 0 CA-C-N 114.872 -1.058 . . . . 72.0 114.134 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 91.9 mt -71.78 114.22 9.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 116.876 0.338 . . . . 73.109999999999999 110.984 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.424 ' HE1' ' HE ' ' A' ' 527' ' ' ARG . 38.2 m-85 -100.5 132.73 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.882 -0.784 . . . . 74.049999999999997 108.882 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -148.23 157.59 43.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.841 -0.537 . . . . 74.319999999999993 110.641 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.572 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 91.9 m-85 -71.56 155.57 40.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.258 . . . . 63.420000000000002 110.319 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.91 -56.28 22.58 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.914 0.759 . . . . 73.030000000000001 109.623 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLU . . . . . 0.416 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.6 mt-10 -134.09 159.51 72.08 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 107.952 -1.129 . . . . 71.420000000000002 107.952 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 62.8 Cg_endo -79.04 -21.49 9.35 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 121.93 1.753 . . . . 65.519999999999996 113.808 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.4 t -138.59 133.34 42.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.702 -0.481 . . . . 60.43 109.702 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.6 139.11 46.34 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.206 0.527 . . . . 55.100000000000001 109.705 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -109.39 132.84 53.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.989 -1.485 . . . . 61.509999999999998 106.989 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.87 163.72 26.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 C-N-CA 120.621 -0.432 . . . . 71.510000000000005 110.449 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 647' ' ' GLU . 27.2 m -82.44 163.68 21.47 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.569 -0.741 . . . . 71.150000000000006 109.574 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 577' ' ' ASP . 19.5 tt0 -81.05 -34.72 32.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.729 -1.212 . . . . 61.119999999999997 107.729 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 577' ' ' ASP . 17.4 m -96.34 27.54 3.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.144 -0.934 . . . . 75.209999999999994 111.022 -176.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 7.4 tt -79.8 -25.08 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.409 0.623 . . . . 74.439999999999998 110.601 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 86.45 -75.71 2.21 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.926 -0.654 . . . . 73.120000000000005 111.668 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 48.4 mm -130.51 137.56 55.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.458 -1.682 . . . . 44.409999999999997 106.458 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.1 ppp? -110.09 147.98 32.6 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.403 -0.962 . . . . 74.219999999999999 108.403 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -110.97 134.38 52.63 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.596 0.56 . . . . 74.219999999999999 110.825 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 46.1 t -121.19 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.68 -0.859 . . . . 74.099999999999994 108.68 171.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -85.52 120.79 27.37 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.572 -0.851 . . . . 74.420000000000002 110.058 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.25 101.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.987 -1.486 . . . . 71.209999999999994 106.987 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.1 mt -84.32 163.4 19.62 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 114.183 -1.371 . . . . 74.010000000000005 111.006 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.608 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 74.6 mtt180 -118.12 109.08 15.98 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.865 -1.062 . . . . 64.430000000000007 110.446 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 22.7 m -66.27 -62.93 1.21 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.269 -0.423 . . . . 65.049999999999997 110.416 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.9 p -75.31 -36.44 61.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.663 0.744 . . . . 72.239999999999995 112.009 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 124.55 -128.78 6.87 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.211 -1.155 . . . . 65.040000000000006 110.211 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . 177.16 168.69 0.58 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.052 1.341 . . . . 63.409999999999997 107.437 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.529 ' HD2' ' OD1' ' A' ' 564' ' ' ASN . 9.9 tpt180 -163.41 81.17 0.46 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.524 -1.287 . . . . 74.25 107.524 172.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 135.34 171.3 12.37 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 110.075 -1.21 . . . . 70.010000000000005 110.075 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -86.84 128.72 35.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.17 0.509 . . . . 71.150000000000006 110.843 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.8 t -136.07 134.32 50.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 70.120000000000005 109.474 -177.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.545 HG12 HD11 ' A' ' 597' ' ' ILE . 44.7 mm -93.75 122.04 44.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.795 -0.817 . . . . 73.420000000000002 108.795 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.65 102.07 54.41 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 123.471 0.482 . . . . 73.420000000000002 110.438 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 6.1 Cg_exo -76.49 148.73 30.02 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 121.932 1.754 . . . . 74.299999999999997 111.127 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -138.05 166.68 23.49 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.972 -1.122 . . . . 74.019999999999996 107.972 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 589' ' ' LEU . 54.3 pttt -157.45 134.83 10.44 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.03 0.443 . . . . 71.299999999999997 111.254 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.6 p -80.44 126.61 31.41 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.678 -0.692 . . . . 74.209999999999994 110.156 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 42.2 mm -95.16 116.45 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.101 -1.444 . . . . 62.109999999999999 107.101 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.73 111.66 18.19 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.41 0.444 . . . . 74.109999999999999 110.672 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.64 -110.93 3.31 Favored Glycine 0 C--N 1.31 -0.894 0 N-CA-C 110.159 -1.176 . . . . 64.040000000000006 110.159 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 586' ' ' SER . 6.5 m -70.06 -35.48 74.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.684 -1.228 . . . . 61.210000000000001 107.684 175.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.92 132.69 35.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.325 -1.307 . . . . 53.32 108.439 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -114.6 157.11 23.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.587 0.708 . . . . 75.109999999999999 111.412 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -88.17 -154.0 27.0 Favored Glycine 0 N--CA 1.427 -1.948 0 CA-C-N 114.829 -1.078 . . . . 73.150000000000006 111.972 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.43 8.84 47.59 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.964 -0.16 . . . . 51.130000000000003 112.99 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.65 24.22 26.35 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 121.152 -0.547 . . . . 71.420000000000002 111.982 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.57 -69.59 0.61 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.478 -0.934 . . . . 60.229999999999997 108.478 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.92 -40.13 6.34 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.398 -1.334 . . . . 73.129999999999995 107.398 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -143.12 172.59 12.52 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-N 114.943 -1.026 . . . . 64.430000000000007 109.761 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 574' ' ' ARG . 1.7 tm-20 -98.04 114.26 26.36 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 75.439999999999998 105.241 175.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.78 136.81 37.47 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.647 0.737 . . . . 75.150000000000006 111.466 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -130.27 125.74 35.56 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 122.145 0.974 . . . . 60.43 111.734 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 38.6 t -132.43 127.13 34.68 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 105.861 -1.903 . . . . 52.009999999999998 105.861 172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.68 -174.61 37.5 Favored Glycine 0 C--N 1.269 -3.161 0 N-CA-C 109.649 -1.38 . . . . 44.399999999999999 109.649 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 8.6 pt-20 -121.01 127.98 52.26 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.364 0.602 . . . . 71.319999999999993 111.424 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.13 136.22 33.07 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.226 -0.897 . . . . 73.030000000000001 108.817 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.17 98.84 9.2 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 121.496 0.665 . . . . 74.549999999999997 109.606 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.608 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 36.2 m-85 -92.61 124.24 36.48 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.823 -0.626 . . . . 71.349999999999994 110.516 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.646 ' H ' HD11 ' A' ' 567' ' ' ILE . 12.9 mm100 -83.63 -146.98 0.09 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.057 -1.831 . . . . 71.349999999999994 106.057 172.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.529 ' OD1' ' HD2' ' A' ' 532' ' ' ARG . 61.2 t30 -63.47 170.49 3.09 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.15 0.58 . . . . 62.399999999999999 110.429 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.81 -11.58 8.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.618 1.167 . . . . 61.009999999999998 113.864 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.07 -21.79 66.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.656 0.782 . . . . 74.129999999999995 112.839 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.646 HD11 ' H ' ' A' ' 563' ' ' GLN . 23.7 pt -114.18 168.9 5.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 O-C-N 121.793 -0.567 . . . . 72.109999999999999 111.265 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.17 147.42 25.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.442 -1.318 . . . . 63.420000000000002 107.442 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 68.4 mmtt -111.34 148.5 32.85 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.088 0.471 . . . . 62.0 111.224 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.1 mt -120.38 132.53 69.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.834 -1.075 . . . . 74.109999999999999 110.328 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.2 mt -91.91 126.46 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.7 -1.593 . . . . 73.329999999999998 106.7 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 572' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 521' ' ' MET . 16.2 p -113.94 112.78 23.87 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.052 0.453 . . . . 63.310000000000002 109.966 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 589' ' ' LEU . 70.1 mt -105.0 130.62 55.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.617 -0.512 . . . . 71.439999999999998 109.617 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' A' ' 554' ' ' GLU . 99.3 mtt180 -78.53 114.95 17.9 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.131 0.491 . . . . 71.239999999999995 110.309 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.9 mm -103.22 137.49 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 106.166 -1.79 . . . . 55.140000000000001 106.166 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 554' ' ' GLU . 47.6 m-85 -105.72 122.9 47.02 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.89 -0.724 . . . . 72.329999999999998 111.739 -176.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 577' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 578' ' ' ARG . 4.0 p-10 -88.64 160.55 17.33 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 115.333 -0.849 . . . . 71.299999999999997 108.831 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 577' ' ' ASP . 17.7 ptp180 61.05 12.76 4.17 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.129 1.772 . . . . 74.099999999999994 111.144 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -95.86 43.17 1.08 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 105.884 -1.895 . . . . 62.450000000000003 105.884 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -76.35 30.99 0.12 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.632 -1.622 . . . . 73.319999999999993 112.62 -172.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -83.01 -18.94 38.03 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.851 -1.166 . . . . 54.240000000000002 107.851 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -104.68 -163.07 0.93 Allowed 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.308 -1.315 . . . . 72.319999999999993 110.397 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -138.07 -152.91 0.45 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 110.241 -0.281 . . . . 74.120000000000005 110.241 -170.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -74.77 101.71 4.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.919 -1.141 . . . . 54.409999999999997 107.919 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 63.3 m -120.87 140.98 51.02 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.191 -0.459 . . . . 62.439999999999998 111.278 -173.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.405 ' H ' ' HB ' ' A' ' 545' ' ' THR . 63.9 p -117.69 149.03 41.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.911 -0.493 . . . . 72.540000000000006 110.875 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.6 p90 -137.15 174.84 10.18 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.324 -0.991 . . . . 74.219999999999999 108.324 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 588' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 13.0 m -124.85 167.03 15.2 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 120.256 -0.577 . . . . 74.239999999999995 109.616 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 573' ' ' ILE . 39.3 tp -141.45 130.87 23.75 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.083 -1.451 . . . . 70.040000000000006 107.083 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.72 157.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 123.343 0.402 . . . . 65.5 110.041 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 75.2 mt -96.76 142.78 28.37 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.096 -1.446 . . . . 75.450000000000003 107.096 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 592' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 538' ' ' PRO . 10.9 mm-40 -104.43 172.24 6.9 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 123.441 0.463 . . . . 73.230000000000004 110.033 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -52.64 112.2 3.24 Favored Pre-proline 0 C--N 1.316 -0.876 0 O-C-N 124.957 1.411 . . . . 75.019999999999996 110.987 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.448 ' O ' ' HD2' ' A' ' 632' ' ' ARG . 33.1 Cg_endo -76.04 153.8 37.21 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 C-N-CA 121.705 1.603 . . . . 73.129999999999995 111.504 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -124.09 132.14 53.63 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.378 -0.601 . . . . 75.519999999999996 109.378 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -93.77 140.82 29.21 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.491 -0.559 . . . . 74.340000000000003 109.491 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 597' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 536' ' ' ILE . 1.8 mp -83.42 89.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 122.752 1.263 . . . . 60.43 110.458 178.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -128.15 85.52 2.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 105.888 -1.893 . . . . 74.310000000000002 105.888 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -70.91 155.95 40.18 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.26 -1.337 . . . . 62.329999999999998 113.553 -172.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 176.69 -154.73 16.99 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 107.418 -2.273 . . . . 71.129999999999995 107.418 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.23 122.15 33.61 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.894 -1.521 . . . . 63.340000000000003 106.894 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -149.9 127.38 11.52 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.159 -0.682 . . . . 62.020000000000003 109.159 -173.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 131.12 -119.86 2.77 Favored Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 119.907 -1.139 . . . . 74.239999999999995 112.804 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 95.89 -142.73 16.27 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 108.993 -1.643 . . . . 72.319999999999993 108.993 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -111.12 87.65 2.59 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.344 1.069 . . . . 62.399999999999999 110.61 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 40.1 m -152.24 144.07 23.66 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 104.891 -2.262 . . . . 74.25 104.891 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 49.0 mm -81.04 -70.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.734 -0.387 . . . . 71.209999999999994 110.454 -175.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 31.5 m 68.6 -44.16 0.51 Allowed 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 124.543 1.137 . . . . 43.140000000000001 112.131 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.5 59.15 4.49 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.899 1.28 . . . . 72.120000000000005 110.838 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -93.95 142.98 26.76 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.332 -0.849 . . . . 73.25 109.703 176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -80.64 85.15 6.07 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.368 -1.345 . . . . 73.010000000000005 107.368 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -111.32 -58.23 2.14 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.003 -1.48 . . . . 62.530000000000001 107.003 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 69.37 -62.78 0.4 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 114.749 1.389 . . . . 73.040000000000006 114.749 170.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 614' ' ' LYS . . . . . 0.517 ' HA ' ' HE3' ' A' ' 614' ' ' LYS . 1.8 tpmt? -88.17 88.81 7.75 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.821 0.82 . . . . 53.329999999999998 109.613 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -105.29 170.02 6.42 Favored Pre-proline 0 C--N 1.28 -2.448 0 CA-C-N 114.726 -1.124 . . . . 71.340000000000003 108.565 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.46 140.09 93.24 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.745 1.63 . . . . 52.530000000000001 109.406 172.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -86.23 -94.32 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 112.42 0.526 . . . . 74.349999999999994 112.42 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 21.6 m -83.0 -36.85 24.7 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 116.318 -0.401 . . . . 63.350000000000001 110.111 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 31.9 t -77.93 97.41 5.3 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.524 0.678 . . . . 71.109999999999999 109.903 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 620' ' ' LYS . . . . . 0.469 ' HE2' ' OE1' ' A' ' 629' ' ' GLU . 65.5 mttp -113.66 176.14 5.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.541 -0.754 . . . . 75.340000000000003 109.562 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -109.88 177.46 4.71 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.147 -0.479 . . . . 70.329999999999998 110.205 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -74.5 93.09 2.42 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.868 -0.79 . . . . 73.099999999999994 108.868 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -140.94 151.26 44.06 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.656 -0.702 . . . . 74.450000000000003 109.872 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.96 -26.01 64.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.405 -0.361 . . . . 54.229999999999997 111.639 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -59.61 -35.67 74.8 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 110.297 -0.26 . . . . 71.530000000000001 110.297 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -63.37 -31.46 72.62 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-O 121.265 0.555 . . . . 74.549999999999997 110.51 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 64.9 mt -70.7 -31.95 47.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.544 0.687 . . . . 72.439999999999998 109.208 177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -72.68 -38.36 67.6 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.996 -0.547 . . . . 72.430000000000007 109.852 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.469 ' OE1' ' HE2' ' A' ' 620' ' ' LYS . 36.4 mt-10 -69.67 -28.12 65.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.574 0.702 . . . . 51.219999999999999 110.038 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 49.0 ttm -72.42 -18.46 61.71 Favored 'General case' 0 N--CA 1.404 -2.743 0 C-N-CA 125.004 1.322 . . . . 63.009999999999998 109.929 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -98.92 17.78 57.74 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.588 -0.605 . . . . 73.030000000000001 111.588 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 594' ' ' PRO . 14.0 mmt85 -97.01 154.27 38.25 Favored Pre-proline 0 C--N 1.301 -1.527 0 C-N-CA 122.703 0.401 . . . . 65.129999999999995 110.025 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -67.51 154.39 73.79 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 106.546 -2.136 . . . . 73.030000000000001 106.546 165.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 634' ' ' ILE . 0.2 OUTLIER -128.79 176.87 7.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 C-N-CA 118.541 -1.264 . . . . 64.230000000000004 113.22 -176.203 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.83 -175.2 2.73 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.893 -1.503 . . . . 65.340000000000003 108.006 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.7 143.71 47.2 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 108.012 -2.035 . . . . 61.32 108.012 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -52.55 -42.44 64.42 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.04 0.536 . . . . 71.040000000000006 111.869 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -128.24 101.02 6.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.028 -1.101 . . . . 64.340000000000003 108.028 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 5.0 t -136.0 110.55 8.58 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-O 122.383 1.087 . . . . 63.43 111.041 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 640' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 35.9 ttmt -146.49 150.82 36.33 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.6 -1.63 . . . . 64.329999999999998 106.6 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 509' ' ' GLU . 61.5 tp -127.54 112.76 15.29 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.2 -0.667 . . . . 62.109999999999999 109.2 174.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.429 ' HB2' HG22 ' A' ' 511' ' ' VAL . 43.5 mt-10 -89.62 125.35 35.2 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.658 -0.867 . . . . 64.040000000000006 108.658 175.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.36 119.45 59.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.427 -0.953 . . . . 71.430000000000007 108.427 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' ILE . . . . . 0.463 HG22 ' HG2' ' A' ' 646' ' ' GLU . 3.9 mp -111.26 125.0 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 115.576 -0.738 . . . . 71.140000000000001 110.207 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.31 96.01 4.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 121.718 0.77 . . . . 73.219999999999999 110.991 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 646' ' ' GLU . . . . . 0.463 ' HG2' HG22 ' A' ' 644' ' ' ILE . 7.1 pt-20 -135.06 117.07 15.3 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.542 -1.208 . . . . 72.299999999999997 109.704 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 515' ' ' SER . 7.3 tp10 -123.29 18.89 9.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.925 1.345 . . . . 74.030000000000001 108.207 -177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.4 p -83.52 20.44 1.38 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 125.815 1.646 . . . . 73.219999999999999 113.099 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -158.8 172.72 17.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.015 -0.735 . . . . 74.120000000000005 109.015 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.97 131.65 51.0 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 123.73 0.643 . . . . 73.109999999999999 109.278 175.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -140.3 139.98 35.59 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.584 -1.265 . . . . 75.430000000000007 107.584 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -84.37 108.43 17.2 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.175 -0.676 . . . . 65.129999999999995 109.175 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 33.2 m -78.33 94.84 4.91 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.405 0.621 . . . . 54.409999999999997 109.702 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.1 m -126.64 115.36 19.35 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.496 -0.774 . . . . 53.340000000000003 109.01 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 10.1 p -86.79 130.85 36.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.059 -0.719 . . . . 73.319999999999993 109.059 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.256 1.397 0 CA-C-N 116.384 -0.371 . . . . 72.230000000000004 110.576 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 121.211 0.529 . . . . 74.409999999999997 110.199 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -137.39 104.97 5.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.894 -0.594 . . . . 74.450000000000003 109.957 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -78.33 149.64 34.14 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 115.496 -0.775 . . . . 72.349999999999994 111.303 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 84.6 mt -127.25 114.73 37.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.013 -1.477 . . . . 73.519999999999996 107.013 176.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.419 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 37.4 m-85 -103.48 136.98 42.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.793 0.33 . . . . 73.219999999999999 110.809 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.2 t -148.02 160.79 42.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.49 -0.929 . . . . 44.020000000000003 108.49 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -79.9 156.09 27.45 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.668 -0.493 . . . . 74.420000000000002 109.668 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.03 -51.1 68.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.894 0.746 . . . . 71.129999999999995 110.07 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -131.85 157.17 78.93 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.16 -0.927 . . . . 74.299999999999997 109.132 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.52 -21.71 7.22 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.261 1.974 . . . . 74.340000000000003 112.501 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.7 t -143.13 133.93 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.372 0.669 . . . . 70.109999999999999 109.275 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -133.59 138.37 45.96 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 109.313 -0.625 . . . . 72.129999999999995 109.313 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -109.52 110.93 22.17 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.857 -1.164 . . . . 74.329999999999998 107.857 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.33 158.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 116.191 -0.459 . . . . 62.420000000000002 110.439 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 518' ' ' ILE . 22.1 m -78.07 137.35 38.19 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.569 -0.741 . . . . 74.349999999999994 109.232 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 646' ' ' GLU . 2.9 mp0 -65.43 -24.77 67.28 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 123.664 0.786 . . . . 74.200000000000003 110.733 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.4 p -100.45 11.11 40.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.781 -0.645 . . . . 63.32 112.286 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 515' ' ' SER . 11.1 tt -71.32 -37.69 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 120.295 -0.562 . . . . 53.409999999999997 112.129 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.21 -73.22 1.51 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.239 -0.982 . . . . 21.120000000000001 111.389 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.28 125.21 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.442 -1.318 . . . . 74.540000000000006 107.442 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.2 ppp? -100.97 143.31 31.28 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.229 -0.656 . . . . 73.439999999999998 109.229 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -110.19 124.63 51.92 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.836 0.71 . . . . 72.549999999999997 110.848 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 641' ' ' LEU . 41.6 t -129.86 131.34 66.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 110.373 -0.232 . . . . 74.450000000000003 110.373 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.29 136.65 32.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.479 0.487 . . . . 73.439999999999998 110.184 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 96.3 t -95.48 118.14 41.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 105.872 -1.899 . . . . 74.409999999999997 105.872 171.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.6 mt -95.87 135.73 37.23 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 116.099 -0.501 . . . . 75.209999999999994 110.774 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 104.12 15.94 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.441 -0.8 . . . . 74.200000000000003 110.391 174.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.0 m -61.0 -62.45 1.85 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.404 1.081 . . . . 63.210000000000001 111.923 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.5 p -73.3 -31.62 64.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.851 0.834 . . . . 73.319999999999993 109.766 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.62 -155.51 22.28 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 109.814 -1.314 . . . . 64.329999999999998 109.814 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -150.63 155.06 38.63 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.732 -1.951 . . . . 42.509999999999998 105.732 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -157.86 126.73 5.68 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.859 -0.793 . . . . 74.310000000000002 108.859 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.86 -125.42 8.24 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 111.171 -0.771 . . . . 73.219999999999999 111.171 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -136.42 102.33 4.92 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 106.311 -1.737 . . . . 72.349999999999994 106.311 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 37.9 t -113.88 120.4 63.6 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.569 0 C-N-CA 119.236 -0.986 . . . . 72.040000000000006 110.79 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.3 mm -92.11 116.4 33.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 114.803 -1.09 . . . . 72.129999999999995 108.628 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.73 100.6 43.27 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.102 -0.954 . . . . 74.129999999999995 109.248 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 558' ' ' GLY . 2.0 Cg_endo -77.1 153.54 32.21 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.861 1.707 . . . . 61.399999999999999 112.497 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -139.65 159.23 42.64 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.7 -0.852 . . . . 62.109999999999999 108.7 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.517 ' O ' HD12 ' A' ' 589' ' ' LEU . 60.5 pttt -152.13 145.97 25.13 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.022 0.439 . . . . 74.420000000000002 111.017 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -88.09 127.37 35.41 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.286 -0.87 . . . . 73.150000000000006 111.911 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 42.4 mm -100.69 116.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.678 -1.23 . . . . 70.319999999999993 107.678 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.473 ' CD ' HH21 ' A' ' 547' ' ' ARG . 39.7 mt-10 -77.66 116.19 18.01 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.601 -0.272 . . . . 74.420000000000002 110.491 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.19 -115.95 4.06 Favored Glycine 0 C--N 1.306 -1.134 0 N-CA-C 109.028 -1.629 . . . . 73.030000000000001 109.028 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.2 p -75.59 -23.98 56.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.738 0.78 . . . . 72.450000000000003 109.387 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.63 129.27 34.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.523 -1.217 . . . . 73.319999999999993 108.602 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.473 HH21 ' CD ' ' A' ' 543' ' ' GLU . 7.4 tpm_? -95.4 140.72 29.87 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 109.202 -0.666 . . . . 73.400000000000006 109.202 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.15 -160.73 33.16 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.935 -0.866 . . . . 74.239999999999995 110.935 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 79.0 16.72 78.42 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.767 -0.73 . . . . 70.349999999999994 111.636 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 550' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' A' ' 652' ' ' LYS . . . 80.29 31.69 37.23 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 111.644 -0.582 . . . . 70.049999999999997 111.644 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -94.25 -71.09 0.68 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 122.447 -0.443 . . . . 74.409999999999997 110.543 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -29.82 12.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.685 1.231 . . . . 74.129999999999995 107.757 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -143.98 157.69 44.18 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.117 -1.438 . . . . 74.219999999999999 107.117 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.525 ' CD ' ' HD2' ' A' ' 574' ' ' ARG . 6.8 tt0 -96.03 135.98 37.08 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 106.861 -1.533 . . . . 73.409999999999997 106.861 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -74.64 120.4 20.14 Favored 'General case' 0 CA--C 1.472 -2.031 0 C-N-CA 120.643 -0.423 . . . . 52.210000000000001 110.745 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.493 ' CG2' HG12 ' A' ' 573' ' ' ILE . 10.1 t -124.58 120.12 31.02 Favored 'General case' 0 N--CA 1.392 -3.325 0 N-CA-C 105.44 -2.059 . . . . 72.400000000000006 105.44 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.5 p -137.14 139.4 41.15 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.412 -1.699 . . . . 63.229999999999997 106.412 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 538' ' ' PRO . . . -175.88 -166.59 33.56 Favored Glycine 0 N--CA 1.397 -3.952 0 C-N-CA 117.951 -2.071 . . . . 71.239999999999995 112.828 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.7 mt-10 -123.46 114.09 19.64 Favored 'General case' 0 N--CA 1.403 -2.777 0 C-N-CA 124.364 1.066 . . . . 70.430000000000007 108.969 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.33 142.62 27.59 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.57 -0.741 . . . . 74.25 109.207 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -103.56 117.25 33.99 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.8 m-85 -115.94 100.17 7.79 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.281 -1.007 . . . . 72.549999999999997 108.281 173.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.661 ' H ' HD11 ' A' ' 567' ' ' ILE . 77.0 mt-30 -77.35 -87.7 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.948 -0.569 . . . . 75.230000000000004 110.502 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -105.27 164.88 11.51 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 109.881 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 565' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 3.7 p30 -56.9 -11.38 1.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.991 1.478 . . . . 74.530000000000001 114.991 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 566' ' ' GLU . 10.2 pt-20 -79.73 -14.34 58.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.089 0.774 . . . . 71.340000000000003 113.089 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.661 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.3 pt -114.82 169.31 5.86 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.115 0.483 . . . . 72.099999999999994 112.244 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.17 160.17 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.42 -0.956 . . . . 63.439999999999998 108.42 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -124.02 154.9 39.2 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 111.925 0.343 . . . . 71.140000000000001 111.925 177.405 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 73.5 mt -125.33 130.65 72.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.011 -0.995 . . . . 73.030000000000001 110.108 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 589' ' ' LEU . 62.1 mt -90.9 129.08 42.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 107.312 -1.366 . . . . 61.219999999999999 107.312 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 7.7 p -115.91 112.84 22.49 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 123.858 0.724 . . . . 71.439999999999998 110.132 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.493 HG12 ' CG2' ' A' ' 556' ' ' THR . 48.9 mt -116.03 130.96 69.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 121.021 -0.271 . . . . 71.209999999999994 110.711 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.525 ' HD2' ' CD ' ' A' ' 554' ' ' GLU . 92.2 mtt180 -71.19 116.75 11.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.559 0.537 . . . . 74.349999999999994 109.977 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 645' ' ' ILE . 38.0 mm -101.47 135.95 35.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.752 -1.113 . . . . 75.349999999999994 109.744 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -139.17 164.05 30.81 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.313 -2.106 . . . . 74.049999999999997 105.313 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 577' ' ' ASP . . . . . 0.586 ' H ' ' HB3' ' A' ' 650' ' ' GLU . 2.2 p-10 -115.93 109.24 17.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.258 -2.127 . . . . 74.239999999999995 105.258 165.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 578' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 579' ' ' GLU . 9.6 tpt180 -58.64 -79.06 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.964 1.098 . . . . 75.319999999999993 113.964 -174.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 578' ' ' ARG . 43.2 tt0 169.6 106.26 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.374 -1.343 . . . . 72.340000000000003 107.374 -169.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -145.9 170.37 16.72 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 121.566 0.698 . . . . 65.019999999999996 112.782 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -145.93 122.49 11.09 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.634 -1.621 . . . . 73.040000000000006 107.442 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 59.1 82.18 0.15 Allowed 'General case' 0 C--O 1.249 1.031 0 C-N-CA 125.35 1.46 . . . . 72.109999999999999 113.304 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? 163.01 169.86 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.006 1.722 . . . . 74.450000000000003 109.248 173.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -113.88 116.24 28.98 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.58 -2.008 . . . . 74.239999999999995 105.58 173.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' ' 645' ' ' ILE . 5.1 p -77.41 124.7 28.23 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.988 -0.685 . . . . 41.240000000000002 110.29 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 80.4 p -134.95 150.73 50.43 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 121.433 0.635 . . . . 52.210000000000001 111.179 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.38 156.87 46.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.013 -1.477 . . . . 61.43 107.013 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 9.4 m -112.19 153.22 27.38 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.669 -0.813 . . . . 54.340000000000003 109.024 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 540' ' ' LYS . 43.1 tp -124.96 131.51 53.41 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.806 -1.553 . . . . 53.109999999999999 106.806 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.05 159.32 43.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 110.071 -0.344 . . . . 72.400000000000006 110.071 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.16 145.75 27.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.705 0.628 . . . . 75.409999999999997 109.685 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 592' ' ' GLU . . . . . 0.417 ' O ' HD11 ' A' ' 635' ' ' LEU . 6.6 mm-40 -96.69 163.02 13.19 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.177 -1.045 . . . . 62.020000000000003 108.177 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.0 122.53 72.8 Favored Pre-proline 0 C--N 1.311 -1.096 0 O-C-N 123.678 0.611 . . . . 71.420000000000002 110.383 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.559 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 59.7 Cg_endo -79.2 151.17 23.24 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 122.841 2.361 . . . . 74.310000000000002 113.31 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -122.11 128.7 51.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.772 -1.104 . . . . 72.430000000000007 110.38 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -84.16 116.81 23.1 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.265 -1.383 . . . . 74.5 107.265 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 597' ' ' ILE . . . . . 0.526 HG21 ' HG2' ' A' ' 601' ' ' MET . 45.4 mm -89.31 128.95 41.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.354 -0.98 . . . . 44.119999999999997 108.354 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -73.68 155.54 38.88 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.081 -0.711 . . . . 71.430000000000007 109.081 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 69.74 -73.46 0.09 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.843 1.257 . . . . 71.109999999999999 111.452 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 150.37 161.62 10.04 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 120.551 -0.833 . . . . 54.520000000000003 112.386 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 601' ' ' MET . . . . . 0.526 ' HG2' HG21 ' A' ' 597' ' ' ILE . 92.7 mmm -140.89 -174.01 3.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.695 -1.224 . . . . 71.129999999999995 107.695 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -155.94 -68.98 0.11 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.908 -1.515 . . . . 74.219999999999999 106.908 170.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 75.5 -59.97 2.86 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 116.06 -0.518 . . . . 54.43 113.889 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 108.66 -58.87 0.38 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 108.676 -1.77 . . . . 62.420000000000002 108.676 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -135.07 -171.78 2.89 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.413 -1.328 . . . . 75.400000000000006 107.413 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 37.3 m -81.39 125.09 29.97 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.666 -0.243 . . . . 72.400000000000006 110.35 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 43.8 mm -96.95 91.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 105.034 -2.21 . . . . 75.439999999999998 105.034 173.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 12.2 t -94.09 81.97 4.14 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 122.469 1.128 . . . . 72.530000000000001 112.632 -172.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.59 -28.92 14.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.809 -1.923 . . . . 74.409999999999997 105.809 170.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -92.66 121.43 34.06 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.78 -1.933 . . . . 54.329999999999998 105.78 170.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -105.28 -24.34 12.72 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.359 0.6 . . . . 72.430000000000007 110.709 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -139.86 -145.1 0.18 Allowed 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.592 -2.003 . . . . 63.229999999999997 105.592 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 50.27 42.77 26.11 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 122.601 1.191 . . . . 73.010000000000005 111.893 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -56.64 -74.86 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.976 -1.92 . . . . 52.520000000000003 113.525 -172.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 615' ' ' GLN . . . . . 0.54 ' HB2' ' HD3' ' A' ' 616' ' ' PRO . 75.9 mt-30 -111.49 -61.95 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 113.083 0.771 . . . . 73.340000000000003 113.083 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 615' ' ' GLN . 1.6 Cg_endo -82.1 148.21 15.03 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.273 1.315 . . . . 71.030000000000001 111.321 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 41.2 mt -120.65 -42.26 2.54 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.297 -1.319 . . . . 72.430000000000007 110.884 -169.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 19.0 p -103.79 -179.4 3.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.809 -0.811 . . . . 64.099999999999994 108.809 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 50.4 m -79.7 114.4 18.6 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.886 0.374 . . . . 72.340000000000003 110.01 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -93.89 131.74 39.01 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.299 -0.41 . . . . 73.319999999999993 110.218 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.12 154.03 7.19 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 124.071 0.948 . . . . 64.140000000000001 110.193 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.69 44.0 30.3 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.972 0.795 . . . . 72.349999999999994 112.397 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.81 166.9 13.11 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.217 -0.593 . . . . 72.099999999999994 110.436 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 8.54 14.27 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.356 -0.979 . . . . 73.010000000000005 108.356 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -54.23 -39.18 66.52 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 114.38 -1.282 . . . . 71.030000000000001 112.718 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 630' ' ' MET . 21.8 tpt180 -58.59 -31.22 67.84 Favored 'General case' 0 C--O 1.211 -0.973 0 C-N-CA 122.617 0.367 . . . . 74.409999999999997 111.844 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.85 -29.08 28.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.367 0.603 . . . . 73.409999999999997 110.284 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -83.85 -40.33 18.79 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.918 0.866 . . . . 73.010000000000005 109.005 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 632' ' ' ARG . 58.9 mt-10 -74.67 -6.22 47.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.196 -0.911 . . . . 72.430000000000007 111.516 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 626' ' ' ARG . 9.3 ptm -76.65 -13.42 60.06 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.036 -1.098 . . . . 75.030000000000001 108.036 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -90.64 0.88 77.84 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.28 -0.873 . . . . 75.310000000000002 111.829 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 632' ' ' ARG . 51.1 mtt180 -76.0 167.1 39.76 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 109.753 -0.462 . . . . 63.450000000000003 109.753 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 34.5 Cg_exo -67.39 121.94 9.11 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 N-CA-C 107.762 -1.669 . . . . 72.049999999999997 107.762 164.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 634' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER -131.56 -175.98 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-O 121.626 0.727 . . . . 71.010000000000005 110.069 -175.099 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.453 ' HG ' ' HD3' ' A' ' 594' ' ' PRO . 22.6 mt -97.59 170.82 8.76 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.196 -1.039 . . . . 64.129999999999995 108.196 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.57 151.08 49.11 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.121 -2.392 . . . . 52.240000000000002 107.121 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.51 -42.06 66.95 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.235 0.517 . . . . 72.340000000000003 111.28 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -124.34 101.0 6.95 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.508 0.67 . . . . 73.140000000000001 110.733 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 7.5 t -136.02 109.78 8.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 122.243 1.02 . . . . 74.049999999999997 109.411 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -146.77 148.87 32.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.828 -1.175 . . . . 72.519999999999996 107.828 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 641' ' ' LEU . . . . . 0.415 HD22 HG11 ' A' ' 523' ' ' VAL . 56.5 tp -129.6 112.98 14.25 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.425 -0.583 . . . . 50.450000000000003 109.425 175.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 642' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 511' ' ' VAL . 46.8 mt-10 -89.24 127.98 35.8 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.636 -0.875 . . . . 72.030000000000001 108.636 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.61 120.68 62.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.31 -0.996 . . . . 71.209999999999994 108.31 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 644' ' ' ILE . 3.6 mp -110.87 134.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.435 -0.802 . . . . 63.520000000000003 110.829 -176.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.439 HG21 HG23 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -128.51 164.06 31.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 124.821 1.248 . . . . 63.350000000000001 109.551 175.732 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 646' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 516' ' ' GLU . 45.0 mt-10 -133.42 178.93 6.54 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.899 0.38 . . . . 62.219999999999999 110.716 -174.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -72.96 122.06 21.09 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 123.969 0.908 . . . . 64.510000000000005 110.626 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 57.9 m -133.66 -91.33 0.36 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 114.718 1.377 . . . . 51.109999999999999 114.718 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -156.81 -11.35 0.09 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 112.891 0.7 . . . . 63.439999999999998 112.891 -170.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 650' ' ' GLU . . . . . 0.586 ' HB3' ' H ' ' A' ' 577' ' ' ASP . 8.7 tp10 -64.16 137.84 58.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.3 1.048 . . . . 73.010000000000005 113.29 -168.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -128.58 116.16 19.2 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 105.98 -1.859 . . . . 75.239999999999995 105.98 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 652' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 550' ' ' GLY . 5.9 tmmm? -65.19 121.12 14.03 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.456 -0.942 . . . . 75.019999999999996 108.456 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 19.3 m -73.85 87.97 1.79 Allowed 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.354 -0.839 . . . . 75.129999999999995 109.989 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 16.3 m -62.33 115.4 4.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.539 -1.21 . . . . 74.120000000000005 110.264 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.83 145.44 12.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 109.2 -0.667 . . . . 64.200000000000003 109.2 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--N 1.301 -1.522 0 CA-C-N 116.165 -0.471 . . . . 71.409999999999997 110.704 -176.081 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 121.124 0.487 . . . . 72.120000000000005 110.309 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -156.23 -64.97 0.11 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.654 -1.61 . . . . 42.219999999999999 106.654 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . 151.35 128.66 1.49 Allowed Glycine 0 N--CA 1.42 -2.394 0 CA-C-N 114.883 -1.053 . . . . 75.209999999999994 111.548 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.48 121.32 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.785 -1.561 . . . . 72.140000000000001 106.785 172.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 56.4 m-85 -110.84 134.46 52.51 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.511 0.507 . . . . 73.230000000000004 110.078 -175.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 6.3 t -148.25 152.79 37.77 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 110.386 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' PHE . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.2 m-85 -74.26 159.74 32.06 Favored 'General case' 0 C--O 1.262 1.718 0 N-CA-C 108.862 -0.792 . . . . 75.109999999999999 108.862 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.35 -51.87 57.54 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.789 0.681 . . . . 63.399999999999999 109.613 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.49 161.54 54.22 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.146 -0.934 . . . . 73.310000000000002 109.088 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.2 Cg_endo -84.73 -20.8 3.59 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.613 1.542 . . . . 34.43 112.425 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 77.7 t -141.53 134.96 30.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.654 -0.499 . . . . 74.329999999999998 109.654 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -133.9 138.23 45.43 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.571 -0.529 . . . . 73.310000000000002 109.571 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -111.06 119.28 38.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 74.239999999999995 107.875 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.93 170.79 16.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.894 0.378 . . . . 70.310000000000002 110.381 -178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.2 t -88.88 158.97 17.91 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.6 0.714 . . . . 34.119999999999997 111.248 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -8.25 59.54 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.122 -0.945 . . . . 63.039999999999999 110.195 172.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 71.2 m -113.8 19.18 16.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.941 -0.572 . . . . 61.210000000000001 111.248 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 7.2 tt -82.22 -26.23 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.15 -0.62 . . . . 45.119999999999997 111.189 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.85 -74.24 2.52 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.588 -0.815 . . . . 64.120000000000005 111.588 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 574' ' ' ARG . 46.1 mm -129.92 131.17 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.503 -0.925 . . . . 63.109999999999999 108.503 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 17.9 ptm -107.15 145.75 32.15 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.97 -0.752 . . . . 63.109999999999999 108.97 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -106.36 129.31 54.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 123.374 0.421 . . . . 54.399999999999999 110.631 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.8 t -115.52 121.19 66.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.81 -0.811 . . . . 73.239999999999995 108.81 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -95.59 130.0 42.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.236 0.541 . . . . 61.329999999999998 110.594 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.43 115.17 35.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.152 -1.055 . . . . 74.409999999999997 108.152 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.422 ' HA ' HH21 ' A' ' 527' ' ' ARG . 79.4 mt -88.08 149.67 23.82 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.661 -0.7 . . . . 73.099999999999994 109.583 -176.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -114.92 103.78 11.27 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.266 -1.013 . . . . 74.409999999999997 108.266 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.1 p -67.23 -58.11 5.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.519 0.676 . . . . 62.140000000000001 110.939 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 24.3 t -73.97 -23.76 59.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.324 -0.853 . . . . 74.140000000000001 110.157 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' GLY . . . . . 0.516 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 108.88 -149.18 16.99 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 110.229 -1.149 . . . . 44.229999999999997 110.229 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -160.16 135.79 8.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.185 -1.413 . . . . 75.030000000000001 107.185 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -136.35 121.47 18.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.261 -0.644 . . . . 73.400000000000006 109.261 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.44 -121.99 7.29 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.798 -0.715 . . . . 43.340000000000003 113.038 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -137.75 104.89 5.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.028 -1.101 . . . . 65.120000000000005 108.028 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.88 126.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.619 0.723 . . . . 54.210000000000001 110.634 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 559' ' ' GLU . 29.8 mm -95.78 118.01 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.349 -0.842 . . . . 70.510000000000005 109.468 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.65 103.72 50.23 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 115.295 -0.866 . . . . 71.420000000000002 108.792 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 1.0 OUTLIER -78.16 156.67 29.92 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 121.424 1.416 . . . . 65.340000000000003 111.082 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -143.01 161.0 39.28 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.384 -1.339 . . . . 73.319999999999993 107.384 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -156.17 135.07 11.89 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.951 0.405 . . . . 74.530000000000001 111.14 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.6 p -82.92 122.96 28.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.661 -0.699 . . . . 71.519999999999996 110.378 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 37.0 mm -92.71 125.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.764 -1.199 . . . . 75.120000000000005 107.764 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.58 113.11 13.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.922 0.392 . . . . 73.140000000000001 111.242 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -92.4 -103.47 1.49 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.433 -1.067 . . . . 41.43 110.433 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -94.1 -18.01 22.23 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 109.69 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.01 149.1 24.21 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.392 -0.822 . . . . 75.530000000000001 108.924 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 45.0 ttt180 -101.84 134.83 44.4 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.11 0.481 . . . . 71.219999999999999 112.055 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.96 -179.75 47.26 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.476 -0.783 . . . . 41.229999999999997 111.367 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.87 57.62 Favored Glycine 0 C--N 1.306 -1.125 0 N-CA-C 110.594 -1.002 . . . . 54.530000000000001 110.594 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.33 19.95 50.65 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 111.491 -0.644 . . . . 71.140000000000001 111.491 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 15.7 mm-40 -80.08 -80.1 0.14 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.361 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.79 -32.18 16.21 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.825 -0.805 . . . . 72.120000000000005 108.825 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -143.94 152.8 41.57 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.02 -1.104 . . . . 75.439999999999998 108.02 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.584 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 23.3 tt0 -87.89 105.08 17.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.681 -2.34 . . . . 75.109999999999999 104.681 176.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.32 144.96 56.78 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.024 0.828 . . . . 62.240000000000002 109.725 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -140.06 114.06 8.93 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-O 122.046 0.927 . . . . 72.129999999999995 110.885 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.2 p -125.15 118.54 26.31 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.212 -1.358 . . . . 52.409999999999997 107.373 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.17 15.54 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 110.668 -0.973 . . . . 75.510000000000005 110.668 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.502 ' HB2' HG23 ' A' ' 536' ' ' ILE . 8.0 pt-20 -132.84 139.18 47.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.334 0.588 . . . . 70.439999999999998 111.866 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.97 144.71 33.2 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.48 -1.236 . . . . 64.540000000000006 108.692 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -109.73 104.21 13.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.208 0.528 . . . . 74.540000000000006 111.052 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.7 m-85 -98.71 120.0 38.41 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.27 -1.011 . . . . 53.210000000000001 108.27 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.491 ' H ' HD11 ' A' ' 567' ' ' ILE . 49.6 mt-30 -98.21 -80.18 0.46 Allowed 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.734 -0.839 . . . . 63.100000000000001 108.734 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -105.33 155.17 19.35 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.966 -0.561 . . . . 63.210000000000001 110.131 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -46.51 -29.16 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.171 1.788 . . . . 72.430000000000007 114.213 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.475 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.8 pt-20 -64.62 -14.14 56.64 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.95 1.093 . . . . 61.329999999999998 113.95 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.491 HD11 ' H ' ' A' ' 563' ' ' GLN . 37.2 pt -112.76 156.46 13.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 119.706 -0.798 . . . . 74.439999999999998 110.283 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.65 144.32 37.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.692 -0.855 . . . . 72.439999999999998 108.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.655 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.4 mmpt? -111.36 149.57 30.97 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 120.404 -0.519 . . . . 73.129999999999995 109.662 176.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 570' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 73.3 mt -126.05 131.45 71.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.481 -1.236 . . . . 75.549999999999997 110.595 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 41.6 mt -92.87 123.75 45.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.321 -1.362 . . . . 75.340000000000003 107.321 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 19.5 p -108.29 114.27 28.0 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 123.466 0.479 . . . . 72.420000000000002 109.814 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 589' ' ' LEU . 36.6 mt -110.01 135.03 50.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.554 -0.535 . . . . 62.409999999999997 109.554 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 574' ' ' ARG . . . . . 0.584 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 71.3 ttt180 -92.21 123.82 35.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.263 -0.643 . . . . 74.340000000000003 109.263 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.2 134.22 46.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.313 -0.625 . . . . 74.310000000000002 109.313 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 576' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 83.1 m-85 -114.22 162.6 16.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.251 -0.648 . . . . 65.219999999999999 109.251 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -104.33 112.0 24.86 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.025 -0.534 . . . . 73.030000000000001 111.124 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -142.63 -43.75 0.31 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.027 -0.533 . . . . 71.209999999999994 110.619 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -81.11 145.04 31.27 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.408 -0.589 . . . . 75.150000000000006 109.408 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -90.16 177.56 6.4 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.286 -0.635 . . . . 72.340000000000003 109.286 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -57.85 -20.39 36.0 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.328 1.051 . . . . 62.140000000000001 110.417 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.67 -45.02 77.82 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.504 1.922 . . . . 64.420000000000002 112.714 -173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -125.79 137.38 53.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.177 -0.675 . . . . 64.310000000000002 109.177 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -78.85 96.67 5.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.864 0.84 . . . . 74.25 111.109 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 585' ' ' CYS . . . . . 0.424 ' SG ' HG12 ' A' ' 645' ' ' ILE . 3.5 p -74.06 115.89 14.05 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.455 -0.793 . . . . 71.230000000000004 109.166 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 15.0 m -138.26 148.55 44.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.23 -0.656 . . . . 73.400000000000006 109.23 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.1 166.25 25.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.855 -1.165 . . . . 71.540000000000006 107.855 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 588' ' ' SER . . . . . 0.412 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 26.5 m -116.29 166.86 11.56 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 119.935 -0.706 . . . . 64.430000000000007 109.686 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 573' ' ' ILE . 31.8 tp -139.58 127.8 22.57 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 107.591 -1.263 . . . . 64.299999999999997 107.591 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.36 157.31 36.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.614 -0.513 . . . . 75.329999999999998 109.614 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 591' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 45.2 mt -95.34 147.23 23.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.114 -1.81 . . . . 55.509999999999998 106.114 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 592' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 593' ' ' GLU . 6.8 tp10 -98.43 177.67 5.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.857 -1.535 . . . . 71.310000000000002 106.857 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 37.6 mt-10 -75.16 119.78 78.54 Favored Pre-proline 0 C--N 1.288 -2.105 0 CA-C-N 116.341 -0.39 . . . . 72.219999999999999 110.638 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.454 ' HD3' HD22 ' A' ' 635' ' ' LEU . 77.3 Cg_endo -72.41 146.14 44.22 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.351 2.701 . . . . 74.200000000000003 113.703 -174.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -110.31 149.28 30.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.442 -0.947 . . . . 74.319999999999993 108.442 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -107.14 127.88 53.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.673 -1.232 . . . . 75.400000000000006 107.673 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 597' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 597' ' ' ILE . 1.9 mp -94.39 90.12 2.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.229 1.014 . . . . 71.450000000000003 108.717 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -74.62 108.57 7.46 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 113.343 -1.753 . . . . 74.530000000000001 107.706 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -78.26 79.07 4.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.06 0.933 . . . . 74.519999999999996 109.962 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -179.96 34.63 0.07 OUTLIER Glycine 0 C--N 1.286 -2.234 0 N-CA-C 106.752 -2.539 . . . . 60.210000000000001 106.752 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 27.3 ttt -172.07 89.53 0.1 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.731 1.612 . . . . 74.409999999999997 106.909 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 602' ' ' LYS . 0.4 OUTLIER -74.04 131.87 41.79 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.872 -0.604 . . . . 33.130000000000003 112.367 -177.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 86.99 -107.29 3.23 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.771 -0.728 . . . . 72.25 111.45 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 86.84 22.17 47.22 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.196 -1.162 . . . . 30.149999999999999 110.196 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 31.3 t80 62.22 82.17 0.18 Allowed 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.223 1.409 . . . . 52.399999999999999 109.804 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 48.2 m -79.4 123.61 27.67 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.905 -1.043 . . . . 73.450000000000003 110.921 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 47.6 mm -89.12 -29.34 5.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.514 -0.766 . . . . 72.200000000000003 110.014 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 11.9 m -70.73 80.91 0.61 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 115.547 1.684 . . . . 35.539999999999999 115.547 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.61 6.58 2.28 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 123.599 1.666 . . . . 73.230000000000004 107.026 165.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -157.36 142.05 16.66 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 100.878 -3.749 . . . . 74.420000000000002 100.878 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -91.7 -76.84 0.44 Allowed 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 118.775 0.716 . . . . 62.409999999999997 111.396 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 612' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 616' ' ' PRO . 6.7 t70 -159.1 -164.3 1.38 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.79 -1.189 . . . . 72.230000000000004 107.79 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 613' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 614' ' ' LYS . 13.0 t70 -133.24 -49.04 0.85 Allowed 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.316 -1.364 . . . . 64.530000000000001 107.316 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 614' ' ' LYS . . . . . 0.525 ' HG3' ' OE1' ' A' ' 615' ' ' GLN . 14.9 pttm 167.12 -23.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.394 2.677 . . . . 62.140000000000001 107.561 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 615' ' ' GLN . . . . . 0.525 ' OE1' ' HG3' ' A' ' 614' ' ' LYS . 26.1 mp0 -126.52 135.96 27.99 Favored Pre-proline 0 C--O 1.246 0.907 0 N-CA-C 106.011 -1.848 . . . . 71.439999999999998 106.011 169.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.417 ' HA ' ' OD2' ' A' ' 612' ' ' ASP . 35.9 Cg_exo -57.16 150.0 60.01 Favored 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 123.177 2.585 . . . . 70.129999999999995 114.638 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -101.47 8.13 42.19 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.551 -0.749 . . . . 71.200000000000003 110.097 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 17.3 p -81.13 -63.68 1.35 Allowed 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.493 -0.776 . . . . 73.540000000000006 109.804 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 30.7 m 54.52 34.62 21.53 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.995 0.918 . . . . 71.030000000000001 110.028 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 620' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 622' ' ' GLU . 17.9 tppt? -96.0 107.6 19.9 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.354 -0.839 . . . . 74.019999999999996 112.634 -172.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -89.39 86.45 6.8 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.921 -1.14 . . . . 60.439999999999998 107.921 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 622' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 625' ' ' ARG . 44.2 tt0 -86.78 149.22 25.01 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.193 -1.367 . . . . 73.340000000000003 109.428 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.54 135.07 50.99 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.075 -0.511 . . . . 74.519999999999996 111.555 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 64.35 25.83 13.5 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.009 1.324 . . . . 71.209999999999994 112.658 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 625' ' ' ARG . . . . . 0.663 ' O ' ' HG2' ' A' ' 629' ' ' GLU . 2.0 mmt180 -60.41 -40.8 92.29 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 114.552 1.316 . . . . 54.299999999999997 114.552 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.607 ' O ' ' HG3' ' A' ' 630' ' ' MET . 14.4 mmm180 -63.99 -46.13 85.93 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 118.62 0.645 . . . . 64.340000000000003 109.397 -178.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 627' ' ' ILE . . . . . 0.442 ' HA ' ' SD ' ' A' ' 630' ' ' MET . 79.4 mt -64.91 -36.53 77.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.057 -0.974 . . . . 65.450000000000003 109.631 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 628' ' ' ALA . . . . . 0.564 ' O ' ' HG3' ' A' ' 632' ' ' ARG . . . -57.07 -52.12 66.56 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.692 -0.686 . . . . 74.049999999999997 109.953 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 629' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 625' ' ' ARG . 31.5 mm-40 -61.51 -30.51 70.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.51 -0.768 . . . . 52.25 111.893 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 630' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 60.8 mtt -63.1 -26.27 68.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.389 -0.823 . . . . 60.210000000000001 110.872 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.43 27.94 11.66 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.491 -0.644 . . . . 42.32 111.491 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 632' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 628' ' ' ALA . 85.8 mtt180 -116.76 163.62 21.82 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.681 -0.488 . . . . 61.439999999999998 109.681 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 632' ' ' ARG . 25.2 Cg_endo -63.85 150.4 88.49 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.675 1.583 . . . . 73.109999999999999 109.833 175.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 19.9 pt -126.85 -177.25 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.966 -0.561 . . . . 63.130000000000003 110.326 -173.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 635' ' ' LEU . . . . . 0.454 HD22 ' HD3' ' A' ' 594' ' ' PRO . 1.9 pt? -134.56 -171.87 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.321 -0.622 . . . . 64.129999999999995 109.321 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -63.66 156.52 43.0 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 121.026 -0.607 . . . . 51.049999999999997 111.822 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.39 -57.2 13.97 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.29 1.036 . . . . 74.200000000000003 110.025 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -131.4 98.8 4.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.733 -0.84 . . . . 71.310000000000002 108.733 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.6 t -130.94 110.45 11.27 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-O 122.625 1.202 . . . . 75.540000000000006 110.465 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 39.5 ttpt -147.61 141.06 25.37 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.924 -1.51 . . . . 72.140000000000001 106.924 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 63.2 tp -117.18 110.0 17.6 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.878 -0.786 . . . . 74.329999999999998 108.878 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.36 123.9 32.81 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.648 -0.871 . . . . 74.129999999999995 108.648 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.4 121.37 61.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.148 -0.933 . . . . 71.5 109.373 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.61 128.43 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.191 -0.913 . . . . 62.229999999999997 109.534 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.424 HG12 ' SG ' ' A' ' 585' ' ' CYS . 0.0 OUTLIER -117.83 127.27 75.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.25 -0.886 . . . . 75.239999999999995 110.066 179.015 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.18 156.66 45.9 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.281 -1.378 . . . . 63.329999999999998 107.281 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -55.96 111.36 0.92 Allowed 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 124.116 0.885 . . . . 73.430000000000007 110.616 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 15.2 m -105.71 96.22 6.34 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 109.457 -0.571 . . . . 73.439999999999998 109.457 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -76.95 -37.92 54.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.196 -1.409 . . . . 73.310000000000002 107.196 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -88.63 84.07 6.74 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 106.945 -1.502 . . . . 74.329999999999998 106.945 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -81.43 120.46 25.01 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 107.468 -1.308 . . . . 73.409999999999997 107.468 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -78.68 142.23 37.31 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.877 -0.601 . . . . 70.409999999999997 112.446 -170.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 12.9 m -85.72 107.51 17.62 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.596 -0.729 . . . . 72.150000000000006 109.607 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 15.1 t -86.97 -21.59 26.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.514 0.673 . . . . 74.430000000000007 110.13 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 47.6 t -91.5 93.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.381 -0.97 . . . . 75.019999999999996 108.381 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 C--N 1.308 -1.209 0 N-CA-C 109.717 -0.475 . . . . 74.230000000000004 109.717 -179.527 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.911 0 N-CA-C 110.973 -0.851 . . . . 74.420000000000002 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.27 114.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.18 -0.674 . . . . 71.040000000000006 109.18 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.19 136.58 52.8 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.084 0.24 . . . . 73.319999999999993 110.445 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.1 t -148.64 160.23 43.34 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.993 -0.373 . . . . 74.129999999999995 109.993 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.71 158.57 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 122.164 0.186 . . . . 72.349999999999994 110.583 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 45.6 mt-10 -58.48 -49.97 75.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.179 0.514 . . . . 75.200000000000003 110.716 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . 0.56 ' OE2' ' HD2' ' A' ' 510' ' ' PRO . 7.7 tp10 -141.96 137.76 16.3 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.523 -2.029 . . . . 64.329999999999998 105.523 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.56 ' HD2' ' OE2' ' A' ' 509' ' ' GLU . 41.4 Cg_endo -70.79 -10.65 28.17 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.491 2.127 . . . . 72.0 114.656 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 642' ' ' GLU . 72.7 t -140.73 126.93 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 122.028 -0.42 . . . . 72.400000000000006 110.161 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.96 130.57 37.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.484 0.659 . . . . 33.439999999999998 109.615 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -110.07 121.61 45.67 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.646 -0.501 . . . . 72.540000000000006 109.646 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.81 160.91 36.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.128 -0.487 . . . . 63.439999999999998 111.709 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 518' ' ' ILE . 20.2 m -71.88 156.47 39.24 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 73.400000000000006 110.832 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -30.73 58.3 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.811 -1.181 . . . . 60.509999999999998 107.811 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.1 p -90.83 16.71 8.83 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.435 -1.257 . . . . 74.349999999999994 111.777 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 515' ' ' SER . 7.5 tt -78.73 -30.09 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 120.281 -0.568 . . . . 72.230000000000004 110.607 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.39 -68.09 3.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.108 -1.044 . . . . 73.120000000000005 112.444 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.2 mm -130.79 132.12 64.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.638 -1.245 . . . . 74.200000000000003 107.638 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -107.15 154.51 21.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.167 -1.049 . . . . 73.340000000000003 108.167 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.55 124.25 40.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.923 0.392 . . . . 71.030000000000001 111.595 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.637 HG12 ' HB ' ' A' ' 571' ' ' ILE . 8.6 p -124.86 133.15 70.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.019 -0.734 . . . . 72.099999999999994 109.019 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 98.7 mttt -93.27 138.68 31.42 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.407 -0.59 . . . . 75.400000000000006 109.407 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 85.3 t -96.03 121.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.926 -1.509 . . . . 71.329999999999998 106.926 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.16 155.59 16.99 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.235 -0.893 . . . . 73.349999999999994 110.314 -174.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -124.86 104.61 8.7 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.327 -0.99 . . . . 65.140000000000001 108.327 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.8 m -64.93 -56.11 15.23 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.28 -0.873 . . . . 73.540000000000006 111.153 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.6 p -73.79 -48.21 33.23 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.593 0.711 . . . . 61.310000000000002 110.005 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.41 -159.91 26.8 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 111.171 -0.771 . . . . 71.519999999999996 111.171 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.485 ' H ' ' HB2' ' A' ' 565' ' ' ASP . . . -148.51 144.95 27.68 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.999 -1.482 . . . . 54.530000000000001 106.999 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -161.12 77.61 0.57 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.759 -0.83 . . . . 75.439999999999998 108.759 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.446 ' HA3' ' HE1' ' A' ' 596' ' ' TRP . . . 157.87 -127.67 1.95 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.018 -1.087 . . . . 24.41 111.311 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -137.22 102.57 4.86 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.395 -1.706 . . . . 65.200000000000003 106.395 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 120.0 62.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.335 0.588 . . . . 61.149999999999999 110.347 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.88 115.88 34.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 N-CA-C 108.457 -0.942 . . . . 63.329999999999998 108.457 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.77 101.51 51.46 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.607 -0.724 . . . . 63.5 109.835 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 2.7 Cg_endo -76.66 155.79 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.088 1.858 . . . . 60.109999999999999 112.275 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -142.15 160.66 39.79 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.435 -0.95 . . . . 74.530000000000001 108.435 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -151.43 136.43 17.37 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.875 0.369 . . . . 71.019999999999996 110.977 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.3 p -85.0 126.89 33.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.853 -0.612 . . . . 63.009999999999998 111.271 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.65 121.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.267 -1.012 . . . . 72.219999999999999 108.267 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -79.16 104.88 10.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.843 -0.799 . . . . 73.439999999999998 108.843 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -86.24 -94.3 0.84 Allowed Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.386 -1.086 . . . . 63.210000000000001 110.386 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.8 p -102.8 -12.27 17.72 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.172 0.511 . . . . 72.109999999999999 110.538 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.43 152.89 21.24 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.391 -0.966 . . . . 65.549999999999997 108.391 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -107.61 131.4 54.41 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.157 -0.617 . . . . 74.219999999999999 109.856 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.19 -154.76 20.35 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.271 -1.132 . . . . 45.130000000000003 110.271 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.92 79.81 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.513 -0.851 . . . . 65.219999999999999 112.094 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' A' ' 576' ' ' PHE . . . 92.29 11.38 59.82 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.779 -0.724 . . . . 74.230000000000004 113.104 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -76.25 -77.95 0.13 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 117.45 0.625 . . . . 70.329999999999998 110.802 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -93.84 -42.72 8.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.882 -1.155 . . . . 42.200000000000003 107.882 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -135.36 163.05 30.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 108.966 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 576' ' ' PHE . 28.2 tt0 -97.62 116.62 30.19 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.294 -1.743 . . . . 72.420000000000002 106.294 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.17 142.15 54.38 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.364 -0.606 . . . . 74.420000000000002 109.364 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -140.12 132.44 28.33 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.684 0.755 . . . . 64.510000000000005 110.229 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.4 p -140.65 122.14 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.714 -1.217 . . . . 40.210000000000001 107.714 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.68 -176.97 36.13 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 109.743 -1.343 . . . . 74.340000000000003 109.743 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 0.3 OUTLIER -126.31 128.68 47.5 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.628 0.728 . . . . 64.329999999999998 111.961 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 79.7 mt -89.53 144.34 26.11 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.094 -1.412 . . . . 72.120000000000005 110.061 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -105.59 101.87 11.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.395 0.617 . . . . 73.409999999999997 111.506 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 42.7 m-85 -100.21 100.41 11.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.791 -0.818 . . . . 70.219999999999999 108.791 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.473 ' H ' HD11 ' A' ' 567' ' ' ILE . 81.4 mt-30 -83.1 -77.9 0.23 Allowed 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.792 -0.763 . . . . 73.340000000000003 110.239 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -105.43 159.25 16.07 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.843 -0.617 . . . . 62.140000000000001 109.369 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.485 ' HB2' ' H ' ' A' ' 531' ' ' ALA . 13.2 t70 -57.99 -23.21 53.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.415 1.086 . . . . 71.439999999999998 111.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.08 -43.49 78.08 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.724 1.209 . . . . 73.340000000000003 112.0 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.473 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -96.39 158.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.255 0.55 . . . . 73.019999999999996 110.705 -173.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.68 154.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.879 -1.156 . . . . 74.5 107.879 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.59 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.5 mmpt? -115.49 154.71 28.83 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.861 0.362 . . . . 65.25 111.167 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 53.0 mt -128.54 136.62 59.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.581 -1.191 . . . . 71.209999999999994 109.529 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.637 ' HB ' HG12 ' A' ' 523' ' ' VAL . 56.3 mt -97.78 125.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.563 -1.643 . . . . 74.030000000000001 106.563 174.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 21.7 p -110.41 112.38 24.27 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.672 -0.862 . . . . 73.430000000000007 108.672 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.618 HD11 HD22 ' A' ' 589' ' ' LEU . 42.5 mt -108.27 134.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.819 -0.808 . . . . 52.43 108.819 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.415 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.0 OUTLIER -82.18 117.13 22.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 109.566 -0.531 . . . . 71.420000000000002 109.566 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.42 123.69 57.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.59 -2.004 . . . . 73.200000000000003 105.59 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 550' ' ' GLY . 90.4 m-85 . . . . . 0 C--N 1.298 -1.646 0 C-N-CA 120.55 -0.46 . . . . 73.400000000000006 111.297 -175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.433 -1.299 0 CA-C-O 122.47 1.129 . . . . 72.120000000000005 113.352 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.7 m -143.65 153.09 42.14 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.368 -1.345 . . . . 62.43 107.368 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -133.49 153.11 51.9 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.406 -0.961 . . . . 75.319999999999993 108.406 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.8 m -111.25 154.51 24.35 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.687 -0.857 . . . . 71.439999999999998 108.687 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.618 HD22 HD11 ' A' ' 573' ' ' ILE . 39.7 tp -129.07 130.46 46.56 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.068 -1.456 . . . . 73.349999999999994 107.068 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.43 158.7 38.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 123.218 0.324 . . . . 71.200000000000003 110.313 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.05 145.52 26.45 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.128 -0.942 . . . . 74.150000000000006 108.49 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 538' ' ' PRO . 17.6 mm-40 -101.59 165.99 10.94 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.324 -0.621 . . . . 71.530000000000001 109.324 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.32 114.55 7.4 Favored Pre-proline 0 C--O 1.245 0.851 0 O-C-N 124.233 0.958 . . . . 75.109999999999999 111.303 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.62 150.56 27.92 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.132 2.554 . . . . 72.420000000000002 111.443 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.93 140.27 51.15 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.415 -0.178 . . . . 51.219999999999999 111.471 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . 0.446 ' HE1' ' HA3' ' A' ' 533' ' ' GLY . 1.0 OUTLIER -103.03 118.05 35.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.675 -0.491 . . . . 74.129999999999995 109.675 -176.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--N 1.294 -1.846 0 C-N-CA 123.407 0.683 . . . . 72.530000000000001 110.432 -179.133 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 N--CA 1.434 -1.238 0 N-CA-C 109.698 -0.482 . . . . 64.209999999999994 109.698 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.48 177.98 4.71 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.229 -1.026 . . . . 74.219999999999999 108.229 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.5 170.65 42.11 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.46 -0.656 . . . . 73.299999999999997 111.46 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -49.75 -61.61 2.03 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.249 1.02 . . . . 72.409999999999997 112.043 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -129.33 102.17 6.31 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.787 -1.56 . . . . 74.030000000000001 106.787 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 3.6 t -129.51 111.85 13.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 122.337 1.065 . . . . 64.420000000000002 110.865 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 37.0 ttmt -147.19 151.74 37.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.876 -1.898 . . . . 74.109999999999999 105.876 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 523' ' ' VAL . 51.8 tp -123.38 103.45 8.5 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.977 -0.749 . . . . 73.549999999999997 108.977 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 511' ' ' VAL . 44.2 mt-10 -87.45 106.53 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.551 -0.907 . . . . 73.430000000000007 108.551 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 32.0 t -96.9 121.69 47.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 114.91 -1.041 . . . . 62.539999999999999 108.197 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 27.9 mt -115.55 133.49 61.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.108 -0.951 . . . . 72.409999999999997 110.896 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.307 -1.249 0 C-N-CA 125.062 1.345 . . . . 71.140000000000001 108.402 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.829 0 N-CA-C 112.067 -0.413 . . . . 52.219999999999999 112.067 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 67.3 mt -127.02 116.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.805 -1.183 . . . . 75.209999999999994 107.805 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -108.16 137.66 45.76 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.618 0.574 . . . . 75.219999999999999 111.67 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.2 t -148.91 157.37 43.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.83 -0.623 . . . . 64.030000000000001 109.371 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.37 155.68 36.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.086 -0.339 . . . . 74.099999999999994 110.086 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -59.39 -48.18 82.63 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 123.615 0.572 . . . . 73.530000000000001 110.47 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.42 151.09 77.31 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.42 -0.956 . . . . 55.530000000000001 108.42 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 2.4 Cg_endo -78.35 -20.63 10.96 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.631 1.554 . . . . 41.32 110.496 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 642' ' ' GLU . 65.8 t -139.98 127.3 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.711 -0.848 . . . . 52.109999999999999 108.711 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -129.42 133.57 47.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.269 -0.641 . . . . 50.539999999999999 109.269 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -107.09 121.41 44.43 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.642 -0.873 . . . . 73.439999999999998 108.642 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.54 148.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.406 0.622 . . . . 72.140000000000001 111.022 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 50.7 m -65.12 141.27 58.76 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.542 -1.208 . . . . 70.200000000000003 110.262 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.55 -24.26 62.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 109.832 177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.39 17.99 17.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.066 -0.515 . . . . 45.109999999999999 110.828 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.1 -23.27 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.247 0.546 . . . . 73.430000000000007 111.036 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.43 -73.32 2.24 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.448 -0.882 . . . . 71.439999999999998 110.935 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.72 126.79 69.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.899 -1.148 . . . . 52.420000000000002 107.899 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.404 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.5 ppp? -98.15 148.7 23.3 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.865 -1.161 . . . . 73.420000000000002 107.865 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.3 119.16 28.5 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.414 0.446 . . . . 71.239999999999995 111.692 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.46 HG21 HD21 ' A' ' 641' ' ' LEU . 52.5 t -127.43 126.72 68.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.107 -0.701 . . . . 74.409999999999997 109.107 173.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.462 ' HG2' HG12 ' A' ' 570' ' ' ILE . 62.6 mttp -91.96 147.75 22.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.026 -0.534 . . . . 64.310000000000002 110.699 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.07 116.15 38.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.293 -1.373 . . . . 74.239999999999995 107.293 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.9 155.99 18.77 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.408 -0.814 . . . . 42.43 110.428 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.88 104.63 12.13 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 107.787 -1.19 . . . . 74.299999999999997 107.787 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.1 m -65.24 -61.22 2.25 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.421 -0.354 . . . . 63.43 110.709 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.2 t -74.57 -49.17 22.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.224 0.535 . . . . 65.140000000000001 109.851 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 151.78 -159.73 28.44 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.381 -1.488 . . . . 50.530000000000001 109.381 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -161.95 139.47 8.65 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.028 -0.73 . . . . 74.299999999999997 109.028 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -156.67 133.81 10.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 106.432 -1.692 . . . . 65.099999999999994 106.432 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 532' ' ' ARG . . . 108.63 -133.4 11.64 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.335 -0.936 . . . . 60.43 111.748 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -137.58 108.42 6.67 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.993 -1.114 . . . . 72.209999999999994 107.993 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.49 124.73 70.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.672 0.749 . . . . 74.239999999999995 111.199 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 559' ' ' GLU . 31.9 mm -93.7 116.45 34.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.043 -0.98 . . . . 71.230000000000004 108.687 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.4 t -108.81 99.24 33.49 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.912 -1.144 . . . . 71.319999999999993 107.912 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.1 159.98 23.66 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.682 1.588 . . . . 75.5 111.514 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -144.82 161.05 40.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.035 -1.098 . . . . 72.409999999999997 108.035 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -152.37 134.83 15.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.009 0.433 . . . . 75.150000000000006 111.006 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . 0.411 HG23 HD13 ' A' ' 589' ' ' LEU . 0.7 OUTLIER -81.9 138.59 34.99 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.089 -0.96 . . . . 74.430000000000007 112.006 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.2 mm -115.52 126.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.582 -1.636 . . . . 62.020000000000003 106.582 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.91 166.72 22.95 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.901 0.382 . . . . 41.109999999999999 110.792 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -162.87 -111.43 0.26 Allowed Glycine 0 CA--C 1.495 -1.215 0 N-CA-C 110.474 -1.05 . . . . 72.040000000000006 110.474 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -31.04 58.75 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.469 -1.308 . . . . 64.239999999999995 107.469 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 552' ' ' ASP . . . -88.56 143.4 26.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.932 -1.485 . . . . 45.229999999999997 107.146 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -109.42 153.35 24.13 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 113.531 0.937 . . . . 75.310000000000002 113.531 -171.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 43.11 -119.58 2.36 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 126.771 2.129 . . . . 73.510000000000005 118.372 168.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -164.89 96.35 0.13 Allowed Glycine 0 N--CA 1.412 -2.902 0 N-CA-C 108.649 -1.78 . . . . 64.340000000000003 108.649 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 123.01 -19.5 7.77 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 109.595 -1.402 . . . . 74.109999999999999 109.595 -175.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 6.2 mp0 -76.97 -73.05 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.981 -0.609 . . . . 52.229999999999997 110.101 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 547' ' ' ARG . 5.7 m-20 -103.22 -44.17 5.26 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 122.136 0.969 . . . . 72.400000000000006 108.988 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -133.79 155.61 49.49 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 107.277 -1.379 . . . . 75.230000000000004 107.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.498 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 3.8 tm-20 -89.01 129.77 35.6 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.529 -1.285 . . . . 74.239999999999995 107.529 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.55 103.1 3.43 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.451 0.644 . . . . 72.040000000000006 111.199 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.6 t -108.43 113.7 26.95 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.384 -0.969 . . . . 70.409999999999997 108.384 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -143.41 100.6 3.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.503 -0.771 . . . . 73.310000000000002 109.231 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.81 -163.56 10.76 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.622 -0.799 . . . . 54.530000000000001 112.228 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.518 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.6 mt-10 -116.83 117.9 31.0 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.422 0.689 . . . . 64.030000000000001 110.582 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.4 mt -89.31 139.5 30.43 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.047 -0.723 . . . . 70.439999999999998 109.047 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.88 105.07 14.71 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.67 -0.812 . . . . 71.329999999999998 111.417 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 31.5 m-85 -96.21 143.79 26.99 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.397 -1.334 . . . . 53.109999999999999 107.397 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.458 ' H ' HD11 ' A' ' 567' ' ' ILE . 79.4 mt-30 -116.29 -86.94 0.61 Allowed 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.245 -1.02 . . . . 65.150000000000006 108.245 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.97 168.53 9.0 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.527 -0.869 . . . . 64.519999999999996 109.043 173.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -59.28 -11.05 3.51 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.244 1.418 . . . . 64.420000000000002 113.575 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.589 ' HG3' HG23 ' A' ' 567' ' ' ILE . 16.1 pt-20 -69.77 -17.88 63.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.729 0.412 . . . . 72.200000000000003 111.973 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.589 HG23 ' HG3' ' A' ' 566' ' ' GLU . 41.0 pt -116.13 163.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 C-N-CA 120.319 -0.552 . . . . 73.140000000000001 111.464 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.3 146.45 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 108.181 -1.044 . . . . 65.319999999999993 108.181 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 70.9 mmtt -109.83 145.05 37.4 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.591 -0.522 . . . . 73.129999999999995 109.591 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 524' ' ' LYS . 63.1 mt -116.92 133.6 63.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.368 -1.287 . . . . 52.0 108.287 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.436 HD13 HD21 ' A' ' 589' ' ' LEU . 55.5 mt -93.15 113.08 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 106.932 -1.507 . . . . 61.219999999999999 106.932 174.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -102.48 112.31 24.99 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.106 -0.952 . . . . 65.140000000000001 109.55 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 521' ' ' MET . 48.6 mt -107.65 129.43 61.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.983 -1.117 . . . . 74.140000000000001 107.983 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.498 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 63.8 mtt85 -78.25 114.62 17.31 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.504 -0.924 . . . . 64.400000000000006 108.504 176.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.4 mm -101.0 126.67 54.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.603 -0.888 . . . . 64.430000000000007 108.603 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 50.8 m-85 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 121.039 0.447 . . . . 65.239999999999995 110.912 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 645' ' ' ILE . 2.2 p . . . . . 0 N--CA 1.435 -1.205 0 CA-C-O 120.647 0.26 . . . . 70.109999999999999 110.711 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 6.7 m -130.57 152.44 49.95 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.743 -0.383 . . . . 55.350000000000001 110.558 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.8 p90 -138.95 175.59 9.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.381 -1.34 . . . . 62.310000000000002 107.381 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 14.7 m -125.59 158.88 33.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.632 -0.827 . . . . 71.450000000000003 110.577 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.436 HD21 HD13 ' A' ' 571' ' ' ILE . 59.2 tp -136.61 132.92 35.72 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 106.551 -1.648 . . . . 72.200000000000003 106.551 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.58 155.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 120.96 -0.296 . . . . 75.219999999999999 110.363 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.469 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 85.7 mt -92.1 142.53 27.41 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.317 -0.994 . . . . 63.240000000000002 108.317 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -93.87 175.57 6.67 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.463 -0.79 . . . . 73.340000000000003 109.404 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -66.58 113.9 14.98 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 123.734 0.646 . . . . 55.210000000000001 109.364 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.57 143.85 34.9 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.754 1.636 . . . . 72.209999999999994 111.264 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.05 140.46 51.9 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.375 -0.829 . . . . 44.130000000000003 110.472 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -102.06 124.22 47.29 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.084 -1.45 . . . . 74.150000000000006 107.084 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--N 1.295 -1.781 0 CA-C-O 121.764 0.793 . . . . 71.299999999999997 108.932 -179.691 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.048 0 CA-C-O 121.19 0.519 . . . . 63.310000000000002 111.358 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.74 176.39 6.37 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.469 -0.937 . . . . 63.509999999999998 108.469 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.06 -128.55 0.21 Allowed Glycine 0 C--N 1.309 -0.929 0 CA-C-O 121.968 0.76 . . . . 52.130000000000003 113.102 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.33 -84.17 0.05 OUTLIER 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.834 -0.683 . . . . 64.519999999999996 109.241 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -141.75 94.93 2.74 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 105.085 -2.191 . . . . 74.209999999999994 105.085 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . 0.41 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 13.3 t -100.65 118.34 36.59 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-O 122.401 1.096 . . . . 54.399999999999999 110.954 -172.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 3.7 ttmp? -145.05 143.64 30.56 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.848 -1.908 . . . . 75.030000000000001 105.848 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.46 HD21 HG21 ' A' ' 523' ' ' VAL . 28.4 tp -119.59 105.68 11.44 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 108.232 -1.025 . . . . 72.310000000000002 108.232 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.405 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.7 mt-10 -90.79 121.76 32.93 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.985 -1.117 . . . . 65.140000000000001 107.985 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.69 120.27 59.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.978 -1.01 . . . . 75.019999999999996 109.308 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.21 121.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 CA-C-N 114.696 -1.138 . . . . 65.340000000000003 108.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.446 HG12 ' SG ' ' A' ' 585' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.29 -2.019 0 CA-C-N 115.334 -0.848 . . . . 75.439999999999998 110.184 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.684 0 N-CA-C 110.278 -1.129 . . . . 54.329999999999998 110.278 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 68.6 mt -127.54 118.94 50.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.92 -1.511 . . . . 71.519999999999996 106.92 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.33 133.07 51.6 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.221 0.452 . . . . 74.310000000000002 112.221 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -148.11 153.97 39.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.688 -0.856 . . . . 70.120000000000005 108.688 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 68.1 m-85 -74.28 156.3 37.32 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.806 -0.442 . . . . 71.340000000000003 109.806 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.58 -49.11 79.03 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.235 0.54 . . . . 74.340000000000003 110.381 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.77 153.7 81.16 Favored Pre-proline 0 N--CA 1.432 -1.35 0 N-CA-C 107.721 -1.215 . . . . 63.109999999999999 107.721 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 83.3 Cg_endo -86.24 -11.32 6.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.024 1.816 . . . . 62.0 113.3 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 70.4 t -143.81 135.34 22.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.281 -0.637 . . . . 64.219999999999999 109.281 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.96 133.97 42.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.712 -0.477 . . . . 73.209999999999994 109.712 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -106.18 110.86 23.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.622 -1.251 . . . . 65.310000000000002 107.622 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.85 155.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 110.757 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.451 ' O ' HG22 ' A' ' 518' ' ' ILE . 2.6 t -77.13 147.03 36.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.668 -1.975 . . . . 71.420000000000002 105.668 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -77.58 -16.94 58.31 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.068 -1.053 . . . . 63.009999999999998 110.813 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.7 m -91.31 13.19 18.01 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.202 -0.454 . . . . 72.030000000000001 111.427 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 515' ' ' SER . 8.1 tt -74.06 -25.67 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.033 0.444 . . . . 72.25 111.736 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.37 -68.96 2.61 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.982 -1.104 . . . . 65.030000000000001 112.2 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 574' ' ' ARG . 41.5 mm -131.97 132.31 61.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.299999999999997 108.286 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 19.0 ptm -108.42 143.02 37.93 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.011 -0.737 . . . . 53.340000000000003 109.011 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -99.25 124.21 44.15 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 123.55 0.531 . . . . 70.310000000000002 110.524 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.0 t -115.55 120.23 64.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.461 -1.311 . . . . 73.040000000000006 107.461 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -106.29 123.68 48.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.297 -0.961 . . . . 75.310000000000002 110.275 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 78.5 t -88.59 110.99 21.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.168 -0.924 . . . . 73.430000000000007 108.833 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.79 122.61 30.11 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.443 -0.798 . . . . 63.509999999999998 110.592 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -87.13 101.3 13.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.908 -1.145 . . . . 71.5 107.908 171.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.9 t -67.19 -47.53 70.66 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 75.209999999999994 112.401 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.1 t -74.58 -24.06 58.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.271 0.558 . . . . 63.329999999999998 109.924 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 115.09 -158.69 14.18 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 110.378 -1.089 . . . . 33.32 110.378 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.87 136.41 17.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.26 -1.385 . . . . 64.340000000000003 107.26 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -135.27 87.1 2.3 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.716 -0.394 . . . . 74.109999999999999 109.967 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 98.63 -178.98 31.54 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.81 -1.316 . . . . 72.230000000000004 109.81 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.637 HD21 ' HG3' ' A' ' 561' ' ' GLU . 4.6 t-20 -74.5 111.54 9.78 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.457 -0.897 . . . . 74.120000000000005 111.201 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.89 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.872 -1.158 . . . . 45.149999999999999 107.872 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.496 HG12 HD13 ' A' ' 597' ' ' ILE . 46.3 mm -99.47 122.65 51.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.553 -0.906 . . . . 70.019999999999996 108.553 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 28.4 t -112.78 105.59 55.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 123.555 0.535 . . . . 52.310000000000002 109.754 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.44 150.55 28.48 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.917 1.745 . . . . 74.310000000000002 111.514 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -142.02 168.29 20.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.989 -1.115 . . . . 70.409999999999997 107.989 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 589' ' ' LEU . 55.0 pttt -161.23 145.14 13.15 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.123 0.487 . . . . 72.450000000000003 111.07 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.5 p -83.6 133.46 34.84 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.994 -1.003 . . . . 72.239999999999995 110.454 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.4 mm -104.2 112.41 37.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.062 -1.459 . . . . 52.32 107.062 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.89 152.16 41.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.656 0.598 . . . . 70.319999999999993 110.064 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -145.51 -116.97 1.06 Allowed Glycine 0 C--N 1.293 -1.837 0 N-CA-C 108.801 -1.72 . . . . 42.420000000000002 108.801 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 24.9 p -75.35 -27.71 59.29 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.21 -1.033 . . . . 64.120000000000005 108.21 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.38 127.98 34.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.604 -1.258 . . . . 62.350000000000001 107.604 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 3.2 tmt_? -104.26 139.67 38.94 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.578 -1.267 . . . . 63.130000000000003 107.578 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -86.94 -156.33 29.08 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.889 -0.672 . . . . 74.540000000000006 112.806 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.81 1.86 59.81 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.798 -0.239 . . . . 72.299999999999997 113.532 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 117.22 0.64 18.91 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.173 -1.013 . . . . 55.420000000000002 113.08 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 12.8 tp10 -69.77 -76.46 0.1 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 117.393 0.597 . . . . 74.239999999999995 109.793 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.18 -35.42 9.65 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.77 -1.196 . . . . 74.129999999999995 107.77 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -144.17 166.63 24.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.869 -1.16 . . . . 73.329999999999998 107.869 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.1 OUTLIER -95.44 144.2 26.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.467 -1.679 . . . . 65.510000000000005 106.467 176.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.91 122.08 28.24 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.264 -0.643 . . . . 74.219999999999999 109.264 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -129.5 124.05 32.99 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.989 0.9 . . . . 74.200000000000003 112.653 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 9.4 p -131.39 129.26 41.1 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.031 -1.841 . . . . 74.5 106.031 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -160.35 171.76 36.63 Favored Glycine 0 CA--C 1.48 -2.128 0 C-N-CA 118.997 -1.573 . . . . 41.109999999999999 112.474 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 7.7 mp0 -107.67 115.61 30.46 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.537 -0.912 . . . . 75.040000000000006 108.537 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.117 -0.327 . . . . 52.240000000000002 110.117 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.637 ' HG3' HD21 ' A' ' 534' ' ' ASN . 40.4 tt0 -106.5 101.97 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.172 0.51 . . . . 73.109999999999999 111.771 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -97.37 156.47 16.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.097 -0.705 . . . . 75.439999999999998 109.097 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.433 ' H ' HD11 ' A' ' 567' ' ' ILE . 70.1 mm-40 -136.79 -81.13 0.38 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.816 1.293 . . . . 74.010000000000005 109.21 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 567' ' ' ILE . 4.3 t-20 -104.19 159.05 16.02 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 115.38 -0.827 . . . . 61.340000000000003 109.594 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -60.65 -16.37 38.18 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 125.151 1.381 . . . . 72.239999999999995 114.017 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -80.75 -16.34 54.12 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.687 -0.805 . . . . 72.299999999999997 112.237 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 563' ' ' GLN . 37.1 pt -99.58 158.98 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.215 -0.994 . . . . 73.310000000000002 110.307 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.57 143.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.267 -1.382 . . . . 55.229999999999997 107.267 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.1 mmpt? -101.69 147.27 26.65 Favored 'General case' 0 CA--C 1.468 -2.186 0 C-N-CA 120.108 -0.637 . . . . 72.349999999999994 110.636 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 22.2 mt -125.28 128.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 CA-C-N 114.578 -1.192 . . . . 63.530000000000001 108.771 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 52.9 mt -90.46 134.05 30.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.803 -1.554 . . . . 74.510000000000005 106.803 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 18.3 p -116.18 111.93 20.93 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.714 -0.847 . . . . 71.230000000000004 108.714 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.445 HD11 HD22 ' A' ' 589' ' ' LEU . 50.0 mt -106.39 128.41 60.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.833 -0.803 . . . . 53.210000000000001 108.833 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.7 mtt180 -75.62 111.93 11.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 124.115 0.884 . . . . 74.430000000000007 109.378 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -106.9 131.39 56.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.238 -1.393 . . . . 71.530000000000001 107.238 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 51.5 m-85 . . . . . 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 73.129999999999995 108.316 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.419 -2.023 0 CA-C-O 121.022 0.439 . . . . 73.519999999999996 111.103 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 45.7 p -137.34 146.66 44.84 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.716 -0.846 . . . . 62.439999999999998 108.716 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -133.17 173.75 11.11 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.23 -1.026 . . . . 73.010000000000005 108.23 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 10.9 m -124.84 156.07 38.42 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.538 -0.912 . . . . 35.130000000000003 108.538 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 540' ' ' LYS . 63.6 tp -128.3 129.1 45.8 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 106.548 -1.649 . . . . 65.310000000000002 106.548 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 31.7 m -127.74 159.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 123.215 0.322 . . . . 73.120000000000005 110.14 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.439 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 93.0 mt -102.33 154.97 18.55 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.533 -0.914 . . . . 72.450000000000003 108.533 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.6 171.4 7.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.641 -0.874 . . . . 73.299999999999997 108.641 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.3 120.88 59.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 O-C-N 123.674 0.609 . . . . 74.340000000000003 110.656 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.58 156.23 44.94 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.367 2.045 . . . . 70.400000000000006 111.932 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -121.25 144.9 48.36 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.572 -0.74 . . . . 54.240000000000002 109.455 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -104.59 121.33 43.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.674 -0.861 . . . . 64.230000000000004 108.674 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . 0.496 HD13 HG12 ' A' ' 536' ' ' ILE . 2.2 mp . . . . . 0 C--N 1.301 -1.54 0 CA-C-O 122.663 1.22 . . . . 64.230000000000004 111.089 -178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 27.3 pt . . . . . 0 N--CA 1.43 -1.447 0 CA-C-O 121.338 0.589 . . . . 71.310000000000002 111.175 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.85 172.7 8.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.537 -1.282 . . . . 64.319999999999993 107.537 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.44 -172.86 38.62 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 120.358 -0.925 . . . . 63.140000000000001 111.249 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . 0.459 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 43.3 tt0 -54.9 -62.36 1.71 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.162 0.585 . . . . 74.530000000000001 110.465 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . 0.459 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 37.1 m80 -135.14 106.11 6.62 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.972 -0.751 . . . . 74.219999999999999 108.972 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 9.0 t -119.41 108.81 15.01 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 122.18 0.99 . . . . 53.32 110.387 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 40.9 ttmt -147.91 142.33 26.37 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.686 -1.227 . . . . 71.400000000000006 107.686 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.424 HD22 HG13 ' A' ' 523' ' ' VAL . 62.1 tp -119.34 110.51 17.05 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.695 -0.854 . . . . 64.409999999999997 108.695 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.98 117.55 28.87 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.445 -0.946 . . . . 70.420000000000002 108.445 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.58 124.74 60.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 114.713 -1.131 . . . . 51.439999999999998 109.542 -175.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.38 123.48 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.598 0 N-CA-C 107.942 -1.133 . . . . 75.129999999999995 107.942 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 115.682 -0.69 . . . . 64.25 111.153 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.42 -2.391 0 N-CA-C 109.951 -1.26 . . . . 54.329999999999998 109.951 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 83.6 mt -127.15 114.88 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.586 -1.265 . . . . 45.509999999999998 107.586 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -103.77 134.65 46.72 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 70.010000000000005 111.873 -175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.1 t -148.13 163.34 37.25 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.934 -0.575 . . . . 75.140000000000001 109.654 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.9 162.37 20.53 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-O 120.958 0.409 . . . . 63.219999999999999 110.678 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.0 -55.77 19.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.106 -0.952 . . . . 73.140000000000001 109.167 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.33 159.36 57.66 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.515 -0.766 . . . . 73.129999999999995 108.976 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.06 -18.16 6.4 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.221 1.281 . . . . 53.240000000000002 111.224 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 642' ' ' GLU . 79.4 t -142.0 130.38 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.247 0.619 . . . . 61.009999999999998 109.364 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.62 140.96 47.42 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.63 -0.878 . . . . 61.240000000000002 108.63 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -119.49 117.21 27.82 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.776 -0.824 . . . . 73.239999999999995 108.776 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.1 m -106.35 162.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.248 0.546 . . . . 61.219999999999999 112.472 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 16.3 m -74.38 138.22 43.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.9 -1.045 . . . . 73.510000000000005 110.052 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -58.71 -33.93 70.75 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.404 0.682 . . . . 72.430000000000007 110.916 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.5 m -110.22 25.42 11.8 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.594 0.59 . . . . 54.420000000000002 112.594 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.6 tt -71.27 -33.2 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.361 0.601 . . . . 64.209999999999994 112.276 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 574' ' ' ARG . . . 89.85 -75.16 1.81 Allowed Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.215 -0.993 . . . . 62.210000000000001 110.845 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.7 mm -120.25 123.27 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.918 -0.401 . . . . 72.510000000000005 109.918 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.495 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 21.5 ptm -94.03 130.05 40.3 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.437 -0.949 . . . . 73.310000000000002 108.437 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -106.56 113.45 26.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.577 0.751 . . . . 70.140000000000001 111.339 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 57.5 t -119.76 131.06 73.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.599 -0.519 . . . . 53.0 109.599 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -92.76 133.71 35.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.062 0.458 . . . . 74.299999999999997 110.366 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 97.6 t -90.3 114.02 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.952 -1.499 . . . . 65.299999999999997 106.952 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.41 151.01 24.32 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.131 -0.94 . . . . 52.539999999999999 109.584 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 530' ' ' GLY . 0.0 OUTLIER -122.46 104.4 9.36 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.167 -1.049 . . . . 75.129999999999995 108.167 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.8 m -63.82 -63.34 1.19 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.99 -1.004 . . . . 71.420000000000002 111.861 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 10.8 p -74.13 -33.68 63.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.641 0.734 . . . . 54.420000000000002 110.725 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . 0.559 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 140.36 -148.6 20.22 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 109.567 -1.413 . . . . 63.450000000000003 109.567 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -162.96 144.01 9.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 54.140000000000001 106.687 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -149.04 131.21 15.45 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.429 0.529 . . . . 73.129999999999995 112.429 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 99.06 -126.38 8.89 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 115.219 -0.901 . . . . 72.450000000000003 111.359 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.02 109.53 7.42 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.321 -1.363 . . . . 73.319999999999993 107.321 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.09 122.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 121.146 0.498 . . . . 71.310000000000002 110.715 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.77 117.77 32.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.127 -1.434 . . . . 63.109999999999999 107.127 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.2 t -108.18 101.1 40.23 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.151 -1.055 . . . . 74.519999999999996 108.151 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.23 139.26 6.98 Favored 'Trans proline' 0 N--CA 1.425 -2.558 0 C-N-CA 121.63 1.553 . . . . 71.400000000000006 111.983 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.509 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.4 p90 -119.6 159.49 24.28 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.963 -1.495 . . . . 75.150000000000006 106.963 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.495 ' HA ' ' SG ' ' A' ' 557' ' ' CYS . 62.3 pttt -146.33 140.66 26.58 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.004 -0.678 . . . . 74.150000000000006 110.963 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.1 p -85.94 132.77 34.01 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.64 -1.164 . . . . 63.030000000000001 110.593 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 39.3 mm -109.59 116.74 52.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.875 -1.157 . . . . 72.010000000000005 107.875 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -67.87 167.76 12.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.398 0.618 . . . . 71.299999999999997 111.047 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 156.99 116.44 0.51 Allowed Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 107.733 -2.147 . . . . 75.540000000000006 107.733 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.407 ' HB ' ' SG ' ' A' ' 585' ' ' CYS 0.295 7.9 p 66.85 -44.43 0.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.124 1.77 . . . . 43.219999999999999 112.437 -172.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.01 19.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.962 -1.496 . . . . 72.439999999999998 106.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.498 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 3.4 mpt_? -111.27 152.53 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.283 0.563 . . . . 71.129999999999995 110.511 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.77 170.47 32.17 Favored Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.323 -1.111 . . . . 62.310000000000002 110.323 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 106.77 23.84 6.95 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.267 -1.133 . . . . 72.430000000000007 110.267 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 63.61 36.36 93.24 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.96 -0.856 . . . . 62.200000000000003 110.96 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.02 -76.36 0.47 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.145 0.578 . . . . 63.240000000000002 111.506 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.61 -40.39 15.2 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.615 -1.254 . . . . 62.43 107.615 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.26 160.67 39.46 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.001 -1.454 . . . . 75.230000000000004 107.469 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.8 OUTLIER -88.71 104.94 17.35 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.084 -1.45 . . . . 75.109999999999999 107.084 177.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.19 98.91 0.84 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.149 . . . . 72.349999999999994 109.039 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.54 138.69 54.31 Favored 'General case' 0 N--CA 1.398 -3.033 0 CA-C-N 114.472 -1.24 . . . . 71.310000000000002 107.993 -171.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 540' ' ' LYS . 56.1 m -149.17 125.0 10.54 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.437 -0.209 . . . . 74.239999999999995 110.437 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 121.3 -133.21 9.45 Favored Glycine 0 C--O 1.211 -1.308 0 N-CA-C 111.222 -0.751 . . . . 75.230000000000004 111.222 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 60.44 -10.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 118.277 2.695 . . . . 74.230000000000004 118.277 171.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 569' ' ' LYS . 39.8 mt -99.41 135.22 41.14 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.523 -1.361 . . . . 70.219999999999999 112.93 -175.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.405 ' HG2' ' NE2' ' A' ' 563' ' ' GLN . 41.6 tt0 -137.12 115.66 11.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.071 -1.085 . . . . 75.209999999999994 108.071 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.99 145.87 29.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.388 -0.967 . . . . 63.049999999999997 108.388 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.477 ' H ' HD11 ' A' ' 567' ' ' ILE . 2.0 mp0 -103.63 -94.55 0.32 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.73 -1.581 . . . . 74.150000000000006 106.73 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -105.22 176.09 5.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.866 -0.606 . . . . 74.349999999999994 111.875 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.09 -25.53 22.33 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.636 1.574 . . . . 73.420000000000002 112.436 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.08 -20.56 54.53 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.001 0.92 . . . . 74.219999999999999 113.153 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.477 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.8 pt -119.64 157.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 119.497 -0.881 . . . . 63.450000000000003 110.617 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.93 148.4 32.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 106.707 -1.59 . . . . 70.439999999999998 106.707 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.6 mmpt? -113.02 164.56 13.31 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.519 -0.472 . . . . 52.439999999999998 112.027 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.11 134.41 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.173 -0.921 . . . . 64.400000000000006 110.426 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.509 HG23 ' CZ ' ' A' ' 539' ' ' TYR . 70.2 mt -90.67 125.64 43.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.531 -1.285 . . . . 71.430000000000007 107.531 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -111.86 112.65 24.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.511 0.672 . . . . 60.509999999999998 110.588 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.495 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 62.2 mt -118.83 130.06 74.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.635 -0.876 . . . . 74.299999999999997 108.635 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 84.0 mtp180 -83.69 132.82 34.84 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.726 0.641 . . . . 73.129999999999995 110.142 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.73 130.18 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.922 -1.14 . . . . 74.109999999999999 107.922 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 . . . . . 0 C--N 1.315 -0.903 0 N-CA-C 112.466 0.543 . . . . 72.340000000000003 112.466 -175.553 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 545' ' ' THR . 75.0 m . . . . . 0 N--CA 1.418 -2.07 0 N-CA-C 112.002 0.371 . . . . 75.430000000000007 112.002 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 644' ' ' ILE . 61.1 p -130.65 120.76 24.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.751 -0.659 . . . . 61.539999999999999 109.797 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -108.13 168.86 8.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.62 -1.252 . . . . 74.310000000000002 107.62 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 3.6 m -121.28 162.89 19.47 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.243 -0.983 . . . . 51.43 109.887 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.495 HD21 HD13 ' A' ' 571' ' ' ILE . 65.9 tp -136.54 125.94 25.02 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.808 -1.553 . . . . 52.140000000000001 106.808 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' A' ' 640' ' ' LYS . 26.8 m -124.52 159.62 30.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.786 -0.45 . . . . 63.240000000000002 109.786 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.61 135.46 43.09 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.265 -1.013 . . . . 53.009999999999998 108.265 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.97 171.63 8.15 Favored 'General case' 0 C--N 1.271 -2.822 0 CA-C-N 115.69 -0.686 . . . . 71.340000000000003 109.476 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.43 121.2 46.29 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 113.49 0.922 . . . . 75.400000000000006 113.49 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -77.06 144.51 23.84 Favored 'Trans proline' 0 N--CA 1.415 -3.094 0 C-N-CA 121.428 1.419 . . . . 73.25 111.191 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . 0.41 ' HB3' ' NZ ' ' A' ' 595' ' ' LYS . 0.1 OUTLIER -118.72 132.37 56.15 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.114 -0.948 . . . . 73.329999999999998 110.062 -176.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -98.27 119.69 37.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.63 -0.714 . . . . 73.109999999999999 109.262 -175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--N 1.294 -1.809 0 N-CA-C 106.997 -1.482 . . . . 54.350000000000001 106.997 176.552 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -94.19 171.25 8.95 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.163 -0.68 . . . . 73.5 109.163 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -74.34 179.02 43.61 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.029 -0.605 . . . . 70.439999999999998 111.803 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . 0.417 ' HG2' ' ND1' ' A' ' 638' ' ' HIS . 34.1 tt0 -46.97 -68.79 0.16 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.399 . . . . 71.030000000000001 111.238 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . 0.417 ' ND1' ' HG2' ' A' ' 637' ' ' GLU . 39.7 m80 -134.31 94.04 3.16 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.461 -0.94 . . . . 74.299999999999997 108.461 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 10.2 t -113.18 108.41 17.24 Favored 'General case' 0 N--CA 1.408 -2.567 0 C-N-CA 119.496 -0.882 . . . . 32.32 109.725 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . 0.404 ' HG3' HG12 ' A' ' 590' ' ' VAL . 39.7 ttpt -147.96 135.96 21.15 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.869 -1.53 . . . . 61.520000000000003 106.869 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.1 tp -113.44 116.27 29.35 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 108.58 -0.896 . . . . 75.329999999999998 108.58 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 511' ' ' VAL . 39.7 mt-10 -93.84 126.55 39.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.248 -1.019 . . . . 75.200000000000003 108.248 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.55 122.76 67.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.786 -0.643 . . . . 60.299999999999997 109.471 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 586' ' ' SER . 3.9 mp -108.95 130.14 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 115.483 -0.78 . . . . 73.450000000000003 109.42 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.094 0 CA-C-O 121.313 0.578 . . . . 65.349999999999994 111.794 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -1.054 0 N-CA-C 112.16 -0.376 . . . . 61.140000000000001 112.16 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 86.5 mt -92.95 114.83 30.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 123.68 0.792 . . . . 55.25 108.912 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.63 144.76 41.58 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.102 -0.333 . . . . 73.349999999999994 110.102 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -149.78 159.45 44.34 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 116.435 -0.348 . . . . 63.149999999999999 110.238 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 85.8 m-85 -73.01 154.19 40.6 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 109.796 -0.446 . . . . 70.329999999999998 109.796 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.01 -57.24 12.94 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 124.06 0.85 . . . . 73.219999999999999 109.733 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -120.11 163.29 29.02 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.058 -0.974 . . . . 34.109999999999999 109.596 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -22.84 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 110.83 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 642' ' ' GLU . 76.2 t -142.1 134.15 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.149 -1.056 . . . . 71.340000000000003 108.149 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.5 t -134.14 126.58 30.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.121 0.486 . . . . 63.329999999999998 109.922 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -98.65 120.69 39.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.466 -1.309 . . . . 75.019999999999996 107.466 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.01 154.44 18.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 116.201 -0.454 . . . . 44.109999999999999 109.963 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.488 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 45.8 m -60.0 154.27 19.43 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 124.246 0.966 . . . . 65.109999999999999 111.424 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.98 -33.3 57.62 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.942 -1.133 . . . . 63.409999999999997 107.942 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.6 m -98.89 28.82 4.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.16 -0.927 . . . . 73.420000000000002 110.232 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -76.94 -34.85 22.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 112.983 0.734 . . . . 74.150000000000006 112.983 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.32 -70.93 3.06 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.204 -0.998 . . . . 55.43 111.867 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.3 mm -130.96 131.57 64.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.776 -0.824 . . . . 74.109999999999999 108.776 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 16.9 ptm -106.29 127.28 53.13 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.601 -0.727 . . . . 71.239999999999995 109.152 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -88.81 114.46 25.45 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.262 0.351 . . . . 71.349999999999994 110.842 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 40.1 t -108.03 114.51 46.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.29 -0.633 . . . . 74.150000000000006 109.29 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -89.13 130.58 35.54 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.528 -0.545 . . . . 73.439999999999998 109.528 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.8 110.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.004 -1.48 . . . . 74.329999999999998 107.004 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.3 151.91 23.2 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.069 -0.969 . . . . 65.0 109.897 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.543 ' HD3' ' H ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -115.66 107.93 15.74 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.588 -0.893 . . . . 54.520000000000003 108.588 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.6 m -65.28 -58.68 5.32 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.395 -0.82 . . . . 54.420000000000002 109.967 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.4 p -74.59 -51.25 15.07 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.665 -0.698 . . . . 71.219999999999999 111.068 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.44 -166.31 26.87 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.347 -1.101 . . . . 71.439999999999998 110.347 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -146.77 134.44 21.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -153.32 99.4 2.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.423 -0.584 . . . . 63.43 109.423 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 127.01 -125.46 5.34 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 110.422 -1.071 . . . . 63.5 110.422 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -138.01 109.32 6.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.592 -0.521 . . . . 73.340000000000003 109.592 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 34.5 t -124.86 128.65 73.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.745 -0.835 . . . . 64.239999999999995 108.745 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.538 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.0 mm -105.34 126.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.379 -0.601 . . . . 74.099999999999994 109.379 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.42 109.76 60.11 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.791 -0.641 . . . . 45.450000000000003 109.956 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.48 146.03 13.51 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.883 1.722 . . . . 74.209999999999994 111.428 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -137.05 157.46 46.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.363 -0.977 . . . . 71.049999999999997 108.363 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -149.9 139.86 21.94 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.099 0.476 . . . . 72.030000000000001 111.235 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -84.65 124.77 31.84 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.197 -0.91 . . . . 50.450000000000003 111.977 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.6 mm -97.29 115.84 38.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.993 -1.484 . . . . 70.129999999999995 106.993 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.34 163.17 25.09 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.836 -0.431 . . . . 41.520000000000003 109.836 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -156.4 -116.67 0.53 Allowed Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 109.426 -1.47 . . . . 71.140000000000001 109.426 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.6 m -70.26 -27.06 64.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.239 -1.023 . . . . 74.239999999999995 108.239 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.18 131.42 38.26 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.782 -1.099 . . . . 64.219999999999999 108.292 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 132.84 43.49 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.424 -1.695 . . . . 74.310000000000002 106.424 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.0 29.1 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.849 -0.691 . . . . 52.399999999999999 111.995 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.28 63.51 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 114.518 0.567 . . . . 70.540000000000006 114.518 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.48 9.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 119.558 -1.306 . . . . 53.030000000000001 113.691 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.86 -79.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.357 0.578 . . . . 62.399999999999999 112.357 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.05 -41.49 12.29 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.048 -1.093 . . . . 54.240000000000002 108.048 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -143.17 163.76 32.01 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.508 -1.224 . . . . 74.349999999999994 107.962 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.587 ' HG3' ' NH2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -90.5 146.08 24.4 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.399 -1.334 . . . . 63.0 107.399 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.83 122.19 29.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.885 -0.413 . . . . 65.219999999999999 109.885 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -128.35 105.18 8.16 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.819 0.818 . . . . 74.019999999999996 109.73 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.55 131.58 51.53 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.227 -1.768 . . . . 44.310000000000002 106.227 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.26 -167.28 34.21 Favored Glycine 0 N--CA 1.432 -1.599 0 C-N-CA 119.169 -1.491 . . . . 64.319999999999993 113.249 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.3 mt-10 -113.83 122.72 47.9 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.811 0.844 . . . . 74.319999999999993 110.774 -176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.63 140.79 29.38 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.88 -0.785 . . . . 51.409999999999997 108.88 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.25 113.35 26.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.49 -0.323 . . . . 72.140000000000001 110.719 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 54.5 m-85 -115.88 115.83 26.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 110.061 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.454 ' H ' HD11 ' A' ' 567' ' ' ILE . 24.9 mp0 -90.08 -84.57 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.141 0.972 . . . . 72.409999999999997 110.507 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.477 HD22 ' HG2' ' A' ' 566' ' ' GLU . 8.8 t30 -105.11 157.8 17.01 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.31 -1.314 . . . . 64.340000000000003 111.216 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.84 -26.3 58.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.543 2.053 . . . . 64.219999999999999 116.543 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.477 ' HG2' HD22 ' A' ' 564' ' ' ASN . 7.9 pt-20 -80.25 7.24 9.85 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.034 1.124 . . . . 73.049999999999997 114.034 -174.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.454 HD11 ' H ' ' A' ' 563' ' ' GLN . 35.6 pt -119.36 161.93 18.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.396 -0.594 . . . . 62.229999999999997 109.396 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.92 154.57 34.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.128 -1.064 . . . . 71.420000000000002 108.128 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -113.97 147.09 39.18 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.988 0.423 . . . . 72.219999999999999 111.204 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -125.26 130.92 72.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.501 -1.227 . . . . 65.129999999999995 109.279 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 40.5 mt -91.99 126.39 44.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.477 -1.675 . . . . 70.150000000000006 106.477 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.1 p -108.52 112.25 24.53 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.461 -0.57 . . . . 63.439999999999998 109.461 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.52 HD11 HD22 ' A' ' 589' ' ' LEU . 52.2 mt -105.19 123.93 59.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 109.02 -0.733 . . . . 73.140000000000001 109.02 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.587 ' NH2' ' HG3' ' A' ' 554' ' ' GLU . 74.6 mtm180 -80.68 108.77 14.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 123.821 0.701 . . . . 73.099999999999994 111.201 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.1 mm -95.26 135.54 29.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.058 -1.83 . . . . 73.510000000000005 106.058 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 . . . . . 0 C--N 1.295 -1.787 0 C-N-CA 120.131 -0.627 . . . . 72.200000000000003 110.437 -178.046 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.437 -1.081 0 CA-C-O 121.129 0.49 . . . . 72.340000000000003 110.944 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 28.4 p -123.78 155.62 37.6 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 119.861 -0.735 . . . . 62.539999999999999 111.998 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -139.12 -177.98 5.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.772 -1.195 . . . . 73.129999999999995 107.772 173.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 26.3 m -135.06 156.58 48.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.653 -0.655 . . . . 72.049999999999997 109.946 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 573' ' ' ILE . 42.8 tp -130.83 130.8 44.08 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.06 -1.459 . . . . 51.149999999999999 107.06 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.02 151.48 33.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 120.964 -0.294 . . . . 74.010000000000005 110.903 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 96.3 mt -95.57 140.01 31.01 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.26 -1.015 . . . . 61.450000000000003 108.26 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -100.41 159.42 15.16 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.357 -0.838 . . . . 62.43 109.05 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 120.84 19.22 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 124.122 0.888 . . . . 74.439999999999998 110.461 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.63 148.13 41.49 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.521 2.814 . . . . 74.340000000000003 112.643 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . 0.538 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 18.2 ptpt -102.42 133.29 47.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.867 -1.16 . . . . 74.140000000000001 107.867 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -105.36 117.6 34.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.28 -0.637 . . . . 72.230000000000004 109.28 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . 0.435 HD13 HG12 ' A' ' 536' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.424 -1.737 0 N-CA-C 107.677 -1.231 . . . . 74.239999999999995 107.677 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.017 0 CA-C-O 121.012 0.434 . . . . 74.099999999999994 111.143 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 26.9 mt -109.63 -158.32 0.64 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.272 -0.877 . . . . 64.439999999999998 109.616 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.36 -164.4 13.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.14 -0.552 . . . . 62.130000000000003 112.465 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -59.75 -73.36 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.489 0.716 . . . . 71.329999999999998 109.568 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -131.24 127.35 37.66 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 106.559 -1.645 . . . . 72.140000000000001 106.559 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 2.6 t -137.94 109.13 6.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 123.139 1.447 . . . . 63.530000000000001 110.664 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -147.18 140.38 25.3 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.564 -1.653 . . . . 71.409999999999997 106.575 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.83 106.92 13.99 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.605 -0.887 . . . . 74.439999999999998 108.605 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.475 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.0 mt-10 -86.4 124.46 32.77 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.92 -1.141 . . . . 44.399999999999999 107.92 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.27 123.73 69.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.737 -0.665 . . . . 74.540000000000006 109.653 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.11 122.9 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 108.474 -0.936 . . . . 72.430000000000007 108.474 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 CA-C-O 121.245 0.545 . . . . 71.230000000000004 111.651 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.429 -1.805 0 N-CA-C 111.304 -0.718 . . . . 32.32 111.304 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 62.5 mt -113.84 114.56 47.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 107.274 -1.38 . . . . 75.219999999999999 107.274 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.06 137.94 47.12 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.236 0.335 . . . . 74.239999999999995 111.056 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.5 t -148.91 165.9 30.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.955 -0.387 . . . . 52.149999999999999 109.955 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.577 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 75.6 m-85 -79.16 157.76 27.84 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.339 0.656 . . . . 72.439999999999998 110.337 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.13 -50.58 71.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.72 0.772 . . . . 63.43 109.534 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.81 151.32 72.19 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 114.891 -1.049 . . . . 75.219999999999999 108.56 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.94 -22.37 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.115 1.877 . . . . 60.200000000000003 112.559 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.81 131.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.962 -0.385 . . . . 74.209999999999994 109.962 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.8 t -133.68 141.03 47.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.088 0.471 . . . . 63.520000000000003 109.84 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . 0.407 ' CD2' ' HB ' ' A' ' 644' ' ' ILE . 77.0 m80 -112.99 119.74 38.96 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.346 -0.983 . . . . 43.420000000000002 108.346 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.67 155.52 19.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.365 0.603 . . . . 72.129999999999995 111.032 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 518' ' ' ILE . 68.7 m -83.1 157.2 22.92 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.513 -0.767 . . . . 73.140000000000001 110.305 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.729 0.776 . . . . 73.129999999999995 111.366 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.5 p -89.84 24.42 2.39 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.213 -0.903 . . . . 71.420000000000002 112.156 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 515' ' ' SER . 5.8 tt -86.46 -25.49 6.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.297 0.57 . . . . 65.239999999999995 110.512 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.25 -71.82 2.86 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.614 -0.803 . . . . 31.309999999999999 111.961 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.2 mm -131.2 138.33 53.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.239 -1.763 . . . . 60.020000000000003 106.239 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.406 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.4 ppp? -112.21 147.85 35.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.176 -0.676 . . . . 70.430000000000007 109.176 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -113.03 130.37 56.17 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.832 0.707 . . . . 64.129999999999995 111.201 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 39.5 t -125.11 124.21 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 107.973 -1.121 . . . . 55.43 107.973 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 570' ' ' ILE . 59.6 mttm -91.05 131.19 36.79 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.994 -1.082 . . . . 61.439999999999998 109.383 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 89.3 t -91.34 109.67 21.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 106.948 -1.501 . . . . 64.25 106.948 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.1 mt -87.12 143.29 27.37 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.742 -1.117 . . . . 74.209999999999994 110.167 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.88 113.54 26.54 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.972 -1.013 . . . . 62.119999999999997 108.672 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 41.0 p -66.54 -63.64 1.03 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.023 -0.671 . . . . 73.430000000000007 111.592 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 51.0 m -74.46 -52.55 11.68 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.041 0.448 . . . . 43.130000000000003 111.513 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . 0.565 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 160.21 -143.85 9.45 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.607 -0.806 . . . . 52.43 111.735 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.64 161.18 18.12 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 106.248 -1.76 . . . . 72.219999999999999 106.248 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -157.19 126.52 6.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.463 0.574 . . . . 62.100000000000001 110.527 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.34 -118.7 5.61 Favored Glycine 0 CA--C 1.494 -1.28 0 C-N-CA 120.723 -0.751 . . . . 43.219999999999999 111.857 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -138.51 111.99 8.16 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.284 -1.006 . . . . 73.329999999999998 108.284 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.6 t -122.34 130.26 74.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.877 -0.515 . . . . 73.519999999999996 110.686 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.37 118.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.497 -0.927 . . . . 74.230000000000004 108.497 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.1 106.63 58.84 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.888 -0.782 . . . . 71.239999999999995 108.888 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -83.98 159.61 13.71 Favored 'Trans proline' 0 N--CA 1.42 -2.798 0 C-N-CA 121.838 1.692 . . . . 62.399999999999999 111.027 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.36 163.34 39.15 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.915 -1.883 . . . . 72.420000000000002 105.915 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -150.81 129.07 11.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.248 -0.581 . . . . 62.43 110.863 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.3 p -78.01 117.38 19.28 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 115.464 -0.789 . . . . 74.230000000000004 110.293 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.5 mm -88.4 120.45 37.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.216 -1.402 . . . . 72.329999999999998 107.216 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.56 113.63 13.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.684 -0.487 . . . . 74.120000000000005 109.684 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -94.18 -108.69 2.07 Favored Glycine 0 CA--C 1.496 -1.128 0 N-CA-C 110.423 -1.071 . . . . 34.32 110.423 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 42.4 p -86.26 -24.22 26.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.591 -0.892 . . . . 74.109999999999999 108.591 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 585' ' ' CYS . . . -88.09 145.41 25.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.22 -0.9 . . . . 74.400000000000006 109.363 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 36.6 mmm-85 -95.02 138.24 33.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.747 0.784 . . . . 64.310000000000002 112.685 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -110.58 129.48 9.32 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 114.182 -1.372 . . . . 74.230000000000004 110.978 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 141.49 -17.82 2.65 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.581 -1.008 . . . . 62.43 110.581 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 155.51 -16.64 0.49 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.858 -1.163 . . . . 73.530000000000001 113.445 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 2.2 mp0 -69.67 -81.79 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.459 0.63 . . . . 64.030000000000001 111.462 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -86.37 -53.7 4.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.981 0.896 . . . . 73.349999999999994 108.617 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -131.2 160.84 33.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.273 -0.876 . . . . 60.5 110.445 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.534 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 27.2 tt0 -96.26 119.06 34.06 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.788 -1.93 . . . . 74.120000000000005 105.788 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.79 143.4 54.63 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.31 0.576 . . . . 74.450000000000003 111.501 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 4.9 t -140.72 136.53 32.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.833 -0.621 . . . . 71.540000000000006 110.076 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.1 p -143.46 110.41 5.64 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.23 0.538 . . . . 64.140000000000001 112.2 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 79.22 105.78 0.23 Allowed Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.535 -0.757 . . . . 74.510000000000005 113.122 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.42 14.54 0.31 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.65 -0.87 . . . . 70.019999999999996 108.65 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 569' ' ' LYS . 46.2 mt -117.45 135.89 53.58 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.289 -0.882 . . . . 71.030000000000001 112.198 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.452 ' H ' ' HD2' ' A' ' 569' ' ' LYS . 36.0 tt0 -134.91 109.69 8.65 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.588 -1.264 . . . . 74.319999999999993 107.588 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 48.8 m-85 -102.37 115.28 30.25 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.822 -0.807 . . . . 63.439999999999998 108.822 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.481 ' H ' HD11 ' A' ' 567' ' ' ILE . 44.6 mt-30 -90.15 -79.64 0.34 Allowed 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.798 -0.637 . . . . 74.040000000000006 109.898 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -104.33 167.1 9.96 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.005 -0.739 . . . . 63.299999999999997 109.005 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -69.34 -20.13 63.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.479 0.712 . . . . 62.439999999999998 112.33 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.2 -10.26 59.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.143 1.164 . . . . 72.219999999999999 114.143 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.481 HD11 ' H ' ' A' ' 563' ' ' GLN . 40.0 pt -113.44 166.46 7.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.223 -0.591 . . . . 64.540000000000006 110.892 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.86 148.23 29.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.863 -1.532 . . . . 71.129999999999995 106.863 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.463 ' HB3' HD22 ' A' ' 560' ' ' LEU . 20.8 mttm -116.48 155.67 28.19 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 112.876 0.695 . . . . 63.520000000000003 112.876 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 32.7 mt -122.0 133.08 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.915 -1.039 . . . . 55.32 110.594 -174.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.462 HD13 HD21 ' A' ' 589' ' ' LEU . 47.8 mt -90.99 129.21 42.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.947 -1.501 . . . . 73.219999999999999 106.947 174.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -115.1 112.66 22.92 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.449 -0.574 . . . . 73.299999999999997 109.449 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 589' ' ' LEU . 62.1 mt -108.36 130.7 60.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.82 -0.807 . . . . 73.200000000000003 108.82 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.534 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 70.7 ttt180 -76.9 112.58 13.66 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.484 -0.561 . . . . 73.510000000000005 109.484 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.16 119.16 47.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.344 -2.095 . . . . 62.329999999999998 105.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 C--N 1.301 -1.507 0 CA-C-O 121.645 0.736 . . . . 74.140000000000001 112.524 -175.066 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 63.4 m . . . . . 0 N--CA 1.427 -1.62 0 CA-C-O 121.0 0.428 . . . . 72.340000000000003 110.518 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.6 p -147.42 151.61 36.75 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.714 -0.847 . . . . 62.039999999999999 108.714 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -149.97 176.69 10.55 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.852 -1.166 . . . . 71.109999999999999 107.852 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 20.0 m -129.85 163.96 25.17 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.972 -0.691 . . . . 74.120000000000005 109.853 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.462 HD21 HD13 ' A' ' 571' ' ' ILE . 41.9 tp -139.67 127.36 21.83 Favored 'General case' 0 C--N 1.263 -3.165 0 N-CA-C 106.729 -1.582 . . . . 74.140000000000001 106.729 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.52 151.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.546 -0.539 . . . . 70.409999999999997 109.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 85.0 mt -92.1 139.42 30.65 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.901 -1.148 . . . . 53.25 107.901 175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.42 167.55 10.56 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 115.476 -0.784 . . . . 73.439999999999998 108.979 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.24 115.19 9.18 Favored Pre-proline 0 N--CA 1.446 -0.637 0 O-C-N 124.598 1.186 . . . . 71.150000000000006 109.333 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.42 142.7 23.98 Favored 'Trans proline' 0 N--CA 1.428 -2.346 0 C-N-CA 121.703 1.602 . . . . 72.109999999999999 111.412 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -110.3 132.34 54.26 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.957 -0.565 . . . . 63.240000000000002 110.421 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -85.02 118.81 24.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.451 -1.314 . . . . 73.219999999999999 107.451 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 43.1 mm . . . . . 0 N--CA 1.411 -2.391 0 N-CA-C 106.0 -1.852 . . . . 65.120000000000005 106.0 176.907 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 121.842 0.829 . . . . 74.510000000000005 111.53 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -99.0 178.87 4.8 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.388 -1.338 . . . . 72.109999999999999 107.388 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.89 -154.79 7.15 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 119.917 -1.135 . . . . 65.420000000000002 113.0 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.53 -68.07 0.36 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 124.388 1.075 . . . . 75.209999999999994 110.269 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -138.44 119.36 14.3 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.641 -1.985 . . . . 50.229999999999997 105.641 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . 0.402 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 4.8 t -134.69 110.24 9.13 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-O 122.361 1.077 . . . . 72.310000000000002 110.839 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -147.89 137.85 22.69 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.177 -1.416 . . . . 74.519999999999996 107.177 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 111.82 22.65 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.177 -1.416 . . . . 70.040000000000006 107.177 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.37 122.26 37.9 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.963 -0.754 . . . . 74.230000000000004 108.963 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.93 125.41 68.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.252 -0.885 . . . . 75.340000000000003 109.139 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . 0.407 ' HB ' ' CD2' ' A' ' 513' ' ' HIS . 4.4 mp -116.84 139.19 44.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.568 -1.271 . . . . 74.219999999999999 107.568 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.308 -1.22 0 N-CA-C 109.435 -0.579 . . . . 74.040000000000006 109.435 -175.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.682 0 N-CA-C 111.076 -0.81 . . . . 71.120000000000005 111.076 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.95 114.8 36.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.38 -1.711 . . . . 51.030000000000001 106.38 172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.62 132.8 53.88 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.669 0.606 . . . . 62.420000000000002 109.975 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -148.39 152.39 36.93 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 120.766 0.317 . . . . 71.439999999999998 110.496 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.566 ' CG ' ' HB2' ' A' ' 641' ' ' LEU . 69.2 m-85 -71.4 148.17 47.2 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.282 0.633 . . . . 73.109999999999999 111.395 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.85 -55.85 20.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.62 0.575 . . . . 74.409999999999997 110.655 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . 0.576 ' O ' HD23 ' A' ' 641' ' ' LEU . 39.2 mt-10 -126.96 158.36 68.95 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 107.542 -1.281 . . . . 64.040000000000006 107.542 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.29 -23.98 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.684 1.589 . . . . 73.430000000000007 112.226 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 644' ' ' ILE . 78.0 t -138.0 138.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.017 -0.364 . . . . 62.039999999999999 110.017 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.2 t -131.33 128.06 38.92 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 74.019999999999996 109.347 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.41 110.73 22.76 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.157 -1.423 . . . . 71.019999999999996 107.157 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.39 159.34 14.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.744 -0.382 . . . . 75.230000000000004 110.148 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 46.2 m -84.27 173.52 10.92 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.478 -0.783 . . . . 62.119999999999997 110.792 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.89 -34.16 18.27 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.738 -0.838 . . . . 64.109999999999999 108.738 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 49.4 m -92.19 17.25 9.87 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.958 -1.019 . . . . 71.409999999999997 111.874 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.16 -29.52 17.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.271 0.558 . . . . 71.299999999999997 110.372 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.19 -70.15 3.24 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.858 -0.687 . . . . 31.34 112.27 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.9 mm -129.06 124.01 59.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.345 -0.983 . . . . 64.450000000000003 108.345 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -95.85 149.86 21.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.878 -1.156 . . . . 73.530000000000001 107.878 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -129.18 112.95 14.47 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.606 0.595 . . . . 72.319999999999993 112.606 -173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 68.8 t -121.3 128.58 75.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.482 -0.781 . . . . 74.319999999999993 109.535 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.08 149.59 21.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.242 0.544 . . . . 64.310000000000002 109.793 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.29 107.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.621 -1.622 . . . . 50.140000000000001 106.621 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 81.8 mt -76.16 137.15 39.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.339 -0.846 . . . . 72.030000000000001 109.877 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.523 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 40.9 mtp180 -104.61 102.18 11.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.335 -1.357 . . . . 73.340000000000003 107.335 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.2 m -68.05 -62.45 1.4 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.565 1.32 . . . . 72.040000000000006 114.565 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 33.4 t -73.13 -50.83 20.54 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.596 0.591 . . . . 70.230000000000004 112.596 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 156.89 -160.44 30.35 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 111.146 -0.782 . . . . 72.219999999999999 111.146 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.38 165.88 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.522 0.729 . . . . 71.019999999999996 109.662 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -176.09 105.02 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.244 1.018 . . . . 74.120000000000005 108.52 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 121.35 -126.25 6.47 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 110.719 -0.952 . . . . 53.350000000000001 110.719 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -136.47 127.78 28.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.239 -1.023 . . . . 71.439999999999998 108.239 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.05 130.29 68.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.134 -0.691 . . . . 74.310000000000002 109.134 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 51.5 mm -100.88 122.47 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.284 -1.006 . . . . 72.209999999999994 108.284 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 43.4 t -116.76 102.33 53.18 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.499 -0.926 . . . . 71.450000000000003 108.499 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.51 135.28 13.04 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.801 1.667 . . . . 70.319999999999993 112.742 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -119.51 168.1 11.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.181 -1.044 . . . . 75.519999999999996 108.181 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -158.43 135.6 9.97 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.822 0.344 . . . . 55.119999999999997 111.154 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 17.8 p -80.41 121.0 25.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.348 -0.842 . . . . 54.329999999999998 110.441 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 29.9 mm -96.11 121.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.47 -1.307 . . . . 71.219999999999999 107.47 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.48 125.23 28.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.691 -0.485 . . . . 74.420000000000002 109.691 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -103.21 -109.02 3.32 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.724 -1.75 . . . . 43.039999999999999 108.724 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 585' ' ' CYS . 8.7 p -89.23 -5.85 57.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.198 0.999 . . . . 72.030000000000001 109.579 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.81 140.49 38.02 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.805 -1.089 . . . . 73.129999999999995 108.427 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.87 147.61 28.53 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.089 0.471 . . . . 64.109999999999999 111.511 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.2 -147.54 9.34 Favored Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 115.189 -0.914 . . . . 72.109999999999999 111.113 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.15 28.47 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 121.679 -0.296 . . . . 54.329999999999998 113.07 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.44 -3.84 34.86 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 111.493 -0.643 . . . . 34.409999999999997 111.493 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.76 -79.95 0.03 OUTLIER 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.001 0.429 . . . . 72.409999999999997 111.543 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -87.2 -46.16 9.99 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.718 -1.216 . . . . 34.0 107.718 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -139.5 165.87 26.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.574 -1.194 . . . . 64.549999999999997 109.732 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 574' ' ' ARG . 1.0 OUTLIER -95.96 116.4 28.88 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.303 -2.11 . . . . 72.010000000000005 105.303 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.72 132.18 35.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.5 0.667 . . . . 73.150000000000006 111.554 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.0 t -128.19 148.39 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.494 -0.775 . . . . 74.209999999999994 109.795 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 15.0 p -148.99 140.11 23.05 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.866 0.365 . . . . 53.299999999999997 111.4 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 80.12 -125.2 6.81 Favored Glycine 0 C--O 1.212 -1.263 0 CA-C-N 115.684 -0.689 . . . . 70.450000000000003 111.576 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 58.73 -6.09 0.05 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.072 2.99 . . . . 74.510000000000005 119.072 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 537' ' ' VAL . 62.2 mt -95.27 133.58 39.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 120.049 1.295 . . . . 74.310000000000002 112.29 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -134.23 108.91 8.52 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.603 -1.18 . . . . 75.540000000000006 107.939 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.523 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 73.8 m-85 -103.53 129.02 50.65 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.207 -0.451 . . . . 63.450000000000003 110.592 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.483 ' HB2' HD11 ' A' ' 567' ' ' ILE . 1.6 mp0 -96.16 -107.03 0.15 Allowed 'General case' 0 C--O 1.246 0.912 0 C-N-CA 118.631 -1.227 . . . . 74.349999999999994 111.306 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.4 155.79 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.715 -0.476 . . . . 64.549999999999997 109.715 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.89 -25.97 67.1 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 114.52 1.304 . . . . 74.230000000000004 114.52 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.52 -15.59 60.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.118 0.784 . . . . 61.530000000000001 113.118 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 563' ' ' GLN . 34.2 pt -103.32 157.09 5.14 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 C-N-CA 119.694 -0.802 . . . . 74.040000000000006 110.174 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.58 156.99 29.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.574 -0.528 . . . . 63.149999999999999 109.574 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.8 mmpt? -110.29 163.82 13.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 110.026 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 62.9 mt -128.42 134.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.773 -1.103 . . . . 71.409999999999997 108.681 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.488 HD13 HD21 ' A' ' 589' ' ' LEU . 58.8 mt -90.14 118.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 106.619 -1.622 . . . . 65.340000000000003 106.619 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 12.8 p -110.47 111.74 23.2 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.622 -0.717 . . . . 54.439999999999998 110.008 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.85 132.55 59.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.665 -0.698 . . . . 63.43 109.564 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 554' ' ' GLU . 79.5 mtt180 -76.99 111.82 12.96 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 123.807 0.692 . . . . 55.049999999999997 110.203 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.29 121.94 55.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.401 -1.703 . . . . 75.519999999999996 106.401 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 74.3 m-85 . . . . . 0 C--N 1.293 -1.86 0 C-N-CA 120.441 -0.504 . . . . 75.400000000000006 109.921 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.435 ' HA ' ' OG1' ' A' ' 545' ' ' THR . 21.4 p . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 121.498 0.666 . . . . 74.040000000000006 110.174 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 44.9 m -144.08 164.36 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.522 -0.547 . . . . 72.420000000000002 109.522 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.1 p90 -142.6 -178.94 6.02 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.78 -0.452 . . . . 72.25 109.78 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 70.9 m -131.09 167.52 18.96 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.238 0.542 . . . . 62.439999999999998 111.024 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.488 HD21 HD13 ' A' ' 571' ' ' ILE . 63.9 tp -136.47 124.51 22.9 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.152 -1.796 . . . . 73.420000000000002 106.152 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.73 159.0 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.489 -0.56 . . . . 71.329999999999998 109.489 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.505 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 74.6 mt -104.58 144.09 32.16 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.235 -1.024 . . . . 61.299999999999997 108.235 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.01 170.95 7.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.173 -0.677 . . . . 74.519999999999996 109.173 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -59.17 109.92 2.28 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 123.92 0.763 . . . . 72.319999999999993 112.749 -175.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.65 158.52 39.59 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.122 2.548 . . . . 61.149999999999999 112.384 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -123.3 140.71 52.74 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 72.030000000000001 110.294 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -103.14 124.54 48.76 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.136 -1.061 . . . . 72.209999999999994 108.136 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 107.184 -1.413 . . . . 73.439999999999998 107.184 176.17 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 38.3 pt . . . . . 0 N--CA 1.426 -1.674 0 CA-C-O 121.432 0.634 . . . . 62.100000000000001 110.951 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.5 176.15 5.25 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.068 -1.456 . . . . 71.439999999999998 107.068 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.22 153.37 52.71 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.231 -1.947 . . . . 44.340000000000003 108.231 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . 0.462 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 41.5 tt0 -41.1 -61.22 1.04 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.157 1.383 . . . . 73.099999999999994 112.737 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . 0.462 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 46.8 m80 -126.22 92.99 3.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.876 -0.787 . . . . 70.409999999999997 108.876 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.8 t -116.09 110.8 19.37 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.556 1.169 . . . . 74.439999999999998 108.954 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -146.29 116.7 7.49 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.211 -1.774 . . . . 71.329999999999998 106.211 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 509' ' ' GLU . 1.6 tm? -106.76 108.62 20.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.059 -1.089 . . . . 73.209999999999994 108.059 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -88.44 131.77 34.74 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.134 -0.939 . . . . 72.409999999999997 109.425 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.49 118.62 59.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.905 -0.776 . . . . 74.540000000000006 108.905 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 511' ' ' VAL . 3.7 mp -110.34 130.08 64.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.565 -1.198 . . . . 72.019999999999996 109.285 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.814 0 CA-C-O 122.254 1.026 . . . . 64.400000000000006 112.101 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.592 0 N-CA-C 110.663 -0.975 . . . . 52.340000000000003 110.663 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -127.08 114.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.11 134.55 48.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.824 0.702 . . . . 74.530000000000001 109.928 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -147.99 156.73 42.99 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.321 -0.622 . . . . 61.100000000000001 109.321 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 74.4 m-85 -73.39 153.18 40.55 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.22 -0.289 . . . . 70.25 110.22 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.3 -51.86 67.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.978 0.799 . . . . 73.310000000000002 110.536 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -135.66 155.66 78.05 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 114.606 -1.179 . . . . 63.32 108.278 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.59 -25.74 2.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.934 1.756 . . . . 74.349999999999994 113.006 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 642' ' ' GLU . 89.3 t -142.02 132.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.127 -0.694 . . . . 72.030000000000001 109.127 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.3 t -133.94 138.26 45.38 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.079 0.466 . . . . 44.340000000000003 109.943 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -102.73 112.92 25.92 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.774 -1.195 . . . . 75.540000000000006 107.774 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.5 m -108.5 145.19 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.313 -0.555 . . . . 71.010000000000005 110.254 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 518' ' ' ILE . 70.8 m -70.81 137.91 49.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.131 -0.941 . . . . 64.129999999999995 111.38 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -31.3 61.65 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.752 1.019 . . . . 75.329999999999998 113.752 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 7.4 p -106.84 25.35 11.39 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.844 0.354 . . . . 54.119999999999997 111.884 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -76.13 -31.02 20.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.511 0.672 . . . . 72.519999999999996 110.228 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 87.12 -70.35 2.89 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.623 -0.798 . . . . 71.329999999999998 111.795 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.75 133.36 68.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.975 -1.121 . . . . 72.319999999999993 107.975 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 572' ' ' THR . 19.6 ptm -107.62 136.4 47.44 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.146 -0.687 . . . . 53.130000000000003 109.146 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -103.14 124.6 48.89 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.397 0.679 . . . . 74.420000000000002 110.0 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.5 t -121.24 123.71 70.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.423 -0.954 . . . . 74.230000000000004 108.423 175.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.77 127.4 35.6 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.684 -0.406 . . . . 73.200000000000003 110.01 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.68 107.93 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.529 -1.656 . . . . 71.109999999999999 106.529 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.8 mt -87.16 153.04 21.82 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.02 -0.991 . . . . 63.109999999999999 110.191 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -121.64 104.83 9.9 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.874 -0.603 . . . . 74.219999999999999 110.062 -178.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.5 m -63.59 -60.78 2.89 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 72.319999999999993 110.133 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -73.04 -43.8 61.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.157 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.02 -152.35 23.13 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 110.209 -1.156 . . . . 70.549999999999997 110.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.532 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -157.75 146.69 19.53 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.194 -1.78 . . . . 74.310000000000002 106.194 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.462 ' NH2' ' HA2' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -160.9 114.55 2.04 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.152 -1.425 . . . . 72.230000000000004 107.152 -178.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.462 ' HA2' ' NH2' ' A' ' 532' ' ' ARG . . . 119.25 -131.45 9.05 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 111.229 -0.748 . . . . 63.0 111.229 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -136.89 103.81 5.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.282 -2.118 . . . . 75.209999999999994 105.282 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 41.2 t -120.14 125.04 73.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 C-N-CA 119.644 -0.822 . . . . 61.140000000000001 111.086 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.73 122.64 42.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 72.349999999999994 107.938 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.12 103.13 54.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 109.006 -0.738 . . . . 45.100000000000001 109.006 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.414 ' HA ' ' HA2' ' A' ' 558' ' ' GLY . 0.9 OUTLIER -80.12 133.27 9.82 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.819 1.68 . . . . 62.43 112.63 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -119.82 161.75 20.27 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.375 -1.343 . . . . 71.209999999999994 107.375 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -155.42 139.66 16.61 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.957 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.0 p -84.47 130.78 34.73 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.285 -0.871 . . . . 44.409999999999997 110.894 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 588' ' ' SER . 43.7 mm -99.09 114.01 35.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.542 -1.281 . . . . 75.329999999999998 107.542 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.01 161.97 27.92 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.989 -0.55 . . . . 75.140000000000001 111.002 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 144.53 117.27 1.14 Allowed Glycine 0 C--O 1.201 -1.939 0 N-CA-C 108.376 -1.889 . . . . 72.340000000000003 108.376 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 47.3 p 75.87 5.53 3.86 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 127.484 2.314 . . . . 61.420000000000002 110.395 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -169.21 140.1 2.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.706 -1.134 . . . . 65.129999999999995 108.249 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -102.47 138.08 39.86 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 123.501 0.501 . . . . 73.010000000000005 109.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -105.44 131.75 10.79 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 116.003 -0.544 . . . . 73.329999999999998 112.823 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 160.38 -49.53 0.38 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.818 -1.713 . . . . 51.240000000000002 108.818 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 179.65 -9.01 0.02 OUTLIER Glycine 0 C--N 1.294 -1.789 0 CA-C-N 113.933 -1.134 . . . . 72.420000000000002 111.286 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.426 ' H ' ' H ' ' A' ' 550' ' ' GLY . 20.5 mp0 -65.16 -61.63 2.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.875 1.27 . . . . 73.430000000000007 111.686 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -122.88 -41.13 2.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.784 0.802 . . . . 72.239999999999995 109.122 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -136.37 160.29 39.18 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.931 -1.507 . . . . 74.120000000000005 106.931 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 22.1 tt0 -89.01 141.45 28.47 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.857 -0.794 . . . . 43.399999999999999 108.857 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.89 106.72 15.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.453 -0.944 . . . . 75.200000000000003 108.453 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -117.38 131.54 56.75 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.1 -1.074 . . . . 64.099999999999994 108.1 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.5 131.59 15.36 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 112.275 0.472 . . . . 62.140000000000001 112.275 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 538' ' ' PRO . . . 85.21 -139.26 17.38 Favored Glycine 0 C--O 1.189 -2.708 0 N-CA-C 111.794 -0.522 . . . . 63.509999999999998 111.794 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 71.2 -8.0 1.07 Allowed 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.698 1.74 . . . . 64.349999999999994 115.698 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 569' ' ' LYS . 41.0 mt -93.4 131.28 38.73 Favored 'General case' 0 CA--C 1.5 -0.97 0 O-C-N 120.647 -1.283 . . . . 72.439999999999998 112.327 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -129.77 118.73 22.28 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.104 -0.953 . . . . 75.400000000000006 109.454 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 37.5 m-85 -104.54 155.31 18.93 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.555 -0.906 . . . . 65.299999999999997 108.555 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.434 ' H ' HD11 ' A' ' 567' ' ' ILE . 72.1 mm-40 -120.66 -88.22 0.63 Allowed 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.721 -1.215 . . . . 73.310000000000002 107.721 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -104.45 165.48 11.03 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.197 -1.038 . . . . 71.430000000000007 108.197 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.532 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 4.4 p30 -63.21 -11.87 24.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.789 1.033 . . . . 63.119999999999997 113.789 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.456 ' HG3' HG23 ' A' ' 567' ' ' ILE . 11.3 pt-20 -69.8 -18.75 63.49 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.945 0.498 . . . . 74.140000000000001 111.794 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.456 HG23 ' HG3' ' A' ' 566' ' ' GLU . 38.8 pt -114.12 164.29 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 120.865 0.364 . . . . 73.319999999999993 110.625 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.56 158.37 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.08 -1.452 . . . . 75.439999999999998 107.08 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.507 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -121.69 149.19 43.58 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 120.965 0.412 . . . . 73.140000000000001 110.435 173.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.56 134.27 64.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.914 -1.039 . . . . 64.310000000000002 109.964 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 50.4 mt -90.91 126.73 43.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 106.552 -1.647 . . . . 74.310000000000002 106.552 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 521' ' ' MET . 15.5 p -117.28 112.5 20.85 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.836 -0.802 . . . . 73.129999999999995 108.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.484 HD11 HD22 ' A' ' 589' ' ' LEU . 50.4 mt -109.84 131.77 59.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.175 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 61.6 mtt180 -78.47 112.04 15.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 123.964 0.79 . . . . 74.230000000000004 111.397 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.5 125.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 106.356 -1.72 . . . . 64.140000000000001 106.356 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.44 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 78.3 m-85 . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 113.129 0.788 . . . . 75.349999999999994 113.129 -174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.402 ' O ' HD12 ' A' ' 645' ' ' ILE . 6.4 p . . . . . 0 N--CA 1.422 -1.853 0 CA-C-O 120.393 0.139 . . . . 73.099999999999994 110.638 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.4 p -134.54 168.18 19.43 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.41 -0.218 . . . . 62.219999999999999 110.41 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.411 ' CE1' HD11 ' A' ' 645' ' ' ILE . 54.8 p90 -163.86 162.33 23.57 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.982 -1.858 . . . . 75.420000000000002 105.982 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 542' ' ' ILE . 11.0 t -113.41 171.96 7.25 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 118.802 -1.159 . . . . 62.439999999999998 108.815 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 573' ' ' ILE . 61.0 tp -145.09 126.84 15.28 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.585 -1.635 . . . . 61.420000000000002 106.585 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 120.668 0.27 . . . . 73.230000000000004 110.383 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 56.5 mt -99.79 141.0 33.18 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.212 -1.033 . . . . 72.219999999999999 108.212 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.76 167.07 10.02 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.077 -1.083 . . . . 75.400000000000006 108.077 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.63 116.17 21.68 Favored Pre-proline 0 C--O 1.247 0.946 0 N-CA-C 112.606 0.595 . . . . 75.219999999999999 112.606 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.401 ' HB2' ' CG1' ' A' ' 535' ' ' VAL . 65.7 Cg_endo -71.15 144.82 47.7 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.0 2.467 . . . . 71.329999999999998 111.527 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 595' ' ' LYS . 0.0 OUTLIER -112.68 130.71 55.95 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.643 -0.708 . . . . 73.239999999999995 110.788 -178.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -84.79 116.05 23.05 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.33 -1.359 . . . . 74.230000000000004 107.33 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 38.7 mm . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 108.389 -0.967 . . . . 62.25 108.389 179.861 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 31.3 pt . . . . . 0 N--CA 1.433 -1.303 0 CA-C-O 121.581 0.705 . . . . 74.019999999999996 111.444 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.07 179.64 5.14 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.033 -1.099 . . . . 53.32 108.033 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -68.7 167.77 44.42 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.899 -0.88 . . . . 74.519999999999996 110.899 175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -48.78 -43.7 38.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.594 1.158 . . . . 74.25 110.782 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.17 123.53 9.63 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.036 -1.438 . . . . 75.329999999999998 107.3 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . 0.426 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 11.2 t -148.97 112.89 5.14 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.812 0.815 . . . . 71.040000000000006 110.209 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -147.42 130.39 16.27 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.888 -1.051 . . . . 74.109999999999999 108.618 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 68.5 tp -108.23 118.86 37.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.917 -0.771 . . . . 75.140000000000001 108.917 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 511' ' ' VAL . 39.7 mt-10 -103.05 122.87 45.53 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.983 -1.117 . . . . 72.120000000000005 107.983 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.0 t -109.88 128.8 65.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.788 -0.819 . . . . 71.239999999999995 108.788 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.03 133.29 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.605 0 N-CA-C 107.269 -1.382 . . . . 74.329999999999998 107.269 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.411 HD11 ' CE1' ' A' ' 587' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.414 -2.245 0 CA-C-N 115.977 -0.556 . . . . 72.530000000000001 109.516 -174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.656 0 N-CA-C 112.831 -0.108 . . . . 75.430000000000007 112.831 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.47 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.1 mt -93.19 121.61 44.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 110.414 -0.217 . . . . 73.129999999999995 110.414 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 91.2 m-85 -109.0 138.5 45.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.769 -0.826 . . . . 72.530000000000001 108.769 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -149.34 158.68 44.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.683 -0.488 . . . . 64.329999999999998 109.683 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.669 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.6 m-85 -74.51 156.79 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.607 0.242 . . . . 75.439999999999998 110.362 174.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.47 -53.03 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.169 0.918 . . . . 41.439999999999998 110.675 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -121.47 157.53 56.12 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.259 -0.882 . . . . 64.019999999999996 108.82 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -84.0 -30.26 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.521 1.481 . . . . 75.140000000000001 110.527 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 642' ' ' GLU . 70.6 t -137.64 129.89 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.0 t -133.89 131.89 39.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.045 -0.724 . . . . 74.239999999999995 109.045 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -96.17 138.01 34.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.384 -1.339 . . . . 70.319999999999993 107.384 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.87 145.49 32.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 120.853 0.359 . . . . 55.350000000000001 110.266 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 69.5 m -75.3 156.27 35.77 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.208 -0.906 . . . . 73.030000000000001 111.749 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -68.17 -46.17 71.44 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.934 -1.03 . . . . 74.109999999999999 111.046 178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 11.2 t -95.17 36.04 1.25 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.771 0.796 . . . . 75.420000000000002 110.173 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.91 -31.66 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 121.722 -0.612 . . . . 73.109999999999999 110.514 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.16 -72.85 2.74 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.818 -0.706 . . . . 61.399999999999999 111.463 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.65 123.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.515 -0.55 . . . . 65.409999999999997 109.515 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.43 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 22.1 ptm -91.36 138.6 31.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.111 -1.07 . . . . 72.430000000000007 108.111 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.74 108.87 20.57 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 123.442 0.464 . . . . 53.240000000000002 111.076 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 40.1 t -105.24 117.63 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.312 -0.625 . . . . 54.229999999999997 109.312 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -96.45 132.39 42.05 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.217 0.532 . . . . 65.230000000000004 110.093 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.8 t -90.96 112.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.463 -1.31 . . . . 72.439999999999998 107.463 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.462 ' HA ' HH21 ' A' ' 527' ' ' ARG . 59.3 mt -82.36 141.99 32.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.292 -0.867 . . . . 54.310000000000002 110.191 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.462 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -106.56 102.12 11.53 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.997 -1.483 . . . . 75.239999999999995 106.997 178.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.7 m -67.73 -63.75 1.0 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.802 -0.635 . . . . 73.540000000000006 110.701 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 10.3 t -75.63 -31.77 59.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 75.310000000000002 110.283 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 131.67 -159.14 23.11 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.919 -0.872 . . . . 42.049999999999997 110.919 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.549 ' N ' ' HB3' ' A' ' 565' ' ' ASP . . . -168.73 142.09 2.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.637 -1.616 . . . . 63.109999999999999 106.637 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -146.06 129.4 16.78 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.128 -0.693 . . . . 71.120000000000005 109.128 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 100.72 -122.85 7.74 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 121.386 -0.435 . . . . 55.340000000000003 112.758 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.62 102.77 5.02 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.749 -1.945 . . . . 74.310000000000002 105.749 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.62 129.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.234 0.54 . . . . 73.299999999999997 110.552 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 559' ' ' GLU . 50.9 mm -98.29 127.62 50.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.536 -0.757 . . . . 74.439999999999998 109.147 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -112.61 104.58 55.99 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.45 0.7 . . . . 70.310000000000002 109.892 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.35 141.27 28.49 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.741 2.294 . . . . 63.229999999999997 113.262 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.53 163.91 30.02 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.375 -0.972 . . . . 72.519999999999996 108.375 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -161.69 137.82 7.98 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 123.192 0.308 . . . . 75.439999999999998 110.655 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.5 p -84.26 126.29 33.03 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.381 0.61 . . . . 31.199999999999999 110.992 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.4 117.77 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.299 -1.741 . . . . 45.130000000000003 106.299 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.86 146.38 49.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 123.355 0.409 . . . . 72.510000000000005 110.125 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.36 -108.13 0.74 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 109.16 -1.576 . . . . 75.230000000000004 109.16 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -72.08 -43.36 64.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.301 -1.74 . . . . 71.310000000000002 106.301 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -73.16 133.88 44.23 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 113.815 -1.539 . . . . 53.32 108.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 37.2 ttt180 -111.27 143.24 42.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.551 0.945 . . . . 71.430000000000007 113.551 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 48.66 -149.75 3.94 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 125.952 1.739 . . . . 74.120000000000005 117.444 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -128.11 80.72 0.36 Allowed Glycine 0 N--CA 1.405 -3.431 0 N-CA-C 109.232 -1.547 . . . . 53.43 109.232 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 146.14 -21.14 1.75 Allowed Glycine 0 C--N 1.292 -1.892 0 C-N-CA 121.054 -0.593 . . . . 74.439999999999998 111.991 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 10.3 mm-40 -77.84 -67.57 0.71 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.315 0.578 . . . . 65.540000000000006 109.908 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -108.28 -43.37 4.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.772 0.796 . . . . 52.450000000000003 109.763 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -136.79 170.73 15.6 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.276 -1.379 . . . . 64.299999999999997 107.276 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.492 ' HG3' ' HE ' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -99.67 128.94 45.76 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.362 -1.718 . . . . 73.230000000000004 106.362 176.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.6 111.37 1.8 Allowed 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 123.802 0.841 . . . . 75.430000000000007 110.815 -173.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 104.7 14.48 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-O 122.075 0.941 . . . . 71.530000000000001 110.946 -174.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.5 p -139.48 129.6 25.17 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.862 -1.063 . . . . 72.040000000000006 108.562 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.24 -168.38 41.12 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.264 -1.134 . . . . 74.120000000000005 110.264 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.522 ' HB2' ' CG2' ' A' ' 536' ' ' ILE . 9.8 pt-20 -131.3 129.26 41.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.306 0.574 . . . . 72.430000000000007 110.904 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.441 HD22 ' CG ' ' A' ' 569' ' ' LYS . 85.5 mt -90.37 143.91 26.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.994 -1.003 . . . . 53.329999999999998 111.436 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.89 117.16 34.41 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.128 -0.629 . . . . 72.040000000000006 110.439 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -111.29 157.72 19.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.625 -1.25 . . . . 52.130000000000003 107.625 172.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -121.08 -87.8 0.63 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.901 -1.148 . . . . 71.420000000000002 107.901 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -104.47 162.43 13.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.826 -1.175 . . . . 74.230000000000004 107.826 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.549 ' HB3' ' N ' ' A' ' 531' ' ' ALA . 4.2 p30 -64.06 -15.41 59.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 113.718 1.007 . . . . 53.32 113.718 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.32 -19.42 63.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.736 0.303 . . . . 72.209999999999994 111.726 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 40.3 pt -107.18 163.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.82 154.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 108.153 -1.054 . . . . 62.109999999999999 108.153 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.441 ' CG ' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -119.19 162.53 18.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 104.884 -2.265 . . . . 72.519999999999996 104.884 175.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 76.6 mt -131.6 137.64 54.76 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.535 0 N-CA-C 107.954 -1.128 . . . . 71.230000000000004 107.954 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 48.7 mt -93.27 122.07 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.125 -1.805 . . . . 72.219999999999999 106.125 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 44.5 p -105.56 112.71 25.9 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.789 -0.448 . . . . 62.43 109.789 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.459 HD11 HD22 ' A' ' 589' ' ' LEU . 59.7 mt -110.85 122.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.563 -0.532 . . . . 72.140000000000001 109.563 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.492 ' HE ' ' HG3' ' A' ' 554' ' ' GLU . 23.3 mtm-85 -72.89 115.89 12.73 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.868 0.73 . . . . 73.140000000000001 110.774 174.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.0 mm -96.06 127.88 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.25 -0.886 . . . . 63.100000000000001 109.077 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 108.797 -0.816 . . . . 73.420000000000002 108.797 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.49 ' HB2' HG12 ' A' ' 645' ' ' ILE . 84.0 m . . . . . 0 N--CA 1.429 -1.506 0 CA-C-O 120.879 0.371 . . . . 55.32 111.242 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 12.9 m -119.95 130.94 55.02 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.852 -0.425 . . . . 74.540000000000006 109.852 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 52.1 p90 -129.57 -179.45 5.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.375 -1.342 . . . . 75.129999999999995 107.375 171.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 8.6 t -131.72 168.16 18.24 Favored 'General case' 0 N--CA 1.409 -2.507 0 C-N-CA 119.07 -1.052 . . . . 73.299999999999997 109.926 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 573' ' ' ILE . 51.5 tp -140.57 123.25 16.23 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 105.688 -1.967 . . . . 51.439999999999998 105.688 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.46 157.06 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 116.423 -0.353 . . . . 75.099999999999994 110.185 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.669 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 64.9 mt -107.79 151.66 25.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.211 -1.033 . . . . 60.25 108.211 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -115.17 178.06 4.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.206 0.316 . . . . 72.430000000000007 110.237 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -59.34 119.17 36.88 Favored Pre-proline 0 C--O 1.245 0.856 0 O-C-N 124.161 0.913 . . . . 65.439999999999998 111.7 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.488 ' HD3' HD22 ' A' ' 635' ' ' LEU . 55.6 Cg_endo -71.11 157.41 57.68 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 122.883 2.388 . . . . 74.340000000000003 112.032 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -124.42 138.1 54.39 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.385 -0.825 . . . . 71.400000000000006 110.328 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -95.32 123.38 38.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.536 -1.283 . . . . 73.109999999999999 107.536 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 44.2 mm . . . . . 0 C--N 1.292 -1.906 0 N-CA-C 108.202 -1.036 . . . . 74.209999999999994 108.202 179.306 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 50.9 pt . . . . . 0 N--CA 1.415 -2.2 0 N-CA-C 107.361 -1.348 . . . . 74.230000000000004 107.361 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 635' ' ' LEU . 2.2 pt? -87.41 -170.18 2.92 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 115.584 -0.734 . . . . 73.349999999999994 111.618 -171.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -61.85 144.36 48.95 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.632 -0.987 . . . . 34.030000000000001 110.632 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.08 -51.88 67.52 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.168 0.508 . . . . 75.239999999999995 110.127 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -123.25 104.35 9.09 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.368 0.604 . . . . 75.120000000000005 109.835 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.0 t -133.22 116.53 16.32 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.627 -0.879 . . . . 71.25 108.627 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -145.39 142.0 28.95 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.453 -0.943 . . . . 73.439999999999998 108.453 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.8 tp -121.84 110.45 15.9 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.932 -0.766 . . . . 64.530000000000001 108.932 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.562 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.5 mt-10 -88.28 112.42 22.79 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.043 -1.095 . . . . 75.209999999999994 108.043 174.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.41 120.67 51.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.976 -1.011 . . . . 75.140000000000001 108.838 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 23.5 mt -119.06 114.45 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-N 114.878 -1.055 . . . . 75.129999999999995 111.159 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.523 ' H ' HD13 ' A' ' 645' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 N-CA-C 107.423 -1.325 . . . . 71.519999999999996 107.423 175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.375 0 N-CA-C 112.906 -0.078 . . . . 43.240000000000002 112.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.1 mt -127.15 114.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.126 -2.176 . . . . 73.239999999999995 105.126 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.533 ' CE1' ' HD2' ' A' ' 527' ' ' ARG . 97.6 m-85 -113.84 128.94 56.61 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.91 -0.316 . . . . 74.510000000000005 110.309 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.44 148.97 30.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.969 -0.56 . . . . 64.049999999999997 110.11 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -67.31 154.08 42.15 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 110.323 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.16 -55.4 35.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.096 -0.705 . . . . 74.439999999999998 109.096 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -127.48 157.38 73.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.914 -1.039 . . . . 72.319999999999993 108.899 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -88.99 -13.76 2.99 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.403 2.069 . . . . 72.230000000000004 113.002 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 642' ' ' GLU . 91.4 t -143.45 133.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.66 -0.496 . . . . 40.200000000000003 109.66 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.3 t -134.51 133.23 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.64 -0.504 . . . . 64.319999999999993 109.64 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -108.85 112.1 24.16 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.301 -1.0 . . . . 64.129999999999995 108.301 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 645' ' ' ILE . 24.1 m -121.26 162.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.146 0.498 . . . . 54.310000000000002 110.919 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 518' ' ' ILE . 37.0 m -77.19 149.63 35.53 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.198 -0.455 . . . . 63.520000000000003 112.009 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.03 -27.58 69.21 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.332 0.587 . . . . 64.129999999999995 110.228 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.3 m -110.59 28.63 8.49 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.762 -0.654 . . . . 73.120000000000005 111.143 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 515' ' ' SER . 10.0 tt -76.89 -28.33 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.101 0.477 . . . . 63.350000000000001 111.417 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.43 -77.8 0.84 Allowed Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.081 -0.808 . . . . 75.409999999999997 111.081 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.2 mm -130.14 146.22 34.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.691 -1.226 . . . . 54.009999999999998 107.691 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.0 ppp? -119.6 153.64 35.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.968 -1.493 . . . . 73.140000000000001 106.968 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -128.13 126.57 41.36 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.068 0.23 . . . . 74.230000000000004 111.153 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.468 HG21 HD21 ' A' ' 641' ' ' LEU . 55.5 t -134.37 131.35 54.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.223 -0.658 . . . . 64.010000000000005 109.223 174.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.42 ' HG2' HG12 ' A' ' 570' ' ' ILE . 55.2 mttp -90.76 151.07 21.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.142 0.496 . . . . 62.539999999999999 110.171 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.0 t -103.95 113.45 40.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 105.964 -1.865 . . . . 64.400000000000006 105.964 172.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.09 134.84 34.46 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.118 -0.492 . . . . 64.439999999999998 110.189 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.685 ' HD3' ' HB2' ' A' ' 531' ' ' ALA . 73.3 ttt180 -106.87 102.61 11.96 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.988 -1.115 . . . . 71.010000000000005 107.988 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.0 m -65.82 -47.7 74.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.588 -1.187 . . . . 71.349999999999994 113.901 -171.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.6 p -69.01 -51.35 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.357 0.873 . . . . 62.119999999999997 113.357 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 155.48 172.83 23.48 Favored Glycine 0 CA--C 1.48 -2.156 0 N-CA-C 108.644 -1.782 . . . . 43.340000000000003 108.644 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.685 ' HB2' ' HD3' ' A' ' 527' ' ' ARG . . . -150.03 121.56 7.98 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 117.658 0.729 . . . . 65.400000000000006 112.552 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.501 ' HD3' ' C ' ' A' ' 532' ' ' ARG . 0.8 OUTLIER -156.71 110.82 2.72 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.633 -0.877 . . . . 74.109999999999999 108.633 171.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 149.19 -142.82 10.18 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 109.614 -1.394 . . . . 75.040000000000006 109.614 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -137.43 112.76 9.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.319 -1.363 . . . . 62.200000000000003 107.319 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.95 132.15 65.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 120.676 -0.41 . . . . 61.5 111.415 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.64 116.82 47.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.716 -0.674 . . . . 72.450000000000003 109.291 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.44 111.1 65.13 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.816 -0.809 . . . . 75.230000000000004 108.816 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 594' ' ' PRO . 10.2 Cg_endo -84.6 149.02 11.32 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.945 1.764 . . . . 71.310000000000002 111.082 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -138.21 159.24 42.56 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.159 -1.052 . . . . 75.400000000000006 108.159 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 589' ' ' LEU . 57.2 pttt -151.59 137.5 18.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.452 . . . . 74.400000000000006 110.021 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -84.2 143.12 29.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.881 -0.6 . . . . 70.450000000000003 111.124 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 48.5 mm -102.37 115.72 44.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.336 -1.728 . . . . 74.319999999999993 106.336 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -73.55 109.88 7.41 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.627 0.58 . . . . 74.129999999999995 111.513 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -135.34 126.17 3.91 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.363 -1.095 . . . . 55.539999999999999 110.363 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.3 m 69.06 -49.34 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.268 2.227 . . . . 73.010000000000005 112.459 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -90.16 150.14 22.14 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.431 -0.952 . . . . 63.409999999999997 108.431 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 40.9 ttp180 -93.14 135.49 34.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.956 0.408 . . . . 71.120000000000005 110.597 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.56 -161.15 35.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.542 -0.754 . . . . 62.409999999999997 111.355 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 85.97 18.56 59.34 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.043 -1.223 . . . . 74.450000000000003 110.043 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.76 27.79 60.22 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.029 -0.829 . . . . 72.239999999999995 111.029 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 10.1 tp10 -87.67 -87.26 0.15 Allowed 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 122.849 0.459 . . . . 61.210000000000001 110.611 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.03 -30.34 17.81 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.065 0.936 . . . . 72.540000000000006 109.208 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.92 148.74 40.9 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 106.704 -1.591 . . . . 71.319999999999993 106.704 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.455 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 0.6 OUTLIER -86.28 105.83 16.92 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 105.988 -1.856 . . . . 71.5 105.988 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.94 91.14 1.18 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.763 1.268 . . . . 74.219999999999999 109.718 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.9 t -83.33 132.77 34.99 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 113.334 -1.757 . . . . 74.450000000000003 112.252 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.0 p -139.46 119.8 13.85 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.447 -2.057 . . . . 74.430000000000007 105.447 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.89 -179.75 27.8 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 119.473 -1.346 . . . . 72.030000000000001 113.048 -173.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -105.17 111.45 24.2 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 123.977 0.911 . . . . 65.439999999999998 108.703 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.99 126.86 43.6 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.57 -0.852 . . . . 71.400000000000006 109.42 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.93 98.58 8.4 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 121.468 0.651 . . . . 72.0 111.72 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 53.1 m-85 -94.37 101.78 13.73 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.591 -0.892 . . . . 73.519999999999996 108.591 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.518 ' H ' HD11 ' A' ' 567' ' ' ILE . 75.4 mt-30 -86.55 -79.59 0.26 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.73 -0.668 . . . . 51.420000000000002 109.735 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -104.63 163.48 12.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.719 -0.673 . . . . 53.130000000000003 109.701 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 531' ' ' ALA . 17.9 t70 -65.37 -21.24 66.66 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.658 1.183 . . . . 74.299999999999997 112.269 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.69 -16.65 63.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.864 0.69 . . . . 73.239999999999995 112.864 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.518 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.7 pt -112.63 160.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.539 -0.464 . . . . 72.120000000000005 110.767 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.47 144.9 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.315 -1.365 . . . . 62.439999999999998 107.315 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 73.0 mmtt -102.51 149.82 24.01 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.045 0.45 . . . . 75.200000000000003 110.756 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.42 HG12 ' HG2' ' A' ' 524' ' ' LYS . 66.2 mt -123.01 128.62 75.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.421 -1.263 . . . . 63.219999999999999 108.807 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.433 HD13 HD21 ' A' ' 589' ' ' LEU . 62.5 mt -90.76 121.72 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 107.529 -1.286 . . . . 72.5 107.529 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 521' ' ' MET . 40.1 p -110.23 113.28 25.83 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.801 -0.636 . . . . 52.119999999999997 109.411 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 589' ' ' LEU . 61.0 mt -103.97 122.5 56.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.061 -1.089 . . . . 71.299999999999997 108.061 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.455 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 80.3 mtt85 -75.76 115.92 15.94 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.868 0.73 . . . . 61.25 109.522 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.05 139.56 19.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.212 -1.403 . . . . 73.019999999999996 107.212 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 C--N 1.297 -1.711 0 CA-C-O 121.194 0.521 . . . . 74.540000000000006 110.166 -178.216 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.469 ' HB2' HG12 ' A' ' 645' ' ' ILE . 59.2 m . . . . . 0 N--CA 1.425 -1.678 0 N-CA-C 108.973 -0.751 . . . . 65.420000000000002 108.973 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 27.4 p -139.43 113.53 8.81 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.492 0.663 . . . . 71.25 111.229 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.3 p90 -109.81 -178.43 3.53 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.169 -1.049 . . . . 70.150000000000006 108.169 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 19.7 m -135.01 167.52 20.79 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.989 -0.684 . . . . 61.219999999999999 110.447 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 573' ' ' ILE . 51.7 tp -137.97 132.49 32.4 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.55 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.663 -0.495 . . . . 71.219999999999999 109.663 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.39 145.31 29.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.7 -0.682 . . . . 73.299999999999997 109.304 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.71 174.19 6.07 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.679 -0.86 . . . . 61.32 108.679 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -66.03 116.8 36.3 Favored Pre-proline 0 C--O 1.246 0.888 0 CA-C-O 121.106 0.479 . . . . 44.43 111.766 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 538' ' ' PRO . 44.4 Cg_endo -71.28 147.56 53.52 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.422 2.081 . . . . 71.129999999999995 111.573 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -113.12 140.27 48.03 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 109.402 -0.592 . . . . 64.239999999999995 109.402 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -92.42 127.57 37.96 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.148 -1.797 . . . . 75.430000000000007 106.148 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 34.6 mm . . . . . 0 C--N 1.287 -2.149 0 N-CA-C 108.692 -0.855 . . . . 75.150000000000006 108.692 -178.811 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.015 0 CA-C-O 121.014 0.435 . . . . 63.210000000000001 111.001 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.27 -174.38 4.15 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.903 -0.777 . . . . 73.030000000000001 108.903 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -81.69 -152.8 10.09 Favored Glycine 0 C--N 1.306 -1.106 0 C-N-CA 120.452 -0.88 . . . . 71.420000000000002 112.272 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -64.85 -42.0 95.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.85 0.833 . . . . 74.409999999999997 109.232 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -167.41 145.34 4.7 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 125.583 1.553 . . . . 73.040000000000006 107.068 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.1 t -153.29 116.53 4.61 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.824 0.821 . . . . 63.420000000000002 110.446 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -146.19 142.93 28.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.714 -1.217 . . . . 73.310000000000002 107.714 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 523' ' ' VAL . 45.5 tp -121.97 113.01 18.99 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.743 -0.836 . . . . 74.319999999999993 108.743 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.433 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.1 mt-10 -92.35 122.86 35.22 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.816 -1.179 . . . . 73.010000000000005 107.816 176.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.12 117.53 55.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 109.243 -0.651 . . . . 63.439999999999998 109.243 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.04 123.42 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.717 0 N-CA-C 108.059 -1.089 . . . . 73.519999999999996 108.059 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.852 0 CA-C-O 121.501 0.667 . . . . 63.119999999999997 110.399 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.341 0 N-CA-C 111.128 -0.789 . . . . 53.039999999999999 111.128 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -79.27 112.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.28 -1.378 . . . . 71.439999999999998 107.28 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 94.9 m-85 -96.3 134.94 38.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.394 0.434 . . . . 71.540000000000006 110.385 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.4 t -149.2 158.24 44.02 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 124.06 0.85 . . . . 61.130000000000003 108.948 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.5 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 64.4 m-85 -79.85 169.39 17.98 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.374 -0.602 . . . . 71.129999999999995 109.374 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 526' ' ' LEU . 48.1 mt-10 -74.69 -41.71 59.74 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.43 0.633 . . . . 73.530000000000001 109.643 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.67 161.52 61.33 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.286 -0.87 . . . . 73.140000000000001 108.934 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.03 -12.18 7.2 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.926 1.751 . . . . 75.140000000000001 112.079 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 642' ' ' GLU . 72.3 t -142.43 138.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.033 -0.729 . . . . 52.520000000000003 109.033 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.2 t -133.7 136.56 44.76 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.121 -0.696 . . . . 74.439999999999998 109.121 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -107.33 114.45 28.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.058 -0.519 . . . . 62.43 110.193 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 27.5 m -129.16 166.0 27.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.051 -0.522 . . . . 72.209999999999994 109.872 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.3 t -85.99 162.76 18.35 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.933 0.397 . . . . 71.140000000000001 110.4 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -80.95 -19.87 43.25 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.955 -1.498 . . . . 74.310000000000002 106.955 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.1 m -107.14 25.83 10.9 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.03 -0.986 . . . . 43.520000000000003 111.296 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 515' ' ' SER . 7.7 tt -87.18 -21.38 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 121.433 0.635 . . . . 73.019999999999996 111.419 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.93 -74.58 1.85 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.491 -0.862 . . . . 74.109999999999999 112.221 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.0 mm -134.97 147.12 29.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.647 -1.612 . . . . 74.140000000000001 106.647 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.2 ppp? -123.29 145.47 48.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.678 -1.23 . . . . 71.329999999999998 107.678 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -111.97 129.01 56.33 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 123.57 0.544 . . . . 62.310000000000002 111.631 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.4 t -122.07 103.95 14.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.415 -0.357 . . . . 55.409999999999997 110.227 174.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.513 ' HB3' HG12 ' A' ' 570' ' ' ILE . 17.9 ptpt -86.69 129.0 35.04 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.613 -0.884 . . . . 71.219999999999999 108.613 172.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.04 133.54 30.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.623 -0.51 . . . . 71.400000000000006 109.623 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 74.6 mt -96.89 149.23 22.11 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.946 -0.57 . . . . 63.43 110.574 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 504' ' ' ILE 0.285 0.0 OUTLIER -130.69 109.21 10.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.655 0.741 . . . . 72.510000000000005 111.397 171.918 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 14.3 m -65.04 -44.9 87.58 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.35 -1.296 . . . . 75.209999999999994 113.277 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 p -72.96 -39.73 65.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.016 0.436 . . . . 51.350000000000001 112.153 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.78 -167.0 26.83 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.685 -1.366 . . . . 73.299999999999997 109.685 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 527' ' ' ARG . . . -162.63 116.31 1.72 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.441 -0.577 . . . . 55.539999999999999 109.441 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -154.95 106.8 2.68 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.634 -1.247 . . . . 61.229999999999997 107.634 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 146.25 -140.5 8.86 Favored Glycine 0 C--N 1.298 -1.538 0 N-CA-C 110.753 -0.939 . . . . 74.409999999999997 110.753 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -136.91 101.03 4.46 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.359 -1.719 . . . . 65.400000000000006 106.359 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.48 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.254 0.55 . . . . 73.430000000000007 110.355 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 559' ' ' GLU . 45.0 mm -102.0 123.77 55.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.886 -0.783 . . . . 64.129999999999995 108.886 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.43 108.83 60.16 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.715 -0.846 . . . . 72.310000000000002 108.715 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -78.16 146.61 22.77 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 73.420000000000002 111.789 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.56 162.4 35.45 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.565 -1.272 . . . . 54.130000000000003 107.565 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -162.1 145.91 12.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.228 0.537 . . . . 74.450000000000003 111.845 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.6 p -85.82 133.84 33.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.936 -1.029 . . . . 63.219999999999999 111.078 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 43.9 mm -100.55 114.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.988 -1.486 . . . . 72.099999999999994 106.988 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.44 126.5 32.81 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.804 -0.443 . . . . 64.319999999999993 109.804 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -128.68 -94.58 0.79 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.658 -0.782 . . . . 64.010000000000005 111.661 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 18.4 p -92.12 17.61 9.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.379 1.085 . . . . 64.430000000000007 110.554 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -146.92 134.7 21.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.888 -1.523 . . . . 24.030000000000001 106.888 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.52 132.83 46.94 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 109.081 -0.711 . . . . 65.420000000000002 109.081 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -97.69 138.41 13.87 Favored Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 115.836 -0.62 . . . . 72.239999999999995 111.97 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 129.25 11.07 2.87 Favored Glycine 0 C--N 1.294 -1.752 0 C-N-CA 120.894 -0.669 . . . . 54.140000000000001 111.93 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 133.49 -17.42 4.48 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.517 -1.325 . . . . 61.119999999999997 113.671 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.86 -79.48 0.12 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.111 -0.636 . . . . 62.32 111.407 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.06 -42.75 9.78 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.974 -1.121 . . . . 71.129999999999995 107.974 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -144.53 174.07 11.26 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.149 -0.932 . . . . 70.040000000000006 109.119 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -103.42 120.56 41.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.231 -2.137 . . . . 64.120000000000005 105.231 177.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.63 139.22 45.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.55 -0.46 . . . . 74.109999999999999 110.353 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -138.54 128.67 25.59 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.813 0.816 . . . . 50.409999999999997 111.33 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.3 p -145.35 133.37 21.41 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.485 -1.302 . . . . 53.210000000000001 107.485 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.25 -165.19 31.59 Favored Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.016 -1.564 . . . . 54.310000000000002 112.718 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.401 ' HB3' HG23 ' A' ' 536' ' ' ILE . 49.8 mt-10 -109.85 116.06 30.97 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.436 0.694 . . . . 61.5 111.13 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.47 138.08 32.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.546 -0.909 . . . . 73.349999999999994 108.546 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -104.8 102.93 12.47 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.626 0.727 . . . . 74.140000000000001 111.976 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.4 m-85 -101.49 99.98 10.37 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.231 -1.025 . . . . 70.450000000000003 108.231 174.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.24 -82.59 0.13 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.933 -0.707 . . . . 61.539999999999999 110.813 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -104.83 177.16 4.93 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.765 0.793 . . . . 54.539999999999999 112.127 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.457 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 23.9 t70 -75.33 -16.21 60.43 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.728 -1.123 . . . . 72.109999999999999 112.049 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.38 -19.62 63.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.082 0.771 . . . . 70.239999999999995 113.082 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 45.0 pt -113.14 168.93 5.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.715 -1.217 . . . . 73.450000000000003 107.715 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.32 143.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.444 -0.947 . . . . 63.340000000000003 108.444 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 71.4 mmtt -98.89 142.53 30.29 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-O 121.253 0.549 . . . . 74.200000000000003 110.73 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 524' ' ' LYS . 14.7 mt -129.25 130.41 67.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.222 -1.354 . . . . 65.329999999999998 109.729 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 44.9 mt -90.23 126.7 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.155 -1.424 . . . . 61.539999999999999 107.155 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 20.9 p -112.71 113.5 25.65 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.287 -0.634 . . . . 55.200000000000003 109.287 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.43 HD11 HD22 ' A' ' 589' ' ' LEU . 71.6 mt -104.1 126.06 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 N-CA-C 108.728 -0.841 . . . . 63.420000000000002 108.728 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.5 OUTLIER -79.27 108.2 12.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.554 -1.276 . . . . 71.430000000000007 107.554 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.78 127.99 46.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.061 -1.829 . . . . 74.109999999999999 106.061 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 96.3 m-85 . . . . . 0 C--N 1.286 -2.162 0 C-N-CA 119.766 -0.774 . . . . 74.430000000000007 110.731 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.475 ' HB2' HG12 ' A' ' 645' ' ' ILE . 75.2 m . . . . . 0 N--CA 1.428 -1.555 0 CA-C-O 121.171 0.51 . . . . 72.109999999999999 109.709 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.2 m -147.05 138.28 23.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.454 -0.573 . . . . 54.43 109.454 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.1 p90 -137.13 163.63 30.37 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.312 -0.995 . . . . 75.209999999999994 108.312 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.6 m -112.94 161.37 17.08 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 119.842 -0.743 . . . . 72.319999999999993 109.828 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 573' ' ' ILE . 70.0 tp -132.71 126.32 32.26 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.458 -1.682 . . . . 71.140000000000001 106.458 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.22 158.14 28.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 120.861 0.362 . . . . 75.230000000000004 110.739 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.5 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 80.0 mt -106.41 148.04 28.59 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.914 -1.143 . . . . 65.109999999999999 107.914 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.08 177.31 4.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.772 -0.455 . . . . 52.140000000000001 109.772 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.23 122.49 73.21 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 113.077 0.769 . . . . 74.239999999999995 113.077 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.566 ' HD3' HD22 ' A' ' 635' ' ' LEU . 75.2 Cg_endo -75.17 145.85 31.36 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.888 2.392 . . . . 71.209999999999994 111.868 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -116.53 140.62 49.17 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 115.704 -0.68 . . . . 71.549999999999997 109.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -104.98 124.21 49.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.252 -1.018 . . . . 74.340000000000003 108.252 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.291 -1.968 0 N-CA-C 107.604 -1.258 . . . . 64.209999999999994 107.604 177.568 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.953 -0.388 . . . . 71.109999999999999 109.953 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.566 HD22 ' HD3' ' A' ' 594' ' ' PRO . 2.5 pt? -112.0 -163.13 0.83 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.62 -1.252 . . . . 75.140000000000001 107.62 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.33 143.48 47.26 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.646 -1.382 . . . . 74.239999999999995 109.646 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.92 -39.49 72.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.722 -0.391 . . . . 75.200000000000003 111.558 -173.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -124.55 107.79 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.347 -0.541 . . . . 64.530000000000001 110.497 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 115.42 5.18 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.742 0.782 . . . . 74.439999999999998 109.397 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -147.9 127.9 13.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.664 -0.865 . . . . 74.329999999999998 108.664 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.93 112.34 25.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.645 -0.502 . . . . 64.230000000000004 109.645 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.463 ' HB2' HG22 ' A' ' 511' ' ' VAL . 45.0 mt-10 -89.76 113.45 24.98 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.605 0.717 . . . . 63.399999999999999 109.438 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 36.7 t -100.43 115.53 41.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.387 -1.279 . . . . 64.230000000000004 108.439 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 21.2 mt -112.32 126.78 69.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 CA-C-N 114.823 -1.081 . . . . 54.43 109.169 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 514' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.221 0 CA-C-N 115.818 -0.628 . . . . 73.120000000000005 112.582 -176.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.658 ' N ' ' HG ' ' A' ' 529' ' ' SER . . . . . . . . 0 N--CA 1.444 -0.83 0 N-CA-C 109.18 -1.568 . . . . 60.229999999999997 109.18 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.586 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.2 mt -127.97 124.26 62.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.609 -0.515 . . . . 74.230000000000004 109.609 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.51 137.3 43.57 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.669 0.606 . . . . 71.019999999999996 110.601 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -149.18 156.28 41.93 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.248 -0.278 . . . . 72.25 110.248 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.47 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 61.4 m-85 -77.2 168.76 19.52 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.213 -1.032 . . . . 71.040000000000006 108.213 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.49 -46.94 36.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.662 0.744 . . . . 73.230000000000004 109.005 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -122.91 164.6 26.14 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 114.838 -1.074 . . . . 73.129999999999995 109.847 -174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -90.47 -19.53 1.09 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.613 2.209 . . . . 70.150000000000006 112.011 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.2 132.75 38.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.363 -0.977 . . . . 71.329999999999998 108.363 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . 0.452 HG22 HD22 ' A' ' 641' ' ' LEU . 10.0 t -131.22 127.31 37.62 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.995 -0.743 . . . . 63.119999999999997 108.995 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -99.88 125.11 45.8 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.492 -0.929 . . . . 75.239999999999995 108.492 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 645' ' ' ILE . 19.8 m -134.59 162.31 39.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.408 0.623 . . . . 64.230000000000004 109.713 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.407 ' O ' HG22 ' A' ' 518' ' ' ILE . 39.3 m -80.9 157.34 25.65 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.71 -0.677 . . . . 64.049999999999997 110.284 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -77.62 -23.66 49.74 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.556 -1.276 . . . . 55.25 107.556 172.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.0 p -95.73 18.95 12.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.035 -1.439 . . . . 70.409999999999997 111.45 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 515' ' ' SER . 9.0 tt -81.77 -31.73 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.941 -0.704 . . . . 72.25 111.274 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.09 -75.27 1.59 Allowed Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.413 -0.898 . . . . 72.530000000000001 111.139 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 574' ' ' ARG . 44.2 mm -126.65 125.67 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.377 -0.972 . . . . 62.219999999999999 108.377 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -97.36 147.22 24.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.357 -0.979 . . . . 64.430000000000007 108.357 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -118.15 115.49 24.91 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.282 0.633 . . . . 60.030000000000001 112.238 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 36.8 t -109.92 124.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.182 -0.463 . . . . 63.020000000000003 110.56 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.33 127.99 41.83 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.795 -0.817 . . . . 72.0 108.795 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.56 118.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 75.019999999999996 109.032 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.7 mt -93.46 148.34 22.16 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.312 -0.858 . . . . 74.219999999999999 109.514 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 102.92 12.28 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.029 -2.582 . . . . 74.319999999999993 104.029 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 10.4 t -66.86 -46.64 74.4 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.844 -0.742 . . . . 71.109999999999999 110.583 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . 0.658 ' HG ' ' N ' ' A' ' 503' ' ' GLY . 30.1 t -74.4 -45.28 47.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.2 0.524 . . . . 71.0 110.095 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.57 -168.83 23.72 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 109.802 -1.319 . . . . 63.32 109.802 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -156.08 137.68 14.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.652 -0.87 . . . . 31.120000000000001 108.652 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -155.81 103.85 2.28 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.952 . . . . 63.43 108.431 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 137.76 -131.08 5.32 Favored Glycine 0 C--N 1.308 -0.991 0 N-CA-C 110.826 -0.909 . . . . 73.409999999999997 110.826 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -136.98 102.5 4.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.337 -1.357 . . . . 54.140000000000001 107.337 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 26.5 t -121.56 122.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.885 -0.726 . . . . 72.030000000000001 111.421 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.429 HG12 HD13 ' A' ' 597' ' ' ILE . 38.7 mm -88.17 120.98 37.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.483 -1.302 . . . . 70.420000000000002 107.483 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.4 t -110.42 104.77 56.42 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.062 -0.718 . . . . 64.319999999999993 109.062 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.497 ' HG2' ' HB3' ' A' ' 592' ' ' GLU . 14.8 Cg_endo -85.16 163.28 11.47 Favored 'Trans proline' 0 N--CA 1.419 -2.89 0 C-N-CA 121.475 1.45 . . . . 74.420000000000002 111.375 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.436 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.6 p90 -149.91 164.29 35.81 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.046 -1.835 . . . . 73.340000000000003 106.046 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.15 133.01 16.03 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.22 -0.592 . . . . 74.430000000000007 111.089 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 555' ' ' ASP . 17.7 p -82.35 121.15 26.33 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.843 -1.071 . . . . 71.329999999999998 109.719 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.72 116.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.289 -1.374 . . . . 71.329999999999998 107.289 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -72.47 110.05 6.59 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.704 0.628 . . . . 61.439999999999998 110.129 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -98.54 -107.68 2.71 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.809 -0.917 . . . . 43.049999999999997 110.809 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.1 p -85.04 -20.59 30.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.571 0.701 . . . . 73.319999999999993 109.901 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.26 134.3 35.6 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.893 -1.151 . . . . 72.219999999999999 107.893 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -92.26 138.42 31.54 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 120.832 0.349 . . . . 73.200000000000003 111.7 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.1 -158.58 20.51 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 111.147 -0.781 . . . . 61.310000000000002 111.147 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.91 17.14 79.29 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.198 -0.761 . . . . 75.519999999999996 111.198 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.16 32.76 60.01 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 111.372 -0.691 . . . . 60.210000000000001 111.372 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.28 -71.23 0.64 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.804 -0.813 . . . . 74.230000000000004 108.804 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.53 -31.01 13.53 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.556 -1.275 . . . . 73.099999999999994 107.556 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.97 150.08 33.35 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 115.276 -0.875 . . . . 72.299999999999997 109.045 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.4 tm-20 -87.14 105.63 17.32 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 105.929 -1.878 . . . . 74.329999999999998 105.929 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.447 ' HB2' ' OG1' ' A' ' 541' ' ' THR . 7.5 p-10 -76.65 135.29 39.13 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.84 0.828 . . . . 70.230000000000004 111.321 -173.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 3.2 t -133.53 148.98 51.69 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.026 -0.988 . . . . 71.209999999999994 110.548 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.9 p -148.33 111.29 4.84 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.136 0.574 . . . . 74.129999999999995 110.925 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 101.51 -164.02 17.76 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.95 -0.643 . . . . 64.310000000000002 112.28 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 84.51 10.51 0.38 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.513 1.525 . . . . 73.030000000000001 114.024 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 569' ' ' LYS . 32.0 mt -106.4 133.43 51.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 118.977 -1.089 . . . . 71.129999999999995 111.061 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -132.1 114.97 15.17 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.919 -0.771 . . . . 72.310000000000002 108.919 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.3 m-85 -111.09 105.94 14.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.321 -0.992 . . . . 72.340000000000003 108.321 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.432 ' H ' HD11 ' A' ' 567' ' ' ILE . 49.2 mt-30 -83.89 -69.15 0.66 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.322 -0.992 . . . . 64.0 108.322 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -105.2 160.93 14.7 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.4 -0.818 . . . . 75.530000000000001 109.228 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.38 -22.63 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.077 0.465 . . . . 70.239999999999995 111.959 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.86 -6.94 9.36 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.987 1.106 . . . . 73.340000000000003 113.987 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.432 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -115.21 162.61 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.896 -0.779 . . . . 73.340000000000003 108.896 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.7 p -131.18 150.71 34.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.688 -1.227 . . . . 65.150000000000006 107.688 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -120.61 155.94 32.7 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.905 -0.405 . . . . 75.129999999999995 109.905 174.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.9 mt -125.34 135.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 124.275 0.984 . . . . 74.25 109.641 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.3 mt -92.32 120.92 42.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.491 -1.67 . . . . 74.420000000000002 106.491 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 31.2 p -110.52 112.79 24.94 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.615 0.572 . . . . 73.239999999999995 109.718 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 589' ' ' LEU . 70.4 mt -112.48 128.43 69.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.897 -0.779 . . . . 65.140000000000001 108.897 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.422 ' HA ' HD13 ' A' ' 520' ' ' ILE . 35.3 ttm180 -85.07 126.94 34.0 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.588 0.555 . . . . 72.209999999999994 109.526 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.2 142.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.039 -1.097 . . . . 53.32 108.039 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 76.3 m-85 . . . . . 0 C--N 1.306 -1.297 0 CA-C-O 121.196 0.522 . . . . 71.040000000000006 109.787 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.429 -1.52 0 N-CA-C 109.617 -0.512 . . . . 53.420000000000002 109.617 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 35.2 p -138.34 153.58 48.97 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.289 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.92 161.34 37.82 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.661 -1.237 . . . . 70.409999999999997 107.661 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.0 m -110.81 158.6 18.5 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 119.541 -0.863 . . . . 65.319999999999993 109.511 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 573' ' ' ILE . 47.0 tp -134.78 121.69 21.07 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.798 -1.186 . . . . 73.450000000000003 107.798 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.73 155.87 26.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 109.584 -0.524 . . . . 71.239999999999995 109.584 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.47 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 82.9 mt -90.96 146.63 23.72 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.137 -1.06 . . . . 71.430000000000007 108.137 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . 0.497 ' HB3' ' HG2' ' A' ' 538' ' ' PRO . 4.7 tp10 -107.12 175.86 5.36 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.78 -1.563 . . . . 71.140000000000001 106.78 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 0.0 OUTLIER -60.82 115.36 13.53 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 113.824 1.046 . . . . 61.240000000000002 113.824 -177.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.424 ' HB2' ' CG1' ' A' ' 535' ' ' VAL . 42.4 Cg_endo -73.82 141.03 29.82 Favored 'Trans proline' 0 N--CA 1.418 -2.949 0 C-N-CA 121.648 1.566 . . . . 72.109999999999999 110.623 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 129.49 56.39 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.857 -0.611 . . . . 74.319999999999993 110.702 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -92.37 117.36 29.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 64.200000000000003 108.18 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . 0.429 HD13 HG12 ' A' ' 536' ' ' ILE . 2.5 mp . . . . . 0 C--N 1.281 -2.392 0 N-CA-C 106.949 -1.5 . . . . 62.240000000000002 106.949 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 33.8 pt . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 121.207 0.527 . . . . 63.049999999999997 111.125 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -101.15 175.13 5.7 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.093 -1.077 . . . . 73.049999999999997 108.093 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.45 179.44 29.43 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 121.009 -0.615 . . . . 65.349999999999994 112.478 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 638' ' ' HIS . 12.3 tp10 -52.5 -60.91 2.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.74 -0.837 . . . . 73.0 108.74 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 637' ' ' GLU . 37.2 m80 -136.46 114.71 11.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.895 -1.52 . . . . 65.109999999999999 106.895 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.7 t -134.19 109.25 8.76 Favored 'General case' 0 N--CA 1.41 -2.433 0 C-N-CA 119.178 -1.009 . . . . 64.310000000000002 109.979 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -149.35 137.63 20.74 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.45 -1.25 . . . . 74.120000000000005 108.13 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 512' ' ' THR . 9.3 mt -104.07 116.65 32.61 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.384 -0.599 . . . . 43.020000000000003 109.384 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.29 113.74 26.08 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.441 -1.689 . . . . 72.310000000000002 106.441 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.4 117.82 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 114.435 -1.257 . . . . 71.5 109.143 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -105.01 127.99 59.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.926 -1.033 . . . . 73.439999999999998 108.406 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.405 HG22 HG23 ' A' ' 514' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.323 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.434 ' N ' ' HG ' ' A' ' 529' ' ' SER . . . . . . . . 0 N--CA 1.423 -2.21 0 CA-C-O 120.568 -0.018 . . . . 73.140000000000001 113.12 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.11 114.1 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 105.367 -2.086 . . . . 51.25 105.367 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.634 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 85.8 m-85 -100.83 138.28 38.08 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 123.571 0.544 . . . . 74.420000000000002 111.103 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 3.8 t -148.27 152.85 37.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.967 -0.56 . . . . 61.219999999999999 110.385 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.488 ' HD2' ' HG1' ' A' ' 639' ' ' THR . 82.3 m-85 -71.68 158.95 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.798 -0.816 . . . . 73.319999999999993 108.798 171.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.0 -47.54 84.32 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.769 0.668 . . . . 75.430000000000007 110.638 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.5 153.9 79.4 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 107.913 -1.143 . . . . 61.399999999999999 107.913 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.3 Cg_endo -81.39 -18.76 8.19 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.06 1.84 . . . . 73.140000000000001 112.747 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' A' ' 642' ' ' GLU . 68.7 t -138.82 136.45 43.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.183 -1.043 . . . . 72.299999999999997 108.183 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.1 t -133.51 128.97 36.47 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.42 0.629 . . . . 43.520000000000003 109.607 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -97.96 117.43 32.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.985 -0.746 . . . . 62.43 108.985 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.54 174.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 121.421 0.629 . . . . 64.120000000000005 109.777 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 518' ' ' ILE . 5.2 m -98.63 150.99 21.18 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.615 -0.72 . . . . 74.319999999999993 110.052 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -66.78 -27.87 67.93 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.383 -0.969 . . . . 73.439999999999998 108.383 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.1 m -103.04 20.82 16.87 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 114.568 -1.196 . . . . 64.219999999999999 111.801 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 515' ' ' SER . 10.6 tt -78.31 -28.09 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 121.446 -0.784 . . . . 55.039999999999999 112.678 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.41 -75.04 1.9 Allowed Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.332 -0.937 . . . . 72.400000000000006 111.483 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 574' ' ' ARG . 45.8 mm -133.61 144.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 107.672 -1.233 . . . . 61.32 107.672 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 18.4 ptm -117.96 128.5 54.86 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.254 -0.647 . . . . 74.040000000000006 109.254 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -100.38 120.31 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.838 0.711 . . . . 71.519999999999996 110.512 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 641' ' ' LEU . 59.1 t -126.55 131.74 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.306 -0.627 . . . . 74.219999999999999 109.306 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 570' ' ' ILE . 61.9 mttp -95.62 149.97 20.87 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.817 0.818 . . . . 74.120000000000005 111.938 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.52 113.06 42.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 106.984 -1.487 . . . . 73.239999999999995 106.984 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 79.5 mt -90.17 160.31 16.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.295 -0.866 . . . . 72.430000000000007 110.147 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 104.3 9.14 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.224 -1.028 . . . . 72.109999999999999 108.224 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.5 m -65.85 -52.67 48.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.669 0.747 . . . . 75.200000000000003 109.776 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 503' ' ' GLY . 30.6 t -73.52 -52.25 14.2 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.932 . . . . 62.140000000000001 111.26 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.77 -156.78 26.8 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 109.681 -1.368 . . . . 64.209999999999994 109.681 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.1 137.07 3.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.957 -0.756 . . . . 75.340000000000003 108.957 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -148.66 148.45 30.09 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 123.427 0.691 . . . . 74.0 109.186 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 85.7 -124.47 6.85 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.84 -0.695 . . . . 73.099999999999994 111.865 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -137.38 104.36 5.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.927 -0.768 . . . . 74.310000000000002 108.927 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.54 125.81 74.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.521 0.677 . . . . 60.009999999999998 110.856 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 559' ' ' GLU . 30.7 mm -96.51 119.54 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.69 -0.687 . . . . 62.119999999999997 109.262 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 50.1 t -106.89 103.11 45.99 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.249 -1.019 . . . . 53.109999999999999 108.249 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.71 147.37 27.72 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.798 1.666 . . . . 71.040000000000006 111.743 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.413 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 52.0 p90 -138.17 158.22 44.74 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.021 -1.103 . . . . 73.019999999999996 108.021 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -154.34 135.5 13.96 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.111 0.482 . . . . 54.119999999999997 110.818 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.54 131.24 36.72 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.976 -1.011 . . . . 64.239999999999995 110.481 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 46.3 mm -100.44 120.31 49.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.695 -0.854 . . . . 71.420000000000002 108.695 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.61 104.81 5.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.682 -0.69 . . . . 74.340000000000003 109.32 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -88.72 -122.1 1.94 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.528 -1.029 . . . . 72.439999999999998 110.528 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -6.61 58.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.923 0.868 . . . . 71.530000000000001 108.926 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.75 27.8 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.567 -1.197 . . . . 63.219999999999999 108.794 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.507 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 38.9 mmt180 -79.47 147.85 32.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.628 -1.249 . . . . 74.219999999999999 107.628 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -109.54 148.49 17.17 Favored Glycine 0 C--N 1.263 -3.498 0 CA-C-N 115.267 -0.879 . . . . 65.030000000000001 114.085 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 88.59 48.02 4.09 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.542 -0.837 . . . . 51.310000000000002 113.657 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.86 43.85 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.706 -1.235 . . . . 73.530000000000001 113.996 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 37.8 mm-40 -96.29 -84.39 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.631 0.715 . . . . 62.509999999999998 110.342 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.6 -44.37 21.15 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.772 -1.566 . . . . 73.010000000000005 106.772 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -136.39 157.58 46.45 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.421 -1.263 . . . . 71.549999999999997 108.83 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -92.24 142.05 27.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.079 -1.822 . . . . 54.420000000000002 106.079 175.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.86 100.78 11.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 72.140000000000001 110.713 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -111.29 104.47 12.95 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-O 122.582 1.182 . . . . 75.340000000000003 109.129 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.7 p -126.72 140.02 52.71 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.959 -1.497 . . . . 54.109999999999999 106.959 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 177.51 -151.32 10.8 Favored Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.487 -1.816 . . . . 42.329999999999998 113.261 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.1 OUTLIER -127.18 125.94 41.97 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.222 1.009 . . . . 55.439999999999998 112.033 -171.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.413 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 86.1 mt -100.92 135.54 42.21 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.63 -0.878 . . . . 64.219999999999999 108.63 173.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.84 109.36 21.06 Favored 'General case' 0 C--N 1.276 -2.603 0 CA-C-O 121.185 0.517 . . . . 74.019999999999996 111.011 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 51.3 m-85 -105.27 101.79 11.31 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.172 -1.047 . . . . 74.450000000000003 108.172 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -80.2 -79.18 0.15 Allowed 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.649 -0.82 . . . . 64.030000000000001 110.754 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 567' ' ' ILE . 59.4 t30 -104.8 158.14 16.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.649 -0.82 . . . . 73.329999999999998 108.953 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.13 -11.55 9.27 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.897 1.279 . . . . 74.439999999999998 113.269 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.463 ' HG3' HG23 ' A' ' 567' ' ' ILE . 12.7 pt-20 -66.92 -11.03 54.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.648 0.779 . . . . 64.129999999999995 111.966 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.463 HG23 ' HG3' ' A' ' 566' ' ' GLU . 35.3 pt -119.07 158.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.48 0.657 . . . . 74.319999999999993 110.674 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.77 143.38 41.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.087 -1.82 . . . . 64.409999999999997 106.087 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 27.1 mttm -111.14 155.99 22.05 Favored 'General case' 0 CA--C 1.469 -2.156 0 C-N-CA 119.393 -0.923 . . . . 75.219999999999999 112.973 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 524' ' ' LYS . 72.3 mt -124.45 136.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.245 -1.343 . . . . 73.25 109.773 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 59.1 mt -98.06 129.03 48.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.816 -1.55 . . . . 64.439999999999998 106.816 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.9 p -118.28 112.56 20.24 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.295 0.569 . . . . 54.229999999999997 110.777 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 589' ' ' LEU . 49.4 mt -106.4 135.47 44.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.812 -0.631 . . . . 64.340000000000003 109.969 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 70.9 mtt180 -80.06 112.01 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.198 -0.667 . . . . 73.209999999999994 109.198 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.83 131.09 49.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.337 -0.847 . . . . 51.25 108.735 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 N--CA 1.422 -1.831 0 N-CA-C 109.57 -0.53 . . . . 73.329999999999998 109.57 -178.68 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.428 -1.567 0 N-CA-C 112.57 0.581 . . . . 71.530000000000001 112.57 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.422 ' HB3' HG12 ' A' ' 644' ' ' ILE . 44.8 p -142.82 147.74 35.94 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.261 0.553 . . . . 73.120000000000005 111.81 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -136.86 -179.88 5.97 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.028 -1.471 . . . . 73.140000000000001 107.028 173.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 22.0 m -130.85 168.43 17.28 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.342 -0.943 . . . . 75.030000000000001 110.631 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 573' ' ' ILE . 46.6 tp -142.12 132.72 25.38 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.977 -1.49 . . . . 72.519999999999996 106.977 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.75 159.27 41.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 120.54 0.21 . . . . 61.399999999999999 110.608 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 65.5 mt -101.65 147.65 26.18 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 106.17 -1.789 . . . . 33.420000000000002 106.17 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.33 177.62 4.8 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.225 -0.657 . . . . 73.120000000000005 109.225 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -61.49 118.49 37.83 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 123.411 0.445 . . . . 74.150000000000006 109.819 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.575 ' HD3' HD22 ' A' ' 635' ' ' LEU . 66.1 Cg_endo -71.99 156.57 56.0 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.451 2.101 . . . . 73.409999999999997 111.333 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -129.55 124.13 33.11 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.044 -0.526 . . . . 62.149999999999999 110.824 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -90.0 120.87 31.57 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.32 -1.363 . . . . 74.340000000000003 107.32 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--N 1.293 -1.864 0 N-CA-C 107.763 -1.199 . . . . 74.340000000000003 107.763 177.066 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 109.255 -0.646 . . . . 64.409999999999997 109.255 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.634 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 1.9 pt? -133.55 179.02 6.48 Favored 'General case' 0 C--N 1.268 -2.966 0 C-N-CA 120.141 -0.624 . . . . 55.100000000000001 109.415 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.94 142.13 42.85 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.846 -1.302 . . . . 72.420000000000002 109.846 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -48.5 -51.05 29.15 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.141 0.977 . . . . 71.040000000000006 111.401 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -126.63 89.77 3.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.112 -0.699 . . . . 61.200000000000003 109.112 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . 0.488 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 15.4 t -119.34 111.02 17.65 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.482 1.135 . . . . 75.120000000000005 109.477 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.9 ttmt -145.06 147.44 32.58 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.81 -1.552 . . . . 64.099999999999994 106.81 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 523' ' ' VAL . 33.6 tp -117.21 107.02 13.94 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.125 -1.065 . . . . 73.519999999999996 108.125 176.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.469 ' HB2' HG22 ' A' ' 511' ' ' VAL . 35.9 mt-10 -86.99 111.28 20.7 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.308 -0.997 . . . . 61.140000000000001 108.308 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.8 118.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.614 -1.176 . . . . 62.420000000000002 109.284 -174.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 586' ' ' SER . 17.3 mt -117.74 119.34 61.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.852 . . . . 44.240000000000002 110.166 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 109.221 -0.659 . . . . 74.319999999999993 109.221 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.06 0 N-CA-C 108.532 -1.827 . . . . 75.239999999999995 108.532 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 57.1 mt -98.75 115.19 38.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.485 -0.561 . . . . 74.450000000000003 109.485 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.458 ' CE1' ' HG3' ' A' ' 527' ' ' ARG . 86.8 m-85 -103.24 139.86 38.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.034 -0.53 . . . . 73.310000000000002 111.456 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.11 154.09 39.72 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.677 -0.49 . . . . 73.25 109.677 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.648 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 58.1 m-85 -75.67 160.36 30.15 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.681 -0.489 . . . . 73.239999999999995 109.681 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.61 -49.48 75.05 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.523 0.514 . . . . 73.109999999999999 110.197 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.87 166.44 27.43 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 116.286 -0.415 . . . . 63.43 111.168 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 4.7 Cg_exo -83.67 -30.9 0.67 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.501 2.134 . . . . 75.019999999999996 111.729 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 642' ' ' GLU . 70.3 t -143.35 130.66 18.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -175.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.3 t -134.13 131.13 38.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.794 -0.817 . . . . 53.219999999999999 108.794 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -106.36 112.43 25.44 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.133 -0.692 . . . . 74.150000000000006 109.133 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 30.6 m -112.87 157.87 13.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.988 0.899 . . . . 73.099999999999994 111.523 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 68.0 m -81.79 174.02 11.72 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.5 -1.227 . . . . 70.109999999999999 110.498 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.03 -30.86 17.47 Favored 'General case' 0 CA--C 1.509 -0.596 0 O-C-N 121.741 -0.6 . . . . 71.439999999999998 110.031 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.4 m -80.23 5.89 13.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.474 -0.784 . . . . 73.340000000000003 110.798 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 4.9 tt -75.69 -28.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.159 0.505 . . . . 74.340000000000003 110.137 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 82.94 -71.61 2.98 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.785 -0.722 . . . . 55.210000000000001 113.199 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 44.6 mm -132.04 126.28 56.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.622 -0.881 . . . . 72.519999999999996 108.622 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.417 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.2 ppp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.178 -0.675 . . . . 71.430000000000007 109.178 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.61 131.69 56.86 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.27 0.628 . . . . 61.32 111.384 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 38.6 t -127.5 115.25 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 109.199 -0.667 . . . . 75.219999999999999 109.199 171.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.4 ' HG2' HG12 ' A' ' 570' ' ' ILE . 98.5 mttt -90.19 127.35 36.1 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.229 -0.588 . . . . 63.240000000000002 110.115 174.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.37 114.58 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.608 -0.886 . . . . 70.329999999999998 108.608 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 51.7 mt -93.14 143.89 25.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.051 -0.977 . . . . 75.120000000000005 110.53 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.458 ' HG3' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -105.54 104.77 14.56 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.394 -1.706 . . . . 73.310000000000002 106.394 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.8 t -66.91 -48.17 69.5 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.943 -0.703 . . . . 64.150000000000006 111.443 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.4 p -74.34 -52.44 12.2 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.495 0.664 . . . . 55.310000000000002 111.479 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 147.96 -170.15 28.64 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 109.53 -1.428 . . . . 72.010000000000005 109.53 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.19 129.24 2.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.61 -0.885 . . . . 52.109999999999999 108.61 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -153.21 81.68 1.19 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.162 0.506 . . . . 64.540000000000006 109.986 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 167.77 -129.43 1.9 Allowed Glycine 0 C--N 1.303 -1.297 0 N-CA-C 109.505 -1.438 . . . . 71.439999999999998 109.505 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -137.32 112.54 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.288 -1.375 . . . . 63.039999999999999 107.288 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.61 130.42 74.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 120.926 0.393 . . . . 71.140000000000001 110.724 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 559' ' ' GLU . 39.2 mm -100.09 113.5 35.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.633 -0.877 . . . . 73.129999999999995 108.633 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.03 102.77 44.78 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.494 -0.928 . . . . 74.519999999999996 108.494 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 4.3 Cg_endo -80.63 161.56 21.87 Favored 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 121.719 1.612 . . . . 65.409999999999997 110.949 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -151.12 163.61 38.42 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.676 -0.861 . . . . 71.219999999999999 108.676 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.425 ' HE2' ' OE2' ' A' ' 592' ' ' GLU . 61.8 pttt -148.99 137.92 21.36 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 112.679 0.622 . . . . 64.239999999999995 112.679 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 22.0 p -87.2 117.55 26.03 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 109.944 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 35.9 mm -92.18 124.54 44.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.248 -1.019 . . . . 71.310000000000002 108.248 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.41 119.33 18.46 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.325 -0.62 . . . . 73.230000000000004 109.325 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -97.96 -107.67 2.63 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.742 -1.343 . . . . 73.530000000000001 109.742 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -86.98 -25.9 24.07 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.643 0.735 . . . . 73.510000000000005 109.035 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.02 149.45 30.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.009 -0.996 . . . . 63.539999999999999 109.034 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -104.55 146.27 29.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.481 0.657 . . . . 75.319999999999993 110.833 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.55 -155.43 30.66 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 114.357 -1.292 . . . . 65.129999999999995 112.354 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.19 6.36 53.03 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 114.128 0.411 . . . . 74.0 114.128 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.78 -0.72 34.06 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.164 -1.017 . . . . 73.25 113.249 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -69.62 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.078 0.439 . . . . 64.530000000000001 110.846 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -99.76 -35.78 9.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.349 -0.611 . . . . 64.329999999999998 109.349 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.56 165.11 30.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.742 -0.663 . . . . 71.109999999999999 109.453 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.9 tm-20 -100.81 122.99 44.35 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.023 -1.473 . . . . 75.109999999999999 107.023 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.09 136.18 57.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 123.162 0.585 . . . . 73.439999999999998 111.4 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.41 ' CG2' HG12 ' A' ' 573' ' ' ILE . 9.3 t -140.56 105.78 5.03 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.043 0.925 . . . . 74.219999999999999 109.437 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 46.9 m -129.57 94.89 3.86 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 106.734 -1.58 . . . . 60.020000000000003 106.734 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -136.24 -156.93 7.63 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.378 -0.828 . . . . 44.240000000000002 111.449 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.1 OUTLIER -132.46 138.98 47.8 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.224 0.535 . . . . 52.240000000000002 110.963 -177.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 73.1 mt -105.5 141.26 37.3 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.201 -0.909 . . . . 61.530000000000001 108.775 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.567 ' HG2' ' NE2' ' A' ' 563' ' ' GLN . 32.9 tt0 -112.92 105.51 13.6 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.409 0.623 . . . . 74.310000000000002 110.398 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 55.3 m-85 -98.15 133.34 42.72 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.574 -0.739 . . . . 74.099999999999994 109.057 177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.567 ' NE2' ' HG2' ' A' ' 561' ' ' GLU . 2.1 mp0 -98.2 -85.38 0.37 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.33 1.062 . . . . 73.0 108.224 174.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.476 ' ND2' ' HB3' ' A' ' 566' ' ' GLU . 0.3 OUTLIER -105.46 161.82 14.0 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.26 -1.336 . . . . 63.439999999999998 110.597 175.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.73 -13.35 31.66 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.708 1.203 . . . . 55.229999999999997 113.162 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.476 ' HB3' ' ND2' ' A' ' 564' ' ' ASN . 32.4 tt0 -56.34 -37.05 69.48 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.021 0.929 . . . . 52.350000000000001 111.277 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.21 162.4 6.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.289 -0.869 . . . . 72.109999999999999 109.665 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.441 HG23 ' NH1' ' A' ' 527' ' ' ARG . 14.8 p -131.1 160.1 42.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.386 -1.339 . . . . 61.43 107.386 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.526 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -117.49 150.96 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.547 0.213 . . . . 74.030000000000001 110.499 176.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 65.8 mt -125.25 131.71 72.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 124.366 1.041 . . . . 72.310000000000002 108.922 -177.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.0 mt -90.6 120.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.242 -1.392 . . . . 73.040000000000006 107.242 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -105.24 112.75 25.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.606 0.566 . . . . 74.319999999999993 109.725 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.505 HD11 HD22 ' A' ' 589' ' ' LEU . 51.1 mt -107.3 132.19 55.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.831 -1.174 . . . . 73.109999999999999 107.831 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -81.34 116.05 21.0 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.086 -0.646 . . . . 61.210000000000001 109.939 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.57 124.37 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.201 -1.037 . . . . 74.510000000000005 108.201 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 58.3 m-85 . . . . . 0 C--N 1.295 -1.785 0 N-CA-C 109.755 -0.461 . . . . 73.530000000000001 109.755 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.53 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.2 m . . . . . 0 N--CA 1.42 -1.928 0 CA-C-O 121.401 0.62 . . . . 63.43 110.9 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 10.5 m -140.08 142.25 36.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.979 -0.749 . . . . 61.100000000000001 108.979 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 50.0 p90 -141.17 165.5 27.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.211 -1.403 . . . . 72.030000000000001 107.211 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 12.1 m -116.64 164.48 14.54 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.614 -0.835 . . . . 75.310000000000002 109.847 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 573' ' ' ILE . 49.3 tp -135.56 130.71 34.96 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.073 -1.454 . . . . 64.450000000000003 107.073 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.4 156.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.787 -0.449 . . . . 61.149999999999999 109.787 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.648 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 70.9 mt -97.05 139.16 33.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.595 -0.891 . . . . 71.400000000000006 108.595 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . 0.425 ' OE2' ' HE2' ' A' ' 540' ' ' LYS . 30.6 mm-40 -94.1 167.26 11.69 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.432 -0.951 . . . . 65.109999999999999 108.432 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.27 116.25 16.82 Favored Pre-proline 0 C--N 1.317 -0.831 0 O-C-N 123.916 0.76 . . . . 60.329999999999998 110.281 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.66 145.32 20.39 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 C-N-CA 122.407 2.071 . . . . 61.119999999999997 110.859 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -118.72 143.92 46.57 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.666 -0.494 . . . . 62.200000000000003 109.666 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -104.07 123.09 46.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.617 -0.883 . . . . 64.25 108.617 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.294 -1.823 0 N-CA-C 106.637 -1.616 . . . . 73.340000000000003 106.637 177.149 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 34.5 pt . . . . . 0 N--CA 1.441 -0.92 0 CA-C-O 121.088 0.47 . . . . 54.149999999999999 110.334 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.29 167.99 10.07 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.848 -0.797 . . . . 75.519999999999996 108.848 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.77 -178.2 21.11 Favored Glycine 0 C--O 1.249 1.06 0 O-C-N 123.465 0.478 . . . . 74.450000000000003 112.585 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -46.98 -61.96 1.63 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.04 0.936 . . . . 74.540000000000006 110.408 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -141.11 104.82 4.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.063 -1.458 . . . . 75.030000000000001 107.063 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.5 t -121.05 109.07 14.6 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 118.659 -1.217 . . . . 73.400000000000006 110.438 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.814 -1.18 . . . . 73.329999999999998 107.814 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 510' ' ' PRO . 62.4 tp -119.79 113.48 20.67 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 123.443 0.464 . . . . 61.439999999999998 111.074 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.415 ' HB2' HG22 ' A' ' 511' ' ' VAL . 2.1 mp0 -84.22 128.65 34.7 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 74.239999999999995 108.07 170.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.65 111.89 38.09 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 107.234 -1.395 . . . . 73.209999999999994 107.234 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.7 mp -105.82 134.44 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 CA-C-N 114.711 -1.132 . . . . 73.030000000000001 108.251 -177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.53 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.286 -2.175 0 N-CA-C 109.484 -0.561 . . . . 75.019999999999996 109.484 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.519 0 N-CA-C 111.47 -0.652 . . . . 73.030000000000001 111.47 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 635' ' ' LEU . 55.8 mt -86.39 114.33 25.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.858 0.361 . . . . 73.209999999999994 110.129 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -112.49 146.11 39.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.48 -0.933 . . . . 65.109999999999999 108.48 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.8 t -148.26 163.54 36.71 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.639 0.587 . . . . 73.120000000000005 109.775 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.65 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 69.2 m-85 -83.96 153.89 23.65 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 123.232 0.613 . . . . 75.219999999999999 110.396 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 49.3 mt-10 -60.35 -41.83 94.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.989 0.423 . . . . 73.319999999999993 110.457 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.2 mt-10 -132.65 151.91 78.98 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.494 -0.928 . . . . 72.109999999999999 108.494 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.407 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 69.9 Cg_endo -87.53 -20.94 1.96 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.125 1.883 . . . . 75.439999999999998 111.137 174.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 52.8 t -146.05 125.67 5.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 124.945 1.298 . . . . 70.319999999999993 107.534 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -133.65 141.03 47.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.33 0.586 . . . . 75.219999999999999 110.064 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -107.93 127.36 53.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.641 -0.708 . . . . 72.239999999999995 109.198 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.8 m -126.08 158.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.06 0.457 . . . . 71.540000000000006 110.92 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.0 m -73.43 157.76 36.25 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.599 -0.728 . . . . 74.409999999999997 109.702 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -29.17 39.84 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.465 0.65 . . . . 71.409999999999997 109.991 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -97.81 18.7 15.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.48 -0.782 . . . . 54.299999999999997 111.086 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.78 -29.85 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 75.299999999999997 111.617 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.15 -72.49 2.83 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.621 -0.799 . . . . 75.25 111.886 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.0 mm -127.42 123.54 61.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.999 -0.741 . . . . 73.230000000000004 108.999 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.457 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.8 ptm -101.18 131.35 47.2 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.627 -0.879 . . . . 65.109999999999999 108.627 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.58 118.46 33.13 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 123.714 0.634 . . . . 72.400000000000006 110.848 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.61 114.64 45.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.384 -1.339 . . . . 75.209999999999994 107.384 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 570' ' ' ILE . 29.0 mtmm -94.06 133.56 37.4 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 119.912 -0.715 . . . . 65.219999999999999 110.486 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.53 109.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.995 -1.113 . . . . 71.200000000000003 107.995 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.7 mt -89.09 122.51 32.48 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.256 -0.884 . . . . 70.150000000000006 110.037 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.465 ' H ' ' NE ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -89.16 103.2 15.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 118.673 -1.211 . . . . 73.319999999999993 108.3 174.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.0 p -67.77 -54.32 20.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.513 -0.767 . . . . 73.109999999999999 111.1 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . 0.515 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 23.1 t -72.94 -50.41 23.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.071 -0.968 . . . . 74.530000000000001 110.211 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' A' ' 565' ' ' ASP . . . 149.61 -179.91 25.99 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.776 -1.202 . . . . 75.239999999999995 112.458 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.61 27.98 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 107.086 -1.45 . . . . 73.209999999999994 107.086 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -149.32 127.75 12.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.562 -0.455 . . . . 74.540000000000006 110.164 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.89 -115.64 4.71 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.886 -0.886 . . . . 24.25 110.886 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -138.1 109.98 7.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.714 -1.217 . . . . 73.150000000000006 107.714 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.09 123.5 66.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.131 0.491 . . . . 64.140000000000001 109.896 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 48.6 mm -96.17 120.59 45.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.245 -0.65 . . . . 71.409999999999997 109.245 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.79 104.36 51.08 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 52.140000000000001 107.993 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.01 143.29 17.9 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.948 1.765 . . . . 70.109999999999999 111.309 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -130.43 163.74 26.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.333 -0.988 . . . . 72.519999999999996 108.333 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -159.29 132.81 7.24 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.276 0.36 . . . . 44.329999999999998 110.847 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 20.7 p -79.75 136.12 36.68 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.884 -0.598 . . . . 63.43 110.368 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.55 117.29 46.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.449 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 40.4 mt-10 -74.88 104.62 5.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.586 -0.524 . . . . 72.049999999999997 109.586 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.63 -102.57 1.21 Allowed Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.838 -1.305 . . . . 72.200000000000003 109.838 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 585' ' ' CYS . 13.2 t -100.83 4.82 43.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.271 0.558 . . . . 71.120000000000005 110.067 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -105.35 149.45 26.06 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.344 -1.354 . . . . 74.400000000000006 107.344 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.449 ' HD2' ' OE1' ' A' ' 543' ' ' GLU . 29.7 tpt180 -107.12 134.07 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.808 0.337 . . . . 64.129999999999995 110.977 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.01 -151.76 9.5 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.741 -0.663 . . . . 64.140000000000001 111.626 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 75.17 -33.76 1.09 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 122.461 -0.434 . . . . 70.230000000000004 114.066 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 144.35 5.76 0.58 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.091 -0.576 . . . . 62.130000000000003 112.55 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -75.13 -79.17 0.1 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.868 0.365 . . . . 73.420000000000002 111.88 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -89.78 -41.19 12.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.829 -1.174 . . . . 75.109999999999999 107.829 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -149.33 169.48 20.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.452 -1.249 . . . . 74.150000000000006 108.717 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.06 119.03 37.13 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.803 -2.295 . . . . 70.319999999999993 104.803 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.39 105.28 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.967 0.889 . . . . 70.040000000000006 110.555 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.9 t -101.91 127.15 48.88 Favored 'General case' 0 N--CA 1.412 -2.354 0 CA-C-N 115.1 -0.955 . . . . 64.400000000000006 111.155 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -140.55 97.82 3.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.607 -1.179 . . . . 73.109999999999999 108.353 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -132.34 179.31 17.33 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 115.485 -0.78 . . . . 61.350000000000001 111.737 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.44 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.3 mt-10 -111.07 114.84 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.224 -0.658 . . . . 64.409999999999997 109.224 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.06 138.19 31.63 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 110.117 -0.327 . . . . 75.310000000000002 110.117 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -105.98 106.28 16.71 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.459 0.647 . . . . 61.32 111.485 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 36.6 m-85 -96.43 147.6 23.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.036 -1.468 . . . . 74.140000000000001 107.036 172.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -124.96 -79.06 0.61 Allowed 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 108.862 -0.792 . . . . 73.510000000000005 108.862 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.03 156.04 18.18 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.149 -0.686 . . . . 64.200000000000003 109.149 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.459 ' OD1' ' HA2' ' A' ' 530' ' ' GLY . 12.0 t70 -56.1 -25.9 47.52 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.162 1.385 . . . . 50.219999999999999 113.193 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.47 -18.52 64.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.139 0.792 . . . . 74.109999999999999 113.139 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.2 pt -106.37 167.5 3.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 119.843 -0.743 . . . . 73.319999999999993 110.935 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.99 159.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.818 -1.179 . . . . 75.230000000000004 107.818 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.495 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 122.208 -0.307 . . . . 71.439999999999998 110.26 175.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 524' ' ' LYS . 18.7 mt -122.2 134.89 64.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 123.825 0.703 . . . . 62.030000000000001 110.259 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 55.2 mt -91.26 122.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.368 -1.345 . . . . 73.340000000000003 107.368 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 9.4 p -106.7 112.86 26.03 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 123.866 0.729 . . . . 72.200000000000003 109.269 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.555 HD11 HD22 ' A' ' 589' ' ' LEU . 38.2 mt -110.76 125.63 68.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.232 -0.655 . . . . 74.450000000000003 109.232 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -79.59 110.59 15.07 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.136 0.898 . . . . 73.099999999999994 109.765 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.4 135.05 36.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.917 -1.512 . . . . 64.319999999999993 106.917 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 109.818 -0.438 . . . . 74.319999999999993 109.818 -178.097 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.534 ' HA ' HG23 ' A' ' 545' ' ' THR . 5.5 p . . . . . 0 N--CA 1.409 -2.502 0 CA-C-O 122.093 0.949 . . . . 33.299999999999997 113.181 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 34.7 p -143.32 154.75 44.09 Favored 'General case' 0 N--CA 1.405 -2.704 0 CA-C-N 114.633 -1.167 . . . . 65.400000000000006 108.967 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -138.53 161.61 36.62 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 61.130000000000003 106.844 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.1 t -113.73 175.69 5.35 Favored 'General case' 0 C--N 1.27 -2.887 0 C-N-CA 119.147 -1.021 . . . . 72.040000000000006 109.108 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 573' ' ' ILE . 33.5 tp -149.9 126.69 11.06 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.016 -1.475 . . . . 71.25 107.016 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.13 157.34 31.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.716 -0.476 . . . . 65.310000000000002 109.716 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.65 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 40.2 mt -101.79 142.97 32.29 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.337 -1.727 . . . . 70.209999999999994 106.337 174.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.86 173.59 6.79 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.869 -0.789 . . . . 71.299999999999997 108.869 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.67 115.46 18.75 Favored Pre-proline 0 C--N 1.316 -0.88 0 O-C-N 123.733 0.646 . . . . 72.319999999999993 110.739 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.411 ' HD3' HD22 ' A' ' 635' ' ' LEU . 32.6 Cg_endo -65.38 153.96 75.81 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.761 2.307 . . . . 64.310000000000002 113.399 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -119.62 134.91 55.03 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.783 -1.099 . . . . 71.230000000000004 109.64 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -99.34 125.07 44.93 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.098 -0.705 . . . . 74.099999999999994 109.098 -175.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . 0.437 HD13 HG12 ' A' ' 536' ' ' ILE . 2.7 mp . . . . . 0 C--N 1.29 -1.986 0 N-CA-C 105.225 -2.139 . . . . 55.25 105.225 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . 0.274 2.6 pp . . . . . 0 N--CA 1.415 -2.216 0 CA-C-O 122.222 1.011 . . . . 74.409999999999997 112.006 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 635' ' ' LEU . 2.2 pt? -76.35 -165.22 0.47 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.255 -2.248 . . . . 72.140000000000001 111.873 -174.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.23 136.25 37.21 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 109.46 -1.456 . . . . 73.310000000000002 109.46 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.56 -42.32 70.85 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.469 0.708 . . . . 74.340000000000003 111.848 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -131.37 84.86 2.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 110.864 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.9 t -119.71 114.71 22.59 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 107.872 -1.158 . . . . 61.229999999999997 107.872 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -147.59 140.24 24.73 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.777 -0.823 . . . . 52.539999999999999 108.777 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 509' ' ' GLU . 60.0 tp -117.59 123.14 45.48 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 123.347 0.404 . . . . 71.209999999999994 109.913 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.78 124.94 43.98 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.941 -1.503 . . . . 74.230000000000004 106.941 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.22 120.22 60.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.464 -0.939 . . . . 73.540000000000006 108.464 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.87 124.18 63.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-N 115.618 -0.719 . . . . 60.420000000000002 109.262 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.31 -1.148 0 CA-C-O 122.213 1.006 . . . . 73.030000000000001 111.125 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.393 0 N-CA-C 114.638 0.615 . . . . 65.5 114.638 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 57.1 mt -128.28 113.94 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 104.72 -2.326 . . . . 72.239999999999995 104.72 167.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.601 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 76.1 m-85 -107.49 132.35 53.32 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.645 -0.502 . . . . 75.329999999999998 109.645 -176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 8.8 t -148.03 152.76 37.96 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.534 0.521 . . . . 54.119999999999997 110.036 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.496 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 90.1 m-85 -74.43 154.5 38.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.909 -0.404 . . . . 74.450000000000003 109.909 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -52.78 -49.92 64.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.819 0.848 . . . . 42.329999999999998 111.147 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -135.32 161.53 62.76 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 107.753 -1.203 . . . . 62.450000000000003 107.753 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 68.4 Cg_endo -82.4 -17.61 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 121.673 1.582 . . . . 64.519999999999996 112.029 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 642' ' ' GLU . 77.9 t -143.07 127.11 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 123.306 0.642 . . . . 72.5 109.966 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 643' ' ' VAL . 12.0 t -135.11 141.5 46.03 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.474 -0.935 . . . . 73.430000000000007 108.474 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -111.14 142.45 43.31 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.301 -1.74 . . . . 74.049999999999997 106.301 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.19 154.81 29.02 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 CA-C-O 121.327 0.584 . . . . 75.230000000000004 111.462 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 20.5 m -73.92 137.46 43.65 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.891 -1.049 . . . . 73.030000000000001 109.482 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -75.58 1.58 13.99 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.799 0.809 . . . . 73.25 112.886 -178.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.5 p -125.53 18.75 8.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.32 -0.855 . . . . 74.430000000000007 110.902 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 8.2 tt -80.76 -23.76 11.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-O 121.376 0.608 . . . . 55.350000000000001 110.479 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.51 -76.26 2.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.721 -0.951 . . . . 72.209999999999994 110.721 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 574' ' ' ARG . 47.9 mm -125.41 128.58 72.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.724 -0.843 . . . . 63.25 108.724 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.488 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.3 ptm -98.48 141.61 31.12 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.673 -0.492 . . . . 71.230000000000004 109.673 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -102.39 128.81 48.83 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 123.792 0.682 . . . . 61.310000000000002 109.917 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 44.0 t -124.92 124.53 67.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.459 -0.941 . . . . 62.43 108.459 174.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -93.87 132.34 38.4 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.006 -0.678 . . . . 70.230000000000004 110.768 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 84.3 t -95.98 111.76 26.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.581 -1.637 . . . . 72.219999999999999 106.581 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.43 143.42 26.62 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.547 -0.751 . . . . 72.239999999999995 110.39 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.0 104.65 14.14 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.844 -0.617 . . . . 75.310000000000002 111.767 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 504' ' ' ILE . 22.9 m -64.78 -61.64 2.06 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.953 -0.567 . . . . 61.5 112.086 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.1 p -73.76 -52.54 12.84 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.107 0.41 . . . . 74.230000000000004 112.107 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 158.02 -145.77 12.31 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.943 -0.863 . . . . 70.099999999999994 110.943 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -178.66 130.8 0.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.211 1.404 . . . . 62.229999999999997 107.467 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -150.59 91.44 1.74 Allowed 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.537 -0.865 . . . . 75.109999999999999 111.879 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 145.51 -116.97 0.95 Allowed Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 110.183 -1.167 . . . . 75.450000000000003 110.183 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.82 104.49 5.3 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.137 -1.06 . . . . 71.420000000000002 108.137 172.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 595' ' ' LYS . 39.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.331 -0.548 . . . . 61.439999999999998 111.381 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 559' ' ' GLU . 42.6 mm -98.99 115.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.423 -0.808 . . . . 73.120000000000005 109.139 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.78 100.24 30.15 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 108.523 -0.917 . . . . 71.430000000000007 108.523 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 536' ' ' ILE . 3.4 Cg_exo -76.65 146.54 27.09 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 121.924 1.75 . . . . 74.519999999999996 111.186 176.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 25.1 p90 -136.68 157.33 47.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.239 -0.652 . . . . 70.239999999999995 109.239 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -147.6 135.04 20.76 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.835 0.35 . . . . 65.109999999999999 111.019 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.4 p -82.72 123.03 28.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.777 -0.647 . . . . 74.140000000000001 111.184 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 41.0 mm -92.16 118.22 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.959 -1.126 . . . . 71.109999999999999 107.959 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.69 143.99 34.09 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.266 -0.642 . . . . 75.310000000000002 109.266 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.72 -110.18 0.83 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 109.076 -1.609 . . . . 62.020000000000003 109.076 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 16.6 p -78.64 -25.21 44.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.586 -0.894 . . . . 74.549999999999997 108.586 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -90.2 131.9 35.78 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.43 -1.322 . . . . 73.340000000000003 107.43 172.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 43.1 ttp180 -104.72 140.96 37.3 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.121 -0.696 . . . . 74.219999999999999 109.121 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.75 -157.4 31.59 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 121.166 -0.54 . . . . 72.340000000000003 112.639 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 69.09 19.94 74.35 Favored Glycine 0 C--N 1.31 -0.871 0 C-N-CA 121.619 -0.324 . . . . 41.229999999999997 112.932 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.03 19.21 40.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.33 -0.938 . . . . 60.43 112.646 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 11.0 tp10 -86.0 -79.51 0.25 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 110.0 -0.37 . . . . 75.319999999999993 110.0 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -94.9 -30.29 14.24 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.701 -1.222 . . . . 63.450000000000003 107.701 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.32 155.79 43.41 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.396 -1.274 . . . . 72.329999999999998 107.952 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -88.46 139.98 29.93 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 105.412 -2.07 . . . . 75.209999999999994 105.412 177.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 15.9 t70 -77.33 121.72 24.13 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.167 -0.308 . . . . 64.409999999999997 110.167 -171.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -127.33 104.43 7.93 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 122.474 1.131 . . . . 61.119999999999997 110.46 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -125.96 102.27 7.18 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.725 -1.954 . . . . 60.310000000000002 105.725 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -133.36 -174.75 13.67 Favored Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.39 -0.91 . . . . 54.130000000000003 112.248 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.0 OUTLIER -121.11 122.46 40.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.313 0.577 . . . . 73.409999999999997 110.669 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 569' ' ' LYS . 83.8 mt -96.58 136.92 36.42 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.882 -0.414 . . . . 71.310000000000002 109.882 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.01 102.53 11.25 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.709 0.766 . . . . 63.539999999999999 111.392 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 60.0 m-85 -99.58 96.8 7.89 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 106.971 -1.492 . . . . 74.099999999999994 106.971 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -75.18 -67.11 0.68 Allowed 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.233 -0.987 . . . . 70.439999999999998 109.829 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -105.94 161.65 14.27 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.222 -0.658 . . . . 65.310000000000002 109.222 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.55 -11.82 60.45 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.208 1.003 . . . . 72.430000000000007 113.527 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.456 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.6 pt-20 -68.09 -7.99 34.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.61 0.967 . . . . 50.350000000000001 113.61 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.456 HG23 ' HG3' ' A' ' 566' ' ' GLU . 45.1 pt -122.32 168.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 O-C-N 121.952 -0.467 . . . . 45.450000000000003 110.837 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.7 p -131.79 140.73 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.839 -1.541 . . . . 63.310000000000002 106.839 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 69.5 mmtt -104.45 145.95 29.55 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.438 -0.505 . . . . 74.239999999999995 111.25 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 69.3 mt -117.45 135.07 59.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.474 -1.239 . . . . 73.349999999999994 110.498 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 64.5 mt -93.55 127.89 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.835 -1.172 . . . . 64.219999999999999 107.835 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 25.7 p -106.59 112.18 25.06 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.374 0.607 . . . . 74.150000000000006 110.139 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.488 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 30.9 mt -112.64 130.04 67.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.74 -1.207 . . . . 62.530000000000001 107.74 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 11.5 ttm180 -85.86 122.92 30.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 0.407 HG23 HG21 ' A' ' 645' ' ' ILE . 44.7 mm -102.33 136.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.724 -0.671 . . . . 65.439999999999998 109.394 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.475 ' CZ ' ' HD2' ' A' ' 574' ' ' ARG . 92.7 m-85 . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 108.682 -0.858 . . . . 72.010000000000005 108.682 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.418 -2.032 0 CA-C-O 121.054 0.454 . . . . 73.519999999999996 111.118 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 23.9 m -144.99 153.71 41.78 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.037 -0.727 . . . . 65.010000000000005 109.037 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.2 p90 -138.6 -176.87 4.62 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.79 -0.448 . . . . 75.140000000000001 109.79 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 35.8 m -132.6 162.83 30.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.589 -0.522 . . . . 32.119999999999997 109.589 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 571' ' ' ILE . 31.2 tp -139.38 134.83 32.98 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.562 -1.273 . . . . 65.439999999999998 107.562 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.85 157.34 43.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 123.18 0.3 . . . . 63.130000000000003 110.696 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.496 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 48.9 mt -101.8 139.79 36.97 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.027 -1.471 . . . . 74.329999999999998 107.027 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -96.36 178.43 5.37 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 123.332 0.395 . . . . 74.420000000000002 110.125 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.52 121.39 78.81 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 109.676 -0.49 . . . . 74.450000000000003 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.505 ' HD3' HD22 ' A' ' 635' ' ' LEU . 59.1 Cg_endo -72.48 164.44 35.6 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.408 2.072 . . . . 70.519999999999996 113.734 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 75.5 mmtt -116.93 140.98 48.82 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 114.847 -1.07 . . . . 75.329999999999998 109.06 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -113.84 109.34 18.37 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 107.227 -1.397 . . . . 75.510000000000005 107.227 176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 C--N 1.281 -2.385 0 N-CA-C 107.599 -1.26 . . . . 53.539999999999999 107.599 179.15 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.662 0.268 . . . . 74.430000000000007 110.292 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.601 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 2.1 pt? -139.53 -168.27 2.44 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.882 -0.784 . . . . 74.430000000000007 108.882 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -66.75 159.62 48.59 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.582 -0.818 . . . . 24.239999999999998 112.612 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.61 -64.71 0.74 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.981 1.313 . . . . 55.240000000000002 110.135 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -130.93 104.33 7.07 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.925 -1.139 . . . . 74.450000000000003 107.925 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . 0.419 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 14.6 t -129.45 114.0 15.6 Favored 'General case' 0 N--CA 1.404 -2.735 0 CA-C-O 122.547 1.165 . . . . 71.439999999999998 110.326 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.8 ttmt -144.09 148.95 35.83 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 106.586 -1.635 . . . . 73.219999999999999 106.586 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 56.4 tp -126.76 109.99 12.63 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.478 -0.934 . . . . 71.530000000000001 108.478 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.445 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.9 mt-10 -87.0 126.42 34.73 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 107.421 -1.325 . . . . 73.140000000000001 107.421 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 512' ' ' THR . 43.9 t -113.62 122.41 67.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 109.048 -0.723 . . . . 64.409999999999997 109.048 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.62 135.55 50.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.79 -1.096 . . . . 73.230000000000004 110.014 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.407 HG21 HG23 ' A' ' 575' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.155 0 C-N-CA 123.096 0.558 . . . . 74.150000000000006 110.142 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.588 0 N-CA-C 110.185 -1.166 . . . . 60.43 110.185 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 68.3 mt -96.89 114.88 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.306 -0.627 . . . . 73.219999999999999 109.306 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -101.24 132.26 46.83 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.017 -0.735 . . . . 75.120000000000005 109.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.1 t -146.38 153.81 40.92 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 120.795 0.331 . . . . 64.299999999999997 110.436 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.54 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.15 153.73 38.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.649 -0.5 . . . . 71.329999999999998 109.649 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 41.7 mt-10 -56.19 -56.19 23.98 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.941 0.775 . . . . 72.430000000000007 110.397 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -122.35 160.84 46.29 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.721 -1.127 . . . . 75.439999999999998 109.136 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -86.73 -20.74 2.39 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.032 1.821 . . . . 73.420000000000002 112.071 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.437 HG13 HD12 ' A' ' 644' ' ' ILE . 75.6 t -144.22 135.61 21.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 71.230000000000004 108.891 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.0 t -133.21 123.96 26.54 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.449 0.643 . . . . 72.319999999999993 110.07 177.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -98.98 115.96 30.12 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.964 -1.124 . . . . 75.209999999999994 107.964 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.14 169.15 17.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 123.492 0.495 . . . . 62.450000000000003 110.422 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 44.6 t -78.3 155.95 29.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.98 -0.554 . . . . 64.129999999999995 111.069 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.14 -20.96 54.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.486 -0.931 . . . . 71.510000000000005 108.486 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 32.75 5.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.66 -0.7 . . . . 74.430000000000007 110.728 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 6.5 tt -82.83 -23.2 8.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 62.0 109.657 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.76 -74.76 2.03 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.33 -0.708 . . . . 73.519999999999996 111.33 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.7 mm -130.28 128.17 63.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.449 -1.315 . . . . 70.239999999999995 107.449 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -99.61 157.04 16.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.296 -0.631 . . . . 74.150000000000006 109.296 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.06 131.59 56.9 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.572 0.545 . . . . 74.310000000000002 111.919 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 41.4 t -126.26 116.33 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 109.603 -0.517 . . . . 44.219999999999999 109.603 173.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 97.5 mttt -92.34 124.87 36.72 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.975 -0.69 . . . . 70.420000000000002 110.027 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.88 112.73 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.479 -1.304 . . . . 75.409999999999997 107.479 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 40.3 mt -96.07 152.76 18.24 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.129 -0.941 . . . . 74.420000000000002 110.406 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 1.8 mpp_? -106.65 114.83 29.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.043 -0.725 . . . . 53.119999999999997 109.043 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.3 m -65.36 -50.87 63.95 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.82 0.819 . . . . 72.329999999999998 109.998 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.0 p -73.75 -52.25 13.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.19 -0.914 . . . . 73.219999999999999 112.248 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 138.9 -155.95 24.05 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 108.423 -1.871 . . . . 44.329999999999998 108.423 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -169.47 149.13 3.92 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 117.339 0.569 . . . . 73.129999999999995 109.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -156.57 102.11 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.573 -2.01 . . . . 65.219999999999999 105.573 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 124.66 -173.04 16.99 Favored Glycine 0 C--N 1.295 -1.738 0 N-CA-C 110.046 -1.222 . . . . 72.430000000000007 110.046 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.553 HD21 ' HG3' ' A' ' 561' ' ' GLU . 3.5 t-20 -99.21 118.98 37.11 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 108.968 -0.753 . . . . 65.140000000000001 108.968 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 14.1 t -120.69 121.31 65.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 109.171 -0.677 . . . . 60.229999999999997 109.171 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.477 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.9 mm -94.39 117.03 37.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.79 -0.818 . . . . 52.229999999999997 108.79 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.7 106.73 56.7 Favored Pre-proline 0 C--N 1.301 -1.516 0 CA-C-N 115.446 -0.797 . . . . 74.319999999999993 110.673 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 5.0 Cg_exo -76.88 150.87 30.75 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.129 1.886 . . . . 65.140000000000001 111.7 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -141.72 161.48 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.84 -1.17 . . . . 73.5 107.84 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.584 ' HE2' HD11 ' A' ' 542' ' ' ILE . 24.0 pttm -152.49 137.06 16.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.056 0.455 . . . . 63.030000000000001 111.638 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.8 p -83.51 134.39 34.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.575 -0.739 . . . . 65.200000000000003 110.224 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.584 HD11 ' HE2' ' A' ' 540' ' ' LYS . 48.1 mm -103.55 126.38 58.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.357 -0.979 . . . . 61.32 108.357 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -78.95 112.31 16.01 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.113 -1.069 . . . . 72.319999999999993 108.113 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -101.36 -106.17 2.9 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.771 -1.332 . . . . 72.25 109.771 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 23.9 p -89.5 -11.37 43.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.438 0.637 . . . . 71.540000000000006 109.827 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -100.65 141.36 33.63 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.06 -1.089 . . . . 73.230000000000004 108.06 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -100.05 133.68 44.07 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.861 0.363 . . . . 64.409999999999997 110.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.72 -159.97 35.43 Favored Glycine 0 N--CA 1.431 -1.66 0 C-N-CA 120.777 -0.725 . . . . 60.409999999999997 111.355 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.0 37.39 64.32 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.025 -0.607 . . . . 41.25 112.187 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.69 5.13 86.89 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.361 -0.447 . . . . 53.240000000000002 113.529 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -81.89 -82.21 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.849 0.325 . . . . 75.219999999999999 111.771 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -46.76 7.63 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.712 -1.218 . . . . 65.040000000000006 107.712 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -131.89 160.63 35.15 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.36 -1.291 . . . . 64.129999999999995 107.575 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.0 OUTLIER -91.98 131.97 36.88 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.861 -1.533 . . . . 51.039999999999999 106.861 175.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.21 125.5 29.93 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.947 -0.569 . . . . 63.539999999999999 109.732 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.8 t -133.99 121.99 22.41 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 122.026 0.917 . . . . 43.020000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.7 p -133.55 129.53 37.19 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.825 -1.546 . . . . 71.019999999999996 106.825 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -172.63 -177.39 41.98 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.029 -1.081 . . . . 73.519999999999996 111.036 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.462 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.1 mt-10 -113.24 129.51 56.5 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.362 0.601 . . . . 70.319999999999993 111.945 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.7 mt -89.24 140.11 29.81 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.649 -1.16 . . . . 62.240000000000002 109.699 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.553 ' HG3' HD21 ' A' ' 534' ' ' ASN . 37.6 tt0 -99.83 101.78 13.02 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.944 -0.571 . . . . 61.229999999999997 109.931 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 43.0 m-85 -96.17 149.71 21.33 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.624 0.725 . . . . 73.329999999999998 110.439 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.411 ' H ' HD11 ' A' ' 567' ' ' ILE . 79.7 mm-40 -127.41 -140.54 0.26 Allowed 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.128 -1.804 . . . . 74.200000000000003 106.128 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -62.21 157.72 18.71 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 122.958 0.503 . . . . 61.340000000000003 110.088 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.422 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 33.6 t70 -54.55 -21.11 9.28 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.598 1.159 . . . . 72.209999999999994 113.74 -175.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.533 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.1 pt-20 -59.27 -30.96 68.67 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.678 0.791 . . . . 71.040000000000006 112.781 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.533 HG23 ' HG3' ' A' ' 566' ' ' GLU . 34.7 pt -101.08 168.93 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.643 0.259 . . . . 74.409999999999997 110.955 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.34 152.38 15.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.88 -1.526 . . . . 72.099999999999994 106.88 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.1 mmpt? -112.8 157.44 21.35 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 120.783 -0.367 . . . . 52.210000000000001 110.8 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -127.32 129.41 70.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.231 -0.895 . . . . 70.409999999999997 109.822 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.9 mt -90.63 122.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.61 -1.626 . . . . 75.140000000000001 106.61 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.0 p -106.86 122.01 45.55 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.239 -0.652 . . . . 63.149999999999999 109.239 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.419 HD11 HD22 ' A' ' 589' ' ' LEU . 61.6 mt -118.31 128.44 75.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.472 -0.566 . . . . 43.130000000000003 109.472 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.4 mtt180 -74.31 119.48 18.58 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.944 0.778 . . . . 70.019999999999996 110.1 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.6 mm -107.25 135.75 44.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.719 -0.845 . . . . 74.040000000000006 108.719 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 C--N 1.305 -1.365 0 N-CA-C 107.776 -1.194 . . . . 71.0 107.776 -178.625 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.517 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.0 m . . . . . 0 N--CA 1.436 -1.128 0 CA-C-O 121.63 0.729 . . . . 73.299999999999997 112.031 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 m -146.77 128.04 14.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.91 -0.774 . . . . 75.340000000000003 108.91 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.2 p90 -131.22 165.76 22.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.714 -0.847 . . . . 55.530000000000001 108.714 174.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 5.0 m -119.7 162.52 18.88 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.523 -0.871 . . . . 70.409999999999997 110.221 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 573' ' ' ILE . 47.0 tp -135.69 130.06 33.68 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.276 -1.379 . . . . 64.239999999999995 107.276 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.83 160.14 42.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 123.603 0.564 . . . . 74.329999999999998 109.674 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.54 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 44.9 mt -106.26 144.4 33.0 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.976 0.798 . . . . 70.230000000000004 109.004 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.77 178.3 5.35 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.178 -1.045 . . . . 73.310000000000002 108.178 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.29 117.36 23.51 Favored Pre-proline 0 C--O 1.247 0.954 0 O-C-N 123.642 0.589 . . . . 62.43 109.759 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.426 ' HD3' HD21 ' A' ' 635' ' ' LEU . 56.4 Cg_endo -77.46 147.78 25.76 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.409 2.072 . . . . 73.200000000000003 111.375 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . 0.477 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 8.7 ptpp? -113.63 123.59 50.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.133 -0.485 . . . . 75.299999999999997 110.055 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -98.23 110.58 23.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.014 -0.539 . . . . 75.420000000000002 110.256 -173.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--N 1.288 -2.078 0 N-CA-C 106.693 -1.595 . . . . 70.340000000000003 106.693 175.803 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 31.2 pt . . . . . 0 N--CA 1.444 -0.754 0 CA-C-O 121.459 0.647 . . . . 75.319999999999993 110.973 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.426 HD21 ' HD3' ' A' ' 594' ' ' PRO . 2.2 mm? -114.61 170.31 8.41 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 64.219999999999999 107.364 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.82 154.59 50.92 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.388 -1.885 . . . . 72.049999999999997 108.388 172.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -39.86 -64.06 0.53 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.1 0.96 . . . . 63.240000000000002 112.641 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -130.07 83.43 2.13 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.827 -1.175 . . . . 71.239999999999995 107.827 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.2 t -100.67 110.88 23.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.241 1.019 . . . . 64.200000000000003 110.64 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -146.72 134.86 21.61 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.411 -1.329 . . . . 72.5 107.411 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 65.0 tp -113.2 112.91 24.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.312 -0.625 . . . . 70.540000000000006 109.312 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.41 ' HB2' HG22 ' A' ' 511' ' ' VAL . 48.7 mt-10 -90.47 117.03 28.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 176.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.63 116.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 N-CA-C 107.66 -1.237 . . . . 54.310000000000002 107.66 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . 0.437 HD12 HG13 ' A' ' 511' ' ' VAL . 16.0 mt -115.47 128.22 72.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.547 0 CA-C-N 114.787 -1.097 . . . . 75.109999999999999 109.901 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.417 -2.116 0 CA-C-N 114.474 -1.239 . . . . 71.030000000000001 108.308 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 C--O 1.204 -1.732 0 N-CA-C 114.134 0.413 . . . . 72.0 114.134 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 91.9 mt -71.78 114.22 9.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 116.876 0.338 . . . . 73.109999999999999 110.984 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.424 ' HE1' ' HE ' ' A' ' 527' ' ' ARG . 38.2 m-85 -100.5 132.73 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.882 -0.784 . . . . 74.049999999999997 108.882 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -148.23 157.59 43.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.841 -0.537 . . . . 74.319999999999993 110.641 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.572 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 91.9 m-85 -71.56 155.57 40.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.258 . . . . 63.420000000000002 110.319 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.91 -56.28 22.58 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.914 0.759 . . . . 73.030000000000001 109.623 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . 0.416 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.6 mt-10 -134.09 159.51 72.08 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 107.952 -1.129 . . . . 71.420000000000002 107.952 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 62.8 Cg_endo -79.04 -21.49 9.35 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 121.93 1.753 . . . . 65.519999999999996 113.808 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.4 t -138.59 133.34 42.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.702 -0.481 . . . . 60.43 109.702 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.6 139.11 46.34 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.206 0.527 . . . . 55.100000000000001 109.705 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -109.39 132.84 53.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.989 -1.485 . . . . 61.509999999999998 106.989 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.87 163.72 26.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 C-N-CA 120.621 -0.432 . . . . 71.510000000000005 110.449 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 27.2 m -82.44 163.68 21.47 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.569 -0.741 . . . . 71.150000000000006 109.574 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -81.05 -34.72 32.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.729 -1.212 . . . . 61.119999999999997 107.729 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.4 m -96.34 27.54 3.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.144 -0.934 . . . . 75.209999999999994 111.022 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 7.4 tt -79.8 -25.08 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.409 0.623 . . . . 74.439999999999998 110.601 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 86.45 -75.71 2.21 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.926 -0.654 . . . . 73.120000000000005 111.668 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 48.4 mm -130.51 137.56 55.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.458 -1.682 . . . . 44.409999999999997 106.458 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.1 ppp? -110.09 147.98 32.6 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.403 -0.962 . . . . 74.219999999999999 108.403 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -110.97 134.38 52.63 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.596 0.56 . . . . 74.219999999999999 110.825 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 46.1 t -121.19 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.68 -0.859 . . . . 74.099999999999994 108.68 171.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -85.52 120.79 27.37 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.572 -0.851 . . . . 74.420000000000002 110.058 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.25 101.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.987 -1.486 . . . . 71.209999999999994 106.987 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.1 mt -84.32 163.4 19.62 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 114.183 -1.371 . . . . 74.010000000000005 111.006 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.608 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 74.6 mtt180 -118.12 109.08 15.98 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.865 -1.062 . . . . 64.430000000000007 110.446 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 22.7 m -66.27 -62.93 1.21 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.269 -0.423 . . . . 65.049999999999997 110.416 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.9 p -75.31 -36.44 61.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.663 0.744 . . . . 72.239999999999995 112.009 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 124.55 -128.78 6.87 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.211 -1.155 . . . . 65.040000000000006 110.211 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . 177.16 168.69 0.58 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.052 1.341 . . . . 63.409999999999997 107.437 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.529 ' HD2' ' OD1' ' A' ' 564' ' ' ASN . 9.9 tpt180 -163.41 81.17 0.46 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.524 -1.287 . . . . 74.25 107.524 172.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 135.34 171.3 12.37 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 110.075 -1.21 . . . . 70.010000000000005 110.075 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -86.84 128.72 35.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.17 0.509 . . . . 71.150000000000006 110.843 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.8 t -136.07 134.32 50.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 70.120000000000005 109.474 -177.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.545 HG12 HD11 ' A' ' 597' ' ' ILE . 44.7 mm -93.75 122.04 44.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.795 -0.817 . . . . 73.420000000000002 108.795 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.65 102.07 54.41 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 123.471 0.482 . . . . 73.420000000000002 110.438 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 6.1 Cg_exo -76.49 148.73 30.02 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 121.932 1.754 . . . . 74.299999999999997 111.127 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -138.05 166.68 23.49 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.972 -1.122 . . . . 74.019999999999996 107.972 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 589' ' ' LEU . 54.3 pttt -157.45 134.83 10.44 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.03 0.443 . . . . 71.299999999999997 111.254 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.6 p -80.44 126.61 31.41 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.678 -0.692 . . . . 74.209999999999994 110.156 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 42.2 mm -95.16 116.45 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.101 -1.444 . . . . 62.109999999999999 107.101 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.73 111.66 18.19 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.41 0.444 . . . . 74.109999999999999 110.672 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.64 -110.93 3.31 Favored Glycine 0 C--N 1.31 -0.894 0 N-CA-C 110.159 -1.176 . . . . 64.040000000000006 110.159 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 586' ' ' SER . 6.5 m -70.06 -35.48 74.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.684 -1.228 . . . . 61.210000000000001 107.684 175.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.92 132.69 35.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.325 -1.307 . . . . 53.32 108.439 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -114.6 157.11 23.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.587 0.708 . . . . 75.109999999999999 111.412 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -88.17 -154.0 27.0 Favored Glycine 0 N--CA 1.427 -1.948 0 CA-C-N 114.829 -1.078 . . . . 73.150000000000006 111.972 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.43 8.84 47.59 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.964 -0.16 . . . . 51.130000000000003 112.99 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.65 24.22 26.35 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 121.152 -0.547 . . . . 71.420000000000002 111.982 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.57 -69.59 0.61 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.478 -0.934 . . . . 60.229999999999997 108.478 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.92 -40.13 6.34 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.398 -1.334 . . . . 73.129999999999995 107.398 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -143.12 172.59 12.52 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-N 114.943 -1.026 . . . . 64.430000000000007 109.761 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 574' ' ' ARG . 1.7 tm-20 -98.04 114.26 26.36 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 75.439999999999998 105.241 175.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.78 136.81 37.47 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.647 0.737 . . . . 75.150000000000006 111.466 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -130.27 125.74 35.56 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 122.145 0.974 . . . . 60.43 111.734 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 38.6 t -132.43 127.13 34.68 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 105.861 -1.903 . . . . 52.009999999999998 105.861 172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.68 -174.61 37.5 Favored Glycine 0 C--N 1.269 -3.161 0 N-CA-C 109.649 -1.38 . . . . 44.399999999999999 109.649 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 8.6 pt-20 -121.01 127.98 52.26 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.364 0.602 . . . . 71.319999999999993 111.424 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.13 136.22 33.07 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.226 -0.897 . . . . 73.030000000000001 108.817 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.17 98.84 9.2 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 121.496 0.665 . . . . 74.549999999999997 109.606 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.608 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 36.2 m-85 -92.61 124.24 36.48 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.823 -0.626 . . . . 71.349999999999994 110.516 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.646 ' H ' HD11 ' A' ' 567' ' ' ILE . 27.8 mm-40 -83.63 -146.98 0.09 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.057 -1.831 . . . . 71.349999999999994 106.057 172.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.529 ' OD1' ' HD2' ' A' ' 532' ' ' ARG . 61.2 t30 -63.47 170.49 3.09 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.15 0.58 . . . . 62.399999999999999 110.429 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.81 -11.58 8.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.618 1.167 . . . . 61.009999999999998 113.864 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.07 -21.79 66.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.656 0.782 . . . . 74.129999999999995 112.839 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.646 HD11 ' H ' ' A' ' 563' ' ' GLN . 23.7 pt -114.18 168.9 5.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 O-C-N 121.793 -0.567 . . . . 72.109999999999999 111.265 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.17 147.42 25.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.442 -1.318 . . . . 63.420000000000002 107.442 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 68.4 mmtt -111.34 148.5 32.85 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.088 0.471 . . . . 62.0 111.224 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.1 mt -120.38 132.53 69.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.834 -1.075 . . . . 74.109999999999999 110.328 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.2 mt -91.91 126.46 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.7 -1.593 . . . . 73.329999999999998 106.7 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 521' ' ' MET . 16.2 p -113.94 112.78 23.87 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.052 0.453 . . . . 63.310000000000002 109.966 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 589' ' ' LEU . 70.1 mt -105.0 130.62 55.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.617 -0.512 . . . . 71.439999999999998 109.617 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' A' ' 554' ' ' GLU . 99.3 mtt180 -78.53 114.95 17.9 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.131 0.491 . . . . 71.239999999999995 110.309 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.9 mm -103.22 137.49 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 106.166 -1.79 . . . . 55.140000000000001 106.166 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 554' ' ' GLU . 47.6 m-85 . . . . . 0 C--N 1.298 -1.655 0 C-N-CA 119.89 -0.724 . . . . 72.329999999999998 111.739 -176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.443 -0.809 0 CA-C-O 120.553 0.215 . . . . 62.439999999999998 111.278 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.405 ' H ' ' HB ' ' A' ' 545' ' ' THR . 63.9 p -117.69 149.03 41.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.911 -0.493 . . . . 72.540000000000006 110.875 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.6 p90 -137.15 174.84 10.18 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.324 -0.991 . . . . 74.219999999999999 108.324 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 13.0 m -124.85 167.03 15.2 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 120.256 -0.577 . . . . 74.239999999999995 109.616 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 573' ' ' ILE . 39.3 tp -141.45 130.87 23.75 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.083 -1.451 . . . . 70.040000000000006 107.083 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.72 157.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 123.343 0.402 . . . . 65.5 110.041 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 75.2 mt -96.76 142.78 28.37 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.096 -1.446 . . . . 75.450000000000003 107.096 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 538' ' ' PRO . 10.9 mm-40 -104.43 172.24 6.9 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 123.441 0.463 . . . . 73.230000000000004 110.033 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -52.64 112.2 3.24 Favored Pre-proline 0 C--N 1.316 -0.876 0 O-C-N 124.957 1.411 . . . . 75.019999999999996 110.987 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -76.04 153.8 37.21 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 C-N-CA 121.705 1.603 . . . . 73.129999999999995 111.504 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -124.09 132.14 53.63 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.378 -0.601 . . . . 75.519999999999996 109.378 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -93.77 140.82 29.21 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.491 -0.559 . . . . 74.340000000000003 109.491 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 536' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.423 -1.795 0 CA-C-O 122.752 1.263 . . . . 60.43 110.458 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 122.233 1.016 . . . . 64.230000000000004 113.22 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.83 -175.2 2.73 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.893 -1.503 . . . . 65.340000000000003 108.006 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.7 143.71 47.2 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 108.012 -2.035 . . . . 61.32 108.012 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . 0.449 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 32.7 tt0 -52.55 -42.44 64.42 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.04 0.536 . . . . 71.040000000000006 111.869 -174.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . 0.449 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 52.3 m80 -128.24 101.02 6.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.028 -1.101 . . . . 64.340000000000003 108.028 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 5.0 t -136.0 110.55 8.58 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-O 122.383 1.087 . . . . 63.43 111.041 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 35.9 ttmt -146.49 150.82 36.33 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.6 -1.63 . . . . 64.329999999999998 106.6 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 509' ' ' GLU . 61.5 tp -127.54 112.76 15.29 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.2 -0.667 . . . . 62.109999999999999 109.2 174.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.429 ' HB2' HG22 ' A' ' 511' ' ' VAL . 43.5 mt-10 -89.62 125.35 35.2 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.658 -0.867 . . . . 64.040000000000006 108.658 175.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.36 119.45 59.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.427 -0.953 . . . . 71.430000000000007 108.427 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.26 125.0 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 115.576 -0.738 . . . . 71.140000000000001 110.207 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.187 0 CA-C-O 121.718 0.77 . . . . 73.219999999999999 110.991 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.963 0 N-CA-C 111.303 -0.719 . . . . 72.349999999999994 111.303 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 84.6 mt -127.25 114.73 37.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.013 -1.477 . . . . 73.519999999999996 107.013 176.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.419 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 37.4 m-85 -103.48 136.98 42.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.793 0.33 . . . . 73.219999999999999 110.809 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.2 t -148.02 160.79 42.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.49 -0.929 . . . . 44.020000000000003 108.49 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -79.9 156.09 27.45 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.668 -0.493 . . . . 74.420000000000002 109.668 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.03 -51.1 68.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.894 0.746 . . . . 71.129999999999995 110.07 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -131.85 157.17 78.93 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.16 -0.927 . . . . 74.299999999999997 109.132 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.52 -21.71 7.22 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.261 1.974 . . . . 74.340000000000003 112.501 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.7 t -143.13 133.93 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.372 0.669 . . . . 70.109999999999999 109.275 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -133.59 138.37 45.96 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 109.313 -0.625 . . . . 72.129999999999995 109.313 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -109.52 110.93 22.17 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.857 -1.164 . . . . 74.329999999999998 107.857 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.33 158.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 116.191 -0.459 . . . . 62.420000000000002 110.439 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 518' ' ' ILE . 22.1 m -78.07 137.35 38.19 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.569 -0.741 . . . . 74.349999999999994 109.232 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -65.43 -24.77 67.28 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 123.664 0.786 . . . . 74.200000000000003 110.733 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.4 p -100.45 11.11 40.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.781 -0.645 . . . . 63.32 112.286 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 515' ' ' SER . 11.1 tt -71.32 -37.69 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 120.295 -0.562 . . . . 53.409999999999997 112.129 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.21 -73.22 1.51 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.239 -0.982 . . . . 21.120000000000001 111.389 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.28 125.21 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.442 -1.318 . . . . 74.540000000000006 107.442 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.2 ppp? -100.97 143.31 31.28 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.229 -0.656 . . . . 73.439999999999998 109.229 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -110.19 124.63 51.92 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.836 0.71 . . . . 72.549999999999997 110.848 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 641' ' ' LEU . 41.6 t -129.86 131.34 66.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 110.373 -0.232 . . . . 74.450000000000003 110.373 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.29 136.65 32.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.479 0.487 . . . . 73.439999999999998 110.184 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 96.3 t -95.48 118.14 41.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 105.872 -1.899 . . . . 74.409999999999997 105.872 171.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.6 mt -95.87 135.73 37.23 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 116.099 -0.501 . . . . 75.209999999999994 110.774 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 104.12 15.94 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.441 -0.8 . . . . 74.200000000000003 110.391 174.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.0 m -61.0 -62.45 1.85 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.404 1.081 . . . . 63.210000000000001 111.923 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.5 p -73.3 -31.62 64.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.851 0.834 . . . . 73.319999999999993 109.766 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.62 -155.51 22.28 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 109.814 -1.314 . . . . 64.329999999999998 109.814 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -150.63 155.06 38.63 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.732 -1.951 . . . . 42.509999999999998 105.732 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -157.86 126.73 5.68 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.859 -0.793 . . . . 74.310000000000002 108.859 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.86 -125.42 8.24 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 111.171 -0.771 . . . . 73.219999999999999 111.171 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -136.42 102.33 4.92 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 106.311 -1.737 . . . . 72.349999999999994 106.311 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 37.9 t -113.88 120.4 63.6 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.569 0 C-N-CA 119.236 -0.986 . . . . 72.040000000000006 110.79 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.3 mm -92.11 116.4 33.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 114.803 -1.09 . . . . 72.129999999999995 108.628 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.73 100.6 43.27 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.102 -0.954 . . . . 74.129999999999995 109.248 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 558' ' ' GLY . 2.0 Cg_endo -77.1 153.54 32.21 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.861 1.707 . . . . 61.399999999999999 112.497 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -139.65 159.23 42.64 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.7 -0.852 . . . . 62.109999999999999 108.7 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.517 ' O ' HD12 ' A' ' 589' ' ' LEU . 60.5 pttt -152.13 145.97 25.13 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.022 0.439 . . . . 74.420000000000002 111.017 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -88.09 127.37 35.41 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.286 -0.87 . . . . 73.150000000000006 111.911 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 42.4 mm -100.69 116.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.678 -1.23 . . . . 70.319999999999993 107.678 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.473 ' CD ' HH21 ' A' ' 547' ' ' ARG . 39.7 mt-10 -77.66 116.19 18.01 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.601 -0.272 . . . . 74.420000000000002 110.491 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.19 -115.95 4.06 Favored Glycine 0 C--N 1.306 -1.134 0 N-CA-C 109.028 -1.629 . . . . 73.030000000000001 109.028 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.2 p -75.59 -23.98 56.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.738 0.78 . . . . 72.450000000000003 109.387 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.63 129.27 34.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.523 -1.217 . . . . 73.319999999999993 108.602 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.473 HH21 ' CD ' ' A' ' 543' ' ' GLU . 7.4 tpm_? -95.4 140.72 29.87 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 109.202 -0.666 . . . . 73.400000000000006 109.202 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.15 -160.73 33.16 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.935 -0.866 . . . . 74.239999999999995 110.935 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 79.0 16.72 78.42 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.767 -0.73 . . . . 70.349999999999994 111.636 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 80.29 31.69 37.23 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 111.644 -0.582 . . . . 70.049999999999997 111.644 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -94.25 -71.09 0.68 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 122.447 -0.443 . . . . 74.409999999999997 110.543 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -29.82 12.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.685 1.231 . . . . 74.129999999999995 107.757 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -143.98 157.69 44.18 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.117 -1.438 . . . . 74.219999999999999 107.117 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.525 ' CD ' ' HD2' ' A' ' 574' ' ' ARG . 6.8 tt0 -96.03 135.98 37.08 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 106.861 -1.533 . . . . 73.409999999999997 106.861 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -74.64 120.4 20.14 Favored 'General case' 0 CA--C 1.472 -2.031 0 C-N-CA 120.643 -0.423 . . . . 52.210000000000001 110.745 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.493 ' CG2' HG12 ' A' ' 573' ' ' ILE . 10.1 t -124.58 120.12 31.02 Favored 'General case' 0 N--CA 1.392 -3.325 0 N-CA-C 105.44 -2.059 . . . . 72.400000000000006 105.44 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.5 p -137.14 139.4 41.15 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.412 -1.699 . . . . 63.229999999999997 106.412 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 538' ' ' PRO . . . -175.88 -166.59 33.56 Favored Glycine 0 N--CA 1.397 -3.952 0 C-N-CA 117.951 -2.071 . . . . 71.239999999999995 112.828 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.7 mt-10 -123.46 114.09 19.64 Favored 'General case' 0 N--CA 1.403 -2.777 0 C-N-CA 124.364 1.066 . . . . 70.430000000000007 108.969 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.33 142.62 27.59 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.57 -0.741 . . . . 74.25 109.207 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -103.56 117.25 33.99 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.8 m-85 -115.94 100.17 7.79 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.281 -1.007 . . . . 72.549999999999997 108.281 173.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.661 ' H ' HD11 ' A' ' 567' ' ' ILE . 77.0 mt-30 -77.35 -87.7 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.948 -0.569 . . . . 75.230000000000004 110.502 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -105.27 164.88 11.51 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 109.881 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 3.7 p30 -56.9 -11.38 1.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.991 1.478 . . . . 74.530000000000001 114.991 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 566' ' ' GLU . 10.2 pt-20 -79.73 -14.34 58.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.089 0.774 . . . . 71.340000000000003 113.089 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.661 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.3 pt -114.82 169.31 5.86 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.115 0.483 . . . . 72.099999999999994 112.244 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.17 160.17 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.42 -0.956 . . . . 63.439999999999998 108.42 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -124.02 154.9 39.2 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 111.925 0.343 . . . . 71.140000000000001 111.925 177.405 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 73.5 mt -125.33 130.65 72.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.011 -0.995 . . . . 73.030000000000001 110.108 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 589' ' ' LEU . 62.1 mt -90.9 129.08 42.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 107.312 -1.366 . . . . 61.219999999999999 107.312 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 7.7 p -115.91 112.84 22.49 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 123.858 0.724 . . . . 71.439999999999998 110.132 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.493 HG12 ' CG2' ' A' ' 556' ' ' THR . 48.9 mt -116.03 130.96 69.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 121.021 -0.271 . . . . 71.209999999999994 110.711 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.525 ' HD2' ' CD ' ' A' ' 554' ' ' GLU . 92.2 mtt180 -71.19 116.75 11.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.559 0.537 . . . . 74.349999999999994 109.977 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 645' ' ' ILE . 38.0 mm -101.47 135.95 35.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.752 -1.113 . . . . 75.349999999999994 109.744 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 105.313 -2.106 . . . . 74.049999999999997 105.313 178.378 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' ' 645' ' ' ILE . 5.1 p . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 121.443 0.64 . . . . 41.240000000000002 110.29 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 80.4 p -134.95 150.73 50.43 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 121.433 0.635 . . . . 52.210000000000001 111.179 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.38 156.87 46.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.013 -1.477 . . . . 61.43 107.013 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 9.4 m -112.19 153.22 27.38 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.669 -0.813 . . . . 54.340000000000003 109.024 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 540' ' ' LYS . 43.1 tp -124.96 131.51 53.41 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.806 -1.553 . . . . 53.109999999999999 106.806 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.05 159.32 43.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 110.071 -0.344 . . . . 72.400000000000006 110.071 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.16 145.75 27.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.705 0.628 . . . . 75.409999999999997 109.685 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . 0.417 ' O ' HD11 ' A' ' 635' ' ' LEU . 6.6 mm-40 -96.69 163.02 13.19 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.177 -1.045 . . . . 62.020000000000003 108.177 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.0 122.53 72.8 Favored Pre-proline 0 C--N 1.311 -1.096 0 O-C-N 123.678 0.611 . . . . 71.420000000000002 110.383 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.453 ' HD3' ' HG ' ' A' ' 635' ' ' LEU . 59.7 Cg_endo -79.2 151.17 23.24 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 122.841 2.361 . . . . 74.310000000000002 113.31 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -122.11 128.7 51.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.772 -1.104 . . . . 72.430000000000007 110.38 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -84.16 116.81 23.1 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.265 -1.383 . . . . 74.5 107.265 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 45.4 mm . . . . . 0 C--N 1.28 -2.421 0 N-CA-C 108.354 -0.98 . . . . 44.119999999999997 108.354 -179.221 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.429 -1.503 0 CA-C-O 121.626 0.727 . . . . 71.010000000000005 110.069 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.453 ' HG ' ' HD3' ' A' ' 594' ' ' PRO . 22.6 mt -97.59 170.82 8.76 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.196 -1.039 . . . . 64.129999999999995 108.196 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.57 151.08 49.11 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.121 -2.392 . . . . 52.240000000000002 107.121 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.51 -42.06 66.95 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.235 0.517 . . . . 72.340000000000003 111.28 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -124.34 101.0 6.95 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.508 0.67 . . . . 73.140000000000001 110.733 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 7.5 t -136.02 109.78 8.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 122.243 1.02 . . . . 74.049999999999997 109.411 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -146.77 148.87 32.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.828 -1.175 . . . . 72.519999999999996 107.828 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . 0.415 HD22 HG11 ' A' ' 523' ' ' VAL . 56.5 tp -129.6 112.98 14.25 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.425 -0.583 . . . . 50.450000000000003 109.425 175.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 511' ' ' VAL . 46.8 mt-10 -89.24 127.98 35.8 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.636 -0.875 . . . . 72.030000000000001 108.636 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.61 120.68 62.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.31 -0.996 . . . . 71.209999999999994 108.31 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 644' ' ' ILE . 3.6 mp -110.87 134.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.435 -0.802 . . . . 63.520000000000003 110.829 -176.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.439 HG21 HG23 ' A' ' 575' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 C-N-CA 124.821 1.248 . . . . 63.350000000000001 109.551 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.42 -2.394 0 N-CA-C 111.548 -0.621 . . . . 75.209999999999994 111.548 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.48 121.32 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.785 -1.561 . . . . 72.140000000000001 106.785 172.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 56.4 m-85 -110.84 134.46 52.51 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.511 0.507 . . . . 73.230000000000004 110.078 -175.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 6.3 t -148.25 152.79 37.77 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 110.386 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.2 m-85 -74.26 159.74 32.06 Favored 'General case' 0 C--O 1.262 1.718 0 N-CA-C 108.862 -0.792 . . . . 75.109999999999999 108.862 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.35 -51.87 57.54 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.789 0.681 . . . . 63.399999999999999 109.613 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.49 161.54 54.22 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.146 -0.934 . . . . 73.310000000000002 109.088 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.2 Cg_endo -84.73 -20.8 3.59 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.613 1.542 . . . . 34.43 112.425 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 77.7 t -141.53 134.96 30.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.654 -0.499 . . . . 74.329999999999998 109.654 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -133.9 138.23 45.43 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.571 -0.529 . . . . 73.310000000000002 109.571 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -111.06 119.28 38.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 74.239999999999995 107.875 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.93 170.79 16.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.894 0.378 . . . . 70.310000000000002 110.381 -178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.2 t -88.88 158.97 17.91 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.6 0.714 . . . . 34.119999999999997 111.248 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -8.25 59.54 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.122 -0.945 . . . . 63.039999999999999 110.195 172.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 71.2 m -113.8 19.18 16.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.941 -0.572 . . . . 61.210000000000001 111.248 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 7.2 tt -82.22 -26.23 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.15 -0.62 . . . . 45.119999999999997 111.189 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.85 -74.24 2.52 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.588 -0.815 . . . . 64.120000000000005 111.588 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 574' ' ' ARG . 46.1 mm -129.92 131.17 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.503 -0.925 . . . . 63.109999999999999 108.503 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 17.9 ptm -107.15 145.75 32.15 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.97 -0.752 . . . . 63.109999999999999 108.97 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -106.36 129.31 54.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 123.374 0.421 . . . . 54.399999999999999 110.631 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.8 t -115.52 121.19 66.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.81 -0.811 . . . . 73.239999999999995 108.81 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -95.59 130.0 42.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.236 0.541 . . . . 61.329999999999998 110.594 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.43 115.17 35.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.152 -1.055 . . . . 74.409999999999997 108.152 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.422 ' HA ' HH21 ' A' ' 527' ' ' ARG . 79.4 mt -88.08 149.67 23.82 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.661 -0.7 . . . . 73.099999999999994 109.583 -176.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -114.92 103.78 11.27 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.266 -1.013 . . . . 74.409999999999997 108.266 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.1 p -67.23 -58.11 5.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.519 0.676 . . . . 62.140000000000001 110.939 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 24.3 t -73.97 -23.76 59.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.324 -0.853 . . . . 74.140000000000001 110.157 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . 0.516 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 108.88 -149.18 16.99 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 110.229 -1.149 . . . . 44.229999999999997 110.229 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -160.16 135.79 8.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.185 -1.413 . . . . 75.030000000000001 107.185 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -136.35 121.47 18.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.261 -0.644 . . . . 73.400000000000006 109.261 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.44 -121.99 7.29 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.798 -0.715 . . . . 43.340000000000003 113.038 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -137.75 104.89 5.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.028 -1.101 . . . . 65.120000000000005 108.028 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.88 126.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.619 0.723 . . . . 54.210000000000001 110.634 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 559' ' ' GLU . 29.8 mm -95.78 118.01 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.349 -0.842 . . . . 70.510000000000005 109.468 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.65 103.72 50.23 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 115.295 -0.866 . . . . 71.420000000000002 108.792 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 1.0 OUTLIER -78.16 156.67 29.92 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 121.424 1.416 . . . . 65.340000000000003 111.082 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -143.01 161.0 39.28 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.384 -1.339 . . . . 73.319999999999993 107.384 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -156.17 135.07 11.89 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.951 0.405 . . . . 74.530000000000001 111.14 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.6 p -82.92 122.96 28.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.661 -0.699 . . . . 71.519999999999996 110.378 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 37.0 mm -92.71 125.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.764 -1.199 . . . . 75.120000000000005 107.764 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.58 113.11 13.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.922 0.392 . . . . 73.140000000000001 111.242 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -92.4 -103.47 1.49 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.433 -1.067 . . . . 41.43 110.433 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -94.1 -18.01 22.23 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 109.69 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.01 149.1 24.21 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.392 -0.822 . . . . 75.530000000000001 108.924 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 45.0 ttt180 -101.84 134.83 44.4 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.11 0.481 . . . . 71.219999999999999 112.055 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.96 -179.75 47.26 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.476 -0.783 . . . . 41.229999999999997 111.367 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.87 57.62 Favored Glycine 0 C--N 1.306 -1.125 0 N-CA-C 110.594 -1.002 . . . . 54.530000000000001 110.594 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.33 19.95 50.65 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 111.491 -0.644 . . . . 71.140000000000001 111.491 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 15.7 mm-40 -80.08 -80.1 0.14 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.361 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.79 -32.18 16.21 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.825 -0.805 . . . . 72.120000000000005 108.825 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -143.94 152.8 41.57 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.02 -1.104 . . . . 75.439999999999998 108.02 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.584 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 23.3 tt0 -87.89 105.08 17.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.681 -2.34 . . . . 75.109999999999999 104.681 176.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.32 144.96 56.78 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.024 0.828 . . . . 62.240000000000002 109.725 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -140.06 114.06 8.93 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-O 122.046 0.927 . . . . 72.129999999999995 110.885 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.2 p -125.15 118.54 26.31 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.212 -1.358 . . . . 52.409999999999997 107.373 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.17 15.54 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 110.668 -0.973 . . . . 75.510000000000005 110.668 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.502 ' HB2' HG23 ' A' ' 536' ' ' ILE . 8.0 pt-20 -132.84 139.18 47.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.334 0.588 . . . . 70.439999999999998 111.866 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.97 144.71 33.2 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.48 -1.236 . . . . 64.540000000000006 108.692 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -109.73 104.21 13.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.208 0.528 . . . . 74.540000000000006 111.052 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.7 m-85 -98.71 120.0 38.41 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.27 -1.011 . . . . 53.210000000000001 108.27 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.491 ' H ' HD11 ' A' ' 567' ' ' ILE . 49.6 mt-30 -98.21 -80.18 0.46 Allowed 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.734 -0.839 . . . . 63.100000000000001 108.734 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -105.33 155.17 19.35 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.966 -0.561 . . . . 63.210000000000001 110.131 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -46.51 -29.16 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.171 1.788 . . . . 72.430000000000007 114.213 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.475 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.8 pt-20 -64.62 -14.14 56.64 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.95 1.093 . . . . 61.329999999999998 113.95 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.491 HD11 ' H ' ' A' ' 563' ' ' GLN . 37.2 pt -112.76 156.46 13.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 119.706 -0.798 . . . . 74.439999999999998 110.283 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.65 144.32 37.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.692 -0.855 . . . . 72.439999999999998 108.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.655 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.4 mmpt? -111.36 149.57 30.97 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 120.404 -0.519 . . . . 73.129999999999995 109.662 176.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 570' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 73.3 mt -126.05 131.45 71.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.481 -1.236 . . . . 75.549999999999997 110.595 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 41.6 mt -92.87 123.75 45.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.321 -1.362 . . . . 75.340000000000003 107.321 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 19.5 p -108.29 114.27 28.0 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 123.466 0.479 . . . . 72.420000000000002 109.814 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 589' ' ' LEU . 36.6 mt -110.01 135.03 50.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.554 -0.535 . . . . 62.409999999999997 109.554 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 574' ' ' ARG . . . . . 0.584 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 71.3 ttt180 -92.21 123.82 35.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.263 -0.643 . . . . 74.340000000000003 109.263 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.2 134.22 46.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.313 -0.625 . . . . 74.310000000000002 109.313 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 83.1 m-85 . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 109.251 -0.648 . . . . 65.219999999999999 109.251 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' CYS . . . . . 0.424 ' SG ' HG12 ' A' ' 645' ' ' ILE . 3.5 p . . . . . 0 N--CA 1.424 -1.759 0 N-CA-C 109.166 -0.679 . . . . 71.230000000000004 109.166 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 15.0 m -138.26 148.55 44.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.23 -0.656 . . . . 73.400000000000006 109.23 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.1 166.25 25.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.855 -1.165 . . . . 71.540000000000006 107.855 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' SER . . . . . 0.412 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 26.5 m -116.29 166.86 11.56 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 119.935 -0.706 . . . . 64.430000000000007 109.686 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 573' ' ' ILE . 31.8 tp -139.58 127.8 22.57 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 107.591 -1.263 . . . . 64.299999999999997 107.591 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.36 157.31 36.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.614 -0.513 . . . . 75.329999999999998 109.614 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 45.2 mt -95.34 147.23 23.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.114 -1.81 . . . . 55.509999999999998 106.114 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 593' ' ' GLU . 6.8 tp10 -98.43 177.67 5.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.857 -1.535 . . . . 71.310000000000002 106.857 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 37.6 mt-10 -75.16 119.78 78.54 Favored Pre-proline 0 C--N 1.288 -2.105 0 CA-C-N 116.341 -0.39 . . . . 72.219999999999999 110.638 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.454 ' HD3' HD22 ' A' ' 635' ' ' LEU . 77.3 Cg_endo -72.41 146.14 44.22 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.351 2.701 . . . . 74.200000000000003 113.703 -174.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -110.31 149.28 30.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.442 -0.947 . . . . 74.319999999999993 108.442 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -107.14 127.88 53.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.673 -1.232 . . . . 75.400000000000006 107.673 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 597' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.3 -1.578 0 CA-C-O 122.229 1.014 . . . . 71.450000000000003 108.717 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 19.9 pt . . . . . 0 N--CA 1.424 -1.728 0 CA-C-O 120.792 0.329 . . . . 63.130000000000003 110.326 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 635' ' ' LEU . . . . . 0.454 HD22 ' HD3' ' A' ' 594' ' ' PRO . 1.9 pt? -134.56 -171.87 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.321 -0.622 . . . . 64.129999999999995 109.321 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -63.66 156.52 43.0 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 121.026 -0.607 . . . . 51.049999999999997 111.822 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.39 -57.2 13.97 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.29 1.036 . . . . 74.200000000000003 110.025 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.4 98.8 4.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.733 -0.84 . . . . 71.310000000000002 108.733 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.6 t -130.94 110.45 11.27 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-O 122.625 1.202 . . . . 75.540000000000006 110.465 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 640' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 39.5 ttpt -147.61 141.06 25.37 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.924 -1.51 . . . . 72.140000000000001 106.924 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 63.2 tp -117.18 110.0 17.6 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.878 -0.786 . . . . 74.329999999999998 108.878 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.36 123.9 32.81 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.648 -0.871 . . . . 74.129999999999995 108.648 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.4 121.37 61.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.148 -0.933 . . . . 71.5 109.373 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.61 128.43 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.191 -0.913 . . . . 62.229999999999997 109.534 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.424 HG12 ' SG ' ' A' ' 585' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.462 0 CA-C-N 115.25 -0.886 . . . . 75.239999999999995 110.066 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 61.5 m80 . . . . . 0 C--O 1.242 0.696 0 N-CA-C 107.298 -1.371 . . . . 72.430000000000007 107.298 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -83.12 87.85 6.9 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.457 -0.572 . . . . 50.229999999999997 109.457 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -83.39 133.95 12.36 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.973 -0.851 . . . . 74.420000000000002 110.973 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 63.8 mt -127.27 114.82 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.18 -0.674 . . . . 71.040000000000006 109.18 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.19 136.58 52.8 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 123.084 0.24 . . . . 73.319999999999993 110.445 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.1 t -148.64 160.23 43.34 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.993 -0.373 . . . . 74.129999999999995 109.993 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -76.71 158.57 30.88 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 122.164 0.186 . . . . 72.349999999999994 110.583 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 45.6 mt-10 -58.48 -49.97 75.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.179 0.514 . . . . 75.200000000000003 110.716 177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . 0.56 ' OE2' ' HD2' ' A' ' 510' ' ' PRO . 7.7 tp10 -141.96 137.76 16.3 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.523 -2.029 . . . . 64.329999999999998 105.523 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.56 ' HD2' ' OE2' ' A' ' 509' ' ' GLU . 41.4 Cg_endo -70.79 -10.65 28.17 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.491 2.127 . . . . 72.0 114.656 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 642' ' ' GLU . 72.7 t -140.73 126.93 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 O-C-N 122.028 -0.42 . . . . 72.400000000000006 110.161 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.96 130.57 37.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.484 0.659 . . . . 33.439999999999998 109.615 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -110.07 121.61 45.67 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.646 -0.501 . . . . 72.540000000000006 109.646 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.81 160.91 36.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.128 -0.487 . . . . 63.439999999999998 111.709 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 518' ' ' ILE . 20.2 m -71.88 156.47 39.24 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.41 -0.814 . . . . 73.400000000000006 110.832 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.13 -30.73 58.3 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.811 -1.181 . . . . 60.509999999999998 107.811 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.1 p -90.83 16.71 8.83 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.435 -1.257 . . . . 74.349999999999994 111.777 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 515' ' ' SER . 7.5 tt -78.73 -30.09 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 120.281 -0.568 . . . . 72.230000000000004 110.607 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.39 -68.09 3.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 120.108 -1.044 . . . . 73.120000000000005 112.444 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.2 mm -130.79 132.12 64.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.638 -1.245 . . . . 74.200000000000003 107.638 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -107.15 154.51 21.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.167 -1.049 . . . . 73.340000000000003 108.167 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -125.55 124.25 40.88 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.923 0.392 . . . . 71.030000000000001 111.595 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.637 HG12 ' HB ' ' A' ' 571' ' ' ILE . 8.6 p -124.86 133.15 70.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.019 -0.734 . . . . 72.099999999999994 109.019 172.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 98.7 mttt -93.27 138.68 31.42 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.407 -0.59 . . . . 75.400000000000006 109.407 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 85.3 t -96.03 121.04 46.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 106.926 -1.509 . . . . 71.329999999999998 106.926 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.16 155.59 16.99 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.235 -0.893 . . . . 73.349999999999994 110.314 -174.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -124.86 104.61 8.7 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.327 -0.99 . . . . 65.140000000000001 108.327 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.8 m -64.93 -56.11 15.23 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.28 -0.873 . . . . 73.540000000000006 111.153 -174.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.6 p -73.79 -48.21 33.23 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.593 0.711 . . . . 61.310000000000002 110.005 177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.41 -159.91 26.8 Favored Glycine 0 N--CA 1.418 -2.516 0 N-CA-C 111.171 -0.771 . . . . 71.519999999999996 111.171 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.485 ' H ' ' HB2' ' A' ' 565' ' ' ASP . . . -148.51 144.95 27.68 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.999 -1.482 . . . . 54.530000000000001 106.999 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -161.12 77.61 0.57 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.759 -0.83 . . . . 75.439999999999998 108.759 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.535 ' HA2' ' C ' ' A' ' 600' ' ' GLY . . . 157.87 -127.67 1.95 Allowed Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.018 -1.087 . . . . 24.41 111.311 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -137.22 102.57 4.86 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 106.395 -1.706 . . . . 65.200000000000003 106.395 172.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 120.0 62.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.335 0.588 . . . . 61.149999999999999 110.347 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.88 115.88 34.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 N-CA-C 108.457 -0.942 . . . . 63.329999999999998 108.457 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.77 101.51 51.46 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-N 115.607 -0.724 . . . . 63.5 109.835 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 2.7 Cg_endo -76.66 155.79 35.51 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.088 1.858 . . . . 60.109999999999999 112.275 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -142.15 160.66 39.79 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.435 -0.95 . . . . 74.530000000000001 108.435 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -151.43 136.43 17.37 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.875 0.369 . . . . 71.019999999999996 110.977 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.3 p -85.0 126.89 33.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.853 -0.612 . . . . 63.009999999999998 111.271 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.65 121.25 47.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.267 -1.012 . . . . 72.219999999999999 108.267 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -79.16 104.88 10.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.843 -0.799 . . . . 73.439999999999998 108.843 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -86.24 -94.3 0.84 Allowed Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.386 -1.086 . . . . 63.210000000000001 110.386 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.8 p -102.8 -12.27 17.72 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.172 0.511 . . . . 72.109999999999999 110.538 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.43 152.89 21.24 Favored 'General case' 0 C--O 1.25 1.128 0 N-CA-C 108.391 -0.966 . . . . 65.549999999999997 108.391 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -107.61 131.4 54.41 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 120.157 -0.617 . . . . 74.219999999999999 109.856 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.19 -154.76 20.35 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 110.271 -1.132 . . . . 45.130000000000003 110.271 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.23 12.92 79.81 Favored Glycine 0 C--N 1.307 -1.047 0 C-N-CA 120.513 -0.851 . . . . 65.219999999999999 112.094 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.464 ' HA2' ' CE1' ' A' ' 576' ' ' PHE . . . 92.29 11.38 59.82 Favored Glycine 0 N--CA 1.427 -1.901 0 C-N-CA 120.779 -0.724 . . . . 74.230000000000004 113.104 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -76.25 -77.95 0.13 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 117.45 0.625 . . . . 70.329999999999998 110.802 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -93.84 -42.72 8.95 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.882 -1.155 . . . . 42.200000000000003 107.882 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -135.36 163.05 30.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 108.966 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 576' ' ' PHE . 28.2 tt0 -97.62 116.62 30.19 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 106.294 -1.743 . . . . 72.420000000000002 106.294 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.17 142.15 54.38 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.364 -0.606 . . . . 74.420000000000002 109.364 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -140.12 132.44 28.33 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-O 121.684 0.755 . . . . 64.510000000000005 110.229 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.4 p -140.65 122.14 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.714 -1.217 . . . . 40.210000000000001 107.714 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.68 -176.97 36.13 Favored Glycine 0 CA--C 1.474 -2.47 0 N-CA-C 109.743 -1.343 . . . . 74.340000000000003 109.743 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 0.3 OUTLIER -126.31 128.68 47.5 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 121.628 0.728 . . . . 64.329999999999998 111.961 -179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 79.7 mt -89.53 144.34 26.11 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.094 -1.412 . . . . 72.120000000000005 110.061 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -105.59 101.87 11.37 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.395 0.617 . . . . 73.409999999999997 111.506 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 42.7 m-85 -100.21 100.41 11.23 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.791 -0.818 . . . . 70.219999999999999 108.791 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.473 ' H ' HD11 ' A' ' 567' ' ' ILE . 81.4 mt-30 -83.1 -77.9 0.23 Allowed 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.792 -0.763 . . . . 73.340000000000003 110.239 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -105.43 159.25 16.07 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.843 -0.617 . . . . 62.140000000000001 109.369 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.485 ' HB2' ' H ' ' A' ' 531' ' ' ALA . 13.2 t70 -57.99 -23.21 53.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.415 1.086 . . . . 71.439999999999998 111.931 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.08 -43.49 78.08 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 124.724 1.209 . . . . 73.340000000000003 112.0 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.473 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -96.39 158.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.255 0.55 . . . . 73.019999999999996 110.705 -173.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.68 154.78 41.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.879 -1.156 . . . . 74.5 107.879 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.59 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.5 mmpt? -115.49 154.71 28.83 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 120.861 0.362 . . . . 65.25 111.167 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 53.0 mt -128.54 136.62 59.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.581 -1.191 . . . . 71.209999999999994 109.529 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.637 ' HB ' HG12 ' A' ' 523' ' ' VAL . 56.3 mt -97.78 125.7 50.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.563 -1.643 . . . . 74.030000000000001 106.563 174.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 21.7 p -110.41 112.38 24.27 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.672 -0.862 . . . . 73.430000000000007 108.672 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.618 HD11 HD22 ' A' ' 589' ' ' LEU . 42.5 mt -108.27 134.93 48.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.819 -0.808 . . . . 52.43 108.819 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.415 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.0 OUTLIER -82.18 117.13 22.09 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 109.566 -0.531 . . . . 71.420000000000002 109.566 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.3 mm -103.42 123.69 57.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 105.59 -2.004 . . . . 73.200000000000003 105.59 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 550' ' ' GLY . 90.4 m-85 -85.67 147.24 26.46 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 120.55 -0.46 . . . . 73.400000000000006 111.297 -175.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.05 75.77 2.92 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.617 -1.253 . . . . 64.329999999999998 107.617 176.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.11 115.16 29.7 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.38 -1.282 . . . . 73.239999999999995 109.243 -176.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -112.57 78.93 1.17 Allowed 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 105.527 -2.027 . . . . 74.25 105.527 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -91.88 -94.44 0.14 Allowed 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 114.244 -1.344 . . . . 72.230000000000004 110.079 -174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -155.0 153.52 31.13 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 105.032 -2.21 . . . . 71.150000000000006 105.032 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -63.13 120.58 11.75 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.907 0.706 . . . . 73.409999999999997 112.907 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 646' ' ' GLU . 35.3 mtmm -129.35 176.15 8.18 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.946 -1.501 . . . . 74.420000000000002 106.946 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -108.77 42.41 1.41 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.567 -1.642 . . . . 70.049999999999997 106.567 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 583' ' ' LYS . 16.2 p -67.77 120.51 14.23 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.075 -1.421 . . . . 72.120000000000005 113.352 -172.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.7 m -143.65 153.09 42.14 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.368 -1.345 . . . . 62.43 107.368 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -133.49 153.11 51.9 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.406 -0.961 . . . . 75.319999999999993 108.406 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.8 m -111.25 154.51 24.35 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 108.687 -0.857 . . . . 71.439999999999998 108.687 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.618 HD22 HD11 ' A' ' 573' ' ' ILE . 39.7 tp -129.07 130.46 46.56 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.068 -1.456 . . . . 73.349999999999994 107.068 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.43 158.7 38.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 123.218 0.324 . . . . 71.200000000000003 110.313 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 67.5 mt -98.05 145.52 26.45 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.128 -0.942 . . . . 74.150000000000006 108.49 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 538' ' ' PRO . 17.6 mm-40 -101.59 165.99 10.94 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.324 -0.621 . . . . 71.530000000000001 109.324 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -55.32 114.55 7.4 Favored Pre-proline 0 C--O 1.245 0.851 0 O-C-N 124.233 0.958 . . . . 75.109999999999999 111.303 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 633' ' ' PRO . 88.6 Cg_endo -77.62 150.56 27.92 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.132 2.554 . . . . 72.420000000000002 111.443 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.93 140.27 51.15 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.415 -0.178 . . . . 51.219999999999999 111.471 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . 0.446 ' HE1' ' HA3' ' A' ' 533' ' ' GLY . 1.0 OUTLIER -103.03 118.05 35.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.675 -0.491 . . . . 74.129999999999995 109.675 -176.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.01 150.08 4.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 C-N-CA 123.407 0.683 . . . . 72.530000000000001 110.432 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -65.83 -179.98 0.78 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.51 1.524 . . . . 74.140000000000001 112.412 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 67.15 -21.08 0.11 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 115.54 1.681 . . . . 74.540000000000006 115.54 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . 0.535 ' C ' ' HA2' ' A' ' 533' ' ' GLY . . . -87.59 -6.75 76.61 Favored Glycine 0 C--N 1.311 -0.854 0 C-N-CA 120.066 -1.064 . . . . 73.439999999999998 112.62 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 88.3 mtp -100.76 -167.92 1.5 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.517 -0.92 . . . . 54.109999999999999 108.517 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -143.93 131.83 21.53 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.633 -0.506 . . . . 74.230000000000004 109.633 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 89.13 -79.27 1.61 Allowed Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 111.648 -0.581 . . . . 71.25 111.648 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -94.62 128.98 9.71 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.713 -0.955 . . . . 73.430000000000007 110.713 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -128.28 134.39 48.93 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.618 -0.882 . . . . 73.120000000000005 108.618 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 68.2 m -86.63 102.96 14.66 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 108.813 -0.81 . . . . 72.099999999999994 108.813 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 40.1 mm -86.88 91.44 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 107.54 -1.282 . . . . 75.239999999999995 107.54 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 7.1 m -70.71 89.6 0.74 Allowed 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 114.976 -1.011 . . . . 74.010000000000005 109.594 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.97 -13.16 12.54 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.414 -0.812 . . . . 51.539999999999999 110.393 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -102.03 99.77 9.97 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.544 -0.909 . . . . 74.230000000000004 108.544 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -145.93 148.66 33.03 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 106.374 -1.713 . . . . 74.109999999999999 106.374 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . 0.601 ' HB2' ' HB3' ' A' ' 619' ' ' SER . 16.5 t70 -119.23 131.11 55.77 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.322 -0.621 . . . . 51.210000000000001 109.322 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -58.81 -21.52 56.55 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 125.152 1.381 . . . . 73.310000000000002 112.727 -174.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -67.96 -49.44 61.68 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 119.345 -0.36 . . . . 61.439999999999998 111.261 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -175.68 -56.71 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 114.762 1.393 . . . . 71.040000000000006 114.762 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -86.77 171.47 7.05 Favored 'Trans proline' 0 C--N 1.363 1.304 0 N-CA-C 115.953 1.482 . . . . 35.340000000000003 115.953 -169.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -89.49 -51.92 5.29 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 105.809 -1.923 . . . . 73.310000000000002 105.809 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 26.5 m -82.54 93.79 7.36 Favored 'General case' 0 N--CA 1.404 -2.728 0 CA-C-N 113.791 -1.55 . . . . 73.019999999999996 107.921 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.601 ' HB3' ' HB2' ' A' ' 612' ' ' ASP . 10.5 p -90.48 22.43 3.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 123.67 0.788 . . . . 63.409999999999997 111.304 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.62 -158.56 0.67 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.71 -1.219 . . . . 74.400000000000006 107.71 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -84.55 -157.05 0.26 Allowed 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.293 -1.002 . . . . 54.409999999999997 108.293 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.7 71.39 10.4 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.369 -0.832 . . . . 63.130000000000003 113.085 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -82.55 63.25 6.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.605 -0.725 . . . . 73.519999999999996 110.132 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 56.63 35.06 25.53 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.593 -0.73 . . . . 74.230000000000004 110.734 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -57.16 -34.97 68.98 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 115.0 -1.0 . . . . 72.219999999999999 112.379 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 630' ' ' MET . 20.4 ttp180 -67.16 -38.65 85.82 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 120.578 -0.449 . . . . 64.519999999999996 110.363 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 65.8 mt -70.06 -37.03 71.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.258 -0.645 . . . . 61.43 109.258 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.57 96.49 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.536 -0.756 . . . . 41.299999999999997 109.499 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 632' ' ' ARG . 48.8 mt-10 -70.18 -25.9 63.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.566 0.58 . . . . 74.439999999999998 112.566 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 71.4 mtm -76.23 -8.32 56.8 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.355 0.598 . . . . 75.140000000000001 110.275 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -103.51 14.63 54.01 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.524 -1.03 . . . . 70.329999999999998 110.524 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 629' ' ' GLU . 83.3 mtp180 -107.95 156.47 38.15 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 108.349 -0.982 . . . . 72.400000000000006 108.349 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 594' ' ' PRO . 37.4 Cg_endo -66.89 143.58 67.15 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.047 1.831 . . . . 75.230000000000004 110.689 175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 26.4 pt -133.24 -176.98 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 C-N-CA 123.086 0.554 . . . . 64.209999999999994 109.698 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.48 177.98 4.71 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.229 -1.026 . . . . 74.219999999999999 108.229 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.5 170.65 42.11 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.46 -0.656 . . . . 73.299999999999997 111.46 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -49.75 -61.61 2.03 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.249 1.02 . . . . 72.409999999999997 112.043 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -129.33 102.17 6.31 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.787 -1.56 . . . . 74.030000000000001 106.787 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 3.6 t -129.51 111.85 13.17 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 122.337 1.065 . . . . 64.420000000000002 110.865 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 37.0 ttmt -147.19 151.74 37.24 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.876 -1.898 . . . . 74.109999999999999 105.876 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 523' ' ' VAL . 51.8 tp -123.38 103.45 8.5 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.977 -0.749 . . . . 73.549999999999997 108.977 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 511' ' ' VAL . 44.2 mt-10 -87.45 106.53 18.04 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.551 -0.907 . . . . 73.430000000000007 108.551 176.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 32.0 t -96.9 121.69 47.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 114.91 -1.041 . . . . 62.539999999999999 108.197 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 27.9 mt -115.55 133.49 61.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 115.108 -0.951 . . . . 72.409999999999997 110.896 -173.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 646' ' ' GLU . 0.1 OUTLIER -142.58 163.23 18.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 125.062 1.345 . . . . 71.140000000000001 108.402 -176.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 583' ' ' LYS . 8.1 tp10 144.74 164.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 127.486 2.314 . . . . 73.049999999999997 106.967 169.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.07 123.67 18.75 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.452 -0.573 . . . . 75.319999999999993 109.452 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 50.0 m 67.96 86.36 0.13 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.412 1.085 . . . . 71.530000000000001 113.563 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -111.23 168.5 9.46 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 106.22 -1.77 . . . . 63.049999999999997 106.22 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -106.48 128.38 54.04 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.132 -0.627 . . . . 71.230000000000004 110.412 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -92.24 107.22 19.05 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.655 -0.702 . . . . 75.140000000000001 109.368 -176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 166.71 13.18 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.22 -1.03 . . . . 72.140000000000001 108.22 177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 37.0 p -70.36 88.12 0.64 Allowed 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.182 0.515 . . . . 74.129999999999995 111.653 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 18.2 m -84.85 99.51 10.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.22 -1.03 . . . . 75.219999999999999 108.22 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 45.5 t -133.19 151.86 34.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 109.784 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 109.428 -0.582 . . . . 63.020000000000003 109.428 174.416 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 27.2 p80 . . . . . 0 C--O 1.243 0.737 0 CA-C-O 121.577 0.703 . . . . 74.209999999999994 110.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -140.6 -178.3 5.45 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.095 -0.957 . . . . 70.430000000000007 108.838 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -67.74 137.55 32.43 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.797 -0.716 . . . . 52.219999999999999 112.067 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 67.3 mt -127.02 116.18 43.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.805 -1.183 . . . . 75.209999999999994 107.805 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -108.16 137.66 45.76 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 123.618 0.574 . . . . 75.219999999999999 111.67 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.2 t -148.91 157.37 43.38 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.83 -0.623 . . . . 64.030000000000001 109.371 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.469 ' CE2' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.37 155.68 36.23 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 110.086 -0.339 . . . . 74.099999999999994 110.086 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -59.39 -48.18 82.63 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 123.615 0.572 . . . . 73.530000000000001 110.47 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -129.42 151.09 77.31 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 108.42 -0.956 . . . . 55.530000000000001 108.42 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 2.4 Cg_endo -78.35 -20.63 10.96 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.631 1.554 . . . . 41.32 110.496 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 642' ' ' GLU . 65.8 t -139.98 127.3 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.711 -0.848 . . . . 52.109999999999999 108.711 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -129.42 133.57 47.41 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.269 -0.641 . . . . 50.539999999999999 109.269 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -107.09 121.41 44.43 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.642 -0.873 . . . . 73.439999999999998 108.642 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.54 148.31 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.406 0.622 . . . . 72.140000000000001 111.022 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.52 ' HB3' ' OE1' ' A' ' 647' ' ' GLU . 50.7 m -65.12 141.27 58.76 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.542 -1.208 . . . . 70.200000000000003 110.262 177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.527 ' HG2' ' HB2' ' A' ' 647' ' ' GLU . 12.2 pt-20 -70.55 -24.26 62.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 109.832 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.39 17.99 17.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.066 -0.515 . . . . 45.109999999999999 110.828 -177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.4 tt -76.1 -23.27 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.247 0.546 . . . . 73.430000000000007 111.036 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.43 -73.32 2.24 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.448 -0.882 . . . . 71.439999999999998 110.935 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.72 126.79 69.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 107.899 -1.148 . . . . 52.420000000000002 107.899 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.404 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.5 ppp? -98.15 148.7 23.3 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.865 -1.161 . . . . 73.420000000000002 107.865 175.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -124.3 119.16 28.5 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.414 0.446 . . . . 71.239999999999995 111.692 -175.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.46 HG21 HD21 ' A' ' 641' ' ' LEU . 52.5 t -127.43 126.72 68.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.107 -0.701 . . . . 74.409999999999997 109.107 173.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.462 ' HG2' HG12 ' A' ' 570' ' ' ILE . 62.6 mttp -91.96 147.75 22.72 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.026 -0.534 . . . . 64.310000000000002 110.699 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.07 116.15 38.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.293 -1.373 . . . . 74.239999999999995 107.293 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.9 155.99 18.77 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.408 -0.814 . . . . 42.43 110.428 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.88 104.63 12.13 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 107.787 -1.19 . . . . 74.299999999999997 107.787 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.1 m -65.24 -61.22 2.25 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.421 -0.354 . . . . 63.43 110.709 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 18.2 t -74.57 -49.17 22.86 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.224 0.535 . . . . 65.140000000000001 109.851 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 151.78 -159.73 28.44 Favored Glycine 0 N--CA 1.434 -1.482 0 N-CA-C 109.381 -1.488 . . . . 50.530000000000001 109.381 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -161.95 139.47 8.65 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.028 -0.73 . . . . 74.299999999999997 109.028 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -156.67 133.81 10.49 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 106.432 -1.692 . . . . 65.099999999999994 106.432 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 532' ' ' ARG . . . 108.63 -133.4 11.64 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 120.335 -0.936 . . . . 60.43 111.748 175.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -137.58 108.42 6.67 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.993 -1.114 . . . . 72.209999999999994 107.993 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.49 124.73 70.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-O 121.672 0.749 . . . . 74.239999999999995 111.199 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.518 HG23 ' HB3' ' A' ' 559' ' ' GLU . 31.9 mm -93.7 116.45 34.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.043 -0.98 . . . . 71.230000000000004 108.687 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 34.4 t -108.81 99.24 33.49 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.912 -1.144 . . . . 71.319999999999993 107.912 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -80.1 159.98 23.66 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.682 1.588 . . . . 75.5 111.514 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -144.82 161.05 40.23 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.035 -1.098 . . . . 72.409999999999997 108.035 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -152.37 134.83 15.22 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.009 0.433 . . . . 75.150000000000006 111.006 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . 0.411 HG23 HD13 ' A' ' 589' ' ' LEU . 0.7 OUTLIER -81.9 138.59 34.99 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 115.089 -0.96 . . . . 74.430000000000007 112.006 179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.483 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.2 mm -115.52 126.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.582 -1.636 . . . . 62.020000000000003 106.582 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.91 166.72 22.95 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.901 0.382 . . . . 41.109999999999999 110.792 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -162.87 -111.43 0.26 Allowed Glycine 0 CA--C 1.495 -1.215 0 N-CA-C 110.474 -1.05 . . . . 72.040000000000006 110.474 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.0 -31.04 58.75 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.469 -1.308 . . . . 64.239999999999995 107.469 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 552' ' ' ASP . . . -88.56 143.4 26.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.932 -1.485 . . . . 45.229999999999997 107.146 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -109.42 153.35 24.13 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 113.531 0.937 . . . . 75.310000000000002 113.531 -171.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 43.11 -119.58 2.36 Favored Glycine 0 CA--C 1.503 -0.659 0 C-N-CA 126.771 2.129 . . . . 73.510000000000005 118.372 168.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -164.89 96.35 0.13 Allowed Glycine 0 N--CA 1.412 -2.902 0 N-CA-C 108.649 -1.78 . . . . 64.340000000000003 108.649 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 123.01 -19.5 7.77 Favored Glycine 0 C--N 1.289 -2.069 0 N-CA-C 109.595 -1.402 . . . . 74.109999999999999 109.595 -175.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 6.2 mp0 -76.97 -73.05 0.31 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.981 -0.609 . . . . 52.229999999999997 110.101 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 547' ' ' ARG . 5.7 m-20 -103.22 -44.17 5.26 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 122.136 0.969 . . . . 72.400000000000006 108.988 178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -133.79 155.61 49.49 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 107.277 -1.379 . . . . 75.230000000000004 107.277 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.498 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 3.8 tm-20 -89.01 129.77 35.6 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 107.529 -1.285 . . . . 74.239999999999995 107.529 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.55 103.1 3.43 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 121.451 0.644 . . . . 72.040000000000006 111.199 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.6 t -108.43 113.7 26.95 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.384 -0.969 . . . . 70.409999999999997 108.384 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -143.41 100.6 3.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.503 -0.771 . . . . 73.310000000000002 109.231 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.81 -163.56 10.76 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.622 -0.799 . . . . 54.530000000000001 112.228 -174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.518 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.6 mt-10 -116.83 117.9 31.0 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.422 0.689 . . . . 64.030000000000001 110.582 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.4 mt -89.31 139.5 30.43 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.047 -0.723 . . . . 70.439999999999998 109.047 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.88 105.07 14.71 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.67 -0.812 . . . . 71.329999999999998 111.417 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.478 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 31.5 m-85 -96.21 143.79 26.99 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 107.397 -1.334 . . . . 53.109999999999999 107.397 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.458 ' H ' HD11 ' A' ' 567' ' ' ILE . 79.4 mt-30 -116.29 -86.94 0.61 Allowed 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 108.245 -1.02 . . . . 65.150000000000006 108.245 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.97 168.53 9.0 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.527 -0.869 . . . . 64.519999999999996 109.043 173.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -59.28 -11.05 3.51 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.244 1.418 . . . . 64.420000000000002 113.575 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.589 ' HG3' HG23 ' A' ' 567' ' ' ILE . 16.1 pt-20 -69.77 -17.88 63.46 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.729 0.412 . . . . 72.200000000000003 111.973 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.589 HG23 ' HG3' ' A' ' 566' ' ' GLU . 41.0 pt -116.13 163.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 C-N-CA 120.319 -0.552 . . . . 73.140000000000001 111.464 -177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.3 146.45 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 108.181 -1.044 . . . . 65.319999999999993 108.181 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 562' ' ' PHE . 70.9 mmtt -109.83 145.05 37.4 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.591 -0.522 . . . . 73.129999999999995 109.591 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 524' ' ' LYS . 63.1 mt -116.92 133.6 63.1 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.7 0 CA-C-N 114.368 -1.287 . . . . 52.0 108.287 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.436 HD13 HD21 ' A' ' 589' ' ' LEU . 55.5 mt -93.15 113.08 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.351 0 N-CA-C 106.932 -1.507 . . . . 61.219999999999999 106.932 174.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -102.48 112.31 24.99 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 115.106 -0.952 . . . . 65.140000000000001 109.55 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 521' ' ' MET . 48.6 mt -107.65 129.43 61.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.983 -1.117 . . . . 74.140000000000001 107.983 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.498 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 63.8 mtt85 -78.25 114.62 17.31 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.504 -0.924 . . . . 64.400000000000006 108.504 176.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.4 mm -101.0 126.67 54.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.603 -0.888 . . . . 64.430000000000007 108.603 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.429 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 50.8 m-85 -107.45 112.13 24.76 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.039 0.447 . . . . 65.239999999999995 110.912 -177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -68.44 150.36 48.21 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.165 0.986 . . . . 64.120000000000005 111.402 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -138.73 -46.66 0.49 Allowed 'General case' 0 C--O 1.246 0.898 0 CA-C-N 116.035 -0.529 . . . . 75.530000000000001 111.354 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -119.15 -177.41 3.34 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 120.96 0.409 . . . . 71.329999999999998 111.167 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -78.49 -36.65 44.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 106.536 -1.653 . . . . 75.25 106.536 174.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -145.32 98.36 3.14 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.791 -1.095 . . . . 63.420000000000002 108.587 175.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.5 ' OE1' ' HA ' ' A' ' 582' ' ' GLU . 3.1 mm-40 -63.9 157.14 25.57 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 119.228 -0.989 . . . . 71.109999999999999 111.672 171.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' A' ' 583' ' ' LYS . 5.9 mptt -88.31 69.03 9.06 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.058 0.392 . . . . 73.530000000000001 112.058 -168.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 51.98 31.58 8.85 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.162 0.985 . . . . 74.530000000000001 112.594 174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 645' ' ' ILE . 2.2 p -63.12 128.49 36.08 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 120.647 0.26 . . . . 70.109999999999999 110.711 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 6.7 m -130.57 152.44 49.95 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 120.743 -0.383 . . . . 55.350000000000001 110.558 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.8 p90 -138.95 175.59 9.42 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.381 -1.34 . . . . 62.310000000000002 107.381 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 14.7 m -125.59 158.88 33.52 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.632 -0.827 . . . . 71.450000000000003 110.577 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.436 HD21 HD13 ' A' ' 571' ' ' ILE . 59.2 tp -136.61 132.92 35.72 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 106.551 -1.648 . . . . 72.200000000000003 106.551 176.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.58 155.14 40.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 C-N-CA 120.96 -0.296 . . . . 75.219999999999999 110.363 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.469 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 85.7 mt -92.1 142.53 27.41 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.317 -0.994 . . . . 63.240000000000002 108.317 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -93.87 175.57 6.67 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.463 -0.79 . . . . 73.340000000000003 109.404 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -66.58 113.9 14.98 Favored Pre-proline 0 C--N 1.319 -0.751 0 O-C-N 123.734 0.646 . . . . 55.210000000000001 109.364 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.4 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 49.4 Cg_endo -73.57 143.85 34.9 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 121.754 1.636 . . . . 72.209999999999994 111.264 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -121.05 140.46 51.9 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.375 -0.829 . . . . 44.130000000000003 110.472 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . 0.424 ' HB2' ' HD3' ' A' ' 633' ' ' PRO . 3.7 t90 -102.06 124.22 47.29 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.084 -1.45 . . . . 74.150000000000006 107.084 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.56 98.48 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.764 0.793 . . . . 71.299999999999997 108.932 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -58.88 126.41 27.57 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.695 -1.593 . . . . 63.310000000000002 111.748 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -74.32 114.24 12.46 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.121 -1.066 . . . . 71.040000000000006 108.121 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 97.58 81.8 1.61 Allowed Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 108.884 -1.686 . . . . 54.009999999999998 108.884 -173.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 21.5 ptp -96.02 162.37 13.58 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.541 -0.54 . . . . 71.310000000000002 109.541 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -115.93 112.38 21.79 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.805 0.812 . . . . 73.450000000000003 112.3 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -150.56 -46.77 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 109.675 -1.37 . . . . 70.230000000000004 109.675 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -85.68 56.96 4.89 Favored Glycine 0 CA--C 1.506 -0.507 0 N-CA-C 110.532 -1.027 . . . . 54.219999999999999 110.532 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -95.27 156.91 16.12 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 108.759 -0.83 . . . . 75.519999999999996 108.759 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 4.9 m -68.21 105.25 2.04 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 123.06 0.544 . . . . 60.149999999999999 111.16 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 37.2 mm -120.05 88.08 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 108.032 -1.099 . . . . 75.319999999999993 108.032 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 21.1 m -132.28 -54.17 0.97 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.655 -0.498 . . . . 62.32 109.655 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -89.97 -19.21 24.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.68 -0.859 . . . . 64.409999999999997 108.68 174.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -79.62 137.52 37.13 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.326 -1.307 . . . . 75.219999999999999 108.089 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -104.69 -15.67 15.19 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.013 0.435 . . . . 74.329999999999998 110.511 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -111.03 127.05 55.41 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.512 -0.313 . . . . 63.439999999999998 110.291 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -68.78 146.15 53.16 Favored 'General case' 0 CA--C 1.49 -1.36 0 CA-C-O 120.878 0.37 . . . . 74.0 110.463 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.19 83.79 6.94 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 122.301 1.048 . . . . 65.120000000000005 110.787 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . 0.557 ' OE1' ' HD2' ' A' ' 616' ' ' PRO . 6.5 tp-100 -137.14 127.55 15.97 Favored Pre-proline 0 C--N 1.285 -2.22 0 N-CA-C 104.76 -2.311 . . . . 71.510000000000005 104.76 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.557 ' HD2' ' OE1' ' A' ' 615' ' ' GLN . 27.7 Cg_exo -56.96 136.96 79.75 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 C-N-CA 122.031 1.821 . . . . 75.109999999999999 110.401 178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.1 104.23 10.52 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 108.656 -0.868 . . . . 75.030000000000001 108.656 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 6.5 p -82.94 -7.14 59.69 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.962 0.887 . . . . 75.439999999999998 110.065 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 10.0 p -70.58 -17.08 62.91 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.403 -1.271 . . . . 52.439999999999998 108.164 172.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -134.57 -150.93 0.41 Allowed 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 126.467 1.907 . . . . 74.019999999999996 106.212 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -125.84 179.51 5.16 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 104.653 -2.351 . . . . 61.350000000000001 104.653 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.88 105.24 17.27 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.061 -2.2 . . . . 62.299999999999997 105.061 164.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -51.02 155.62 1.2 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.562 -0.744 . . . . 75.230000000000004 112.042 -176.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 64.22 34.17 11.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 122.13 0.967 . . . . 70.530000000000001 108.489 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 0.2 OUTLIER -55.72 -27.34 49.92 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 113.852 -1.522 . . . . 70.329999999999998 112.956 -175.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.581 ' O ' ' HG3' ' A' ' 630' ' ' MET . 95.2 mtt180 -58.76 -46.0 88.46 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.139 0.495 . . . . 65.140000000000001 110.452 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.06 -35.79 65.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.041 -0.981 . . . . 55.100000000000001 109.624 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.67 78.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.927 -0.578 . . . . 74.310000000000002 110.261 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 35.6 mt-10 -79.47 -15.72 57.3 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 116.08 -0.509 . . . . 73.120000000000005 111.207 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 64.6 mtt -76.63 -10.27 59.27 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.895 -1.15 . . . . 64.019999999999996 107.895 173.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -105.84 21.44 34.11 Favored Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.551 -1.419 . . . . 42.340000000000003 109.551 174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -129.3 156.65 78.07 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 107.512 -1.292 . . . . 61.439999999999998 107.512 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 596' ' ' TRP . 23.7 Cg_exo -71.24 156.11 59.7 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 N-CA-C 107.707 -1.69 . . . . 64.239999999999995 107.707 168.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 634' ' ' ILE . 0.2 OUTLIER -131.45 -177.95 2.38 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 CA-C-O 121.19 0.519 . . . . 63.310000000000002 111.358 -175.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -93.74 176.39 6.37 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.469 -0.937 . . . . 63.509999999999998 108.469 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.06 -128.55 0.21 Allowed Glycine 0 C--N 1.309 -0.929 0 CA-C-O 121.968 0.76 . . . . 52.130000000000003 113.102 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -74.33 -84.17 0.05 OUTLIER 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.834 -0.683 . . . . 64.519999999999996 109.241 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -141.75 94.93 2.74 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 105.085 -2.191 . . . . 74.209999999999994 105.085 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . 0.41 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 13.3 t -100.65 118.34 36.59 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-O 122.401 1.096 . . . . 54.399999999999999 110.954 -172.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 3.7 ttmp? -145.05 143.64 30.56 Favored 'General case' 0 N--CA 1.416 -2.132 0 N-CA-C 105.848 -1.908 . . . . 75.030000000000001 105.848 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.46 HD21 HG21 ' A' ' 523' ' ' VAL . 28.4 tp -119.59 105.68 11.44 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 108.232 -1.025 . . . . 72.310000000000002 108.232 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.405 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.7 mt-10 -90.79 121.76 32.93 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 107.985 -1.117 . . . . 65.140000000000001 107.985 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.69 120.27 59.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.978 -1.01 . . . . 75.019999999999996 109.308 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.21 121.44 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 CA-C-N 114.696 -1.138 . . . . 65.340000000000003 108.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.446 HG12 ' SG ' ' A' ' 585' ' ' CYS . 0.1 OUTLIER -106.71 117.73 53.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 CA-C-N 115.334 -0.848 . . . . 75.439999999999998 110.184 -178.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -165.88 136.5 3.6 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.406 -1.702 . . . . 74.409999999999997 106.406 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.527 ' HB2' ' HG2' ' A' ' 516' ' ' GLU . 10.4 tp10 -78.87 82.33 5.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.31 -1.356 . . . . 75.010000000000005 110.25 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 17.1 t -88.25 88.94 7.8 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 106.472 -1.677 . . . . 74.230000000000004 106.472 176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -130.41 145.09 51.76 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.738 0.78 . . . . 64.430000000000007 111.821 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.54 147.8 12.35 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 101.141 -3.651 . . . . 64.010000000000005 101.141 169.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -78.33 -23.41 47.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.057 -0.719 . . . . 42.219999999999999 109.057 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? 57.29 26.22 12.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.388 1.475 . . . . 62.240000000000002 113.679 174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 27.5 t -98.62 83.76 3.04 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 108.695 -0.854 . . . . 62.43 108.695 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 56.7 m -126.83 118.76 25.27 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.314 -0.857 . . . . 73.409999999999997 109.429 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 8.6 p -115.23 117.89 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 N-CA-C 108.373 -0.973 . . . . 65.409999999999997 108.373 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 C--N 1.294 -1.835 0 N-CA-C 108.679 -0.86 . . . . 43.25 108.679 -178.108 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.45 ' HB3' ' O ' ' A' ' 632' ' ' ARG . 53.2 t60 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.702 -0.851 . . . . 71.329999999999998 108.702 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . 71.72 -51.22 0.69 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.874 1.67 . . . . 25.149999999999999 111.617 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -124.17 125.27 5.75 Favored Glycine 0 N--CA 1.416 -2.684 0 N-CA-C 110.278 -1.129 . . . . 54.329999999999998 110.278 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 68.6 mt -127.54 118.94 50.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.92 -1.511 . . . . 71.519999999999996 106.92 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -106.33 133.07 51.6 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.221 0.452 . . . . 74.310000000000002 112.221 -173.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -148.11 153.97 39.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.688 -0.856 . . . . 70.120000000000005 108.688 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 68.1 m-85 -74.28 156.3 37.32 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.806 -0.442 . . . . 71.340000000000003 109.806 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.58 -49.11 79.03 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.235 0.54 . . . . 74.340000000000003 110.381 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.77 153.7 81.16 Favored Pre-proline 0 N--CA 1.432 -1.35 0 N-CA-C 107.721 -1.215 . . . . 63.109999999999999 107.721 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 83.3 Cg_endo -86.24 -11.32 6.32 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.024 1.816 . . . . 62.0 113.3 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 70.4 t -143.81 135.34 22.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.281 -0.637 . . . . 64.219999999999999 109.281 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.96 133.97 42.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.712 -0.477 . . . . 73.209999999999994 109.712 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -106.18 110.86 23.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.622 -1.251 . . . . 65.310000000000002 107.622 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.85 155.58 22.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 110.757 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.451 ' O ' HG22 ' A' ' 518' ' ' ILE . 2.6 t -77.13 147.03 36.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.668 -1.975 . . . . 71.420000000000002 105.668 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -77.58 -16.94 58.31 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 119.068 -1.053 . . . . 63.009999999999998 110.813 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 17.7 m -91.31 13.19 18.01 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.202 -0.454 . . . . 72.030000000000001 111.427 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 515' ' ' SER . 8.1 tt -74.06 -25.67 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 121.033 0.444 . . . . 72.25 111.736 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.37 -68.96 2.61 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.982 -1.104 . . . . 65.030000000000001 112.2 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 574' ' ' ARG . 41.5 mm -131.97 132.31 61.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.299999999999997 108.286 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 19.0 ptm -108.42 143.02 37.93 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.011 -0.737 . . . . 53.340000000000003 109.011 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -99.25 124.21 44.15 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 123.55 0.531 . . . . 70.310000000000002 110.524 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.0 t -115.55 120.23 64.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.461 -1.311 . . . . 73.040000000000006 107.461 172.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -106.29 123.68 48.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.297 -0.961 . . . . 75.310000000000002 110.275 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 78.5 t -88.59 110.99 21.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.168 -0.924 . . . . 73.430000000000007 108.833 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 82.5 mt -85.79 122.61 30.11 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.443 -0.798 . . . . 63.509999999999998 110.592 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.469 ' O ' ' HD2' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -87.13 101.3 13.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.908 -1.145 . . . . 71.5 107.908 171.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 2.9 t -67.19 -47.53 70.66 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.673 -0.694 . . . . 75.209999999999994 112.401 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.1 t -74.58 -24.06 58.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.271 0.558 . . . . 63.329999999999998 109.924 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 115.09 -158.69 14.18 Favored Glycine 0 N--CA 1.427 -1.928 0 N-CA-C 110.378 -1.089 . . . . 33.32 110.378 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -150.87 136.41 17.92 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.26 -1.385 . . . . 64.340000000000003 107.26 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -135.27 87.1 2.3 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.716 -0.394 . . . . 74.109999999999999 109.967 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 98.63 -178.98 31.54 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 109.81 -1.316 . . . . 72.230000000000004 109.81 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.637 HD21 ' HG3' ' A' ' 561' ' ' GLU . 4.6 t-20 -74.5 111.54 9.78 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.457 -0.897 . . . . 74.120000000000005 111.201 -174.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.89 125.91 74.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 107.872 -1.158 . . . . 45.149999999999999 107.872 176.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.496 HG12 HD13 ' A' ' 597' ' ' ILE . 46.3 mm -99.47 122.65 51.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.553 -0.906 . . . . 70.019999999999996 108.553 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 28.4 t -112.78 105.59 55.78 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 123.555 0.535 . . . . 52.310000000000002 109.754 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.44 150.55 28.48 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 121.917 1.745 . . . . 74.310000000000002 111.514 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -142.02 168.29 20.1 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.989 -1.115 . . . . 70.409999999999997 107.989 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 589' ' ' LEU . 55.0 pttt -161.23 145.14 13.15 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.123 0.487 . . . . 72.450000000000003 111.07 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 13.5 p -83.6 133.46 34.84 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.994 -1.003 . . . . 72.239999999999995 110.454 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.4 mm -104.2 112.41 37.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.062 -1.459 . . . . 52.32 107.062 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -72.89 152.16 41.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.656 0.598 . . . . 70.319999999999993 110.064 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -145.51 -116.97 1.06 Allowed Glycine 0 C--N 1.293 -1.837 0 N-CA-C 108.801 -1.72 . . . . 42.420000000000002 108.801 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 24.9 p -75.35 -27.71 59.29 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 108.21 -1.033 . . . . 64.120000000000005 108.21 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -84.38 127.98 34.31 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.604 -1.258 . . . . 62.350000000000001 107.604 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 3.2 tmt_? -104.26 139.67 38.94 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.578 -1.267 . . . . 63.130000000000003 107.578 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -86.94 -156.33 29.08 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.889 -0.672 . . . . 74.540000000000006 112.806 -177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.81 1.86 59.81 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.798 -0.239 . . . . 72.299999999999997 113.532 177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 117.22 0.64 18.91 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 120.173 -1.013 . . . . 55.420000000000002 113.08 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 12.8 tp10 -69.77 -76.46 0.1 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 117.393 0.597 . . . . 74.239999999999995 109.793 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.479 ' OD1' ' HD3' ' A' ' 578' ' ' ARG . 12.8 m-20 -100.18 -35.42 9.65 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 107.77 -1.196 . . . . 74.129999999999995 107.77 174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -144.17 166.63 24.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.869 -1.16 . . . . 73.329999999999998 107.869 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.1 OUTLIER -95.44 144.2 26.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.467 -1.679 . . . . 65.510000000000005 106.467 176.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.91 122.08 28.24 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.264 -0.643 . . . . 74.219999999999999 109.264 -174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -129.5 124.05 32.99 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.989 0.9 . . . . 74.200000000000003 112.653 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 9.4 p -131.39 129.26 41.1 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.031 -1.841 . . . . 74.5 106.031 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -160.35 171.76 36.63 Favored Glycine 0 CA--C 1.48 -2.128 0 C-N-CA 118.997 -1.573 . . . . 41.109999999999999 112.474 -174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.448 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 7.7 mp0 -107.67 115.61 30.46 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.537 -0.912 . . . . 75.040000000000006 108.537 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.2 mt -85.99 139.46 31.17 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.117 -0.327 . . . . 52.240000000000002 110.117 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.637 ' HG3' HD21 ' A' ' 534' ' ' ASN . 40.4 tt0 -106.5 101.97 11.4 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.172 0.51 . . . . 73.109999999999999 111.771 -176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -97.37 156.47 16.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.097 -0.705 . . . . 75.439999999999998 109.097 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.433 ' H ' HD11 ' A' ' 567' ' ' ILE . 70.1 mm-40 -136.79 -81.13 0.38 Allowed 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.816 1.293 . . . . 74.010000000000005 109.21 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.412 ' O ' HG12 ' A' ' 567' ' ' ILE . 4.3 t-20 -104.19 159.05 16.02 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-N 115.38 -0.827 . . . . 61.340000000000003 109.594 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -60.65 -16.37 38.18 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 125.151 1.381 . . . . 72.239999999999995 114.017 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -80.75 -16.34 54.12 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.687 -0.805 . . . . 72.299999999999997 112.237 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 563' ' ' GLN . 37.1 pt -99.58 158.98 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 119.215 -0.994 . . . . 73.310000000000002 110.307 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.57 143.07 34.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.267 -1.382 . . . . 55.229999999999997 107.267 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.1 mmpt? -101.69 147.27 26.65 Favored 'General case' 0 CA--C 1.468 -2.186 0 C-N-CA 120.108 -0.637 . . . . 72.349999999999994 110.636 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 22.2 mt -125.28 128.77 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.175 0 CA-C-N 114.578 -1.192 . . . . 63.530000000000001 108.771 -175.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.596 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 52.9 mt -90.46 134.05 30.48 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.185 0 N-CA-C 106.803 -1.554 . . . . 74.510000000000005 106.803 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 18.3 p -116.18 111.93 20.93 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.714 -0.847 . . . . 71.230000000000004 108.714 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.445 HD11 HD22 ' A' ' 589' ' ' LEU . 50.0 mt -106.39 128.41 60.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.833 -0.803 . . . . 53.210000000000001 108.833 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.7 mtt180 -75.62 111.93 11.45 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 124.115 0.884 . . . . 74.430000000000007 109.378 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -106.9 131.39 56.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.238 -1.393 . . . . 71.530000000000001 107.238 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 51.5 m-85 -119.31 143.79 47.18 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.316 -0.994 . . . . 73.129999999999995 108.316 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -80.81 127.25 32.31 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.292 -1.373 . . . . 72.230000000000004 107.292 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.479 ' HD3' ' OD1' ' A' ' 552' ' ' ASP . 56.7 ttt-85 -121.13 138.53 54.15 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.697 -0.683 . . . . 74.049999999999997 112.039 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -73.39 108.03 6.03 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.839 -1.073 . . . . 71.140000000000001 110.776 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.471 ' HG2' ' H ' ' A' ' 582' ' ' GLU . 38.3 tt0 -167.52 141.63 3.63 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.272 -1.381 . . . . 63.210000000000001 107.272 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -87.21 -22.24 25.37 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.543 -0.863 . . . . 75.230000000000004 111.378 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 580' ' ' GLU . 33.9 mt-10 -76.03 -71.42 0.38 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.124 -0.489 . . . . 73.040000000000006 110.656 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 585' ' ' CYS . 25.2 mmmt 64.51 36.84 8.42 Favored 'General case' 0 CA--C 1.511 -0.523 0 C-N-CA 124.186 0.994 . . . . 72.439999999999998 113.58 177.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -89.33 31.96 0.87 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.923 -1.14 . . . . 64.239999999999995 107.923 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.412 ' H ' ' C ' ' A' ' 583' ' ' LYS . 57.7 m -80.16 115.94 19.99 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.729 -1.578 . . . . 73.519999999999996 111.103 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 45.7 p -137.34 146.66 44.84 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 108.716 -0.846 . . . . 62.439999999999998 108.716 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -133.17 173.75 11.11 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.23 -1.026 . . . . 73.010000000000005 108.23 175.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 10.9 m -124.84 156.07 38.42 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 108.538 -0.912 . . . . 35.130000000000003 108.538 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 540' ' ' LYS . 63.6 tp -128.3 129.1 45.8 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 106.548 -1.649 . . . . 65.310000000000002 106.548 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 31.7 m -127.74 159.39 38.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 123.215 0.322 . . . . 73.120000000000005 110.14 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.439 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 93.0 mt -102.33 154.97 18.55 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.533 -0.914 . . . . 72.450000000000003 108.533 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.6 171.4 7.6 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.641 -0.874 . . . . 73.299999999999997 108.641 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.3 120.88 59.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 O-C-N 123.674 0.609 . . . . 74.340000000000003 110.656 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 52.2 Cg_endo -74.58 156.23 44.94 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.367 2.045 . . . . 70.400000000000006 111.932 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -121.25 144.9 48.36 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.572 -0.74 . . . . 54.240000000000002 109.455 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -104.59 121.33 43.3 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.674 -0.861 . . . . 64.230000000000004 108.674 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . 0.496 HD13 HG12 ' A' ' 536' ' ' ILE . 2.2 mp -106.27 91.1 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-O 122.663 1.22 . . . . 64.230000000000004 111.089 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -116.49 164.84 13.97 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.427 -1.715 . . . . 63.32 107.38 172.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -72.67 114.29 10.65 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.499 -0.926 . . . . 72.230000000000004 108.499 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 119.26 -11.77 11.43 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.74 -0.944 . . . . 73.209999999999994 110.74 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 92.3 mmm -80.18 122.15 26.47 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 108.464 -0.939 . . . . 72.109999999999999 108.464 176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -107.59 110.06 21.86 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.536 0.684 . . . . 65.319999999999993 111.202 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 166.19 39.37 0.02 OUTLIER Glycine 0 C--N 1.298 -1.548 0 N-CA-C 110.223 -1.151 . . . . 64.219999999999999 110.223 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -126.06 63.29 0.59 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 111.33 -0.708 . . . . 52.210000000000001 111.33 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -122.67 25.67 8.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.43 -1.322 . . . . 70.010000000000005 107.43 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 67.2 m -74.1 129.57 38.09 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.501 -1.227 . . . . 72.150000000000006 108.483 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 51.2 mm -82.06 99.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.849 0 N-CA-C 108.708 -0.849 . . . . 54.130000000000003 108.708 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 7.5 t -94.66 -14.15 25.16 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.584 -0.735 . . . . 65.109999999999999 110.552 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.57 -26.34 66.24 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.686 0.755 . . . . 72.099999999999994 110.294 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -120.44 150.44 40.8 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 106.197 -1.779 . . . . 75.120000000000005 106.197 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -88.05 132.2 34.37 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.498 0.666 . . . . 75.439999999999998 111.271 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -135.95 134.23 38.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.408 -1.701 . . . . 63.350000000000001 106.408 174.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.91 -67.71 0.65 Allowed 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 120.494 -0.482 . . . . 74.409999999999997 110.506 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -160.67 103.93 1.37 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.379 -0.971 . . . . 72.439999999999998 108.379 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -142.79 116.64 6.3 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 116.5 -0.318 . . . . 53.030000000000001 110.469 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.79 150.48 39.3 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.217 1.944 . . . . 52.439999999999998 110.567 173.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.55 161.25 14.27 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.499 -0.773 . . . . 65.450000000000003 111.018 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 18.0 m -57.79 120.41 8.38 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 124.113 0.965 . . . . 74.450000000000003 108.864 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 20.2 m -119.71 167.61 11.88 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 116.317 -0.402 . . . . 64.120000000000005 110.886 -174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -105.86 163.28 12.86 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.323 -1.362 . . . . 72.340000000000003 107.323 176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -92.18 85.41 5.45 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 120.616 -0.433 . . . . 74.219999999999999 110.162 174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.71 177.02 6.14 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.195 -1.002 . . . . 74.430000000000007 109.553 173.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -97.43 160.69 14.17 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 122.319 -0.238 . . . . 60.530000000000001 111.057 -177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 62.03 24.75 14.77 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.193 0.933 . . . . 54.100000000000001 111.934 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.593 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 35.9 mtp-105 -61.83 -47.85 83.21 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.018 -0.364 . . . . 64.409999999999997 110.018 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 630' ' ' MET . 54.5 ttp180 -75.53 -34.79 60.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.917 -1.038 . . . . 73.150000000000006 110.14 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 98.6 mt -65.86 -35.76 75.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.775 -0.648 . . . . 74.239999999999995 110.509 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.55 73.97 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.243 -0.435 . . . . 74.310000000000002 110.111 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 42.7 mt-10 -73.57 -23.24 59.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.856 -0.611 . . . . 62.030000000000001 110.39 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 60.0 mtt -75.93 -28.06 57.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.547 -0.751 . . . . 62.350000000000001 109.037 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -92.03 42.31 2.76 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.043 -0.823 . . . . 60.119999999999997 111.043 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.523 ' NH1' ' HG2' ' A' ' 629' ' ' GLU . 96.6 mtt180 -135.16 163.28 52.17 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 105.646 -1.983 . . . . 63.329999999999998 105.646 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.53 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 45.1 Cg_exo -62.68 151.37 84.06 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 108.087 -1.543 . . . . 75.120000000000005 108.087 171.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 27.3 pt -130.73 -179.4 3.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-O 121.338 0.589 . . . . 71.310000000000002 111.175 -173.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.85 172.7 8.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.537 -1.282 . . . . 64.319999999999993 107.537 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.44 -172.86 38.62 Favored Glycine 0 C--N 1.301 -1.398 0 C-N-CA 120.358 -0.925 . . . . 63.140000000000001 111.249 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . 0.459 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 43.3 tt0 -54.9 -62.36 1.71 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.162 0.585 . . . . 74.530000000000001 110.465 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . 0.459 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 37.1 m80 -135.14 106.11 6.62 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.972 -0.751 . . . . 74.219999999999999 108.972 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 9.0 t -119.41 108.81 15.01 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 122.18 0.99 . . . . 53.32 110.387 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 40.9 ttmt -147.91 142.33 26.37 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.686 -1.227 . . . . 71.400000000000006 107.686 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.424 HD22 HG13 ' A' ' 523' ' ' VAL . 62.1 tp -119.34 110.51 17.05 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.695 -0.854 . . . . 64.409999999999997 108.695 174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -89.98 117.55 28.87 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.445 -0.946 . . . . 70.420000000000002 108.445 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.0 t -105.58 124.74 60.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 114.713 -1.131 . . . . 51.439999999999998 109.542 -175.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.38 123.48 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.598 0 N-CA-C 107.942 -1.133 . . . . 75.129999999999995 107.942 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.85 110.7 32.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.682 -0.69 . . . . 64.25 111.153 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 515' ' ' SER . 32.9 tt0 -149.54 154.13 38.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.922 -1.51 . . . . 73.239999999999995 106.922 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -73.06 89.48 1.46 Allowed 'General case' 0 N--CA 1.431 -1.377 0 CA-C-O 121.787 0.803 . . . . 61.140000000000001 110.211 170.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 17.6 t -161.12 -177.37 6.03 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 105.847 -1.908 . . . . 62.32 105.847 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -145.17 169.29 18.47 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.398 -1.334 . . . . 73.439999999999998 107.398 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.59 125.18 46.13 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.704 -1.961 . . . . 65.230000000000004 105.704 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -74.19 109.96 8.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.12 -1.067 . . . . 73.109999999999999 108.12 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -118.83 168.54 10.67 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.208 -0.906 . . . . 73.400000000000006 111.441 -172.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 8.5 t -108.4 134.52 51.08 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 106.113 -1.81 . . . . 52.329999999999998 106.113 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 19.6 m -63.6 109.52 1.7 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.057 0.456 . . . . 63.109999999999999 110.753 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.42 170.55 19.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.959 -0.564 . . . . 65.409999999999997 109.667 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--N 1.309 -1.185 0 N-CA-C 109.686 -0.487 . . . . 70.219999999999999 109.686 -179.118 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.7 p80 . . . . . 0 CA--C 1.511 -0.527 0 CA-C-O 121.768 0.794 . . . . 71.439999999999998 109.674 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -67.33 -16.0 64.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.349 -1.296 . . . . 61.350000000000001 110.166 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . -133.81 119.72 2.35 Favored Glycine 0 N--CA 1.42 -2.391 0 N-CA-C 109.951 -1.26 . . . . 54.329999999999998 109.951 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 83.6 mt -127.15 114.88 38.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.586 -1.265 . . . . 45.509999999999998 107.586 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -103.77 134.65 46.72 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 70.010000000000005 111.873 -175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.1 t -148.13 163.34 37.25 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.934 -0.575 . . . . 75.140000000000001 109.654 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.9 162.37 20.53 Favored 'General case' 0 C--O 1.249 1.038 0 CA-C-O 120.958 0.409 . . . . 63.219999999999999 110.678 176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.0 -55.77 19.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.106 -0.952 . . . . 73.140000000000001 109.167 176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.33 159.36 57.66 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 115.515 -0.766 . . . . 73.129999999999995 108.976 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -83.06 -18.16 6.4 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.221 1.281 . . . . 53.240000000000002 111.224 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 642' ' ' GLU . 79.4 t -142.0 130.38 21.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.247 0.619 . . . . 61.009999999999998 109.364 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.7 t -133.62 140.96 47.42 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 108.63 -0.878 . . . . 61.240000000000002 108.63 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -119.49 117.21 27.82 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.776 -0.824 . . . . 73.239999999999995 108.776 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 19.1 m -106.35 162.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.248 0.546 . . . . 61.219999999999999 112.472 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 16.3 m -74.38 138.22 43.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.9 -1.045 . . . . 73.510000000000005 110.052 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -58.71 -33.93 70.75 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 123.404 0.682 . . . . 72.430000000000007 110.916 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.5 m -110.22 25.42 11.8 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.594 0.59 . . . . 54.420000000000002 112.594 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.441 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 13.6 tt -71.27 -33.2 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.361 0.601 . . . . 64.209999999999994 112.276 -178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 574' ' ' ARG . . . 89.85 -75.16 1.81 Allowed Glycine 0 N--CA 1.436 -1.309 0 C-N-CA 120.215 -0.993 . . . . 62.210000000000001 110.845 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 39.7 mm -120.25 123.27 70.28 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.918 -0.401 . . . . 72.510000000000005 109.918 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.495 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 21.5 ptm -94.03 130.05 40.3 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.437 -0.949 . . . . 73.310000000000002 108.437 173.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -106.56 113.45 26.96 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.577 0.751 . . . . 70.140000000000001 111.339 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 57.5 t -119.76 131.06 73.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 109.599 -0.519 . . . . 53.0 109.599 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -92.76 133.71 35.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.062 0.458 . . . . 74.299999999999997 110.366 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 97.6 t -90.3 114.02 27.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.952 -1.499 . . . . 65.299999999999997 106.952 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.0 mt -85.41 151.01 24.32 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.131 -0.94 . . . . 52.539999999999999 109.584 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 530' ' ' GLY . 0.0 OUTLIER -122.46 104.4 9.36 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.167 -1.049 . . . . 75.129999999999995 108.167 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.8 m -63.82 -63.34 1.19 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.99 -1.004 . . . . 71.420000000000002 111.861 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 10.8 p -74.13 -33.68 63.63 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.641 0.734 . . . . 54.420000000000002 110.725 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . 0.559 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 140.36 -148.6 20.22 Favored Glycine 0 N--CA 1.418 -2.529 0 N-CA-C 109.567 -1.413 . . . . 63.450000000000003 109.567 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -162.96 144.01 9.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.687 -1.597 . . . . 54.140000000000001 106.687 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -149.04 131.21 15.45 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 112.429 0.529 . . . . 73.129999999999995 112.429 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 99.06 -126.38 8.89 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 115.219 -0.901 . . . . 72.450000000000003 111.359 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.02 109.53 7.42 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.321 -1.363 . . . . 73.319999999999993 107.321 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.09 122.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 121.146 0.498 . . . . 71.310000000000002 110.715 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.77 117.77 32.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.127 -1.434 . . . . 63.109999999999999 107.127 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.2 t -108.18 101.1 40.23 Favored Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 108.151 -1.055 . . . . 74.519999999999996 108.151 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.23 139.26 6.98 Favored 'Trans proline' 0 N--CA 1.425 -2.558 0 C-N-CA 121.63 1.553 . . . . 71.400000000000006 111.983 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.509 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.4 p90 -119.6 159.49 24.28 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 106.963 -1.495 . . . . 75.150000000000006 106.963 176.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.495 ' HA ' ' SG ' ' A' ' 557' ' ' CYS . 62.3 pttt -146.33 140.66 26.58 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.004 -0.678 . . . . 74.150000000000006 110.963 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 5.1 p -85.94 132.77 34.01 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 114.64 -1.164 . . . . 63.030000000000001 110.593 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 39.3 mm -109.59 116.74 52.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 107.875 -1.157 . . . . 72.010000000000005 107.875 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -67.87 167.76 12.94 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.398 0.618 . . . . 71.299999999999997 111.047 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 156.99 116.44 0.51 Allowed Glycine 0 CA--C 1.478 -2.252 0 N-CA-C 107.733 -2.147 . . . . 75.540000000000006 107.733 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.407 ' HB ' ' SG ' ' A' ' 585' ' ' CYS 0.295 7.9 p 66.85 -44.43 0.44 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.124 1.77 . . . . 43.219999999999999 112.437 -172.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.07 154.01 19.7 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 106.962 -1.496 . . . . 72.439999999999998 106.962 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.498 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 3.4 mpt_? -111.27 152.53 27.07 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.283 0.563 . . . . 71.129999999999995 110.511 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.77 170.47 32.17 Favored Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.323 -1.111 . . . . 62.310000000000002 110.323 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 106.77 23.84 6.95 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 110.267 -1.133 . . . . 72.430000000000007 110.267 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 63.61 36.36 93.24 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.96 -0.856 . . . . 62.200000000000003 110.96 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.448 ' HB3' ' OH ' ' A' ' 581' ' ' TYR . 6.1 mm-40 -93.02 -76.36 0.47 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.145 0.578 . . . . 63.240000000000002 111.506 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.61 -40.39 15.2 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.615 -1.254 . . . . 62.43 107.615 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -140.26 160.67 39.46 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.001 -1.454 . . . . 75.230000000000004 107.469 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.8 OUTLIER -88.71 104.94 17.35 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.084 -1.45 . . . . 75.109999999999999 107.084 177.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.19 98.91 0.84 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.673 -1.149 . . . . 72.349999999999994 109.039 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.54 138.69 54.31 Favored 'General case' 0 N--CA 1.398 -3.033 0 CA-C-N 114.472 -1.24 . . . . 71.310000000000002 107.993 -171.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 540' ' ' LYS . 56.1 m -149.17 125.0 10.54 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 110.437 -0.209 . . . . 74.239999999999995 110.437 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 121.3 -133.21 9.45 Favored Glycine 0 C--O 1.211 -1.308 0 N-CA-C 111.222 -0.751 . . . . 75.230000000000004 111.222 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 60.44 -10.09 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 118.277 2.695 . . . . 74.230000000000004 118.277 171.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.548 HD22 ' HB3' ' A' ' 569' ' ' LYS . 39.8 mt -99.41 135.22 41.14 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.523 -1.361 . . . . 70.219999999999999 112.93 -175.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.405 ' HG2' ' NE2' ' A' ' 563' ' ' GLN . 41.6 tt0 -137.12 115.66 11.98 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.071 -1.085 . . . . 75.209999999999994 108.071 175.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.99 145.87 29.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.388 -0.967 . . . . 63.049999999999997 108.388 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.477 ' H ' HD11 ' A' ' 567' ' ' ILE . 2.0 mp0 -103.63 -94.55 0.32 Allowed 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 106.73 -1.581 . . . . 74.150000000000006 106.73 170.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -105.22 176.09 5.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.866 -0.606 . . . . 74.349999999999994 111.875 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -54.09 -25.53 22.33 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.636 1.574 . . . . 73.420000000000002 112.436 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.08 -20.56 54.53 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.001 0.92 . . . . 74.219999999999999 113.153 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.477 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.8 pt -119.64 157.7 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 119.497 -0.881 . . . . 63.450000000000003 110.617 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.93 148.4 32.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 106.707 -1.59 . . . . 70.439999999999998 106.707 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.6 mmpt? -113.02 164.56 13.31 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.519 -0.472 . . . . 52.439999999999998 112.027 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.11 134.41 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.173 -0.921 . . . . 64.400000000000006 110.426 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.509 HG23 ' CZ ' ' A' ' 539' ' ' TYR . 70.2 mt -90.67 125.64 43.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.531 -1.285 . . . . 71.430000000000007 107.531 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 22.5 p -111.86 112.65 24.46 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.511 0.672 . . . . 60.509999999999998 110.588 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.495 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 62.2 mt -118.83 130.06 74.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.635 -0.876 . . . . 74.299999999999997 108.635 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 84.0 mtp180 -83.69 132.82 34.84 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 123.726 0.641 . . . . 73.129999999999995 110.142 176.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.73 130.18 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.922 -1.14 . . . . 74.109999999999999 107.922 178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -116.09 115.01 25.31 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 112.466 0.543 . . . . 72.340000000000003 112.466 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -117.67 123.61 46.53 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.11 -0.7 . . . . 71.519999999999996 109.11 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -128.31 -72.85 0.6 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.823 -0.806 . . . . 75.530000000000001 108.823 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -102.98 -165.69 1.2 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.28 -1.007 . . . . 62.329999999999998 108.28 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.17 -68.05 0.36 Allowed 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.649 -1.241 . . . . 74.409999999999997 107.649 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.448 ' OH ' ' HB3' ' A' ' 551' ' ' GLU . 17.4 t80 61.43 17.68 8.63 Favored 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 113.957 1.095 . . . . 75.209999999999994 113.957 166.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.9 81.04 0.21 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.789 0.663 . . . . 60.310000000000002 112.789 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -98.09 85.57 3.51 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.863 0.84 . . . . 71.319999999999993 109.313 173.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -156.28 27.31 0.35 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 104.224 -2.51 . . . . 73.25 104.224 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 545' ' ' THR . 75.0 m -102.93 141.52 35.58 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 112.956 -1.929 . . . . 75.430000000000007 112.002 -170.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.467 ' HB3' HG13 ' A' ' 644' ' ' ILE . 61.1 p -130.65 120.76 24.41 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.751 -0.659 . . . . 61.539999999999999 109.797 176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -108.13 168.86 8.99 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.62 -1.252 . . . . 74.310000000000002 107.62 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 3.6 m -121.28 162.89 19.47 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.243 -0.983 . . . . 51.43 109.887 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.495 HD21 HD13 ' A' ' 571' ' ' ILE . 65.9 tp -136.54 125.94 25.02 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.808 -1.553 . . . . 52.140000000000001 106.808 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' A' ' 640' ' ' LYS . 26.8 m -124.52 159.62 30.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.786 -0.45 . . . . 63.240000000000002 109.786 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.61 135.46 43.09 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.265 -1.013 . . . . 53.009999999999998 108.265 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -97.97 171.63 8.15 Favored 'General case' 0 C--N 1.271 -2.822 0 CA-C-N 115.69 -0.686 . . . . 71.340000000000003 109.476 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.43 121.2 46.29 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 113.49 0.922 . . . . 75.400000000000006 113.49 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.476 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 28.7 Cg_endo -77.06 144.51 23.84 Favored 'Trans proline' 0 N--CA 1.415 -3.094 0 C-N-CA 121.428 1.419 . . . . 73.25 111.191 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.41 ' HB3' ' NZ ' ' A' ' 595' ' ' LYS . 0.1 OUTLIER -118.72 132.37 56.15 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 115.114 -0.948 . . . . 73.329999999999998 110.062 -176.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -98.27 119.69 37.39 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.63 -0.714 . . . . 73.109999999999999 109.262 -175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.15 92.07 3.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 106.997 -1.482 . . . . 54.350000000000001 106.997 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -124.18 154.75 39.62 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.878 -1.056 . . . . 71.019999999999996 109.842 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -74.32 117.46 16.16 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.514 -0.55 . . . . 62.039999999999999 109.514 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 147.59 -41.46 0.93 Allowed Glycine 0 C--N 1.307 -1.066 0 N-CA-C 109.905 -1.278 . . . . 64.120000000000005 109.905 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 24.4 ttt -82.89 65.63 8.11 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 121.553 0.692 . . . . 73.420000000000002 109.497 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -165.46 -57.88 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.267 -0.879 . . . . 63.299999999999997 109.099 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 80.52 -66.12 3.75 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.526 -0.629 . . . . 43.009999999999998 111.526 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 166.41 31.57 0.02 OUTLIER Glycine 0 C--N 1.296 -1.64 0 N-CA-C 109.036 -1.625 . . . . 74.239999999999995 109.036 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -164.84 -175.5 3.8 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.497 -1.297 . . . . 65.200000000000003 107.497 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 50.9 m -98.46 122.9 42.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.936 -0.764 . . . . 70.5 108.936 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.42 103.49 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 N-CA-C 108.26 -1.015 . . . . 73.409999999999997 108.26 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 19.1 m -92.55 -10.29 38.17 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.853 0.835 . . . . 72.120000000000005 108.901 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.85 81.83 3.43 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.01 0.909 . . . . 64.430000000000007 109.662 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -145.97 131.08 18.35 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 113.999 -1.455 . . . . 74.349999999999994 107.762 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . 0.506 ' CE2' ' HB2' ' A' ' 613' ' ' ASP . 27.6 t80 -69.16 138.75 54.41 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.41 -1.33 . . . . 75.319999999999993 107.41 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -60.77 -37.18 81.0 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 120.662 -0.415 . . . . 75.099999999999994 111.137 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.506 ' HB2' ' CE2' ' A' ' 611' ' ' TYR . 23.2 m-20 -81.57 145.0 30.87 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 108.844 -0.799 . . . . 60.43 108.844 174.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -55.68 -45.08 77.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 123.598 0.561 . . . . 72.120000000000005 111.958 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -153.42 162.63 26.07 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 104.754 -2.313 . . . . 73.310000000000002 104.754 173.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.36 132.92 23.32 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.009 1.139 . . . . 61.149999999999999 109.583 174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.11 -53.89 3.13 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.492 -0.929 . . . . 51.420000000000002 108.492 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 2.9 m -102.35 92.06 4.54 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 107.73 -1.211 . . . . 74.239999999999995 107.73 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 47.4 m -86.6 130.99 34.28 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.963 0.411 . . . . 72.140000000000001 111.296 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -114.08 -27.67 7.6 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.951 -0.759 . . . . 75.319999999999993 108.951 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -94.95 150.84 19.73 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.193 -1.04 . . . . 72.239999999999995 108.193 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.88 131.88 41.06 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.768 -0.827 . . . . 72.150000000000006 108.768 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -126.02 154.19 43.31 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.207 -0.597 . . . . 65.400000000000006 110.443 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 624' ' ' GLU . 0.1 OUTLIER -111.36 19.16 18.53 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 124.142 0.977 . . . . 72.109999999999999 109.032 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -52.41 -37.05 55.66 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-N 114.229 -1.35 . . . . 54.109999999999999 112.317 -174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.628 ' O ' ' HG3' ' A' ' 630' ' ' MET . 40.2 mmt180 -57.22 -42.04 80.61 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 122.231 0.212 . . . . 75.519999999999996 111.142 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.477 ' HA ' ' SD ' ' A' ' 630' ' ' MET . 64.9 mt -68.65 -33.17 58.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.241 0.543 . . . . 74.310000000000002 109.836 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -72.59 -37.53 68.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.819 -0.628 . . . . 74.099999999999994 109.526 176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 632' ' ' ARG . 45.2 mt-10 -71.09 -23.29 62.09 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-N 115.982 -0.553 . . . . 44.240000000000002 111.02 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 64.5 mtt -64.76 -8.85 16.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.216 0.606 . . . . 75.439999999999998 111.849 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -101.95 -4.75 51.14 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 121.014 -0.612 . . . . 70.109999999999999 112.132 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.404 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 29.5 ptt180 -122.16 165.42 20.79 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 108.964 -0.754 . . . . 55.130000000000003 108.964 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.476 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 19.3 Cg_endo -61.55 137.08 67.05 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.777 1.651 . . . . 72.329999999999998 109.797 170.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER -136.2 -177.38 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 109.482 -0.562 . . . . 73.219999999999999 109.482 -178.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -94.19 171.25 8.95 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.163 -0.68 . . . . 73.5 109.163 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -74.34 179.02 43.61 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.029 -0.605 . . . . 70.439999999999998 111.803 176.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . 0.417 ' HG2' ' ND1' ' A' ' 638' ' ' HIS . 34.1 tt0 -46.97 -68.79 0.16 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.196 1.399 . . . . 71.030000000000001 111.238 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . 0.417 ' ND1' ' HG2' ' A' ' 637' ' ' GLU . 39.7 m80 -134.31 94.04 3.16 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.461 -0.94 . . . . 74.299999999999997 108.461 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 10.2 t -113.18 108.41 17.24 Favored 'General case' 0 N--CA 1.408 -2.567 0 C-N-CA 119.496 -0.882 . . . . 32.32 109.725 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . 0.404 ' HG3' HG12 ' A' ' 590' ' ' VAL . 39.7 ttpt -147.96 135.96 21.15 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.869 -1.53 . . . . 61.520000000000003 106.869 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.1 tp -113.44 116.27 29.35 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 108.58 -0.896 . . . . 75.329999999999998 108.58 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.408 ' HB2' HG22 ' A' ' 511' ' ' VAL . 39.7 mt-10 -93.84 126.55 39.1 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 108.248 -1.019 . . . . 75.200000000000003 108.248 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 40.5 t -112.55 122.76 67.38 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.786 -0.643 . . . . 60.299999999999997 109.471 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' ' 586' ' ' SER . 3.9 mp -108.95 130.14 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 115.483 -0.78 . . . . 73.450000000000003 109.42 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.17 99.67 7.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-O 121.313 0.578 . . . . 65.349999999999994 111.794 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -173.84 168.27 4.3 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.63 -1.619 . . . . 71.420000000000002 106.63 175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.21 -35.92 19.75 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.469 0.544 . . . . 71.010000000000005 112.469 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 15.6 m -94.29 87.61 5.28 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.468 0.652 . . . . 73.25 112.521 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -99.98 122.67 43.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.057 -1.46 . . . . 74.439999999999998 107.057 173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -101.2 100.65 11.22 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 120.339 -0.544 . . . . 52.340000000000003 110.912 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -83.22 78.84 9.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.266 -1.383 . . . . 73.329999999999998 107.266 175.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.13 112.27 1.64 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.601 -1.636 . . . . 72.510000000000005 109.703 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 38.6 m -111.71 114.12 26.93 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.052 -0.976 . . . . 70.549999999999997 110.69 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 12.4 t -151.94 176.23 11.68 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.283 -1.747 . . . . 62.509999999999998 106.283 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 57.7 t -102.96 94.32 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 117.981 0.355 . . . . 74.409999999999997 110.054 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.485 1.283 0 C-N-CA 123.844 0.858 . . . . 74.010000000000005 112.915 176.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 48.4 t60 . . . . . 0 C--O 1.238 0.475 0 CA-C-O 120.969 0.414 . . . . 62.439999999999998 110.116 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -145.96 163.54 34.87 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.572 -1.64 . . . . 73.040000000000006 106.572 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -90.24 104.29 3.12 Favored Glycine 0 C--O 1.215 -1.054 0 C-N-CA 120.772 -0.728 . . . . 61.140000000000001 112.16 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 86.5 mt -92.95 114.83 30.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 123.68 0.792 . . . . 55.25 108.912 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.63 144.76 41.58 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.102 -0.333 . . . . 73.349999999999994 110.102 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.2 t -149.78 159.45 44.34 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 116.435 -0.348 . . . . 63.149999999999999 110.238 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 85.8 m-85 -73.01 154.19 40.6 Favored 'General case' 0 C--O 1.251 1.134 0 N-CA-C 109.796 -0.446 . . . . 70.329999999999998 109.796 174.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -56.01 -57.24 12.94 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 124.06 0.85 . . . . 73.219999999999999 109.733 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -120.11 163.29 29.02 Favored Pre-proline 0 C--N 1.306 -1.284 0 CA-C-N 115.058 -0.974 . . . . 34.109999999999999 109.596 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.04 -22.84 1.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.68 2.253 . . . . 74.140000000000001 110.83 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' A' ' 642' ' ' GLU . 76.2 t -142.1 134.15 26.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 108.149 -1.056 . . . . 71.340000000000003 108.149 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 13.5 t -134.14 126.58 30.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 121.121 0.486 . . . . 63.329999999999998 109.922 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 649' ' ' TYR . 6.8 p-80 -98.65 120.69 39.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.466 -1.309 . . . . 75.019999999999996 107.466 172.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 27.2 m -117.01 154.44 18.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 116.201 -0.454 . . . . 44.109999999999999 109.963 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.488 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 45.8 m -60.0 154.27 19.43 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 124.246 0.966 . . . . 65.109999999999999 111.424 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.98 -33.3 57.62 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.942 -1.133 . . . . 63.409999999999997 107.942 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.6 m -98.89 28.82 4.11 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.16 -0.927 . . . . 73.420000000000002 110.232 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 9.8 tt -76.94 -34.85 22.76 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 N-CA-C 112.983 0.734 . . . . 74.150000000000006 112.983 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.32 -70.93 3.06 Favored Glycine 0 N--CA 1.437 -1.248 0 C-N-CA 120.204 -0.998 . . . . 55.43 111.867 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.3 mm -130.96 131.57 64.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.776 -0.824 . . . . 74.109999999999999 108.776 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 16.9 ptm -106.29 127.28 53.13 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.601 -0.727 . . . . 71.239999999999995 109.152 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -88.81 114.46 25.45 Favored 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 123.262 0.351 . . . . 71.349999999999994 110.842 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.518 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 40.1 t -108.03 114.51 46.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 109.29 -0.633 . . . . 74.150000000000006 109.29 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -89.13 130.58 35.54 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.528 -0.545 . . . . 73.439999999999998 109.528 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 95.6 t -93.8 110.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 107.004 -1.48 . . . . 74.329999999999998 107.004 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 83.3 mt -86.3 151.91 23.2 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.069 -0.969 . . . . 65.0 109.897 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.543 ' HD3' ' H ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -115.66 107.93 15.74 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.588 -0.893 . . . . 54.520000000000003 108.588 179.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.6 m -65.28 -58.68 5.32 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.395 -0.82 . . . . 54.420000000000002 109.967 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.4 p -74.59 -51.25 15.07 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.665 -0.698 . . . . 71.219999999999999 111.068 178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.44 -166.31 26.87 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 110.347 -1.101 . . . . 71.439999999999998 110.347 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -146.77 134.44 21.07 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -153.32 99.4 2.35 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.423 -0.584 . . . . 63.43 109.423 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 127.01 -125.46 5.34 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 110.422 -1.071 . . . . 63.5 110.422 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -138.01 109.32 6.89 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.592 -0.521 . . . . 73.340000000000003 109.592 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 34.5 t -124.86 128.65 73.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.745 -0.835 . . . . 64.239999999999995 108.745 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.538 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.0 mm -105.34 126.05 60.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.379 -0.601 . . . . 74.099999999999994 109.379 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.42 109.76 60.11 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.791 -0.641 . . . . 45.450000000000003 109.956 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.48 146.03 13.51 Favored 'Trans proline' 0 N--CA 1.441 -1.568 0 C-N-CA 121.883 1.722 . . . . 74.209999999999994 111.428 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -137.05 157.46 46.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.363 -0.977 . . . . 71.049999999999997 108.363 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -149.9 139.86 21.94 Favored 'General case' 0 C--O 1.251 1.181 0 CA-C-O 121.099 0.476 . . . . 72.030000000000001 111.235 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -84.65 124.77 31.84 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.197 -0.91 . . . . 50.450000000000003 111.977 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 39.6 mm -97.29 115.84 38.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.993 -1.484 . . . . 70.129999999999995 106.993 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.34 163.17 25.09 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.836 -0.431 . . . . 41.520000000000003 109.836 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -156.4 -116.67 0.53 Allowed Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 109.426 -1.47 . . . . 71.140000000000001 109.426 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.6 m -70.26 -27.06 64.14 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 108.239 -1.023 . . . . 74.239999999999995 108.239 175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.18 131.42 38.26 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 114.782 -1.099 . . . . 64.219999999999999 108.292 175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.35 132.84 43.49 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.424 -1.695 . . . . 74.310000000000002 106.424 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.0 29.1 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.849 -0.691 . . . . 52.399999999999999 111.995 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.63 10.28 63.51 Favored Glycine 0 C--N 1.303 -1.266 0 N-CA-C 114.518 0.567 . . . . 70.540000000000006 114.518 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 121.62 -15.48 9.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 119.558 -1.306 . . . . 53.030000000000001 113.691 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.86 -79.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.357 0.578 . . . . 62.399999999999999 112.357 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.05 -41.49 12.29 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.048 -1.093 . . . . 54.240000000000002 108.048 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -143.17 163.76 32.01 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.508 -1.224 . . . . 74.349999999999994 107.962 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.587 ' HG3' ' NH2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -90.5 146.08 24.4 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.399 -1.334 . . . . 63.0 107.399 177.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.83 122.19 29.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.885 -0.413 . . . . 65.219999999999999 109.885 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.0 t -128.35 105.18 8.16 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-O 121.819 0.818 . . . . 74.019999999999996 109.73 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.55 131.58 51.53 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.227 -1.768 . . . . 44.310000000000002 106.227 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -175.26 -167.28 34.21 Favored Glycine 0 N--CA 1.432 -1.599 0 C-N-CA 119.169 -1.491 . . . . 64.319999999999993 113.249 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.517 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 46.3 mt-10 -113.83 122.72 47.9 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.811 0.844 . . . . 74.319999999999993 110.774 -176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.63 140.79 29.38 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.88 -0.785 . . . . 51.409999999999997 108.88 175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -107.25 113.35 26.71 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 116.49 -0.323 . . . . 72.140000000000001 110.719 -176.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 54.5 m-85 -115.88 115.83 26.92 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 110.061 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.454 ' H ' HD11 ' A' ' 567' ' ' ILE . 24.9 mp0 -90.08 -84.57 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.141 0.972 . . . . 72.409999999999997 110.507 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.477 HD22 ' HG2' ' A' ' 566' ' ' GLU . 8.8 t30 -105.11 157.8 17.01 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.31 -1.314 . . . . 64.340000000000003 111.216 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.84 -26.3 58.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.543 2.053 . . . . 64.219999999999999 116.543 -174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.477 ' HG2' HD22 ' A' ' 564' ' ' ASN . 7.9 pt-20 -80.25 7.24 9.85 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.034 1.124 . . . . 73.049999999999997 114.034 -174.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.454 HD11 ' H ' ' A' ' 563' ' ' GLN . 35.6 pt -119.36 161.93 18.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.396 -0.594 . . . . 62.229999999999997 109.396 175.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.92 154.57 34.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.128 -1.064 . . . . 71.420000000000002 108.128 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -113.97 147.09 39.18 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.988 0.423 . . . . 72.219999999999999 111.204 174.147 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -125.26 130.92 72.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.501 -1.227 . . . . 65.129999999999995 109.279 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 40.5 mt -91.99 126.39 44.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.477 -1.675 . . . . 70.150000000000006 106.477 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 29.1 p -108.52 112.25 24.53 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 109.461 -0.57 . . . . 63.439999999999998 109.461 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.52 HD11 HD22 ' A' ' 589' ' ' LEU . 52.2 mt -105.19 123.93 59.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 109.02 -0.733 . . . . 73.140000000000001 109.02 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.587 ' NH2' ' HG3' ' A' ' 554' ' ' GLU . 74.6 mtm180 -80.68 108.77 14.6 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 123.821 0.701 . . . . 73.099999999999994 111.201 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 51.1 mm -95.26 135.54 29.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.058 -1.83 . . . . 73.510000000000005 106.058 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -112.19 161.97 15.97 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.131 -0.627 . . . . 72.200000000000003 110.437 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . 0.459 ' HA ' ' HG2' ' A' ' 580' ' ' GLU . 8.2 p-10 -141.86 88.89 2.15 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.666 1.222 . . . . 72.030000000000001 109.117 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.448 ' HA ' ' NE ' ' A' ' 578' ' ' ARG . 3.0 mmp_? -118.61 -50.49 2.42 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.473 -1.24 . . . . 65.299999999999997 108.734 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -111.8 -25.98 9.19 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.281 -0.872 . . . . 71.219999999999999 109.972 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.604 ' HB3' ' HD2' ' A' ' 583' ' ' LYS . 1.5 pm0 -77.85 97.74 5.36 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 114.195 1.183 . . . . 63.340000000000003 114.195 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -136.56 7.38 3.04 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.878 -1.51 . . . . 70.5 108.058 172.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -144.39 15.8 1.66 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.565 -1.198 . . . . 72.450000000000003 110.332 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.604 ' HD2' ' HB3' ' A' ' 580' ' ' GLU . 89.5 mttt -92.76 167.75 11.66 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 118.992 -1.083 . . . . 75.349999999999994 113.769 -173.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -150.05 21.66 0.87 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.584 -1.189 . . . . 65.219999999999999 108.227 174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 10.0 p -61.22 140.69 57.89 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.757 -1.111 . . . . 72.340000000000003 110.944 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 28.4 p -123.78 155.62 37.6 Favored 'General case' 0 N--CA 1.416 -2.148 0 C-N-CA 119.861 -0.735 . . . . 62.539999999999999 111.998 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -139.12 -177.98 5.14 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.772 -1.195 . . . . 73.129999999999995 107.772 173.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 26.3 m -135.06 156.58 48.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.653 -0.655 . . . . 72.049999999999997 109.946 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 573' ' ' ILE . 42.8 tp -130.83 130.8 44.08 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.06 -1.459 . . . . 51.149999999999999 107.06 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.02 151.48 33.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 120.964 -0.294 . . . . 74.010000000000005 110.903 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 96.3 mt -95.57 140.01 31.01 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.26 -1.015 . . . . 61.450000000000003 108.26 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -100.41 159.42 15.16 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.357 -0.838 . . . . 62.43 109.05 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 120.84 19.22 Favored Pre-proline 0 N--CA 1.443 -0.794 0 O-C-N 124.122 0.888 . . . . 74.439999999999998 110.461 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.63 148.13 41.49 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.521 2.814 . . . . 74.340000000000003 112.643 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.538 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 18.2 ptpt -102.42 133.29 47.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.867 -1.16 . . . . 74.140000000000001 107.867 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -105.36 117.6 34.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.28 -0.637 . . . . 72.230000000000004 109.28 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . 0.435 HD13 HG12 ' A' ' 536' ' ' ILE . 2.3 mp -93.28 96.82 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 107.677 -1.231 . . . . 74.239999999999995 107.677 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -129.26 84.72 2.25 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.943 -1.026 . . . . 75.209999999999994 110.423 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 73.1 mtt-85 -121.97 -43.01 2.36 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.779 -1.193 . . . . 75.540000000000006 107.779 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 108.54 133.64 6.99 Favored Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 107.357 -2.297 . . . . 34.439999999999998 107.357 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 52.0 ttp -73.81 101.56 3.77 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 117.947 0.874 . . . . 73.420000000000002 110.013 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -85.57 173.1 10.42 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.104 -0.953 . . . . 70.25 110.663 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -76.41 64.15 2.9 Favored Glycine 0 C--O 1.237 0.291 0 CA-C-N 116.437 -0.347 . . . . 45.109999999999999 113.767 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 179.84 167.11 36.5 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 110.032 -1.227 . . . . 63.329999999999998 110.032 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -97.31 -40.25 8.83 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.29 -1.004 . . . . 64.209999999999994 108.29 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 12.7 m -117.25 107.27 14.22 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 106.989 -1.486 . . . . 62.340000000000003 106.989 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 43.5 mm -87.79 -30.69 5.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.858 -0.423 . . . . 73.230000000000004 109.858 -177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 608' ' ' THR . 33.6 m 63.18 34.81 13.19 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.748 1.261 . . . . 53.509999999999998 109.645 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -89.71 -25.25 21.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 121.541 -0.724 . . . . 71.129999999999995 110.42 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -100.32 124.93 46.41 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 108.666 -0.864 . . . . 72.120000000000005 108.666 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -95.18 -33.68 12.53 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.469 -0.787 . . . . 74.450000000000003 111.378 -176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -131.52 158.16 41.64 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.046 0.387 . . . . 74.150000000000006 112.046 -169.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -78.51 139.19 38.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.739 -0.664 . . . . 64.519999999999996 110.665 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 614' ' ' LYS . 10.9 mmpt? -86.72 92.84 9.08 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.092 0.472 . . . . 75.140000000000001 109.839 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -83.2 130.57 56.41 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 108.67 -0.863 . . . . 63.039999999999999 108.67 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.54 148.4 87.5 Favored 'Trans proline' 0 CA--C 1.509 -0.769 0 C-N-CA 121.923 1.749 . . . . 74.030000000000001 110.986 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 30.9 mt -103.63 137.76 41.23 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.547 -1.206 . . . . 52.450000000000003 110.812 -169.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 20.8 p -90.95 17.21 8.16 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 122.237 1.018 . . . . 62.350000000000001 109.635 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 11.0 m -75.75 105.49 6.82 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 114.25 -1.341 . . . . 54.100000000000001 108.89 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -92.83 116.26 28.87 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.454 -0.898 . . . . 74.099999999999994 109.193 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.3 156.42 35.61 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.778 -0.823 . . . . 75.120000000000005 108.778 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -80.27 61.26 4.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.467 1.127 . . . . 61.43 111.059 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -153.03 169.0 23.99 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 126.721 2.008 . . . . 63.310000000000002 106.031 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -62.33 146.18 51.82 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 123.438 0.461 . . . . 74.230000000000004 110.577 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -58.88 -39.93 82.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.082 -0.508 . . . . 64.200000000000003 111.272 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 630' ' ' MET . 61.7 ttt180 -67.53 -39.32 85.04 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-N 116.124 -0.489 . . . . 64.319999999999993 110.953 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.427 ' O ' ' HG2' ' A' ' 630' ' ' MET . 84.2 mt -72.08 -33.66 47.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.381 0.61 . . . . 64.299999999999997 110.389 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -70.16 -51.34 32.05 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.458 -0.497 . . . . 61.200000000000003 110.326 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 632' ' ' ARG . 38.8 mt-10 -82.8 -2.25 53.99 Favored 'General case' 0 C--O 1.205 -1.284 0 N-CA-C 113.668 0.988 . . . . 72.519999999999996 113.668 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.474 ' HB3' ' O ' ' A' ' 626' ' ' ARG . 17.2 ptm -62.11 -15.98 49.26 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.834 -0.541 . . . . 71.510000000000005 110.594 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -85.97 -3.93 84.98 Favored Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 115.579 -0.737 . . . . 52.310000000000002 112.585 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 629' ' ' GLU . 11.8 ptm180 -116.28 159.32 40.24 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 106.599 -1.63 . . . . 62.520000000000003 106.599 176.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.31 126.78 16.91 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.477 1.451 . . . . 72.420000000000002 110.521 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.21 -177.72 2.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.012 0.434 . . . . 74.099999999999994 111.143 -178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 26.9 mt -109.63 -158.32 0.64 Allowed 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.272 -0.877 . . . . 64.439999999999998 109.616 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -75.36 -164.4 13.84 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.14 -0.552 . . . . 62.130000000000003 112.465 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -59.75 -73.36 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 123.489 0.716 . . . . 71.329999999999998 109.568 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -131.24 127.35 37.66 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 106.559 -1.645 . . . . 72.140000000000001 106.559 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 2.6 t -137.94 109.13 6.82 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 123.139 1.447 . . . . 63.530000000000001 110.664 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -147.18 140.38 25.3 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.564 -1.653 . . . . 71.409999999999997 106.575 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 61.2 tp -116.83 106.92 13.99 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.605 -0.887 . . . . 74.439999999999998 108.605 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.475 ' HB2' HG22 ' A' ' 511' ' ' VAL . 42.0 mt-10 -86.4 124.46 32.77 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.92 -1.141 . . . . 44.399999999999999 107.92 176.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.27 123.73 69.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.737 -0.665 . . . . 74.540000000000006 109.653 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.2 mp -115.11 122.9 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 108.474 -0.936 . . . . 72.430000000000007 108.474 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.4 106.65 20.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.245 0.545 . . . . 71.230000000000004 111.651 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -152.67 139.92 19.43 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.544 -1.65 . . . . 65.219999999999999 106.544 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -82.35 65.57 7.54 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.95 0.881 . . . . 72.329999999999998 109.409 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 48.9 m -160.07 94.0 1.09 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.838 -1.073 . . . . 41.219999999999999 109.551 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.403 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 14.7 p90 -91.09 157.63 17.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.165 -1.05 . . . . 74.109999999999999 108.165 174.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -94.25 129.06 41.04 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.815 -0.754 . . . . 70.340000000000003 111.51 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -137.9 80.51 1.81 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.334 -1.728 . . . . 73.329999999999998 106.334 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 652' ' ' LYS . 1.3 tpmt? -92.79 -38.34 11.83 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 114.49 -1.232 . . . . 73.109999999999999 109.93 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 19.8 m -123.32 140.61 52.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.124 0.488 . . . . 51.350000000000001 111.121 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 24.2 m -101.4 129.12 47.36 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.534 -1.284 . . . . 74.430000000000007 107.534 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 11.8 p -79.4 133.66 29.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.745 -0.465 . . . . 72.099999999999994 109.745 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 109.445 -0.576 . . . . 64.310000000000002 109.445 178.805 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 . . . . . 0 N--CA 1.462 0.133 0 CA-C-O 121.183 0.516 . . . . 74.409999999999997 110.619 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -75.53 102.97 5.45 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.51 -0.768 . . . . 61.32 110.776 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . -79.23 95.3 1.41 Allowed Glycine 0 N--CA 1.429 -1.805 0 CA-C-N 115.329 -0.851 . . . . 32.32 111.304 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 62.5 mt -113.84 114.56 47.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 107.274 -1.38 . . . . 75.219999999999999 107.274 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.06 137.94 47.12 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.236 0.335 . . . . 74.239999999999995 111.056 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.5 t -148.91 165.9 30.17 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.955 -0.387 . . . . 52.149999999999999 109.955 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.577 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 75.6 m-85 -79.16 157.76 27.84 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.339 0.656 . . . . 72.439999999999998 110.337 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.13 -50.58 71.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.72 0.772 . . . . 63.43 109.534 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.81 151.32 72.19 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 114.891 -1.049 . . . . 75.219999999999999 108.56 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.94 -22.37 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.115 1.877 . . . . 60.200000000000003 112.559 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 91.0 t -137.81 131.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.962 -0.385 . . . . 74.209999999999994 109.962 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.8 t -133.68 141.03 47.41 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.088 0.471 . . . . 63.520000000000003 109.84 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.45 ' CD2' ' HA ' ' A' ' 648' ' ' SER . 77.0 m80 -112.99 119.74 38.96 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.346 -0.983 . . . . 43.420000000000002 108.346 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.67 155.52 19.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.365 0.603 . . . . 72.129999999999995 111.032 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 518' ' ' ILE . 68.7 m -83.1 157.2 22.92 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.513 -0.767 . . . . 73.140000000000001 110.305 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.729 0.776 . . . . 73.129999999999995 111.366 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.5 p -89.84 24.42 2.39 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.213 -0.903 . . . . 71.420000000000002 112.156 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 515' ' ' SER . 5.8 tt -86.46 -25.49 6.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.297 0.57 . . . . 65.239999999999995 110.512 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.25 -71.82 2.86 Favored Glycine 0 N--CA 1.438 -1.171 0 C-N-CA 120.614 -0.803 . . . . 31.309999999999999 111.961 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.2 mm -131.2 138.33 53.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.239 -1.763 . . . . 60.020000000000003 106.239 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.406 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.4 ppp? -112.21 147.85 35.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.176 -0.676 . . . . 70.430000000000007 109.176 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -113.03 130.37 56.17 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.832 0.707 . . . . 64.129999999999995 111.201 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 39.5 t -125.11 124.21 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.288 0 N-CA-C 107.973 -1.121 . . . . 55.43 107.973 174.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.436 ' HG2' HG12 ' A' ' 570' ' ' ILE . 59.6 mttm -91.05 131.19 36.79 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 118.994 -1.082 . . . . 61.439999999999998 109.383 174.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 89.3 t -91.34 109.67 21.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 106.948 -1.501 . . . . 64.25 106.948 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.1 mt -87.12 143.29 27.37 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 114.742 -1.117 . . . . 74.209999999999994 110.167 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.88 113.54 26.54 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.972 -1.013 . . . . 62.119999999999997 108.672 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 41.0 p -66.54 -63.64 1.03 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.023 -0.671 . . . . 73.430000000000007 111.592 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 51.0 m -74.46 -52.55 11.68 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.041 0.448 . . . . 43.130000000000003 111.513 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . 0.565 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 160.21 -143.85 9.45 Favored Glycine 0 N--CA 1.432 -1.575 0 C-N-CA 120.607 -0.806 . . . . 52.43 111.735 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.64 161.18 18.12 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 106.248 -1.76 . . . . 72.219999999999999 106.248 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -157.19 126.52 6.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.463 0.574 . . . . 62.100000000000001 110.527 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.34 -118.7 5.61 Favored Glycine 0 CA--C 1.494 -1.28 0 C-N-CA 120.723 -0.751 . . . . 43.219999999999999 111.857 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -138.51 111.99 8.16 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.284 -1.006 . . . . 73.329999999999998 108.284 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 64.6 t -122.34 130.26 74.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.877 -0.515 . . . . 73.519999999999996 110.686 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.6 mm -96.37 118.35 42.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.497 -0.927 . . . . 74.230000000000004 108.497 177.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.1 106.63 58.84 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.888 -0.782 . . . . 71.239999999999995 108.888 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -83.98 159.61 13.71 Favored 'Trans proline' 0 N--CA 1.42 -2.798 0 C-N-CA 121.838 1.692 . . . . 62.399999999999999 111.027 176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -151.36 163.34 39.15 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 105.915 -1.883 . . . . 72.420000000000002 105.915 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -150.81 129.07 11.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.248 -0.581 . . . . 62.43 110.863 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.3 p -78.01 117.38 19.28 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-N 115.464 -0.789 . . . . 74.230000000000004 110.293 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 42.5 mm -88.4 120.45 37.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.216 -1.402 . . . . 72.329999999999998 107.216 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.56 113.63 13.21 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.684 -0.487 . . . . 74.120000000000005 109.684 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -94.18 -108.69 2.07 Favored Glycine 0 CA--C 1.496 -1.128 0 N-CA-C 110.423 -1.071 . . . . 34.32 110.423 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 42.4 p -86.26 -24.22 26.07 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.591 -0.892 . . . . 74.109999999999999 108.591 176.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 585' ' ' CYS . . . -88.09 145.41 25.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.22 -0.9 . . . . 74.400000000000006 109.363 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.401 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 36.6 mmm-85 -95.02 138.24 33.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.747 0.784 . . . . 64.310000000000002 112.685 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -110.58 129.48 9.32 Favored Glycine 0 N--CA 1.416 -2.659 0 CA-C-N 114.182 -1.372 . . . . 74.230000000000004 110.978 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 141.49 -17.82 2.65 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.581 -1.008 . . . . 62.43 110.581 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 155.51 -16.64 0.49 Allowed Glycine 0 N--CA 1.429 -1.798 0 C-N-CA 119.858 -1.163 . . . . 73.530000000000001 113.445 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 2.2 mp0 -69.67 -81.79 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.459 0.63 . . . . 64.030000000000001 111.462 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -86.37 -53.7 4.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.981 0.896 . . . . 73.349999999999994 108.617 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -131.2 160.84 33.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.273 -0.876 . . . . 60.5 110.445 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.534 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 27.2 tt0 -96.26 119.06 34.06 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 105.788 -1.93 . . . . 74.120000000000005 105.788 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.79 143.4 54.63 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.31 0.576 . . . . 74.450000000000003 111.501 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 4.9 t -140.72 136.53 32.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.833 -0.621 . . . . 71.540000000000006 110.076 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.1 p -143.46 110.41 5.64 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 121.23 0.538 . . . . 64.140000000000001 112.2 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 79.22 105.78 0.23 Allowed Glycine 0 C--O 1.226 -0.347 0 CA-C-N 115.535 -0.757 . . . . 74.510000000000005 113.122 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.42 14.54 0.31 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.65 -0.87 . . . . 70.019999999999996 108.65 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 569' ' ' LYS . 46.2 mt -117.45 135.89 53.58 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 121.289 -0.882 . . . . 71.030000000000001 112.198 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.452 ' H ' ' HD2' ' A' ' 569' ' ' LYS . 36.0 tt0 -134.91 109.69 8.65 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.588 -1.264 . . . . 74.319999999999993 107.588 175.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 48.8 m-85 -102.37 115.28 30.25 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.822 -0.807 . . . . 63.439999999999998 108.822 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.481 ' H ' HD11 ' A' ' 567' ' ' ILE . 44.6 mt-30 -90.15 -79.64 0.34 Allowed 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.798 -0.637 . . . . 74.040000000000006 109.898 -178.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -104.33 167.1 9.96 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.005 -0.739 . . . . 63.299999999999997 109.005 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -69.34 -20.13 63.86 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 123.479 0.712 . . . . 62.439999999999998 112.33 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.2 -10.26 59.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 114.143 1.164 . . . . 72.219999999999999 114.143 -175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.481 HD11 ' H ' ' A' ' 563' ' ' GLN . 40.0 pt -113.44 166.46 7.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 120.223 -0.591 . . . . 64.540000000000006 110.892 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.3 p -134.86 148.23 29.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.863 -1.532 . . . . 71.129999999999995 106.863 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.463 ' HB3' HD22 ' A' ' 560' ' ' LEU . 20.8 mttm -116.48 155.67 28.19 Favored 'General case' 0 CA--C 1.481 -1.693 0 N-CA-C 112.876 0.695 . . . . 63.520000000000003 112.876 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 32.7 mt -122.0 133.08 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 114.915 -1.039 . . . . 55.32 110.594 -174.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.462 HD13 HD21 ' A' ' 589' ' ' LEU . 47.8 mt -90.99 129.21 42.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.947 -1.501 . . . . 73.219999999999999 106.947 174.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -115.1 112.66 22.92 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.449 -0.574 . . . . 73.299999999999997 109.449 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 589' ' ' LEU . 62.1 mt -108.36 130.7 60.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.82 -0.807 . . . . 73.200000000000003 108.82 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.534 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 70.7 ttt180 -76.9 112.58 13.66 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.484 -0.561 . . . . 73.510000000000005 109.484 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -100.16 119.16 47.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 105.344 -2.095 . . . . 62.329999999999998 105.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -73.06 100.14 2.94 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.645 0.736 . . . . 74.140000000000001 112.524 -175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.91 -19.16 61.32 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.737 -1.12 . . . . 72.420000000000002 110.795 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 578' ' ' ARG . 71.7 ttt180 -92.9 31.86 1.35 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 122.495 1.141 . . . . 64.530000000000001 108.35 176.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -147.77 155.98 42.26 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 106.985 -1.487 . . . . 74.230000000000004 106.985 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -161.55 124.74 3.15 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.421 -0.585 . . . . 75.120000000000005 109.421 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.46 158.69 22.17 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.708 -0.849 . . . . 74.129999999999995 108.708 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.08 31.18 5.72 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 122.581 1.181 . . . . 63.530000000000001 109.317 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -118.16 154.75 31.64 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 106.779 -1.563 . . . . 75.040000000000006 106.779 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -76.22 85.34 3.04 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.515 1.15 . . . . 74.409999999999997 109.902 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 546' ' ' ALA . 63.4 m -72.17 124.26 24.64 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 114.103 -1.408 . . . . 72.340000000000003 110.518 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 64.6 p -147.42 151.61 36.75 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.714 -0.847 . . . . 62.039999999999999 108.714 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.7 p90 -149.97 176.69 10.55 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.852 -1.166 . . . . 71.109999999999999 107.852 176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 20.0 m -129.85 163.96 25.17 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.972 -0.691 . . . . 74.120000000000005 109.853 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.462 HD21 HD13 ' A' ' 571' ' ' ILE . 41.9 tp -139.67 127.36 21.83 Favored 'General case' 0 C--N 1.263 -3.165 0 N-CA-C 106.729 -1.582 . . . . 74.140000000000001 106.729 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.52 151.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.546 -0.539 . . . . 70.409999999999997 109.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.577 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 85.0 mt -92.1 139.42 30.65 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.901 -1.148 . . . . 53.25 107.901 175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -99.42 167.55 10.56 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 115.476 -0.784 . . . . 73.439999999999998 108.979 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.24 115.19 9.18 Favored Pre-proline 0 N--CA 1.446 -0.637 0 O-C-N 124.598 1.186 . . . . 71.150000000000006 109.333 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.42 142.7 23.98 Favored 'Trans proline' 0 N--CA 1.428 -2.346 0 C-N-CA 121.703 1.602 . . . . 72.109999999999999 111.412 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -110.3 132.34 54.26 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.957 -0.565 . . . . 63.240000000000002 110.421 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -85.02 118.81 24.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.451 -1.314 . . . . 73.219999999999999 107.451 -176.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 43.1 mm -86.92 88.4 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.391 0 N-CA-C 106.0 -1.852 . . . . 65.120000000000005 106.0 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . 0.513 ' HA ' ' HE ' ' A' ' 598' ' ' ARG . 3.9 tpm_? -110.53 106.96 16.43 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.288 -1.375 . . . . 64.5 107.288 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -83.16 119.06 24.06 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.849 -0.797 . . . . 74.0 108.849 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 127.48 -14.85 6.43 Favored Glycine 0 N--CA 1.434 -1.497 0 C-N-CA 120.832 -0.699 . . . . 61.219999999999999 111.898 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -83.83 -25.54 30.25 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.637 0.732 . . . . 51.539999999999999 109.969 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -85.57 84.23 7.67 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.57 -1.27 . . . . 72.329999999999998 107.57 177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -159.84 -78.72 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 119.596 -1.288 . . . . 41.329999999999998 112.662 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -84.4 35.59 2.99 Favored Glycine 0 C--N 1.314 -0.648 0 C-N-CA 121.262 -0.494 . . . . 71.0 113.137 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -131.88 164.13 26.77 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.596 -1.261 . . . . 70.450000000000003 107.596 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 28.3 m -81.18 99.69 8.69 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.638 0.732 . . . . 75.510000000000005 109.325 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 42.3 mm -94.29 101.85 12.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 107.677 -1.231 . . . . 73.200000000000003 107.677 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 9.8 t -80.38 -21.39 42.38 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.919 -0.582 . . . . 65.239999999999995 110.251 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 71.18 -50.17 0.68 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.949 1.7 . . . . 52.240000000000002 112.823 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -74.91 154.58 38.12 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.049 -0.723 . . . . 62.219999999999999 109.049 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -82.29 71.45 9.35 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.538 0.685 . . . . 73.25 111.651 -173.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -107.95 2.33 23.22 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.424 -1.324 . . . . 64.019999999999996 107.424 171.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -86.8 149.35 24.91 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 113.618 -1.628 . . . . 64.299999999999997 107.856 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -75.91 -46.41 30.17 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.229 -0.656 . . . . 65.209999999999994 109.229 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . 0.561 ' HB3' ' HD3' ' A' ' 616' ' ' PRO . 35.1 tt0 -174.36 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 125.266 1.426 . . . . 70.319999999999993 108.118 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 615' ' ' GLN . 16.5 Cg_exo -71.89 156.06 57.01 Favored 'Trans proline' 0 C--N 1.374 1.894 0 N-CA-C 107.024 -1.952 . . . . 73.310000000000002 107.024 165.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.97 -37.56 69.88 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.599 0.714 . . . . 52.439999999999998 110.106 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 10.6 p -94.3 126.39 39.52 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.364 -0.834 . . . . 75.329999999999998 111.35 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 46.4 m -74.42 -33.66 63.04 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.821 -0.807 . . . . 64.150000000000006 108.821 175.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -79.21 99.76 7.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.054 -1.462 . . . . 74.140000000000001 107.054 173.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.0 106.62 17.23 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.751 0.786 . . . . 73.030000000000001 111.765 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.36 -26.17 17.38 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.505 -0.77 . . . . 54.020000000000003 110.775 178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -79.69 116.06 19.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.822 -1.547 . . . . 74.219999999999999 106.822 172.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -55.41 142.26 33.25 Favored 'General case' 0 CA--C 1.51 -0.56 0 O-C-N 123.528 0.518 . . . . 71.230000000000004 110.75 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.457 ' HE ' ' CD ' ' A' ' 629' ' ' GLU . 32.7 ttt180 -51.86 -45.82 64.22 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 112.902 0.704 . . . . 74.299999999999997 112.902 -175.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.526 ' O ' ' HG3' ' A' ' 630' ' ' MET . 51.1 ttp180 -61.55 -36.04 79.46 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.35 0.595 . . . . 75.040000000000006 110.771 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 71.2 mt -72.89 -41.79 60.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.075 -0.713 . . . . 74.329999999999998 109.075 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -62.87 -39.43 94.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.913 -0.585 . . . . 34.119999999999997 110.308 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.457 ' CD ' ' HE ' ' A' ' 625' ' ' ARG . 51.1 mt-10 -72.1 -19.28 61.83 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 116.291 -0.413 . . . . 60.25 111.361 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 73.4 mtm -82.57 -8.08 59.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.607 0.718 . . . . 62.310000000000002 109.645 173.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -108.6 24.74 21.39 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.415 -0.812 . . . . 55.5 111.652 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 8.2 ptp180 -142.38 170.85 8.09 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 106.378 -1.712 . . . . 74.420000000000002 106.378 177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -79.74 143.57 16.77 Favored 'Trans proline' 0 N--CA 1.441 -1.574 0 N-CA-C 107.922 -1.607 . . . . 63.439999999999998 107.922 171.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.407 ' H ' HD13 ' A' ' 634' ' ' ILE . 0.2 OUTLIER -136.06 177.64 6.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-O 121.842 0.829 . . . . 74.510000000000005 111.53 -174.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -99.0 178.87 4.8 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.388 -1.338 . . . . 72.109999999999999 107.388 174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -77.89 -154.79 7.15 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 119.917 -1.135 . . . . 65.420000000000002 113.0 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.53 -68.07 0.36 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 124.388 1.075 . . . . 75.209999999999994 110.269 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -138.44 119.36 14.3 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 105.641 -1.985 . . . . 50.229999999999997 105.641 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . 0.402 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 4.8 t -134.69 110.24 9.13 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-O 122.361 1.077 . . . . 72.310000000000002 110.839 -175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -147.89 137.85 22.69 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.177 -1.416 . . . . 74.519999999999996 107.177 176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.32 111.82 22.65 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.177 -1.416 . . . . 70.040000000000006 107.177 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.37 122.26 37.9 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.963 -0.754 . . . . 74.230000000000004 108.963 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.93 125.41 68.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.252 -0.885 . . . . 75.340000000000003 109.139 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . 0.407 ' HB ' ' CD2' ' A' ' 513' ' ' HIS . 4.4 mp -116.84 139.19 44.8 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 107.568 -1.271 . . . . 74.219999999999999 107.568 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.3 136.75 42.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 109.435 -0.579 . . . . 74.040000000000006 109.435 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 71.53 -54.57 0.67 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 125.772 1.629 . . . . 62.520000000000003 111.598 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.5 151.88 45.34 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 123.854 0.862 . . . . 75.400000000000006 109.655 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . 0.45 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 29.1 t -146.33 105.02 3.84 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 108.527 -0.916 . . . . 64.329999999999998 108.527 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -127.78 120.08 27.11 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 121.173 0.511 . . . . 64.409999999999997 110.273 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -142.56 130.41 21.68 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.771 -0.826 . . . . 71.239999999999995 108.771 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.62 58.32 1.76 Allowed 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 104.403 -2.443 . . . . 60.340000000000003 104.403 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -35.67 113.02 0.19 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 128.185 2.594 . . . . 74.430000000000007 115.969 -170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 54.2 m 53.76 33.85 17.76 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 114.718 1.377 . . . . 71.040000000000006 114.718 170.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 98.1 m -64.29 -42.66 96.28 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.018 -1.475 . . . . 51.130000000000003 107.018 172.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.44 109.88 29.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 105.53 -2.026 . . . . 74.030000000000001 105.53 169.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--N 1.3 -1.551 0 CA-C-N 116.385 -0.37 . . . . 63.530000000000001 110.496 -175.391 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.544 ' N ' HH22 ' A' ' 598' ' ' ARG . 53.6 m-70 . . . . . 0 CA--C 1.504 -0.821 0 N-CA-C 109.395 -0.594 . . . . 71.530000000000001 109.395 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -122.2 146.32 47.37 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.04 -1.096 . . . . 71.049999999999997 108.04 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -114.83 126.79 7.39 Favored Glycine 0 N--CA 1.416 -2.682 0 C-N-CA 119.948 -1.12 . . . . 71.120000000000005 111.076 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 64.9 mt -127.95 114.8 36.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.38 -1.711 . . . . 51.030000000000001 106.38 172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -110.62 132.8 53.88 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 123.669 0.606 . . . . 62.420000000000002 109.975 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -148.39 152.39 36.93 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 120.766 0.317 . . . . 71.439999999999998 110.496 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.566 ' CG ' ' HB2' ' A' ' 641' ' ' LEU . 69.2 m-85 -71.4 148.17 47.2 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.282 0.633 . . . . 73.109999999999999 111.395 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.85 -55.85 20.1 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.62 0.575 . . . . 74.409999999999997 110.655 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . 0.576 ' O ' HD23 ' A' ' 641' ' ' LEU . 39.2 mt-10 -126.96 158.36 68.95 Favored Pre-proline 0 C--N 1.307 -1.24 0 N-CA-C 107.542 -1.281 . . . . 64.040000000000006 107.542 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.29 -23.98 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.684 1.589 . . . . 73.430000000000007 112.226 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 644' ' ' ILE . 78.0 t -138.0 138.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.017 -0.364 . . . . 62.039999999999999 110.017 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.2 t -131.33 128.06 38.92 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.347 -0.612 . . . . 74.019999999999996 109.347 177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -102.41 110.73 22.76 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.157 -1.423 . . . . 71.019999999999996 107.157 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.39 159.34 14.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 120.744 -0.382 . . . . 75.230000000000004 110.148 -176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 646' ' ' GLU . 46.2 m -84.27 173.52 10.92 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.478 -0.783 . . . . 62.119999999999997 110.792 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.537 ' HB2' ' H ' ' A' ' 578' ' ' ARG . 0.3 OUTLIER -87.89 -34.16 18.27 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.738 -0.838 . . . . 64.109999999999999 108.738 179.172 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 49.4 m -92.19 17.25 9.87 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.958 -1.019 . . . . 71.409999999999997 111.874 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.16 -29.52 17.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.271 0.558 . . . . 71.299999999999997 110.372 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.19 -70.15 3.24 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 120.858 -0.687 . . . . 31.34 112.27 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.9 mm -129.06 124.01 59.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.345 -0.983 . . . . 64.450000000000003 108.345 -177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.5 ppp? -95.85 149.86 21.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.878 -1.156 . . . . 73.530000000000001 107.878 176.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -129.18 112.95 14.47 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 112.606 0.595 . . . . 72.319999999999993 112.606 -173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 68.8 t -121.3 128.58 75.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.482 -0.781 . . . . 74.319999999999993 109.535 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -91.08 149.59 21.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.242 0.544 . . . . 64.310000000000002 109.793 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.29 107.61 22.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.621 -1.622 . . . . 50.140000000000001 106.621 173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 81.8 mt -76.16 137.15 39.88 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.339 -0.846 . . . . 72.030000000000001 109.877 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.523 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 40.9 mtp180 -104.61 102.18 11.8 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.335 -1.357 . . . . 73.340000000000003 107.335 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.2 m -68.05 -62.45 1.4 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.565 1.32 . . . . 72.040000000000006 114.565 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 33.4 t -73.13 -50.83 20.54 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.596 0.591 . . . . 70.230000000000004 112.596 -173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 156.89 -160.44 30.35 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 111.146 -0.782 . . . . 72.219999999999999 111.146 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -175.38 165.88 3.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.522 0.729 . . . . 71.019999999999996 109.662 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -176.09 105.02 0.07 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.244 1.018 . . . . 74.120000000000005 108.52 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 121.35 -126.25 6.47 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 110.719 -0.952 . . . . 53.350000000000001 110.719 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -136.47 127.78 28.27 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.239 -1.023 . . . . 71.439999999999998 108.239 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 38.6 t -129.05 130.29 68.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 109.134 -0.691 . . . . 74.310000000000002 109.134 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 51.5 mm -100.88 122.47 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.284 -1.006 . . . . 72.209999999999994 108.284 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 43.4 t -116.76 102.33 53.18 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 108.499 -0.926 . . . . 71.450000000000003 108.499 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.51 135.28 13.04 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.801 1.667 . . . . 70.319999999999993 112.742 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -119.51 168.1 11.32 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.181 -1.044 . . . . 75.519999999999996 108.181 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -158.43 135.6 9.97 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 120.822 0.344 . . . . 55.119999999999997 111.154 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 17.8 p -80.41 121.0 25.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.348 -0.842 . . . . 54.329999999999998 110.441 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 29.9 mm -96.11 121.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.47 -1.307 . . . . 71.219999999999999 107.47 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.48 125.23 28.13 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.691 -0.485 . . . . 74.420000000000002 109.691 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -103.21 -109.02 3.32 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 108.724 -1.75 . . . . 43.039999999999999 108.724 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.435 ' OG1' ' HA ' ' A' ' 585' ' ' CYS . 8.7 p -89.23 -5.85 57.32 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.198 0.999 . . . . 72.030000000000001 109.579 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.81 140.49 38.02 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.805 -1.089 . . . . 73.129999999999995 108.427 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.87 147.61 28.53 Favored 'General case' 0 C--O 1.255 1.343 0 CA-C-O 121.089 0.471 . . . . 64.109999999999999 111.511 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.2 -147.54 9.34 Favored Glycine 0 N--CA 1.428 -1.866 0 CA-C-N 115.189 -0.914 . . . . 72.109999999999999 111.113 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 72.06 -2.15 28.47 Favored Glycine 0 C--N 1.315 -0.619 0 C-N-CA 121.679 -0.296 . . . . 54.329999999999998 113.07 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.44 -3.84 34.86 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 111.493 -0.643 . . . . 34.409999999999997 111.493 -177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.76 -79.95 0.03 OUTLIER 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.001 0.429 . . . . 72.409999999999997 111.543 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -87.2 -46.16 9.99 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.718 -1.216 . . . . 34.0 107.718 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -139.5 165.87 26.09 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.574 -1.194 . . . . 64.549999999999997 109.732 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 574' ' ' ARG . 1.0 OUTLIER -95.96 116.4 28.88 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.303 -2.11 . . . . 72.010000000000005 105.303 176.12 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.72 132.18 35.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.5 0.667 . . . . 73.150000000000006 111.554 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.0 t -128.19 148.39 50.61 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.494 -0.775 . . . . 74.209999999999994 109.795 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 15.0 p -148.99 140.11 23.05 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 120.866 0.365 . . . . 53.299999999999997 111.4 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 80.12 -125.2 6.81 Favored Glycine 0 C--O 1.212 -1.263 0 CA-C-N 115.684 -0.689 . . . . 70.450000000000003 111.576 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 58.73 -6.09 0.05 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.072 2.99 . . . . 74.510000000000005 119.072 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 537' ' ' VAL . 62.2 mt -95.27 133.58 39.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 120.049 1.295 . . . . 74.310000000000002 112.29 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -134.23 108.91 8.52 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.603 -1.18 . . . . 75.540000000000006 107.939 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.523 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 73.8 m-85 -103.53 129.02 50.65 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 116.207 -0.451 . . . . 63.450000000000003 110.592 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.483 ' HB2' HD11 ' A' ' 567' ' ' ILE . 1.6 mp0 -96.16 -107.03 0.15 Allowed 'General case' 0 C--O 1.246 0.912 0 C-N-CA 118.631 -1.227 . . . . 74.349999999999994 111.306 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.4 155.79 29.79 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.715 -0.476 . . . . 64.549999999999997 109.715 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.89 -25.97 67.1 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 114.52 1.304 . . . . 74.230000000000004 114.52 -174.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.52 -15.59 60.37 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 113.118 0.784 . . . . 61.530000000000001 113.118 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 563' ' ' GLN . 34.2 pt -103.32 157.09 5.14 Favored 'Isoleucine or valine' 0 C--O 1.253 1.288 0 C-N-CA 119.694 -0.802 . . . . 74.040000000000006 110.174 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.58 156.99 29.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.574 -0.528 . . . . 63.149999999999999 109.574 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.504 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.8 mmpt? -110.29 163.82 13.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.966 0.412 . . . . 73.340000000000003 110.026 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 62.9 mt -128.42 134.47 64.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.773 -1.103 . . . . 71.409999999999997 108.681 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.488 HD13 HD21 ' A' ' 589' ' ' LEU . 58.8 mt -90.14 118.84 36.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 106.619 -1.622 . . . . 65.340000000000003 106.619 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 12.8 p -110.47 111.74 23.2 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.622 -0.717 . . . . 54.439999999999998 110.008 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.85 132.55 59.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.665 -0.698 . . . . 63.43 109.564 -177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 554' ' ' GLU . 79.5 mtt180 -76.99 111.82 12.96 Favored 'General case' 0 C--O 1.249 1.04 0 O-C-N 123.807 0.692 . . . . 55.049999999999997 110.203 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.5 mm -103.29 121.94 55.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 106.401 -1.703 . . . . 75.519999999999996 106.401 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 74.3 m-85 -94.42 158.5 15.53 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.441 -0.504 . . . . 75.400000000000006 109.921 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -68.06 93.49 0.44 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.712 0.767 . . . . 71.409999999999997 110.191 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.537 ' H ' ' HB2' ' A' ' 516' ' ' GLU . 1.3 tpm_? -66.48 106.33 1.73 Allowed 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 114.377 -1.283 . . . . 62.520000000000003 109.928 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -81.68 -22.94 37.16 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.788 -0.642 . . . . 72.310000000000002 111.1 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.2 126.27 35.76 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.111 -0.95 . . . . 73.450000000000003 109.996 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -121.98 24.55 9.53 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.249 -0.649 . . . . 74.150000000000006 109.249 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -39.4 -62.87 0.62 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.279 1.832 . . . . 74.200000000000003 111.163 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.452 ' HA ' ' HE3' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -148.34 175.94 10.68 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.826 -1.546 . . . . 74.530000000000001 106.826 177.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.63 103.19 4.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.211 0.529 . . . . 73.219999999999999 111.654 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.435 ' HA ' ' OG1' ' A' ' 545' ' ' THR . 21.4 p -97.48 126.86 43.0 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 121.498 0.666 . . . . 74.040000000000006 110.174 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 44.9 m -144.08 164.36 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.522 -0.547 . . . . 72.420000000000002 109.522 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.1 p90 -142.6 -178.94 6.02 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.78 -0.452 . . . . 72.25 109.78 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 70.9 m -131.09 167.52 18.96 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.238 0.542 . . . . 62.439999999999998 111.024 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.488 HD21 HD13 ' A' ' 571' ' ' ILE . 63.9 tp -136.47 124.51 22.9 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.152 -1.796 . . . . 73.420000000000002 106.152 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -122.73 159.0 26.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 109.489 -0.56 . . . . 71.329999999999998 109.489 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.505 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 74.6 mt -104.58 144.09 32.16 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.235 -1.024 . . . . 61.299999999999997 108.235 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -109.01 170.95 7.72 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 109.173 -0.677 . . . . 74.519999999999996 109.173 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 593' ' ' GLU . 0.3 OUTLIER -59.17 109.92 2.28 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 123.92 0.763 . . . . 72.319999999999993 112.749 -175.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.65 158.52 39.59 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 123.122 2.548 . . . . 61.149999999999999 112.384 -176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -123.3 140.71 52.74 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.723 -0.671 . . . . 72.030000000000001 110.294 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -103.14 124.54 48.76 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.136 -1.061 . . . . 72.209999999999994 108.136 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.0 mp -102.32 89.58 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.184 -1.413 . . . . 73.439999999999998 107.184 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . 0.544 HH22 ' N ' ' A' ' 501' ' ' HIS . 14.1 ttm180 -108.05 -29.34 9.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.402 -1.332 . . . . 72.319999999999993 107.402 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -135.93 155.43 50.3 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.704 -1.135 . . . . 74.519999999999996 108.745 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -156.41 41.06 0.57 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 110.365 -1.094 . . . . 71.120000000000005 110.365 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . 0.553 ' SD ' ' HG2' ' A' ' 602' ' ' LYS . 0.0 OUTLIER -78.96 -56.51 4.33 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 106.932 -1.507 . . . . 71.409999999999997 106.932 -179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.553 ' HG2' ' SD ' ' A' ' 601' ' ' MET . 21.6 pttp -171.89 136.71 0.92 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.705 1.602 . . . . 55.450000000000003 108.111 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -72.76 -39.28 55.72 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.309 -0.472 . . . . 45.299999999999997 113.138 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 168.27 -142.4 7.43 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.043 -1.075 . . . . 71.340000000000003 111.936 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -151.16 132.58 14.65 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 123.023 0.529 . . . . 73.530000000000001 109.598 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 85.3 m -149.35 98.12 2.75 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.622 -1.251 . . . . 71.409999999999997 107.622 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.47 125.54 40.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.611 -0.885 . . . . 74.140000000000001 108.611 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 47.2 m -75.88 84.63 2.82 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 122.074 0.94 . . . . 72.129999999999995 110.416 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.79 -20.37 20.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.612 -1.176 . . . . 60.520000000000003 108.732 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.74 81.29 8.94 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 122.669 1.223 . . . . 75.319999999999993 108.429 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . 0.403 ' O ' ' HD2' ' A' ' 614' ' ' LYS . 62.9 t80 -95.52 -5.34 43.01 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.635 -2.075 . . . . 75.299999999999997 109.376 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -110.16 159.08 17.67 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.913 -1.143 . . . . 73.530000000000001 107.913 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 35.5 t70 59.35 83.77 0.12 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.223 1.009 . . . . 71.329999999999998 111.22 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 614' ' ' LYS . 0.1 OUTLIER -117.36 95.01 4.78 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.493 -0.776 . . . . 63.119999999999997 109.735 -177.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . 0.441 ' HB3' ' HD3' ' A' ' 616' ' ' PRO . 34.9 tt0 -170.55 -55.77 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.15 0 O-C-N 123.606 0.566 . . . . 74.340000000000003 110.801 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 615' ' ' GLN . 97.0 Cg_endo -85.94 -165.98 0.3 Allowed 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-N 120.082 1.065 . . . . 50.340000000000003 109.692 173.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.96 138.07 36.6 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.346 -0.983 . . . . 60.420000000000002 108.346 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 2.3 p -58.28 108.98 0.68 Allowed 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 123.648 0.593 . . . . 62.109999999999999 110.056 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 22.1 m -83.71 -5.08 59.1 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.436 -0.802 . . . . 71.420000000000002 112.881 -172.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -88.59 106.86 18.59 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 119.994 -0.682 . . . . 73.219999999999999 109.616 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.15 104.65 7.2 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.315 0.579 . . . . 74.140000000000001 110.198 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.27 -16.27 57.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.59 0.709 . . . . 64.030000000000001 110.713 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -102.76 129.02 49.27 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 107.452 -1.314 . . . . 61.119999999999997 107.452 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -76.16 94.05 3.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.589 -0.523 . . . . 64.409999999999997 109.589 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -67.29 -39.97 86.05 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.819 -0.628 . . . . 65.150000000000006 110.999 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 630' ' ' MET . 46.9 ttt180 -61.07 -45.63 93.97 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.768 0.318 . . . . 73.310000000000002 110.431 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 70.1 mt -65.91 -37.25 79.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.345 -0.389 . . . . 61.409999999999997 110.406 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.02 -43.21 99.34 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.963 -0.384 . . . . 60.240000000000002 109.963 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.01 -14.59 60.63 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 112.344 0.498 . . . . 64.530000000000001 112.344 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 75.3 mtm -84.52 -5.21 59.28 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.535 0.683 . . . . 62.130000000000003 110.101 172.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -96.05 5.16 65.8 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.328 -1.109 . . . . 61.140000000000001 110.328 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -85.1 162.53 48.96 Favored Pre-proline 0 C--N 1.307 -1.24 0 C-N-CA 124.344 1.058 . . . . 65.230000000000004 109.142 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.7 146.39 95.2 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 N-CA-C 107.262 -1.861 . . . . 71.25 107.262 167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 38.3 pt -129.76 -177.38 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-O 121.432 0.634 . . . . 62.100000000000001 110.951 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.5 176.15 5.25 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.068 -1.456 . . . . 71.439999999999998 107.068 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.22 153.37 52.71 Favored Glycine 0 N--CA 1.418 -2.544 0 N-CA-C 108.231 -1.947 . . . . 44.340000000000003 108.231 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . 0.462 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 41.5 tt0 -41.1 -61.22 1.04 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.157 1.383 . . . . 73.099999999999994 112.737 -174.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . 0.462 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 46.8 m80 -126.22 92.99 3.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.876 -0.787 . . . . 70.409999999999997 108.876 177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 11.8 t -116.09 110.8 19.37 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 122.556 1.169 . . . . 74.439999999999998 108.954 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -146.29 116.7 7.49 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.211 -1.774 . . . . 71.329999999999998 106.211 -175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 509' ' ' GLU . 1.6 tm? -106.76 108.62 20.23 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.059 -1.089 . . . . 73.209999999999994 108.059 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -88.44 131.77 34.74 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 115.134 -0.939 . . . . 72.409999999999997 109.425 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.49 118.62 59.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.905 -0.776 . . . . 74.540000000000006 108.905 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . 0.418 HD13 HG13 ' A' ' 511' ' ' VAL . 3.7 mp -110.34 130.08 64.25 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.565 -1.198 . . . . 72.019999999999996 109.285 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.95 108.75 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 CA-C-O 122.254 1.026 . . . . 64.400000000000006 112.101 179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 515' ' ' SER . 73.6 mm-40 -145.96 -154.3 0.53 Allowed 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 102.596 -3.112 . . . . 44.350000000000001 102.596 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -105.08 125.26 50.78 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 106.44 -1.689 . . . . 72.219999999999999 106.44 166.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 13.5 t -72.1 110.62 6.7 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 106.952 -1.499 . . . . 54.140000000000001 106.952 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -75.11 149.63 39.03 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.933 -0.576 . . . . 64.420000000000002 111.201 -176.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -165.81 90.36 0.45 Allowed 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 105.599 -2.0 . . . . 72.0 105.599 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -79.74 -34.45 39.94 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 108.042 -1.096 . . . . 73.329999999999998 108.042 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -132.57 142.5 49.19 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.257 -1.386 . . . . 71.329999999999998 107.257 171.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 22.6 m -76.27 85.87 3.07 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.786 0.803 . . . . 74.450000000000003 108.914 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 9.8 t -121.1 9.06 10.43 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.958 -1.019 . . . . 75.209999999999994 109.151 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 8.1 p -117.58 143.27 28.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.86 -1.163 . . . . 63.030000000000001 107.86 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--N 1.305 -1.343 0 N-CA-C 110.192 -0.299 . . . . 61.530000000000001 110.192 -179.326 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 . . . . . 0 C--O 1.24 0.584 0 N-CA-C 109.529 -0.545 . . . . 74.239999999999995 109.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -121.54 90.45 3.32 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.404 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -70.51 147.96 44.61 Favored Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 110.663 -0.975 . . . . 52.340000000000003 110.663 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -127.08 114.47 37.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.655 -0.869 . . . . 71.230000000000004 108.655 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.11 134.55 48.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.824 0.702 . . . . 74.530000000000001 109.928 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.2 t -147.99 156.73 42.99 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.321 -0.622 . . . . 61.100000000000001 109.321 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.558 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 74.4 m-85 -73.39 153.18 40.55 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.22 -0.289 . . . . 70.25 110.22 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -57.3 -51.86 67.69 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.978 0.799 . . . . 73.310000000000002 110.536 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -135.66 155.66 78.05 Favored Pre-proline 0 N--CA 1.435 -1.218 0 CA-C-N 114.606 -1.179 . . . . 63.32 108.278 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.59 -25.74 2.92 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 121.934 1.756 . . . . 74.349999999999994 113.006 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 642' ' ' GLU . 89.3 t -142.02 132.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.127 -0.694 . . . . 72.030000000000001 109.127 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.3 t -133.94 138.26 45.38 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.079 0.466 . . . . 44.340000000000003 109.943 177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -102.73 112.92 25.92 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.774 -1.195 . . . . 75.540000000000006 107.774 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.5 m -108.5 145.19 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 C-N-CA 120.313 -0.555 . . . . 71.010000000000005 110.254 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 518' ' ' ILE . 70.8 m -70.81 137.91 49.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.131 -0.941 . . . . 64.129999999999995 111.38 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -31.3 61.65 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.752 1.019 . . . . 75.329999999999998 113.752 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 7.4 p -106.84 25.35 11.39 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.844 0.354 . . . . 54.119999999999997 111.884 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 515' ' ' SER . 9.9 tt -76.13 -31.02 20.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.511 0.672 . . . . 72.519999999999996 110.228 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 87.12 -70.35 2.89 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.623 -0.798 . . . . 71.329999999999998 111.795 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 46.9 mm -126.75 133.36 68.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.975 -1.121 . . . . 72.319999999999993 107.975 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.438 ' O ' ' HA ' ' A' ' 572' ' ' THR . 19.6 ptm -107.62 136.4 47.44 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.146 -0.687 . . . . 53.130000000000003 109.146 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -103.14 124.6 48.89 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 123.397 0.679 . . . . 74.420000000000002 110.0 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 39.5 t -121.24 123.71 70.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.423 -0.954 . . . . 74.230000000000004 108.423 175.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -88.77 127.4 35.6 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 120.684 -0.406 . . . . 73.200000000000003 110.01 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 86.5 t -88.68 107.93 18.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 106.529 -1.656 . . . . 71.109999999999999 106.529 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.8 mt -87.16 153.04 21.82 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.02 -0.991 . . . . 63.109999999999999 110.191 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -121.64 104.83 9.9 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.874 -0.603 . . . . 74.219999999999999 110.062 -178.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 7.5 m -63.59 -60.78 2.89 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 72.319999999999993 110.133 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.9 t -73.04 -43.8 61.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.157 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 141.02 -152.35 23.13 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 110.209 -1.156 . . . . 70.549999999999997 110.209 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.532 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -157.75 146.69 19.53 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.194 -1.78 . . . . 74.310000000000002 106.194 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.462 ' NH2' ' HA2' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -160.9 114.55 2.04 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.152 -1.425 . . . . 72.230000000000004 107.152 -178.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.462 ' HA2' ' NH2' ' A' ' 532' ' ' ARG . . . 119.25 -131.45 9.05 Favored Glycine 0 CA--C 1.485 -1.836 0 N-CA-C 111.229 -0.748 . . . . 63.0 111.229 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -136.89 103.81 5.29 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 105.282 -2.118 . . . . 75.209999999999994 105.282 174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 41.2 t -120.14 125.04 73.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 C-N-CA 119.644 -0.822 . . . . 61.140000000000001 111.086 -173.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 48.1 mm -90.73 122.64 42.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.938 -1.134 . . . . 72.349999999999994 107.938 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.12 103.13 54.49 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 109.006 -0.738 . . . . 45.100000000000001 109.006 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.414 ' HA ' ' HA2' ' A' ' 558' ' ' GLY . 0.9 OUTLIER -80.12 133.27 9.82 Favored 'Trans proline' 0 N--CA 1.437 -1.838 0 C-N-CA 121.819 1.68 . . . . 62.43 112.63 178.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -119.82 161.75 20.27 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.375 -1.343 . . . . 71.209999999999994 107.375 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -155.42 139.66 16.61 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.957 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.0 p -84.47 130.78 34.73 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.285 -0.871 . . . . 44.409999999999997 110.894 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 588' ' ' SER . 43.7 mm -99.09 114.01 35.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 107.542 -1.281 . . . . 75.329999999999998 107.542 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -77.01 161.97 27.92 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.989 -0.55 . . . . 75.140000000000001 111.002 -175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 144.53 117.27 1.14 Allowed Glycine 0 C--O 1.201 -1.939 0 N-CA-C 108.376 -1.889 . . . . 72.340000000000003 108.376 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 47.3 p 75.87 5.53 3.86 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 127.484 2.314 . . . . 61.420000000000002 110.395 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -169.21 140.1 2.32 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.706 -1.134 . . . . 65.129999999999995 108.249 -178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -102.47 138.08 39.86 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 123.501 0.501 . . . . 73.010000000000005 109.906 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -105.44 131.75 10.79 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 116.003 -0.544 . . . . 73.329999999999998 112.823 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 160.38 -49.53 0.38 Allowed Glycine 0 C--N 1.3 -1.46 0 N-CA-C 108.818 -1.713 . . . . 51.240000000000002 108.818 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.44 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 179.65 -9.01 0.02 OUTLIER Glycine 0 C--N 1.294 -1.789 0 CA-C-N 113.933 -1.134 . . . . 72.420000000000002 111.286 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.426 ' H ' ' H ' ' A' ' 550' ' ' GLY . 20.5 mp0 -65.16 -61.63 2.02 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.875 1.27 . . . . 73.430000000000007 111.686 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -122.88 -41.13 2.37 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.784 0.802 . . . . 72.239999999999995 109.122 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -136.37 160.29 39.18 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.931 -1.507 . . . . 74.120000000000005 106.931 171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 22.1 tt0 -89.01 141.45 28.47 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.857 -0.794 . . . . 43.399999999999999 108.857 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.89 106.72 15.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.453 -0.944 . . . . 75.200000000000003 108.453 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.1 t -117.38 131.54 56.75 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 108.1 -1.074 . . . . 64.099999999999994 108.1 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -149.5 131.59 15.36 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 112.275 0.472 . . . . 62.140000000000001 112.275 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 538' ' ' PRO . . . 85.21 -139.26 17.38 Favored Glycine 0 C--O 1.189 -2.708 0 N-CA-C 111.794 -0.522 . . . . 63.509999999999998 111.794 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 71.2 -8.0 1.07 Allowed 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.698 1.74 . . . . 64.349999999999994 115.698 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 569' ' ' LYS . 41.0 mt -93.4 131.28 38.73 Favored 'General case' 0 CA--C 1.5 -0.97 0 O-C-N 120.647 -1.283 . . . . 72.439999999999998 112.327 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -129.77 118.73 22.28 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 115.104 -0.953 . . . . 75.400000000000006 109.454 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 37.5 m-85 -104.54 155.31 18.93 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.555 -0.906 . . . . 65.299999999999997 108.555 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.434 ' H ' HD11 ' A' ' 567' ' ' ILE . 72.1 mm-40 -120.66 -88.22 0.63 Allowed 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.721 -1.215 . . . . 73.310000000000002 107.721 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -104.45 165.48 11.03 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.197 -1.038 . . . . 71.430000000000007 108.197 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.532 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 4.4 p30 -63.21 -11.87 24.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 113.789 1.033 . . . . 63.119999999999997 113.789 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.456 ' HG3' HG23 ' A' ' 567' ' ' ILE . 11.3 pt-20 -69.8 -18.75 63.49 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 122.945 0.498 . . . . 74.140000000000001 111.794 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.456 HG23 ' HG3' ' A' ' 566' ' ' GLU . 38.8 pt -114.12 164.29 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 120.865 0.364 . . . . 73.319999999999993 110.625 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.56 158.37 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 107.08 -1.452 . . . . 75.439999999999998 107.08 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.507 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -121.69 149.19 43.58 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 120.965 0.412 . . . . 73.140000000000001 110.435 173.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 66.9 mt -120.56 134.27 64.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 114.914 -1.039 . . . . 64.310000000000002 109.964 -175.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.493 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 50.4 mt -90.91 126.73 43.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 106.552 -1.647 . . . . 74.310000000000002 106.552 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 521' ' ' MET . 15.5 p -117.28 112.5 20.85 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.836 -0.802 . . . . 73.129999999999995 108.836 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.484 HD11 HD22 ' A' ' 589' ' ' LEU . 50.4 mt -109.84 131.77 59.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.175 -176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 61.6 mtt180 -78.47 112.04 15.11 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 123.964 0.79 . . . . 74.230000000000004 111.397 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 49.3 mm -97.5 125.77 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 106.356 -1.72 . . . . 64.140000000000001 106.356 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.44 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 78.3 m-85 -105.63 113.64 27.32 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.129 0.788 . . . . 75.349999999999994 113.129 -174.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -79.49 121.72 25.55 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.36 -1.718 . . . . 72.109999999999999 106.36 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.578 ' HD2' ' O ' ' A' ' 578' ' ' ARG . 1.8 tmm_? -121.22 6.01 10.24 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.586 -0.894 . . . . 72.450000000000003 108.586 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 81.51 90.03 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 125.874 1.67 . . . . 63.5 111.563 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -140.43 164.05 31.18 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 113.806 -1.543 . . . . 73.329999999999998 110.138 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -111.36 -48.72 3.07 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.292 -0.413 . . . . 74.510000000000005 110.436 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -124.26 89.83 3.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.199 0.523 . . . . 71.340000000000003 112.097 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -138.12 83.36 1.97 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.135 -0.939 . . . . 65.200000000000003 110.404 173.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.37 90.6 6.7 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 106.052 -1.833 . . . . 74.209999999999994 106.052 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.402 ' O ' HD12 ' A' ' 645' ' ' ILE . 6.4 p -108.66 142.74 38.7 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.986 -1.006 . . . . 73.099999999999994 110.638 -175.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 68.4 p -134.54 168.18 19.43 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.41 -0.218 . . . . 62.219999999999999 110.41 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.411 ' CE1' HD11 ' A' ' 645' ' ' ILE . 54.8 p90 -163.86 162.33 23.57 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 105.982 -1.858 . . . . 75.420000000000002 105.982 173.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . 0.42 ' HB3' ' HB ' ' A' ' 542' ' ' ILE . 11.0 t -113.41 171.96 7.25 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 118.802 -1.159 . . . . 62.439999999999998 108.815 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 573' ' ' ILE . 61.0 tp -145.09 126.84 15.28 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.585 -1.635 . . . . 61.420000000000002 106.585 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.6 156.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 120.668 0.27 . . . . 73.230000000000004 110.383 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.558 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 56.5 mt -99.79 141.0 33.18 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.212 -1.033 . . . . 72.219999999999999 108.212 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.76 167.07 10.02 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 108.077 -1.083 . . . . 75.400000000000006 108.077 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -62.63 116.17 21.68 Favored Pre-proline 0 C--O 1.247 0.946 0 N-CA-C 112.606 0.595 . . . . 75.219999999999999 112.606 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.401 ' HB2' ' CG1' ' A' ' 535' ' ' VAL . 65.7 Cg_endo -71.15 144.82 47.7 Favored 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.0 2.467 . . . . 71.329999999999998 111.527 -175.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' A' ' 595' ' ' LYS . 0.0 OUTLIER -112.68 130.71 55.95 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.643 -0.708 . . . . 73.239999999999995 110.788 -178.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -84.79 116.05 23.05 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.33 -1.359 . . . . 74.230000000000004 107.33 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 38.7 mm -81.34 89.62 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 108.389 -0.967 . . . . 62.25 108.389 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -96.14 127.87 42.53 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.703 -1.135 . . . . 73.010000000000005 107.963 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -103.11 141.04 36.51 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.785 0.326 . . . . 55.340000000000003 110.394 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 150.82 176.03 23.34 Favored Glycine 0 C--N 1.303 -1.292 0 N-CA-C 110.289 -1.124 . . . . 64.219999999999999 110.289 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -115.55 111.24 20.41 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.844 -1.539 . . . . 53.240000000000002 106.844 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -78.53 -24.01 45.93 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 114.216 1.191 . . . . 73.329999999999998 114.216 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 80.59 -56.33 4.72 Favored Glycine 0 C--N 1.312 -0.76 0 C-N-CA 121.188 -0.529 . . . . 23.219999999999999 112.621 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -91.62 31.34 5.88 Favored Glycine 0 N--CA 1.44 -1.088 0 O-C-N 122.656 -0.32 . . . . 51.299999999999997 112.757 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -84.99 88.06 7.42 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.976 0.893 . . . . 73.120000000000005 109.782 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 14.9 m -85.91 122.3 29.77 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.841 -0.618 . . . . 64.099999999999994 109.404 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 49.1 mm -82.58 119.44 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 107.138 -1.43 . . . . 71.120000000000005 107.138 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 30.6 m -71.6 89.58 0.99 Allowed 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.698 0.761 . . . . 64.129999999999995 111.484 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -88.71 -12.66 41.67 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.19 -0.914 . . . . 73.299999999999997 108.772 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.99 150.72 47.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.405 -1.702 . . . . 74.409999999999997 106.405 171.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -80.16 103.35 9.97 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.73 -0.788 . . . . 72.510000000000005 108.986 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -102.4 -177.62 3.45 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.51 -0.768 . . . . 73.140000000000001 109.226 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.62 165.94 18.58 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.681 -0.489 . . . . 73.400000000000006 109.681 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -73.86 -28.04 61.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.759 -0.46 . . . . 62.119999999999997 109.759 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 69.8 96.4 0.05 OUTLIER Pre-proline 0 C--O 1.24 0.574 0 C-N-CA 125.195 1.398 . . . . 73.040000000000006 111.343 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.49 154.53 73.28 Favored 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.663 2.242 . . . . 62.0 112.195 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -80.85 -23.93 38.76 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.641 0.734 . . . . 65.019999999999996 109.273 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 6.1 p -77.11 -64.13 1.2 Allowed 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.938 -1.028 . . . . 64.420000000000002 111.191 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 42.4 m -130.89 132.59 45.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 120.682 0.277 . . . . 73.200000000000003 111.213 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -134.13 145.76 49.6 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.511 -0.922 . . . . 74.430000000000007 108.511 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -83.88 -33.95 24.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.537 0.684 . . . . 63.409999999999997 109.826 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -97.97 89.46 4.57 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.643 -0.708 . . . . 74.099999999999994 110.769 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.53 78.06 1.1 Allowed 'General case' 0 N--CA 1.423 -1.814 0 CA-C-O 122.646 1.212 . . . . 75.409999999999997 108.427 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.72 153.8 23.97 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.395 -1.275 . . . . 72.150000000000006 109.91 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 1.8 mpp_? -60.13 -38.63 83.64 Favored 'General case' 0 C--O 1.209 -1.042 0 O-C-N 123.598 0.561 . . . . 64.209999999999994 110.468 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 630' ' ' MET . 50.5 ttt180 -60.94 -42.63 98.55 Favored 'General case' 0 C--O 1.213 -0.868 0 C-N-CA 120.796 -0.362 . . . . 73.329999999999998 110.818 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 72.7 mt -66.53 -41.01 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.662 -0.495 . . . . 72.209999999999994 109.662 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -60.88 -36.02 78.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.787 -0.642 . . . . 55.329999999999998 110.312 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 48.6 mt-10 -76.99 -25.4 52.69 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.121 -0.491 . . . . 64.140000000000001 111.684 177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 67.0 mtt -68.46 -56.6 7.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.061 -1.089 . . . . 54.009999999999998 108.061 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -98.22 45.89 1.62 Allowed Glycine 0 N--CA 1.418 -2.512 0 CA-C-N 114.685 -1.143 . . . . 71.140000000000001 114.147 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 633' ' ' PRO 0.591 0.1 OUTLIER -91.52 -27.74 0.3 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 116.704 2.113 . . . . 74.310000000000002 116.704 170.598 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 632' ' ' ARG . 18.1 Cg_endo -65.73 109.67 1.5 Allowed 'Trans proline' 0 C--N 1.376 1.978 0 N-CA-C 106.922 -1.992 . . . . 75.420000000000002 106.922 163.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 31.3 pt -132.89 -176.71 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.581 0.705 . . . . 74.019999999999996 111.444 -171.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -95.07 179.64 5.14 Favored 'General case' 0 N--CA 1.418 -2.044 0 N-CA-C 108.033 -1.099 . . . . 53.32 108.033 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -68.7 167.77 44.42 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.899 -0.88 . . . . 74.519999999999996 110.899 175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -48.78 -43.7 38.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.594 1.158 . . . . 74.25 110.782 -177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.17 123.53 9.63 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.036 -1.438 . . . . 75.329999999999998 107.3 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . 0.426 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 11.2 t -148.97 112.89 5.14 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 121.812 0.815 . . . . 71.040000000000006 110.209 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -147.42 130.39 16.27 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.888 -1.051 . . . . 74.109999999999999 108.618 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 68.5 tp -108.23 118.86 37.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.917 -0.771 . . . . 75.140000000000001 108.917 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 511' ' ' VAL . 39.7 mt-10 -103.05 122.87 45.53 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.983 -1.117 . . . . 72.120000000000005 107.983 176.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.0 t -109.88 128.8 65.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 108.788 -0.819 . . . . 71.239999999999995 108.788 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.03 133.29 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.605 0 N-CA-C 107.269 -1.382 . . . . 74.329999999999998 107.269 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.411 HD11 ' CE1' ' A' ' 587' ' ' PHE . 1.0 OUTLIER -115.16 130.82 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 CA-C-N 115.977 -0.556 . . . . 72.530000000000001 109.516 -174.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . 0.477 ' HB3' ' OG ' ' A' ' 648' ' ' SER . 2.9 tm-20 -174.33 -177.37 1.24 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 103.195 -2.891 . . . . 65.109999999999999 103.195 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -86.23 27.1 0.95 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 120.861 1.664 . . . . 72.209999999999994 109.656 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 646' ' ' GLU . 13.0 m -45.11 113.48 0.58 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 126.35 1.86 . . . . 71.129999999999995 112.843 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -92.01 120.85 33.03 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 105.889 -1.893 . . . . 71.129999999999995 105.889 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -103.38 111.29 23.65 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.595 0.712 . . . . 74.129999999999995 112.6 -177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -82.85 -10.65 58.74 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.868 -1.06 . . . . 63.109999999999999 108.432 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -67.61 103.69 1.43 Allowed 'General case' 0 C--O 1.245 0.864 0 CA-C-N 115.078 -0.965 . . . . 71.109999999999999 108.629 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 15.3 m -148.11 79.24 1.46 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 121.352 0.596 . . . . 75.340000000000003 112.048 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 62.5 m -151.35 99.75 2.67 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.791 -1.189 . . . . 72.200000000000003 107.791 169.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 18.9 m 52.5 24.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 125.687 1.595 . . . . 72.340000000000003 112.05 -174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 . . . . . 0 C--O 1.253 1.246 0 CA-C-N 115.154 -0.93 . . . . 72.299999999999997 109.883 -179.003 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 C--O 1.245 0.856 0 CA-C-O 121.857 0.836 . . . . 75.150000000000006 110.199 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -98.94 -33.17 10.95 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.145 -0.934 . . . . 60.409999999999997 110.781 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 174.92 97.24 0.11 Allowed Glycine 0 C--O 1.222 -0.656 0 C-N-CA 120.729 -0.748 . . . . 75.430000000000007 112.831 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.47 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.1 mt -93.19 121.61 44.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 110.414 -0.217 . . . . 73.129999999999995 110.414 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 91.2 m-85 -109.0 138.5 45.24 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.769 -0.826 . . . . 72.530000000000001 108.769 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -149.34 158.68 44.39 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.683 -0.488 . . . . 64.329999999999998 109.683 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.669 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.6 m-85 -74.51 156.79 36.51 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.607 0.242 . . . . 75.439999999999998 110.362 174.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -61.47 -53.03 61.8 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.169 0.918 . . . . 41.439999999999998 110.675 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -121.47 157.53 56.12 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.259 -0.882 . . . . 64.019999999999996 108.82 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -84.0 -30.26 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.521 1.481 . . . . 75.140000000000001 110.527 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 642' ' ' GLU . 70.6 t -137.64 129.89 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.0 t -133.89 131.89 39.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.045 -0.724 . . . . 74.239999999999995 109.045 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -96.17 138.01 34.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.384 -1.339 . . . . 70.319999999999993 107.384 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.87 145.49 32.07 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-O 120.853 0.359 . . . . 55.350000000000001 110.266 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 69.5 m -75.3 156.27 35.77 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.208 -0.906 . . . . 73.030000000000001 111.749 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 577' ' ' ASP . 15.2 mm-40 -68.17 -46.17 71.44 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.934 -1.03 . . . . 74.109999999999999 111.046 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 11.2 t -95.17 36.04 1.25 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.771 0.796 . . . . 75.420000000000002 110.173 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.6 tt -89.91 -31.66 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 O-C-N 121.722 -0.612 . . . . 73.109999999999999 110.514 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.16 -72.85 2.74 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.818 -0.706 . . . . 61.399999999999999 111.463 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.65 123.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 N-CA-C 109.515 -0.55 . . . . 65.409999999999997 109.515 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.43 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 22.1 ptm -91.36 138.6 31.46 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.111 -1.07 . . . . 72.430000000000007 108.111 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.74 108.87 20.57 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 123.442 0.464 . . . . 53.240000000000002 111.076 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.49 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 40.1 t -105.24 117.63 51.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 109.312 -0.625 . . . . 54.229999999999997 109.312 177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -96.45 132.39 42.05 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.217 0.532 . . . . 65.230000000000004 110.093 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.8 t -90.96 112.71 25.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.463 -1.31 . . . . 72.439999999999998 107.463 175.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.462 ' HA ' HH21 ' A' ' 527' ' ' ARG . 59.3 mt -82.36 141.99 32.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.292 -0.867 . . . . 54.310000000000002 110.191 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.462 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -106.56 102.12 11.53 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.997 -1.483 . . . . 75.239999999999995 106.997 178.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.7 m -67.73 -63.75 1.0 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.802 -0.635 . . . . 73.540000000000006 110.701 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 10.3 t -75.63 -31.77 59.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.303 -0.862 . . . . 75.310000000000002 110.283 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 131.67 -159.14 23.11 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.919 -0.872 . . . . 42.049999999999997 110.919 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.549 ' N ' ' HB3' ' A' ' 565' ' ' ASP . . . -168.73 142.09 2.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.637 -1.616 . . . . 63.109999999999999 106.637 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -146.06 129.4 16.78 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.128 -0.693 . . . . 71.120000000000005 109.128 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 100.72 -122.85 7.74 Favored Glycine 0 C--N 1.31 -0.894 0 C-N-CA 121.386 -0.435 . . . . 55.340000000000003 112.758 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -136.62 102.77 5.02 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.749 -1.945 . . . . 74.310000000000002 105.749 176.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.0 t -122.62 129.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.234 0.54 . . . . 73.299999999999997 110.552 -173.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 559' ' ' GLU . 50.9 mm -98.29 127.62 50.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.536 -0.757 . . . . 74.439999999999998 109.147 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -112.61 104.58 55.99 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.45 0.7 . . . . 70.310000000000002 109.892 -177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.35 141.27 28.49 Favored 'Trans proline' 0 C--O 1.243 0.756 0 C-N-CA 122.741 2.294 . . . . 63.229999999999997 113.262 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.53 163.91 30.02 Favored 'General case' 0 C--O 1.249 1.057 0 N-CA-C 108.375 -0.972 . . . . 72.519999999999996 108.375 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -161.69 137.82 7.98 Favored 'General case' 0 C--O 1.251 1.142 0 O-C-N 123.192 0.308 . . . . 75.439999999999998 110.655 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.5 p -84.26 126.29 33.03 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 121.381 0.61 . . . . 31.199999999999999 110.992 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.4 117.77 40.1 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 106.299 -1.741 . . . . 45.130000000000003 106.299 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -70.86 146.38 49.68 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 123.355 0.409 . . . . 72.510000000000005 110.125 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.36 -108.13 0.74 Allowed Glycine 0 CA--C 1.491 -1.458 0 N-CA-C 109.16 -1.576 . . . . 75.230000000000004 109.16 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.3 m -72.08 -43.36 64.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 106.301 -1.74 . . . . 71.310000000000002 106.301 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -73.16 133.88 44.23 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 113.815 -1.539 . . . . 53.32 108.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 37.2 ttt180 -111.27 143.24 42.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.551 0.945 . . . . 71.430000000000007 113.551 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . 48.66 -149.75 3.94 Favored Glycine 0 CA--C 1.497 -1.089 0 C-N-CA 125.952 1.739 . . . . 74.120000000000005 117.444 168.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -128.11 80.72 0.36 Allowed Glycine 0 N--CA 1.405 -3.431 0 N-CA-C 109.232 -1.547 . . . . 53.43 109.232 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 146.14 -21.14 1.75 Allowed Glycine 0 C--N 1.292 -1.892 0 C-N-CA 121.054 -0.593 . . . . 74.439999999999998 111.991 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 10.3 mm-40 -77.84 -67.57 0.71 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.315 0.578 . . . . 65.540000000000006 109.908 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -108.28 -43.37 4.37 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.772 0.796 . . . . 52.450000000000003 109.763 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -136.79 170.73 15.6 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.276 -1.379 . . . . 64.299999999999997 107.276 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.492 ' HG3' ' HE ' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -99.67 128.94 45.76 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.362 -1.718 . . . . 73.230000000000004 106.362 176.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.6 111.37 1.8 Allowed 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 123.802 0.841 . . . . 75.430000000000007 110.815 -173.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 104.7 14.48 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-O 122.075 0.941 . . . . 71.530000000000001 110.946 -174.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.5 p -139.48 129.6 25.17 Favored 'General case' 0 N--CA 1.412 -2.375 0 CA-C-N 114.862 -1.063 . . . . 72.040000000000006 108.562 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.24 -168.38 41.12 Favored Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.264 -1.134 . . . . 74.120000000000005 110.264 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.522 ' HB2' ' CG2' ' A' ' 536' ' ' ILE . 9.8 pt-20 -131.3 129.26 41.26 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.306 0.574 . . . . 72.430000000000007 110.904 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.441 HD22 ' CG ' ' A' ' 569' ' ' LYS . 85.5 mt -90.37 143.91 26.32 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.994 -1.003 . . . . 53.329999999999998 111.436 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -100.89 117.16 34.41 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.128 -0.629 . . . . 72.040000000000006 110.439 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -111.29 157.72 19.84 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.625 -1.25 . . . . 52.130000000000003 107.625 172.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -121.08 -87.8 0.63 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 107.901 -1.148 . . . . 71.420000000000002 107.901 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -104.47 162.43 13.24 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.826 -1.175 . . . . 74.230000000000004 107.826 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.549 ' HB3' ' N ' ' A' ' 531' ' ' ALA . 4.2 p30 -64.06 -15.41 59.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 113.718 1.007 . . . . 53.32 113.718 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -70.32 -19.42 63.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.736 0.303 . . . . 72.209999999999994 111.726 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 40.3 pt -107.18 163.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.82 154.44 34.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 108.153 -1.054 . . . . 62.109999999999999 108.153 178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.441 ' CG ' HD22 ' A' ' 560' ' ' LEU . 0.1 OUTLIER -119.19 162.53 18.51 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 104.884 -2.265 . . . . 72.519999999999996 104.884 175.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 76.6 mt -131.6 137.64 54.76 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.535 0 N-CA-C 107.954 -1.128 . . . . 71.230000000000004 107.954 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 48.7 mt -93.27 122.07 44.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 106.125 -1.805 . . . . 72.219999999999999 106.125 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 44.5 p -105.56 112.71 25.9 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.789 -0.448 . . . . 62.43 109.789 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.459 HD11 HD22 ' A' ' 589' ' ' LEU . 59.7 mt -110.85 122.88 66.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.563 -0.532 . . . . 72.140000000000001 109.563 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.492 ' HE ' ' HG3' ' A' ' 554' ' ' GLU . 23.3 mtm-85 -72.89 115.89 12.73 Favored 'General case' 0 C--N 1.316 -0.854 0 O-C-N 123.868 0.73 . . . . 73.140000000000001 110.774 174.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.0 mm -96.06 127.88 47.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.25 -0.886 . . . . 63.100000000000001 109.077 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -105.61 109.78 21.86 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.797 -0.816 . . . . 73.420000000000002 108.797 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 516' ' ' GLU . 7.3 p-10 -77.95 157.39 29.74 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.097 -0.956 . . . . 64.219999999999999 113.24 -171.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -131.31 175.47 9.1 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.618 -1.623 . . . . 64.439999999999998 106.618 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -99.64 -13.24 19.45 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.468 -0.493 . . . . 72.200000000000003 111.796 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -95.49 113.47 25.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 112.242 0.46 . . . . 62.530000000000001 112.242 -173.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -77.86 -8.24 57.79 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.07 -0.514 . . . . 74.129999999999995 111.854 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.468 ' HG3' ' HD2' ' A' ' 583' ' ' LYS . 6.9 pt-20 -66.17 -19.97 66.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.435 -0.348 . . . . 64.519999999999996 110.998 173.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.468 ' HD2' ' HG3' ' A' ' 582' ' ' GLU . 14.1 mptt -91.44 107.59 19.31 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.937 -0.394 . . . . 60.310000000000002 109.937 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.08 111.78 22.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.994 -1.113 . . . . 73.420000000000002 107.994 172.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.49 ' HB2' HG12 ' A' ' 645' ' ' ILE . 84.0 m -110.73 132.54 54.11 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.885 -0.726 . . . . 55.32 111.242 -176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 12.9 m -119.95 130.94 55.02 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 109.852 -0.425 . . . . 74.540000000000006 109.852 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 546' ' ' ALA . 52.1 p90 -129.57 -179.45 5.18 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.375 -1.342 . . . . 75.129999999999995 107.375 171.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 8.6 t -131.72 168.16 18.24 Favored 'General case' 0 N--CA 1.409 -2.507 0 C-N-CA 119.07 -1.052 . . . . 73.299999999999997 109.926 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 573' ' ' ILE . 51.5 tp -140.57 123.25 16.23 Favored 'General case' 0 C--N 1.271 -2.812 0 N-CA-C 105.688 -1.967 . . . . 51.439999999999998 105.688 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.46 157.06 29.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 116.423 -0.353 . . . . 75.099999999999994 110.185 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.669 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 64.9 mt -107.79 151.66 25.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.211 -1.033 . . . . 60.25 108.211 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -115.17 178.06 4.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.206 0.316 . . . . 72.430000000000007 110.237 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -59.34 119.17 36.88 Favored Pre-proline 0 C--O 1.245 0.856 0 O-C-N 124.161 0.913 . . . . 65.439999999999998 111.7 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.523 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 55.6 Cg_endo -71.11 157.41 57.68 Favored 'Trans proline' 0 N--CA 1.437 -1.832 0 C-N-CA 122.883 2.388 . . . . 74.340000000000003 112.032 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -124.42 138.1 54.39 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.385 -0.825 . . . . 71.400000000000006 110.328 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . 0.442 ' HB2' ' HD3' ' A' ' 633' ' ' PRO . 3.5 t90 -95.32 123.38 38.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.536 -1.283 . . . . 73.109999999999999 107.536 -178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.45 97.44 7.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.202 -1.036 . . . . 74.209999999999994 108.202 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -152.82 142.4 21.82 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 109.248 -0.649 . . . . 65.340000000000003 109.248 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 63.3 ttt-85 -143.64 139.79 29.78 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.291 -1.744 . . . . 73.430000000000007 106.291 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -132.01 -175.79 14.14 Favored Glycine 0 C--N 1.284 -2.339 0 N-CA-C 109.693 -1.363 . . . . 33.130000000000003 109.693 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 28.1 ttt -75.31 102.87 5.23 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.007 -1.479 . . . . 74.25 107.007 174.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -81.21 105.44 12.41 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.394 -0.821 . . . . 62.109999999999999 111.263 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 82.48 -134.36 12.89 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 111.282 -0.727 . . . . 65.150000000000006 111.282 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -151.69 -151.56 5.65 Favored Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 111.201 -0.76 . . . . 41.310000000000002 111.201 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 57.0 65.83 1.3 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.573 1.149 . . . . 75.109999999999999 111.222 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . 0.444 ' O ' HD13 ' A' ' 607' ' ' ILE . 59.5 m -137.65 86.2 2.17 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 121.407 0.622 . . . . 65.349999999999994 110.939 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 606' ' ' THR . 20.3 mm -130.76 96.85 2.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.789 -1.559 . . . . 72.519999999999996 106.789 176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 26.6 m 75.46 -21.86 0.29 Allowed 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 113.367 0.877 . . . . 61.240000000000002 113.367 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -61.42 -39.93 92.58 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.238 0.615 . . . . 63.439999999999998 110.456 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -83.07 92.97 7.5 Favored 'General case' 0 CA--C 1.483 -1.61 0 CA-C-O 122.385 1.088 . . . . 71.030000000000001 109.579 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -87.9 -30.89 19.78 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-N 112.945 -1.934 . . . . 70.5 107.674 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.17 109.01 11.1 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.735 -1.58 . . . . 73.540000000000006 106.735 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -96.91 -39.65 9.29 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 114.709 1.374 . . . . 72.109999999999999 114.709 -168.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -76.62 86.82 3.29 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.617 0.969 . . . . 62.200000000000003 113.617 -173.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -163.76 150.78 10.37 Favored Pre-proline 0 C--N 1.314 -0.964 0 C-N-CA 125.153 1.381 . . . . 71.420000000000002 108.912 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.9 144.56 98.83 Favored 'Trans proline' 0 C--O 1.245 0.829 0 C-N-CA 121.942 1.761 . . . . 72.450000000000003 107.699 167.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -67.0 97.11 0.47 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.218 0.821 . . . . 71.109999999999999 113.218 -171.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 4.9 p -95.14 138.71 32.49 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.28 -0.873 . . . . 73.030000000000001 109.051 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 40.0 m 70.01 11.53 7.68 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.569 1.148 . . . . 65.5 111.179 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -147.02 78.16 1.48 Allowed 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.628 -1.249 . . . . 74.239999999999995 107.628 172.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.26 124.79 41.17 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.968 -1.014 . . . . 73.200000000000003 108.779 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' A' ' 624' ' ' GLU . 0.0 OUTLIER -126.18 -171.68 2.44 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.587 -0.733 . . . . 62.009999999999998 110.007 -172.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -74.46 -25.88 59.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.234 0.54 . . . . 74.340000000000003 111.516 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.531 ' H ' ' HG2' ' A' ' 622' ' ' GLU . 4.1 mp0 -67.34 -12.66 60.73 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.814 -0.63 . . . . 74.129999999999995 111.659 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -38.7 91.99 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 108.007 -1.108 . . . . 73.400000000000006 108.007 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 630' ' ' MET . 38.8 ttp180 -67.04 -37.64 84.46 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.868 -1.06 . . . . 73.530000000000001 109.513 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.05 -35.69 76.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.182 0.515 . . . . 74.519999999999996 110.221 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -66.19 -29.27 69.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.219 0.533 . . . . 72.439999999999998 110.332 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -81.89 -25.72 34.75 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.748 -0.66 . . . . 75.409999999999997 110.699 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 66.6 mtt -66.97 -35.25 79.55 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.594 -0.891 . . . . 71.430000000000007 108.594 174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -81.73 44.44 3.11 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.798 -1.092 . . . . 73.409999999999997 112.306 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 633' ' ' PRO . 98.2 mtt180 -124.2 140.88 35.88 Favored Pre-proline 0 C--N 1.292 -1.92 0 N-CA-C 106.246 -1.761 . . . . 64.400000000000006 106.246 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 11.9 Cg_exo -72.41 150.77 52.75 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 121.981 1.787 . . . . 75.439999999999998 111.454 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 50.9 pt -126.44 145.81 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.2 0 N-CA-C 107.361 -1.348 . . . . 74.230000000000004 107.361 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 635' ' ' LEU . 2.2 pt? -87.41 -170.18 2.92 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 115.584 -0.734 . . . . 73.349999999999994 111.618 -171.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -61.85 144.36 48.95 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.632 -0.987 . . . . 34.030000000000001 110.632 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -57.08 -51.88 67.52 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.168 0.508 . . . . 75.239999999999995 110.127 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -123.25 104.35 9.09 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.368 0.604 . . . . 75.120000000000005 109.835 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.0 t -133.22 116.53 16.32 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.627 -0.879 . . . . 71.25 108.627 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -145.39 142.0 28.95 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.453 -0.943 . . . . 73.439999999999998 108.453 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 58.8 tp -121.84 110.45 15.9 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.932 -0.766 . . . . 64.530000000000001 108.932 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.562 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.5 mt-10 -88.28 112.42 22.79 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 108.043 -1.095 . . . . 75.209999999999994 108.043 174.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.9 t -101.41 120.67 51.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-N 114.976 -1.011 . . . . 75.140000000000001 108.838 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 23.5 mt -119.06 114.45 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 CA-C-N 114.878 -1.055 . . . . 75.129999999999995 111.159 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.523 ' H ' HD13 ' A' ' 645' ' ' ILE . 0.0 OUTLIER -89.31 108.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.423 -1.325 . . . . 71.519999999999996 107.423 175.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.79 153.28 28.07 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.489 -1.232 . . . . 73.430000000000007 108.073 -172.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -80.79 79.09 7.5 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 104.884 -2.265 . . . . 70.030000000000001 104.884 168.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.5 t -92.05 121.18 33.37 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 114.993 -1.003 . . . . 62.039999999999999 109.542 -170.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -110.22 121.1 44.48 Favored 'General case' 0 N--CA 1.421 -1.882 0 C-N-CA 120.45 -0.5 . . . . 63.539999999999999 110.169 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -147.39 120.76 9.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.116 -1.438 . . . . 74.310000000000002 107.116 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -95.91 102.02 13.76 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 108.958 -0.756 . . . . 75.349999999999994 108.958 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . 0.268 0.0 OUTLIER -93.85 123.16 37.02 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 119.971 -0.692 . . . . 74.030000000000001 110.01 175.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 25.9 t -98.06 135.58 39.54 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.39 -0.823 . . . . 62.32 110.071 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 38.3 m -114.89 112.9 23.45 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.947 -1.131 . . . . 73.200000000000003 107.947 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 27.3 t -78.99 132.51 32.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.47 -0.567 . . . . 72.129999999999995 109.47 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 C--N 1.302 -1.464 0 CA-C-N 115.837 -0.619 . . . . 55.329999999999998 109.855 -178.141 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 . . . . . 0 C--O 1.246 0.881 0 CA-C-O 122.168 0.985 . . . . 62.219999999999999 109.068 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -83.88 -60.39 2.12 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.032 -0.985 . . . . 64.209999999999994 110.376 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -177.89 124.49 0.94 Allowed Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.323 -0.941 . . . . 43.240000000000002 112.906 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.1 mt -127.15 114.25 36.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 105.126 -2.176 . . . . 73.239999999999995 105.126 171.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.533 ' CE1' ' HD2' ' A' ' 527' ' ' ARG . 97.6 m-85 -113.84 128.94 56.61 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.91 -0.316 . . . . 74.510000000000005 110.309 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.44 148.97 30.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.969 -0.56 . . . . 64.049999999999997 110.11 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -67.31 154.08 42.15 Favored 'General case' 0 C--O 1.255 1.383 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 110.323 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -58.16 -55.4 35.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.096 -0.705 . . . . 74.439999999999998 109.096 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -127.48 157.38 73.1 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.914 -1.039 . . . . 72.319999999999993 108.899 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -88.99 -13.76 2.99 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.403 2.069 . . . . 72.230000000000004 113.002 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 642' ' ' GLU . 91.4 t -143.45 133.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.66 -0.496 . . . . 40.200000000000003 109.66 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 9.3 t -134.51 133.23 40.11 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.64 -0.504 . . . . 64.319999999999993 109.64 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 649' ' ' TYR . 69.9 m80 -108.85 112.1 24.16 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.301 -1.0 . . . . 64.129999999999995 108.301 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 645' ' ' ILE . 24.1 m -121.26 162.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.146 0.498 . . . . 54.310000000000002 110.919 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.419 ' O ' HG22 ' A' ' 518' ' ' ILE . 37.0 m -77.19 149.63 35.53 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.198 -0.455 . . . . 63.520000000000003 112.009 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.03 -27.58 69.21 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.332 0.587 . . . . 64.129999999999995 110.228 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.3 m -110.59 28.63 8.49 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.762 -0.654 . . . . 73.120000000000005 111.143 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 515' ' ' SER . 10.0 tt -76.89 -28.33 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 121.101 0.477 . . . . 63.350000000000001 111.417 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 95.43 -77.8 0.84 Allowed Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.081 -0.808 . . . . 75.409999999999997 111.081 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 38.2 mm -130.14 146.22 34.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 107.691 -1.226 . . . . 54.009999999999998 107.691 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.0 ppp? -119.6 153.64 35.17 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.968 -1.493 . . . . 73.140000000000001 106.968 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -128.13 126.57 41.36 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 123.068 0.23 . . . . 74.230000000000004 111.153 -175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.468 HG21 HD21 ' A' ' 641' ' ' LEU . 55.5 t -134.37 131.35 54.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 109.223 -0.658 . . . . 64.010000000000005 109.223 174.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.42 ' HG2' HG12 ' A' ' 570' ' ' ILE . 55.2 mttp -90.76 151.07 21.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.142 0.496 . . . . 62.539999999999999 110.171 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.0 t -103.95 113.45 40.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 105.964 -1.865 . . . . 64.400000000000006 105.964 172.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.09 134.84 34.46 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 116.118 -0.492 . . . . 64.439999999999998 110.189 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.685 ' HD3' ' HB2' ' A' ' 531' ' ' ALA . 73.3 ttt180 -106.87 102.61 11.96 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.988 -1.115 . . . . 71.010000000000005 107.988 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.0 m -65.82 -47.7 74.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.588 -1.187 . . . . 71.349999999999994 113.901 -171.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 5.6 p -69.01 -51.35 40.13 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.357 0.873 . . . . 62.119999999999997 113.357 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 155.48 172.83 23.48 Favored Glycine 0 CA--C 1.48 -2.156 0 N-CA-C 108.644 -1.782 . . . . 43.340000000000003 108.644 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.685 ' HB2' ' HD3' ' A' ' 527' ' ' ARG . . . -150.03 121.56 7.98 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 117.658 0.729 . . . . 65.400000000000006 112.552 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.501 ' HD3' ' C ' ' A' ' 532' ' ' ARG . 0.8 OUTLIER -156.71 110.82 2.72 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.633 -0.877 . . . . 74.109999999999999 108.633 171.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 149.19 -142.82 10.18 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 109.614 -1.394 . . . . 75.040000000000006 109.614 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -137.43 112.76 9.27 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.319 -1.363 . . . . 62.200000000000003 107.319 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.95 132.15 65.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 C-N-CA 120.676 -0.41 . . . . 61.5 111.415 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.64 116.82 47.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.716 -0.674 . . . . 72.450000000000003 109.291 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 23.6 t -104.44 111.1 65.13 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 108.816 -0.809 . . . . 75.230000000000004 108.816 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 594' ' ' PRO . 10.2 Cg_endo -84.6 149.02 11.32 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.945 1.764 . . . . 71.310000000000002 111.082 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -138.21 159.24 42.56 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.159 -1.052 . . . . 75.400000000000006 108.159 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 589' ' ' LEU . 57.2 pttt -151.59 137.5 18.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.452 . . . . 74.400000000000006 110.021 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 6.1 p -84.2 143.12 29.81 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.881 -0.6 . . . . 70.450000000000003 111.124 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 48.5 mm -102.37 115.72 44.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 106.336 -1.728 . . . . 74.319999999999993 106.336 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -73.55 109.88 7.41 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 123.627 0.58 . . . . 74.129999999999995 111.513 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -135.34 126.17 3.91 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 110.363 -1.095 . . . . 55.539999999999999 110.363 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.3 m 69.06 -49.34 0.59 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.268 2.227 . . . . 73.010000000000005 112.459 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -90.16 150.14 22.14 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.431 -0.952 . . . . 63.409999999999997 108.431 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 40.9 ttp180 -93.14 135.49 34.28 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 120.956 0.408 . . . . 71.120000000000005 110.597 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.56 -161.15 35.47 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.542 -0.754 . . . . 62.409999999999997 111.355 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 85.97 18.56 59.34 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 110.043 -1.223 . . . . 74.450000000000003 110.043 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.76 27.79 60.22 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.029 -0.829 . . . . 72.239999999999995 111.029 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 10.1 tp10 -87.67 -87.26 0.15 Allowed 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 122.849 0.459 . . . . 61.210000000000001 110.611 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 578' ' ' ARG . 32.8 t70 -90.03 -30.34 17.81 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-O 122.065 0.936 . . . . 72.540000000000006 109.208 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -140.92 148.74 40.9 Favored 'General case' 0 N--CA 1.407 -2.621 0 N-CA-C 106.704 -1.591 . . . . 71.319999999999993 106.704 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.455 ' CB ' ' HB2' ' A' ' 574' ' ' ARG . 0.6 OUTLIER -86.28 105.83 16.92 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 105.988 -1.856 . . . . 71.5 105.988 179.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.94 91.14 1.18 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 122.763 1.268 . . . . 74.219999999999999 109.718 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.9 t -83.33 132.77 34.99 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 113.334 -1.757 . . . . 74.450000000000003 112.252 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.0 p -139.46 119.8 13.85 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.447 -2.057 . . . . 74.430000000000007 105.447 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.89 -179.75 27.8 Favored Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 119.473 -1.346 . . . . 72.030000000000001 113.048 -173.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -105.17 111.45 24.2 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 123.977 0.911 . . . . 65.439999999999998 108.703 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.99 126.86 43.6 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.57 -0.852 . . . . 71.400000000000006 109.42 174.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -103.93 98.58 8.4 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 121.468 0.651 . . . . 72.0 111.72 -175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 53.1 m-85 -94.37 101.78 13.73 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.591 -0.892 . . . . 73.519999999999996 108.591 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.518 ' H ' HD11 ' A' ' 567' ' ' ILE . 75.4 mt-30 -86.55 -79.59 0.26 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.73 -0.668 . . . . 51.420000000000002 109.735 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -104.63 163.48 12.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.719 -0.673 . . . . 53.130000000000003 109.701 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 531' ' ' ALA . 17.9 t70 -65.37 -21.24 66.66 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.658 1.183 . . . . 74.299999999999997 112.269 -177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.69 -16.65 63.38 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.864 0.69 . . . . 73.239999999999995 112.864 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.518 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.7 pt -112.63 160.85 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 120.539 -0.464 . . . . 72.120000000000005 110.767 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.9 p -141.47 144.9 25.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.315 -1.365 . . . . 62.439999999999998 107.315 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 73.0 mmtt -102.51 149.82 24.01 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.045 0.45 . . . . 75.200000000000003 110.756 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.42 HG12 ' HG2' ' A' ' 524' ' ' LYS . 66.2 mt -123.01 128.62 75.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 CA-C-N 114.421 -1.263 . . . . 63.219999999999999 108.807 -178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.433 HD13 HD21 ' A' ' 589' ' ' LEU . 62.5 mt -90.76 121.72 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 N-CA-C 107.529 -1.286 . . . . 72.5 107.529 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 521' ' ' MET . 40.1 p -110.23 113.28 25.83 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-N 115.801 -0.636 . . . . 52.119999999999997 109.411 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 589' ' ' LEU . 61.0 mt -103.97 122.5 56.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 108.061 -1.089 . . . . 71.299999999999997 108.061 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.455 ' HB2' ' CB ' ' A' ' 554' ' ' GLU . 80.3 mtt85 -75.76 115.92 15.94 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.868 0.73 . . . . 61.25 109.522 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.6 mm -98.05 139.56 19.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 N-CA-C 107.212 -1.403 . . . . 73.019999999999996 107.212 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -128.1 163.04 25.49 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.194 0.521 . . . . 74.540000000000006 110.166 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.3 87.34 3.61 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.781 -1.562 . . . . 50.32 106.781 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 552' ' ' ASP . 38.3 mmt180 -132.93 -27.7 1.63 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.427 1.64 . . . . 73.340000000000003 115.427 -177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.463 ' HG3' ' SG ' ' A' ' 585' ' ' CYS . 64.5 mm-40 -67.55 101.64 1.03 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.952 0.882 . . . . 75.010000000000005 110.82 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -78.49 -47.78 16.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.353 -1.748 . . . . 73.219999999999999 111.951 -170.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -98.56 -21.05 16.7 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.295 -0.562 . . . . 62.439999999999998 111.917 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 579' ' ' GLU . 10.5 tp10 -75.26 149.73 38.76 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.69 0.281 . . . . 73.519999999999996 110.709 -177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -92.21 -49.46 6.17 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.849 -0.614 . . . . 54.539999999999999 109.976 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.65 137.7 38.71 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.562 -0.745 . . . . 73.230000000000004 109.285 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.469 ' HB2' HG12 ' A' ' 645' ' ' ILE . 59.2 m -122.85 140.35 53.04 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.973 -0.751 . . . . 65.420000000000002 108.973 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 27.4 p -139.43 113.53 8.81 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.492 0.663 . . . . 71.25 111.229 176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 52.3 p90 -109.81 -178.43 3.53 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.169 -1.049 . . . . 70.150000000000006 108.169 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 19.7 m -135.01 167.52 20.79 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.989 -0.684 . . . . 61.219999999999999 110.447 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 573' ' ' ILE . 51.7 tp -137.97 132.49 32.4 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 107.328 -1.36 . . . . 74.239999999999995 107.328 176.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 30.3 m -131.55 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 109.663 -0.495 . . . . 71.219999999999999 109.663 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.39 145.31 29.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.7 -0.682 . . . . 73.299999999999997 109.304 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.71 174.19 6.07 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.679 -0.86 . . . . 61.32 108.679 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -66.03 116.8 36.3 Favored Pre-proline 0 C--O 1.246 0.888 0 CA-C-O 121.106 0.479 . . . . 44.43 111.766 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 538' ' ' PRO . 44.4 Cg_endo -71.28 147.56 53.52 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 C-N-CA 122.422 2.081 . . . . 71.129999999999995 111.573 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -113.12 140.27 48.03 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 109.402 -0.592 . . . . 64.239999999999995 109.402 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -92.42 127.57 37.96 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.148 -1.797 . . . . 75.430000000000007 106.148 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 34.6 mm -83.3 109.98 17.66 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 108.692 -0.855 . . . . 75.150000000000006 108.692 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 600' ' ' GLY . 16.2 mmm180 -72.33 99.3 2.39 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 114.39 -1.277 . . . . 63.240000000000002 111.457 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -69.49 -38.46 77.65 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.539 -1.652 . . . . 73.319999999999993 106.539 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 598' ' ' ARG . . . -84.35 111.94 3.54 Favored Glycine 0 N--CA 1.434 -1.454 0 N-CA-C 106.576 -2.61 . . . . 62.439999999999998 106.576 169.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 57.6 ttp -66.19 99.46 0.53 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.243 0.831 . . . . 54.539999999999999 113.243 -171.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -164.56 101.95 0.82 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.869 -1.9 . . . . 72.239999999999995 105.869 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -76.56 170.19 54.95 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.962 -0.563 . . . . 75.420000000000002 112.974 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -95.39 119.97 6.36 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 108.809 -1.716 . . . . 33.25 108.809 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -74.43 91.78 2.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.043 -0.725 . . . . 73.340000000000003 109.043 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 21.2 m -129.68 134.18 47.51 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 106.367 -1.716 . . . . 74.329999999999998 106.367 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 44.2 mm -81.84 85.15 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.684 0.754 . . . . 71.329999999999998 110.452 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 14.0 t -125.16 7.87 7.9 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.673 1.225 . . . . 74.510000000000005 108.05 174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -79.43 -24.85 42.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.629 -1.619 . . . . 62.210000000000001 106.629 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -137.3 140.77 41.76 Favored 'General case' 0 N--CA 1.408 -2.571 0 N-CA-C 101.775 -3.417 . . . . 73.200000000000003 101.775 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -81.55 99.15 8.66 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.305 -1.358 . . . . 71.549999999999997 112.49 -173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.75 125.97 35.86 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 104.199 -2.519 . . . . 73.019999999999996 104.199 170.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -68.17 143.91 55.19 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.998 -0.681 . . . . 74.219999999999999 110.289 -175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -53.25 -37.08 61.77 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.807 0.669 . . . . 72.329999999999998 112.807 -174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -107.66 145.04 30.5 Favored Pre-proline 0 C--N 1.316 -0.863 0 C-N-CA 120.0 -0.68 . . . . 71.349999999999994 110.28 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.04 169.21 18.02 Favored 'Trans proline' 0 C--O 1.243 0.758 0 C-N-CA 122.113 1.875 . . . . 72.200000000000003 110.774 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.55 -26.73 24.36 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.597 0.713 . . . . 71.319999999999993 109.528 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.68 169.01 14.73 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 114.992 -1.004 . . . . 54.530000000000001 110.242 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 17.7 m -85.42 26.67 0.89 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.187 0.518 . . . . 65.219999999999999 112.085 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -103.36 81.27 1.91 Allowed 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.64 -0.663 . . . . 74.439999999999998 110.295 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -102.67 108.0 19.1 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.465 -1.309 . . . . 71.230000000000004 107.465 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.33 127.0 29.95 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.994 1.109 . . . . 73.129999999999995 113.994 -170.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -75.71 -31.2 59.57 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.693 -1.139 . . . . 71.430000000000007 108.034 174.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -64.4 -26.7 68.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.426 -1.261 . . . . 65.510000000000005 110.279 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 2.2 mmm180 -60.71 -43.56 97.66 Favored 'General case' 0 C--O 1.213 -0.828 0 CA-C-N 115.879 -0.6 . . . . 70.420000000000002 110.175 175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' A' ' 630' ' ' MET . 29.7 tpt180 -73.19 -35.88 66.46 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 120.625 -0.43 . . . . 74.120000000000005 110.198 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 630' ' ' MET . 90.3 mt -63.4 -37.59 79.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.927 -0.397 . . . . 51.310000000000002 109.927 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.63 81.8 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.138 -0.483 . . . . 73.349999999999994 109.976 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 44.1 mt-10 -67.78 -19.22 65.07 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 116.171 -0.468 . . . . 65.120000000000005 111.345 177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.524 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 67.9 mtt -68.27 -16.26 63.89 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.344 0.592 . . . . 75.129999999999995 110.248 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -107.69 23.12 26.88 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.035 -1.226 . . . . 75.049999999999997 110.035 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -133.65 163.67 49.49 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 106.975 -1.491 . . . . 63.43 106.975 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.402 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 64.5 Cg_endo -86.81 126.19 2.47 Favored 'Trans proline' 0 N--CA 1.435 -1.921 0 C-N-CA 120.816 1.011 . . . . 73.329999999999998 110.51 174.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.52 -177.41 2.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 121.014 0.435 . . . . 63.210000000000001 111.001 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -90.27 -174.38 4.15 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.903 -0.777 . . . . 73.030000000000001 108.903 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -81.69 -152.8 10.09 Favored Glycine 0 C--N 1.306 -1.106 0 C-N-CA 120.452 -0.88 . . . . 71.420000000000002 112.272 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -64.85 -42.0 95.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.85 0.833 . . . . 74.409999999999997 109.232 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -167.41 145.34 4.7 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 125.583 1.553 . . . . 73.040000000000006 107.068 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.1 t -153.29 116.53 4.61 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.824 0.821 . . . . 63.420000000000002 110.446 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -146.19 142.93 28.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.714 -1.217 . . . . 73.310000000000002 107.714 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.468 HD21 HG21 ' A' ' 523' ' ' VAL . 45.5 tp -121.97 113.01 18.99 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 108.743 -0.836 . . . . 74.319999999999993 108.743 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.433 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.1 mt-10 -92.35 122.86 35.22 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.816 -1.179 . . . . 73.010000000000005 107.816 176.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.12 117.53 55.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 109.243 -0.651 . . . . 63.439999999999998 109.243 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.04 123.42 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.717 0 N-CA-C 108.059 -1.089 . . . . 73.519999999999996 108.059 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.1 OUTLIER -106.23 115.43 47.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 CA-C-O 121.501 0.667 . . . . 63.119999999999997 110.399 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -161.06 -75.43 0.06 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.499 -1.297 . . . . 75.230000000000004 107.499 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -153.18 161.75 42.08 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 105.178 -2.156 . . . . 73.209999999999994 105.178 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 50.1 m -78.51 79.4 4.94 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.195 0.998 . . . . 74.040000000000006 110.451 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 513' ' ' HIS . 9.0 t80 -93.55 128.8 39.85 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.386 -2.079 . . . . 74.129999999999995 105.386 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -100.89 104.91 16.13 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 118.354 -1.339 . . . . 72.120000000000005 110.077 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -136.73 124.8 22.91 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 114.657 -1.156 . . . . 74.099999999999994 108.777 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -106.19 143.24 34.6 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.48 -0.933 . . . . 52.130000000000003 108.48 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 14.2 m -89.61 103.46 16.1 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.595 -1.261 . . . . 72.140000000000001 107.595 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 35.3 m -144.02 106.16 4.37 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.082 -1.081 . . . . 74.25 108.082 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.14 131.86 70.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.996 -0.547 . . . . 74.530000000000001 110.317 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 C--N 1.299 -1.608 0 CA-C-N 115.605 -0.725 . . . . 51.32 110.202 178.1 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.4 p80 . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.254 0.549 . . . . 64.25 109.866 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -111.66 150.83 29.58 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.554 -0.748 . . . . 34.539999999999999 110.084 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -90.4 123.53 7.08 Favored Glycine 0 N--CA 1.421 -2.341 0 N-CA-C 111.128 -0.789 . . . . 53.039999999999999 111.128 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 72.2 mt -79.27 112.42 17.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.28 -1.378 . . . . 71.439999999999998 107.28 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 94.9 m-85 -96.3 134.94 38.81 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.394 0.434 . . . . 71.540000000000006 110.385 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.4 t -149.2 158.24 44.02 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 124.06 0.85 . . . . 61.130000000000003 108.948 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.5 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 64.4 m-85 -79.85 169.39 17.98 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.374 -0.602 . . . . 71.129999999999995 109.374 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.442 ' HG2' HD11 ' A' ' 526' ' ' LEU . 48.1 mt-10 -74.69 -41.71 59.74 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.43 0.633 . . . . 73.530000000000001 109.643 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -136.67 161.52 61.33 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.286 -0.87 . . . . 73.140000000000001 108.934 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -85.03 -12.18 7.2 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.926 1.751 . . . . 75.140000000000001 112.079 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 642' ' ' GLU . 72.3 t -142.43 138.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.033 -0.729 . . . . 52.520000000000003 109.033 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.2 t -133.7 136.56 44.76 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.121 -0.696 . . . . 74.439999999999998 109.121 174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -107.33 114.45 28.48 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.058 -0.519 . . . . 62.43 110.193 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 27.5 m -129.16 166.0 27.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.051 -0.522 . . . . 72.209999999999994 109.872 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 518' ' ' ILE . 33.3 t -85.99 162.76 18.35 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.933 0.397 . . . . 71.140000000000001 110.4 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -80.95 -19.87 43.25 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.955 -1.498 . . . . 74.310000000000002 106.955 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.1 m -107.14 25.83 10.9 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.03 -0.986 . . . . 43.520000000000003 111.296 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 515' ' ' SER . 7.7 tt -87.18 -21.38 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 CA-C-O 121.433 0.635 . . . . 73.019999999999996 111.419 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.93 -74.58 1.85 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.491 -0.862 . . . . 74.109999999999999 112.221 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 23.0 mm -134.97 147.12 29.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 106.647 -1.612 . . . . 74.140000000000001 106.647 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.2 ppp? -123.29 145.47 48.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.678 -1.23 . . . . 71.329999999999998 107.678 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -111.97 129.01 56.33 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 123.57 0.544 . . . . 62.310000000000002 111.631 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.41 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.4 t -122.07 103.95 14.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.415 -0.357 . . . . 55.409999999999997 110.227 174.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.513 ' HB3' HG12 ' A' ' 570' ' ' ILE . 17.9 ptpt -86.69 129.0 35.04 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.613 -0.884 . . . . 71.219999999999999 108.613 172.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 48.8 t -89.04 133.54 30.91 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 109.623 -0.51 . . . . 71.400000000000006 109.623 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 74.6 mt -96.89 149.23 22.11 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.946 -0.57 . . . . 63.43 110.574 -175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 504' ' ' ILE 0.285 0.0 OUTLIER -130.69 109.21 10.46 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.655 0.741 . . . . 72.510000000000005 111.397 171.918 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 14.3 m -65.04 -44.9 87.58 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.35 -1.296 . . . . 75.209999999999994 113.277 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 p -72.96 -39.73 65.92 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.016 0.436 . . . . 51.350000000000001 112.153 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.78 -167.0 26.83 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 109.685 -1.366 . . . . 73.299999999999997 109.685 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 527' ' ' ARG . . . -162.63 116.31 1.72 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.441 -0.577 . . . . 55.539999999999999 109.441 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -154.95 106.8 2.68 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.634 -1.247 . . . . 61.229999999999997 107.634 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 146.25 -140.5 8.86 Favored Glycine 0 C--N 1.298 -1.538 0 N-CA-C 110.753 -0.939 . . . . 74.409999999999997 110.753 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -136.91 101.03 4.46 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.359 -1.719 . . . . 65.400000000000006 106.359 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 48.4 t -122.48 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.254 0.55 . . . . 73.430000000000007 110.355 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 559' ' ' GLU . 45.0 mm -102.0 123.77 55.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.886 -0.783 . . . . 64.129999999999995 108.886 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.43 108.83 60.16 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.715 -0.846 . . . . 72.310000000000002 108.715 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -78.16 146.61 22.77 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 73.420000000000002 111.789 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -140.56 162.4 35.45 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.565 -1.272 . . . . 54.130000000000003 107.565 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -162.1 145.91 12.13 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.228 0.537 . . . . 74.450000000000003 111.845 175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 14.6 p -85.82 133.84 33.96 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.936 -1.029 . . . . 63.219999999999999 111.078 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 43.9 mm -100.55 114.51 39.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.988 -1.486 . . . . 72.099999999999994 106.988 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -83.44 126.5 32.81 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.804 -0.443 . . . . 64.319999999999993 109.804 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -128.68 -94.58 0.79 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.658 -0.782 . . . . 64.010000000000005 111.661 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 18.4 p -92.12 17.61 9.26 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.379 1.085 . . . . 64.430000000000007 110.554 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -146.92 134.7 21.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.888 -1.523 . . . . 24.030000000000001 106.888 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.52 132.83 46.94 Favored 'General case' 0 C--O 1.251 1.144 0 N-CA-C 109.081 -0.711 . . . . 65.420000000000002 109.081 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -97.69 138.41 13.87 Favored Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 115.836 -0.62 . . . . 72.239999999999995 111.97 -176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 129.25 11.07 2.87 Favored Glycine 0 C--N 1.294 -1.752 0 C-N-CA 120.894 -0.669 . . . . 54.140000000000001 111.93 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 576' ' ' PHE . . . 133.49 -17.42 4.48 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.517 -1.325 . . . . 61.119999999999997 113.671 177.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.86 -79.48 0.12 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.111 -0.636 . . . . 62.32 111.407 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.06 -42.75 9.78 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.974 -1.121 . . . . 71.129999999999995 107.974 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -144.53 174.07 11.26 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.149 -0.932 . . . . 70.040000000000006 109.119 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.4 OUTLIER -103.42 120.56 41.05 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.231 -2.137 . . . . 64.120000000000005 105.231 177.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -73.63 139.22 45.32 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.55 -0.46 . . . . 74.109999999999999 110.353 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -138.54 128.67 25.59 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 121.813 0.816 . . . . 50.409999999999997 111.33 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.3 p -145.35 133.37 21.41 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.485 -1.302 . . . . 53.210000000000001 107.485 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.25 -165.19 31.59 Favored Glycine 0 N--CA 1.426 -1.99 0 C-N-CA 119.016 -1.564 . . . . 54.310000000000002 112.718 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.401 ' HB3' HG23 ' A' ' 536' ' ' ILE . 49.8 mt-10 -109.85 116.06 30.97 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.436 0.694 . . . . 61.5 111.13 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 93.5 mt -93.47 138.08 32.13 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.546 -0.909 . . . . 73.349999999999994 108.546 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -104.8 102.93 12.47 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.626 0.727 . . . . 74.140000000000001 111.976 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.4 m-85 -101.49 99.98 10.37 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.231 -1.025 . . . . 70.450000000000003 108.231 174.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.24 -82.59 0.13 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.933 -0.707 . . . . 61.539999999999999 110.813 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -104.83 177.16 4.93 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 121.765 0.793 . . . . 54.539999999999999 112.127 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.457 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 23.9 t70 -75.33 -16.21 60.43 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 114.728 -1.123 . . . . 72.109999999999999 112.049 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -70.38 -19.62 63.01 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.082 0.771 . . . . 70.239999999999995 113.082 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 45.0 pt -113.14 168.93 5.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 107.715 -1.217 . . . . 73.450000000000003 107.715 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 9.8 p -144.32 143.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.444 -0.947 . . . . 63.340000000000003 108.444 175.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 71.4 mmtt -98.89 142.53 30.29 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-O 121.253 0.549 . . . . 74.200000000000003 110.73 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 524' ' ' LYS . 14.7 mt -129.25 130.41 67.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.222 -1.354 . . . . 65.329999999999998 109.729 -176.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 44.9 mt -90.23 126.7 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 107.155 -1.424 . . . . 61.539999999999999 107.155 177.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 20.9 p -112.71 113.5 25.65 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 109.287 -0.634 . . . . 55.200000000000003 109.287 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.43 HD11 HD22 ' A' ' 589' ' ' LEU . 71.6 mt -104.1 126.06 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.837 0 N-CA-C 108.728 -0.841 . . . . 63.420000000000002 108.728 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 0.5 OUTLIER -79.27 108.2 12.6 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.554 -1.276 . . . . 71.430000000000007 107.554 -179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.5 mm -94.78 127.99 46.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 106.061 -1.829 . . . . 74.109999999999999 106.061 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 550' ' ' GLY . 96.3 m-85 -95.03 141.54 28.56 Favored 'General case' 0 C--N 1.286 -2.162 0 C-N-CA 119.766 -0.774 . . . . 74.430000000000007 110.731 -177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.74 90.09 2.31 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 106.749 -1.575 . . . . 75.239999999999995 106.749 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.458 ' HG3' ' OE1' ' A' ' 579' ' ' GLU . 5.0 tpm_? -114.49 -64.43 1.32 Allowed 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 114.791 -1.095 . . . . 70.310000000000002 109.826 -175.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.481 ' OE2' ' HG3' ' A' ' 583' ' ' LYS . 6.5 mm-40 -101.41 163.18 12.4 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.487 -0.779 . . . . 73.109999999999999 109.31 -176.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.27 6.99 0.09 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 123.981 0.801 . . . . 74.019999999999996 111.533 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -126.87 82.82 2.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 111.953 0.353 . . . . 73.340000000000003 111.953 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 42.55 56.44 3.81 Favored 'General case' 0 C--O 1.247 0.972 0 O-C-N 124.762 1.289 . . . . 73.150000000000006 112.266 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.58 ' HD2' ' SG ' ' A' ' 585' ' ' CYS . 4.7 tmtp? -104.82 129.07 53.19 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.422 -1.325 . . . . 65.109999999999999 107.422 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -79.95 79.03 6.53 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.048 0.451 . . . . 53.340000000000003 110.907 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 583' ' ' LYS . 75.2 m -107.52 115.3 29.91 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.937 -0.574 . . . . 72.109999999999999 109.709 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 18.2 m -147.05 138.28 23.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.454 -0.573 . . . . 54.43 109.454 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.1 p90 -137.13 163.63 30.37 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.312 -0.995 . . . . 75.209999999999994 108.312 175.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.6 m -112.94 161.37 17.08 Favored 'General case' 0 C--N 1.284 -2.262 0 C-N-CA 119.842 -0.743 . . . . 72.319999999999993 109.828 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 573' ' ' ILE . 70.0 tp -132.71 126.32 32.26 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.458 -1.682 . . . . 71.140000000000001 106.458 176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.22 158.14 28.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 120.861 0.362 . . . . 75.230000000000004 110.739 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.5 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 80.0 mt -106.41 148.04 28.59 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.914 -1.143 . . . . 65.109999999999999 107.914 177.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.08 177.31 4.7 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.772 -0.455 . . . . 52.140000000000001 109.772 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.23 122.49 73.21 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 113.077 0.769 . . . . 74.239999999999995 113.077 -175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.566 ' HD3' HD22 ' A' ' 635' ' ' LEU . 75.2 Cg_endo -75.17 145.85 31.36 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.888 2.392 . . . . 71.209999999999994 111.868 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -116.53 140.62 49.17 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 115.704 -0.68 . . . . 71.549999999999997 109.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -104.98 124.21 49.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.252 -1.018 . . . . 74.340000000000003 108.252 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.2 mp -88.39 103.21 13.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.604 -1.258 . . . . 64.209999999999994 107.604 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -68.64 -45.6 71.41 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.912 -1.04 . . . . 71.299999999999997 109.674 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 600' ' ' GLY . 33.3 ttp-105 -177.52 -176.84 0.64 Allowed 'General case' 0 C--O 1.249 1.03 0 N-CA-C 104.116 -2.55 . . . . 75.049999999999997 104.116 -175.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . 0.409 ' H ' ' HG2' ' A' ' 599' ' ' ARG . . . -68.03 98.51 0.5 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 105.964 -2.855 . . . . 54.119999999999997 105.964 166.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 12.8 tpt -79.79 88.33 5.23 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.05 1.13 . . . . 62.43 114.05 -165.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -101.5 95.74 6.67 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 106.074 -1.824 . . . . 74.409999999999997 106.074 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 151.15 32.71 0.04 OUTLIER Glycine 0 C--N 1.296 -1.65 0 N-CA-C 110.595 -1.002 . . . . 43.119999999999997 110.595 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -152.92 49.26 0.52 Allowed Glycine 0 CA--C 1.483 -1.945 0 N-CA-C 105.96 -2.856 . . . . 72.430000000000007 105.96 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -59.82 103.71 0.23 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.168 -1.516 . . . . 74.120000000000005 112.82 -170.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 11.2 m -137.23 91.3 2.6 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 105.923 -1.88 . . . . 74.319999999999993 105.923 175.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 33.6 mm -78.55 134.25 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.879 -0.785 . . . . 73.409999999999997 108.879 -176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 34.3 m 64.1 67.2 0.61 Allowed 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 122.339 1.066 . . . . 74.439999999999998 109.121 -176.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.25 -23.93 19.17 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.11 -0.95 . . . . 63.240000000000002 111.418 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.68 81.2 5.85 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.893 -1.151 . . . . 71.400000000000006 107.893 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -146.35 107.17 4.12 Favored 'General case' 0 C--N 1.272 -2.78 0 CA-C-N 113.912 -1.494 . . . . 65.319999999999993 107.736 -174.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.32 -18.96 43.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.456 -0.793 . . . . 74.540000000000006 111.506 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.76 95.14 3.96 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 107.831 -1.174 . . . . 74.450000000000003 107.831 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -62.3 139.86 58.51 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.69 0.757 . . . . 71.530000000000001 112.355 -175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -90.58 161.58 36.16 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 114.47 -1.241 . . . . 73.519999999999996 108.973 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -62.64 137.74 65.72 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.711 1.607 . . . . 74.209999999999994 108.503 172.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.72 105.16 11.74 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.926 -0.398 . . . . 74.120000000000005 109.926 -174.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 39.0 p -67.23 125.08 24.93 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.173 -0.677 . . . . 70.420000000000002 109.173 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.3 m -77.38 -2.95 37.71 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 120.923 0.392 . . . . 61.140000000000001 111.946 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.47 161.14 39.8 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.225 -1.398 . . . . 72.150000000000006 107.225 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 70.87 7.19 6.13 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.755 1.222 . . . . 73.450000000000003 113.291 175.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.61 145.89 43.07 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.864 -1.161 . . . . 73.319999999999993 107.864 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -86.25 136.34 33.21 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 106.64 -1.615 . . . . 63.140000000000001 106.64 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -57.46 115.65 2.87 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 122.065 0.936 . . . . 72.450000000000003 112.466 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.525 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 10.1 ttm180 -62.91 -35.13 79.04 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 113.513 -1.676 . . . . 62.32 111.057 -173.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 626' ' ' ARG . 2.5 tpm_? -62.4 -39.38 93.07 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.086 0.469 . . . . 74.540000000000006 110.224 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 62.4 mt -70.75 -38.16 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.58 -0.526 . . . . 61.25 109.58 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.567 ' O ' ' HG2' ' A' ' 632' ' ' ARG . . . -59.84 -41.38 91.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.872 -0.604 . . . . 54.119999999999997 110.461 177.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 44.1 mt-10 -67.49 -37.08 82.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.945 -0.571 . . . . 73.230000000000004 110.768 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 75.4 mtm -66.77 -31.73 72.56 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.652 0.263 . . . . 64.5 111.404 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -80.72 -8.61 87.31 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.952 -0.642 . . . . 43.310000000000002 112.703 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 628' ' ' ALA . 39.2 mmt180 -77.19 145.77 73.61 Favored Pre-proline 0 C--N 1.32 -0.704 0 O-C-N 122.617 -0.343 . . . . 74.140000000000001 111.105 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 632' ' ' ARG . 7.8 Cg_exo -71.94 141.28 36.52 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.29 1.993 . . . . 71.239999999999995 110.047 174.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 36.0 pt -128.01 162.71 33.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 109.953 -0.388 . . . . 71.109999999999999 109.953 178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.566 HD22 ' HD3' ' A' ' 594' ' ' PRO . 2.5 pt? -112.0 -163.13 0.83 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.62 -1.252 . . . . 75.140000000000001 107.62 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.33 143.48 47.26 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.646 -1.382 . . . . 74.239999999999995 109.646 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.92 -39.49 72.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 120.722 -0.391 . . . . 75.200000000000003 111.558 -173.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -124.55 107.79 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.347 -0.541 . . . . 64.530000000000001 110.497 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 15.0 t -150.82 115.42 5.18 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.742 0.782 . . . . 74.439999999999998 109.397 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -147.9 127.9 13.63 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.664 -0.865 . . . . 74.329999999999998 108.664 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.93 112.34 25.26 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.645 -0.502 . . . . 64.230000000000004 109.645 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.463 ' HB2' HG22 ' A' ' 511' ' ' VAL . 45.0 mt-10 -89.76 113.45 24.98 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.605 0.717 . . . . 63.399999999999999 109.438 177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 36.7 t -100.43 115.53 41.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 114.387 -1.279 . . . . 64.230000000000004 108.439 -175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 21.2 mt -112.32 126.78 69.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 CA-C-N 114.823 -1.081 . . . . 54.43 109.169 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 514' ' ' VAL . 0.0 OUTLIER -106.85 112.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.818 -0.628 . . . . 73.120000000000005 112.582 -176.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -176.13 146.89 0.7 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.519 -2.03 . . . . 75.530000000000001 105.519 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -67.04 118.5 10.58 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 119.153 0.888 . . . . 73.219999999999999 111.818 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 9.1 m -86.93 91.05 8.55 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-N 114.723 -1.126 . . . . 65.219999999999999 111.032 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -106.79 -24.66 12.01 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.908 0.861 . . . . 63.039999999999999 109.15 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -84.3 175.36 9.45 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.87 -1.53 . . . . 75.319999999999993 106.87 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 653' ' ' SER . 64.3 t80 -115.92 89.75 3.18 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 119.596 -0.842 . . . . 74.129999999999995 111.209 -176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -87.44 83.56 7.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.292 0.568 . . . . 71.450000000000003 109.764 176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . 0.443 ' HB2' ' CE2' ' A' ' 651' ' ' PHE . 50.8 m -154.59 166.12 34.34 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.42 -1.326 . . . . 60.140000000000001 107.42 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.0 m -72.31 124.78 25.8 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.737 -0.468 . . . . 63.329999999999998 109.737 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 10.1 p -130.51 147.74 33.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 108.49 -0.93 . . . . 74.510000000000005 108.49 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 C--O 1.255 1.363 0 N-CA-C 110.116 -0.327 . . . . 65.200000000000003 110.116 -178.438 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 CA--C 1.522 -0.122 0 N-CA-C 108.93 -0.767 . . . . 74.200000000000003 108.93 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -107.24 115.19 29.73 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.208 -1.034 . . . . 73.209999999999994 108.208 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 98.66 88.24 1.93 Allowed Glycine 0 C--N 1.307 -1.053 0 N-CA-C 109.18 -1.568 . . . . 60.229999999999997 109.18 -174.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.586 ' H ' ' HB3' ' A' ' 529' ' ' SER . 68.2 mt -127.97 124.26 62.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 109.609 -0.515 . . . . 74.230000000000004 109.609 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.51 137.3 43.57 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 123.669 0.606 . . . . 71.019999999999996 110.601 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 10.0 t -149.18 156.28 41.93 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.248 -0.278 . . . . 72.25 110.248 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.47 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 61.4 m-85 -77.2 168.76 19.52 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.213 -1.032 . . . . 71.040000000000006 108.213 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.49 -46.94 36.22 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.662 0.744 . . . . 73.230000000000004 109.005 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -122.91 164.6 26.14 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 114.838 -1.074 . . . . 73.129999999999995 109.847 -174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -90.47 -19.53 1.09 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.613 2.209 . . . . 70.150000000000006 112.011 174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.2 132.75 38.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.363 -0.977 . . . . 71.329999999999998 108.363 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . 0.452 HG22 HD22 ' A' ' 641' ' ' LEU . 10.0 t -131.22 127.31 37.62 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 108.995 -0.743 . . . . 63.119999999999997 108.995 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -99.88 125.11 45.8 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.492 -0.929 . . . . 75.239999999999995 108.492 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 645' ' ' ILE . 19.8 m -134.59 162.31 39.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.408 0.623 . . . . 64.230000000000004 109.713 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.407 ' O ' HG22 ' A' ' 518' ' ' ILE . 39.3 m -80.9 157.34 25.65 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.71 -0.677 . . . . 64.049999999999997 110.284 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -77.62 -23.66 49.74 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.556 -1.276 . . . . 55.25 107.556 172.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.0 p -95.73 18.95 12.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.035 -1.439 . . . . 70.409999999999997 111.45 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 515' ' ' SER . 9.0 tt -81.77 -31.73 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 119.941 -0.704 . . . . 72.25 111.274 -177.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 91.09 -75.27 1.59 Allowed Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 120.413 -0.898 . . . . 72.530000000000001 111.139 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 574' ' ' ARG . 44.2 mm -126.65 125.67 67.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 108.377 -0.972 . . . . 62.219999999999999 108.377 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -97.36 147.22 24.4 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.357 -0.979 . . . . 64.430000000000007 108.357 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -118.15 115.49 24.91 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.282 0.633 . . . . 60.030000000000001 112.238 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 36.8 t -109.92 124.99 67.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.182 -0.463 . . . . 63.020000000000003 110.56 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.33 127.99 41.83 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.795 -0.817 . . . . 72.0 108.795 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.56 118.52 41.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.032 -0.729 . . . . 75.019999999999996 109.032 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.7 mt -93.46 148.34 22.16 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.312 -0.858 . . . . 74.219999999999999 109.514 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 102.92 12.28 Favored 'General case' 0 C--N 1.278 -2.522 0 N-CA-C 104.029 -2.582 . . . . 74.319999999999993 104.029 174.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 10.4 t -66.86 -46.64 74.4 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.844 -0.742 . . . . 71.109999999999999 110.583 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . 0.586 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 30.1 t -74.4 -45.28 47.77 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.2 0.524 . . . . 71.0 110.095 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.57 -168.83 23.72 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 109.802 -1.319 . . . . 63.32 109.802 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -156.08 137.68 14.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.652 -0.87 . . . . 31.120000000000001 108.652 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -155.81 103.85 2.28 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.431 -0.952 . . . . 63.43 108.431 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 137.76 -131.08 5.32 Favored Glycine 0 C--N 1.308 -0.991 0 N-CA-C 110.826 -0.909 . . . . 73.409999999999997 110.826 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -136.98 102.5 4.87 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.337 -1.357 . . . . 54.140000000000001 107.337 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 594' ' ' PRO . 26.5 t -121.56 122.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 119.885 -0.726 . . . . 72.030000000000001 111.421 -175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.429 HG12 HD13 ' A' ' 597' ' ' ILE . 38.7 mm -88.17 120.98 37.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.483 -1.302 . . . . 70.420000000000002 107.483 174.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 560' ' ' LEU . 44.4 t -110.42 104.77 56.42 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.062 -0.718 . . . . 64.319999999999993 109.062 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.497 ' HG2' ' HB3' ' A' ' 592' ' ' GLU . 14.8 Cg_endo -85.16 163.28 11.47 Favored 'Trans proline' 0 N--CA 1.419 -2.89 0 C-N-CA 121.475 1.45 . . . . 74.420000000000002 111.375 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.436 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 23.6 p90 -149.91 164.29 35.81 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.046 -1.835 . . . . 73.340000000000003 106.046 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -150.15 133.01 16.03 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.22 -0.592 . . . . 74.430000000000007 111.089 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 555' ' ' ASP . 17.7 p -82.35 121.15 26.33 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.843 -1.071 . . . . 71.329999999999998 109.719 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.72 116.3 32.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.289 -1.374 . . . . 71.329999999999998 107.289 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -72.47 110.05 6.59 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.704 0.628 . . . . 61.439999999999998 110.129 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -98.54 -107.68 2.71 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.809 -0.917 . . . . 43.049999999999997 110.809 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 1.1 p -85.04 -20.59 30.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.571 0.701 . . . . 73.319999999999993 109.901 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.26 134.3 35.6 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.893 -1.151 . . . . 72.219999999999999 107.893 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -92.26 138.42 31.54 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 120.832 0.349 . . . . 73.200000000000003 111.7 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -81.1 -158.58 20.51 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 111.147 -0.781 . . . . 61.310000000000002 111.147 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 73.91 17.14 79.29 Favored Glycine 0 C--N 1.309 -0.956 0 N-CA-C 111.198 -0.761 . . . . 75.519999999999996 111.198 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 73.16 32.76 60.01 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 111.372 -0.691 . . . . 60.210000000000001 111.372 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -91.28 -71.23 0.64 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 108.804 -0.813 . . . . 74.230000000000004 108.804 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.53 -31.01 13.53 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.556 -1.275 . . . . 73.099999999999994 107.556 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.97 150.08 33.35 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-N 115.276 -0.875 . . . . 72.299999999999997 109.045 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.4 tm-20 -87.14 105.63 17.32 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 105.929 -1.878 . . . . 74.329999999999998 105.929 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.447 ' HB2' ' OG1' ' A' ' 541' ' ' THR . 7.5 p-10 -76.65 135.29 39.13 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.84 0.828 . . . . 70.230000000000004 111.321 -173.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 3.2 t -133.53 148.98 51.69 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.026 -0.988 . . . . 71.209999999999994 110.548 -173.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.9 p -148.33 111.29 4.84 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.136 0.574 . . . . 74.129999999999995 110.925 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 101.51 -164.02 17.76 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 120.95 -0.643 . . . . 64.310000000000002 112.28 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 84.51 10.51 0.38 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 125.513 1.525 . . . . 73.030000000000001 114.024 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 569' ' ' LYS . 32.0 mt -106.4 133.43 51.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 118.977 -1.089 . . . . 71.129999999999995 111.061 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -132.1 114.97 15.17 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.919 -0.771 . . . . 72.310000000000002 108.919 177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.3 m-85 -111.09 105.94 14.83 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.321 -0.992 . . . . 72.340000000000003 108.321 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.432 ' H ' HD11 ' A' ' 567' ' ' ILE . 49.2 mt-30 -83.89 -69.15 0.66 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.322 -0.992 . . . . 64.0 108.322 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -105.2 160.93 14.7 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.4 -0.818 . . . . 75.530000000000001 109.228 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -67.38 -22.63 65.55 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.077 0.465 . . . . 70.239999999999995 111.959 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.86 -6.94 9.36 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.987 1.106 . . . . 73.340000000000003 113.987 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.432 HD11 ' H ' ' A' ' 563' ' ' GLN . 38.2 pt -115.21 162.61 13.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 108.896 -0.779 . . . . 73.340000000000003 108.896 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.7 p -131.18 150.71 34.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.688 -1.227 . . . . 65.150000000000006 107.688 176.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -120.61 155.94 32.7 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.905 -0.405 . . . . 75.129999999999995 109.905 174.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.9 mt -125.34 135.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 O-C-N 124.275 0.984 . . . . 74.25 109.641 -177.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.3 mt -92.32 120.92 42.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.491 -1.67 . . . . 74.420000000000002 106.491 173.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 31.2 p -110.52 112.79 24.94 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 123.615 0.572 . . . . 73.239999999999995 109.718 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 589' ' ' LEU . 70.4 mt -112.48 128.43 69.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.897 -0.779 . . . . 65.140000000000001 108.897 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.422 ' HA ' HD13 ' A' ' 520' ' ' ILE . 35.3 ttm180 -85.07 126.94 34.0 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.588 0.555 . . . . 72.209999999999994 109.526 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.2 142.2 18.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 108.039 -1.097 . . . . 53.32 108.039 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 76.3 m-85 -123.14 113.51 19.07 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.196 0.522 . . . . 71.040000000000006 109.787 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -84.29 2.81 38.41 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.779 -0.823 . . . . 73.409999999999997 108.779 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.516 ' HG3' ' HG2' ' A' ' 579' ' ' GLU . 33.8 ptt180 -58.78 -38.36 78.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.643 -0.708 . . . . 63.539999999999999 111.427 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.516 ' HG2' ' HG3' ' A' ' 578' ' ' ARG . 26.2 mm-40 -95.9 -8.6 33.53 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 112.994 0.739 . . . . 60.229999999999997 112.994 -174.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -132.59 149.72 52.27 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 118.437 -1.305 . . . . 74.040000000000006 111.967 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -103.69 -58.71 1.83 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.56 -0.745 . . . . 73.219999999999999 109.079 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.406 ' HB2' ' OE1' ' A' ' 646' ' ' GLU . 1.6 pm0 -163.28 133.6 4.46 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.366 -0.975 . . . . 73.109999999999999 108.366 171.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -176.7 156.34 1.42 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 105.297 -2.112 . . . . 72.230000000000004 105.297 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -82.4 76.46 9.27 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.475 -0.89 . . . . 71.310000000000002 109.518 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 70.2 m -92.82 122.65 35.42 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.527 -0.761 . . . . 53.420000000000002 109.617 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 35.2 p -138.34 153.58 48.97 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 116.041 -0.527 . . . . 75.150000000000006 110.289 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -139.92 161.34 37.82 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.661 -1.237 . . . . 70.409999999999997 107.661 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 6.0 m -110.81 158.6 18.5 Favored 'General case' 0 C--N 1.282 -2.346 0 C-N-CA 119.541 -0.863 . . . . 65.319999999999993 109.511 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 573' ' ' ILE . 47.0 tp -134.78 121.69 21.07 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 107.798 -1.186 . . . . 73.450000000000003 107.798 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 33.1 m -121.73 155.87 26.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 109.584 -0.524 . . . . 71.239999999999995 109.584 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.47 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 82.9 mt -90.96 146.63 23.72 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.137 -1.06 . . . . 71.430000000000007 108.137 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . 0.497 ' HB3' ' HG2' ' A' ' 538' ' ' PRO . 4.7 tp10 -107.12 175.86 5.36 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.78 -1.563 . . . . 71.140000000000001 106.78 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 0.0 OUTLIER -60.82 115.36 13.53 Favored Pre-proline 0 C--N 1.313 -1.02 0 N-CA-C 113.824 1.046 . . . . 61.240000000000002 113.824 -177.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 42.4 Cg_endo -73.82 141.03 29.82 Favored 'Trans proline' 0 N--CA 1.418 -2.949 0 C-N-CA 121.648 1.566 . . . . 72.109999999999999 110.623 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.02 129.49 56.39 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.857 -0.611 . . . . 74.319999999999993 110.702 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . 0.494 ' CG ' ' HB3' ' A' ' 599' ' ' ARG . 4.2 t90 -92.37 117.36 29.83 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 64.200000000000003 108.18 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . 0.531 HG22 ' HG3' ' A' ' 598' ' ' ARG . 2.5 mp -93.84 133.37 35.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 106.949 -1.5 . . . . 62.240000000000002 106.949 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . 0.531 ' HG3' HG22 ' A' ' 597' ' ' ILE . 88.5 mtt180 70.65 55.18 0.27 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.516 -0.92 . . . . 73.049999999999997 108.516 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . 0.494 ' HB3' ' CG ' ' A' ' 596' ' ' TRP . 5.3 ppt_? -103.24 26.51 8.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.867 0.841 . . . . 72.5 111.651 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 161.76 -38.64 0.39 Allowed Glycine 0 N--CA 1.427 -1.943 0 N-CA-C 109.598 -1.401 . . . . 73.120000000000005 109.598 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 47.2 ttm -152.9 147.93 26.56 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.463 -0.94 . . . . 62.340000000000003 108.463 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -77.26 100.24 5.78 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.004 -2.221 . . . . 74.150000000000006 105.004 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 140.25 -138.15 8.86 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 108.844 -1.702 . . . . 51.140000000000001 108.844 -175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 85.85 53.73 2.95 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 108.621 -1.792 . . . . 72.510000000000005 108.621 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -64.06 107.77 1.35 Allowed 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.41 -0.895 . . . . 74.420000000000002 110.164 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 15.4 m -76.59 135.54 39.21 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.572 -1.194 . . . . 73.420000000000002 108.263 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 33.0 mm -61.25 116.74 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 108.796 -0.816 . . . . 72.120000000000005 108.796 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 38.8 m 69.53 82.36 0.16 Allowed 'General case' 0 N--CA 1.422 -1.872 0 O-C-N 124.273 0.983 . . . . 61.030000000000001 111.863 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -118.97 -6.12 10.52 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.189 -1.412 . . . . 74.109999999999999 107.189 172.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -122.52 138.34 54.59 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 103.25 -2.87 . . . . 74.200000000000003 103.25 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 72.5 t80 62.99 27.48 15.93 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 123.552 1.644 . . . . 73.209999999999994 107.555 -172.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . 0.517 ' OD1' ' HG2' ' A' ' 614' ' ' LYS . 16.1 t70 -88.93 146.75 24.72 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 112.913 -1.949 . . . . 74.219999999999999 111.192 -176.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -143.99 39.51 1.35 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.684 -0.858 . . . . 64.530000000000001 108.684 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . 0.517 ' HG2' ' OD1' ' A' ' 612' ' ' ASP . 21.9 pttm -81.59 68.79 8.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 123.294 1.521 . . . . 73.129999999999995 110.502 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . 0.509 ' HB3' ' HD3' ' A' ' 616' ' ' PRO . 35.9 tt0 -77.0 -49.73 2.4 Favored Pre-proline 0 N--CA 1.419 -2.013 0 CA-C-N 112.883 -1.962 . . . . 73.409999999999997 110.501 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 615' ' ' GLN . 1.1 Cg_endo -85.6 135.72 5.14 Favored 'Trans proline' 0 N--CA 1.42 -2.845 0 CA-C-N 120.255 1.127 . . . . 73.439999999999998 110.191 174.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' A' ' 626' ' ' ARG . 2.0 mm? -89.24 -20.12 24.54 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.998 -1.482 . . . . 63.43 106.998 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 19.1 m -90.84 78.33 6.1 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 107.038 -1.468 . . . . 70.400000000000006 107.038 172.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 14.8 m -60.61 133.1 55.77 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 114.899 -1.046 . . . . 71.200000000000003 109.024 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -72.19 -23.05 61.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.037 0.446 . . . . 74.030000000000001 109.844 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.36 145.55 28.98 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.427 -1.694 . . . . 73.019999999999996 106.427 171.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.98 89.11 2.39 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.343 1.068 . . . . 62.240000000000002 109.226 178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -111.64 127.53 55.78 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.868 -1.514 . . . . 74.109999999999999 109.118 -175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.12 -9.49 52.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.658 0.783 . . . . 74.519999999999996 112.995 -175.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -51.77 -40.27 60.04 Favored 'General case' 0 CA--C 1.495 -1.146 0 O-C-N 123.489 0.493 . . . . 63.299999999999997 110.017 173.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.655 ' O ' ' HG3' ' A' ' 630' ' ' MET . 73.9 mtm180 -56.24 -51.68 67.23 Favored 'General case' 0 C--O 1.198 -1.641 0 CA-C-N 115.111 -0.949 . . . . 64.0 110.671 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.24 -32.39 57.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.237 0.541 . . . . 64.340000000000003 110.816 -176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.18 62.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.097 -0.502 . . . . 44.409999999999997 109.668 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.458 ' HA ' ' HD2' ' A' ' 632' ' ' ARG . 51.3 mt-10 -77.14 -8.38 57.41 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 112.771 0.656 . . . . 73.239999999999995 112.771 -178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.655 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 64.4 mtt -71.73 -27.69 63.16 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.234 -0.654 . . . . 73.349999999999994 109.234 170.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -117.7 73.9 0.29 Allowed Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.338 -0.846 . . . . 74.120000000000005 111.165 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 633' ' ' PRO . 11.2 ptm180 -148.72 -175.39 0.47 Allowed Pre-proline 0 C--N 1.296 -1.745 0 N-CA-C 105.045 -2.206 . . . . 73.219999999999999 105.045 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.537 ' O ' ' HG3' ' A' ' 632' ' ' ARG . 50.3 Cg_exo -59.67 126.49 20.71 Favored 'Trans proline' 0 C--N 1.358 1.031 0 N-CA-C 107.164 -1.899 . . . . 54.210000000000001 107.164 167.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 33.8 pt -127.88 -177.37 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-O 121.207 0.527 . . . . 63.049999999999997 111.125 -172.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -101.15 175.13 5.7 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 108.093 -1.077 . . . . 73.049999999999997 108.093 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.45 179.44 29.43 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 121.009 -0.615 . . . . 65.349999999999994 112.478 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 638' ' ' HIS . 12.3 tp10 -52.5 -60.91 2.66 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.74 -0.837 . . . . 73.0 108.74 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 637' ' ' GLU . 37.2 m80 -136.46 114.71 11.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.895 -1.52 . . . . 65.109999999999999 106.895 175.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.7 t -134.19 109.25 8.76 Favored 'General case' 0 N--CA 1.41 -2.433 0 C-N-CA 119.178 -1.009 . . . . 64.310000000000002 109.979 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -149.35 137.63 20.74 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.45 -1.25 . . . . 74.120000000000005 108.13 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 512' ' ' THR . 9.3 mt -104.07 116.65 32.61 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.384 -0.599 . . . . 43.020000000000003 109.384 171.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.29 113.74 26.08 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 106.441 -1.689 . . . . 72.310000000000002 106.441 169.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.4 117.82 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 114.435 -1.257 . . . . 71.5 109.143 -172.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -105.01 127.99 59.13 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 114.926 -1.033 . . . . 73.439999999999998 108.406 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.405 HG22 HG23 ' A' ' 514' ' ' VAL . 0.0 OUTLIER -112.96 90.04 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.323 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 647' ' ' GLU . 6.7 tp10 -171.81 95.27 0.16 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.525 -1.216 . . . . 63.420000000000002 110.085 -176.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 646' ' ' GLU . 5.3 tp10 171.04 94.71 0.0 OUTLIER 'General case' 0 C--O 1.242 0.705 0 O-C-N 124.141 0.901 . . . . 74.319999999999993 111.441 174.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 49.5 m -92.97 108.82 20.3 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.691 -1.596 . . . . 73.109999999999999 106.691 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -143.08 169.46 17.55 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.626 -0.509 . . . . 71.319999999999993 109.626 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -127.94 120.67 28.13 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-O 121.716 0.769 . . . . 63.240000000000002 109.786 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -118.14 115.33 24.59 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 105.99 -1.856 . . . . 75.230000000000004 105.99 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 652' ' ' LYS . 0.0 OUTLIER -82.41 86.45 6.73 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.63 0.728 . . . . 71.400000000000006 110.26 -179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 5.1 p -70.28 128.39 36.07 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 114.966 -1.015 . . . . 62.219999999999999 109.324 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 88.4 m -68.34 110.1 3.94 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.612 -0.722 . . . . 75.019999999999996 111.078 -177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.54 163.33 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.133 -0.94 . . . . 75.329999999999998 108.647 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 4.0 p30 . . . . . 0 C--N 1.301 -1.54 0 N-CA-C 109.127 -0.694 . . . . 50.140000000000001 109.127 178.414 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.468 ' CD2' ' HE ' ' A' ' 532' ' ' ARG . 15.9 p-80 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 120.808 0.337 . . . . 72.0 110.299 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.32 76.82 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 115.121 -0.945 . . . . 74.219999999999999 110.428 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 105.88 115.88 4.11 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.328 -0.939 . . . . 73.140000000000001 113.12 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 59.6 mt -128.11 114.1 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.942 0 N-CA-C 105.367 -2.086 . . . . 51.25 105.367 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.634 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 85.8 m-85 -100.83 138.28 38.08 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 123.571 0.544 . . . . 74.420000000000002 111.103 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 3.8 t -148.27 152.85 37.85 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.967 -0.56 . . . . 61.219999999999999 110.385 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.488 ' HD2' ' HG1' ' A' ' 639' ' ' THR . 82.3 m-85 -71.68 158.95 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.798 -0.816 . . . . 73.319999999999993 108.798 171.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.0 -47.54 84.32 Favored 'General case' 0 C--N 1.319 -0.73 0 O-C-N 123.769 0.668 . . . . 75.430000000000007 110.638 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.5 153.9 79.4 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 107.913 -1.143 . . . . 61.399999999999999 107.913 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.3 Cg_endo -81.39 -18.76 8.19 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.06 1.84 . . . . 73.140000000000001 112.747 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.469 HG22 ' HB2' ' A' ' 642' ' ' GLU . 68.7 t -138.82 136.45 43.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.183 -1.043 . . . . 72.299999999999997 108.183 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.1 t -133.51 128.97 36.47 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.42 0.629 . . . . 43.520000000000003 109.607 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -97.96 117.43 32.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.985 -0.746 . . . . 62.43 108.985 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 30.6 m -119.54 174.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 121.421 0.629 . . . . 64.120000000000005 109.777 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 518' ' ' ILE . 5.2 m -98.63 150.99 21.18 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.615 -0.72 . . . . 74.319999999999993 110.052 -175.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -66.78 -27.87 67.93 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.383 -0.969 . . . . 73.439999999999998 108.383 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 2.1 m -103.04 20.82 16.87 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-N 114.568 -1.196 . . . . 64.219999999999999 111.801 -175.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 515' ' ' SER . 10.6 tt -78.31 -28.09 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 121.446 -0.784 . . . . 55.039999999999999 112.678 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 89.41 -75.04 1.9 Allowed Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.332 -0.937 . . . . 72.400000000000006 111.483 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 574' ' ' ARG . 45.8 mm -133.61 144.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 107.672 -1.233 . . . . 61.32 107.672 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 18.4 ptm -117.96 128.5 54.86 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.254 -0.647 . . . . 74.040000000000006 109.254 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -100.38 120.31 39.76 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.838 0.711 . . . . 71.519999999999996 110.512 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 641' ' ' LEU . 59.1 t -126.55 131.74 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.306 -0.627 . . . . 74.219999999999999 109.306 177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 570' ' ' ILE . 61.9 mttp -95.62 149.97 20.87 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.817 0.818 . . . . 74.120000000000005 111.938 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 99.8 t -106.52 113.06 42.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 106.984 -1.487 . . . . 73.239999999999995 106.984 172.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 79.5 mt -90.17 160.31 16.3 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.295 -0.866 . . . . 72.430000000000007 110.147 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.01 104.3 9.14 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.224 -1.028 . . . . 72.109999999999999 108.224 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.5 m -65.85 -52.67 48.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.669 0.747 . . . . 75.200000000000003 109.776 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 30.6 t -73.52 -52.25 14.2 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.151 -0.932 . . . . 62.140000000000001 111.26 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 143.77 -156.78 26.8 Favored Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 109.681 -1.368 . . . . 64.209999999999994 109.681 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -166.1 137.07 3.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.957 -0.756 . . . . 75.340000000000003 108.957 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.468 ' HE ' ' CD2' ' A' ' 501' ' ' HIS . 28.2 mtm180 -148.66 148.45 30.09 Favored 'General case' 0 CA--C 1.497 -1.059 0 C-N-CA 123.427 0.691 . . . . 74.0 109.186 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 85.7 -124.47 6.85 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.84 -0.695 . . . . 73.099999999999994 111.865 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -137.38 104.36 5.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.927 -0.768 . . . . 74.310000000000002 108.927 176.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.7 t -117.54 125.81 74.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 CA-C-O 121.521 0.677 . . . . 60.009999999999998 110.856 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 559' ' ' GLU . 30.7 mm -96.51 119.54 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.69 -0.687 . . . . 62.119999999999997 109.262 177.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 50.1 t -106.89 103.11 45.99 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.249 -1.019 . . . . 53.109999999999999 108.249 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.71 147.37 27.72 Favored 'Trans proline' 0 N--CA 1.441 -1.617 0 C-N-CA 121.798 1.666 . . . . 71.040000000000006 111.743 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.413 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 52.0 p90 -138.17 158.22 44.74 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.021 -1.103 . . . . 73.019999999999996 108.021 176.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -154.34 135.5 13.96 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.111 0.482 . . . . 54.119999999999997 110.818 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.54 131.24 36.72 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.976 -1.011 . . . . 64.239999999999995 110.481 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 46.3 mm -100.44 120.31 49.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.695 -0.854 . . . . 71.420000000000002 108.695 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -74.61 104.81 5.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.682 -0.69 . . . . 74.340000000000003 109.32 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -88.72 -122.1 1.94 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 110.528 -1.029 . . . . 72.439999999999998 110.528 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.12 -6.61 58.98 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.923 0.868 . . . . 71.530000000000001 108.926 178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.75 27.8 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.567 -1.197 . . . . 63.219999999999999 108.794 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.507 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 38.9 mmt180 -79.47 147.85 32.11 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.628 -1.249 . . . . 74.219999999999999 107.628 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -109.54 148.49 17.17 Favored Glycine 0 C--N 1.263 -3.498 0 CA-C-N 115.267 -0.879 . . . . 65.030000000000001 114.085 -170.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 88.59 48.02 4.09 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.542 -0.837 . . . . 51.310000000000002 113.657 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.86 43.85 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.706 -1.235 . . . . 73.530000000000001 113.996 173.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 37.8 mm-40 -96.29 -84.39 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 117.631 0.715 . . . . 62.509999999999998 110.342 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -79.6 -44.37 21.15 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.772 -1.566 . . . . 73.010000000000005 106.772 174.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -136.39 157.58 46.45 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.421 -1.263 . . . . 71.549999999999997 108.83 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -92.24 142.05 27.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 106.079 -1.822 . . . . 54.420000000000002 106.079 175.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -83.86 100.78 11.19 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.154 0.502 . . . . 72.140000000000001 110.713 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -111.29 104.47 12.95 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-O 122.582 1.182 . . . . 75.340000000000003 109.129 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.7 p -126.72 140.02 52.71 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 106.959 -1.497 . . . . 54.109999999999999 106.959 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 177.51 -151.32 10.8 Favored Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 118.487 -1.816 . . . . 42.329999999999998 113.261 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.1 OUTLIER -127.18 125.94 41.97 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 124.222 1.009 . . . . 55.439999999999998 112.033 -171.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.413 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 86.1 mt -100.92 135.54 42.21 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.63 -0.878 . . . . 64.219999999999999 108.63 173.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -103.84 109.36 21.06 Favored 'General case' 0 C--N 1.276 -2.603 0 CA-C-O 121.185 0.517 . . . . 74.019999999999996 111.011 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 51.3 m-85 -105.27 101.79 11.31 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.172 -1.047 . . . . 74.450000000000003 108.172 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -80.2 -79.18 0.15 Allowed 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.649 -0.82 . . . . 64.030000000000001 110.754 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 567' ' ' ILE . 59.4 t30 -104.8 158.14 16.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.649 -0.82 . . . . 73.329999999999998 108.953 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -61.13 -11.55 9.27 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.897 1.279 . . . . 74.439999999999998 113.269 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.463 ' HG3' HG23 ' A' ' 567' ' ' ILE . 12.7 pt-20 -66.92 -11.03 54.99 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.648 0.779 . . . . 64.129999999999995 111.966 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.463 HG23 ' HG3' ' A' ' 566' ' ' GLU . 35.3 pt -119.07 158.71 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.48 0.657 . . . . 74.319999999999993 110.674 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.77 143.38 41.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.087 -1.82 . . . . 64.409999999999997 106.087 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 27.1 mttm -111.14 155.99 22.05 Favored 'General case' 0 CA--C 1.469 -2.156 0 C-N-CA 119.393 -0.923 . . . . 75.219999999999999 112.973 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 524' ' ' LYS . 72.3 mt -124.45 136.04 61.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 114.245 -1.343 . . . . 73.25 109.773 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 59.1 mt -98.06 129.03 48.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 106.816 -1.55 . . . . 64.439999999999998 106.816 174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.9 p -118.28 112.56 20.24 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.295 0.569 . . . . 54.229999999999997 110.777 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.527 HD11 HD22 ' A' ' 589' ' ' LEU . 49.4 mt -106.4 135.47 44.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.812 -0.631 . . . . 64.340000000000003 109.969 -177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 70.9 mtt180 -80.06 112.01 16.96 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.198 -0.667 . . . . 73.209999999999994 109.198 174.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 46.5 mm -100.83 131.09 49.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.337 -0.847 . . . . 51.25 108.735 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -113.85 154.8 26.84 Favored 'General case' 0 N--CA 1.422 -1.831 0 N-CA-C 109.57 -0.53 . . . . 73.329999999999998 109.57 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.94 13.96 17.08 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.818 -0.628 . . . . 52.43 110.889 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -98.99 99.84 10.93 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.714 -0.675 . . . . 64.400000000000006 110.81 -176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -110.86 146.68 36.05 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 106.994 -1.484 . . . . 72.430000000000007 106.994 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -73.18 -38.41 66.16 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.162 1.171 . . . . 73.439999999999998 114.162 -168.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.22 -96.91 0.46 Allowed 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.584 -0.846 . . . . 71.519999999999996 110.643 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -164.91 81.65 0.37 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.655 -1.609 . . . . 70.219999999999999 106.655 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -132.85 148.93 52.3 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.573 -1.194 . . . . 60.32 108.893 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 584' ' ' GLU . 0.9 OUTLIER -81.57 75.72 8.51 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.039 -1.837 . . . . 74.430000000000007 106.039 167.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 9.1 t -62.91 141.4 58.71 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 111.829 -2.441 . . . . 71.530000000000001 112.57 -168.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.422 ' HB3' HG12 ' A' ' 644' ' ' ILE . 44.8 p -142.82 147.74 35.94 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-O 121.261 0.553 . . . . 73.120000000000005 111.81 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -136.86 -179.88 5.97 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.028 -1.471 . . . . 73.140000000000001 107.028 173.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 22.0 m -130.85 168.43 17.28 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.342 -0.943 . . . . 75.030000000000001 110.631 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 573' ' ' ILE . 46.6 tp -142.12 132.72 25.38 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.977 -1.49 . . . . 72.519999999999996 106.977 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.75 159.27 41.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 120.54 0.21 . . . . 61.399999999999999 110.608 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 507' ' ' PHE . 65.5 mt -101.65 147.65 26.18 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 106.17 -1.789 . . . . 33.420000000000002 106.17 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -105.33 177.62 4.8 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 109.225 -0.657 . . . . 73.120000000000005 109.225 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -61.49 118.49 37.83 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 123.411 0.445 . . . . 74.150000000000006 109.819 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.575 ' HD3' HD22 ' A' ' 635' ' ' LEU . 66.1 Cg_endo -71.99 156.57 56.0 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 C-N-CA 122.451 2.101 . . . . 73.409999999999997 111.333 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -129.55 124.13 33.11 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.044 -0.526 . . . . 62.149999999999999 110.824 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . 0.505 ' HB2' ' HG3' ' A' ' 633' ' ' PRO . 3.1 t90 -90.0 120.87 31.57 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.32 -1.363 . . . . 74.340000000000003 107.32 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.19 94.93 3.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 107.763 -1.199 . . . . 74.340000000000003 107.763 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -88.33 113.37 23.87 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.748 -1.115 . . . . 74.109999999999999 110.271 -178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -79.35 -25.02 42.34 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.832 -1.173 . . . . 71.140000000000001 107.832 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -138.24 124.25 2.88 Favored Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 108.65 -1.78 . . . . 74.340000000000003 108.65 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -154.05 179.36 9.0 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 117.108 0.454 . . . . 74.340000000000003 110.922 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -64.18 123.6 19.5 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 123.892 0.745 . . . . 63.439999999999998 110.426 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -135.47 146.62 18.63 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.193 -1.163 . . . . 54.119999999999997 110.193 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 87.55 36.25 8.81 Favored Glycine 0 C--N 1.302 -1.345 0 N-CA-C 111.233 -0.747 . . . . 53.32 111.233 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -134.14 141.81 47.24 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.16 -0.681 . . . . 74.129999999999995 109.16 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 8.4 m -78.59 100.12 6.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.879 -1.156 . . . . 72.409999999999997 107.879 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 37.9 mm -83.1 -41.13 16.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.032 -0.729 . . . . 63.119999999999997 109.032 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 52.7 m -113.64 97.62 6.54 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 109.477 -0.564 . . . . 62.439999999999998 109.477 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.96 -9.69 45.15 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.852 -0.613 . . . . 73.329999999999998 111.321 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -63.16 135.44 57.15 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 116.183 -0.462 . . . . 71.209999999999994 109.856 176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -79.65 -36.6 37.53 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 123.226 0.61 . . . . 71.010000000000005 112.32 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 16.0 t70 56.34 86.12 0.07 Allowed 'General case' 0 N--CA 1.483 1.186 0 O-C-N 124.236 0.96 . . . . 72.010000000000005 110.018 -176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -138.28 -48.95 0.54 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.426 -0.807 . . . . 61.539999999999999 110.818 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 615' ' ' GLN . 0.0 OUTLIER -80.99 44.13 0.74 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 124.325 1.05 . . . . 71.010000000000005 110.138 -176.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 614' ' ' LYS . 2.0 mp0 72.51 167.67 0.12 Allowed Pre-proline 0 C--O 1.243 0.724 0 C-N-CA 124.245 1.018 . . . . 71.400000000000006 109.053 -171.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.47 132.32 51.46 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 121.386 1.391 . . . . 72.420000000000002 110.928 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -83.56 118.55 23.88 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.086 -0.961 . . . . 74.209999999999994 111.337 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 72.0 m -60.58 103.65 0.27 Allowed 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.733 -1.21 . . . . 70.140000000000001 107.733 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 15.3 m -85.56 88.37 7.51 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-O 121.746 0.784 . . . . 63.409999999999997 111.524 -171.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -92.97 75.11 4.78 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 122.658 1.218 . . . . 74.319999999999993 109.942 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -153.09 98.64 2.31 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 113.67 -1.604 . . . . 74.510000000000005 108.309 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.82 -21.42 18.12 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.429 -0.35 . . . . 71.25 111.156 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -73.91 -54.81 7.12 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.477 -0.329 . . . . 72.540000000000006 111.697 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -63.25 -33.72 76.12 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 119.723 -0.791 . . . . 72.439999999999998 110.645 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 71.7 ttt180 -59.06 -49.55 77.47 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 123.842 0.714 . . . . 72.549999999999997 110.249 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.581 ' HA ' ' HE ' ' A' ' 626' ' ' ARG . 0.3 OUTLIER -57.17 -43.84 82.97 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.278 0.361 . . . . 65.120000000000005 110.694 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.3 -44.44 91.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.446 -0.343 . . . . 74.239999999999995 110.76 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -62.41 -35.85 80.51 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.356 0.598 . . . . 50.350000000000001 110.572 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 71.8 mt-10 -73.2 -22.99 60.34 Favored 'General case' 0 C--O 1.204 -1.338 0 CA-C-N 115.948 -0.569 . . . . 62.200000000000003 110.898 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.523 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 76.3 mtm -79.76 0.12 32.02 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.326 0.584 . . . . 72.299999999999997 111.146 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.21 15.91 32.78 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 111.001 -0.84 . . . . 63.020000000000003 111.001 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -146.58 167.66 13.33 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 106.488 -1.671 . . . . 73.329999999999998 106.488 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.505 ' HG3' ' HB2' ' A' ' 596' ' ' TRP . 61.5 Cg_endo -70.82 135.34 27.7 Favored 'Trans proline' 0 C--O 1.262 1.678 0 C-N-CA 121.194 1.263 . . . . 65.010000000000005 110.295 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.411 HG21 ' HB3' ' A' ' 629' ' ' GLU . 0.2 OUTLIER -135.1 -176.6 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 115.431 -0.804 . . . . 64.409999999999997 109.255 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.634 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 1.9 pt? -133.55 179.02 6.48 Favored 'General case' 0 C--N 1.268 -2.966 0 C-N-CA 120.141 -0.624 . . . . 55.100000000000001 109.415 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.94 142.13 42.85 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.846 -1.302 . . . . 72.420000000000002 109.846 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -48.5 -51.05 29.15 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.141 0.977 . . . . 71.040000000000006 111.401 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -126.63 89.77 3.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.112 -0.699 . . . . 61.200000000000003 109.112 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . 0.488 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 15.4 t -119.34 111.02 17.65 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.482 1.135 . . . . 75.120000000000005 109.477 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.9 ttmt -145.06 147.44 32.58 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 106.81 -1.552 . . . . 64.099999999999994 106.81 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.453 HD22 HG11 ' A' ' 523' ' ' VAL . 33.6 tp -117.21 107.02 13.94 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 108.125 -1.065 . . . . 73.519999999999996 108.125 176.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.469 ' HB2' HG22 ' A' ' 511' ' ' VAL . 35.9 mt-10 -86.99 111.28 20.7 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.308 -0.997 . . . . 61.140000000000001 108.308 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.8 118.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 114.614 -1.176 . . . . 62.420000000000002 109.284 -174.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 586' ' ' SER . 17.3 mt -117.74 119.34 61.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.327 -0.852 . . . . 44.240000000000002 110.166 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.4 110.45 24.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 109.221 -0.659 . . . . 74.319999999999993 109.221 179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -132.22 95.23 3.61 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.642 -0.708 . . . . 65.329999999999998 110.759 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 55.55 -163.53 0.14 Allowed 'General case' 0 C--O 1.253 1.238 0 C-N-CA 124.807 1.243 . . . . 71.439999999999998 112.721 175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 24.7 m -90.85 98.05 11.54 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.82 -0.807 . . . . 45.210000000000001 108.82 175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -96.71 127.91 43.15 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.34 -0.985 . . . . 71.519999999999996 108.34 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -103.68 152.43 21.81 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 120.538 -0.465 . . . . 73.400000000000006 111.06 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 47.6 t80 66.49 88.21 0.11 Allowed 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.935 1.294 . . . . 71.209999999999994 112.979 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 91.12 2.92 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.237 -0.892 . . . . 72.230000000000004 108.753 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 32.6 t -73.03 129.57 38.38 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.638 -1.164 . . . . 53.310000000000002 110.977 -172.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.3 m -96.67 114.35 25.99 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.689 -1.597 . . . . 53.299999999999997 106.689 176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 33.3 m -101.61 145.87 10.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.895 0.379 . . . . 72.400000000000006 110.57 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 . . . . . 0 C--N 1.298 -1.668 0 N-CA-C 109.714 -0.476 . . . . 52.350000000000001 109.714 178.655 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 . . . . . 0 CA--C 1.512 -0.512 0 CA-C-O 121.216 0.531 . . . . 71.209999999999994 110.004 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -64.09 -64.67 0.83 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.173 -0.921 . . . . 44.240000000000002 109.929 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -125.2 102.5 0.68 Allowed Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 108.532 -1.827 . . . . 75.239999999999995 108.532 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 57.1 mt -98.75 115.19 38.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 109.485 -0.561 . . . . 74.450000000000003 109.485 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.458 ' CE1' ' HG3' ' A' ' 527' ' ' ARG . 86.8 m-85 -103.24 139.86 38.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.034 -0.53 . . . . 73.310000000000002 111.456 -176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.0 t -148.11 154.09 39.72 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.677 -0.49 . . . . 73.25 109.677 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.648 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 58.1 m-85 -75.67 160.36 30.15 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.681 -0.489 . . . . 73.239999999999995 109.681 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -62.61 -49.48 75.05 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.523 0.514 . . . . 73.109999999999999 110.197 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.87 166.44 27.43 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 116.286 -0.415 . . . . 63.43 111.168 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 4.7 Cg_exo -83.67 -30.9 0.67 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.501 2.134 . . . . 75.019999999999996 111.729 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 642' ' ' GLU . 70.3 t -143.35 130.66 18.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -175.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 12.3 t -134.13 131.13 38.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.794 -0.817 . . . . 53.219999999999999 108.794 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -106.36 112.43 25.44 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.133 -0.692 . . . . 74.150000000000006 109.133 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 645' ' ' ILE . 30.6 m -112.87 157.87 13.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-O 121.988 0.899 . . . . 73.099999999999994 111.523 -177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 68.0 m -81.79 174.02 11.72 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.5 -1.227 . . . . 70.109999999999999 110.498 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.03 -30.86 17.47 Favored 'General case' 0 CA--C 1.509 -0.596 0 O-C-N 121.741 -0.6 . . . . 71.439999999999998 110.031 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.4 m -80.23 5.89 13.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.474 -0.784 . . . . 73.340000000000003 110.798 -176.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 4.9 tt -75.69 -28.94 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-O 121.159 0.505 . . . . 74.340000000000003 110.137 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 82.94 -71.61 2.98 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.785 -0.722 . . . . 55.210000000000001 113.199 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 44.6 mm -132.04 126.28 56.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.622 -0.881 . . . . 72.519999999999996 108.622 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.417 ' SD ' HD12 ' A' ' 573' ' ' ILE . 5.2 ppp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.178 -0.675 . . . . 71.430000000000007 109.178 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -115.61 131.69 56.86 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.27 0.628 . . . . 61.32 111.384 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 38.6 t -127.5 115.25 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 N-CA-C 109.199 -0.667 . . . . 75.219999999999999 109.199 171.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.4 ' HG2' HG12 ' A' ' 570' ' ' ILE . 98.5 mttt -90.19 127.35 36.1 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 120.229 -0.588 . . . . 63.240000000000002 110.115 174.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 63.1 t -91.37 114.58 28.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.608 -0.886 . . . . 70.329999999999998 108.608 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 51.7 mt -93.14 143.89 25.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.051 -0.977 . . . . 75.120000000000005 110.53 -173.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.458 ' HG3' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -105.54 104.77 14.56 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 106.394 -1.706 . . . . 73.310000000000002 106.394 177.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.8 t -66.91 -48.17 69.5 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.943 -0.703 . . . . 64.150000000000006 111.443 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 36.4 p -74.34 -52.44 12.2 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.495 0.664 . . . . 55.310000000000002 111.479 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 147.96 -170.15 28.64 Favored Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 109.53 -1.428 . . . . 72.010000000000005 109.53 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -164.19 129.24 2.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.61 -0.885 . . . . 52.109999999999999 108.61 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -153.21 81.68 1.19 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.162 0.506 . . . . 64.540000000000006 109.986 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 167.77 -129.43 1.9 Allowed Glycine 0 C--N 1.303 -1.297 0 N-CA-C 109.505 -1.438 . . . . 71.439999999999998 109.505 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -137.32 112.54 9.17 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.288 -1.375 . . . . 63.039999999999999 107.288 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.61 130.42 74.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 120.926 0.393 . . . . 71.140000000000001 110.724 -176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 559' ' ' GLU . 39.2 mm -100.09 113.5 35.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.633 -0.877 . . . . 73.129999999999995 108.633 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 38.2 t -107.03 102.77 44.78 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 108.494 -0.928 . . . . 74.519999999999996 108.494 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 4.3 Cg_endo -80.63 161.56 21.87 Favored 'Trans proline' 0 N--CA 1.439 -1.726 0 C-N-CA 121.719 1.612 . . . . 65.409999999999997 110.949 176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -151.12 163.61 38.42 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.676 -0.861 . . . . 71.219999999999999 108.676 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.425 ' HE2' ' OE2' ' A' ' 592' ' ' GLU . 61.8 pttt -148.99 137.92 21.36 Favored 'General case' 0 C--O 1.247 0.954 0 N-CA-C 112.679 0.622 . . . . 64.239999999999995 112.679 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 22.0 p -87.2 117.55 26.03 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 109.944 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 35.9 mm -92.18 124.54 44.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 108.248 -1.019 . . . . 71.310000000000002 108.248 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -74.41 119.33 18.46 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 109.325 -0.62 . . . . 73.230000000000004 109.325 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -97.96 -107.67 2.63 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.742 -1.343 . . . . 73.530000000000001 109.742 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -86.98 -25.9 24.07 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.643 0.735 . . . . 73.510000000000005 109.035 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.02 149.45 30.73 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.009 -0.996 . . . . 63.539999999999999 109.034 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -104.55 146.27 29.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.481 0.657 . . . . 75.319999999999993 110.833 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.55 -155.43 30.66 Favored Glycine 0 C--N 1.285 -2.291 0 CA-C-N 114.357 -1.292 . . . . 65.129999999999995 112.354 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.19 6.36 53.03 Favored Glycine 0 C--N 1.305 -1.16 0 N-CA-C 114.128 0.411 . . . . 74.0 114.128 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 107.78 -0.72 34.06 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 120.164 -1.017 . . . . 73.25 113.249 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -69.62 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 117.078 0.439 . . . . 64.530000000000001 110.846 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -99.76 -35.78 9.68 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.349 -0.611 . . . . 64.329999999999998 109.349 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -146.56 165.11 30.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.742 -0.663 . . . . 71.109999999999999 109.453 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 576' ' ' PHE . 1.9 tm-20 -100.81 122.99 44.35 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.023 -1.473 . . . . 75.109999999999999 107.023 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -60.09 136.18 57.94 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 123.162 0.585 . . . . 73.439999999999998 111.4 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.41 ' CG2' HG12 ' A' ' 573' ' ' ILE . 9.3 t -140.56 105.78 5.03 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.043 0.925 . . . . 74.219999999999999 109.437 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 46.9 m -129.57 94.89 3.86 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 106.734 -1.58 . . . . 60.020000000000003 106.734 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -136.24 -156.93 7.63 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.378 -0.828 . . . . 44.240000000000002 111.449 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.1 OUTLIER -132.46 138.98 47.8 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.224 0.535 . . . . 52.240000000000002 110.963 -177.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 73.1 mt -105.5 141.26 37.3 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.201 -0.909 . . . . 61.530000000000001 108.775 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.567 ' HG2' ' NE2' ' A' ' 563' ' ' GLN . 32.9 tt0 -112.92 105.51 13.6 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.409 0.623 . . . . 74.310000000000002 110.398 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 55.3 m-85 -98.15 133.34 42.72 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.574 -0.739 . . . . 74.099999999999994 109.057 177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.567 ' NE2' ' HG2' ' A' ' 561' ' ' GLU . 2.1 mp0 -98.2 -85.38 0.37 Allowed 'General case' 0 C--N 1.291 -1.959 0 CA-C-O 122.33 1.062 . . . . 73.0 108.224 174.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.476 ' ND2' ' HB3' ' A' ' 566' ' ' GLU . 0.3 OUTLIER -105.46 161.82 14.0 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.26 -1.336 . . . . 63.439999999999998 110.597 175.04 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.73 -13.35 31.66 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.708 1.203 . . . . 55.229999999999997 113.162 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.476 ' HB3' ' ND2' ' A' ' 564' ' ' ASN . 32.4 tt0 -56.34 -37.05 69.48 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.021 0.929 . . . . 52.350000000000001 111.277 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.21 162.4 6.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 CA-C-N 115.289 -0.869 . . . . 72.109999999999999 109.665 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.441 HG23 ' NH1' ' A' ' 527' ' ' ARG . 14.8 p -131.1 160.1 42.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 107.386 -1.339 . . . . 61.43 107.386 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.526 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -117.49 150.96 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 120.547 0.213 . . . . 74.030000000000001 110.499 176.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 65.8 mt -125.25 131.71 72.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 124.366 1.041 . . . . 72.310000000000002 108.922 -177.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.483 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 58.0 mt -90.6 120.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 107.242 -1.392 . . . . 73.040000000000006 107.242 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 24.7 p -105.24 112.75 25.98 Favored 'General case' 0 C--N 1.285 -2.199 0 O-C-N 123.606 0.566 . . . . 74.319999999999993 109.725 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.505 HD11 HD22 ' A' ' 589' ' ' LEU . 51.1 mt -107.3 132.19 55.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.831 -1.174 . . . . 73.109999999999999 107.831 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -81.34 116.05 21.0 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.086 -0.646 . . . . 61.210000000000001 109.939 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.57 124.37 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.201 -1.037 . . . . 74.510000000000005 108.201 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 58.3 m-85 -108.47 154.88 21.27 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 109.755 -0.461 . . . . 73.530000000000001 109.755 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -82.14 136.1 35.2 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 104.147 -2.538 . . . . 75.209999999999994 104.147 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.46 ' NH2' ' HB ' ' A' ' 645' ' ' ILE . 0.0 OUTLIER -112.35 -97.19 0.43 Allowed 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 113.631 0.975 . . . . 73.219999999999999 113.631 -170.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -120.93 121.35 37.87 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 107.094 -1.447 . . . . 73.450000000000003 107.094 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.407 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 44.6 tt0 -56.71 130.71 46.63 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 123.996 0.81 . . . . 74.120000000000005 109.848 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.407 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 49.5 m-85 65.14 81.61 0.2 Allowed 'General case' 0 C--O 1.244 0.801 0 CA-C-O 122.473 1.13 . . . . 73.400000000000006 108.44 -173.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -95.29 161.71 13.98 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 113.544 -1.662 . . . . 73.230000000000004 112.924 -167.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -58.65 -62.42 1.87 Allowed 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 125.45 1.5 . . . . 61.210000000000001 112.544 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 155.9 92.02 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 102.948 -2.982 . . . . 72.420000000000002 102.948 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.53 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.2 m -91.53 115.87 28.4 Favored 'General case' 0 C--N 1.279 -2.491 0 C-N-CA 119.78 -0.768 . . . . 63.43 110.9 -172.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 10.5 m -140.08 142.25 36.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.979 -0.749 . . . . 61.100000000000001 108.979 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 50.0 p90 -141.17 165.5 27.37 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.211 -1.403 . . . . 72.030000000000001 107.211 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 12.1 m -116.64 164.48 14.54 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.614 -0.835 . . . . 75.310000000000002 109.847 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 573' ' ' ILE . 49.3 tp -135.56 130.71 34.96 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.073 -1.454 . . . . 64.450000000000003 107.073 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 36.0 m -128.4 156.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 109.787 -0.449 . . . . 61.149999999999999 109.787 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.648 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 70.9 mt -97.05 139.16 33.46 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.595 -0.891 . . . . 71.400000000000006 108.595 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . 0.425 ' OE2' ' HE2' ' A' ' 540' ' ' LYS . 30.6 mm-40 -94.1 167.26 11.69 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 108.432 -0.951 . . . . 65.109999999999999 108.432 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -60.27 116.25 16.82 Favored Pre-proline 0 C--N 1.317 -0.831 0 O-C-N 123.916 0.76 . . . . 60.329999999999998 110.281 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.66 145.32 20.39 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 C-N-CA 122.407 2.071 . . . . 61.119999999999997 110.859 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -118.72 143.92 46.57 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.666 -0.494 . . . . 62.200000000000003 109.666 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . 0.516 ' HB2' ' HD3' ' A' ' 633' ' ' PRO . 1.9 t90 -104.07 123.09 46.62 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.617 -0.883 . . . . 64.25 108.617 -175.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.86 89.17 2.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 106.637 -1.616 . . . . 73.340000000000003 106.637 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -99.05 103.76 15.72 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 113.638 -1.619 . . . . 75.239999999999995 108.738 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -92.7 -75.05 0.5 Allowed 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 114.852 -1.067 . . . . 73.340000000000003 109.298 -177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 62.74 -120.07 20.03 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 111.423 -0.671 . . . . 64.150000000000006 111.423 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 55.4 ttp -105.64 -7.15 18.68 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.615 -0.513 . . . . 61.219999999999999 109.615 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -86.68 121.73 29.6 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.472 0.653 . . . . 70.209999999999994 112.501 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -126.22 -118.24 2.21 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 107.795 -2.122 . . . . 13.5 107.795 172.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 55.62 59.15 11.02 Favored Glycine 0 CA--C 1.504 -0.617 0 O-C-N 124.12 0.541 . . . . 64.420000000000002 112.426 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -79.46 81.67 5.69 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.713 0.768 . . . . 75.239999999999995 111.458 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 15.1 m -99.77 96.78 7.83 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 106.111 -1.811 . . . . 64.349999999999994 106.111 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 31.8 mm -83.32 70.08 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 122.754 1.264 . . . . 61.530000000000001 109.268 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 27.7 m -129.68 -6.71 4.6 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 113.786 -1.552 . . . . 61.520000000000003 108.582 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -31.54 51.77 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.901 -1.045 . . . . 61.25 108.4 174.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.6 117.61 20.69 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 105.477 -2.046 . . . . 73.230000000000004 105.477 171.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 614' ' ' LYS . 0.9 OUTLIER -60.21 128.19 35.53 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.956 0.902 . . . . 71.310000000000002 113.194 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -91.23 -36.62 13.81 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.59 -0.732 . . . . 65.200000000000003 109.422 176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.16 -28.17 38.86 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.373 -0.603 . . . . 63.25 109.373 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 611' ' ' TYR . 66.1 mttm 59.64 22.46 11.19 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.089 1.144 . . . . 60.32 114.089 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -122.27 82.58 45.57 Favored Pre-proline 0 N--CA 1.432 -1.33 0 CA-C-O 121.574 0.702 . . . . 73.430000000000007 109.738 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.76 150.52 68.3 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.689 2.259 . . . . 74.120000000000005 112.638 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.83 -177.58 3.26 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.599 -1.63 . . . . 63.439999999999998 106.599 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 1.2 p -68.75 92.37 0.48 Allowed 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 121.783 0.802 . . . . 72.200000000000003 109.335 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 50.4 m -155.08 166.17 34.42 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 114.669 -1.151 . . . . 51.439999999999998 108.111 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -101.19 137.56 39.37 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.489 -0.93 . . . . 73.040000000000006 108.489 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.62 103.7 10.97 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 121.692 0.758 . . . . 74.239999999999995 110.677 176.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -84.96 76.92 10.21 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.965 0.888 . . . . 71.239999999999995 109.036 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.482 ' HG3' ' HG2' ' A' ' 626' ' ' ARG . 13.5 pt-20 -88.43 143.26 27.1 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.048 -1.433 . . . . 62.229999999999997 108.386 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.17 -8.64 58.5 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 116.248 -0.433 . . . . 75.439999999999998 110.255 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.409 ' HB3' ' OE1' ' A' ' 623' ' ' GLU . 1.2 tmm_? -61.03 -36.85 80.64 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.731 -0.668 . . . . 72.329999999999998 110.071 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 630' ' ' MET . 31.0 mmt180 -67.03 -36.76 82.81 Favored 'General case' 0 C--O 1.208 -1.102 0 N-CA-C 109.354 -0.61 . . . . 71.129999999999995 109.354 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.481 ' HA ' ' SD ' ' A' ' 630' ' ' MET . 67.4 mt -67.61 -38.29 80.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.664 -0.698 . . . . 73.530000000000001 109.128 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -62.44 -32.58 73.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.408 -0.815 . . . . 54.43 109.768 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 632' ' ' ARG . 50.5 mt-10 -83.09 -14.71 53.16 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 112.309 0.485 . . . . 64.439999999999998 112.309 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 65.6 mtt -73.11 -25.88 61.02 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.554 -0.906 . . . . 74.140000000000001 108.554 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -135.21 70.96 0.5 Allowed Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 110.082 -1.207 . . . . 62.109999999999999 110.082 176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.453 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 0.1 OUTLIER -121.72 149.31 52.86 Favored Pre-proline 0 N--CA 1.431 -1.414 0 CA-C-O 120.454 0.169 . . . . 70.239999999999995 111.23 -178.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 596' ' ' TRP . 33.7 Cg_endo -70.64 145.34 51.77 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.344 2.029 . . . . 65.540000000000006 109.616 176.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 34.5 pt -134.18 -177.82 2.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.088 0.47 . . . . 54.149999999999999 110.334 -174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.29 167.99 10.07 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.848 -0.797 . . . . 75.519999999999996 108.848 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -69.77 -178.2 21.11 Favored Glycine 0 C--O 1.249 1.06 0 O-C-N 123.465 0.478 . . . . 74.450000000000003 112.585 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -46.98 -61.96 1.63 Allowed 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.04 0.936 . . . . 74.540000000000006 110.408 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -141.11 104.82 4.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.063 -1.458 . . . . 75.030000000000001 107.063 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 13.5 t -121.05 109.07 14.6 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 118.659 -1.217 . . . . 73.400000000000006 110.438 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -149.64 131.67 15.3 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.814 -1.18 . . . . 73.329999999999998 107.814 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 510' ' ' PRO . 62.4 tp -119.79 113.48 20.67 Favored 'General case' 0 C--N 1.291 -1.971 0 O-C-N 123.443 0.464 . . . . 61.439999999999998 111.074 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.415 ' HB2' HG22 ' A' ' 511' ' ' VAL . 2.1 mp0 -84.22 128.65 34.7 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 74.239999999999995 108.07 170.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 52.0 t -112.65 111.89 38.09 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 107.234 -1.395 . . . . 73.209999999999994 107.234 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . 0.51 HG22 ' HG3' ' A' ' 646' ' ' GLU . 4.7 mp -105.82 134.44 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 CA-C-N 114.711 -1.132 . . . . 73.030000000000001 108.251 -177.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.53 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER -116.91 114.78 46.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 109.484 -0.561 . . . . 75.019999999999996 109.484 179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . 0.51 ' HG3' HG22 ' A' ' 644' ' ' ILE . 44.0 mt-10 -135.22 123.95 23.8 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.818 -0.628 . . . . 72.019999999999996 110.787 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.98 157.12 23.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 105.862 -1.903 . . . . 73.209999999999994 105.862 167.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 46.5 m 70.12 28.64 3.98 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.049 -1.093 . . . . 71.319999999999993 108.049 -170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -145.36 139.17 26.8 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.47 -1.241 . . . . 63.100000000000001 107.746 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . 0.444 ' OE2' HG22 ' A' ' 654' ' ' THR . 5.7 mm-40 -110.86 126.28 54.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.185 0.809 . . . . 73.409999999999997 113.185 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -81.68 -45.17 16.11 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.23 -1.396 . . . . 72.510000000000005 107.23 174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -139.67 112.17 7.78 Favored 'General case' 0 N--CA 1.399 -2.987 0 N-CA-C 106.356 -1.72 . . . . 62.200000000000003 106.356 177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 33.8 m -52.0 115.32 1.64 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.877 1.066 . . . . 74.129999999999995 113.877 -175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.444 HG22 ' OE2' ' A' ' 650' ' ' GLU . 8.8 t -82.79 -18.64 39.88 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.745 -0.835 . . . . 71.510000000000005 108.745 171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 64.5 t -120.97 98.75 6.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.194 -1.41 . . . . 71.340000000000003 107.194 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 C--N 1.3 -1.564 0 CA-C-N 116.013 -0.539 . . . . 61.219999999999999 110.761 -177.084 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 21.8 p80 . . . . . 0 C--O 1.24 0.571 0 N-CA-C 110.78 -0.081 . . . . 73.150000000000006 110.78 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . 73.86 -48.31 0.66 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.092 1.757 . . . . 33.140000000000001 112.936 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -148.68 87.4 0.15 Allowed Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.47 -0.652 . . . . 73.030000000000001 111.47 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 635' ' ' LEU . 55.8 mt -86.39 114.33 25.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-O 120.858 0.361 . . . . 73.209999999999994 110.129 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -112.49 146.11 39.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.48 -0.933 . . . . 65.109999999999999 108.48 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 9.8 t -148.26 163.54 36.71 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 123.639 0.587 . . . . 73.120000000000005 109.775 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.65 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 69.2 m-85 -83.96 153.89 23.65 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 123.232 0.613 . . . . 75.219999999999999 110.396 177.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 49.3 mt-10 -60.35 -41.83 94.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.989 0.423 . . . . 73.319999999999993 110.457 176.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.2 mt-10 -132.65 151.91 78.98 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.494 -0.928 . . . . 72.109999999999999 108.494 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.407 ' O ' ' HA ' ' A' ' 641' ' ' LEU . 69.9 Cg_endo -87.53 -20.94 1.96 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.125 1.883 . . . . 75.439999999999998 111.137 174.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 52.8 t -146.05 125.67 5.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 124.945 1.298 . . . . 70.319999999999993 107.534 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -133.65 141.03 47.43 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.33 0.586 . . . . 75.219999999999999 110.064 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -107.93 127.36 53.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.641 -0.708 . . . . 72.239999999999995 109.198 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.8 m -126.08 158.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.06 0.457 . . . . 71.540000000000006 110.92 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.0 m -73.43 157.76 36.25 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.599 -0.728 . . . . 74.409999999999997 109.702 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -29.17 39.84 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.465 0.65 . . . . 71.409999999999997 109.991 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.7 m -97.81 18.7 15.17 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.48 -0.782 . . . . 54.299999999999997 111.086 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 8.3 tt -71.78 -29.85 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.11 0.481 . . . . 75.299999999999997 111.617 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 83.15 -72.49 2.83 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.621 -0.799 . . . . 75.25 111.886 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.0 mm -127.42 123.54 61.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.999 -0.741 . . . . 73.230000000000004 108.999 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.457 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.8 ptm -101.18 131.35 47.2 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.627 -0.879 . . . . 65.109999999999999 108.627 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.58 118.46 33.13 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 123.714 0.634 . . . . 72.400000000000006 110.848 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.61 114.64 45.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.384 -1.339 . . . . 75.209999999999994 107.384 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 570' ' ' ILE . 29.0 mtmm -94.06 133.56 37.4 Favored 'General case' 0 C--N 1.282 -2.327 0 C-N-CA 119.912 -0.715 . . . . 65.219999999999999 110.486 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 66.6 t -87.53 109.4 19.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 107.995 -1.113 . . . . 71.200000000000003 107.995 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 55.7 mt -89.09 122.51 32.48 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.256 -0.884 . . . . 70.150000000000006 110.037 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.465 ' H ' ' NE ' ' A' ' 527' ' ' ARG . 0.0 OUTLIER -89.16 103.2 15.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 118.673 -1.211 . . . . 73.319999999999993 108.3 174.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.0 p -67.77 -54.32 20.19 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.513 -0.767 . . . . 73.109999999999999 111.1 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . 0.515 ' HB3' ' H ' ' A' ' 504' ' ' ILE . 23.1 t -72.94 -50.41 23.62 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.071 -0.968 . . . . 74.530000000000001 110.211 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' A' ' 565' ' ' ASP . . . 149.61 -179.91 25.99 Favored Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.776 -1.202 . . . . 75.239999999999995 112.458 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.61 27.98 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 107.086 -1.45 . . . . 73.209999999999994 107.086 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -149.32 127.75 12.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.562 -0.455 . . . . 74.540000000000006 110.164 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 90.89 -115.64 4.71 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.886 -0.886 . . . . 24.25 110.886 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -138.1 109.98 7.18 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.714 -1.217 . . . . 73.150000000000006 107.714 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 43.9 t -124.09 123.5 66.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.131 0.491 . . . . 64.140000000000001 109.896 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 48.6 mm -96.17 120.59 45.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.245 -0.65 . . . . 71.409999999999997 109.245 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.79 104.36 51.08 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 52.140000000000001 107.993 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -79.01 143.29 17.9 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.948 1.765 . . . . 70.109999999999999 111.309 177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -130.43 163.74 26.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.333 -0.988 . . . . 72.519999999999996 108.333 176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -159.29 132.81 7.24 Favored 'General case' 0 C--O 1.248 1.008 0 O-C-N 123.276 0.36 . . . . 44.329999999999998 110.847 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 20.7 p -79.75 136.12 36.68 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.884 -0.598 . . . . 63.43 110.368 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.55 117.29 46.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.449 ' OE1' ' HD2' ' A' ' 547' ' ' ARG . 40.4 mt-10 -74.88 104.62 5.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.586 -0.524 . . . . 72.049999999999997 109.586 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -90.63 -102.57 1.21 Allowed Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 109.838 -1.305 . . . . 72.200000000000003 109.838 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 585' ' ' CYS . 13.2 t -100.83 4.82 43.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.271 0.558 . . . . 71.120000000000005 110.067 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -105.35 149.45 26.06 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.344 -1.354 . . . . 74.400000000000006 107.344 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.449 ' HD2' ' OE1' ' A' ' 543' ' ' GLU . 29.7 tpt180 -107.12 134.07 50.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.808 0.337 . . . . 64.129999999999995 110.977 -176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.01 -151.76 9.5 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.741 -0.663 . . . . 64.140000000000001 111.626 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 75.17 -33.76 1.09 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 122.461 -0.434 . . . . 70.230000000000004 114.066 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 144.35 5.76 0.58 Allowed Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.091 -0.576 . . . . 62.130000000000003 112.55 -176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.487 ' HB3' ' NH1' ' A' ' 578' ' ' ARG . 56.0 mm-40 -75.13 -79.17 0.1 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.868 0.365 . . . . 73.420000000000002 111.88 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -89.78 -41.19 12.01 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.829 -1.174 . . . . 75.109999999999999 107.829 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -149.33 169.48 20.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.452 -1.249 . . . . 74.150000000000006 108.717 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.06 119.03 37.13 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.803 -2.295 . . . . 70.319999999999993 104.803 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -71.39 105.28 3.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.967 0.889 . . . . 70.040000000000006 110.555 -175.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.9 t -101.91 127.15 48.88 Favored 'General case' 0 N--CA 1.412 -2.354 0 CA-C-N 115.1 -0.955 . . . . 64.400000000000006 111.155 -174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 6.0 p -140.55 97.82 3.29 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.607 -1.179 . . . . 73.109999999999999 108.353 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -132.34 179.31 17.33 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 115.485 -0.78 . . . . 61.350000000000001 111.737 -175.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.44 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 40.3 mt-10 -111.07 114.84 28.42 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.224 -0.658 . . . . 64.409999999999997 109.224 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.06 138.19 31.63 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 110.117 -0.327 . . . . 75.310000000000002 110.117 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -105.98 106.28 16.71 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.459 0.647 . . . . 61.32 111.485 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 569' ' ' LYS . 36.6 m-85 -96.43 147.6 23.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.036 -1.468 . . . . 74.140000000000001 107.036 172.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -124.96 -79.06 0.61 Allowed 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 108.862 -0.792 . . . . 73.510000000000005 108.862 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.03 156.04 18.18 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.149 -0.686 . . . . 64.200000000000003 109.149 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.459 ' OD1' ' HA2' ' A' ' 530' ' ' GLY . 12.0 t70 -56.1 -25.9 47.52 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.162 1.385 . . . . 50.219999999999999 113.193 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.47 -18.52 64.42 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.139 0.792 . . . . 74.109999999999999 113.139 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 38.2 pt -106.37 167.5 3.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 119.843 -0.743 . . . . 73.319999999999993 110.935 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.99 159.31 29.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.818 -1.179 . . . . 75.230000000000004 107.818 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.495 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -121.6 152.7 38.99 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 122.208 -0.307 . . . . 71.439999999999998 110.26 175.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.473 HG12 ' HG2' ' A' ' 524' ' ' LYS . 18.7 mt -122.2 134.89 64.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 123.825 0.703 . . . . 62.030000000000001 110.259 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 55.2 mt -91.26 122.47 42.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.368 -1.345 . . . . 73.340000000000003 107.368 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 9.4 p -106.7 112.86 26.03 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 123.866 0.729 . . . . 72.200000000000003 109.269 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.555 HD11 HD22 ' A' ' 589' ' ' LEU . 38.2 mt -110.76 125.63 68.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.232 -0.655 . . . . 74.450000000000003 109.232 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -79.59 110.59 15.07 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 124.136 0.898 . . . . 73.099999999999994 109.765 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.1 mm -99.4 135.05 36.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 106.917 -1.512 . . . . 64.319999999999993 106.917 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -116.53 131.46 56.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.818 -0.438 . . . . 74.319999999999993 109.818 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -85.86 86.53 7.36 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 122.836 1.303 . . . . 74.239999999999995 111.271 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.487 ' NH1' ' HB3' ' A' ' 551' ' ' GLU . 28.5 ttp180 -101.05 155.24 18.1 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.883 -1.525 . . . . 70.099999999999994 106.883 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -80.05 157.17 26.81 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.087 -1.079 . . . . 70.319999999999993 108.087 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.429 ' HB3' HH21 ' A' ' 578' ' ' ARG . 2.5 pp20? -148.26 168.63 22.02 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 120.375 -0.53 . . . . 72.420000000000002 110.451 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -125.12 101.32 6.96 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.625 -0.261 . . . . 72.439999999999998 111.471 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 65.19 17.14 10.91 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.83 1.789 . . . . 62.299999999999997 115.83 170.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -115.8 110.56 19.24 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.4 -0.812 . . . . 65.430000000000007 111.647 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -77.46 87.17 3.81 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.709 -1.96 . . . . 72.5 105.709 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.534 ' HA ' HG23 ' A' ' 545' ' ' THR . 5.5 p -77.99 138.78 39.01 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.501 -1.227 . . . . 33.299999999999997 113.181 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 34.7 p -143.32 154.75 44.09 Favored 'General case' 0 N--CA 1.405 -2.704 0 CA-C-N 114.633 -1.167 . . . . 65.400000000000006 108.967 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -138.53 161.61 36.62 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.844 -1.539 . . . . 61.130000000000003 106.844 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 13.1 t -113.73 175.69 5.35 Favored 'General case' 0 C--N 1.27 -2.887 0 C-N-CA 119.147 -1.021 . . . . 72.040000000000006 109.108 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 573' ' ' ILE . 33.5 tp -149.9 126.69 11.06 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 107.016 -1.475 . . . . 71.25 107.016 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.13 157.34 31.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.716 -0.476 . . . . 65.310000000000002 109.716 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.65 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 40.2 mt -101.79 142.97 32.29 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.337 -1.727 . . . . 70.209999999999994 106.337 174.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.86 173.59 6.79 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 108.869 -0.789 . . . . 71.299999999999997 108.869 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -63.67 115.46 18.75 Favored Pre-proline 0 C--N 1.316 -0.88 0 O-C-N 123.733 0.646 . . . . 72.319999999999993 110.739 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.53 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 32.6 Cg_endo -65.38 153.96 75.81 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.761 2.307 . . . . 64.310000000000002 113.399 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 45.5 pttt -119.62 134.91 55.03 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.783 -1.099 . . . . 71.230000000000004 109.64 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -99.34 125.07 44.93 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.098 -0.705 . . . . 74.099999999999994 109.098 -175.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . 0.437 HD13 HG12 ' A' ' 536' ' ' ILE . 2.7 mp -97.09 89.87 2.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 105.225 -2.139 . . . . 55.25 105.225 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -86.97 -13.2 45.27 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.195 -1.366 . . . . 74.409999999999997 110.077 -172.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -89.37 120.61 30.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.674 -0.862 . . . . 75.129999999999995 108.674 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -70.73 -46.88 43.7 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.649 -0.58 . . . . 50.130000000000003 111.649 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 23.0 ptp -101.25 163.64 12.18 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.26 -0.644 . . . . 75.120000000000005 109.26 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -140.61 100.94 3.98 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.847 -0.797 . . . . 62.310000000000002 108.847 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -147.02 60.39 0.47 Allowed Glycine 0 C--N 1.286 -2.245 0 N-CA-C 108.558 -1.817 . . . . 73.109999999999999 108.558 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -122.65 -120.31 2.61 Favored Glycine 0 N--CA 1.421 -2.311 0 CA-C-N 114.839 -0.68 . . . . 71.349999999999994 111.97 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -122.8 14.72 10.07 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.848 0.684 . . . . 75.510000000000005 112.848 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 18.9 m -137.9 124.87 21.33 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.811 -0.755 . . . . 54.409999999999997 110.879 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 44.9 mm -85.05 147.56 5.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.435 -1.321 . . . . 75.340000000000003 107.435 175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 31.7 m -56.11 -28.03 56.22 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.837 0.855 . . . . 63.32 113.26 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . 0.25 0.2 OUTLIER -86.48 -7.31 58.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.521 -0.872 . . . . 73.430000000000007 113.324 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.23 178.94 7.69 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.171 -0.678 . . . . 71.439999999999998 109.171 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -55.56 108.54 0.44 Allowed 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 122.205 1.002 . . . . 72.510000000000005 112.346 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -89.43 -54.07 4.25 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.708 -1.133 . . . . 72.340000000000003 108.839 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -126.66 106.47 9.42 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.121 -0.945 . . . . 75.099999999999994 110.816 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -91.27 96.3 10.48 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.54 -0.464 . . . . 65.430000000000007 110.066 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -68.2 127.37 93.28 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.272 -0.64 . . . . 74.120000000000005 109.272 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -91.39 -179.38 1.37 Allowed 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.136 1.89 . . . . 71.340000000000003 111.808 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -93.26 -40.06 10.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.708 -1.219 . . . . 74.239999999999995 107.708 175.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 19.2 m -125.15 122.87 38.35 Favored 'General case' 0 N--CA 1.406 -2.646 0 CA-C-N 114.92 -1.036 . . . . 73.209999999999994 109.434 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 18.6 t -82.37 -15.68 51.87 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.474 -0.936 . . . . 54.509999999999998 108.474 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -69.82 79.61 0.45 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.848 0.832 . . . . 72.299999999999997 110.192 174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 625' ' ' ARG . 37.3 tt0 -127.6 70.91 1.33 Allowed 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.194 -1.41 . . . . 53.409999999999997 107.194 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 59.56 22.09 10.69 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.218 -1.356 . . . . 64.209999999999994 111.055 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 626' ' ' ARG . 0.7 OUTLIER 58.33 11.92 1.79 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.22 1.408 . . . . 71.120000000000005 113.61 -174.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -74.31 -30.22 61.96 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.559 -0.904 . . . . 72.299999999999997 108.559 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 621' ' ' GLU . 0.0 OUTLIER -71.55 -30.3 65.73 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.083 -1.08 . . . . 75.140000000000001 108.083 176.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 623' ' ' GLU . 65.7 ttt180 -65.43 -38.91 91.28 Favored 'General case' 0 C--O 1.219 -0.5 0 N-CA-C 109.033 -0.729 . . . . 75.120000000000005 109.033 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 73.8 mt -68.36 -35.78 72.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.071 0.463 . . . . 71.319999999999993 109.771 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -63.96 -43.3 96.19 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.472 -0.331 . . . . 61.009999999999998 110.391 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -74.91 -19.52 60.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.016 0.436 . . . . 72.129999999999995 111.91 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 46.7 ttm -75.5 -28.23 59.09 Favored 'General case' 0 N--CA 1.406 -2.633 0 C-N-CA 123.907 0.883 . . . . 71.519999999999996 108.694 172.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -82.63 -0.93 90.42 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.22 -0.9 . . . . 74.349999999999994 111.088 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -96.05 140.04 22.08 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.833 -1.543 . . . . 72.010000000000005 106.833 174.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.53 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 36.8 Cg_endo -68.62 138.05 40.62 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 N-CA-C 106.691 -2.08 . . . . 64.099999999999994 106.691 170.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . 0.274 2.6 pp -124.89 144.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 C-N-CA 117.314 -1.755 . . . . 74.409999999999997 112.006 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 635' ' ' LEU . 2.2 pt? -76.35 -165.22 0.47 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.255 -2.248 . . . . 72.140000000000001 111.873 -174.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.23 136.25 37.21 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 109.46 -1.456 . . . . 73.310000000000002 109.46 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -54.56 -42.32 70.85 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.469 0.708 . . . . 74.340000000000003 111.848 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -131.37 84.86 2.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 110.864 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.9 t -119.71 114.71 22.59 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 107.872 -1.158 . . . . 61.229999999999997 107.872 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -147.59 140.24 24.73 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.777 -0.823 . . . . 52.539999999999999 108.777 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 509' ' ' GLU . 60.0 tp -117.59 123.14 45.48 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 123.347 0.404 . . . . 71.209999999999994 109.913 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.78 124.94 43.98 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.941 -1.503 . . . . 74.230000000000004 106.941 173.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.22 120.22 60.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.464 -0.939 . . . . 73.540000000000006 108.464 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.87 124.18 63.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-N 115.618 -0.719 . . . . 60.420000000000002 109.262 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.51 92.16 2.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 122.213 1.006 . . . . 73.030000000000001 111.125 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -163.11 159.67 23.39 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 105.279 -2.119 . . . . 75.340000000000003 105.279 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -73.84 97.43 2.76 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 109.358 -0.608 . . . . 73.120000000000005 109.358 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 19.4 t -88.47 98.81 11.84 Favored 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 105.611 -1.996 . . . . 74.409999999999997 105.611 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -108.59 153.43 23.39 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.131 -0.94 . . . . 74.310000000000002 110.547 -174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -106.48 116.71 32.4 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.96 -1.867 . . . . 64.299999999999997 105.96 173.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -75.73 -24.4 56.13 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.027 -0.669 . . . . 74.120000000000005 109.27 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 134.38 46.16 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.126 0.488 . . . . 72.340000000000003 110.517 176.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 23.1 t -81.99 113.33 19.81 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.749 -1.204 . . . . 61.409999999999997 107.749 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 16.3 m -82.45 131.13 35.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.897 -0.779 . . . . 74.140000000000001 108.897 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 28.8 t -80.48 84.28 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 122.186 0.993 . . . . 65.120000000000005 109.162 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 12.6 t70 . . . . . 0 C--N 1.289 -2.032 0 CA-C-N 113.985 -1.461 . . . . 73.109999999999999 109.269 -179.1 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 . . . . . 0 C--O 1.234 0.283 0 CA-C-O 120.832 0.349 . . . . 71.230000000000004 110.648 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -89.6 -26.07 20.99 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 108.489 -0.93 . . . . 54.119999999999997 108.489 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.0 144.41 8.57 Favored Glycine 0 N--CA 1.42 -2.393 0 CA-C-N 114.445 -1.252 . . . . 65.5 114.638 174.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 57.1 mt -128.28 113.94 32.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 104.72 -2.326 . . . . 72.239999999999995 104.72 167.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.601 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 76.1 m-85 -107.49 132.35 53.32 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 109.645 -0.502 . . . . 75.329999999999998 109.645 -176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 8.8 t -148.03 152.76 37.96 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.534 0.521 . . . . 54.119999999999997 110.036 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.496 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 90.1 m-85 -74.43 154.5 38.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.909 -0.404 . . . . 74.450000000000003 109.909 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -52.78 -49.92 64.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.819 0.848 . . . . 42.329999999999998 111.147 177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -135.32 161.53 62.76 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 107.753 -1.203 . . . . 62.450000000000003 107.753 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 68.4 Cg_endo -82.4 -17.61 7.53 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 121.673 1.582 . . . . 64.519999999999996 112.029 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 642' ' ' GLU . 77.9 t -143.07 127.11 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 123.306 0.642 . . . . 72.5 109.966 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 643' ' ' VAL . 12.0 t -135.11 141.5 46.03 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.474 -0.935 . . . . 73.430000000000007 108.474 175.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.426 ' CD2' ' HA ' ' A' ' 648' ' ' SER . 14.2 p-80 -111.14 142.45 43.31 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.301 -1.74 . . . . 74.049999999999997 106.301 172.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.19 154.81 29.02 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 CA-C-O 121.327 0.584 . . . . 75.230000000000004 111.462 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 20.5 m -73.92 137.46 43.65 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.891 -1.049 . . . . 73.030000000000001 109.482 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 516' ' ' GLU . 0.0 OUTLIER -75.58 1.58 13.99 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.799 0.809 . . . . 73.25 112.886 -178.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.5 p -125.53 18.75 8.1 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.32 -0.855 . . . . 74.430000000000007 110.902 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 8.2 tt -80.76 -23.76 11.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-O 121.376 0.608 . . . . 55.350000000000001 110.479 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 85.51 -76.26 2.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.721 -0.951 . . . . 72.209999999999994 110.721 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 574' ' ' ARG . 47.9 mm -125.41 128.58 72.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.724 -0.843 . . . . 63.25 108.724 -177.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.488 ' CG ' ' HB ' ' A' ' 573' ' ' ILE . 20.3 ptm -98.48 141.61 31.12 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.673 -0.492 . . . . 71.230000000000004 109.673 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -102.39 128.81 48.83 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 123.792 0.682 . . . . 61.310000000000002 109.917 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 44.0 t -124.92 124.53 67.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.459 -0.941 . . . . 62.43 108.459 174.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -93.87 132.34 38.4 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.006 -0.678 . . . . 70.230000000000004 110.768 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 84.3 t -95.98 111.76 26.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 106.581 -1.637 . . . . 72.219999999999999 106.581 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 69.1 mt -91.43 143.42 26.62 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.547 -0.751 . . . . 72.239999999999995 110.39 -173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 0.0 OUTLIER -108.0 104.65 14.14 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.844 -0.617 . . . . 75.310000000000002 111.767 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 504' ' ' ILE . 22.9 m -64.78 -61.64 2.06 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.953 -0.567 . . . . 61.5 112.086 -177.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.1 p -73.76 -52.54 12.84 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.107 0.41 . . . . 74.230000000000004 112.107 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 158.02 -145.77 12.31 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.943 -0.863 . . . . 70.099999999999994 110.943 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -178.66 130.8 0.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 125.211 1.404 . . . . 62.229999999999997 107.467 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -150.59 91.44 1.74 Allowed 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.537 -0.865 . . . . 75.109999999999999 111.879 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 145.51 -116.97 0.95 Allowed Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 110.183 -1.167 . . . . 75.450000000000003 110.183 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -137.82 104.49 5.3 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.137 -1.06 . . . . 71.420000000000002 108.137 172.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 595' ' ' LYS . 39.8 t -115.57 124.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.331 -0.548 . . . . 61.439999999999998 111.381 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 559' ' ' GLU . 42.6 mm -98.99 115.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.423 -0.808 . . . . 73.120000000000005 109.139 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 39.9 t -106.78 100.24 30.15 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 108.523 -0.917 . . . . 71.430000000000007 108.523 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 536' ' ' ILE . 3.4 Cg_exo -76.65 146.54 27.09 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 121.924 1.75 . . . . 74.519999999999996 111.186 176.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 571' ' ' ILE . 25.1 p90 -136.68 157.33 47.02 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.239 -0.652 . . . . 70.239999999999995 109.239 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -147.6 135.04 20.76 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 120.835 0.35 . . . . 65.109999999999999 111.019 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 11.4 p -82.72 123.03 28.92 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.777 -0.647 . . . . 74.140000000000001 111.184 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 587' ' ' PHE . 41.0 mm -92.16 118.22 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 107.959 -1.126 . . . . 71.109999999999999 107.959 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.69 143.99 34.09 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.266 -0.642 . . . . 75.310000000000002 109.266 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -140.72 -110.18 0.83 Allowed Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 109.076 -1.609 . . . . 62.020000000000003 109.076 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 16.6 p -78.64 -25.21 44.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.586 -0.894 . . . . 74.549999999999997 108.586 174.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 587' ' ' PHE . . . -90.2 131.9 35.78 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.43 -1.322 . . . . 73.340000000000003 107.43 172.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 551' ' ' GLU . 43.1 ttp180 -104.72 140.96 37.3 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 109.121 -0.696 . . . . 74.219999999999999 109.121 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.75 -157.4 31.59 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 121.166 -0.54 . . . . 72.340000000000003 112.639 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 69.09 19.94 74.35 Favored Glycine 0 C--N 1.31 -0.871 0 C-N-CA 121.619 -0.324 . . . . 41.229999999999997 112.932 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.03 19.21 40.43 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.33 -0.938 . . . . 60.43 112.646 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 547' ' ' ARG . 11.0 tp10 -86.0 -79.51 0.25 Allowed 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 110.0 -0.37 . . . . 75.319999999999993 110.0 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 578' ' ' ARG . 14.1 m-20 -94.9 -30.29 14.24 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.701 -1.222 . . . . 63.450000000000003 107.701 178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -145.32 155.79 43.41 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-N 114.396 -1.274 . . . . 72.329999999999998 107.952 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 574' ' ' ARG . 0.2 OUTLIER -88.46 139.98 29.93 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 105.412 -2.07 . . . . 75.209999999999994 105.412 177.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 15.9 t70 -77.33 121.72 24.13 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 110.167 -0.308 . . . . 64.409999999999997 110.167 -171.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -127.33 104.43 7.93 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 122.474 1.131 . . . . 61.119999999999997 110.46 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 58.4 m -125.96 102.27 7.18 Favored 'General case' 0 N--CA 1.41 -2.442 0 N-CA-C 105.725 -1.954 . . . . 60.310000000000002 105.725 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -133.36 -174.75 13.67 Favored Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.39 -0.91 . . . . 54.130000000000003 112.248 -174.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 536' ' ' ILE . 0.0 OUTLIER -121.11 122.46 40.08 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.313 0.577 . . . . 73.409999999999997 110.669 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 569' ' ' LYS . 83.8 mt -96.58 136.92 36.42 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.882 -0.414 . . . . 71.310000000000002 109.882 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -110.01 102.53 11.25 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.709 0.766 . . . . 63.539999999999999 111.392 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 60.0 m-85 -99.58 96.8 7.89 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 106.971 -1.492 . . . . 74.099999999999994 106.971 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -75.18 -67.11 0.68 Allowed 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.233 -0.987 . . . . 70.439999999999998 109.829 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -105.94 161.65 14.27 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 109.222 -0.658 . . . . 65.310000000000002 109.222 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.55 -11.82 60.45 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.208 1.003 . . . . 72.430000000000007 113.527 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.456 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.6 pt-20 -68.09 -7.99 34.27 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.61 0.967 . . . . 50.350000000000001 113.61 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.456 HG23 ' HG3' ' A' ' 566' ' ' GLU . 45.1 pt -122.32 168.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 O-C-N 121.952 -0.467 . . . . 45.450000000000003 110.837 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 13.7 p -131.79 140.73 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.839 -1.541 . . . . 63.310000000000002 106.839 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 69.5 mmtt -104.45 145.95 29.55 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.438 -0.505 . . . . 74.239999999999995 111.25 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 69.3 mt -117.45 135.07 59.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.474 -1.239 . . . . 73.349999999999994 110.498 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.506 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 64.5 mt -93.55 127.89 45.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.835 -1.172 . . . . 64.219999999999999 107.835 175.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 25.7 p -106.59 112.18 25.06 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.374 0.607 . . . . 74.150000000000006 110.139 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.488 ' HB ' ' CG ' ' A' ' 521' ' ' MET . 30.9 mt -112.64 130.04 67.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.74 -1.207 . . . . 62.530000000000001 107.74 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 554' ' ' GLU . 11.5 ttm180 -85.86 122.92 30.61 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.202 -0.666 . . . . 75.109999999999999 109.202 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 0.407 HG23 HG21 ' A' ' 645' ' ' ILE . 44.7 mm -102.33 136.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.724 -0.671 . . . . 65.439999999999998 109.394 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.475 ' CZ ' ' HD2' ' A' ' 574' ' ' ARG . 92.7 m-85 -112.11 162.11 15.77 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.682 -0.858 . . . . 72.010000000000005 108.682 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.44 156.49 18.17 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.787 -0.449 . . . . 74.010000000000005 109.787 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 552' ' ' ASP . 4.3 tpm_? -130.51 173.66 10.65 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.231 -0.655 . . . . 71.310000000000002 109.231 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 578' ' ' ARG . 64.5 mm-40 -68.47 126.1 28.57 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.547 -1.279 . . . . 73.219999999999999 107.547 173.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.56 -25.37 64.87 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.421 0.629 . . . . 73.129999999999995 109.653 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -108.53 81.37 1.46 Allowed 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 122.159 0.98 . . . . 73.25 108.562 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -162.7 -163.15 0.85 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.526 -1.67 . . . . 64.409999999999997 106.936 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -98.98 117.52 33.67 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.839 -1.171 . . . . 72.030000000000001 107.839 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -52.01 122.63 8.76 Favored 'General case' 0 C--O 1.24 0.558 0 O-C-N 123.959 0.787 . . . . 73.519999999999996 110.779 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 4.5 p -91.14 140.82 29.45 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 115.38 -0.827 . . . . 73.519999999999996 111.118 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 23.9 m -144.99 153.71 41.78 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.037 -0.727 . . . . 65.010000000000005 109.037 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 45.2 p90 -138.6 -176.87 4.62 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.79 -0.448 . . . . 75.140000000000001 109.79 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 35.8 m -132.6 162.83 30.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.589 -0.522 . . . . 32.119999999999997 109.589 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 571' ' ' ILE . 31.2 tp -139.38 134.83 32.98 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.562 -1.273 . . . . 65.439999999999998 107.562 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.85 157.34 43.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 123.18 0.3 . . . . 63.130000000000003 110.696 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.496 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 48.9 mt -101.8 139.79 36.97 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.027 -1.471 . . . . 74.329999999999998 107.027 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -96.36 178.43 5.37 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 123.332 0.395 . . . . 74.420000000000002 110.125 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.52 121.39 78.81 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 109.676 -0.49 . . . . 74.450000000000003 109.676 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.505 ' HD3' HD22 ' A' ' 635' ' ' LEU . 59.1 Cg_endo -72.48 164.44 35.6 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.408 2.072 . . . . 70.519999999999996 113.734 -177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 75.5 mmtt -116.93 140.98 48.82 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-N 114.847 -1.07 . . . . 75.329999999999998 109.06 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . 0.416 ' N ' ' HG3' ' A' ' 633' ' ' PRO . 3.9 t90 -113.84 109.34 18.37 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 107.227 -1.397 . . . . 75.510000000000005 107.227 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . 0.416 HG22 ' HG2' ' A' ' 599' ' ' ARG . 2.9 mp -95.74 90.18 2.47 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 107.599 -1.26 . . . . 53.539999999999999 107.599 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.0 98.18 9.25 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.141 -1.059 . . . . 71.409999999999997 108.141 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . 0.416 ' HG2' HG22 ' A' ' 597' ' ' ILE . 35.1 mmt180 -98.68 125.13 43.88 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.681 -0.69 . . . . 74.340000000000003 109.812 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -173.65 163.25 34.41 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 107.789 -2.124 . . . . 32.130000000000003 107.789 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 14.6 tpt -83.04 -33.18 26.53 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 117.694 0.747 . . . . 75.409999999999997 110.253 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -98.54 83.32 2.99 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.232 -0.655 . . . . 72.099999999999994 109.232 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -117.57 -18.58 5.24 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.28 -0.962 . . . . 54.299999999999997 112.209 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 66.94 32.7 81.71 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.428 -1.069 . . . . 52.299999999999997 110.428 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -64.43 103.34 0.64 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.111 0.481 . . . . 72.310000000000002 110.008 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 7.1 m -127.04 81.11 2.0 Allowed 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 121.854 0.835 . . . . 74.200000000000003 108.871 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 26.5 mm -81.46 75.81 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 CA-C-N 115.267 -0.879 . . . . 63.329999999999998 109.31 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 30.0 m -130.88 -25.29 2.31 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.086 -1.415 . . . . 73.209999999999994 107.998 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -62.43 -46.71 87.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.909 -1.515 . . . . 75.209999999999994 106.909 173.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.22 124.1 39.08 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 105.23 -2.137 . . . . 73.140000000000001 105.23 173.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -148.53 150.98 34.32 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 105.384 -2.08 . . . . 74.409999999999997 105.384 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . 0.268 17.2 m-20 -79.25 72.85 5.86 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 122.396 1.093 . . . . 50.200000000000003 113.135 -176.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 34.5 t70 165.32 72.79 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 129.583 3.153 . . . . 73.150000000000006 104.578 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 616' ' ' PRO . 12.9 tppt? -152.16 95.25 2.04 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 114.715 -1.13 . . . . 75.120000000000005 109.411 -175.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -81.83 -49.01 0.94 Allowed Pre-proline 0 C--N 1.293 -1.878 0 CA-C-N 116.032 -0.531 . . . . 71.400000000000006 110.948 175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 614' ' ' LYS . 38.3 Cg_endo -67.65 177.33 4.17 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 120.884 1.056 . . . . 71.219999999999999 109.461 170.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . 0.475 HD22 ' H ' ' A' ' 617' ' ' LEU . 2.4 mm? -65.84 -60.99 2.32 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.703 -0.481 . . . . 55.25 109.703 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 4.8 m -142.16 158.68 43.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 105.606 -1.998 . . . . 74.040000000000006 105.606 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 41.4 m -88.19 71.2 9.24 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.664 0.745 . . . . 63.130000000000003 110.049 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -144.37 164.17 31.61 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 105.177 -2.157 . . . . 72.510000000000005 105.177 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -83.21 151.04 25.84 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 120.414 -0.514 . . . . 54.409999999999997 109.998 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 68.91 24.3 6.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.516 1.126 . . . . 72.140000000000001 113.006 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -76.18 101.67 5.47 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.647 0.737 . . . . 73.230000000000004 110.606 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.446 ' OE1' ' HD3' ' A' ' 625' ' ' ARG . 0.3 OUTLIER -112.18 142.79 44.21 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.853 -1.536 . . . . 75.129999999999995 106.853 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 629' ' ' GLU . 0.1 OUTLIER -63.3 -30.32 71.48 Favored 'General case' 0 C--O 1.206 -1.234 0 C-N-CA 120.256 -0.577 . . . . 74.019999999999996 111.108 -177.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 53.9 ttp85 -63.03 -33.4 75.34 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.286 0.565 . . . . 74.409999999999997 110.901 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.5 ' O ' ' HG2' ' A' ' 630' ' ' MET . 63.9 mt -80.41 -33.8 14.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.457 -0.571 . . . . 61.399999999999999 109.457 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.67 88.32 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.076 -0.713 . . . . 60.130000000000003 109.076 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 625' ' ' ARG . 48.6 mt-10 -71.42 -30.76 66.44 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.494 -0.775 . . . . 73.0 111.392 176.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 627' ' ' ILE . 7.8 ptp -74.86 -7.36 53.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.213 -0.595 . . . . 74.040000000000006 110.06 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -107.38 22.67 28.45 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.571 -0.612 . . . . 54.149999999999999 111.571 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 629' ' ' GLU . 14.4 ptp180 -145.37 168.82 11.01 Favored Pre-proline 0 C--N 1.317 -0.809 0 N-CA-C 107.72 -1.215 . . . . 72.109999999999999 107.72 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 632' ' ' ARG . 56.3 Cg_endo -67.7 142.84 59.64 Favored 'Trans proline' 0 C--O 1.255 1.354 0 C-N-CA 121.858 1.705 . . . . 71.209999999999994 109.674 172.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 28.7 pt -134.56 -177.89 2.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 116.387 -0.37 . . . . 74.430000000000007 110.292 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.601 ' HA ' ' H ' ' A' ' 505' ' ' PHE . 2.1 pt? -139.53 -168.27 2.44 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.882 -0.784 . . . . 74.430000000000007 108.882 176.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -66.75 159.62 48.59 Favored Glycine 0 N--CA 1.432 -1.595 0 C-N-CA 120.582 -0.818 . . . . 24.239999999999998 112.612 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.61 -64.71 0.74 Allowed 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.981 1.313 . . . . 55.240000000000002 110.135 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -130.93 104.33 7.07 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.925 -1.139 . . . . 74.450000000000003 107.925 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . 0.419 ' HG1' ' HD2' ' A' ' 507' ' ' PHE . 14.6 t -129.45 114.0 15.6 Favored 'General case' 0 N--CA 1.404 -2.735 0 CA-C-O 122.547 1.165 . . . . 71.439999999999998 110.326 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 36.8 ttmt -144.09 148.95 35.83 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 106.586 -1.635 . . . . 73.219999999999999 106.586 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 56.4 tp -126.76 109.99 12.63 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 108.478 -0.934 . . . . 71.530000000000001 108.478 175.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.445 ' HB2' HG22 ' A' ' 511' ' ' VAL . 40.9 mt-10 -87.0 126.42 34.73 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 107.421 -1.325 . . . . 73.140000000000001 107.421 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 512' ' ' THR . 43.9 t -113.62 122.41 67.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 N-CA-C 109.048 -0.723 . . . . 64.409999999999997 109.048 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.62 135.55 50.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 114.79 -1.096 . . . . 73.230000000000004 110.014 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.407 HG21 HG23 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -126.75 148.08 31.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 123.096 0.558 . . . . 74.150000000000006 110.142 178.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 73.53 -28.86 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.982 1.313 . . . . 71.030000000000001 111.87 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.7 96.56 9.88 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.05 -1.833 . . . . 63.229999999999997 106.05 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 29.6 t -98.7 133.35 43.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.785 -0.45 . . . . 75.409999999999997 109.785 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -131.68 178.14 6.98 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.603 -0.888 . . . . 75.549999999999997 108.603 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.55 112.9 18.34 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 120.207 -0.597 . . . . 74.140000000000001 109.838 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -71.18 113.36 8.14 Favored 'General case' 0 N--CA 1.401 -2.89 0 N-CA-C 108.874 -0.787 . . . . 71.519999999999996 108.874 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -23.82 55.55 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.517 1.302 . . . . 73.030000000000001 114.517 -171.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 19.4 m 60.75 20.37 10.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.491 0.717 . . . . 63.450000000000003 111.547 175.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.4 m -135.65 121.53 19.86 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.772 -0.649 . . . . 50.509999999999998 109.838 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 29.8 m -98.46 147.83 6.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.982 -0.748 . . . . 72.319999999999993 108.982 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 . . . . . 0 C--N 1.305 -1.357 0 CA-C-N 116.584 -0.28 . . . . 72.150000000000006 111.201 -176.298 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.157 0.503 . . . . 74.310000000000002 111.711 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -76.41 -54.43 6.75 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.903 -0.777 . . . . 64.439999999999998 108.903 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -142.94 91.43 0.17 Allowed Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 110.185 -1.166 . . . . 60.43 110.185 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 68.3 mt -96.89 114.88 34.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.306 -0.627 . . . . 73.219999999999999 109.306 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -101.24 132.26 46.83 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.017 -0.735 . . . . 75.120000000000005 109.017 177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.1 t -146.38 153.81 40.92 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 120.795 0.331 . . . . 64.299999999999997 110.436 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.54 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 72.4 m-85 -75.15 153.73 38.08 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.649 -0.5 . . . . 71.329999999999998 109.649 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 524' ' ' LYS . 41.7 mt-10 -56.19 -56.19 23.98 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.941 0.775 . . . . 72.430000000000007 110.397 176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -122.35 160.84 46.29 Favored Pre-proline 0 C--N 1.31 -1.128 0 CA-C-N 114.721 -1.127 . . . . 75.439999999999998 109.136 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -86.73 -20.74 2.39 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 122.032 1.821 . . . . 73.420000000000002 112.071 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.437 HG13 HD12 ' A' ' 644' ' ' ILE . 75.6 t -144.22 135.61 21.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.891 -0.781 . . . . 71.230000000000004 108.891 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.0 t -133.21 123.96 26.54 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.449 0.643 . . . . 72.319999999999993 110.07 177.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -98.98 115.96 30.12 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.964 -1.124 . . . . 75.209999999999994 107.964 175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.14 169.15 17.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 123.492 0.495 . . . . 62.450000000000003 110.422 -178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 44.6 t -78.3 155.95 29.9 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.98 -0.554 . . . . 64.129999999999995 111.069 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.14 -20.96 54.86 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.486 -0.931 . . . . 71.510000000000005 108.486 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.0 p -112.56 32.75 5.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.66 -0.7 . . . . 74.430000000000007 110.728 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 6.5 tt -82.83 -23.2 8.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 62.0 109.657 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 88.76 -74.76 2.03 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.33 -0.708 . . . . 73.519999999999996 111.33 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 45.7 mm -130.28 128.17 63.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.449 -1.315 . . . . 70.239999999999995 107.449 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -99.61 157.04 16.74 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.296 -0.631 . . . . 74.150000000000006 109.296 177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.06 131.59 56.9 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.572 0.545 . . . . 74.310000000000002 111.919 -174.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 41.4 t -126.26 116.33 45.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 109.603 -0.517 . . . . 44.219999999999999 109.603 173.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 97.5 mttt -92.34 124.87 36.72 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.975 -0.69 . . . . 70.420000000000002 110.027 173.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 77.1 t -94.88 112.73 27.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.479 -1.304 . . . . 75.409999999999997 107.479 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 40.3 mt -96.07 152.76 18.24 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.129 -0.941 . . . . 74.420000000000002 110.406 -172.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 504' ' ' ILE . 1.8 mpp_? -106.65 114.83 29.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.043 -0.725 . . . . 53.119999999999997 109.043 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.3 m -65.36 -50.87 63.95 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.82 0.819 . . . . 72.329999999999998 109.998 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.0 p -73.75 -52.25 13.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 115.19 -0.914 . . . . 73.219999999999999 112.248 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 138.9 -155.95 24.05 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 108.423 -1.871 . . . . 44.329999999999998 108.423 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -169.47 149.13 3.92 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 117.339 0.569 . . . . 73.129999999999995 109.983 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -156.57 102.11 2.04 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.573 -2.01 . . . . 65.219999999999999 105.573 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 124.66 -173.04 16.99 Favored Glycine 0 C--N 1.295 -1.738 0 N-CA-C 110.046 -1.222 . . . . 72.430000000000007 110.046 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.553 HD21 ' HG3' ' A' ' 561' ' ' GLU . 3.5 t-20 -99.21 118.98 37.11 Favored 'General case' 0 C--O 1.201 -1.465 0 N-CA-C 108.968 -0.753 . . . . 65.140000000000001 108.968 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 14.1 t -120.69 121.31 65.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 109.171 -0.677 . . . . 60.229999999999997 109.171 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.477 ' HB ' ' CG ' ' A' ' 595' ' ' LYS . 49.9 mm -94.39 117.03 37.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.79 -0.818 . . . . 52.229999999999997 108.79 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.7 106.73 56.7 Favored Pre-proline 0 C--N 1.301 -1.516 0 CA-C-N 115.446 -0.797 . . . . 74.319999999999993 110.673 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 5.0 Cg_exo -76.88 150.87 30.75 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.129 1.886 . . . . 65.140000000000001 111.7 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -141.72 161.48 37.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.84 -1.17 . . . . 73.5 107.84 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.584 ' HE2' HD11 ' A' ' 542' ' ' ILE . 24.0 pttm -152.49 137.06 16.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.056 0.455 . . . . 63.030000000000001 111.638 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.8 p -83.51 134.39 34.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.575 -0.739 . . . . 65.200000000000003 110.224 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.584 HD11 ' HE2' ' A' ' 540' ' ' LYS . 48.1 mm -103.55 126.38 58.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.357 -0.979 . . . . 61.32 108.357 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -78.95 112.31 16.01 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.113 -1.069 . . . . 72.319999999999993 108.113 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -101.36 -106.17 2.9 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 109.771 -1.332 . . . . 72.25 109.771 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 23.9 p -89.5 -11.37 43.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.438 0.637 . . . . 71.540000000000006 109.827 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -100.65 141.36 33.63 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 108.06 -1.089 . . . . 73.230000000000004 108.06 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -100.05 133.68 44.07 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.861 0.363 . . . . 64.409999999999997 110.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -92.72 -159.97 35.43 Favored Glycine 0 N--CA 1.431 -1.66 0 C-N-CA 120.777 -0.725 . . . . 60.409999999999997 111.355 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 71.0 37.39 64.32 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.025 -0.607 . . . . 41.25 112.187 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.69 5.13 86.89 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.361 -0.447 . . . . 53.240000000000002 113.529 176.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -81.89 -82.21 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.849 0.325 . . . . 75.219999999999999 111.771 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.04 -46.76 7.63 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.712 -1.218 . . . . 65.040000000000006 107.712 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -131.89 160.63 35.15 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.36 -1.291 . . . . 64.129999999999995 107.575 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 574' ' ' ARG . 0.0 OUTLIER -91.98 131.97 36.88 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.861 -1.533 . . . . 51.039999999999999 106.861 175.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -80.21 125.5 29.93 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.947 -0.569 . . . . 63.539999999999999 109.732 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.8 t -133.99 121.99 22.41 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 122.026 0.917 . . . . 43.020000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 13.7 p -133.55 129.53 37.19 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 106.825 -1.546 . . . . 71.019999999999996 106.825 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -172.63 -177.39 41.98 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 120.029 -1.081 . . . . 73.519999999999996 111.036 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.462 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.1 mt-10 -113.24 129.51 56.5 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.362 0.601 . . . . 70.319999999999993 111.945 -178.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.7 mt -89.24 140.11 29.81 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.649 -1.16 . . . . 62.240000000000002 109.699 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.553 ' HG3' HD21 ' A' ' 534' ' ' ASN . 37.6 tt0 -99.83 101.78 13.02 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.944 -0.571 . . . . 61.229999999999997 109.931 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 43.0 m-85 -96.17 149.71 21.33 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-O 121.624 0.725 . . . . 73.329999999999998 110.439 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.411 ' H ' HD11 ' A' ' 567' ' ' ILE . 79.7 mm-40 -127.41 -140.54 0.26 Allowed 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.128 -1.804 . . . . 74.200000000000003 106.128 177.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -62.21 157.72 18.71 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 122.958 0.503 . . . . 61.340000000000003 110.088 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.422 ' HA ' ' NH2' ' A' ' 527' ' ' ARG . 33.6 t70 -54.55 -21.11 9.28 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.598 1.159 . . . . 72.209999999999994 113.74 -175.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.533 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.1 pt-20 -59.27 -30.96 68.67 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.678 0.791 . . . . 71.040000000000006 112.781 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.533 HG23 ' HG3' ' A' ' 566' ' ' GLU . 34.7 pt -101.08 168.93 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.643 0.259 . . . . 74.409999999999997 110.955 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 8.3 p -144.34 152.38 15.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.88 -1.526 . . . . 72.099999999999994 106.88 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.592 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.1 mmpt? -112.8 157.44 21.35 Favored 'General case' 0 CA--C 1.485 -1.524 0 C-N-CA 120.783 -0.367 . . . . 52.210000000000001 110.8 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 67.2 mt -127.32 129.41 70.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.231 -0.895 . . . . 70.409999999999997 109.822 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.518 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.9 mt -90.63 122.98 42.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.61 -1.626 . . . . 75.140000000000001 106.61 174.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 27.0 p -106.86 122.01 45.55 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.239 -0.652 . . . . 63.149999999999999 109.239 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.419 HD11 HD22 ' A' ' 589' ' ' LEU . 61.6 mt -118.31 128.44 75.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 109.472 -0.566 . . . . 43.130000000000003 109.472 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 99.4 mtt180 -74.31 119.48 18.58 Favored 'General case' 0 C--N 1.313 -0.996 0 O-C-N 123.944 0.778 . . . . 70.019999999999996 110.1 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.6 mm -107.25 135.75 44.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.719 -0.845 . . . . 74.040000000000006 108.719 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -123.33 164.48 18.74 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.776 -1.194 . . . . 71.0 107.776 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.81 143.72 20.27 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 123.017 0.198 . . . . 61.299999999999997 111.406 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 578' ' ' ARG . 0.0 OUTLIER -40.34 113.3 0.35 Allowed 'General case' 0 CA--C 1.564 1.502 0 O-C-N 125.128 1.518 . . . . 73.510000000000005 113.34 -174.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -102.84 141.7 35.2 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 120.82 -1.175 . . . . 65.140000000000001 110.265 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 68.81 97.07 0.06 Allowed 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 124.77 1.228 . . . . 62.409999999999997 111.573 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -77.04 167.54 21.62 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.269 -0.878 . . . . 64.510000000000005 108.633 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 72.53 12.18 5.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.665 0.786 . . . . 54.219999999999999 110.238 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -139.14 154.59 48.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.99 -1.485 . . . . 71.340000000000003 106.99 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.51 129.55 52.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.994 -1.113 . . . . 71.25 107.994 172.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.517 ' HB2' HG12 ' A' ' 645' ' ' ILE . 60.0 m -73.95 115.45 13.42 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.63 0.729 . . . . 73.299999999999997 112.031 -174.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 31.2 m -146.77 128.04 14.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.91 -0.774 . . . . 75.340000000000003 108.91 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 49.2 p90 -131.22 165.76 22.65 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.714 -0.847 . . . . 55.530000000000001 108.714 174.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 5.0 m -119.7 162.52 18.88 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.523 -0.871 . . . . 70.409999999999997 110.221 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 573' ' ' ILE . 47.0 tp -135.69 130.06 33.68 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 107.276 -1.379 . . . . 64.239999999999995 107.276 176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.2 m -130.83 160.14 42.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 123.603 0.564 . . . . 74.329999999999998 109.674 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.54 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 44.9 mt -106.26 144.4 33.0 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 123.976 0.798 . . . . 70.230000000000004 109.004 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.77 178.3 5.35 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.178 -1.045 . . . . 73.310000000000002 108.178 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -60.29 117.36 23.51 Favored Pre-proline 0 C--O 1.247 0.954 0 O-C-N 123.642 0.589 . . . . 62.43 109.759 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.43 ' HG2' ' HB2' ' A' ' 633' ' ' PRO . 56.4 Cg_endo -77.46 147.78 25.76 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.409 2.072 . . . . 73.200000000000003 111.375 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.477 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 8.7 ptpp? -113.63 123.59 50.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 116.133 -0.485 . . . . 75.299999999999997 110.055 -178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . 0.405 ' HB2' ' HG3' ' A' ' 633' ' ' PRO . 2.9 t90 -98.23 110.58 23.14 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.014 -0.539 . . . . 75.420000000000002 110.256 -173.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . . . . . . . . . 3.1 mp -91.74 89.4 2.93 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 106.693 -1.595 . . . . 70.340000000000003 106.693 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . 0.548 ' O ' ' HA3' ' A' ' 603' ' ' GLY . 15.0 ptm180 -103.43 91.76 4.19 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.886 -1.052 . . . . 64.409999999999997 109.027 177.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -41.78 111.38 0.23 Allowed 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.88 1.672 . . . . 70.329999999999998 112.421 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -171.25 -164.67 27.33 Favored Glycine 0 N--CA 1.418 -2.515 0 N-CA-C 110.342 -1.103 . . . . 73.409999999999997 110.342 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 52.6 tpp -72.94 -43.17 62.64 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.271 0.557 . . . . 61.119999999999997 109.615 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -90.15 -26.46 20.16 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.048 -0.524 . . . . 73.140000000000001 110.345 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 598' ' ' ARG . . . -89.29 68.17 2.75 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 111.395 -0.682 . . . . 72.010000000000005 111.395 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -135.46 61.86 0.62 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.02 -1.232 . . . . 72.5 110.02 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -147.19 146.33 29.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.656 -0.498 . . . . 73.400000000000006 109.656 -178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 85.1 m -146.66 109.94 4.77 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.632 -1.247 . . . . 73.120000000000005 107.632 173.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 609' ' ' GLU . 47.6 mm -96.12 123.56 48.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 108.758 -0.83 . . . . 72.209999999999994 108.758 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 11.4 m -115.14 18.04 16.43 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 123.061 1.41 . . . . 74.450000000000003 107.498 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . 0.413 ' H ' HG22 ' A' ' 607' ' ' ILE . 9.3 pt-20 -125.76 83.54 2.18 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-N 114.089 -1.414 . . . . 75.140000000000001 110.809 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -80.58 104.28 11.0 Favored 'General case' 0 N--CA 1.408 -2.541 0 N-CA-C 105.113 -2.181 . . . . 75.340000000000003 105.113 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -71.49 -26.8 62.84 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 114.668 -1.151 . . . . 73.299999999999997 113.983 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -144.45 103.02 3.91 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.179 0.514 . . . . 65.549999999999997 110.075 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -91.08 69.73 6.24 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.832 -1.173 . . . . 74.209999999999994 107.832 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 616' ' ' PRO . 30.9 mmmt -140.75 22.46 2.3 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.418 -0.355 . . . . 62.399999999999999 111.295 -176.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -86.28 117.04 68.03 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 120.632 -0.427 . . . . 75.319999999999993 111.782 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 614' ' ' LYS . 93.9 Cg_endo -93.23 171.0 2.12 Favored 'Trans proline' 0 N--CA 1.432 -2.099 0 C-N-CA 122.328 2.019 . . . . 54.340000000000003 110.397 174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' A' ' 639' ' ' THR . 2.7 mm? -100.27 77.64 1.98 Allowed 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 122.271 1.034 . . . . 70.010000000000005 109.765 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 16.8 p -126.55 137.13 53.31 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.649 -1.614 . . . . 71.120000000000005 108.401 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 35.4 m -133.23 114.07 13.39 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.034 0.445 . . . . 75.450000000000003 110.029 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -137.75 64.87 1.5 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.388 -1.338 . . . . 60.020000000000003 107.388 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -122.23 164.73 17.34 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.373 -1.285 . . . . 70.540000000000006 109.688 -177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . 0.409 ' OE1' ' HG2' ' A' ' 624' ' ' GLU . 0.9 OUTLIER -78.67 145.44 34.58 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.617 -2.364 . . . . 72.129999999999995 104.617 174.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.72 -16.36 64.18 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 115.149 1.537 . . . . 73.329999999999998 115.149 -171.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.409 ' HG2' ' OE1' ' A' ' 622' ' ' GLU . 10.2 pt-20 -65.7 -26.8 67.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 119.018 -1.073 . . . . 74.230000000000004 110.789 174.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -67.08 -39.55 86.8 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.961 -0.755 . . . . 63.140000000000001 108.961 173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -67.29 -33.91 76.28 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.06 -0.973 . . . . 74.299999999999997 110.781 -178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 94.6 mt -58.47 -40.96 80.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 CA-C-O 120.866 0.365 . . . . 44.420000000000002 110.373 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.423 ' O ' ' HG2' ' A' ' 632' ' ' ARG . . . -67.55 -41.99 83.38 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.654 -0.703 . . . . 35.210000000000001 109.574 177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.411 ' HB3' HG21 ' A' ' 634' ' ' ILE . 47.4 mt-10 -63.22 -29.34 70.7 Favored 'General case' 0 C--O 1.217 -0.647 0 CA-C-N 115.698 -0.683 . . . . 74.530000000000001 111.599 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 71.0 mtm -66.67 -9.66 38.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.228 0.537 . . . . 64.530000000000001 112.397 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -112.31 12.72 26.06 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 110.246 -1.142 . . . . 72.530000000000001 110.246 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 628' ' ' ALA . 28.3 mmm180 -119.82 162.24 34.03 Favored Pre-proline 0 C--N 1.313 -1.013 0 C-N-CA 122.932 0.493 . . . . 73.409999999999997 109.996 -177.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.43 ' HB2' ' HG2' ' A' ' 594' ' ' PRO . 49.5 Cg_endo -70.81 120.61 7.2 Favored 'Trans proline' 0 C--O 1.247 0.97 0 C-N-CA 122.25 1.967 . . . . 74.420000000000002 108.977 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.411 HG21 ' HB3' ' A' ' 629' ' ' GLU . 31.2 pt -138.87 -178.61 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.459 0.647 . . . . 75.319999999999993 110.973 -175.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.426 HD21 ' HD3' ' A' ' 594' ' ' PRO . 2.2 mm? -114.61 170.31 8.41 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.364 -1.347 . . . . 64.219999999999999 107.364 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -65.82 154.59 50.92 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 108.388 -1.885 . . . . 72.049999999999997 108.388 172.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -39.86 -64.06 0.53 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.1 0.96 . . . . 63.240000000000002 112.641 -172.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -130.07 83.43 2.13 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.827 -1.175 . . . . 71.239999999999995 107.827 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . 0.425 HG22 ' HG ' ' A' ' 617' ' ' LEU . 11.2 t -100.67 110.88 23.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.241 1.019 . . . . 64.200000000000003 110.64 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -146.72 134.86 21.61 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.411 -1.329 . . . . 72.5 107.411 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 65.0 tp -113.2 112.91 24.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 109.312 -0.625 . . . . 70.540000000000006 109.312 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.41 ' HB2' HG22 ' A' ' 511' ' ' VAL . 48.7 mt-10 -90.47 117.03 28.85 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.001 -0.74 . . . . 72.150000000000006 109.001 176.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.63 116.06 43.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.508 0 N-CA-C 107.66 -1.237 . . . . 54.310000000000002 107.66 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . 0.437 HD12 HG13 ' A' ' 511' ' ' VAL . 16.0 mt -115.47 128.22 72.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.547 0 CA-C-N 114.787 -1.097 . . . . 75.109999999999999 109.901 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 585' ' ' CYS . 0.0 OUTLIER -119.34 125.37 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 114.474 -1.239 . . . . 71.030000000000001 108.308 179.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -131.46 140.32 49.56 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 109.403 -0.591 . . . . 75.329999999999998 109.403 -175.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -84.36 129.43 34.87 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 105.476 -2.046 . . . . 74.109999999999999 105.476 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 70.6 m 68.57 32.51 4.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.924 0.869 . . . . 53.25 109.457 -174.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -56.05 165.68 0.93 Allowed 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.957 1.303 . . . . 75.430000000000007 112.508 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.72 111.18 19.43 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.26 -1.755 . . . . 72.420000000000002 106.26 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -116.98 132.11 56.79 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.431 -1.322 . . . . 64.040000000000006 107.431 -177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.2 -35.65 61.49 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.322 0.86 . . . . 61.420000000000002 113.322 -174.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 54.2 m 52.56 30.94 9.2 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.768 0.827 . . . . 62.140000000000001 112.034 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 85.2 m -87.6 110.68 20.55 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.719 -0.673 . . . . 35.350000000000001 110.025 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 13.6 p -90.38 -21.6 6.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.578 0.704 . . . . 73.219999999999999 110.102 -176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.3 -1.555 0 CA-C-N 115.254 -0.884 . . . . 71.540000000000006 110.742 -179.19 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.793 0.806 . . . . 72.140000000000001 110.12 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -72.93 110.39 7.2 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.826 -1.079 . . . . 44.119999999999997 111.562 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . 63.82 58.83 9.76 Favored Glycine 0 C--O 1.204 -1.732 0 CA-C-N 114.872 -1.058 . . . . 72.0 114.134 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 527' ' ' ARG . 91.9 mt -71.78 114.22 9.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 CA-C-N 116.876 0.338 . . . . 73.109999999999999 110.984 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.424 ' HE1' ' HE ' ' A' ' 527' ' ' ARG . 38.2 m-85 -100.5 132.73 45.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.882 -0.784 . . . . 74.049999999999997 108.882 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.6 t -148.23 157.59 43.59 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.841 -0.537 . . . . 74.319999999999993 110.641 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.572 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 91.9 m-85 -71.56 155.57 40.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.258 . . . . 63.420000000000002 110.319 176.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -55.91 -56.28 22.58 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 123.914 0.759 . . . . 73.030000000000001 109.623 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . 0.416 ' O ' HD13 ' A' ' 641' ' ' LEU . 48.6 mt-10 -134.09 159.51 72.08 Favored Pre-proline 0 C--N 1.3 -1.577 0 N-CA-C 107.952 -1.129 . . . . 71.420000000000002 107.952 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 62.8 Cg_endo -79.04 -21.49 9.35 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 121.93 1.753 . . . . 65.519999999999996 113.808 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.4 t -138.59 133.34 42.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.702 -0.481 . . . . 60.43 109.702 -179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.0 t -133.6 139.11 46.34 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.206 0.527 . . . . 55.100000000000001 109.705 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -109.39 132.84 53.75 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.989 -1.485 . . . . 61.509999999999998 106.989 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.8 m -125.87 163.72 26.83 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 C-N-CA 120.621 -0.432 . . . . 71.510000000000005 110.449 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 647' ' ' GLU . 27.2 m -82.44 163.68 21.47 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.569 -0.741 . . . . 71.150000000000006 109.574 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 577' ' ' ASP . 19.5 tt0 -81.05 -34.72 32.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.729 -1.212 . . . . 61.119999999999997 107.729 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 577' ' ' ASP . 17.4 m -96.34 27.54 3.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.144 -0.934 . . . . 75.209999999999994 111.022 -176.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 7.4 tt -79.8 -25.08 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.409 0.623 . . . . 74.439999999999998 110.601 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 86.45 -75.71 2.21 Favored Glycine 0 N--CA 1.431 -1.652 0 C-N-CA 120.926 -0.654 . . . . 73.120000000000005 111.668 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 48.4 mm -130.51 137.56 55.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.458 -1.682 . . . . 44.409999999999997 106.458 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.1 ppp? -110.09 147.98 32.6 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.403 -0.962 . . . . 74.219999999999999 108.403 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -110.97 134.38 52.63 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.596 0.56 . . . . 74.219999999999999 110.825 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 570' ' ' ILE . 46.1 t -121.19 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.68 -0.859 . . . . 74.099999999999994 108.68 171.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -85.52 120.79 27.37 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.572 -0.851 . . . . 74.420000000000002 110.058 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.25 101.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 106.987 -1.486 . . . . 71.209999999999994 106.987 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 79.1 mt -84.32 163.4 19.62 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 114.183 -1.371 . . . . 74.010000000000005 111.006 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.608 ' NH2' ' HB3' ' A' ' 562' ' ' PHE . 74.6 mtt180 -118.12 109.08 15.98 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.865 -1.062 . . . . 64.430000000000007 110.446 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 22.7 m -66.27 -62.93 1.21 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.269 -0.423 . . . . 65.049999999999997 110.416 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 11.9 p -75.31 -36.44 61.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.663 0.744 . . . . 72.239999999999995 112.009 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 124.55 -128.78 6.87 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.211 -1.155 . . . . 65.040000000000006 110.211 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . 177.16 168.69 0.58 Allowed 'General case' 0 CA--C 1.487 -1.45 0 C-N-CA 125.052 1.341 . . . . 63.409999999999997 107.437 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.529 ' HD2' ' OD1' ' A' ' 564' ' ' ASN . 9.9 tpt180 -163.41 81.17 0.46 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.524 -1.287 . . . . 74.25 107.524 172.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 135.34 171.3 12.37 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 110.075 -1.21 . . . . 70.010000000000005 110.075 -176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -86.84 128.72 35.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.17 0.509 . . . . 71.150000000000006 110.843 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.8 t -136.07 134.32 50.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 70.120000000000005 109.474 -177.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.545 HG12 HD11 ' A' ' 597' ' ' ILE . 44.7 mm -93.75 122.04 44.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.795 -0.817 . . . . 73.420000000000002 108.795 177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.4 t -113.65 102.07 54.41 Favored Pre-proline 0 C--N 1.312 -1.031 0 O-C-N 123.471 0.482 . . . . 73.420000000000002 110.438 -178.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 6.1 Cg_exo -76.49 148.73 30.02 Favored 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 121.932 1.754 . . . . 74.299999999999997 111.127 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -138.05 166.68 23.49 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.972 -1.122 . . . . 74.019999999999996 107.972 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.401 ' O ' HD12 ' A' ' 589' ' ' LEU . 54.3 pttt -157.45 134.83 10.44 Favored 'General case' 0 C--O 1.25 1.11 0 CA-C-O 121.03 0.443 . . . . 71.299999999999997 111.254 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 15.6 p -80.44 126.61 31.41 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.678 -0.692 . . . . 74.209999999999994 110.156 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 42.2 mm -95.16 116.45 36.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 107.101 -1.444 . . . . 62.109999999999999 107.101 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -81.73 111.66 18.19 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.41 0.444 . . . . 74.109999999999999 110.672 -176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -100.64 -110.93 3.31 Favored Glycine 0 C--N 1.31 -0.894 0 N-CA-C 110.159 -1.176 . . . . 64.040000000000006 110.159 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.405 ' HB ' ' H ' ' A' ' 586' ' ' SER . 6.5 m -70.06 -35.48 74.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.684 -1.228 . . . . 61.210000000000001 107.684 175.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -89.92 132.69 35.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.325 -1.307 . . . . 53.32 108.439 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -114.6 157.11 23.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.587 0.708 . . . . 75.109999999999999 111.412 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -88.17 -154.0 27.0 Favored Glycine 0 N--CA 1.427 -1.948 0 CA-C-N 114.829 -1.078 . . . . 73.150000000000006 111.972 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.43 8.84 47.59 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.964 -0.16 . . . . 51.130000000000003 112.99 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.65 24.22 26.35 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 121.152 -0.547 . . . . 71.420000000000002 111.982 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -82.57 -69.59 0.61 Allowed 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.478 -0.934 . . . . 60.229999999999997 108.478 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -103.92 -40.13 6.34 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.398 -1.334 . . . . 73.129999999999995 107.398 175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -143.12 172.59 12.52 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-N 114.943 -1.026 . . . . 64.430000000000007 109.761 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 574' ' ' ARG . 1.7 tm-20 -98.04 114.26 26.36 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 105.241 -2.133 . . . . 75.439999999999998 105.241 175.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -78.78 136.81 37.47 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.647 0.737 . . . . 75.150000000000006 111.466 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -130.27 125.74 35.56 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 122.145 0.974 . . . . 60.43 111.734 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 38.6 t -132.43 127.13 34.68 Favored 'General case' 0 N--CA 1.406 -2.637 0 N-CA-C 105.861 -1.903 . . . . 52.009999999999998 105.861 172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -168.68 -174.61 37.5 Favored Glycine 0 C--N 1.269 -3.161 0 N-CA-C 109.649 -1.38 . . . . 44.399999999999999 109.649 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 538' ' ' PRO . 8.6 pt-20 -121.01 127.98 52.26 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.364 0.602 . . . . 71.319999999999993 111.424 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 92.9 mt -88.13 136.22 33.07 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.226 -0.897 . . . . 73.030000000000001 108.817 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.17 98.84 9.2 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-O 121.496 0.665 . . . . 74.549999999999997 109.606 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.608 ' HB3' ' NH2' ' A' ' 527' ' ' ARG . 36.2 m-85 -92.61 124.24 36.48 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.823 -0.626 . . . . 71.349999999999994 110.516 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.646 ' H ' HD11 ' A' ' 567' ' ' ILE . 27.8 mm-40 -83.63 -146.98 0.09 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.057 -1.831 . . . . 71.349999999999994 106.057 172.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.529 ' OD1' ' HD2' ' A' ' 532' ' ' ARG . 61.2 t30 -63.47 170.49 3.09 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 123.15 0.58 . . . . 62.399999999999999 110.429 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.81 -11.58 8.14 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.618 1.167 . . . . 61.009999999999998 113.864 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.07 -21.79 66.66 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.656 0.782 . . . . 74.129999999999995 112.839 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.646 HD11 ' H ' ' A' ' 563' ' ' GLN . 23.7 pt -114.18 168.9 5.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 O-C-N 121.793 -0.567 . . . . 72.109999999999999 111.265 -178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.17 147.42 25.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.442 -1.318 . . . . 63.420000000000002 107.442 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 68.4 mmtt -111.34 148.5 32.85 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.088 0.471 . . . . 62.0 111.224 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 64.1 mt -120.38 132.53 69.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.834 -1.075 . . . . 74.109999999999999 110.328 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 55.2 mt -91.91 126.46 44.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.7 -1.593 . . . . 73.329999999999998 106.7 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 521' ' ' MET . 16.2 p -113.94 112.78 23.87 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.052 0.453 . . . . 63.310000000000002 109.966 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 589' ' ' LEU . 70.1 mt -105.0 130.62 55.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.617 -0.512 . . . . 71.439999999999998 109.617 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' A' ' 554' ' ' GLU . 99.3 mtt180 -78.53 114.95 17.9 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.131 0.491 . . . . 71.239999999999995 110.309 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 48.9 mm -103.22 137.49 31.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 106.166 -1.79 . . . . 55.140000000000001 106.166 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 554' ' ' GLU . 47.6 m-85 -105.72 122.9 47.02 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.89 -0.724 . . . . 72.329999999999998 111.739 -176.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 578' ' ' ARG . 4.0 p-10 -88.64 160.55 17.33 Favored 'General case' 0 CA--C 1.491 -1.303 0 CA-C-N 115.333 -0.849 . . . . 71.299999999999997 108.831 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 577' ' ' ASP . 17.7 ptp180 61.05 12.76 4.17 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 126.129 1.772 . . . . 74.099999999999994 111.144 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -95.86 43.17 1.08 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 105.884 -1.895 . . . . 62.450000000000003 105.884 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -76.35 30.99 0.12 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.632 -1.622 . . . . 73.319999999999993 112.62 -172.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -83.01 -18.94 38.03 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.851 -1.166 . . . . 54.240000000000002 107.851 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -104.68 -163.07 0.93 Allowed 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.308 -1.315 . . . . 72.319999999999993 110.397 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -138.07 -152.91 0.45 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 110.241 -0.281 . . . . 74.120000000000005 110.241 -170.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -74.77 101.71 4.42 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.919 -1.141 . . . . 54.409999999999997 107.919 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . . . . . . . . . 63.3 m -120.87 140.98 51.02 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.191 -0.459 . . . . 62.439999999999998 111.278 -173.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.405 ' H ' ' HB ' ' A' ' 545' ' ' THR . 63.9 p -117.69 149.03 41.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.911 -0.493 . . . . 72.540000000000006 110.875 175.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 542' ' ' ILE . 51.6 p90 -137.15 174.84 10.18 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.324 -0.991 . . . . 74.219999999999999 108.324 171.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . 0.475 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 13.0 m -124.85 167.03 15.2 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 120.256 -0.577 . . . . 74.239999999999995 109.616 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.416 HD22 HD11 ' A' ' 573' ' ' ILE . 39.3 tp -141.45 130.87 23.75 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 107.083 -1.451 . . . . 70.040000000000006 107.083 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 27.4 m -128.72 157.28 41.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 123.343 0.402 . . . . 65.5 110.041 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 75.2 mt -96.76 142.78 28.37 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.096 -1.446 . . . . 75.450000000000003 107.096 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 538' ' ' PRO . 10.9 mm-40 -104.43 172.24 6.9 Favored 'General case' 0 C--N 1.281 -2.379 0 O-C-N 123.441 0.463 . . . . 73.230000000000004 110.033 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -52.64 112.2 3.24 Favored Pre-proline 0 C--N 1.316 -0.876 0 O-C-N 124.957 1.411 . . . . 75.019999999999996 110.987 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.448 ' O ' ' HD2' ' A' ' 632' ' ' ARG . 33.1 Cg_endo -76.04 153.8 37.21 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 C-N-CA 121.705 1.603 . . . . 73.129999999999995 111.504 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -124.09 132.14 53.63 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.378 -0.601 . . . . 75.519999999999996 109.378 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -93.77 140.82 29.21 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.491 -0.559 . . . . 74.340000000000003 109.491 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 536' ' ' ILE . 1.8 mp -83.42 89.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 CA-C-O 122.752 1.263 . . . . 60.43 110.458 178.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -128.15 85.52 2.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 105.888 -1.893 . . . . 74.310000000000002 105.888 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -70.91 155.95 40.18 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.26 -1.337 . . . . 62.329999999999998 113.553 -172.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 176.69 -154.73 16.99 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 107.418 -2.273 . . . . 71.129999999999995 107.418 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.23 122.15 33.61 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.894 -1.521 . . . . 63.340000000000003 106.894 174.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -149.9 127.38 11.52 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.159 -0.682 . . . . 62.020000000000003 109.159 -173.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 131.12 -119.86 2.77 Favored Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 119.907 -1.139 . . . . 74.239999999999995 112.804 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 95.89 -142.73 16.27 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 108.993 -1.643 . . . . 72.319999999999993 108.993 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -111.12 87.65 2.59 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.344 1.069 . . . . 62.399999999999999 110.61 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 40.1 m -152.24 144.07 23.66 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 104.891 -2.262 . . . . 74.25 104.891 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 49.0 mm -81.04 -70.72 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.734 -0.387 . . . . 71.209999999999994 110.454 -175.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 31.5 m 68.6 -44.16 0.51 Allowed 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 124.543 1.137 . . . . 43.140000000000001 112.131 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.5 59.15 4.49 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 124.899 1.28 . . . . 72.120000000000005 110.838 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -93.95 142.98 26.76 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.332 -0.849 . . . . 73.25 109.703 176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -80.64 85.15 6.07 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.368 -1.345 . . . . 73.010000000000005 107.368 175.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -111.32 -58.23 2.14 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.003 -1.48 . . . . 62.530000000000001 107.003 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 69.37 -62.78 0.4 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 114.749 1.389 . . . . 73.040000000000006 114.749 170.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . 0.517 ' HA ' ' HE3' ' A' ' 614' ' ' LYS . 1.8 tpmt? -88.17 88.81 7.75 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.821 0.82 . . . . 53.329999999999998 109.613 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -105.29 170.02 6.42 Favored Pre-proline 0 C--N 1.28 -2.448 0 CA-C-N 114.726 -1.124 . . . . 71.340000000000003 108.565 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -58.46 140.09 93.24 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.745 1.63 . . . . 52.530000000000001 109.406 172.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -86.23 -94.32 0.08 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 112.42 0.526 . . . . 74.349999999999994 112.42 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 21.6 m -83.0 -36.85 24.7 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 116.318 -0.401 . . . . 63.350000000000001 110.111 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 31.9 t -77.93 97.41 5.3 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.524 0.678 . . . . 71.109999999999999 109.903 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . 0.469 ' HE2' ' OE1' ' A' ' 629' ' ' GLU . 65.5 mttp -113.66 176.14 5.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 115.541 -0.754 . . . . 75.340000000000003 109.562 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -109.88 177.46 4.71 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.147 -0.479 . . . . 70.329999999999998 110.205 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -74.5 93.09 2.42 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.868 -0.79 . . . . 73.099999999999994 108.868 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -140.94 151.26 44.06 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.656 -0.702 . . . . 74.450000000000003 109.872 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -68.96 -26.01 64.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.405 -0.361 . . . . 54.229999999999997 111.639 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -59.61 -35.67 74.8 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 110.297 -0.26 . . . . 71.530000000000001 110.297 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -63.37 -31.46 72.62 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-O 121.265 0.555 . . . . 74.549999999999997 110.51 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 64.9 mt -70.7 -31.95 47.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.544 0.687 . . . . 72.439999999999998 109.208 177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -72.68 -38.36 67.6 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.996 -0.547 . . . . 72.430000000000007 109.852 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.469 ' OE1' ' HE2' ' A' ' 620' ' ' LYS . 36.4 mt-10 -69.67 -28.12 65.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.574 0.702 . . . . 51.219999999999999 110.038 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . . . . . . . . . 49.0 ttm -72.42 -18.46 61.71 Favored 'General case' 0 N--CA 1.404 -2.743 0 C-N-CA 125.004 1.322 . . . . 63.009999999999998 109.929 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -98.92 17.78 57.74 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.588 -0.605 . . . . 73.030000000000001 111.588 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 594' ' ' PRO . 14.0 mmt85 -97.01 154.27 38.25 Favored Pre-proline 0 C--N 1.301 -1.527 0 C-N-CA 122.703 0.401 . . . . 65.129999999999995 110.025 178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -67.51 154.39 73.79 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 106.546 -2.136 . . . . 73.030000000000001 106.546 165.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 634' ' ' ILE . 0.2 OUTLIER -128.79 176.87 7.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 C-N-CA 118.541 -1.264 . . . . 64.230000000000004 113.22 -176.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.83 -175.2 2.73 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.893 -1.503 . . . . 65.340000000000003 108.006 -176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -64.7 143.71 47.2 Favored Glycine 0 N--CA 1.435 -1.405 0 N-CA-C 108.012 -2.035 . . . . 61.32 108.012 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . 0.449 ' HG2' ' CE1' ' A' ' 638' ' ' HIS . 32.7 tt0 -52.55 -42.44 64.42 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.04 0.536 . . . . 71.040000000000006 111.869 -174.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . 0.449 ' CE1' ' HG2' ' A' ' 637' ' ' GLU . 52.3 m80 -128.24 101.02 6.06 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.028 -1.101 . . . . 64.340000000000003 108.028 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 5.0 t -136.0 110.55 8.58 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-O 122.383 1.087 . . . . 63.43 111.041 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 35.9 ttmt -146.49 150.82 36.33 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.6 -1.63 . . . . 64.329999999999998 106.6 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 509' ' ' GLU . 61.5 tp -127.54 112.76 15.29 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.2 -0.667 . . . . 62.109999999999999 109.2 174.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.429 ' HB2' HG22 ' A' ' 511' ' ' VAL . 43.5 mt-10 -89.62 125.35 35.2 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.658 -0.867 . . . . 64.040000000000006 108.658 175.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 42.8 t -111.36 119.45 59.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 N-CA-C 108.427 -0.953 . . . . 71.430000000000007 108.427 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . 0.463 HG22 ' HG2' ' A' ' 646' ' ' GLU . 3.9 mp -111.26 125.0 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 115.576 -0.738 . . . . 71.140000000000001 110.207 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.31 96.01 4.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 121.718 0.77 . . . . 73.219999999999999 110.991 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . 0.463 ' HG2' HG22 ' A' ' 644' ' ' ILE . 7.1 pt-20 -135.06 117.07 15.3 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.542 -1.208 . . . . 72.299999999999997 109.704 176.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.409 ' OE2' ' HB3' ' A' ' 515' ' ' SER . 7.3 tp10 -123.29 18.89 9.84 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.925 1.345 . . . . 74.030000000000001 108.207 -177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.4 p -83.52 20.44 1.38 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 125.815 1.646 . . . . 73.219999999999999 113.099 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -158.8 172.72 17.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.015 -0.735 . . . . 74.120000000000005 109.015 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.97 131.65 51.0 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 123.73 0.643 . . . . 73.109999999999999 109.278 175.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -140.3 139.98 35.59 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.584 -1.265 . . . . 75.430000000000007 107.584 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -84.37 108.43 17.2 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.175 -0.676 . . . . 65.129999999999995 109.175 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 33.2 m -78.33 94.84 4.91 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.405 0.621 . . . . 54.409999999999997 109.702 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 30.1 m -126.64 115.36 19.35 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.496 -0.774 . . . . 53.340000000000003 109.01 -177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 10.1 p -86.79 130.85 36.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.059 -0.719 . . . . 73.319999999999993 109.059 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.256 1.397 0 CA-C-N 116.384 -0.371 . . . . 72.230000000000004 110.576 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 121.211 0.529 . . . . 74.409999999999997 110.199 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -137.39 104.97 5.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.894 -0.594 . . . . 74.450000000000003 109.957 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -78.33 149.64 34.14 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 115.496 -0.775 . . . . 72.349999999999994 111.303 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 634' ' ' ILE . 84.6 mt -127.25 114.73 37.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.013 -1.477 . . . . 73.519999999999996 107.013 176.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.419 ' H ' ' HA ' ' A' ' 635' ' ' LEU . 37.4 m-85 -103.48 136.98 42.21 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 120.793 0.33 . . . . 73.219999999999999 110.809 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.2 t -148.02 160.79 42.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.49 -0.929 . . . . 44.020000000000003 108.49 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -79.9 156.09 27.45 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.668 -0.493 . . . . 74.420000000000002 109.668 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -56.03 -51.1 68.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 123.894 0.746 . . . . 71.129999999999995 110.07 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -131.85 157.17 78.93 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.16 -0.927 . . . . 74.299999999999997 109.132 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -80.52 -21.71 7.22 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.261 1.974 . . . . 74.340000000000003 112.501 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' A' ' 642' ' ' GLU . 73.7 t -143.13 133.93 22.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 123.372 0.669 . . . . 70.109999999999999 109.275 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -133.59 138.37 45.96 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 109.313 -0.625 . . . . 72.129999999999995 109.313 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -109.52 110.93 22.17 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.857 -1.164 . . . . 74.329999999999998 107.857 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.33 158.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 116.191 -0.459 . . . . 62.420000000000002 110.439 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.537 ' O ' HG22 ' A' ' 518' ' ' ILE . 22.1 m -78.07 137.35 38.19 Favored 'General case' 0 N--CA 1.411 -2.416 0 CA-C-N 115.569 -0.741 . . . . 74.349999999999994 109.232 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 646' ' ' GLU . 2.9 mp0 -65.43 -24.77 67.28 Favored 'General case' 0 C--N 1.287 -2.149 0 C-N-CA 123.664 0.786 . . . . 74.200000000000003 110.733 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 15.4 p -100.45 11.11 40.17 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.781 -0.645 . . . . 63.32 112.286 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 515' ' ' SER . 11.1 tt -71.32 -37.69 66.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 120.295 -0.562 . . . . 53.409999999999997 112.129 -176.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 92.21 -73.22 1.51 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.239 -0.982 . . . . 21.120000000000001 111.389 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.28 125.21 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.442 -1.318 . . . . 74.540000000000006 107.442 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.412 ' O ' ' HA ' ' A' ' 572' ' ' THR . 5.2 ppp? -100.97 143.31 31.28 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.229 -0.656 . . . . 73.439999999999998 109.229 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -110.19 124.63 51.92 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.836 0.71 . . . . 72.549999999999997 110.848 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 641' ' ' LEU . 41.6 t -129.86 131.34 66.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 110.373 -0.232 . . . . 74.450000000000003 110.373 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.29 136.65 32.95 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 123.479 0.487 . . . . 73.439999999999998 110.184 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 96.3 t -95.48 118.14 41.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 105.872 -1.899 . . . . 74.409999999999997 105.872 171.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.6 mt -95.87 135.73 37.23 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 116.099 -0.501 . . . . 75.209999999999994 110.774 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 104.12 15.94 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.441 -0.8 . . . . 74.200000000000003 110.391 174.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 9.0 m -61.0 -62.45 1.85 Allowed 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.404 1.081 . . . . 63.210000000000001 111.923 -174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 25.5 p -73.3 -31.62 64.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.851 0.834 . . . . 73.319999999999993 109.766 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 135.62 -155.51 22.28 Favored Glycine 0 N--CA 1.421 -2.354 0 N-CA-C 109.814 -1.314 . . . . 64.329999999999998 109.814 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 565' ' ' ASP . . . -150.63 155.06 38.63 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.732 -1.951 . . . . 42.509999999999998 105.732 178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -157.86 126.73 5.68 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.859 -0.793 . . . . 74.310000000000002 108.859 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.86 -125.42 8.24 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 111.171 -0.771 . . . . 73.219999999999999 111.171 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -136.42 102.33 4.92 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 106.311 -1.737 . . . . 72.349999999999994 106.311 174.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 37.9 t -113.88 120.4 63.6 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.569 0 C-N-CA 119.236 -0.986 . . . . 72.040000000000006 110.79 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.596 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 44.3 mm -92.11 116.4 33.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 CA-C-N 114.803 -1.09 . . . . 72.129999999999995 108.628 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.73 100.6 43.27 Favored Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 115.102 -0.954 . . . . 74.129999999999995 109.248 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 558' ' ' GLY . 2.0 Cg_endo -77.1 153.54 32.21 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.861 1.707 . . . . 61.399999999999999 112.497 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -139.65 159.23 42.64 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.7 -0.852 . . . . 62.109999999999999 108.7 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.517 ' O ' HD12 ' A' ' 589' ' ' LEU . 60.5 pttt -152.13 145.97 25.13 Favored 'General case' 0 C--O 1.251 1.146 0 CA-C-O 121.022 0.439 . . . . 74.420000000000002 111.017 -177.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -88.09 127.37 35.41 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.286 -0.87 . . . . 73.150000000000006 111.911 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 42.4 mm -100.69 116.44 44.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.678 -1.23 . . . . 70.319999999999993 107.678 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.473 ' CD ' HH21 ' A' ' 547' ' ' ARG . 39.7 mt-10 -77.66 116.19 18.01 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 116.601 -0.272 . . . . 74.420000000000002 110.491 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -102.19 -115.95 4.06 Favored Glycine 0 C--N 1.306 -1.134 0 N-CA-C 109.028 -1.629 . . . . 73.030000000000001 109.028 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 2.2 p -75.59 -23.98 56.53 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.738 0.78 . . . . 72.450000000000003 109.387 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.63 129.27 34.96 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.523 -1.217 . . . . 73.319999999999993 108.602 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.473 HH21 ' CD ' ' A' ' 543' ' ' GLU . 7.4 tpm_? -95.4 140.72 29.87 Favored 'General case' 0 C--O 1.256 1.409 0 N-CA-C 109.202 -0.666 . . . . 73.400000000000006 109.202 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -85.15 -160.73 33.16 Favored Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 110.935 -0.866 . . . . 74.239999999999995 110.935 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 79.0 16.72 78.42 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 120.767 -0.73 . . . . 70.349999999999994 111.636 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' A' ' 652' ' ' LYS . . . 80.29 31.69 37.23 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 111.644 -0.582 . . . . 70.049999999999997 111.644 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -94.25 -71.09 0.68 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 122.447 -0.443 . . . . 74.409999999999997 110.543 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -100.84 -29.82 12.03 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.685 1.231 . . . . 74.129999999999995 107.757 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -143.98 157.69 44.18 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.117 -1.438 . . . . 74.219999999999999 107.117 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.525 ' CD ' ' HD2' ' A' ' 574' ' ' ARG . 6.8 tt0 -96.03 135.98 37.08 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 106.861 -1.533 . . . . 73.409999999999997 106.861 177.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -74.64 120.4 20.14 Favored 'General case' 0 CA--C 1.472 -2.031 0 C-N-CA 120.643 -0.423 . . . . 52.210000000000001 110.745 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.493 ' CG2' HG12 ' A' ' 573' ' ' ILE . 10.1 t -124.58 120.12 31.02 Favored 'General case' 0 N--CA 1.392 -3.325 0 N-CA-C 105.44 -2.059 . . . . 72.400000000000006 105.44 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 14.5 p -137.14 139.4 41.15 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.412 -1.699 . . . . 63.229999999999997 106.412 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 538' ' ' PRO . . . -175.88 -166.59 33.56 Favored Glycine 0 N--CA 1.397 -3.952 0 C-N-CA 117.951 -2.071 . . . . 71.239999999999995 112.828 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.7 mt-10 -123.46 114.09 19.64 Favored 'General case' 0 N--CA 1.403 -2.777 0 C-N-CA 124.364 1.066 . . . . 70.430000000000007 108.969 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.33 142.62 27.59 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.57 -0.741 . . . . 74.25 109.207 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -103.56 117.25 33.99 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.488 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 52.8 m-85 -115.94 100.17 7.79 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.281 -1.007 . . . . 72.549999999999997 108.281 173.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.661 ' H ' HD11 ' A' ' 567' ' ' ILE . 77.0 mt-30 -77.35 -87.7 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.948 -0.569 . . . . 75.230000000000004 110.502 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -105.27 164.88 11.51 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.058 -0.657 . . . . 72.430000000000007 109.881 177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 531' ' ' ALA . 3.7 p30 -56.9 -11.38 1.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.991 1.478 . . . . 74.530000000000001 114.991 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 566' ' ' GLU . 10.2 pt-20 -79.73 -14.34 58.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.089 0.774 . . . . 71.340000000000003 113.089 -175.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.661 HD11 ' H ' ' A' ' 563' ' ' GLN . 28.3 pt -114.82 169.31 5.86 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-O 121.115 0.483 . . . . 72.099999999999994 112.244 -177.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.17 160.17 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 108.42 -0.956 . . . . 63.439999999999998 108.42 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -124.02 154.9 39.2 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 111.925 0.343 . . . . 71.140000000000001 111.925 177.405 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . . . . . . . . . 73.5 mt -125.33 130.65 72.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.011 -0.995 . . . . 73.030000000000001 110.108 -176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 589' ' ' LEU . 62.1 mt -90.9 129.08 42.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 107.312 -1.366 . . . . 61.219999999999999 107.312 176.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 521' ' ' MET . 7.7 p -115.91 112.84 22.49 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 123.858 0.724 . . . . 71.439999999999998 110.132 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.493 HG12 ' CG2' ' A' ' 556' ' ' THR . 48.9 mt -116.03 130.96 69.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 C-N-CA 121.021 -0.271 . . . . 71.209999999999994 110.711 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.525 ' HD2' ' CD ' ' A' ' 554' ' ' GLU . 92.2 mtt180 -71.19 116.75 11.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.559 0.537 . . . . 74.349999999999994 109.977 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 645' ' ' ILE . 38.0 mm -101.47 135.95 35.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.752 -1.113 . . . . 75.349999999999994 109.744 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -139.17 164.05 30.81 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.313 -2.106 . . . . 74.049999999999997 105.313 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . 0.586 ' H ' ' HB3' ' A' ' 650' ' ' GLU . 2.2 p-10 -115.93 109.24 17.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.258 -2.127 . . . . 74.239999999999995 105.258 165.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 579' ' ' GLU . 9.6 tpt180 -58.64 -79.06 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.964 1.098 . . . . 75.319999999999993 113.964 -174.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 578' ' ' ARG . 43.2 tt0 169.6 106.26 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.374 -1.343 . . . . 72.340000000000003 107.374 -169.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -145.9 170.37 16.72 Favored 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 121.566 0.698 . . . . 65.019999999999996 112.782 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -145.93 122.49 11.09 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.634 -1.621 . . . . 73.040000000000006 107.442 172.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 59.1 82.18 0.15 Allowed 'General case' 0 C--O 1.249 1.031 0 C-N-CA 125.35 1.46 . . . . 72.109999999999999 113.304 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? 163.01 169.86 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.006 1.722 . . . . 74.450000000000003 109.248 173.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -113.88 116.24 28.98 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 105.58 -2.008 . . . . 74.239999999999995 105.58 173.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' A' ' 645' ' ' ILE . 5.1 p -77.41 124.7 28.23 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.988 -0.685 . . . . 41.240000000000002 110.29 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 80.4 p -134.95 150.73 50.43 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-O 121.433 0.635 . . . . 52.210000000000001 111.179 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -133.38 156.87 46.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.013 -1.477 . . . . 61.43 107.013 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . . . . . . . . . 9.4 m -112.19 153.22 27.38 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.669 -0.813 . . . . 54.340000000000003 109.024 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 540' ' ' LYS . 43.1 tp -124.96 131.51 53.41 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 106.806 -1.553 . . . . 53.109999999999999 106.806 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.05 159.32 43.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 110.071 -0.344 . . . . 72.400000000000006 110.071 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.16 145.75 27.65 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.705 0.628 . . . . 75.409999999999997 109.685 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . 0.417 ' O ' HD11 ' A' ' 635' ' ' LEU . 6.6 mm-40 -96.69 163.02 13.19 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.177 -1.045 . . . . 62.020000000000003 108.177 176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.0 122.53 72.8 Favored Pre-proline 0 C--N 1.311 -1.096 0 O-C-N 123.678 0.611 . . . . 71.420000000000002 110.383 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.559 ' HG2' ' O ' ' A' ' 633' ' ' PRO . 59.7 Cg_endo -79.2 151.17 23.24 Favored 'Trans proline' 0 N--CA 1.437 -1.804 0 C-N-CA 122.841 2.361 . . . . 74.310000000000002 113.31 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -122.11 128.7 51.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.772 -1.104 . . . . 72.430000000000007 110.38 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -84.16 116.81 23.1 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.265 -1.383 . . . . 74.5 107.265 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . 0.526 HG21 ' HG2' ' A' ' 601' ' ' MET . 45.4 mm -89.31 128.95 41.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.354 -0.98 . . . . 44.119999999999997 108.354 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -73.68 155.54 38.88 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.081 -0.711 . . . . 71.430000000000007 109.081 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 69.74 -73.46 0.09 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.843 1.257 . . . . 71.109999999999999 111.452 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . 150.37 161.62 10.04 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 120.551 -0.833 . . . . 54.520000000000003 112.386 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . 0.526 ' HG2' HG21 ' A' ' 597' ' ' ILE . 92.7 mmm -140.89 -174.01 3.87 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.695 -1.224 . . . . 71.129999999999995 107.695 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -155.94 -68.98 0.11 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.908 -1.515 . . . . 74.219999999999999 106.908 170.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 75.5 -59.97 2.86 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 116.06 -0.518 . . . . 54.43 113.889 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 108.66 -58.87 0.38 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 108.676 -1.77 . . . . 62.420000000000002 108.676 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -135.07 -171.78 2.89 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.413 -1.328 . . . . 75.400000000000006 107.413 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 37.3 m -81.39 125.09 29.97 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.666 -0.243 . . . . 72.400000000000006 110.35 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 43.8 mm -96.95 91.9 2.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 105.034 -2.21 . . . . 75.439999999999998 105.034 173.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 12.2 t -94.09 81.97 4.14 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 122.469 1.128 . . . . 72.530000000000001 112.632 -172.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.59 -28.92 14.61 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.809 -1.923 . . . . 74.409999999999997 105.809 170.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -92.66 121.43 34.06 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.78 -1.933 . . . . 54.329999999999998 105.78 170.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -105.28 -24.34 12.72 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.359 0.6 . . . . 72.430000000000007 110.709 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -139.86 -145.1 0.18 Allowed 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.592 -2.003 . . . . 63.229999999999997 105.592 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 50.27 42.77 26.11 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 122.601 1.191 . . . . 73.010000000000005 111.893 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -56.64 -74.86 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 112.976 -1.92 . . . . 52.520000000000003 113.525 -172.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . 0.54 ' HB2' ' HD3' ' A' ' 616' ' ' PRO . 75.9 mt-30 -111.49 -61.95 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 113.083 0.771 . . . . 73.340000000000003 113.083 176.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 615' ' ' GLN . 1.6 Cg_endo -82.1 148.21 15.03 Favored 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.273 1.315 . . . . 71.030000000000001 111.321 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 41.2 mt -120.65 -42.26 2.54 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.297 -1.319 . . . . 72.430000000000007 110.884 -169.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 19.0 p -103.79 -179.4 3.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.809 -0.811 . . . . 64.099999999999994 108.809 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 50.4 m -79.7 114.4 18.6 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.886 0.374 . . . . 72.340000000000003 110.01 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -93.89 131.74 39.01 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.299 -0.41 . . . . 73.319999999999993 110.218 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.12 154.03 7.19 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 124.071 0.948 . . . . 64.140000000000001 110.193 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 53.69 44.0 30.3 Favored 'General case' 0 C--O 1.245 0.831 0 O-C-N 123.972 0.795 . . . . 72.349999999999994 112.397 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.81 166.9 13.11 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 120.217 -0.593 . . . . 72.099999999999994 110.436 -176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 8.54 14.27 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.356 -0.979 . . . . 73.010000000000005 108.356 176.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -54.23 -39.18 66.52 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 114.38 -1.282 . . . . 71.030000000000001 112.718 -175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.407 ' O ' ' HB3' ' A' ' 630' ' ' MET . 21.8 tpt180 -58.59 -31.22 67.84 Favored 'General case' 0 C--O 1.211 -0.973 0 C-N-CA 122.617 0.367 . . . . 74.409999999999997 111.844 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . . . . . . . . . 75.8 mt -72.85 -29.08 28.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 121.367 0.603 . . . . 73.409999999999997 110.284 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . . . . . . . . . . . -83.85 -40.33 18.79 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.918 0.866 . . . . 73.010000000000005 109.005 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 632' ' ' ARG . 58.9 mt-10 -74.67 -6.22 47.51 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.196 -0.911 . . . . 72.430000000000007 111.516 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 626' ' ' ARG . 9.3 ptm -76.65 -13.42 60.06 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.036 -1.098 . . . . 75.030000000000001 108.036 176.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -90.64 0.88 77.84 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.28 -0.873 . . . . 75.310000000000002 111.829 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 632' ' ' ARG . 51.1 mtt180 -76.0 167.1 39.76 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 109.753 -0.462 . . . . 63.450000000000003 109.753 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.559 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 34.5 Cg_exo -67.39 121.94 9.11 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 N-CA-C 107.762 -1.669 . . . . 72.049999999999997 107.762 164.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 504' ' ' ILE . 0.2 OUTLIER -131.56 -175.98 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-O 121.626 0.727 . . . . 71.010000000000005 110.069 -175.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.453 ' HG ' ' HD3' ' A' ' 594' ' ' PRO . 22.6 mt -97.59 170.82 8.76 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 108.196 -1.039 . . . . 64.129999999999995 108.196 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -70.57 151.08 49.11 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 107.121 -2.392 . . . . 52.240000000000002 107.121 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -53.51 -42.06 66.95 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.235 0.517 . . . . 72.340000000000003 111.28 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -124.34 101.0 6.95 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.508 0.67 . . . . 73.140000000000001 110.733 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 7.5 t -136.02 109.78 8.1 Favored 'General case' 0 N--CA 1.421 -1.875 0 CA-C-O 122.243 1.02 . . . . 74.049999999999997 109.411 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -146.77 148.87 32.38 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.828 -1.175 . . . . 72.519999999999996 107.828 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . 0.415 HD22 HG11 ' A' ' 523' ' ' VAL . 56.5 tp -129.6 112.98 14.25 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 109.425 -0.583 . . . . 50.450000000000003 109.425 175.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . 0.431 ' HB2' HG22 ' A' ' 511' ' ' VAL . 46.8 mt-10 -89.24 127.98 35.8 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.636 -0.875 . . . . 72.030000000000001 108.636 173.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 38.5 t -111.61 120.68 62.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.372 0 N-CA-C 108.31 -0.996 . . . . 71.209999999999994 108.31 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 644' ' ' ILE . 3.6 mp -110.87 134.4 53.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.435 -0.802 . . . . 63.520000000000003 110.829 -176.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.439 HG21 HG23 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -128.51 164.06 31.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 124.821 1.248 . . . . 63.350000000000001 109.551 175.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 516' ' ' GLU . 45.0 mt-10 -133.42 178.93 6.54 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.899 0.38 . . . . 62.219999999999999 110.716 -174.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -72.96 122.06 21.09 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 123.969 0.908 . . . . 64.510000000000005 110.626 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 57.9 m -133.66 -91.33 0.36 Allowed 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 114.718 1.377 . . . . 51.109999999999999 114.718 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -156.81 -11.35 0.09 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 112.891 0.7 . . . . 63.439999999999998 112.891 -170.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . 0.586 ' HB3' ' H ' ' A' ' 577' ' ' ASP . 8.7 tp10 -64.16 137.84 58.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.3 1.048 . . . . 73.010000000000005 113.29 -168.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -128.58 116.16 19.2 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 105.98 -1.859 . . . . 75.239999999999995 105.98 175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 550' ' ' GLY . 5.9 tmmm? -65.19 121.12 14.03 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 108.456 -0.942 . . . . 75.019999999999996 108.456 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 19.3 m -73.85 87.97 1.79 Allowed 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.354 -0.839 . . . . 75.129999999999995 109.989 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 16.3 m -62.33 115.4 4.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.539 -1.21 . . . . 74.120000000000005 110.264 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 33.9 m -71.83 145.44 12.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 109.2 -0.667 . . . . 64.200000000000003 109.2 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 C--N 1.301 -1.522 0 CA-C-N 116.165 -0.471 . . . . 71.409999999999997 110.704 -176.081 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 121.124 0.487 . . . . 72.120000000000005 110.309 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -156.23 -64.97 0.11 Allowed 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.654 -1.61 . . . . 42.219999999999999 106.654 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . 151.35 128.66 1.49 Allowed Glycine 0 N--CA 1.42 -2.394 0 CA-C-N 114.883 -1.053 . . . . 75.209999999999994 111.548 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 65.4 mt -128.48 121.32 54.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 106.785 -1.561 . . . . 72.140000000000001 106.785 172.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 635' ' ' LEU . 56.4 m-85 -110.84 134.46 52.51 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 123.511 0.507 . . . . 73.230000000000004 110.078 -175.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 6.3 t -148.25 152.79 37.77 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 110.386 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . 0.559 ' CZ ' ' HG ' ' A' ' 591' ' ' LEU . 83.2 m-85 -74.26 159.74 32.06 Favored 'General case' 0 C--O 1.262 1.718 0 N-CA-C 108.862 -0.792 . . . . 75.109999999999999 108.862 173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.35 -51.87 57.54 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.789 0.681 . . . . 63.399999999999999 109.613 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.49 161.54 54.22 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.146 -0.934 . . . . 73.310000000000002 109.088 -177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 640' ' ' LYS . 73.2 Cg_endo -84.73 -20.8 3.59 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.613 1.542 . . . . 34.43 112.425 176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 77.7 t -141.53 134.96 30.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.654 -0.499 . . . . 74.329999999999998 109.654 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 15.3 t -133.9 138.23 45.43 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.571 -0.529 . . . . 73.310000000000002 109.571 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -111.06 119.28 38.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.875 -1.157 . . . . 74.239999999999995 107.875 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.93 170.79 16.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 120.894 0.378 . . . . 70.310000000000002 110.381 -178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 36.2 t -88.88 158.97 17.91 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.6 0.714 . . . . 34.119999999999997 111.248 -177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -8.25 59.54 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.122 -0.945 . . . . 63.039999999999999 110.195 172.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 71.2 m -113.8 19.18 16.88 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.941 -0.572 . . . . 61.210000000000001 111.248 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 7.2 tt -82.22 -26.23 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.15 -0.62 . . . . 45.119999999999997 111.189 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . 84.85 -74.24 2.52 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.588 -0.815 . . . . 64.120000000000005 111.588 -177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 574' ' ' ARG . 46.1 mm -129.92 131.17 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 108.503 -0.925 . . . . 63.109999999999999 108.503 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 17.9 ptm -107.15 145.75 32.15 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.97 -0.752 . . . . 63.109999999999999 108.97 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -106.36 129.31 54.38 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 123.374 0.421 . . . . 54.399999999999999 110.631 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.525 ' HB ' ' HB ' ' A' ' 571' ' ' ILE . 45.8 t -115.52 121.19 66.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.81 -0.811 . . . . 73.239999999999995 108.81 174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -95.59 130.0 42.6 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.236 0.541 . . . . 61.329999999999998 110.594 177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 58.6 t -96.43 115.17 35.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.152 -1.055 . . . . 74.409999999999997 108.152 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.422 ' HA ' HH21 ' A' ' 527' ' ' ARG . 79.4 mt -88.08 149.67 23.82 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.661 -0.7 . . . . 73.099999999999994 109.583 -176.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.422 HH21 ' HA ' ' A' ' 526' ' ' LEU . 0.0 OUTLIER -114.92 103.78 11.27 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.266 -1.013 . . . . 74.409999999999997 108.266 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 12.1 p -67.23 -58.11 5.45 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.519 0.676 . . . . 62.140000000000001 110.939 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 24.3 t -73.97 -23.76 59.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.324 -0.853 . . . . 74.140000000000001 110.157 177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . 0.516 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 108.88 -149.18 16.99 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 110.229 -1.149 . . . . 44.229999999999997 110.229 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -160.16 135.79 8.31 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.185 -1.413 . . . . 75.030000000000001 107.185 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -136.35 121.47 18.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.261 -0.644 . . . . 73.400000000000006 109.261 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 97.44 -121.99 7.29 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.798 -0.715 . . . . 43.340000000000003 113.038 174.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -137.75 104.89 5.43 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.028 -1.101 . . . . 65.120000000000005 108.028 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.88 126.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.619 0.723 . . . . 54.210000000000001 110.634 -176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 559' ' ' GLU . 29.8 mm -95.78 118.01 41.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.349 -0.842 . . . . 70.510000000000005 109.468 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.7 t -107.65 103.72 50.23 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 115.295 -0.866 . . . . 71.420000000000002 108.792 -178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 1.0 OUTLIER -78.16 156.67 29.92 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 121.424 1.416 . . . . 65.340000000000003 111.082 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -143.01 161.0 39.28 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.384 -1.339 . . . . 73.319999999999993 107.384 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -156.17 135.07 11.89 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.951 0.405 . . . . 74.530000000000001 111.14 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 12.6 p -82.92 122.96 28.95 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.661 -0.699 . . . . 71.519999999999996 110.378 178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 588' ' ' SER . 37.0 mm -92.71 125.08 45.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 107.764 -1.199 . . . . 75.120000000000005 107.764 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.58 113.11 13.84 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.922 0.392 . . . . 73.140000000000001 111.242 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . -92.4 -103.47 1.49 Allowed Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 110.433 -1.067 . . . . 41.43 110.433 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 17.6 p -94.1 -18.01 22.23 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.616 0.722 . . . . 73.239999999999995 109.69 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.01 149.1 24.21 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.392 -0.822 . . . . 75.530000000000001 108.924 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 551' ' ' GLU . 45.0 ttt180 -101.84 134.83 44.4 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-O 121.11 0.481 . . . . 71.219999999999999 112.055 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -87.96 -179.75 47.26 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.476 -0.783 . . . . 41.229999999999997 111.367 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.87 57.62 Favored Glycine 0 C--N 1.306 -1.125 0 N-CA-C 110.594 -1.002 . . . . 54.530000000000001 110.594 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 88.33 19.95 50.65 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 111.491 -0.644 . . . . 71.140000000000001 111.491 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 547' ' ' ARG . 15.7 mm-40 -80.08 -80.1 0.14 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.361 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.79 -32.18 16.21 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 108.825 -0.805 . . . . 72.120000000000005 108.825 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -143.94 152.8 41.57 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.02 -1.104 . . . . 75.439999999999998 108.02 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.584 ' CB ' ' HB3' ' A' ' 574' ' ' ARG . 23.3 tt0 -87.89 105.08 17.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.681 -2.34 . . . . 75.109999999999999 104.681 176.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -65.32 144.96 56.78 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 124.024 0.828 . . . . 62.240000000000002 109.725 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.8 t -140.06 114.06 8.93 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-O 122.046 0.927 . . . . 72.129999999999995 110.885 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.2 p -125.15 118.54 26.31 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-N 114.212 -1.358 . . . . 52.409999999999997 107.373 173.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -161.16 -164.17 15.54 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 110.668 -0.973 . . . . 75.510000000000005 110.668 -174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.502 ' HB2' HG23 ' A' ' 536' ' ' ILE . 8.0 pt-20 -132.84 139.18 47.33 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.334 0.588 . . . . 70.439999999999998 111.866 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 88.8 mt -106.97 144.71 33.2 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.48 -1.236 . . . . 64.540000000000006 108.692 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -109.73 104.21 13.15 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.208 0.528 . . . . 74.540000000000006 111.052 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 59.7 m-85 -98.71 120.0 38.41 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.27 -1.011 . . . . 53.210000000000001 108.27 176.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.491 ' H ' HD11 ' A' ' 567' ' ' ILE . 49.6 mt-30 -98.21 -80.18 0.46 Allowed 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 108.734 -0.839 . . . . 63.100000000000001 108.734 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -105.33 155.17 19.35 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.966 -0.561 . . . . 63.210000000000001 110.131 175.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -46.51 -29.16 1.64 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.171 1.788 . . . . 72.430000000000007 114.213 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.475 ' HG3' HG23 ' A' ' 567' ' ' ILE . 13.8 pt-20 -64.62 -14.14 56.64 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.95 1.093 . . . . 61.329999999999998 113.95 -175.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.491 HD11 ' H ' ' A' ' 563' ' ' GLN . 37.2 pt -112.76 156.46 13.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 119.706 -0.798 . . . . 74.439999999999998 110.283 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.65 144.32 37.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.692 -0.855 . . . . 72.439999999999998 108.692 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.655 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.4 mmpt? -111.36 149.57 30.97 Favored 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 120.404 -0.519 . . . . 73.129999999999995 109.662 176.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 570' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 73.3 mt -126.05 131.45 71.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.481 -1.236 . . . . 75.549999999999997 110.595 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 523' ' ' VAL . 41.6 mt -92.87 123.75 45.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.321 -1.362 . . . . 75.340000000000003 107.321 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 19.5 p -108.29 114.27 28.0 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 123.466 0.479 . . . . 72.420000000000002 109.814 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 589' ' ' LEU . 36.6 mt -110.01 135.03 50.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.554 -0.535 . . . . 62.409999999999997 109.554 -177.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' ARG . . . . . 0.584 ' HB3' ' CB ' ' A' ' 554' ' ' GLU . 71.3 ttt180 -92.21 123.82 35.83 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.263 -0.643 . . . . 74.340000000000003 109.263 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.2 134.22 46.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.313 -0.625 . . . . 74.310000000000002 109.313 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 554' ' ' GLU . 83.1 m-85 -114.22 162.6 16.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.251 -0.648 . . . . 65.219999999999999 109.251 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -104.33 112.0 24.86 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.025 -0.534 . . . . 73.030000000000001 111.124 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -142.63 -43.75 0.31 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.027 -0.533 . . . . 71.209999999999994 110.619 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -81.11 145.04 31.27 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.408 -0.589 . . . . 75.150000000000006 109.408 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -90.16 177.56 6.4 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.286 -0.635 . . . . 72.340000000000003 109.286 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -57.85 -20.39 36.0 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.328 1.051 . . . . 62.140000000000001 110.417 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -55.67 -45.02 77.82 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.504 1.922 . . . . 64.420000000000002 112.714 -173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -125.79 137.38 53.79 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.177 -0.675 . . . . 64.310000000000002 109.177 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -78.85 96.67 5.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.864 0.84 . . . . 74.25 111.109 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' CYS . . . . . 0.424 ' SG ' HG12 ' A' ' 645' ' ' ILE . 3.5 p -74.06 115.89 14.05 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.455 -0.793 . . . . 71.230000000000004 109.166 174.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 15.0 m -138.26 148.55 44.82 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.23 -0.656 . . . . 73.400000000000006 109.23 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.1 166.25 25.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.855 -1.165 . . . . 71.540000000000006 107.855 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' SER . . . . . 0.412 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 26.5 m -116.29 166.86 11.56 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 119.935 -0.706 . . . . 64.430000000000007 109.686 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 573' ' ' ILE . 31.8 tp -139.58 127.8 22.57 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 107.591 -1.263 . . . . 64.299999999999997 107.591 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.36 157.31 36.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 N-CA-C 109.614 -0.513 . . . . 75.329999999999998 109.614 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' LEU . . . . . 0.559 ' HG ' ' CZ ' ' A' ' 507' ' ' PHE . 45.2 mt -95.34 147.23 23.73 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.114 -1.81 . . . . 55.509999999999998 106.114 175.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . 0.484 ' HG3' ' H ' ' A' ' 593' ' ' GLU . 6.8 tp10 -98.43 177.67 5.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 106.857 -1.535 . . . . 71.310000000000002 106.857 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.484 ' H ' ' HG3' ' A' ' 592' ' ' GLU . 37.6 mt-10 -75.16 119.78 78.54 Favored Pre-proline 0 C--N 1.288 -2.105 0 CA-C-N 116.341 -0.39 . . . . 72.219999999999999 110.638 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.454 ' HD3' HD22 ' A' ' 635' ' ' LEU . 77.3 Cg_endo -72.41 146.14 44.22 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.351 2.701 . . . . 74.200000000000003 113.703 -174.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -110.31 149.28 30.42 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.442 -0.947 . . . . 74.319999999999993 108.442 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -107.14 127.88 53.9 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.673 -1.232 . . . . 75.400000000000006 107.673 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 597' ' ' ILE . 1.9 mp -94.39 90.12 2.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 122.229 1.014 . . . . 71.450000000000003 108.717 178.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -74.62 108.57 7.46 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 113.343 -1.753 . . . . 74.530000000000001 107.706 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -78.26 79.07 4.72 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.06 0.933 . . . . 74.519999999999996 109.962 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' GLY . . . . . . . . . . . . . . . -179.96 34.63 0.07 OUTLIER Glycine 0 C--N 1.286 -2.234 0 N-CA-C 106.752 -2.539 . . . . 60.210000000000001 106.752 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' MET . . . . . . . . . . . . . 27.3 ttt -172.07 89.53 0.1 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.731 1.612 . . . . 74.409999999999997 106.909 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 602' ' ' LYS . 0.4 OUTLIER -74.04 131.87 41.79 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.872 -0.604 . . . . 33.130000000000003 112.367 -177.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . 86.99 -107.29 3.23 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.771 -0.728 . . . . 72.25 111.45 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 86.84 22.17 47.22 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.196 -1.162 . . . . 30.149999999999999 110.196 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' PHE . . . . . . . . . . . . . 31.3 t80 62.22 82.17 0.18 Allowed 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.223 1.409 . . . . 52.399999999999999 109.804 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' THR . . . . . . . . . . . . . 48.2 m -79.4 123.61 27.67 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.905 -1.043 . . . . 73.450000000000003 110.921 -176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' ILE . . . . . . . . . . . . . 47.6 mm -89.12 -29.34 5.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.514 -0.766 . . . . 72.200000000000003 110.014 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' THR . . . . . . . . . . . . . 11.9 m -70.73 80.91 0.61 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 115.547 1.684 . . . . 35.539999999999999 115.547 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.61 6.58 2.28 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 123.599 1.666 . . . . 73.230000000000004 107.026 165.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -157.36 142.05 16.66 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 100.878 -3.749 . . . . 74.420000000000002 100.878 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -91.7 -76.84 0.44 Allowed 'General case' 0 N--CA 1.409 -2.495 0 CA-C-N 118.775 0.716 . . . . 62.409999999999997 111.396 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' ASP . . . . . 0.417 ' OD2' ' HA ' ' A' ' 616' ' ' PRO . 6.7 t70 -159.1 -164.3 1.38 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.79 -1.189 . . . . 72.230000000000004 107.79 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.472 ' OD1' ' HG2' ' A' ' 614' ' ' LYS . 13.0 t70 -133.24 -49.04 0.85 Allowed 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.316 -1.364 . . . . 64.530000000000001 107.316 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' LYS . . . . . 0.525 ' HG3' ' OE1' ' A' ' 615' ' ' GLN . 14.9 pttm 167.12 -23.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.394 2.677 . . . . 62.140000000000001 107.561 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' GLN . . . . . 0.525 ' OE1' ' HG3' ' A' ' 614' ' ' LYS . 26.1 mp0 -126.52 135.96 27.99 Favored Pre-proline 0 C--O 1.246 0.907 0 N-CA-C 106.011 -1.848 . . . . 71.439999999999998 106.011 169.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.417 ' HA ' ' OD2' ' A' ' 612' ' ' ASP . 35.9 Cg_exo -57.16 150.0 60.01 Favored 'Trans proline' 0 N--CA 1.481 0.784 0 C-N-CA 123.177 2.585 . . . . 70.129999999999995 114.638 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -101.47 8.13 42.19 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.551 -0.749 . . . . 71.200000000000003 110.097 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' THR . . . . . . . . . . . . . 17.3 p -81.13 -63.68 1.35 Allowed 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.493 -0.776 . . . . 73.540000000000006 109.804 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 30.7 m 54.52 34.62 21.53 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.995 0.918 . . . . 71.030000000000001 110.028 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 622' ' ' GLU . 17.9 tppt? -96.0 107.6 19.9 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.354 -0.839 . . . . 74.019999999999996 112.634 -172.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -89.39 86.45 6.8 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.921 -1.14 . . . . 60.439999999999998 107.921 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 625' ' ' ARG . 44.2 tt0 -86.78 149.22 25.01 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.193 -1.367 . . . . 73.340000000000003 109.428 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.54 135.07 50.99 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 116.075 -0.511 . . . . 74.519999999999996 111.555 -176.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 64.35 25.83 13.5 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.009 1.324 . . . . 71.209999999999994 112.658 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . 0.663 ' O ' ' HG2' ' A' ' 629' ' ' GLU . 2.0 mmt180 -60.41 -40.8 92.29 Favored 'General case' 0 C--O 1.195 -1.796 0 N-CA-C 114.552 1.316 . . . . 54.299999999999997 114.552 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.607 ' O ' ' HG3' ' A' ' 630' ' ' MET . 14.4 mmm180 -63.99 -46.13 85.93 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 118.62 0.645 . . . . 64.340000000000003 109.397 -178.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' ILE . . . . . 0.442 ' HA ' ' SD ' ' A' ' 630' ' ' MET . 79.4 mt -64.91 -36.53 77.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.057 -0.974 . . . . 65.450000000000003 109.631 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' ALA . . . . . 0.564 ' O ' ' HG3' ' A' ' 632' ' ' ARG . . . -57.07 -52.12 66.56 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.692 -0.686 . . . . 74.049999999999997 109.953 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 625' ' ' ARG . 31.5 mm-40 -61.51 -30.51 70.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.51 -0.768 . . . . 52.25 111.893 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 60.8 mtt -63.1 -26.27 68.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.389 -0.823 . . . . 60.210000000000001 110.872 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.43 27.94 11.66 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 111.491 -0.644 . . . . 42.32 111.491 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' ARG . . . . . 0.564 ' HG3' ' O ' ' A' ' 628' ' ' ALA . 85.8 mtt180 -116.76 163.62 21.82 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 109.681 -0.488 . . . . 61.439999999999998 109.681 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 632' ' ' ARG . 25.2 Cg_endo -63.85 150.4 88.49 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.675 1.583 . . . . 73.109999999999999 109.833 175.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' ILE . . . . . . . . . . . . . 19.9 pt -126.85 -177.25 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.966 -0.561 . . . . 63.130000000000003 110.326 -173.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' LEU . . . . . 0.454 HD22 ' HD3' ' A' ' 594' ' ' PRO . 1.9 pt? -134.56 -171.87 2.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 109.321 -0.622 . . . . 64.129999999999995 109.321 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' GLY . . . . . . . . . . . . . . . -63.66 156.52 43.0 Favored Glycine 0 N--CA 1.438 -1.197 0 C-N-CA 121.026 -0.607 . . . . 51.049999999999997 111.822 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -58.39 -57.2 13.97 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 124.29 1.036 . . . . 74.200000000000003 110.025 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.4 98.8 4.63 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.733 -0.84 . . . . 71.310000000000002 108.733 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' THR . . . . . . . . . . . . . 14.6 t -130.94 110.45 11.27 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-O 122.625 1.202 . . . . 75.540000000000006 110.465 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 39.5 ttpt -147.61 141.06 25.37 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 106.924 -1.51 . . . . 72.140000000000001 106.924 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' LEU . . . . . . . . . . . . . 63.2 tp -117.18 110.0 17.6 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.878 -0.786 . . . . 74.329999999999998 108.878 177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.36 123.9 32.81 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.648 -0.871 . . . . 74.129999999999995 108.648 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.4 121.37 61.32 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.148 -0.933 . . . . 71.5 109.373 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' ILE . . . . . . . . . . . . . 4.6 mp -114.61 128.43 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.374 0 CA-C-N 115.191 -0.913 . . . . 62.229999999999997 109.534 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.424 HG12 ' SG ' ' A' ' 585' ' ' CYS . 0.0 OUTLIER -117.83 127.27 75.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.25 -0.886 . . . . 75.239999999999995 110.066 179.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.18 156.66 45.9 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.281 -1.378 . . . . 63.329999999999998 107.281 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -55.96 111.36 0.92 Allowed 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 124.116 0.885 . . . . 73.430000000000007 110.616 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 15.2 m -105.71 96.22 6.34 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 109.457 -0.571 . . . . 73.439999999999998 109.457 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -76.95 -37.92 54.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.196 -1.409 . . . . 73.310000000000002 107.196 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -88.63 84.07 6.74 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 106.945 -1.502 . . . . 74.329999999999998 106.945 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -81.43 120.46 25.01 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 107.468 -1.308 . . . . 73.409999999999997 107.468 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -78.68 142.23 37.31 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.877 -0.601 . . . . 70.409999999999997 112.446 -170.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' SER . . . . . . . . . . . . . 12.9 m -85.72 107.51 17.62 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.596 -0.729 . . . . 72.150000000000006 109.607 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 15.1 t -86.97 -21.59 26.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.514 0.673 . . . . 74.430000000000007 110.13 -178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . . . . . . . . . 47.6 t -91.5 93.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.381 -0.97 . . . . 75.019999999999996 108.381 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 C--N 1.308 -1.209 0 N-CA-C 109.717 -0.475 . . . . 74.230000000000004 109.717 -179.527 . . . . . . . . 0 0 . 1 stop_ save_